PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Raichaudhuri, A; Peng, MS; Naponelli, V; Chen, S; Sanchez-Fernandez, R; Gu, HL; Gregory, JF; Hanson, AD; Rea, PA				Raichaudhuri, Ayan; Peng, Mingsheng; Naponelli, Valeria; Chen, Sixue; Sanchez-Fernandez, Rocio; Gu, Honglan; Gregory, Jesse F., III; Hanson, Andrew D.; Rea, Philip A.			Plant Vacuolar ATP-binding Cassette Transporters That Translocate Folates and Antifolates in Vitro and Contribute to Antifolate Tolerance in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANCE-ASSOCIATED PROTEIN; ABC TRANSPORTERS; FOLYLPOLYGLUTAMATE SYNTHETASE; ARABIDOPSIS; MEMBRANE; CELLS; POLYGLUTAMATES; DETOXIFICATION; CHLOROPHYLL; ATMRP2	The vacuoles of pea (Pisum sativum) leaves and red beet ( Beta vulgaris) storage root are major sites for the intracellular compartmentation of folates. In the light of these findings and preliminary experiments indicating that some plant multidrug resistance-associated protein (MRP) subfamily ATP-binding cassette transporters are able to transport compounds of this type, the Arabidopsis thaliana vacuolar MRP, AtMRP1(AtABCC1), and its functional equivalent(s) in vacuolar membrane vesicles purified from red beet storage root were studied. In so doing, it has been determined that heterologously expressed AtMRP1 and its equivalents in red beet vacuolar membranes are not only competent in the transport of glutathione conjugates but also folate monoglutamates and antifolates as exemplified by pteroyl-L-glutamicacid and methotrexate (MTX), respectively. In agreement with the results of these in vitro transport measurements, analyses of atmrp1 T-DNA insertion mutants of Arabidopsis ecotypes Wassilewskia and Columbia disclose an MTX-hypersensitive phenotype. atmrp1 knock-out mutants are more sensitive than wild-type plants to growth retardation by nanomolar concentrations of MTX, and this is associated with impaired vacuolar antifolate sequestration. The vacuoles of protoplasts isolated from the leaves of Wassilewskia atmrp1 mutants accumulate 50% less [H-3] MTX than the vacuoles of protoplasts from wild-type plants when incubated in media containing nanomolar concentrations of this antifolate, and vacuolar membrane-enriched vesicles purified from the mutant catalyze MgATP-dependent [H-3] MTX uptake at only 40% of the capacity of the equivalent membrane fraction from wild-type plants. AtMRP1 and its counterparts in other plant species therefore have the potential for participating in the vacuolar accumulation of folates and related compounds.	[Rea, Philip A.] Univ Penn, Inst Plant Sci, Dept Biol, Carolyn Hoff Lynch Biol Lab, Philadelphia, PA 19104 USA; [Naponelli, Valeria; Gregory, Jesse F., III] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA; [Hanson, Andrew D.] Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA	University of Pennsylvania; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Rea, PA (corresponding author), Univ Penn, Inst Plant Sci, Dept Biol, Carolyn Hoff Lynch Biol Lab, 433 S Univ Ave, Philadelphia, PA 19104 USA.	parea@sas.upenn.edu		naponelli, valeria/0000-0001-5210-1522; Gregory, Jesse/0000-0002-9976-2085	United States Department of Energy [DE-FG02-91ER20055]; National Institutes of Health [RO1 GM071382]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071382] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States Department of Energy Grant DE-FG02-91ER20055 ( to P. A. R.) and in part by National Institutes of Health Grant RO1 GM071382 ( to A. D. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BARRUECO JR, 1992, J BIOL CHEM, V267, P15356; Bartholomew DM, 2002, PLANT PHYSIOL, V130, P1562, DOI 10.1104/pp.008334; Bedhomme M, 2005, J BIOL CHEM, V280, P34823, DOI 10.1074/jbc.M506045200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen SX, 2000, J BIOL CHEM, V275, P22955, DOI 10.1074/jbc.M002768200; Coleman JOD, 1997, TRENDS PLANT SCI, V2, P144, DOI 10.1016/S1360-1385(97)01019-4; Dean JV, 2004, PHYSIOL PLANTARUM, V120, P603, DOI 10.1111/j.0031-9317.2004.0263.x; Dunkley TPJ, 2006, P NATL ACAD SCI USA, V103, P6518, DOI 10.1073/pnas.0506958103; Farre EM, 2001, PLANT PHYSIOL, V127, P685, DOI 10.1104/pp.127.2.685; FELDMANN KA, 1991, PLANT J, V1, P71, DOI 10.1111/j.1365-313X.1991.00071.x; Frelet-Barrand A, 2008, PLANT CELL PHYSIOL, V49, P557, DOI 10.1093/pcp/pcn034; Geisler M, 2004, MOL BIOL CELL, V15, P3393, DOI 10.1091/mbc.E03-11-0831; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Goyer A, 2005, J BIOL CHEM, V280, P26137, DOI 10.1074/jbc.M503106200; Hanson AD, 2002, CURR OPIN PLANT BIOL, V5, P244, DOI 10.1016/S1369-5266(02)00249-2; Ilias A, 2002, J BIOL CHEM, V277, P16860, DOI 10.1074/jbc.M110918200; Ishikawa T, 1997, BIOSCIENCE REP, V17, P189, DOI 10.1023/A:1027385513483; KIM EJ, 1995, J BIOL CHEM, V270, P2630, DOI 10.1074/jbc.270.6.2630; Klaus SMJ, 2005, J BIOL CHEM, V280, P38457, DOI 10.1074/jbc.M507432200; Klein M, 2004, PLANT J, V39, P219, DOI 10.1111/j.1365-313X.2004.02125.x; Kreuz K, 1996, PLANT PHYSIOL, V111, P349, DOI 10.1104/pp.111.2.349; Kruh GD, 2001, J BIOENERG BIOMEMBR, V33, P493, DOI 10.1023/A:1012827221844; LI ZS, 1995, PLANT PHYSIOL, V107, P1257, DOI 10.1104/pp.107.4.1257; Liu GS, 2001, J BIOL CHEM, V276, P8648, DOI 10.1074/jbc.M009690200; Lu YP, 1998, PLANT CELL, V10, P267, DOI 10.1105/tpc.10.2.267; Lu YP, 1997, P NATL ACAD SCI USA, V94, P8243, DOI 10.1073/pnas.94.15.8243; *MAFF ROYAL SOC CH, 1991, MCCAN WIDD COMP FOOD, P237; MARTINOIA E, 1993, NATURE, V364, P247, DOI 10.1038/364247a0; Musgrave ME, 1998, ANN BOT-LONDON, V81, P503, DOI 10.1006/anbo.1998.0585; Naponelli V, 2007, ANAL BIOCHEM, V371, P127, DOI 10.1016/j.ab.2007.08.026; Orsomando G, 2005, J BIOL CHEM, V280, P28877, DOI 10.1074/jbc.M504306200; POOLE RJ, 1985, BIOCH FUNCTION ADENO, P114; Ravanel S, 2001, P NATL ACAD SCI USA, V98, P15360, DOI 10.1073/pnas.261585098; Rea P.A., 1990, METHODS PLANT BIOCH, V3, P385, DOI DOI 10.1016/B978-0-12-461013-2.50035-6; Rea PA, 1998, ANNU REV PLANT PHYS, V49, P727, DOI 10.1146/annurev.arplant.49.1.727; REA PA, 2003, ABC TRANSPORTERS BAC, P355; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; SAUNDERS JA, 1978, PLANT PHYSIOL, V61, P154, DOI 10.1104/pp.61.2.154; Sirotnak FM, 1999, ANNU REV NUTR, V19, P91, DOI 10.1146/annurev.nutr.19.1.91; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; SZCZYPKA MS, 1994, J BIOL CHEM, V269, P22853; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; WILKINS TA, 1990, PLANT CELL, V2, P301, DOI 10.1105/tpc.2.4.301; WINTER H, 1994, PLANTA, V193, P530, DOI 10.1007/BF02411558; Zeng H, 2001, CANCER RES, V61, P7225; Zeng H, 2000, CANCER RES, V60, P4779	46	42	44	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8449	8460		10.1074/jbc.M808632200	http://dx.doi.org/10.1074/jbc.M808632200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19136566	Green Published, hybrid			2022-12-25	WOS:000264397800029
J	Tsuboi, S; Takada, H; Hara, T; Mochizuki, N; Funyu, T; Saitoh, H; Terayama, Y; Yamaya, K; Ohyama, C; Nonoyama, S; Ochs, HD				Tsuboi, Shigeru; Takada, Hidetoshi; Hara, Toshiro; Mochizuki, Naoki; Funyu, Tomihisa; Saitoh, Hisao; Terayama, Yuriko; Yamaya, Kanemitsu; Ohyama, Chikara; Nonoyama, Shigeaki; Ochs, Hans D.			FBP17 Mediates a Common Molecular Step in the Formation of Podosomes and Phagocytic Cups in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WISKOTT-ALDRICH-SYNDROME; PLASMA-MEMBRANE INVAGINATION; SYNDROME PROTEIN WASP; ACTIN CYTOSKELETON; REGULATES PODOSOMES; DIFFERENTIAL ROLE; CELL-ADHESION; RHO GTPASES; DYNAMIN; WIP	Macrophages act to protect the body against inflammation and infection by engaging in chemotaxis and phagocytosis. In chemotaxis, macrophages use an actin-based membrane structure, the podosome, to migrate to inflamed tissues. In phagocytosis, macrophages form another type of actin-based membrane structure, the phagocytic cup, to ingest foreign materials such as bacteria. The formation of these membrane structures is severely affected in macrophages from patients with Wiskott-Aldrich syndrome (WAS), an X chromosome-linked immunodeficiency disorder. WAS patients lack WAS protein (WASP), suggesting that WASP is required for the formation of podosomes and phagocytic cups. Here we have demonstrated that formin-binding protein 17 (FBP17) recruits WASP, WASP-interacting protein (WIP), and dynamin-2 to the plasma membrane and that this recruitment is necessary for the formation of podosomes and phagocytic cups. The N-terminal EFC (extended FER-CIP4 homology)/F-BAR (FER-CIP4 homology and Bin-amphiphysin-Rvs) domain of FBP17 was previously shown to have membrane binding and deformation activities. Our results suggest that FBP17 facilitates membrane deformation and actin polymerization to occur simultaneously at the same membrane sites, which mediates a common molecular step in the formation of podosomes and phagocytic cups. These results provide a potential mechanism underlying the recurrent infections in WAS patients.	Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [Takada, Hidetoshi; Hara, Toshiro] Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Fukuoka 8128582, Japan; [Mochizuki, Naoki] Res Inst, Natl Cardiovasc Ctr, Dept Struct Anal, Osaka 5658565, Japan; [Tsuboi, Shigeru] Oyokyo Kidney Res Inst, Dept Biochem, Hirosaki, Aomori 0368243, Japan; [Ohyama, Chikara] Hirosaki Univ, Sch Med, Dept Urol, Hirosaki, Aomori 0368562, Japan; [Nonoyama, Shigeaki] Natl Def Med Coll, Dept Pediat, Saitama 3590042, Japan; [Ochs, Hans D.] Seattle Childrens Hosp, Res Inst, Res Ctr Immun & Immunotherapy, Dept Pediat, Seattle, WA 98101 USA	Sanford Burnham Prebys Medical Discovery Institute; Kyushu University; National Cerebral & Cardiovascular Center - Japan; Hirosaki University; National Defense Medical College - Japan; Seattle Children's Hospital	Tsuboi, S (corresponding author), Oyokyo Kidney Res Inst, Dept Biochem, 90 Yamazaki, Hirosaki, Aomori 0368243, Japan.	tsuboi@oyokyo.jp			National Institutes of Health [R01HD042752]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HD042752 ( to S. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALDRICH RA, 1954, PEDIATRICS, V13, P133; Anton IM, 2002, IMMUNITY, V16, P193, DOI 10.1016/S1074-7613(02)00268-6; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Bruzzaniti A, 2005, MOL BIOL CELL, V16, P3301, DOI 10.1091/mbc.e04-12-1117; Calle Y, 2008, J MICROSC-OXFORD, V231, P494, DOI 10.1111/j.1365-2818.2008.02062.x; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Chan DC, 1996, EMBO J, V15, P1045, DOI 10.1002/j.1460-2075.1996.tb00442.x; Chellaiah MA, 2005, J BIOL CHEM, V280, P32930, DOI 10.1074/jbc.M500154200; Chou HC, 2006, CURR BIOL, V16, P2337, DOI 10.1016/j.cub.2006.10.037; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Dewitt S, 2006, J CELL SCI, V119, P443, DOI 10.1242/jcs.02756; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Imai K, 2004, BLOOD, V103, P456, DOI 10.1182/blood-2003-05-1480; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Jin YZ, 2004, BLOOD, V104, P4010, DOI 10.1182/blood-2003-05-1592; Kakimoto T, 2006, J BIOL CHEM, V281, P29042, DOI 10.1074/jbc.M604025200; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Kato M, 2007, J IMMUNOL, V179, P6052, DOI 10.4049/jimmunol.179.9.6052; Leverrier Y, 2001, CURR BIOL, V11, P195, DOI 10.1016/S0960-9822(01)00047-1; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Lorenzi R, 2000, BLOOD, V95, P2943, DOI 10.1182/blood.V95.9.2943.009k17_2943_2946; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; McNiven MA, 2004, FRONT BIOSCI-LANDMRK, V9, P1944, DOI 10.2741/1348; Notarangelo LD, 2008, CURR OPIN HEMATOL, V15, P30, DOI 10.1097/MOH.0b013e3282f30448; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Ramesh N, 1997, P NATL ACAD SCI USA, V94, P14671, DOI 10.1073/pnas.94.26.14671; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Takayama S, 1998, CANCER RES, V58, P3116; Tse SML, 2003, J BIOL CHEM, V278, P3331, DOI 10.1074/jbc.M207966200; Tsuboi S, 2006, EMBO REP, V7, P506, DOI 10.1038/sj.embor.7400665; Tsuboi S, 2007, J BIOL CHEM, V282, P34194, DOI 10.1074/jbc.M705999200; Tsuboi S, 2007, J IMMUNOL, V178, P2987, DOI 10.4049/jimmunol.178.5.2987; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; WISKOTT A, 1937, MONATSSCHR KINDERH, V68, P212	42	51	52	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8548	8556		10.1074/jbc.M805638200	http://dx.doi.org/10.1074/jbc.M805638200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19155218	Green Published, hybrid			2022-12-25	WOS:000264397800039
J	Zhu, QS; Azimov, R; Kao, LY; Newman, D; Liu, WX; Abuladze, N; Pushkin, A; Kurtz, I				Zhu, Quansheng; Azimov, Rustam; Kao, Liyo; Newman, Debra; Liu, Weixin; Abuladze, Natalia; Pushkin, Alexander; Kurtz, Ira			NBCe1-A Transmembrane Segment 1 Lines the Ion Translocation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BICARBONATE COTRANSPORTER PNBC1; MOLECULAR-BASIS; SCANNING MUTAGENESIS; CRYSTAL-STRUCTURE; CHANNEL; IDENTIFICATION; TOPOLOGY; RESIDUES; BAND-3; STOICHIOMETRY	The electrogenic Na+/HCO3- cotransporter (NBCe1-A) transports sodium and bicarbonate across the basolateral membrane of the renal proximal tubule. In this study the structural requirement of transmembrane segment 1 (TM1) residues in mediating NBCe1-A transport was investigated. Twenty-five introduced cysteine mutants at positions Gln-424 to Gly-448 were tested for their sensitivity to the methanethiosulfonate reagents (2-sulfonatoethyl) methanethiosulfonate (MTSES), [2-(trimethylammonium)ethyl] methanethiosulfonate (MTSET), and (2-aminoethyl) methanethiosulfonate (MTSEA). Two mutants, T442C and A435C, showed 100 and 70% sensitivity, respectively, to inhibition by all the three methanethiosulfonate (MTS) reagents, I441C had >50% sensitivity to MTSET and MTSEA, and A428C had 50% sensitivity to MTSEA inhibition. A helical wheel plot showed that mutants T442C, A435C, and A428C are clustered on one face of TM1 within a 100 arc. Topology analysis of TM1 with biotin maleimide and 2-((5(6)tetramethylrhodamine) carboxylamino) ethyl methanethiosulfonate (MTS-TAMRA) revealed Thr-442 marks the C-terminal end of TM1 and that extracellular FGGLLG stretch is in a small aqueous-accessible cavity. Functional studies indicated that Thr-442 resides in a narrow region of the ion translocation pore with strong delta(-) helical dipole influence. Analysis of the corresponding residue of NBCe1-A-Thr-442 in AE1 (Thr-422) shows it is functionally insensitive to MTSES and unlabeled with MTS-TAMRA, indicating that AE1-TM1 is oriented differently from NBCe1-A. In summary, we have identified residues Thr-442, Ala-435, and Ala-428 in TM1 lining the ion translocation pore of NBCe1-A. Our findings are suggestive of delta(-) helical dipole at the C-terminal end of TM1 involving Thr-442 that plays a critical role in the function of the cotransporter.	[Zhu, Quansheng; Azimov, Rustam; Kao, Liyo; Newman, Debra; Liu, Weixin; Abuladze, Natalia; Pushkin, Alexander; Kurtz, Ira] Univ Calif Los Angeles, Div Nephrol, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kurtz, I (corresponding author), Univ Calif Los Angeles, Div Nephrol, David Geffen Sch Med, 10833 Le Conte Ave,Rm 7-155 Factor Bldg, Los Angeles, CA 90095 USA.	ikurtz@mednet.ucla.edu			National Institutes of Health [DK077162, DK058563, DK063125, ES12935]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077162, R01DK063125, R01DK058563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077162, DK058563, DK063125, and ES12935. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abuladze N, 2005, J PHYSIOL-LONDON, V565, P717, DOI 10.1113/jphysiol.2005.084988; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Azimov R, 2007, FASEB J, V21, pA1283; Bok D, 2001, AM J PHYSIOL-RENAL, V281, pF920, DOI 10.1152/ajprenal.2001.281.5.F920; Boron WF, 2006, J AM SOC NEPHROL, V17, P2368, DOI 10.1681/ASN.2006060620; Cheung JC, 2005, BIOCHEM J, V390, P137, DOI 10.1042/BJ20050315; Cheung M, 1996, BIOPHYS J, V70, P2688, DOI 10.1016/S0006-3495(96)79838-7; Choi I, 2007, J PHYSIOL-LONDON, V578, P131, DOI 10.1113/jphysiol.2006.114959; Dinour D, 2004, J BIOL CHEM, V279, P52238, DOI 10.1074/jbc.M406591200; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Frillingos S, 1998, FASEB J, V12, P1281, DOI 10.1096/fasebj.12.13.1281; Gross E, 2001, J PHYSIOL-LONDON, V537, P659; Gross E, 2001, J PHYSIOL-LONDON, V531, P375, DOI 10.1111/j.1469-7793.2001.0375i.x; GROVES JD, 1993, FEBS LETT, V330, P186, DOI 10.1016/0014-5793(93)80270-5; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; JAROLIM P, 1991, P NATL ACAD SCI USA, V88, P11022, DOI 10.1073/pnas.88.24.11022; Kao LY, 2008, J BIOL CHEM, V283, P26782, DOI 10.1074/jbc.M804006200; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kuma H, 2002, BIOCHEMISTRY-US, V41, P3311, DOI 10.1021/bi011678+; KURTZ I, 1987, J CLIN INVEST, V80, P928, DOI 10.1172/JCI113184; LODISH H, 2000, MOL CELL BIOL, P702; McAlear SD, 2006, J BIOL CHEM, V281, P32417, DOI 10.1074/jbc.M607253200; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; Tang XB, 1999, J BIOL CHEM, V274, P3557, DOI 10.1074/jbc.274.6.3557; Tatishchev S, 2003, BIOCHEMISTRY-US, V42, P755, DOI 10.1021/bi026826q; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhu QS, 2004, J BIOL CHEM, V279, P23565, DOI 10.1074/jbc.M401380200; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200; Zhu QS, 2007, METHODS, V41, P439, DOI 10.1016/j.ymeth.2006.08.004	31	27	28	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8909	8920		10.1074/jbc.M806674200	http://dx.doi.org/10.1074/jbc.M806674200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19158093	hybrid, Green Published			2022-12-25	WOS:000264397800074
J	Yeeles, JTP; Cammack, R; Dillingham, MS				Yeeles, Joseph T. P.; Cammack, Richard; Dillingham, Mark S.			An Iron-Sulfur Cluster Is Essential for the Binding of Broken DNA by AddAB-type Helicase-Nucleases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; STRAND BREAK REPAIR; COLI RECBCD ENZYME; C-TERMINAL DOMAIN; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; ENDONUCLEASE-III; ATP HYDROLYSIS; YEAST DNA2; PROTEIN	The bacterial helicase-nuclease complex AddAB converts double-stranded DNA breaks into substrates for RecA-dependent recombinational repair. Here we show that the AddB subunit contains a novel class of nuclease domain distinguished by the presence of an iron-sulfur cluster. The cluster is coordinated by an unusual arrangement of cysteine residues that originate from both sides of the AddB nuclease, forming an "iron staple" that is required for the local structural integrity of this domain. Disruption of the iron-sulfur cluster by mutagenesis eliminates the ability of AddAB to bind to duplex DNA ends without affecting the single-stranded DNA-dependent ATPase activity. Sequence analysis suggests that a related iron staple nuclease domain is present in the eukaryotic DNA replication/repair factor Dna2, where it is also associated with a DNA helicase motor.	[Yeeles, Joseph T. P.; Dillingham, Mark S.] Univ Bristol, Sch Med Sci, Dept Biochem, DNA Prot Interact Unit, Bristol BS8 1TD, Avon, England; [Cammack, Richard] Kings Coll London, Pharmaceut Sci Res Div, Mol Biophys Grp, London SE1 9NH, England	University of Bristol; University of London; King's College London	Dillingham, MS (corresponding author), Univ Bristol, Sch Med Sci, Dept Biochem, DNA Prot Interact Unit, Univ Walk, Bristol BS8 1TD, Avon, England.	Mark.Dillingham@bristol.ac.uk	Cammack, Richard/B-7841-2008	Yeeles, Joseph/0000-0002-2255-2119; Dillingham, Mark/0000-0002-4612-7141	Biotechnology and Biological Sciences Research Council; Royal Society University Research Fellowship	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society University Research Fellowship(Royal Society of London)	This work was supported by a Biotechnology and Biological Sciences Research Council doctoral training grant (to J.T.P.Y.) and a Royal Society University Research Fellowship (to M.S.D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amundsen SK, 2008, MOL MICROBIOL, V69, P994, DOI 10.1111/j.1365-2958.2008.06336.x; Anderson DG, 1997, GENE DEV, V11, P571, DOI 10.1101/gad.11.5.571; Aravind L, 2000, NUCLEIC ACIDS RES, V28, P3417, DOI 10.1093/nar/28.18.3417; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; ARCHIBALD F, 1983, FEMS MICROBIOL LETT, V19, P29, DOI 10.1111/j.1574-6968.1983.tb00504.x; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; BEINERT H, 1983, ARCH BIOCHEM BIOPHYS, V222, P333, DOI 10.1016/0003-9861(83)90531-3; BRUSCHI M, 1976, BIOCHIM BIOPHYS ACTA, V449, P275, DOI 10.1016/0005-2728(76)90139-0; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, MUTAT RES-DNA REPAIR, V459, P173, DOI 10.1016/S0921-8777(99)00072-5; Chedin F, 2000, J MOL BIOL, V298, P7, DOI 10.1006/jmbi.2000.3556; Chedin F, 2002, MOL MICROBIOL, V43, P823, DOI 10.1046/j.1365-2958.2002.02785.x; Chepanoske CL, 2000, ARCH BIOCHEM BIOPHYS, V380, P11, DOI 10.1006/abbi.2000.1890; CUNNINGHAM RP, 1989, BIOCHEMISTRY-US, V28, P4450, DOI 10.1021/bi00436a049; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; Eggleston AK, 1996, NUCLEIC ACIDS RES, V24, P1179, DOI 10.1093/nar/24.7.1179; Ferrer M, 2007, NATURE, V445, P91, DOI 10.1038/nature05362; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Fiorentino DF, 1997, MOL BIOL CELL, V8, P2519, DOI 10.1091/mbc.8.12.2519; Gostick DO, 1998, MICROBIOL-SGM, V144, P705, DOI 10.1099/00221287-144-3-705; Guan Y, 1998, NAT STRUCT BIOL, V5, P1058, DOI 10.1038/4168; Hirata A, 2008, NATURE, V451, P851, DOI 10.1038/nature06530; Hogbom M, 2005, MOL CELL PROTEOMICS, V4, P827, DOI 10.1074/mcp.T400023-MCP200; Holmes K, 2005, MICROBIOL-SGM, V151, P243, DOI 10.1099/mic.0.27412-0; Jang SJ, 2007, J BIOL CHEM, V282, P929, DOI 10.1074/jbc.M607646200; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kinch LN, 2005, NUCLEIC ACIDS RES, V33, P3598, DOI 10.1093/nar/gki676; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Lambert AR, 2008, STRUCTURE, V16, P558, DOI 10.1016/j.str.2008.01.017; Liao SR, 2008, NUCLEIC ACIDS RES, V36, P6091, DOI 10.1093/nar/gkn616; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Mertens K, 2008, MOL MICROBIOL, V69, P1411, DOI 10.1111/j.1365-2958.2008.06373.x; MEYER J, 1988, TRENDS ECOL EVOL, V3, P222, DOI 10.1016/0169-5347(88)90162-0; Meyer J, 2008, J BIOL INORG CHEM, V13, P157, DOI 10.1007/s00775-007-0318-7; MICHAELS ML, 1990, NUCLEIC ACIDS RES, V18, P3841, DOI 10.1093/nar/18.13.3841; Morris PD, 1999, BIOCHEMISTRY-US, V38, P5164, DOI 10.1021/bi9822269; PANDEY A, 1994, APPL MICROBIOL BIOT, V40, P735, DOI [10.1007/BF00173337, 10.1007/s002530050058]; Pieroni L, 2001, CLIN CHEM, V47, P2059; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Pugh RA, 2008, J BIOL CHEM, V283, P1732, DOI 10.1074/jbc.M707064200; Quiberoni A, 2001, J BACTERIOL, V183, P4071, DOI 10.1128/JB.183.13.4071-4078.2001; Rigden DJ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-9; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2873, DOI 10.1021/bi00433a019; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Sisakova E, 2008, NUCLEIC ACIDS RES, V36, P3939, DOI 10.1093/nar/gkn333; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; THOMSON AJ, 1981, BIOCHIM BIOPHYS ACTA, V637, P423, DOI 10.1016/0005-2728(81)90047-5; Tomita K, 2004, MOL CELL BIOL, V24, P9557, DOI 10.1128/MCB.24.21.9557-9567.2004; Wang JD, 2000, J BIOL CHEM, V275, P507, DOI 10.1074/jbc.275.1.507; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yeeles JTP, 2007, J MOL BIOL, V371, P66, DOI 10.1016/j.jmb.2007.05.053; Yu M, 1998, P NATL ACAD SCI USA, V95, P981, DOI 10.1073/pnas.95.3.981; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zuniga-Castillo J, 2004, J BACTERIOL, V186, P7905, DOI 10.1128/JB.186.23.7905-7913.2004	62	83	87	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7746	7755		10.1074/jbc.M808526200	http://dx.doi.org/10.1074/jbc.M808526200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19129187	Green Published, hybrid			2022-12-25	WOS:000264195600036
J	Hollmen, M; Maatta, JA; Bald, L; Sliwkowski, MX; Elenius, K				Hollmen, M.; Maatta, J. A.; Bald, L.; Sliwkowski, M. X.; Elenius, K.			Suppression of breast cancer cell growth by a monoclonal antibody targeting cleavable ErbB4 isoforms	ONCOGENE			English	Article						ectodomain shedding; EGFR; HER4; neuregulins; therapeutic antibodies	RECEPTOR TYROSINE KINASES; NUCLEAR-LOCALIZATION; ECTODOMAIN CLEAVAGE; EXPRESSION; HER2; PHOSPHORYLATION; DEGRADATION; ACTIVATION; SURVIVAL; PROTEIN	ErbB4 isoforms mediate different cellular activities depending on their susceptibility to proteolytic cleavage. The biological significance of ErbB4 cleavage in tumorigenesis, however, remains poorly understood. Here, we describe characterization of a monoclonal antibody (mAb 1479) that selectively recognizes the ectodomain of cleavable ErbB4 JM-a isoforms both in vitro and in vivo. mAb 1479 was used to analyse ErbB4 JM-a expression and ectodomain shedding in a series of 17 matched breast cancer/histologically normal peripheral breast tissue pairs. ErbB4 ectodomain was observed in 75% of tumors expressing ErbB4 but only in 18% of normal breast tissue samples expressing ErbB4. Difference in the relative quantity of ErbB4 ectodomain between normal and tumor tissue pairs was statistically significant (P=0.015). Treatment with mAb 1479 suppressed ErbB4 function by inhibiting ErbB4 tyrosine phosphorylation and ectodomain shedding, and by stimulating ErbB4 downregulation and ubiquitination. mAb 1479 suppressed both anchorage-dependent and -independent growth of human breast cancer cell lines that naturally express cleavable ErbB4 JM-a. These findings indicate that ErbB4 ectodomain shedding is enhanced in breast cancer tissue in vivo, and that mAb 1479 represents a potential drug candidate that suppresses breast cancer cell growth by selectively binding cleavable ErbB4 isoforms.	[Hollmen, M.; Maatta, J. A.; Elenius, K.] Univ Turku, Dept Med Biochem & Genet, Med Res Labs, FIN-20520 Turku, Finland; [Hollmen, M.] Turku Grad Sch Biomed Sci, Turku, Finland; [Bald, L.; Sliwkowski, M. X.] Genentech Inc, San Francisco, CA 94080 USA; [Elenius, K.] Turku Univ Hosp, Dept Oncol, FIN-20520 Turku, Finland	University of Turku; University of Turku; Roche Holding; Genentech; University of Turku	Elenius, K (corresponding author), Univ Turku, Dept Med Biochem & Genet, Med Res Labs, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.	klaus.elenius@utu.fi	Hollmén, Maija/B-5831-2017; Elenius, Klaus/AAI-7594-2021	Hollmén, Maija/0000-0002-3250-7653; Elenius, Klaus/0000-0001-5700-0827; Maatta, Jorma/0000-0001-8752-6862	Academy of Finland; Finnish Cancer Organizations; Finnish Cultural Foundation; Foundation for the Finnish Cancer Institute; Jenny and Antti Wihuri Foundation; Sigrid Juselius Foundation; Turku University Central Hospital; Research and Science Foundation of Farmos	Academy of Finland(Academy of Finland); Finnish Cancer Organizations; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Foundation for the Finnish Cancer Institute; Jenny and Antti Wihuri Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Turku University Central Hospital; Research and Science Foundation of Farmos	We thank Tero Vahlberg and Tuire Palokangas for statistical analyses, and Maria Tuominen, Minna Santanen and Mika Savisalo for excellent technical assistance. This work has been supported by Academy of Finland, Finnish Cancer Organizations, Finnish Cultural Foundation, Foundation for the Finnish Cancer Institute, Jenny and Antti Wihuri Foundation, Sigrid Juselius Foundation, Turku University Central Hospital and Research and Science Foundation of Farmos.	Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Bao JX, 2003, J CELL BIOL, V161, P1133, DOI 10.1083/jcb.200212085; Borrell-Pages M, 2003, EMBO J, V22, P1114, DOI 10.1093/emboj/cdg111; Carter P, 2001, NAT REV CANCER, V1, P118, DOI 10.1038/35101072; Cheng QC, 2003, J BIOL CHEM, V278, P38421, DOI 10.1074/jbc.M302111200; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Elenius K, 1997, J BIOL CHEM, V272, P26761, DOI 10.1074/jbc.272.42.26761; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Furger C, 1998, CANCER RES, V58, P1773; Gilbertson RJ, 1997, CANCER RES, V57, P3272; Gilbertson RJ, 2002, CLIN CANCER RES, V8, P3054; Gilmore JL, 2004, ONCOL RES, V14, P589, DOI 10.3727/0965040042707907; Gomes AQ, 2003, MOL BIOL CELL, V14, P1882, DOI 10.1091/mbc.E02-10-0639; Haugen DRF, 1996, CANCER RES, V56, P1184; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Iivanainen E, 2007, EXP CELL RES, V313, P2896, DOI 10.1016/j.yexcr.2007.03.042; Junttila TT, 2005, CANCER RES, V65, P1384, DOI 10.1158/0008-5472.CAN-04-3150; Junttila TT, 2000, TRENDS CARDIOVAS MED, V10, P304, DOI 10.1016/S1050-1738(01)00065-2; Junttila TT, 2003, CLIN CANCER RES, V9, P5346; Kainulainen V, 2000, J BIOL CHEM, V275, P8641, DOI 10.1074/jbc.275.12.8641; Katz M, 2002, TRAFFIC, V3, P740, DOI 10.1034/j.1600-0854.2002.31006.x; Klapper LN, 2000, CANCER RES, V60, P3384; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Lee HJ, 2002, J BIOL CHEM, V277, P6318, DOI 10.1074/jbc.M110371200; Maatta JA, 2006, MOL BIOL CELL, V17, P67, DOI 10.1091/mbc.E05-05-0402; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Molina MA, 2001, CANCER RES, V61, P4744; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Omerovic J, 2007, FASEB J, V21, P2849, DOI 10.1096/fj.06-7925com; Paatero Ilkka, 2008, Recent Pat DNA Gene Seq, V2, P27; PABORSKY LR, 1990, PROTEIN ENG, V3, P547, DOI 10.1093/protein/3.6.547; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; Prewett M, 1998, CLIN CANCER RES, V4, P2957; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Schlessinger J, 2006, CELL, V127, P45, DOI 10.1016/j.cell.2006.09.013; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Srinivasan R, 1999, CLIN CANCER RES, V5, P2877; Srinivasan R, 1998, J PATHOL, V185, P236, DOI 10.1002/(SICI)1096-9896(199807)185:3<236::AID-PATH118>3.0.CO;2-7; SUNADA H, 1986, P NATL ACAD SCI USA, V83, P3825, DOI 10.1073/pnas.83.11.3825; Sundvall M, 2007, ONCOGENE, V26, P6905, DOI 10.1038/sj.onc.1210501; Sundvall M, 2008, J MAMMARY GLAND BIOL, V13, P259, DOI 10.1007/s10911-008-9079-3; Sundvall M, 2008, P NATL ACAD SCI USA, V105, P4162, DOI 10.1073/pnas.0708333105; Vecchi M, 1996, J BIOL CHEM, V271, P18989, DOI 10.1074/jbc.271.31.18989; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; Zhang K, 1996, J BIOL CHEM, V271, P3884	46	42	48	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	10					1309	1319		10.1038/onc.2008.481	http://dx.doi.org/10.1038/onc.2008.481			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	417ZC	19151766				2022-12-25	WOS:000264116000003
J	Xu, K; Chang, CM; Gao, H; Shu, HK				Xu, K.; Chang, C-M; Gao, H.; Shu, H-KG			Epidermal growth factor-dependent cyclooxygenase-2 induction in gliomas requires protein kinase C-delta	ONCOGENE			English	Article						epidermal growth factor receptor; cyclooxygenase-2; protein kinase C-delta; Sp1 transcription factor; glioma	VASCULAR SMOOTH-MUSCLE; MAPK SIGNAL PATHWAYS; FACTOR RECEPTOR; MESSENGER-RNA; SP1 PHOSPHORYLATION; COX-2 INHIBITOR; CELL-LINES; IN-VITRO; GLIOBLASTOMA-MULTIFORME; MALIGNANT GLIOMAS	Earlier, we showed that epidermal growth factor receptor (EGFR) signaling in human glioma cells increased cyclooxygenase-2 (COX-2) expression through p38-mitogen-activated protein kinase (MAPK)-dependent activation of the Sp family of transcription factors. Further mechanistic details of EGFR-dependent induction of COX-2 expression in glioma cells remained elusive. Protein kinase Cs (PKCs) comprise a family of serine-threonine kinases that are major mediators of signaling from receptor tyrosine kinases. Here, we report that PKC-delta, a novel PKC isoform, plays a role in EGF-dependent COX-2 induction in human glioma cells. Pharmacological inhibition and genetic silencing (through siRNA or dominant-negative expression) of PKC-delta confirm a role for this PKC isoform in EGF-dependent COX-2 induction. Overexpression of a functional PKC-delta enhanced COX-2 expression indicating that PKC-delta is not only necessary but also sufficient to regulate COX-2 levels. Inhibition of p38-MAPK pharmacologically or with siRNA further shows that p38-MAPK is required for activation of PKC-delta by EGF while inhibition of PKC-delta had no discernible effects on p38-MAPK activation. Finally, EGF stimulation promotes physical interactions between PKC-delta and Sp1 resulting in phosphorylation and nuclear localization of this transcription factor. These data provide the first evidence that PKC-delta is a critical link between p38-MAPK and Sp1-dependent COX-2 expression in human glioma cells.	[Xu, K.; Chang, C-M; Gao, H.; Shu, H-KG] Emory Univ, Dept Radiat Oncol, Atlanta, GA 30332 USA	Emory University	Shu, HK (corresponding author), Emory Univ, Dept Radiat Oncol, 1365 Clifton Rd,NE,Bldg C,Room C-3082, Atlanta, GA 30332 USA.	hui-kuo@radonc.emory.org			Childhood Brain Tumor Foundation	Childhood Brain Tumor Foundation	This study was supported, in part, by a grant to H-K Shu from the Childhood Brain Tumor Foundation. We thank Dr Jiahuai Han for providing mammalian expression plasmids-containing MKK3 and MKK6 and Dr Jae-Won Soh for providing mammalian expression plasmids-containing PKC-delta variants.	Abbott KL, 2000, MOL PHARMACOL, V58, P946, DOI 10.1124/mol.58.5.946; Awasthi V, 2000, AM J PHYSIOL-LUNG C, V279, pL942, DOI 10.1152/ajplung.2000.279.5.L942; Baltuch GH, 1996, BRAIN RES, V710, P143, DOI 10.1016/0006-8993(95)01395-4; Bijnsdorp IV, 2007, J NEURO-ONCOL, V85, P25, DOI 10.1007/s11060-007-9385-4; Bornancin F, 1997, J BIOL CHEM, V272, P3544, DOI 10.1074/jbc.272.6.3544; Bredel M, 1997, ACTA NEUROCHIR, V139, P1000, DOI 10.1007/BF01411552; Buccoliero AM, 2006, CLIN NEUROPATHOL, V25, P59; Chupreta S, 2000, AM J PHYSIOL-CELL PH, V278, pC697, DOI 10.1152/ajpcell.2000.278.4.C697; COULDWELL WT, 1991, NEUROSURGERY, V29, P880, DOI 10.1227/00006123-199112000-00013; COULDWELL WT, 1990, J NEUROSURG, V73, P594, DOI 10.3171/jns.1990.73.4.0594; D'Addario M, 2002, J BIOL CHEM, V277, P47541, DOI 10.1074/jbc.M207681200; D'Addario M, 2006, GENE, V379, P51, DOI 10.1016/j.gene.2006.04.012; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Guan ZH, 1998, J BIOL CHEM, V273, P28670, DOI 10.1074/jbc.273.44.28670; Hofmann J, 2004, CURR CANCER DRUG TAR, V4, P125, DOI 10.2174/1568009043481579; Hsieh HL, 2007, CELL SIGNAL, V19, P330, DOI 10.1016/j.cellsig.2006.07.006; HUMPHREY PA, 1991, BIOCHEM BIOPH RES CO, V178, P1413, DOI 10.1016/0006-291X(91)91051-D; Iwabu A, 2004, J BIOL CHEM, V279, P14551, DOI 10.1074/jbc.M311981200; Joki T, 2000, CANCER RES, V60, P4926; Kang KB, 2007, INT J RADIAT ONCOL, V67, P888, DOI 10.1016/j.ijrobp.2006.09.055; Karim A, 2005, ANTICANCER RES, V25, P675; Kuwahara J, 2000, Nucleic Acids Symp Ser, P265; Lee J, 2006, FASEB J, V20, P2375, DOI 10.1096/fj.06-5957fje; Lee MY, 2006, AM J PHYSIOL-GASTR L, V291, pG744, DOI 10.1152/ajpgi.00551.2005; Li B, 2004, ONCOGENE, V23, P4594, DOI 10.1038/sj.onc.1207602; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Machide M, 1998, J NEUROCHEM, V71, P592; Martelli AM, 2003, HISTOL HISTOPATHOL, V18, P1301, DOI 10.14670/HH-18.1301; Merchant JL, 1999, BIOCHEM BIOPH RES CO, V254, P454, DOI 10.1006/bbrc.1998.9964; Mimura Y, 2004, J INVEST DERMATOL, V122, P1390, DOI 10.1111/j.0022-202X.2004.22618.x; MORIYA M, 1994, NEUROREPORT, V5, P929, DOI 10.1097/00001756-199404000-00019; Murphy TJ, 2002, METHOD ENZYMOL, V345, P539; Musashi M, 2000, INT J HEMATOL, V72, P12; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Pal S, 1998, J BIOL CHEM, V273, P26277, DOI 10.1074/jbc.273.41.26277; Pang LH, 2002, FASEB J, V16, P1435, DOI 10.1096/fj.02-0169fje; Park YS, 2007, ARTERIOSCL THROM VAS, V27, P1319, DOI 10.1161/ATVBAHA.106.132837; POLLACK IF, 1990, J NEUROSURG, V73, P98, DOI 10.3171/jns.1990.73.1.0098; Prayson Richard A, 2002, Ann Diagn Pathol, V6, P148, DOI 10.1053/adpa.2002.33900; Rafty LA, 2001, NUCLEIC ACIDS RES, V29, P1027, DOI 10.1093/nar/29.5.1027; Reisinger K, 2003, J CELL SCI, V116, P225, DOI 10.1242/jcs.00237; Rojo AI, 2006, FREE RADICAL BIO MED, V41, P247, DOI 10.1016/j.freeradbiomed.2006.04.002; Rosell R, 2006, CLIN CANCER RES, V12, P7222, DOI 10.1158/1078-0432.CCR-06-0627; Shono T, 2001, CANCER RES, V61, P4375; Sminia P, 2005, J CANCER RES CLIN, V131, P653, DOI 10.1007/s00432-005-0020-5; Soh JW, 1999, MOL CELL BIOL, V19, P1313; Subbaramaiah K, 1998, J BIOL CHEM, V273, P32943, DOI 10.1074/jbc.273.49.32943; Wang HQ, 2001, MOL PHARMACOL, V59, P860, DOI 10.1124/mol.59.4.860; Xu KM, 2007, CANCER RES, V67, P6121, DOI 10.1158/0008-5472.CAN-07-0141; Xu KM, 2000, J BIOL CHEM, V275, P7604, DOI 10.1074/jbc.275.11.7604; Xu Q, 2000, J BIOL CHEM, V275, P24583, DOI 10.1074/jbc.M003894200; Yu WS, 2003, J BIOL CHEM, V278, P11167, DOI 10.1074/jbc.M211424200; Zheng XL, 2001, J BIOL CHEM, V276, P13822, DOI 10.1074/jbc.M011031200	54	21	22	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	11					1410	1420		10.1038/onc.2008.500	http://dx.doi.org/10.1038/onc.2008.500			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	421JE	19169273				2022-12-25	WOS:000264354400002
J	Fukuzawa, R; Anaka, MR; Weeks, RJ; Morison, IM; Reeve, AE				Fukuzawa, R.; Anaka, M. R.; Weeks, R. J.; Morison, I. M.; Reeve, A. E.			Canonical WNT signalling determines lineage specificity in Wilms tumour	ONCOGENE			English	Article						WTX; cancer stem cell; nephrogenic rest; mesenchymal stem cell; multiplex ligation-dependent probe amplification	GROWTH-FACTOR-II; BETA-CATENIN; STEM-CELLS; NEPHROGENIC RESTS; CTNNB1 MUTATIONS; TARGET GENES; WT1; CANCER; OVEREXPRESSION; PATHOGENESIS	Wilms tumours (WTs) have two distinct types of histology with or without ectopic mesenchymal elements, suggesting that WTs arise from either the mesenchymal or epithelial nephrogenic lineages. Regardless of the presence or absence of CTNNB1 mutations, nuclear accumulation of beta-catenin is often observed in WTs with ectopic mesenchymal elements. Here, we addressed the relationship between the WNT-signalling pathway and lineage in WTs by examining CTNNB1 and WT1 mutations, nuclear accumulation of beta-catenin, tumour histology and gene expression profiles. In addition, we screened for mutations in WTX, which has been proposed to be a negative regulator of the canonical WNT-signalling pathway. Unsupervised clustering analysis identified two classes of tumours: mesenchymal lineage WNT-dependent tumours, and epithelial lineage WNT-independent tumours. In contrast to the mesenchymal lineage specificity of CTNNB1 mutations, WTX mutations were surprisingly observed in both lineages. WTX-mutant WTs with ectopic mesenchymal elements had nuclear accumulation of beta-catenin, upregulation of WNT target genes and an association with CTNNB1 mutations in exon 7 or 8. However, epithelial lineage WTs with WTX mutations had no indications of active WNT signalling, suggesting that the involvement of WTX in the WNT-signalling pathway may be lineage dependent, and that WTX may have an alternative function to its role in the canonical WNT-signalling pathway.	[Fukuzawa, R.; Anaka, M. R.; Weeks, R. J.; Morison, I. M.; Reeve, A. E.] Univ Otago, Dept Biochem, Canc Genet Lab, Dunedin, New Zealand	University of Otago	Fukuzawa, R (corresponding author), Univ Otago, Dept Biochem, Canc Genet Lab, POB 56, Dunedin, New Zealand.	ryuji.fukuzawa@otago.ac.nz	Weeks, Robert J/A-6876-2012; Morison, Ian M/A-1236-2008	Weeks, Robert J/0000-0003-0474-9089; Morison, Ian M/0000-0003-3616-0025	Health Research Council of New Zealand	Health Research Council of New Zealand(Health Research Council of New Zealand)	This study was supported by the Health Research Council of New Zealand.	Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; BECKWITH J B, 1990, Pediatric Pathology, V10, P1; Beckwith JB, 1998, AM J MED GENET, V79, P268, DOI 10.1002/(SICI)1096-8628(19981002)79:4<268::AID-AJMG7>3.0.CO;2-I; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Breslow NE, 2006, PEDIATR BLOOD CANCER, V47, P260, DOI 10.1002/pbc.20891; Bunting KD, 2002, STEM CELLS, V20, P11, DOI 10.1002/stem.200011; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Eberhart CG, 2001, PEDIATR DEVEL PATHOL, V4, P351, DOI 10.1007/s10024001-0037-y; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849; Fodde R, 2003, NAT CELL BIOL, V5, P190, DOI 10.1038/ncb0303-190; Fukuzawa R, 2008, J PATHOL, V215, P377, DOI 10.1002/path.2366; Fukuzawa R, 2004, PEDIATR DEVEL PATHOL, V7, P125, DOI 10.1007/s10024-003-3023-8; Fukuzawa R, 2004, LANCET, V363, P446, DOI 10.1016/S0140-6736(04)15491-3; Fukuzawa R, 2007, J CLIN PATHOL, V60, P1013, DOI 10.1136/jcp.2006.043083; Grohmann A, 2007, J CELL SCI, V120, P3738, DOI 10.1242/jcs.011320; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; JENKINS ZA, NAT GENET IN PRESS; Koesters R, 1999, CANCER RES, V59, P3880; Koesters R, 2003, J PATHOL, V199, P68, DOI 10.1002/path.1248; Li CM, 2004, AM J PATHOL, V165, P1943, DOI 10.1016/S0002-9440(10)63246-4; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Maiti S, 2000, CANCER RES, V60, P6288; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Mishra L, 2005, SCIENCE, V310, P68, DOI 10.1126/science.1118389; Morison IM, 1996, NAT MED, V2, P311, DOI 10.1038/nm0396-311; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Perotti D, 2008, ONCOGENE, V27, P4625, DOI 10.1038/onc.2008.93; Ridgeway AG, 2001, J BIOL CHEM, V276, P19033, DOI 10.1074/jbc.M011491200; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Ruteshouser EC, 2008, GENE CHROMOSOME CANC, V47, P461, DOI 10.1002/gcc.20553; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Wang YJ, 2005, J BONE MINER RES, V20, P1624, DOI 10.1359/JBMR.050516; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zirn B, 2006, GENE CHROMOSOME CANC, V45, P565, DOI 10.1002/gcc.20319	39	45	47	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB	2009	28	8					1063	1075		10.1038/onc.2008.455	http://dx.doi.org/10.1038/onc.2008.455			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	412KE	19137020				2022-12-25	WOS:000263722900002
J	Taylor-Cousar, JL; Zariwala, MA; Burch, LH; Pace, RG; Drumm, ML; Calloway, H; Fan, HY; Weston, BW; Wright, FA; Knowles, MR				Taylor-Cousar, Jennifer L.; Zariwala, Maimoona A.; Burch, Lauranell H.; Pace, Rhonda G.; Drumm, Mitchell L.; Calloway, Hollin; Fan, Haiying; Weston, Brent W.; Wright, Fred A.; Knowles, Michael R.		Gene Modifier Study Grp	Histo-Blood Group Gene Polymorphisms as Potential Genetic Modifiers of Infection and Cystic Fibrosis Lung Disease Severity	PLOS ONE			English	Article								Background: The pulmonary phenotype in cystic fibrosis (CF) is variable; thus, environmental and genetic factors likely contribute to clinical heterogeneity. We hypothesized that genetically determined ABO histo-blood group antigen (ABH) differences in glycosylation may lead to differences in microbial binding by airway mucus, and thus predispose to early lung infection and more severe lung disease in a subset of patients with CF. Methods and Principal Findings: Clinical information and DNA was collected on > 800 patients with the Delta F508/Delta F508 genotype. Patients in the most severe and mildest quartiles for lung phenotype were enrolled. Blood samples underwent lymphocyte transformation and DNA extraction using standard methods. PCR and sequencing were performed using standard techniques to identify the 9 SNPs required to determine ABO blood type, and to identify the four SNPs that account for 90-95% of Lewis status in Caucasians. Allele identification of the one nonsynonymous SNP in FUT2 that accounts for > 95% of the incidence of nonsecretor phenotype in Caucasians was completed using an ABI Taqman assay. The overall prevalence of ABO types, and of FUT2 (secretor) and FUT 3 (Lewis) alleles was consistent with that found in the Caucasian population. There was no difference in distribution of ABH type in the severe versus mild patients, or the age of onset of Pseudomonas aeruginosa infection in the severe or mild groups. Multivariate analyses of other clinical phenotypes, including gender, asthma, and meconium ileus demonstrated no differences between groups based on ABH type. Conclusions and Significance: Polymorphisms in the genes encoding ABO blood type, secretor or Lewis genotypes were not shown to associate with severity of CF lung disease, or age of onset of P. aeruginosa infection, nor was there any association with other clinical phenotypes in a group of 808 patients homozygous for the Delta F508 mutation.	Univ New Mexico, Hlth Sci Ctr, Div Pulm, Albuquerque, NM 87131 USA; [Zariwala, Maimoona A.; Pace, Rhonda G.; Calloway, Hollin; Knowles, Michael R.] Univ N Carolina, Cystic Fibrosis Pulmonary Res & Treatment Ctr, Chapel Hill, NC USA; [Burch, Lauranell H.] Natl Inst Environm Hlth Sci, Res Triangle Pk, NC USA; [Wright, Fred A.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Fan, Haiying; Weston, Brent W.] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA; [Drumm, Mitchell L.] Case Western Reserve Univ, Dept Pediat, Div Pediat Pulmonary, Cleveland, OH 44106 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Case Western Reserve University	Taylor-Cousar, JL (corresponding author), Univ New Mexico, Hlth Sci Ctr, Div Pulm, Albuquerque, NM 87131 USA.	JTCousar@salud.unm.edu	/L-2667-2019	Pace, Rhonda/0000-0001-8606-0327	NIH [HL068890, 1F32HL082207-01]; GlaxoSmithKline Pulmonary Fellowship Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068890, F32HL082207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK027651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102546] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline Pulmonary Fellowship Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH HL068890, NIH 1F32HL082207-01, and the GlaxoSmithKline Pulmonary Fellowship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CYSTIC FIBROSIS MUTA; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Boyle Michael P, 2007, Proc Am Thorac Soc, V4, P52, DOI 10.1513/pats.200605-129JG; Bremer LA, 2008, HUM MOL GENET, V17, P2228, DOI 10.1093/hmg/ddn123; CAMERON HS, 1995, J BIOL CHEM, V270, P20112, DOI 10.1074/jbc.270.34.20112; CARNOY C, 1993, AM J RESP CELL MOL, V9, P323, DOI 10.1165/ajrcmb/9.3.323; CLAMP JR, 1979, CLIN SCI, V57, P445, DOI 10.1042/cs0570445; COHEN BH, 1980, AM J EPIDEMIOL, V111, P285, DOI 10.1093/oxfordjournals.aje.a112898; Cutting GR, 2005, ANNU REV GENOM HUM G, V6, P237, DOI 10.1146/annurev.genom.6.080604.162254; DEVARAJ N, 1994, GLYCOBIOLOGY, V4, P307, DOI 10.1093/glycob/4.3.307; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; ELMGREN A, 2002, PEDIAT PULMONOLOGY, V34, P226; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; HAPONIK EF, 1985, EUR J RESPIR DIS, V67, P381; Harmening D.., 2008, MODERN BLOOD BANKING, V5; Huang PW, 2003, J INFECT DIS, V188, P19, DOI 10.1086/375742; IMUNDO L, 1995, P NATL ACAD SCI USA, V92, P3019, DOI 10.1073/pnas.92.7.3019; Kauffmann F, 1996, AM J RESP CRIT CARE, V153, P76, DOI 10.1164/ajrccm.153.1.8542166; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; KOMIYAMA K, 1987, INFECT IMMUN, V55, P2364, DOI 10.1128/IAI.55.10.2364-2369.1987; Li ZH, 2005, JAMA-J AM MED ASSOC, V293, P581, DOI 10.1001/jama.293.5.581; Marionneau S, 2005, J INFECT DIS, V192, P1071, DOI 10.1086/432546; Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9; Orntoft TF, 1996, J BIOL CHEM, V271, P32260, DOI 10.1074/jbc.271.50.32260; Pang H, 1998, HUM GENET, V102, P675, DOI 10.1007/s004390050760; PITTMAN JCH, 2008, PEDIAT PULMONOLOGY, V43, pA332; Rhim AD, 2001, GLYCOCONJUGATE J, V18, P649, DOI 10.1023/A:1020815205022; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Ronchetti F, 2001, EUR RESPIR J, V17, P1236, DOI 10.1183/09031936.01.99109101; Rowntree RK, 2003, ANN HUM GENET, V67, P471, DOI 10.1046/j.1469-1809.2003.00028.x; SAADI AT, 1994, FEMS IMMUNOL MED MIC, V8, P315, DOI 10.1111/j.1574-695X.1994.tb00458.x; Salomaa V, 2000, J INTERN MED, V247, P689, DOI 10.1046/j.1365-2796.2000.00682.x; Schluchter MD, 2006, AM J RESP CRIT CARE, V174, P780, DOI 10.1164/rccm.200512-1919OC; Shori DK, 2001, PFLUG ARCH EUR J PHY, V443, pS55; Svensson L, 2000, TRANSFUSION, V40, P856, DOI 10.1046/j.1537-2995.2000.40070856.x; THIRU S, 1990, J CLIN PATHOL, V43, P1014, DOI 10.1136/jcp.43.12.1014; Thomsson KA, 2002, BIOCHEM J, V367, P609, DOI 10.1042/BJ20020371; Vanscoy LL, 2007, AM J RESP CRIT CARE, V175, P1036, DOI 10.1164/rccm.200608-1164OC; WANG EEL, 1984, NEW ENGL J MED, V311, P1653, DOI 10.1056/NEJM198412273112602; Wat D, 2008, J CYST FIBROS, V7, P320, DOI 10.1016/j.jcf.2007.12.002; Wu AM, 2006, BIOCHIMIE, V88, P1479, DOI 10.1016/j.biochi.2006.05.004; Yip SP, 2002, ANN HUM GENET, V66, P1, DOI 10.1017/S0003480001008995; Zemel BS, 2000, J PEDIATR-US, V137, P374, DOI 10.1067/mpd.2000.107891	45	26	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2009	4	1					CP5	U11	e4270	10.1371/journal.pone.0004270	http://dx.doi.org/10.1371/journal.pone.0004270			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JE	19169360	Green Published, Green Submitted, gold			2022-12-25	WOS:000265482800001
J	Paupe, V; Dassa, EP; Goncalves, S; Auchere, F; Lonn, M; Holmgren, A; Rustin, P				Paupe, Vincent; Dassa, Emmanuel P.; Goncalves, Sergio; Auchere, Francoise; Loenn, Maria; Holmgren, Arne; Rustin, Pierre			Impaired Nuclear Nrf2 Translocation Undermines the Oxidative Stress Response in Friedreich Ataxia	PLOS ONE			English	Article							IRON-SULFUR PROTEIN; ANTIOXIDANT DEFENSES; SUPEROXIDE-DISMUTASE; HUMAN GLUTAREDOXIN-2; DROSOPHILA MODEL; PHASE-2 ENZYMES; REACTIVE OXYGEN; TRANSGENIC MICE; NARP MUTATION; FRATAXIN	Background: Friedreich ataxia originates from a decrease in mitochondrial frataxin, which causes the death of a subset of neurons. The biochemical hallmarks of the disease include low activity of the iron sulfur cluster-containing proteins (ISP) and impairment of antioxidant defense mechanisms that may play a major role in disease progression. Methodology/Principal Findings: We thus investigated signaling pathways involved in antioxidant defense mechanisms. We showed that cultured fibroblasts from patients with Friedreich ataxia exhibited hypersensitivity to oxidative insults because of an impairment in the Nrf2 signaling pathway, which led to faulty induction of antioxidant enzymes. This impairment originated from previously reported actin remodeling by hydrogen peroxide. Conclusions/Significance: Thus, the defective machinery for ISP synthesis by causing mitochondrial iron dysmetabolism increases hydrogen peroxide production that accounts for the increased susceptibility to oxidative stress.	[Paupe, Vincent; Dassa, Emmanuel P.; Goncalves, Sergio; Rustin, Pierre] Hop Robert Debre, INSERM, U676, F-75019 Paris, France; [Paupe, Vincent; Dassa, Emmanuel P.; Goncalves, Sergio; Rustin, Pierre] Univ Paris 07, Fac Med, Lab Ingenierie Proteines Controle Metabol, IFR02, F-75221 Paris, France; [Auchere, Francoise] CNRS, Inst Jacques Monod, Dept Biol Genomes, UMR 7592, Paris, France; [Loenn, Maria; Holmgren, Arne] Karolinska Inst, Med Nobel Inst Biochem, Dept Med Biochem & Biophys, Stockholm, Sweden	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet	Paupe, V (corresponding author), Hop Robert Debre, INSERM, U676, Bat Ecran, F-75019 Paris, France.	pierre.rustin@inserm.fr			AFAF; REVAmoto; ACHAF; FARA; European Community sixth Framework Program for Research [LSHM-CT-2004-503116]; Leducq foundation; ANR MRAR Friedreich project; AFM (Association Francaise contre les Myopathies); AMMi (Association contre les Maladies Mitochondriales)	AFAF; REVAmoto; ACHAF; FARA; European Community sixth Framework Program for Research; Leducq foundation(Leducq Foundation); ANR MRAR Friedreich project(French National Research Agency (ANR)); AFM (Association Francaise contre les Myopathies)(Association Francaise contre les Myopathies); AMMi (Association contre les Maladies Mitochondriales)	This work was supported by Friedreich ataxia patient organizations in France (AFAF and REVAmoto), Switzerland (ACHAF), and the US (FARA). EPD and PR were supported by the European Community sixth Framework Program for Research, contract number LSHM-CT-2004-503116; EPD and PR by the Leducq foundation; SG, V, and PR by the ANR MRAR Friedreich project; and PR by the AFM (Association Francaise contre les Myopathies) and AMMi (Association contre les Maladies Mitochondriales). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PR, 2008, P NATL ACAD SCI USA, V105, P611, DOI 10.1073/pnas.0709691105; AUCHERE F, 2008, HUM MOL GENET; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Berndt C, 2007, ANTIOXID REDOX SIGN, V9, P151, DOI 10.1089/ars.2007.9.151; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulteau AL, 2007, FREE RADICAL BIO MED, V42, P1561, DOI 10.1016/j.freeradbiomed.2007.02.014; Byrne RD, 2007, CELL SIGNAL, V19, P321, DOI 10.1016/j.cellsig.2006.07.004; Campanella A, 2004, HUM MOL GENET, V13, P2279, DOI 10.1093/hmg/ddh232; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Chantrel-Groussard K, 2001, HUM MOL GENET, V10, P2061, DOI 10.1093/hmg/10.19.2061; Dassa EP, 2008, BIOCHEM BIOPH RES CO, V368, P620, DOI 10.1016/j.bbrc.2008.01.125; Di Prospero NA, 2007, LANCET NEUROL, V6, P878, DOI 10.1016/S1474-4422(07)70220-X; DROBINSKAYA IE, 1978, FEBS LETT, V96, P111, DOI 10.1016/0014-5793(78)81073-4; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221; Gianello P, 1996, TRANSPLANTATION, V62, P1664, DOI 10.1097/00007890-199612150-00022; Goncalves S, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-20; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Huang HC, 2000, P NATL ACAD SCI USA, V97, P12475, DOI 10.1073/pnas.220418997; Isaya G, 2004, ACTA PAEDIATR, V93, P68, DOI 10.0180/08035320310021318; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jauslin ML, 2002, HUM MOL GENET, V11, P3055, DOI 10.1093/hmg/11.24.3055; Jiralerspong S, 2001, FEBS LETT, V509, P101, DOI 10.1016/S0014-5793(01)03140-4; KAHL R, 1989, TOXICOLOGY, V59, P179, DOI 10.1016/0300-483X(89)90056-5; Koehler CM, 2006, ANTIOXID REDOX SIGN, V8, P813, DOI 10.1089/ars.2006.8.813; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Llorens JV, 2007, FASEB J, V21, P333, DOI 10.1096/fj.05-5709com; Lo SC, 2008, EXP CELL RES, V314, P1789, DOI 10.1016/j.yexcr.2008.02.014; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; Nicolakakis N, 2008, J NEUROSCI, V28, P9287, DOI 10.1523/JNEUROSCI.3348-08.2008; Pastore A, 2003, J BIOL CHEM, V278, P42588, DOI 10.1074/jbc.M301872200; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Rustin P, 1999, LANCET, V354, P477, DOI 10.1016/S0140-6736(99)01341-0; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Rustin P, 2003, EXPERT OPIN INV DRUG, V12, P569, DOI 10.1517/eoid.12.4.569.23756; Rustin P, 2002, NAT GENET, V30, P352, DOI 10.1038/ng0402-352; Rustin P, 1999, BIOFACTORS, V9, P247, DOI 10.1002/biof.5520090220; Rustin P, 2002, FREE RADICAL RES, V36, P467, DOI 10.1080/10715760290021333; Schutz B, 2005, J NEUROSCI, V25, P7805, DOI 10.1523/JNEUROSCI.2038-05.2005; Seznec H, 2005, HUM MOL GENET, V14, P463, DOI 10.1093/hmg/ddi042; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Tzagoloff A, 1982, MITOCHONDRIA; Vazquez-Manrique RP, 2005, FASEB J, V19, P172, DOI 10.1096/fj.05-4212fje; Wallace DC, 1998, NAT GENET, V19, P105, DOI 10.1038/448; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425; Yang HP, 2005, MOL CELL BIOL, V25, P5933, DOI 10.1128/MCB.25.14.5933-5946.2005; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhu H, 2005, FEBS LETT, V579, P3029, DOI 10.1016/j.febslet.2005.04.058; Zhu H, 2008, EXP BIOL MED, V233, P463, DOI 10.3181/0711-RM-304	53	147	156	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2009	4	1							e4253	10.1371/journal.pone.0004253	http://dx.doi.org/10.1371/journal.pone.0004253			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JC	19158945	gold, Green Submitted, Green Published			2022-12-25	WOS:000265482200009
J	Fujimoto, T; Miyasaka, K; Koyanagi, M; Tsunoda, T; Baba, I; Doi, K; Ohta, M; Kato, N; Sasazuki, T; Shirasawa, S				Fujimoto, Takahiro; Miyasaka, Kyoko; Koyanagi, Midori; Tsunoda, Toshiyuki; Baba, Iwai; Doi, Keiko; Ohta, Minoru; Kato, Norihiro; Sasazuki, Takehiko; Shirasawa, Senji			Altered Energy Homeostasis and Resistance to Diet-Induced Obesity in KRAP-Deficient Mice	PLOS ONE			English	Article							STEAROYL-COA DESATURASE-1; FATTY-ACID OXIDATION; GROWTH-HORMONE; EXPRESSION; PROTEIN; LEPTIN; GENE; ADIPOCYTES; LOCALIZATION; TRANSLATION	Obesity and related metabolic disorders have become leading causes of adult morbidity and mortality. KRAP (Ki-ras-induced actin-interacting protein) is a cytoskeleton-associated protein and a ubiquitous protein among tissues, originally identified as a cancer-related molecule, however, its physiological roles remain unknown. Here we demonstrate that KRAP-deficient (KRAP(-/-)) mice show enhanced metabolic rate, decreased adiposity, improved glucose tolerance, hypoinsulinemia and hypoleptinemia. KRAP(-/-) mice are also protected against high-fat diet-induced obesity and insulin resistance despite of hyperphagia. Notably, glucose uptake in the brown adipose tissue (BAT) in KRAP(-/-) mice is enhanced in an insulin-independent manner, suggesting that BAT is involved in altered energy homeostasis in KRAP(-/-) mice, although UCP (Uncoupling protein) expressions are not altered. Of interest is the down-regulation of fatty acid metabolism-related molecules, including acetyl-CoA carboxylase (ACC)-1, ACC-2 and fatty acid synthase in the liver of KRAP(-/-) mice, which could in part account for the metabolic phenotype in KRAP(-/-) mice. Thus, KRAP is a novel regulator in whole-body energy homeostasis and may be a therapeutic target in obesity and related diseases.	[Fujimoto, Takahiro; Koyanagi, Midori; Tsunoda, Toshiyuki; Baba, Iwai; Doi, Keiko; Shirasawa, Senji] Fukuoka Univ, Fac Med, Dept Cell Biol, Jonan Ku, Fukuoka 81401, Japan; [Fujimoto, Takahiro; Koyanagi, Midori; Tsunoda, Toshiyuki; Doi, Keiko; Shirasawa, Senji] Fukuoka Univ, Ctr Advanced Mol Med, Fukuoka, Japan; [Miyasaka, Kyoko; Ohta, Minoru] Tokyo Metropolitan Inst Gerontol, Dept Clin Physiol, Tokyo, Japan; [Kato, Norihiro; Sasazuki, Takehiko] Int Med Ctr Japan, Res Inst, Dept Gene Diagnost & Therapeut, Tokyo, Japan	Fukuoka University; Fukuoka University; Tokyo Metropolitan Institute of Gerontology; National Center for Global Health & Medicine - Japan	Fujimoto, T (corresponding author), Fukuoka Univ, Fac Med, Dept Cell Biol, Jonan Ku, Fukuoka 81401, Japan.	sshirasa@fukuoka-u.ac.jp		Fujimoto, Takahiro/0000-0002-9975-7008	Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); Genome Network Project from the Ministry of Education, Culture, Sports, Science and Technology, Japan	Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Genome Network Project from the Ministry of Education, Culture, Sports, Science and Technology, Japan	This study was supported in part by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) and the Genome Network Project from the Ministry of Education, Culture, Sports, Science and Technology, Japan (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elheiga L, 2000, P NATL ACAD SCI USA, V97, P1444, DOI 10.1073/pnas.97.4.1444; Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Ayuk J, 2006, POSTGRAD MED J, V82, P24, DOI 10.1136/pgmj.2005.036087; Bianco AC, 2006, J CLIN INVEST, V116, P2571, DOI 10.1172/JCI29812; Chakrabarti P, 2008, MOL ENDOCRINOL, V22, P2260, DOI 10.1210/me.2008-0148; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chevillard Gregory, 2004, BMC Biochemistry, V5, P3, DOI 10.1186/1471-2091-5-3; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; FOLCH J, 1957, J BIOL CHEM, V226, P497; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fujimoto T, 2007, J HUM GENET, V52, P978, DOI 10.1007/s10038-007-0204-8; Greenhalgh CJ, 2005, J CLIN INVEST, V115, P397, DOI 10.1172/JCI200522710; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049; Ichikawa M, 2000, J NUTR, V130, P2562, DOI 10.1093/jn/130.10.2562; Inokuchi J, 2004, J HUM GENET, V49, P46, DOI 10.1007/s10038-003-0106-3; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Lee MJ, 2007, J BIOL CHEM, V282, P72, DOI 10.1074/jbc.M609518200; Levin N, 1996, P NATL ACAD SCI USA, V93, P1726, DOI 10.1073/pnas.93.4.1726; Maeda N, 2006, BIOL PHARM BULL, V29, P1936, DOI 10.1248/bpb.29.1936; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Rahman SM, 2005, AM J PHYSIOL-ENDOC M, V288, pE381, DOI 10.1152/ajpendo.00314.2004; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosenbaum M, 1997, NEW ENGL J MED, V337, P396, DOI 10.1056/NEJM199708073370606; Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130; Shimizu Y, 1998, BIOCHEM J, V330, P397, DOI 10.1042/bj3300397; Shirasawa S, 2004, P NATL ACAD SCI USA, V101, P13921, DOI 10.1073/pnas.0404217101; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	37	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4240	10.1371/journal.pone.0004240	http://dx.doi.org/10.1371/journal.pone.0004240			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JB	19156225	gold, Green Submitted, Green Published			2022-12-25	WOS:000265482100012
J	Nakamura, S; Yang, CS; Sakon, N; Ueda, M; Tougan, T; Yamashita, A; Goto, N; Takahashi, K; Yasunaga, T; Ikuta, K; Mizutani, T; Okamoto, Y; Tagami, M; Morita, R; Maeda, N; Kawai, J; Hayashizaki, Y; Nagai, Y; Horii, T; Iida, T; Nakaya, T				Nakamura, Shota; Yang, Cheng-Song; Sakon, Naomi; Ueda, Mayo; Tougan, Takahiro; Yamashita, Akifumi; Goto, Naohisa; Takahashi, Kazuo; Yasunaga, Teruo; Ikuta, Kazuyoshi; Mizutani, Tetsuya; Okamoto, Yoshiko; Tagami, Michihira; Morita, Ryoji; Maeda, Norihiro; Kawai, Jun; Hayashizaki, Yoshihide; Nagai, Yoshiyuki; Horii, Toshihiro; Iida, Tetsuya; Nakaya, Takaaki			Direct Metagenomic Detection of Viral Pathogens in Nasal and Fecal Specimens Using an Unbiased High-Throughput Sequencing Approach	PLOS ONE			English	Article								With the severe acute respiratory syndrome epidemic of 2003 and renewed attention on avian influenza viral pandemics, new surveillance systems are needed for the earlier detection of emerging infectious diseases. We applied a "nextgeneration'' parallel sequencing platform for viral detection in nasopharyngeal and fecal samples collected during seasonal influenza virus (Flu) infections and norovirus outbreaks from 2005 to 2007 in Osaka, Japan. Random RT-PCR was performed to amplify RNA extracted from 0.1-0.25 ml of nasopharyngeal aspirates (N = 3) and fecal specimens (N = 5), and more than 10 mu g of cDNA was synthesized. Unbiased high-throughput sequencing of these 8 samples yielded 15,298-32,335 (average 24,738) reads in a single 7.5 h run. In nasopharyngeal samples, although whole genome analysis was not available because the majority (>90%) of reads were host genome-derived, 20-460 Flu-reads were detected, which was sufficient for subtype identification. In fecal samples, bacteria and host cells were removed by centrifugation, resulting in gain of 484-15,260 reads of norovirus sequence (78-98% of the whole genome was covered), except for one specimen that was under-detectable by RT-PCR. These results suggest that our unbiased high-throughput sequencing approach is useful for directly detecting pathogenic viruses without advance genetic information. Although its cost and technological availability make it unlikely that this system will very soon be the diagnostic standard worldwide, this system could be useful for the earlier discovery of novel emerging viruses and bioterrorism, which are difficult to detect with conventional procedures.	[Yamashita, Akifumi; Goto, Naohisa; Yasunaga, Teruo] Osaka Univ, RIMD, Dept Genome Informat, Osaka, Japan; [Yang, Cheng-Song; Ueda, Mayo; Horii, Toshihiro; Iida, Tetsuya; Nakaya, Takaaki] Osaka Univ, RIMD, Int Res Ctr Infect Dis, Suita, Osaka 565, Japan; [Yang, Cheng-Song; Ueda, Mayo; Ikuta, Kazuyoshi] Osaka Univ, RIMD, Dept Virol, Suita, Osaka 565, Japan; [Sakon, Naomi; Takahashi, Kazuo] Osaka Prefectural Inst Publ Hlth, Dept Infect Dis, Osaka, Japan; [Tougan, Takahiro; Horii, Toshihiro] Osaka Univ, RIMD, Dept Mol Protozool, Suita, Osaka 565, Japan; [Mizutani, Tetsuya] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan; [Okamoto, Yoshiko; Nagai, Yoshiyuki] RIKEN, Ctr Res Network Infect Dis, Tokyo, Japan; [Tagami, Michihira; Morita, Ryoji; Maeda, Norihiro; Kawai, Jun; Hayashizaki, Yoshihide] RIKEN, OSC, Kanagawa, Japan	Osaka University; Osaka University; Osaka University; Osaka Prefectural Institute of Public Health; Osaka University; National Institute of Infectious Diseases (NIID); RIKEN; RIKEN	Nakamura, S (corresponding author), Osaka Univ, RIMD, Dept Genome Informat, Osaka, Japan.	tnakaya@biken.osaka-u.ac.jp	Tougan, Takahiro/AAP-5129-2020; Hayashizaki, Yoshihide/N-6590-2015; Kawai, Jun/A-6451-2016; Nakamura, Shota/E-3033-2010; MIZUTANI, Tetsuya/G-1086-2013	Nakamura, Shota/0000-0003-2058-5942; MIZUTANI, Tetsuya/0000-0003-2570-0452; Horii, Toshihiro/0000-0002-3000-2045	Ministry of Education, Science, Sports Culture and Technology (MEXT) [Grant-in-Aid for Scientific Research]	Ministry of Education, Science, Sports Culture and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports Culture and Technology (MEXT), The Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases by the MEXT (S. N., T. H., T. I. and T. N.), a Research Grant for RIKEN OSC from MEXT (J. K., and Y.H.) and the project for the International Research Center for Infectious Diseases, Research Institute for Microbial Diseases, Osaka University from the MEXT (T. H., T. I. and T. N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Bainbridge MN, 2007, BIOINFORMATICS, V23, P2622, DOI 10.1093/bioinformatics/btl513; Bialasiewicza S, 2007, J CLIN VIROL, V40, P15, DOI 10.1016/j.jcv.2007.07.001; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Chan PKS, 2004, EMERG INFECT DIS, V10, P825, DOI 10.3201/eid1005.030682; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Fox JD, 2007, J CLIN VIROL, V40, pS15, DOI 10.1016/S1386-6532(07)70005-7; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; GOTO N, 2003, GENOME INFORM, V14, P629; Ilyushina NA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000043; Lau SKP, 2006, J CLIN MICROBIOL, V44, P2063, DOI 10.1128/JCM.02614-05; Lin BC, 2006, GENOME RES, V16, P527, DOI 10.1101/gr.4337206; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lodes MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000924; Lopman B, 2008, PLOS MED, V5, P187, DOI 10.1371/journal.pmed.0050042; MacConaill L, 2008, NAT GENET, V40, P380, DOI 10.1038/ng0408-380; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; Nakamura S, 2008, EMERG INFECT DIS, V14, P1784, DOI 10.3201/eid1411.080589; Norja P, 2007, J CLIN VIROL, V40, P307, DOI 10.1016/j.jcv.2007.09.008; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quan PL, 2007, J CLIN MICROBIOL, V45, P2359, DOI 10.1128/JCM.00737-07; Sakon N, 2007, JPN J INFECT DIS, V60, P409; Spatz SJ, 2008, VIRUS GENES, V36, P479, DOI 10.1007/s11262-008-0213-5; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Torres TT, 2008, GENOME RES, V18, P172, DOI 10.1101/gr.6984908; Vabret A, 2006, CLIN INFECT DIS, V42, P634, DOI 10.1086/500136; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Watanabe S, 2008, J CLIN VIROL, V43, P56, DOI 10.1016/j.jcv.2008.05.004; Wicker T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-275; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Woo PCY, 2005, J INFECT DIS, V192, P1898, DOI 10.1086/497151; Yang J, 2000, RNA, V6, P1551, DOI 10.1017/S135583820000100X; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003	41	176	189	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2009	4	1							e4219	10.1371/journal.pone.0004219	http://dx.doi.org/10.1371/journal.pone.0004219			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IZ	19156205	gold, Green Published, Green Submitted			2022-12-25	WOS:000265481900002
J	Hayakawa, J; Washington, K; Uchida, N; Phang, O; Kang, EM; Hsieh, MM; Tisdale, JF				Hayakawa, Jun; Washington, Kareem; Uchida, Naoya; Phang, Oswald; Kang, Elizabeth M.; Hsieh, Matthew M.; Tisdale, John F.			Long-Term Vector Integration Site Analysis Following Retroviral Mediated Gene Transfer to Hematopoietic Stem Cells for the Treatment of HIV Infection	PLOS ONE			English	Article							BLOOD PROGENITOR CELLS; THERAPY; SCID-X1; CLONES; MDS1-EVI1; REGIONS; LUNG	We previously reported the efficacy of nonmyeloablative allogeneic transplantation in 2 HIV positive recipients, one of whom received retrovirus transduced hematopoietic stem cells to confer resistance to HIV. Here we report an assessment of retroviral integration sites (RISs) recovered out to 3 years post-transplantation. We identified 213 unique RISs from the patient's peripheral blood samples by linear amplification-mediated PCR (LAM-PCR). While vector integration patterns were similar to that previously reported, only 3.76% of RISs were common among early (up to 3 months) and late samples (beyond 1 year). Additionally, common integration sites were enriched among late samples (14.9% vs. 36.8%, respectively). Three RISs were found near or within known oncogenes, but 2 were limited to early timepoints. Interestingly, an integration site near the MDS1 gene was detected in long-term follow-up samples; however, the overall contribution of MDS1 integrated clone remained stably low during follow-up.	[Hayakawa, Jun; Washington, Kareem; Uchida, Naoya; Phang, Oswald; Kang, Elizabeth M.; Hsieh, Matthew M.; Tisdale, John F.] NIDDK, Mol & Clin Hematol Branch, NIH, Bethesda, MD 20892 USA; [Hayakawa, Jun; Washington, Kareem; Uchida, Naoya; Phang, Oswald; Kang, Elizabeth M.; Hsieh, Matthew M.; Tisdale, John F.] NHLBI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Hayakawa, J (corresponding author), NIDDK, Mol & Clin Hematol Branch, NIH, Bethesda, MD 20892 USA.	johntis@mail.nih.gov			intramural research program of the National Institute of Diabetes, Digestive, and Kidney Diseases; National Heart, Lung, and Blood Institute of the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000991, ZIAAI000991] Funding Source: NIH RePORTER	intramural research program of the National Institute of Diabetes, Digestive, and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the intramural research program of the National Institute of Diabetes, Digestive, and Kidney Diseases and the National Heart, Lung, and Blood Institute of the National Institutes of Health. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Abkowitz JL, 1996, NAT MED, V2, P190, DOI 10.1038/nm0296-190; Aiuti A, 2007, J CLIN INVEST, V117, P2233, DOI 10.1172/JCI31666; Baum C, 2003, BLOOD, V101, P2099, DOI 10.1182/blood-2002-07-2314; Calin GA, 2005, NEW ENGL J MED, V352, P1667, DOI 10.1056/NEJMoa042280; Calmels B, 2005, BLOOD, V106, P2530, DOI 10.1182/blood-2005-03-1115; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Christensen C, 2005, CANCER RES, V65, P6167, DOI 10.1158/0008-5472.CAN-04-4309; Deichmann A, 2007, J CLIN INVEST, V117, P2225, DOI 10.1172/JCI31659; Fears S, 1996, P NATL ACAD SCI USA, V93, P1642, DOI 10.1073/pnas.93.4.1642; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hematti P, 2004, PLOS BIOL, V2, P2183, DOI 10.1371/journal.pbio.0020423; Horn PA, 2003, BLOOD, V102, P4329, DOI 10.1182/blood-2003-01-0082; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Kang EM, 2002, J HEMATOTH STEM CELL, V11, P809, DOI 10.1089/152581602760404612; Kang EM, 2002, BLOOD, V99, P698, DOI 10.1182/blood.V99.2.698; Kim HJ, 2000, BLOOD, V96, P1; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; Kustikova OS, 2007, BLOOD, V109, P1897, DOI 10.1182/blood-2006-08-044156; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Mautino MR, 2001, J VIROL, V75, P3590, DOI 10.1128/JVI.75.8.3590-3599.2001; Metais JY, 2008, MOL THER, V16, P439, DOI 10.1038/sj.mt.6300372; MEZQUITA P, 2008, GENE THER; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Morgan RA, 1996, HUM GENE THER, V7, P1281, DOI 10.1089/hum.1996.7.10-1281; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Schmidt M, 2002, BLOOD, V100, P2737, DOI 10.1182/blood-2002-02-0407; Schwarzwaelder K, 2007, J CLIN INVEST, V117, P2241, DOI 10.1172/JCI31661; Senchenko VN, 2004, ONCOGENE, V23, P5719, DOI 10.1038/sj.onc.1207760; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Tisdale JF, 1998, BLOOD, V92, P1131, DOI 10.1182/blood.V92.4.1131.416k41_1131_1141; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413	33	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2009	4	1							e4211	10.1371/journal.pone.0004211	http://dx.doi.org/10.1371/journal.pone.0004211			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IH	19148292	gold, Green Submitted, Green Published			2022-12-25	WOS:000265479900005
J	Joshi, T; Ganesan, LP; Cheney, C; Ostrowski, MC; Muthusamy, N; Byrd, JC; Tridandapani, S				Joshi, Trupti; Ganesan, Latha P.; Cheney, Carolyn; Ostrowski, Michael C.; Muthusamy, Natarajan; Byrd, John C.; Tridandapani, Susheela			The PtdIns 3-Kinase/Akt Pathway Regulates Macrophage-Mediated ADCC against B Cell Lymphoma	PLOS ONE			English	Article								Macrophages are important effectors in the clearance of antibody-coated tumor cells. However, the signaling pathways that regulate macrophage-induced ADCC are poorly defined. To understand the regulation of macrophage-mediated ADCC, we used human B cell lymphoma coated with Rituximab as the tumor target and murine macrophages primed with IFN gamma as the effectors. Our data demonstrate that the PtdIns 3-kinase/Akt pathway is activated during macrophage-induced ADCC and that the inhibition of PtdIns 3-kinase results in the inhibition of macrophage-mediated cytotoxicity. Interestingly, downstream of PtdIns 3-kinase, expression of constitutively active Akt (Myr-Akt) in macrophages significantly enhanced their ability to mediate ADCC. Further analysis revealed that in this model, macrophage-mediated ADCC is dependent upon the release of nitric oxide (NO). However, the PtdIns 3-kinase/Akt pathway does not appear to regulate NO production. An examination of the role of the PtdIns 3-kinase/Akt pathway in regulating conjugate formation indicated that macrophages treated with an inhibitor of PtdIns 3-kinase fail to polarize the cytoskeleton at the synapse and show a significant reduction in the number of conjugates formed with tumor targets. Further, inhibition of PtdIns 3-kinase also reduced macrophage spreading on Rituximab-coated surfaces. On the other hand, Myr-Akt expressing macrophages displayed a significantly greater ability to form conjugates with tumor cells. Taken together, these findings illustrate that the PtdIns 3-kinase/Akt pathway plays a critical role in macrophage ADCC through its influence on conjugate formation between macrophages and antibody-coated tumor cells.	[Tridandapani, Susheela] Ohio State Univ, Biochem Program, Columbus, OH 43210 USA; [Ganesan, Latha P.; Tridandapani, Susheela] Ohio State Univ, Dept Internal Med, Div Pulmonary & Critical Care, Columbus, OH 43210 USA; [Ganesan, Latha P.; Tridandapani, Susheela] Ohio State Univ, Comprehensive Canc Ctr, Columbus, OH 43210 USA; [Cheney, Carolyn; Muthusamy, Natarajan; Byrd, John C.] Ohio State Univ, Coll Med, Div Hematol Oncol, Columbus, OH 43210 USA; [Ostrowski, Michael C.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Joshi, T (corresponding author), Ohio State Univ, Biochem Program, Columbus, OH 43210 USA.	tridandapani.2@osu.edu	Tridandapani, Susheela/E-4209-2011; Ostrowski, Michael/H-3108-2011	Ostrowski, Michael/0000-0003-2948-6297	NIH/NCI [R01 AI059406, P01 CA095426]; Leukemia and Lymphoma Society; D. Warren Brown Foundation; NATIONAL CANCER INSTITUTE [P01CA095426, R01CA053271, P01CA097189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059406] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); D. Warren Brown Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by NIH/NCI grants R01 AI059406 (ST), and P01 CA095426 (ST,NM, JCB) and Leukemia and Lymphoma Society and D. Warren Brown Foundation grants (JCB). The funders had no role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DO, 1980, J IMMUNOL, V124, P286; Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; AZZONI L, 1992, J EXP MED, V176, P1745, DOI 10.1084/jem.176.6.1745; Baron-Bodo W, 2005, IMMUNOBIOLOGY, V210, P267, DOI 10.1016/j.imbio.2005.05.021; Billadeau DD, 1998, J EXP MED, V188, P549, DOI 10.1084/jem.188.3.549; Brumbaugh KM, 1997, J EXP MED, V186, P1965, DOI 10.1084/jem.186.12.1965; CARPEN O, 1983, J IMMUNOL, V131, P2695; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Davis DM, 2002, TRENDS IMMUNOL, V23, P356, DOI 10.1016/S1471-4906(02)02243-3; DUERKSENHUGHES PJ, 1992, J IMMUNOL, V149, P2114; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Galandrini R, 2005, BLOOD, V106, P577, DOI 10.1182/blood-2004-10-4100; Ganesan LP, 2004, J BIOL CHEM, V279, P54416, DOI 10.1074/jbc.M408188200; Gismondi A, 2004, BLOOD, V104, P436, DOI 10.1182/blood-2003-07-2621; HIBBS JB, 1987, J IMMUNOL, V138, P550; HIGUCHI M, 1990, J IMMUNOL, V144, P1425; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; IYENGAR R, 1987, P NATL ACAD SCI USA, V84, P6369, DOI 10.1073/pnas.84.18.6369; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Joshi T, 2006, INT J HEMATOL, V84, P210, DOI 10.1532/IJH97.06140; KATZ P, 1982, J IMMUNOL, V129, P2816; KELLER R, 1990, INT J CANCER, V46, P682, DOI 10.1002/ijc.2910460422; Kota RS, 2006, BIOCHEM BIOPH RES CO, V342, P1137, DOI 10.1016/j.bbrc.2006.02.087; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; KUPFER A, 1983, P NATL ACAD SCI-BIOL, V80, P7224, DOI 10.1073/pnas.80.23.7224; LE JM, 1983, J IMMUNOL, V131, P2821; Lefebvre ML, 2006, J IMMUNOTHER, V29, P388, DOI 10.1097/01.cji.0000203081.43235.d7; MACE KF, 1988, CANCER RES, V48, P5427; May RC, 2001, J CELL SCI, V114, P1061; Miura TA, 2003, J IMMUNOL, V170, P4119, DOI 10.4049/jimmunol.170.8.4119; Nascimento FRF, 1998, BRAZ J MED BIOL RES, V31, P1593; NATHAN CF, 1979, J EXP MED, V149, P100, DOI 10.1084/jem.149.1.100; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Orange JS, 2003, P NATL ACAD SCI USA, V100, P14151, DOI 10.1073/pnas.1835830100; PACE JL, 1983, J IMMUNOL, V130, P2011; Patel JC, 2002, MOL BIOL CELL, V13, P1215, DOI 10.1091/mbc.02-01-0002; Plosker GL, 2003, DRUGS, V63, P803, DOI 10.2165/00003495-200363080-00005; POWELL CB, 1990, CANCER IMMUNOL IMMUN, V32, P131, DOI 10.1007/BF01754210; Ptak W, 1998, SCAND J IMMUNOL, V47, P136; Qian Y, 2004, AM J PHYSIOL-CELL PH, V286, pC153, DOI 10.1152/ajpcell.00142.2003; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Roda JM, 2006, J IMMUNOL, V177, P120, DOI 10.4049/jimmunol.177.1.120; Romieu-Mourez R, 2006, CANCER RES, V66, P10576, DOI 10.1158/0008-5472.CAN-06-1279; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; SHEPARD HM, 1988, J CLIN IMMUNOL, V8, P333, DOI 10.1007/BF00917148; Siddhanta U, 1998, J CELL BIOL, V143, P1647, DOI 10.1083/jcb.143.6.1647; STUEHR DJ, 1985, P NATL ACAD SCI USA, V82, P7738, DOI 10.1073/pnas.82.22.7738; SUGARMAN BJ, 1985, SCIENCE, V230, P943, DOI 10.1126/science.3933111; Uchida JJ, 2004, J EXP MED, V199, P1659, DOI 10.1084/jem.20040119; Vandermoere F, 2007, MOL CELL PROTEOMICS, V6, P114, DOI 10.1074/mcp.M600335-MCP200; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Vyas YM, 2002, IMMUNOL REV, V189, P161, DOI 10.1034/j.1600-065X.2002.18914.x; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Wei S, 1998, J EXP MED, V187, P1753, DOI 10.1084/jem.187.11.1753; Zhang Q, 1998, J BIOL CHEM, V273, P19977, DOI 10.1074/jbc.273.32.19977	57	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2009	4	1							e4208	10.1371/journal.pone.0004208	http://dx.doi.org/10.1371/journal.pone.0004208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IH	19148288	gold, Green Submitted, Green Published			2022-12-25	WOS:000265479900002
J	Wieten, L; Berlo, SE; ten Brink, CB; van Kooten, PJ; Singh, M; van der Zee, R; Glant, TT; Broere, F; van Eden, W				Wieten, Lotte; Berlo, Suzanne E.; ten Brink, Corlinda B.; van Kooten, Peter J.; Singh, Mahavir; van der Zee, Ruurd; Glant, Tibor T.; Broere, Femke; van Eden, Willem			IL-10 Is Critically Involved in Mycobacterial HSP70 Induced Suppression of Proteoglycan-Induced Arthritis	PLOS ONE			English	Article								Background: The anti-inflammatory capacity of heat shock proteins (HSP) has been demonstrated in various animal models of inflammatory diseases and in patients. However, the mechanisms underlying this anti-inflammatory capacity are poorly understood. Therefore, the possible protective potential of HSP70 and its mechanisms were studied in proteoglycan (PG) induced arthritis (PGIA), a chronic and relapsing, T cell mediated murine model of arthritis. Methodology/Principal Findings: HSP70 immunization, 10 days prior to disease induction with PG, inhibited arthritis both clinically and histologically. In addition, it significantly reduced PG-specific IgG2a but not IgG1 antibody production. Furthermore, IFN-gamma and IL-10 production upon in vitro restimulation with HSP70 was indicative of the induction of an HSP70-specific T cell response in HSP70 immunized mice. Remarkably, HSP70 treatment also modulated the PG-specific T cell response, as shown by the increased production of IL-10 and IFN-gamma upon in vitro PG restimulation. Moreover, it increased IL-10 mRNA expression in CD4(+)CD25(+) cells. HSP70 vaccination did not suppress arthritis in IL-10(-/-) mice, indicating the crucial role of IL-10 in the protective effect. Conclusions/Significance: In conclusion, a single mycobacterial HSP70 immunization can suppress inflammation and tissue damage in PGIA and results in an enhanced regulatory response as shown by the antigen-specific IL-10 production. Moreover, HSP70 induced protection is critically IL-10 dependent.	[Wieten, Lotte; Berlo, Suzanne E.; ten Brink, Corlinda B.; van Kooten, Peter J.; van der Zee, Ruurd; Broere, Femke; van Eden, Willem] Univ Utrecht, Div Immunol, Inst Infect Dis & Immunol, Utrecht, Netherlands; [Singh, Mahavir] LIONEX Diagnost & Therapeut GmbH, Braunschweig, Germany; [Glant, Tibor T.] Rush Univ, Med Ctr, Dept Orthoped Surg, Sect Mol Med, Chicago, IL USA	Utrecht University; Lionex Diagnostics & Therapeutics GmbH; Rush University	Wieten, L (corresponding author), Univ Utrecht, Div Immunol, Inst Infect Dis & Immunol, Utrecht, Netherlands.	f.broere@uu.nl	van der Zee, Ruurd/O-5256-2015; Broere, femke/C-2675-2012	van der Zee, Ruurd/0000-0002-4331-2755; van Eden, Willem/0000-0003-1272-704X; Broere, Femke/0000-0001-9343-0111	Dutch Arthritis Association; SenterNovem; IOP Genomics project [IGE03018]; European Union FP7 TOLERAGE [HEALTH-F4-2008-202156]	Dutch Arthritis Association; SenterNovem; IOP Genomics project; European Union FP7 TOLERAGE	This work was supported by grants of the Dutch Arthritis Association, "Reumafonds" and SenterNovem, IOP Genomics project nr IGE03018, the European Union FP7 TOLERAGE: HEALTH-F4-2008-202156. Funders were not involved in design and conduct of the study, collection analysis and interpretation of the data or in the preperation, review or approval of the manuscript.	ALBANI S, 1995, NAT MED, V1, P448, DOI 10.1038/nm0595-448; Berlo SE, 2006, ARTHRITIS RHEUM-US, V54, P2423, DOI 10.1002/art.22013; Bockova J, 1997, J AUTOIMMUN, V10, P323, DOI 10.1006/jaut.1997.0150; BOOG CJP, 1992, J EXP MED, V175, P1805, DOI 10.1084/jem.175.6.1805; Corrigall VM, 2001, J IMMUNOL, V166, P1492, DOI 10.4049/jimmunol.166.3.1492; de Kleer IM, 2003, ARTHRITIS RHEUM, V48, P2001, DOI 10.1002/art.11174; DEGRAEFFMEEDER ER, 1991, LANCET, V337, P1368, DOI 10.1016/0140-6736(91)93057-G; Edwards JCW, 2006, NAT REV IMMUNOL, V6, P394, DOI 10.1038/nri1838; Giant TT, 2004, METH MOLEC MED, V102, P313; Glant TT, 2003, CRIT REV IMMUNOL, V23, P199, DOI 10.1615/CritRevImmunol.v23.i3.20; Guichelaar T, 2008, J IMMUNOL, V180, P1373, DOI 10.4049/jimmunol.180.3.1373; Hanyecz A, 2004, ARTHRITIS RHEUM-US, V50, P1665, DOI 10.1002/art.20180; Haug M, 2005, EUR J IMMUNOL, V35, P3163, DOI 10.1002/eji.200535050; Kamphuis S, 2005, LANCET, V366, P50, DOI 10.1016/S0140-6736(05)66827-4; Kaplan C, 2002, ARTHRITIS RES, V4, P54, DOI 10.1186/ar383; KATSIKIS PD, 1994, J EXP MED, V179, P1517, DOI 10.1084/jem.179.5.1517; Kim HR, 2006, J IMMUNOL, V177, P6634, DOI 10.4049/jimmunol.177.10.6634; Kingston AE, 1996, CLIN EXP IMMUNOL, V103, P77, DOI 10.1046/j.1365-2249.1996.929628.x; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Mekala DJ, 2005, P NATL ACAD SCI USA, V102, P11817, DOI 10.1073/pnas.0505445102; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; O'Neill SK, 2005, J IMMUNOL, V174, P3781, DOI 10.4049/jimmunol.174.6.3781; Prakken BJ, 2004, P NATL ACAD SCI USA, V101, P4228, DOI 10.1073/pnas.0400061101; Prakken BJ, 2001, J IMMUNOL, V167, P4147, DOI 10.4049/jimmunol.167.8.4147; Quintana FJ, 2004, ARTHRITIS RHEUM-US, V50, P3712, DOI 10.1002/art.20635; Raz I, 2001, LANCET, V358, P1749, DOI 10.1016/S0140-6736(01)06801-5; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Roncarolo MG, 2008, EUR J IMMUNOL, V38, P925, DOI 10.1002/eji.200838168; Schett G, 1998, J CLIN INVEST, V102, P302, DOI 10.1172/JCI2465; Tanaka S, 1999, J IMMUNOL, V163, P5560; TANG Q, 2005, NAT IMMUNOL, V9, P239; Ulmansky R, 2002, J IMMUNOL, V168, P6463, DOI 10.4049/jimmunol.168.12.6463; van der Zee R, 1998, SEMIN IMMUNOL, V10, P35, DOI 10.1006/smim.1997.0103; van Eden W, 2003, ARTHRITIS RHEUM-US, V48, P1788, DOI 10.1002/art.11077; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; Van Eden W, 2007, ANN NY ACAD SCI, V1113, P217, DOI 10.1196/annals.1391.020; van Puijvelde HM, 2007, ARTERIOSCL THROM VAS, V27, P2677, DOI 10.1161/ATVBAHA.107.151274; vanRoon JAG, 1996, ARTHRITIS RHEUM, V39, P829, DOI 10.1002/art.1780390516; Verhoef CM, 2001, J RHEUMATOL, V28, P1960; Wendling U, 2000, J IMMUNOL, V164, P2711, DOI 10.4049/jimmunol.164.5.2711	40	51	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4186	10.1371/journal.pone.0004186	http://dx.doi.org/10.1371/journal.pone.0004186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142233	Green Published, gold, Green Submitted			2022-12-25	WOS:000265479700007
J	Bhak, G; Lee, JH; Hahn, JS; Paik, SR				Bhak, Ghibom; Lee, Jung-Ho; Hahn, Ji-Sook; Paik, Seung R.			Granular Assembly of alpha-Synuclein Leading to the Accelerated Amyloid Fibril Formation with Shear Stress	PLOS ONE			English	Article								alpha-Synuclein participates in the Lewy body formation of Parkinson's disease. Elucidation of the underlying molecular mechanism of the amyloid fibril formation is crucial not only to develop a controlling strategy toward the disease, but also to apply the protein fibrils for future biotechnology. Discernable homogeneous granules of alpha-synuclein composed of approximately 11 monomers in average were isolated in the middle of a lag phase during the in vitro fibrillation process. They were demonstrated to experience almost instantaneous fibrillation during a single 12-min centrifugal membrane-filtration at 14,000xg. The granular assembly leading to the drastically accelerated fibril formation was demonstrated to be a result of the physical influence of shear force imposed on the preformed granular structures by either centrifugal filtration or rheometer. Structural rearrangement of the preformed oligomomeric structures is attributable for the suprastructure formation in which the granules act as a growing unit for the fibril formation. To parallel the prevailing notion of nucleation-dependent amyloidosis, we propose a double-concerted fibrillation model as one of the mechanisms to explain the in vitro fibrillation of alpha-synuclein, in which two consecutive concerted associations of monomers and subsequent oligomeric granular species are responsible for the eventual amyloid fibril formation.	[Bhak, Ghibom; Lee, Jung-Ho; Hahn, Ji-Sook; Paik, Seung R.] Seoul Natl Univ, Sch Chem & Biol Engn, Coll Engn, Seoul, South Korea	Seoul National University (SNU)	Bhak, G (corresponding author), Seoul Natl Univ, Sch Chem & Biol Engn, Coll Engn, Seoul, South Korea.	srpaik@snu.ac.kr	Rho, Hyunji/R-6242-2016	Rho, Hyunji/0000-0001-7650-8933	Korea Science and Engineering Foundation [R01-2007-000-20089-0]; Institute of Bioengineering at SNU [10538]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Institute of Bioengineering at SNU	This study was supported in part by a basic research program grant (R01-2007-000-20089-0) from Korea Science and Engineering Foundation and by another grant from the Seoul R&BD Program (10538) through Institute of Bioengineering at SNU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrer K, 2006, J MEMBRANE SCI, V274, P108, DOI 10.1016/j.memsci.2005.08.018; Apetri MM, 2006, J MOL BIOL, V355, P63, DOI 10.1016/j.jmb.2005.10.071; ASAKURA T, 1973, NATURE, V244, P437, DOI 10.1038/244437a0; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bajaj H, 2004, BIOPHYS J, V87, P4048, DOI 10.1529/biophysj.104.048686; Barg A, 2007, THROMB HAEMOSTASIS, V97, P514, DOI 10.1160/TH06-05-0274; Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Calamai M, 2005, J MOL BIOL, V346, P603, DOI 10.1016/j.jmb.2004.11.067; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; CHARM SE, 1971, BIOTECHNOL BIOENG, V13, P185, DOI 10.1002/bit.260130203; Cheon M, 2007, PLOS COMPUT BIOL, V3, P1727, DOI 10.1371/journal.pcbi.0030173; Cherny I, 2008, ANGEW CHEM INT EDIT, V47, P4062, DOI 10.1002/anie.200703133; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Elias C B, 1998, Adv Biochem Eng Biotechnol, V59, P47; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hill EK, 2006, BIOMACROMOLECULES, V7, P10, DOI 10.1021/bm0505078; Kaylor J, 2005, J MOL BIOL, V353, P357, DOI 10.1016/j.jmb.2005.08.046; KIM KJ, 1993, BIOTECHNOL BIOENG, V42, P260, DOI 10.1002/bit.260420216; Kurnaz ML, 1997, PHYS REV E, V55, P572, DOI 10.1103/PhysRevE.55.572; LEE JH, 2008, BIOPHYS J IN PRESS; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Maa YF, 1996, BIOTECHNOL BIOENG, V51, P458, DOI 10.1002/(SICI)1097-0290(19960820)51:4<458::AID-BIT9>3.0.CO;2-H; Maiti NC, 2004, J AM CHEM SOC, V126, P2399, DOI 10.1021/ja0356176; MAR CD, 2005, P NATL ACAD SCI USA, V102, P15477; Maruyama T, 2001, BIOTECHNOL BIOENG, V75, P233, DOI 10.1002/bit.10001; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; MOAKE JL, 1986, J CLIN INVEST, V78, P1456, DOI 10.1172/JCI112736; Modler AJ, 2003, J MOL BIOL, V325, P135, DOI 10.1016/S0022-2836(02)01175-0; Murphy R. M., 2006, MISBEHAVING PROTEINS; Naiki H, 1999, METHOD ENZYMOL, V309, P305; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nguyen PH, 2007, P NATL ACAD SCI USA, V104, P111, DOI 10.1073/pnas.0607440104; Paik SR, 1997, ARCH BIOCHEM BIOPHYS, V344, P325, DOI 10.1006/abbi.1997.0207; Pallitto MM, 2001, BIOPHYS J, V81, P1805, DOI 10.1016/S0006-3495(01)75831-6; REESE ET, 1980, BIOTECHNOL BIOENG, V22, P323, DOI 10.1002/bit.260220207; Ruggeri ZM, 2003, J THROMB HAEMOST, V1, P1335, DOI 10.1046/j.1538-7836.2003.00260.x; Ruggeri ZM, 1997, J CLIN INVEST, V99, P559, DOI 10.1172/JCI119195; Sacchettini JC, 2002, NAT REV DRUG DISCOV, V1, P267, DOI 10.1038/nrd769; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tappel A, 2004, MED HYPOTHESES, V63, P98, DOI 10.1016/j.mehy.2004.01.022; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874	59	48	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2009	4	1							e4177	10.1371/journal.pone.0004177	http://dx.doi.org/10.1371/journal.pone.0004177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ID	19137068	Green Submitted, gold, Green Published			2022-12-25	WOS:000265479500008
J	Kumar, S; Farhana, A; Hasnain, SE				Kumar, Sandeep; Farhana, Aisha; Hasnain, Seyed E.			In-Vitro Helix Opening of M. tuberculosis oriC by DnaA Occurs at Precise Location and Is Inhibited by IciA Like Protein	PLOS ONE			English	Article								Background: Mycobacterium tuberculosis (M.tb), the pathogen that causes tuberculosis, is capable of staying asymptomatically in a latent form, persisting for years in very low replicating state, before getting reactivated to cause active infection. It is therefore important to study M.tb chromosome replication, specifically its initiation and regulation. While the region between dnaA and dnaN gene is capable of autonomous replication, little is known about the interaction between DnaA initiator protein, oriC origin of replication sequences and their negative effectors of replication. Methodology/Principal Findings: By KMnO4 mapping assays the sequences involved in open complex formation within oriC, mediated by M.tb DnaA protein, were mapped to position 2500 to 2518 with respect to the dnaN gene. Contrary to E. coli, the M.tb DnaA in the presence of non-hydrolysable analogue of ATP (ATP gamma S) was unable to participate in helix opening thereby pointing to the importance of ATP hydrolysis. Interestingly, ATPase activity in the presence of supercoiled template was higher than that observed for DnaA box alone. M.tb rRv1985c, a homologue of E. coli IciA (Inhibitor of chromosomal initiation) protein, could inhibit DnaA-mediated in-vitro helix opening by specifically binding to A+T rich region of oriC, provided the open complex formation had not initiated. rIciA could also inhibit in-vitro replication of plasmid carrying the M.tb origin of replication. Conclusions/Significance: These results have a bearing on the functional role of the important regulator of M.tb chromosomal replication belonging to the LysR family of bacterial regulatory proteins in the context of latency.	[Farhana, Aisha] CDFD, Lab Mol & Cellular Biol, Hyderabad, Andhra Pradesh, India; [Hasnain, Seyed E.] Univ Hyderabad, Inst Life Sci, Hyderabad 500134, Andhra Pradesh, India; [Hasnain, Seyed E.] Univ Hyderabad, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India; [Hasnain, Seyed E.] Jawaharlal Nehru Ctr Advanced Sci Res, Bangalore, Karnataka, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); University of Hyderabad; University of Hyderabad; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Kumar, S (corresponding author), CDFD, Lab Mol & Cellular Biol, Hyderabad, Andhra Pradesh, India.	seh@uohyd.ernet.in	Farhana, Aisha/AAR-7356-2020; KUMAR, SANDEEP/GZA-7182-2022	Farhana, Aisha/0000-0002-4631-2769; Hasnain, Seyed/0000-0002-2967-0791	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India; Government of India [J. C. Bose National Fellow, Senior Research Fellowships]; Council of Scientific and Industrial Research (CSIR), Government of India	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Government of India; Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was partly supported by research grant to SEH from the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India. SEH is a J. C. Bose National Fellow, Government of India. SK and AF thank the Council of Scientific and Industrial Research (CSIR), Government of India for Senior Research Fellowships.	Azam TA, 1999, J BIOL CHEM, V274, P33105, DOI 10.1074/jbc.274.46.33105; Banerjee S, 2007, J BACTERIOL, V189, P4046, DOI 10.1128/JB.00026-07; BRAMHILL D, 1988, CELL, V54, P915, DOI 10.1016/0092-8674(88)90102-X; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; FULLER RS, 1981, P NATL ACAD SCI-BIOL, V78, P7370, DOI 10.1073/pnas.78.12.7370; Ghosh S, 2004, BIOTECHNIQUES, V37, P418, DOI 10.2144/04373ST07; GILLE H, 1991, METHOD ENZYMOL, V208, P146; Han JS, 1998, MOL GEN GENET, V259, P610, DOI 10.1007/s004380050854; HWANG DS, 1992, J BIOL CHEM, V267, P23087; HWANG DS, 1990, CELL, V63, P325, DOI 10.1016/0092-8674(90)90165-B; Katayama T, 2001, MOL MICROBIOL, V41, P9, DOI 10.1046/j.1365-2958.2001.02483.x; Kitagawa R, 1996, MOL MICROBIOL, V19, P1137, DOI 10.1046/j.1365-2958.1996.453983.x; Krause M, 1997, J MOL BIOL, V274, P365, DOI 10.1006/jmbi.1997.1404; Lee YS, 1996, MOL MICROBIOL, V19, P389, DOI 10.1046/j.1365-2958.1996.485902.x; Madiraju MVVS, 2006, MOL MICROBIOL, V59, P1876, DOI 10.1111/j.1365-2958.2006.05068.x; McGarry KC, 2004, P NATL ACAD SCI USA, V101, P2811, DOI 10.1073/pnas.0400340101; MORIYA S, 1992, MOL MICROBIOL, V6, P309, DOI 10.1111/j.1365-2958.1992.tb01473.x; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; Nandineni MR, 2004, J BACTERIOL, V186, P3539, DOI 10.1128/JB.186.11.3539-3546.2004; Ogawa T, 2002, MOL MICROBIOL, V44, P1367, DOI 10.1046/j.1365-2958.2002.02969.x; Prakash P, 2005, J BIOL CHEM, V280, P19641, DOI 10.1074/jbc.M413026200; Prakash P, 2005, BIOINFORMATICS, V21, P2161, DOI 10.1093/bioinformatics/bti375; Qin MH, 1997, J BACTERIOL, V179, P6311, DOI 10.1128/jb.179.20.6311-6317.1997; Qin MH, 1999, GENE, V233, P121, DOI 10.1016/S0378-1119(99)00148-1; RAJAGOPALAN M, 1995, J BACTERIOL, V177, P6527, DOI 10.1128/jb.177.22.6527-6535.1995; Salazar L, 1996, MOL MICROBIOL, V20, P283, DOI 10.1111/j.1365-2958.1996.tb02617.x; SCHAPER S, 1995, J BIOL CHEM, V270, P17622, DOI 10.1074/jbc.270.29.17622; Seitz H, 2001, EMBO REP, V2, P1003, DOI 10.1093/embo-reports/kve225; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; SEKIMIZU K, 1988, J BIOL CHEM, V263, P7124; THONY B, 1991, P NATL ACAD SCI USA, V88, P4066, DOI 10.1073/pnas.88.10.4066; WAYNE LG, 1994, EUR J CLIN MICROBIOL, V13, P908, DOI 10.1007/BF02111491; Wei T, 1996, NUCLEIC ACIDS RES, V24, P1865, DOI 10.1093/nar/24.10.1865; Zawilak A, 2004, BIOCHEM J, V382, P247, DOI 10.1042/BJ20040338; Zawilak-Pawlik A, 2005, BIOCHEM J, V389, P471, DOI 10.1042/BJ20050143	37	18	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4139	10.1371/journal.pone.0004139	http://dx.doi.org/10.1371/journal.pone.0004139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FX	19127296	Green Published, gold			2022-12-25	WOS:000265473300007
J	Peters, M; Simmons, LW; Rhodes, G				Peters, Marianne; Simmons, Leigh W.; Rhodes, Gillian			Preferences across the Menstrual Cycle for Masculinity and Symmetry in Photographs of Male Faces and Bodies	PLOS ONE			English	Article							HUMAN FEMALE PREFERENCES; WOMENS PREFERENCES; SEXUAL-DIMORPHISM; FACIAL ATTRACTIVENESS; EVOLUTIONARY PSYCHOLOGY; APPARENT HEALTH; MATING SUCCESS; TESTOSTERONE; OVULATION; SCENT	Background: Previous studies have shown that women increase their preference for masculinity during the fertile phase of the menstrual cycle. Evidence for a similar preference shift for symmetry is equivocal. These studies have required participants to choose between subtle variations in computer-generated stimuli, and preferences for more natural stimuli have not been investigated. Methodology/Principal Findings: Our study employed photographs of individual males to investigate women's preferences for face and body masculinity and symmetry across the menstrual cycle. We collected attractiveness ratings from 25 normally cycling women at high- and low-fertility days of the menstrual cycle. Attractiveness ratings made by these women were correlated with independent ratings of masculinity and symmetry provided by different sets of raters. We found no evidence for any cyclic shift in female preferences. Correlations between attractiveness and masculinity, and attractiveness and symmetry did not differ significantly between high- and low-fertility test sessions. Furthermore, there was no significant difference between high- and low-fertility ratings of attractiveness. Conclusions: These results suggest that a menstrual cycle shift in visual preferences for masculinity and symmetry may be too subtle to influence responses to real faces and bodies, and subsequent mate-choice decisions.	[Simmons, Leigh W.] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, Australia; [Peters, Marianne; Rhodes, Gillian] Univ Western Australia, Sch Psychol, Crawley, WA, Australia	University of Western Australia; University of Western Australia	Peters, M (corresponding author), Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, Australia.	mpeters@cyllene.uwa.edu.au	Simmons, Leigh W/B-1815-2011	Simmons, Leigh W/0000-0003-0562-1474; Rhodes, Gillian/0000-0002-3631-8518	University of Western Australia [scholarship]; Australian Research Council (ARC)	University of Western Australia; Australian Research Council (ARC)(Australian Research Council)	MP was supported with a scholarship from the University of Western Australia. GR & LWS were supported with Australian Research Council (ARC) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber N, 1995, ETHOL SOCIOBIOL, V16, P395, DOI 10.1016/0162-3095(95)00068-2; Bullivant SB, 2004, J SEX RES, V41, P82, DOI 10.1080/00224490409552216; Cardenas RA, 2007, EVOL HUM BEHAV, V28, P96, DOI 10.1016/j.evolhumbehav.2006.08.003; Cohen J., 1983, APPL MULTIPLE REGRES; DeBruine LM, 2006, P ROY SOC B-BIOL SCI, V273, P1355, DOI 10.1098/rspb.2005.3445; DOTY RL, 1981, J COMP PHYSIOL PSYCH, V95, P45, DOI 10.1037/h0077755; Feinberg DR, 2006, HORM BEHAV, V49, P215, DOI 10.1016/j.yhbeh.2005.07.004; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; FROST P, 1994, PERCEPT MOTOR SKILL, V79, P507, DOI 10.2466/pms.1994.79.1.507; Gangestad SW, 1998, P ROY SOC B-BIOL SCI, V265, P927, DOI 10.1098/rspb.1998.0380; Gangestad SW, 2002, P ROY SOC B-BIOL SCI, V269, P975, DOI 10.1098/rspb.2001.1952; Gangestad SW, 2004, PSYCHOL SCI, V15, P203, DOI 10.1111/j.0956-7976.2004.01503010.x; Gangestad SW., 1997, EVOLUTIONARY SOCIAL, P169; Gilbert S.F., 2000, DEV BIOL, V6th ed.; Guermandi E, 2001, OBSTET GYNECOL, V97, P92, DOI 10.1016/S0029-7844(00)01083-8; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Havlicek J, 2005, BIOL LETTERS, V1, P256, DOI 10.1098/rsbl.2005.0332; Johnston VS, 2001, EVOL HUM BEHAV, V22, P251, DOI 10.1016/S1090-5138(01)00066-6; Jones BC, 2005, HORM BEHAV, V48, P283, DOI 10.1016/j.yhbeh.2005.03.010; Jones BC, 2005, P ROY SOC B-BIOL SCI, V272, P347, DOI 10.1098/rspb.2004.2962; Koehler N, 2004, P ROY SOC B-BIOL SCI, V271, pS233, DOI 10.1098/rsbl.2003.0146; Koehler N, 2002, ANIM BEHAV, V64, P233, DOI 10.1006/anbe.2002.3063; Little AC, 2002, P ROY SOC B-BIOL SCI, V269, P1095, DOI 10.1098/rspb.2002.1984; Little AC, 2007, BIOL PSYCHOL, V76, P209, DOI 10.1016/j.biopsycho.2007.08.003; Little AC, 2007, HORM BEHAV, V51, P633, DOI 10.1016/j.yhbeh.2007.03.006; Moller A.P., 1997, ASYMMETRY DEV STABIL; Oinonen KA, 2007, BIOL PSYCHOL, V75, P136, DOI 10.1016/j.biopsycho.2007.01.003; Pawlowski B, 2005, BIOL PSYCHOL, V70, P38, DOI 10.1016/j.biopsycho.2005.02.002; Penton-Voak IS, 1999, NATURE, V399, P741, DOI 10.1038/21557; Penton-Voak IS, 2000, EVOL HUM BEHAV, V21, P39, DOI 10.1016/S1090-5138(99)00033-1; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Peters M, 2008, J EVOLUTION BIOL, V21, P572, DOI 10.1111/j.1420-9101.2007.01477.x; Peters M, 2008, ANIM BEHAV, V76, P297, DOI 10.1016/j.anbehav.2008.02.008; Polak M., 2003, CAUSES CONSEQUENCES; Puts DA, 2005, EVOL HUM BEHAV, V26, P388, DOI 10.1016/j.evolhumbehav.2005.03.001; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G, 2005, EVOL HUM BEHAV, V26, P186, DOI 10.1016/j.evolhumbehav.2004.08.014; Rhodes G, 2003, P ROY SOC B-BIOL SCI, V270, pS93, DOI 10.1098/rsbl.2003.0023; Rikowski A, 1999, P ROY SOC B-BIOL SCI, V266, P869, DOI 10.1098/rspb.1999.0717; Simmons LW, 2004, BEHAV ECOL, V15, P864, DOI 10.1093/beheco/arh099; Sinha-Hikim I, 1998, J CLIN ENDOCR METAB, V83, P1312, DOI 10.1210/jc.83.4.1312; Small CM, 2007, ANN EPIDEMIOL, V17, P163, DOI 10.1016/j.annepidem.2006.05.005; Stern K, 1998, NATURE, V392, P177, DOI 10.1038/32408; Thornhill R, 1999, EVOL HUM BEHAV, V20, P175, DOI 10.1016/S1090-5138(99)00005-7; Thornhill R, 2003, BEHAV ECOL, V14, P668, DOI 10.1093/beheco/arg043; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; Thornhill R, 1997, BIOL REV, V72, P497, DOI 10.1017/S0006323197005082; Welling LLM, 2007, HORM BEHAV, V52, P156, DOI 10.1016/j.yhbeh.2007.01.010; WILCOX AJ, 1995, NEW ENGL J MED, V333, P1517, DOI 10.1056/NEJM199512073332301	49	68	70	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4138	10.1371/journal.pone.0004138	http://dx.doi.org/10.1371/journal.pone.0004138			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437FX	19127295	Green Published, Green Submitted, gold			2022-12-25	WOS:000265473300006
J	Lanner, JT; Bruton, JD; Assefaw-Redda, Y; Andronache, Z; Zhang, SJ; Severa, D; Zhang, ZB; Melzer, W; Zhang, SL; Katz, A; Westerblad, H				Lanner, Johanna T.; Bruton, Joseph D.; Assefaw-Redda, Yohannes; Andronache, Zoita; Zhang, Shi-Jin; Severa, Denise; Zhang, Zhi-Bin; Melzer, Werner; Zhang, Shi-Li; Katz, Abram; Westerblad, Hakan			Knockdown of TRPC3 with siRNA coupled to carbon nanotubes results in decreased insulin-mediated glucose uptake in adult skeletal muscle cells	FASEB JOURNAL			English	Article						Ca(2+); sarcolemma; transverse tubules; near-membrane Ca(2+); colocalization	PROTEIN-KINASE-C; STIMULATED GLUT4 TRANSLOCATION; CATION CHANNELS; TRANSVERSE TUBULES; PLASMA-MEMBRANE; CALCIUM SENSOR; VESICLE FUSION; SLOW-TWITCH; CA2+ INFLUX; ACTIVATION	The involvement of Ca(2+) in the insulin-mediated signaling cascade, resulting in glucose uptake in skeletal muscle, is uncertain. Here, we test the hypothesis that Ca(2+) influx through canonical transient receptor potential 3 (TRPC3) channels modulates insulin-mediated glucose uptake in adult skeletal muscle. Experiments were performed on adult skeletal muscle cells of wild-type (WT) and obese, insulin-resistant ob/ob mice. Application of the diacylglycerol analog 1-oleyl-2-acetyl-sn-glycerol (OAG) induced a nonselective cation current, which was inhibited by the addition of anti-TRPC3 antibody in the patch pipette and smaller in ob/ob than in WT cells. Knockdown of TRPC3, using a novel technique based on small interfering RNA (siRNA) coupled to functionalized carbon nanotubes, resulted in pronounced (similar to 70%) decreases in OAG-induced Ca(2+) influx and insulin-mediated glucose uptake. TRPC3 and the insulin-sensitive glucose transporter 4 (GLUT4) coimmunoprecipitated, and immunofluorescence staining showed that they were colocalized in the proximity of the transverse tubular system, which is the predominant site of insulin-mediated glucose transport in skeletal muscle. In conclusion, our results indicate that TRPC3 interacts functionally and physically with GLUT4, and Ca(2+) influx through TRPC3 modulates insulin-mediated glucose uptake. Thus, TRPC3 is a potential target for treatment of insulin-resistant conditions.-Lanner, J. T., Bruton, J. D., Assefaw-Redda, Y., Andronache, Z., Zhang, S.- J., Severa, D., Zhang, Z.- B., Melzer, W., Zhang, S.-L., Katz, A., Westerblad, H. Knockdown of TRPC3 with siRNA coupled to carbon nanotubes results in decreased insulin-mediated glucose uptake in adult skeletal muscle cells. FASEB J. 23, 1728-1738 (2009)	[Lanner, Johanna T.; Bruton, Joseph D.; Zhang, Shi-Jin; Severa, Denise; Katz, Abram; Westerblad, Hakan] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Assefaw-Redda, Yohannes; Zhang, Zhi-Bin; Zhang, Shi-Li] Royal Inst Technol, Sch Informat & Commun Technol, Stockholm, Sweden; [Andronache, Zoita; Melzer, Werner] Univ Ulm, Inst Angew Physiol, Ulm, Germany	Karolinska Institutet; Royal Institute of Technology; Ulm University	Lanner, JT (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden.	lanner@bcm.tmc.edu	Tuluc, Petronel/C-2527-2011; Zhang, Zhibin/H-4917-2016; Katz, Abram/AAL-2244-2020	Lanner, Johanna/0000-0002-1222-9473; Bruton, Joseph/0000-0002-6985-099X; Westerblad, Hakan/0000-0002-8180-3029	Swedish Research Council; Biovitrum Partner Fund; Swedish Diabetes Foundation; Karolinska Institutet, Tornspiran; Lars Hierta Memorial Fund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Biovitrum Partner Fund; Swedish Diabetes Foundation; Karolinska Institutet, Tornspiran; Lars Hierta Memorial Fund	We thank Margareta Forsgren, Katrin Bergdahl, Kerstin Larsson, and Christina Sorving for the assistance with RT-PCR analysis. The present study was supported by the Swedish Research Council, the Biovitrum Partner Fund, the Swedish Diabetes Foundation, funds at the Karolinska Institutet, Tornspiran, and the Lars Hierta Memorial Fund.	Albert AP, 2006, J PHYSIOL-LONDON, V571, P361, DOI 10.1113/jphysiol.2005.102780; Andrade FH, 1998, J PHYSIOL-LONDON, V509, P565, DOI 10.1111/j.1469-7793.1998.565bn.x; Baylor SM, 2003, J PHYSIOL-LONDON, V551, P125, DOI 10.1113/jphysiol.2003.041608; Bruton JD, 1999, P NATL ACAD SCI USA, V96, P3281, DOI 10.1073/pnas.96.6.3281; Bruton JD, 2001, ACTA PHYSIOL SCAND, V171, P259, DOI 10.1046/j.1365-201x.2001.00828.x; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; BURGOYNE RD, 1993, BIOCHEM J, V293, P305, DOI 10.1042/bj2930305; Cheatham B, 2000, TRENDS ENDOCRIN MET, V11, P356, DOI 10.1016/S1043-2760(00)00308-8; DEFRONZO RA, 1985, J CLIN INVEST, V76, P149, DOI 10.1172/JCI111938; Dugani CB, 2005, EMBO REP, V6, P1137, DOI 10.1038/sj.embor.7400584; Dumortier H, 2006, NANO LETT, V6, P1522, DOI 10.1021/nl061160x; Fauconnier J, 2007, CARDIOVASC RES, V73, P376, DOI 10.1016/j.cardiores.2006.10.018; Foster LJ, 2000, AM J PHYSIOL-CELL PH, V279, pC877, DOI 10.1152/ajpcell.2000.279.4.C877; HANDBERG A, 1990, DIABETOLOGIA, V33, P625, DOI 10.1007/BF00400207; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; HUXLEY AF, 1954, NATURE, V173, P971, DOI 10.1038/173971a0; Inoue G, 1999, P NATL ACAD SCI USA, V96, P14919, DOI 10.1073/pnas.96.26.14919; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Kam NWS, 2005, J AM CHEM SOC, V127, P12492, DOI 10.1021/ja053962k; Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Khan AH, 2002, DIABETOLOGIA, V45, P1475, DOI 10.1007/s00125-002-0974-7; Khan AH, 2001, J BIOL CHEM, V276, P4063, DOI 10.1074/jbc.M007419200; Kostarelos K, 2007, NAT NANOTECHNOL, V2, P108, DOI 10.1038/nnano.2006.209; Kraegen EW, 2006, AM J PHYSIOL-ENDOC M, V290, pE471, DOI 10.1152/ajpendo.00316.2005; Kruger J, 2008, NEUROMUSCULAR DISORD, V18, P501, DOI 10.1016/j.nmd.2008.04.003; Kubis HP, 2003, AM J PHYSIOL-CELL PH, V285, pC56, DOI 10.1152/ajpcell.00377.2002; Kwan HY, 2006, J CELL PHYSIOL, V207, P315, DOI 10.1002/jcp.20567; Lanner JT, 2008, CURR OPIN PHARMACOL, V8, P339, DOI 10.1016/j.coph.2008.01.006; Lanner JT, 2006, DIABETES, V55, P2077, DOI 10.2337/db05-1613; Lauritzen HPMM, 2006, DIABETES, V55, P1300, DOI 10.2337/db05-1216; Lee EH, 2006, J BIOL CHEM, V281, P10042, DOI 10.1074/jbc.M600981200; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Li YY, 2007, BIOCHEM BIOPH RES CO, V362, P658, DOI 10.1016/j.bbrc.2007.08.023; LIN S, 1978, P NATL ACAD SCI USA, V75, P329, DOI 10.1073/pnas.75.1.329; Liu YW, 1997, AM J PHYSIOL-CELL PH, V273, pC1915, DOI 10.1152/ajpcell.1997.273.6.C1915; Liu Z, 2007, NAT NANOTECHNOL, V2, P47, DOI 10.1038/nnano.2006.170; LUND S, 1994, AM J PHYSIOL, V267, pE461, DOI 10.1152/ajpendo.1994.267.3.E461; MARETTE A, 1992, DIABETES, V41, P1562, DOI 10.2337/diabetes.41.12.1562; Martin S, 1996, J CELL BIOL, V134, P625, DOI 10.1083/jcb.134.3.625; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; MUNOZ P, 1995, BIOCHEM J, V312, P393, DOI 10.1042/bj3120393; Okada S, 2007, BIOCHEM BIOPH RES CO, V356, P102, DOI 10.1016/j.bbrc.2007.02.095; PEDERSEN O, 1990, DIABETES, V39, P865, DOI 10.2337/diabetes.39.7.865; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Plant TD, 2005, N-S ARCH PHARMACOL, V371, P266, DOI 10.1007/s00210-005-1055-5; Plant TD, 2003, CELL CALCIUM, V33, P441, DOI 10.1016/S0143-4160(03)00055-1; Pramfalk C, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-7; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Sapru MK, 2002, J NEUROSCI METH, V114, P99, DOI 10.1016/S0165-0270(01)00518-0; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Smyth JT, 2006, J BIOL CHEM, V281, P11712, DOI 10.1074/jbc.M510541200; Trebak M, 2005, MOL PHARMACOL, V67, P558, DOI 10.1124/mol.104.007252; Trebak M, 2003, CELL CALCIUM, V33, P451, DOI 10.1016/S0143-4160(03)00056-3; Trebak M, 2003, J BIOL CHEM, V278, P16244, DOI 10.1074/jbc.M300544200; Trebak M, 2002, J BIOL CHEM, V277, P21617, DOI 10.1074/jbc.M202549200; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Vazquez G, 2004, BBA-MOL CELL RES, V1742, P21, DOI 10.1016/j.bbamcr.2004.08.015; Vazquez G, 2003, J BIOL CHEM, V278, P21649, DOI 10.1074/jbc.M302162200; Venkatachalam K, 2003, J BIOL CHEM, V278, P29031, DOI 10.1074/jbc.M302751200; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; Whitehead JP, 2001, J BIOL CHEM, V276, P27816, DOI 10.1074/jbc.M011590200; Yoshihara M, 2003, CURR OPIN NEUROBIOL, V13, P315, DOI 10.1016/S0959-4388(03)00063-1; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhang YH, 2003, CIRC RES, V92, P765, DOI 10.1161/01.RES.0000065920.64121.FC	69	47	50	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2009	23	6					1728	1738		10.1096/fj.08-116814	http://dx.doi.org/10.1096/fj.08-116814			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19141536				2022-12-25	WOS:000266652400013
J	Ziemba, SE; Menard, SL; McCabe, MJ; Rosenspire, AJ				Ziemba, Stamatina E.; Menard, Sherri L.; McCabe, Michael J., Jr.; Rosenspire, Allen J.			T-cell receptor signaling is mediated by transient Lck activity, which is inhibited by inorganic mercury	FASEB JOURNAL			English	Article						Hg2+; ZAP-70; lymphocyte; signal transduction	TYROSINE PROTEIN-KINASE; INDUCED AUTOIMMUNITY; SH2 DOMAIN; ACTIVATION; PHOSPHORYLATION; ZAP-70; MECHANISM; LAT; TCR; TRANSDUCTION	Genetically susceptible rodents exposed to low nontoxic levels of inorganic mercury (Hg2+) develop idiosyncratic autoimmune disease associated with defective T-cell function. However, the molecular mechanisms underlying this phenomenon remain mostly unexplained. Brief exposure of T cells to micromolar concentrations of Hg2+ leads to physiologically relevant nontoxic cellular mercury burdens, and as we have previously reported, attenuates T-cell receptor (TCR) signal strength by similar to 50%. We have found this to be the result of an inadequate activation of the tyrosine kinase ZAP-70, which is hypophosphorylated following TCR stimulation in Hg2+ burdened cells when compared to untreated controls. In T cells, ZAP-70 phosphorylation is dependent on lymphocyte-specific protein tyrosine kinase (Lck) activity, which in turn is either positively or negatively regulated by the phosphorylation of specific Lck tyrosine residues. In particular, the general belief is that Lck is negatively regulated by phosphorylation of tyrosine 192 (Y192). We now demonstrate by Western blotting that, in Jurkat T cells, TCR signal transduction (and ZAP-70 phosphorylation) was positively associated with a rapid transient phosphorylation of Y192, which was inhibited in cells that were briefly (5 min) exposed to 5 mu M Hg2+. Thus, Hg2+ inhibits a critical activating role played by Lck Y192 during the most proximal events of the TCR-induced cell signaling.-Ziemba, S. E., Menard, S. L., McCabe, Jr., M. J., Rosenspire, A.J.T-cell receptor signaling is mediated by transient Lck activity, which is inhibited by inorganic mercury. FASEB J. 23, 1663-1671 (2009)	[Ziemba, Stamatina E.; Menard, Sherri L.; Rosenspire, Allen J.] Wayne State Univ, Sch Med, Dept Immunol & Microbiol, Detroit, MI 48201 USA; [McCabe, Michael J., Jr.] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY USA	Wayne State University; University of Rochester	Rosenspire, AJ (corresponding author), Wayne State Univ, Sch Med, Dept Immunol & Microbiol, 221 Lande Res Bldg, Detroit, MI 48201 USA.	arosenspire@wayne.edu			NIH [ES11000, ES12403, ES01247]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012403, R01ES011000, P30ES001247] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by NIH grants ES11000, ES12403 and ES01247.	Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; Akhand AA, 1998, J CELL BIOCHEM, V71, P243, DOI 10.1002/(SICI)1097-4644(19981101)71:2<243::AID-JCB9>3.0.CO;2-V; Bagenstose LM, 1998, J IMMUNOL, V160, P1612; Bernier J, 1995, ENVIRON HEALTH PERSP, V103, P23, DOI 10.2307/3432720; BOLLAG AG, 1991, PROTEIN METHODS; Bommhardt U, 2000, J IMMUNOL, V164, P2326, DOI 10.4049/jimmunol.164.5.2326; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; CARON L, 1992, MOL CELL BIOL, V12, P2720, DOI 10.1128/MCB.12.6.2720; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; Couture C, 1996, J BIOL CHEM, V271, P24880, DOI 10.1074/jbc.271.40.24880; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; FIRESTONE GL, 1990, METHOD ENZYMOL, V182, P688; FRANKLIN RA, 1994, J CLIN INVEST, V93, P2134, DOI 10.1172/JCI117209; Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264; Hansson M, 2004, SCAND J IMMUNOL, V59, P469, DOI 10.1111/j.0300-9475.2004.01415.x; Havarinasab S, 2005, AUTOIMMUN REV, V4, P270, DOI 10.1016/j.autrev.2004.12.001; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Hong R, 1999, MUTAT RES-FUND MOL M, V428, P109, DOI 10.1016/S1383-5742(99)00038-1; Hu H, 1999, IMMUNOLOGY, V96, P348; Huang YP, 2004, J BIOL CHEM, V279, P28827, DOI 10.1074/jbc.R400012200; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Kazantzis G, 2002, Med Lav, V93, P139; KEVORKIAN J, 1972, AM J PUBLIC HEALTH N, V62, P504, DOI 10.2105/AJPH.62.4.504; Kishimoto H, 2000, CLIN IMMUNOL, V95, pS3, DOI 10.1006/clim.1999.4818; LoGrasso PV, 1996, P NATL ACAD SCI USA, V93, P12165, DOI 10.1073/pnas.93.22.12165; Lysechko TL, 2005, J IMMUNOL, V174, P7807, DOI 10.4049/jimmunol.174.12.7807; Mattingly RR, 2001, TOXICOL APPL PHARM, V176, P162, DOI 10.1006/taap.2001.9272; MCFARLAND EDC, 1993, P NATL ACAD SCI USA, V90, P1402, DOI 10.1073/pnas.90.4.1402; NAKASHIMA I, 1994, J IMMUNOL, V152, P1064; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Parashar A, 1999, FREE RADICAL BIO MED, V26, P227, DOI 10.1016/S0891-5849(98)00169-5; Pitcher LA, 2003, TRENDS IMMUNOL, V24, P554, DOI 10.1016/j.it.2003.08.003; Pitcher LA, 2003, J IMMUNOL, V171, P845, DOI 10.4049/jimmunol.171.2.845; RAHMAN SMJ, 1993, FEBS LETT, V317, P35, DOI 10.1016/0014-5793(93)81486-J; SHEPHARD EG, 1988, ANAL BIOCHEM, V168, P306, DOI 10.1016/0003-2697(88)90323-5; SOULA M, 1993, J BIOL CHEM, V268, P27420; Straus DB, 1996, J BIOL CHEM, V271, P9976, DOI 10.1074/jbc.271.17.9976; Yamasaki S, 1996, MOL CELL BIOL, V16, P7151; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zheng Y, 2003, J IMMUNOL, V171, P1596, DOI 10.4049/jimmunol.171.3.1596; Ziemba SE, 2006, TOXICOL SCI, V89, P145, DOI 10.1093/toxsci/kfj029	45	12	12	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1663	1671		10.1096/fj.08-117283	http://dx.doi.org/10.1096/fj.08-117283			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19168706	Green Published			2022-12-25	WOS:000266652400006
J	Bascove, M; Huin-Schohn, C; Gueguinou, N; Tschirhart, E; Frippiat, JP				Bascove, Matthieu; Huin-Schohn, Cecile; Gueguinou, Nathan; Tschirhart, Eric; Frippiat, Jean-Pol			Spaceflight-associated changes in immunoglobulin VH gene expression in the amphibian Pleurodeles waltl	FASEB JOURNAL			English	Article						microgravity; B lymphocytes; selection; immune response; antibodies	GAMMA-IRRADIATION; LEUKOCYTE SUBSETS; HEAVY-CHAIN; STRESS; MOUSE; MICROGRAVITY; SENSITIVITY; ANTIBODIES; PHYSIOLOGY; POSITION	Understanding why the immune system is depressed during spaceflight is of obvious importance for future human deep-space missions, such as the foreseen missions to Mars. However, little is known about the effects of these flights on humoral immunity. We previously immunized adult Pleurodeles waltl (urodele amphibian) onboard the Mir space station and showed that heavy-chain variable (VH) domains of specific IgM antibodies are encoded by genes belonging to the VHII and VHVI families. We have now determined how these animals use their individual VHII and VHVI genes by screening IgM heavy-chain cDNA libraries and by quantifying IgM heavy-chain transcripts encoded by these genes. Results were compared with those obtained using control animals immunized on Earth under the same conditions as onboard Mir. Our experiments revealed an increase in the expression of IgM heavy-chain mRNAs encoded by the VHII and VHVI. C genes and a strong decrease in the expression of IgM heavy-chain mRNAs encoded by the VHVI. A and VHVI. B genes in spaceflight animals. Consequently, different heavy-chain mRNAs are expressed by spaceflight animals, demonstrating that this environment affects the humoral response. These observations may be due to a change in B-cell selection under spaceflight conditions. Bascove, M., Huin-Schohn, C., Gueguinou, N., Tschirhart, E., Frippiat, J.-P. Spaceflight-associated changes in immunoglobulin VH gene expression in the amphibian Pleurodeles waltl. FASEB J. 23, 1607-1615 (2009)	[Bascove, Matthieu; Huin-Schohn, Cecile; Gueguinou, Nathan; Frippiat, Jean-Pol] Nancy Univ, EA 3442, Lab Expt Biol & Immunol, Dev & Immunogenet Grp, F-54506 Vandoeuvre Les Nancy, France; [Huin-Schohn, Cecile; Tschirhart, Eric] Univ Luxembourg, Life Sci Res Unit, Luxembourg, Luxembourg	Universite de Lorraine; University of Luxembourg	Frippiat, JP (corresponding author), Nancy Univ, EA 3442, Lab Expt Biol & Immunol, Dev & Immunogenet Grp, Blvd Aiguillettes,BP 239, F-54506 Vandoeuvre Les Nancy, France.	jean-pol.frippiat@scbiol.uhp-nancy.fr		Frippiat, Jean-Pol/0000-0002-4027-6269	Centre National d'Etudes Spatiales; European Space Agency; Ministere de l'Enseignement Superieur et de la Recherche; Nancy-University; Lorraine Region; University of Luxembourg	Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales); European Space Agency(European Space AgencyEuropean Commission); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Nancy-University; Lorraine Region(Region Grand-Est); University of Luxembourg	We thank the French cosmonaut J.-P. Haignere for performing the Genesis experiment onboard the Mir space station, N. Touche for helpful discussions, the Centre National d'Etudes Spatiales, the European Space Agency, the Ministere de l'Enseignement Superieur et de la Recherche, Nancy-University, the Lorraine Region, and the University of Luxembourg for their financial support. M. B. is supported by the Ministere de l'Enseignement Superieur et de la Recherche, and C.H.-S. is supported by the Ministry of Culture, Higher Education, and Research of Luxembourg.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; ALLEBBAN Z, 1994, J LEUKOCYTE BIOL, V55, P209, DOI 10.1002/jlb.55.2.209; BAILLY S, 1973, CR ACAD SCI D NAT, V276, P1867; BENNETT MF, 1983, J COMP PHYSIOL, V153, P81, DOI 10.1007/BF00610345; BIRNSTEIN VJ, 1983, J MOL EVOL, V18, P73; Borchers AT, 2002, NUTRITION, V18, P889, DOI 10.1016/S0899-9007(02)00913-9; Bouic PJD, 1999, INT J SPORTS MED, V20, P258, DOI 10.1055/s-2007-971127; Boxio R, 2005, J APPL PHYSIOL, V98, P905, DOI 10.1152/japplphysiol.00957.2004; BRODEUR PH, 1984, EUR J IMMUNOL, V14, P922, DOI 10.1002/eji.1830141012; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COGOLI A, 1984, SCIENCE, V225, P228, DOI 10.1126/science.6729481; Cogoli-Greuter M., 2004, GRAV SPACE BIO B, V17, P27; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; Courtade M, 2001, INT J RADIAT BIOL, V77, P587, DOI 10.1080/09553000110034621; Dournon C, 2003, ADV SPACE B, V9, P101, DOI 10.1016/S1569-2574(03)09005-1; Frippiat C, 2001, IMMUNOGENETICS, V52, P264; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Glaser R, 2000, PSYCHOSOM MED, V62, P804, DOI 10.1097/00006842-200011000-00010; GOULD CL, 1987, AVIAT SPACE ENVIR MD, V58, P983; Gridley DS, 2008, IN VIVO, V22, P159; Gridley DS, 2002, IMMUNOL LETT, V80, P55, DOI 10.1016/S0165-2478(01)00306-6; GROVE DS, 1995, EXP CELL RES, V219, P102, DOI 10.1006/excr.1995.1210; Heppener M, 2008, EMBO REP, V9, pS4, DOI 10.1038/embor.2008.98; Jacobs H, 2001, CURR OPIN IMMUNOL, V13, P208, DOI 10.1016/S0952-7915(00)00206-5; Kimzey SL, 1977, BIOMEDICAL RESULTS S, P248; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; KONSTANTINOVA IV, 1993, J LEUKOCYTE BIOL, V54, P189, DOI 10.1002/jlb.54.3.189; Lefranc MP, 1999, HUM GENET, V104, P361, DOI 10.1007/s004390050969; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; O'Donnell PM, 2009, STRESS, V12, P82, DOI 10.1080/10253890802049269; Pecaut MJ, 2006, RADIAT RES, V165, P68, DOI 10.1667/RR3493.1; Pecaut MJ, 2003, J APPL PHYSIOL, V94, P2085, DOI 10.1152/japplphysiol.01052.2002; Pecaut MJ, 2001, IN VIVO, V15, P195; Schaerlinger B, 2008, DEV COMP IMMUNOL, V32, P908, DOI 10.1016/j.dci.2008.01.001; Schaerlinger B, 2008, MOL IMMUNOL, V45, P776, DOI 10.1016/j.molimm.2007.06.356; Sonnenfeld G, 2002, NUTRITION, V18, P899, DOI 10.1016/S0899-9007(02)00903-6; SONNENFELD G, 1992, J APPL PHYSIOL, V73, pS191, DOI 10.1152/jappl.1992.73.2.S191; Sonnenfeld Gerald, 2003, Rev Environ Health, V18, P1; Stowe RP, 1999, J LEUKOCYTE BIOL, V65, P179, DOI 10.1002/jlb.65.2.179; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Vernikos J, 1996, BIOESSAYS, V18, P1029, DOI 10.1002/bies.950181215; Veynachter L, 2002, SCAND J LAB ANIM SCI, V29, P100; VOSS EW, 1984, SCIENCE, V225, P214, DOI 10.1126/science.6729476; WILSON M, 1992, EMBO J, V11, P4337, DOI 10.1002/j.1460-2075.1992.tb05533.x; WU TT, 1993, PROTEINS, V16, P1, DOI 10.1002/prot.340160102	46	32	34	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2009	23	5					1607	1615		10.1096/fj.08-121327	http://dx.doi.org/10.1096/fj.08-121327			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19141535				2022-12-25	WOS:000266651700035
J	Kuo, TT; de Muinck, EJ; Claypool, SM; Yoshida, M; Nagaishi, T; Aveson, VG; Lencer, WI; Blumberg, RS				Kuo, Timothy T.; de Muinck, Eric J.; Claypool, Steven M.; Yoshida, Masaru; Nagaishi, Takashi; Aveson, Victoria G.; Lencer, Wayne I.; Blumberg, Richard S.			N-Glycan Moieties in Neonatal Fc Receptor Determine Steady-state Membrane Distribution and Directional Transport of IgG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; CANINE KIDNEY-CELLS; I-RELATED RECEPTOR; IMMUNOGLOBULIN-G; BIDIRECTIONAL TRANSCYTOSIS; CRYSTAL-STRUCTURE; SORTING SIGNALS; BINDING; ANTIGEN; ENDOCYTOSIS	The neonatal Fc receptor (FcRn) is a major histocompatibility complex class I-related molecule known to protect IgG and albumin from catabolism and transport IgG across polarized epithelial cells in a bidirectional manner. Previous studies have shown species-specific differences in ligand binding, IgG transport direction, and steady-state membrane distribution when expressed in polarized epithelial cells. We hypothesized that these differences may be due to the additional N-glycans expressed on the rat FcRn, because N-glycans have been proposed to function as apical targeting signals, and that two of the N-glycan moieties have been shown to contribute to the IgG binding of rat FcRn. A panel of mutant human FcRn variants was generated to resemble the N-glycan expression of rat FcRn in various combinations and subsequently transfected into Madin-Darby canine kidney II cells together with human beta(2)-microglobulin. Mutant human FcRn clones that contained additional N-glycan side-chain modifications, including that which was fully rodentized, still exhibited specificity for human IgG and failed to bind to mouse IgG. At steady state, the mutant human FcRn with additional N-glycans redistributed to the apical cell surface similar to that of rat FcRn. Furthermore, the rodentized human FcRn exhibited a reversal of IgG transport with predominant transcytosis from an apical-to-basolateral direction, which resembled that of the rat FcRn isoform. These studies show that the N-glycans in FcRn contribute significantly to the steady-state membrane distribution and direction of IgG transport in polarized epithelia.	[Kuo, Timothy T.; de Muinck, Eric J.; Claypool, Steven M.; Yoshida, Masaru; Nagaishi, Takashi; Aveson, Victoria G.; Blumberg, Richard S.] Brigham & Womens Hosp, Dept Gastroenterol, Boston, MA 02115 USA; [Kuo, Timothy T.; de Muinck, Eric J.; Claypool, Steven M.; Yoshida, Masaru; Nagaishi, Takashi; Aveson, Victoria G.; Lencer, Wayne I.; Blumberg, Richard S.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Lencer, Wayne I.] Childrens Hosp, Dept Gastroenterol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Blumberg, RS (corresponding author), Brigham & Womens Hosp, Div Gastroenterol, Dept Med, 75 Francis St, Boston, MA 02115 USA.	rblumberg@partners.org		Claypool, Steven/0000-0001-5316-1623; Lencer, Wayne/0000-0001-7346-2730; de Muinck, Eric/0000-0001-5606-3172	National Institutes of Health [DK071798, DK053056]; American Liver Foundation; Crohn's & Colitis Foundation of America; Harvard Digestive Diseases Center [P30 DK034854]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, R01DK048106, P30DK040561, K08DK071798, R01DK053056] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Liver Foundation; Crohn's & Colitis Foundation of America; Harvard Digestive Diseases Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK071798 (to T. T. K.) and DK053056 (to R. S. B. and W. I. L.). This work was also supported by the American Liver Foundation, the Crohn's & Colitis Foundation of America (to M. Y. and T. N.), and Harvard Digestive Diseases Center Grant P30 DK034854 (to R. S. B. and W. I. L.).	BRAMBELL FW, 1969, P NUTR SOC, V28, P35, DOI 10.1079/PNS19690007; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Claypool SM, 2004, MOL BIOL CELL, V15, P1746, DOI 10.1091/mbc.E03-11-0832; Claypool SM, 2002, J BIOL CHEM, V277, P28038, DOI 10.1074/jbc.M202367200; Dickinson BL, 2008, MOL BIOL CELL, V19, P414, DOI 10.1091/mbc.E07-07-0658; Gill RK, 1999, INDIAN J BIOCHEM BIO, V36, P252; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Kim KJ, 2004, AM J PHYSIOL-LUNG C, V287, pL616, DOI 10.1152/ajplung.00121.2004; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Marzolo MP, 1997, P NATL ACAD SCI USA, V94, P1834, DOI 10.1073/pnas.94.5.1834; McCarthy KM, 2000, J CELL SCI, V113, P1277; McCarthy KM, 2001, J CELL SCI, V114, P1591; Mi WT, 2008, J IMMUNOL, V181, P7550, DOI 10.4049/jimmunol.181.11.7550; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; RODEWALD R, 1983, CIBA F SYMP, V95, P287; Rodriguez-Boulan E, 1999, TRENDS CELL BIOL, V9, P291, DOI 10.1016/S0962-8924(99)01595-0; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; SIMISTER NE, 1989, COLD SPRING HARB SYM, V54, P571, DOI 10.1101/SQB.1989.054.01.068; Stefaner I, 1999, J BIOL CHEM, V274, P8998, DOI 10.1074/jbc.274.13.8998; Tesar DB, 2006, TRAFFIC, V7, P1127, DOI 10.1111/j.1600-0854.2006.00457.x; Vaughn DE, 1998, STRUCTURE, V6, P63, DOI 10.1016/S0969-2126(98)00008-2; Wu Z, 2001, J BIOL CHEM, V276, P5240, DOI 10.1074/jbc.M006684200; Yeaman C, 1997, J CELL BIOL, V139, P929, DOI 10.1083/jcb.139.4.929; Yoshida M, 2004, IMMUNITY, V20, P769, DOI 10.1016/j.immuni.2004.05.007; Yoshida M, 2006, SPRINGER SEMIN IMMUN, V28, P397, DOI 10.1007/s00281-006-0054-z; Zhou JC, 2003, J MOL BIOL, V332, P901, DOI 10.1016/S0022-2836(03)00952-5; Zhou JC, 2005, J MOL BIOL, V345, P1071, DOI 10.1016/j.jmb.2004.11.014	29	40	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8292	8300		10.1074/jbc.M805877200	http://dx.doi.org/10.1074/jbc.M805877200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19164298	Green Published, hybrid			2022-12-25	WOS:000264397800013
J	Matmati, N; Kitagaki, H; Montefusco, D; Mohanty, BK; Hannun, YA				Matmati, Nabil; Kitagaki, Hiroshi; Montefusco, David; Mohanty, Bidyut K.; Hannun, Yusuf A.			Hydroxyurea Sensitivity Reveals a Role for ISC1 in the Regulation of G(2)/M	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOSPHINGOLIPID-PHOSPHOLIPASE-C; YEAST SACCHAROMYCES-CEREVISIAE; CELL-CYCLE CONTROL; BUDDING YEAST; PROTEIN-KINASE; S-PHASE; CDC28; DNA; MORPHOGENESIS; ACTIVATION	Saccharomyces cerevisiae cells lacking ISC1 (inositol phosphosphingolipase C) exhibit sensitivity to genotoxic agents such as methyl methanesulfonate and hydroxyurea ( HU). Cell cycle analysis by flow cytometry revealed a G(2)/M block in isc1 Delta cells when treated with methyl methanesulfonate or HU. Further investigation revealed that the levels of Cdc28 phosphorylated on Tyr-19, which plays an essential role in the regulation of the G2/M checkpoint, were higher in synchronized and asynchronous cells lacking ISC1 in response to HU. Use of a Cdc28-Y19F mutant protected isc1 Delta from the G2/M block. In wild type cells, HU induced a loss of the Swe1p kinase, the enzyme that phosphorylates Cdc28-Tyr-19, correlating with resumption of the cell cycle. In the isc1 Delta cells, however, the levels of Swe1p remained at sustained high levels in response to HU. Significantly, deletion of SWE1 in an isc1 Delta background overcame the G(2)/M block in response to HU. The double isc1 Delta/swe1 Delta mutant also overcame the growth defect on HU. Taken together, these findings implicate Isc1p as an upstream regulator of Swe1p levels and stability and Cdc28-Tyr-19 phosphorylation, in effect signaling recovery from the effects of genotoxic stress and allowing G(2)/M progression.	[Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29403 USA; [Kitagaki, Hiroshi] Saga Univ, Fac Agr, Saga 8408502, Japan	Medical University of South Carolina; Saga University	Hannun, YA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29403 USA.	hannun@musc.edu	Kitagaki, Hiroshi/N-1666-2019		National Institutes of Health [GM-43825, P20 RR-016461]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043825, R37GM043825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-43825 (to Y.A.H.) and P20 RR-016461 (to N.M.) (from the Post Doctoral Academic Career Development Program).	Almeida T, 2008, MOL BIOL CELL, V19, P865, DOI 10.1091/mbc.E07-06-0604; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Betz C, 2002, EUR J BIOCHEM, V269, P4033, DOI 10.1046/j.1432-1033.2002.03096.x; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; BOOHER RN, 1993, EMBO J, V12, P3417, DOI 10.1002/j.1460-2075.1993.tb06016.x; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; de Avalos SV, 2004, J BIOL CHEM, V279, P11537, DOI 10.1074/jbc.M309586200; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; FITCH I, 1992, MOL BIOL CELL, V3, P805, DOI 10.1091/mbc.3.7.805; GHIARA JB, 1991, CELL, V65, P163, DOI 10.1016/0092-8674(91)90417-W; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; HARTWELL LH, 1974, BACTERIOL REV, V38, P164, DOI 10.1128/MMBR.38.2.164-198.1974; Jenkins GM, 2001, J BIOL CHEM, V276, P8574, DOI 10.1074/jbc.M007425200; Koc A, 2004, J BIOL CHEM, V279, P223, DOI 10.1074/jbc.M303952200; LAWLEY PD, 1989, MUTAT RES, V213, P3, DOI 10.1016/0027-5107(89)90028-6; Lee JY, 2000, EXP CELL RES, V261, P303, DOI 10.1006/excr.2000.5028; LEW DJ, 1993, J CELL BIOL, V120, P1305, DOI 10.1083/jcb.120.6.1305; LEW DJ, 1995, J CELL BIOL, V129, P739, DOI 10.1083/jcb.129.3.739; Lim HH, 1996, MOL CELL BIOL, V16, P6385; Liu H, 2006, MOL BIOL CELL, V17, P2746, DOI 10.1091/mbc.E05-11-1093; Matmati N, 2008, J LIPID RES, V49, P922, DOI 10.1194/jlr.R800004-JLR200; McMillan JN, 1999, MOL CELL BIOL, V19, P6929; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Mitchell DA, 2001, MOL CELL BIOL, V21, P488, DOI 10.1128/MCB.21.2.488-500.2001; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; PEGG AE, 1984, CANCER INVEST, V2, P223, DOI 10.3109/07357908409104376; RICHARDSON H, 1992, GENE DEV, V6, P2021, DOI 10.1101/gad.6.11.2021; Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200; Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509; SURANA U, 1991, CELL, V65, P145, DOI 10.1016/0092-8674(91)90416-V	30	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8241	8246		10.1074/jbc.M900004200	http://dx.doi.org/10.1074/jbc.M900004200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19158081	Green Published, hybrid			2022-12-25	WOS:000264397800007
J	Venkatachalam, K; Prabhu, SD; Reddy, VS; Boylston, WH; Valente, AJ; Chandrasekar, B				Venkatachalam, Kaliyamurthi; Prabhu, Sumanth D.; Reddy, Venkatapuram Seenu; Boylston, William H.; Valente, Anthony J.; Chandrasekar, Bysani			Neutralization of Interleukin-18 Ameliorates Ischemia/Reperfusion-induced Myocardial Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CCAAT/ENHANCER BINDING-PROTEIN; HUMAN CARDIAC FIBROBLASTS; ENDOTHELIAL-CELL DEATH; SMOOTH-MUSCLE-CELLS; C-REACTIVE PROTEIN; REPERFUSION INJURY; ISCHEMIA-REPERFUSION; TRANSCRIPTION FACTOR; LATE-PHASE	Ischemia/reperfusion (I/R) injury is characterized by the induction of oxidative stress and proinflammatory cytokine expression. Recently demonstrating that oxidative stress and TNF-alpha each stimulate interleukin (IL)-18 expression in cardiomyocytes, we hypothesized that I/R also induces IL-18 expression and thus exacerbates inflammation and tissue damage. Neutralization of IL-18 signaling should therefore diminish tissue injury following I/R. I/R studies were performed using a chronically instrumented closed chest mouse model. Male C57BL/6 mice underwent 30 min of ischemia by LAD coronary artery ligation followed by various periods of reperfusion. Sham-operated or ischemia-only mice served as controls. A sub-set of animals was treated with IL-18-neutralizing antibodies 1 h prior to LAD ligation. Ischemic LV tissue was used for analysis. Our results demonstrate that, compared with sham operation and ischemia alone, I/R significantly increased (i) oxidative stress (increased MDA/4-HNE levels), (ii) neutrophil infiltration (increased MPO activity), (iii) NF-kappa B DNA binding activity (p50, p65), and (iv) increased expression of IL-18R beta, but not IL-18R alpha or IL-18BP transcripts. Administration of IL-18-neutralizing antibodies significantly reduced I/R injury measured by reduced infarct size (versus control IgG). In isolated adult mouse cardiomyocytes, simulated ischemia/reperfusion enhanced oxidative stress and biologically active IL-18 expression via IKK-dependent NF-kappa B activation. These results indicate that IL-18 plays a critical role in I/R injury and thus represents a promising therapeutic target.	[Venkatachalam, Kaliyamurthi; Boylston, William H.; Chandrasekar, Bysani] Univ Texas Hlth Sci Ctr San Antonio, Dept Vet Affairs S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA; [Venkatachalam, Kaliyamurthi; Boylston, William H.; Valente, Anthony J.; Chandrasekar, Bysani] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Reddy, Venkatapuram Seenu] Univ Texas Hlth Sci Ctr San Antonio, Dept Surg, San Antonio, TX 78229 USA; [Prabhu, Sumanth D.] Univ Louisville, Dept Med, Inst Mol Cardiol, Louisville, KY 40292 USA; [Prabhu, Sumanth D.] Louisville Vet Affairs Med Ctr, Med Serv, Louisville, KY 40206 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Louisville	Chandrasekar, B (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Vet Affairs S Texas Vet Hlth Care Syst, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	chandraseka@uthscsa.edu	Venkatachalam, Kaliyamurthi/GXM-4890-2022; Prabhu, Sumanth/D-5223-2009		Department of Veterans Affairs	Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by the Research Service of the Department of Veterans Affairs. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Arenillas I, 2008, TERRA NOVA, V20, P38, DOI 10.1111/j.1365-3121.2007.00784.x; Born TL, 1998, J BIOL CHEM, V273, P29445, DOI 10.1074/jbc.273.45.29445; Brown M, 2005, AM J PHYSIOL-HEART C, V289, pH466, DOI 10.1152/ajpheart.00170.2004; Chandrasekar B, 2000, FREE RADICAL BIO MED, V28, P1579, DOI 10.1016/S0891-5849(00)00273-2; Chandrasekar B, 2005, J BIOL CHEM, V280, P4553, DOI 10.1074/jbc.M411787200; Chandrasekar B, 2004, BIOCHEM BIOPH RES CO, V319, P304, DOI 10.1016/j.bbrc.2004.04.185; Chandrasekar B, 2004, J BIOL CHEM, V279, P20221, DOI 10.1074/jbc.M313980200; Chandrasekar B, 2003, BIOCHEM BIOPH RES CO, V303, P1152, DOI 10.1016/S0006-291X(03)00496-0; Chandrasekar B, 1998, BBA-MOL BASIS DIS, V1406, P91, DOI 10.1016/S0925-4439(97)00062-8; Chandrasekar B, 1999, CIRCULATION, V99, P427, DOI 10.1161/01.CIR.99.3.427; Chandrasekar B, 2006, J BIOL CHEM, V281, P15099, DOI 10.1074/jbc.M600200200; Colston JT, 2007, AM J PHYSIOL-HEART C, V293, pH1839, DOI 10.1152/ajpheart.00428.2007; Cortez DM, 2007, AM J PHYSIOL-HEART C, V293, pH3356, DOI 10.1152/ajpheart.00928.2007; Dinarello CA, 1998, J LEUKOCYTE BIOL, V63, P658, DOI 10.1002/jlb.63.6.658; Fan CG, 2003, J BIOL CHEM, V278, P2072, DOI 10.1074/jbc.M206718200; Fantuzzi G, 2003, J LEUKOCYTE BIOL, V74, P889, DOI 10.1189/jlb.0503230; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Grisham MB, 1998, FREE RADICAL BIO MED, V25, P404, DOI 10.1016/S0891-5849(98)00094-X; Guo YR, 1998, AM J PHYSIOL-HEART C, V275, pH1375; Hernesniemi JA, 2008, ATHEROSCLEROSIS, V196, P643, DOI 10.1016/j.atherosclerosis.2007.07.018; Hewins P, 2006, KIDNEY INT, V69, P605, DOI 10.1038/sj.ki.5000167; Hulthe J, 2006, ATHEROSCLEROSIS, V188, P450, DOI 10.1016/j.atherosclerosis.2005.11.013; Hurgin V, 2002, P NATL ACAD SCI USA, V99, P16957, DOI 10.1073/pnas.262663399; Jones WK, 2005, CARDIOVASC TOXICOL, V5, P183, DOI 10.1385/CT:5:2:183; Jordan JE, 1999, CARDIOVASC RES, V43, P860, DOI 10.1016/S0008-6363(99)00187-X; KILGORE KS, 1993, CLIN BIOCHEM, V26, P359, DOI 10.1016/0009-9120(93)90112-J; Kim SH, 2000, P NATL ACAD SCI USA, V97, P1190, DOI 10.1073/pnas.97.3.1190; Kim Y, 2003, MOL PHARMACOL, V63, P368, DOI 10.1124/mol.63.2.368; Liu SF, 1999, CIRCULATION, V100, P1330, DOI 10.1161/01.CIR.100.12.1330; Mallat Z, 2002, HEART, V88, P467, DOI 10.1136/heart.88.5.467; Misra A, 2003, CIRCULATION, V108, P3075, DOI 10.1161/01.CIR.0000108929.93074.0B; *NAT RES COUNC, 1996, GUID CAR US LAB AN; Nossuli TO, 2001, AM J PHYSIOL-HEART C, V281, pH2549, DOI 10.1152/ajpheart.2001.281.6.H2549; Nossuli TO, 2000, AM J PHYSIOL-HEART C, V278, pH1049, DOI 10.1152/ajpheart.2000.278.4.H1049; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Patel DN, 2007, J BIOL CHEM, V282, P27229, DOI 10.1074/jbc.M703250200; Reddy VS, 2008, J CELL PHYSIOL, V215, P697, DOI 10.1002/jcp.21348; Sambrano GR, 2002, NATURE, V420, P712, DOI 10.1038/nature01306; Swift LM, 2000, AM J PHYSIOL-HEART C, V278, pH982, DOI 10.1152/ajpheart.2000.278.3.H982; Tone M, 1997, J IMMUNOL, V159, P6156; Torigoe K, 1997, J BIOL CHEM, V272, P25737, DOI 10.1074/jbc.272.41.25737; Wang MJ, 2008, SHOCK, V30, P3, DOI 10.1097/SHK.0b013e318160f215; Westphal E, 2006, EUR CYTOKINE NETW, V17, P19; Wietek C, 2007, TRENDS BIOCHEM SCI, V32, P311, DOI 10.1016/j.tibs.2007.05.003; Wyman TH, 2002, J LEUKOCYTE BIOL, V72, P401; Xuan YT, 1999, CIRC RES, V84, P1095, DOI 10.1161/01.RES.84.9.1095; Yuen CM, 2007, CIRC J, V71, P1691, DOI 10.1253/circj.71.1691; Zabalgoitia M, 2008, FREE RADICAL BIO MED, V44, P284, DOI 10.1016/j.freeradbiomed.2007.08.012	48	98	105	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7853	7865		10.1074/jbc.M808824200	http://dx.doi.org/10.1074/jbc.M808824200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19164288	hybrid, Green Published			2022-12-25	WOS:000264195600047
J	Hindlet, P; Bado, A; Kamenicky, P; Delomenie, C; Bourasset, F; Nazaret, C; Farinotti, R; Buyse, M				Hindlet, Patrick; Bado, Andre; Kamenicky, Peter; Delomenie, Claudine; Bourasset, Fanchon; Nazaret, Corinne; Farinotti, Robert; Buyse, Marion			Reduced Intestinal Absorption of Dipeptides via PepT1 in Mice with Diet-induced Obesity Is Associated with Leptin Receptor Down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUMINAL LEPTIN; LONG-FORM; CANCER CELLS; EXPRESSION; PROTEIN; ACTIVATION; SECRETION; COTRANSPORTER-1; INHIBITION; MECHANISMS	Leptin is a major determinant of energy homeostasis, acting both centrally and in the gastrointestinal tract. We previously reported that acute leptin treatment enhances the absorption of di- and tripeptides via the proton-dependent PepT1 transporter. In this study, we investigated the long term effect of leptin on PepT1 levels and activity in Caco2 cell monolayers in vitro. We then assessed the significance of the regulation of PepT1 in vivo in a model of diet-induced obesity. We demonstrated that 1) leptin regulated PepT1 at the transcriptional level, via the MAPK pathway, and at the translational level, via ribosomal protein S6 activation, in Caco2 cells and 2) this activation was systematically followed by a time-and concentration-dependent loss of leptin action reflecting desensitization. Deciphering this desensitization, we demonstrated that leptin induced a down-regulation of its own receptor protein and mRNA expression. More importantly, we showed, in mice with diet-induced obesity, that a 4-week hypercaloric diet resulted in a 46% decrease in PepT1-specific transport, because of a 30% decrease in PepT1 protein and a 50% decrease in PepT1 mRNA levels. As shown in Caco2 cells, these changes in PepT1 were supported by a parallel 2-fold decrease in leptin receptor expression in mice. Taken together, these results indicate that during induction of obesity, leptin resistance may also occur peripherally in the gastrointestinal tract, disrupting the absorption of oligopeptides and peptidomimetic drugs.	[Hindlet, Patrick; Bourasset, Fanchon; Farinotti, Robert; Buyse, Marion] Univ Paris 11, Fac Pharm, Lab Pharm Clin, UPRES EA2706, F-92296 Chatenay Malabry, France; [Hindlet, Patrick; Delomenie, Claudine; Bourasset, Fanchon; Farinotti, Robert; Buyse, Marion] Univ Paris 11, Fac Pharm, IFR 141, F-92296 Chatenay Malabry, France; [Bado, Andre; Nazaret, Corinne] Univ Paris 07, INSERM, Fac Med, Med Unite 773, F-75018 Paris, France; [Kamenicky, Peter] Univ Paris 11, Fac Med, INSERM, Med Unite 693, F-94270 Le Kremlin Bicetre, France; [Farinotti, Robert; Buyse, Marion] Hop La Pitie Salpetriere, AP HP, Serv Pharm, F-75013 Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Hindlet, P (corresponding author), Univ Paris Sud, Fac Pharm, Lab Pharma Clin, UPRES EA2706, 11-5 Rue Jean Baptiste Clement, F-92296 Chatenay Malabry, France.	patrick.hindlet@u-psud.fr	Kamenicky, Peter/S-4554-2018; Buyse, Marc/J-4658-2013; Bourasset, Fanchon/A-1870-2017	Bourasset, Fanchon/0000-0002-1409-8323; KAMENICKY, Peter/0000-0002-1994-4226; BADO, Andre/0000-0002-8007-1460; Delomenie, Claudine/0000-0002-6326-966X				Anini Y, 2003, DIABETES, V52, P252, DOI 10.2337/diabetes.52.2.252; Badman MK, 2007, GASTROENTEROLOGY, V132, P2103, DOI 10.1053/j.gastro.2007.03.058; Bado A, 1998, NATURE, V394, P790, DOI 10.1038/29547; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Barrenetxe J, 2004, BIOCHEM BIOPH RES CO, V317, P717, DOI 10.1016/j.bbrc.2004.03.106; Barrenetxe J, 2002, GUT, V50, P797, DOI 10.1136/gut.50.6.797; Bjorbaek C, 2001, J BIOL CHEM, V276, P4747, DOI 10.1074/jbc.M007439200; Buyse M, 2002, J BIOL CHEM, V277, P28182, DOI 10.1074/jbc.M203281200; Buyse M, 2001, J CLIN INVEST, V108, P1483, DOI 10.1172/JCI13219; Cammisotto PG, 2005, J HISTOCHEM CYTOCHEM, V53, P851, DOI 10.1369/jhc.5A6620.2005; Cinti S, 2000, INT J OBESITY, V24, P789, DOI 10.1038/sj.ijo.0801228; Darcel NP, 2005, J NUTR, V135, P1491, DOI 10.1093/jn/135.6.1491; Dube N, 2001, J CELL BIOCHEM, V81, P613, DOI 10.1002/jcb.1090; Ducroc R, 2005, DIABETES, V54, P348, DOI 10.2337/diabetes.54.2.348; El Homsi M, 2007, AM J PHYSIOL-GASTR L, V293, pG365, DOI 10.1152/ajpgi.00091.2007; Gong Y, 2007, J BIOL CHEM, V282, P31019, DOI 10.1074/jbc.M702838200; Guilmeau S, 2003, DIABETES, V52, P1664, DOI 10.2337/diabetes.52.7.1664; Hansen GH, 2008, J HISTOCHEM CYTOCHEM, V56, P677, DOI 10.1369/jhc.2008.950782; Hegyi K, 2004, CELL BIOL INT, V28, P159, DOI 10.1016/j.cellbi.2003.12.003; Hikita M, 2000, BIOCHEM BIOPH RES CO, V271, P703, DOI 10.1006/bbrc.2000.2692; Hindlet P, 2007, J PHARMACOL EXP THER, V323, P192, DOI 10.1124/jpet.107.125799; Hoda MR, 2007, BRIT J SURG, V94, P346, DOI 10.1002/bjs.5530; Igel M, 2002, LIPIDS, V37, P153, DOI 10.1007/s11745-002-0875-5; Kiely JM, 2006, J PEDIATR SURG, V41, P1243, DOI 10.1016/j.jpedsurg.2006.03.047; Kiess W, 2008, BEST PRACT RES CL EN, V22, P135, DOI 10.1016/j.beem.2007.10.002; Martin RL, 2000, METABOLISM, V49, P1479, DOI 10.1053/meta.2000.17695; MELLINKOFF SM, 1956, J APPL PHYSIOL, V8, P535, DOI 10.1152/jappl.1956.8.5.535; Morton NM, 1998, J BIOL CHEM, V273, P26194, DOI 10.1074/jbc.273.40.26194; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Nduati V, 2007, J BIOL CHEM, V282, P1359, DOI 10.1074/jbc.M604267200; Ogunwobi OO, 2007, DIGEST DIS SCI, V52, P1934, DOI 10.1007/s10620-007-9784-6; Paddon-Jones D, 2008, AM J CLIN NUTR, V87, p1558S, DOI 10.1093/ajcn/87.5.1558S; Shimakura J, 2005, AM J PHYSIOL-GASTR L, V289, pG471, DOI 10.1152/ajpgi.00025.2005; SHIMAKURA J, 2006, AM J PHYSIOL, V291, pG951; Shimakura J, 2006, BIOCHEM PHARMACOL, V71, P1581, DOI 10.1016/j.bcp.2006.03.001; Valerio A, 2006, J BIOL CHEM, V281, P12950, DOI 10.1074/jbc.M508691200; van den Brink Gijs R., 2000, Molecular Cell Biology Research Communications, V4, P144, DOI 10.1006/mcbr.2001.0270; Wilsey J, 2004, J ENDOCRINOL, V181, P297, DOI 10.1677/joe.0.1810297; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	39	33	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6801	6808		10.1074/jbc.M805564200	http://dx.doi.org/10.1074/jbc.M805564200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19144638	Green Published, hybrid			2022-12-25	WOS:000263919000025
J	Seif, E; Hallberg, BM				Seif, Elias; Hallberg, B. Martin			RNA-Protein Mutually Induced Fit STRUCTURE OF ESCHERICHIA COLI ISOPENTENYL-tRNA TRANSFERASE IN COMPLEX WITH tRNA(Phe)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; DIMETHYLALLYLTRANSFERASE; ANTICODON; RECOGNITION; MITOCHONDRIAL; TRANSLATION; SEQUENCES	tRNAs that read codons starting with U are usually modified at their A37 by isopentenyl-tRNA transferases to minimize peptidyl-tRNA slippage in translation. The consensus substrate requirements of the isopentenyl-tRNA transferase of Escherichia coli, MiaA, have been the focus of extensive study. However, the molecular basis of tRNA-MiaA recognition remains unknown. Here we describe the 2.5 angstrom crystal structure of MiaA in complex with substrate tRNA(Phe). Comparative structural analysis reveals that the enzymatic reaction involves an RNA-protein mutually induced fit mechanism in which large domain movements in MiaA provoke the partial unfolding of the substrate tRNA anticodon loop. In addition, we show how substrate tRNAs are recognized by MiaA through a combination of direct and indirect sequence readouts.	[Seif, Elias; Hallberg, B. Martin] Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet	Hallberg, BM (corresponding author), Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	Martin.Hallberg@ki.se	Hallberg, B. Martin/C-5361-2009	Hallberg, B. Martin/0000-0002-6781-0345	Swedish Research Council; Royal Swedish Academy of Sciences; Jeansson's Foundation; Langmanska kulturfonden; Helge Ax:son Johnson's Foundation; Magnus Bergvall's Foundation; O.E. and Edla Johansson's Foundation; Otto Sward's and Ulrika Eklund's Foundation; Karolinska Institutet; Wenner-Gren Foundations	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Swedish Academy of Sciences; Jeansson's Foundation; Langmanska kulturfonden; Helge Ax:son Johnson's Foundation; Magnus Bergvall's Foundation; O.E. and Edla Johansson's Foundation; Otto Sward's and Ulrika Eklund's Foundation; Karolinska Institutet(Karolinska Institutet); Wenner-Gren Foundations	The work was supported by grants from the Swedish Research Council, the Royal Swedish Academy of Sciences, Jeansson's Foundation, Langmanska kulturfonden, Helge Ax:son Johnson's Foundation, Magnus Bergvall's Foundation, O.E. and Edla Johansson's Foundation, Otto Sward's and Ulrika Eklund's Foundation, and Karolinska Institutet ( to B. M. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported through a post-doctoral fellowship from the Wenner-Gren Foundations.	Agris PF, 2008, EMBO REP, V9, P629, DOI 10.1038/embor.2008.104; Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Batey RT, 2007, RNA, V13, P1384, DOI 10.1261/rna.528007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GILLMAN EC, 1991, MOL CELL BIOL, V11, P2382, DOI 10.1128/MCB.11.5.2382; Golovko A, 2000, GENE, V258, P85, DOI 10.1016/S0378-1119(00)00421-2; GROSJEAN H, 1985, NUCLEIC ACIDS RES, V13, P5697, DOI 10.1093/nar/13.15.5697; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Motorin Y, 1997, RNA, V3, P721; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; SIBLER AP, 1986, FEBS LETT, V194, P131, DOI 10.1016/0014-5793(86)80064-3; Soderberg T, 2000, BIOCHEMISTRY-US, V39, P6546, DOI 10.1021/bi992775u; Soderberg T, 2001, BIOCHEMISTRY-US, V40, P1734, DOI 10.1021/bi002149t; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; Xie W, 2007, J MOL BIOL, V367, P872, DOI 10.1016/j.jmb.2007.01.048; Zhou C, 2008, P NATL ACAD SCI USA, V105, P16142, DOI 10.1073/pnas.0805680105	20	28	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6600	6604		10.1074/jbc.C800235200	http://dx.doi.org/10.1074/jbc.C800235200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19158097	Green Published, hybrid			2022-12-25	WOS:000263919000003
J	Blackinton, J; Lakshminarasimhan, M; Thomas, KJ; Ahmad, R; Greggio, E; Raza, AS; Cookson, MR; Wilson, MA				Blackinton, Jeff; Lakshminarasimhan, Mahadevan; Thomas, Kelly J.; Ahmad, Rili; Greggio, Elisa; Raza, Ashraf S.; Cookson, Mark R.; Wilson, Mark A.			Formation of a Stabilized Cysteine Sulfinic Acid Is Critical for the Mitochondrial Function of the Parkinsonism Protein DJ-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLUTION CRYSTAL-STRUCTURE; DISEASE GENE DJ-1; ALPHA-SYNUCLEIN; SACCHAROMYCES-CEREVISIAE; LOCALIZATION; SUPERFAMILY; MUTATIONS; OXIDATION; IDENTIFICATION; EVOLUTIONARY	The formation of cysteine-sulfinic acid has recently become appreciated as a modification that links protein function to cellular oxidative status. Human DJ-1, a protein associated with inherited parkinsonism, readily forms cysteine-sulfinic acid at a conserved cysteine residue (Cys(106) in human DJ-1). Mutation of Cys(106) causes the protein to lose its normal protective function in cell culture and model organisms. However, it is unknown whether the loss of DJ-1 protective function in these mutants is due to the absence of Cys(106) oxidation or the absence of the cysteine residue itself. To address this question, we designed a series of substitutions at a proximal glutamic acid residue (Glu(18)) in human DJ-1 that alter the oxidative propensity of Cys(106) through changes in hydrogen bonding. We show that two mutations, E18N and E18Q, allow Cys(106) to be oxidized to Cys(106)-sulfinic acid under mild conditions. In contrast, the E18D mutation stabilizes a cysteine-sulfenic acid that is readily reduced to the thiol in solution and in vivo. We show that E18N and E18Q can both partially substitute for wild-type DJ-1 using mitochondrial fission and cell viability assays. In contrast, the oxidatively impaired E18D mutant behaves as an inactive C106A mutant and fails to protect cells. We therefore conclude that formation of Cys(106)-sulfinic acid is a key modification that regulates the protective function of DJ-1.	[Blackinton, Jeff; Thomas, Kelly J.; Ahmad, Rili; Greggio, Elisa; Cookson, Mark R.] NIA, Cell Biol & Gene Express Unit, Neurogenet Lab, NIH, Bethesda, MD 20982 USA; [Lakshminarasimhan, Mahadevan; Raza, Ashraf S.; Wilson, Mark A.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Lakshminarasimhan, Mahadevan; Raza, Ashraf S.; Wilson, Mark A.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Cookson, MR (corresponding author), NIA, Cell Biol & Gene Express Unit, Neurogenet Lab, NIH, Rm 1A116,MSC 3707,35 Convent Dr, Bethesda, MD 20982 USA.	cookson@mail.nih.gov; mwilson13@unl.edu	Greggio, Elisa/H-6119-2013; Raza, Faisal/AAG-4567-2021; Cookson, Mark/AAW-2516-2021	Greggio, Elisa/0000-0002-8172-3598; Raza, Faisal/0000-0001-5569-3535; Cookson, Mark/0000-0002-1058-3831; Lakshminarasimhan, Mahadevan/0000-0001-9475-4927	National Institutes of Health [P20RR17675]; National Institutes of Health, NIA [Z01-AG000953]; American Parkinson's Disease Association; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017675, P41RR007707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000953] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Parkinson's Disease Association; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant P20RR17675 (to M. A. W.) and by the Intramural Research Program of the National Institutes of Health, NIA, Project Z01-AG000953 (to M. R. C.). This work was also supported in part by the American Parkinson's Disease Association. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aleyasin H, 2007, P NATL ACAD SCI USA, V104, P18748, DOI 10.1073/pnas.0709379104; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Annesi G, 2005, ANN NEUROL, V58, P803, DOI 10.1002/ana.20666; Bandyopadhyay S, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-6; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Blackinton J, 2005, MOL BRAIN RES, V134, P76, DOI 10.1016/j.molbrainres.2004.09.004; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chandran JS, 2008, NEUROBIOL DIS, V29, P505, DOI 10.1016/j.nbd.2007.11.011; Cheung ECC, 2007, APOPTOSIS, V12, P979, DOI 10.1007/s10495-007-0745-5; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Hod Y, 1999, J CELL BIOCHEM, V72, P435, DOI 10.1002/(SICI)1097-4644(19990301)72:3<435::AID-JCB12>3.3.CO;2-8; Holyoak T, 2003, ACTA CRYSTALLOGR D, V59, P2356, DOI 10.1107/S0907444903021784; Ito G, 2006, BIOCHEM BIOPH RES CO, V339, P667, DOI 10.1016/j.bbrc.2005.11.058; Jonsson TJ, 2005, BIOCHEMISTRY-US, V44, P8634, DOI 10.1021/bi050131i; Junn E, 2009, J NEUROSCI RES, V87, P123, DOI 10.1002/jnr.21831; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Lucas JI, 2007, MOL BIOL EVOL, V24, P551, DOI 10.1093/molbev/msl186; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Meulener MC, 2006, P NATL ACAD SCI USA, V103, P12517, DOI 10.1073/pnas.0601891103; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Szabadkai G, 2006, BBA-MOL CELL RES, V1763, P442, DOI 10.1016/j.bbamcr.2006.04.002; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; Wei Y, 2007, PLOS COMPUT BIOL, V3, P120, DOI 10.1371/journal.pcbi.0030010; Wilson MA, 2005, J MOL BIOL, V353, P678, DOI 10.1016/j.jmb.2005.08.033; Wilson MA, 2004, P NATL ACAD SCI USA, V101, P1531, DOI 10.1073/pnas.0308089100; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Witt AC, 2008, BIOCHEMISTRY-US, V47, P7430, DOI 10.1021/bi800282d; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200	40	216	219	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6476	6485		10.1074/jbc.M806599200	http://dx.doi.org/10.1074/jbc.M806599200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19124468	hybrid, Green Published			2022-12-25	WOS:000263742700050
J	Kim, MA; Kim, HJ; Jee, HJ; Kim, AJ; Bae, YS; Bae, SS; Yun, J				Kim, M-A; Kim, H-J; Jee, H. J.; Kim, A. J.; Bae, Y-S; Bae, S. S.; Yun, J.			Akt2, but not Akt1, is required for cell survival by inhibiting activation of JNK and p38 after UV irradiation	ONCOGENE			English	Article						Akt1; Akt2; isotype-specific function; UV; JNK; p38	PROTEIN-KINASE-B; ISOFORM-SPECIFIC REGULATION; INSULIN-RESISTANCE; PHOSPHORYLATION; PATHWAY; CANCER; APOPTOSIS; AKT/PKB; ALPHA; MICE	The serine/threonine protein kinase, Akt/PKB, has an essential function in cell survival during response to various stresses. Recent studies have demonstrated that Akt isoforms exhibit some distinct physiological functions, but the isotype-specific functions for Akt in the stress response have not been fully identified. In this study, we analysed the cellular response to genotoxic stress using isogenic wild-type, Akt1(-/-) and Akt2(-/-) mouse embryonic fibroblasts (MEFs). Marked hypersensitivity of Akt2(-/-) MEFs was observed to UV irradiation, whereas wild-type and Akt1(-/-) MEFs showed comparable levels of resistance. Akt2(-/-) mouse aortic endothelial cells also showed hypersensitivity to UV and the reconstitution of Akt2 expression in the Akt2(-/-) MEFs restored the UV resistance of the cells. Interestingly, upon UV irradiation, JNK and p38 were significantly upregulated in Akt2(-/-) MEFs, compared to wild-type and Akt1(-/-) MEFs. Additionally, inhibition of JNK and p38 activation reduced UV-induced cell death. Furthermore, both the hyperactivation of JNK and p38 and the UV-induced cell death in Akt2(-/-) MEFs were completely inhibited by restoring Akt2 expression. These results indicate that Akt2, but not Akt1, is essential for cell survival upon UV irradiation, and that Akt2 prevents UV-induced cell death by inhibiting activation of JNK and p38.	[Kim, M-A; Kim, H-J; Jee, H. J.; Kim, A. J.; Bae, Y-S; Yun, J.] Dong A Univ, Coll Med, Dept Biochem, Pusan 602714, South Korea; [Bae, S. S.] Pusan Natl Univ, Coll Med, Dept Pharmacol, Pusan, South Korea	Dong A University; Pusan National University	Yun, J (corresponding author), Dong A Univ, Coll Med, Dept Biochem, 3-1 Dongdaesin Dong, Pusan 602714, South Korea.	yunj@dau.ac.kr			National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [0620060-2]; KOSEF (Korea Science and Engineering Foundation) [M1075604000107N560400110]	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); KOSEF (Korea Science and Engineering Foundation)(Korea Science and Engineering Foundation)	This work was supported by a grant of the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (0620060-2) and Research Program of dual regulation mechanisms of aging and cancer from KOSEF (Korea Science and Engineering Foundation) (M1075604000107N560400110).	Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Bae SS, 2003, J BIOL CHEM, V278, P49530, DOI 10.1074/jbc.M306782200; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Coffer PJ, 1998, BIOCHEM J, V335, P1; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; Heron-Milhavet L, 2006, MOL CELL BIOL, V26, P8267, DOI 10.1128/MCB.00201-06; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kim MA, 2007, EXP MOL MED, V39, P205, DOI 10.1038/emm.2007.23; Liao Y, 2003, MOL CELL BIOL, V23, P6836, DOI 10.1128/MCB.23.19.6836-6848.2003; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; Rane MJ, 2001, J BIOL CHEM, V276, P3517, DOI 10.1074/jbc.M005953200; Ronai Z, 1999, ONCOGENE, V18, P6084, DOI 10.1038/sj.onc.1203175; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Yuan ZQ, 2003, J BIOL CHEM, V278, P23432, DOI 10.1074/jbc.M302674200; Yuan ZQ, 2002, J BIOL CHEM, V277, P29973, DOI 10.1074/jbc.M203636200; Yun JH, 2005, ONCOGENE, V24, P4009, DOI 10.1038/sj.onc.1208575; Yun SJ, 2008, BIOCHEM BIOPH RES CO, V371, P138, DOI 10.1016/j.bbrc.2008.04.029	24	19	19	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 5	2009	28	9					1241	1247		10.1038/onc.2008.487	http://dx.doi.org/10.1038/onc.2008.487			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	415AH	19151757				2022-12-25	WOS:000263906200008
J	Hallows, KR; Wang, HM; Edinger, RS; Butterworth, MB; Oyster, NM; Li, H; Buck, J; Levin, LR; Johnson, JP; Pastor-Soler, NM				Hallows, Kenneth R.; Wang, Huamin; Edinger, Robert S.; Butterworth, Michael B.; Oyster, Nicholas M.; Li, Hui; Buck, Jochen; Levin, Lonny R.; Johnson, John P.; Pastor-Soler, Nuria M.			Regulation of Epithelial Na+ Transport by Soluble Adenylyl Cyclase in Kidney Collecting Duct Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; V-ATPASE; SURFACE EXPRESSION; SODIUM-TRANSPORT; GAMMA-SUBUNIT; CYCLIC-AMP; K+-ATPASE; A6 CELLS; CAMP; CHANNEL	Alkalosis impairs the natriuretic response to diuretics, but the underlying mechanisms are unclear. The soluble adenylyl cyclase (sAC) is a chemosensor that mediates bicarbonate-dependent elevation of cAMP in intracellular microdomains. We hypothesized that sAC may be an important regulator of Na+ transport in the kidney. Confocal images of rat kidney revealed specific immunolocalization of sAC in collecting duct cells, and immunoblots confirmed sAC expression in mouse cortical collecting duct (mpkCCD(c14)) cells. These cells exhibit aldosterone-stimulated transepithelial Na+ currents that depend on both the apical epithelial Na+ channel (ENaC) and basolateral Na+, K+-ATPase. RNA interference-mediated 60-70% knockdown of sAC expression comparably inhibited basal transepithelial short circuit currents (I-sc) in mpkCCD(c14) cells. Moreover, the sAC inhibitors KH7 and 2-hydroxyestradiol reduced I-sc in these cells by 50-60% within 30 min. 8-Bromoadenosine-3',5'-cyclic-monophosphate substantially rescued the KH7 inhibition of transepithelial Na+ current. Aldosterone doubled ENaC-dependent Isc over 4 h, an effect that was abolished in the presence of KH7. The sAC contribution to Isc was unaffected with apical membrane nystatin-mediated permeabilization, whereas the sAC-dependent Na+ current was fully inhibited by basolateral ouabain treatment, suggesting that the Na+, K+-ATPase, rather than ENaC, is the relevant transporter target of sAC. Indeed, neither overexpression of sAC nor treatment with KH7 modulated ENaC currents in Xenopus oocytes. ATPase and biotinylation assays in mpkCCDc14 cells demonstrated that sAC inhibition decreases catalytic activity rather than surface expression of the Na+, K+-ATPase. In summary, these results suggest that sAC regulates both basal and agonist-stimulated Na+ reabsorption in the kidney collecting duct, acting to enhance Na+, K+-ATPase activity.	[Hallows, Kenneth R.; Wang, Huamin; Edinger, Robert S.; Oyster, Nicholas M.; Li, Hui; Johnson, John P.; Pastor-Soler, Nuria M.] Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Dept Med, Pittsburgh, PA 15261 USA; [Hallows, Kenneth R.; Butterworth, Michael B.; Johnson, John P.; Pastor-Soler, Nuria M.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Buck, Jochen; Levin, Lonny R.] Cornell Univ, Dept Pharmacol, Weill Med Coll, New York, NY 10021 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cornell University	Hallows, KR (corresponding author), Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Dept Med, S976 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	hallows@pitt.edu		Levin, Lonny/0000-0002-5204-6356; Hallows, Kenneth/0000-0002-2964-2440	National Institutes of Health [R01 DK075048, K99 DK078917, R01 GM062328, K08 HD045524, R01 DK057718, DK047874]; American Diabetes Association; Hirschl Foundation; Cystic Fibrosis Foundation [HALLOW06P0, BUTTER06G0]; Cell Physiology and Morphology Cores of the Pittsburgh Center for Kidney Research [NIH P30 DK079307]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD045524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307, R01DK047874, R01DK057718, R01DK075048, R00DK078917, K99DK078917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Hirschl Foundation; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Cell Physiology and Morphology Cores of the Pittsburgh Center for Kidney Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK075048 ( to K. R. H.), K99 DK078917 ( to M. B. B.), R01 GM062328 ( to J.B.), K08 HD045524 ( to N.M.P.S.), and R01 DK057718 and DK047874 ( to J.P.J.). This work was also supported by American Diabetes Association and Hirschl Foundation grants ( to L. R. L.) and by Cystic Fibrosis Foundation Grants HALLOW06P0 ( to K. R. H.) and BUTTER06G0 ( to M. B. B.). This work was also supported by the Cell Physiology and Morphology Cores of the Pittsburgh Center for Kidney Research (NIH P30 DK079307).	Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bhalla V, 2006, AM J PHYSIOL-RENAL, V291, pF714, DOI 10.1152/ajprenal.00061.2006; BOSCH JP, 1977, AM J PHYSIOL, V232, pF397, DOI 10.1152/ajprenal.1977.232.5.F397; Breton S, 1998, AM J PHYSIOL-CELL PH, V275, pC1134, DOI 10.1152/ajpcell.1998.275.4.C1134; Breton S, 2000, AM J PHYSIOL-RENAL, V278, pF717, DOI 10.1152/ajprenal.2000.278.5.F717; Brown D, 2003, AM J PHYSIOL-RENAL, V284, pF893, DOI 10.1152/ajprenal.00387.2002; Brown D, 1996, HISTOCHEM CELL BIOL, V105, P261, DOI 10.1007/BF01463929; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Bundey Richard A, 2004, Sci STKE, V2004, ppe19, DOI 10.1126/stke.2312004pe19; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; CASS A, 1970, J GEN PHYSIOL, V56, P100, DOI 10.1085/jgp.56.1.100; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Cheng XJ, 1997, AM J PHYSIOL-CELL PH, V273, pC893, DOI 10.1152/ajpcell.1997.273.3.C893; Cortes VF, 2006, INT J BIOCHEM CELL B, V38, P1901, DOI 10.1016/j.biocel.2006.05.002; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Erlij D, 1999, PFLUG ARCH EUR J PHY, V438, P195, DOI 10.1007/s004240050898; Farrell J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003251; FORBUSH B, 1983, ANAL BIOCHEM, V128, P159, DOI 10.1016/0003-2697(83)90356-1; Franzin CM, 2007, J BIOENERG BIOMEMBR, V39, P379, DOI 10.1007/s10863-007-9105-y; Geng WD, 2005, AM J PHYSIOL-CELL PH, V288, pC1305, DOI 10.1152/ajpcell.00584.2004; Gonin S, 2001, MOL BIOL CELL, V12, P255, DOI 10.1091/mbc.12.2.255; Harvey BJ, 2008, J STEROID BIOCHEM, V108, P310, DOI 10.1016/j.jsbmb.2007.09.005; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Jaiswal BS, 2003, P NATL ACAD SCI USA, V100, P10676, DOI 10.1073/pnas.1831008100; Kamenetsky M, 2006, J MOL BIOL, V362, P623, DOI 10.1016/j.jmb.2006.07.045; Kleizen B, 2000, EUR J CELL BIOL, V79, P544, DOI 10.1078/0171-9335-00078; KLEYMAN TR, 1994, AM J PHYSIOL, V266, pF506, DOI 10.1152/ajprenal.1994.266.3.F506; LEWIS SA, 1977, J GEN PHYSIOL, V70, P427, DOI 10.1085/jgp.70.4.427; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Loon NR, 1998, CLIN SCI, V94, P287, DOI 10.1042/cs0940287; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; MITTAG TW, 1993, AM J PHYSIOL, V264, pF1060, DOI 10.1152/ajprenal.1993.264.6.F1060; Mohan S, 2004, J BIOL CHEM, V279, P32071, DOI 10.1074/jbc.M405091200; NELSON RD, 1992, P NATL ACAD SCI USA, V89, P3541, DOI 10.1073/pnas.89.8.3541; PALMER LG, 1985, J MEMBRANE BIOL, V83, P57, DOI 10.1007/BF01868738; Pastor-Soler N, 2003, J BIOL CHEM, V278, P49523, DOI 10.1074/jbc.M309543200; Pastor-Soler NM, 2008, AM J PHYSIOL-CELL PH, V294, pC488, DOI 10.1152/ajpcell.00537.2007; Paunescu TG, 2008, AM J PHYSIOL-RENAL, V294, pF130, DOI 10.1152/ajprenal.00406.2007; Pochynyuk O, 2006, AM J PHYSIOL-RENAL, V290, pF949, DOI 10.1152/ajprenal.00386.2005; Ramos LS, 2008, J GEN PHYSIOL, V132, P329, DOI 10.1085/jgp.200810044; Rokaw MD, 1996, J BIOL CHEM, V271, P32468, DOI 10.1074/jbc.271.50.32468; Schmid A, 2007, J GEN PHYSIOL, V130, P99, DOI 10.1085/jgp.200709784; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Steegborn C, 2005, J BIOL CHEM, V280, P31754, DOI 10.1074/jbc.M507144200; Stessin AM, 2006, J BIOL CHEM, V281, P17253, DOI 10.1074/jbc.M603500200; Stockand JD, 2000, NEWS PHYSIOL SCI, V15, P161; Summa V, 2004, J PHYSIOL-LONDON, V555, P355, DOI 10.1113/jphysiol.2003.054270; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; USSING HH, 1951, ACTA PHYSIOL SCAND, V23, P110, DOI 10.1111/j.1748-1716.1951.tb00800.x; Wang Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1145, DOI 10.1152/ajpcell.00627.2004; Weber WM, 1999, PFLUG ARCH EUR J PHY, V438, P561, DOI 10.1007/s004240051076; WELLING PA, 1993, J BIOL CHEM, V268, P23469; Wetzel RK, 2001, AM J PHYSIOL-RENAL, V281, pF531, DOI 10.1152/ajprenal.2001.281.3.F531; Wu KY, 2006, NAT NEUROSCI, V9, P1257, DOI 10.1038/nn1767; Young JJ, 2008, J NEUROSCI RES, V86, P118, DOI 10.1002/jnr.21458; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje	59	43	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5774	5783		10.1074/jbc.M805501200	http://dx.doi.org/10.1074/jbc.M805501200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19126549	Green Published, hybrid			2022-12-25	WOS:000263560600041
J	Urbach, A; Benvenisty, N				Urbach, Achia; Benvenisty, Nissim			Studying Early Lethality of 45,XO (Turner's Syndrome) Embryos Using Human Embryonic Stem Cells	PLOS ONE			English	Article							X-CHROMOSOME INACTIVATION; GENE-EXPRESSION; CANDIDATE GENE; SHORT STATURE; DIFFERENTIATION; DELETIONS; CULTURE; ESCAPE; GENOME; MODEL	Turner's syndrome (caused by monosomy of chromosome X) is one of the most common chromosomal abnormalities in females. Although 3% of all pregnancies start with XO embryos, 99% of these pregnancies terminate spontaneously during the first trimester. The common genetic explanation for the early lethality of monosomy X embryos, as well as the phenotype of surviving individuals is haploinsufficiency of pseudoautosomal genes on the X chromosome. Another possible mechanism is null expression of imprinted genes on the X chromosome due to the loss of the expressed allele. In contrast to humans, XO mice are viable, and fertile. Thus, neither cells from patients nor mouse models can be used in order to study the cause of early lethality in XO embryos. Human embryonic stem cells (HESCs) can differentiate in culture into cells from the three embryonic germ layers as well as into extraembryonic cells. These cells have been shown to have great value in modeling human developmental genetic disorders. In order to study the reasons for the early lethality of 45, XO embryos we have isolated HESCs that have spontaneously lost one of their sex chromosomes. To examine the possibility that imprinted genes on the X chromosome play a role in the phenotype of XO embryos, we have identified genes that were no longer expressed in the mutant cells. None of these genes showed a monoallelic expression in XX cells, implying that imprinting is not playing a major role in the phenotype of XO embryos. To suggest an explanation for the embryonic lethality caused by monosomy X, we have differentiated the XO HESCs in vitro an in vivo. DNA microarray analysis of the differentiated cells enabled us to compare the expression of tissue specific genes in XO and XX cells. The tissue that showed the most significant differences between the clones was the placenta. Many placental genes are expressed at much higher levels in XX cells in compare to XO cells. Thus, we suggest that abnormal placental differentiation as a result of haploinsufficiency of X-linked pseudoautosomal genes causes the early lethality in XO human embryos.	[Urbach, Achia; Benvenisty, Nissim] Hebrew Univ Jerusalem, Dept Genet, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Urbach, A (corresponding author), Hebrew Univ Jerusalem, Dept Genet, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel.	nissimb@cc.huji.ac.il	/GLR-9975-2022	Urbach, Achia/0000-0001-9393-4504	Bereshit Consortium; Israeli Ministry of Trade and Industry; European Community [018739]; Israel Science Foundation [227/06]	Bereshit Consortium; Israeli Ministry of Trade and Industry; European Community(European Commission); Israel Science Foundation(Israel Science Foundation)	This research was partially supported by funds from the Bereshit Consortium, the Israeli Ministry of Trade and Industry, the European Community (ESTOOLS, Grant number 018739), and by a grant from the Israel Science Foundation grant #227/06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHWORTH A, 1991, NATURE, V351, P406, DOI 10.1038/351406a0; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Ben-Nun IF, 2006, MOL CELL ENDOCRINOL, V252, P154, DOI 10.1016/j.mce.2006.03.034; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; BURGOYNE PS, 1989, NATURE, V342, P860, DOI 10.1038/342860a0; CANKI N, 1988, ANN GENET-PARIS, V31, P4; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; COCKWELL A, 1991, J MED GENET, V28, P151, DOI 10.1136/jmg.28.3.151; Davies W, 2007, BIOL PSYCHIAT, V61, P1351, DOI 10.1016/j.biopsych.2006.08.011; Dhara SK, 2004, NUCLEIC ACIDS RES, V32, P3995, DOI 10.1093/nar/gkh746; Disteche CM, 2002, CYTOGENET GENOME RES, V99, P36, DOI 10.1159/000071572; Dvash T, 2004, BEST PRACT RES CL OB, V18, P929, DOI 10.1016/j.bpobgyn.2004.06.005; Dvash T, 2004, HUM REPROD, V19, P2875, DOI 10.1093/humrep/deh529; Eggan K, 2002, NAT BIOTECHNOL, V20, P455, DOI 10.1038/nbt0502-455; Eiges R, 2007, CELL STEM CELL, V1, P568, DOI 10.1016/j.stem.2007.09.001; Ellison JW, 1997, HUM MOL GENET, V6, P1341, DOI 10.1093/hmg/6.8.1341; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; Geerkens C, 1996, HUM GENET, V97, P39; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Kopper O, 2005, STEM CELL REV, V1, P145, DOI 10.1385/SCR:1:2:145; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Meroni G, 1996, HUM MOL GENET, V5, P423, DOI 10.1093/hmg/5.4.423; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Ranke MB, 2001, LANCET, V358, P309, DOI 10.1016/S0140-6736(01)05487-3; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; Saenger P, 1996, NEW ENGL J MED, V335, P1749, DOI 10.1056/NEJM199612053352307; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Sjoblom C, 2005, ENDOCRINOLOGY, V146, P2142, DOI 10.1210/en.2004-1260; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; Staessen C, 2003, HUM REPROD UPDATE, V9, P319, DOI 10.1093/humupd/dmg029; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Turner HH, 1938, ENDOCRINOLOGY, V23, P566, DOI 10.1210/endo-23-5-566; Urbach A, 2004, STEM CELLS, V22, P635, DOI 10.1634/stemcells.22-4-635; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; YEN PH, 1987, CELL, V49, P443, DOI 10.1016/0092-8674(87)90447-8; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zinn AR, 1998, CURR OPIN GENET DEV, V8, P322, DOI 10.1016/S0959-437X(98)80089-0	40	67	73	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2009	4	1							e4175	10.1371/journal.pone.0004175	http://dx.doi.org/10.1371/journal.pone.0004175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ID	19137066	Green Published, gold, Green Submitted			2022-12-25	WOS:000265479500006
J	Drexler, HCA				Drexler, Hannes C. A.			Synergistic Apoptosis Induction in Leukemic Cells by the Phosphatase Inhibitor Salubrinal and Proteasome Inhibitors	PLOS ONE			English	Article								Background: Cells adapt to endoplasmic reticulum (ER)-stress by arresting global protein synthesis while simultaneously activating specific transcription factors and their downstream targets. These processes are mediated in part by the phosphorylation-dependent inactivation of the translation initiation factor eIF2 alpha. Following restoration of homeostasis protein synthesis is resumed when the serine/threonine-protein phosphatase PP1 dephosphorylates and reactivates eIF2 alpha. Proteasome inhibitors, used to treat multiple myeloma patients evoke ER-stress and apoptosis by blocking the ER-associated degradation of misfolded proteins (ERAD), however, the role of eIF2 alpha phosphorylation in leukemic cells under conditions of proteasome inhibitor-mediated ER stress is currently unclear. Methodology and Principal Findings: Bcr-Abl-positive and negative leukemic cell lines were used to investigate the functional implications of PP1-related phosphatase activities on eIF2 alpha phosphorylation in proteasome inhibitor-mediated ER stress and apoptosis. Rather unexpectedly, salubrinal, a recently identified PP1 inhibitor capable to protect against ER stress in various model systems, strongly synergized with proteasome inhibitors to augment apoptotic death of different leukemic cell lines. Salubrinal treatment did not affect the phosphorlyation status of eIF2 alpha. Furthermore, the proapoptotic effect of salubrinal occurred independently from the chemical nature of the proteasome inhibitor, was recapitulated by a second unrelated phosphatase inhibitor and was unaffected by overexpression of a dominant negative eIF2 alpha S51A variant that can not be phosphorylated. Salubrinal further aggravated ER-stress and proteotoxicity inflicted by the proteasome inhibitors on the leukemic cells since characteristic ER stress responses, such as ATF4 and CHOP synthesis, XBP1 splicing, activation of MAP kinases and eventually apoptosis were efficiently abrogated by the translational inhibitor cycloheximide. Conclusions: Although PP1 activity does not play a major role in regulating the ER stress response in leukemic cells, phosphatase signaling nevertheless significantly limits proteasome inhibitor-mediated ER-stress and apoptosis. Inclusion of specific phosphatase inhibitors might therefore represent an option to improve current proteasome inhibitor-based treatment modalities for hematological cancers.	Max Planck Inst Mol Biomed, Dept Vasc Cell Biol, Munster, Germany	Max Planck Society	Drexler, HCA (corresponding author), Max Planck Inst Mol Biomed, Dept Vasc Cell Biol, Munster, Germany.	hannes.drexler@mpi-muenster.mpg.de	Drexler, Hannes/AAI-3449-2020		Max Planck Society	Max Planck Society(Max Planck Society)	This study was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrabi S, 2007, P NATL ACAD SCI USA, V104, P19011, DOI 10.1073/pnas.0706696104; Arai K, 2004, J NEUROCHEM, V89, P232, DOI 10.1111/j.1471-4159.2004.02317.x; Bali P, 2005, CLIN CANCER RES, V11, P6382, DOI 10.1158/1078-0432.CCR-05-0344; Boccadoro M, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-18; Boyce M, 2008, CELL DEATH DIFFER, V15, P589, DOI 10.1038/sj.cdd.4402296; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Cavaletti G, 2007, EXP NEUROL, V204, P317, DOI 10.1016/j.expneurol.2006.11.010; Chapman R, 1998, ANNU REV CELL DEV BI, V14, P459, DOI 10.1146/annurev.cellbio.14.1.459; Chauhan D, 2005, MOL CANCER THER, V4, P686, DOI 10.1158/1535-7163.MCT-04-0338; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; Dai Y, 2003, ONCOGENE, V22, P7108, DOI 10.1038/sj.onc.1206863; Davenport EL, 2007, BLOOD, V110, P2641, DOI 10.1182/blood-2006-11-053728; David E, 2005, BLOOD, V106, P4322, DOI 10.1182/blood-2005-06-2584; Drexler HCA, 2005, APOPTOSIS, V10, P743, DOI 10.1007/s10495-005-2942-4; Emanuele S, 2007, APOPTOSIS, V12, P1327, DOI 10.1007/s10495-007-0063-y; Fernandez Y, 2006, J BIOL CHEM, V281, P1107, DOI 10.1074/jbc.M511607200; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Ghribi O, 2004, NEUROBIOL DIS, V16, P417, DOI 10.1016/j.nbd.2004.04.002; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hideshima T, 2005, P NATL ACAD SCI USA, V102, P8567, DOI 10.1073/pnas.0503221102; HONKANEN RE, 1993, FEBS LETT, V330, P283, DOI 10.1016/0014-5793(93)80889-3; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Long K, 2005, BIOORG MED CHEM LETT, V15, P3849, DOI 10.1016/j.bmcl.2005.05.120; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Luo S, 2002, BIOCHEM J, V366, P787, DOI 10.1042/BJ20011802; Miller CP, 2007, BLOOD, V110, P267, DOI 10.1182/blood-2006-03-013128; Nawrocki ST, 2006, CANCER RES, V66, P3773, DOI 10.1158/0008-5472.CAN-05-2961; Nawrocki ST, 2005, CANCER RES, V65, P11510, DOI 10.1158/0008-5472.CAN-05-2394; Nawrocki ST, 2005, CANCER RES, V65, P11658, DOI 10.1158/0008-5472.CAN-05-2370; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Pei XY, 2004, CLIN CANCER RES, V10, P3839, DOI 10.1158/1078-0432.CCR-03-0561; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Russo SM, 2001, INT J RADIAT ONCOL, V50, P183, DOI 10.1016/S0360-3016(01)01446-8; Saelens X, 2001, J BIOL CHEM, V276, P41620, DOI 10.1074/jbc.M103674200; Saito J, 2007, BIOCHEM J, V405, P591, DOI 10.1042/BJ20070231; Sakoff JA, 2002, INVEST NEW DRUG, V20, P1, DOI 10.1023/A:1014460818734; Smith WW, 2005, HUM MOL GENET, V14, P3801, DOI 10.1093/hmg/ddi396; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Sutheesophon K, 2006, ACTA HAEMATOL-BASEL, V115, P78, DOI 10.1159/000089471; Swingle Mark, 2007, V365, P23; Sydor JR, 2006, P NATL ACAD SCI USA, V103, P17408, DOI 10.1073/pnas.0608372103; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Urano F, 2000, J CELL SCI, V113, P3697; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Yew EHJ, 2005, J NEUROCHEM, V94, P943, DOI 10.1111/j.1471-4159.2005.03220.x; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu CR, 2003, BLOOD, V102, P3765, DOI 10.1182/blood-2003-03-0737	57	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2009	4	1							e4161	10.1371/journal.pone.0004161	http://dx.doi.org/10.1371/journal.pone.0004161			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FZ	19129918	Green Published, Green Submitted, gold			2022-12-25	WOS:000265473500008
J	Guwatudde, D; Wabwire-Mangen, F; Eller, LA; Eller, M; McCutchan, F; Kibuuka, H; Millard, M; Sewankambo, N; Serwadda, D; Michael, N; Robb, M				Guwatudde, David; Wabwire-Mangen, Fred; Eller, Leigh Anne; Eller, Michael; McCutchan, Francine; Kibuuka, Hannah; Millard, Monica; Sewankambo, Nelson; Serwadda, David; Michael, Nelson; Robb, Merlin		Kayunga Cohort Res Team	Relatively Low HIV Infection Rates in Rural Uganda, but with High Potential for a Rise: A Cohort Study in Kayunga District, Uganda	PLOS ONE			English	Article								Background: Few studies have been conducted in Uganda to identify and quantify the determinants of HIV-1 infection. We report results from a community-based cohort study, whose primary objectives were to determine HIV-1 prevalence, incidence, and determinants of these infections, among other objectives. Methodology: Consenting volunteers from the rural district of Kayunga in Uganda aged 15-49 years were enrolled between March and July 2006. Participants were evaluated every six months. A questionnaire that collected information on behavioral and other HIV-1 risk factors was administered, and a blood sample obtained for laboratory analysis at each study visit. Principal Findings: HIV-1 prevalence among the 2025 participants was 9.9% (95% CI = 8.6%-11.2%). By the end of 12 months of follow-up, 1689.7 person-years had been accumulated, with a median follow-up time of 11.97 months. Thirteen HIV-1 incident cases were detected giving an annual HIV-1 incidence of 0.77% (95% CI = 0.35-1.19). Prevalence of HSV-2 infection was 57% and was strongly associated with prevalent HIV-1 infection (adjusted Odds Ratio = 3.9, 95% CI = 2.50-6.17); as well as incident HIV-1 infection (adjusted Rate Ratio (RR) = 8.7, 95% CI = 1.11-67.2). The single most important behavioral characteristic associated with incident HIV infection was the number of times in the past 6 months, a participant had sex with person(s) they suspected/knew were having sex with others; attaining statistical significance at 10 times and higher (adjusted RR = 6.3, 95% CI = 1.73-23.1). By the end of 12 months of follow-up, 259 participants (13%) were lost to follow-up, 13 (0.6%) had died, and 2 (0.1%) had withdrawn consent. Conclusions: Despite relatively low HIV-1 incidence observed in this community, prevalence remains relatively high. In the presence of high prevalence of HSV-2 infection and the behavioral characteristic of having sex with more than one partner, there is potential for increase in HIV-1 incidence.	[Guwatudde, David; Eller, Leigh Anne; Eller, Michael; Kibuuka, Hannah; Millard, Monica] Makerere Univ, Walter Reed Project, Kampala, Uganda; [Guwatudde, David; Wabwire-Mangen, Fred; Serwadda, David] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Eller, Leigh Anne; Eller, Michael; McCutchan, Francine; Robb, Merlin] Henry M Jackson Fdn, Rockville, MD USA; [Sewankambo, Nelson] Makerere Univ, Sch Med, Kampala, Uganda; [Michael, Nelson] Walter Reed Army Inst Res, Div Retrovirol, Rockville, MD USA	Makerere University; Makerere University; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Makerere University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Guwatudde, D (corresponding author), Makerere Univ, Walter Reed Project, Kampala, Uganda.	dguwatudde@muwrp.org	Eller, Michael A./I-2156-2019	Eller, Michael A./0000-0003-3905-4877; Sewankambo, Nelson/0000-0001-9362-053X	U.S. Army Medical Research and Material Command [W81XWH-04-02-0005]; Henry M. Jackson Foundation for the Advancement of Military Medicine [1Y-A1-26-42-07]; DAIDS [1Y-A1-26-42-07]	U.S. Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Henry M. Jackson Foundation for the Advancement of Military Medicine; DAIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the U.S. Army Medical Research and Material Command and its cooperative agreement (W81XWH-04-02-0005) with the Henry M. Jackson Foundation for the Advancement of Military Medicine and by an interagency agreement (1Y-A1-26-42-07) with DAIDS. The funders of this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo MA, 2004, AIDS RES HUM RETROV, V20, P895, DOI 10.1089/0889222041725235; Arroyo MA, 2006, JAIDS-J ACQ IMM DEF, V43, P440, DOI 10.1097/01.qai.0000243053.80945.f0; Auvert B, 2001, AIDS, V15, P885, DOI 10.1097/00002030-200105040-00009; Celum C, 2004, B WORLD HEALTH ORGAN, V82, P447; Corey L, 2000, JAMA-J AM MED ASSOC, V283, P791, DOI 10.1001/jama.283.6.791; Dowling WE, 2002, AIDS, V16, P1809, DOI 10.1097/00002030-200209060-00015; Eller LA, 2007, J CLIN MICROBIOL, V45, P3281, DOI 10.1128/JCM.00894-07; Fylkesnes K, 1998, AIDS, V12, P1227, DOI 10.1097/00002030-199810000-00015; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hallett T B, 2006, Sex Transm Infect, V82 Suppl 1, pi1; Harris ME, 2002, AIDS RES HUM RETROV, V18, P1281, DOI 10.1089/088922202320886325; Hoelscher M, 2002, AIDS, V16, P2055, DOI 10.1097/00002030-200210180-00011; Kamali A, 2002, TROP MED INT HEALTH, V7, P1053, DOI 10.1046/j.1365-3156.2002.00963.x; KengeyaKayondo JF, 1996, INT J EPIDEMIOL, V25, P1077, DOI 10.1093/ije/25.5.1077; Kilian AHD, 1999, AIDS, V13, P391, DOI 10.1097/00002030-199902250-00012; Kwesigabo G, 2000, J ACQ IMMUN DEF SYND, V23, P410; Laeyendecker O, 2004, J CLIN MICROBIOL, V42, P1794, DOI 10.1128/JCM.42.4.1794-1796.2004; Lihana RW, 2006, AIDS RES HUM RETROV, V22, P1172, DOI 10.1089/aid.2006.22.1172; Mbulaiteye SM, 2002, LANCET, V360, P41, DOI 10.1016/S0140-6736(02)09331-5; Mermin J, 2008, JAMA-J AM MED ASSOC, V300, P540, DOI 10.1001/jama.300.5.540; Murphy EM, 2006, PLOS MED, V3, P1443, DOI 10.1371/journal.pmed.0030379; Okware S, 2001, B WORLD HEALTH ORGAN, V79, P1113; Parikh SA, 2007, AM J PUBLIC HEALTH, V97, P1198, DOI 10.2105/AJPH.2006.088682; Quigley MA, 2004, AIDS, V18, P2055, DOI 10.1097/00002030-200410210-00010; Rodriguez MDM, 2002, AIDS, V16, P451; *SAS I INC, 2001, STAT AN SOFTW SAS VE; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; *UBOS, 2001, UG BUR STAT UBOS POP; Uganda-MOH, 2006, UG MIN HLTH UG HIV A; *UNAIDS, 2002, EP FACT SHEETS HIV S; *UNAIDS, 2006, OV GLOB AIDS EP REP; *UNAIDS, 2006, WKLY EPIDEMIOL REC, V81, P40; WAWER MJ, 1991, BRIT MED J, V303, P1303, DOI 10.1136/bmj.303.6813.1303; Weiss HA, 2001, AIDS, V15, pS97, DOI 10.1097/00002030-200108004-00011; Whitworth JAG, 2002, TROP MED INT HEALTH, V7, P1047, DOI 10.1046/j.1365-3156.2002.00973.x; WHO, 2001, WHO CONRAD TECHNICAL, P11; Zablotska IB, 2006, AIDS, V20, P1191, DOI 10.1097/01.aids.0000226960.25589.72	37	22	22	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4145	10.1371/journal.pone.0004145	http://dx.doi.org/10.1371/journal.pone.0004145			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FX	19127290	Green Published, Green Submitted, gold			2022-12-25	WOS:000265473300010
J	Klok, CJ; Harrison, JF				Klok, C. Jaco; Harrison, Jon F.			Atmospheric Hypoxia Limits Selection for Large Body Size in Insects	PLOS ONE			English	Article							PAS PROTEIN; OXYGEN; DROSOPHILA; RESPONSES; EVOLUTION; TEMPERATURE; MODEL	Background: The correlations between Phanerozoic atmospheric oxygen fluctuations and insect body size suggest that higher oxygen levels facilitate the evolution of larger size in insects. Methods and Principal Findings: Testing this hypothesis we selected Drosophila melanogaster for large size in three oxygen atmospheric partial pressures (aPO(2)). Fly body sizes increased by 15% during 11 generations of size selection in 21 and 40 kPa aPO(2). However, in 10 kPa aPO(2), sizes were strongly reduced. Beginning at the 12(th) generation, flies were returned to normoxia. All flies had similar, enlarged sizes relative to the starting populations, demonstrating that selection for large size had functionally equivalent genetic effects on size that were independent of aPO(2). Significance: Hypoxia provided a physical constraint on body size even in a tiny insect strongly selected for larger mass, supporting the hypothesis that Triassic hypoxia may have contributed to a reduction in insect size.	[Klok, C. Jaco; Harrison, Jon F.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Klok, CJ (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	cjklok@asu.edu			National Science Foundation [IBN 0419704]	National Science Foundation(National Science Foundation (NSF))	This research was funded by the National Science Foundation, IBN 0419704, to JFH.	Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; Berner RA, 2003, ANNU REV EARTH PL SC, V31, P105, DOI 10.1146/annurev.earth.31.100901.141329; Berner RA, 2007, SCIENCE, V316, P557, DOI 10.1126/science.1140273; Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; Bonner J.T., 2006, WHY SIZE MATTERS; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Chapelle G, 1999, NATURE, V399, P114, DOI 10.1038/20099; Chapelle G, 2004, OIKOS, V106, P167, DOI 10.1111/j.0030-1299.2004.12934.x; Cikala M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-26; de Crespigny FEC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1229, DOI 10.1007/s00265-007-0353-y; Dudley R, 1998, J EXP BIOL, V201, P1043; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Frazier MR, 2001, PHYSIOL BIOCHEM ZOOL, V74, P641, DOI 10.1086/322172; Gibert P, 2001, PHYSIOL BIOCHEM ZOOL, V74, P429, DOI 10.1086/320429; Gorr TA, 2006, J INSECT PHYSIOL, V52, P349, DOI 10.1016/j.jinsphys.2006.01.002; GRAHAM JB, 1995, NATURE, V375, P117, DOI 10.1038/375117a0; Harrison J, 2006, RESP PHYSIOL NEUROBI, V154, P4, DOI 10.1016/j.resp.2006.02.008; Henry JR, 2004, J EXP BIOL, V207, P3559, DOI 10.1242/jeb.01189; Hetz SK, 2005, NATURE, V433, P516, DOI 10.1038/nature03106; Jaenike J, 2007, TRENDS ECOL EVOL, V22, P167, DOI 10.1016/j.tree.2007.01.008; Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Kaiser A, 2007, P NATL ACAD SCI USA, V104, P13198, DOI 10.1073/pnas.0611544104; KLOEK GP, 1979, AVIAT SPACE ENVIR MD, V50, P1126; Lavista-Llanos S, 2002, MOL CELL BIOL, V22, P6842, DOI 10.1128/MCB.22.19.6842-6853.2002; Padilla PA, 2002, MOL BIOL CELL, V13, P1473, DOI 10.1091/mbc.01-12-0594; Partridge L, 1999, GENET RES, V74, P43, DOI 10.1017/S0016672399003778; Webster KA, 2003, J EXP BIOL, V206, P2911, DOI 10.1242/jeb.00516; Wenger RH, 2000, J EXP BIOL, V203, P1253; Wootton RJ, 2000, BIOL REV, V75, P129, DOI 10.1017/S0006323199005459; WOOTTON RJ, 1981, ANNU REV ENTOMOL, V26, P319, DOI 10.1146/annurev.en.26.010181.001535	31	40	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e3876	10.1371/journal.pone.0003876	http://dx.doi.org/10.1371/journal.pone.0003876			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FX	19127286	Green Submitted, gold, Green Published			2022-12-25	WOS:000265473300001
J	Hanif, M; Rosengardten, Y; Sagelius, H; Rozell, B; Eriksson, M				Hanif, Mubashir; Rosengardten, Ylva; Sagelius, Hanna; Rozell, Bjorn; Eriksson, Maria			Differential Expression of A-Type and B-Type Lamins during Hair Cycling	PLOS ONE			English	Article								Multiple genetic disorders caused by mutations that affect the proteins lamin A and C show strong skin phenotypes. These disorders include the premature aging disorders Hutchinson-Gilford progeria syndrome and mandibuloacral dysplasia, as well as restrictive dermopathy. Prior studies have shown that the lamin A/C and B proteins are expressed in skin, but little is known about their normal expression in the different skin cell-types and during the hair cycle. Our immunohistochemical staining for lamins A/C and B in wild-type mice revealed strong expression in the basal cell layer of the epidermis, the outer root sheath, and the dermal papilla during all stages of the hair cycle. Lower expression of both lamins A/C and B was seen in suprabasal cells of the epidermis, in the hypodermis, and in the bulb of catagen follicles. In addition, we have utilized a previously described mouse model of Hutchinson-Gilford progeria syndrome and show here that the expression of progerin does not result in pronounced effects on hair cycling or the expression of lamin B.	Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland; [Rosengardten, Ylva; Sagelius, Hanna; Eriksson, Maria] Karolinska Univ Hosp, Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Rozell, Bjorn] Karolinska Univ Hosp, Karolinska Inst, Clin Res Ctr, Dept Lab Med, Huddinge, Sweden	University of Helsinki; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Hanif, M (corresponding author), Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland.	Maria.Eriksson.2@ki.se			Loo and Hans Osterman Foundation; Torsten and Ragnar Soderberg Foundations; Jeansson Foundation; Swedish Medical Research Council; Swedish Foundation for Strategic Research; Wennergrenska samfundet [postdoctoral fellowship]	Loo and Hans Osterman Foundation(Instituto de Salud Carlos III); Torsten and Ragnar Soderberg Foundations; Jeansson Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wennergrenska samfundet	This work was supported by grants from the Loo and Hans Osterman Foundation, the Torsten and Ragnar Soderberg Foundations, the Jeansson Foundation, the Swedish Medical Research Council, and the Swedish Foundation for Strategic Research. M.H. is supported by a postdoctoral fellowship from the Wennergrenska samfundet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Bailey DM, 1998, BRIT J UROL, V81, P745; Broers JLV, 1997, HISTOCHEM CELL BIOL, V107, P505, DOI 10.1007/s004180050138; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346; Hoffman RM, 2006, EXPERT OPIN DRUG DEL, V3, P437, DOI 10.1517/17425247.3.3.437; Krause K, 2006, SEMIN CUTAN MED SURG, V25, P2, DOI 10.1016/j.sder.2006.01.002; Lambert JF, 2000, J NEUROSCI METH, V95, P127, DOI 10.1016/S0165-0270(99)00157-0; Lavker RM, 2003, J INVEST DERM SYMP P, V8, P28, DOI 10.1046/j.1523-1747.2003.12169.x; Machiels BM, 1996, J BIOL CHEM, V271, P9249, DOI 10.1074/jbc.271.16.9249; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Navarro CL, 2004, HUM MOL GENET, V13, P2493, DOI 10.1093/hmg/ddh265; Novelli G, 2002, AM J HUM GENET, V71, P426, DOI 10.1086/341908; Oguchi M, 2002, BRIT J DERMATOL, V147, P853, DOI 10.1046/j.1365-2133.2002.04948.x; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Paus R, 2004, DIFFERENTIATION, V72, P489, DOI 10.1111/j.1432-0436.2004.07209004.x; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; ROBER RA, 1989, DEVELOPMENT, V105, P365; Sagelius H, 2008, J CELL SCI, V121, P969, DOI 10.1242/jcs.022913; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; SLOMINSKI A, 1991, J INVEST DERMATOL, V96, P172, DOI 10.1111/1523-1747.ep12460956; So PL, 2004, TRENDS BIOTECHNOL, V22, P493, DOI 10.1016/j.tibtech.2004.08.007; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; STEWART C, 1987, CELL, V51, P383, DOI 10.1016/0092-8674(87)90634-9; Tilli CMLJ, 2003, BRIT J DERMATOL, V148, P102, DOI 10.1046/j.1365-2133.2003.05026.x; Yang SH, 2006, J CLIN INVEST, V116, P2115, DOI 10.1172/JCI28968	38	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2009	4	1							e4114	10.1371/journal.pone.0004114	http://dx.doi.org/10.1371/journal.pone.0004114			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FT	19122810	Green Published, gold, Green Submitted			2022-12-25	WOS:000265472900001
J	Crow, A; Liu, YM; Moller, MC; Le Brun, NE; Hederstedt, L				Crow, Allister; Liu, Yiming; Moller, Mirja Carlsson; Le Brun, Nick E.; Hederstedt, Lars			Structure and Functional Properties of Bacillus subtilis Endospore Biogenesis Factor StoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; ESCHERICHIA-COLI THIOREDOXIN; CYTOCHROME-C MATURATION; ACTIVE-SITE; CYSTEINE RESIDUES; PK(A) VALUES; PROTEIN; RESA; MUTANTS; GENE	Bacillus subtilis StoA is an extracytoplasmic thiol-disulfide oxidoreductase (TDOR) important for the synthesis of the endospore peptidoglycan cortex protective layer. Here we demonstrate that StoA is membrane-associated in B. subtilis and report the crystal structure of the soluble protein lacking its membrane anchor. This showed that StoA adopts a thioredoxin-like fold with N-terminal and internal additions that are characteristic of extracytoplasmic TDORs. The CXXC active site of the crystallized protein was found to be in a mixture of oxidized and reduced states, illustrating that there is little conformational variation between redox states. The midpoint reduction potential was determined as -248 mV versus normal hydrogen electrode at pH 7 consistent with StoA fulfilling a reductive role in endospore biogenesis. pKa values of the active site cysteines, Cys-65 and Cys-68, were determined to be 5.5 and 7.8. Although Cys-68 is buried within the structure, both cysteines were found to be accessible to cysteine-specific alkylating reagents. In vivo studies of site-directed variants of StoA revealed that the active site cysteines are functionally important, as is Glu-71, which lies close to the active site and is conserved in many reducing extracytoplasmic TDORs. The structure and biophysical properties of StoA are very similar to those of ResA, a B. subtilis extracytoplasmic TDOR involved in cytochrome c maturation, raising important general questions about how these similar but non-redundant proteins achieve specificity. A detailed comparison of the two proteins demonstrates that relatively subtle differences, largely located around the active sites of the proteins, are sufficient to confer specificity.	[Crow, Allister; Le Brun, Nick E.] Univ E Anglia, Sch Chem Sci & Pharm, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England; [Liu, Yiming; Moller, Mirja Carlsson; Hederstedt, Lars] Lund Univ, Dept Cell & Organism Biol, SE-22362 Lund, Sweden	University of East Anglia; Lund University	Le Brun, NE (corresponding author), Univ E Anglia, Sch Chem Sci & Pharm, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England.	n.le-brun@uea.ac.uk; Lars.Hederstedt@cob.lu.se	Crow, Allister/F-2147-2018	Crow, Allister/0000-0001-6856-5962; Carlsson Moller, Mirja/0000-0001-8695-6262; Hederstedt, Lars/0000-0002-6650-6296; Le Brun, Nick/0000-0001-9780-4061	Federation of European Microbiological Societies research fellowship; Swedish Research Council [6212007-6094]; Wellcome Trust Grant [076017/Z/04/Z]; Biotechnology and Biological Sciences Research Council [BB/C503597/1] Funding Source: researchfish	Federation of European Microbiological Societies research fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Wellcome Trust Grant(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Federation of European Microbiological Societies research fellowship ( to M. C. M.), by Swedish Research Council Grant 6212007-6094, and by Wellcome Trust Grant 076017/Z/04/Z. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AMANN E, 1983, GENE, V25, P167, DOI 10.1016/0378-1119(83)90222-6; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P14985, DOI 10.1021/bi970071j; Crow A, 2005, BIOCHEM SOC T, V33, P149, DOI 10.1042/BST0330149; Crow A, 2004, J BIOL CHEM, V279, P23654, DOI 10.1074/jbc.M402823200; DAILEY FE, 1993, P NATL ACAD SCI USA, V90, P1043, DOI 10.1073/pnas.90.3.1043; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Edeling MA, 2002, STRUCTURE, V10, P973, DOI 10.1016/S0969-2126(02)00794-3; Erlendsson LS, 2004, J BACTERIOL, V186, P6230, DOI 10.1128/JB.186.18.6230-6238.2004; Erlendsson LS, 2003, J BIOL CHEM, V278, P17852, DOI 10.1074/jbc.M300103200; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FORTNAGEL P, 1968, J BACTERIOL, V95, P1431, DOI 10.1128/JB.95.4.1431-1438.1968; Goulding CW, 2004, J BIOL CHEM, V279, P3516, DOI 10.1074/jbc.M311833200; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; HAUGLAND RP, 2005, HDB GUIDE FLUORESCEN, pCH2; Hodson CTC, 2008, J BACTERIOL, V190, P4697, DOI 10.1128/JB.00145-08; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Imamura D, 2004, J BACTERIOL, V186, P5450, DOI 10.1128/JB.186.16.5450-5459.2004; JENG MF, 1995, BIOCHEMISTRY-US, V34, P10101, DOI 10.1021/bi00032a001; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; KALLIS GB, 1980, J BIOL CHEM, V255, P261; KORTEMME T, 1995, J MOL BIOL, V253, P799, DOI 10.1006/jmbi.1995.0592; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lewin A, 2008, BIOCHEM J, V414, P81, DOI 10.1042/BJ20080356; Lewin A, 2006, J BIOL CHEM, V281, P35467, DOI 10.1074/jbc.M607047200; LIN TY, 1989, BIOCHEMISTRY-US, V28, P5282, DOI 10.1021/bi00438a054; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Meima R, 2002, J BIOL CHEM, V277, P6994, DOI 10.1074/jbc.M111380200; Moller M, 2006, ANTIOXID REDOX SIGN, V8, P823, DOI 10.1089/ars.2006.8.823; Moller MC, 2008, J BACTERIOL, V190, P4660, DOI 10.1128/JB.00252-08; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; Nordstrand K, 1999, FEBS LETT, V449, P196, DOI 10.1016/S0014-5793(99)00401-9; Ouyang N, 2006, PROTEINS, V65, P1021, DOI 10.1002/prot.21184; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Raina S, 1997, ANNU REV MICROBIOL, V51, P179, DOI 10.1146/annurev.micro.51.1.179; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; Schiott T, 2000, J BACTERIOL, V182, P2845, DOI 10.1128/JB.182.10.2845-2854.2000; Schiott T, 1997, J BACTERIOL, V179, P4523, DOI 10.1128/jb.179.14.4523-4529.1997; Schiott T, 1997, J BACTERIOL, V179, P1962, DOI 10.1128/jb.179.6.1962-1973.1997; Smits WK, 2005, J BACTERIOL, V187, P3921, DOI 10.1128/JB.187.12.3921-3930.2005; STRAGIER P, 1988, CELL, V52, P697, DOI 10.1016/0092-8674(88)90407-2; YAMANAKA H, 1994, J BACTERIOL, V176, P2906, DOI 10.1128/JB.176.10.2906-2913.1994	46	13	13	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10056	10066		10.1074/jbc.M809566200	http://dx.doi.org/10.1074/jbc.M809566200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19144642	Green Published, hybrid			2022-12-25	WOS:000264892900048
J	Ferry, C; Gianni, M; Lalevee, S; Bruck, N; Plassat, JL; Raska, I; Garattini, E; Rochette-Egly, C				Ferry, Christine; Gianni, Maurizio; Lalevee, Sebastien; Bruck, Nathalie; Plassat, Jean-Luc; Raska, Ivan, Jr.; Garattini, Enrico; Rochette-Egly, Cecile			SUG-1 Plays Proteolytic and Non-proteolytic Roles in the Control of Retinoic Acid Target Genes via Its Interaction with SRC-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME PATHWAY; NUCLEAR RECEPTORS; MEDIATED TRANSCRIPTION; 26S PROTEASOME; ATPASE SUG1; RAR-ALPHA; PHOSPHORYLATION; RECRUITMENT; PROMOTER; COACTIVATORS	Nuclear retinoic acid receptor alpha (RAR alpha) activates gene expression through dynamic interactions with coregulatory protein complexes, the assembly of which is directed by the ligand and the AF-2 domain of RAR alpha. Then RAR alpha and its coactivator SRC-3 are degraded by the proteasome. Recently it has emerged that the proteasome also plays a key role in RAR alpha-mediated transcription. Here we show that SUG-1, one of the six ATPases of the 19 S regulatory complex of the 26 S proteasome, interacts with SRC-3, is recruited at the promoters of retinoic acid (RA) target genes, and thereby participates to their transcription. In addition, SUG-1 also mediates the proteasomal degradation of SRC-3. However, when present in excess amounts, SUG-1 blocks the activation of RAR alpha target genes and the degradation of RAR alpha that occurs in response to RA, via its ability to interfere with the recruitment of SRC-3 and other coregulators at the AF-2 domain of RAR alpha. We propose a model in which the ratio between SUG-1 and SRC-3 is crucial for the control of RAR alpha functioning. This study provides new insights into how SUG-1 has a unique role in linking the transcription and degradation processes via its ability to interact with SRC-3.	[Ferry, Christine; Lalevee, Sebastien; Bruck, Nathalie; Plassat, Jean-Luc; Rochette-Egly, Cecile] Univ Strasbourg 1, CNRS, INSERM,Unite Mixte Rech 7104, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, CU Strasbourg, France; [Gianni, Maurizio; Raska, Ivan, Jr.; Garattini, Enrico] Ist Ric Farmacol Mario Negri, Mol Biol Lab, I-20156 Milan, Italy	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Rochette-Egly, C (corresponding author), Univ Strasbourg 1, CNRS, INSERM,Unite Mixte Rech 7104, Inst Genet & Biol Mol & Cellulaire, Boite Postale 10142, F-67404 Illkirch Graffenstaden, CU Strasbourg, France.	cegly@igbmc.u-strasbg.fr	Raska, Ivan/E-9179-2017; Gianni, Maurizio/ABG-6322-2020; Garattini, Enrico/AAI-1998-2019	Raska, Ivan/0000-0003-3895-5286; Gianni, Maurizio/0000-0002-6945-708X; Garattini, Enrico/0000-0001-8983-886X	CNRS; INSERM; Agence Nationale pour la Recherche [ANR-05-BLAN-0390-02]; Institut National du Cancer [INCa PL06-095, PL07-96099]; Association pour la Recherche sur le Cancer [ARC A05/2/3139]; Associazione Italiana per la Ricerca contro il Cancro; Istituto Superiore di Sanita; Progetto Finalizzato Oncologia; Fondo D'Investimento per la Ricerca Biotecnologica	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Institut National du Cancer(Institut National du Cancer (INCA) France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Associazione Italiana per la Ricerca contro il Cancro(Fondazione AIRC per la ricerca sul cancro); Istituto Superiore di Sanita; Progetto Finalizzato Oncologia; Fondo D'Investimento per la Ricerca Biotecnologica	This work was supported in part by funds from CNRS, INSERM, the Agence Nationale pour la Recherche (ANR-05-BLAN-0390-02), the Institut National du Cancer (INCa PL06-095 and PL07-96099), the Association pour la Recherche sur le Cancer (ARC A05/2/3139), the Associazione Italiana per la Ricerca contro il Cancro, the Istituto Superiore di Sanita, the Progetto Finalizzato Oncologia (CNR and Ministero dell'Universita e della Ricerca Scientifica), and the Fondo D'Investimento per la Ricerca Biotecnologica.	Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Bhat KP, 2008, MOL IMMUNOL, V45, P2214, DOI 10.1016/j.molimm.2007.12.001; Bour G, 2005, J BIOL CHEM, V280, P17027, DOI 10.1074/jbc.M501344200; Bour G, 2007, TRENDS CELL BIOL, V17, P302, DOI 10.1016/j.tcb.2007.04.003; Brown K, 2003, J BIOL CHEM, V278, P39402, DOI 10.1074/jbc.M307832200; Bruck N, 2009, EMBO J, V28, P34, DOI 10.1038/emboj.2008.256; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Das PM, 2004, BIOTECHNIQUES, V37, P961, DOI 10.2144/04376RV01; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; Dennis AP, 2005, J STEROID BIOCHEM, V93, P139, DOI 10.1016/j.jsbmb.2004.12.015; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Gianni M, 2006, EMBO J, V25, P739, DOI 10.1038/sj.emboj.7600981; Gianni M, 2002, EMBO J, V21, P3760, DOI 10.1093/emboj/cdf374; Gillette TG, 2004, P NATL ACAD SCI USA, V101, P5904, DOI 10.1073/pnas.0305411101; Glass CK, 2000, GENE DEV, V14, P121; Kinyamu HK, 2005, J MOL ENDOCRINOL, V34, P281, DOI 10.1677/jme.1.01680; Kopf E, 2000, J BIOL CHEM, V275, P33280, DOI 10.1074/jbc.M002840200; Koues OI, 2008, MOL CELL BIOL, V28, P5837, DOI 10.1128/MCB.00535-08; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Laudet V., 2001, NUCL RECEPTOR FACTSB; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Lefebvre P, 2005, VITAM HORM, V70, P199, DOI 10.1016/S0083-6729(05)70007-8; Lonard DM, 2005, TRENDS BIOCHEM SCI, V30, P126, DOI 10.1016/j.tibs.2005.01.001; Loudig O, 2005, BIOCHEM J, V392, P241, DOI 10.1042/BJ20050874; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Morris MC, 2003, NATURE, V423, P1009, DOI 10.1038/nature01720; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Perissi V, 2008, MOL CELL, V29, P755, DOI 10.1016/j.molcel.2008.01.020; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Rasti M, 2006, EMBO J, V25, P2710, DOI 10.1038/sj.emboj.7601169; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Rochette-Egly C, 2005, J BIOL CHEM, V280, P32565, DOI 10.1074/jbc.R500008200; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Satoh K, 2001, BIOCHEMISTRY-US, V40, P314, DOI 10.1021/bi001815n; Shao WL, 2004, P NATL ACAD SCI USA, V101, P11599, DOI 10.1073/pnas.0402997101; Tansey WP, 2001, GENE DEV, V15, P1045, DOI 10.1101/gad.896501; VOM BE, 1996, EMBO J, V15, P110; Weeda G, 1997, NUCLEIC ACIDS RES, V25, P2274, DOI 10.1093/nar/25.12.2274; Widschwendter M, 2000, J NATL CANCER I, V92, P826, DOI 10.1093/jnci/92.10.826; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang H, 2006, EMBO J, V25, P4223, DOI 10.1038/sj.emboj.7601306; Zhu Q, 2007, ONCOGENE, V26, P4199, DOI 10.1038/sj.onc.1210191; Zhu QZ, 2004, FEBS LETT, V556, P19, DOI 10.1016/S0014-5793(03)01347-4	47	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8127	8135		10.1074/jbc.M808815200	http://dx.doi.org/10.1074/jbc.M808815200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19144644	hybrid, Green Published			2022-12-25	WOS:000264195600075
J	Irikura, D; Aritake, K; Nagata, N; Maruyama, T; Shimamoto, S; Urade, Y				Irikura, Daisuke; Aritake, Kosuke; Nagata, Nanae; Maruyama, Toshihiko; Shimamoto, Shigeru; Urade, Yoshihiro			Biochemical, Functional, and Pharmacological Characterization of AT-56, an Orally Active and Selective Inhibitor of Lipocalin-type Prostaglandin D Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CEREBROSPINAL-FLUID; EYE-MOVEMENT SLEEP; BETA-TRACE; SEMINAL PLASMA; D SYNTHETASE; RAT; CELLS; PURIFICATION; EXPRESSION; BINDING	We report here that 4-dibenzo[a,d] cyclohepten-5-ylidene-1[4-(2H-tetrazol-5-yl)-butyl]-piperidine (AT-56) is an orally active and selective inhibitor of lipocalin-type prostaglandin (PG) D synthase (L-PGDS). AT-56 inhibited human and mouse L-PGDSs in a concentration (3-250 mu M)-dependent manner but did not affect the activities of hematopoietic PGD synthase (H-PGDS), cyclooxygenase-1 and -2, and microsomal PGE synthase1. AT-56 inhibited the L-PGDS activity in a competitive manner against the substrate-PGH(2) (K-m = 14 mu M) with a K-i value of 75 mu M but did not inhibit the binding of 13-cis-retinoic acid, a nonsubstrate lipophilic ligand, to L-PGDS. NMR titration analysis revealed that AT-56 occupied the catalytic pocket, but not the retinoid-binding pocket, of L-PGDS. AT-56 inhibited the production of PGD(2) by L-PGDS-expressing human TE-671 cells after stimulation with Ca2+ ionophore (5 mu M A23187) with an IC50 value of about 3 mu M without affecting their production of PGE(2) and PGF(2 alpha) but had no effect on the PGD2 production by H-PGDS-expressing human megakaryocytes. Orally administered AT-56 (< 30 mg/ kg body weight) decreased the PGD2 production to 40% in the brain of H-PGDS-deficient mice after a stab wound injury in a dose-dependent manner without affecting the production of PGE2 and PGF(2 alpha) and also suppressed the accumulation of eosinophils and monocytes in the bronco-alveolar lavage fluid from the antigen-induced lung inflammation model of human L-PGDS-transgenic mice.	[Shimamoto, Shigeru] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Irikura, Daisuke; Aritake, Kosuke; Nagata, Nanae; Maruyama, Toshihiko; Urade, Yoshihiro] Osaka Biosci Inst, Dept Mol Behav Biol, Osaka 5650874, Japan	Osaka University	Urade, Y (corresponding author), Osaka Biosci Inst, Dept Mol Behav Biol, 6-2-4 Furuedai, Osaka 5650874, Japan.	uradey@obi.or.jp						Aritake K, 2006, J BIOL CHEM, V281, P15277, DOI 10.1074/jbc.M506431200; Beuckmann CT, 2000, J COMP NEUROL, V428, P62, DOI 10.1002/1096-9861(20001204)428:1<62::AID-CNE6>3.0.CO;2-E; Beuckmann CT, 1996, J NEUROSCI, V16, P6119; Beuckmann CT, 1999, BIOCHEMISTRY-US, V38, P8006, DOI 10.1021/bi990261p; CHRISTHAZELHOF E, 1979, BIOCHIM BIOPHYS ACTA, V572, P43, DOI 10.1016/0005-2760(79)90198-X; CLAUSEN E, 1961, Ugeskr Laeger, V123, P620; Craik D J, 1997, Methods Mol Biol, V60, P195; Eguchi N, 1999, P NATL ACAD SCI USA, V96, P726, DOI 10.1073/pnas.96.2.726; Eguchi Y, 1997, P NATL ACAD SCI USA, V94, P14689, DOI 10.1073/pnas.94.26.14689; Fujimori K, 2008, GENE, V426, P72, DOI 10.1016/j.gene.2008.08.023; Fujimori K, 2007, J BIOL CHEM, V282, P18458, DOI 10.1074/jbc.M701141200; Fujitani Y, 2002, J IMMUNOL, V168, P443, DOI 10.4049/jimmunol.168.1.443; Gerena RL, 2000, J ANDROL, V21, P848; Gerena RL, 1998, BIOL REPROD, V58, P826, DOI 10.1095/biolreprod58.3.826; Hirai K, 2001, CURR TOP MICROBIOL, V255, P261; HIRATA M, 1994, P NATL ACAD SCI USA, V91, P11192, DOI 10.1073/pnas.91.23.11192; HOFFMANN A, 1993, J NEUROCHEM, V61, P451; Inoue T, 2003, NAT STRUCT BIOL, V10, P291, DOI 10.1038/nsb907; Inui T, 2003, J BIOL CHEM, V278, P2845, DOI 10.1074/jbc.M209934200; Irikura D, 2003, J BIOCHEM, V133, P29, DOI 10.1093/jb/mvg006; ISLAM F, 1991, ARCH BIOCHEM BIOPHYS, V289, P161, DOI 10.1016/0003-9861(91)90456-S; Kanaoka Y, 1997, CELL, V90, P1085, DOI 10.1016/S0092-8674(00)80374-8; Kanekiyo T, 2007, P NATL ACAD SCI USA, V104, P6412, DOI 10.1073/pnas.0701585104; Lazarus M, 2002, ARCH BIOCHEM BIOPHYS, V397, P336, DOI 10.1006/abbi.2001.2614; LEWIS RA, 1982, J IMMUNOL, V129, P1627; Mahmud I, 1997, J BIOL CHEM, V272, P28263, DOI 10.1074/jbc.272.45.28263; Malki S, 2005, EMBO J, V24, P1798, DOI 10.1038/sj.emboj.7600660; MATSUMURA H, 1991, P NATL ACAD SCI USA, V88, P9046, DOI 10.1073/pnas.88.20.9046; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; Mizoguchi A, 2001, P NATL ACAD SCI USA, V98, P11674, DOI 10.1073/pnas.201398898; Mohri I, 2006, J NEUROCHEM, V97, P641, DOI 10.1111/j.1471-4159.2006.03753.x; NAGATA A, 1991, P NATL ACAD SCI USA, V88, P4020, DOI 10.1073/pnas.88.9.4020; Nagata K, 1999, FEBS LETT, V459, P195, DOI 10.1016/S0014-5793(99)01251-X; PERVAIZ S, 1987, FASEB J, V1, P209, DOI 10.1096/fasebj.1.3.3622999; Pinzar E, 2000, P NATL ACAD SCI USA, V97, P4903, DOI 10.1073/pnas.090093997; Qu WM, 2006, P NATL ACAD SCI USA, V103, P17949, DOI 10.1073/pnas.0608581103; Ragolia L, 2005, J BIOL CHEM, V280, P29946, DOI 10.1074/jbc.M502927200; Shimamoto S, 2007, J BIOL CHEM, V282, P31373, DOI 10.1074/jbc.M700123200; Tanaka R, 2009, BIOCHEM BIOPH RES CO, V378, P851, DOI 10.1016/j.bbrc.2008.11.152; Tanaka T, 1997, J BIOL CHEM, V272, P15789, DOI 10.1074/jbc.272.25.15789; Tokugawa Y, 1998, BIOL REPROD, V58, P600, DOI 10.1095/biolreprod58.2.600; Trivedi SG, 2006, P NATL ACAD SCI USA, V103, P5179, DOI 10.1073/pnas.0507175103; UENO R, 1982, BIOCHEM BIOPH RES CO, V109, P576, DOI 10.1016/0006-291X(82)91760-0; UJIHARA M, 1988, ARCH BIOCHEM BIOPHYS, V264, P428, DOI 10.1016/0003-9861(88)90308-6; Urade Y, 2000, VITAM HORM, V58, P89, DOI 10.1016/S0083-6729(00)58022-4; Urade Y, 2002, PROSTAG OTH LIPID M, V68-9, P375, DOI 10.1016/S0090-6980(02)00042-4; URADE Y, 1987, J BIOL CHEM, V262, P3820; URADE Y, 1985, J BIOL CHEM, V260, P2410; Urade Y, 2000, BBA-PROTEIN STRUCT M, V1482, P259, DOI 10.1016/S0167-4838(00)00161-8; URADE Y, 2006, FUNCTIONAL STRUCTURA, P135; Urade Y., 2006, LIPOCALINS, V9, P99; WATANABE K, 1994, BIOCHEM BIOPH RES CO, V203, P1110, DOI 10.1006/bbrc.1994.2297; White DM, 1997, J BIOL CHEM, V272, P14387, DOI 10.1074/jbc.272.22.14387; YAMAMOTO S, 1982, METHOD ENZYMOL, V86, P55	54	35	35	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7623	7630		10.1074/jbc.M808593200	http://dx.doi.org/10.1074/jbc.M808593200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19131342	Green Published, hybrid			2022-12-25	WOS:000264195600024
J	Jin, ZG; Liu, L; Bian, W; Chen, YF; Xu, GL; Cheng, LP; Jing, NH				Jin, Zhigang; Liu, Li; Bian, Wei; Chen, Yongfeng; Xu, Guoliang; Cheng, Leping; Jing, Naihe			Different Transcription Factors Regulate nestin Gene Expression during P19 Cell Neural Differentiation and Central Nervous System Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE-FILAMENT PROTEIN; EMBRYONIC CARCINOMA-CELLS; GFP TRANSGENIC MICE; CNS STEM-CELLS; PROGENITOR CELLS; NEURONAL DIFFERENTIATION; PRECURSOR CELLS; 2ND INTRON; IN-VITRO; PROMOTER	Nestin is a molecular marker for neural progenitor cells. Rat and human nestin genes possess a central nervous system-specific enhancer within their second introns. However, the transcription factors that bind to the nestin enhancer have not been fully elucidated. Here, we show that the second intron of the mouse nestin gene is sufficient to drive reporter gene expression in the developing nervous system. The core sequence of this central nervous system-specific enhancer localizes to the 3' 320-bp region. The cis-elements for Sox and POU family transcription factors and the hormone-responsive element are essential for nestin expression during embryonic carcinoma P19 cell neural differentiation and in the developing chick neural tube. Interestingly, different transcription factors bind to the nestin enhancer at different stages of P19 cell neural differentiation and central nervous system development. Sox2 and SF1 may mediate basal nestin expression in undifferentiated P19EC cells, whereas Sox2, Brn1, and Brn2 bind to the enhancer in P19 neural progenitor cells. Similarly, in vivo, Oct1 binds to the nestin enhancer in embryonic day 8.5 (E8.5) mouse embryos, and Oct1, Brn1, and Brn2 bind to this enhancer in E10.5 and E12.5 mouse embryos. Our studies therefore suggest a temporal coordination of transcription factors in determining nestin gene expression.	[Jin, Zhigang; Liu, Li; Bian, Wei; Chen, Yongfeng; Cheng, Leping; Jing, Naihe] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China; [Xu, Guoliang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Cheng, LP (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China.	lpcheng@sibs.ac.cn; njing@sibs.ac.cn	Jin, Zhigang/T-7125-2019	Jin, Zhigang/0000-0001-7557-2968	National Natural Science Foundation of China [30623003, 30721065, 30830034]; National Key Basic Research and Development Program of China [2005CB522704, 2006CB943902, 2007CB947101, 2008KR0695, 2009CB941100, 2006CB943900, 2007CB947102]; National High-Tech Research and Development Program of China [2006AA02Z186]; Shanghai Key Project of Basic Science Research [06DJ14001, 06DZ22032, 08DJ1400501]; Council of Shanghai Municipal Government for Science and Technology [05814578, 07pj14098]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program of China(National Basic Research Program of China); National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Shanghai Key Project of Basic Science Research; Council of Shanghai Municipal Government for Science and Technology	This work was supported by the National Natural Science Foundation of China (Grants 30623003, 30721065, and 30830034 to N.J.), the National Key Basic Research and Development Program of China (Grants 2005CB522704, 2006CB943902, 2007CB947101, 2008KR0695, and 2009CB941100 to N. J.; Grants 2006CB943900 and 2007CB947102 to L. C.), the National High-Tech Research and Development Program of China (Grant 2006AA02Z186 to N. J.), the Shanghai Key Project of Basic Science Research (Grants 06DJ14001, 06DZ22032, and 08DJ1400501 to N. J.), and the Council of Shanghai Municipal Government for Science and Technology (Grants 05814578 to N. J. and 07pj14098 to L. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; BAIN G, 1994, BIOESSAYS, V16, P343, DOI 10.1002/bies.950160509; Barnea E, 2000, J BIOL CHEM, V275, P6608, DOI 10.1074/jbc.275.9.6608; Catena R, 2004, J BIOL CHEM, V279, P41846, DOI 10.1074/jbc.M405514200; Cheng LP, 2000, ACTA BIOCH BIOPH SIN, V32, P649; Cheng LP, 2004, FEBS LETT, V565, P195, DOI 10.1016/j.febslet.2004.03.097; Chou YH, 2003, MOL BIOL CELL, V14, P1468, DOI 10.1091/mbc.E02-08-0545; DAHLSTRAND J, 1992, CANCER RES, V52, P5334; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; DAILEY L, 1994, MOL CELL BIOL, V14, P7758, DOI 10.1128/MCB.14.12.7758; Ding S, 2003, P NATL ACAD SCI USA, V100, P7632, DOI 10.1073/pnas.0732087100; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; Gao X, 2001, BIOCHEM BIOPH RES CO, V284, P1098, DOI 10.1006/bbrc.2001.5089; Gu HY, 2002, BRAIN RES, V943, P174, DOI 10.1016/S0006-8993(02)02615-X; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hou QL, 2004, EUR J NEUROSCI, V20, P1593, DOI 10.1111/j.1460-9568.2004.03600.x; Isaka F, 1999, EUR J NEUROSCI, V11, P2582, DOI 10.1046/j.1460-9568.1999.00699.x; Itoh K., 2007, PRINCIPLES DEV GENET, P241; Jin ZG, 2006, ACTA BIOCH BIOPH SIN, V38, P207, DOI 10.1111/j.1745-7270.2006.00149.x; Josephson R, 1998, DEVELOPMENT, V125, P3087; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; LeersSucheta S, 1997, J BIOL CHEM, V272, P7960, DOI 10.1074/jbc.272.12.7960; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lenka N, 2002, J CELL SCI, V115, P1471; Lonigro R, 2001, J BIOL CHEM, V276, P47807, DOI 10.1074/jbc.M107692200; Lothian C, 1997, EUR J NEUROSCI, V9, P452, DOI 10.1111/j.1460-9568.1997.tb01622.x; Lothian C, 1999, EXP CELL RES, V248, P509, DOI 10.1006/excr.1999.4417; MCBURNEY MW, 1982, DEV BIOL, V89, P503, DOI 10.1016/0012-1606(82)90338-4; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Miyagi S, 2006, J BIOL CHEM, V281, P13374, DOI 10.1074/jbc.M512669200; Pelizzoi R, 2008, INT J DEV BIOL, V52, P55, DOI 10.1387/ijdb.062196rp; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Robertson E. J., 1987, TERATOCARCINOMAS EMB; Sahlgren CM, 2003, MOL CELL BIOL, V23, P5090, DOI 10.1128/MCB.23.14.5090-5106.2003; Smukler SR, 2006, J CELL BIOL, V172, P79, DOI 10.1083/jcb.200508085; Sunabori T, 2008, J CELL SCI, V121, P1204, DOI 10.1242/jcs.025064; Tanaka S, 2004, MOL CELL BIOL, V24, P8834, DOI 10.1128/MCB.24.20.8834-8846.2004; Tang K, 2002, BIOCHEM BIOPH RES CO, V293, P167, DOI 10.1016/S0006-291X(02)00215-2; TOMOOKA Y, 1993, P NATL ACAD SCI USA, V90, P9683, DOI 10.1073/pnas.90.20.9683; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; Wakamatsu Y, 2007, DEVELOPMENT, V134, P2425, DOI 10.1242/dev.02862; Wang C, 2006, MOL BIOL CELL, V17, P3075, DOI 10.1091/mbc.E05-11-1087; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Xia CH, 2007, DIFFERENTIATION, V75, P912, DOI 10.1111/j.1432-0436.2007.00188.x; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Yan Y, 2004, DEV DYNAM, V231, P248, DOI 10.1002/dvdy.20126; Yang J, 2000, MECH DEVELOP, V94, P287, DOI 10.1016/S0925-4773(00)00301-4; Yang J, 2001, BBA-GENE STRUCT EXPR, V1520, P251, DOI 10.1016/S0167-4781(01)00275-5; Yaworsky PJ, 1999, DEV BIOL, V205, P309, DOI 10.1006/dbio.1998.9035; Yeom YI, 1996, DEVELOPMENT, V122, P881; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	55	74	77	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8160	8173		10.1074/jbc.M805632200	http://dx.doi.org/10.1074/jbc.M805632200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19147497	Green Published, hybrid			2022-12-25	WOS:000264195600078
J	Kular, RK; Cvetanovic, M; Siferd, S; Kini, AR; Opal, P				Kular, Rupinder K.; Cvetanovic, Marija; Siferd, Steve; Kini, Ameet R.; Opal, Puneet			Neuronal Differentiation Is Regulated by Leucine-rich Acidic Nuclear Protein (LANP), a Member of the Inhibitor of Histone Acetyltransferase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; RUBINSTEIN-TAYBI SYNDROME; GENE-EXPRESSION; PC12 CELLS; TRANSCRIPTIONAL REPRESSION; PHEOCHROMOCYTOMA CELLS; HIPPOCAMPAL-NEURONS; PC-12 CELLS; PP32; INHAT	Neuronal differentiation is a tightly regulated process characterized by temporal and spatial alterations in gene expression. A number of studies indicate a significant role for histone acetylation in the regulation of genes involved in development. Histone acetylation is regulated by histone deacetylases and histone acetyltransferases. Recent findings suggest that these catalytic activities, in turn, are modulated by yet another set of regulators. Of considerable interest in this context is the possible role of the INHAT (inhibitor of histone acetyltransferase) complex, comprised of a group of acidic proteins that suppress histone acetylation by a novel "histone-masking" mechanism. In this study, we specifically examined the role of the leucine-rich acidic nuclear protein (LANP), a defining member of the INHAT complex whose expression is tightly regulated in neuronal development. We report that depleting LANP in neuronal cell lines promotes neurite outgrowth by inducing changes in gene expression. In addition, we show that LANP directly regulates expression of the neurofilament light chain, an important neuron-specific cytoskeletal gene, by binding to the promoter of this gene and modulating histone acetylation levels. Finally, we corroborated our findings in vivo by demonstrating increased neurite outgrowth in primary neurons obtained from LANP null mice, which is also accompanied by increased histone acetylation at the NF-L promoter. Taken together, these results implicate INHATs as a distinct class of developmental regulators involved in the epigenetic modulation of neuronal differentiation.	[Kular, Rupinder K.; Cvetanovic, Marija; Opal, Puneet] Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol, Chicago, IL 60611 USA; [Kular, Rupinder K.; Cvetanovic, Marija; Opal, Puneet] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Siferd, Steve] Express Anal Inc, Durham, NC 27713 USA; [Kini, Ameet R.] Loyola Univ, Stritch Sch Med, Dept Pathol, Maywood, IL 60302 USA; [Kini, Ameet R.] Loyola Univ, Stritch Sch Med, Cardinal Bernardin Canc Ctr, Maywood, IL 60302 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Loyola University Chicago; Loyola University Chicago	Opal, P (corresponding author), Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol, Chicago, IL 60611 USA.	p-opal@northwestern.edu	Cvetanovic, Marija/B-8907-2016	Siferd, Stephen/0000-0001-6870-984X	National Institutes of Health [K08 NS02246, K02 NS051340, R21 NS060080, 5T32 NS41234-01]; National Organization for Rare Disorders (NORD); National Ataxia Foundation, and the American Cancer Society, IL Division; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS041234, K02NS051340, K08NS002246, R01NS082351, R21NS060080] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Organization for Rare Disorders (NORD); National Ataxia Foundation, and the American Cancer Society, IL Division; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants K08 NS02246, K02 NS051340, and R21 NS060080 (to P.O.) and Training Grant 5T32 NS41234-01 (to R. K.). This work was also supported by grants from the National Organization for Rare Disorders (NORD), the National Ataxia Foundation, and the American Cancer Society, IL Division (to P.O.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Angelastro JM, 2000, P NATL ACAD SCI USA, V97, P10424, DOI 10.1073/pnas.97.19.10424; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Braveman Melissa W., 2004, V277, P261; Brody JR, 2007, MODERN PATHOL, V20, P1238, DOI 10.1038/modpathol.3800974; Brown AJH, 1999, MOL CELL NEUROSCI, V13, P119, DOI 10.1006/mcne.1999.0736; Buck MJ, 2004, GENOMICS, V83, P349, DOI 10.1016/j.ygeno.2003.11.004; Christova R, 2002, NAT CELL BIOL, V4, P79, DOI 10.1038/ncb733; Cvetanovic M, 2007, EMBO REP, V8, P671, DOI 10.1038/sj.embor.7400983; Dawson HN, 2001, J CELL SCI, V114, P1179; DIJKMANS TF, 2009, J NEUROCHEM IN PRESS; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Kadkol SS, 1998, PROSTATE, V34, P231, DOI 10.1002/(SICI)1097-0045(19980215)34:3<231::AID-PROS11>3.0.CO;2-F; Kadkol SS, 2001, BREAST CANCER RES TR, V68, P65, DOI 10.1023/A:1017919507109; Kutney SN, 2004, J BIOL CHEM, V279, P30850, DOI 10.1074/jbc.M404969200; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Lee KH, 2005, NEUROCHEM RES, V30, P533, DOI 10.1007/s11064-005-2688-y; LEE NH, 1995, P NATL ACAD SCI USA, V92, P8303, DOI 10.1073/pnas.92.18.8303; Lin WC, 2006, CURR OPIN GENET DEV, V16, P137, DOI 10.1016/j.gde.2006.02.002; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Marek L, 2004, J CELL PHYSIOL, V201, P459, DOI 10.1002/jcp.20087; Matilla A, 2005, CEREBELLUM, V4, P7, DOI 10.1080/14734220410019020; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; MATSUOKA K, 1994, P NATL ACAD SCI USA, V91, P9670, DOI 10.1073/pnas.91.21.9670; Opal P, 2003, J BIOL CHEM, V278, P34691, DOI 10.1074/jbc.M302785200; Opal P, 2004, MOL CELL BIOL, V24, P3140, DOI 10.1128/MCB.24.8.3140-3149.2004; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Schimmelpfeng J, 2004, J NEUROSCI METH, V139, P299, DOI 10.1016/j.jneumeth.2004.05.010; Schneider R, 2004, J BIOL CHEM, V279, P23859, DOI 10.1074/jbc.C400151200; Seo SB, 2002, J BIOL CHEM, V277, P14005, DOI 10.1074/jbc.M112455200; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suzuki-Mizushima Y, 2002, BRAIN RES, V951, P209, DOI 10.1016/S0006-8993(02)03163-3; Tanaka Y, 1997, P NATL ACAD SCI USA, V94, P10215, DOI 10.1073/pnas.94.19.10215; Ulitzur N, 1997, J BIOL CHEM, V272, P30577, DOI 10.1074/jbc.272.48.30577; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Vician L, 1997, J NEUROSCI RES, V50, P32, DOI 10.1002/(SICI)1097-4547(19971001)50:1<32::AID-JNR4>3.0.CO;2-M; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	40	30	32	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7783	7792		10.1074/jbc.M806150200	http://dx.doi.org/10.1074/jbc.M806150200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19136565	Green Published, hybrid			2022-12-25	WOS:000264195600040
J	Nam, S; Min, K; Hwang, H; Lee, HO; Lee, JH; Yoon, J; Lee, H; Park, S; Lee, J				Nam, Seunghee; Min, Kyoengwoo; Hwang, Hyejin; Lee, Hae-ock; Lee, Jung Hwa; Yoon, Jongbok; Lee, Hyunsook; Park, Sungsu; Lee, Junho			Control of Rapsyn Stability by the CUL-3-containing E3 Ligase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; NEUROMUSCULAR SYNAPSE FORMATION; UBIQUITIN LIGASE; GLUTAMATE RECEPTORS; RING-H2 FINGER; 43K PROTEIN; CELL-CYCLE; C-ELEGANS; AGRIN; DEGRADATION	Rapsyn is a postsynaptic protein required for clustering of nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction. Here we report the mechanism for posttranslational control of rapsyn protein stability. We confirmed that C18H9.7-encoded RPY-1 is a rapsyn homolog in Caenorhabditis elegans by showing that human rapsyn rescued rpy-1 mutant phenotypes in nematodes, as determined by levamisole assays and micropost array behavioral assays. We found that RPY-1 was degraded in the absence of functional UNC-29, a non-alpha subunit of the receptor, in an allele-specific manner, but not in the absence of other receptor subunits. The cytoplasmic loop of UNC-29 was found to be critical for RPY-1 stability. Through RNA interference screening, we found that UBC-1, UBC-12, NEDD-8, and RBX-1 were required for degradation of RPY-1. We identified cullin (CUL)-3 as a component of E3 ligase and KEL-8 as the substrate adaptor of RPY-1. Mammalian rapsyn was ubiquitinated by the CUL3/KLHL8-containing E3 ligase in vitro, and the knockdown of KLHL-8, a mammalian KEL-8 homolog, inhibited rapsyn ubiquitination in vivo, implying evolutionary conservation of the rapsyn stability control machinery. kel-8 suppression and rpy-1 overexpression in C. elegans produced a phenotype similar to that of a loss-of-function mutation of rpy-1, suggesting that control of rapsyn abundance is important for proper function of the receptor. Our results suggest a link between the control of rapsyn abundance and congenital myasthenic syndromes.	[Nam, Seunghee; Min, Kyoengwoo; Lee, Hae-ock; Lee, Jung Hwa; Lee, Hyunsook; Lee, Junho] Seoul Natl Univ, Sch Biol Sci, Inst Mol Biol & Genet, Res Ctr Cellul, Seoul 151742, South Korea; [Hwang, Hyejin; Park, Sungsu] Ewha Womans Univ, Div Nano Sci BK21, Seoul 120750, South Korea; [Yoon, Jongbok] Yonsei Univ, Dept Biochem, Prot Network Res Ctr, Seoul 120749, South Korea	Seoul National University (SNU); Ewha Womans University; Yonsei University	Lee, J (corresponding author), Seoul Natl Univ, Sch Biol Sci, Inst Mol Biol & Genet, Res Ctr Cellul, Seoul 151742, South Korea.	elegans@snu.ac.kr	Park, Sungsu/L-1920-2013; Park, Sungsu/AAF-4792-2020; Lee, Junho/AAO-4706-2021	Park, Sungsu/0000-0003-3062-1302; Lee, Hyunsook/0000-0002-2251-5019; Yoon, Jong-Bok/0000-0002-3563-0702	Korea Science and Engineering Foundation (KOSEF), South Korea; Ministry of Science and Technology, Korea [M10748000241-07N4800-24100]; KRF [KRF-2005C00097]; Korean government (MEST) [M10536090002-05N3609-00210]; Korean Research Foundation [2005-037-C00027]; BK21 program; Seoul R BD Program	Korea Science and Engineering Foundation (KOSEF), South Korea(Korea Science and Engineering Foundation); Ministry of Science and Technology, Korea(Ministry of Science & Technology (MOST), Republic of Korea); KRF(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korean Research Foundation(National Research Foundation of Korea); BK21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Seoul R BD Program(Seoul RBD program)	This work was supported in part by Research Center for Cellulomics, Seoul National University funding from the Korea Science and Engineering Foundation (KOSEF), South Korea (to J. Lee), Molecular and Cellular BioDiscovery Research Program Grant M10748000241-07N4800-24100 from the Ministry of Science and Technology, Korea (to J. Lee), KRF grant KRF-2005C00097 (to J. Lee), and KOSEF Grant M10536090002-05N3609-00210 funded by the Korean government (MEST) (to S. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a postdoctoral grant from KOSEF (2004), the BK21 program (2006), and the Seoul R&BD Program (2006).; Supported by a postdoctoral grant from the Korean Research Foundation Grant 2005-037-C00027, BK21 program (2007), and the Seoul R&BD Program (2007).	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; APEL ED, 1995, NEURON, V15, P115, DOI 10.1016/0896-6273(95)90069-1; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; BRENNER S, 1974, GENETICS, V77, P71; Brockhausen J, 2008, DEV NEUROBIOL, V68, P1153, DOI 10.1002/dneu.20654; Bruneau E, 2007, J BIOL CHEM, V282, P9932, DOI 10.1074/jbc.M608714200; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; Bush KT, 1997, J BIOL CHEM, V272, P9086; Chen A, 2000, J BIOL CHEM, V275, P15432, DOI 10.1074/jbc.M907300199; Chen F, 2007, NEURON, V55, P247, DOI 10.1016/j.neuron.2007.06.031; Cheusova T, 2006, GENE DEV, V20, P1800, DOI 10.1101/gad.375206; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Colledge M, 1998, CURR OPIN NEUROBIOL, V8, P357, DOI 10.1016/S0959-4388(98)80061-5; Courbard JR, 2002, J BIOL CHEM, V277, P45267, DOI 10.1074/jbc.M206460200; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Dunne V, 2003, J HUM GENET, V48, P204, DOI 10.1007/s10038-003-0005-7; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Engel AG, 2003, MUSCLE NERVE, V27, P4, DOI 10.1002/mus.10269; Ferns M, 1996, J CELL BIOL, V132, P937, DOI 10.1083/jcb.132.5.937; Finn AJ, 2003, NAT NEUROSCI, V6, P717, DOI 10.1038/nn1071; Forrester WC, 1999, NATURE, V400, P881, DOI 10.1038/23722; FRAIL DE, 1989, NEURON, V2, P1077, DOI 10.1016/0896-6273(89)90232-8; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; FROEHNER SC, 1990, NEURON, V5, P403, DOI 10.1016/0896-6273(90)90079-U; Fuhrer C, 1997, EMBO J, V16, P4951, DOI 10.1093/emboj/16.16.4951; Gally C, 2004, NATURE, V431, P578, DOI 10.1038/nature02893; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Han H, 2000, J NEUROSCI RES, V60, P155, DOI 10.1002/(SICI)1097-4547(20000415)60:2<155::AID-JNR4>3.3.CO;2-E; Han H, 1999, J NEUROCYTOL, V28, P763, DOI 10.1023/A:1007098406748; Hantai D, 2004, CURR OPIN NEUROL, V17, P539, DOI 10.1097/00019052-200410000-00004; Hrus A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000731; HUBBARD JI, 1973, PHYSIOL REV, V53, P674, DOI 10.1152/physrev.1973.53.3.674; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Jones D, 2002, GENOME BIOL, V3; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; KULKA RG, 1988, J BIOL CHEM, V263, P15726; LAROCHELLE WJ, 1986, J BIOL CHEM, V261, P5270; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lecker SH, 2003, CURR OPIN CLIN NUTR, V6, P271, DOI 10.1097/01.mco.0000068963.34812.e5; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315; LEWIS JA, 1980, GENETICS, V95, P905; LEWIS JA, 1980, NEUROSCIENCE, V5, P967, DOI 10.1016/0306-4522(80)90180-3; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; McConville J, 2002, CURR OPIN PHARMACOL, V2, P296, DOI 10.1016/S1471-4892(02)00156-X; MEIER T, 1995, J CELL BIOL, V131, P441, DOI 10.1083/jcb.131.2.441; Meier T, 1997, J NEUROSCI, V17, P6534; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Min KW, 2003, J BIOL CHEM, V278, P15905, DOI 10.1074/jbc.M213070200; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; NOAKES PG, 1993, DEV BIOL, V155, P275, DOI 10.1006/dbio.1993.1025; Ohno K, 2002, AM J HUM GENET, V70, P875, DOI 10.1086/339465; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Park S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002550; Parry G, 2004, SEMIN CELL DEV BIOL, V15, P221, DOI 10.1016/j.semcdb.2003.12.003; PHILLIPS WD, 1991, SCIENCE, V251, P568, DOI 10.1126/science.1703661; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Ramarao MK, 1998, P NATL ACAD SCI USA, V95, P4007, DOI 10.1073/pnas.95.7.4007; Rand James B, 2007, WormBook, P1; Rocca A, 2001, MOL BIOL CELL, V12, P1293, DOI 10.1091/mbc.12.5.1293; Rodova M, 2004, MOL CELL BIOL, V24, P7188, DOI 10.1128/MCB.24.16.7188-7196.2004; Schaefer H, 2006, MOL BIOL CELL, V17, P1250, DOI 10.1091/mbc.E05-08-0794; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Tyers M, 2000, CURR OPIN GENET DEV, V10, P54, DOI 10.1016/S0959-437X(99)00049-0; van den Heuvel S, 2004, CURR BIOL, V14, pR59, DOI 10.1016/j.cub.2003.12.044; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Wang JM, 2003, NAT NEUROSCI, V6, P1017, DOI 10.1038/nn1128; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G; YOSHIHARA CM, 1993, J CELL BIOL, V122, P169, DOI 10.1083/jcb.122.1.169; YU XM, 1994, J NEUROSCI, V14, P785; Zhang B, 2007, J NEUROSCI, V27, P3968, DOI 10.1523/JNEUROSCI.4691-06.2007	82	19	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8192	8206		10.1074/jbc.M808230200	http://dx.doi.org/10.1074/jbc.M808230200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19158078	Green Published, hybrid			2022-12-25	WOS:000264195600081
J	Fu, JJ; Jiang, J; Li, JW; Wang, SS; Shi, G; Feng, Q; White, E; Qin, J; Wong, JM				Fu, Junjiang; Jiang, Jun; Li, Jiwen; Wang, Shanshan; Shi, Guang; Feng, Qin; White, Eileen; Qin, Jun; Wong, Jiemin			Deleted in Breast Cancer 1, a Novel Androgen Receptor (AR) Coactivator That Promotes AR DNA-binding Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTOR; NUCLEAR-RECEPTOR; TRANSCRIPTIONAL ACTIVATION; PROSTATE-CANCER; HISTONE ACETYLTRANSFERASE; MOLECULAR-BIOLOGY; COMPLEX; CHROMATIN; COREGULATORS; PROTEIN	Androgen receptor (AR) plays a critical role in development and maintenance of male reproductive functions and the etiology of prostate cancer. As a ligand-regulated transcription factor, identification and characterization of AR coregulators are essential for understanding the molecular mechanisms underlying its diverse biological functions. Here we reported the identification of a novel AR coactivator, deleted in breast cancer 1 (DBC1), through a biochemical approach. DBC1 interacts with AR in a ligand-stimulated manner and facilitates AR transcriptional activation in transfected cells as well as in Xenopus oocytes. In in vitro gel shift experiments, recombinant DBC1 drastically enhanced AR DNA-binding activity. Expression of DBC1 also enhanced the binding of AR to chromatinized template in vivo, whereas knockdown of DBC1 impaired the binding of AR to endogenous prostate-specific antigen (PSA) gene in the prostate cancer cell line LNCaP. Thus, our data identify DBC1 as a novel AR coactivator.	[Li, Jiwen; Wang, Shanshan; Shi, Guang; Wong, Jiemin] E China Normal Univ, Coll Life Sci, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Fu, Junjiang; Jiang, Jun; Feng, Qin; Qin, Jun] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Qin, Jun] Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Fu, Junjiang] Cent S Univ, Xiangya Sch Med, Xiangya 410013, Peoples R China; [White, Eileen] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	East China Normal University; Baylor College of Medicine; Baylor College of Medicine; Central South University; Rutgers State University New Brunswick	Wong, JM (corresponding author), E China Normal Univ, Coll Life Sci, Inst Biomed Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.	jmweng@bio.ecnu.edu.cn	White, Eileen/ABD-6745-2021	White, Eileen/0000-0003-2961-3065; Wong, Jiemin/0000-0002-5311-842X; Fu, Junjiang/0000-0002-0708-2200				ALMOUZNI G, 1993, GENE DEV, V7, P2033, DOI 10.1101/gad.7.10.2033; Boonyaratanakornkit V, 1998, MOL CELL BIOL, V18, P4471, DOI 10.1128/MCB.18.8.4471; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Chmelar R, 2007, INT J CANCER, V120, P719, DOI 10.1002/ijc.22365; Culig Z, 2003, UROLOGY, V62, P21, DOI 10.1016/S0090-4295(03)00698-8; Estebanez-Perpina E, 2005, J BIOL CHEM, V280, P8060, DOI 10.1074/jbc.M407046200; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Fu JHJ, 2007, MOL CELL BIOL, V27, P4641, DOI 10.1128/MCB.00857-06; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Hamaguchi M, 2002, P NATL ACAD SCI USA, V99, P13647, DOI 10.1073/pnas.212516099; He B, 2002, J BIOL CHEM, V277, P10226, DOI 10.1074/jbc.M111975200; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Hosohata K, 2003, MOL CELL BIOL, V23, P7019, DOI 10.1128/MCB.23.19.7019-7029.2003; Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003; Hsiao PW, 1999, J BIOL CHEM, V274, P20229, DOI 10.1074/jbc.274.29.20229; Huang ZQ, 2003, EMBO J, V22, P2146, DOI 10.1093/emboj/cdg219; Huang ZQ, 2002, MOL ENDOCRINOL, V16, P924, DOI 10.1210/me.16.5.924; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kang ZG, 2004, MOL ENDOCRINOL, V18, P2633, DOI 10.1210/me.2004-0245; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Lee HJ, 2003, CELL MOL LIFE SCI, V60, P1613, DOI 10.1007/s00018-003-2309-3; Leotoing L, 2008, ONCOGENE, V27, P2858, DOI 10.1038/sj.onc.1210942; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; Li JW, 2006, MOL ENDOCRINOL, V20, P776, DOI 10.1210/me.2005-0298; Li JW, 2000, MOL CELL BIOL, V20, P2031, DOI 10.1128/MCB.20.6.2031-2042.2000; Link KA, 2005, MOL CELL BIOL, V25, P2200, DOI 10.1128/MCB.25.6.2200-2215.2005; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; ONATE SA, 1995, SCIENCE, V270, P1354; Pratt WB, 2004, ESSAYS BIOCHEM, V40, P41, DOI 10.1042/bse0400041; Qin J, 1997, ANAL CHEM, V69, P4002, DOI 10.1021/ac970489n; Rachez C, 1998, GENE DEV, V12, P1787, DOI 10.1101/gad.12.12.1787; Radvanyi L, 2005, P NATL ACAD SCI USA, V102, P11005, DOI 10.1073/pnas.0500904102; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Sundararajan R, 2005, ONCOGENE, V24, P4908, DOI 10.1038/sj.onc.1208681; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Trauernicht AM, 2007, MOL ENDOCRINOL, V21, P1526, DOI 10.1210/me.2007-0064; Verrijdt G, 2002, BIOCHEM J, V361, P97, DOI 10.1042/0264-6021:3610097; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wang L, 2005, PROSTATE, V63, P117, DOI 10.1002/pros.20170; WANG Q, 2002, J BIOL CHEM, V5, P5; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Wolffe AP, 2000, VITAM HORM, V58, P449, DOI 10.1016/S0083-6729(00)58033-9; WONG JM, 1995, GENE DEV, V9, P2696, DOI 10.1101/gad.9.21.2696; Wong JM, 1997, EMBO J, V16, P3158, DOI 10.1093/emboj/16.11.3158; Yeh SY, 1996, P NATL ACAD SCI USA, V93, P5517, DOI 10.1073/pnas.93.11.5517; Yoon HG, 2006, MOL ENDOCRINOL, V20, P1048, DOI 10.1210/me.2005-0324; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	56	58	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6832	6840		10.1074/jbc.M808988200	http://dx.doi.org/10.1074/jbc.M808988200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19126541	hybrid, Green Published			2022-12-25	WOS:000263919000029
J	Begle, A; Tryoen-Toth, P; de Barry, J; Bader, MF; Vitale, N				Begle, Aurelie; Tryoen-Toth, Petra; de Barry, Jean; Bader, Marie-France; Vitale, Nicolas			ARF6 Regulates the Synthesis of Fusogenic Lipids for Calcium-regulated Exocytosis in Neuroendocrine Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT MEMBRANE-FUSION; RIBOSYLATION FACTOR 6; DENSE-CORE VESICLES; PLASMA-MEMBRANE; CHROMAFFIN CELLS; PHOSPHOLIPASE-D; PHOSPHATIDIC-ACID; SECRETORY GRANULES; PORE FORMATION; PC12 CELLS	An important role for specific lipids in membrane fusion has recently emerged, but regulation of their biosynthesis remains poorly understood. Among fusogenic lipids, phosphatidic acid and phosphoinositol 4,5-bisphosphate (PIP2) have been proposed to act at various steps of neurotransmitter and hormone exocytosis. Using real time FRET (fluorescence resonance energy transfer) measurements, we show here that the GTPase ARF6, potentially involved in the synthesis of these lipids, is activated at the exocytotic sites in PC12 cells stimulated for secretion. Depletion of endogenous ARF6 by siRNA dramatically inhibited secretagogue-evoked exocytosis. ARF6-siRNA greatly reduced secretagogue-evoked phospholipase D (PLD) activation and phosphatidic acid formation at the plasma membrane and moderately reduced constitutive levels of PIP2 present at the plasma membrane in resting cells. Expression of an ARF6 insensitive to short interference RNA (siRNA) fully rescued secretion in ARF6-depleted cells. However, a mutated ARF6 protein specifically impaired in its ability to stimulate PLD had no effect. Finally, we show that the ARF6-siRNA-mediated inhibition of exocytosis could be rescued by an exogenous addition of lysophosphatidylcholine, a lipid that favors negative curvature on the inner leaflet of the plasma membrane. Altogether these data indicate that ARF6 is a critical upstream signaling element in the activation of PLD necessary to produce the fusogenic lipids required for exocytosis.	[Vitale, Nicolas] CNRS, UPR 3212, Inst Neurosci Cellulaires & Integrat, Dept Neurotransmiss & Secret, F-67084 Strasbourg, France; Univ Strasbourg, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Vitale, N (corresponding author), CNRS, UPR 3212, Inst Neurosci Cellulaires & Integrat, Dept Neurotransmiss & Secret, 5 Rue Blaise Pascal, F-67084 Strasbourg, France.	vitalen@neurochem.u-strasbg.fr	Vitale, Nicolas/G-5967-2014; Bader, Marie-France/O-2098-2016	Vitale, Nicolas/0000-0002-4752-4907; Toth, Petra/0000-0003-4573-4705				Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; Caumon AS, 2000, J BIOL CHEM, V275, P15637, DOI 10.1074/jbc.M908347199; Caumont AS, 1998, J BIOL CHEM, V273, P1373, DOI 10.1074/jbc.273.3.1373; Chasserot-Golaz S, 2005, MOL BIOL CELL, V16, P1108, DOI 10.1091/mbc.E04-07-0627; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Choi WS, 2002, ANN NY ACAD SCI, V968, P198, DOI 10.1111/j.1749-6632.2002.tb04336.x; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Corrotte M, 2006, TRAFFIC, V7, P365, DOI 10.1111/j.1600-0854.2006.00389.x; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; de Barry J, 2006, J BIOL CHEM, V281, P18098, DOI 10.1074/jbc.M509842200; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Donaldson JG, 2005, BIOCHEM SOC T, V33, P1276, DOI 10.1042/BST0331276; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Du GW, 2003, J CELL BIOL, V162, P305, DOI 10.1083/jcb.200302033; Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1; Galas MC, 1997, J BIOL CHEM, V272, P2788, DOI 10.1074/jbc.272.5.2788; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Hughes WE, 2004, J BIOL CHEM, V279, P27534, DOI 10.1074/jbc.M403012200; Humeau Y, 2001, P NATL ACAD SCI USA, V98, P15300, DOI 10.1073/pnas.261358698; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Jones DH, 1999, BIOCHEM J, V341, P185, DOI 10.1042/0264-6021:3410185; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P17007, DOI 10.1021/bi0518794; Kozlovsky Y, 2002, BIOPHYS J, V83, P2634, DOI 10.1016/S0006-3495(02)75274-0; Lahuna O, 2005, EMBO J, V24, P1364, DOI 10.1038/sj.emboj.7600616; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Liu LX, 2005, MOL BIOL CELL, V16, P4463, DOI 10.1091/mbc.E05-03-0231; MASSENBURG D, 1994, P NATL ACAD SCI USA, V91, P11718, DOI 10.1073/pnas.91.24.11718; Meyer MZ, 2006, J BIOL CHEM, V281, P7919, DOI 10.1074/jbc.M600081200; Millar CA, 1999, J BIOL CHEM, V274, P17619, DOI 10.1074/jbc.274.25.17619; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; MOUBOISSE F, 2009, J CELL SCI IN PRESS; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Schweitzer JK, 2002, J BIOL CHEM, V277, P27210, DOI 10.1074/jbc.M201569200; Skippen A, 2002, J BIOL CHEM, V277, P5823, DOI 10.1074/jbc.M110274200; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Vicogne J, 2006, P NATL ACAD SCI USA, V103, P14761, DOI 10.1073/pnas.0606881103; Vitale N, 1996, EUR J NEUROSCI, V8, P1275, DOI 10.1111/j.1460-9568.1996.tb01296.x; Vitale N, 1998, J BIOL CHEM, V273, P2553, DOI 10.1074/jbc.273.5.2553; Vitale N, 2005, J BIOL CHEM, V280, P29921, DOI 10.1074/jbc.M413748200; Vitale N, 2002, ANN NY ACAD SCI, V971, P193, DOI 10.1111/j.1749-6632.2002.tb04463.x; Vitale N, 2002, J CELL BIOL, V159, P79, DOI 10.1083/jcb.200203027; VITALE N, 1993, J BIOL CHEM, V268, P14715; Vitale N, 2001, EMBO J, V20, P2424, DOI 10.1093/emboj/20.10.2424; Waselle L, 2005, MOL ENDOCRINOL, V19, P3097, DOI 10.1210/me.2004-0530; Yang CZ, 1999, J BIOL CHEM, V274, P25297, DOI 10.1074/jbc.274.36.25297; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200; Zhang Q, 1999, MOL CELL BIOL, V19, P8158	52	47	49	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4836	4845		10.1074/jbc.M806894200	http://dx.doi.org/10.1074/jbc.M806894200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19124467	hybrid			2022-12-25	WOS:000263416600012
J	Yarkoni, T; Barch, DM; Gray, JR; Conturo, TE; Braver, TS				Yarkoni, Tal; Barch, Deanna M.; Gray, Jeremy R.; Conturo, Thomas E.; Braver, Todd S.			BOLD Correlates of Trial-by-Trial Reaction Time Variability in Gray and White Matter: A Multi-Study fMRI Analysis	PLOS ONE			English	Article								Background: Reaction time (RT) is one of the most widely used measures of performance in experimental psychology, yet relatively few fMRI studies have included trial-by-trial differences in RT as a predictor variable in their analyses. Using a multi-study approach, we investigated whether there are brain regions that show a general relationship between trial-by-trial RT variability and activation across a range of cognitive tasks. Methodology/Principal Findings: The relation between trial-by-trial differences in RT and brain activation was modeled in five different fMRI datasets spanning a range of experimental tasks and stimulus modalities. Three main findings were identified. First, in a widely distributed set of gray and white matter regions, activation was delayed on trials with long RTs relative to short RTs, suggesting delayed initiation of underlying physiological processes. Second, in lateral and medial frontal regions, activation showed a "time-on-task'' effect, increasing linearly as a function of RT. Finally, RT variability reliably modulated the BOLD signal not only in gray matter but also in diffuse regions of white matter. Conclusions/Significance: The results highlight the importance of modeling trial-by-trial RT in fMRI analyses and raise the possibility that RT variability may provide a powerful probe for investigating the previously elusive white matter BOLD signal.	[Yarkoni, Tal; Barch, Deanna M.; Braver, Todd S.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA; [Barch, Deanna M.; Conturo, Thomas E.; Braver, Todd S.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63130 USA; [Gray, Jeremy R.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Washington University (WUSTL); Washington University (WUSTL); Yale University	Yarkoni, T (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.	tyarkoni@wustl.edu	Warfield, Simon/B-3352-2009; Barch, Deanna M/G-8638-2013	Warfield, Simon/0000-0002-7659-3880; Braver, Todd/0000-0002-2631-3393	NIH [MH066088, MH066031, MH71616, NS39538]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066088, R01MH066078, P50MH071616, R01MH066031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039538] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by NIH grants MH066088, MH066031, MH71616, and NS39538. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird AA, 2005, J COGNITIVE NEUROSCI, V17, P687, DOI 10.1162/0898929053467569; Barch DM, 2007, AM J PSYCHIAT, V164, P1090, DOI 10.1176/appi.ajp.164.7.1090; Bellgowan PSF, 2003, P NATL ACAD SCI USA, V100, P1415, DOI 10.1073/pnas.0337747100; Binder JR, 2005, NEUROIMAGE, V27, P677, DOI 10.1016/j.neuroimage.2005.04.029; Bonner-Jackson A, 2005, BIOL PSYCHIAT, V58, P47, DOI 10.1016/j.biopsych.2005.05.011; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Buckner RL, 1998, NEUROIMAGE, V7, P163, DOI 10.1006/nimg.1998.0328; CARPENTER DA, 1990, NEUROLOGY, V40, P1587, DOI 10.1212/WNL.40.10.1587; Cavaglia M, 2001, BRAIN RES, V910, P81, DOI 10.1016/S0006-8993(01)02637-3; Christoff K, 2001, NEUROIMAGE, V14, P1136, DOI 10.1006/nimg.2001.0922; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; Desai R, 2006, J COGNITIVE NEUROSCI, V18, P278, DOI 10.1162/089892906775783633; Desjardins AE, 2001, NEUROIMAGE, V13, P751, DOI 10.1006/nimg.2000.0719; Dobbins IG, 2006, J COGNITIVE NEUROSCI, V18, P1439, DOI 10.1162/jocn.2006.18.9.1439; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Dux PE, 2006, NEURON, V52, P1109, DOI 10.1016/j.neuron.2006.11.009; Epstein RA, 2007, J NEUROSCI, V27, P6141, DOI 10.1523/JNEUROSCI.0799-07.2007; Fleck MS, 2006, CEREB CORTEX, V16, P1623, DOI 10.1093/cercor/bhj097; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Gilbert SJ, 2005, EUR J NEUROSCI, V21, P1423, DOI 10.1111/j.1460-9568.2005.03981.x; Gray JR, 2005, COGN AFFECT BEHAV NE, V5, P182, DOI 10.3758/CABN.5.2.182; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; GRINBAND J, 2008, NEUROIMAGE; Hahn B, 2007, CEREB CORTEX, V17, P1664, DOI 10.1093/cercor/bhl075; Hester RL, 2004, J COGNITIVE NEUROSCI, V16, P776, DOI 10.1162/089892904970726; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Kane MJ, 2007, J EXP PSYCHOL LEARN, V33, P615, DOI 10.1037/0278-7393.33.3.615; Karadottir R, 2008, NAT NEUROSCI; KERNS JG, 2004, ANTERIOR CINGULATE C, P1023; Kerns JG, 2006, NEUROIMAGE, V33, P399, DOI 10.1016/j.neuroimage.2006.06.012; Kerr DL, 2004, NEUROREPORT, V15, P607, DOI 10.1097/00001756-200403220-00007; Kukley M, 2007, NAT NEUROSCI, V10, P311, DOI 10.1038/nn1850; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Luks TL, 2002, NEUROIMAGE, V17, P792, DOI 10.1006/nimg.2002.1210; Madden DJ, 2004, NEUROIMAGE, V21, P1174, DOI 10.1016/j.neuroimage.2003.11.004; Mandeville JB, 1999, MAGN RESON MED, V42, P944, DOI 10.1002/(SICI)1522-2594(199911)42:5<944::AID-MRM15>3.0.CO;2-W; MENON RS, 1998, MENTAL CHRONOMETRY U, P10902; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Ostergaard L, 1998, J CEREBR BLOOD F MET, V18, P935, DOI 10.1097/00004647-199809000-00002; Ostergaard L, 1996, MAGNET RESON MED, V36, P726, DOI 10.1002/mrm.1910360511; POWERS WJ, 1985, J CEREBR BLOOD F MET, V5, P600, DOI 10.1038/jcbfm.1985.89; REMPP KA, 1994, RADIOLOGY, V193, P637, DOI 10.1148/radiology.193.3.7972800; ROSENTHAL R, 1978, PSYCHOL BULL, V85, P185, DOI 10.1037/0033-2909.85.1.185; Sapir A, 2005, P NATL ACAD SCI USA, V102, P17810, DOI 10.1073/pnas.0504678102; Schaefer A, 2006, J NEUROSCI, V26, P10120, DOI 10.1523/JNEUROSCI.2567-06.2006; Schulte T, 2005, CEREB CORTEX, V15, P1384, DOI 10.1093/cercor/bhi020; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Stern ER, 2007, BRAIN RES, V1176, P92, DOI 10.1016/j.brainres.2007.07.060; Sternberg S, 1966, HIGH SPEED SCANNING, P652; TETTAMANTI M, 2002, INTERHEMISPHERIC TRA, P1051; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Visscher KM, 2003, NEUROIMAGE, V19, P1694, DOI 10.1016/S1053-8119(03)00178-2; Weber B, 2005, J COGNITIVE NEUROSCI, V17, P113, DOI 10.1162/0898929052880002; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Yarkoni T, 2005, J EXP ANAL BEHAV, V84, P537, DOI 10.1901/jeab.2005.121-04; Yarkoni T, 2005, COGNITIVE BRAIN RES, V23, P71, DOI 10.1016/j.cogbrainres.2005.01.013; YARKONI T, MEDIAL POSTERI UNPUB; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	69	229	229	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2009	4	1							e4257	10.1371/journal.pone.0004257	http://dx.doi.org/10.1371/journal.pone.0004257			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JD	19165335	Green Published, gold			2022-12-25	WOS:000265482400005
J	Yang, JW; Zhang, YX; Xu, J; Geng, Y; Chen, XY; Yang, HL; Wang, SN; Wang, HA; Jiang, XC; Guo, XK; Zhao, GP				Yang, Junwei; Zhang, Yixuan; Xu, Jing; Geng, Yan; Chen, Xiaoying; Yang, Hongliang; Wang, Shengnian; Wang, Hengan; Jiang, Xucheng; Guo, Xiaokui; Zhao, Guoping			Serum Activity of Platelet-Activating Factor Acetylhydrolase Is a Potential Clinical Marker for Leptospirosis Pulmonary Hemorrhage	PLOS ONE			English	Article							GUINEA-PIG; ICTEROHAEMORRHAGIAE; SUSCEPTIBILITY; IMMUNOGLOBULIN; NICARAGUA; HEMOLYSIN; PROTEOME; ANTIGEN; LIVER; TRIAL	Pulmonary hemorrhage has been recognized as a major, often lethal, manifestation of severe leptospirosis albeit the pathogenesis remains unclear. The Leptospira interrogans virulent serogroup Icterohaemorrhagiae serovar Lai encodes a protein (LA2144), which exhibited the platelet-activating factor acetylhydrolase (PAF-AH) activity in vitro similar to that of human serum with respect to its substrate affinity and specificity and thus designated L-PAF-AH. On the other hand, the primary amino acid sequence of L-PAF-AH is homologous to the alpha 1-subunit of the bovine brain PAF-AH isoform I. The L-PAFAH was proven to be an intracellular protein, which was encoded unanimously and expressed similarly in either pathogenic or saprophytic leptospires. Mongolian gerbil is an appropriate experimental model to study the PAF-AH level in serum with its basal activity level comparable to that of human while elevated directly associated with the course of pulmonary hemorrhage during severe leptospirosis. Mortality occurred around the peak of pulmonary hemorrhage, along with the transition of the PAF-AH activity level in serum, from the increasing phase to the final decreasing phase. Limited clinical data indicated that the serum activity of PAF-AH was likely to be elevated in the patients infected by L. interrogans serogroup Icterohaemorrhagiae, but not in those infected by other less severe serogroups. Although L-PAF-AH might be released into the micro-environment via cell lysis, its PAF-AH activity apparently contributed little to this elevation. Therefore, the change of PAF-AH in serum not only may be influential for pulmonary hemorrhage, but also seems suitable for disease monitoring to ensure prompt clinical treatment, which is critical for reducing the mortality of severe leptospirosis.	[Zhao, Guoping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Lab Synthet Biol, Shanghai, Peoples R China; [Zhang, Yixuan; Geng, Yan; Chen, Xiaoying] Shenyang Pharm Univ, Sch Life Sci & Biopharm, Shenyang, Peoples R China; [Xu, Jing; Yang, Hongliang; Wang, Hengan; Jiang, Xucheng; Guo, Xiaokui] Shanghai Jiao Tong Univ, Dept Med Microbiol & Parasitol, Dept Pathol, Dept Animal Biotechnol, Shanghai, Peoples R China; [Xu, Jing] Shanghai Inst Hlth Sci, Shanghai, Peoples R China; [Wang, Shengnian; Zhao, Guoping] Natl Engn Ctr Biochip Shanghai, Shanghai, Peoples R China; [Zhao, Guoping] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Peoples R China; [Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shenyang Pharmaceutical University; Shanghai Jiao Tong University; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Yang, JW (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Lab Synthet Biol, Shanghai, Peoples R China.	gpzhao@sibs.ac.cn		Zhao, Guo-Ping/0000-0002-7621-6620; Guo, Xiao-Kui/0000-0002-1595-9965	National Natural Science Foundation of China [30830002, 30370071, 30670102, 30770820]; National High Technology Research and Development Program of China; Shanghai Leading Academic Discipline Project [T0206]; Shanghai Natural Science Foundation of China [062R14056]; Shanghai Educational Development Foundation [2007CGB06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Shanghai Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Educational Development Foundation	This work was supported in part by grants from the National Natural Science Foundation of China (No. 30830002, 30370071, 30670102 and 30770820), the National High Technology Research and Development Program of China and Shanghai Leading Academic Discipline Project (T0206), Shanghai Natural Science Foundation of China (No. 062R14056), and Shanghai Educational Development Foundation (2007CGB06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVES VAF, 1992, EXP TOXICOL PATHOL, V44, P425, DOI 10.1016/S0940-2993(11)80185-5; BERNHEIMER AW, 1986, INFECT IMMUN, V54, P262, DOI 10.1128/IAI.54.1.262-264.1986; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Branger C, 2005, INFECT IMMUN, V73, P4062, DOI 10.1128/IAI.73.7.4062-4069.2005; CHAO W, 1993, BIOCHEM J, V292, P617, DOI 10.1042/bj2920617; Claus RA, 2005, CRIT CARE MED, V33, P1416, DOI 10.1097/01.CCM.0000165807.26485.ED; DEBRITO T, 1992, INT J EXP PATHOL, V73, P633; DOBRINA A, 1995, INFECT IMMUN, V63, P2995, DOI 10.1128/IAI.63.8.2995-2999.1995; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Galfre G, 1981, Methods Enzymol, V73, P3; Garofalo P, 1967, Minerva Pediatr, V19, P1464; Gomes RN, 2006, SHOCK, V26, P41, DOI 10.1097/01.shk.0000209562.00070.1a; GRAHAM RM, 1994, CRIT CARE MED, V22, P204, DOI 10.1097/00003246-199402000-00009; Guidugli F., 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14657858; HATTORI M, 1994, J BIOL CHEM, V269, P23150; He P, 2005, PROTEOMICS, V5, P3442, DOI 10.1002/pmic.200401301; Ho YS, 1997, NATURE, V385, P89, DOI 10.1038/385089a0; Howard KM, 1997, J BIOL CHEM, V272, P27543, DOI 10.1074/jbc.272.44.27543; IM JG, 1989, AM J ROENTGENOL, V152, P955, DOI 10.2214/ajr.152.5.955; ISOGAI E, 1986, ZBL BAKT-INT J MED M, V262, P438; ISOGAI E, 1986, ZBL BAKT-INT J MED M, V261, P53, DOI 10.1016/S0176-6724(86)80062-1; Lee C, 1999, ARTERIOSCL THROM VAS, V19, P1437, DOI 10.1161/01.ATV.19.6.1437; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Liu GC, 2004, J BIOL CHEM, V279, P17738, DOI 10.1074/jbc.M400143200; Manya H, 1999, J BIOL CHEM, V274, P31827, DOI 10.1074/jbc.274.45.31827; Memon RA, 1999, AM J PHYSIOL-REG I, V277, pR94, DOI 10.1152/ajpregu.1999.277.1.R94; Merien F, 1998, FEMS MICROBIOL LETT, V169, P95, DOI 10.1111/j.1574-6968.1998.tb13304.x; Min JH, 2001, BIOCHEMISTRY-US, V40, P4539, DOI 10.1021/bi002600g; Moon TC, 2003, ARCH PHARM RES, V26, P554, DOI 10.1007/BF02976880; Nally JE, 2007, INFECT IMMUN, V75, P766, DOI 10.1128/IAI.00741-06; Nally JE, 2004, AM J PATHOL, V164, P1115, DOI 10.1016/S0002-9440(10)63198-7; Opal S, 2004, CRIT CARE MED, V32, P332, DOI 10.1097/01.CCM.0000108867.87890.6D; Palaniappan RUM, 2006, INFECT IMMUN, V74, P1745, DOI 10.1128/IAI.74.3.1745-1750.2006; RANDALL WBD, 2002, ECKERT ANIMAL PHYSL; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sheffield PJ, 2001, PROTEIN ENG, V14, P513, DOI 10.1093/protein/14.7.513; SORENSEN J, 1994, INTENS CARE MED, V20, P555, DOI 10.1007/BF01705721; Stafforini DM, 1997, J BIOL CHEM, V272, P17895, DOI 10.1074/jbc.272.29.17895; TAKAFUJI ET, 1984, NEW ENGL J MED, V310, P497, DOI 10.1056/NEJM198402233100805; Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424; Vinetz JM, 2001, CURR OPIN INFECT DIS, V14, P527, DOI 10.1097/00001432-200110000-00005; WATT G, 1988, LANCET, V1, P433; YASUDA PH, 1986, EXP PATHOL-JENA, V29, P35, DOI 10.1016/S0232-1513(86)80004-4; YUKAWA M, 1990, VET MICROBIOL, V24, P63, DOI 10.1016/0378-1135(90)90051-V; YUKAWA M, 1994, VET MICROBIOL, V41, P99, DOI 10.1016/0378-1135(94)90139-2; Zaki SR, 1996, LANCET, V347, P535, DOI 10.1016/S0140-6736(96)91167-8	47	15	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2009	4	1							e4181	10.1371/journal.pone.0004181	http://dx.doi.org/10.1371/journal.pone.0004181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IG	19145243	Green Submitted, Green Published, gold			2022-12-25	WOS:000265479800001
J	Polouliakh, N; Nock, R; Nielsen, F; Kitano, H				Polouliakh, Natalia; Nock, Richard; Nielsen, Frank; Kitano, Hiroaki			G-Protein Coupled Receptor Signaling Architecture of Mammalian Immune Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; NETWORKS; RECONSTRUCTION	A series of recent studies on large-scale networks of signaling and metabolic systems revealed that a certain network structure often called "bow-tie network" are observed. In signaling systems, bow-tie network takes a form with diverse and redundant inputs and outputs connected via a small numbers of core molecules. While arguments have been made that such network architecture enhances robustness and evolvability of biological systems, its functional role at a cellular level remains obscure. A hypothesis was proposed that such a network function as a stimuli-reaction classifier where dynamics of core molecules dictate downstream transcriptional activities, hence physiological responses against stimuli. In this study, we examined whether such hypothesis can be verified using experimental data from Alliance for Cellular Signaling (AfCS) that comprehensively measured GPCR related ligands response for B-cell and macrophage. In a GPCR signaling system, cAMP and Ca2+ act as core molecules. Stimuli-response for 32 ligands to B-Cells and 23 ligands to macrophages has been measured. We found that ligands with correlated changes of cAMP and Ca2+ tend to cluster closely together within the hyperspaces of both cell types and they induced genes involved in the same cellular processes. It was found that ligands inducing cAMP synthesis activate genes involved in cell growth and proliferation; cAMP and Ca2+ molecules that increased together form a feedback loop and induce immune cells to migrate and adhere together. In contrast, ligands without a core molecules response are scattered throughout the hyperspace and do not share clusters. G-protein coupling receptors together with immune response specific receptors were found in cAMP and Ca2+ activated clusters. Analyses have been done on the original software applicable for discovering 'bow-tie' network architectures within the complex network of intracellular signaling where ab initio clustering has been implemented as well. Groups of potential transcription factors for each specific group of genes were found to be partly conserved across B-Cell and macrophage. A series of findings support the hypothesis.	[Polouliakh, Natalia; Nielsen, Frank; Kitano, Hiroaki] Sony Comp Sci Labs Inc, Tokyo, Japan; [Polouliakh, Natalia; Kitano, Hiroaki] Syst Biol Inst, Tokyo, Japan; [Nock, Richard] Univ Antilles Guyane, CEREGMIA, Schoelcher, France	Sony Corporation	Polouliakh, N (corresponding author), Sony Comp Sci Labs Inc, Tokyo, Japan.	h.kitano@csl.sony.co.jp		Polouliakh, Natalia/0000-0001-8266-2697; Nielsen, Frank/0000-0001-5728-0726	ERATO/SORST program (Japan Science and Technology Agency: JST); Sweden-Japan Strategic Collaboration Program (JST); Genome Network Project (Ministry of Education, Sports, Culture, Science, and Technology)	ERATO/SORST program (Japan Science and Technology Agency: JST)(Japan Science & Technology Agency (JST)); Sweden-Japan Strategic Collaboration Program (JST)(Japan Science & Technology Agency (JST)); Genome Network Project (Ministry of Education, Sports, Culture, Science, and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research is supported, in part, by the ERATO/SORST program (Japan Science and Technology Agency: JST), the Sweden-Japan Strategic Collaboration Program (JST), and the Genome Network Project (Ministry of Education, Sports, Culture, Science, and Technology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Csete M, 2004, TRENDS BIOTECHNOL, V22, P446, DOI 10.1016/j.tibtech.2004.07.007; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Foletta VC, 1998, J LEUKOCYTE BIOL, V63, P139, DOI 10.1002/jlb.63.2.139; GEMAN S, 1992, NEURAL COMPUT, V4, P1, DOI 10.1162/neco.1992.4.1.1; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gilman AG, 2002, NATURE, V420, P703, DOI 10.1038/nature01304; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Kel A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S13; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Liu XH, 2006, AM J PHYSIOL-CELL PH, V290, pC873, DOI 10.1152/ajpcell.00229.2005; Ma HW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100177; Ma HW, 2003, BIOINFORMATICS, V19, P270, DOI 10.1093/bioinformatics/19.2.270; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Nock R, 2003, INT J PATTERN RECOGN, V17, P1369, DOI 10.1142/S0218001403002952; Oda K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100057; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Polouliakh Natalia, 2006, Journal of Bioinformatics and Computational Biology, V4, P469, DOI 10.1142/S0219720006001849; Pradervand S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r11; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Zass R., 2006, ADV NEURAL INFORM PR; Zhu XC, 2004, J IMMUNOL, V173, P7141, DOI 10.4049/jimmunol.173.12.7141; [No title captured]	27	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4189	10.1371/journal.pone.0004189	http://dx.doi.org/10.1371/journal.pone.0004189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142232	Green Submitted, Green Published, gold			2022-12-25	WOS:000265479700010
J	Sawka, AM; Goldstein, DP; Brierley, JD; Tsang, RW; Rotstein, L; Ezzat, S; Straus, S; George, SR; Abbey, S; Rodin, G; O'Brien, MA; Gafni, A; Thabane, L; Goguen, J; Naeem, A; Magalhaes, L				Sawka, Anna M.; Goldstein, David P.; Brierley, James D.; Tsang, Richard W.; Rotstein, Lorne; Ezzat, Shereen; Straus, Sharon; George, Susan R.; Abbey, Susan; Rodin, Gary; O'Brien, Mary Ann; Gafni, Amiram; Thabane, Lehana; Goguen, Jeannette; Naeem, Asima; Magalhaes, Lilian			The Impact of Thyroid Cancer and Post-Surgical Radioactive Iodine Treatment on the Lives of Thyroid Cancer Survivors: A Qualitative Study	PLOS ONE			English	Article							TREATMENT DECISION-MAKING; BREAST-CANCER; OF-LIFE; ADJUVANT CHEMOTHERAPY; REMNANT ABLATION; COMPUTER-PROGRAM; CARCINOMA; THERAPY; ASSIST; WOMEN	Background: Adjuvant treatment with radioactive iodine (RAI) is often considered in the treatment of well-differentiated thyroid carcinoma (WDTC). We explored the recollections of thyroid cancer survivors on the diagnosis of WDTC, adjuvant radioactive iodine (RAI) treatment, and decision-making related to RAI treatment. Participants provided recommendations for healthcare providers on counseling future patients on adjuvant RAI treatment. Methods: We conducted three focus group sessions, including WDTC survivors recruited from two Canadian academic hospitals. Participants had a prior history of WDTC that was completely resected at primary surgery and had been offered adjuvant RAI treatment. Open-ended questions were used to generate discussion in the groups. Saturation of major themes was achieved among the groups. Findings: There were 16 participants in the study, twelve of whom were women (75%). All but one participant had received RAI treatment (94%). Participants reported that a thyroid cancer diagnosis was life-changing, resulting in feelings of fear and uncertainty. Some participants felt dismissed as not having a serious disease. Some participants reported receiving conflicting messages from healthcare providers on the appropriateness of adjuvant RAI treatment or insufficient information. If RAI-related side effects occurred, their presence was not legitimized by some healthcare providers. Conclusions: The diagnosis and treatment of thyroid cancer significantly impacts the lives of survivors. Fear and uncertainty related to a cancer diagnosis, feelings of the diagnosis being dismissed as not serious, conflicting messages about adjuvant RAI treatment, and treatment-related side effects, have been raised as important concerns by thyroid cancer survivors.	[Ezzat, Shereen; George, Susan R.; Goguen, Jeannette] Univ Toronto, Dept Med, Div Endocrinol, Toronto, ON, Canada; [Sawka, Anna M.; George, Susan R.; Naeem, Asima] Univ Hlth Network, Dept Med, Div Endocrinol, Toronto, ON, Canada; [Goldstein, David P.] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada; [Goldstein, David P.] Univ Hlth Network, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada; [Brierley, James D.; Tsang, Richard W.] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada; [Brierley, James D.; Tsang, Richard W.] Univ Hlth Network, Dept Radiat Oncol, Toronto, ON, Canada; [Rotstein, Lorne] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Rotstein, Lorne] Univ Hlth Network, Dept Surg, Toronto, ON, Canada; [Ezzat, Shereen] Mt Sinai Hosp, Dept Med, Div Endocrinol, Toronto, ON, Canada; [Ezzat, Shereen] Freeman Ctr Endocrine Oncol, Toronto, ON, Canada; [Ezzat, Shereen; Rodin, Gary] Ontario Canc Inst, Toronto, ON, Canada; [Straus, Sharon] Univ Toronto, Dept Knowledge Translat, Toronto, ON, Canada; [Abbey, Susan] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Abbey, Susan] Univ Hlth Network, Dept Psychiat, Toronto, ON, Canada; [Rodin, Gary] Univ Hlth Network, Princess Margaret Hosp, Dept Psychosocial Oncol & Palliative Care, Toronto, ON, Canada; [O'Brien, Mary Ann] McMaster Univ, Juravinski Canc Ctr, Supportive Canc Care Res Unit, Hamilton, ON, Canada; [Gafni, Amiram; Thabane, Lehana] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Gafni, Amiram] McMaster Univ, Ctr Hlth Econ & Policy Evaluat, Hamilton, ON, Canada; [Thabane, Lehana] St Josephs Healthcare, Ctr Evaluat Med, Hamilton, ON, Canada; [Goguen, Jeannette] St Michaels Hosp, Dept Med, Div Endocrinol, Toronto, ON, Canada; [Magalhaes, Lilian] Univ Western Ontario, Sch Occupat Therapy, London, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; McMaster University; McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Western University (University of Western Ontario)	Sawka, AM (corresponding author), Univ Toronto, Dept Med, Div Endocrinol, Toronto, ON, Canada.	sawkaam@yahoo.com	Sawka, Anna/AAA-4336-2020; George, Susan/W-7494-2019; Magalhães, Lilian V/B-2458-2008; goldstein, David/AAT-6302-2020	Magalhães, Lilian V/0000-0003-3666-3685; Rodin, Gary/0000-0002-6626-6974; Tsang, Richard/0000-0002-7487-8487	Canadian Institutes of Health Research New Investigator Program [CNI-80701]; University Health Network Thyroid Research Centre Endowment Fund; Connaught New Staff Matching Grant of the University of Toronto	Canadian Institutes of Health Research New Investigator Program(Canadian Institutes of Health Research (CIHR)); University Health Network Thyroid Research Centre Endowment Fund; Connaught New Staff Matching Grant of the University of Toronto	A. Sawka and this project are supported by the Canadian Institutes of Health Research New Investigator Program (CNI-80701). This study is also supported in part by the University Health Network Thyroid Research Centre Endowment Fund and the Connaught New Staff Matching Grant of the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Air M, 2007, THYROID, V17, P259, DOI 10.1089/thy.2006.0300; Allen JD, 2009, PSYCHO-ONCOLOGY, V18, P71, DOI 10.1002/pon.1380; *AM ASS CLIN END, 2001, ENDOCR PRACT, V7, P202; *AM CANC SOC, 2007, EST NEW CANC CAS DEA; [Anonymous], NATURALISTIC INQUIRY; Ashbury J., 1999, QUAL HEALTH RES, V5, P414; Barry MJ, 2002, ANN INTERN MED, V136, P127, DOI 10.7326/0003-4819-136-2-200201150-00010; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; British Thyroid Association Royal College of Physicians., 2007, GUID MAN THYR CANC; *CANC RES UK, 2008, THYR CANC; Charles C, 2005, HEALTH EXPECT, V8, P114, DOI 10.1111/j.1369-7625.2005.00325.x; Crevenna R, 2003, SUPPORT CARE CANCER, V11, P597, DOI 10.1007/s00520-003-0474-4; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Davis DA, 1997, CAN MED ASSOC J, V157, P408; Denzin L. K., 2005, SAGE HDB QUALITATIVE; Edwards BK, 2002, CANCER-AM CANCER SOC, V94, P2766, DOI 10.1002/cncr.10593; Elit L, 2003, GYNECOL ONCOL, V88, P89, DOI 10.1016/S0090-8258(02)00090-2; Finlay L, 2002, QUAL HEALTH RES, V12, P531, DOI 10.1177/104973202129120052; GIACOMINI MK, 2000, JAMA-J AM MED ASSOC, V284, P505; Giusti M, 2005, J ENDOCRINOL INVEST, V28, P599, DOI 10.1007/BF03347258; Hay Ian D, 2007, Endocr Pract, V13, P521; Hay ID, 2006, J SURG ONCOL, V94, P692, DOI 10.1002/jso.20696; Hay Ian D, 2002, Trans Am Clin Climatol Assoc, V113, P241; Hayat MJ, 2007, ONCOLOGIST, V12, P20, DOI 10.1634/theoncologist.12-1-20; Hewitt M., 2005, CANC PATIENT CANC SU; Hoftijzer HC, 2008, J CLIN ENDOCR METAB, V93, P200, DOI 10.1210/jc.2007-1203; Holmes-Rovner M, 2000, J EVAL CLIN PRACT, V6, P263, DOI 10.1046/j.1365-2753.2000.00258.x; Irwin E, 1999, PATIENT EDUC COUNS, V37, P283, DOI 10.1016/S0738-3991(98)00117-7; Jonklaas J, 2006, THYROID, V16, P1229, DOI 10.1089/thy.2006.16.1229; Kennelly C., 2001, QUAL HLTH CARE S1, V10, P23, DOI [10.1136/qhc.0100023, DOI 10.1136/QHC.0100023]; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Kreling B, 2006, PSYCHO-ONCOLOGY, V15, P1065, DOI 10.1002/pon.1042; LEVINE MN, 1992, ANN INTERN MED, V117, P53, DOI 10.7326/0003-4819-117-1-53; Liamputtong P., 2005, QUALITATIVE RES METH; *NAT CANC I, 2006, THYR CANC PDQ TREATM; National Comprehensive Cancer Network, 2008, NCCN CLIN PRACT GUID; O'Connor A, 2001, ACP J Club, V135, pA11; O'Connor A, 2003, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001431; Pacini F, 2008, ANN ONCOL, V19, P99, DOI 10.1093/annonc/mdn115; Pacini F, 2006, J CLIN ENDOCR METAB, V91, P926, DOI 10.1210/jc.2005-1651; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; PARK SH, 1988, JPN J CLIN ONCOL, V18, P297; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Peele PB, 2005, MED DECIS MAKING, V25, P301, DOI 10.1177/0272989X05276851; Pieterse AH, 2008, BRIT J CANCER, V99, P875, DOI 10.1038/sj.bjc.6604611; Ravdin PM, 2001, J CLIN ONCOL, V19, P980, DOI 10.1200/JCO.2001.19.4.980; Ravdin PM, 1995, B CANCER, V82, pS561; Ravdin PM, 1996, SEMIN ONCOL, V23, P43; SAWKA A, 2005, I 131 REMNANT ABLATI; Sawka AM, 2004, J CLIN ENDOCR METAB, V89, P3668, DOI 10.1210/jc.2003-031167; Sawka Anna M, 2008, Endocr Pract, V14, P175; Sawka AM, 2008, ENDOCRIN METAB CLIN, V37, P457, DOI 10.1016/j.ecl.2008.02.007; Sawka AM, 2007, THYROID, V17, P1235, DOI 10.1089/thy.2007.0077; Silverman D., 2017, DOING QUALITATIVE RE; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Tan LGL, 2007, LARYNGOSCOPE, V117, P507, DOI 10.1097/MLG.0b013e31802e3739; Trevena L, 2003, PATIENT EDUC COUNS, V50, P265, DOI 10.1016/S0738-3991(03)00047-8; Verdecchia A, 2007, LANCET ONCOL, V8, P784, DOI 10.1016/S1470-2045(07)70246-2; Weinfurt KP, 2003, CLIN THER, V25, P671, DOI 10.1016/S0149-2918(03)80104-2; Whelan T, 2003, J NATL CANCER I, V95, P581, DOI 10.1093/jnci/95.8.581; Whelan TJ, 2005, J CLIN ONCOL, V23, P1627, DOI 10.1200/JCO.2005.10.072	61	47	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4191	10.1371/journal.pone.0004191	http://dx.doi.org/10.1371/journal.pone.0004191			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437IF	19142227	Green Published, gold			2022-12-25	WOS:000265479700012
J	Mellberg, S; Dimberg, A; Bahram, F; Hayashi, M; Rennel, E; Ameur, A; Westholm, JO; Larsson, E; Lindahl, P; Cross, MJ; Claesson-Welsh, L				Mellberg, Sofie; Dimberg, Anna; Bahram, Fuad; Hayashi, Makoto; Rennel, Emma; Ameur, Adam; Westholm, Jakub Orzechowski; Larsson, Erik; Lindahl, Per; Cross, Michael J.; Claesson-Welsh, Lena			Transcriptional profiling reveals a critical role for tyrosine phosphatase VE-PTP in regulation of VEGFR2 activity and endothelial cell morphogenesis	FASEB JOURNAL			English	Article						angiogenesis; gene expression; PTPRB; HPTP beta; signal transduction	GENE-EXPRESSION; TIP-CELLS; ANGIOGENESIS; DIFFERENTIATION; ADRENOMEDULLIN; VASCULOGENESIS; IDENTIFICATION; RECEPTOR-2	To define molecular events accompanying formation of the 3-dimensional (3D) vascular tube, we have characterized gene expression during vascular endothelial growth factor (VEGF)-induced tubular morphogenesis of endothelial cells. Microarray analyses were performed comparing gene induction in growth-arrested, tube-forming endothelial cells harvested from 3D collagen cultures to that in proliferating endothelial cells cultured on fibronectin. Differentially expressed genes were clustered and analyzed for specific endothelial expression through publicly available datasets. We validated the contribution of one of the identified genes, vascular endothelial protein tyrosine phosphatase (VE-PTP), to endothelial morphogenesis. Silencing of VE-PTP expression was accompanied by increased VEGF receptor-2 (VEGFR2) tyrosine phosphorylation and activation of downstream signaling pathways. The increased VEGFR2 activity promoted endothelial cell cycle progression, overcoming the G(0)/G(1) arrest associated with organization into tubular structures in the 3D cultures. Proximity ligation showed close association between VEGFR2 and VE-PTP in resting cells. Activation of VEGFR2 by VEGF led to rapid loss of association, which was resumed with time in parallel with decreased receptor activity. In conclusion, we have identified genes, which may serve critical functions in formation of the vascular tube. One of these, VE-PTP, regulates VEGFR2 activity thereby modulating the VEGF-response during angiogenesis.-Mellberg, S., Dimberg, A., Bahram, F., Hayashi, M., Rennel, E., Ameur, A., Westholm, J. O., Larsson, E., Lindahl, P., Cross, M. J., Claesson-Welsh, L. Transcriptional profiling reveals a critical role for tyrosine phosphatase VE-PTP in regulation of VEGFR2 activity and endothelial cell morphogenesis. FASEB J. 23, 1490-1502 (2009)	[Mellberg, Sofie; Dimberg, Anna; Bahram, Fuad; Hayashi, Makoto; Rennel, Emma; Cross, Michael J.; Claesson-Welsh, Lena] Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, Uppsala, Sweden; [Ameur, Adam; Westholm, Jakub Orzechowski] Uppsala Univ, Biomed Ctr, Linnaeus Ctr Bioinformat, Uppsala, Sweden; [Larsson, Erik; Lindahl, Per] Sahlgrens Univ Hosp, Wallenberg Lab Cardiovasc Res, S-41345 Gothenburg, Sweden	Uppsala University; Uppsala University; Sahlgrenska University Hospital	Rennel, E (corresponding author), Univ Bristol, Preclin Vet Sch, Dept Physiol & Pharmacol, Microvasc Res Labs, Southwell St, Bristol BS2 8EJ, Avon, England.	lena.welsh@genpat.uu.se	Ameur, Adam/E-6207-2011; Larsson Lekholm, Erik/AHE-0932-2022; Larsson Lekholm, Erik/HDM-8032-2022	Ameur, Adam/0000-0001-6085-6749; Larsson Lekholm, Erik/0000-0003-1400-0119; Larsson Lekholm, Erik/0000-0003-1400-0119; Dimberg, Anna/0000-0003-4422-9125; Westholm, Jakub/0000-0002-6849-6220	Swedish Cancer Society [4734-B03-02XBB, 3820-B04-09XAC]; Swedish Research Council [K2005-32X-12552-08A]; Novo Nordisk foundation; Svenska Lakarsallskapet for medicinsk forskning; Association for International Cancer Research [04-069]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); Svenska Lakarsallskapet for medicinsk forskning; Association for International Cancer Research	This study was supported by grants to M.J.C. (Swedish Cancer Society project 4734-B03-02XBB) and to L. C.-W. (Swedish Cancer Society project 3820-B04-09XAC, Swedish Research Council project K2005-32X-12552-08A, and the Novo Nordisk foundation). A. D. was supported by Svenska Lakarsallskapet for medicinsk forskning and by a grant to L. C.-W. from the Association for International Cancer Research (04-069).	ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; Ameur A, 2006, BIOINFORMATICS, V22, P1024, DOI 10.1093/bioinformatics/btl036; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baumer S, 2006, BLOOD, V107, P4754, DOI 10.1182/blood-2006-01-0141; Bell SE, 2001, J CELL SCI, V114, P2755; Bohman S, 2005, J BIOL CHEM, V280, P42397, DOI 10.1074/jbc.M506724200; Cavallaro U, 2006, EXP CELL RES, V312, P659, DOI 10.1016/j.yexcr.2005.09.019; Chabot C, 2009, MOL CELL BIOL, V29, P241, DOI 10.1128/MCB.01374-08; Dimberg A, 2008, BLOOD, V111, P2015, DOI 10.1182/blood-2007-04-087841; Dominguez MG, 2007, P NATL ACAD SCI USA, V104, P3243, DOI 10.1073/pnas.0611510104; Eklund L, 2006, EXP CELL RES, V312, P630, DOI 10.1016/j.yexcr.2005.09.002; Fachinger G, 1999, ONCOGENE, V18, P5948, DOI 10.1038/sj.onc.1202992; Fernandez-Sauze S, 2004, INT J CANCER, V108, P797, DOI 10.1002/ijc.11663; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; GAITS F, 1995, BIOCHEM J, V311, P97, DOI 10.1042/bj3110097; Gerritsen ME, 2003, MICROCIRCULATION, V10, P63, DOI 10.1038/sj.mn.7800170; Glesne DA, 2006, CANCER RES, V66, P4030, DOI 10.1158/0008-5472.CAN-05-3294; Hahn CN, 2005, PHYSIOL GENOMICS, V22, P57, DOI 10.1152/physiolgenomics.00278.2004; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Ho M, 2003, PHYSIOL GENOMICS, V13, P249, DOI 10.1152/physiolgenomics.00186.2002; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Ichikawa-Shindo Y, 2008, J CLIN INVEST, V118, P29, DOI 10.1172/JCI33022; Ishimitsu T, 2006, PHARMACOL THERAPEUT, V111, P909, DOI 10.1016/j.pharmthera.2006.02.004; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Kahn J, 2000, AM J PATHOL, V156, P1887, DOI 10.1016/S0002-9440(10)65062-6; Kappert K, 2005, CARDIOVASC RES, V65, P587, DOI 10.1016/j.cardiores.2004.08.016; Matsumoto T, 2008, ARTERIOSCL THROM VAS, V28, P2123, DOI 10.1161/ATVBAHA.108.169128; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; Niemela H, 2005, BLOOD, V106, P3405, DOI 10.1182/blood-2005-01-0254; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; PORTER CW, 1991, CANCER RES, V51, P3715; Saal LH, 2002, GENOME BIOL, V3; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shindo T, 2001, CIRCULATION, V104, P1964, DOI 10.1161/hc4101.097111; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Venetsanakos E, 2002, EXP CELL RES, V273, P21, DOI 10.1006/excr.2001.5424; VINDELOV LL, 1983, CYTOMETRY, V3, P317, DOI 10.1002/cyto.990030502; Wallgard E, 2008, ARTERIOSCL THROM VAS, V28, P1469, DOI 10.1161/ATVBAHA.108.165738; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	43	80	88	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2009	23	5					1490	1502		10.1096/fj.08-123810	http://dx.doi.org/10.1096/fj.08-123810			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19136612				2022-12-25	WOS:000266651700025
J	Wang, LK; Zhu, H; Shuman, S				Wang, Li Kai; Zhu, Hui; Shuman, Stewart			Structure-guided Mutational Analysis of the Nucleotidyltransferase Domain of Escherichia coli DNA Ligase (LigA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T4 RNA LIGASE; ADENYLATE INTERMEDIATE; CRYSTAL-STRUCTURE; NICK; POLYNUCLEOTIDES; ARCHITECTURE; RECOGNITION	NAD(+)-dependent DNA ligases (LigA) are ubiquitous in bacteria, where they are essential for growth and present attractive targets for antimicrobial drug discovery. LigA has a distinctive modular structure in which a nucleotidyltransferase catalytic domain is flanked by an upstream NMN-binding module and by downstream OB-fold, zinc finger, helix-hairpin-helix, and BRCT domains. Here we conducted a structure-function analysis of the nucleotidyltransferase domain of Escherichia coli LigA, guided by the crystal structure of the LigA-DNA-adenylate intermediate. We tested the effects of 29 alanine and conservative mutations at 15 amino acids on ligase activity in vitro and in vivo. We thereby identified essential functional groups that coordinate the reactive phosphates (Arg(136)), contact the AMP adenine (Lys(290)), engage the phosphodiester backbone flanking the nick (Arg(218), Arg(308), Arg(97) plus Arg(101)), or stabilize the active domain fold (Arg(171)). Finer analysis of the mutational effects revealed step-specific functions for Arg136, which is essential for the reaction of LigA with NAD(+) to form the covalent ligase-AMP intermediate (step 1) and for the transfer of AMP to the nick 5'-PO4 to form the DNA-adenylate intermediate (step 2) but is dispensable for phosphodiester formation at a preadenylylated nick (step 3).	[Wang, Li Kai; Zhu, Hui; Shuman, Stewart] Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA.	s-shuman@ski.mskcc.org			National Institutes of Health [GM63611]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063611] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM63611. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Benarroch D, 2006, VIROLOGY, V353, P133, DOI 10.1016/j.virol.2006.04.032; El Omari K, 2006, J BIOL CHEM, V281, P1573, DOI 10.1074/jbc.M509658200; Gajiwala KS, 2004, STRUCTURE, V12, P1449, DOI 10.1016/j.str.2004.05.017; GUMPORT RI, 1971, P NATL ACAD SCI USA, V68, P2559, DOI 10.1073/pnas.68.10.2559; Jeon HJ, 2004, FEMS MICROBIOL LETT, V237, P111, DOI 10.1016/j.femsle.2004.06.018; Kaczmarek FS, 2001, J BACTERIOL, V183, P3016, DOI 10.1128/JB.183.10.3016-3024.2001; Lee JY, 2000, EMBO J, V19, P1119, DOI 10.1093/emboj/19.5.1119; Lim JH, 2001, ARCH BIOCHEM BIOPHYS, V388, P253, DOI 10.1006/abbi.2001.2291; LITTLE JW, 1967, P NATL ACAD SCI USA, V58, P2004, DOI 10.1073/pnas.58.5.2004; Nair PA, 2007, NAT STRUCT MOL BIOL, V14, P770, DOI 10.1038/nsmb1266; Nandakumar J, 2007, MOL CELL, V26, P257, DOI 10.1016/j.molcel.2007.02.026; Nandakumar J, 2006, CELL, V127, P71, DOI 10.1016/j.cell.2006.08.038; Odell M, 2000, MOL CELL, V6, P1183, DOI 10.1016/S1097-2765(00)00115-5; OLIVERA BM, 1968, P NATL ACAD SCI USA, V61, P237, DOI 10.1073/pnas.61.1.237; Raymond A, 2007, NUCLEIC ACIDS RES, V35, P839, DOI 10.1093/nar/gkl1090; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; Singleton MR, 1999, STRUCTURE, V7, P35, DOI 10.1016/S0969-2126(99)80007-0; Sriskanda V, 1999, NUCLEIC ACIDS RES, V27, P3953, DOI 10.1093/nar/27.20.3953; Sriskanda V, 2001, J BIOL CHEM, V276, P36100, DOI 10.1074/jbc.M105643200; SRISKANDA V, 2002, J BIOL CHEM, V277, P9685; Srivastava SK, 2005, J BIOL CHEM, V280, P30273, DOI 10.1074/jbc.M503780200; Timson DJ, 1999, J MOL BIOL, V285, P73, DOI 10.1006/jmbi.1998.2302; Wang LK, 2008, J BIOL CHEM, V283, P23343, DOI 10.1074/jbc.M802945200; Wang LK, 2006, RNA, V12, P2126, DOI 10.1261/rna.271706; Wang LK, 2003, J BIOL CHEM, V278, P29454, DOI 10.1074/jbc.M304320200; Yin SM, 2003, J BIOL CHEM, V278, P17601, DOI 10.1074/jbc.M300817200; Zhao A, 2006, MOL MICROBIOL, V59, P743, DOI 10.1111/j.1365-2958.2005.04975.x; Zhu H, 2005, J BIOL CHEM, V280, P12137, DOI 10.1074/jbc.M413685200	28	8	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8486	8494		10.1074/jbc.M808476200	http://dx.doi.org/10.1074/jbc.M808476200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19150981	hybrid, Green Published			2022-12-25	WOS:000264397800033
J	Taniguchi, Y; Ido, H; Sanzen, N; Hayashi, M; Sato-Nishiuchi, R; Futaki, S; Sekiguchi, K				Taniguchi, Yukimasa; Ido, Hiroyuki; Sanzen, Noriko; Hayashi, Maria; Sato-Nishiuchi, Ryoko; Futaki, Sugiko; Sekiguchi, Kiyotoshi			The C-terminal Region of Laminin beta Chains Modulates the Integrin Binding Affinities of Laminins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOMERULAR-BASEMENT-MEMBRANE; GLUTAMIC-ACID RESIDUE; CELL-ADHESION; GLOBULAR DOMAIN; MICE LACKING; MUTANT MICE; NEUROMUSCULAR-JUNCTION; ALPHA-CHAINS; COILED COILS; RECOMBINANT	Laminins are major cell-adhesive proteins in basement membranes that are capable of binding to integrins. Laminins consist of three chains (alpha, beta, and gamma), in which three laminin globular modules in the alpha chain and the Glu residue in the C-terminal tail of the gamma chain have been shown to be prerequisites for binding to integrins. However, it remains unknown whether any part of the beta chain is involved in laminin-integrin interactions. We compared the binding affinities of pairs of laminin isoforms containing the beta 1 or beta 2 chain toward a panel of laminin-binding integrins, and we found that beta 2 chain-containing laminins (beta 2-laminins) bound more avidly to alpha 3 beta 1 and alpha 7X2 beta 1 integrins than beta 1 chain-containing laminins (beta 1-laminins), whereas alpha 6 beta 1, alpha 6 beta 4, and alpha 7X1 beta 1 integrins did not show any preference toward beta 2-laminins. Because alpha 3 beta 1 contains the "X2-type" variable region in the alpha 3 subunit and alpha 6 beta 1 and alpha 6 beta 4 contain the "X1-type" region in the alpha 6 subunit, we hypothesized that only integrins containing the X2-type region were capable of discriminating between beta 1-laminins and beta 2-laminins. In support of this possibility, a putative X2-type variant of alpha 6 beta 1 was produced and found to bind preferentially to beta 2-laminins. Production of a series of swap mutants between the beta 1 and beta 2 chains revealed that the C-terminal 20 amino acids in the coiled-coil domain were responsible for the enhanced integrin binding by beta 2-laminins. Taken together, the results provide evidence that the C-terminal region of beta chains is involved in laminin recognition by integrins and modulates the binding affinities of laminins toward X2-type integrins.	[Taniguchi, Yukimasa; Ido, Hiroyuki; Sanzen, Noriko; Hayashi, Maria; Sato-Nishiuchi, Ryoko; Futaki, Sugiko; Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, Suita, Osaka 5650871, Japan	Osaka University	Sekiguchi, K (corresponding author), Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sekiguch@protein.osaka-u.ac.jp		Sanzen, Noriko/0000-0001-6518-403X	Grants-in-aid for Scientific Research [17082005, 20370046]; New Energy and Industrial Technology Development Organization of Japan [06001294-0]	Grants-in-aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); New Energy and Industrial Technology Development Organization of Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by Grants-in-aid for Scientific Research 17082005 and 20370046 (to K.S.) and Research Contract 06001294-0 with the New Energy and Industrial Technology Development Organization of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Altroff H, 2003, J BIOL CHEM, V278, P491, DOI 10.1074/jbc.M209992200; AOTA S, 1994, J BIOL CHEM, V269, P24756; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Belkin AM, 2000, MICROSC RES TECHNIQ, V51, P280, DOI 10.1002/1097-0029(20001101)51:3<280::AID-JEMT7>3.0.CO;2-O; BROWN JC, 1994, J CELL SCI, V107, P329; Champliaud MF, 2000, EXP CELL RES, V259, P326, DOI 10.1006/excr.2000.4980; Champliaud MF, 1996, J CELL BIOL, V132, P1189, DOI 10.1083/jcb.132.6.1189; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; DELWEL GO, 1995, CELL ADHES COMMUN, V3, P143, DOI 10.3109/15419069509081283; DEUTZMANN R, 1990, EUR J BIOCHEM, V191, P513, DOI 10.1111/j.1432-1033.1990.tb19151.x; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Fujiwara H, 2001, J BIOL CHEM, V276, P17550, DOI 10.1074/jbc.M010155200; Hayashi Y, 2002, BIOCHEM BIOPH RES CO, V299, P498, DOI 10.1016/S0006-291X(02)02642-6; Hirosaki T, 2000, J BIOL CHEM, V275, P22495, DOI 10.1074/jbc.M001326200; Humphries MJ, 2002, ARTHRITIS RES THER, V4, pS69, DOI 10.1186/ar563; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; Ido H, 2006, MATRIX BIOL, V25, P112, DOI 10.1016/j.matbio.2005.10.003; Ido H, 2004, J BIOL CHEM, V279, P10946, DOI 10.1074/jbc.M313626200; Ido H, 2008, J BIOL CHEM, V283, P28149, DOI 10.1074/jbc.M803553200; Ido H, 2007, J BIOL CHEM, V282, P11144, DOI 10.1074/jbc.M609402200; Kikkawa Y, 2003, J CELL BIOL, V161, P187, DOI 10.1083/jcb.200211121; Kikkawa Y, 2007, J BIOL CHEM, V282, P14853, DOI 10.1074/jbc.M611706200; Kuang W, 1998, EXP CELL RES, V241, P117, DOI 10.1006/excr.1998.4025; Kunneken K, 2004, J BIOL CHEM, V279, P5184, DOI 10.1074/jbc.M310424200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Martin PT, 1996, DEV BIOL, V174, P125, DOI 10.1006/dbio.1996.0057; Miner JH, 2006, DEVELOPMENT, V133, P967, DOI 10.1242/dev.02270; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Miner JH, 2000, DEV BIOL, V217, P278, DOI 10.1006/dbio.1999.9546; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713; Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7; Mould AP, 2003, J BIOL CHEM, V278, P39993, DOI 10.1074/jbc.M304627200; Nguyet NM, 2005, DEV BIOL, V282, P111, DOI 10.1016/j.ydbio.2005.02.031; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; Nishiuchi R, 2003, J BIOCHEM, V134, P497, DOI 10.1093/jb/mvg185; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; NOAKES PG, 1995, NAT GENET, V10, P400, DOI 10.1038/ng0895-400; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Sasaki T, 2002, EUR J BIOCHEM, V269, P431, DOI 10.1046/j.0014-2956.2001.02663.x; Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151; Sterk LMT, 1998, CELL ADHES COMMUN, V5, P177; SUNG U, 1993, J CELL BIOL, V123, P1255, DOI 10.1083/jcb.123.5.1255; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Timpl R, 2000, MATRIX BIOL, V19, P309, DOI 10.1016/S0945-053X(00)00072-X; Tunggal P, 2000, MICROSC RES TECHNIQ, V51, P214, DOI 10.1002/1097-0029(20001101)51:3<214::AID-JEMT2>3.0.CO;2-J; von der Mark H, 2007, J MOL BIOL, V371, P1188, DOI 10.1016/j.jmb.2007.05.074; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Zenker M, 2004, HUM MOL GENET, V13, P2625, DOI 10.1093/hmg/ddh284; ZIOBER BL, 1993, J BIOL CHEM, V268, P26773	56	58	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7820	7831		10.1074/jbc.M809332200	http://dx.doi.org/10.1074/jbc.M809332200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19147489	Green Published, hybrid			2022-12-25	WOS:000264195600044
J	Yamaoka, K; Inoue, M; Miyazaki, K; Hirama, M; Kondo, C; Kinoshita, E; Miyoshi, H; Seyama, I				Yamaoka, Kaoru; Inoue, Masayuki; Miyazaki, Keisuke; Hirama, Masahiro; Kondo, Chie; Kinoshita, Eiji; Miyoshi, Hiroshi; Seyama, Issei			Synthetic Ciguatoxins Selectively Activate Na(v)1.8-derived Chimeric Sodium Channels Expressed in HEK293 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT GANGLION NEURONS; RESISTANT NA+ CURRENT; INFLAMMATORY PAIN; NEUROPATHIC PAIN; SENSORY NEURONS; RAT-BRAIN; BREVETOXIN RECEPTOR; HYPERALGESIA; NAV1.8; CTX3C	The synthetic ciguatoxin CTX3C has been shown to activate tetrodotoxin (TTX)-sensitive sodium channels (Na(v)1.2, Na(v)1.4, and Na(v)1.5) by accelerating activation kinetics and shifting the activation curve toward hyperpolarization (Yamaoka, K., Inoue, M., Miyahara, H., Miyazaki, K., and Hirama, M. (2004) Br. J. Pharmacol. 142, 879-889). In this study, we further explored the effects of CTX3C on the TTX-resistant sodium channel Na(v)1.8. TTX-resistant channels have been shown to be involved in transducing pain and related sensations (Akopian, A.N., Sivilotti, L., and Wood, J.N. (1996) Nature 379, 257-262). Thus, we hypothesized that ciguatoxin-induced activation of the Nav1.8 current would account for the neurological symptoms of ciguatera poisoning. We found that 0.1 mu M CTX3C preferentially affected the activation process of the Nav1.8 channel compared with those of the Nav1.2 and Na(v)1.4 channels. Importantly, without stimulation, 0.1 mu M CTX3C induced a large leakage current (I-L). The conductance of the I-L calculated relative to the maximum conductance (Gmax) was 10 times larger than that of Na(v)1.2 or Na(v)1.4. To determine the molecular domain of Na(v)1.8 responsible for conferring higher sensitivity to CTX3C, we made two chimeric constructs from Na(v)1.4 and Na(v)1.8. Chimeras containing the N-terminal half of Na(v)1.8 exhibited a large response similar to wild-type Na(v)1.8, indicating that the region conferring high sensitivity to ciguatoxin action is located in the D1 or D2 domains.	[Yamaoka, Kaoru] Hiroshima Int Univ, Fac Hlth Sci, Dept Phys Therapy, Higashihiroshima 7392695, Japan; [Inoue, Masayuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Miyazaki, Keisuke; Hirama, Masahiro] Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan; [Kondo, Chie] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Kinoshita, Eiji] Hiroshima Univ, Grad Sch Biomed Sci, Div Med Chem, Dept Funct Mol Sci, Hiroshima 7348553, Japan; [Miyoshi, Hiroshi] Hiroshima Univ, Fac Med, Dept Obstet & Gynecol, Hiroshima 7348551, Japan; [Seyama, Issei] Hiroshima Jogakuin Univ, Fac Human Life Sci, Hiroshima 7320063, Japan	University of Tokyo; Tohoku University; Japan Science & Technology Agency (JST); Hiroshima University; Hiroshima University	Yamaoka, K (corresponding author), Kurose Gakuendai 555-36, Hiroshima 7392695, Japan.	k-yamao@hs.hirokoku-u.ac.jp	Kinoshita, Eiji/H-2284-2019		Solution Oriented Research for Science and Technology, Japan Science and Technology Agency [17390056]; Ministry of Education and Culture of Japan	Solution Oriented Research for Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Solution Oriented Research for Science and Technology, Japan Science and Technology Agency, and Grant 17390056 from the Ministry of Education and Culture of Japan	Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; Baker MD, 2003, J PHYSIOL-LONDON, V548, P373, DOI 10.1113/jphysiol.2003.039131; BENOIT E, 1986, TOXICON, V24, P357, DOI 10.1016/0041-0101(86)90195-9; Black JA, 2004, PAIN, V108, P237, DOI 10.1016/j.pain.2003.12.035; Cardenas LM, 2001, J NEUROPHYSIOL, V86, P241, DOI 10.1152/jn.2001.86.1.241; DUNN PM, 1991, BRAIN RES, V545, P80, DOI 10.1016/0006-8993(91)91272-3; Gold MS, 1999, P NATL ACAD SCI USA, V96, P7645, DOI 10.1073/pnas.96.14.7645; Gold MS, 2003, J NEUROSCI, V23, P158; Gold MS, 1996, P NATL ACAD SCI USA, V93, P1108, DOI 10.1073/pnas.93.3.1108; Hirama M, 2001, SCIENCE, V294, P1904, DOI 10.1126/science.1065757; Hong SS, 2004, J BIOL CHEM, V279, P29341, DOI 10.1074/jbc.M404167200; Inoue M, 2004, P NATL ACAD SCI USA, V101, P12013, DOI 10.1073/pnas.0401684101; Inoue M, 2006, J AM CHEM SOC, V128, P9352, DOI 10.1021/ja063041p; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; John VH, 2004, NEUROPHARMACOLOGY, V46, P425, DOI 10.1016/j.neuropharm.2003.09.018; Kerr BJ, 2001, NEUROREPORT, V12, P3077, DOI 10.1097/00001756-200110080-00019; Khasar SG, 1998, NEUROSCI LETT, V256, P17, DOI 10.1016/S0304-3940(98)00738-1; Lai J, 2002, PAIN, V95, P143, DOI 10.1016/S0304-3959(01)00391-8; Laird JMA, 2002, J NEUROSCI, V22, P8352; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; Okuse K, 2002, NATURE, V417, P653, DOI 10.1038/nature00781; Porreca F, 1999, P NATL ACAD SCI USA, V96, P7640, DOI 10.1073/pnas.96.14.7640; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Roza C, 2003, J PHYSIOL-LONDON, V550, P921, DOI 10.1113/jphysiol.2003.046110; Rush AM, 2007, J PHYSIOL-LONDON, V579, P1, DOI 10.1113/jphysiol.2006.121483; Strachan LC, 1999, J PHARMACOL EXP THER, V288, P379; Tanaka M, 1998, NEUROREPORT, V9, P967, DOI 10.1097/00001756-199804200-00003; ToledoAral JJ, 1997, P NATL ACAD SCI USA, V94, P1527, DOI 10.1073/pnas.94.4.1527; TRAINER VL, 1991, MOL PHARMACOL, V40, P988; TRAINER VL, 1994, J BIOL CHEM, V269, P19904; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; Yamaoka K, 2004, BRIT J PHARMACOL, V142, P879, DOI 10.1038/sj.bjp.0705852; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153; Yasumoto T, 2001, CHEM REC, V1, P228, DOI 10.1002/tcr.1010; Yoshimura N, 2001, Urology, V57, P116, DOI 10.1016/S0090-4295(01)01060-3	39	33	33	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7597	7605		10.1074/jbc.M806481200	http://dx.doi.org/10.1074/jbc.M806481200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19164297	Green Published, hybrid			2022-12-25	WOS:000264195600022
J	Fagone, P; Gunter, C; Sage, CR; Gunn, KE; Brewer, JW; Jackowski, S				Fagone, Paolo; Gunter, Christopher; Sage, Christopher R.; Gunn, Kathryn E.; Brewer, Joseph W.; Jackowski, Suzanne			CTP:Phosphocholine Cytidylyltransferase alpha Is Required for B-cell Proliferation and Class Switch Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; ENDOPLASMIC-RETICULUM STRESS; ER STRESS; PHOSPHOLIPID BIOSYNTHESIS; TARGETED DELETION; EXPRESSION; DIFFERENTIATION; GENE; XBP1	CTP:phosphocholine cytidylyltransferase (CCT) is a key rate-controlling enzyme in the biosynthetic pathway leading to the principle membrane phospholipid, phosphatidylcholine. CCT alpha is the predominant isoform expressed in mammalian cells. To investigate the role of CCT alpha in the development and function of B-lymphocytes, mice with B-lymphocytes that selectively lacked CCT alpha were derived using the CD19-driven Cre/loxP system. When challenged with a T-cell-dependent antigen, the animals harboring CCT alpha-deficient B-cells exhibited a hyper-IgM secretion phenotype coupled with a lack of IgG production. The inability of CCT alpha(-/-) B-cells to undergo class switch recombination correlated with a proliferation defect in vivo and in vitro in response to antigenic and mitogenic stimuli. Lipopolysaccharide stimulation of CCT alpha(-/-) B-cells resulted in an early trigger of the unfolded protein response-mediated splicing of Xbp-1 mRNA, and this was accompanied by accelerated kinetics of IgM secretion and higher incidence of IgM-secreting cells. Thus, the inability of stimulated B-cells to produce enough phosphatidylcholine prevents proliferation and class switch recombination but leads to unfolded protein response activation and a hyper-IgM secretion phenotype.	[Fagone, Paolo; Gunter, Christopher; Sage, Christopher R.; Jackowski, Suzanne] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Gunn, Kathryn E.] Mt St Marys Univ, Emmitsburg, MD 21727 USA; [Brewer, Joseph W.] Univ S Alabama, Coll Med, Dept Microbiol & Immunol, Mobile, AL 36688 USA	St Jude Children's Research Hospital; University of South Alabama	Jackowski, S (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	suzanne.jackowski@stjude.org	Jackowski, Suzanne/N-8168-2018	Jackowski, Suzanne/0000-0002-6855-1429; Fagone, Paolo/0000-0002-0102-3701	National Institutes of Health [GM45737, GM61970, CA23944]; Cancer Center (CORE) [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765, R25CA023944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061970, R01GM045737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center (CORE); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM45737 (to S.J.), GM61970 (to J.W.B.),CA23944 ( to C. S.), and Cancer Center (CORE) Support Grant CA21765. This work was also supported by the American Lebanese Syrian Associated Charities. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Baburina I, 1998, J BIOL CHEM, V273, P2169, DOI 10.1074/jbc.273.4.2169; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; BOGGS KP, 1995, J BIOL CHEM, V270, P11612, DOI 10.1074/jbc.270.19.11612; Brewer JW, 2005, NAT IMMUNOL, V6, P23, DOI 10.1038/ni1149; Brewer JW, 1999, P NATL ACAD SCI USA, V96, P8505, DOI 10.1073/pnas.96.15.8505; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Clement JM, 1999, BIOCHEM BIOPH RES CO, V257, P643, DOI 10.1006/bbrc.1999.0512; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; ESKO JD, 1981, J BIOL CHEM, V256, P7388; Fagone P, 2007, J BIOL CHEM, V282, P7591, DOI 10.1074/jbc.M608175200; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Gass JN, 2008, MOL IMMUNOL, V45, P1035, DOI 10.1016/j.molimm.2007.07.029; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; Gunter C, 2007, BBA-MOL CELL BIOL L, V1771, P845, DOI 10.1016/j.bbalip.2007.04.015; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; Jackowski S, 1996, J BIOL CHEM, V271, P20219, DOI 10.1074/jbc.271.34.20219; Jackowski S, 2005, J BIOL CHEM, V280, P853, DOI 10.1074/jbc.R400031200; Jackowski S, 2004, MOL CELL BIOL, V24, P4720, DOI 10.1128/MCB.24.11.4720-4733.2004; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Karim M, 2003, BBA-MOL CELL BIOL L, V1633, P1, DOI 10.1016/S1388-1981(03)00067-2; KRUISBEEK AM, 2008, CURRENT PROTOCOLS IM; Little JL, 2007, CANCER RES, V67, P1262, DOI 10.1158/0008-5472.CAN-06-1794; Lykidis A, 2001, PROG NUCLEIC ACID RE, V65, P361; Lykidis A, 1998, J BIOL CHEM, V273, P14022, DOI 10.1074/jbc.273.22.14022; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; Tian Y, 2008, J CELL BIOL, V181, P945, DOI 10.1083/jcb.200706152; Tian Y, 2007, MOL CELL BIOL, V27, P975, DOI 10.1128/MCB.01512-06; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; Van der Sanden MHM, 2003, BIOCHEM J, V369, P643, DOI 10.1042/BJ20020285; Waite KA, 2000, J BIOL CHEM, V275, P21197, DOI 10.1074/jbc.M003539200; Wang LM, 2005, MOL CELL BIOL, V25, P3357, DOI 10.1128/MCB.25.8.3357-3363.2005; WIEST DL, 1990, J CELL BIOL, V110, P1501, DOI 10.1083/jcb.110.5.1501; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang DJ, 2000, J BIOL CHEM, V275, P35368, DOI 10.1074/jbc.M007099200	40	15	15	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6847	6854		10.1074/jbc.M807338200	http://dx.doi.org/10.1074/jbc.M807338200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19139091	Green Published, hybrid			2022-12-25	WOS:000263919000031
J	Appleby, JH; Zhou, KS; Volkmann, G; Liu, XQ				Appleby, Julia H.; Zhou, Kaisong; Volkmann, Gerrit; Liu, Xiang-Qin			Novel Split Intein for trans-Splicing Synthetic Peptide onto C Terminus of Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL MINI-INTEINS; CRYSTAL-STRUCTURE; TRICHODESMIUM-ERYTHRAEUM; HOMING ENDONUCLEASE; DNAB INTEIN; PCC6803; GENE; CYCLIZATION; DEFINITION; EVOLUTION	Conventional split inteins have been useful for trans-splicing between recombinant proteins, and an artificial S1 split intein is useful for adding synthetic peptide onto the N terminus of recombinant proteins. Here we have engineered a novel S11 split intein for trans-splicing synthetic peptide onto the C terminus of recombinant proteins. The C-intein of the S11 split intein is extremely small (6 amino acids (aa)); thus it can easily be produced together with a synthetic C-extein to be added to the C terminus of target proteins. The S11 intein was derived from the Ssp GyrB intein after deleting the homing endonuclease domain and splitting the remaining intein sequence near the C terminus, producing a 150-aa N-intein (I-N) and a 6-aa C-intein (I-C). Its trans-splicing activity was demonstrated first in Escherichia coli cells and then in vitro for trans-splicing between a synthetic peptide and a recombinant protein. The in vitro trans-splicing reaction exhibited a typical rate constant of (6.9 +/- 2.2) x 10(-5) s(-1) and reached a high efficiency of similar to 80%. This S-1 split intein can be useful for adding any desirable chemical groups to the C terminus of a protein of interest, which may include modified and unnatural amino acids, biotin and fluorescent labels, and even drug molecules.	[Appleby, Julia H.; Zhou, Kaisong; Volkmann, Gerrit; Liu, Xiang-Qin] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada	Dalhousie University	Liu, XQ (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada.	Paul.Liu@Dal.Ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a research grant from the Canadian Institutes of Health Research.	Brenzel S, 2006, BIOCHEMISTRY-US, V45, P1571, DOI 10.1021/bi051697+; Caspi J, 2003, MOL MICROBIOL, V50, P1569, DOI 10.1046/j.1365-2958.2003.03825.x; Dalgaard JZ, 1997, J COMPUT BIOL, V4, P193, DOI 10.1089/cmb.1997.4.193; Derbyshire V, 1997, P NATL ACAD SCI USA, V94, P11466, DOI 10.1073/pnas.94.21.11466; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Duan XQ, 1997, CELL, V89, P555, DOI 10.1016/S0092-8674(00)80237-8; Evans TC, 2000, J BIOL CHEM, V275, P9091, DOI 10.1074/jbc.275.13.9091; Ichiyanagi K, 2000, J MOL BIOL, V300, P889, DOI 10.1006/jmbi.2000.3873; Klabunde T, 1998, NAT STRUCT BIOL, V5, P31, DOI 10.1038/nsb0198-31; Liu XQ, 2004, FEBS LETT, V572, P46, DOI 10.1016/j.febslet.2004.07.016; Liu XQ, 2003, J BIOL CHEM, V278, P46826, DOI 10.1074/jbc.M309575200; Liu XQ, 2003, J BIOL CHEM, V278, P26315, DOI 10.1074/jbc.C300202200; Liu XQ, 2000, ANNU REV GENET, V34, P61, DOI 10.1146/annurev.genet.34.1.61; Ludwig C, 2006, ANGEW CHEM INT EDIT, V45, P5218, DOI 10.1002/anie.200600570; Martin DD, 2001, BIOCHEMISTRY-US, V40, P1393, DOI 10.1021/bi001786g; Mills KV, 1998, P NATL ACAD SCI USA, V95, P3543, DOI 10.1073/pnas.95.7.3543; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; PERLER FB, 1994, NUCLEIC ACIDS RES, V22, P1125, DOI 10.1093/nar/22.7.1125; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Pietrokovski S, 1998, PROTEIN SCI, V7, P64, DOI 10.1002/pro.5560070106; Saleh L, 2006, CHEM REC, V6, P183, DOI 10.1002/tcr.20082; Southworth MW, 1998, EMBO J, V17, P918, DOI 10.1093/emboj/17.4.918; Sun WC, 2004, J BIOL CHEM, V279, P35281, DOI 10.1074/jbc.M405491200; Telenti A, 1997, J BACTERIOL, V179, P6378, DOI 10.1128/jb.179.20.6378-6382.1997; Wu H, 1998, BBA-PROTEIN STRUCT M, V1387, P422, DOI 10.1016/S0167-4838(98)00157-5; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; Xu MQ, 1996, EMBO J, V15, P5146, DOI 10.1002/j.1460-2075.1996.tb00898.x; Yang J, 2004, MOL MICROBIOL, V51, P1185, DOI 10.1046/j.1365-2958.2003.03902.x	28	42	47	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6194	6199		10.1074/jbc.M805474200	http://dx.doi.org/10.1074/jbc.M805474200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19136555	hybrid			2022-12-25	WOS:000263742700022
J	Yang, XY; Guan, M; Vigil, D; Der, CJ; Lowy, DR; Popescu, NC				Yang, X-Y; Guan, M.; Vigil, D.; Der, C. J.; Lowy, D. R.; Popescu, N. C.			p120Ras-GAP binds the DLC1 Rho-GAP tumor suppressor protein and inhibits its RhoA GTPase and growth-suppressing activities	ONCOGENE			English	Article						deleted in liver cancer; Ras-GAP; protein interaction; modulation of tumor cell proliferation; Rho-GAP; SH3	ACTIVATING PROTEIN; CELL-PROLIFERATION; GENE-EXPRESSION; RAS; CANCER; SH3; DOMAIN; CLONING; TUMORIGENICITY; TRANSFORMATION	DLC1 (deleted in liver cancer 1), which encodes a Rho GTPase-activating protein (Rho-GAP), is a potent tumor suppressor gene that is frequently inactivated in several human cancers. DLC1 is a multidomain protein that has been shown previously to bind members of the tensin gene family. Here we show that p120Ras-GAP (Ras-GAP; also known as RASA1) interacts and extensively colocalizes with DLC1 in focal adhesions. The binding was mapped to the SH3 domain located in the N terminus of Ras-GAP and to the Rho-GAP catalytic domain located in the C terminus of the DLC1. In vitro analyses with purified proteins determined that the isolated Ras-GAP SH3 domain inhibits DLC1 Rho-GAP activity, suggesting that Ras-GAP is a negative regulator of DLC1 Rho-GAP activity. Consistent with this possibility, we found that ectopic overexpression of Ras-GAP in a Ras-GAP-insensitive tumor line impaired the growth-suppressing activity of DLC1 and increased RhoA activity in vivo. Our observations expand the complexity of proteins that regulate DLC1 function and define a novel mechanism of the cross talk between Ras and Rho GTPases.	[Yang, X-Y; Guan, M.; Popescu, N. C.] NCI, Expt Carcinogenesis Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Vigil, D.; Der, C. J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Lowy, D. R.] NCI, Cellular Oncol Lab, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Popescu, NC (corresponding author), NCI, Expt Carcinogenesis Lab, Ctr Canc Res, Bldg 37,Room 4128,37 Convent Dr,MSC4262, Bethesda, MD 20892 USA.	popescun@mail.nih.gov	yang, xuyu/D-1414-2012	Der, Channing/0000-0002-7751-2747	NIH [1R01CA129610]; American Cancer Society; NATIONAL CANCER INSTITUTE [ZIABC010038, ZIABC008905, R01CA129610] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Intramural Research Program of the National Cancer Institute, Center for Cancer Research, NIH supported this work. CJD is also supported by an NIH grant (1R01CA129610), and DV was supported by a fellowship from the American Cancer Society.	Abdellatif M, 1998, MOL CELL BIOL, V18, P6729, DOI 10.1128/MCB.18.11.6729; Baselga J, 2008, J CLIN ONCOL, V26, P1582, DOI 10.1200/JCO.2007.15.3700; Bradley WD, 2006, MOL BIOL CELL, V17, P4827, DOI 10.1091/mbc.E06-02-0132; Bradshaw JM, 2003, ADV PROTEIN CHEM, V61, P161; Brouns MR, 2000, DEVELOPMENT, V127, P4891; BRYANT SS, 1995, J BIOL CHEM, V270, P17947, DOI 10.1074/jbc.270.30.17947; Clark GJ, 1997, J BIOL CHEM, V272, P1677, DOI 10.1074/jbc.272.3.1677; Durkin ME, 2007, ONCOGENE, V26, P4580, DOI 10.1038/sj.onc.1210244; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Durkin ME, 2005, FEBS LETT, V579, P1191, DOI 10.1016/j.febslet.2004.12.090; Ferraro E, 2007, NUCLEIC ACIDS RES, V35, pW451, DOI 10.1093/nar/gkm296; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Gigoux V, 2002, J BIOL CHEM, V277, P23742, DOI 10.1074/jbc.C200121200; Guan M, 2008, CANCER GENE THER, V15, P371, DOI 10.1038/cgt.2008.13; Healy KD, 2008, MOL CARCINOGEN, V47, P326, DOI 10.1002/mc.20389; Hu KQ, 1997, EMBO J, V16, P473, DOI 10.1093/emboj/16.3.473; Jin YL, 2008, ONCOL REP, V19, P669; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kawai K, 2007, BIOCHEM BIOPH RES CO, V364, P783, DOI 10.1016/j.bbrc.2007.10.052; Kennedy D, 2002, J CELL BIOCHEM, V84, P173, DOI 10.1002/jcb.1277; Kim TY, 2008, J BIOL CHEM, V283, P32762, DOI 10.1074/jbc.M800617200; Kim TY, 2007, BIOCHEM BIOPH RES CO, V355, P72, DOI 10.1016/j.bbrc.2007.01.121; Leblanc V, 1999, ONCOGENE, V18, P4884, DOI 10.1038/sj.onc.1202855; Leblanc V, 1998, MOL CELL BIOL, V18, P5567, DOI 10.1128/MCB.18.9.5567; Leung THY, 2005, P NATL ACAD SCI USA, V102, P15207, DOI 10.1073/pnas.0504501102; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Liao YC, 2008, CANCER RES, V68, P7718, DOI 10.1158/0008-5472.CAN-08-2042; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; MAYER BJ, 1995, CURR BIOL, V5, P364, DOI 10.1016/S0960-9822(95)00073-X; Musacchio A, 2003, ADV PROTEIN CHEM, V61, P211; Pamonsinlapatham P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002902; Qian XL, 2007, P NATL ACAD SCI USA, V104, P9012, DOI 10.1073/pnas.0703033104; Ross B, 2007, BIOCHEM BIOPH RES CO, V353, P463, DOI 10.1016/j.bbrc.2006.12.044; Shang X, 2007, J BIOL CHEM, V282, P8801, DOI 10.1074/jbc.M609375200; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Shutes A, 2005, METHODS, V37, P183, DOI 10.1016/j.ymeth.2005.05.019; Tocque B, 1997, CELL SIGNAL, V9, P153, DOI 10.1016/S0898-6568(96)00135-0; TRAHEY M, 1988, SCIENCE, V242, P1697, DOI 10.1126/science.3201259; Ullmannova V, 2006, INT J ONCOL, V29, P1127; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; Wong CM, 2005, CANCER RES, V65, P8861, DOI 10.1158/0008-5472.CAN-05-1318; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Yam JWP, 2006, CANCER RES, V66, P8367, DOI 10.1158/0008-5472.CAN-05-2850; Yuan BZ, 1998, CANCER RES, V58, P2196; Yue YZ, 2004, J BIOL CHEM, V279, P12883, DOI 10.1074/jbc.M312308200; Zhou X, 2008, INT J ONCOL, V32, P1285; Zhou XL, 2004, ONCOGENE, V23, P1308, DOI 10.1038/sj.onc.1207246	48	44	47	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	11					1401	1409		10.1038/onc.2008.498	http://dx.doi.org/10.1038/onc.2008.498			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	421JE	19151751	Green Submitted, Green Accepted			2022-12-25	WOS:000264354400001
J	Li, SY; Ouellet, H; Sherman, DH; Podust, LM				Li, Shengying; Ouellet, Hugues; Sherman, David H.; Podust, Larissa M.			Analysis of Transient and Catalytic Desosamine-binding Pockets in Cytochrome P-450 PikC from Streptomyces venezuelae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMBINATORIAL BIOSYNTHESIS; STRUCTURAL BASIS; CONSTRUCTION; ANTIBIOTICS; TELITHROMYCIN; HYDROXYLATION; SPECIFICITY; MACROLIDES; HYBRID; SYSTEM	The cytochrome P-450 PikC from Streptomyces venezuelae exhibits significant substrate tolerance and performs multiple hydroxylation reactions on structurally variant macrolides bearing the deoxyamino sugar desosamine. In previously determined co-crystal structures (Sherman, D. H., Li,S., Yermalitskaya, L.V., Kim, Y., Smith, J.A., Waterman, M.R., and Podust, L. M. (2006) J. Biol. Chem. 281, 26289-26297), the desosamine moiety of the native substrates YC-17 and narbomycin is bound in two distinct buried and surface-exposed binding pockets, mediated by specific interactions between the protonated dimethylamino group and the acidic amino acid residues Asp(50), Glu(85), and Glu(94). Although the Glu(85) and Glu(94) negative charges are essential for maximal catalytic activity of native enzyme, elimination of the surface-exposed negative charge at Asp(50) results in significantly enhanced catalytic activity. Nevertheless, the D50N substitution could not rescue catalytic activity of PikC(E94Q) based on lack of activity in the corresponding double mutant PikC(D50N/E94Q). To address the specific role for each desosamine-binding pocket, we analyzed the x-ray structures of the PikC(D50N) mutant co-crystallized with narbomycin (1.85 angstrom resolution) and YC-17 (3.2 angstrom resolution). In PikC(D50N), the desosamine moiety of both YC-17 and narbomycin was bound in a catalytically productive "buried site." This finding suggested a two-step substrate binding mechanism, whereby desosamine is recognized in the two subsites to allow the macrolide substrate to sequentially progress toward a catalytically favorable orientation. Collectively, the binding, mutagenesis, kinetic, and x-ray structural data suggest that enhancement of the catalytic activity of PikC(D50N) is due to the facilitated relocation of substrate to the buried site, which has higher binding affinity, as opposed to dissociation in solution from the transient "surface-exposed site."	[Ouellet, Hugues; Podust, Larissa M.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Li, Shengying; Sherman, David H.] Univ Michigan, Dept Med Chem, Inst Life Sci, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Chem, Inst Life Sci, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Microbiol & Immunol, Inst Life Sci, Ann Arbor, MI 48109 USA	University of California System; University of California San Francisco; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Podust, LM (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, 600 16th St, San Francisco, CA USA.	larissa.podust@ucsf.edu	Podust, Larissa/ABB-7940-2020	Podust, Larissa/0000-0002-8537-8760	National Institutes of Health [GM078553]; United States Dept. of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078553] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Dept. of Energy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078553. This work was also supported by United States Dept. of Energy Contract DE-AC02-05CH11231.	Ackermann G, 2003, J ANTIMICROB CHEMOTH, V51, P497, DOI 10.1093/jac/dkg123; ANDERSEN JF, 1993, BIOCHEMISTRY-US, V32, P1905, DOI 10.1021/bi00059a004; Anzai Y, 2008, CHEM BIOL, V15, P950, DOI 10.1016/j.chembiol.2008.07.014; Auerbach T, 2004, TRENDS BIOTECHNOL, V22, P570, DOI 10.1016/j.tibtech.2004.09.006; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blasi F, 2006, FUTURE MICROBIOL, V1, P7, DOI 10.2217/17460913.1.1.7; Borisova SA, 1999, ORG LETT, V1, P133, DOI 10.1021/ol9906007; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hansen JL, 2002, MOL CELL, V10, P117, DOI 10.1016/S1097-2765(02)00570-1; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hutchinson CR, 1998, CURR OPIN MICROBIOL, V1, P319, DOI 10.1016/S1369-5274(98)80036-2; Jenni S, 2003, CURR OPIN STRUC BIOL, V13, P212, DOI 10.1016/S0959-440X(03)00034-4; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Khosla C, 1999, ANNU REV BIOCHEM, V68, P219, DOI 10.1146/annurev.biochem.68.1.219; LAMBALOT RH, 1995, BIOCHEMISTRY-US, V34, P1858, DOI 10.1021/bi00006a006; Li SY, 2007, J AM CHEM SOC, V129, P12940, DOI 10.1021/ja075842d; Ma Zhenkun, 2002, Current Medicinal Chemistry - Anti-Infective Agents, V1, P15, DOI 10.2174/1568012023355027; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nodate M, 2006, APPL MICROBIOL BIOT, V71, P455, DOI 10.1007/s00253-005-0147-y; Ogura H, 2004, BIOCHEMISTRY-US, V43, P14712, DOI 10.1021/bi048980d; OMURA T, 1964, J BIOL CHEM, V239, P2379; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Podust LM, 2004, PROTEIN SCI, V13, P255, DOI 10.1110/ps.03384804; Rix U, 2002, NAT PROD REP, V19, P542, DOI 10.1039/b103920m; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Sherman DH, 2006, J BIOL CHEM, V281, P26289, DOI 10.1074/jbc.M605478200; Sherman DH, 2005, NAT BIOTECHNOL, V23, P1083, DOI 10.1038/nbt0905-1083; Srinivasan A, 2004, BIOTECHNOL BIOENG, V88, P528, DOI 10.1002/bit.20285; Tang L, 2001, CHEM BIOL, V8, P547, DOI 10.1016/S1074-5521(01)00032-1; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Walsh CT, 2002, CHEMBIOCHEM, V3, P125; Xue YQ, 1998, CHEM BIOL, V5, P661, DOI 10.1016/S1074-5521(98)90293-9; Yoon YJ, 2002, CHEM BIOL, V9, P203, DOI 10.1016/S1074-5521(02)00095-9; Zhao LS, 1999, J AM CHEM SOC, V121, P9881, DOI 10.1021/ja992810k; Zhao LS, 1998, J AM CHEM SOC, V120, P10256, DOI 10.1021/ja981782n; Zhao LS, 1998, J AM CHEM SOC, V120, P12159, DOI 10.1021/ja982942y	38	40	41	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5723	5730		10.1074/jbc.M807592200	http://dx.doi.org/10.1074/jbc.M807592200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19124459	Green Published, hybrid			2022-12-25	WOS:000263560600036
J	Oslakovic, C; Krisinger, MJ; Andersson, A; Jauhiainen, M; Ehnholm, C; Dahlback, B				Oslakovic, Cecilia; Krisinger, Michael J.; Andersson, Astra; Jauhiainen, Matti; Ehnholm, Christian; Dahlback, Bjorn			Anionic Phospholipids Lose Their Procoagulant Properties When Incorporated into High Density Lipoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; ACTIVATED PROTEIN-C; CLOTTING FACTOR-X; PROTHROMBINASE COMPLEX; BLOOD-COAGULATION; FACTOR-VIII; MEMBRANE-BINDING; FACTOR-VA; PLASMA; ANTICOAGULANT	Blood coagulation involves a series of enzymatic protein complexes that assemble on the surface of anionic phospholipid. To investigate whether apolipoproteins affect coagulation reactions, they were included during the preparation of anionic phospholipid vesicles using a detergent solubilization-dialysis method. Apolipoprotein components of high density lipoproteins, especially apolipoprotein A-I, had a pronounced anticoagulant effect. The anionic phospholipids lost their procoagulant effect when the vesicle preparation method was performed in the presence of apolipoprotein A-I. The anionic phospholipid-apolipoprotein A-I particles were 8-10 nm in diameter and contained around 60-80 phospholipid molecules, depending on the phospholipid composition. The phospholipids of these particles were unable to support the activation of prothrombin by factor Xa in the presence of factor Va and unable to support binding of factor Va, whereas binding of prothrombin and factor Xa were efficient. Phospholipid transfer protein was shown to mediate transfer of phospholipids from liposomes to apolipoprotein A-I-containing reconstituted high density lipoprotein. In addition, serum was also shown to neutralize the procoagulant effect of anionic liposomes and to efficiently mediate transfer of phospholipids from liposomes to either apolipoprotein A-I-or apolipoprotein B-containing particles. In conclusion, apolipoprotein A-I was found to neutralize the procoagulant properties of anionic phospholipids by arranging the phospholipids in surface areas that are too small to accommodate the prothrombinase complex. This anionic phospholipid scavenger function may be an important mechanism to control the exposure of such phospholipids to circulating blood and thereby prevent inappropriate stimulation of blood coagulation.	[Oslakovic, Cecilia; Krisinger, Michael J.; Andersson, Astra; Dahlback, Bjorn] Lund Univ, Malmo Univ Hosp, Div Clin Chem, Dept Lab Med, SE-20502 Malmo, Sweden; [Jauhiainen, Matti; Ehnholm, Christian] Natl Publ Hlth Inst, FIN-00251 Helsinki, Finland; [Jauhiainen, Matti; Ehnholm, Christian] Finnish Inst Mol Med, FIN-00251 Helsinki, Finland	Lund University; Skane University Hospital; Finland National Institute for Health & Welfare	Dahlback, B (corresponding author), Lund Univ, Malmo Univ Hosp, Wallenberg Lab, Div Clin Chem,Dept Lab Med, Entrance 46,Floor 6, S-20502 Malmo, Sweden.	bjorn.dahlback@med.lu.se		Dahlback, Bjorn/0000-0003-1546-0328	Swedish Research Council [71430]; Swedish Heart-Lung Foundation; Soderberg Foundation; Pahlsson Foundation; Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research; University Hospital in Malmo	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Soderberg Foundation; Pahlsson Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research; University Hospital in Malmo	This work was supported by Swedish Research Council Grant 71430; grants from the Swedish Heart-Lung Foundation, the Soderberg Foundation, the Pahlsson Foundation, the Sigrid Juselius Foundation, and the Finnish Foundation for Cardiovascular Research; and research funds from the University Hospital in Malmo. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams TE, 2004, P NATL ACAD SCI USA, V101, P8918, DOI 10.1073/pnas.0403072101; Alder-Baerens N, 2005, J BIOL CHEM, V280, P26321, DOI 10.1074/jbc.M413993200; ARAI M, 1989, P NATL ACAD SCI USA, V86, P4277, DOI 10.1073/pnas.86.11.4277; Autin L, 2006, PROTEINS, V63, P440, DOI 10.1002/prot.20848; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Butenas S, 2002, BIOCHEMISTRY-MOSCOW+, V67, P3; Curtiss LK, 2006, ARTERIOSCL THROM VAS, V26, P12, DOI 10.1161/01.ATV.0000194291.94269.5a; Dahlback B, 2005, J INTERN MED, V257, P209, DOI 10.1111/j.1365-2796.2004.01444.x; DAHLBACK B, 1980, J CLIN INVEST, V66, P583, DOI 10.1172/JCI109890; DAHLBACK B, 1980, EUR J BIOCHEM, V104, P549, DOI 10.1111/j.1432-1033.1980.tb04458.x; Deguchi H, 2005, CIRCULATION, V112, P893, DOI 10.1161/CIRCULATIONAHA.104.521344; DELLANGELICA EC, 2000, CURRRENT PROTOCOLS C; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; Florentin M, 2008, CURR OPIN CARDIOL, V23, P370, DOI 10.1097/HCO.0b013e3283043806; GALLAGHER SR, 2007, CURRENT PROTOCOLS CE; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; GORDON JI, 1983, J BIOL CHEM, V258, P4037; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Griffin JH, 1999, J CLIN INVEST, V103, P219, DOI 10.1172/JCI5006; GRIMSLEY GR, 2003, CURRENT PROTOCOLS PR; Hansson K, 2005, J THROMB HAEMOST, V3, P2633, DOI 10.1111/j.1538-7836.2005.01478.x; JONAS A, 1986, METHOD ENZYMOL, V128, P553; Kjalke M, 2000, ARTERIOSCL THROM VAS, V20, P1835, DOI 10.1161/01.ATV.20.7.1835; Klein A, 2006, ARTERIOSCL THROM VAS, V26, P2160, DOI 10.1161/01.ATV.0000235699.98024.11; KRISHNASWAMY S, 1993, METHOD ENZYMOL, V222, P260; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P3823; Lynch SF, 2007, BRIT J HAEMATOL, V137, P36, DOI 10.1111/j.1365-2141.2007.06514.x; Majumder R, 2008, BLOOD, V112, P2795, DOI 10.1182/blood-2008-02-138941; McDonald JF, 1997, BIOCHEMISTRY-US, V36, P5120, DOI 10.1021/bi9626160; Moyer MP, 1998, ARTERIOSCL THROM VAS, V18, P458, DOI 10.1161/01.ATV.18.3.458; NELSESTUEN GL, 1977, BIOCHEMISTRY-US, V16, P4164, DOI 10.1021/bi00638a005; NELSESTUEN GL, 1977, BIOCHEMISTRY-US, V16, P4172, DOI 10.1021/bi00638a006; ORTEL TL, 1994, J BIOL CHEM, V269, P15898; Ortel TL, 1998, BLOOD, V91, P4188, DOI 10.1182/blood.V91.11.4188.411k33_4188_4196; ROSING J, 1993, J BIOL CHEM, V268, P21130; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; Saenko EL, 1999, TRENDS CARDIOVAS MED, V9, P185, DOI 10.1016/S1050-1738(00)00019-0; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; Shaw AW, 2007, J BIOL CHEM, V282, P6556, DOI 10.1074/jbc.M607973200; Silva RAGD, 2008, P NATL ACAD SCI USA, V105, P12176, DOI 10.1073/pnas.0803626105; STENFLO J, 1974, P NATL ACAD SCI USA, V71, P2730, DOI 10.1073/pnas.71.7.2730; Stone MD, 2005, BIOCHEMISTRY-US, V44, P4037, DOI 10.1021/bi047655n; TAIT JF, 1992, ARCH BIOCHEM BIOPHYS, V298, P187, DOI 10.1016/0003-9861(92)90111-9; TANS G, 1991, BLOOD, V77, P2641; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Vikstedt R, 2007, BIOCHEMISTRY-US, V46, P11979, DOI 10.1021/bi700833h; WILSCHUT J, 1985, BIOCHEMISTRY-US, V24, P8, DOI 10.1021/bi00322a002; YOKOYAMA WM, 2006, CURRENT PROTOCOLS IM	49	47	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5896	5904		10.1074/jbc.M807286200	http://dx.doi.org/10.1074/jbc.M807286200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19129179	hybrid, Green Submitted			2022-12-25	WOS:000263560600053
J	Lin, L; Amin, R; Gallicano, GI; Glasgow, E; Jogunoori, W; Jessup, JM; Zasloff, M; Marshall, JL; Shetty, K; Johnson, L; Mishra, L; He, AR				Lin, L.; Amin, R.; Gallicano, G. I.; Glasgow, E.; Jogunoori, W.; Jessup, J. M.; Zasloff, M.; Marshall, J. L.; Shetty, K.; Johnson, L.; Mishra, L.; He, A. R.			The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling	ONCOGENE			English	Article						IL6; stem cell; TGF-beta; STAT3; beta 2SP; hepatocellular carcinoma	LIVER STEM-CELLS; SERINE PHOSPHORYLATION; STEM/PROGENITOR CELLS; GENE-EXPRESSION; CARCINOMA CELLS; MICE; ACTIVATION; PATHWAY; CHEMORESISTANCE; CD133(+)	Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide, with few effective therapeutic options for advanced disease. At least 40% of HCCs are clonal, potentially arising from STAT3+, NANOG+ and OCT3/4+ liver progenitor/stem cell transformation, along with inactivation of transforming growth factor-beta (TGF-beta) signaling. Here we report significantly greater signal transducer and activator of transcription 3 (STAT3) and tyrosine phosphorylated STAT3 in human HCC tissues (P<0.0030 and P<0.0455, respectively) than in human normal liver. Further, in HCC cells with loss of response to TGF-b, NSC 74859, a STAT3-specific inhibitor, markedly suppresses growth. In contrast, CD133(+) status did not affect the response to STAT3 inhibition: both CD133(+) Huh-7 cells and CD133(-) Huh-7 cells are equally sensitive to NSC 74859 treatment and STAT3 inhibition, with an IC50 of 100 mu M. Thus, the TGF-beta/beta2 spectrin (beta 2SP) pathway may reflect a more functional 'stem/progenitor' state than CD133. Furthermore, NSC 74859 treatment of Huh-7 xenografts in nude mice significantly retarded tumor growth, with an effective dose of only 5 mg/kg. Moreover, NSC 74859 inhibited tyrosine phosphorylation of STAT3 in HCC cells in vivo. We conclude that inhibiting interleukin 6 (IL6)/STAT3 in HCCs with inactivation of the TGF-beta/beta 2SP pathway is an effective approach in management of HCCs. Thus, IL6/STAT3, a major signaling pathway in HCC stem cell renewal and proliferation, can provide a novel approach to the treatment of specific HCCs.	[Lin, L.; Glasgow, E.; Marshall, J. L.; He, A. R.] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Med & Oncol, Washington, DC 20007 USA; [Lin, L.; Amin, R.; Glasgow, E.; Jogunoori, W.; Zasloff, M.; Shetty, K.; Johnson, L.; Mishra, L.; He, A. R.] Georgetown Univ, Dept Surg, Washington, DC 20007 USA; [Gallicano, G. I.] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC 20007 USA; [Jessup, J. M.] NCI, Canc Diag Program, Rockville, MD USA; [Shetty, K.; Johnson, L.] Georgetown Univ, Inst Transplant Surg, Dept Surg, Washington, DC USA; [Mishra, L.] Dept Vet Affairs Med Ctr, Washington, DC USA	Georgetown University; Georgetown University; Georgetown University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Georgetown University	He, AR (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Med & Oncol, 3800 Reservoir Rd NW, Washington, DC 20007 USA.	lm229@georgetown.edu; aiwu.r.he@gunet.georgetown.edu		Mishra, Lopa/0000-0002-6850-0808; Glasgow, Eric/0000-0001-7729-3954	NCI NIH HHS [P01 CA130821, R01 CA042857, R01 CA106614A, R01 CA4285718A, P30 CA51008-13, P30 CA051008, R01 CA106614-01A2, R01 CA106614, R01 CA042857-18A1] Funding Source: Medline; NIDDK NIH HHS [R01 DK056111-01, R01 DK56111, R01 DK056111] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA051008, ZIABC011199, R01CA042857, R01CA106614, P01CA130821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056111] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Alison MR, 2005, STEM CELL REV, V1, P253, DOI 10.1385/SCR:1:3:253; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Cabibbo A, 1998, ONCOGENE, V16, P2935, DOI 10.1038/sj.onc.1201825; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; Dando JS, 2005, STEM CELLS, V23, P550, DOI 10.1634/stemcells.2004-0205; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Hambardzumyan D, 2006, CANCER CELL, V10, P454, DOI 10.1016/j.ccr.2006.11.008; Im YH, 2001, CANCER RES, V61, P6665; Kanzler S, 2001, ONCOGENE, V20, P5015, DOI 10.1038/sj.onc.1204544; KEW MC, 1971, BMJ-BRIT MED J, V4, P408, DOI 10.1136/bmj.4.5784.408; Kitisin K, 2007, ONCOGENE, V26, P7103, DOI 10.1038/sj.onc.1210513; Kojima H, 2005, P NATL ACAD SCI USA, V102, P4524, DOI 10.1073/pnas.0500679102; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; LaBarge MA, 2008, J CLIN INVEST, V118, P2021, DOI 10.1172/JCI36046; Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055; Lim CP, 2001, J BIOL CHEM, V276, P21004, DOI 10.1074/jbc.M007592200; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Manghisi G, 1998, HEPATOLOGY, V28, P751; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Nguyen LN, 2007, HEPATOLOGY, V45, P31, DOI 10.1002/hep.21466; Ohkawara B, 2004, GENE DEV, V18, P381, DOI 10.1101/gad.1166904; Roskams T, 2006, ONCOGENE, V25, P3818, DOI 10.1038/sj.onc.1209558; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Sicklick JK, 2006, AM J PHYSIOL-GASTR L, V290, pG859, DOI 10.1152/ajpgi.00456.2005; Sicklick JK, 2006, CARCINOGENESIS, V27, P748, DOI 10.1093/carcin/bgi292; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; Tang BW, 1998, NAT MED, V4, P802, DOI 10.1038/nm0798-802; Tang Y, 2003, SCIENCE, V299, P574, DOI 10.1126/science.1075994; Tang Y, 2008, P NATL ACAD SCI USA, V105, P2445, DOI 10.1073/pnas.0705395105; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; VISTICA DT, 1991, CANCER RES, V51, P2515; Wallner L, 2006, CANCER RES, V66, P3087, DOI 10.1158/0008-5472.CAN-05-3447; Weinstein M, 2000, CYTOKINE GROWTH F R, V11, P49, DOI 10.1016/S1359-6101(99)00028-3; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Yang SF, 2007, J CLIN PATHOL, V60, P642, DOI 10.1136/jcp.2006.036970; Yeoh GCT, 2007, HEPATOLOGY, V45, P486, DOI 10.1002/hep.21535; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	45	174	195	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 19	2009	28	7					961	972		10.1038/onc.2008.448	http://dx.doi.org/10.1038/onc.2008.448			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	408TH	19137011	Green Accepted			2022-12-25	WOS:000263457400003
J	Kwon, HJ; Koo, JH; Zufall, F; Leinders-Zufall, T; Margolis, FL				Kwon, Hyun J.; Koo, Jae Hyung; Zufall, Frank; Leinders-Zufall, Trese; Margolis, Frank L.			Ca2+ Extrusion by NCX Is Compromised in Olfactory Sensory Neurons of OMP-/- Mice	PLOS ONE			English	Article							NUCLEOTIDE-ACTIVATED CHANNELS; VECTOR-MEDIATED RESCUE; GENE DELETION CAUSES; MARKER PROTEIN; RECEPTOR NEURONS; SODIUM/CALCIUM EXCHANGER; GATED CHANNELS; CYTOCHEMICAL-LOCALIZATION; NA+/CA2+ EXCHANGER; CALCIUM-ENTRY	Background: The role of olfactory marker protein (OMP), a hallmark of mature olfactory sensory neurons (OSNs), has been poorly understood since its discovery. The electrophysiological and behavioral phenotypes of OMP knockout mice indicated that OMP influences olfactory signal transduction. However, the mechanism by which this occurs remained unknown. Principal Findings: We used intact olfactory epithelium obtained from WT and OMP-/- mice to monitor the Ca2+ dynamics induced by the activation of cyclic nucleotide-gated channels, voltage-operated Ca2+ channels, or Ca2+ stores in single dendritic knobs of OSNs. Our data suggested that OMP could act to modulate the Ca2+-homeostasis in these neurons by influencing the activity of the plasma membrane Na+/Ca2+-exchanger (NCX). Immunohistochemistry verifies colocalization of NCX1 and OMP in the cilia and knobs of OSNs. To test the role of NCX activity, we compared the kinetics of Ca2+ elevation by stimulating the reverse mode of NCX in both WT and OMP-/- mice. The resulting Ca2+ responses indicate that OMP facilitates NCX activity and allows rapid Ca2+ extrusion from OSN knobs. To address the mechanism by which OMP influences NCX activity in OSNs we studied protein-peptide interactions in real-time using surface plasmon resonance technology. We demonstrate the direct interaction of the XIP regulatory-peptide of NCX with calmodulin (CaM). Conclusions: Since CaM also binds to the Bex protein, an interacting protein partner of OMP, these observations strongly suggest that OMP can influence CaM efficacy and thus alters NCX activity by a series of protein-protein interactions.	[Kwon, Hyun J.; Koo, Jae Hyung; Margolis, Frank L.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Kwon, Hyun J.] Andrews Univ, Dept Engn & Comp Sci, Berrien Springs, MI 49104 USA; [Zufall, Frank; Leinders-Zufall, Trese] Univ Saarland, Dept Physiol, Homburg, Germany	University System of Maryland; University of Maryland Baltimore; Andrews University; Saarland University	Kwon, HJ (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	trese.leinders@uks.eu; flmomp@gmail.com	Zufall, Frank/AAE-5290-2021; Leinders-Zufall, Trese/B-4103-2009; Koo, JaeHyung/R-3036-2019; Leinders-Zufall, Trese/S-3664-2019	Zufall, Frank/0000-0002-4383-8618; Leinders-Zufall, Trese/0000-0002-0678-362X; Koo, JaeHyung/0000-0002-5538-8001; Leinders-Zufall, Trese/0000-0002-0678-362X	NIH/NIDCD [R01-DC-003112, R01-DC-02227, R01-DC-005249, T32 DC-00054]; Andrews University; Lichtenberg Professor of the Volkswagen Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000054, R01DC003112, R01DC005249, R01DC002227] Funding Source: NIH RePORTER	NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Andrews University; Lichtenberg Professor of the Volkswagen Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by research grants from NIH/NIDCD R01-DC-003112 (FLM), R01-DC-02227 (TLZ), R01-DC-005249 (FZ) and T32 DC-00054 (FLM) and Andrews University (HJK). TLZ is a Lichtenberg Professor of the Volkswagen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASANUMA N, 1993, HISTOCHEM J, V25, P348, DOI 10.1007/BF00159499; ASANUMA N, 1991, HISTOCHEM J, V23, P83, DOI 10.1007/BF01047112; Baldisseri DM, 2002, J MOL BIOL, V319, P823, DOI 10.1016/S0022-2836(02)00282-6; Behrens M, 2003, J NEUROCHEM, V86, P1289, DOI 10.1046/j.1471-4159.2003.01940.x; BREER H, 1993, CIBA F SYMP, V179, P97; BREER H, 1993, CIBA F SYMP, V179, P97; BREER H, 1993, CIBA F SYMP, V179, P147; Buiakova OI, 1996, P NATL ACAD SCI USA, V93, P9858, DOI 10.1073/pnas.93.18.9858; BUIAKOVA OI, 1994, GENOMICS, V20, P452, DOI 10.1006/geno.1994.1200; Carr VM, 1998, J NEUROBIOL, V34, P377, DOI 10.1002/(SICI)1097-4695(199803)34:4<377::AID-NEU7>3.0.CO;2-3; Castillo K, 2007, EUR J NEUROSCI, V26, P2524, DOI 10.1111/j.1460-9568.2007.05863.x; Cook O, 1998, BBA-BIOMEMBRANES, V1371, P40, DOI 10.1016/S0005-2736(97)00272-1; Dzeja C, 1999, EMBO J, V18, P131, DOI 10.1093/emboj/18.1.131; FARBMAN AI, 1980, DEV BIOL, V74, P205, DOI 10.1016/0012-1606(80)90062-7; Fierro L, 1998, J PHYSIOL-LONDON, V510, P499, DOI 10.1111/j.1469-7793.1998.499bk.x; FRANK JS, 1992, J CELL BIOL, V117, P337, DOI 10.1083/jcb.117.2.337; FRINGS S, 1995, NEURON, V15, P169, DOI 10.1016/0896-6273(95)90074-8; Frings S, 2001, CELL MOL LIFE SCI, V58, P510, DOI 10.1007/PL00000876; GATTO C, 1993, AM J PHYSIOL, V264, pC1577, DOI 10.1152/ajpcell.1993.264.6.C1577; Hallani M, 1998, J MEMBRANE BIOL, V161, P163, DOI 10.1007/s002329900323; Ivic L, 2000, NAT NEUROSCI, V3, P1113, DOI 10.1038/80632; Iwamoto T, 1996, J BIOL CHEM, V271, P22391, DOI 10.1074/jbc.271.37.22391; JUNG A, 1994, NEUROREPORT, V5, P1741, DOI 10.1097/00001756-199409080-00013; Kaneko H, 2006, J GEN PHYSIOL, V127, P737, DOI 10.1085/jgp.200609497; KAO JPY, 1989, J BIOL CHEM, V264, P8179; KELLER A, 1975, J NEUROCHEM, V24, P1101, DOI 10.1111/j.1471-4159.1975.tb03883.x; KLEENE SJ, 1993, NEURON, V11, P123, DOI 10.1016/0896-6273(93)90276-W; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; KLEENE SJ, 2008, CHEM SENSES; KOLESNIKOV SS, 1993, BIOCHIM BIOPHYS ACTA, V1150, P63, DOI 10.1016/0005-2736(93)90122-G; KOLESNIKOV SS, 1990, FEBS LETT, V266, P96, DOI 10.1016/0014-5793(90)81515-P; Koo JH, 2007, BIOCHEM BIOPH RES CO, V363, P405, DOI 10.1016/j.bbrc.2007.08.186; Koo JH, 2005, J COMP NEUROL, V487, P1, DOI 10.1002/cne.20486; Koo JH, 2004, J NEUROCHEM, V90, P102, DOI 10.1111/j.1471-4159.2004.02463.x; Krasznai Z, 2006, CELL MOTIL CYTOSKEL, V63, P66, DOI 10.1002/cm.20108; KURAHASHI T, 1991, NEUROREPORT, V2, P5, DOI 10.1097/00001756-199101000-00001; KURAHASHI T, 1993, NATURE, V363, P71, DOI 10.1038/363071a0; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; Kuzmiski JB, 2001, J NEUROSCI, V21, P8707, DOI 10.1523/JNEUROSCI.21-22-08707.2001; LANCET D, 1986, ANNU REV NEUROSCI, V9, P329, DOI 10.1146/annurev.ne.09.030186.001553; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leinders-Zufall T, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-14-j0005.1999; Leinders-Zufall T, 1998, J NEUROSCI, V18, P5630; Leinders-Zufall T, 2007, P NATL ACAD SCI USA, V104, P14507, DOI 10.1073/pnas.0704965104; LeindersZufall T, 1997, J NEUROSCI, V17, P4136; LI ZP, 1991, J BIOL CHEM, V266, P1014; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; Lucero MT, 2000, PHILOS T ROY SOC B, V355, P1215, DOI 10.1098/rstb.2000.0670; Ma MH, 2000, P NATL ACAD SCI USA, V97, P12869, DOI 10.1073/pnas.220301797; Margolis F L, 1982, Scand J Immunol Suppl, V9, P181; MARGOLIS FL, 1972, P NATL ACAD SCI USA, V69, P1221, DOI 10.1073/pnas.69.5.1221; MARGOLIS FL, 1991, PROG BRAIN RES, V89, P97; Matthews HR, 2003, CURR OPIN NEUROBIOL, V13, P469, DOI 10.1016/S0959-4388(03)00097-7; Menco BPM, 1997, J NEUROCYTOL, V26, P691, DOI 10.1023/A:1018554029186; Menini A, 1999, CURR OPIN NEUROBIOL, V9, P419, DOI 10.1016/S0959-4388(99)80063-4; Monti-Graziadei G A, 1977, J Histochem Cytochem, V25, P1311; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Noe J, 1997, NEUROCHEM INT, V30, P523, DOI 10.1016/S0197-0186(96)00090-3; PHILIPSON KD, 1988, BIOCHIM BIOPHYS ACTA, V945, P298, DOI 10.1016/0005-2736(88)90492-0; Pyrski M, 2007, J COMP NEUROL, V501, P944, DOI 10.1002/cne.21290; RASGADOFLORES H, 1989, J GEN PHYSIOL, V93, P1219, DOI 10.1085/jgp.93.6.1219; REED RR, 1992, NEURON, V8, P205, DOI 10.1016/0896-6273(92)90287-N; Reisert J, 1998, J GEN PHYSIOL, V112, P529, DOI 10.1085/jgp.112.5.529; Reisert J, 2001, J PHYSIOL-LONDON, V530, P113, DOI 10.1111/j.1469-7793.2001.0113m.x; Reisert J, 2007, J PHYSIOL-LONDON, V585, P731, DOI 10.1113/jphysiol.2007.142471; Rogister F, 2001, EUR J MED CHEM, V36, P597, DOI 10.1016/S0223-5234(01)01247-8; Ruknudin AM, 2007, ANN NY ACAD SCI, V1099, P103, DOI 10.1196/annals.1387.036; Saba RI, 1999, BIOCHEM J, V338, P139, DOI 10.1042/0264-6021:3380139; SCHILD D, 1994, CELL CALCIUM, V15, P341, DOI 10.1016/0143-4160(94)90009-4; Schulze DH, 2002, ANN NY ACAD SCI, V976, P67; Schulze DH, 2003, J BIOL CHEM, V278, P28849, DOI 10.1074/jbc.M300754200; Schwarzenbacher K, 2005, HISTOCHEM CELL BIOL, V123, P419, DOI 10.1007/s00418-005-0790-5; SCHWOB JE, 1992, J NEUROSCI, V12, P3896; Shmigol A, 1998, PFLUG ARCH EUR J PHY, V437, P158, DOI 10.1007/s004240050761; SIEGL PKS, 1984, P NATL ACAD SCI-BIOL, V81, P3238, DOI 10.1073/pnas.81.10.3238; THOMPSON MP, 1988, CALCIUM BINDING PROT, P89; Turner JH, 2004, J BIOL CHEM, V279, P17027, DOI 10.1074/jbc.M313919200; Weeraratne SD, 2006, CHEM SENSES, V31, P725, DOI 10.1093/chemse/bjl014; Wei J, 1998, NEURON, V21, P495, DOI 10.1016/S0896-6273(00)80561-9; Youngentob SL, 2004, BEHAV NEUROSCI, V118, P636, DOI 10.1037/0735-7044.118.3.636; Youngentob SL, 2001, BEHAV NEUROSCI, V115, P626, DOI 10.1037//0735-7044.115.3.626; Youngentob SL, 1999, NEUROREPORT, V10, P15, DOI 10.1097/00001756-199901180-00003; Youngentob SL, 2003, J NEUROPHYSIOL, V90, P3864, DOI 10.1152/jn.00806.2002; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473; Zufall F, 2000, J NEUROPHYSIOL, V83, P501, DOI 10.1152/jn.2000.83.1.501; ZUFALL F, 1994, ANNU REV BIOPH BIOM, V23, P577, DOI 10.1146/annurev.bb.23.060194.003045	88	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2009	4	1							e4260	10.1371/journal.pone.0004260	http://dx.doi.org/10.1371/journal.pone.0004260			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JD	19165324	gold, Green Submitted, Green Published			2022-12-25	WOS:000265482400008
J	Mangano, VD; Clark, TG; Auburn, S; Campino, S; Diakite, M; Fry, AE; Green, A; Richardson, A; Jallow, M; Sisay-Joof, F; Pinder, M; Griffiths, MJ; Newton, C; Peshu, N; Williams, TN; Marsh, K; Molyneux, ME; Taylor, TE; Modiano, D; Kwiatkowski, DP; Rockett, KA				Mangano, Valentina D.; Clark, Taane G.; Auburn, Sarah; Campino, Susana; Diakite, Mahamadou; Fry, Andrew E.; Green, Angela; Richardson, Anna; Jallow, Muminatou; Sisay-Joof, Fatou; Pinder, Margaret; Griffiths, Michael J.; Newton, Charles; Peshu, Norbert; Williams, Thomas N.; Marsh, Kevin; Molyneux, Malcolm E.; Taylor, Terrie E.; Modiano, David; Kwiatkowski, Dominic P.; Rockett, Kirk A.			Lack of Association of Interferon Regulatory Factor 1 with Severe Malaria in Affected Child-Parental Trio Studies across Three African Populations	PLOS ONE			English	Article								Interferon Regulatory Factor 1 (IRF-1) is a member of the IRF family of transcription factors, which have key and diverse roles in the gene-regulatory networks of the immune system. IRF-1 has been described as a critical mediator of IFN-gamma signalling and as the major player in driving TH1 type responses. It is therefore likely to be crucial in both innate and adaptive responses against intracellular pathogens such as Plasmodium falciparum. Polymorphisms at the human IRF1 locus have been previously found to be associated with the ability to control P. falciparum infection in populations naturally exposed to malaria. In order to test whether genetic variation at the IRF1 locus also affects the risk of developing severe malaria, we performed a family-based test of association for 18 Single Nucleotide Polymorphisms (SNPs) across the gene in three African populations, using genotype data from 961 trios consisting of one affected child and his/her two parents (555 from The Gambia, 204 from Kenya and 202 from Malawi). No significant association with severe malaria or severe malaria subphenotypes (cerebral malaria and severe malaria anaemia) was observed for any of the SNPs/haplotypes tested in any of the study populations. Our results offer no evidence that the molecular pathways regulated by the transcription factor IRF-1 are involved in the immune-based pathogenesis of severe malaria.	[Mangano, Valentina D.; Clark, Taane G.; Auburn, Sarah; Campino, Susana; Diakite, Mahamadou; Fry, Andrew E.; Green, Angela; Richardson, Anna; Kwiatkowski, Dominic P.; Rockett, Kirk A.] Wellcome Trust Ctr Human Genet, Childhood Infect Grp, Oxford, England; [Mangano, Valentina D.; Modiano, David] Univ Roma La Sapienza, Dept Publ Hlth Sci, Sect Parasitol, Rome, Italy; [Clark, Taane G.; Auburn, Sarah; Campino, Susana; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Hinxton, England; [Jallow, Muminatou; Sisay-Joof, Fatou; Pinder, Margaret] MRC, Fajara, Gambia; [Griffiths, Michael J.; Newton, Charles; Peshu, Norbert; Williams, Thomas N.; Marsh, Kevin] Ctr Geograph Med Res, Kenya Med Res Inst, Kilifi, Kenya; [Williams, Thomas N.; Marsh, Kevin] John Radcliffe Hosp, Nuffield Dept Med, Oxford, England; [Molyneux, Malcolm E.; Taylor, Terrie E.] Malawi Liverpool Wellcome Trust Progr Clin Trop, Coll Med, Blantyre Malaria Project, Blantyre, Malawi; [Molyneux, Malcolm E.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Taylor, Terrie E.] Michigan State Univ, Coll Osteopath Med, Dept Internal Med, E Lansing, MI 48824 USA	University of Oxford; Wellcome Centre for Human Genetics; Sapienza University Rome; Wellcome Trust Sanger Institute; University of London; London School of Hygiene & Tropical Medicine; Kenya Medical Research Institute; University of Oxford; University of Malawi; Liverpool School of Tropical Medicine; Michigan State University; Michigan State University College of Osteopathic Medicine	Mangano, VD (corresponding author), Wellcome Trust Ctr Human Genet, Childhood Infect Grp, Oxford, England.	vmangano@well.ox.ac.uk	mangano, valentina/I-2456-2012; Newton, Charles/V-7872-2019; Campino, Susana/AAM-2577-2020; Clark, Taane G./AAM-2570-2020; Fry, Andrew/AFK-7448-2022; Newton, Charles RJC/B-7578-2014; Fry, Andrew/AAN-2730-2020; Auburn, Sarah/N-2266-2013	Newton, Charles/0000-0002-6999-5507; Campino, Susana/0000-0003-1403-6138; Clark, Taane G./0000-0001-8985-9265; Fry, Andrew/0000-0001-9778-6924; Newton, Charles RJC/0000-0002-6999-5507; Fry, Andrew/0000-0001-9778-6924; Kwiatkowski, Dominic/0000-0002-5023-0176; Mangano, Valentina D/0000-0002-2021-6162; Auburn, Sarah/0000-0002-4638-536X	Priority 1 Life Sciences, Genomics and Biotechnology for Health in the 6th Framework Programme [LSHP-CT-2004-503578]; BioMalPar PhD Fellowship; UK Medical Research Council; Wellcome Trust; Bill and Melinda Gates Foundation; National Institutes of Health; Medical Research Council [G19/9, G0600230] Funding Source: researchfish; MRC [G19/9, G0600230] Funding Source: UKRI	Priority 1 Life Sciences, Genomics and Biotechnology for Health in the 6th Framework Programme; BioMalPar PhD Fellowship; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is part of the activities of the BioMalPar European Network of Excellence supported by a European grant (LSHP-CT-2004-503578) from the Priority 1 Life Sciences, Genomics and Biotechnology for Health in the 6th Framework Programme, and Mangano VD was funded by a BioMalPar PhD Fellowship. The sample collections and resources used in this study received funding from the UK Medical Research Council, the Wellcome Trust, the Bill and Melinda Gates Foundation, and the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman H, 2005, ANN HUM GENET, V69, P559, DOI 10.1111/j.1529-8817.2005.00180.x; Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; CLARK T, 2008, J INFECT DI IN PRESS; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Dodoo D, 2002, J INFECT DIS, V185, P971, DOI 10.1086/339408; Evans DM, 2006, BEHAV GENET, V36, P947, DOI 10.1007/s10519-006-9087-2; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gonzalez JM, 2005, ENVIRON MICROBIOL, V7, P1024, DOI 10.1111/j.1462-2920.2005.00779.x; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; Honda K, 2006, IUBMB LIFE, V58, P290, DOI 10.1080/15216540600702206; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Luty AJF, 1999, J INFECT DIS, V179, P980, DOI 10.1086/314689; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Mackintosh CL, 2004, TRENDS PARASITOL, V20, P597, DOI 10.1016/j.pt.2004.09.006; Mangano VD, 2008, GENES IMMUN, V9, P122, DOI 10.1038/sj.gene.6364456; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Modiano D, 2008, HUM MOL GENET, V17, P789, DOI 10.1093/hmg/ddm350; Ozato K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/jbc.R700003200; Plebanski M, 2000, CURR OPIN IMMUNOL, V12, P437, DOI 10.1016/S0952-7915(00)00117-5; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Ross P, 1998, NAT BIOTECHNOL, V16, P1347, DOI 10.1038/4328; Sakuntabhai A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002000; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Teo YY, 2007, ANN HUM GENET, V71, P701, DOI 10.1111/j.1469-1809.2007.00356.x; TEO YY, 2008, HUM HEREDIT IN PRESS; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	34	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2009	4	1							e4206	10.1371/journal.pone.0004206	http://dx.doi.org/10.1371/journal.pone.0004206			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IG	19145247	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000265479800012
J	Religa, P; Grudzinska, MK; Bojakowski, K; Soin, J; Nozynski, J; Zakliczynski, M; Gaciong, Z; Zembala, M; Soderberg-Naucler, C				Religa, Piotr; Grudzinska, Monika K.; Bojakowski, Krzysztof; Soin, Joanna; Nozynski, Jerzy; Zakliczynski, Michal; Gaciong, Zbigniew; Zembala, Marian; Soderberg-Naucler, Cecilia			Host-Derived Smooth Muscle Cells Accumulate in Cardiac Allografts: Role of Inflammation and Monocyte Chemoattractant Protein 1	PLOS ONE			English	Article								Transplant arteriosclerosis is characterized by inflammation and intimal thickening caused by accumulation of smooth muscle cells (SMCs) both from donor and recipient. We assessed the relationship between clinical factors and the presence of host-derived SMCs in 124 myocardial biopsies from 26 consecutive patients who received hearts from opposite-sex donors. Clinical and demographic information was obtained from the patients' medical records. Host-derived SMCs accounted for 3.35 +/- 2.3% of cells in arterioles (range, 0.08-12.51%). As shown by linear regression analysis, an increased number of SMCs was associated with rejection grade (mean, 1.41 +/- 1.03, p = 0.034) and the number of leukocytes (19.1 +/- 12.7 per 20 high-power fields, p = 0.01). The accumulation of host-derived SMCs was associated with an increased number of leukocytes in the allografts. In vitro, monocyte chemoattractant protein 1 (MCP-1) released from leukocytes was crucial for SMC migration. After heart allotransplantion, mice treated with MCP-1-specific antibodies had significantly fewer host-derived SMCs in the grafts than mice treated with isotypic antibody controls. We conclude that the number of host-derived SMCs in human cardiac allografts is associated with the rejection grade and that MCP-1 may play pivotal role in recruiting host-derived SMCs into cardiac allografts.	[Religa, Piotr; Grudzinska, Monika K.; Soderberg-Naucler, Cecilia] Karolinska Inst, Stockholm, Sweden; [Religa, Piotr; Bojakowski, Krzysztof; Soin, Joanna; Gaciong, Zbigniew] Warsaw Univ Med, Dept Internal Med & Hypertens, Warsaw, Poland; [Bojakowski, Krzysztof] Warsaw Univ Med, Dept Gen Vasc & Oncol Surg, Warsaw, Poland; [Soin, Joanna] Warsaw Univ Med, Dept Gen Biochem & Nutr, Warsaw, Poland; [Nozynski, Jerzy; Zakliczynski, Michal; Zembala, Marian] Silesian Ctr Heart Dis, Zabrze, Poland	Karolinska Institutet; Silesian Center for Heart Diseases	Religa, P (corresponding author), Karolinska Inst, Stockholm, Sweden.	piotr.religa@ki.se		Religa, Piotr/0000-0002-3884-2954; Bojakowski, Krzysztof/0000-0001-6899-8741; Zakliczynski, Michal/0000-0002-5730-019X; Grudzinska Pechhacker, Monika/0000-0001-7007-461X	Science Research Committee MNiSW [3B138]; Swedish Research Council [K2004-16X-12615-07A, K2007-56X-12615-10-3]; Swedish Society of Medicine [2003-633]; Tobias Foundation [28/03, 29/04]; Heart and Lung Foundation [199941305, 200241138, 20030055, 20050266]; King Gustaf V's 80-Year Anniversary Foundation; Swedish Cancer Foundation [060253]; Children's Cancer Foundation [05/100]; Royal Swedish Academy of Science [Research Fellow]; Knut and Alice Wallenberg Foundation	Science Research Committee MNiSW; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine; Tobias Foundation; Heart and Lung Foundation(Swedish Heart-Lung Foundation); King Gustaf V's 80-Year Anniversary Foundation; Swedish Cancer Foundation; Children's Cancer Foundation; Royal Swedish Academy of Science; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by grants from the Science Research Committee MNiSW 3B138, Swedish Research Council (K2004-16X-12615-07A, K2007-56X-12615-10-3), the Swedish Society of Medicine (2003-633), the Tobias Foundation (28/03 and 29/04), and the Heart and Lung Foundation (199941305, 200241138, 20030055, and 20050266). King Gustaf V's 80-Year Anniversary Foundation, Swedish Cancer Foundation (060253), and Children's Cancer Foundation (05/100). C.S.-N. is a Royal Swedish Academy of Science Research Fellow supported by a grant from the Knut and Alice Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bojakowski K, 2000, TRANSPLANTATION, V70, P65; Cheng C, 2007, J CLIN INVEST, V117, P616, DOI 10.1172/JCI28180; Davies WR, 2005, J HEART LUNG TRANSPL, V24, P1868, DOI 10.1016/j.healun.2005.04.004; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; Fujiyama S, 2003, CIRC RES, V93, P980, DOI 10.1161/01.RES.0000099245.08637.CE; Hillebrands JL, 2001, J CLIN INVEST, V107, P1411, DOI 10.1172/JCI10233; Hu YH, 2004, J CLIN INVEST, V113, P1258, DOI 10.1172/JCI200419628; Huang BJ, 2006, TRANSPL IMMUNOL, V16, P88, DOI 10.1016/j.trim.2006.03.010; Leri A, 2005, PHYSIOL REV, V85, P1373, DOI 10.1152/physrev.00013.2005; Libby P, 2001, IMMUNITY, V14, P387, DOI 10.1016/S1074-7613(01)00119-4; Lietz Katherine, 2004, Semin Thorac Cardiovasc Surg, V16, P386, DOI 10.1053/j.semtcvs.2004.09.004; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Minami E, 2005, CIRCULATION, V112, P2951, DOI 10.1161/CIRCULATIONAHA.105.576017; Mitchell RN, 2007, CIRC RES, V100, P967, DOI 10.1161/01.RES.0000261982.76892.09; Morimoto H, 2006, CIRC RES, V99, P891, DOI 10.1161/01.RES.0000246113.82111.2d; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Orloff SL, 2002, TRANSPLANTATION, V73, P679, DOI 10.1097/00007890-200203150-00005; Religa P, 2005, CARDIOVASC RES, V65, P535, DOI 10.1016/j.cardiores.2004.10.011; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; Soderberg-Naucler C, 2001, TRANSPLANTATION, V71, pSS24; Soler MJ, 2005, AM J TRANSPLANT, V5, P2154, DOI 10.1111/j.1600-6143.2005.01010.x; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; Stoica SC, 2006, J HEART LUNG TRANSPL, V25, P420, DOI 10.1016/j.healun.2005.11.449; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Wojakowski W, 2004, CIRCULATION, V110, P3213, DOI 10.1161/01.CIR.0000147609.39780.02	29	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4187	10.1371/journal.pone.0004187	http://dx.doi.org/10.1371/journal.pone.0004187			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142231	Green Published, gold, Green Submitted			2022-12-25	WOS:000265479700008
J	Lohler, J; Hirner, H; Schmidt, B; Kramer, K; Fischer, D; Thal, DR; Leithauser, F; Knippschild, U				Loehler, Juergen; Hirner, Heidrun; Schmidt, Bernhard; Kramer, Klaus; Fischer, Dietmar; Thal, Dietmar R.; Leithaeuser, Frank; Knippschild, Uwe			Immunohistochemical Characterisation of Cell-Type Specific Expression of CK1 delta in Various Tissues of Young Adult BALB/c Mice	PLOS ONE			English	Article							CASEIN-KINASE-I; PROTEIN-KINASE; BETA-CATENIN; 1 DELTA; POSSIBLE INVOLVEMENT; NEGATIVE REGULATION; MOLECULAR-CLONING; ALZHEIMER BRAIN; CKI-DELTA; PHOSPHORYLATION	Background: Casein kinase 1 delta (CK1d) phosphorylates many key proteins playing important roles in such biological processes as cell growth, differentiation, apoptosis, circadian rhythm and vesicle transport. Furthermore, deregulation of CK1d has been linked to neurodegenerative diseases and cancer. In this study, the cell specific distribution of CK1d in various tissues and organs of young adult BALB/c mice was analysed by immunohistochemistry. Methodology/Principal Findings: Immunohistochemical staining of CK1d was performed using three different antibodies against CK1d. A high expression of CK1d was found in a variety of tissues and organ systems and in several cell types of endodermal, mesodermal and ectodermal origin. Conclusions: These results give an overview of the cell-type specific expression of CK1d in different organs under normal conditions. Thus, they provide evidence for possible cell-type specific functions of CK1d, where CK1d can interact with and modulate the activity of key regulator proteins by site directed phosphorylation. Furthermore, they provide the basis for future analyses of CK1d in these tissues.	Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, Mol Pathol Grp, D-2000 Hamburg, Germany; [Hirner, Heidrun; Schmidt, Bernhard; Kramer, Klaus; Knippschild, Uwe] Univ Ulm, Dept Gen Visceral & Transplant Surg, D-89069 Ulm, Germany; [Fischer, Dietmar] Univ Ulm, Dept Expt Neurol, D-89069 Ulm, Germany; [Thal, Dietmar R.] Univ Ulm, Inst Pathol, Lab Neuropathol, D-89069 Ulm, Germany; [Leithaeuser, Frank] Univ Ulm, Dept Pathol, D-89069 Ulm, Germany	Heinrich Pette Institute; University of Hamburg; Ulm University; Ulm University; Ulm University; Ulm University	Lohler, J (corresponding author), Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, Mol Pathol Grp, Martinistr 52, D-2000 Hamburg, Germany.	uwe.knippschild@uniklinik-ulm.de	Thal, Dietmar R/O-7483-2018	Thal, Dietmar R/0000-0002-1036-1075; Fischer, Dietmar/0000-0002-1816-3014	Deutsche Krebshilfe [10-2237-KN3, 108489]	Deutsche Krebshilfe(Deutsche Krebshilfe)	Deutsche Krebshilfe, Dr. Mildred Scheel Stiftung, 10-2237-KN3 and 108489. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Bagheri-Yarmand R, 2004, DEVELOPMENT, V131, P3469, DOI 10.1242/dev.01213; BECKSTEAD JH, 1994, J HISTOCHEM CYTOCHEM, V42, P1127, DOI 10.1177/42.8.8027531; Behrend L, 2000, ONCOGENE, V19, P5303, DOI 10.1038/sj.onc.1203939; Behrend L, 2000, EUR J CELL BIOL, V79, P240, DOI 10.1078/S0171-9335(04)70027-8; BENNETT MK, 1993, J NEUROSCI, V13, P1701; BEYAERT R, 1995, J BIOL CHEM, V270, P23293, DOI 10.1074/jbc.270.40.23293; BROCKMAN JL, 1992, P NATL ACAD SCI USA, V89, P9454, DOI 10.1073/pnas.89.20.9454; BROCKSCHMIDT C, 2008, GUT; Bustos VH, 2005, BIOCHEM J, V391, P417, DOI 10.1042/BJ20050717; Camacho F, 2001, FEBS LETT, V489, P159, DOI 10.1016/S0014-5793(00)02434-0; Chergui K, 2005, J NEUROSCI, V25, P6601, DOI 10.1523/JNEUROSCI.1082-05.2005; Chergui M, 2006, SCIENCE, V313, P1246, DOI 10.1126/science.1132749; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; Dubois T, 2002, EUR J BIOCHEM, V269, P909, DOI 10.1046/j.0014-2956.2001.02725.x; Dupre-Crochet S, 2007, MOL CELL BIOL, V27, P3804, DOI 10.1128/MCB.01590-06; Ebisawa T, 2001, EMBO REP, V2, P342, DOI 10.1093/embo-reports/kve070; Eide EJ, 2001, CHRONOBIOL INT, V18, P389, DOI 10.1081/CBI-100103963; ELIAS L, 1981, CANCER RES, V41, P2182; Fuja TJ, 2004, CANCER RES, V64, P942, DOI 10.1158/0008-5472.CAN-03-2100; Ghoshal N, 1999, AM J PATHOL, V155, P1163, DOI 10.1016/S0002-9440(10)65219-4; Giamas G, 2007, BIOCHEM J, V406, P389, DOI 10.1042/BJ20070091; GRAVES PR, 1993, J BIOL CHEM, V268, P6394; GROSS SD, 1995, J CELL BIOL, V130, P711, DOI 10.1083/jcb.130.3.711; Gross SD, 1997, J CELL SCI, V110, P3083; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Horiguchi R, 2005, BBA-GENE STRUCT EXPR, V1727, P75, DOI 10.1016/j.bbaexp.2004.11.002; Izeradjene K, 2004, CLIN CANCER RES, V10, P6650, DOI 10.1158/1078-0432.CCR-04-0576; Kannanayakal TJ, 2006, ACTA NEUROPATHOL, V111, P413, DOI 10.1007/s00401-006-0049-9; Kataoka M, 2000, J NEUROCHEM, V74, P2058, DOI 10.1046/j.1471-4159.2000.0742058.x; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Knippschild U, 1996, ONCOGENE, V13, P1387; Krueger SK, 1999, BIOTECH HISTOCHEM, V74, P105, DOI 10.3109/10520299909066485; Kuret J, 1997, J NEUROCHEM, V69, P2506; Li GB, 2004, J BIOL CHEM, V279, P15938, DOI 10.1074/jbc.M314116200; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu F, 2001, P NATL ACAD SCI USA, V98, P11062, DOI 10.1073/pnas.191353898; Marin O, 2003, P NATL ACAD SCI USA, V100, P10193, DOI 10.1073/pnas.1733909100; Maritzen T, 2003, EUR J CELL BIOL, V82, P369, DOI 10.1078/0171-9335-00323; McKenzie JAG, 2006, FEBS LETT, V580, P2388, DOI 10.1016/j.febslet.2006.03.048; Milne DM, 2001, EXP CELL RES, V263, P43, DOI 10.1006/excr.2000.5100; Murakami A, 1999, J BIOL CHEM, V274, P3804, DOI 10.1074/jbc.274.6.3804; Okamura A, 2004, BLOOD, V103, P2997, DOI 10.1182/blood-2003-08-2768; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Petronczki M, 2006, CELL, V126, P1049, DOI 10.1016/j.cell.2006.07.029; Pozzi D, 2008, P NATL ACAD SCI USA, V105, P323, DOI 10.1073/pnas.0706211105; Price RD, 2006, J BIOMOL SCREEN, V11, P155, DOI 10.1177/1087057105283344; PUCHTLER H, 1968, HISTOCHEMISTRY, V16, P361, DOI 10.1007/BF00306359; Pyle RA, 2000, J BIOL CHEM, V275, P17195, DOI 10.1074/jbc.M000674200; Reisinger EC, 1999, WIEN KLIN WOCHENSCHR, V111, P537; Schwab C, 2000, NEUROBIOL AGING, V21, P503, DOI 10.1016/S0197-4580(00)00110-X; Shimazaki Y, 1996, J BIOL CHEM, V271, P14548, DOI 10.1074/jbc.271.24.14548; Snyder DA, 2006, CELL BIOCHEM BIOPHYS, V45, P111, DOI 10.1385/CBB:45:1:111; Stoter M, 2005, ONCOGENE, V24, P7964, DOI 10.1038/sj.onc.1208941; Swiatek W, 2006, J BIOL CHEM, V281, P12233, DOI 10.1074/jbc.M510580200; Takano A, 2004, NEUROREPORT, V15, P1461, DOI 10.1097/01.wnr.0000133297.77278.81; Takenaka Y, 2004, MOL CELL BIOL, V24, P4395, DOI 10.1128/MCB.24.10.4395-4406.2004; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Walter J, 1998, BIOCHEMISTRY-US, V37, P5961, DOI 10.1021/bi971763a; Wolff S, 2005, BBA-MOL CELL RES, V1745, P196, DOI 10.1016/j.bbamcr.2005.05.004; Wolff S, 2006, FEBS LETT, V580, P6477, DOI 10.1016/j.febslet.2006.10.068; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yasojima K, 2001, NEUROSCI LETT, V297, P97, DOI 10.1016/S0304-3940(00)01675-X; Yasojima K, 2000, BRAIN RES, V865, P116, DOI 10.1016/S0006-8993(00)02200-9; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhao Y, 2004, J BIOL CHEM, V279, P30844, DOI 10.1074/jbc.M404651200	70	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2009	4	1							e4174	10.1371/journal.pone.0004174	http://dx.doi.org/10.1371/journal.pone.0004174			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ID	19137063	Green Published, Green Submitted, gold			2022-12-25	WOS:000265479500005
J	Gioiosa, L; Chiarotti, F; Alleva, E; Laviola, G				Gioiosa, Laura; Chiarotti, Flavia; Alleva, Enrico; Laviola, Giovanni			A Trouble Shared Is a Trouble Halved: Social Context and Status Affect Pain in Mouse Dyads	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; MALE-MICE; NONSELECTIVE ATTENTION; AGONISTIC ENCOUNTERS; ALLOSTATIC LOAD; FORMALIN TEST; NITRIC-OXIDE; BEHAVIOR; STRESS; EXPOSURE	In mice behavioral response to pain is modulated by social status. Recently, social context also has been shown to affect pain sensitivity. In our study, we aimed to investigate the effects of interaction between status and social context in dyads of outbred CD-1 male mice in which the dominance/submission relationship was stable. Mice were assessed for pain response in a formalin (1% concentration) test either alone (individually tested-IT), or in pairs of dominant and subordinate mice. In the latter condition, they could be either both injected (BI) or only one injected (OI) with formalin. We observed a remarkable influence of social context on behavioral response to painful stimuli regardless of the social status of the mice. In the absence of differences between OI and IT conditions, BI mice exhibited half as much Paw-licking behavior than OI group. As expected, subordinates were hypoalgesic in response to the early phase of the formalin effects compared to dominants. Clear cut-differences in coping strategies of dominants and subordinates appeared. The former were more active, whereas the latter were more passive. Finally, analysis of behavior of the non-injected subjects (the observers) in the OI dyads revealed that dominant observers were more often involved in Self-grooming behavior upon observation of their subordinate partner in pain. This was not the case for subordinate mice observing the pain response of their dominant partner. In contrast, subordinate observers Stared at the dominant significantly more frequently compared to observer dominants in other dyads. The observation of a cagemate in pain significantly affected the observer's behavior. Additionally, the quality of observer's response was also modulated by the dominance/submission relationship.	[Gioiosa, Laura; Chiarotti, Flavia; Alleva, Enrico; Laviola, Giovanni] Ist Super Sanita, Sect Behav Neurosci, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Gioiosa, Laura] Consiglio Nazl Ricerche, Inst Neurobiol & Mol Med, Rome, Italy	Istituto Superiore di Sanita (ISS)	Gioiosa, L (corresponding author), Ist Super Sanita, Sect Behav Neurosci, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	giovanni.laviola@iss.it	Alleva, Enrico/B-1630-2013; Chiarotti, Flavia/K-7970-2016; Laviola, Giovanni/AAA-2391-2022; Laviola, Giovanni/K-4392-2016	Chiarotti, Flavia/0000-0003-0084-6914; Laviola, Giovanni/0000-0003-0388-0835; Laviola, Giovanni/0000-0003-0388-0835; Alleva, Enrico/0000-0002-9633-7657	Italy-USA Program on Rare Disease "X-linked or autosomal rare mental retardation syndromes"; ERARE-EuroRETT Network; Consiglio Nanzionale delle Ricerche (Roma, Italy) [fellowship]	Italy-USA Program on Rare Disease "X-linked or autosomal rare mental retardation syndromes"; ERARE-EuroRETT Network; Consiglio Nanzionale delle Ricerche (Roma, Italy)	This work was supported by Italy-USA Program on Rare Disease "X-linked or autosomal rare mental retardation syndromes" and by ERARE-EuroRETT Network to Dr G. Laviola. Dr L. Gioiosa was a recipient of a fellowship from Consiglio Nanzionale delle Ricerche (Roma, Italy).	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; ALLEVA E, 1993, PARADIGMS STUDY BEHA, P111; ALOE L, 1994, AUTOIMMUNITY, V19, P141, DOI 10.3109/08916939409009542; Archer J., 1988, BEHAV BIOL AGGRESSIO, DOI DOI 10.1046/J.1420-9101.1991.4030515.X; Aspide R, 1998, BEHAV BRAIN RES, V95, P123, DOI 10.1016/S0166-4328(97)00217-9; Bartolomucci A, 2004, PSYCHONEUROENDOCRINO, V29, P899, DOI 10.1016/j.psyneuen.2003.08.003; Bartolomucci A, 2003, PSYCHONEUROENDOCRINO, V28, P540, DOI 10.1016/S0306-4530(02)00039-2; BENTON D, 1980, COMP MEASURES DOMINA, P1274; BENUS RF, 1989, BEHAV PROCESS, V20, P1, DOI 10.1016/0376-6357(89)90008-9; BRAIN P, 1981, MULTIDISCIPLINARY AP, P209; Branchi I, 2006, BEHAV BRAIN RES, V172, P299, DOI 10.1016/j.bbr.2006.05.019; DELLASETA D, 1994, PHARMACOL BIOCHEM BE, V49, P701, DOI 10.1016/0091-3057(94)90090-6; DeLorey TM, 2008, BEHAV BRAIN RES, V187, P207, DOI 10.1016/j.bbr.2007.09.009; ELY DL, 1978, HORM BEHAV, V10, P156, DOI 10.1016/0018-506X(78)90005-3; Fiore M, 1998, NEUROTOXICOL TERATOL, V20, P543, DOI 10.1016/S0892-0362(98)00003-8; Gioiosa L, 2008, HORM BEHAV, V53, P124, DOI 10.1016/j.yhbeh.2007.09.003; Gioiosa L, 2007, HORM BEHAV, V52, P307, DOI 10.1016/j.yhbeh.2007.05.006; Goymann W, 2004, ANIM BEHAV, V67, P591, DOI 10.1016/j.anbehav.2003.08.007; Grammatikopoulos G, 2002, BEHAV BRAIN RES, V130, P127, DOI 10.1016/S0166-4328(01)00424-7; *HENR STEPH, 1977, STRESS HLTH SOC ENV; Kiyokawa Y, 2007, EUR J NEUROSCI, V26, P3606, DOI 10.1111/j.1460-9568.2007.05969.x; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; KUDRYAVTSEVA NN, 1991, AGGRESSIVE BEHAV, V17, P285, DOI 10.1002/1098-2337(1991)17:5<285::AID-AB2480170505>3.0.CO;2-P; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Levine S, 1989, PSYCHOENDOCRINOLOGY, V1989, P341, DOI DOI 10.1016/B978-0-12-137952-0.50012-4; Lindberg A. Cecilia, 2001, P37, DOI 10.1079/9780851993973.0037; MAESTRIPIERI D, 1990, PHYSIOL BEHAV, V47, P161, DOI 10.1016/0031-9384(90)90056-A; MICZEK KA, 1982, SCIENCE, V215, P1520, DOI 10.1126/science.7199758; Niederberger E, 2007, EUR J PHARMACOL, V559, P55, DOI 10.1016/j.ejphar.2006.11.074; RODGERS RJ, 1986, PHYSIOL BEHAV, V38, P427, DOI 10.1016/0031-9384(86)90116-2; RODGERS RJ, 1983, PHYSIOL BEHAV, V30, P775, DOI 10.1016/0031-9384(83)90177-4; RODGERS RJ, 1986, PHYSIOL BEHAV, V36, P947, DOI 10.1016/0031-9384(86)90458-0; Rutter M, 2002, ANNU REV PSYCHOL, V53, P463, DOI 10.1146/annurev.psych.53.100901.135223; Scattoni ML, 2004, BEHAV BRAIN RES, V152, P375, DOI 10.1016/j.bbr.2003.10.021; Sherwin CM, 1996, APPL ANIM BEHAV SCI, V48, P203, DOI 10.1016/0168-1591(96)01027-1; SIEGFRIED B, 1987, BEHAV NEUROSCI, V101, P797, DOI 10.1037/0735-7044.101.6.797; Sufka KJ, 1998, EUR J PAIN-LONDON, V2, P351, DOI 10.1016/S1090-3801(98)90033-7; Terranova ML, 1999, PSYCHONEUROENDOCRINO, V24, P639; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Vekovishcheva O Y, 2000, Neurosci Behav Physiol, V30, P195, DOI 10.1007/BF02463158	41	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2009	4	1							e4143	10.1371/journal.pone.0004143	http://dx.doi.org/10.1371/journal.pone.0004143			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437FZ	19129917	Green Published, Green Submitted, gold			2022-12-25	WOS:000265473500003
J	Bhattacharya, J				Bhattacharya, Joydeep			Increase of Universality in Human Brain during Mental Imagery from Visual Perception	PLOS ONE			English	Article							RANGE TEMPORAL CORRELATIONS; SCALING BEHAVIOR; TIME-SERIES; SURROGATE DATA; DYNAMICS; OSCILLATIONS; TASK; BAND; EEG; METASTABILITY	Background: Different complex systems behave in a similar way near their critical points of phase transitions which leads to an emergence of a universal scaling behaviour. Universality indirectly implies a long-range correlation between constituent subsystems. As the distributed correlated processing is a hallmark of higher complex cognition, I investigated a measure of universality in human brain during perception and mental imagery of complex real-life visual object like visual art. Methodology/Principal Findings: A new method was presented to estimate the strength of hidden universal structure in a multivariate data set. In this study, I investigated this method in the electrical activities (electroencephalogram signals) of human brain during complex cognition. Two broad groups - artists and non-artists - were studied during the encoding (perception) and retrieval (mental imagery) phases of actual paintings. Universal structure was found to be stronger in visual imagery than in visual perception, and this difference was stronger in artists than in non-artists. Further, this effect was found to be largest in the theta band oscillations and over the prefrontal regions bilaterally. Conclusions/Significance: Phase transition like dynamics was observed in the electrical activities of human brain during complex cognitive processing, and closeness to phase transition was higher in mental imagery than in real perception. Further, the effect of long-term training on the universal scaling was also demonstrated.	Univ London Goldsmiths Coll, Dept Psychol, London SE14 6NW, England; [Bhattacharya, Joydeep] Austrian Acad Sci, Commission Scient Visualizat, Vienna, Austria	University of London; Goldsmiths University London; Austrian Academy of Sciences	Bhattacharya, J (corresponding author), Univ London Goldsmiths Coll, Dept Psychol, London SE14 6NW, England.	pss01jb@gold.ac.uk			JST.ERATO Shimojo Implicit Brain Functions project	JST.ERATO Shimojo Implicit Brain Functions project	The study was supported by JST.ERATO Shimojo Implicit Brain Functions project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak P, 1996, NATURE WORKS SCI SEL, Vxiii; Banavar JR, 2002, NATURE, V420, P626, DOI 10.1038/420626a; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bhattacharya J, 2001, P ROY SOC B-BIOL SCI, V268, P2423, DOI 10.1098/rspb.2001.1802; Bhattacharya J, 2002, COGNITIVE BRAIN RES, V13, P179, DOI 10.1016/S0926-6410(01)00110-0; Bhattacharya J, 2002, NEUROREPORT, V13, P1727, DOI 10.1097/00001756-200210070-00007; BINNEY J, 1996, THEORY CRITICAL PHEN; Bressler SL, 2001, TRENDS COGN SCI, V5, P26, DOI 10.1016/S1364-6613(00)01564-3; Buiatti M, 2007, NEUROSCIENCE, V146, P1400, DOI 10.1016/j.neuroscience.2007.02.048; Cohen L., 1995, TIME FREQUENCY ANAL; Corral A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.108501; Doppelmayr M, 2000, NEUROSCI LETT, V278, P141, DOI 10.1016/S0304-3940(99)00925-8; Efron B., 1994, INTRO BOOTSTRAP; Espinel CH, 1998, LANCET, V352, P2007, DOI 10.1016/S0140-6736(98)10102-2; Fortunato S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138701; FREEMAN WJ, 1985, BRAIN RES REV, V10, P147, DOI 10.1016/0165-0173(85)90022-0; Friston KJ, 1997, NEUROIMAGE, V5, P164, DOI 10.1006/nimg.1997.0259; Frith C, 1997, PHILOS T R SOC B, V352, P1221, DOI 10.1098/rstb.1997.0104; Gelfand I. M., 1964, GEN FUNCTIONS; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Gisiger T, 2001, BIOL REV, V76, P161, DOI 10.1017/S1464793101005607; HAYKIN SS, 2001, COMMUNICATION SYSTEM, pR18; Hwa RC, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.021901; Ivanov PC, 1996, NATURE, V383, P323, DOI 10.1038/383323a0; Ivanov PC, 1998, PHYSICA A, V249, P587, DOI 10.1016/S0378-4371(97)00522-0; Kadanoff L. P., 1966, PHYSICS, V2, P263, DOI DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.2.263; KELSO JAS, 1992, PHYS LETT A, V169, P134, DOI 10.1016/0375-9601(92)90583-8; Kiyono K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.178103; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kosslyn S. M., 1980, IMAGE MIND; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; KULLBOCK S, 1959, INFORM THEORY STAT; Li WL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.206807; Linkenkaer-Hansen K, 2004, EUR J NEUROSCI, V19, P203, DOI 10.1111/j.1460-9568.2004.03116.x; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; MACKAY DJG, 2004, INFORM THEORY INFERE, pR12; MALLAT SG, 1999, WAVELET TOUR SIGNAL, pR24; Murphy D, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.025301; Nikulin VV, 2005, NEUROSCIENCE, V130, P549, DOI 10.1016/j.neuroscience.2004.10.007; PANTER PF, 1965, MODULATION NOISE SPE, pR8; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Popivanov D, 2006, BIOL CYBERN, V94, P149, DOI 10.1007/s00422-005-0037-5; PRICHARD D, 1994, PHYS REV LETT, V73, P951, DOI 10.1103/PhysRevLett.73.951; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Stanley H.E., 1971, INTRO PHASE TRANSITI; TallonBaudry C, 1997, J NEUROSCI, V17, P722; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Werner G, 2007, BIOSYSTEMS, V90, P496, DOI 10.1016/j.biosystems.2006.12.001	51	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2009	4	1							e4121	10.1371/journal.pone.0004121	http://dx.doi.org/10.1371/journal.pone.0004121			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437FT	19122817	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000265472900004
J	Langlois, MJ; Roy, SAB; Auclair, BA; Jones, C; Boudreau, F; Carrier, JC; Rivard, N; Perreault, N				Langlois, Marie-Josee; Roy, Sebastien A. B.; Auclair, Benoit A.; Jones, Christine; Boudreau, Francois; Carrier, Julie C.; Rivard, Nathalie; Perreault, Nathalie			Epithelial phosphatase and tensin homolog regulates intestinal architecture and secretory cell commitment and acts as a modifier gene in neoplasia	FASEB JOURNAL			English	Article						phosphatidylinositol 3-kinase; Akt; beta-catenin; cell fate; organomegaly; differentiation	CYCLIN D1; ENTEROENDOCRINE CELLS; COLORECTAL-CANCER; TUMOR SUPPRESSION; STEM-CELLS; PTEN; DIFFERENTIATION; EXPRESSION; MOUSE; MICE	Phosphatase and tensin homolog (PTEN), a negative regulator of the phosphatidylinositol 3-kinase/Akt pathway, is one of the most frequently mutated/deleted tumor suppressor genes in human cancers. The aim of this study was to gain insight into the role played by PTEN in intestinal homeostasis and epithelial cell function. Using the Cre/loxP system, we have generated a mouse with a conditional intestinal epithelial Pten deficiency. Pten mutant mice and controls were sacrificed for histology, immunofluorescence, Western blot, and quantitative polymerase chain reaction analysis. Our results show that loss of epithelial Pten leads to an intestinalomegaly associated with an increase in epithelial cell proliferation. Histological analysis demonstrated significant perturbation of the crypt-villus architecture, a marked increase in goblet cells and a decrease in enteroendocrine cells, suggesting a role for Pten in the commitment of the multipotential-secretory precursor cell. Loss of epithelial Pten does not result in induction of nuclear beta-catenin protein levels, nor is it sufficient to promote tumorigenesis initiation. However, it severely enhances intestinal tumor load in Apc(Min/+) mice, in which c-Myc is already deregulated. These results reveal an unknown function for Pten signaling in the commitment of multipotential-secretory progenitor cells and suggest that epithelial Pten functions as a modifier gene in intestinal neoplasia.-Langlois, M.- J., Roy, S. A. B., Auclair, B. A., Jones, C., Boudreau, F., Carrier, J. C., Rivard, N., Perreault, N. Epithelial phosphatase and tensin homolog regulates intestinal architecture and secretory cell commitment and acts as a modifier gene in neoplasia. FASEB J. 23, 1835-1844 (2009)	[Langlois, Marie-Josee; Roy, Sebastien A. B.; Auclair, Benoit A.; Jones, Christine; Boudreau, Francois; Rivard, Nathalie; Perreault, Nathalie] Univ Sherbrooke, Fac Med & Sci Sante, Dept Anat & Biol Cellulaire, Sherbrooke, PQ J1H 5N4, Canada; [Langlois, Marie-Josee; Roy, Sebastien A. B.; Auclair, Benoit A.; Jones, Christine; Boudreau, Francois; Carrier, Julie C.; Rivard, Nathalie; Perreault, Nathalie] Univ Sherbrooke, Canadian Inst Hlth Res, Team Digest Epithelium, Sherbrooke, PQ J1H 5N4, Canada; [Carrier, Julie C.] Univ Sherbrooke, Fac Med & Sci Sante, Dept Med, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke; Institute for Work & Health; University of Sherbrooke; University of Sherbrooke	Perreault, N (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Anat & Biol Cellulaire, 3001 12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	nathalie.perreault@usherbrooke.ca			Canadian Institutes of Health Research (CIHR) [MOP-84327, MT-14405, CTP-82942]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research was supported by the Canadian Institutes of Health Research (CIHR) (MOP-84327 to N.P. and MT-14405 to N.R.) and a CIHR team grant (CTP-82942). N.P., N.R., F.B., and J.C. are members of the Fonds de la Recherche en Sante du Quebec (FRSQ)-funded Centre de Recherche Clinique Etienne Lebel. N.P., F.B., and J.C. are scholars from the FRSQ. N.R. is the recipient of a Canadian Research Chair in Signaling and Digestive Physiopathology. M.-J.L. is the recipient of a Natural Sciences and Engineering Research Council of Canada fellowship. The authors thank Elizabeth Herring for critical reading of the manuscript, M.P. Garand and S. Lamarre for help with statistical analysis, and Dr. Deborah L. Gumucio (University of Michigan, Ann Arbor, MI, USA) for providing the 12.4-kbVilCre transgenic line used in the study.	Abubaker J, 2008, ONCOGENE, V27, P3539, DOI 10.1038/sj.onc.1211013; Auclair BA, 2007, GASTROENTEROLOGY, V133, P887, DOI 10.1053/j.gastro.2007.06.066; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Boulanger J, 2005, J BIOL CHEM, V280, P18095, DOI 10.1074/jbc.M502184200; Chow LML, 2006, CANCER LETT, V241, P184, DOI 10.1016/j.canlet.2005.11.042; Clarke AR, 2006, ONCOGENE, V25, P7512, DOI 10.1038/sj.onc.1210065; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Duchesne C, 2003, J BIOL CHEM, V278, P14274, DOI 10.1074/jbc.M300425200; Goessling W, 2006, GASTROENTEROL CLIN N, V35, P713, DOI 10.1016/j.gtc.2006.07.006; Hardwick JC, 2008, NAT REV CANCER, V8, P806, DOI 10.1038/nrc2467; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Kim S, 2002, GASTROENTEROLOGY, V123, P1163, DOI 10.1053/gast.2002.36043; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Lopez-Diaz L, 2007, DEV BIOL, V309, P298, DOI 10.1016/j.ydbio.2007.07.015; Lu TL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001237; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MENARD D, 1985, GASTROENTEROLOGY, V88, P691, DOI 10.1016/0016-5085(85)90139-8; Menard D, 2006, CELL SIGNALING AND GROWTH FACTORS IN DEVELOPMENT: FROM MOLECULES TO ORGANOGENESIS, P755; Munkholm P, 2003, ALIMENT PHARM THER, V18, P1, DOI 10.1046/j.1365-2036.18.s2.2.x; Mutoh H, 1997, P NATL ACAD SCI USA, V94, P3560, DOI 10.1073/pnas.94.8.3560; Ng AYN, 2002, GASTROENTEROLOGY, V122, P1455, DOI 10.1053/gast.2002.32990; Perreault N, 2005, GENE DEV, V19, P311, DOI 10.1101/gad.1260605; Perreault N, 2001, J BIOL CHEM, V276, P43328, DOI 10.1074/jbc.M104366200; Philipp-Staheli J, 2002, CANCER CELL, V1, P355, DOI 10.1016/S1535-6108(02)00054-5; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Sansom OJ, 2005, J BIOL CHEM, V280, P28463, DOI 10.1074/jbc.M500191200; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Shao J, 2007, CARCINOGENESIS, V28, P2476, DOI 10.1093/carcin/bgm186; Shroyer NF, 2007, GASTROENTEROLOGY, V133, P1035, DOI 10.1053/j.gastro.2007.07.018; STEIN ED, 1989, J NUTR, V119, P1973, DOI 10.1093/jn/119.12.1973; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Vagefi Parsia A, 2005, Clin Colorectal Cancer, V4, P313, DOI 10.3816/CCC.2005.n.003; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Varnat F, 2006, GASTROENTEROLOGY, V131, P538, DOI 10.1053/j.gastro.2006.05.004; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Yoo LI, 2006, CANCER RES, V66, P1929, DOI 10.1158/0008-5472.CAN-05-1986	47	29	31	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1835	1844		10.1096/fj.08-123125	http://dx.doi.org/10.1096/fj.08-123125			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19168705				2022-12-25	WOS:000266652400024
J	Bard, JD; Gelebart, P; Amin, HM; Young, LC; Ma, Y; Lai, R				Bard, J. Dien; Gelebart, P.; Amin, H. M.; Young, L. C.; Ma, Y.; Lai, R.			Signal transducer and activator of transcription 3 is a transcriptional factor regulating the gene expression of SALL4	FASEB JOURNAL			English	Article						cell signaling; luciferase assay; chromatin immunoprecipitation	EMBRYONIC STEM-CELLS; LEUKEMIA INHIBITORY FACTOR; BREAST-CANCER; SELF-RENEWAL; FACTOR-RECEPTOR; MOUSE EMBRYOS; ONCOSTATIN M; DNA-BINDING; IN-VITRO; ES CELLS	Both signal transducer and activator of transcription 3 (STAT3) and SALL4 are important in maintaining the pluripotent and self-renewal state of embryonic stem cells. We hypothesized that STAT3, a latent transcriptional factor, may regulate the gene expression of SALL4. In support of this hypothesis, DNA sequence analysis of the SALL4 gene promoter revealed four putative STAT3-binding sites. Using a SALL4-luciferase reporter gene assay, we found that modulation of the STAT3 activity significantly up-regulated the luciferase activity. By chromatin immunoprecipitation, the segment of the SALL4 promoter showing the highest affinity to STAT3 was localized to -366 to -163, in which there was only one putative STAT3 binding site starting at -199. Site-directed mutagenesis of all four putative STAT3-binding sites in the SALL4 promoter significantly reduced its responsiveness to STAT3, although the most dramatic effect was seen at the binding site starting at -199. We further tested the functional relationship between STAT3 and SALL4 using MDA-MB-231, a breast cell line carrying constitutive SALL4 expression and STAT3 activity. Down-regulation of the STAT3 activity using a dominant-negative construct resulted in a significant decrease in the expression of SALL4. To conclude, our data suggest that STAT3 and SALL4 probably cooperate in both physiological and pathological states.-Dien Bard, J., Gelebart, P., Amin, H. M., Young, L. C., Ma, Y., Lai, R. Signal transducer and activator of transcription 3 is a transcriptional factor regulating the gene expression of SALL4. FASEB J. 23, 1405-1414 (2009)	[Bard, J. Dien; Gelebart, P.; Young, L. C.; Lai, R.] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB T6G 1Z2, Canada; [Amin, H. M.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Ma, Y.] Nevada Canc Ctr, Dept Hematopathol, Las Vegas, NV USA	University of Alberta; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Diego	Lai, R (corresponding author), Univ Alberta, Dept Lab Med & Pathol, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada.	raymondl@cancerboard.ab.ca	Young, Leah/AAN-3579-2020; Young, Leah C/B-9051-2012; Gelebart, Pascal/AAI-1439-2020	Young, Leah C/0000-0001-7156-1006; Gelebart, Pascal/0000-0003-2434-8987	Canadian Institute of Health Research; Canadian Cancer Society; Lymphoma Research Foundation of Canada Fellowship Award	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Lymphoma Research Foundation of Canada Fellowship Award	We thank Dr. Hanan Armanious for her technical assistance. This study was supported by research grants from the Canadian Institute of Health Research and the Canadian Cancer Society awarded to R.L. P.G. is a recipient of a Lymphoma Research Foundation of Canada Fellowship Award.	Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Amin HM, 2003, ARCH PATHOL LAB MED, V127, P424; Amin HM, 2004, ONCOGENE, V23, P5426, DOI 10.1038/sj.onc.1207703; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bohm J, 2006, BIOCHEM BIOPH RES CO, V348, P898, DOI 10.1016/j.bbrc.2006.07.124; Boeuf H, 1997, J CELL BIOL, V138, P1207, DOI 10.1083/jcb.138.6.1207; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Burke WM, 2001, ONCOGENE, V20, P7925, DOI 10.1038/sj.onc.1204990; Chambers I, 2004, CLONING STEM CELLS, V6, P386, DOI 10.1089/clo.2004.6.386; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Clevenger CV, 2004, AM J PATHOL, V165, P1449, DOI 10.1016/S0002-9440(10)63403-7; Cui W, 2006, MODERN PATHOL, V19, P1585, DOI 10.1038/modpathol.3800694; Dien J, 2006, AM J PATHOL, V169, P633, DOI 10.2353/ajpath.2006.051109; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Guo Y, 2008, STEM CELLS, V26, P30, DOI 10.1634/stemcells.2007-0401; Kohlhase J, 1996, GENOMICS, V38, P291, DOI 10.1006/geno.1996.0631; Kunisada K, 1998, CIRCULATION, V98, P346, DOI 10.1161/01.CIR.98.4.346; Ma YP, 2006, BLOOD, V108, P2726, DOI 10.1182/blood-2006-02-001594; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Monk M, 2001, ONCOGENE, V20, P8085, DOI 10.1038/sj.onc.1205088; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2001, CELL STRUCT FUNCT, V26, P137, DOI 10.1247/csf.26.137; Qian L, 2006, BIOCHEM BIOPH RES CO, V345, P660, DOI 10.1016/j.bbrc.2006.04.153; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Scholz A, 2003, GASTROENTEROLOGY, V125, P891, DOI 10.1016/S0016-5085(03)01064-3; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Skinnider BF, 1999, HEMATOL ONCOL, V17, P137, DOI 10.1002/(SICI)1099-1069(199912)17:4<137::AID-HON642>3.3.CO;2-M; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Vernallis AB, 1997, J BIOL CHEM, V272, P26947, DOI 10.1074/jbc.272.43.26947; Yang JC, 2008, BLOOD, V112, P805, DOI 10.1182/blood-2007-11-126326; Yang JC, 2007, P NATL ACAD SCI USA, V104, P10494, DOI 10.1073/pnas.0704001104; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zamo A, 2002, ONCOGENE, V21, P1038, DOI 10.1038/sj.onc.1205152; Zhang F, 2003, ONCOGENE, V22, P894, DOI 10.1038/sj.onc.1206158; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	44	43	46	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2009	23	5					1405	1414		10.1096/fj.08-117721	http://dx.doi.org/10.1096/fj.08-117721			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19151334				2022-12-25	WOS:000266651700017
J	Matalon, S; Shrestha, K; Kirk, M; Waldheuser, S; McDonald, B; Smith, K; Gao, ZQ; Belaaouaj, A; Crouch, EC				Matalon, Sadis; Shrestha, Kedar; Kirk, Marion; Waldheuser, Stephanie; McDonald, Barbara; Smith, Kelly; Gao, Zhiqian; Belaaouaj, Abderrazzak; Crouch, Erika C.			Modification of surfactant protein D by reactive oxygen-nitrogen intermediates is accompanied by loss of aggregating activity, in vitro and in vivo	FASEB JOURNAL			English	Article						collectin; covalent cross-linking; free radicals; nitrogen dioxide; peroxynitrite	RESPIRATORY-DISTRESS-SYNDROME; NITRIC-OXIDE; TYROSINE NITRATION; SP-A; BACTERIAL LIPOPOLYSACCHARIDES; CARBOHYDRATE-RECOGNITION; BRONCHOALVEOLAR LAVAGE; KLEBSIELLA-PNEUMONIAE; ALVEOLAR MACROPHAGES; HYDROGEN-PEROXIDE	Surfactant protein D (SP-D) is an important effector of innate immunity. We have previously shown that SP-D accumulates at sites of acute bacterial infection and neutrophil infiltration, a setting associated with the release of reactive species such as peroxynitrite. Incubation of native SP-D or trimeric SP-D lectin domains (NCRDs) with peroxynitrite resulted in nitration and nondisulfide cross-linking. Modifications were blocked by peroxynitrite scavengers or pH inactivation of peroxynitrite, and mass spectroscopy confirmed nitration of conserved tyrosine residues within the C-terminal neck and lectin domains. Mutant NCRDs lacking one or more of the tyrosines allowed us to demonstrate preferential nitration of Tyr314 and the formation of Tyr228-dependent cross-links. Although there was no effect of peroxynitrite or tyrosine mutations on lectin activity, incubation of SP-D dodecamers or murine lavage with peroxynitrite decreased the SP-D-dependent aggregation of lipopolysaccharide-coated beads, supporting our hypothesis that defective aggregation results from abnormal cross-linking. We also observed nitration, cross-linking of SP-D, and a significant decrease in SP-D-dependent aggregating activity in the lavage of mice acutely exposed to nitrogen dioxide. Thus, modification of SP-D by reactive oxygen-nitrogen species could contribute to alterations in the structure and function of SP-D at sites of inflammation in vivo.-Matalon, S., Shrestha, K., Kirk, M., Waldheuser, S., McDonald, B., Smith, K., Gao, Z., Belaaouaj, A., Crouch, E. C. Modification of surfactant protein D by reactive oxygen-nitrogen intermediates is accompanied by loss of aggregating activity, in vitro and in vivo. FASEB J. 23, 1415-1430 (2009)	[Waldheuser, Stephanie; McDonald, Barbara; Smith, Kelly; Crouch, Erika C.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Matalon, Sadis; Shrestha, Kedar; Gao, Zhiqian] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL USA; [Matalon, Sadis] Univ Alabama Birmingham, Dept Environm Hlth Sci, Birmingham, AL USA; [Kirk, Marion] Univ Alabama Birmingham, Sch Med, Ctr Comprehens Canc, Mass Spectrometry Facil, Birmingham, AL USA; [Kirk, Marion] Univ Alabama Birmingham, Sch Publ Hlth, Ctr Comprehens Canc, Mass Spectrometry Facil, Birmingham, AL USA; [Belaaouaj, Abderrazzak] INSERM, UMRS 514, Reims, France	Washington University (WUSTL); University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Institut National de la Sante et de la Recherche Medicale (Inserm)	Crouch, EC (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, Campus Box 8118,660 S Euclid, St Louis, MO 63110 USA.	crouch@path.wustl.edu	Bentaher, Abderrazzaq/M-4424-2017; A, Bentaher/F-6531-2018	A, Bentaher/0000-0001-6001-5456	U.S. National Institutes of Health [HL-44015, HL-29594, UO1ES015676, HL075540, HL311197]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075540, R01HL044015, P01HL029594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES015676] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Sharmin Sheikh and Bruce Linders for technical assistance, and Janet North for administrative support. We thank Dr. Edward Postlethwait and his lab for performing the nitrogen dioxide exposures. We also thank German Fierro Perez for work performed early in the course of this investigation. The studies were supported by U.S. National Institutes of Health grants HL-44015 and HL-29594 (E.C.C.) and UO1ES015676, HL075540, and HL311197 (S.M.).	BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; COCHRANE CG, 1983, J CLIN INVEST, V71, P754, DOI 10.1172/JCI110823; Crouch E, 2005, J BIOL CHEM, V280, P17046, DOI 10.1074/jbc.M413932200; Crouch E, 2001, ANNU REV PHYSIOL, V63, P521, DOI 10.1146/annurev.physiol.63.1.521; Crouch E, 2000, IMMUNOL REV, V173, P52, DOI 10.1034/j.1600-065X.2000.917311.x; Crouch E C, 2000, Respir Res, V1, P93; Crouch E, 2007, BIOCHEMISTRY-US, V46, P5160, DOI 10.1021/bi700037x; Crouch E, 2006, J BIOL CHEM, V281, P18008, DOI 10.1074/jbc.M601749200; Davis IC, 2002, FREE RADICAL BIO MED, V33, P1703, DOI 10.1016/S0891-5849(02)01170-X; Eiserich JP, 1996, J BIOL CHEM, V271, P19199, DOI 10.1074/jbc.271.32.19199; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Gaut JP, 2002, J CLIN INVEST, V109, P1311, DOI 10.1172/JCI200215021; Gole MD, 2000, AM J PHYSIOL-LUNG C, V278, pL961, DOI 10.1152/ajplung.2000.278.5.L961; Greene KE, 1999, AM J RESP CRIT CARE, V160, P1843, DOI 10.1164/ajrccm.160.6.9901117; Greis KD, 1996, ARCH BIOCHEM BIOPHYS, V335, P396, DOI 10.1006/abbi.1996.0522; Griese M, 2003, BBA-MOL BASIS DIS, V1638, P157, DOI 10.1016/S0925-4439(03)00063-2; Guo CJ, 2008, PLOS BIOL, V6, P2414, DOI 10.1371/journal.pbio.0060266; Haddad IY, 1996, AM J PHYSIOL-LUNG C, V270, pL281, DOI 10.1152/ajplung.1996.270.2.L281; HADDAD IY, 1994, AM J PHYSIOL, V267, pL242, DOI 10.1152/ajplung.1994.267.3.L242; HARTSHORN KL, 1994, J CLIN INVEST, V94, P311, DOI 10.1172/JCI117323; Head JF, 2003, J BIOL CHEM, V278, P43254, DOI 10.1074/jbc.M305628200; Herbein JF, 2001, AM J PHYSIOL-LUNG C, V281, pL268, DOI 10.1152/ajplung.2001.281.1.L268; Hirche TO, 2004, J BIOL CHEM, V279, P27688, DOI 10.1074/jbc.M402936200; Honda Y, 1996, CHEST, V109, P1006, DOI 10.1378/chest.109.4.1006; HOPPE HJ, 1994, FEBS LETT, V344, P191, DOI 10.1016/0014-5793(94)00383-1; Kirsch M, 1998, J BIOL CHEM, V273, P12716, DOI 10.1074/jbc.273.21.12716; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Kishore U, 2001, Results Probl Cell Differ, V33, P225; Kovacs H, 2002, J BIOMOL NMR, V24, P89, DOI 10.1023/A:1020980006628; KUAN SF, 1992, J CLIN INVEST, V90, P97, DOI 10.1172/JCI115861; Madsen J, 2000, J IMMUNOL, V164, P5866, DOI 10.4049/jimmunol.164.11.5866; Matalon S, 1996, AM J PHYSIOL-LUNG C, V270, pL273, DOI 10.1152/ajplung.1996.270.2.L273; Ofek I, 2001, INFECT IMMUN, V69, P24, DOI 10.1128/IAI.69.1.24-33.2001; Postle AD, 1999, AM J RESP CELL MOL, V20, P90, DOI 10.1165/ajrcmb.20.1.3253; Quinlan GJ, 1997, AM J RESP CRIT CARE, V155, P479, DOI 10.1164/ajrccm.155.2.9032182; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Sahly H, 2002, J IMMUNOL, V169, P3267, DOI 10.4049/jimmunol.169.6.3267; Shrive AK, 2003, J MOL BIOL, V331, P509, DOI 10.1016/S0022-2836(03)00761-7; Souza JM, 1999, ARCH BIOCHEM BIOPHYS, V371, P169, DOI 10.1006/abbi.1999.1480; Starosta V, 2006, FREE RADICAL RES, V40, P419, DOI 10.1080/10715760600571248; SZNAJDER JI, 1989, CHEST, V96, P606, DOI 10.1378/chest.96.3.606; van Rozendaal BAWM, 1999, BBA-MOL BASIS DIS, V1454, P261, DOI 10.1016/S0925-4439(99)00042-3; vanderVliet A, 1997, J BIOL CHEM, V272, P7617, DOI 10.1074/jbc.272.12.7617; Velsor LW, 1997, AM J PHYSIOL-LUNG C, V273, pL1265, DOI 10.1152/ajplung.1997.273.6.L1265; von Bredow C, 2003, LUNG, V181, P79, DOI 10.1007/s00408-003-1008-z; Wang H, 2008, BIOCHEMISTRY-US, V47, P710, DOI 10.1021/bi7020553; Whitsett JA, 2005, BIOL NEONATE, V88, P175, DOI 10.1159/000087580; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Zhu S, 2001, AM J RESP CRIT CARE, V163, P166, DOI 10.1164/ajrccm.163.1.2005068; Zhu S, 1998, AM J PHYSIOL-LUNG C, V275, pL1031, DOI 10.1152/ajplung.1998.275.6.L1031; Zhu S, 1996, ARCH BIOCHEM BIOPHYS, V333, P282, DOI 10.1006/abbi.1996.0392; Zhu S, 2000, AM J PHYSIOL-LUNG C, V278, pL1025, DOI 10.1152/ajplung.2000.278.5.L1025	52	48	49	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2009	23	5					1415	1430		10.1096/fj.08-120568	http://dx.doi.org/10.1096/fj.08-120568			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19126597	Green Published			2022-12-25	WOS:000266651700018
J	Wu, D; Li, Y; Song, GJ; Zhang, D; Shaw, N; Liu, ZJ				Wu, Dong; Li, Yang; Song, Gaojie; Zhang, David; Shaw, Neil; Liu, Zhi-Jie			Crystal structure of human esterase D: a potential genetic marker of retinoblastoma	FASEB JOURNAL			English	Article						Wilson disease; X-ray; endogenous uveitis; hydrolase fold; carcinoma	S-FORMYLGLUTATHIONE HYDROLASE; LINKAGE; CLONING; MODEL; CHROMOSOME-13; ASSIGNMENT; IDENTITY	Retinoblastoma (RB), a carcinoma of the retina, is caused by mutations in the long arm of chromosome 13, band 13q14. The esterase D (ESD) gene maps at a similar location as the RB gene locus and therefore serves as a potential marker for the prognosis of retinoblastoma. Because very little is known about the structure and function of ESD, we determined the 3-dimensional structure of the enzyme at 1.5 angstrom resolution using X-ray crystallography. ESD shows a single domain with an alpha/beta-hydrolase fold. A number of insertions are observed in the canonical alpha/beta-hydrolase fold. The active site is located in a positively charged, shallow cleft on the surface lined by a number of aromatic residues. Superimposition studies helped identify the typical catalytic triad residues-Ser-153, His264, and Asp230-involved in catalysis. Mutagenesis of any of the catalytic triad residues to alanine abolished the enzyme activity. Backbone amides of Leu54 and Met150 are involved in the formation of the oxyanion hole. Interestingly, a M150A mutation increased the enzyme activity by 62%. The structure of human ESD determined in this study will aid the elucidation of the physiological role of the enzyme in the human body and will assist in the early diagnosis of retinoblastoma. Wu, D., Li, Y., Song, G., Zhang, D., Shaw, N., Liu, Z. J. Crystal structure of human esterase D: a potential genetic marker of retinoblastoma. FASEB J. 23, 1441-1446 (2009)	[Wu, Dong; Li, Yang; Song, Gaojie; Zhang, David; Shaw, Neil; Liu, Zhi-Jie] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS	Shaw, N (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Lu, Beijing 100101, Peoples R China.	neilshaw@moon.ibp.ac.cn; zjliu@ibp.ac.cn	Liu, Zhi-Jie/A-3946-2012; Li, Yang/G-3685-2011; Li, Yang/M-1246-2013	Liu, Zhi-Jie/0000-0001-7279-2893; Shaw, Neil/0000-0003-2722-9967	National Natural Science Foundation of China [20572063, 30670427, 30721003]; Ministry of Science and Technology of China [2006AA02A316, 2006CB910901]; Ministry of Health of China [2008ZX10404]; China Postdoctoral Science Foundation [20070420533]; Chinese Academy of Sciences research [07CF09]; Office of Basic Energy Sciences; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Health of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chinese Academy of Sciences research(Chinese Academy of Sciences); Office of Basic Energy Sciences(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was funded by the National Natural Science Foundation of China (grants 20572063, 30670427, and 30721003), the Ministry of Science and Technology of China (grants 2006AA02A316 and 2006CB910901), the Ministry of Health of China (grant 2008ZX10404), the China Postdoctoral Science Foundation (20070420533), and a Chinese Academy of Sciences research grant (07CF09). Crystallographic data were collected at SER-CAT 22-ID beamline at the Advanced Photon Source (Argonne National Laboratory, Lemont, IL, USA). The use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract W-31-109-Eng-38. Atomic coordinates and structure factors of human esterase D have been deposited in the Protein Data Bank under accession code 3FCX.	BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; COWELL JK, 1987, ARCH DIS CHILD, V62, P8, DOI 10.1136/adc.62.1.8; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; EIBERG H, 1986, HUM GENET, V74, P174, DOI 10.1007/BF00282085; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRYDMAN M, 1985, P NATL ACAD SCI USA, V82, P1819, DOI 10.1073/pnas.82.6.1819; Harms N, 1996, J BACTERIOL, V178, P6296, DOI 10.1128/jb.178.21.6296-6299.1996; Kim MH, 2008, PROTEINS, V70, P578, DOI 10.1002/prot.21680; Larsen NA, 2006, BIOCHEMISTRY-US, V45, P10184, DOI 10.1021/bi060950i; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; LEE EYHP, 1986, P NATL ACAD SCI USA, V83, P6337, DOI 10.1073/pnas.83.17.6337; LEE WH, 1986, P NATL ACAD SCI USA, V83, P6790, DOI 10.1073/pnas.83.18.6790; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; Legler PM, 2008, BIOCHEMISTRY-US, V47, P9592, DOI 10.1021/bi8010016; LOUGHNA S, 1993, AM J HUM GENET, V53, P810; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okunuki Y, 2008, MOL VIS, V14, P1094; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ronning DR, 2000, NAT STRUCT BIOL, V7, P141; Schefler AC, 2008, CURR OPIN OPHTHALMOL, V19, P526, DOI 10.1097/ICU.0b013e328312975b; Shields CL, 2006, J PEDIAT OPHTH STRAB, V43, P313, DOI 10.3928/01913913-20060901-08; SPARKES RS, 1983, SCIENCE, V219, P971, DOI 10.1126/science.6823558; SPARKES RS, 1980, SCIENCE, V208, P1042, DOI 10.1126/science.7375916; SQUIRE J, 1986, P NATL ACAD SCI USA, V83, P6573, DOI 10.1073/pnas.83.17.6573; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; VARKI A, 1986, P NATL ACAD SCI USA, V83, P882, DOI 10.1073/pnas.83.4.882; YOUNG LJS, 1988, HUM GENET, V79, P137, DOI 10.1007/BF00280552; YUZBASIYANGURKAN V, 1993, GENOMICS, V15, P86, DOI 10.1006/geno.1993.1013	28	27	32	2	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2009	23	5					1441	1446		10.1096/fj.08-125286	http://dx.doi.org/10.1096/fj.08-125286			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19126594				2022-12-25	WOS:000266651700020
J	Meng, D; Lynch, MJ; Huston, E; Beyermann, M; Eichhorst, J; Adams, DR; Klussmann, E; Houslay, MD; Baillie, GS				Meng, Dong; Lynch, Martin J.; Huston, Elaine; Beyermann, Michael; Eichhorst, Jenny; Adams, David R.; Klussmann, Enno; Houslay, Miles D.; Baillie, George S.			MEK1 Binds Directly to beta Arrestin1, Influencing Both Its Phosphorylation by ERK and the Timing of Its Isoprenaline-stimulated Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-SPECIFIC PHOSPHODIESTERASE; SIGNALING SCAFFOLD PROTEINS; COUPLED-RECEPTOR KINASES; BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTOR; MEMBRANE TRANSLOCATION; ADRENERGIC-RECEPTOR; REGULATED KINASES; TERMINAL REGION; MAP KINASE	beta Arrestin is a multifunctional signal scaffold protein. Using SPOT immobilized peptide arrays, coupled with scanning alanine substitution and mutagenesis, we show that the MAPK kinase, MEK1, interacts directly with beta arrestin1. Asp26 and Asp29 in the N-terminal domain of beta arrestin1 are critical for its binding to MEK1, whereas Arg47 and Arg49 in the N-terminal domain of MEK1 are critical for its binding to beta arrestin1. Wildtype FLAG-tagged beta arrestin1 co-immunopurifies with MEK1 in HEKB2 cells, whereas the D26A/D29A mutant does not. ERK-dependent phosphorylation at Ser412 was compromised in the D26A/D29A-beta arrestin1 mutant. A cell-permeable, 25-mer N-stearoylated beta arrestin1 peptide that encompassed the N-domain MEK1 binding site blocked beta arrestin1/MEK1 association in HEK cells and recapitulated the altered phenotype seen with the D26A/D29A-beta arrestin1 in compromising the ERK-dependent phosphorylation of beta arrestin1. In addition, the MEK disruptor peptide promoted the ability of beta arrestin1 to co-immunoprecipitate with endogenous c-Src and clathrin, facilitating the isoprenaline-stimulated internalization of the beta(2)-adrenergic receptor.	[Meng, Dong; Lynch, Martin J.; Huston, Elaine; Houslay, Miles D.; Baillie, George S.] Univ Glasgow, Fac Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Beyermann, Michael; Eichhorst, Jenny; Klussmann, Enno] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Adams, David R.] Heriot Watt Univ, Dept Chem, Edinburgh EH14 4AS, Midlothian, Scotland	University of Glasgow; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Heriot Watt University	Baillie, GS (corresponding author), Univ Glasgow, Fac Biomed & Life Sci, Wolfson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	gbma25@udcf.gla.ac.uk	Houslay, Miles/AAM-5281-2020; Adams, David R/E-3916-2010; Houslay, Miles D/A-6825-2011	Adams, David R/0000-0002-7154-7332; Houslay, Miles/0000-0002-3826-8091	Medical Research Council [G8604010, G0400053]; European Union [037189]; Fondation Leducq [06CVD02]; MRC [G8604010, G0600765, G0400053] Funding Source: UKRI; Medical Research Council [G0600765] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Fondation Leducq(Leducq Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council Grants G8604010 and G0400053, European Union Grant 037189, and Fondation Leducq Grant 06CVD02. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ahn S, 1999, J BIOL CHEM, V274, P1185, DOI 10.1074/jbc.274.3.1185; Baillie GS, 2007, BIOCHEM J, V404, P71, DOI 10.1042/BJ20070005; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Bolger GB, 2003, J BIOL CHEM, V278, P49230, DOI 10.1074/jbc.M303772200; Bolger GB, 2006, BIOCHEM J, V398, P23, DOI 10.1042/BJ20060423; CATLING AD, 1995, MOL CELL BIOL, V15, P5214; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; English JM, 2002, TRENDS PHARMACOL SCI, V23, P40, DOI 10.1016/S0165-6147(00)01865-4; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Futaki S, 2001, BIOCONJUGATE CHEM, V12, P1005, DOI 10.1021/bc015508l; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2003, STRUCTURE, V11, P1037, DOI 10.1016/S0969-2126(03)00184-9; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hupfeld CJ, 2005, J BIOL CHEM, V280, P1016, DOI 10.1074/jbc.M403674200; Kim YM, 2002, J BIOL CHEM, V277, P16837, DOI 10.1074/jbc.M201379200; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; LEFKOWITZ RJ, 1992, COLD SPRING HARB SYM, V57, P127, DOI 10.1101/SQB.1992.057.01.016; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Li X, 2006, BIOCHEM J, V394, P427, DOI 10.1042/BJ20051560; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Lin FT, 2002, BIOCHEMISTRY-US, V41, P10692, DOI 10.1021/bi025705n; Lin FT, 1999, J BIOL CHEM, V274, P15971, DOI 10.1074/jbc.274.23.15971; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; MacKenzie SJ, 2000, BIOCHEM J, V347, P571, DOI 10.1042/0264-6021:3470571; McDonald PH, 2001, CELL SIGNAL, V13, P683, DOI 10.1016/S0898-6568(01)00203-0; Milano SK, 2006, J BIOL CHEM, V281, P9812, DOI 10.1074/jbc.M512703200; Miller WE, 2000, J BIOL CHEM, V275, P11312, DOI 10.1074/jbc.275.15.11312; Murdoch H, 2007, J NEUROSCI, V27, P9513, DOI 10.1523/JNEUROSCI.1493-07.2007; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Pelaia G, 2005, J CELL PHYSIOL, V202, P642, DOI 10.1002/jcp.20169; Perry SJ, 2002, TRENDS CELL BIOL, V12, P130, DOI 10.1016/S0962-8924(01)02239-5; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Shepherd MC, 2004, BRIT J PHARMACOL, V142, P339, DOI 10.1038/sj.bjp.0705770; Smith KJ, 2007, CELL SIGNAL, V19, P2612, DOI 10.1016/j.cellsig.2007.08.015; SONG X, 2008, J BIOL CHEM; Sweeney SE, 2006, ANN RHEUM DIS, V65, P83, DOI 10.1136/ard.2006.058388; Tanoue T, 2002, PHARMACOL THERAPEUT, V93, P193, DOI 10.1016/S0163-7258(02)00188-2; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Vishnivetskiy SA, 2004, J BIOL CHEM, V279, P1262, DOI 10.1074/jbc.M308834200; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Xu TR, 2008, BIOCHEM J, V413, P51, DOI 10.1042/BJ20080685	46	51	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11425	11435		10.1074/jbc.M806395200	http://dx.doi.org/10.1074/jbc.M806395200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19153083	Green Published, hybrid			2022-12-25	WOS:000265494500047
J	Rider, LW; Ottosen, MB; Gattis, SG; Palfey, BA				Rider, Lance W.; Ottosen, Mette B.; Gattis, Samuel G.; Palfey, Bruce A.			Mechanism of Dihydrouridine Synthase 2 from Yeast and the Importance of Modifications for Efficient tRNA Reduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; BIOSYNTHESIS; TEMPERATURE; FAMILY	Dihydrouridinesynthases(DUSs) areflavin-dependent enzymes that catalyze site-specific reduction of uracils in tRNAs. The mechanism of DUS2 from Saccharomyces cerevisiae was studied. Previously published turnover rates for this DUS were very low. Our studies show that the catalytic cycle consists of reductive and oxidative half-reactions. The enzyme is reduced by NADPH rapidly but has a very slow oxidative half-reaction using in vitro transcribed tRNA substrates. Using tRNALeu purified from a DUS 2 knockout strain of yeast we obtained reaction rate enhancements of 600-fold over in vitro transcribed substrates, indicating that other RNA modifications are required for rapid uracil reduction. This demonstrates a previously unknown ordering of modifications and indicates that dihydrouridine formation is a later step in tRNA maturation. We also show that an active site cysteine is important for catalysis, likely in the protonation of uracil during tRNA reduction. Dihydrouridine of modified tRNA from Escherichia coli was also oxidized to uridine showing the reaction to be reversible.	[Rider, Lance W.; Ottosen, Mette B.; Gattis, Samuel G.; Palfey, Bruce A.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Palfey, BA (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	brupalf@umich.edu		Palfey, Bruce/0000-0001-5098-259X	National Institutes of Health [GM61087]; University of Michigan Biomedical Research Council [G001915]; NIGMS [GM08597]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061087, T32GM008597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Biomedical Research Council(University of Michigan System); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM61087. This work was also supported by the University of Michigan Biomedical Research Council (Grant G001915). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by NIGMS Training Grant GM08597.	Alexandrov A, 2006, MOL CELL, V21, P87, DOI 10.1016/j.molcel.2005.10.036; Bishop AC, 2002, J BIOL CHEM, V277, P25090, DOI 10.1074/jbc.M203208200; Cavaille J, 1999, RNA, V5, P66, DOI 10.1017/S1355838299981475; Dalluge JJ, 1996, NUCLEIC ACIDS RES, V24, P1073, DOI 10.1093/nar/24.6.1073; ENGEL PC, 1977, ANAL BIOCHEM, V82, P512, DOI 10.1016/0003-2697(77)90190-7; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; House CH, 1996, BIOCHEMISTRY-US, V35, P315, DOI 10.1021/bi951577+; HUNNINGHAKE D, 1966, ANAL BIOCHEM, V16, P200, DOI 10.1016/0003-2697(66)90147-3; Kallansrud G, 1996, ANAL BIOCHEM, V236, P134, DOI 10.1006/abio.1996.0141; Kato T, 2005, CANCER RES, V65, P5638, DOI 10.1158/0008-5472.CAN-05-0600; KUCHINO Y, 1978, NATURE, V271, P126, DOI 10.1038/271126a0; Noon KR, 2003, J BACTERIOL, V185, P5483, DOI 10.1128/JB.185.18.5483-5490.2003; OTTOLINA G, 1989, BIOCHIM BIOPHYS ACTA, V998, P173, DOI 10.1016/0167-4838(89)90270-7; Palfey B. A., 1998, COMPREHENSIVE BIOL C, VIII, P83; PALTEY BA, 2003, KINETIC ANAL MACROMO, P203; Park F, 2004, PROTEINS, V55, P772, DOI 10.1002/prot.20086; Savage DF, 2006, FEBS LETT, V580, P5198, DOI 10.1016/j.febslet.2006.08.062; Shigi N, 2006, J BIOL CHEM, V281, P2104, DOI 10.1074/jbc.M510771200; Sprinzl M, 1996, NUCLEIC ACIDS RES, V24, P68, DOI 10.1093/nar/24.1.68; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WHITBY LG, 1953, BIOCHEM J, V54, P437, DOI 10.1042/bj0540437; Xing F, 2004, J BIOL CHEM, V279, P17850, DOI 10.1074/jbc.M401221200; Xing F, 2002, RNA, V8, P370, DOI 10.1017/S1355838202029825	24	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10324	10333		10.1074/jbc.M806137200	http://dx.doi.org/10.1074/jbc.M806137200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19139092	hybrid, Green Published			2022-12-25	WOS:000265104600006
J	Hiyama, A; Gajghate, S; Sakai, D; Mochida, J; Shapiro, IM; Risbud, MV				Hiyama, Akihiko; Gajghate, Sachin; Sakai, Daisuke; Mochida, Joji; Shapiro, Irving M.; Risbud, Makarand V.			Activation of TonEBP by Calcium Controls beta 1,3-Glucuronosyltransferase-I Expression, a Key Regulator of Glycosaminoglycan Synthesis in Cells of the Intervertebral Disc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEUS PULPOSUS CELLS; PROTEOGLYCAN SYNTHESIS; GLUCURONOSYLTRANSFERASE-I; CALCINEURIN; PATHWAY; ENZYME; TRANSCRIPTION; DEGENERATION; CHONDROCYTES; HIF-1-ALPHA	The goal of this investigation was to study the expression and regulation of beta 1,3-Glucuronosyltransferase-I (GlcAT-I), a key enzyme regulating GAG synthesis in cells of the intervertebral disc. There was a robust expression of GlcAT-I in the nucleus pulposus in vivo. Treatment with the calcium ionophore ionomycin resulted in increased GlcAT-I expression, whereas GlcAT-I promoter constructs lacking TonE site or a mutant TonE were unresponsive to the ionophore. Experiments using TonEBP and DN-TonEBP constructs showed that TonEBP positively regulated GlcAT-I promoter activity. ChIP analysis confirmed binding of TonEBP to the promoter. We further validated the role of TonEBP in controlling GlcAT-I expression using mouse embryo fibroblasts from TonEBP null mice. GlcAT-I promoter activity in null cells was significantly lower than the wild type cells. In contrast to wild type cells, treatment with ionomycin failed to increase GlcAT-I promoter activity in null cells. Wethen investigated if calcineurin (Cn)-NFAT signaling played a regulatory role in GlcAT-I expression. Inhibition of Cn following ionomycin treatment did not block GlcAT-I and tauT, a TonEBP-responsive reporter activity. GlcAT-I promoter activity was suppressed by co-expression of Cn, NFAT2, NFAT3, and NFAT4. Moreover, following ionomycin treatment, fibroblasts from CnA alpha and CnA beta null mice exhibited robust induction in GlcAT-I promoter activity compared with wild type cells. Results of these studies demonstrate that calcium regulates GlcAT-I expression in cells of the nucleus pulposus through a signaling network comprising both activator and suppressor molecules. The results suggest that by controlling both GAG and aggrecan synthesis, disc cells can autoregulate their osmotic environment and accommodate mechanical loading.	[Hiyama, Akihiko; Gajghate, Sachin; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Dept Orthoped Surg, Philadelphia, PA 19107 USA; [Hiyama, Akihiko; Sakai, Daisuke; Mochida, Joji] Tokai Univ, Sch Med, Dept Orthoped Surg, Kanagawa 2591193, Japan	Jefferson University; Tokai University	Risbud, MV (corresponding author), Thomas Jefferson Univ, Dept Orthoped Surg, 1015 Walnut St,Suite 501 Curtis Bldg, Philadelphia, PA 19107 USA.	makarand.risbud@jefferson.edu	Sakai, Daisuke/X-9164-2019; Hiyama, Akihiko/AAW-7362-2021	Sakai, Daisuke/0000-0003-4189-9270; Hiyama, Akihiko/0000-0002-2474-9118	National Institutes of Health [AR050087, AR055655]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050087, R01AR055655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR050087 and AR055655. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alford AI, 2003, J CELL BIOCHEM, V90, P938, DOI 10.1002/jcb.10715; Bai XM, 1999, J BIOL CHEM, V274, P13017, DOI 10.1074/jbc.274.19.13017; Barre L, 2006, FASEB J, V20, P1692, DOI 10.1096/fj.05-5073fje; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Fagnen G, 2000, J CELL BIOCHEM, V76, P322; Feng HY, 2006, J BONE JOINT SURG AM, V88A, P25, DOI 10.2106/JBJS.E.01341; Gouze JN, 2001, ARTHRITIS RHEUM, V44, P351, DOI 10.1002/1529-0131(200102)44:2<351::AID-ANR53>3.3.CO;2-D; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Ichida M, 2001, J BIOL CHEM, V276, P3524, DOI 10.1074/jbc.M004275200; Ito T, 2004, BIOCHEM J, V382, P177, DOI 10.1042/BJ20031838; Jeon US, 2006, ACTA PHYSIOL, V187, P241, DOI 10.1111/j.1748-1716.2006.01551.x; Kitagawa H, 1996, J BIOL CHEM, V271, P6583, DOI 10.1074/jbc.271.12.6583; Lam AKM, 2004, J BIOL CHEM, V279, P48048, DOI 10.1074/jbc.M407224200; Li SZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1606, DOI 10.1152/ajpcell.00588.2005; Monticelli S, 2002, EUR J IMMUNOL, V32, P2971, DOI 10.1002/1521-4141(2002010)32:10<2971::AID-IMMU2971>3.0.CO;2-G; Ng L, 2003, J STRUCT BIOL, V143, P242, DOI 10.1016/j.jsb.2003.08.006; Parvizi J, 2002, J ORTHOPAED RES, V20, P51, DOI 10.1016/S0736-0266(01)00069-9; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Setton LA, 2006, J BONE JOINT SURG AM, V88A, P52, DOI 10.2106/JBJS.F.00001; Trama J, 2000, J IMMUNOL, V165, P4884, DOI 10.4049/jimmunol.165.9.4884; Tsai TT, 2007, J BONE MINER RES, V22, P965, DOI 10.1359/JBMR.070322; Tsai TT, 2006, J BIOL CHEM, V281, P25416, DOI 10.1074/jbc.M601969200; Venkatesan N, 2004, P NATL ACAD SCI USA, V101, P18087, DOI 10.1073/pnas.0404504102; Vijayagopal P, 2001, ATHEROSCLEROSIS, V157, P353, DOI 10.1016/S0021-9150(00)00742-5; Woo SK, 2002, MOL CELL BIOL, V22, P5753, DOI 10.1128/MCB.22.16.5753-5760.2002; Zeng Y, 2007, J BONE MINER RES, V22, P1851, DOI 10.1359/JBMR.070620	26	39	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9824	9834		10.1074/jbc.M807081200	http://dx.doi.org/10.1074/jbc.M807081200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19147493	Green Published, hybrid			2022-12-25	WOS:000264892900023
J	Kovacs, JM; Hannan, JP; Eisenmesser, EZ; Holers, VM				Kovacs, James M.; Hannan, Jonathan P.; Eisenmesser, Elan Z.; Holers, V. Michael			Mapping of the C3d Ligand Binding Site on Complement Receptor 2 (CR2/CD21) Using Nuclear Magnetic Resonance and Chemical Shift Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSTEIN-BARR-VIRUS; HUMAN LYMPHOCYTES-B; SYSTEMIC-LUPUS-ERYTHEMATOSUS; MONOCLONAL-ANTIBODY; ANTIGEN RECEPTOR; NMR-SPECTROSCOPY; CR-2 CD21; IDENTIFICATION; PROTEIN; EXPRESSION	Complement receptor 2 (CR2, CD21) is a cell membrane protein, with 15 or 16 extracellular short consensus repeats (SCRs), that promotes B lymphocyte responses and bridges innate and acquired immunity. The most distally located SCRs (SCR1-2) mediate the interaction of CR2 with its four known ligands (C3d, Epstein-Barr virus gp350, interferon-alpha, and CD23). Inhibitory monoclonal antibodies against SCR1-2 block binding of all ligands. To develop ligand-specific inhibitors that would also assist in identifying residues unique to each receptor-ligand interaction, phage were selected from randomly generated libraries by panning with recombinant SCR1-2, followed by specific ligand-driven elution. Derived peptides were tested by competition ELISA. One peptide, C3dp1 (APQHLSSQYSRT) exhibited ligand-specific inhibition at midmicromolar IC50. C3d was titrated into N-15-labeled SCR1-2, which revealed chemical shift changes indicative of specific intermolecular interactions. With backbone assignments made, the chemical shift changes were mapped onto the crystal structure of SCR1-2. With regard to C3d, the binding surface includes regions of SCR1, SCR2, and the inter-SCR linker, specifically residues Arg(13), Tyr(16), Arg(28), Tyr(29), Ser(32), Thr(34), Lys(48), Asp(56), Lys(57), Tyr(68), Arg(83), Gly(84), Asn(101), Asn(105), and Ser(109). SCR1 and SCR2 demonstrated distinct binding modes. The CR2 binding surface incorporating SCR1 is inconsistent with a previous x-ray CR2-C3d co-crystal analysis but consistent with mutagenesis, x-ray neutron scattering, and inhibitory monoclonal antibody epitope mapping. Titration with C3dp1 yielded chemical shift changes (Arg(13), Tyr(16), Thr(34), Lys(48), Asp(56), Lys(57), Tyr(68), Arg(83), Gly(84), Asn(105), and Ser(109)) overlapping with C3d, indicating that C3dp1 interacts at the same CR2 site as C3d.	[Kovacs, James M.; Hannan, Jonathan P.; Holers, V. Michael] Univ Colorado Denver, Sch Med, Dept Med, Aurora, CO 80045 USA; [Kovacs, James M.; Hannan, Jonathan P.; Holers, V. Michael] Univ Colorado Denver, Sch Med, Dept Immunol, Aurora, CO 80045 USA; [Eisenmesser, Elan Z.] Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Holers, VM (corresponding author), 1775 N Ursula St,M20-3102E Mail Stop B115, Aurora, CO 80045 USA.	michael.holers@ucdenver.edu		Hannan, Jonathan/0000-0003-3318-2341	National Institutes of Health [R0-1 CA053615]; American Heart Association; University of Colorado Denver-Rocky Mountain Regional [900-MHzNMR]; NATIONAL CANCER INSTITUTE [R01CA053615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of Colorado Denver-Rocky Mountain Regional; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R0-1 CA053615 ( to V. M. H.). This work was also supported by an American Heart Association predoctoral fellowship ( to J. M. K.) and assisted by the University of Colorado Denver-Rocky Mountain Regional 900-MHzNMR Facility. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AHEARN JM, 1989, ADV IMMUNOL, V46, P183, DOI 10.1016/S0065-2776(08)60654-9; Asokan R, 2006, J IMMUNOL, V177, P383, DOI 10.4049/jimmunol.177.1.383; AUBRY JP, 1994, J IMMUNOL, V152, P5806; AUBRY JP, 1992, NATURE, V358, P505, DOI 10.1038/358505a0; BOHNSACK JF, 1988, J IMMUNOL, V141, P2569; CAREL JC, 1990, J BIOL CHEM, V265, P12293; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; CARTER RH, 1988, J IMMUNOL, V141, P457; CARTER RH, 1989, J IMMUNOL, V143, P1755; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Clemenza L, 2000, J IMMUNOL, V165, P3839, DOI 10.4049/jimmunol.165.7.3839; COOPER NR, 1988, ANNU REV IMMUNOL, V6, P85; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DELCAYRE AX, 1991, EMBO J, V10, P919, DOI 10.1002/j.1460-2075.1991.tb08025.x; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; FINGEROTH JD, 1988, J VIROL, V62, P1442, DOI 10.1128/JVI.62.4.1442-1447.1988; FINGEROTH JD, 1984, P NATL ACAD SCI-BIOL, V81, P4510, DOI 10.1073/pnas.81.14.4510; FISCHER E, 1991, J IMMUNOL, V146, P865; FUJISAKU A, 1989, J BIOL CHEM, V264, P2118; Gilbert HE, 2006, J MOL BIOL, V362, P1132, DOI 10.1016/j.jmb.2006.08.012; Gilbert HE, 2005, J MOL BIOL, V346, P859, DOI 10.1016/j.jmb.2004.12.006; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; Guthridge JM, 2001, J IMMUNOL, V167, P5758, DOI 10.4049/jimmunol.167.10.5758; Guthridge JM, 2001, BIOCHEMISTRY-US, V40, P5931, DOI 10.1021/bi0101749; Hannan JP, 2005, J MOL BIOL, V346, P845, DOI 10.1016/j.jmb.2004.12.007; HOLERS VM, 1995, PRINCIPLES PRACTICES, P363; IIDA K, 1983, J EXP MED, V158, P1021, DOI 10.1084/jem.158.4.1021; LEVY E, 1992, CLIN EXP IMMUNOL, V90, P235; Li KY, 2008, J MOL BIOL, V384, P137, DOI 10.1016/j.jmb.2008.08.084; LUXEMBOURG AT, 1994, J IMMUNOL, V153, P4448; Lyubchenko T, 2005, J IMMUNOL, V174, P3264, DOI 10.4049/jimmunol.174.6.3264; MARTIN DR, 1991, J EXP MED, V174, P1299, DOI 10.1084/jem.174.6.1299; MERRIFIELD RB, 1969, ADV ENZYMOL RAMB, V32, P221; MOLINA H, 1991, J BIOL CHEM, V266, P12173; MOORE MD, 1987, P NATL ACAD SCI USA, V84, P9194, DOI 10.1073/pnas.84.24.9194; Morikis D, 2004, J IMMUNOL, V172, P7537, DOI 10.4049/jimmunol.172.12.7537; NEMEROW GR, 1985, J VIROL, V55, P347, DOI 10.1128/JVI.55.2.347-351.1985; NEMEROW GR, 1989, CELL, V56, P369, DOI 10.1016/0092-8674(89)90240-7; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Prota AE, 2002, P NATL ACAD SCI USA, V99, P10641, DOI 10.1073/pnas.162360499; REYNES M, 1985, J IMMUNOL, V135, P2687; Sarrias MR, 2001, J IMMUNOL, V167, P1490, DOI 10.4049/jimmunol.167.3.1490; Szakonyi G, 2001, SCIENCE, V292, P1725, DOI 10.1126/science.1059118; TEDDER TF, 1984, J IMMUNOL, V133, P678; Tolnay M, 1998, CLIN IMMUNOL IMMUNOP, V88, P123, DOI 10.1006/clin.1998.4552; TUVESON DA, 1991, J EXP MED, V173, P1083, DOI 10.1084/jem.173.5.1083; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WEIS JJ, 1984, P NATL ACAD SCI-BIOL, V81, P881, DOI 10.1073/pnas.81.3.881; WEIS JJ, 1988, J EXP MED, V167, P1047, DOI 10.1084/jem.167.3.1047; WEIS JJ, 1986, P NATL ACAD SCI USA, V83, P5639, DOI 10.1073/pnas.83.15.5639; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Young KA, 2008, J VIROL, V82, P11217, DOI 10.1128/JVI.01673-08; Young KA, 2007, J BIOL CHEM, V282, P36614, DOI 10.1074/jbc.M706324200; Zhang L, 2007, J MOL BIOL, V369, P567, DOI 10.1016/j.jmb.2007.02.101; ZUIDERWEG ERP, 1989, BIOCHEMISTRY-US, V28, P2387, DOI 10.1021/bi00432a008	55	19	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9513	9520		10.1074/jbc.M808404200	http://dx.doi.org/10.1074/jbc.M808404200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19164292	Green Published, hybrid			2022-12-25	WOS:000264669100057
J	Schupp, M; Cristancho, AG; Lefterova, MI; Hanniman, EA; Briggs, ER; Steger, DJ; Qatanani, M; Curtin, JC; Schug, J; Ochsner, SA; McKenna, NJ; Lazar, MA				Schupp, Michael; Cristancho, Ana G.; Lefterova, Martina I.; Hanniman, Elyisha A.; Briggs, Erika R.; Steger, David J.; Qatanani, Mohammed; Curtin, Joshua C.; Schug, Jonathan; Ochsner, Scott A.; McKenna, Neil J.; Lazar, Mitchell A.			Re-expression of GATA2 Cooperates with Peroxisome Proliferator-activated Receptor-gamma Depletion to Revert the Adipocyte Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; TRANSCRIPTION FACTOR; ENERGY-BALANCE; DIFFERENTIATION; ADIPOGENESIS; EXPRESSION; TRIACYLGLYCEROL; SUPPRESSION; METABOLISM; REGULATOR	Nuclear peroxisome proliferator-activated receptor-gamma (PPAR gamma) is required for adipocyte differentiation, but its role in mature adipocytes is less clear. Here, we report that knockdown of PPAR gamma expression in 3T3-L1 adipocytes returned the expression of most adipocyte genes to preadipocyte levels. Consistently, down-regulated but not up-regulated genes showed strong enrichment of PPAR gamma binding. Surprisingly, not all adipocyte genes were reversed, and the adipocyte morphology was maintained for an extended period after PPAR gamma depletion. To explain this, we focused on transcriptional regulators whose adipogenic regulation was not reversed upon PPAR gamma depletion. We identified GATA2, a transcription factor whose down-regulation early in adipogenesis is required for preadipocyte differentiation and whose levels remain low after PPAR gamma knockdown. Forced expression of GATA2 in mature adipocytes complemented PPAR gamma depletion and impaired adipocyte functionality with a more preadipocyte-like gene expression profile. Ectopic expression of GATA2 in adipose tissue in vivo had a similar effect on adipogenic gene expression. These results suggest that PPAR gamma-independent down-regulation of GATA2 prevents reversion of mature adipocytes after PPAR gamma depletion.	[Schupp, Michael; Cristancho, Ana G.; Lefterova, Martina I.; Hanniman, Elyisha A.; Briggs, Erika R.; Steger, David J.; Qatanani, Mohammed; Curtin, Joshua C.; Lazar, Mitchell A.] Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med, Philadelphia, PA 19104 USA; [Schupp, Michael; Cristancho, Ana G.; Lefterova, Martina I.; Hanniman, Elyisha A.; Briggs, Erika R.; Steger, David J.; Qatanani, Mohammed; Curtin, Joshua C.; Lazar, Mitchell A.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Schug, Jonathan] Univ Penn, Sch Med, Dept Genet, Ctr Bioinformat, Philadelphia, PA 19104 USA; [Ochsner, Scott A.; McKenna, Neil J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Baylor College of Medicine	Lazar, MA (corresponding author), Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med, 700 CRB,415 Curie Blvd, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Lazar, Mitchell A/AAF-3738-2019	Schupp, Michael/0000-0003-3720-1052; Ochsner, Scott/0000-0003-1099-7863; Cristancho, Ana/0000-0001-9250-8757; McKenna, Neil/0000-0001-6689-0104	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007314, U19DK062434, F32DK070405, R01DK049780] Funding Source: NIH RePORTER; NIDDK NIH HHS [U19DK62434, 5-F32-DK070405, T32-DK07314, R01 DK49780] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Badman MK, 2007, GASTROENTEROLOGY, V132, P2103, DOI 10.1053/j.gastro.2007.03.058; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Dolinsky VW, 2003, BBA-MOL CELL BIOL L, V1635, P20, DOI 10.1016/j.bbalip.2003.09.007; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; IHAKA R, 1996, J GRAPH COMPUT STAT, V1, P299; Imai T, 2004, P NATL ACAD SCI USA, V101, P4543, DOI 10.1073/pnas.0400356101; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lehner R, 1999, BIOCHEM J, V343, P1, DOI 10.1042/0264-6021:3430001; Liao W, 2007, AM J PHYSIOL-ENDOC M, V293, pE219, DOI 10.1152/ajpendo.00695.2006; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Prestwich TC, 2007, CURR OPIN CELL BIOL, V19, P612, DOI 10.1016/j.ceb.2007.09.014; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Soni KG, 2004, J BIOL CHEM, V279, P40683, DOI 10.1074/jbc.M400541200; Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Wang F, 2008, AM J PHYSIOL-CELL PH, V295, pC213, DOI 10.1152/ajpcell.00422.2007; Wozniak RJ, 2008, CURR TOP DEV BIOL, V82, P55, DOI [10.1016/S0070-2153(07)00003-8, 10.1016/S0070-2153(67-)0000-3-8]; Xu Z, 2008, P NATL ACAD SCI USA, V105, P2421, DOI 10.1073/pnas.0707082105	28	50	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9458	9464		10.1074/jbc.M809498200	http://dx.doi.org/10.1074/jbc.M809498200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19136559	Green Published, hybrid			2022-12-25	WOS:000264669100052
J	Teertstra, WR; van der Velden, GJ; de Jong, JF; Kruijtzer, JAW; Liskamp, RMJ; Kroon-Batenburg, LMJ; Muller, WH; Gebbink, MFBG; Wosten, HAB				Teertstra, Wieke R.; van der Velden, Gisela J.; de Jong, Jan F.; Kruijtzer, John A. W.; Liskamp, Rob M. J.; Kroon-Batenburg, Loes M. J.; Muller, Wally H.; Gebbink, Martijn F. B. G.; Wosten, Han A. B.			The Filament-specific Rep1-1 Repellent of the Phytopathogen Ustilago maydis Forms Functional Surface-active Amyloid-like Fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AERIAL HYPHAE FORMATION; STREPTOMYCES-COELICOLOR; SCHIZOPHYLLUM-COMMUNE; FUNGAL HYDROPHOBIN; PROTEIN; PEPTIDE; IDENTIFICATION; GROWTH; LOCALIZATION; RECOGNITION	Repellents of the maize pathogen Ustilago maydis are involved in formation of hydrophobic aerial hyphae and in cellular attachment. These peptides, called Rep1-1 to Rep1-11, are encoded by the rep1 gene and result from cleavage of the precursor protein Rep1 during passage of the secretion pathway. Using green fluorescent protein as a reporter, we here show that rep1 is expressed in filaments and not in the yeast form of U. maydis. In situ hybridization localized rep1 mRNA in the apex of the filament, which correlates with the expected site of secretion of the repellents into the cell wall. We also produced a synthetic peptide, Rep1-1. This peptide reduced the water surface tension to as low as 36 mJ m(-2). In addition, it formed amyloid-like fibrils as was shown by negative staining, by thioflavin T fluorescence, and by x-ray diffraction. These fibrils were not soluble in SDS but could be dissociated with trifluoroacetic acid. The repellents in the hyphal cell wall had a similar solubility and also stained with thioflavin T, strongly indicating that they are present as amyloid fibrils. However, such fibrils could not be observed at the hyphal surface. This can be explained by the fact that the Rep1-1 filaments decrease in length at increasing concentrations. Taken together, we have identified the second class of fungal proteins that form functional amyloid-like filaments at the hyphal surface.	[Teertstra, Wieke R.; van der Velden, Gisela J.; de Jong, Jan F.; Wosten, Han A. B.] Univ Utrecht, Fac Sci, Dept Microbiol, Utrecht, Netherlands; [Kruijtzer, John A. W.; Liskamp, Rob M. J.] Univ Utrecht, Fac Sci, Dept Med Chem, Utrecht, Netherlands; [Kroon-Batenburg, Loes M. J.] Univ Utrecht, Fac Sci, Dept Crystal & Struct Chem, Utrecht, Netherlands; [Muller, Wally H.] Univ Utrecht, Fac Sci, Dept Cell Biol, Utrecht, Netherlands; [Gebbink, Martijn F. B. G.] Univ Med Ctr, Dept Haematol, NL-3584 CM Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University; Utrecht University; Utrecht University Medical Center	Teertstra, WR (corresponding author), Univ Utrecht, Fac Sci, Dept Microbiol, Padualaan 8, Utrecht, Netherlands.	w.r.teertstra@uu.nl	Kroon-Batenburg, Loes/J-9058-2016; van der Velden, Gisela J./A-5133-2013; Wösten, Han AB/K-2769-2016; Müller, Wally/B-8215-2011; Liskamp, Rob M/I-5889-2012	Wösten, Han AB/0000-0002-0399-3648; Liskamp, Rob M/0000-0001-8897-8975				BANUETT F, 1992, TRENDS GENET, V8, P174, DOI 10.1016/0168-9525(92)90091-H; BANUETT F, 1989, P NATL ACAD SCI USA, V86, P5878, DOI 10.1073/pnas.86.15.5878; Becht P, 2006, J CELL SCI, V119, P4964, DOI 10.1242/jcs.03287; BOHLMANN R, 1996, THESIS U MUNICH; BOLKER M, 1995, CAN J BOT, V73, pS320; BOLKER M, 1992, CELL, V68, P441, DOI 10.1016/0092-8674(92)90182-C; Brachmann A, 2001, MOL MICROBIOL, V42, P1047, DOI 10.1046/j.1365-2958.2001.02699.x; Brachmann A, 2004, MOL GENET GENOMICS, V272, P216, DOI 10.1007/s00438-004-1047-z; Butko P, 2001, BIOCHEM BIOPH RES CO, V280, P212, DOI 10.1006/bbrc.2000.4098; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; CHRISTENSEN J. J., 1963, Monogr. Amer. phyto-path. Soc.; Claessen D, 2003, GENE DEV, V17, P1714, DOI 10.1101/gad.264303; de Vocht ML, 2000, J BIOL CHEM, V275, P28428, DOI 10.1074/jbc.M000691200; DEVRIES OMH, 1993, ARCH MICROBIOL, V159, P330, DOI 10.1007/BF00290915; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Duisenberg AJM, 2003, J APPL CRYSTALLOGR, V36, P220, DOI 10.1107/S0021889802022628; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; GILLISSEN B, 1992, CELL, V68, P647, DOI 10.1016/0092-8674(92)90141-X; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Holliday R., 1974, HDB GENETICS, P575, DOI 10.1007/978-1-4899-1710-2_31; KAMPER J, 1995, CELL, V81, P73, DOI 10.1016/0092-8674(95)90372-0; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688; Kwan AHY, 2006, P NATL ACAD SCI USA, V103, P3621, DOI 10.1073/pnas.0505704103; Lugones LG, 2004, MOL MICROBIOL, V53, P707, DOI 10.1111/j.1365-2958.2004.04187.x; MOUKHA SM, 1993, J GEN MICROBIOL, V139, P969, DOI 10.1099/00221287-139-5-969; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Otoo HN, 2008, EUKARYOT CELL, V7, P776, DOI 10.1128/EC.00309-07; Perry-O'Keefe H, 2001, J MICROBIOL METH, V47, P281, DOI 10.1016/S0167-7012(01)00303-7; Rauceo JM, 2004, INFECT IMMUN, V72, P4948, DOI 10.1128/IAI.72.9.4948-4955.2004; Romeis T, 2000, MOL MICROBIOL, V37, P54, DOI 10.1046/j.1365-2958.2000.01978.x; Schladitz C, 1999, BIOPHYS J, V77, P3305, DOI 10.1016/S0006-3495(99)77161-4; Sikorski P, 2003, STRUCTURE, V11, P915, DOI 10.1016/S0969-2126(03)00149-7; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Teertstra WR, 2006, MICROBIOL-SGM, V152, P3607, DOI 10.1099/mic.0.29034-0; Teertstra WR, 2004, FUNGAL GENET BIOL, V41, P1099, DOI 10.1016/j.fgb.2004.08.010; Tillotson RD, 1998, MOL MICROBIOL, V30, P595, DOI 10.1046/j.1365-2958.1998.01093.x; Wosten HAB, 2000, BBA-REV BIOMEMBRANES, V1469, P79, DOI 10.1016/S0304-4157(00)00002-2; Wosten HAB, 1999, FUNGAL GENET BIOL, V27, P153, DOI 10.1006/fgbi.1999.1130; Wosten HAB, 1996, EMBO J, V15, P4274, DOI 10.1002/j.1460-2075.1996.tb00802.x; Wosten HAB, 1999, CURR BIOL, V9, P85, DOI 10.1016/S0960-9822(99)80019-0; WOSTEN HAB, 1993, PLANT CELL, V5, P1567; WOSTEN HAB, 1991, J GEN MICROBIOL, V137, P2017, DOI 10.1099/00221287-137-8-2017; WOSTEN HAB, 1994, EUR J CELL BIOL, V63, P122; Wosten HAB, 2001, ANNU REV MICROBIOL, V55, P625, DOI 10.1146/annurev.micro.55.1.625; [No title captured]	48	33	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9153	9159		10.1074/jbc.M900095200	http://dx.doi.org/10.1074/jbc.M900095200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19164282	hybrid, Green Published			2022-12-25	WOS:000264669100020
J	Xie, Y; Ke, S; Ouyang, NT; He, JH; Xie, W; Bedford, MT; Tian, YN,				Xie, Ying; Ke, Sui; Ouyang, Nengtai; He, Jinhan; Xie, Wen; Bedford, Mark T.; Tian, Yanan			Epigenetic Regulation of Transcriptional Activity of Pregnane X Receptor by Protein Arginine Methyltransferase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; XENOBIOTIC RECEPTOR; HISTONE H4; IN-VIVO; METHYLATION; METABOLISM; ACTIVATION; PRMT1; COACTIVATOR; EXPRESSION	Pregnane X receptor (PXR) is a ligand-dependent transcription factor, regulating gene expression of enzymes and transporters involved in xenobiotic/drug metabolism. Here, we report that protein arginine methyltransferase 1 (PRMT1) is required for the transcriptional activity of PXR. PRMT1 regulates expression of numerous genes, including nuclear receptor-regulated transcription, through methylating histone and non-histone proteins. Co-immunoprecipitation and histone methyltransferase assays revealed that PRMT1 is a major histone methyltransferase associated with PXR. The PXR ligand-binding domain is responsible for PXR-PRMT1 interaction as determined by mammalian two-hybrid and glutathione S-transferase (GST) pull-down assays. The chromatin immunoprecipitation (ChIP) assay showed that PRMT1 was recruited to the regulatory region of the PXR target gene cytochrome P450 3A4 (CYP3A4), with a concomitant methylation of arginine 3 of histone H4, in response to the PXR agonist rifampicin. In mammalian cells, small interfering RNA (siRNA) knockdown and gene deletion of PRMT1 greatly diminished the transcriptional activity of PXR, suggesting an indispensable role of PRMT1 in PXR-regulated gene expression. Interestingly, PXR appears to have a reciprocal effect on the PRMT1 functions by regulating its cellular compartmentalization as well as its substrate specificity. Taken together, these results demonstrated mutual interactions and functional interplays between PXR and PRMT1, and this interaction may be important for the epigenetics of PXR-regulated gene expression.	[Xie, Ying; Ke, Sui; Ouyang, Nengtai; Tian, Yanan] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [He, Jinhan; Xie, Wen] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15213 USA; [He, Jinhan; Xie, Wen] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15213 USA; [Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Smithville, TX 78957 USA	Texas A&M University System; Texas A&M University College Station; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; UTMD Anderson Cancer Center	Tian, YN, (corresponding author), Texas A&M Univ, Dept Vet Physiol & Pharmacol, Mail Stop 4466, College Stn, TX 77843 USA.	ytian@cvm.tamu.edu	Xie, Wen/M-1768-2016; Xie, Ying/AAX-4282-2020; Bedford, Mark T/E-7856-2011		NIEHS, National Institutes of Health [ES 09859, ES 09106]; American Heart Association [0355131Y]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009106, R01ES009859] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by NIEHS, National Institutes of Health Grants ES 09859 and ES 09106. This work was also supported by American Heart Association Grant 0355131Y.	Barrero MJ, 2006, MOL CELL, V24, P233, DOI 10.1016/j.molcel.2006.09.020; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cheung N, 2007, NAT CELL BIOL, V9, P1208, DOI 10.1038/ncb1642; Cote J, 2003, MOL BIOL CELL, V14, P274, DOI 10.1091/mbc.E02-08-0484; Dery U, 2008, MOL CELL BIOL, V28, P3058, DOI 10.1128/MCB.02025-07; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Gu XS, 2006, J BIOL CHEM, V281, P17882, DOI 10.1074/jbc.M601302200; Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Huang S, 2007, MOL CELL BIOL, V27, P7991, DOI 10.1128/MCB.01326-07; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kliewer SA, 2002, ENDOCR REV, V23, P687, DOI 10.1210/er.2001-0038; Kliewer SA, 2002, J LIPID RES, V43, P359; Koh SS, 2001, J BIOL CHEM, V276, P1089, DOI 10.1074/jbc.M004228200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lim Y, 2005, BBA-GEN SUBJECTS, V1723, P240, DOI 10.1016/j.bbagen.2005.02.015; Nishioka K, 2003, METHODS, V31, P49, DOI 10.1016/S1046-2023(03)00087-2; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Qi C, 2002, J BIOL CHEM, V277, P28624, DOI 10.1074/jbc.M201053200; Rizzo G, 2005, MOL PHARMACOL, V68, P551, DOI 10.1124/mol.105.012104; Robin-Lespinasse Y, 2007, J CELL SCI, V120, P638, DOI 10.1242/jcs.03357; Tan CP, 2006, MOL CELL BIOL, V26, P7224, DOI 10.1128/MCB.00473-06; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Tian YA, 2009, BIOCHEM PHARMACOL, V77, P670, DOI 10.1016/j.bcp.2008.10.023; Tian YN, 2003, J BIOL CHEM, V278, P44041, DOI 10.1074/jbc.M306443200; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Xie W, 2006, CELL METAB, V4, P177, DOI 10.1016/j.cmet.2006.08.004	30	53	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9199	9205		10.1074/jbc.M806193200	http://dx.doi.org/10.1074/jbc.M806193200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19144646	hybrid, Green Published			2022-12-25	WOS:000264669100026
J	Igaz, LM; Kwong, LK; Chen-Plotkin, A; Winton, MJ; Unger, TL; Xu, Y; Neumann, M; Trojanowski, JQ; Lee, VMY				Igaz, Lionel M.; Kwong, Linda K.; Chen-Plotkin, Alice; Winton, Matthew J.; Unger, Travis L.; Xu, Yan; Neumann, Manuela; Trojanowski, John Q.; Lee, Virginia M. -Y.			Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; NUCLEAR FACTOR TDP-43; TARDBP MUTATIONS; CFTR EXON-9; INCLUSIONS; REGULATOR; DISEASE; GENE; DETERMINANTS	The disease protein in frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U) and amyotrophic lateral sclerosis (ALS) was identified recently as the TDP-43 (TAR DNA-binding protein 43), thereby providing a molecular link between these two disorders. In FTLD-U and ALS, TDP-43 is redistributed from its normal nuclear localization to form cytoplasmic insoluble aggregates. Moreover, pathological TDP-43 is abnormally ubiquitinated, hyperphosphorylated, and N-terminally cleaved to generate C-terminal fragments (CTFs). However, the specific cleavage site(s) and the biochemical properties as well as the functional consequences of pathological TDP-43 CTFs remained unknown. Here we have identified the specific cleavage site, Arg(208), of a pathological TDP-43 CTF purified from FTLD-U brains and show that the expression of this and other TDP-43 CTFs in cultured cells recapitulates key features of TDP-43 proteinopathy. These include the formation of cytoplasmic aggregates that are ubiquitinated and abnormally phosphorylated at sites found in FTLD-U and ALS brain and spinal cord samples. Furthermore, we observed splicing abnormalities in a cell culture system expressing TDP-43 CTFs, and this is significant because the regulation of exon splicing is a known function of TDP-43. Thus, our results show that TDP-43 CTF expression recapitulates key biochemical features of pathological TDP-43 and support the hypothesis that the generation of TDP-43 CTFs is an important step in the pathogenesis of FTLD-U and ALS.	[Igaz, Lionel M.; Kwong, Linda K.; Chen-Plotkin, Alice; Winton, Matthew J.; Unger, Travis L.; Xu, Yan; Trojanowski, John Q.; Lee, Virginia M. -Y.] Univ Penn, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Sch Med, Philadelphia, PA 19104 USA; [Chen-Plotkin, Alice] Univ Penn, Dept Neurol, Sch Med, Philadelphia, PA 19104 USA; [Trojanowski, John Q.; Lee, Virginia M. -Y.] Univ Penn, Inst Aging, Sch Med, Philadelphia, PA 19104 USA; [Neumann, Manuela] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Zurich; University Zurich Hospital	Lee, VMY (corresponding author), Univ Penn, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Sch Med, 3600 Spruce St,3rd Floor,Maloney Bldg, Philadelphia, PA 19104 USA.	vmylee@mail.med.upenn.edu	Neumann, Manuela/F-6558-2011; Igaz, Lionel/AAP-3059-2020	Neumann, Manuela/0000-0002-6232-4057; Igaz, Lionel Muller/0000-0001-9988-3242	National Institutes of Health [AG17586]; Deutsche Forschungsgemeinschaft [SFB 596]; Federal Ministry of Education and Research [01GI0704]; NATIONAL INSTITUTE ON AGING [P01AG017586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG17586. This work was also supported by Deutsche Forschungsgemeinschaft Grant SFB 596 and Federal Ministry of Education and Research Grant 01GI0704. The costs of publication of this article were defrayed in part by the	Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Forman MS, 2007, CURR OPIN NEUROBIOL, V17, P548, DOI 10.1016/j.conb.2007.08.005; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Muro AF, 1998, FEBS LETT, V437, P137, DOI 10.1016/S0014-5793(98)01201-0; Murphy JM, 2007, ARCH NEUROL-CHICAGO, V64, P530, DOI 10.1001/archneur.64.4.530; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Pagani F, 2000, J BIOL CHEM, V275, P21041, DOI 10.1074/jbc.M910165199; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200	29	276	286	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8516	8524		10.1074/jbc.M809462200	http://dx.doi.org/10.1074/jbc.M809462200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19164285	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000264397800036
J	Killock, DJ; Parsons, M; Zarrouk, M; Ameer-Beg, SM; Ridley, AJ; Haskard, DO; Zvelebil, M; Ivetic, A				Killock, David J.; Parsons, Maddy; Zarrouk, Marouan; Ameer-Beg, Simon M.; Ridley, Anne J.; Haskard, Dorian O.; Zvelebil, Marketa; Ivetic, Aleksandar			In Vitro and in Vivo Characterization of Molecular Interactions between Calmodulin, Ezrin/Radixin/Moesin, and L-selectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; ERM PROTEINS; CYTOPLASMIC DOMAIN; CRYSTAL-STRUCTURE; ACTIN-BINDING; FERM DOMAIN; ADHESION; RECRUITMENT; ACTIVATION; TAIL	L-selectin is a cell adhesion molecule that tethers leukocytes to the luminal walls of venules during inflammation and enables them to roll under the force of blood flow. Clustering of L-selectin during rolling is thought to promote outside-in signals that lead to integrin activation and chemokine receptor expression, ultimately contributing to leukocyte arrest. Several studies have underscored the importance of the L-selectin cytoplasmic tail in functionally regulating adhesion and signaling. Interestingly, the L-selectin tail comprises only 17 amino acids, and yet it is thought to bind simultaneously to several proteins. For example, constitutive association of calmodulin (CaM) and ezrin/radixin/moesin (ERM) to L-selectin confers resistance to proteolysis and microvillar positioning, respectively. In this report we found that recombinant purified CaM and ERM bound noncompetitively to the same tail of L-selectin. Furthermore, molecular modeling supported the possibility that CaM, L-selectin, and moesin could form a heterotrimeric complex. Finally, using fluorescence lifetime imaging microscopy to measure fluorescence resonance energy transfer, it was shown that CaM, L-selectin, and ERM could interact simultaneously in vivo. Moreover, L-selectin clustering promoted CaM/ERM interaction in cis (i.e. derived from neighboring L-selectin tails). These results highlight a novel intracellular event that occurs as a consequence of L-selectin clustering, which could participate in transducing signals that promote the transition from rolling to arrest.	[Haskard, Dorian O.; Ivetic, Aleksandar] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Cardiovasc Sci Unit, London W12 0NN, England; [Parsons, Maddy; Ridley, Anne J.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Ameer-Beg, Simon M.] Kings Coll London, Richard Dimbleby Dept Canc Res, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Ameer-Beg, Simon M.] Kings Coll London, Richard Dimbleby Dept Canc Res, Div Canc Studies, London SE1 1UL, England; [Zvelebil, Marketa] Breakthrough Breast Canc Res Ctr, Inst Canc Res, London SW3 6JB, England	Imperial College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Ivetic, A (corresponding author), Kings Coll London, James Black Ctr, Div Cardiovasc, 125 Coldharbour Lane, London SE5 9NU, England.	alex.ivetic@kcl.ac.uk	Parsons, Maddy/B-2203-2013; Zarrouk, Marouan/K-7541-2019	Parsons, Maddy/0000-0002-2021-8379; Zvelebil, Marketa/0000-0001-8018-5591; Ivetic, Aleksandar/0000-0001-9844-6518; Ameer-Beg, Simon/0000-0001-5227-575X; Zarrouk, Marouan/0000-0002-3259-6123; Killock, David/0000-0002-3267-8284; Ridley, Anne/0000-0001-8186-5708	Wellcome Trust; Ludwig Institute for Cancer Research;  [FP6 contract LHSG-CT-2003-502935]	Wellcome Trust(Wellcome Trust); Ludwig Institute for Cancer Research; 	This work was supported in part by the Wellcome Trust, the Ludwig Institute for Cancer Research, and the European Union (FP6 contract LHSG-CT-2003-502935). All the authors declare that they have no financially competing interests. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Brenner B, 1996, P NATL ACAD SCI USA, V93, P15376, DOI 10.1073/pnas.93.26.15376; Brown MJ, 2003, BLOOD, V102, P3890, DOI 10.1182/blood-2002-12-3807; Canutescu AA, 2005, BIOINFORMATICS, V21, P2914, DOI 10.1093/bioinformatics/bti438; Chen CX, 2006, J BIOCHEM, V140, P229, DOI 10.1093/jb/mvj149; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Ding ZQ, 2003, BLOOD, V101, P4245, DOI 10.1182/blood-2002-06-1782; Dwir O, 2002, J BIOL CHEM, V277, P21130, DOI 10.1074/jbc.M201999200; Dwir O, 2001, J CELL BIOL, V155, P145, DOI 10.1083/jcb.200103042; Edwards SD, 2001, BIOCHEMISTRY-US, V40, P7061, DOI 10.1021/bi010419h; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; ERLANDSEN SL, 1993, J HISTOCHEM CYTOCHEM, V41, P327, DOI 10.1177/41.3.7679125; Evans SS, 1999, J IMMUNOL, V162, P3615; Galkina E, 2006, J EXP MED, V203, P1273, DOI 10.1084/jem.20052205; Giblin PA, 1997, J IMMUNOL, V159, P3498; Gonzalez-Amaro R, 1999, CRIT REV IMMUNOL, V19, P389; Green CE, 2004, J IMMUNOL, V172, P7780, DOI 10.4049/jimmunol.172.12.7780; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Hao JJ, 2008, J PROTEOME RES, V7, P2911, DOI 10.1021/pr800016a; Hidalgo A, 2007, IMMUNITY, V26, P477, DOI 10.1016/j.immuni.2007.03.011; Hishiya A, 1999, J BIOL CHEM, V274, P26705, DOI 10.1074/jbc.274.38.26705; Hwang ST, 1996, J EXP MED, V184, P1343, DOI 10.1084/jem.184.4.1343; Ilani T, 2007, J CELL BIOL, V179, P733, DOI 10.1083/jcb.200707199; Ivetic A, 2004, BIOCHEM SOC T, V32, P1118, DOI 10.1042/BST0321118; Ivetic A, 2004, J BIOL CHEM, V279, P33263, DOI 10.1074/jbc.M312212200; Ivetic A, 2004, IMMUNOLOGY, V112, P165, DOI 10.1111/j.1365-2567.2004.01882.x; Ivetic A, 2002, J BIOL CHEM, V277, P2321, DOI 10.1074/jbc.M109460200; Kahn J, 1998, CELL, V92, P809, DOI 10.1016/S0092-8674(00)81408-7; Kilian K, 2004, J BIOL CHEM, V279, P34472, DOI 10.1074/jbc.M405916200; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krieger Elmar, 2003, Methods Biochem Anal, V44, P509; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li X, 1998, J EXP MED, V188, P1385, DOI 10.1084/jem.188.7.1385; Mattila PE, 2005, AM J PHYSIOL-CELL PH, V289, pC323, DOI 10.1152/ajpcell.00603.2004; Nunomura W, 2000, J BIOL CHEM, V275, P6360, DOI 10.1074/jbc.275.9.6360; Orian-Rousseau W, 2007, MOL BIOL CELL, V18, P76, DOI 10.1091/mbc.E06-08-0674; Parsons M, 2005, MOL CELL BIOL, V25, P1680, DOI 10.1128/MCB.25.5.1680-1695.2005; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; PAVALKO FM, 1995, J CELL BIOL, V129, P1155, DOI 10.1083/jcb.129.4.1155; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Renkonen J, 2002, AM J PATHOL, V161, P543, DOI 10.1016/S0002-9440(10)64210-1; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Takai Y, 2008, J MOL BIOL, V381, P634, DOI 10.1016/j.jmb.2008.05.085; Takai Y, 2007, GENES CELLS, V12, P1329, DOI 10.1111/j.1365-2443.2007.01137.x; Urzainqui A, 2002, IMMUNITY, V17, P401, DOI 10.1016/S1074-7613(02)00420-X; Villalonga P, 2001, MOL CELL BIOL, V21, P7345, DOI 10.1128/MCB.21.21.7345-7354.2001; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497; Zarbock A, 2008, AM J PATHOL, V172, P1, DOI 10.2353/ajpath.2008.070502	51	41	42	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8824	8836		10.1074/jbc.M806983200	http://dx.doi.org/10.1074/jbc.M806983200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19129194	Green Published, hybrid			2022-12-25	WOS:000264397800066
J	Alvino, CL; McNeil, KA; Ong, SC; Delaine, C; Booker, GW; Wallace, JC; Whittaker, J; Forbes, BE				Alvino, Clair L.; McNeil, Kerrie A.; Ong, Shee Chee; Delaine, Carlie; Booker, Grant W.; Wallace, John C.; Whittaker, Jonathan; Forbes, Briony E.			A Novel Approach to Identify Two Distinct Receptor Binding Surfaces of Insulin-like Growth Factor II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALANINE-SCANNING MUTAGENESIS; CHAIN ALPHA-HELIX; LIGAND-BINDING; IGF-I; MONOCLONAL-ANTIBODIES; 6-PHOSPHATE RECEPTOR; BIOLOGICAL-ACTIVITY; SYNTHETIC PEPTIDE; HYBRID RECEPTORS; STRUCTURAL BASIS	Very little is known about the residues important for the interaction of insulin-like growth factor II (IGF-II) with the type 1 IGF receptor (IGF-1R) and the insulin receptor (IR). Insulin, to which IGF-II is homologous, is proposed to cross-link opposite halves of the IR dimer through two receptor binding surfaces, site 1 and site 2. In the present study we have analyzed the contribution of IGF-II residues equivalent to insulin's two binding surfaces toward the interaction of IGF-II with the IGF-1R and IR. Four "site 1" and six "site 2" analogues were produced and analyzed in terms of IGF-1R and IR binding and activation. The results show that Val(43), Phe(28), and Val(14) (equivalent to site 1) are critical to IGF-1R and IR binding, whereas mutation to alanine of Gln(18) affects only IGF-1R and not IR binding. Alanine substitutions at Glu(12), Asp(15), Phe(19), Leu(53), and Glu(57) analogues resulted in significant (>2-fold) decreases in affinity for both the IGF-1R and IR. Furthermore, taking a novel approach using a monomeric, single-chain minimized IGF-1R we have defined a distinct second binding surface formed by Glu(12), Phe(19), Leu(53), and Glu(57) that potentially engages the IGF-1R at one or more of the FnIII domains.	[Alvino, Clair L.; McNeil, Kerrie A.; Ong, Shee Chee; Delaine, Carlie; Booker, Grant W.; Wallace, John C.; Forbes, Briony E.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Whittaker, Jonathan] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Whittaker, Jonathan] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	University of Adelaide; Case Western Reserve University; Case Western Reserve University	Forbes, BE (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Gate 8,Victoria Dr, Adelaide, SA 5005, Australia.	briony.forbes@adelaide.edu.au	Forbes, Briony/R-1838-2019; , John/AAP-5150-2020	Forbes, Briony/0000-0003-4360-9927				Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Bass J, 1996, J BIOL CHEM, V271, P19367, DOI 10.1074/jbc.271.32.19367; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; Benyoucef S, 2007, BIOCHEM J, V403, P603, DOI 10.1042/BJ20061709; Chan SJ, 2007, J BIOL CHEM, V282, P13754, DOI 10.1074/jbc.M700724200; COOKE RM, 1991, BIOCHEMISTRY-US, V30, P5484, DOI 10.1021/bi00236a022; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; De Meyts P, 2008, TRENDS BIOCHEM SCI, V33, P376, DOI 10.1016/j.tibs.2008.06.003; Delaine C, 2007, J BIOL CHEM, V282, P18886, DOI 10.1074/jbc.M700531200; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; Denley A, 2005, MOL ENDOCRINOL, V19, P711, DOI 10.1210/me.2004-0409; Denley A, 2003, HORM METAB RES, V35, P778; Denley A, 2005, CYTOKINE GROWTH F R, V16, P421, DOI 10.1016/j.cytogfr.2005.04.004; Epa VC, 2006, PROTEIN ENG DES SEL, V19, P377, DOI 10.1093/protein/gzl022; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Gauguin L, 2008, J BIOL CHEM, V283, P20821, DOI 10.1074/jbc.M802620200; Gauguin L, 2008, J BIOL CHEM, V283, P2604, DOI 10.1074/jbc.M709220200; Glendorf T, 2008, BIOCHEMISTRY-US, V47, P4743, DOI 10.1021/bi800054z; Hao CL, 2006, BIOCHEM BIOPH RES CO, V347, P334, DOI 10.1016/j.bbrc.2006.06.089; HODGSON DR, 1995, EUR J BIOCHEM, V233, P299, DOI 10.1111/j.1432-1033.1995.299_1.x; HU SQ, 1993, J PROTEIN CHEM, V12, P741, DOI 10.1007/BF01024932; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Huang K, 2004, J MOL BIOL, V341, P529, DOI 10.1016/j.jmb.2004.05.023; Jansson M, 1997, BIOCHEMISTRY-US, V36, P4108, DOI 10.1021/bi961553i; Jensen M, 2000, THESIS U COPENHAGEN; Jensen M, 2008, BIOCHEM J, V412, P435, DOI 10.1042/BJ20080279; Jensen M, 2007, J BIOL CHEM, V282, P35179, DOI 10.1074/jbc.M704599200; KING R, 1992, J MOL ENDOCRINOL, V8, P29, DOI 10.1677/jme.0.0080029; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Kristensen C, 1999, J BIOL CHEM, V274, P37351, DOI 10.1074/jbc.274.52.37351; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; Mynarcik DC, 1996, J BIOL CHEM, V271, P2439, DOI 10.1074/jbc.271.5.2439; Mynarcik DC, 1997, J BIOL CHEM, V272, P18650, DOI 10.1074/jbc.272.30.18650; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; SAKANO KI, 1991, J BIOL CHEM, V266, P20626; SATO A, 1993, INT J PEPT PROT RES, V41, P433; SCHAFFER L, 1993, BIOCHIM BIOPHYS ACTA, V1203, P205, DOI 10.1016/0167-4838(93)90084-5; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; SCHWARTZ GP, 1987, P NATL ACAD SCI USA, V84, P6408, DOI 10.1073/pnas.84.18.6408; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; Slaaby R, 2006, J BIOL CHEM, V281, P25869, DOI 10.1074/jbc.M605189200; SOOS MA, 1992, J BIOL CHEM, V267, P12955; SOOS MA, 1989, P NATL ACAD SCI USA, V86, P5217, DOI 10.1073/pnas.86.14.5217; Sorensen H, 2004, FEBS LETT, V565, P19, DOI 10.1016/j.febslet.2004.03.077; TERASAWA H, 1994, EMBO J, V13, P5590, DOI 10.1002/j.1460-2075.1994.tb06896.x; TORRES AM, 1995, J MOL BIOL, V248, P385, DOI 10.1006/jmbi.1995.0229; Walenkamp MJE, 2005, J CLIN ENDOCR METAB, V90, P2855, DOI 10.1210/jc.2004-1254; Wan ZL, 2005, BIOCHEMISTRY-US, V44, P5000, DOI 10.1021/bi047585k; WANG ZX, 1995, FEBS LETT, V360, P111, DOI 10.1016/0014-5793(95)00062-E; Ward C, 2008, ACTA PHYSIOL, V192, P3, DOI 10.1111/j.1748-1716.2007.01781.x; Whittaker J, 2005, J BIOL CHEM, V280, P20932, DOI 10.1074/jbc.M411320200; Whittaker J, 2002, J BIOL CHEM, V277, P47380, DOI 10.1074/jbc.M208371200; Whittaker J, 2001, J BIOL CHEM, V276, P43980, DOI 10.1074/jbc.M102863200	56	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7656	7664		10.1074/jbc.M808061200	http://dx.doi.org/10.1074/jbc.M808061200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19139090	hybrid, Green Published			2022-12-25	WOS:000264195600027
J	Lee, CC; Kuo, CJ; Ko, TP; Hsu, MF; Tsui, YC; Chang, SC; Yang, S; Chen, SJ; Chen, HC; Hsu, MC; Shih, SR; Liang, PH; Wang, AHJ				Lee, Cheng-Chung; Kuo, Chih-Jung; Ko, Tzu-Ping; Hsu, Min-Feng; Tsui, Yao-Chen; Chang, Shih-Cheng; Yang, Syaulan; Chen, Shu-Jen; Chen, Hua-Chien; Hsu, Ming-Chu; Shih, Shin-Ru; Liang, Po-Huang; Wang, Andrew H. -J.			Structural Basis of Inhibition Specificities of 3C and 3C-like Proteases by Zinc-coordinating and Peptidomimetic Compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE RESPIRATORY SYNDROME; ANTIVIRAL ACTIVITY; SARS-COV; IRREVERSIBLE INHIBITORS; CRYSTAL-STRUCTURE; MAIN PROTEASE; CORONAVIRUS; VIRUS; DESIGN; PROTEINASE	Human coxsackievirus (CV) belongs to the picornavirus family, which consists of over 200 medically relevant viruses. In picornavirus, a chymotrypsin-like protease (3C(pro)) is required for viral replication by processing the polyproteins, and thus it is regarded as an antiviral drug target. A 3C-like protease (3CL(pro)) also exists in human coronaviruses (CoV) such as 229E and the one causing severe acute respiratory syndrome (SARS). To combat SARS, we previously had developed peptidomimetic and zinc-coordinating inhibitors of 3CL(pro). As shown in the present study, some of these compounds were also found to be active against 3C(pro) of CV strain B3 (CVB3). Several crystal structures of 3C(pro) from CVB3 and 3CLpro from CoV-229E and SARS-CoV in complex with the inhibitors were solved. The zinc-coordinating inhibitor is tetrahedrally coordinated to the His(40)-Cys(147) catalytic dyad of CVB3 3C(pro). The presence of specific binding pockets for the residues of peptidomimetic inhibitors explains the binding specificity. Our results provide a structural basis for inhibitor optimization and development of potential drugs for antiviral therapies.	[Lee, Cheng-Chung; Kuo, Chih-Jung; Ko, Tzu-Ping; Hsu, Min-Feng; Tsui, Yao-Chen; Liang, Po-Huang; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Lee, Cheng-Chung; Ko, Tzu-Ping; Hsu, Min-Feng; Liang, Po-Huang; Wang, Andrew H. -J.] Acad Sinica, Natl Core Facil High Throughput Prot Crystallog, Taipei 11529, Taiwan; [Kuo, Chih-Jung; Liang, Po-Huang; Wang, Andrew H. -J.] Acad Sinica, Taiwan Int Grad Program, Taipei 11529, Taiwan; [Lee, Cheng-Chung; Wang, Andrew H. -J.] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Struct Biol Program, Taipei 11221, Taiwan; [Tsui, Yao-Chen; Liang, Po-Huang; Wang, Andrew H. -J.] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10617, Taiwan; [Chang, Shih-Cheng; Shih, Shin-Ru] Chang Gung Mem Hosp, Dept Clin Pathol, Clin Virol Lab, Tao Yuan 333, Taiwan; [Chang, Shih-Cheng; Shih, Shin-Ru] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan 333, Taiwan; [Yang, Syaulan; Chen, Shu-Jen; Chen, Hua-Chien; Hsu, Ming-Chu] TaiGen Biotechnol, Taipei 114, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University	Liang, PH (corresponding author), Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan.	phliang@gate.sinica.edu.tw; ahjwang@gate.sinica.edu.tw	Liang, Po-Huang/H-6610-2015; Shih, Shin-Ru/M-9711-2016	Liang, Po-Huang/0000-0003-1207-5256; Kuo, Chih-Jung/0000-0002-4988-5124; Shih, Shin-Ru/0000-0003-4874-401X	Academia Sinica; National Science Council, Taiwan [NSC-95-3112-B-001-015-Y]	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Academia Sinica and the National Science Council, Taiwan (NSC-95-3112-B-001-015-Y to A.H.-J.W.) for the National Core Facility of High-Throughput Protein Crystallography at Academia Sinica, Taiwan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Binford SL, 2005, ANTIMICROB AGENTS CH, V49, P619, DOI 10.1128/AAC.49.2.619-626.2005; Birtley JR, 2005, J BIOL CHEM, V280, P11520, DOI 10.1074/jbc.M413254200; BRADBURNE AF, 1967, BMJ-BRIT MED J, V3, P767, DOI 10.1136/bmj.3.5568.767; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DAVID MK, 2007, FIELDS VIROLOGY, P795; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Fan KQ, 2004, J BIOL CHEM, V279, P1637, DOI 10.1074/jbc.M310875200; Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; Hsu JTA, 2004, FEBS LETT, V574, P116, DOI 10.1016/j.febslet.2004.08.015; Hsu MF, 2005, J BIOL CHEM, V280, P31257, DOI 10.1074/jbc.M502577200; Johnson TO, 2002, J MED CHEM, V45, P2016, DOI 10.1021/jm010435c; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P392; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kuo CJ, 2004, BIOCHEM BIOPH RES CO, V318, P862, DOI 10.1016/j.bbrc.2004.04.098; Lee CC, 2007, FEBS LETT, V581, P5454, DOI 10.1016/j.febslet.2007.10.048; Liang PH, 2006, CURR TOP MED CHEM, V6, P361, DOI 10.2174/156802606776287090; Matthews DA, 1999, P NATL ACAD SCI USA, V96, P11000, DOI 10.1073/pnas.96.20.11000; MAZE SS, 1990, CLIN CARDIOL, V13, P69, DOI 10.1002/clc.4960130203; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Monpoeho S, 2000, BIOTECHNIQUES, V29, P88, DOI 10.2144/00291st03; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; PORTER AG, 1993, J VIROL, V67, P6917, DOI 10.1128/JVI.67.12.6917-6921.1993; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shi JH, 2004, J BIOL CHEM, V279, P24765, DOI 10.1074/jbc.M311744200; Shie JJ, 2005, BIOORGAN MED CHEM, V13, P5240, DOI 10.1016/j.bmc.2005.05.065; Shih SR, 2004, J BIOMED SCI, V11, P239, DOI 10.1159/000076036; van der Hoek L, 2006, FEMS MICROBIOL REV, V30, P760, DOI 10.1111/j.1574-6976.2006.00032.x; Wang HM, 2007, EXPERT OPIN THER PAT, V17, P533, DOI 10.1517/13543776.17.5.533; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Yang S, 2006, J MED CHEM, V49, P4971, DOI 10.1021/jm0603926	33	86	95	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7646	7655		10.1074/jbc.M807947200	http://dx.doi.org/10.1074/jbc.M807947200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19144641	hybrid, Green Published			2022-12-25	WOS:000264195600026
J	Li, B; Jackson, J; Simon, MD; Fleharty, B; Gogol, M; Seidel, C; Workman, JL; Shilatifard, A				Li, Bing; Jackson, Jessica; Simon, Matthew D.; Fleharty, Brian; Gogol, Madelaine; Seidel, Chris; Workman, Jerry L.; Shilatifard, Ali			Histone H3 Lysine 36 Dimethylation (H3K36me2) Is Sufficient to Recruit the Rpd3s Histone Deacetylase Complex and to Repress Spurious Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLATION STATES; SACCHAROMYCES-CEREVISIAE; CHROMATIN MODIFICATIONS; GENOME-WIDE; TRIMETHYLATION; CHROMODOMAIN; ACETYLATION; RECOGNITION; ELONGATION; BINDING	Histone methylation is associated with both transcription activation and repression. However, the functions of different states of methylation remain largely elusive. Here, using methyllysine analog technology, we demonstrate that the histone deacetylase complex, Rpd3S, can distinguish the nucleosomes methylated to different extents and that K36me2 is sufficient to target Rpd3S in vitro. Through a genome-wide survey, we identified a few mutants in which the level of K36me3 is significantly reduced, whereas the level of K36me2 is sustained. Transcription analysis and genome-wide histone modification studies on these mutants suggested that K36me2 is sufficient to target Rpd3S in vivo, thereby maintaining a functional Set2-Rpd3S pathway.	[Li, Bing; Jackson, Jessica; Fleharty, Brian; Gogol, Madelaine; Seidel, Chris; Workman, Jerry L.; Shilatifard, Ali] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Li, Bing] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Simon, Matthew D.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Stowers Institute for Medical Research; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Massachusetts General Hospital	Workman, JL (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	jlw@stowers.org	Simon, Matthew/ABF-9127-2020	Gogol, Madelaine/0000-0002-8738-0995; Simon, Matthew/0000-0001-7423-5265	National Institutes of Health [GM047867, 2R01GM069905]; Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047867, R01GM069905, R01GM047867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM047867 through the NIGMS (to J. L. W.) and National Institutes of Health Grant 2R01GM069905 (to A. S.). This work was also supported by funding from the Stowers Institute for Medical Research.	Bell O, 2007, EMBO J, V26, P4974, DOI 10.1038/sj.emboj.7601926; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chu Y, 2007, EMBO J, V26, P4646, DOI 10.1038/sj.emboj.7601887; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Frederiks F, 2008, NAT STRUCT MOL BIOL, V15, P550, DOI 10.1038/nsmb.1432; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Li B, 2001, J BIOL CHEM, V276, P33788, DOI 10.1074/jbc.M104220200; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Martin DGE, 2006, MOL CELL BIOL, V26, P7871, DOI 10.1128/MCB.00573-06; Merkera JD, 2008, DNA REPAIR, V7, P1298, DOI 10.1016/j.dnarep.2008.04.009; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Royce-Tolland M, 2008, CURR BIOL, V18, pR255, DOI 10.1016/j.cub.2008.01.039; Schneider J, 2004, METHOD ENZYMOL, V377, P227; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Steger DJ, 1997, METHODS, V12, P276, DOI 10.1006/meth.1997.0479; Xu L, 2008, MOL CELL BIOL, V28, P1348, DOI 10.1128/MCB.01607-07; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08; Zhang Y, 2006, NAT STRUCT MOL BIOL, V13, P572, DOI 10.1038/nsmb0706-572	33	115	116	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7970	7976		10.1074/jbc.M808220200	http://dx.doi.org/10.1074/jbc.M808220200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19155214	Green Published, hybrid			2022-12-25	WOS:000264195600059
J	Matulova, P; Marini, V; Burgess, RC; Sisakova, A; Kwon, Y; Rothstein, R; Sung, P; Krejci, L				Matulova, Petra; Marini, Victoria; Burgess, Rebecca C.; Sisakova, Alexandra; Kwon, Youngho; Rothstein, Rodney; Sung, Patrick; Krejci, Lumir			Cooperativity of Mus81.Mms4 with Rad54 in the Resolution of Recombination and Replication Intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE MUS81-MMS4; HUMAN MUS81-EME1 ENDONUCLEASE; HOLLIDAY JUNCTION RESOLUTION; HOMOLOGOUS RECOMBINATION; HUMAN-CELLS; DNA-DAMAGE; BRANCH MIGRATION; MAMMALIAN-CELLS; BUDDING YEAST; PROTEIN	The Saccharomyces cerevisiae Mus81.Mms4 protein complex, a DNA structure-specific endonuclease, helps preserve genomic integrity by resolving pathological DNA structures that arise from damaged or aborted replication forks and may also play a role in the resolution of DNA intermediates arising through homologous recombination. Previous yeast two-hybrid studies have found an interaction of the Mus81 protein with Rad54, a Swi2/Snf2-like factor that serves multiple roles in homologous recombination processes. However, the functional significance of this novel interaction remains unknown. Here, using highly purified S. cerevisiae proteins, we show that Rad54 strongly stimulates the Mus81.Mms4 nuclease activity on a broad range of DNA substrates. This nuclease enhancement does not require ATP binding nor its hydrolysis by Rad54. We present evidence that Rad54 acts by targeting the Mus81.Mms4 complex to its DNA substrates. In addition, we demonstrate that the Rad54-mediated enhancement of the Mus81.Mms4 (Eme1) nuclease function is evolutionarily conserved. We propose that Mus81.Mms4 together with Rad54 efficiently process perturbed replication forks to promote recovery and may constitute an alternative mechanism to the resolution/dissolution of the recombination intermediates by Sgs1.Top3. These findings provide functional insights into the biological importance of the higher order complex of Mus81.Mms4 or its orthologue with Rad54.	[Matulova, Petra; Marini, Victoria; Sisakova, Alexandra; Krejci, Lumir] Masaryk Univ, Natl Ctr Biomol Res, Brno 62500, Czech Republic; [Kwon, Youngho; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Burgess, Rebecca C.; Rothstein, Rodney] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA	Masaryk University Brno; Yale University; Columbia University	Krejci, L (corresponding author), Masaryk Univ, Natl Ctr Biomol Res, Kamenice 5-A4, Brno 62500, Czech Republic.	lkrejci@chemi.muni.cz	Palomeque, María Victoria Marini/L-7480-2017; Krejci, Lumir/B-7842-2009	Krejci, Lumir/0000-0002-4732-1405; Rothstein, Rodney/0000-0002-4107-9654	National Institutes of Health [ES07061, GM57814, GM50237, GM67055, GM73567]; Wellcome International Senior Research Fellowship [WT076476]; EMBO/HHMI; Ministry of Education Youth and Sport of the Czech Republic [ME 888, MSM 0021622413, LC06030]; Grant Agency of Czech Republic [301/09/1917, 203/09/HO46]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067055, R01GM057814, R37GM050237, R01GM050237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome International Senior Research Fellowship; EMBO/HHMI(Howard Hughes Medical InstituteEuropean Molecular Biology Organization (EMBO)); Ministry of Education Youth and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of Czech Republic(Grant Agency of the Czech Republic); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES07061 (to P. S.), GM57814 (to P. S.), GM50237 (to R. R.), GM67055 (to R. R.), and GM73567 (to R. C. B.). This study was also supported by Wellcome International Senior Research Fellowship WT076476, EMBO/HHMI start up program, Ministry of Education Youth and Sport of the Czech Republic Grants ME 888, MSM 0021622413, and LC06030, and by the Grant Agency of Czech Republic Grants GACR 301/09/1917 and GACR 203/09/HO46. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abraham J, 2003, EMBO J, V22, P6137, DOI 10.1093/emboj/cdg580; Amitani I, 2006, MOL CELL, V23, P143, DOI 10.1016/j.molcel.2006.05.009; Bastin-Shanower SA, 2003, MOL CELL BIOL, V23, P3487, DOI 10.1128/MCB.23.10.3487-3496.2003; Boddy MN, 2000, MOL CELL BIOL, V20, P8758, DOI 10.1128/MCB.20.23.8758-8766.2000; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Bugreev DV, 2007, NAT STRUCT MOL BIOL, V14, P746, DOI 10.1038/nsmb1268; Bugreev DV, 2006, NATURE, V442, P590, DOI 10.1038/nature04889; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Chen XB, 2001, MOL CELL, V8, P1117, DOI 10.1016/S1097-2765(01)00375-6; Ciccia A, 2003, J BIOL CHEM, V278, P25172, DOI 10.1074/jbc.M302882200; Clever B, 1997, EMBO J, V16, P2535, DOI 10.1093/emboj/16.9.2535; Constantinou A, 2002, EMBO J, V21, P5577, DOI 10.1093/emboj/cdf554; de los Santos T, 2003, GENETICS, V164, P81; de los Santos T, 2001, GENETICS, V159, P1511; Ehmsen KT, 2008, NUCLEIC ACIDS RES, V36, P2182, DOI 10.1093/nar/gkm1152; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Fricke WM, 2005, DNA REPAIR, V4, P243, DOI 10.1016/j.dnarep.2004.10.001; Gaillard PHL, 2003, MOL CELL, V12, P747, DOI 10.1016/S1097-2765(03)00342-3; Gaskell LJ, 2007, EMBO J, V26, P1891, DOI 10.1038/sj.emboj.7601645; Haber JE, 2001, CELL, V107, P551, DOI 10.1016/S0092-8674(01)00593-1; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Hays SL, 1998, MOL CELL BIOL, V18, P4400, DOI 10.1128/MCB.18.7.4400; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; Hiyama T, 2006, NUCLEIC ACIDS RES, V34, P880, DOI 10.1093/nar/gkj495; Hollingsworth NM, 2004, GENE DEV, V18, P117, DOI 10.1101/gad.1165904; Interthal H, 2000, MOL GEN GENET, V263, P812, DOI 10.1007/s004380000241; Jiang H, 1996, J BIOL CHEM, V271, P33181, DOI 10.1074/jbc.271.52.33181; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Kiianitsa K, 2006, P NATL ACAD SCI USA, V103, P9767, DOI 10.1073/pnas.0604240103; Krejci L, 2001, MOL CELL BIOL, V21, P966, DOI 10.1128/MCB.21.3.966-976.2001; Lehmann AR, 2003, CELL CYCLE, V2, P300, DOI 10.4161/cc.2.4.407; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Mazina OM, 2007, J BIOL CHEM, V282, P21068, DOI 10.1074/jbc.M701992200; Mazina OM, 2008, P NATL ACAD SCI USA, V105, P18249, DOI 10.1073/pnas.0807016105; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; Michel B, 2001, P NATL ACAD SCI USA, V98, P8181, DOI 10.1073/pnas.111008798; Mimida N, 2007, PLANT CELL PHYSIOL, V48, P648, DOI 10.1093/pcp/pcm029; Mullen JR, 2001, GENETICS, V157, P103; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; Osman F, 2007, DNA REPAIR, V6, P1004, DOI 10.1016/j.dnarep.2007.02.019; Petukhova G, 1999, J BIOL CHEM, V274, P29453, DOI 10.1074/jbc.274.41.29453; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Qiu JZ, 1999, MOL CELL BIOL, V19, P8361, DOI 10.1128/mcb.19.12.8361; Raschle M, 2004, J BIOL CHEM, V279, P51973, DOI 10.1074/jbc.M410101200; Ristic D, 2001, P NATL ACAD SCI USA, V98, P8454, DOI 10.1073/pnas.151056798; Seong C, 2008, J BIOL CHEM, V283, P12166, DOI 10.1074/jbc.M800763200; Sigurdsson S, 2002, J BIOL CHEM, V277, P42790, DOI 10.1074/jbc.M208004200; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Swagemakers SMA, 1998, J BIOL CHEM, V273, P28292, DOI 10.1074/jbc.273.43.28292; Tan TLR, 2003, DNA REPAIR, V2, P787, DOI 10.1016/S1568-7864(03)00070-3; Taylor ER, 2008, P NATL ACAD SCI USA, V105, P3757, DOI 10.1073/pnas.0710291105; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Whitby MC, 2003, J BIOL CHEM, V278, P6928, DOI 10.1074/jbc.M210006200; Zhang R, 2005, CANCER RES, V65, P2526, DOI 10.1158/0008-5472.CAN-04-2421	57	49	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7733	7745		10.1074/jbc.M806192200	http://dx.doi.org/10.1074/jbc.M806192200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19129197	Green Published, hybrid			2022-12-25	WOS:000264195600035
J	Motani, A; Wang, ZL; Conn, M; Siegler, K; Zhang, Y; Liu, QX; Johnstone, S; Xu, HD; Thibault, S; Wang, YC; Fan, PC; Connors, R; Le, H; Xu, GF; Walker, N; Shan, B; Coward, P				Motani, Alykhan; Wang, Zhulun; Conn, Marion; Siegler, Karen; Zhang, Ying; Liu, Qingxiang; Johnstone, Sheree; Xu, Haoda; Thibault, Steve; Wang, Yingcai; Fan, Pingchen; Connors, Richard; Le, Hoa; Xu, Guifen; Walker, Nigel; Shan, Bei; Coward, Peter			Identification and Characterization of a Non-retinoid Ligand for Retinol-binding Protein 4 Which Lowers Serum Retinol-binding Protein 4 Levels in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA RETINOL; INSULIN-RESISTANCE; METABOLIC SYNDROME; CRYSTAL-STRUCTURE; CANCER-PATIENTS; RETINOL-BINDING-PROTEIN-4; TRANSTHYRETIN; REFINEMENT; RESOLUTION; COMPLEX	Retinol-binding protein 4 (RBP4) transports retinol from the liver to extrahepatic tissues, and RBP4 lowering is reported to improve insulin sensitivity in mice. We have identified A1120, a high affinity (K-i = 8.3 nM) non-retinoid ligand for RBP4, which disrupts the interaction between RBP4 and its binding partner transthyretin. Analysis of the RBP4-A1120 co-crystal structure reveals that A1120 induces critical conformational changes at the RBP4-transthyretin interface. Administration of A1120 to mice lowers serum RBP4 and retinol levels but, unexpectedly, does not improve insulin sensitivity. In addition, we show that Rpb4(-/-) mice display normal insulin sensitivity and are not protected from high fat diet-induced insulin resistance. We conclude that lowering RBP4 levels does not improve insulin sensitivity in mice. Therefore, RBP4 lowering may not be an effective strategy for treating diabetes.	[Motani, Alykhan; Conn, Marion; Siegler, Karen; Zhang, Ying; Liu, Qingxiang; Shan, Bei; Coward, Peter] Amgen Inc, Dept Metab Disorders, San Francisco, CA 94080 USA; [Wang, Zhulun; Johnstone, Sheree; Xu, Haoda; Thibault, Steve; Walker, Nigel] Amgen Inc, Dept Mol Struct, San Francisco, CA 94080 USA; [Wang, Yingcai; Fan, Pingchen; Connors, Richard] Amgen Inc, Dept Chem, San Francisco, CA 94080 USA; [Le, Hoa; Xu, Guifen] Amgen Inc, Dept Pharmacokinet & Drug Metab, San Francisco, CA 94080 USA	Amgen; Amgen; Amgen; Amgen	Coward, P (corresponding author), Amgen Inc, Dept Metab Disorders, 1120 Vet Blvd, San Francisco, CA 94080 USA.	pcoward@amgen.com		Siegler, Karen/0000-0002-1945-7559; Wang, Yingcai/0000-0001-5555-8712				Balagopal P, 2007, J CLIN ENDOCR METAB, V92, P1971, DOI 10.1210/jc.2006-2712; BERNI R, 1992, FEBS LETT, V308, P43, DOI 10.1016/0014-5793(92)81046-O; BERNI R, 1993, FASEB J, V7, P1179, DOI 10.1096/fasebj.7.12.8375617; Cho YM, 2006, DIABETES CARE, V29, P2457, DOI 10.2337/dc06-0360; COGAN U, 1976, EUR J BIOCHEM, V65, P71, DOI 10.1111/j.1432-1033.1976.tb10390.x; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; COWAN SW, 1993, J MOL BIOL, V230, P1225, DOI 10.1006/jmbi.1993.1238; COWAN SW, 1990, PROTEINS, V8, P44, DOI 10.1002/prot.340080108; Coward P, 2009, ANAL BIOCHEM, V384, P312, DOI 10.1016/j.ab.2008.09.051; Fanjul AN, 1996, J BIOL CHEM, V271, P22441, DOI 10.1074/jbc.271.37.22441; FORMELLI F, 1989, CANCER RES, V49, P6149; Goodman DS, 1984, RETINOIDS, P41, DOI DOI 10.1016/B978-0-12-658102-7.50008-7; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Greene LH, 2001, PROTEIN SCI, V10, P2301, DOI 10.1110/ps.22901; Henze A, 2008, DIABETES, V57, P3323, DOI 10.2337/db08-0866; Janke J, 2006, DIABETES, V55, P2805, DOI 10.2337/db06-0616; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Lewis JG, 2008, CLIN BIOCHEM, V41, P1034, DOI 10.1016/j.clinbiochem.2008.06.002; MAKOVER A, 1989, J LIPID RES, V30, P171; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MONACO HL, 1995, SCIENCE, V268, P1039, DOI 10.1126/science.7754382; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naylor HM, 1999, BIOCHEMISTRY-US, V38, P2647, DOI 10.1021/bi982291i; NEWCOMER ME, 1984, EMBO J, V3, P1451, DOI 10.1002/j.1460-2075.1984.tb01995.x; PENG YM, 1989, INT J CANCER, V43, P22, DOI 10.1002/ijc.2910430106; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Promintzer M, 2007, J CLIN ENDOCR METAB, V92, P4306, DOI 10.1210/jc.2006-2522; Qi QB, 2007, J CLIN ENDOCR METAB, V92, P4827, DOI 10.1210/jc.2007-1219; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Stefan N, 2007, DIABETES CARE, V30, P1173, DOI 10.2337/dc06-2342; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; ZANOTTI G, 1993, J MOL BIOL, V230, P613, DOI 10.1006/jmbi.1993.1173; ZANOTTI G, 1994, J BIOL CHEM, V269, P29613; ZANOTTI G, 1993, J BIOL CHEM, V268, P24873	34	60	74	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7673	7680		10.1074/jbc.M809654200	http://dx.doi.org/10.1074/jbc.M809654200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19147488	Green Published, hybrid			2022-12-25	WOS:000264195600029
J	Yellaturu, CR; Deng, X; Cagen, LM; Wilcox, HG; Mansbach, CM; Siddiqi, SA; Park, EA; Raghow, R; Elam, MB				Yellaturu, Chandrahasa R.; Deng, Xiong; Cagen, Lauren M.; Wilcox, Henry G.; Mansbach, Charles M., II; Siddiqi, Shadab A.; Park, Edwards A.; Raghow, Rajendra; Elam, Marshall B.			Insulin Enhances Post-translational Processing of Nascent SREBP-1c by Promoting Its Phosphorylation and Association with COPII Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN-1C; MAMMALIAN ENDOPLASMIC-RETICULUM; FATTY-ACID SYNTHESIS; TRANSCRIPTION FACTORS; RAT HEPATOCYTES; GENE-EXPRESSION; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNALING PATHWAYS; LIPID HOMEOSTASIS; MESSENGER-RNAS	The regulation of lipid homeostasis by insulin is mediated in part by the enhanced transcription of the gene encoding SREBP-1c (sterol regulatory element-binding protein-1c). Nascent SREBP-1c is synthesized and embedded in the endoplasmic reticulum (ER) and must be transported to the Golgi in coatomer protein II (COPII) vesicles where two sequential cleavages generate the transcriptionally active NH2-terminal fragment, nSREBP-1c. There is limited indirect evidence to suggest that insulin may also regulate the post-translational processing of the nascent SREBP-1c protein. Therefore, we designed experiments to directly assess the action of insulin on the post-translational processing of epitope-tagged full-length SREBP-1c and SREBP-2 proteins expressed in cultured hepatocytes. We demonstrate that insulin treatment led to enhanced post-translational processing of SREBP-1c, which was associated with phosphorylation of ER-bound nascent SREBP-1c protein that increased affinity of the SREBP-1c cleavage-activating protein (SCAP)-SREBP-1c complex for the Sec23/24 proteins of the COPII vesicles. Furthermore, chemical and molecular inhibitors of the phosphoinositide 3-kinase pathway and its downstream kinase protein kinase B (PKB)/Akt prevented both insulin-mediated phosphorylation of nascent SREBP-1c protein and its post-translational processing. Insulin had no effect on the proteolysis of nascent SREBP-2 under identical conditions. We also show that in vitro incubation of an active PKB/Akt enzyme with recombinant full-length SREBP-1c led to its phosphorylation. Thus, insulin selectively stimulates the processing of SREBP-1c in rat hepatocytes by enhancing the association between the SCAP-SREBP-1c complex and COPII proteins and subsequent ER to Golgi transport and proteolytic cleavage. This effect of insulin is tightly linked to phosphoinositide 3-kinase and PKB/Akt-dependent serine phosphorylation of the precursor SREBP-1c protein.	[Yellaturu, Chandrahasa R.; Deng, Xiong; Cagen, Lauren M.; Wilcox, Henry G.; Park, Edwards A.; Raghow, Rajendra; Elam, Marshall B.] Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Memphis, TN 38163 USA; [Mansbach, Charles M., II; Siddiqi, Shadab A.] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38163 USA; [Deng, Xiong; Raghow, Rajendra; Elam, Marshall B.] Dept Vet Affairs Med Ctr, Memphis, TN 38103 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Yellaturu, CR (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.	cyellatu@utmem.edu			National Institutes of Health [DK075504]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059368, R01DK075504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK075504 (to M.B.E., R.R., and C.R.Y.). This work was also supported by a postdoctoral fellowship grant, American Heart Association (to C.R.Y.),	Adams CM, 2003, P NATL ACAD SCI USA, V100, P10647, DOI 10.1073/pnas.1534833100; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Aridor M, 2000, J BIOL CHEM, V275, P35673, DOI 10.1074/jbc.C000449200; Azzout-Marniche D, 2000, BIOCHEM J, V350, P389, DOI 10.1042/0264-6021:3500389; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Cagen LM, 2005, BIOCHEM J, V385, P207, DOI 10.1042/BJ20040162; Chrysis D, 2005, ENDOCRINOLOGY, V146, P1391, DOI 10.1210/en.2004-1152; CZECH MP, 1988, J BIOL CHEM, V263, P11017; Deng X, 2007, J BIOL CHEM, V282, P17517, DOI 10.1074/jbc.M702228200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Edwards PA, 2000, BBA-MOL CELL BIOL L, V1529, P103, DOI 10.1016/S1388-1981(00)00140-2; Elam MB, 2001, J LIPID RES, V42, P2039; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Espenshade PJ, 2006, J CELL SCI, V119, P973, DOI 10.1242/jcs02866; Fleischmann M, 2000, BIOCHEM J, V349, P13, DOI 10.1042/bj3490013; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hegarty BD, 2005, P NATL ACAD SCI USA, V102, P791, DOI 10.1073/pnas.0405067102; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; HUA XX, 1995, GENOMICS, V25, P667, DOI 10.1016/0888-7543(95)80009-B; Kierbel A, 2005, MOL BIOL CELL, V16, P2577, DOI 10.1091/mbc.E04-08-0717; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Koo SH, 2001, J BIOL CHEM, V276, P9437, DOI 10.1074/jbc.M010029200; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Lu M, 2006, AM J PHYSIOL-CELL PH, V290, pC1477, DOI 10.1152/ajpcell.00374.2005; Matsumoto M, 2002, DIABETES, V51, P1672, DOI 10.2337/diabetes.51.6.1672; McPherson R, 2004, BIOCHEM CELL BIOL, V82, P201, DOI 10.1139/o03-090; Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905; Peak M, 1998, DIABETOLOGIA, V41, P16, DOI 10.1007/s001250050861; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; Ribaux PG, 2003, BIOCHEM J, V376, P697, DOI 10.1042/BJ20031287; Roth G, 2000, J BIOL CHEM, V275, P33302, DOI 10.1074/jbc.M005425200; Rowe T, 1996, J CELL BIOL, V135, P895, DOI 10.1083/jcb.135.4.895; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; SRINIVASAN M, 1994, J BIOL CHEM, V269, P12514; Sun LP, 2005, J BIOL CHEM, V280, P26483, DOI 10.1074/jbc.M504041200; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Taniguchi CM, 2006, CELL METAB, V3, P343, DOI 10.1016/j.cmet.2006.04.005; THORNGATE FE, 1994, P NATL ACAD SCI USA, V91, P5392, DOI 10.1073/pnas.91.12.5392; TOBE K, 1992, J BIOL CHEM, V267, P21089; WHITE MF, 1994, J BIOL CHEM, V269, P1; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yellaturu CR, 2005, BIOCHEM BIOPH RES CO, V332, P174, DOI 10.1016/j.bbrc.2005.04.112	55	100	107	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7518	7532		10.1074/jbc.M805746200	http://dx.doi.org/10.1074/jbc.M805746200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19158095	hybrid, Green Published			2022-12-25	WOS:000264195600015
J	Zhao, XB; Yu, SW; Ranguelova, K; Suarez, J; Metlitsky, L; Schelvis, JPM; Magliozzo, RS				Zhao, Xiangbo; Yu, Shengwei; Ranguelova, Kalina; Suarez, Javier; Metlitsky, Leonid; Schelvis, Johannes P. M.; Magliozzo, Richard S.			Role of the Oxyferrous Heme Intermediate and Distal Side Adduct Radical in the Catalase Activity of Mycobacterium tuberculosis KatG Revealed by the W107F Mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; ELECTRON-PARAMAGNETIC-RESONANCE; NADH OXIDASE ACTIVITY; TRP CROSS-LINK; PEROXIDASE KATG; ISONIAZID ACTIVATION; BURKHOLDERIA-PSEUDOMALLEI; HYDROGEN-PEROXIDE; HORSERADISH-PEROXIDASE; CRYSTAL-STRUCTURE	Catalase-peroxidase (KatG) is essential in Mycobacterium tuberculosis for oxidative stress management and activation of the antitubercular pro-drug isoniazid. The role of a unique distal side adduct found in KatG enzymes, involving linked side chains of residues Met(255), Tyr(229), and Trp(107) (MYW), in the unusual catalase activity of KatG is addressed here and in our companion paper (Suarez, J., Ranguelova, K., Jarzecki, A. A., Manzerova, J., Krymov, V., Zhao, X., Yu, S., Metlitsky, L., Gerfen, G. J., and Magliozzo, R. S. (2009) J. Biol. Chem. 284, in press). The KatG[W107F] mutant exhibited severely reduced catalase activity yet normal peroxidase activity, and as isolated contains more abundant 6-coordinate heme in high spin and low spin forms compared with the wild-type enzyme. Most interestingly, oxyferrous heme is also found in the purified enzyme. Oxyferrous KatG[W107F] was prepared by photolysis in air of the carbonyl enzyme or was generated using hydrogen peroxide decayed with a t(1/2) of 2 days compared with 6 min for wild-type protein. The stability of oxyenyzme was modestly enhanced in KatG[Y229F] but was not affected in KatG[M255A]. Optical stopped-flow experiments showed rapid formation of Compound I in KatG[W107F] and facile formation of oxyferrous heme in the presence of micromolar hydrogen peroxide. An analysis of the relationships between catalase activity, stability of oxyferrous enzyme, and a proposed MYW adduct radical is presented. The loss of catalase function is assigned to the loss of the MYW adduct radical and structural changes that lead to greatly enhanced stability of oxyenzyme, an intermediate of the catalase cycle of native enzyme.	[Zhao, Xiangbo; Yu, Shengwei; Ranguelova, Kalina; Suarez, Javier; Metlitsky, Leonid; Magliozzo, Richard S.] CUNY Brooklyn Coll, Dept Chem, Brooklyn, NY 11210 USA; [Suarez, Javier; Magliozzo, Richard S.] CUNY, Grad Ctr, Dept Chem, New York, NY 10016 USA; [Suarez, Javier; Magliozzo, Richard S.] CUNY, Grad Ctr, Dept Biochem, New York, NY 10016 USA; [Schelvis, Johannes P. M.] NYU, Dept Chem, New York, NY 10003 USA	City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; New York University	Magliozzo, RS (corresponding author), CUNY Brooklyn Coll, Dept Chem, 2900 Bedford Ave, Brooklyn, NY 11210 USA.	rmaglioz@brooklyn.cuny.edu			National Institutes of Health [AI-43582, AI-060014]; National Science Foundation; Heiser Program for Research in Leprosy and Tuberculosis; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043582, R56AI060014, R01AI060014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Heiser Program for Research in Leprosy and Tuberculosis; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-43582 and AI-060014 (NIAID) (to R. S. M.). This work was also supported by National Science Foundation grant (to J. P. M. S.) and the Heiser Program for Research in Leprosy and Tuberculosis (to S. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANTONINI E, 1971, HEMOGLOBIN MYOGLOBIN, P44; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Bertrand T, 2004, J BIOL CHEM, V279, P38991, DOI 10.1074/jbc.M402382200; BLUMBERG WE, 1968, J BIOL CHEM, V243, P1854; Carpena X, 2006, BIOCHEMISTRY-US, V45, P5171, DOI 10.1021/bi060017f; Carpena X, 2003, J MOL BIOL, V327, P475, DOI 10.1016/S0022-2836(03)00122-0; Chouchane S, 2003, J BIOL CHEM, V278, P8154, DOI 10.1074/jbc.M208256200; Chouchane S, 2000, BIOCHEMISTRY-US, V39, P9975, DOI 10.1021/bi0005815; Deemagarn T, 2007, PROTEINS, V66, P219, DOI 10.1002/prot.21209; DeLano WL, 2004, PYMOL MOL GRAPHICS S; DUNFORD HB, 1999, HEME PEROXIDASES, P276; Ghiladi RA, 2005, BIOCHEMISTRY-US, V44, P15093, DOI 10.1021/bi051463q; Ghiladi RA, 2005, J BIOL CHEM, V280, P22651, DOI 10.1074/jbc.M502486200; GonzalezFlecha B, 1997, J BACTERIOL, V179, P382, DOI 10.1128/jb.179.2.382-388.1997; Hillar A, 2000, BIOCHEMISTRY-US, V39, P5868, DOI 10.1021/bi0000059; IKEDASAITO M, 1992, J BIOL CHEM, V267, P22843; Ivancich A, 2003, J AM CHEM SOC, V125, P14093, DOI 10.1021/ja035582+; Jakopitsch C, 2005, J BIOL CHEM, V280, P9037, DOI 10.1074/jbc.M413317200; Jakopitsch C, 2005, J BIOL CHEM, V280, P42411, DOI 10.1074/jbc.M508009200; Jakopitsch C, 2003, EUR J BIOCHEM, V270, P1006, DOI 10.1046/j.1432-1033.2003.03476.x; Jakopitsch C, 2001, BIOCHEM BIOPH RES CO, V287, P682, DOI 10.1006/bbrc.2001.5616; Jakopitsch C, 2004, J BIOL CHEM, V279, P46082, DOI 10.1074/jbc.M408399200; Jakopitsch C, 2003, J BIOL CHEM, V278, P20185, DOI 10.1074/jbc.M211625200; Jakopitsch C, 2007, BIOCHEMISTRY-US, V46, P1183, DOI 10.1021/bi062266+; JOHNSSON K, 1994, J AM CHEM SOC, V116, P7425, DOI 10.1021/ja00095a063; Kapetanaki S, 2003, BIOCHEMISTRY-US, V42, P3835, DOI 10.1021/bi026992y; Magliozzo RS, 1996, J AM CHEM SOC, V118, P11303, DOI 10.1021/ja962047j; MARCINKEVICIENE JA, 1995, J BIOL CHEM, V270, P22290, DOI 10.1074/jbc.270.38.22290; Metcalfe C, 2008, J BIOL CHEM, V283, P6193, DOI 10.1074/jbc.M707412200; MILLER MA, 1992, BIOCHEMISTRY-US, V31, P2789, DOI 10.1021/bi00125a020; MILLER MA, 1994, NAT STRUCT BIOL, V1, P524, DOI 10.1038/nsb0894-524; PEISACH J, 1971, P 1 INT AM S HEM, P199; Pierattelli R, 2004, J BIOL CHEM, V279, P39000, DOI 10.1074/jbc.M402384200; Ranguelova K, 2008, BIOCHEMISTRY-US, V47, P12583, DOI 10.1021/bi801511u; Ranguelova K, 2007, J BIOL CHEM, V282, P6255, DOI 10.1074/jbc.M607309200; Regelsberger G, 2000, J BIOL CHEM, V275, P22854, DOI 10.1074/jbc.M002371200; Regelsberger G, 2001, BIOCHEM SOC T, V29, P99; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; Saint-Joanis B, 1999, BIOCHEM J, V338, P753, DOI 10.1042/0264-6021:3380753; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Singh R, 2004, J BIOL CHEM, V279, P43098, DOI 10.1074/jbc.M406374200; Suarez J, 2009, J BIOL CHEM, V284, P7017, DOI 10.1074/jbc.M808106200; Svistunenko DA, 2000, BIOCHEM J, V351, P595, DOI 10.1042/0264-6021:3510595; Vlasits J, 2007, FEBS LETT, V581, P320, DOI 10.1016/j.febslet.2006.12.037; Wengenack NL, 1998, BIOCHEMISTRY-US, V37, P15825, DOI 10.1021/bi982023k; WITTENBE.BA, 1967, BIOCHEMISTRY-US, V6, P1970, DOI 10.1021/bi00859a013; Yamada Y, 2002, NAT STRUCT BIOL, V9, P691, DOI 10.1038/nsb834; Yu SW, 2003, J BIOL CHEM, V278, P44121, DOI 10.1074/jbc.M304757200; ZHANG Y, 1993, RES MICROBIOL, V144, P143, DOI 10.1016/0923-2508(93)90029-2; Zhao XB, 2006, BIOCHEMISTRY-US, V45, P4131, DOI 10.1021/bi051967o; Zhao XB, 2007, BIOCHEMISTRY-US, V46, P3161, DOI 10.1021/bi062218p	51	16	16	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7030	7037		10.1074/jbc.M808107200	http://dx.doi.org/10.1074/jbc.M808107200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19139098	hybrid, Green Published			2022-12-25	WOS:000263919000051
J	Soderhall, I; Wu, CL; Novotny, M; Lee, BL; Soderhall, K				Soderhall, Irene; Wu, Chenglin; Novotny, Marian; Lee, Bok Luel; Soderhall, Kenneth			A Novel Protein Acts as a Negative Regulator of Prophenoloxidase Activation and Melanization in the Freshwater Crayfish Pacifastacus leniusculus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNITY; PHENOLOXIDASE; DEFENSE; TRYPSINOGEN; INHIBITOR; COMPONENT; CLONING; SYSTEM	Melanization is an important immune component of the innate immune system of invertebrates and is vital for defense as well as for wound healing. In most invertebrates melanin synthesis is achieved by the prophenoloxidase-activating system, a proteolytic cascade similar to vertebrate complement. Even though melanin formation is necessary for host defense in crustaceans and insects, the process needs to be tightly regulated because of the hazard to the animal of unwanted production of quinone intermediates and melanization in places where it is not suitable. In the present study we have identified a new melanization inhibition protein (MIP) from the hemolymph of the crayfish, Pacifastacus leniusculus. Crayfish MIP has a similar function as the insect MIP molecule we recently discovered in the beetle Tenebrio molitor but interestingly has a completely different sequence. Crayfish MIP as well as Tenebrio MIP do not affect phenoloxidase activity in itself but instead interfere with the melanization reaction from quinone compounds to melanin. Importantly, crayfish MIP in contrast to Tenebrio MIP contains a fibrinogen-like domain, most similar to the substrate recognition domain of vertebrate L-ficolins. Surprisingly, an Asp-rich region similar to that found in ficolins that is likely to be involved in Ca2+ binding is present in crayfish MIP. However, crayfish MIP did not show any hemagglutinating activity as is common for the vertebrate ficolins. A mutant form of MIP with a deletion lacking four Asp amino acids from the Asp-rich region lost most of its activity, implicating that this part of the protein is involved in regulating the prophenoloxidase activating cascade. Overall, a new negative regulator of melanization was identified in freshwater crayfish that shows interesting parallels with proteins (i.e. ficolins) involved in vertebrate immune response.	[Soderhall, Irene; Wu, Chenglin; Soderhall, Kenneth] Uppsala Univ, Dept Comparat Physiol, S-75236 Uppsala, Sweden; [Novotny, Marian] Charles Univ Prague, Dept Cell Biol, Fac Nat Sci, Prague 12843, Czech Republic; [Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea	Uppsala University; Charles University Prague; Pusan National University	Soderhall, I (corresponding author), Uppsala Univ, Dept Comparat Physiol, Norbyvagen 18A, S-75236 Uppsala, Sweden.	Irene.Soderhall@ebc.uu.se	Novotny, Marian/B-7036-2008; Soderhall, Irene/AAS-5433-2020	Novotny, Marian/0000-0001-8788-3202; 	Swedish Science Research Council; Swedish Research Council Formas	Swedish Science Research Council; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This work was supported by the Swedish Science Research Council and The Swedish Research Council Formas. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ashida Masaaki, 1998, P135; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Eleftherianos I, 2007, P NATL ACAD SCI USA, V104, P2419, DOI 10.1073/pnas.0610525104; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Gokudan S, 1999, P NATL ACAD SCI USA, V96, P10086, DOI 10.1073/pnas.96.18.10086; Gorman MJ, 2007, J BIOL CHEM, V282, P11742, DOI 10.1074/jbc.M611243200; HOPP TP, 1981, P NATL ACAD SCI USA, V86, P152; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kim MS, 2002, J BIOL CHEM, V277, P39999, DOI 10.1074/jbc.M205508200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liang ZC, 1997, P NATL ACAD SCI USA, V94, P6682, DOI 10.1073/pnas.94.13.6682; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Liu H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706113200; Lu ZQ, 2007, INSECT BIOCHEM MOLEC, V37, P478, DOI 10.1016/j.ibmb.2007.02.004; Nemoda Z, 2005, J BIOL CHEM, V280, P29645, DOI 10.1074/jbc.M505661200; Okino N, 1995, J BIOL CHEM, V270, P31008, DOI 10.1074/jbc.270.52.31008; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; RADHAKRI.TM, 1969, BIOCHEMISTRY-US, V8, P4020, DOI 10.1021/bi00838a019; Rodriguez R, 1998, BIOINFORMATICS, V14, P523, DOI 10.1093/bioinformatics/14.6.523; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shi L, 2006, INSECT MOL BIOL, V15, P313, DOI 10.1111/j.1365-2583.2006.00643.x; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Wang RG, 2001, EUR J BIOCHEM, V268, P895, DOI 10.1046/j.1432-1327.2001.01945.x; Zhao MY, 2005, J BIOL CHEM, V280, P24744, DOI 10.1074/jbc.M504173200	29	67	68	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6301	6310		10.1074/jbc.M806764200	http://dx.doi.org/10.1074/jbc.M806764200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19129195	hybrid			2022-12-25	WOS:000263742700033
J	Bhattacharyya, S; Ishida, W; Wu, M; Wilkes, M; Mori, Y; Hinchcliff, M; Leof, E; Varga, J				Bhattacharyya, S.; Ishida, W.; Wu, M.; Wilkes, M.; Mori, Y.; Hinchcliff, M.; Leof, E.; Varga, J.			A non-Smad mechanism of fibroblast activation by transforming growth factor-beta via c-Abl and Egr-1: selective modulation by imatinib mesylate	ONCOGENE			English	Article						c-Abl; imatinib mesylate; TGF-beta; Egr-1; fibrosis; fibroblast	CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE-ACTIVITY; TGF-BETA; SYSTEMIC-SCLEROSIS; TRANSCRIPTION FACTORS; SKIN FIBROBLASTS; CELLULAR-RESPONSE; POSITIVE CELLS; COLLAGEN GENE; DNA-DAMAGE	The nonreceptor protein tyrosine kinase c-Abl regulates cell proliferation and survival. Recent studies provide evidence that implicate c-Abl as a mediator for. brotic responses induced by transforming growth factor-beta (TGF-beta), but the precise mechanisms underlying this novel oncogene function are unknown. Here, we report that when expressed in normal fibroblasts, a constitutively active mutant of Abl that causes chronic myelogenous leukemia (CML) stimulated the expression and transcriptional activity of the early growth response factor 1 (Egr1). Mouse embryonic fibroblasts (MEFs), lacking c-Abl, were resistant to TGF-beta stimulation. Responsiveness of these MEFs to TGF-beta could be rescued by wild-type c-Abl, but not by a kinase-deficient mutant form of c-Abl. Furthermore, Abl kinase activity was necessary for the induction of Egr-1 by TGF-beta in normal fibroblasts, and Egr-1 was required for stimulation of collagen by Bcr-Abl. Lesional skin fibroblasts in mice with bleomycin-induced fibrosis of skin displayed evidence of c-Abl activation in situ, and elevated phospho-c-Abl correlated with increased local expression of Egr-1. Collectively, these results position Egr-1 downstream of c-Abl in the. brotic response, delineate a novel Egr-1-dependent intracellular signaling mechanism that underlies the involvement of c-Abl in certain TGF-beta responses, and identify Egr-1 as a target of inhibition by imatinib. Furthermore, the findings show in situ activation of c-Abl paralleling the upregulated tissue expression of Egr-1 that accompanies fibrosis. Pharmacological targeting of c-Abl and its downstream effector pathways may, therefore, represent a novel therapeutic approach to blocking TGF-beta-dependent fibrotic processes.	[Bhattacharyya, S.; Ishida, W.; Wu, M.; Mori, Y.; Hinchcliff, M.; Varga, J.] Northwestern Univ, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA; [Wilkes, M.; Leof, E.] Mayo Clin, Div Pulm Med, Rochester, MN USA	Northwestern University; Feinberg School of Medicine; Mayo Clinic	Varga, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Rheumatol, 240 E Huron St, Chicago, IL 60611 USA.	j-varga@northwestern.edu	Varga, John/AAK-6472-2021; Bhattacharyya, Swati/W-8145-2019	Wilkes, Mark/0000-0002-9600-6831; Hinchcliff, Monique/0000-0002-8652-9890	National Institutes of Health [AR-42309]; Department of Defence [W81-XWH-06-01-0278]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM055816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defence; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Anthony Koleske (Yale University, New Haven, CT, USA) and Pamela Woodring (The Salk Institute, La Jolla, CA) for Abl- null/Arg-null and Abl reconstituted mouse embryonic. broblasts, and Leonidas Platanias (North-western University Feinberg School of Medicine) for Bcr-Abl plasmids and helpful discussions. This study was supported by grants from the National Institutes of Health (AR-42309) and the Department of Defence (W81-XWH-06-01-0278).	Bhattacharyya S, 2008, AM J PATHOL, V173, P1085, DOI 10.2353/ajpath.2008.080382; Bonn D, 2004, LANCET INFECT DIS, V4, P255, DOI 10.1016/S1473-3099(04)01014-X; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Ceni E, 2006, GASTROENTEROLOGY, V131, P1235, DOI 10.1053/j.gastro.2006.08.009; Che W, 2001, CIRCULATION, V104, P1399, DOI 10.1161/hc3701.095581; Chen SJ, 2006, J BIOL CHEM, V281, P21183, DOI 10.1074/jbc.M603270200; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; Danial NN, 2000, ONCOGENE, V19, P2523, DOI 10.1038/sj.onc.1203484; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Deininger MWN, 1997, BLOOD, V90, P3691, DOI 10.1182/blood.V90.9.3691; Distler JHW, 2007, ARTHRITIS RHEUM-US, V56, P311, DOI 10.1002/art.22314; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; He X, 2006, CELL, V127, P40, DOI 10.1016/j.cell.2006.09.016; Hernandez SE, 2004, TRENDS CELL BIOL, V14, P36, DOI 10.1016/j.tcb.2003.11.003; Ihn H, 1997, J BIOL CHEM, V272, P24666, DOI 10.1074/jbc.272.39.24666; Ishida W, 2006, ARTHRITIS RHEUM, V54, pS776; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Jimenez SA, 2004, ANN INTERN MED, V140, P37, DOI 10.7326/0003-4819-140-1-200401060-00010; Khachigian LM, 2006, CIRC RES, V98, P186, DOI 10.1161/01.RES.0000200177.53882.c3; Kharas NG, 2005, CANCER RES, V65, P2047, DOI 10.1158/0008-5472.CAN-04-3888; Kharbanda S, 1997, NATURE, V386, P732, DOI 10.1038/386732a0; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; Kharbanda S, 1995, J BIOL CHEM, V270, P30278, DOI 10.1074/jbc.270.51.30278; La Rosee P, 2002, EXP HEMATOL, V30, P729, DOI 10.1016/S0301-472X(02)00836-6; Lakos G, 2004, AM J PATHOL, V165, P203, DOI 10.1016/S0002-9440(10)63289-0; Leask A, 2008, CELL SIGNAL, V20, P1409, DOI 10.1016/j.cellsig.2008.01.006; Lewis JM, 1998, J BIOL CHEM, V273, P14225, DOI 10.1074/jbc.273.23.14225; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; Lobo VJSA, 2005, BIOCHEM J, V387, P231, DOI 10.1042/BJ20040927; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mori Y, 2004, ARTHRITIS RHEUM-US, V50, P4008, DOI 10.1002/art.20658; Mori Y, 2000, EXP CELL RES, V258, P374, DOI 10.1006/excr.2000.4930; MOUSTAKAS A, 2005, ONCOGENE, V24, P5742; Pannu J, 2004, CURR OPIN RHEUMATOL, V16, P739, DOI 10.1097/01.bor.0000137894.63091.1a; Pannu J, 2008, ARTHRITIS RHEUM-US, V58, P2528, DOI 10.1002/art.23698; Pannu J, 2007, J BIOL CHEM, V282, P10405, DOI 10.1074/jbc.M611742200; RAITANO AB, 1995, P NATL ACAD SCI USA, V92, P11746, DOI 10.1073/pnas.92.25.11746; Rajkumar VS, 2006, AM J PATHOL, V169, P2254, DOI 10.2353/ajpath.2006.060196; Renshaw MW, 2000, ONCOGENE, V19, P3216, DOI 10.1038/sj.onc.1203667; Rosenbloom J, 2008, ARTHRITIS RHEUM, V58, P2219, DOI 10.1002/art.23634; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Schubert C, 2007, J BIOL CHEM, V282, P4094, DOI 10.1074/jbc.M608183200; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Stuart JR, 2005, ONCOGENE, V24, P8085, DOI 10.1038/sj.onc.1208953; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; Svaren J, 2000, J BIOL CHEM, V275, P38524, DOI 10.1074/jbc.M005220200; Takagawa S, 2003, J INVEST DERMATOL, V121, P41, DOI 10.1046/j.1523-1747.2003.12308.x; Takahashi T, 2005, J BIOL CHEM, V280, P7100, DOI 10.1074/jbc.M411064200; Teckchandani AM, 2001, ONCOGENE, V20, P1739, DOI 10.1038/sj.onc.1204246; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Varga JA, 2008, RHEUM DIS CLIN N AM, V34, P115, DOI 10.1016/j.rdc.2007.11.002; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Wang SN, 2005, FASEB J, V19, P1, DOI 10.1096/fj.04-2370com; Wenner CE, 2003, J CELL PHYSIOL, V196, P42, DOI 10.1002/jcp.10243; Wilkes MC, 2006, J BIOL CHEM, V281, P27846, DOI 10.1074/jbc.M603721200; Woodring PJ, 2002, J CELL BIOL, V156, P879, DOI 10.1083/jcb.200110014; Yoshida K, 2000, MOL CELL BIOL, V20, P5370, DOI 10.1128/MCB.20.15.5370-5380.2000	63	61	62	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	10					1285	1297		10.1038/onc.2008.479	http://dx.doi.org/10.1038/onc.2008.479			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	417ZC	19151753	Green Accepted			2022-12-25	WOS:000264116000001
J	Greenow, KR; Clarke, AR; Jones, RH				Greenow, K. R.; Clarke, A. R.; Jones, R. H.			Chk1 deficiency in the mouse small intestine results in p53-independent crypt death and subsequent intestinal compensation	ONCOGENE			English	Article						Chk1; DNA damage; small intestine; apoptosis; p53	DNA-DAMAGE CHECKPOINT; CELL-DEATH; SERINE 139; CANCER; P53; PHOSPHORYLATION; EXPRESSION; REPLICATION; INHIBITION; INITIATION	Chk1 is a serine/threonine protein kinase that is activated by a wide range of DNA-damaging agents to slow the cell cycle during S phase and G2/M. Abrogation of these cell-cycle checkpoints using Chk1 inhibitors results in hypersensitivity to DNA-damaging agents in vitro and may provide a potential therapeutic tool to sensitize tumour cells in vivo. We have generated a Cre-Lox-based mouse model in which Chk1 can be inducibly deleted from somatic epithelial cells in the adult mouse small intestine and liver. Loss of Chk1 in the liver is tolerated with no apparent phenotype. In contrast, the loss of Chk1 within the small intestine results in immediate DNA damage and high levels of p53-independent apoptosis leading to crypt death. However, the intestine is able to compensate for this death by undergoing complete re-population with Chk1-proficient cells. These data therefore show that Chk1 deficiency is cell lethal, but the intestine can tolerate such lethality at the organ level.	[Greenow, K. R.; Clarke, A. R.; Jones, R. H.] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3US, S Glam, Wales; [Jones, R. H.] Univ Bristol, Dept Cellular & Mol Med, Bristol, Avon, England	Cardiff University; University of Bristol	Jones, RH (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Museum Ave, Cardiff CF10 3US, S Glam, Wales.	jonesrh7@cardiff.ac.uk	Clarke, Alan R/A-6256-2008; clarke, alan r/P-2820-2014	Clarke, Alan/0000-0002-4281-426X	Cancer Research UK; MRC [G0301154] Funding Source: UKRI; Medical Research Council [G0301154] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by Cancer Research UK. We thank Mark Bishop, Lucie Pietzka and Derek Scarborough for technical assistance.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; BJERKNES M, 1981, ANAT REC, V199, P565, DOI 10.1002/ar.1091990412; Chen ZH, 2003, MOL CANCER THER, V2, P543; Hapke G, 2001, CANCER METAST REV, V20, P109, DOI 10.1023/A:1013116826788; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kawabe T, 2004, MOL CANCER THER, V3, P513; Koniaras K, 2001, ONCOGENE, V20, P7453, DOI 10.1038/sj.onc.1204942; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liu QH, 2000, GENE DEV, V14, P1448; Merritt AJ, 1997, ONCOGENE, V14, P2759, DOI 10.1038/sj.onc.1201126; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Robinson HMR, 2006, ONCOGENE, V25, P5359, DOI 10.1038/sj.onc.1209532; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sansom OJ, 2005, ONCOGENE, V24, P8205, DOI 10.1038/sj.onc.1208956; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Takai H, 2000, GENE DEV, V14, P1439; Tse AN, 2007, CLIN CANCER RES, V13, P1955, DOI 10.1158/1078-0432.CCR-06-2793; Wang QZ, 1996, J NATL CANCER I, V88, P956, DOI 10.1093/jnci/88.14.956; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; Zachos G, 2003, EMBO J, V22, P713, DOI 10.1093/emboj/cdg060; Zaugg K, 2007, P NATL ACAD SCI USA, V104, P3805, DOI 10.1073/pnas.0611584104	29	32	32	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2009	28	11					1443	1453		10.1038/onc.2008.482	http://dx.doi.org/10.1038/onc.2008.482			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	421JE	19169280	Green Accepted			2022-12-25	WOS:000264354400005
J	Asada, K; Kurokawa, J; Furukawa, T				Asada, Ken; Kurokawa, Junko; Furukawa, Tetsushi			Redox- and Calmodulin-dependent S-Nitrosylation of the KCNQ1 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFIER K+ CURRENT; DENSITY PROTEIN PSD-95; LONG-QT SYNDROME; NITRIC-OXIDE; GUINEA-PIG; CARDIAC REPOLARIZATION; RECEPTOR MODULATION; POTASSIUM CHANNELS; CYSTEINE; NO	Nitric oxide (NO) is a gaseous signal mediator showing numerous important biological effects. NO has been shown in many instances to exhibit its action via the protein S-nitrosylation mechanism, in which binding of NO to Cys residues regulate protein function independently of activation of soluble guanylate cyclase. The direct link between protein S-nitrosylation and functional modulation, however, has been demonstrated only in limited examples. Furthermore, although most proteins have more than one Cys residue, the mechanism by which a certain Cys becomes a specific target residue of S-nitrosylation is poorly understood. We have previously reported that NO regulates currents through the cardiac slowly activating delayed rectifier potassium channel (I-Ks) irrespective of soluble guanylate cyclase activation. Here we demonstrate using a biotin-switch assay that NO induced S-nitrosylation of the alpha-subunit of the IKs channel, KCNQ1, at Cys(445) in the C terminus. A redox motif flanking Cys(445) and the interaction of KCNQ1 with calmodulin are required for preferential S-nitrosylation of Cys(445). A patch clamp experiment shows that S-nitrosylation of Cys(445) modulates the KCNQ1/KCNE1 channel function. Our data provide a molecular basis of NO-mediated regulation of the I-Ks channel. This novel regulatory mechanism of the I-Ks channel may play a role in previously demonstrated NO-mediated phenomenon in cardiac electrophysiology, including shortening in action potential duration in response to intracellular Ca2+ or sex hormones.	[Asada, Ken; Kurokawa, Junko; Furukawa, Tetsushi] Tokyo Med & Dent Univ, Med Res Inst, Dept Bioinformat Pharmacol, Bunkyo Ku, Tokyo 1138510, Japan	Tokyo Medical & Dental University (TMDU)	Furukawa, T (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Bioinformat Pharmacol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	t_furukawa.bip@mri.tmd.ac.jp	Kurokawa, Junko/ABF-7557-2021; furukawa, tetsushi/ABD-3178-2020; Kurokawa, Junko/Q-6287-2017; Asada, Ken/AAP-6668-2020	Kurokawa, Junko/0000-0002-9098-0908; Kurokawa, Junko/0000-0002-9098-0908; Asada, Ken/0000-0003-0548-4449	Ministry of Education, Science, Culture, Sports and Technology of Japan [17081007, 18659066, 19689006]; Vehicle Racing Commemorative Foundation; Kanae Foundation for the promotion of medical science; Suzuken Memorial Foundation; Naito Foundation	Ministry of Education, Science, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Vehicle Racing Commemorative Foundation; Kanae Foundation for the promotion of medical science; Suzuken Memorial Foundation; Naito Foundation(Naito Memorial Foundation)	This work was supported by Grant-in-aid for Scientific Research on Priority Areas 17081007 (to T. F.); Grants 18659066 (to T. F.) and 19689006 (to J.K.) from the Ministry of Education, Science, Culture, Sports and Technology of Japan; a research grant (to T. F.) from The Vehicle Racing Commemorative Foundation; and research grants (to J.K.) from the Kanae Foundation for the promotion of medical science, Suzuken Memorial Foundation, and Naito Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bai CX, 2005, CIRCULATION, V112, P1701, DOI 10.1161/CIRCULATIONAHA.104.523217; Bai CX, 2005, CIRC RES, V96, P64, DOI 10.1161/01.RES.0000151846.19788.E0; Bai CX, 2004, BRIT J PHARMACOL, V142, P567, DOI 10.1038/sj.bjp.0705814; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Broillet MC, 2000, J BIOL CHEM, V275, P15135, DOI 10.1074/jbc.275.20.15135; Choi YB, 2000, NAT NEUROSCI, V3, P15, DOI 10.1038/71090; Clancy CE, 2003, ANNU REV PHARMACOL, V43, P441, DOI 10.1146/annurev.pharmtox.43.100901.140245; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dilly KW, 2004, J BIOL CHEM, V279, P40778, DOI 10.1074/jbc.M406010200; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hess DT, 2001, NAT CELL BIOL, V3, pE46, DOI 10.1038/35055152; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kurokawa J, 2008, J PHYSIOL-LONDON, V586, P2961, DOI 10.1113/jphysiol.2007.150367; Li HY, 2005, J INORG BIOCHEM, V99, P293, DOI 10.1016/j.jinorgbio.2004.10.016; Lipton SA, 2002, TRENDS NEUROSCI, V25, P474, DOI 10.1016/S0166-2236(02)02245-2; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; Nakamura H, 2007, CIRCULATION, V116, P2913, DOI 10.1161/CIRCULATIONAHA.107.702407; Nedospasov A, 2000, P NATL ACAD SCI USA, V97, P13543, DOI 10.1073/pnas.250398197; NITTA J, 1994, CIRC RES, V74, P96, DOI 10.1161/01.RES.74.1.96; Perez-Mato I, 1999, J BIOL CHEM, V274, P17075, DOI 10.1074/jbc.274.24.17075; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Sun JH, 2001, P NATL ACAD SCI USA, V98, P11158, DOI 10.1073/pnas.201289098; Sun JH, 2007, CIRC RES, V101, P1155, DOI 10.1161/CIRCRESAHA.107.155879; TOHSE N, 1990, AM J PHYSIOL, V258, pH1200, DOI 10.1152/ajpheart.1990.258.4.H1200; Ueda K, 2008, P NATL ACAD SCI USA, V105, P9355, DOI 10.1073/pnas.0801294105; Wiener R, 2008, J BIOL CHEM, V283, P5815, DOI 10.1074/jbc.M707541200; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200	33	51	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					6014	6020		10.1074/jbc.M807158200	http://dx.doi.org/10.1074/jbc.M807158200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19124472	hybrid			2022-12-25	WOS:000263560600065
J	Lam, MHY; Urban-Grimal, D; Bugnicourt, A; Greenblatt, JF; Haguenauer-Tsapis, R; Emili, A				Lam, Mandy H. Y.; Urban-Grimal, Daniele; Bugnicourt, Amandine; Greenblatt, Jack F.; Haguenauer-Tsapis, Rosine; Emili, Andrew			Interaction of the Deubiquitinating Enzyme Ubp2 and the E3 Ligase Rsp5 Is Required for Transporter/Receptor Sorting in the Multivesicular Body Pathway	PLOS ONE			English	Article								Protein ubiquitination is essential for many events linked to intracellular protein trafficking. We sought to elucidate the possible involvement of the S. cerevisiae deubiquitinating enzyme Ubp2 in transporter and receptor trafficking after we (this study) and others established that affinity purified Ubp2 interacts stably with the E3 ubiquitin ligase Rsp5 and the (ubiquitin associated) UBA domain containing protein Rup1. UBP2 interacts genetically with RSP5, while Rup1 facilitates the tethering of Ubp2 to Rsp5 via a PPPSY motif. Using the uracil permease Fur4 as a model reporter system, we establish a role for Ubp2 in membrane protein turnover. Similar to hypomorphic rsp5 alleles, cells deleted for UBP2 exhibited a temporal stabilization of Fur4 at the plasma membrane, indicative of perturbed protein trafficking. This defect was ubiquitin dependent, as a Fur4 N-terminal ubiquitin fusion construct bypassed the block and restored sorting in the mutant. Moreover, the defect was absent in conditions where recycling was absent, implicating Ubp2 in sorting at the multivesicular body. Taken together, our data suggest a previously overlooked role for Ubp2 as a positive regulator of Rsp5-mediated membrane protein trafficking subsequent to endocytosis.	[Lam, Mandy H. Y.; Greenblatt, Jack F.; Emili, Andrew] Univ Toronto, Banting & Best Dept Med Res, Donnelly Ctr Cellular & Biomol Res, Dept Mol Genet, Toronto, ON, Canada; [Urban-Grimal, Daniele; Bugnicourt, Amandine; Haguenauer-Tsapis, Rosine] Univ Paris 06, Inst Jacques Monod, CNRS, F-75252 Paris, France; [Urban-Grimal, Daniele; Bugnicourt, Amandine; Haguenauer-Tsapis, Rosine] Univ Paris 07, F-75221 Paris, France	University of Toronto; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Lam, MHY (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Donnelly Ctr Cellular & Biomol Res, Dept Mol Genet, Toronto, ON, Canada.	andrew.emili@utoronto.ca	Haguenauer-Tsapis, Rosine/C-5446-2012		Protein Engineering Network Centre of Excellence of Canada (PENCE); Ontario Graduate Scholarships; University of Toronto [Open Fellowships]; Centre National de la Recherche Scientifique; Universities Paris 6; Universities Paris 7; Association pour la Recherche sur le Cancer (ARC) [3298]; European Program 6 (FP6) [018683]	Protein Engineering Network Centre of Excellence of Canada (PENCE); Ontario Graduate Scholarships(Ontario Graduate Scholarship); University of Toronto(University of Toronto); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universities Paris 6; Universities Paris 7; Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); European Program 6 (FP6)(European Commission)	This work was supported by funds from the Protein Engineering Network Centre of Excellence of Canada (PENCE) to A.E.. Ontario Graduate Scholarships and University of Toronto Open Fellowships to M.H.Y.L. Work in R.H.T.'s lab was supported by the Centre National de la Recherche Scientifique and the Universities Paris 6 and Paris 7, by a grant from the Association pour la Recherche sur le Cancer (ARC) (grant no. 3298), by a special grant from the CNRS (ACI BCMS), and by a grant from the European Program 6 (FP6) (RUBICON, contrat no. 018683). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; BAKER RT, 1992, J BIOL CHEM, V267, P23364; Baxter BK, 2005, J BIOL CHEM, V280, P39067, DOI 10.1074/jbc.M508064200; Blondel MO, 2004, MOL BIOL CELL, V15, P883, DOI 10.1091/mbc.E03-04-0202; Brachmann CB, 1998, YEAST, V14, P115; BUCKINGTHROM E, 1973, EXP CELL RES, V76, P99, DOI 10.1016/0014-4827(73)90424-2; Bugnicourt A, 2004, MOL BIOL CELL, V15, P4203, DOI 10.1091/mbc.E04-05-0420; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; Cohen M, 2003, J BIOL CHEM, V278, P51989, DOI 10.1074/jbc.C300451200; Cohen M, 2003, NAT CELL BIOL, V5, P661, DOI 10.1038/ncb1003; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Dunn R, 2001, MOL BIOL CELL, V12, P421, DOI 10.1091/mbc.12.2.421; Dupre S, 2004, BBA-MOL CELL RES, V1695, P89, DOI 10.1016/j.bbamcr.2004.09.024; Dupre S, 2001, MOL CELL BIOL, V21, P4482, DOI 10.1128/MCB.21.14.4482-4494.2001; Emili A, 2001, MOL CELL, V7, P13, DOI 10.1016/S1097-2765(01)00150-2; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gitan RS, 2000, BIOCHEM J, V346, P329, DOI 10.1042/0264-6021:3460329; Gwizdek C, 2005, J BIOL CHEM, V280, P13401, DOI 10.1074/jbc.C500040200; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hicke L, 1997, FASEB J, V11, P1215, DOI 10.1096/fasebj.11.14.9409540; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Horak J, 2003, BBA-BIOMEMBRANES, V1614, P139, DOI 10.1016/S0005-2736(03)00195-0; JUND R, 1970, J BACTERIOL, V102, P607, DOI 10.1128/JB.102.3.607-615.1970; Kaminska J, 2002, MOL CELL BIOL, V22, P6946, DOI 10.1128/MCB.22.20.6946-6958.2002; Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Kee Y, 2006, J BIOL CHEM, V281, P36724, DOI 10.1074/jbc.M608756200; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Leon S, 2008, MOL BIOL CELL, V19, P2379, DOI 10.1091/mbc.E08-01-0068; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marchal C, 2000, J BIOL CHEM, V275, P23608, DOI 10.1074/jbc.M001735200; Marchal C, 2002, J CELL SCI, V115, P217; Marchal C, 1998, MOL CELL BIOL, V18, P314, DOI 10.1128/MCB.18.1.314; Morvan J, 2004, TRAFFIC, V5, P383, DOI 10.1111/j.1398-9219.2004.00183.x; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; Ren JH, 2007, MOL BIOL CELL, V18, P324, DOI 10.1091/mbc.E06-06-0557; RENEKE JE, 1988, CELL, V55, P221, DOI 10.1016/0092-8674(88)90045-1; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; SCHANDEL KA, 1994, MOL CELL BIOL, V14, P7245, DOI 10.1128/MCB.14.11.7245; Schmitz C, 2005, MOL BIOL CELL, V16, P1319, DOI 10.1091/mbc.E04-05-0425; Seron K, 1999, J BACTERIOL, V181, P1793; SONI R, 1993, CURR GENET, V24, P455, DOI 10.1007/BF00351857; Springael JY, 1999, J CELL SCI, V112, P1375; Stamenova SD, 2004, J BIOL CHEM, V279, P16017, DOI 10.1074/jbc.M313479200; Stawiecka-Mirota M, 2007, TRAFFIC, V8, P1280, DOI 10.1111/j.1600-0854.2007.00610.x; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Swanson KA, 2003, EMBO J, V22, P4597, DOI 10.1093/emboj/cdg471; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; Wang GL, 1999, MOL CELL BIOL, V19, P342; Wang GL, 2001, MOL CELL BIOL, V21, P3564, DOI 10.1128/MCB.21.10.3564-3575.2001; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wu XY, 2001, CURR GENET, V40, P234, DOI 10.1007/s00294-001-0257-8	71	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2009	4	1							e4259	10.1371/journal.pone.0004259	http://dx.doi.org/10.1371/journal.pone.0004259			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JD	19165343	Green Published, Green Submitted, gold			2022-12-25	WOS:000265482400007
J	Diaz, SL; Padler-Karavani, V; Ghaderi, D; Hurtado-Ziola, N; Yu, H; Chen, X; Brinkman-Van der Linden, ECM; Varki, A; Varki, NM				Diaz, Sandra L.; Padler-Karavani, Vered; Ghaderi, Darius; Hurtado-Ziola, Nancy; Yu, Hai; Chen, Xi; Brinkman-Van der Linden, Els C. M.; Varki, Ajit; Varki, Nissi M.			Sensitive and Specific Detection of the Non-Human Sialic Acid N-Glycolylneuraminic Acid In Human Tissues and Biotherapeutic Products	PLOS ONE			English	Article								Background: Humans are genetically defective in synthesizing the common mammalian sialic acid N-glycolylneuraminic acid (Neu5Gc), but can metabolically incorporate it from dietary sources (particularly red meat and milk) into glycoproteins and glycolipids of human tumors, fetuses and some normal tissues. Metabolic incorporation of Neu5Gc from animal-derived cells and medium components also results in variable contamination of molecules and cells intended for human therapies. These Neu5Gc-incorporation phenomena are practically significant, because normal humans can have high levels of circulating anti-Neu5Gc antibodies. Thus, there is need for the sensitive and specific detection of Neu5Gc in human tissues and biotherapeutic products. Unlike monoclonal antibodies that recognize Neu5Gc only in the context of underlying structures, chicken immunoglobulin Y (IgY) polyclonal antibodies can recognize Neu5Gc in broader contexts. However, prior preparations of such antibodies (including our own) suffered from some non-specificity, as well as some cross-reactivity with the human sialic acid N-acetylneuraminic acid (Neu5Ac). Methodology/Principal Findings: We have developed a novel affinity method utilizing sequential columns of immobilized human and chimpanzee serum sialoglycoproteins, followed by specific elution from the latter column by free Neu5Gc. The resulting mono-specific antibody shows no staining in tissues or cells from mice with a human-like defect in Neu5Gc production. It allows sensitive and specific detection of Neu5Gc in all underlying glycan structural contexts studied, and is applicable to immunohistochemical, enzyme-linked immunosorbent assay (ELISA), Western blot and flow cytometry analyses. Non-immune chicken IgY is used as a reliable negative control. We show that these approaches allow sensitive detection of Neu5Gc in human tissue samples and in some biotherapeutic products, and finally show an example of how Neu5Gc might be eliminated from such products, by using a human cell line grown under defined conditions. Conclusions: We report a reliable antibody-based method for highly sensitive and specific detection of the non-human sialic acid Neu5Gc in human tissues and biotherapeutic products that has not been previously described.	[Diaz, Sandra L.; Padler-Karavani, Vered; Ghaderi, Darius; Varki, Ajit; Varki, Nissi M.] Univ Calif San Diego, Sch Med, Glycobiol Res & Training Ctr, Dept Med, La Jolla, CA 92093 USA; [Hurtado-Ziola, Nancy] Gc Free Inc, La Jolla, CA USA; [Yu, Hai; Chen, Xi] Univ Calif Davis, Dept Chem, Davis, CA USA; [Brinkman-Van der Linden, Els C. M.] Crucell Holland BV, Leiden, Netherlands	University of California System; University of California San Diego; University of California System; University of California Davis; Johnson & Johnson	Diaz, SL (corresponding author), Univ Calif San Diego, Sch Med, Glycobiol Res & Training Ctr, Dept Med, La Jolla, CA 92093 USA.	a1varki@ucsd.edu	Chen, Xi/H-1811-2018; PADLER-KARAVANI, VERED/AAC-6055-2022	Chen, Xi/0000-0002-3160-614X; PADLER-KARAVANI, VERED/0000-0002-4761-3571	National institute of Health [R01GM32373, R41GM080959]; ISEF Foundation [postdoctoral fellowship]; NATIONAL CANCER INSTITUTE [U01CA128442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373, R41GM080959] Funding Source: NIH RePORTER	National institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ISEF Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National institute of Health grants R01GM32373 (to A.V.), R41GM080959 (to N.H.), and an ISEF Foundation postdoctoral fellowship to V. P-K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byres E, 2008, NATURE, V456, P648, DOI 10.1038/nature07428; Chung CH, 2008, NEW ENGL J MED, V358, P1109, DOI 10.1056/NEJMoa074943; Fallaux FJ, 1998, HUM GENE THER, V9, P1909, DOI 10.1089/hum.1998.9.13-1909; FUKUI Y, 1989, BIOCHEM BIOPH RES CO, V160, P1149, DOI 10.1016/S0006-291X(89)80123-8; GATHURU JK, 1989, JPN J VET RES, V37, P71; HARA S, 1986, J CHROMATOGR, V377, P111, DOI 10.1016/S0378-4347(00)80766-5; Hashii N, 2007, J CHROMATOGR A, V1160, P263, DOI 10.1016/j.chroma.2007.05.062; Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07; Hedlund M, 2008, P NATL ACAD SCI USA, V105, P18936, DOI 10.1073/pnas.0803943105; Heiskanen A, 2007, STEM CELLS, V25, P197, DOI 10.1634/stemcells.2006-0444; HERMENTIN P, 1992, ANAL BIOCHEM, V203, P281, DOI 10.1016/0003-2697(92)90314-W; HIGASHI H, 1985, CANCER RES, V45, P3796; HIGASHI H, 1984, GANN, V75, P1025; HIGASHI H, 1988, JPN J CANCER RES, V79, P952, DOI 10.1111/j.1349-7006.1988.tb00060.x; HIGASHI H, 1977, BIOCHEM BIOPH RES CO, V79, P388, DOI 10.1016/0006-291X(77)90169-3; HIRABAYASHI Y, 1987, JPN J CANCER RES, V78, P251; Houliston RS, 2007, BIOCHEMISTRY-US, V46, P36, DOI 10.1021/bi062001v; Jones D, 2003, BIOTECHNOL PROGR, V19, P163, DOI 10.1021/bp025574h; Kawachi Shigeo, 1992, Journal of Dermatology (Tokyo), V19, P827; Kim YG, 2008, PROTEOMICS, V8, P2596, DOI 10.1002/pmic.200700972; Lee M, 2006, J ORG CHEM, V71, P5082, DOI 10.1021/jo052659z; Lewis J.A., 2006, DEV BIOL BASEL, V123, P183; Lewis JA, 2006, DEV BIOLOGICALS, V123, P165; Malykh YN, 2001, BIOCHIMIE, V83, P623, DOI 10.1016/S0300-9084(01)01303-7; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; MIYAKE M, 1988, CANCER RES, V48, P6154; Montesino R, 2008, ARCH BIOCHEM BIOPHYS, V470, P163, DOI 10.1016/j.abb.2007.11.019; MUKURIA CJ, 1994, JPN J MED SCI BIOL, V47, P253, DOI 10.7883/yoken1952.47.253; Nasonkin IO, 2006, EXP NEUROL, V201, P525, DOI 10.1016/j.expneurol.2006.05.002; Nichols W. W., 2002, ADENOVIRAL VECTORS G, P129; NOGUCHI A, 1995, J BIOCHEM-TOKYO, V117, P59, DOI 10.1093/oxfordjournals.jbchem.a124721; OHASHI Y, 1983, AM J OPHTHALMOL, V96, P321, DOI 10.1016/S0002-9394(14)77822-5; PADLAN EA, 1988, P NATL ACAD SCI USA, V85, P6885, DOI 10.1073/pnas.85.18.6885; Padler-Karavani V, 2008, GLYCOBIOLOGY, V18, P818, DOI 10.1093/glycob/cwn072; Raju TS, 2000, GLYCOBIOLOGY, V10, P477, DOI 10.1093/glycob/10.5.477; Rohrer JS, 1998, GLYCOBIOLOGY, V8, P35, DOI 10.1093/glycob/8.1.35; SAIDA T, 1990, ARCH DERMATOL RES, V282, P179, DOI 10.1007/BF00372619; SIGURSKJOLD BW, 1992, J BIOL CHEM, V267, P8371; TAI T, 1988, ARCH BIOCHEM BIOPHYS, V260, P51, DOI 10.1016/0003-9861(88)90423-7; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Varki A, 2001, YEARB PHYS ANTHROPOL, V44, P54, DOI 10.1002/ajpa.10018; VARKI A, 2008, GLYCOCONJ J IN PRESS; YALLOP CA, MODERN BIOPHARMACEUT, V3, P779; Yu H, 2007, ORG BIOMOL CHEM, V5, P2458, DOI 10.1039/b706507h; Zhu A, 2002, XENOTRANSPLANTATION, V9, P376, DOI 10.1034/j.1399-3089.2002.02138.x	45	108	117	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4241	10.1371/journal.pone.0004241	http://dx.doi.org/10.1371/journal.pone.0004241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JB	19156207	Green Published, gold			2022-12-25	WOS:000265482100013
J	Mellata, M; Touchman, JW; Curtiss, R				Mellata, Melha; Touchman, Jeffrey W.; Curtiss, Roy, III			Full Sequence and Comparative Analysis of the Plasmid pAPEC-1 of Avian Pathogenic E-coli chi 7122 (O78:K80:H9)	PLOS ONE			English	Article								Background: Extra-intestinal pathogenic E. coli (ExPEC), including Avian Pathogenic E. coli (APEC), are very diverse. They cause a complex of diseases in Human, animals, and birds. Even though large plasmids are often associated with the virulence of ExPEC, their characterization is still in its infancy. Methodology/Principal Findings: We fully sequenced and analyzed the large plasmid pAPEC-1 (103,275-bp) associated with the APEC strain chi 7122, from worldwide serogroup O78:K80:H9. A putative virulence region spanning an 80-kb region of pAPEC-1 possesses four iron acquisition systems (iutA iucABCD, sitABCD, iroBCDN, and temperature-sensitive hemagglutinin tsh), a colicin V operon, increasing serum sensitivity iss, ompT, hlyF, and etsABC. Thirty three ORFs in pAPEC-1 are identified as insertion sequences (ISs) that belong to nine families with diverse origins. The full length of the transfer region in pAPEC-1 (11 kb) is shorter compared to the tra region of other sequenced F plasmids; the absence of some tra genes in pAPEC-1 affects its self-transferability, and the conjugative function of the plasmid was effective only in the presence of other plasmids. Two-replicon systems, repFIIA-repFIC and repFIB, and two post-segregational systems, srnB and hok/sok, are also present in the sequence of pAPEC-1. The comparison of the pAPEC-1 sequence with the two available plasmid sequences reveals more gene loss and reorganization than previously appreciated. The presence of pAPEC-1-associated genes is assessed in human ExPEC by PCR. Many patterns of association between genes are found. Conclusions/Significance: The pathotype typical of pAPEC-1 was present in some human strains, which indicates a horizontal transfer between strains and the zoonotic risk of APEC strains. ColV plasmids could have common virulence genes that could be acquired by transposition, without sharing genes of plasmid function.	[Curtiss, Roy, III] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; [Touchman, Jeffrey W.; Curtiss, Roy, III] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Mellata, M (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA.	rcurtiss@asu.edu	Mellata, Melha/AAP-5491-2020	Mellata, Melha/0000-0002-4967-7173	National Institutes of Health [U01060557]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for research was provided by National Institutes of Health grant U01060557. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Barnes H. J., 2003, DIS POULTRY, V11th, P631; Baumler AJ, 1998, J BACTERIOL, V180, P1446; Baumler AJ, 1996, GENE, V183, P207, DOI 10.1016/S0378-1119(96)00560-4; Bearden SW, 1999, MOL MICROBIOL, V32, P403, DOI 10.1046/j.1365-2958.1999.01360.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brown PK, 1996, P NATL ACAD SCI USA, V93, P11149, DOI 10.1073/pnas.93.20.11149; Burrus V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/j.resmic.2004.01.012; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; CAVARD D, 1990, J BACTERIOL, V172, P648, DOI 10.1128/jb.172.2.648-652.1990; CROSA JH, 1989, MICROBIOL REV, V53, P517, DOI 10.1128/MMBR.53.4.517-530.1989; Crosa JH., 2004, IRON TRANSPORT BACTE; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Dho-Moulin M, 1999, VET RES, V30, P299; Dobrindt U, 2001, INFECT IMMUN, V69, P4248, DOI 10.1128/IAI.69.7.4248-4256.2001; Doetkott DM, 1996, AVIAN DIS, V40, P927, DOI 10.2307/1592319; Dominique SA, 2004, RES MICROBIOL, V155, P319, DOI 10.1016/j.resmic.2003.12.008; Dozois CM, 2003, P NATL ACAD SCI USA, V100, P247, DOI 10.1073/pnas.232686799; Dozois CM, 2000, INFECT IMMUN, V68, P4145, DOI 10.1128/IAI.68.7.4145-4154.2000; Dutta PR, 2003, J BIOL CHEM, V278, P39912, DOI 10.1074/jbc.M303595200; Dutta PR, 2002, INFECT IMMUN, V70, P7105, DOI 10.1128/IAI.70.12.7105-7113.2002; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; FREDERICQ P, 1964, ANN I PASTEUR PARIS, VS, P7; FROST LS, 1994, MICROBIOL REV, V58, P162, DOI 10.1128/MMBR.58.2.162-210.1994; GERDES K, 1992, J MOL BIOL, V226, P637, DOI 10.1016/0022-2836(92)90621-P; GILSON L, 1990, EMBO J, V9, P3875, DOI 10.1002/j.1460-2075.1990.tb07606.x; Gratia A, 1925, CR SOC BIOL, V93, P1040; Hantke K, 2003, P NATL ACAD SCI USA, V100, P3677, DOI 10.1073/pnas.0737682100; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Heimer SR, 2004, INFECT IMMUN, V72, P593, DOI 10.1128/IAI.72.1.593-597.2004; HIRAGA S, 1992, ANNU REV BIOCHEM, V61, P283; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Johnson JR, 2002, J LAB CLIN MED, V139, P155, DOI 10.1067/mlc.2002.121550; Johnson TJ, 2006, J BACTERIOL, V188, P5975, DOI 10.1128/JB.00204-06; Johnson TJ, 2004, AVIAN DIS, V48, P351, DOI 10.1637/7121; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Johnson TJ, 2002, AVIAN DIS, V46, P342, DOI 10.1637/0005-2086(2002)046[0342:LOISSG]2.0.CO;2; Jun L, 2002, PLASMID, V48, P24, DOI 10.1016/S0147-619X(02)00007-0; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kaniga K, 1998, INFECT IMMUN, V66, P5599, DOI 10.1128/IAI.66.12.5599-5606.1998; Kobayashi N, 2001, J BACTERIOL, V183, P5639, DOI 10.1128/JB.183.19.5639-5644.2001; Kostakioti M, 2004, INFECT IMMUN, V72, P5548, DOI 10.1128/IAI.72.10.5548-5554.2004; LANE D, 1979, J BACTERIOL, V139, P141, DOI 10.1128/JB.139.1.141-151.1979; Lawley TD, 2003, J BACTERIOL, V185, P3060, DOI 10.1128/JB.185.10.3060-3067.2003; Lucchini S, 2005, INFECT IMMUN, V73, P88, DOI 10.1128/IAI.73.1.88-102.2005; LUNDRIGAN MD, 1992, FEMS MICROBIOL LETT, V97, P51; MAINIL JG, 1992, INFECT IMMUN, V60, P3376, DOI 10.1128/IAI.60.8.3376-3380.1992; Maurer JJ, 1998, AVIAN DIS, V42, P106, DOI 10.2307/1592582; Mellata M, 2003, INFECT IMMUN, V71, P494, DOI 10.1128/IAI.71.1.494-503.2003; Mellata M, 2003, INFECT IMMUN, V71, P536, DOI 10.1128/IAI.71.1.536-540.2003; Morales Cesar, 2004, Foodborne Pathog Dis, V1, P160; Moulin-Schouleur M, 2007, J CLIN MICROBIOL, V45, P3366, DOI 10.1128/JCM.00037-07; Otto BR, 1998, J EXP MED, V188, P1091, DOI 10.1084/jem.188.6.1091; Otto BR, 2002, INFECT IMMUN, V70, P5, DOI 10.1128/IAI.70.1.5-10.2002; OZANNE G, 1977, INFECT IMMUN, V17, P497, DOI 10.1128/IAI.17.3.497-503.1977; PROVENCE DL, 1994, INFECT IMMUN, V62, P1369, DOI 10.1128/IAI.62.4.1369-1380.1994; QUACKENBUSH RL, 1979, INFECT IMMUN, V24, P562, DOI 10.1128/IAI.24.2.562-564.1979; Restieri C, 2007, APPL ENVIRON MICROB, V73, P1553, DOI 10.1128/AEM.01542-06; Rodriguez-Siek KE, 2005, VET RES, V36, P241, DOI 10.1051/vetres:2004057; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; SAADI S, 1984, PLASMID, V12, P61, DOI 10.1016/0147-619X(84)90067-2; Sabri M, 2006, MICROBIOL-SGM, V152, P745, DOI 10.1099/mic.0.28682-0; Sabri M, 2008, INFECT IMMUN, V76, P601, DOI 10.1128/IAI.00789-07; SEIDMAN CE, 2001, CURR PROTOC MOL BIOL, V1, P1; Skyberg JA, 2006, INFECT IMMUN, V74, P6287, DOI 10.1128/IAI.00363-06; SMITH HW, 1980, J GEN MICROBIOL, V121, P387; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Stathopoulos C, 1998, Membr Cell Biol, V12, P1; Stehling EG, 2003, VET MICROBIOL, V95, P111, DOI 10.1016/S0378-1135(03)00125-1; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Stumpe S, 1998, J BACTERIOL, V180, P4002, DOI 10.1128/JB.180.15.4002-4006.1998; SUGIMURA K, 1988, J BACTERIOL, V170, P5625, DOI 10.1128/jb.170.12.5625-5632.1988; Tivendale KA, 2004, INFECT IMMUN, V72, P6554, DOI 10.1128/IAI.72.11.6554-6560.2004; Touchman JW, 2001, GENOME RES, V11, P78, DOI 10.1101/gr.165801; Valdebenito M, 2006, INT J MED MICROBIOL, V296, P513, DOI 10.1016/j.ijmm.2006.06.003; WARNER PJ, 1981, INFECT IMMUN, V33, P540, DOI 10.1128/IAI.33.2.540-545.1981; WILLIAMS PH, 1980, INFECT IMMUN, V29, P411; Wooley RE, 1998, AVIAN DIS, V42, P194, DOI 10.2307/1592596; WOOLEY RE, 1994, AVIAN DIS, V38, P141, DOI 10.2307/1591847; Zaharik ML, 2004, INFECT IMMUN, V72, P5522, DOI 10.1128/IAI.72.9.5522-5525.2004; Zahrl D, 2006, J BACTERIOL, V188, P6611, DOI 10.1128/JB.00632-06; ZHANG LH, 1995, GENETICS, V141, P25; Ziebuhr W, 1999, CELL MOL LIFE SCI, V56, P719, DOI 10.1007/s000180050018; Zienkiewicz M, 2007, ANTIMICROB AGENTS CH, V51, P1164, DOI 10.1128/AAC.00772-06	84	60	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4232	10.1371/journal.pone.0004232	http://dx.doi.org/10.1371/journal.pone.0004232			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JB	19156210	Green Published, gold, Green Submitted			2022-12-25	WOS:000265482100004
J	Zhu, LY; Sun, GX; Zhang, HJ; Zhang, Y; Chen, X; Jiang, XH; Jiang, XY; Krauss, S; Zhang, JF; Xiang, Y; Zhang, CY				Zhu, Lingyun; Sun, Guoxun; Zhang, Hongjie; Zhang, Yan; Chen, Xi; Jiang, Xiaohong; Jiang, Xueyuan; Krauss, Stefan; Zhang, Junfeng; Xiang, Yang; Zhang, Chen-Yu			PGC-1 alpha Is a Key Regulator of Glucose-Induced Proliferation and Migration in Vascular Smooth Muscle Cells	PLOS ONE			English	Article								Background: Atherosclerosis is a complex pathological condition caused by a number of mechanisms including the accelerated proliferation of vascular smooth muscle cells (VSMCs). Diabetes is likely to be an important risk factor for atherosclerosis, as hyperglycemia induces vascular smooth muscle cell (VSMC) proliferation and migration and may thus contribute to the formation of atherosclerotic lesions. This study was performed to investigate whether PGC-1 alpha, a PPAR gamma coactivator and metabolic master regulator, plays a role in regulating VSMC proliferation and migration induced by high glucose. Methodology/Principal Findings: PGC-1 alpha mRNA levels are decreased in blood vessel media of STZ-treated diabetic rats. In cultured rat VSMCs, high glucose dose-dependently inhibits PGC-1 alpha mRNA expression. Overexpression of PGC-1 alpha either by infection with adenovirus, or by stimulation with palmitic acid, significantly reduces high glucose-induced VSMC proliferation and migration. In contrast, suppression of PGC-1 alpha by siRNA mimics the effects of glucose on VSMCs. Finally, mechanistic studies suggest that PGC-1 alpha-mediated inhibition of VSMC proliferation and migration is regulated through preventing ERK1/2 phosphorylation. Conclusions/Significance: These results indicate that PGC-1 alpha is a key regulator of high glucose-induced proliferation and migration in VSMCs, and suggest that elevation of PGC-1 alpha in VSMC could be a useful strategy in preventing the development of diabetic atherosclerosis.	[Zhu, Lingyun; Sun, Guoxun; Zhang, Hongjie; Zhang, Yan; Chen, Xi; Jiang, Xiaohong; Jiang, Xueyuan; Zhang, Junfeng; Xiang, Yang; Zhang, Chen-Yu] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Diabet Ctr, Nanjing 210008, Peoples R China; [Zhang, Hongjie] Nanjing Med Univ, First Affiliated Hosp, Dept Gastroenterol, Nanjing, Peoples R China; [Krauss, Stefan] Merck Res Lab, Dept Canc Biol & Therapeut, Boston, MA USA	Nanjing University; Nanjing Medical University; Merck & Company	Zhu, LY (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Diabet Ctr, Nanjing 210008, Peoples R China.	jfzhang@nju.edu.cn; xiangy@nju.edu.cn; cyzhang@nju.edu.cn		/0000-0002-0420-4508	National Natural Science Foundation of China [30570731, 90813035, 30890044, 30471991]; 973 Program of China [2006CB503909, 2004CB518603]; "111" Project; Natural Science Foundation of Jiangsu Province [BK2004082, BK2006714]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program of China(National Basic Research Program of China); "111" Project(Ministry of Education, China - 111 Project); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by grants from the National Natural Science Foundation of China (30570731, 90813035, 30890044), the 973 Program of China (no. 2006CB503909, 2004CB518603), the "111" Project, and the Natural Science Foundation of Jiangsu Province (no. BK2004082, BK2006714) to C.Y.Z., and National Natural Science Foundation of China (30471991) to Y.X.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; DUBEY RK, 1993, AM J PHYSIOL, V265, pR726, DOI 10.1152/ajpregu.1993.265.4.R726; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; FUJIWARA R, 1994, CARDIOVASC DRUG THER, V8, P861, DOI 10.1007/BF00877405; Goetze S, 1999, J CARDIOVASC PHARM, V33, P798, DOI 10.1097/00005344-199905000-00018; Graf K, 1997, HYPERTENSION, V29, P334, DOI 10.1161/01.HYP.29.1.334; GROTENDORST GR, 1981, P NATL ACAD SCI-BIOL, V78, P3669, DOI 10.1073/pnas.78.6.3669; Hammarstedt A, 2003, BIOCHEM BIOPH RES CO, V301, P578, DOI 10.1016/S0006-291X(03)00014-7; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hsueh W. A., 1998, AM J MED, V105, P4, DOI DOI 10.1016/S0002-9343(98)00205-8; Hsueh WA, 2001, ARTERIOSCL THROM VAS, V21, P1891, DOI 10.1161/hq1201.100261; Igarashi M, 1999, J CLIN INVEST, V103, P185, DOI 10.1172/JCI3326; KROLEWSKI AS, 1991, AM J MED S2A, V90, P56; Law RE, 1996, J CLIN INVEST, V98, P1897, DOI 10.1172/JCI118991; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; MAJACK RA, 1984, J CELL PHYSIOL, V118, P253, DOI 10.1002/jcp.1041180306; Natarajan R, 1999, HYPERTENSION, V33, P378, DOI 10.1161/01.HYP.33.1.378; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Ramana KV, 2004, DIABETES, V53, P2910, DOI 10.2337/diabetes.53.11.2910; Sarkar R, 1996, CIRC RES, V78, P225, DOI 10.1161/01.RES.78.2.225; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Suzuki M, 2002, LIFE SCI, V72, P59, DOI 10.1016/S0024-3205(02)02182-3; Wakino S, 2000, J BIOL CHEM, V275, P22435, DOI 10.1074/jbc.M910452199; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang PX, 2005, FEBS LETT, V579, P1446, DOI 10.1016/j.febslet.2005.01.046; Zhang Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001137; Zhao W, 2000, DIABETES OBES METAB, V2, P165, DOI 10.1046/j.1463-1326.2000.00079.x	32	33	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4182	10.1371/journal.pone.0004182	http://dx.doi.org/10.1371/journal.pone.0004182			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142226	Green Submitted, gold, Green Published			2022-12-25	WOS:000265479700005
J	Wolf, LV; Yang, Y; Wang, JH; Xie, Q; Braunger, B; Tamm, ER; Zavadil, J; Cvekl, A				Wolf, Louise V.; Yang, Ying; Wang, Jinhua; Xie, Qing; Braunger, Barbara; Tamm, Ernst R.; Zavadil, Jiri; Cvekl, Ales			Identification of Pax6-Dependent Gene Regulatory Networks in the Mouse Lens	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION SITES; RETINAL PROGENITOR CELLS; ALPHA-A-CRYSTALLIN; PAIRED-DOMAIN; TARGET GENES; SEGMENT ABNORMALITIES; EMBRYONIC-DEVELOPMENT; MICROARRAY ANALYSIS; PLACODE DEVELOPMENT; DOWNSTREAM TARGET	Lineage-specific DNA-binding transcription factors regulate development by activating and repressing particular set of genes required for the acquisition of a specific cell type. Pax6 is a paired domain and homeodomain-containing transcription factor essential for development of central nervous, olfactory and visual systems, as well as endocrine pancreas. Haploinsufficiency of Pax6 results in perturbed lens development and homeostasis. Loss-of-function of Pax6 is incompatible with lens lineage formation and results in abnormal telencephalic development. Using DNA microarrays, we have identified 559 genes expressed differentially between 1-day old mouse Pax6 heterozygous and wild type lenses. Of these, 178 (31.8%) were similarly increased and decreased in Pax6 homozygous embryonic telencephalon [Holm PC, Mader MT, Haubst N, Wizenmann A, Sigvardsson M, Gotz M (2007) Loss- and gain-of-function analyses reveals targets of Pax6 in the developing mouse telencephalon. Mol Cell Neurosci 34: 99 - 119]. In contrast, 381 (68.2%) genes were differently regulated between the lens and embryonic telencephalon. Differential expression of nine genes implicated in lens development and homeostasis: Cspg2, Igfbp5, Mab21l2, Nrf2f, Olfm3, Spag5, Spock1, Spon1 and Tgfb2, was confirmed by quantitative RT-PCR, with five of these genes: Cspg2, Mab21l2, Olfm3, Spag5 and Tgfb2, identified as candidate direct Pax6 target genes by quantitative chromatin immunoprecipitation (qChIP). In Mab21l2 and Tgfb2 promoter regions, twelve putative individual Pax6-binding sites were tested by electrophoretic mobility shift assays (EMSAs) with recombinant Pax6 proteins. This led to the identification of two and three sites in the respective Mab21l2 and Tgfb2 promoter regions identified by qChIPs. Collectively, the present studies represent an integrative genome-wide approach to identify downstream networks controlled by Pax6 that control mouse lens and forebrain development.	[Wolf, Louise V.; Yang, Ying; Xie, Qing; Cvekl, Ales] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci & Genet, Bronx, NY 10467 USA; [Wang, Jinhua; Zavadil, Jiri] NYU, Langone Med Ctr, Canc Inst, New York, NY USA; [Braunger, Barbara; Tamm, Ernst R.] Univ Regensburg, Inst Human Anat & Embryol, D-8400 Regensburg, Germany; [Zavadil, Jiri] NYU, Langone Med Ctr, Dept Pathol, New York, NY USA	Yeshiva University; Albert Einstein College of Medicine; New York University; NYU Langone Medical Center; University of Regensburg; New York University; NYU Langone Medical Center	Wolf, LV (corresponding author), Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci & Genet, Bronx, NY 10467 USA.	cvekl@aecom.yu.edu	Cvekl, Ales/B-2427-2013; Braunger, Barbara Maria/K-4272-2015; Zavadil, Jiri/ABG-1780-2020; Tamm, Ernst/AAB-9772-2019	Braunger, Barbara Maria/0000-0002-3926-6725; Zavadil, Jiri/0000-0003-0640-5562; Tamm, Ernst/0000-0002-6679-8743	NIH [EY012200, EY017296]; DFG [FOR1075]; Irma T. Hirschl Career Scientist Award; NATIONAL EYE INSTITUTE [R01EY012200, R21EY017296] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); Irma T. Hirschl Career Scientist Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grants EY012200 (AC), EY017296 (AC), and DFG grant FOR1075 (ERT). AC is a recipient of the Irma T. Hirschl Career Scientist Award.	Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Baldessari D, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-48; Ballif BA, 2008, J PROTEOME RES, V7, P311, DOI 10.1021/pr0701254; Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Baulmann DC, 2002, MECH DEVELOP, V118, P3, DOI 10.1016/S0925-4773(02)00260-5; Bernier G, 2001, DEVELOPMENT, V128, P3987; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Cancla L, 2007, MOL CELL NEUROSCI, V36, P1, DOI 10.1016/j.mcn.2007.05.007; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Chauhan BK, 2002, J BIOL CHEM, V277, P11539, DOI 10.1074/jbc.M110531200; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; CHOW KL, 1995, DEVELOPMENT, V121, P3615; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Collinson JM, 2001, P NATL ACAD SCI USA, V98, P9688, DOI 10.1073/pnas.161144098; Cvekl A, 2004, BIOESSAYS, V26, P374, DOI 10.1002/bies.20009; Cvekl A, 1996, BIOESSAYS, V18, P621, DOI 10.1002/bies.950180805; Cvekl A, 2007, PROG RETIN EYE RES, V26, P555, DOI 10.1016/j.preteyeres.2007.07.002; De Maria A, 2007, INVEST OPHTH VIS SCI, V48, P5638, DOI 10.1167/iovs.07-0782; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Donner AL, 2007, GENE EXPR PATTERNS, V7, P606, DOI 10.1016/j.modgep.2007.01.001; Duncan MK, 2000, J CELL SCI, V113, P3173; Duncan MK, 1998, MOL CELL BIOL, V18, P5579, DOI 10.1128/MCB.18.9.5579; Dunker N, 2003, CELL TISSUE RES, V313, P1, DOI 10.1007/s00441-003-0761-x; Enwright JF, 2000, DEV BIOL, V221, P10, DOI 10.1006/dbio.2000.9652; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; Gilmour DT, 1998, EMBO J, V17, P1860, DOI 10.1093/emboj/17.7.1860; Gotoh N, 2004, P NATL ACAD SCI USA, V101, P17144, DOI 10.1073/pnas.0407577101; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Grinchuk O, 2005, J BIOL CHEM, V280, P35228, DOI 10.1074/jbc.M506195200; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Grocott T, 2007, NUCLEIC ACIDS RES, V35, P890, DOI 10.1093/nar/gkl1105; Gruber J, 2002, J CELL SCI, V115, P4053, DOI 10.1242/jcs.00088; Hecht J, 2007, GENE EXPR PATTERNS, V7, P102, DOI 10.1016/j.modgep.2006.05.014; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Higashijima S, 1997, DEV BIOL, V192, P211, DOI 10.1006/dbio.1997.8760; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HOGAN BLM, 1986, J EMBRYOL EXP MORPH, V97, P95; Holm PC, 2007, MOL CELL NEUROSCI, V34, P99, DOI 10.1016/j.mcn.2006.10.008; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ittner Lars M, 2005, J Biol, V4, P11, DOI 10.1186/jbiol29; James MJ, 2006, J BONE MINER RES, V21, P1034, DOI 10.1359/JBMR.060413; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Jun S, 1996, DEVELOPMENT, V122, P2639; Kralova J, 2002, GENE, V286, P271, DOI 10.1016/S0378-1119(02)00425-0; Kudo C, 2005, J COMP NEUROL, V487, P255, DOI 10.1002/cne.20551; Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1; Makarenkova HP, 2000, DEVELOPMENT, V127, P2563; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Michaut L, 2003, P NATL ACAD SCI USA, V100, P4024, DOI 10.1073/pnas.0630561100; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; Oron-Karni V, 2008, DEVELOPMENT, V135, P4037, DOI 10.1242/dev.028308; Ostrin EJ, 2006, GENOME RES, V16, P466, DOI 10.1101/gr.4673006; Ovodenko B, 2007, INVEST OPHTH VIS SCI, V48, P1447, DOI 10.1167/iovs.06-0411; Pera EM, 2001, DEV CELL, V1, P655, DOI 10.1016/S1534-5807(01)00069-7; PLAZA S, 1995, ONCOGENE, V10, P329; Pontoriero GF, 2008, DEV DYNAM, V237, P602, DOI 10.1002/dvdy.21445; Purcell P, 2005, GENE EXPR PATTERNS, V6, P110, DOI 10.1016/j.modgep.2005.04.010; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saika S, 2001, DEV BIOL, V240, P419, DOI 10.1006/dbio.2001.0480; Sakurai K, 2008, J NEUROSCI, V28, P4604, DOI 10.1523/JNEUROSCI.5074-07.2008; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; SCHMAHL W, 1993, ACTA NEUROPATHOL, V86, P126, DOI 10.1007/BF00334879; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; Stock M, 2004, J BONE MINER RES, V19, P959, DOI 10.1359/jbmr.2004.19.6.959; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Stopka T, 2005, EMBO J, V24, P3712, DOI 10.1038/sj.emboj.7600834; Stoykova A, 1996, DEVELOPMENT, V122, P3453; SUTER DM, 2008, STEM CELLS; Suzuki R, 2000, MECH DEVELOP, V98, P37, DOI 10.1016/S0925-4773(00)00450-0; Tripodi M, 2004, DEVELOPMENT, V131, P6119, DOI 10.1242/dev.01530; Underhill DA, 1997, J BIOL CHEM, V272, P14175, DOI 10.1074/jbc.272.22.14175; Vaes BLT, 2006, BONE, V39, P724, DOI 10.1016/j.bone.2006.04.024; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Visel A, 2007, PLOS GENET, V3, P1867, DOI 10.1371/journal.pgen.0030178; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wawersik S, 1999, DEV BIOL, V207, P176, DOI 10.1006/dbio.1998.9153; Wurm A, 2008, EXP EYE RES, V86, P895, DOI 10.1016/j.exer.2008.03.004; Xu PX, 1997, DEVELOPMENT, V124, P219; Yamada R, 2004, DEV BIOL, V274, P295, DOI 10.1016/j.ydbio.2004.07.016; Yamada R, 2003, DEVELOPMENT, V130, P1759, DOI 10.1242/dev.00399; Yang Y, 2005, J MOL BIOL, V351, P453, DOI 10.1016/j.jmb.2005.05.072; Yang Y, 2004, J MOL BIOL, V344, P351, DOI 10.1016/j.jmb.2004.07.102; Yang Y, 2006, EMBO J, V25, P2107, DOI 10.1038/sj.emboj.7601114; Zaccarini R, 2007, INVEST OPHTH VIS SCI, V48, P5408, DOI 10.1167/iovs.07-0413	91	70	70	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2009	4	1							e4159	10.1371/journal.pone.0004159	http://dx.doi.org/10.1371/journal.pone.0004159			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GB	19132093	Green Published, gold			2022-12-25	WOS:000265473700002
J	Leong, WF; Zhou, TL; Lim, GL; Li, BJ				Leong, Wai Fook; Zhou, Tielin; Lim, Gek Liang; Li, Baojie			Protein Palmitoylation Regulates Osteoblast Differentiation through BMP-Induced Osterix Expression	PLOS ONE			English	Article								Osteoporosis is one of the most common diseases and can be treated by either anti-resorption drugs, anabolic drugs, or both. To search for anabolic drug targets for osteoporosis therapy, it is crucial to understand the biology of bone forming cells, osteoblasts, in terms of their proliferation, differentiation, and function. Here we found that protein palmitoylation participates in signaling pathways that control osterix expression and osteoblast differentiation. Mouse calvarial osteoblasts express most of the 24 palmitoyl transferases, with some being up-regulated during differentiation. Inhibition of protein palmitoylation, with a substrate-analog inhibitor, diminished osteoblast differentiation and mineralization, but not proliferation or survival. The decrease in differentiation capacity is associated with a reduction in osterix, but not Runx2 or Atf4. Inhibition of palmitoyl transferases had little effect in p53(-/-) osteoblasts that show accelerated differentiation due to overexpression of osterix, suggesting that osterix, at least partially, mediated the effect of inhibition of palmitoyl transferases on osteoblast differentiation. BMPs are the major driving force of osteoblast differentiation in the differentiation assays. We found that inhibition of palmitoyl transferases also compromised BMP2-induced osteoblast differentiation through down-regulating osterix induction. However, palmitoyl transferases inhibitor did not inhibit Smad1/5/8 activation. Instead, it compromised the activation of p38 MAPK, which are known positive regulators of osterix expression and differentiation. These results indicate that protein palmitoylation plays an important role in BMP-induced MAPK activation, osterix expression, and osteoblast differentiation.	[Leong, Wai Fook; Zhou, Tielin; Lim, Gek Liang; Li, Baojie] ASTAR, Inst Mol & Cell Biol, Canc & Dev Biol Div, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Leong, WF (corresponding author), ASTAR, Inst Mol & Cell Biol, Canc & Dev Biol Div, Singapore, Singapore.	libj@imcb.a-star.edu.sg	Leong, Wai Fook Peter/GXG-9911-2022	Leong, Wai Fook Peter/0000-0002-2438-2715	Agency of Science, Technology, and Research of the Republic of Singapore	Agency of Science, Technology, and Research of the Republic of Singapore(Agency for Science Technology & Research (A*STAR))	The work was supported by the Agency of Science, Technology, and Research of the Republic of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Goltzman D, 2002, NAT REV DRUG DISCOV, V1, P784, DOI 10.1038/nrd916; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hasselbaink DM, 2002, MOL CELL BIOCHEM, V239, P101, DOI 10.1023/A:1020584808730; Kaback LA, 2008, J CELL PHYSIOL, V214, P173, DOI 10.1002/jcp.21176; Karsenty G, 2001, ENDOCRINOLOGY, V142, P2731, DOI 10.1210/en.142.7.2731; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Krane SM, 2005, J EXP MED, V201, P841, DOI 10.1084/jem.20050354; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Li BJ, 2000, NAT GENET, V24, P304, DOI 10.1038/73542; Li BJ, 2002, J BIOL CHEM, V277, P28870, DOI 10.1074/jbc.M202388200; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lu XH, 2006, J BIOL CHEM, V281, P6297, DOI 10.1074/jbc.M507804200; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mishina Y, 2003, FRONT BIOSCI-LANDMRK, V8, pD855, DOI 10.2741/1097; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Rasheed N, 2006, HUM MOL GENET, V15, P1938, DOI 10.1093/hmg/ddl116; Resh MD, 2006, METHODS, V40, P191, DOI 10.1016/j.ymeth.2006.04.013; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Rodan GA, 1997, CELL, V89, P677, DOI 10.1016/S0092-8674(00)80249-4; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Stein GS, 1996, PHYSIOL REV, V76, P593, DOI 10.1152/physrev.1996.76.2.593; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Wang XY, 2007, ENDOCRINOLOGY, V148, P1629, DOI 10.1210/en.2006-1000; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Yang XL, 2002, TRENDS MOL MED, V8, P340, DOI 10.1016/S1471-4914(02)02340-7; Zaidi M, 2003, J BONE MINER RES, V18, P599, DOI 10.1359/jbmr.2003.18.4.599; Zambetti GP, 2006, J CELL BIOL, V172, P795, DOI 10.1083/jcb.200601114; Zuzarte-Luis V, 2004, DEV BIOL, V272, P39, DOI 10.1016/j.ydbio.2004.04.015	39	33	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2009	4	1							e4135	10.1371/journal.pone.0004135	http://dx.doi.org/10.1371/journal.pone.0004135			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FV	19125191	Green Published, Green Submitted, gold			2022-12-25	WOS:000265473100009
J	Zhang, H; Lin, SJ				Zhang, Huan; Lin, Senjie			Retrieval of Missing Spliced Leader in Dinoflagellates	PLOS ONE			English	Article								Spliced leader (SL) trans-splicing has recently been shown to be a common mRNA processing mechanism in dinoflagellates, in which a short (22-nt) sequence, DCCGUAGCCAUUUUGGCUCAAG (D = U, A, or G), is transplanted from the 5'-end of a small non-coding RNA (SL RNA) to the 59 end of mRNA molecules. The widespread existence of the mechanism in dinoflagellates has been demonstrated by detection of this SL (DinoSL) in a wide phylogenetic range of dinoflagellates. Furthermore, the presence of DinoSL in the transcripts of highly diverse groups of nuclear-encoded genes has led us to postulate that SL trans-splicing is universal in dinoflagellate nuclear genome. However, some observations inconsistent to this postulation have been reported, exemplified by a recent article reporting apparent absence of DinoSL in the transcripts of some nuclear-encoded genes in Amphidinium carterae. Absence of SL in these gene transcripts would have important implication on gene regulation in dinoflagellates and utility of DinoSL as a universal dinoflagellate- specific primer to study dinoflagellate transcriptomics. In this study, we re-examined transcripts of these genes and found that all of them actually contained DinoSL. Therefore, results to date are consistent to our initial postulation that DinoSL occurs in all dinoflagellate nuclear-encoded mRNAs.	[Zhang, Huan; Lin, Senjie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA	University of Connecticut	Zhang, H (corresponding author), Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA.	senjie.lin@uconn.edu	Guo, chentao/G-7320-2016; Lin, Senjie/A-7466-2011		NSF [EF-0626678]	NSF(National Science Foundation (NSF))	This study is supported by the NSF grants EF-0626678. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachvaroff TR, 2004, PROTIST, V155, P65, DOI 10.1078/1434461000165; Bachvaroff TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002929; BLUML M, 1995, CUR I ELECTR MODEL, V1, P1; Hastings KEM, 2005, TRENDS GENET, V21, P240, DOI 10.1016/j.tig.2005.02.005; Lidie KB, 2007, J EUKARYOT MICROBIOL, V54, P427, DOI 10.1111/j.1550-7408.2007.00282.x; Lin SJ, 2002, J MOL BIOL, V320, P727, DOI 10.1016/S0022-2836(02)00468-0; Mayer MG, 2005, MEM I OSWALDO CRUZ, V100, P501, DOI 10.1590/S0074-02762005000500010; Pouchkina-Stantcheva NN, 2005, MOL BIOL EVOL, V22, P1482, DOI 10.1093/molbev/msi139; Thompson JD, 1994, NUCLEIC ACIDS RES, V22, P4678; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104	10	39	43	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2009	4	1							e4129	10.1371/journal.pone.0004129	http://dx.doi.org/10.1371/journal.pone.0004129			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FT	19122814	Green Published, Green Submitted, gold			2022-12-25	WOS:000265472900008
J	Mikelis, C; Sfaelou, E; Koutsioumpa, M; Kieffer, N; Papadimitriou, E				Mikelis, Constantinos; Sfaelou, Evanthia; Koutsioumpa, Marina; Kieffer, Nelly; Papadimitriou, Evangelia			Integrin alpha(v)beta(3) is a pleiotrophin receptor required for pleiotrophin-induced endothelial cell migration through receptor protein tyrosine phosphatase beta/zeta	FASEB JOURNAL			English	Article						heparin affin regulatory peptide; heparin-binding growth associated molecule; angiogenesis; tumor growth; glioma	GROWTH-FACTOR PLEIOTROPHIN; PROSTATE-CANCER CELLS; C6 GLIOMA-CELLS; BETA(3) INTEGRIN; CYTOPLASMIC DOMAIN; GENE-EXPRESSION; UP-REGULATION; IN-VITRO; ANGIOGENESIS; ACTIVATION	We have previously shown that the angiogenic growth factor pleiotrophin (PTN) induces migration of endothelial cells through binding to its receptor protein tyrosine phosphatase beta/zeta (RPTP beta/zeta). In this study, we show that a monoclonal antibody against alpha(v)beta(3) but not alpha(5)beta(1) integrin abolished PTN-induced human endothelial cell migration in a concentration-dependent manner. Integrin alpha(v)beta(3) was found to directly interact with PTN in an RGD-independent manner, whereas a synthetic peptide corresponding to the specificity loop of the beta(3) integrin extracellular domain ((CYD)-C-177-MKTTC184) inhibited PTN-alpha(v)beta(3) interaction and totally abolished PTN-induced endothelial cell migration. Interestingly, alpha(v)beta(3) was also found to directly interact with RPTP beta/zeta, and PTN-induced Y773 phosphorylation of beta(3) integrin was dependent on both RPTP beta/zeta and the downstream c-src kinase activation. Midkine was found to interact with RPTP beta/zeta, but not with alpha(v)beta(3), and caused a small but statistically significant decrease in cell migration. In the same line, PTN decreased migration of different glioma cell lines that express RPTP beta/zeta but do not express alpha(v)beta(3), while it stimulated migration of U87MG cells that express alpha(v)beta(3) on their cell membrane. Overexpression or down-regulation of beta 3 stimulated or abolished, respectively, the effect of PTN on cell migration. Collectively, these data suggest that alpha(v)beta(3) is a key molecule that determines the stimulatory or inhibitory effect of PTN on cell migration.-Mikelis, C., Sfaelou, E., Koutsioumpa, M., Kieffer, N., Papadimitriou, E. Integrin alpha(v)beta(3) is a pleiotrophin receptor required for pleiotrophin-induced endothelial cell migration through receptor protein tyrosine phosphatase beta/zeta. FASEB J. 23, 1459-1469 (2009)	[Mikelis, Constantinos; Sfaelou, Evanthia; Koutsioumpa, Marina; Papadimitriou, Evangelia] Univ Patras, Dept Pharm, Mol Pharmacol Lab, GR-26504 Patras, Greece; [Kieffer, Nelly] Jiao Tong Univ, Sch Med, Rui Jin Hosp, Sino French Res Ctr Life Sci & Genom,CNRS,LIA124, Shanghai 200030, Peoples R China	University of Patras; Shanghai Jiao Tong University	Papadimitriou, E (corresponding author), Univ Patras, Dept Pharm, Mol Pharmacol Lab, GR-26504 Patras, Greece.	epapad@upatras.gr	Papadimitriou, Evangelia/F-3396-2010; Mikelis, Constantinos/AGF-9423-2022; Papadimitriou, Evangelia/ABG-1356-2020; KOUTSIOUMPA, MARINA/CAI-1960-2022	Papadimitriou, Evangelia/0000-0001-6429-4325; KOUTSIOUMPA, MARINA/0000-0002-6359-573X	E.U.; Greek Ministry of Development-GSRT [PENED 036Delta560]	E.U.(European Commission); Greek Ministry of Development-GSRT(Greek Ministry of Development-GSRT)	This research project is cofinanced by the E.U.-European Social Fund (75%) and the Greek Ministry of Development-GSRT (25%) (PENED 036 Delta 560). We are grateful to Drs. Vasilis Roukos, Zoi Lygerou, Yannis Misirlis, and Mr. Stergios Dermenoudis for their kind hospitality and help with confocal microscopy.	Arias-Salgado EG, 2005, J CELL BIOL, V170, P837, DOI 10.1083/jcb.200503125; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Borges E, 2000, J BIOL CHEM, V275, P39867, DOI 10.1074/jbc.M007040200; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Chen HM, 2007, BLOOD, V110, P287, DOI 10.1182/blood-2006-08-042374; Chen YQ, 1997, INT J CANCER, V72, P642, DOI 10.1002/(SICI)1097-0215(19970807)72:4<642::AID-IJC16>3.0.CO;2-D; Chow JPH, 2008, J BIOL CHEM, V283, P30879, DOI 10.1074/jbc.M802976200; Ezquerra L, 2008, GROWTH FACTORS, V26, P44, DOI 10.1080/08977190801987711; Falcioni R, 1997, EXP CELL RES, V236, P76, DOI 10.1006/excr.1997.3695; Fujikawa A, 2003, NAT GENET, V33, P375, DOI 10.1038/ng1112; Fukazawa N, 2008, MOL CELL BIOL, V28, P4494, DOI 10.1128/MCB.00074-08; Garwood J, 2003, J BIOL CHEM, V278, P24164, DOI 10.1074/jbc.M211721200; Harroch S, 2002, NAT GENET, V32, P411, DOI 10.1038/ng1004; Hatziapostolou M, 2006, J BIOL CHEM, V281, P32217, DOI 10.1074/jbc.M607104200; Heroult M, 2004, ONCOGENE, V23, P1745, DOI 10.1038/sj.onc.1206879; Hodivala-Dilke KM, 2003, CELL TISSUE RES, V314, P131, DOI 10.1007/s00441-003-0774-5; Huang Y, 2006, BLOOD, V107, P3564, DOI 10.1182/blood-2005-07-2961; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Koutsioumpa M, 2009, EUR J PHARMACOL, V602, P245, DOI 10.1016/j.ejphar.2008.11.046; Li G, 2006, J BIOL CHEM, V281, P10663, DOI 10.1074/jbc.M512509200; Lorente G, 2005, NEURO-ONCOLOGY, V7, P154, DOI 10.1215/S1152851704000547; MAEDA N, 1994, FEBS LETT, V354, P67, DOI 10.1016/0014-5793(94)01093-5; Mahabeleshwar GH, 2008, CELL CYCLE, V7, P335, DOI 10.4161/cc.7.3.5234; Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655; Maile LA, 2006, MOL ENDOCRINOL, V20, P405, DOI 10.1210/me.2005-0241; Mikelis C, 2008, CONNECT TISSUE RES, V49, P149, DOI 10.1080/03008200802148652; Mikelis C, 2007, RECENT PAT ANTI-CANC, V2, P175, DOI 10.2174/157489207780832405; Muramatsu H, 2004, J CELL SCI, V117, P5405, DOI 10.1242/jcs.01423; Parthymou A, 2004, INT J CANCER, V110, P807, DOI 10.1002/ijc.20188; Parthymou A, 2008, EUR J CELL BIOL, V87, P17, DOI 10.1016/j.ejcb.2007.07.007; Patsenker E, 2007, J HEPATOL, V46, P878, DOI 10.1016/j.jhep.2006.11.011; Peles E, 1998, TRENDS BIOCHEM SCI, V23, P121, DOI 10.1016/S0968-0004(98)01195-5; Polykratis A, 2005, J BIOL CHEM, V280, P22454, DOI 10.1074/jbc.M414407200; Polytarchou C, 2005, J BIOL CHEM, V280, P40428, DOI 10.1074/jbc.M505120200; Polytarchou C, 2009, INT J CANCER, V124, P1785, DOI 10.1002/ijc.24084; Reardon DA, 2006, J CLIN ONCOL, V24, P1253, DOI 10.1200/JCO.2005.04.5302; Ren J, 2007, J MOL CELL CARDIOL, V42, P367, DOI 10.1016/j.yjmcc.2006.11.002; Sato Y, 2002, J BIOCHEM, V131, P877, DOI 10.1093/oxfordjournals.jbchem.a003178; Schaffner-Reckinger E, 1998, J BIOL CHEM, V273, P12623, DOI 10.1074/jbc.273.20.12623; Schmitz M, 2007, INT J CANCER, V120, P1284, DOI 10.1002/ijc.22359; Schneider GB, 1999, BONE, V24, P321, DOI 10.1016/S8756-3282(99)00007-1; Schnell O, 2008, BRAIN PATHOL, V18, P378, DOI 10.1111/j.1750-3639.2008.00137.x; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; Stupack DG, 2004, CURR TOP DEV BIOL, V64, P207, DOI 10.1016/S0070-2153(04)64009-9; Switala-Jelen K, 2004, FOLIA BIOL-PRAGUE, V50, P143; Takagi J, 1997, J BIOL CHEM, V272, P19794, DOI 10.1074/jbc.272.32.19794; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Vulin AI, 2005, ENDOCRINOLOGY, V146, P3535, DOI 10.1210/en.2004-1386; Wang DJ, 2003, HYPERTENSION, V42, P88, DOI 10.1161/01.HYP.0000074905.22908.A6; Yuki T, 2006, AM J PHYSIOL-GASTR L, V291, pG735, DOI 10.1152/ajpgi.00388.2005	50	65	66	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2009	23	5					1459	1469		10.1096/fj.08-117564	http://dx.doi.org/10.1096/fj.08-117564			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19141530				2022-12-25	WOS:000266651700022
J	Yasuda, D; Okuno, T; Yokomizo, T; Hori, T; Hirota, N; Hashidate, T; Miyano, M; Shimizu, T; Nakamura, M				Yasuda, Daisuke; Okuno, Toshiaki; Yokomizo, Takehiko; Hori, Tetsuya; Hirota, Nobuaki; Hashidate, Tomomi; Miyano, Masashi; Shimizu, Takao; Nakamura, Motonao			Helix 8 of leukotriene B-4 type-2 receptor is required for the folding to pass the quality control in the endoplasmic reticulum	FASEB JOURNAL			English	Article						G protein-coupled receptor; trafficking; pharmacological chaperone; ERAD; 12-HHT	PROTEIN-COUPLED RECEPTOR; VASOPRESSIN V1B/V3 RECEPTOR; CELL-SURFACE EXPRESSION; CRYSTAL-STRUCTURE; PHARMACOLOGICAL CHAPERONES; MELANOCORTIN-4 RECEPTOR; SIGNAL-TRANSDUCTION; THERAPEUTIC TARGET; IN-VIVO; TRANSPORT	Many G protein-coupled receptors (GPCRs) possess a putative cytoplasmic helical domain, termed helix 8 (H8), at the proximal region of the C-terminal tail. However, the significance of this domain is not fully understood. Here, we demonstrate the requirement of H8 for the proper folding of GPCRs for passage through the quality control in the endoplasmic reticulum (ER). In the human leukotriene B-4 type-2 receptor (hBLT2), lack of H8 led to an accumulation of the receptor (hBLT2/Delta H8) in the ER. Similar results were obtained in two representative human GPCRs, dopamine type-1 and lysophosphatidic acid type-2 receptors, which were engineered to lack H8. Treatment with the several ligands, which act as pharmacological chaperones, facilitated the surface expression of hBLT2/Delta H8. The surface-trafficked hBLT2/Delta H8 exhibited an agonist-evoked increase in Ca2+, demonstrating that H8 is not critical for ligand binding and activation of coupled G proteins. Thus, these results suggest that the H8 region of hBLT2 plays an important role in transport-competent receptor folding.-Yasuda, D., Okuno, T., Yokomizo, T., Hori, T., Hirota, N., Hashidate, T., Miyano, M., Shimizu, T., Nakamura, M. Helix 8 of leukotriene B4 type-2 receptor is required for the folding to pass the quality control in the endoplasmic reticulum. FASEB J. 23, 1470-1481 (2009)	[Nakamura, Motonao] Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan; [Okuno, Toshiaki; Yokomizo, Takehiko] Kyushu Univ, Grad Sch Med Sci, Dept Med Biochem, Fukuoka 812, Japan; [Hori, Tetsuya; Miyano, Masashi] Spring 8, Harima Inst, RIKEN, Struct Biophys Lab, Kobe, Hyogo, Japan	University of Tokyo; Kyushu University; Japan Synchrotron Radiation Research Institute; RIKEN	Nakamura, M (corresponding author), Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	moto-nakamura@umin.net	Yokomizo, Takehiko/P-5673-2016; Miyano, Masashi/R-2785-2016; Shimizu, Takao/AAV-7052-2021	Yokomizo, Takehiko/0000-0002-5219-1553; Miyano, Masashi/0000-0003-2253-6175; Yasuda, Daisuke/0000-0001-5513-0695	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Center for NanoBio Integration at the University of Tokyo	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center for NanoBio Integration at the University of Tokyo	We are grateful to Drs. S. Ishii, Y. Kita, and H. Shindou, and to N. Murakami (the University of Tokyo) and to all members of our laboratory for technical advice and useful discussions. This work was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. S.) and grants from the Japan Society for the Promotion of Science (Global COE program) and the Center for NanoBio Integration at the University of Tokyo.	Anavi-Goffer S, 2007, J BIOL CHEM, V282, P25100, DOI 10.1074/jbc.M703388200; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Bernier V, 2004, TRENDS ENDOCRIN MET, V15, P222, DOI 10.1016/j.tem.2004.05.003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; Delos Santos NM, 2006, J BIOL CHEM, V281, P12896, DOI 10.1074/jbc.M508500200; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; Fan J, 2005, MOL ENDOCRINOL, V19, P2579, DOI 10.1210/me.2004-0301; Fitzsimmons TJ, 2003, J BIOL CHEM, V278, P14313, DOI 10.1074/jbc.M211946200; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Ghosh M, 2006, J BIOL CHEM, V281, P16615, DOI 10.1074/jbc.M601770200; Hinney A, 1999, J CLIN ENDOCR METAB, V84, P1483, DOI 10.1210/jc.84.4.1483; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Iizuka Y, 2005, J BIOL CHEM, V280, P24816, DOI 10.1074/jbc.M413257200; Ishii S, 2005, J BIOL CHEM, V280, P9083, DOI 10.1074/jbc.M407832200; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Janicki S, 1997, J CELL BIOL, V139, P485, DOI 10.1083/jcb.139.2.485; Janovick JA, 2002, J CLIN ENDOCR METAB, V87, P3255, DOI 10.1210/jc.87.7.3255; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kang DS, 2002, MOL PHARMACOL, V62, P281, DOI 10.1124/mol.62.2.281; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; Okuno T, 2005, J BIOL CHEM, V280, P32049, DOI 10.1074/jbc.R500007200; Okuno T, 2003, J BIOL CHEM, V278, P41500, DOI 10.1074/jbc.M307335200; Okuno T, 2008, J EXP MED, V205, P759, DOI 10.1084/jem.20072329; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Robert J, 2005, J BIOL CHEM, V280, P42198, DOI 10.1074/jbc.M510180200; Robert J, 2005, J BIOL CHEM, V280, P2300, DOI 10.1074/jbc.M410655200; Rutz C, 2006, J BIOL CHEM, V281, P24910, DOI 10.1074/jbc.M601554200; Sano T, 1997, J BIOL CHEM, V272, P23631, DOI 10.1074/jbc.272.38.23631; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; Serhan CN, 1996, FASEB J, V10, P1147, DOI 10.1096/fasebj.10.10.8751717; SHIMIZU T, 1990, J NEUROCHEM, V55, P1, DOI 10.1111/j.1471-4159.1990.tb08813.x; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Simonin F, 2004, J NEUROCHEM, V89, P766, DOI 10.1111/j.1471-4159.2004.02411.x; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Tan CM, 2003, J BIOL CHEM, V278, P35678, DOI 10.1074/jbc.M301888200; Udawela M, 2004, SEMIN CELL DEV BIOL, V15, P299, DOI 10.1016/j.semcdb.2003.12.019; VanLeeuwen D, 2003, J BIOL CHEM, V278, P15935, DOI 10.1074/jbc.M211546200; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Yokomizo T, 2001, J BIOL CHEM, V276, P12454, DOI 10.1074/jbc.M011361200; Zhong M, 2004, BIOCHEMISTRY-US, V43, P3490, DOI 10.1021/bi035899m	52	23	23	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2009	23	5					1470	1481		10.1096/fj.08-125385	http://dx.doi.org/10.1096/fj.08-125385			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19126593				2022-12-25	WOS:000266651700023
J	Zhang, YM; Herbert, BS; Rajashekhar, G; Ingram, DA; Yoder, MC; Clauss, M; Rehman, J				Zhang, Yanmin; Herbert, Brittney-Shea; Rajashekhar, Gangaraju; Ingram, David A.; Yoder, Mervin C.; Clauss, Matthias; Rehman, Jalees			Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-alpha via the p38 mitogen-activated protein kinase pathway	FASEB JOURNAL			English	Article						cytokines; aging; inflammation; vascular cells	P16(INK4A); TELOMERASE; BLOOD; EXPRESSION; HIERARCHY	Senescence of endothelial cells increases with systemic aging and is thought to contribute to the development of atherosclerosis. Cell therapy with highly proliferative endothelial progenitor cells (EPCs) is an emerging therapeutic option to promote endothelial regeneration, but little is known about their senescence and their vulnerability to inflammatory stressors. We therefore studied the senescence of proliferative human EPCs and investigated the effects of the proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) on their senescence. Human EPCs had a significantly lower rate of senescence at baseline, compared with that of mature endothelial cells. However, EPCs up-regulated the expression of the senescence-associated cell cycle arrest protein p16(INK4a) and markedly increased measured senescence levels when exposed to chronic TNF-alpha treatment. Analysis of telomere length showed that the increases in senescence were not related to changes in telomere length. Inhibition of the p38 mitogen-activated protein kinase pathway blocked the induction of p16(INK4a) and cellular senescence. In conclusion, highly proliferative EPCs have a low rate of intrinsic senescence but are vulnerable to premature senescence induction by chronic proinflammatory stimulation. These findings will lead to a better understanding of physiological endothelial regeneration as well as to targeted therapies with the aim of promoting endothelial regeneration through endothelial progenitor cells.-Zhang, Y., Herbert, B.-S., Rajashekhar, G., Ingram, D. A., Yoder, M. C., Clauss, M., Rehman. J. Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-alpha via the p38 mitogen-activated protein kinase pathway. FASEB J. 23, 1358-1365 (2009)	[Zhang, Yanmin; Rehman, Jalees] Univ Chicago, Pritzker Sch Med, Cardiol Sect, Chicago, IL 60637 USA; [Zhang, Yanmin; Rehman, Jalees] Indiana Univ, Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA; [Herbert, Brittney-Shea] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Rajashekhar, Gangaraju; Clauss, Matthias] Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Ingram, David A.; Yoder, Mervin C.] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Rajashekhar, Gangaraju; Clauss, Matthias] Indiana Ctr Vasc Biol & Med, Indianapolis, IN USA	University of Chicago; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Rehman, J (corresponding author), Univ Chicago, Pritzker Sch Med, Cardiol Sect, 5841 S Maryland Ave,Mail Code 6080, Chicago, IL 60637 USA.	jrehman@medicine.bsd.uchicago.edu	Rehman, Jalees/GVU-1981-2022; Gangaraju, Rajashekhar/I-7852-2019; Gangaraju, Rajashekhar/I-6620-2013; Rehman, Jalees/J-8258-2012; Rehman, Jalees/B-8064-2009	Rehman, Jalees/0000-0002-2787-9292; Gangaraju, Rajashekhar/0000-0002-6664-8286; Gangaraju, Rajashekhar/0000-0003-3337-1329; Rehman, Jalees/0000-0002-2787-9292; Yoder, Mervin/0000-0003-4354-7631; Clauss, Matthias/0000-0001-5180-3899	U.S. National Institutes of Health [K08-HL080082]; Indiana Genomics Initiative (INGEN) of Indiana University; Lilly Endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL080082] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana Genomics Initiative (INGEN) of Indiana University; Lilly Endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Erin Gentry for her technical assistance. This work was supported in part by U.S. National Institutes of Health grant K08-HL080082 (principal investigator J.R.). B.-S.H. acknowledges support from the Indiana Genomics Initiative (INGEN) of Indiana University, supported in part by the Lilly Endowment. D.A.I. and M.C.Y own stock in EndGenitor Technologies, Inc. (Indianapolis, IN, USA). They have also acted as consultants to and served as officers or members of the board of EndGenitor Technologies, Inc., within the past 2 years.	Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Assmus B, 2003, CIRC RES, V92, P1049, DOI 10.1161/01.RES.0000070067.64040.7C; Chen J, 2006, AM J PHYSIOL-HEART C, V290, pH1575, DOI 10.1152/ajpheart.00364.2005; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Gulati R, 2003, CIRC RES, V93, P1023, DOI 10.1161/01.RES.0000105569.77539.21; Gutierrez J, 2006, CIRC RES, V99, P924, DOI 10.1161/01.RES.0000248212.86638.e9; Ha JM, 2007, FEBS LETT, V581, P2663, DOI 10.1016/j.febslet.2007.05.010; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Herbert B-S, 2003, ANAL TELOMERES TELOM; Herbert BS, 2006, NAT PROTOC, V1, P1583, DOI 10.1038/nprot.2006.239; Herbert BS, 2002, ONCOGENE, V21, P7897, DOI 10.1038/sj.onc.1205902; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Ingram DA, 2005, BLOOD, V105, P2783, DOI 10.1182/blood-2004-08-3057; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kupatt C, 2005, FASEB J, V19, P1576, DOI 10.1096/fj.04-3282fje; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Murasawa S, 2002, CIRCULATION, V106, P1133, DOI 10.1161/01.CIR.0000027584.85865.B4; Opitz CA, 2007, FEBS LETT, V581, P4927, DOI 10.1016/j.febslet.2007.09.032; Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072; Rajashekhar G, 2007, PHYSIOL GENOMICS, V31, P104, DOI 10.1152/physiolgenomics.00157.2006; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Rehman J, 2008, CIRC RES, V102, P1146, DOI 10.1161/CIRCRESAHA.108.177311; Seeger FH, 2005, CIRCULATION, V111, P1184, DOI 10.1161/01.CIR.0000157156.85397.A1; Yan GJ, 2008, CIRC RES, V103, P591, DOI 10.1161/CIRCRESAHA.108.173963; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yoon CH, 2005, CIRCULATION, V112, P1618, DOI 10.1161/CIRCULATIONAHA.104.503433; Zhou Z, 2008, AM J PHYSIOL-RENAL, V295, pF932, DOI 10.1152/ajprenal.00066.2008	30	96	99	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2009	23	5					1358	1365		10.1096/fj.08-110296	http://dx.doi.org/10.1096/fj.08-110296			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19124561	Green Published			2022-12-25	WOS:000266651700012
J	Zhang, G; Chen, S; Goldoni, S; Calder, BW; Simpson, HC; Owens, RT; McQuillan, DJ; Young, MF; Iozzo, RV; Birk, DE				Zhang, Guiyun; Chen, Shoujun; Goldoni, Silvia; Calder, Bennett W.; Simpson, Holly C.; Owens, Rick T.; McQuillan, David J.; Young, Marian F.; Iozzo, Renato V.; Birk, David E.			Genetic Evidence for the Coordinated Regulation of Collagen Fibrillogenesis in the Cornea by Decorin and Biglycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KERATAN SULFATE PROTEOGLYCAN; LEUCINE-RICH PROTEOGLYCANS; DEFICIENT MICE; FIBRIL SEGMENTS; LUMICAN-DEFICIENT; IN-SITU; EXTRACELLULAR COMPARTMENTS; TARGETED DISRUPTION; SKIN FRAGILITY; LATERAL GROWTH	Decorin and biglycan are class I small leucine-rich proteoglycans (SLRPs) involved in regulation of collagen fibril and matrix assembly. We hypothesize that tissue-specific matrix assembly, such as in the cornea, requires a coordinate regulation involving multiple SLRPs. To this end, we investigated the expression of decorin and biglycan in the cornea of mice deficient in either SLRP gene and in double-mutant mice. Decorin and biglycan exhibited overlapping spatial expression patterns throughout the corneal stroma with differential temporal expression. Whereas decorin was expressed at relatively high levels in all developmental stages, biglycan expression was high early, decreased during development, and was present at very low levels in the mature cornea. Ultrastructural analyses demonstrated comparable fibril structure in the decorin-and biglycan-null corneas compared with wild-type controls. We found a compensatory up-regulation of biglycan gene expression in the decorin-deficient mice, but not the reverse. Notably, the corneas of compound decorin/biglycan-null mice showed severe disruption in fibril structure and organization, especially affecting the posterior corneal regions, corroborating the idea that biglycan compensates for the loss of decorin. Fibrillogenesis assays using recombinant decorin and biglycan confirmed a functional compensation, with both having similar effects at high SLRP/collagen ratios. However, at low ratios decorin was a more efficient regulator. The use of proteoglycan or protein core yielded comparable results. These findings provide firm genetic evidence for an interaction of decorin and biglycan during corneal development and further suggest that decorin has a primary role in regulating fibril assembly, a function that can be fine-tuned by biglycan during early development.	[Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Owens, Rick T.; McQuillan, David J.] LifeCell Corp, Branchburg, NJ 08876 USA; [Young, Marian F.] NIDCR, NIH, Bethesda, MD 20892 USA; [Chen, Shoujun; Birk, David E.] Univ S Florida, Dept Pathol & Cell Biol, Coll Med, Tampa, FL 33612 USA	Jefferson University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); State University System of Florida; University of South Florida	Birk, DE (corresponding author), 12901 Bruce B Downs Blvd,MDC11, Tampa, FL 33612 USA.	dbirk@health.usf.edu	Birk, David/I-4072-2012; Iozzo, Renato/AAS-1980-2020	Birk, David/0000-0002-4865-9088; Iozzo, Renato/0000-0002-5908-5112; Young, Marian F/0000-0003-0929-8854	National Institutes of Health NEI [EY005129]; Intramural Research Program, NIDCR; NATIONAL CANCER INSTITUTE [R01CA039481] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY005129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000379] Funding Source: NIH RePORTER	National Institutes of Health NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Intramural Research Program, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health NEI Grant EY005129 (to D.E.B.) and support from the Intramural Research Program, NIDCR (to M.F.Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Ameye L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0848com; Beales MP, 1999, INVEST OPHTH VIS SCI, V40, P1658; BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616; Birk DE, 2005, TOP CURR CHEM, V247, P185, DOI 10.1007/b103823; BIRK DE, 1984, ARCH BIOCHEM BIOPHYS, V235, P178, DOI 10.1016/0003-9861(84)90266-2; BIRK DE, 1995, DEV DYNAM, V202, P229, DOI 10.1002/aja.1002020303; BIRK DE, 1994, J ANAT, V184, P457; Birk DE, 1997, DEV DYNAM, V208, P291; Birk DE, 1996, MATRIX BIOL, V15, P111, DOI 10.1016/S0945-053X(96)90152-3; BIRK DE, 1984, J CELL BIOL, V99, P2024, DOI 10.1083/jcb.99.6.2024; BIRK DE, 1989, P NATL ACAD SCI USA, V86, P4549, DOI 10.1073/pnas.86.12.4549; BIRK DE, 1990, ANN NY ACAD SCI, V580, P176, DOI 10.1111/j.1749-6632.1990.tb17928.x; Birk DE., 1991, MATRIX ASSEMBLY, P221; Blaschke UK, 2000, J BIOL CHEM, V275, P10370, DOI 10.1074/jbc.275.14.10370; BLOCHBERGER TC, 1992, J BIOL CHEM, V267, P20613; Bredrup C, 2005, INVEST OPHTH VIS SCI, V46, P420, DOI 10.1167/iovs.04-0804; Carlson EC, 2005, J BIOL CHEM, V280, P25541, DOI 10.1074/jbc.M500249200; Carlson EC, 2003, BIOCHEM J, V369, P461, DOI 10.1042/BJ20020593; Chakravarti S, 2000, INVEST OPHTH VIS SCI, V41, P3365; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chakravarti S, 2006, DEV DYNAM, V235, P2493, DOI 10.1002/dvdy.20868; Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Dunlevy JR, 2000, EXP EYE RES, V70, P349, DOI 10.1006/exer.1999.0789; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; Funderburgh JL, 1997, J BIOL CHEM, V272, P28089, DOI 10.1074/jbc.272.44.28089; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Liu CY, 2003, J BIOL CHEM, V278, P21672, DOI 10.1074/jbc.M301169200; McEwan PA, 2006, J STRUCT BIOL, V155, P294, DOI 10.1016/j.jsb.2006.01.016; Quantock AJ, 2001, INVEST OPHTH VIS SCI, V42, P1750; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Rodahl E, 2006, AM J OPHTHALMOL, V142, P520, DOI 10.1016/j.ajo.2006.03.064; Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; SCHONHERR E, 1995, J BIOL CHEM, V270, P2776, DOI 10.1074/jbc.270.6.2776; SCHONHERR E, 1995, J BIOL CHEM, V270, P8877, DOI 10.1074/jbc.270.15.8877; Schonherr E, 2004, J VASC RES, V41, P499, DOI 10.1159/000081806; Svensson L, 2000, FEBS LETT, V470, P178, DOI 10.1016/S0014-5793(00)01314-4; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Tasheva ES, 2002, MOL VIS, V8, P407; Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Zhang CM, 2005, CHINESE J ASTRON AST, V5, P21, DOI 10.1088/1009-9271/5/S1/21; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776	48	157	162	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8888	8897		10.1074/jbc.M806590200	http://dx.doi.org/10.1074/jbc.M806590200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19136671	Green Published, hybrid			2022-12-25	WOS:000264397800071
J	Balcazar, N; Sathyamurthy, A; Elghazi, L; Gould, A; Weiss, A; Shiojima, I; Walsh, K; Bernal-Mizrachi, E				Balcazar, Norman; Sathyamurthy, Aruna; Elghazi, Lynda; Gould, Aaron; Weiss, Aaron; Shiojima, Ichiro; Walsh, Kenneth; Bernal-Mizrachi, Ernesto			mTORC1 Activation Regulates beta-Cell Mass and Proliferation by Modulation of Cyclin D2 Synthesis and Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS SCLEROSIS COMPLEX-2; DEPENDENT KINASE-4; DIRECT TARGET; GROWTH; AKT; PHOSPHORYLATION; DEGRADATION; TSC2; D1; DISRUPTION	Growth factors, insulin signaling, and nutrients are important regulators of beta-cell mass and function. The events linking these signals to the regulation of beta-cell mass are not completely understood. The mTOR pathway integrates signals from growth factors and nutrients. Here, we evaluated the role of the mTOR/raptor (mTORC1) signaling in proliferative conditions induced by controlled activation of Akt signaling. These experiments show that the mTORC1 is a major regulator of beta-cell cycle progression by modulation of cyclin D2, D3, and Cdk4 activity. The regulation of cell cycle progression by mTORC1 signaling resulted from modulation of the synthesis and stability of cyclin D2, a critical regulator of beta-cell cycle, proliferation, and mass. These studies provide novel insights into the regulation of cell cycle by the mTORC1, provide a mechanism for the antiproliferative effects of rapamycin, and imply that the use of rapamycin could negatively impact the success of islet transplantation and the adaptation of beta-cells to insulin resistance.	[Balcazar, Norman; Sathyamurthy, Aruna; Elghazi, Lynda; Gould, Aaron; Weiss, Aaron; Bernal-Mizrachi, Ernesto] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Shiojima, Ichiro; Walsh, Kenneth] Boston Univ, Sch Med, Mol Cardiol Whitaker Cardiovasc Inst, Boston, MA 02118 USA	Washington University (WUSTL); Boston University	Bernal-Mizrachi, E (corresponding author), Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, 660 S Euclid Ave,Campus Box 8127, St Louis, MO 63110 USA.	ebernal@wustl.edu		Elghazi, Lynda/0000-0003-1755-9217	National Institutes of Health [R01DK073716-01]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073716] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK073716-01 (to E.B.-M.). This work was also supported by a Career Development Award from the American Diabetes Association (to E.B.-M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Bernal-Mizrachi E, 2000, J BIOL CHEM, V275, P25681, DOI 10.1074/jbc.M003424200; Bonner-Weir S, 2000, J MOL ENDOCRINOL, V24, P297, DOI 10.1677/jme.0.0240297; Casanovas O, 2004, ONCOGENE, V23, P7537, DOI 10.1038/sj.onc.1208040; Cozar-Castellano I, 2004, DIABETES, V53, P149, DOI 10.2337/diabetes.53.1.149; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Fatrai S, 2006, DIABETES, V55, P318, DOI 10.2337/diabetes.55.02.06.db05-0757; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Girish V, 2004, Indian J Cancer, V41, P47; HARRIS TE, 2003, SCI STKE, V212, P1; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Kida A, 2007, ONCOGENE, V26, P6630, DOI 10.1038/sj.onc.1210490; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kulkarni RN, 2005, REV ENDOCR METAB DIS, V6, P199, DOI 10.1007/s11154-005-3051-y; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Kwon G, 2006, J BIOL CHEM, V281, P3261, DOI 10.1074/jbc.M508821200; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; Milo-Landesman D, 2001, CELL TRANSPLANT, V10, P645; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Naderi S, 2004, J CELL SCI, V117, P3769, DOI 10.1242/jcs.01210; Nielsen JH, 2001, DIABETES, V50, pS25, DOI 10.2337/diabetes.50.2007.S25; Rachdi L, 2008, P NATL ACAD SCI USA, V105, P9250, DOI 10.1073/pnas.0803047105; Rane SG, 2000, FRONT BIOSCI, V5, pD1, DOI 10.2741/Rane; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shigeyama Y, 2008, MOL CELL BIOL, V28, P2971, DOI 10.1128/MCB.01695-07; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Zeng ZH, 2007, BLOOD, V109, P3509, DOI 10.1182/blood-2006-06-030833; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019; Zhang N, 2006, DIABETES, V55, P2429, DOI 10.2337/db06-0173; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	44	86	89	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7832	7842		10.1074/jbc.M807458200	http://dx.doi.org/10.1074/jbc.M807458200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19144649	Green Published, hybrid			2022-12-25	WOS:000264195600045
J	Leonhardt, K; Gebhardt, R; Mossner, J; Lutsenko, S; Huster, D				Leonhardt, Karoline; Gebhardt, Rolf; Moessner, Joachim; Lutsenko, Svetlana; Huster, Dominik			Functional Interactions of Cu-ATPase ATP7B with Cisplatin and the Role of ATP7B in the Resistance of Cells to the Drug	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE-TRIPHOSPHATASE ATP7B; WILSONS-DISEASE PROTEIN; COPPER TRANSPORTERS; HEPATOCELLULAR-CARCINOMA; CELLULAR PHARMACOLOGY; BINDING SITES; EFFLUX; TRAFFICKING; EXPRESSION; PLATINUM	Cisplatin is a widely used chemotherapeutic agent for treatment of ovarian, testicular, lung, and stomach cancers. The initial response to the drug is robust; however, tumor cells commonly develop resistance to cisplatin, which complicates treatment. Recently, overexpression of the Cu-ATPase ATP7B in ovary cells was linked to the increased cellular resistance to cisplatin; and the role for Cu-ATPases in the export of cisplatin from cells was proposed. Our results support functional interactions between cisplatin and ATP7B but argue against the active transport through the copper translocation pathway as a mechanism of drug resistance. In hepatocytes, we observed no correlation between the levels of endogenous ATP7B and the resistance of cells to cisplatin. Unlike copper, cisplatin does not induce trafficking of ATP7B in hepatoma cells, neither does it compete with copper in a transport assay. However, cisplatin binds to ATP7B and stimulates catalytic phosphorylation with EC50 similar to that of copper. Mutations of the first five N-terminal copper-binding sites of ATP7B do not inhibit the cisplatin-induced phosphorylation of ATP7B. In contrast, the deletion of the first four copper-binding sites abolishes the effect of cisplatin on the ATP7B activity. Thus, cisplatin binding to ATP7B and/or general changes in cellular copper homeostasis are likely contributors to the increased resistance to the drug. The link between changes in copper homeostasis and cisplatin resistance was confirmed by treating the Huh7 cells with copper chelator and increasing their resistance to cisplatin.	[Lutsenko, Svetlana] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Leonhardt, Karoline; Moessner, Joachim; Huster, Dominik] Univ Leipzig, Dept Med 2, D-04103 Leipzig, Germany; [Gebhardt, Rolf] Univ Leipzig, Dept Biochem, D-04103 Leipzig, Germany; [Huster, Dominik] Otto VonGuericke Univ Magdegurg, Dept Gastroenterol Hepatol & Infect Dis, D-39120 Magdeburg, Germany	Oregon Health & Science University; Leipzig University; Leipzig University; Otto von Guericke University	Lutsenko, S (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.	lutsenko@ohsu.edu; dominik.huster@med.ovgu.de			National Institutes of Health [R01 DK071865]; German Research Foundation [HU 932/3-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071865] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK071865 (to S. L.). This work was also supported by German Research Foundation Grant HU 932/3-1 (to D. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akiyama S, 1999, ANTI-CANCER DRUG DES, V14, P143; ANDREWS PA, 1990, CANCER COMMUN-US, V2, P93, DOI 10.3727/095535490820874641; Barocas DA, 2008, CURR OPIN ONCOL, V20, P307, DOI 10.1097/CCO.0b013e3282f8b03e; Bartee MY, 2007, BIOMETALS, V20, P627, DOI 10.1007/s10534-006-9074-3; BIER H, 1988, ARCH OTO-RHINO-LARYN, V245, P166, DOI 10.1007/BF00464020; Brozovic A, 2004, INT J CANCER, V112, P974, DOI 10.1002/ijc.20522; Buiakova OI, 1999, HUM MOL GENET, V8, P1665, DOI 10.1093/hmg/8.9.1665; Cater MA, 2006, GASTROENTEROLOGY, V130, P493, DOI 10.1053/j.gastro.2005.10.054; Cater MA, 2007, BIOCHEM J, V401, P143, DOI 10.1042/BJ20061055; DiDonato M, 1997, J BIOL CHEM, V272, P33279, DOI 10.1074/jbc.272.52.33279; Dolgova NV, 2009, BIOCHEM J, V419, P51, DOI 10.1042/BJ20081359; Ferraldeschi R, 2007, DRUGS, V67, P2135, DOI 10.2165/00003495-200767150-00003; Forbes JR, 1998, AM J HUM GENET, V63, P1663, DOI 10.1086/302163; Forbes JR, 2000, HUM MOL GENET, V9, P1927, DOI 10.1093/hmg/9.13.1927; GEBHARDT R, 1982, EUR J CELL BIOL, V29, P68; GMAJ P, 1983, EUR J BIOCHEM, V136, P71, DOI 10.1111/j.1432-1033.1983.tb07706.x; HAMILTON TC, 1985, BIOCHEM PHARMACOL, V34, P2583, DOI 10.1016/0006-2952(85)90551-9; Hatori Y, 2008, J BIOL CHEM, V283, P22541, DOI 10.1074/jbc.M802735200; Hatori Y, 2007, J BIOL CHEM, V282, P25213, DOI 10.1074/jbc.M703520200; Higashimoto M, 2003, INT J MOL MED, V11, P337; Huster D, 2003, J BIOL CHEM, V278, P32212, DOI 10.1074/jbc.M305408200; Huster D, 2007, J BIOL CHEM, V282, P8343, DOI 10.1074/jbc.M607496200; Jamieson ER, 1999, CHEM REV, V99, P2467, DOI 10.1021/cr980421n; Jordan P, 2000, CELL MOL LIFE SCI, V57, P1229, DOI 10.1007/PL00000762; Kanzaki A, 2002, JPN J CANCER RES, V93, P70, DOI 10.1111/j.1349-7006.2002.tb01202.x; Katano K, 2004, CLIN CANCER RES, V10, P4578, DOI 10.1158/1078-0432.CCR-03-0689; Katano K, 2002, CANCER RES, V62, P6559; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Komatsu M, 2000, CANCER RES, V60, P1312; Kruger N J, 1994, Methods Mol Biol, V32, P9; Kuo MT, 2007, CANCER METAST REV, V26, P71, DOI 10.1007/s10555-007-9045-3; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Mathurin P, 1998, ALIMENT PHARM THERAP, V12, P111; Moehler M, 2007, BEST PRACT RES CL GA, V21, P965, DOI 10.1016/j.bpg.2007.10.003; Mukai M, 2002, ONCOL REP, V9, P839; Ohbu M, 2003, CANCER LETT, V189, P33, DOI 10.1016/S0304-3835(02)00462-7; Petris MJ, 2002, J BIOL CHEM, V277, P46736, DOI 10.1074/jbc.M208864200; Safaei R, 2005, MOL CANCER THER, V4, P1595, DOI 10.1158/1535-7163.MCT-05-0102; Safaei R, 2006, CANCER LETT, V234, P34, DOI 10.1016/j.canlet.2005.07.046; Safaei R, 2004, CANCER CHEMOTH PHARM, V53, P239, DOI 10.1007/s00280-003-0736-3; Safaei R, 2005, CRIT REV ONCOL HEMAT, V53, P13, DOI 10.1016/j.critrevonc.2004.09.007; Safaei R, 2008, MOL PHARMACOL, V73, P461, DOI 10.1124/mol.107.040980; Samimi G, 2004, CLIN CANCER RES, V10, P4661, DOI 10.1158/1078-0432.CCR-04-0137; SEGLEN PO, 1973, EXP CELL RES, V82, P391, DOI 10.1016/0014-4827(73)90357-1; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Tsivkovskii R, 2002, J BIOL CHEM, V277, P976, DOI 10.1074/jbc.M109368200; Uthus EO, 2007, J NUTR, V137, P1370, DOI 10.1093/jn/137.6.1370; Vanderwerf SM, 2001, J BIOL CHEM, V276, P36289, DOI 10.1074/jbc.M102055200; Wakamatsu T, 2007, INT J ONCOL, V31, P1465; Wong E, 1999, CHEM REV, V99, P2451, DOI 10.1021/cr980420v; Yoshizawa K, 2007, ONCOL REP, V18, P987; Yuan JN, 2008, MED ONCOL, V25, P201, DOI 10.1007/s12032-007-9013-3; ZELAZOWSKI AJ, 1984, ARCH BIOCHEM BIOPHYS, V229, P246; Zisowsky J, 2007, BIOCHEM PHARMACOL, V73, P298, DOI 10.1016/j.bcp.2006.10.003	55	53	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7793	7802		10.1074/jbc.M805145200	http://dx.doi.org/10.1074/jbc.M805145200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19141620	Green Published, hybrid			2022-12-25	WOS:000264195600041
J	Ros, S; Garcia-Rocha, M; Dominguez, J; Ferrer, JC; Guinovart, JJ				Ros, Susana; Garcia-Rocha, Mar; Dominguez, Jorge; Ferrer, Juan C.; Guinovart, Joan J.			Control of Liver Glycogen Synthase Activity and Intracellular Distribution by Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; PHOSPHOSERINE RESIDUES INVIVO; RAT HEPATOCYTES; MOLECULAR-MECHANISM; COS CELLS; GLUCOSE; ACTIVATION; GLUCOSE-6-PHOSPHATE; GLUCOKINASE; SITES	Eukaryotic glycogen synthase activity is regulated by reversible phosphorylation at multiple sites. Of the two GS isoforms found in mammals, the muscle enzyme (muscle glycogen synthase) has received more attention and the relative importance of every known phosphorylation site in the control of its activity and intracellular distribution has been previously addressed. We have analyzed the impact of the dephosphorylation at the homologous sites of the glycogen synthase liver (LGS) isoform. Serine residues at these sites were replaced by non-phosphorylatable alanine residues, singly or in pairs, and the resultant LGS variants were expressed in cultured cells using adenoviral vectors. The sole mutation at site 2 (Ser(7)) yielded an enzyme that was almost fully active and able to induce glycogen deposition in primary hepatocytes incubated in the absence of glucose and in FTO2B cells, a cell line that does not normally synthesize glycogen. Mutation at site 2 was also sufficient to trigger the aggregation and translocation of LGS from the cytoplasm to the hepatocyte cell cortex in the absence of glucose. However, this redistribution was not observed in hepatocytes incubated without glucose when an additional mutation (E509A), which renders the enzyme inactive, was introduced. This result suggests that LGS translocation is strictly dependent on glycogen synthesis.	[Ros, Susana; Garcia-Rocha, Mar; Dominguez, Jorge; Guinovart, Joan J.] Univ Barcelona, IRB Barcelona, E-08028 Barcelona, Spain; [Ros, Susana; Garcia-Rocha, Mar; Dominguez, Jorge; Guinovart, Joan J.] Univ Barcelona, CIBERDEM, E-08028 Barcelona, Spain; [Ros, Susana; Garcia-Rocha, Mar; Dominguez, Jorge; Ferrer, Juan C.; Guinovart, Joan J.] Univ Barcelona, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; University of Barcelona	Guinovart, JJ (corresponding author), Univ Barcelona, IRB Barcelona, Baldiri Reixac 10, E-08028 Barcelona, Spain.	guinovart@irbbarcelona.org	Ferrer, Joan C./AAP-2145-2021; Ros, Susana/B-6350-2019	Ros, Susana/0000-0002-5451-1880; Garcia-Rocha, Mar/0000-0003-2467-2090; Ferrer, Joan C./0000-0003-1212-5161	Ministry of Education and Science, Spain [BFU2005-02253, SAF2007-64722]; Autonomous Government of Catalonia [2005-SGR-00570]; Fundacion Marcelino Botin, CIBER de Diabetes y Enfermedades Metabolicas Asociadas, an ISCIII project	Ministry of Education and Science, Spain(Spanish Government); Autonomous Government of Catalonia(Generalitat de Catalunya); Fundacion Marcelino Botin, CIBER de Diabetes y Enfermedades Metabolicas Asociadas, an ISCIII project	This work was supported in part by Grants BFU2005-02253 and SAF2007-64722 from the Ministry of Education and Science, Spain, Grant 2005-SGR-00570 from the Autonomous Government of Catalonia, and the Fundacion Marcelino Botin, CIBER de Diabetes y Enfermedades Metabolicas Asociadas, an ISCIII project. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ARINO J, 1984, FEBS LETT, V170, P310, DOI 10.1016/0014-5793(84)81334-4; ARINO J, 1986, BIOCHEM BIOPH RES CO, V134, P113, DOI 10.1016/0006-291X(86)90534-6; Baba O, 1993, Kokubyo Gakkai Zasshi, V60, P264; BAI G, 1990, J BIOL CHEM, V265, P7843; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Berman HK, 1998, J BIOL CHEM, V273, P26421, DOI 10.1074/jbc.273.41.26421; BOSCH F, 1986, J BIOL CHEM, V261, P6927; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cid E, 2000, J BIOL CHEM, V275, P33614, DOI 10.1074/jbc.M005358200; Cid E, 2005, FEBS J, V272, P3197, DOI 10.1111/j.1742-4658.2005.04738.x; CIUDAD CJ, 1988, ARCH BIOCHEM BIOPHYS, V264, P30, DOI 10.1016/0003-9861(88)90566-8; DEWULF H, 1967, EUR J BIOCHEM, V2, P50; DEWULF H, 1970, EUR J BIOCHEM, V15, P1; Fernandez-Novell JM, 2002, FEBS LETT, V531, P222, DOI 10.1016/S0014-5793(02)03506-8; FernandezNovell JM, 1997, BIOCHEM J, V321, P227, DOI 10.1042/bj3210227; Ferrer JC, 1997, FEBS LETT, V415, P249, DOI 10.1016/S0014-5793(97)01136-8; Garcia-Rocha M, 2001, BIOCHEM J, V357, P17, DOI 10.1042/0264-6021:3570017; Gomis RR, 2002, J BIOL CHEM, V277, P23246, DOI 10.1074/jbc.M111208200; Gomis RR, 2000, BIOCHEM J, V351, P811, DOI 10.1042/0264-6021:3510811; Hanashiro I, 2002, ARCH BIOCHEM BIOPHYS, V397, P286, DOI 10.1006/abbi.2001.2623; Kadotani A, 2007, ARCH BIOCHEM BIOPHYS, V466, P283, DOI 10.1016/j.abb.2007.08.006; KATZ J, 1979, BIOCHEM J, V180, P389, DOI 10.1042/bj1800389; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; MASSAGUE J, 1977, FEBS LETT, V82, P317, DOI 10.1016/0014-5793(77)80610-8; NAKIELNY S, 1991, EUR J BIOCHEM, V199, P713, DOI 10.1111/j.1432-1033.1991.tb16175.x; NEWGARD CB, 1983, J BIOL CHEM, V258, P8046; O'Doherty RM, 2000, J CLIN INVEST, V105, P479, DOI 10.1172/JCI8673; PARKER PJ, 1983, EUR J BIOCHEM, V130, P227; PARKER PJ, 1982, EUR J BIOCHEM, V124, P47, DOI 10.1111/j.1432-1033.1982.tb05904.x; PICTON C, 1982, FEBS LETT, V150, P191, DOI 10.1016/0014-5793(82)81332-X; POULTER L, 1988, EUR J BIOCHEM, V175, P497, DOI 10.1111/j.1432-1033.1988.tb14222.x; Roach P. J., 1986, ENZYMES, VXVII, P499; Roach Peter J., 1998, Journal of Basic and Clinical Physiology and Pharmacology, V9, P139; ROACH PJ, 1990, FASEB J, V4, P2961, DOI 10.1096/fasebj.4.12.2168324; Seoane J, 1996, J BIOL CHEM, V271, P23756, DOI 10.1074/jbc.271.39.23756; SKURAT AV, 1994, J BIOL CHEM, V269, P25534; Skurat AV, 1996, BIOCHEM J, V313, P45, DOI 10.1042/bj3130045; SKURAT AV, 1995, J BIOL CHEM, V270, P12491, DOI 10.1074/jbc.270.21.12491; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; VALERA A, 1994, EUR J BIOCHEM, V222, P533, DOI 10.1111/j.1432-1033.1994.tb18895.x; VillarPalasi C, 1997, FASEB J, V11, P544, DOI 10.1096/fasebj.11.7.9212078; Wilson WA, 2005, P NATL ACAD SCI USA, V102, P16596, DOI 10.1073/pnas.0508481102; Zvibel I, 1998, DIFFERENTIATION, V63, P215, DOI 10.1111/j.1432-0436.1998.00215.x	43	43	44	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6370	6378		10.1074/jbc.M808576200	http://dx.doi.org/10.1074/jbc.M808576200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19124463	hybrid			2022-12-25	WOS:000263742700040
J	De Martino, I; Visone, R; Fedele, M; Petrocca, F; Palmieri, D; Hoyos, JM; Forzati, F; Croce, CM; Fusco, A				De Martino, I.; Visone, R.; Fedele, M.; Petrocca, F.; Palmieri, D.; Hoyos, J. M.; Forzati, F.; Croce, C. M.; Fusco, A.			Regulation of microRNA expression by HMGA1 proteins	ONCOGENE			English	Article						HMGA1; microRNA; MEF; ATXN1; STC1; HMGA2	GROUP-A PROTEINS; GENE-EXPRESSION; STANNIOCALCIN-1 EXPRESSION; NEOPLASTIC TRANSFORMATION; MESSENGER-RNA; HUMAN CANCER; CELL LINES; C GENES; HMGI(Y); ATAXIN-1	The High Mobility Group proteins HMGA1 are nuclear architectural factors that play a critical role in a wide range of biological processes. Since recent studies have identified the microRNAs (miRNAs) as important regulators of gene expression, modulating critical cellular functions such as proliferation, apoptosis and differentiation, the aim of our work was to identify the miRNAs that are physiologically regulated by HMGA1 proteins. To this purpose, we have analysed the miRNA expression profile of mouse embryonic fibroblasts (MEFs) carrying two, one or no Hmga1 functional alleles using a microarray (miRNA microarray). By this approach, we found a miRNA expression profile that differentiates Hmga1-null MEFs from the wild-type ones. In particular, a significant decrease in miR-196a-2, miR-101b, miR-331 and miR-29a was detected in homozygous Hmga1-knockout MEFs in comparison with wild-type cells. Consistently, these miRNAs are downregulated in most of the analysed tissues of Hmga1-null mice in comparison with the wild-type mice. ChIP assay shows that HMGA1 is able to bind regions upstream of these miRNAs. Moreover, we identified the HMGA2 gene product as a putative target of miR-196a-2, suggesting that HMGA1 proteins are able to downregulate the expression of the other member of the HMGA family through the regulation of the miR-196a-2 expression. Finally, ATXN1 and STC1 gene products have been identified as targets of miR-101b. Therefore, it is reasonable to hypothesize that HMGA1 proteins are involved in several functions by regulating miRNA expression.	[De Martino, I.; Visone, R.; Fedele, M.; Palmieri, D.; Hoyos, J. M.; Forzati, F.; Fusco, A.] Univ Naples Federico II, Ist Endocrinol & Oncol Sperimentale, CNR, Dipartimento Biol Patol Cellulare Mol,Fac Med & C, I-80131 Naples, Italy; [De Martino, I.; Fedele, M.; Fusco, A.] European Sch Mol Med Naples Site, Naples, Italy; [De Martino, I.; Fedele, M.; Fusco, A.] CEINGE, NOGEC, Naples, Italy; [De Martino, I.; Visone, R.; Petrocca, F.; Croce, C. M.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; CEINGE Biotecnologie Avanzate; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	De Martino, I (corresponding author), Univ Naples Federico II, Ist Endocrinol & Oncol Sperimentale, CNR Gaetano Salvatore, Via Pansini 5, I-80131 Naples, Italy.	afusco@napoli.com	Fedele, Monica/C-1417-2015; visone, rosa/K-7910-2016; Young, Richard A/F-6495-2012	Fedele, Monica/0000-0002-9171-1312; Young, Richard A/0000-0001-8855-8647; Palmieri, Dario/0000-0002-0797-4268; Martinez Hoyos, Josefina/0000-0002-6909-8259; Fusco, Alfredo/0000-0003-3332-5197; VISONE, Rosa/0000-0002-4993-0220	Associazione Italiana Ricerca sul Cancro (AIRC); Ministero dell'Universita e della Ricerca Scientifica e Tecnologica (MIUR); NOGEC-Naples Oncogenomic Center; Associazione Partenopea per le Ricerche Oncologiche (APRO)	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Universita e della Ricerca Scientifica e Tecnologica (MIUR)(Ministry of Education, Universities and Research (MIUR)); NOGEC-Naples Oncogenomic Center; Associazione Partenopea per le Ricerche Oncologiche (APRO)	We thank Professor Stefano Volinia for miRNA microarray data analysis. This work was supported by grants from the Associazione Italiana Ricerca sul Cancro (AIRC), and the Ministero dell'Universita e della Ricerca Scientifica e Tecnologica (MIUR). This work was supported from NOGEC-Naples Oncogenomic Center. We thank the Associazione Partenopea per le Ricerche Oncologiche (APRO) for its support.	ASHAR HR, 1995, CELL, V82, P57; Baldassarre G, 2001, P NATL ACAD SCI USA, V98, P7970, DOI 10.1073/pnas.141224998; Battista S, 1999, CANCER RES, V59, P4793; BERLINGIERI MT, 1995, MOL CELL BIOL, V15, P1545; Chang ACM, 2003, ENDOCR-RELAT CANCER, V10, P359, DOI 10.1677/erc.0.0100359; CHANG ACM, 1995, MOL CELL ENDOCRINOL, V112, P241, DOI 10.1016/0303-7207(95)03601-3; Chiappetta G, 1996, ONCOGENE, V13, P2439; De Martino I, 2007, ENDOCR-RELAT CANCER, V14, P875, DOI 10.1677/ERC-07-0036; Eisenhofer G, 2004, ENDOCR-RELAT CANCER, V11, P897, DOI 10.1677/erc.1.00838; Fedele M, 2006, CANCER RES, V66, P2536, DOI 10.1158/0008-5472.CAN-05-1889; Fedele M, 2005, ONCOGENE, V24, P3427, DOI 10.1038/sj.onc.1208501; Fedele M, 1998, ONCOGENE, V17, P413, DOI 10.1038/sj.onc.1201952; Fedele M, 2002, ONCOGENE, V21, P3190, DOI 10.1038/sj.onc.1205428; Fedele M, 2001, CARCINOGENESIS, V22, P1583, DOI 10.1093/carcin/22.10.1583; Foti D, 2005, NAT MED, V11, P765, DOI 10.1038/nm1254; Fujiwara Y, 2000, INT J ONCOL, V16, P799; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gerritsen ME, 2002, PHYSIOL GENOMICS, V10, P13, DOI 10.1152/physiolgenomics.00035.2002; Giannini G, 1999, CANCER RES, V59, P2484; Giannini G, 2000, BRIT J CANCER, V83, P1503, DOI 10.1054/bjoc.2000.1494; Hebert C, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-5; Holmes DIR, 2008, CELL SIGNAL, V20, P569, DOI 10.1016/j.cellsig.2007.11.009; Hoyos JM, 2004, CANCER RES, V64, P5728, DOI 10.1158/0008-5472.CAN-04-1410; Irwin S, 2005, J CELL SCI, V118, P233, DOI 10.1242/jcs.01611; Ishibashi K, 2002, AM J PHYSIOL-RENAL, V282, pF367, DOI 10.1152/ajprenal.00364.2000; Ismail RS, 2000, CANCER RES, V60, P6744; Jellinek DA, 2000, BIOCHEM J, V350, P453, DOI 10.1042/0264-6021:3500453; JOHNSON KR, 1989, MOL CELL BIOL, V9, P2114, DOI 10.1128/MCB.9.5.2114; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Lai KP, 2007, BIOCHEM BIOPH RES CO, V356, P968, DOI 10.1016/j.bbrc.2007.03.074; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lee Y, 2008, NAT NEUROSCI, V11, P1137, DOI 10.1038/nn.2183; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; MANFIOLETTI G, 1991, NUCLEIC ACIDS RES, V19, P6793, DOI 10.1093/nar/19.24.6793; McCudden CR, 2004, MOL CELL ENDOCRINOL, V213, P167, DOI 10.1016/j.mce.2003.10.042; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Melillo RM, 2001, MOL CELL BIOL, V21, P2485, DOI 10.1128/MCB.21.7.2485-2495.2001; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Negrini M, 2007, J CELL SCI, V120, P1833, DOI 10.1242/jcs.03450; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Okabe H, 2001, CANCER RES, V61, P2129; Olsen HS, 1996, P NATL ACAD SCI USA, V93, P1792, DOI 10.1073/pnas.93.5.1792; REEVES R, 1990, J BIOL CHEM, V265, P8573; Scala S, 2000, P NATL ACAD SCI USA, V97, P4256, DOI 10.1073/pnas.070029997; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; SCHOENMAKERS EFPM, 1995, NAT GENET, V10, P436, DOI 10.1038/ng0895-436; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Tallini G, 1999, ADV ANAT PATHOL, V6, P237, DOI 10.1097/00125480-199909000-00001; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Tsai CC, 2004, P NATL ACAD SCI USA, V101, P4047, DOI 10.1073/pnas.0400615101; Varghese R, 1998, ENDOCRINOLOGY, V139, P4714, DOI 10.1210/en.139.11.4714; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; WAGNER GF, 1986, GEN COMP ENDOCR, V63, P481, DOI 10.1016/0016-6480(86)90149-8; Wascher RA, 2003, CLIN CANCER RES, V9, P1427; Watanabe T, 2002, AM J PATHOL, V161, P249, DOI 10.1016/S0002-9440(10)64176-4; Wong CKC, 2002, J ENDOCRINOL, V173, P199, DOI 10.1677/joe.0.1730199; Yeung HY, 2005, ENDOCRINOLOGY, V146, P4951, DOI 10.1210/en.2005-0365; Yue S, 2001, HUM MOL GENET, V10, P25, DOI 10.1093/hmg/10.1.25; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	64	42	42	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	11					1432	1442		10.1038/onc.2008.495	http://dx.doi.org/10.1038/onc.2008.495			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	421JE	19169275				2022-12-25	WOS:000264354400004
J	Ho, VM; Schaffer, BE; Karnezis, AN; Park, KS; Sage, J				Ho, V. M.; Schaffer, B. E.; Karnezis, A. N.; Park, K. S.; Sage, J.			The retinoblastoma gene Rb and its family member p130 suppress lung adenocarcinoma induced by oncogenic K-Ras	ONCOGENE			English	Article						K-Ras; Rb; p130; p107; lung adenocarcinoma; mouse model	TUMOR-SUPPRESSOR; N-RAS; CANCER; PRB; PROTEIN; P107; DIFFERENTIATION; MOUSE; TUMORIGENESIS; PROGRESSION	Mutations of the retinoblastoma tumor suppressor gene RB are frequently observed in human cancers, but rarely in non-small cell lung carcinomas (NSCLCs). Emerging evidence also suggests that the RB-related gene p130 is inactivated in a subset of human NSCLCs. To directly test the specific tumor suppressor roles of RB and p130 in NSCLC, we crossed Rb and p130 conditional mutant mice to mice carrying a conditional oncogenic K-Ras allele. In this model, controlled oncogenic K-Ras activation leads to the development of adenocarcinoma, a major subtype of NSCLC. We found that loss of p130 accelerated the death of mice, providing direct evidence in vivo that p130 is a tumor suppressor gene, albeit a weak one in this context. Loss of Rb increased the efficiency of lung cancer initiation and resulted in the development of high-grade adenocarcinomas and rapid death. Thus, despite the low frequency of RB mutations in human NSCLCs and reports that K-Ras activation and loss of RB function are rarely found in the same human tumors, loss of Rb clearly cooperates with activation of oncogenic K-Ras in lung adenocarcinoma development in mice.	[Ho, V. M.; Schaffer, B. E.; Park, K. S.; Sage, J.] Stanford Med Sch, Dept Pediat & Genet, Stanford, CA 94305 USA; [Karnezis, A. N.] Univ Calif San Francisco, Canc Res Inst, Dept Pathol, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Sage, J (corresponding author), Stanford Med Sch, Dept Pediat & Genet, 269 Campus Dr,CCSR1215A, Stanford, CA 94305 USA.	julien.sage@stanford.edu			NATIONAL CANCER INSTITUTE [R01CA114102] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA114102-02, R01 CA114102] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Caterina C, 2005, ONCOGENE, V24, P5821, DOI 10.1038/sj.onc.1208880; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Classon M, 2000, P NATL ACAD SCI USA, V97, P10820, DOI 10.1073/pnas.190343497; Claudio PP, 2000, CLIN CANCER RES, V6, P754; Cobrinik D, 1996, GENE DEV, V10, P1633, DOI 10.1101/gad.10.13.1633; Dannenberg Jan-Hermen, 2006, V42, P183, DOI 10.1007/002; Dannenberg JH, 2004, GENE DEV, V18, P2952, DOI 10.1101/gad.322004; DeGregori J, 2006, MOL CELL BIOL, V26, P1165, DOI 10.1128/MCB.26.4.1165-1169.2006; Geng Y, 1996, ONCOGENE, V12, P1173; Grasemann C, 2005, ONCOGENE, V24, P6441, DOI 10.1038/sj.onc.1208792; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; Kaye FJ, 2002, ONCOGENE, V21, P6908, DOI 10.1038/sj.onc.1205834; Lara MF, 2008, MOL CARCINOGEN, V47, P105, DOI 10.1002/mc.20367; Lee KY, 1999, MOL CELL BIOL, V19, P7724; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; Mulligan GJ, 1998, MOL CELL BIOL, V18, P206, DOI 10.1128/MCB.18.1.206; Olsson AY, 2007, ONCOGENE, V26, P1028, DOI 10.1038/sj.onc.1209854; RODENHUIS S, 1990, AM REV RESPIR DIS, V142, pS27, DOI 10.1164/ajrccm/142.6_Pt_2.S27; Ruiz S, 2005, CANCER RES, V65, P9678, DOI 10.1158/0008-5472.CAN-05-1853; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Suzuki T, 2006, EMBO J, V25, P3422, DOI 10.1038/sj.emboj.7601215; Takahashi C, 2006, NAT GENET, V38, P118, DOI 10.1038/ng1703; Takahashi C, 2004, MOL CELL BIOL, V24, P10406, DOI 10.1128/MCB.24.23.10406-10415.2004; Takahashi C, 2003, MOL CELL BIOL, V23, P5256, DOI 10.1128/MCB.23.15.5256-5268.2003; Takahashi C, 2006, CANCER RES, V66, P9345, DOI 10.1158/0008-5472.CAN-06-1250; Tedesco D, 2002, GENE DEV, V16, P2946, DOI 10.1101/gad.1011202; TRAVIS WD, 1995, CANCER-AM CANCER SOC, V75, P191, DOI 10.1002/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Wikenheiser-Brokamp KA, 2006, CELL MOL LIFE SCI, V63, P767, DOI 10.1007/s00018-005-5487-3; Wikenheiser-Brokamp KA, 2004, DEVELOPMENT, V131, P4299, DOI 10.1242/dev.01232; Williams JP, 2006, MOL CELL BIOL, V26, P1170, DOI 10.1128/MCB.26.4.1170-1182.2006; Wistuba II, 2001, SEMIN ONCOL, V28, P3, DOI 10.1053/sonc.2001.25738	37	39	41	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	10					1393	1399		10.1038/onc.2008.491	http://dx.doi.org/10.1038/onc.2008.491			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	417ZC	19151761	Green Accepted			2022-12-25	WOS:000264116000012
J	Nagarajan, P; Parikh, N; Garrett-Sinha, LA; Sinha, S				Nagarajan, Priyadharsini; Parikh, Neha; Garrett-Sinha, Lee Ann; Sinha, Satrajit			Ets1 Induces Dysplastic Changes When Expressed in Terminally-Differentiating Squamous Epidermal Cells	PLOS ONE			English	Article								Background: Ets1 is an oncogene that functions as a transcription factor and regulates the activity of many genes potentially important for tumor initiation and progression. Interestingly, the Ets1 oncogene is over-expressed in many human squamous cell cancers and over-expression is highly correlated with invasion and metastasis. Thus, Ets1 is believed to mainly play a role in later stages of the oncogenic process, but not early events. Methodology/Principal Findings: To better define the role of Ets1 in squamous cell carcinogenesis, we generated a transgenic mouse model in which expression of the Ets1 oncogene could be temporally and spatially regulated. Upon Ets1 induction in differentiating cells of stratified squamous epithelium, these mice exhibited dramatic changes in epithelial organization including increased proliferation and blocked terminal differentiation. The phenotype was completely reversed when Ets1 expression was suppressed. In mice where Ets1 expression was re-induced at a later age, the phenotype was more localized and the lesions that developed were more invasive. Many potential Ets1 targets were upregulated in the skin of these mice with the most dramatic being the metalloprotease MMP13, which we demonstrate to be a direct transcriptional target of Ets1. Conclusions/Significance: Collectively, our data reveal that upregulation of Ets1 can be an early event that promotes pre-neoplastic changes in epidermal tissues via its regulation of key genes driving growth and invasion. Thus, the Ets1 oncogene may be important for oncogenic processes in both early and late stages of tumor development.	[Nagarajan, Priyadharsini; Parikh, Neha; Garrett-Sinha, Lee Ann; Sinha, Satrajit] SUNY Buffalo, Dept Biochem, Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Nagarajan, P (corresponding author), SUNY Buffalo, Dept Biochem, Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14214 USA.	leesinha@buffalo.edu; ssinha2@buffalo.edu	Nagarajan, Priyadharsini/C-4786-2014; Garrett-Sinha, Lee Ann/K-5911-2019	Nagarajan, Priyadharsini/0000-0002-5346-2669; Garrett-Sinha, Lee Ann/0000-0001-7806-4352	American Cancer Society; National Institutes of Dental and Craniofacial Research	American Cancer Society(American Cancer Society); National Institutes of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	These studies were supported by grants from the American Cancer Society and the National Institutes of Dental and Craniofacial Research. Neither funder was involved in design or conduct of the study nor in data collection and analysis or manuscript preparation/review/approval.	Akgul B, 2006, EXP DERMATOL, V15, P35, DOI 10.1111/j.0906-6705.2005.00387.x; Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Baillat D, 2002, J BIOL CHEM, V277, P29386, DOI 10.1074/jbc.M200088200; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Bull JJ, 2005, BRIT J DERMATOL, V152, P1125, DOI 10.1111/j.1365-2133.2005.06458.x; Cirillo N, 2007, ORAL DIS, V13, P341, DOI 10.1111/j.1601-0825.2006.01287.x; COFFER P, 1994, ONCOGENE, V9, P911; DARMIENTO J, 1995, MOL CELL BIOL, V15, P5732; Davies G, 2001, CLIN CANCER RES, V7, P3289; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Dunne AA, 2003, ANTICANCER RES, V23, P2233; Endo K, 2006, HUM PATHOL, V37, P1111, DOI 10.1016/j.humpath.2006.03.020; Gu LB, 2004, J BIOL CHEM, V279, P52141, DOI 10.1074/jbc.M407915200; Ha HY, 2001, CANCER RES, V61, P984; Hartenstein B, 2006, J INVEST DERMATOL, V126, P486, DOI 10.1038/sj.jid.5700084; HORVATH B, 2005, HEAD NECK; Hussein MR, 2005, J CUTAN PATHOL, V32, P191, DOI 10.1111/j.0303-6987.2005.00281.x; Impola U, 2005, BRIT J DERMATOL, V152, P720, DOI 10.1111/j.1365-2133.2005.06447.x; Jaubert J, 2004, J INVEST DERMATOL, V123, P313, DOI 10.1111/j.0022-202X.2004.23203.x; Jin XL, 2006, CANCER SCI, V97, P1327, DOI 10.1111/j.1349-7006.2006.00328.x; Johansson N, 1997, AM J PATHOL, V151, P499; JOHN SA, 2007, J BIOL CHEM; Johnson R, 1996, MOL CELL BIOL, V16, P4504; Kahle A, 2005, GENE, V344, P53, DOI 10.1016/j.gene.2004.10.020; KAVURMA MM, 2002, J BIOL CHEM; Keehn CA, 2004, J CUTAN PATHOL, V31, P8, DOI 10.1046/j.0303-6987.2004.0158.x; Kim E, 2003, ONCOGENE, V22, P7716, DOI 10.1038/sj.onc.1207155; Kuramoto N, 2002, J CLIN INVEST, V109, P243, DOI 10.1172/JCI200213563; Lai HC, 2005, GYNECOL ONCOL, V96, P314, DOI 10.1016/j.ygyno.2004.09.065; Lee KH, 2007, EUR SURG RES, V39, P208, DOI 10.1159/000101452; Lee S, 2008, BRAIN RES, V1207, P19, DOI 10.1016/j.brainres.2008.02.016; Leeman MF, 2002, CRIT REV BIOCHEM MOL, V37, P149, DOI 10.1080/10409230290771483; Li RZ, 2000, ONCOGENE, V19, P745, DOI 10.1038/sj.onc.1203385; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; Lo Muzio L, 2005, HUM PATHOL, V36, P187, DOI 10.1016/j.humpath.2004.12.003; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; Luukkaa M, 2006, HEAD NECK-J SCI SPEC, V28, P225, DOI 10.1002/hed.20322; Magnusdottir E, 2007, P NATL ACAD SCI USA, V104, P14988, DOI 10.1073/pnas.0707323104; MAROULAKOU IG, 1994, ONCOGENE, V9, P1551; Mukherjee T, 2003, J CANCER RES CLIN, V129, P430, DOI 10.1007/s00432-003-0457-3; NAKAZAWA Y, 2007, ONCOGENE; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Pande P, 1999, J PATHOL, V189, P40, DOI 10.1002/(SICI)1096-9896(199909)189:1<40::AID-PATH405>3.0.CO;2-#; Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Perez-Losada J, 2003, NAT REV CANCER, V3, P434, DOI 10.1038/nrc1095; Pons M, 2006, Clin Transl Oncol, V8, P466, DOI 10.1007/s12094-006-0046-4; Quinn CO, 2000, J MOL ENDOCRINOL, V25, P73, DOI 10.1677/jme.0.0250073; Reis JS, 2002, J CUTAN PATHOL, V29, P517, DOI 10.1034/j.1600-0560.2002.290902.x; Reisdorff J, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015617.39974.FB; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; ROUSSEL MF, 1994, ONCOGENE, V9, P405; Rudolph-Owen LA, 1998, CANCER RES, V58, P5500; Saeki H, 2000, CANCER, V89, P1670, DOI 10.1002/1097-0142(20001015)89:8<1670::AID-CNCR4>3.0.CO;2-J; SAEZ E, 1995, CELL, V82, P721, DOI 10.1016/0092-8674(95)90469-7; SALNIKOW K, 2008, CARCINOGENESIS; Sampath J, 2001, J BIOL CHEM, V276, P39359, DOI 10.1074/jbc.M103429200; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Seth A, 1999, CELL DEATH DIFFER, V6, P902, DOI 10.1038/sj.cdd.4400567; Sternlicht MD, 2000, ONCOGENE, V19, P1102, DOI 10.1038/sj.onc.1203347; Symowicz J, 2007, CANCER RES, V67, P2030, DOI 10.1158/0008-5472.CAN-06-2808; Vairaktaris E, 2007, IN VIVO, V21, P615; Vairaktaris E, 2007, J CANCER RES CLIN, V133, P227, DOI 10.1007/s00432-006-0161-1; Venanzoni MC, 1996, ONCOGENE, V12, P1199; Vitale-Cross L, 2004, CANCER RES, V64, P8804, DOI 10.1158/0008-5472.CAN-04-2623; WASYLYK C, 1991, EMBO J, V10, P1127, DOI 10.1002/j.1460-2075.1991.tb08053.x; Watabe T, 1998, INT J CANCER, V77, P128, DOI 10.1002/(SICI)1097-0215(19980703)77:1<128::AID-IJC20>3.0.CO;2-9; Weiske J, 2001, J BIOL CHEM, V276, P41175, DOI 10.1074/jbc.M105769200; Westermarck J, 1997, ONCOGENE, V14, P2651, DOI 10.1038/sj.onc.1201111; Wu NJ, 2002, MATRIX BIOL, V21, P149, DOI 10.1016/S0945-053X(01)00192-5; Xu DK, 2002, EMBO J, V21, P4081, DOI 10.1093/emboj/cdf413; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Zhang CL, 2003, J BIOL CHEM, V278, P27903, DOI 10.1074/jbc.M304328200	75	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4179	10.1371/journal.pone.0004179	http://dx.doi.org/10.1371/journal.pone.0004179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142229	Green Published, Green Submitted, gold			2022-12-25	WOS:000265479700004
J	Courtney, HS; Ofek, I; Penfound, T; Nizet, V; Pence, MA; Kreikemeyer, B; Podbielbski, A; Hasty, DL; Dale, JB				Courtney, Harry S.; Ofek, Itzhak; Penfound, Thomas; Nizet, Victor; Pence, Morgan A.; Kreikemeyer, Bernd; Podbielbski, Andreas; Hasty, David L.; Dale, James B.			Relationship between Expression of the Family of M Proteins and Lipoteichoic Acid to Hydrophobicity and Biofilm Formation in Streptococcus pyogenes	PLOS ONE			English	Article								Background: Hydrophobicity is an important attribute of bacteria that contributes to adhesion and biofilm formation. Hydrophobicity of Streptococcus pyogenes is primarily due to lipoteichoic acid (LTA) on the streptococcal surface but the mechanism(s) whereby LTA is retained on the surface is poorly understood. In this study, we sought to determine whether members of the M protein family consisting of Emm (M protein), Mrp (M-related protein), Enn (an M-like protein), and the streptococcal protective antigen (Spa) are involved in anchoring LTA in a manner that contributes to hydrophobicity of the streptococci and its ability to form biofilms. Methodology/Principal Findings: Isogenic mutants defective in expression of emm, mrp, enn, and/or spa genes of eight different serotypes and their parental strains were tested for differences in LTA bound to surface proteins, LTA released into the culture media, and membrane-bound LTA. The effect of these mutations on the ability of streptococci to form a hydrophobic surface and to generate biofilms was also investigated. A recombinant strain overexpressing Emm1 was also engineered and similarly tested. The serotypes tested ranged from those that express only a single M protein gene to those that express two or three members of the M protein family. Overexpression of Emm1 led to enhanced hydrophobicity and biofilm formation. Inactivation of emm in those serotypes expressing only a single emm gene reduced biofilm formation, and protein-bound LTA on the surface, but did not alter the levels of membrane-bound LTA. The results were more varied in those serotypes that express two to three members of the M protein family. Conclusions/Significance: Our findings suggest that the formation of complexes with members of the M protein family is a common mechanism for anchoring LTA on the surface in a manner that contributes to hydrophobicity and to biofilm formation in S. pyogenes, but these activities in some serotypes are dependent on a trypsin-sensitive protein(s) that remains to be identified. The need for interactions between LTA and M proteins may impose functional constraints that limit variations in the sequence of the M proteins, major virulence factors of S. pyogenes.	[Ofek, Itzhak; Penfound, Thomas; Dale, James B.] Univ Tennessee, Dept Med, Memphis, TN 38104 USA; [Hasty, David L.] Univ Tennessee, Dept Anat & Neurobiol, Knoxville, TN 37996 USA; [Courtney, Harry S.; Hasty, David L.; Dale, James B.] Univ Tennessee, Dept Mol Sci, Knoxville, TN 37996 USA; [Dale, James B.] Univ Tennessee, Dept Vet Affairs Med Ctr, Knoxville, TN 37996 USA; [Ofek, Itzhak] Tel Aviv Univ, Sackler Fac Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel; [Nizet, Victor; Pence, Morgan A.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Kreikemeyer, Bernd; Podbielbski, Andreas] Univ Rostock Hosp, Dept Med Microbiol & Hosp Hyg, D-2500 Rostock, Germany	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; Tel Aviv University; Sackler Faculty of Medicine; University of California System; University of California San Diego; University of Rostock	Courtney, HS (corresponding author), Univ Tennessee, Dept Med, Memphis, TN 38104 USA.	hcourtney@utmem.edu	Pence, Morgan A./N-1620-2019; Nizet, Victor/AAF-3190-2019; Ofek, Itzhak/L-4616-2019	Pence, Morgan A./0000-0003-0239-0228; Kreikemeyer, Bernd/0000-0001-9527-5098; Nizet, Victor/0000-0003-3847-0422; Dale, James/0000-0001-9860-9233	US Department of Veterans Affairs; US Public Health Service [AI-10085]; BMBF; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI010085, R01AI077780, R37AI010085, R55AI010085] Funding Source: NIH RePORTER	US Department of Veterans Affairs(US Department of Veterans Affairs); US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); BMBF(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by research funds from the US Department of Veterans Affairs (HSC, DLH) and from the US Public Health Service Grant AI-10085 (JBD). The work in the labs of Bernd Kreikemeyer and Andreas Podbielski was funded by the BMBF "ERANet Pathogenomics" program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldassarri L, 2006, J CLIN MICROBIOL, V44, P2721, DOI 10.1128/JCM.00512-06; Bessen DE, 1996, J INFECT DIS, V173, P896, DOI 10.1093/infdis/173.4.896; Bessen DE, 1997, GENE, V196, P75, DOI 10.1016/S0378-1119(97)00201-1; Carlsson F, 2006, NATURE, V442, P943, DOI 10.1038/nature05021; Chaffin DO, 1998, GENE, V219, P91, DOI 10.1016/S0378-1119(98)00396-5; Cho KH, 2005, MOL MICROBIOL, V57, P1545, DOI 10.1111/j.1365-2958.2005.04786.x; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Courtney H. S., 1990, MICROBIAL CELL SURFA, P361; Courtney HS, 2006, MOL MICROBIOL, V59, P936, DOI 10.1111/j.1365-2958.2005.04977.x; Courtney HS, 2002, ANN MED, V34, P77, DOI 10.1080/07853890252953464; COURTNEY HS, 1983, J BACTERIOL, V153, P763, DOI 10.1128/JB.153.2.763-770.1983; COURTNEY HS, 1994, INFECT IMMUN, V62, P4868, DOI 10.1128/IAI.62.11.4868-4873.1994; COURTNEY HS, 2004, BACTERIAL INVASION H, P239; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dale JB, 1999, J CLIN INVEST, V103, P1261, DOI 10.1172/JCI5118; Doyle R. J., 1990, MICROBIAL CELL SURFA; Eran Y, 2007, MOL MICROBIOL, V63, P1209, DOI 10.1111/j.1365-2958.2007.05581.x; Fedtke I, 2007, MOL MICROBIOL, V65, P1078, DOI 10.1111/j.1365-2958.2007.05854.x; FISCHER W, 1988, ADV MICROB PHYSIOL, V29, P233, DOI 10.1016/S0065-2911(08)60349-5; Frick IM, 2000, MOL MICROBIOL, V37, P1232, DOI 10.1046/j.1365-2958.2000.02084.x; Ginsburg I, 2002, LANCET INFECT DIS, V2, P171, DOI 10.1016/S1473-3099(02)00226-8; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; Hasty DL, 2006, J IMMUNOL, V176, P5567, DOI 10.4049/jimmunol.176.9.5567; HASTY DL, 1992, INFECT IMMUN, V60, P2147, DOI 10.1128/IAI.60.6.2147-2152.1992; HOGG SD, 1993, ANTON LEEUW INT J G, V63, P29, DOI 10.1007/BF00871728; Jeng A, 2003, J BACTERIOL, V185, P1208, DOI 10.1128/JB.185.4.1208-1217.2003; Kalia A, 2004, J BACTERIOL, V186, P110, DOI 10.1128/JB.186.1.110-121.2004; Kansal RG, 2000, INFECT IMMUN, V68, P6362, DOI 10.1128/IAI.68.11.6362-6369.2000; KRAUS W, 1987, J IMMUNOL, V139, P3084; LANCEFIELD RC, 1928, J EXP MED, V47, P9; Lembke C, 2006, APPL ENVIRON MICROB, V72, P2864, DOI 10.1128/AEM.72.4.2864-2875.2006; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; McLellan DGJ, 2001, INFECT IMMUN, V69, P2943, DOI 10.1128/IAI.69.5.2943-2949.2001; MIORNER H, 1983, INFECT IMMUN, V39, P336; Morath S, 2002, J EXP MED, V195, P1635, DOI 10.1084/jem.20020322; Morath S, 2002, INFECT IMMUN, V70, P938, DOI 10.1128/IAI.70.2.938-944.2002; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; NORGREN M, 1989, INFECT IMMUN, V57, P3846, DOI 10.1128/IAI.57.12.3846-3850.1989; OFEK I, 1982, J BACTERIOL, V149, P426, DOI 10.1128/JB.149.2.426-433.1982; OFEK I, 1975, J EXP MED, V141, P990, DOI 10.1084/jem.141.5.990; OFEK I, 1983, J BACTERIOL, V154, P139, DOI 10.1128/JB.154.1.139-145.1983; Perez-Caballero D, 2004, J IMMUNOL, V173, P6899, DOI 10.4049/jimmunol.173.11.6899; PODBIELSKI A, 1995, INFECT IMMUN, V63, P9, DOI 10.1128/IAI.63.1.9-20.1995; Podbielski A, 1996, MOL MICROBIOL, V19, P429, DOI 10.1046/j.1365-2958.1996.377910.x; SLADE HD, 1957, J GEN PHYSIOL, V41, P63, DOI 10.1085/jgp.41.1.63	46	89	90	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2009	4	1							e4166	10.1371/journal.pone.0004166	http://dx.doi.org/10.1371/journal.pone.0004166			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GB	19132104	Green Submitted, Green Published, gold			2022-12-25	WOS:000265473700005
J	Stromberg, PE; Woolsey, CA; Clark, AT; Clark, JA; Turnbull, IR; McConnell, KW; Chang, KC; Chung, CS; Ayala, A; Buchman, TG; Hotchkiss, RS; Coopersmith, CM				Stromberg, Paul E.; Woolsey, Cheryl A.; Clark, Andrew T.; Clark, Jessica A.; Turnbull, Isaiah R.; McConnell, Kevin W.; Chang, Katherine C.; Chung, Chun-Shiang; Ayala, Alfred; Buchman, Timothy G.; Hotchkiss, Richard S.; Coopersmith, Craig M.			CD4+ lymphocytes control gut epithelial apoptosis and mediate survival in sepsis	FASEB JOURNAL			English	Article						crosstalk; intestine; Bcl-2; cell death; cecal ligation and puncture	HUMAN LEUKEMIA-CELLS; IMPROVES SURVIVAL; T-CELLS; INTESTINAL EPITHELIUM; CECAL LIGATION; BCL-2; EXPRESSION; MOLECULES; INJURY; OVEREXPRESSION	Lymphocytes help determine whether gut epithelial cells proliferate or differentiate but are not known to affect whether they live or die. Here, we report that lymphocytes play a controlling role in mediating gut epithelial apoptosis in sepsis but not under basal conditions. Gut epithelial apoptosis is similar in unmanipulated Rag-1(-/-) and wild-type (WT) mice. However, Rag-1(-/-) animals have a 5-fold augmentation in gut epithelial apoptosis following cecal ligation and puncture (CLP) compared to septic WT mice. Reconstitution of lymphocytes in Rag-1(-/-) mice via adoptive transfer decreases intestinal apoptosis to levels seen in WT animals. Subset analysis indicates that CD4(+) but not CD8(+), gamma delta, or B cells are responsible for the antiapoptotic effect of lymphocytes on the gut epithelium. Gut-specific overexpression of Bcl-2 in transgenic mice decreases mortality following CLP. This survival benefit is lymphocyte dependent since gut-specific overexpression of Bcl-2 fails to alter survival when the transgene is overexpressed in Rag-1(-/-) mice. Further, adoptively transferring lymphocytes to Rag-1(-/-) mice that simultaneously overexpress gut-specific Bcl-2 results in improved mortality following sepsis. Thus, sepsis unmasks CD4(+) lymphocyte control of gut apoptosis that is not present under homeostatic conditions, which acts as a key determinant of both cellular survival and host mortality.-Stromberg, P. E., Woolsey, C. A., Clark, A. T., Clark, J. A., Turnbull, I. R., McConnell, K. W., Chang, K. C., Chung, C.-S., Ayala, A., Buchman, T. G., Hotchkiss, R. S., Coopersmith, C. M. CD4(+) lymphocytes control gut epithelial apoptosis and mediate survival in sepsis. FASEB J. 23, 1817-1825 (2009)	[Stromberg, Paul E.; Woolsey, Cheryl A.; Clark, Andrew T.; Clark, Jessica A.; Turnbull, Isaiah R.; McConnell, Kevin W.; Buchman, Timothy G.; Coopersmith, Craig M.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Chang, Katherine C.; Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Chung, Chun-Shiang; Ayala, Alfred] Brown Univ, Sch Med, Providence, RI 02912 USA; [Chung, Chun-Shiang; Ayala, Alfred] Rhode Isl Hosp, Dept Surg, Providence, RI USA	Washington University (WUSTL); Washington University (WUSTL); Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Coopersmith, CM (corresponding author), Washington Univ, Sch Med, Dept Surg, 660 S Euclid Ave,Campus Box 8109, St Louis, MO 63110 USA.	coopersmithc@wustl.edu		Buchman, Timothy/0000-0001-7350-5921; Ayala, Alfred/0000-0002-5034-2995; Dominguez Rieg, Jessica/0000-0001-6190-7464	National Institutes of Health [GM072808, GM66202, GM008795, GM055194, GM044118, DK052574]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066202, R01GM044118, T32GM008795, R01GM055194, R01GM072808, R37GM044118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Washington University Digestive Diseases Research Morphology Core. This study was supported by funding from the National Institutes of Health (GM072808, GM66202, GM008795, GM055194, GM044118, DK052574).	Alverdy JC, 2003, CRIT CARE MED, V31, P598, DOI 10.1097/01.CCM.0000045576.55937.67; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; BAKER CC, 1983, SURGERY, V94, P331; Bilbault P, 2007, CRIT CARE MED, V35, P69, DOI 10.1097/01.CCM.0000251133.26979.F4; Caruso R, 2007, GASTROENTEROLOGY, V132, P166, DOI 10.1053/j.gastro.2006.09.053; Chen Jun, 2002, Mol Cancer Ther, V1, P961; Chen WJ, 2001, IMMUNITY, V14, P715, DOI 10.1016/S1074-7613(01)00147-9; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Coopersmith CM, 2003, CRIT CARE MED, V31, P1630, DOI 10.1097/01.CCM.0000055385.29232.11; Coopersmith CM, 2002, CRIT CARE MED, V30, P195, DOI 10.1097/00003246-200201000-00028; Coopersmith CM, 2002, JAMA-J AM MED ASSOC, V287, P1716, DOI 10.1001/jama.287.13.1716; Coopersmith CM, 1999, AM J PHYSIOL-GASTR L, V276, pG677, DOI 10.1152/ajpgi.1999.276.3.G677; Crimi E, 2006, FREE RADICAL RES, V40, P665, DOI 10.1080/10715760600669612; Dahan S, 2007, IMMUNOL REV, V215, P243, DOI 10.1111/j.1600-065X.2006.00484.x; Dasmahapatra G, 2006, MOL PHARMACOL, V69, P288, DOI 10.1124/mol.105.016154; De Freitas I, 2004, CHEST, V125, P2238, DOI 10.1378/chest.125.6.2238; De Maio A, 2005, SHOCK, V23, P11, DOI 10.1097/01.shk.0000144134.03598.c5; Enoh VT, 2008, SHOCK, V29, P56, DOI 10.1097/shk.0b013e318070c8b9; George NM, 2007, GENE DEV, V21, P1937, DOI 10.1101/gad.1553607; Halpern MD, 2006, BIOL NEONATE, V89, P227, DOI 10.1159/000090015; Hassoun HT, 2001, SHOCK, V15, P1, DOI 10.1097/00024382-200115010-00001; Hershberg RM, 2000, IMMUNOL TODAY, V21, P123, DOI 10.1016/S0167-5699(99)01575-3; Hershberg RM, 1998, J CLIN INVEST, V102, P792, DOI 10.1172/JCI3201; Hershberg RM, 1997, J CLIN INVEST, V100, P204, DOI 10.1172/JCI119514; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 1999, J IMMUNOL, V162, P4148; Hotchkiss RS, 1997, CRIT CARE MED, V25, P1298, DOI 10.1097/00003246-199708000-00015; Hotchkiss RS, 2003, P NATL ACAD SCI USA, V100, P6724, DOI 10.1073/pnas.1031788100; Iwata A, 2003, J IMMUNOL, V171, P3136, DOI 10.4049/jimmunol.171.6.3136; Kerneis S, 1997, SCIENCE, V277, P949, DOI 10.1126/science.277.5328.949; Kim JM, 1998, J CLIN INVEST, V102, P1815, DOI 10.1172/JCI2466; Martignoni A, 2008, SHOCK, V29, P591, DOI 10.1097/SHK.0b013e318157f427; MAYER L, 1991, GASTROENTEROLOGY, V100, P3, DOI 10.1016/0016-5085(91)90575-6; Nakazawa A, 2004, GASTROENTEROLOGY, V126, P1347, DOI 10.1053/j.gastro.2004.02.004; POWRIE F, 1995, IMMUNITY, V3, P171, DOI 10.1016/1074-7613(95)90086-1; Scumpia PO, 2006, J IMMUNOL, V177, P7943, DOI 10.4049/jimmunol.177.11.7943; Tang L, 2000, BIOCHEM PHARMACOL, V60, P1445, DOI 10.1016/S0006-2952(00)00463-9; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Vyas D, 2007, HISTOL HISTOPATHOL, V22, P623, DOI 10.14670/HH-22.623; Wisnoski N, 2007, SHOCK, V27, P251, DOI 10.1097/01.shk.0000239780.33398.e4; Zaborina O, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030035	42	33	35	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1817	1825		10.1096/fj.08-119024	http://dx.doi.org/10.1096/fj.08-119024			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19158156	Green Published			2022-12-25	WOS:000266652400022
J	Tippmann, F; Hundt, J; Schneider, A; Endres, K; Fahrenholz, F				Tippmann, Frank; Hundt, Jana; Schneider, Anja; Endres, Kristina; Fahrenholz, Falk			Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin	FASEB JOURNAL			English	Article						Alzheimer's disease; amyloid precursor protein; shedding; nuclear receptors; vitamin A	AMYLOID-PRECURSOR-PROTEIN; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; NEUROBLASTOMA-CELLS; VITAMIN-A; X-RECEPTOR; HIPPOCAMPAL-NEURONS; RESPONSE ELEMENT; BETA-PEPTIDE; EXPRESSION	Late-onset Alzheimer's disease is often connected with nutritional misbalance, such as enhanced cholesterol intake, deficiency in polyunsaturated fatty acids, or hypovitaminosis. The alpha-secretase ADAM10 has been found to be regulated by retinoic acid, the bioreactive metabolite of vitamin A. Here we show that retinoids induce gene expression of ADAM10 and alpha-secretase activity by nonpermissive retinoid acid receptor/retinoid X receptor (RAR/RXR) heterodimers, whereby alpha- and beta-isotypes of RAR play a major role. However, ligands of other RXR binding partners, such as the vitamin D receptor, do not stimulate alpha-secretase activity. On the basis of these findings, we examined the effect of synthetic retinoids and found a strong enhancement of nonamyloidogenic processing of the amyloid precursor protein by the vitamin A analog acitretin: it stimulated ADAM10 promoter activity with an EC50 of 1.5 mu M and led to an increase of mature ADAM10 protein that resulted in a two- to three-fold increase of the ratio between alpha- and beta-secretase activity in neuroblastoma cells. The alpha-secretase stimulation by acitretin was completely inhibited by the ADAM10-specific inhibitor GI254023X. Intracerebral injection of acitretin in APP/PS1-21 transgenic mice led to a reduction of A beta(40) and A beta(42). The results of this study may have clinical relevance because acitretin has been approved for the treatment of psoriasis since 1997 and found generally safe for long-term use in humans.-Tippmann, F., Hundt, J., Schneider, A., Endres, K., Fahrenholz, F. Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin. FASEB J. 23, 1643-1654 (2009)	[Tippmann, Frank; Hundt, Jana; Endres, Kristina; Fahrenholz, Falk] Johannes Gutenberg Univ Mainz, Inst Biochem, D-55099 Mainz, Germany; [Schneider, Anja] Univ Med, Dept Psychiat & Psychotherapy, Gottingen, Germany; [Schneider, Anja] Max Planck Inst Expt Med, D-37075 Gottingen, Germany	Johannes Gutenberg University of Mainz; Max Planck Society	Fahrenholz, F (corresponding author), Johannes Gutenberg Univ Mainz, Inst Biochem, Becherweg 30, D-55099 Mainz, Germany.	fahrenho@uni-mainz.de	Endres, Kristina/K-4960-2015; Schneider, Anja/F-5293-2010	Schneider, Anja/0000-0001-9540-8700	Forschungsfond of the Johannes Gutenberg-University, Mainz; Deutsche Forschungsgemeinschaft	Forschungsfond of the Johannes Gutenberg-University, Mainz; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Dr. Claudia Prinzen (Johannes Gutenberg- University, Mainz)for cloning of the human ADAM10 promoter luciferase construct and of RARE luciferase vector and Daniela Kaleve (Johannes Gutenberg-University, Mainz) for studies with overexpressed RARs. This work was supported by grants from the Forschungsfond of the Johannes Gutenberg-University, Mainz (to K.E.), and of the Deutsche Forschungsgemeinschaft (to F.F.).	ALLENBY G, 1993, P NATL ACAD SCI USA, V90, P30, DOI 10.1073/pnas.90.1.30; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Armstrong JL, 2005, BRIT J CANCER, V92, P696, DOI 10.1038/sj.bjc.6602398; ASTROM A, 1990, BIOCHEM BIOPH RES CO, V173, P339, DOI 10.1016/S0006-291X(05)81062-9; Belandia B, 1998, J BIOL CHEM, V273, P30366, DOI 10.1074/jbc.273.46.30366; Bell KFS, 2008, NEUROBIOL AGING, V29, P554, DOI 10.1016/j.neurobiolaging.2006.11.004; BORNEMANN LD, 1988, BIOPHARM DRUG DISPOS, V9, P119, DOI 10.1002/bod.2510090112; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Cappai R, 2008, NEUROCHEM RES, V33, P526, DOI 10.1007/s11064-007-9469-8; Carpentier A, 1997, ONCOGENE, V15, P1805, DOI 10.1038/sj.onc.1201335; Cedazo-Minguez A, 2001, NEUROSCIENCE, V105, P651, DOI 10.1016/S0306-4522(01)00224-X; Chen N, 2008, FASEB J, V22, P236, DOI 10.1096/fj.07-8739com; Chiang MY, 1998, NEURON, V21, P1353, DOI 10.1016/S0896-6273(00)80654-6; Cocco S, 2002, NEUROSCIENCE, V115, P475, DOI 10.1016/S0306-4522(02)00423-2; Colciaghi F, 2002, MOL MED, V8, P67, DOI 10.1007/BF03402076; Connor MJ, 1997, MOL CHEM NEUROPATHOL, V30, P239, DOI 10.1007/BF02815101; Endres K, 2005, FEBS J, V272, P5808, DOI 10.1111/j.1742-4658.2005.04976.x; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Gezen-Ak D, 2007, TOHOKU J EXP MED, V212, P275, DOI 10.1620/tjem.212.275; Goodman AB, 2003, P NATL ACAD SCI USA, V100, P2901, DOI 10.1073/pnas.0437937100; Goodman AB, 2006, J CELL PHYSIOL, V209, P598, DOI 10.1002/jcp.20784; HARMON MA, 1995, P NATL ACAD SCI USA, V92, P6157, DOI 10.1073/pnas.92.13.6157; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; Holback S, 2005, J NEUROCHEM, V95, P1059, DOI 10.1111/j.1471-4159.2005.03440.x; Holback S, 2008, BIOCHEM BIOPH RES CO, V365, P298, DOI 10.1016/j.bbrc.2007.10.167; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Ishida A, 1997, NEUROREPORT, V8, P2133, DOI 10.1097/00001756-199707070-00009; Jimenez-Jimenez FJ, 1999, EUR J NEUROL, V6, P495, DOI 10.1046/j.1468-1331.1999.640495.x; KOBAYASHI M, 1994, FEBS LETT, V337, P259, DOI 10.1016/0014-5793(94)80204-1; Koldamova RP, 2003, J BIOL CHEM, V278, P13244, DOI 10.1074/jbc.M300044200; Koldamova T, 2005, J BIOL CHEM, V280, P4079, DOI 10.1074/jbc.M411420200; Krezel W, 1999, NEUROSCIENCE, V89, P1291, DOI 10.1016/S0306-4522(98)00342-X; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; LANNFELT L, 1995, NAT MED, V1, P829, DOI 10.1038/nm0895-829; LARSEN FG, 1992, CLIN PHARMACOKINET, V23, P42, DOI 10.2165/00003088-199223010-00004; Latasa MJ, 1998, ENDOCRINOLOGY, V139, P2692, DOI 10.1210/en.139.6.2692; Lee CS, 2005, EXPERT OPIN PHARMACO, V6, P1725, DOI 10.1517/14656566.6.10.1725; LEHMANN JM, 1992, MOL CELL BIOL, V12, P2976, DOI 10.1128/MCB.12.7.2976; LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z; Lengqvist J, 2004, MOL CELL PROTEOMICS, V3, P692, DOI 10.1074/mcp.M400003-MCP200; LEROY P, 1991, P NATL ACAD SCI USA, V88, P10138, DOI 10.1073/pnas.88.22.10138; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; MATTSON MP, 1994, J NEUROBIOL, V25, P439, DOI 10.1002/neu.480250409; Melino G, 1996, CELL GROWTH DIFFER, V7, P787; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; Mingaud F, 2008, J NEUROSCI, V28, P279, DOI 10.1523/JNEUROSCI.4065-07.2008; Misner DL, 2001, P NATL ACAD SCI USA, V98, P11714, DOI 10.1073/pnas.191369798; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P194, DOI 10.1001/archneur.60.2.194; Post A, 2006, BIOL PSYCHIAT, V59, P858, DOI 10.1016/j.biopsych.2005.09.007; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Prinzen C, 2005, FASEB J, V19, P1522, DOI 10.1096/fj.04-3619fje; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Reynolds CP, 2003, CANCER LETT, V197, P185, DOI 10.1016/S0304-3835(03)00108-3; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Rizzo Giovanni, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P289, DOI 10.2174/1568008054863781; Sastre M, 2006, P NATL ACAD SCI USA, V103, P443, DOI 10.1073/pnas.0503839103; Saurat JH, 1999, J AM ACAD DERMATOL, V41, pS2, DOI 10.1016/S0190-9622(99)70358-0; Sennvik K, 2000, NEUROSCI LETT, V278, P169, DOI 10.1016/S0304-3940(99)00929-5; SHALITA AR, 1992, J AM ACAD DERMATOL, V27, pS1, DOI 10.1016/S0190-9622(08)80251-4; TALLMAN MS, 1992, J CLIN PHARMACOL, V32, P868, DOI 10.1002/j.1552-4604.1992.tb04633.x; Taylor CJ, 2008, NEUROBIOL DIS, V31, P250, DOI 10.1016/j.nbd.2008.04.011; Tian KR, 1997, BIOCHEMISTRY-US, V36, P5669, DOI 10.1021/bi9627020; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; ZAMAN Z, 1992, AGE AGEING, V21, P91, DOI 10.1093/ageing/21.2.91	64	167	168	2	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1643	1654		10.1096/fj.08-121392	http://dx.doi.org/10.1096/fj.08-121392			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19144697				2022-12-25	WOS:000266652400004
J	Bisbal, M; Wojnacki, J; Peretti, D; Ropolo, A; Sesma, J; Jausoro, I; Caceres, A				Bisbal, Mariano; Wojnacki, Jose; Peretti, Diego; Ropolo, Andrea; Sesma, Juliana; Jausoro, Ignacio; Caceres, Alfredo			KIF4 Mediates Anterograde Translocation and Positioning of Ribosomal Constituents to Axons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL RNA GRANULES; ACTIN MESSENGER-RNA; PROTEIN-SYNTHESIS; INTRACELLULAR TRAFFICKING; SYMPATHETIC NEURONS; MIDZONE FORMATION; GROWTH CONES; KINESIN; TRANSPORT; TRANSLATION	In this study, we have used a combination of biochemical and molecular biology techniques to demonstrate that the C-terminal tail domain of KIF4 directly interacts with P0, a major protein component of ribosomes. Besides, in dorsal root ganglion neurons, KIF4 and P0, as well as other ribosomal constituents, colocalize in clusters distributed along axons and neuritic tips. RNA interference suppression of KIF4 or expression of KIF4 variants lacking the tail domain or mutations of the ATP-binding site result in accumulation of P0 and other ribosomal proteins at the cell body and in their disappearance from axons. Our results also show one additional function for KIF4 involving an Ezrin-Radixin-Moesin-like domain in the second coiled-coiled region of KIF4. Expression of a KIF4 mutant lacking this domain abolishes the clustering of ribosomal constituents and prevents the anterograde translocation of the cell adhesion molecule L1. Taken together, the present results suggest that by binding to P0 through its tail domain and by using its motor activity, KIF4 is involved in the anterograde trafficking of ribosomal constituents to axons and that by means of its Ezrin-Radixin-Moesin-like domain interacts and transports L1.	[Caceres, Alfredo] Consejo Nacl Invest Cient & Tecn, Inst Invest Med Mercedes & Martin Ferreyra, INIMEC, Lab Neurobiol & Cell Biol, RA-5016 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Caceres, A (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Med Mercedes & Martin Ferreyra, INIMEC, Lab Neurobiol & Cell Biol, Av Friuli 2434 5016, RA-5016 Cordoba, Argentina.	acaceres@immf.uncor.edu	Bisbal, Mariano/AAE-9308-2021	Bisbal, Mariano/0000-0002-3870-6151	Agencia Nacional Promocion CientIfica y Tecnica [PICT 05-14398]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 6463]; Howard Hughes Medical Institute	Agencia Nacional Promocion CientIfica y Tecnica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by Agencia Nacional Promocion CientIfica y Tecnica Grant PICT 05-14398), Consejo Nacional de Investigaciones Cientificas y Tecnicas Grant PIP 6463, and a Howard Hughes Medical Institute grant awarded under the International Research Scholar Program (to A. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; Bassell GJ, 1998, J NEUROSCI, V18, P251; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Chuang JZ, 2005, DEV CELL, V9, P75, DOI 10.1016/j.devcel.2005.04.003; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; Delanoue R, 2005, CELL, V122, P97, DOI 10.1016/j.cell.2005.04.033; Dickson TC, 2002, J CELL BIOL, V157, P1105, DOI 10.1083/jcb.200111076; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Eng H, 1999, J NEUROSCI, V19, P1; Giuditta A, 2002, TRENDS NEUROSCI, V25, P400, DOI 10.1016/S0166-2236(02)02188-4; Hagiya A, 2005, J BIOL CHEM, V280, P39193, DOI 10.1074/jbc.M506050200; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Knowles RB, 1997, P NATL ACAD SCI USA, V94, P14804, DOI 10.1073/pnas.94.26.14804; Knowles RB, 1996, J NEUROSCI, V16, P7812; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Kun A, 2007, J NEUROSCI RES, V85, P2087, DOI 10.1002/jnr.21340; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Lee YM, 2004, EXP MOL MED, V36, P93, DOI 10.1038/emm.2004.13; Lee YM, 2001, BIOCHEM J, V360, P549, DOI 10.1042/0264-6021:3600549; Li CX, 2004, J NEUROSCI, V24, P6161, DOI 10.1523/JNEUROSCI.1476-04.2004; Liu G, 2002, MOL BIOL CELL, V13, P579, DOI 10.1091/mbc.01-03-0140; Maddox PS, 2003, CURR BIOL, V13, P1423, DOI 10.1016/S0960-9822(03)00547-5; Martinez NW, 2008, J VIROL, V82, P9937, DOI 10.1128/JVI.00819-08; Mazumdar M, 2006, CURR BIOL, V16, P1559, DOI 10.1016/j.cub.2006.06.029; Midorikawa R, 2006, CELL, V125, P371, DOI 10.1016/j.cell.2006.02.039; NAKATA T, 1995, J CELL BIOL, V131, P1039, DOI 10.1083/jcb.131.4.1039; OlinkCoux M, 1996, J NEUROSCI, V16, P1346; Peretti D, 2000, J CELL BIOL, V149, P141, DOI 10.1083/jcb.149.1.141; Piper M, 2004, ANNU REV CELL DEV BI, V20, P505, DOI 10.1146/annurev.cellbio.20.010403.111746; Rehbein M, 2000, MOL BRAIN RES, V79, P192, DOI 10.1016/S0169-328X(00)00114-5; Rodriguez-Gabriel MA, 2000, J BIOL CHEM, V275, P2130, DOI 10.1074/jbc.275.3.2130; SANTOS C, 1995, J BIOL CHEM, V270, P20608, DOI 10.1074/jbc.270.35.20608; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; SEKINE Y, 1994, J CELL BIOL, V127, P187, DOI 10.1083/jcb.127.1.187; Sossin WS, 2006, TRAFFIC, V7, P1581, DOI 10.1111/j.1600-0854.2006.00500.x; Sotelo-Silveira JR, 2006, TRAFFIC, V7, P508, DOI 10.1111/j.1600-0854.2006.00405.x; Sotelo-Silveira JR, 2004, J NEUROBIOL, V60, P187, DOI 10.1002/neu.20015; Steward O, 2002, NEURON, V36, P338, DOI 10.1016/S0896-6273(02)01006-1; Steward O, 2002, CELL, V110, P537, DOI 10.1016/S0092-8674(02)00934-0; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; VERNOS I, 1995, CELL, V81, P117, DOI 10.1016/0092-8674(95)90376-3; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102	48	21	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9489	9497		10.1074/jbc.M808586200	http://dx.doi.org/10.1074/jbc.M808586200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19158085	Green Published, hybrid			2022-12-25	WOS:000264669100055
J	Her, YR; Chung, IK				Her, Yoon Ra; Chung, In Kwon			Ubiquitin Ligase RLIM Modulates Telomere Length Homeostasis through a Proteolysis of TRF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMEODOMAIN TRANSCRIPTION FACTORS; HUMAN-CELLS; PROTEIN COMPLEX; DNA; KINASE; TIN2; END; PHOSPHORYLATION; RECRUITMENT; MAINTENANCE	The telomeric protein TRF1 negatively regulates telomere length by inhibiting telomerase access at the telomere termini, suggesting that the protein level of TRF1 at telomeres is tightly regulated. Regulation of TRF1 protein abundance is essential for proper telomere function and occurs primarily through post-translational modifications of TRF1. Here we describe RLIM, a RING H2 zinc finger protein with intrinsic ubiquitin ligase activity, as a TRF1-interacting protein. RLIM increases TRF1 turnover by targeting it for degradation by the proteasome in a ubiquitin-dependent manner, independently of Fbx4, which is known to interact with and negatively regulate TRF1. Whereas overexpression of RLIM decreases the level of TRF1 protein, depletion of endogenous RLIM expression by small hairpin RNA increases the level of TRF1 and leads to telomere shortening, thereby impairing cell growth. These results demonstrate that RLIM is involved in the negative regulation of TRF1 function through physical interaction and ubiquitin-mediated proteolysis. Hence, RLIM represents a new pathway for telomere maintenance by modulating the level of TRF1 at telomeres.	[Her, Yoon Ra; Chung, In Kwon] Yonsei Univ, Dept Biol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea	Yonsei University	Chung, IK (corresponding author), Yonsei Univ, Dept Biol, Coll Life Sci & Biotechnol, 134 Shinchon Dong, Seoul 120749, South Korea.	topoviro@yonsei.ac.kr			Molecular Aging Research Center, Korean Ministry of Health and Welfare; the Research Program on Dual Regulation Mechanisms of Aging and Cancer, Korea Science and Engineering Foundation [M1075604000107N560400110]; Korea Research Foundation [KRF-2005-C00097]; Seoul Development Institute	Molecular Aging Research Center, Korean Ministry of Health and Welfare; the Research Program on Dual Regulation Mechanisms of Aging and Cancer, Korea Science and Engineering Foundation; Korea Research Foundation(National Research Foundation of Korea); Seoul Development Institute	This work was supported by grants from the Molecular Aging Research Center, Korean Ministry of Health and Welfare; the Research Program on Dual Regulation Mechanisms of Aging and Cancer, Korea Science and Engineering Foundation (M1075604000107N560400110); Korea Research Foundation (KRF-2005-C00097); and the Seoul Development Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Cerone MA, 2005, ONCOGENE, V24, P7893, DOI 10.1038/sj.onc.1208934; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Cook BD, 2002, MOL CELL BIOL, V22, P332, DOI 10.1128/MCB.22.1.332-342.2002; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Harrington L, 2005, CHROMOSOME RES, V13, P493, DOI 10.1007/s10577-005-0994-5; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kim JH, 2005, GENE DEV, V19, P776, DOI 10.1101/gad.1289405; Kim MK, 2008, J BIOL CHEM, V283, P14144, DOI 10.1074/jbc.M710065200; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kishi S, 2001, J BIOL CHEM, V276, P29282, DOI 10.1074/jbc.M011534200; Lee GE, 2004, J BIOL CHEM, V279, P34750, DOI 10.1074/jbc.M401843200; Lee TH, 2006, J BIOL CHEM, V281, P759, DOI 10.1074/jbc.M509855200; LINGNER J, 1995, SCIENCE, V269, P1533, DOI 10.1126/science.7545310; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Nishiyama A, 2006, EMBO J, V25, P575, DOI 10.1038/sj.emboj.7600964; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; O'Connor MS, 2004, J BIOL CHEM, V279, P28585, DOI 10.1074/jbc.M312913200; Ostendorff HP, 2000, GENOMICS, V69, P120, DOI 10.1006/geno.2000.6311; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; Scanlan MJ, 1999, INT J CANCER, V83, P456, DOI 10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Wu ZQ, 2008, J BIOL CHEM, V283, P25503, DOI 10.1074/jbc.M803304200; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4	40	46	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8557	8566		10.1074/jbc.M806702200	http://dx.doi.org/10.1074/jbc.M806702200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19164295	hybrid, Green Published			2022-12-25	WOS:000264397800040
J	Dalal, K; Nguyen, N; Alami, M; Tan, J; Moraes, TF; Lee, WC; Maurus, R; Sligar, SS; Brayer, GD; Duong, F				Dalal, Kush; Nguyen, Nham; Alami, Meriem; Tan, Jennifer; Moraes, Trevor F.; Lee, Woo Cheol; Maurus, Robert; Sligar, Stephen S.; Brayer, Gary D.; Duong, Franck			Structure, Binding, and Activity of Syd, a SecY-interacting Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PREPROTEIN TRANSLOCASE; TRANSMEMBRANE STRETCHES; CONDUCTING CHANNEL; GENETIC-ANALYSIS; RIBOSOME; SUBUNIT; COMPLEX; DOMAIN; MOTOR	The Syd protein has been implicated in the Sec-dependent transport of polypeptides across the bacterial inner membrane. Using Nanodiscs, we here provide direct evidence that Syd binds the SecY complex, and we demonstrate that interaction involves the two electropositive and cytosolic loops of the SecY subunit. We solve the crystal structure of Syd and together with cysteine cross-link analysis, we show that a conserved concave and electronegative groove constitutes the SecY-binding site. At the membrane, Syd decreases the activity of the translocon containing loosely associated SecY-SecE subunits, whereas in detergent solution Syd disrupts the SecYEG heterotrimeric associations. These results support the role of Syd in proofreading the SecY complex biogenesis and point to the electrostatic nature of the Sec channel interaction with its cytosolic partners.	[Dalal, Kush; Nguyen, Nham; Alami, Meriem; Tan, Jennifer; Moraes, Trevor F.; Maurus, Robert; Brayer, Gary D.; Duong, Franck] Univ British Columbia, Dept Biochem & Mol Biol, Fac Med, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Lee, Woo Cheol] Univ British Columbia, Dept Microbiol & Immunol, Fac Med, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Sligar, Stephen S.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of British Columbia; University of British Columbia; University of Illinois System; University of Illinois Urbana-Champaign	Duong, F (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Fac Med, Inst Life Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	FDuong@interchange.ubc.ca		Duong Van Hoa, Franck/0000-0001-7328-6124	Canadian Institutes of Health Research; Pacific Century Graduate Scholarship from the British Columbia provincial government; Natural Sciences and Engineering Research Council; Canada Research Chair program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Pacific Century Graduate Scholarship from the British Columbia provincial government; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair program(Canada Research Chairs)	This work was supported by the Canadian Institutes of Health Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.; Supported by the Pacific Century Graduate Scholarship from the British Columbia provincial government.; Supported by the Natural Sciences and Engineering Research Council.; Supported by the Canada Research Chair program.	Alami M, 2007, EMBO J, V26, P1995, DOI 10.1038/sj.emboj.7601661; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bessonneau P, 2002, EMBO J, V21, P995, DOI 10.1093/emboj/21.5.995; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Clemons WM, 1999, NATURE, V400, P833, DOI 10.1038/23631; Collinson I, 2001, EMBO J, V20, P2462, DOI 10.1093/emboj/20.10.2462; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Duong F, 1997, EMBO J, V16, P2756, DOI 10.1093/emboj/16.10.2756; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Karamanou S, 2008, MOL MICROBIOL, V70, P311, DOI 10.1111/j.1365-2958.2008.06402.x; KIHARA A, 1995, P NATL ACAD SCI USA, V92, P4532, DOI 10.1073/pnas.92.10.4532; Maillard AP, 2007, J BIOL CHEM, V282, P1281, DOI 10.1074/jbc.M610060200; Matsuo E, 1998, J BIOL CHEM, V273, P18835, DOI 10.1074/jbc.273.30.18835; Matsuo E, 1998, MOL GEN GENET, V258, P240, DOI 10.1007/s004380050728; Menetret JF, 2008, STRUCTURE, V16, P1126, DOI 10.1016/j.str.2008.05.003; Menetret JF, 2007, MOL CELL, V28, P1083, DOI 10.1016/j.molcel.2007.10.034; Nishiyama K, 2000, BIOSCI BIOTECH BIOCH, V64, P2121, DOI 10.1271/bbb.64.2121; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Papanikolau Y, 2007, J MOL BIOL, V366, P1545, DOI 10.1016/j.jmb.2006.12.049; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; SCHATZ PJ, 1991, EMBO J, V10, P1749, DOI 10.1002/j.1460-2075.1991.tb07699.x; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; SHIMOIKE T, 1995, J BIOL CHEM, V270, P5519, DOI 10.1074/jbc.270.10.5519; TAURA T, 1994, MOL GEN GENET, V243, P261, DOI 10.1007/BF00301061; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218	29	25	25	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7897	7902		10.1074/jbc.M808305200	http://dx.doi.org/10.1074/jbc.M808305200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19139097	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000264195600051
J	Lizunov, VA; Lisinski, I; Stenkula, K; Zimmerberg, J; Cushman, SW				Lizunov, Vladimir A.; Lisinski, Ivonne; Stenkula, Karin; Zimmerberg, Joshua; Cushman, Samuel W.			Insulin Regulates Fusion of GLUT4 Vesicles Independent of Exo70-mediated Tethering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT ADIPOSE-CELLS; GLUCOSE-TRANSPORTER GLUT4; PLASMA-MEMBRANE; SIGNALING PATHWAY; TRANSLOCATION; TRAFFICKING; EXOCYST; ADIPOCYTES; INTERACTS; COMPLEX	Insulin regulates cellular glucose uptake by changing the amount of glucose transporter-4 (GLUT4) in the plasma membrane through stimulation of GLUT4 exocytosis. However, how the particular trafficking, tethering, and fusion steps are regulated by insulin is still debated. In a 3T3-L1 adipocyte cell line, the Exocyst complex and its Exo70 subunit were shown to critically affect GLUT4 exocytosis. Here we investigated the effects of Exo70 on tethering and fusion of GLUT4 vesicles in primary isolated rat adipose cells. We found that Exo70 wild type was sequestered away from the plasma membrane in non-stimulated cells, and its overexpression had no effect on GLUT4 trafficking. The addition of insulin increased the amount of Exo70 in the vicinity of the plasma membrane and stimulated the tethering and fusion of GLUT4 vesicles, but the rates of fusion and GLUT4 exposure were not affected by overexpression of Exo70. Surprisingly, the Exo70-N mutant induced insulin-independent tethering of GLUT4 vesicles, which, however, did not lead to fusion and exposure of GLUT4 at the plasma membrane. Upon insulin stimulation, the stationary pretethered GLUT4 vesicles in Exo70-N mutant cells underwent fusion without relocation. Taken together, our data suggest that fusion of GLUT4 vesicles is the rate-limiting step regulated by insulin downstream of Exo70-mediated tethering.	[Lizunov, Vladimir A.; Zimmerberg, Joshua] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Cellular & Mol Biophys, Program Phys Biol, Bethesda, MD 20892 USA; [Lisinski, Ivonne; Stenkula, Karin; Cushman, Samuel W.] NIDDK, Expt Diabet Metab & Nutr Sect, Diabet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Zimmerberg, J (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Cellular & Mol Biophys, Program Phys Biol, Bethesda, MD 20892 USA.	joshz@mail.nih.gov	Lizunov, Vladimir/B-5468-2009	Stenkula, Karin/0000-0002-0739-1150	National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001415] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK055118, Z01DK055118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by an National Institutes of Health grant through the Intramural Research Programs of the NICHD and NIDDK. The costs of publication of this article were defrayed in part by the payment of page charges.	Al-Hasani H, 1998, J BIOL CHEM, V273, P17504, DOI 10.1074/jbc.273.28.17504; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Bao Y, 2008, J BIOL CHEM, V283, P324, DOI 10.1074/jbc.M706873200; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; Ewart MA, 2005, J BIOL CHEM, V280, P3812, DOI 10.1074/jbc.M409928200; He B, 2007, EMBO J, V26, P4053, DOI 10.1038/sj.emboj.7601834; Hsu SC, 1999, TRENDS CELL BIOL, V9, P150, DOI 10.1016/S0962-8924(99)01516-0; Huang SH, 2007, MOL CELL BIOL, V27, P3456, DOI 10.1128/MCB.01719-06; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Jiang ZY, 2002, J BIOL CHEM, V277, P509, DOI 10.1074/jbc.M108280200; Koumanov F, 2005, CELL METAB, V2, P179, DOI 10.1016/j.cmet.2005.08.007; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Lodhi IJ, 2007, CELL METAB, V5, P59, DOI 10.1016/j.cmet.2006.12.006; Malide D, 1997, J HISTOCHEM CYTOCHEM, V45, P1083, DOI 10.1177/002215549704500806; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; QUON MJ, 1994, P NATL ACAD SCI USA, V91, P5587, DOI 10.1073/pnas.91.12.5587; Rea S, 1997, DIABETES, V46, P1667, DOI 10.2337/diabetes.46.11.1667; Saltiel AR, 2003, TRAFFIC, V4, P711, DOI 10.1034/j.1600-0854.2003.00119.x; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Sparling DP, 2008, J BIOL CHEM, V283, P7429, DOI 10.1074/jbc.M800481200; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Vermette M, 2007, BIOMATERIALS, V28, P2850, DOI 10.1016/j.biomaterials.2007.02.030; Williams D, 2008, J CELL BIOL, V180, P375, DOI 10.1083/jcb.200709108; Zaid H, 2008, BIOCHEM J, V413, P201, DOI 10.1042/BJ20080723	28	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7914	7919		10.1074/jbc.M806460200	http://dx.doi.org/10.1074/jbc.M806460200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19155211	hybrid, Green Published			2022-12-25	WOS:000264195600053
J	Rausch, JW; Chelico, L; Goodman, MF; Le Grice, SFJ				Rausch, Jason W.; Chelico, Linda; Goodman, Myron F.; Le Grice, Stuart F. J.			Dissecting APOBEC3G Substrate Specificity by Nucleoside Analog Interference	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV REVERSE-TRANSCRIPTASE; DNA DEAMINASE DOMAIN; SINGLE-STRANDED-DNA; CYTIDINE DEAMINASE; VIF PROTEIN; CRYSTAL-STRUCTURE; FUNCTIONAL IMPLICATIONS; RETROVIRAL INFECTION; ANTIVIRAL ACTIVITY; VIRUS INFECTIVITY	The apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like (APOBEC) cytidine deaminase genes encode a set of enzymes including APOBEC1(A1), APOBEC2(A2), APOBEC4 (A4), and APOBEC3A-H (A3A-H). Although each possesses one or more zinc binding motifs conserved among enzymes catalyzing C -> U conversion, the functions and substrate specificities of these gene products vary considerably. For example, although two closely related enzymes, A3F and A3G, both restrict HIV-1 infection in strains deficient in virus infectivity factor (vif), A3F selectively deaminates cytosine within 5'-TTCA-3' motifs in single stranded DNA, whereas A3G targets 5'-CCCA-3' sequences. In the present study we have used nucleoside analog interference mapping to probe A3G-DNA interactions throughout the enzyme-substrate complex as well as to determine which DNA structural features determine substrate specificity. Our results indicate that multiple components of nucleosides within the consensus sequence are important for substrate recognition by A3G (with base moieties being most critical), whereas deamination interference by analog substitution outside this region is minimal. Furthermore, exocyclic groups in pyrimidines 1-2 nucleotides 5' of the target cytosine were shown to dictate substrate recognition by A3G, with chemical composition at ring positions 3 and 4 found to be more important than at ring position 5. Taken together, these results provide insights into how the enzyme selects A3G hotspot motifs for deamination as well as which approaches might be best suited for forming a stable, catalytically competent crosslinked A3G-DNA complex for future structural studies.	[Chelico, Linda; Goodman, Myron F.] Univ So Calif, Dept Biol Sci, Mol & Computat Sect, Los Angeles, CA 90089 USA; [Rausch, Jason W.; Le Grice, Stuart F. J.] NCI Frederick, Retroviral Replicat Lab, HIV Drug Resistance Program, Natl Inst Hlth, Ft Detrick, MD 21702 USA	University of Southern California; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Le Grice, SFJ (corresponding author), 1050 Boyles St, Frederick, MD 21702 USA.	slegrice@ncifcrf.gov		Chelico, Linda/0000-0003-4673-8978	National Institutes of Health staff; NATIONAL CANCER INSTITUTE [ZIABC010495] Funding Source: NIH RePORTER	National Institutes of Health staff(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was authored, in whole or in part, by National Institutes of Health staff. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; BHATTACHARYA S, 1994, TRENDS BIOCHEM SCI, V19, P105, DOI 10.1016/0968-0004(94)90200-3; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chen KM, 2007, FEBS LETT, V581, P4761, DOI 10.1016/j.febslet.2007.08.076; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Goncalves J, 1996, J VIROL, V70, P8701, DOI 10.1128/JVI.70.12.8701-8709.1996; Guo F, 2007, J VIROL, V81, P11322, DOI 10.1128/JVI.00162-07; Hakata Y, 2006, J BIOL CHEM, V281, P36624, DOI 10.1074/jbc.M604980200; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Huang HF, 2000, CHEM BIOL, V7, P355, DOI 10.1016/S1074-5521(00)00113-7; Huthoff H, 2005, VIROLOGY, V334, P147, DOI 10.1016/j.virol.2005.01.038; Iwatani Y, 2006, J VIROL, V80, P5992, DOI 10.1128/JVI.02680-05; Johansson E, 2002, BIOCHEMISTRY-US, V41, P2563, DOI 10.1021/bi011849a; Kao S, 2003, J VIROL, V77, P11398, DOI 10.1128/JVI.77.21.11398-11407.2003; Kobayashi M, 2005, J BIOL CHEM, V280, P18573, DOI 10.1074/jbc.C500082200; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Li XY, 2007, J BIOL CHEM, V282, P32065, DOI 10.1074/jbc.M703423200; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Losey HC, 2006, NAT STRUCT MOL BIOL, V13, P153, DOI 10.1038/nsmb1047; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Opi S, 2006, J VIROL, V80, P4673, DOI 10.1128/JVI.80.10.4673-4682.2006; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Sarafianos SG, 2003, J BIOL CHEM, V278, P16280, DOI 10.1074/jbc.M212911200; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shindo K, 2003, J BIOL CHEM, V278, P44412, DOI 10.1074/jbc.C300376200; Simon JHM, 1996, J VIROL, V70, P5297, DOI 10.1128/JVI.70.8.5297-5305.1996; STREBEL K, 1987, NATURE, V328, P728, DOI 10.1038/328728a0; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Suspene R, 2006, NUCLEIC ACIDS RES, V34, P4677, DOI 10.1093/nar/gkl555; VONSCHWEDLER U, 1993, J VIROL, V67, P4945, DOI 10.1128/JVI.67.8.4945-4955.1993; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Wedekind JE, 2006, J BIOL CHEM, V281, P38122, DOI 10.1074/jbc.C600253200; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang L, 2008, VIROLOGY, V370, P113, DOI 10.1016/j.virol.2007.08.027; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	49	40	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7047	7058		10.1074/jbc.M807258200	http://dx.doi.org/10.1074/jbc.M807258200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19136562	hybrid, Green Published			2022-12-25	WOS:000263919000053
J	Herz, K; Rimon, A; Jeschke, G; Padan, E				Herz, Katia; Rimon, Abraham; Jeschke, Gunnar; Padan, Etana			beta-Sheet-dependent Dimerization Is Essential for the Stability of NhaA Na+/H+ Antiporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; LOOP-VIII-IX; ESCHERICHIA-COLI; TRANSPORT PROTEIN; CONFORMATIONAL-CHANGE; ION-TRANSPORT; CROSS-LINKING; ALKALINE PH; MEMBRANE; ANT	A structural model of the NhaA dimer showed that a beta-hairpin of each monomer combines to form a beta-sheet at the periplasmic side of the membrane. By Cys scanning the entire beta-hairpin and testing each Cys replacement for functionality and intermolecular cross-linking, we found that Gln(47) and Arg(49) are critical for the NhaA dimer and that K57C causes an acidic shift of 1 pH unit to the pH dependence of NhaA. Comparing the growth of the NhaA variants with the previously isolated beta-hairpin deleted mutant (triangle(P45- N58)) and the wild type validated that NhaA dimers have an advantage over monomers in growth under extreme stress conditions and unraveled that during this growth the apparent K-m for Na+ of triangle( P45- N58) was increased 50-fold as compared with the wild type. Remarkably, the effect of the extreme stress on the NhaA variants is reversible. Testing the temperature stability (4-55 degrees C) of the NhaA variants in dodecyl maltoside micells showed that the mutants impaired in dimerization were much less temperature-stable than the wild type. We suggest that NhaA dimers are crucial for the stability of the antiporter under extreme stress conditions.	[Herz, Katia; Rimon, Abraham; Padan, Etana] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Jeschke, Gunnar] ETH, Dept Phys Chem, CH-8093 Zurich, Switzerland	Hebrew University of Jerusalem; Swiss Federal Institutes of Technology Domain; ETH Zurich	Padan, E (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	etana@vms.huji.ac.il		Jeschke, Gunnar/0000-0001-6853-8585	United States-Israel Binational Science Foundation [501/03-16.2]; European Drug Initiative on Channels and Transporters [EU FP 7]	United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); European Drug Initiative on Channels and Transporters	This work was supported by United States-Israel Binational Science Foundation Grant 501/03-16.2 and European Drug Initiative on Channels and Transporters Grant EU FP 7. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; CASEY JR, 1991, J BIOL CHEM, V266, P15726; DAVIS BD, 1950, J BACTERIOL, V60, P17, DOI 10.1128/JB.60.1.17-28.1950; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; Galili L, 2004, J BIOL CHEM, V279, P23104, DOI 10.1074/jbc.M400288200; Galili L, 2002, BIOCHEMISTRY-US, V41, P609, DOI 10.1021/bi011655v; Gerchman Y, 1999, J BIOL CHEM, V274, P24617, DOI 10.1074/jbc.274.35.24617; GERCHMAN Y, 1993, P NATL ACAD SCI USA, V90, P1212, DOI 10.1073/pnas.90.4.1212; Gerchman Y, 2001, BIOCHEMISTRY-US, V40, P3403, DOI 10.1021/bi002669o; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Hilger D, 2007, BIOPHYS J, V93, P3675, DOI 10.1529/biophysj.107.109769; Hilger D, 2005, BIOPHYS J, V89, P1328, DOI 10.1529/biophysj.105.062232; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; KARPEL R, 1988, J BIOL CHEM, V263, P10408; Maris AE, 2005, J MOL BIOL, V350, P843, DOI 10.1016/j.jmb.2005.05.057; Olami Y, 1997, J BIOL CHEM, V272, P1761, DOI 10.1074/jbc.272.3.1761; Olkhova E., 2006, P NATL ACAD SCI US; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; PADAN E, 1989, J BIOL CHEM, V264, P20297; Padan E, 2001, BBA-BIOENERGETICS, V1505, P144, DOI 10.1016/S0005-2728(00)00284-X; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; PINNER E, 1993, J BIOL CHEM, V268, P1729; Rimon A, 2002, BIOCHEMISTRY-US, V41, P14897, DOI 10.1021/bi0261342; Rimon A, 2007, J BIOL CHEM, V282, P26810, DOI 10.1074/jbc.M704469200; ROSEN BP, 1986, METHOD ENZYMOL, V125, P328; Schagger H., 2003, PRACTICAL GUIDE MEMB, P105; SCHULDINER S, 1978, BIOCHEMISTRY-US, V17, P706, DOI 10.1021/bi00597a023; Screpanti E, 2006, J MOL BIOL, V362, P192, DOI 10.1016/j.jmb.2006.07.019; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382; Tsuboi Y, 2003, J BIOL CHEM, V278, P21467, DOI 10.1074/jbc.M301932200; Tzubery T, 2004, J BIOL CHEM, V279, P3265, DOI 10.1074/jbc.M309021200; Tzubery T, 2008, J BIOL CHEM, V283, P15975, DOI 10.1074/jbc.M800482200; Veenhoff LM, 2002, TRENDS BIOCHEM SCI, V27, P242, DOI 10.1016/S0968-0004(02)02077-7; Veenhoff LM, 2001, EMBO J, V20, P3056, DOI 10.1093/emboj/20.12.3056; Venturi M, 2000, J BIOL CHEM, V275, P4734, DOI 10.1074/jbc.275.7.4734; Williams KA, 1999, EMBO J, V18, P3558, DOI 10.1093/emboj/18.13.3558; Williams KA, 2000, NATURE, V403, P112, DOI 10.1038/47534	43	34	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6337	6347		10.1074/jbc.M807720200	http://dx.doi.org/10.1074/jbc.M807720200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19129192	hybrid			2022-12-25	WOS:000263742700037
J	Ayada, T; Taniguchi, K; Okamoto, F; Kato, R; Komune, S; Takaesu, G; Yoshimura, A				Ayada, T.; Taniguchi, K.; Okamoto, F.; Kato, R.; Komune, S.; Takaesu, G.; Yoshimura, A.			Sprouty4 negatively regulates protein kinase C activation by inhibiting phosphatidylinositol 4,5-biphosphate hydrolysis	ONCOGENE			English	Article						VEGF; phospholipase C; phosphatidylinositol; ERK; Ras	ENDOTHELIAL GROWTH-FACTOR; SUBSTRATE MARCKS PROTEIN; INDUCED ERK ACTIVATION; TYROSINE PHOSPHORYLATION; GENE-EXPRESSION; CELLS; RECEPTOR; FGF; TRANSLOCATION; ANGIOGENESIS	Sproutys have been shown to negatively regulate growth factor-induced extracellular signal-regulated kinase (ERK) activation, and suggested to be an anti-oncogene. However, molecular mechanism of the suppression has not yet been clarified completely. Sprouty4 inhibits vascular endothelial growth factor (VEGF)-A-induced ERK activation, but not VEGF-C-induced ERK activation. It has been shown that VEGF-A-mediated ERK activation is strongly dependent on protein kinase C (PKC), whereas that by VEGF-C is dependent on Ras. This suggests that Sprouty4 inhibits the PKC pathway more specifically than the Ras pathway. In this study, we confirmed that Sprouty4 suppressed various signals downstream of PKC, such as phosphorylation of MARCKS and protein kinase D (PKD), as well as PKC-dependent nuclear factor (NF)-kappa B activation. Furthermore, Sprouty4 suppressed upstream signals of PKC, such as Ca2+ mobilization, phosphatidylinositol 4,5-biphosphate (PIP2) breakdown and inositol 1,4,5-triphosphate (IP3) production in response to VEGF-A. Those effects were dependent on the C-terminal cysteine-rich region, but not on the N-terminal region of Sprouty4, which is critical for the suppression of fibroblast growth factor (FGF)-mediated ERK activation. Sprouty4 overexpression or deletion of the Sprouty4 gene did not affect phospholipase C (PLC) gamma-1 activation, which is an enzyme that catalyzes PIP2 hydrolysis. Moreover, Sprouty4 inhibited not only VEGF-A-mediated PIP2 hydrolysis but also inhibited the lysophosphatidic acid (LPA)-induced PIP2 breakdown that is catalyzed by PLC beta/epsilon activated by G-protein coupled receptor (GPCR). Taken together, Sprouty4 has broader suppression activity for various stimuli than previously thought; it may function as an inhibitor for various types of PLC-dependent signaling as well as for ERK activation.	[Yoshimura, A.] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; [Ayada, T.; Taniguchi, K.; Okamoto, F.; Kato, R.; Takaesu, G.; Yoshimura, A.] Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Fukuoka 812, Japan; [Ayada, T.; Komune, S.] Kyushu Univ, Grad Sch Med Sci, Dept Otorhinolaryngol, Fukuoka 812, Japan	Keio University; Kyushu University; Kyushu University	Yoshimura, A (corresponding author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	yoshimura@a6.keio.jp	Yoshimura, Akihiko/K-5515-2013	Takaesu, Giichi/0000-0002-1581-1055	Ministry of Education, Culture, Sports, Science and Technology of Japan; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); Takeda Science Foundation; Kato Memorial Trust for Nambyo Research; Mitsubishi Pharma Research Foundation; Nakatomi Foundation; Naito Foundation; Astellas Foundation for Research on Metabolic Disorders; Yakult Bioscience Research Foundation; Princess Takamatsu Cancer Research Fund	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kato Memorial Trust for Nambyo Research(Kato Memorial Trust for Nambyo Research); Mitsubishi Pharma Research Foundation; Nakatomi Foundation; Naito Foundation(Naito Memorial Foundation); Astellas Foundation for Research on Metabolic Disorders; Yakult Bioscience Research Foundation; Princess Takamatsu Cancer Research Fund	We thank T Yoshioka and M Ohtsu for technical assistance, Dr Sasaki (Akita University), Dr Kawahara, Dr Okuno and Dr Yokomizo (Kyushu University) for reagents and discussions and Y Nishi for manuscript preparation. This study was supported by special Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), the Takeda Science Foundation, the Kato Memorial Trust for Nambyo Research, the Mitsubishi Pharma Research Foundation, the Nakatomi Foundation, the Naito Foundation, Astellas Foundation for Research on Metabolic Disorders, the Yakult Bioscience Research Foundation and the Princess Takamatsu Cancer Research Fund.	Abe M, 2004, BIOCHEM BIOPH RES CO, V323, P1040, DOI 10.1016/j.bbrc.2004.08.198; Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; Armesilla AL, 1999, MOL CELL BIOL, V19, P2032; Basson MA, 2006, DEV BIOL, V299, P466, DOI 10.1016/j.ydbio.2006.08.051; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Brems H, 2007, NAT GENET, V39, P1120, DOI 10.1038/ng2113; BYERS DM, 1993, J NEUROCHEM, V60, P1414, DOI 10.1111/j.1471-4159.1993.tb03303.x; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Fong CW, 2006, CANCER RES, V66, P2048, DOI 10.1158/0008-5472.CAN-05-1072; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Fukunaga K, 2001, J BIOL CHEM, V276, P43025, DOI 10.1074/jbc.M108288200; Gaudreau R, 1998, BIOCHEM J, V335, P15, DOI 10.1042/bj3350015; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Guy GR, 2003, J CELL SCI, V116, P3061, DOI 10.1242/jcs.00652; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hempstead BL, 2004, J CLIN INVEST, V113, P811, DOI 10.1172/JCI200421309; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Kato R, 2003, BIOCHEM BIOPH RES CO, V302, P767, DOI 10.1016/S0006-291X(03)00259-6; Kelley GG, 2006, J BIOL CHEM, V281, P2639, DOI 10.1074/jbc.M507681200; Kramer S, 1999, DEVELOPMENT, V126, P2515; Kuriyama M, 2004, BIOCHEM BIOPH RES CO, V325, P843, DOI 10.1016/j.bbrc.2004.10.102; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Lim J, 2002, MOL CELL BIOL, V22, P7953, DOI 10.1128/MCB.22.22.7953-7966.2002; Lo TL, 2006, CANCER LETT, V242, P141, DOI 10.1016/j.canlet.2005.12.032; Maeng YS, 2006, CELL SIGNAL, V18, P994, DOI 10.1016/j.cellsig.2005.08.007; Minowada G, 1999, DEVELOPMENT, V126, P4465; Ohmori S, 2000, J BIOL CHEM, V275, P26449, DOI 10.1074/jbc.M003588200; Ozdener F, 2002, MOL PHARMACOL, V62, P672, DOI 10.1124/mol.62.3.672; Qin LL, 2006, J BIOL CHEM, V281, P32550, DOI 10.1074/jbc.M604853200; Reich A, 1999, DEVELOPMENT, V126, P4139; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Sivak JM, 2005, DEV CELL, V8, P689, DOI 10.1016/j.devcel.2005.02.011; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; SWIERCZYNSKI SL, 1995, J BIOL CHEM, V270, P13436, DOI 10.1074/jbc.270.22.13436; Taketomi T, 2005, NAT NEUROSCI, V8, P855, DOI 10.1038/nn1485; Taniguchi K, 2007, MOL CELL BIOL, V27, P4541, DOI 10.1128/MCB.01600-06; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; Wang Y, 2008, GENE DEV, V22, P878, DOI 10.1101/gad.452908; Wong C, 2005, J BIOL CHEM, V280, P33262, DOI 10.1074/jbc.M503198200; Yao YG, 2004, BIOCHEM BIOPH RES CO, V321, P648, DOI 10.1016/j.bbrc.2004.06.176; Yigzaw Y, 2001, J BIOL CHEM, V276, P22742, DOI 10.1074/jbc.M100123200; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200	45	28	29	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2009	28	8					1076	1088		10.1038/onc.2008.464	http://dx.doi.org/10.1038/onc.2008.464			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	412KE	19137008				2022-12-25	WOS:000263722900003
J	Cao, Y; Liu, X; Zhang, W; Deng, X; Zhang, H; Liu, Y; Chen, L; Thompson, EA; Townsend, CM; Ko, TC				Cao, Y.; Liu, X.; Zhang, W.; Deng, X.; Zhang, H.; Liu, Y.; Chen, L.; Thompson, E. A.; Townsend, C. M., Jr.; Ko, T. C.			TGF-beta repression of Id2 induces apoptosis in gut epithelial cells	ONCOGENE			English	Article						apoptosis; affymetrix oligonucleotide microarrays; inhibitor of differentiation; TranSignal Protein/DNA arrays; hypoxia-inducing factor	GROWTH-FACTOR-BETA; LOOP-HELIX PROTEINS; INDUCIBLE TRANSCRIPTION; FACTOR GENE; HYPOXIA; DIFFERENTIATION; EXPRESSION; PROLIFERATION; ID-1; COOPERATION	Transforming growth factor-beta (TGF-beta) regulates epithelial tissue homeostasis by activating processes that control cell cycle arrest, differentiation and apoptosis. Disruption of the TGF-beta signaling pathway often occurs in colorectal cancers. Earlier, we have shown that TGF-beta induces apoptosis through the transcription factor Smad3. Affymetrix oligonucleotide microarrays were used to identify TGF-beta/Smad3 target genes that regulate apoptosis in rat intestinal epithelial cells (RIE-1). We found that TGF-beta repressed the expression of the inhibitor of differentiation (Id) gene family. Knockdown of Id1 and Id2 gene expression induced apoptosis in RIE-1 cells, whereas overexpression of Id2 attenuated TGF-beta-induced apoptosis. TranSignal Protein/ DNA arrays were used to identify the hypoxia-inducing factor-1 (HIF-1) as a downstream target of TGF-beta. HIF-1 is a basic helix-loop-helix protein, and overexpression of Id2 blocked HIF-1 activation by TGF-beta. Furthermore, knockdown of HIF-1 blocked TGF-beta-induced apoptosis. Thus, we have identified HIF-1 as a novel mediator downstream of Id2 in the pathway of TGF-beta-induced apoptosis.	[Cao, Y.; Liu, X.; Zhang, W.; Deng, X.; Zhang, H.; Ko, T. C.] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX 77030 USA; [Liu, Y.; Chen, L.; Thompson, E. A.] Mayo Clin, Ctr Comprehens Canc, Jacksonville, FL 32224 USA; [Townsend, C. M., Jr.] Univ Texas Galveston, Med Branch, Dept Surg, Galveston, TX 77550 USA	University of Texas System; University of Texas Health Science Center Houston; Mayo Clinic; University of Texas System; University of Texas Medical Branch Galveston	Cao, Y (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Surg, MSB4-608,6431 Fannin St, Houston, TX 77030 USA.	Yanna.Cao@uth.tmc.edu; Tien.C.Ko@uth.tmc.edu			Gastrointestinal Research Interdisciplinary Program at the University of Texas Medical Branch (YC); Public Health Service [R01 DK060105, P01 DK035608, P50GM038529]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060105, P01DK035608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM038529] Funding Source: NIH RePORTER	Gastrointestinal Research Interdisciplinary Program at the University of Texas Medical Branch (YC); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D Deng, Dr D Song and Z Chen for technical support; Dr H Guo for real-time quantitative PCR assay at the Real-Time PCR Core Facility, Sealy Center for Cancer Cell Biology, UTMB; Dr C Cox Jr and F Jimenez in the Department of Pediatric Surgery, UTHSC-Houston, and M Grif. n in the Flow Cytometry and Cell Sorting Core Facility, UTMB, for flow cytometric analysis. E Figueroa and S Schuenke in the Department of Surgery, UTMB, for manuscript preparation. This study was supported by a grant from the Gastrointestinal Research Interdisciplinary Program at the University of Texas Medical Branch (YC), and Public Health Service Grants R01 DK060105 (TCK), P01 DK035608 (CMT and TCK) and P50GM038529 (TCK).	Alliston T, 2005, J BIOL CHEM, V280, P24227, DOI 10.1074/jbc.M414305200; AndresBarquin PJ, 1997, CANCER RES, V57, P215; Babyatsky M. W., 1991, TXB GASTROENTEROLOGY, P475; Cao YN, 2007, AM J PHYSIOL-GASTR L, V292, pG28, DOI 10.1152/ajpgi.00437.2005; Cao YN, 2006, SURGERY, V140, P322, DOI 10.1016/j.surg.2006.05.006; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; Conery AR, 2004, NAT CELL BIOL, V6, P366, DOI 10.1038/ncb1117; Florio M, 1998, MOL CELL BIOL, V18, P5435, DOI 10.1128/MCB.18.9.5435; Gold LI, 1999, CRIT REV ONCOGENESIS, V10, P303; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Hasskarl J, 2002, CANCER BIOL THER, V1, P91, DOI 10.4161/cbt.50; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kim D, 1999, MOL CELL BIOL, V19, P8240; Kim HJ, 2007, MOL CANCER RES, V5, P321, DOI 10.1158/1541-7786.MCR-06-0218; Ko T C, 1997, Prog Cell Cycle Res, V3, P43; Kondo M, 2004, CELL DEATH DIFFER, V11, P1092, DOI 10.1038/sj.cdd.4401467; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; LEVY AP, 1995, J BIOL CHEM, V270, P13333, DOI 10.1074/jbc.270.22.13333; Ling MT, 2002, BBA-GEN SUBJECTS, V1570, P145, DOI 10.1016/S0304-4165(02)00189-7; Lofstedt T, 2004, J BIOL CHEM, V279, P39223, DOI 10.1074/jbc.M402904200; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Nakajima T, 1998, P NATL ACAD SCI USA, V95, P10590, DOI 10.1073/pnas.95.18.10590; Nemetski SM, 2007, J BIOL CHEM, V282, P240, DOI 10.1074/jbc.M607275200; Nguyen KA, 2006, ANN SURG, V243, P619, DOI 10.1097/01.sla.0000216783.85214.c1; Norton JD, 2000, J CELL SCI, V113, P3897; Norton JD, 1998, MOL CELL BIOL, V18, P2371, DOI 10.1128/MCB.18.4.2371; Parrinello S, 2001, J BIOL CHEM, V276, P39213, DOI 10.1074/jbc.M104473200; Sanchez-Elsner T, 2004, J MOL BIOL, V336, P9, DOI 10.1016/j.jmb.2003.12.023; Sanchez-Elsner T, 2002, J BIOL CHEM, V277, P43799, DOI 10.1074/jbc.M207160200; Sanchez-Elsner T, 2001, J BIOL CHEM, V276, P38527, DOI 10.1074/jbc.M104536200; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; Shih SC, 2001, GROWTH FACTORS, V19, P19, DOI 10.3109/08977190109001073; Siegel PM, 2003, J BIOL CHEM, V278, P35444, DOI 10.1074/jbc.M301413200; Sikder HA, 2003, CANCER CELL, V3, P525, DOI 10.1016/S1535-6108(03)00141-7; Tanaka K, 1998, J BIOL CHEM, V273, P25922, DOI 10.1074/jbc.273.40.25922; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Yokota Y, 2002, J CELL PHYSIOL, V190, P21, DOI 10.1002/jcp.10042; Zebedee Z, 2001, ONCOGENE, V20, P8317, DOI 10.1038/sj.onc.1205092	44	33	35	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2009	28	8					1089	1098		10.1038/onc.2008.456	http://dx.doi.org/10.1038/onc.2008.456			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	412KE	19137015	Green Accepted			2022-12-25	WOS:000263722900004
J	Fukukawa, C; Nagayama, S; Tsunoda, T; Toguchida, J; Nakamura, Y; Katagiri, T				Fukukawa, C.; Nagayama, S.; Tsunoda, T.; Toguchida, J.; Nakamura, Y.; Katagiri, T.			Activation of the non-canonical Dvl-Rac1-JNK pathway by Frizzled homologue 10 in human synovial sarcoma	ONCOGENE			English	Article						Frizzled; synovial sarcoma; JNK; cytoskeleton; anchorage-independent growth; Rac	BETA-CATENIN; DISHEVELLED PHOSPHORYLATION; SIGNALING CASCADE; GENE-EXPRESSION; PROTEIN; KINASE; RAC; RHO; TRANSLOCATION; BINDING	We previously reported that Frizzled homologue 10 (FZD10), a member of the Wnt signal receptor family, was highly and specifically upregulated in synovial sarcoma and played critical roles in its cell survival and growth. We here report a possible molecular mechanism of the FZD10 signaling in synovial sarcoma cells. We found a significant enhancement of phosphorylation of the Dishevelled (Dvl)2/Dvl3 complex as well as activation of the Rac1-JNK cascade in synovial sarcoma cells in which FZD10 was overexpressed. Activation of the FZD10-Dvls -Rac1 pathway induced lamellipodia formation and enhanced anchorage-independent cell growth cells. FZD10 overexpression also caused the destruction of the actin cytoskeleton structure, probably through the down-regulation of the RhoA activity. Our results have strongly implied that FZD10 transactivation causes the activation of the non-canonical Dvl-Rac1-JNK pathway and plays critical roles in the development/progression of synovial sarcomas.	[Katagiri, T.] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab,Minato Ku, Tokyo 1088639, Japan; [Tsunoda, T.] Inst Phys & Chem Res, RIKEN, SNP Res Ctr, Lab Med Informat, Yokohama, Kanagawa, Japan; [Toguchida, J.] Kyoto Univ, Inst Frontier Med Sci, Kyoto, Japan	University of Tokyo; RIKEN; Kyoto University	Katagiri, T (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	tkatagi@ims.u-tokyo.ac.jp	Katagiri, Toyomasa/I-7344-2012; Tsunoda, Tatsuhiko/K-2061-2014	Tsunoda, Tatsuhiko/0000-0002-5439-7918				Aepfelbacher M, 1996, J IMMUNOL, V157, P5070; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Brett D, 1997, HUM MOL GENET, V6, P1559, DOI 10.1093/hmg/6.9.1559; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Bryja V, 2007, CELL SIGNAL, V19, P610, DOI 10.1016/j.cellsig.2006.08.011; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Cheng TL, 2004, EXP CELL RES, V295, P497, DOI 10.1016/j.yexcr.2004.02.002; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; Coindre JM, 2003, CANCER-AM CANCER SOC, V98, P2700, DOI 10.1002/cncr.11840; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Endo Y, 2005, J BIOL CHEM, V280, P777, DOI 10.1074/jbc.M406391200; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Fukukawa C, 2008, CANCER SCI, V99, P432, DOI 10.1111/j.1349-7006.2007.00701.x; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Habu S, 1998, SURG TODAY, V28, P401, DOI 10.1007/s005950050149; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hamel M, 2006, ENDOTHELIUM-J ENDOTH, V13, P157, DOI 10.1080/10623320600760191; Hino S, 2003, J BIOL CHEM, V278, P14066, DOI 10.1074/jbc.M213265200; Hiraga H, 1999, J BONE JOINT SURG AM, V81A, P558, DOI 10.2106/00004623-199904000-00014; Hosono T, 2005, JPN J CLIN ONCOL, V35, P274, DOI 10.1093/jjco/hyi073; Kinoshita N, 2003, GENE DEV, V17, P1663, DOI 10.1101/gad.1101303; Kishida S, 2004, MOL CELL BIOL, V24, P4487, DOI 10.1128/MCB.24.10.4487-4501.2004; Koike J, 1999, BIOCHEM BIOPH RES CO, V262, P39, DOI 10.1006/bbrc.1999.1161; Lim FL, 1998, ONCOGENE, V17, P2013, DOI 10.1038/sj.onc.1202122; McGilbray TT, 2003, LANCET ONCOL, V4, P283, DOI 10.1016/S1470-2045(03)01075-1; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Nagayama S, 2005, ONCOGENE, V24, P6201, DOI 10.1038/sj.onc.1208780; Nagayama S, 2002, CANCER RES, V62, P5859; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Nunnally AP, 2004, DEV GENES EVOL, V214, P144, DOI 10.1007/s00427-004-0386-4; Ochi N, 2004, ORL-J OTO-RHIN-LARYN, V66, P42, DOI 10.1159/000077233; Otto IM, 2000, CURR BIOL, V10, P345, DOI 10.1016/S0960-9822(00)00388-2; PATERSON HF, 1990, J CELL BIOL, V111, P1001, DOI 10.1083/jcb.111.3.1001; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Segal NH, 2003, AM J PATHOL, V163, P691, DOI 10.1016/S0002-9440(10)63696-6; Shannon BA, 2005, ARCH PATHOL LAB MED, V129, P238; Soulez M, 1999, ONCOGENE, V18, P2739, DOI 10.1038/sj.onc.1202613; Szuhai K, 2004, CANCER GENET CYTOGEN, V153, P48, DOI 10.1016/j.cancergencyto.2003.12.012; TURCCAREL C, 1986, CANCER GENET CYTOGEN, V23, P93, DOI 10.1016/0165-4608(86)90153-6; Wang ZS, 2005, MOL CELL BIOL, V25, P5022, DOI 10.1128/MCB.25.12.5022-5030.2005; Wechezak AR, 2005, J CELL PHYSIOL, V202, P867, DOI 10.1002/jcp.20176; WEISS SW, 2001, ENZINGER WEISSS SOFT; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Wiggan O, 2002, J CELL SCI, V115, P531; Williams DH, 2004, J UROLOGY, V171, P2376, DOI 10.1097/01.ju.0000125319.92634.9b	50	51	53	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2009	28	8					1110	1120		10.1038/onc.2008.467	http://dx.doi.org/10.1038/onc.2008.467			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	412KE	19137009				2022-12-25	WOS:000263722900006
J	Fink, BD; O'Malley, Y; Dake, BL; Ross, NC; Prisinzano, TE; Sivitz, WI				Fink, Brian D.; O'Malley, Yunxia; Dake, Brian L.; Ross, Nicolette C.; Prisinzano, Thomas E.; Sivitz, William I.			Mitochondrial Targeted Coenzyme Q, Superoxide, and Fuel Selectivity in Endothelial Cells	PLOS ONE			English	Article							FATTY-ACID OXIDATION; REACTIVE OXYGEN; COMPLEX-I; UNCOUPLING PROTEIN-2; DAMAGE; ANTIOXIDANT; EXPRESSION; RESPIRATION; UBIQUINONE; GENERATION	Background: Previously, we reported that the "antioxidant'' compound "mitoQ'' (mitochondrial-targeted ubiquinol/ubiquinone) actually increased superoxide production by bovine aortic endothelial (BAE) cell mitochondria incubated with complex I but not complex II substrates. Methods and Results: To further define the site of action of the targeted coenzyme Q compound, we extended these studies to include different substrate and inhibitor conditions. In addition, we assessed the effects of mitoquinone on mitochondrial respiration, measured respiration and mitochondrial membrane potential in intact cells, and tested the intriguing hypothesis that mitoquinone might impart fuel selectivity in intact BAE cells. In mitochondria respiring on differing concentrations of complex I substrates, mitoquinone and rotenone had interactive effects on ROS consistent with redox cycling at multiple sites within complex I. Mitoquinone increased respiration in isolated mitochondria respiring on complex I but not complex II substrates. Mitoquinone also increased oxygen consumption by intact BAE cells. Moreover, when added to intact cells at 50 to 1000 nM, mitoquinone increased glucose oxidation and reduced fat oxidation, at doses that did not alter membrane potential or induce cell toxicity. Although high dose mitoquinone reduced mitochondrial membrane potential, the positively charged mitochondrial-targeted cation, decyltriphenylphosphonium (mitoquinone without the coenzyme Q moiety), decreased membrane potential more than mitoquinone, but did not alter fuel selectivity. Therefore, non-specific effects of the positive charge were not responsible and the quinone moiety is required for altered nutrient selectivity. Conclusions: In summary, the interactive effects of mitoquinone and rotenone are consistent with redox cycling at more than one site within complex I. In addition, mitoquinone has substrate dependent effects on mitochondrial respiration, increases repiration by intact cells, and alters fuel selectivity favoring glucose over fatty acid oxidation at the intact cell level.	[Fink, Brian D.; O'Malley, Yunxia; Dake, Brian L.; Sivitz, William I.] Iowa City VA Med Ctr, Dept Internal Med, Div Endocrinol & Metab, Iowa City, IA USA; [Ross, Nicolette C.; Prisinzano, Thomas E.] Univ Iowa, Iowa City, IA 52242 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa	Fink, BD (corresponding author), Iowa City VA Med Ctr, Dept Internal Med, Div Endocrinol & Metab, Iowa City, IA USA.	william-sivitz@uiowa.edu	Prisinzano, Thomas E/B-7877-2010	Prisinzano, Thomas/0000-0002-0649-8052; Prisinzano, Loredana/0000-0002-8893-2210; Sivitz, William/0000-0002-7829-0189; Fink, Brian/0000-0002-1149-7935	Veterans Affairs Medical Research Funds; National Institutes of Health [DK25295]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER	Veterans Affairs Medical Research Funds(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Veterans Affairs Medical Research Funds and grant DK25295 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asin-Cayuela J, 2004, FEBS LETT, V571, P9, DOI 10.1016/j.febslet.2004.06.045; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Bedogni B, 2003, J BIOL CHEM, V278, P16510, DOI 10.1074/jbc.M301089200; Boss O, 2000, DIABETES, V49, P143, DOI 10.2337/diabetes.49.2.143; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Brand MD, 2004, BIOCHEM SOC SYMP, V71, P203; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Coppey LJ, 2003, FREE RADICAL RES, V37, P33, DOI 10.1080/1071576021000028442; Dhanasekaran A, 2004, J BIOL CHEM, V279, P37575, DOI 10.1074/jbc.M404003200; Doughan AK, 2007, ANTIOXID REDOX SIGN, V9, P1825, DOI 10.1089/ars.2007.1693; Du XL, 2000, P NATL ACAD SCI USA, V97, P12222, DOI 10.1073/pnas.97.22.12222; Du YP, 2003, FREE RADICAL BIO MED, V35, P1491, DOI 10.1016/j.freeradbiomed.2003.08.018; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Fink BD, 2007, AM J PHYSIOL-REG I, V293, pR1773, DOI 10.1152/ajpregu.00478.2007; Green K, 2004, DIABETES, V53, pS110, DOI 10.2337/diabetes.53.2007.S110; Hong Y, 2001, ENDOCRINOLOGY, V142, P249, DOI 10.1210/en.142.1.249; James AM, 2004, ARCH BIOCHEM BIOPHYS, V423, P47, DOI 10.1016/j.abb.2003.12.025; James AM, 2002, J BIOMED SCI, V9, P475, DOI 10.1007/BF02254975; Jekabsons MB, 2004, J BIOL CHEM, V279, P32989, DOI 10.1074/jbc.M401540200; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kiritoshi S, 2003, DIABETES, V52, P2570, DOI 10.2337/diabetes.52.10.2570; Lambert AJ, 2008, BBA-BIOENERGETICS, V1777, P397, DOI 10.1016/j.bbabio.2008.03.005; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; LOSCHEN G, 1971, FEBS LETT, V18, P261, DOI 10.1016/0014-5793(71)80459-3; MOSER DR, 1992, MOL ENDOCRINOL, V6, P1805, DOI 10.1210/me.6.11.1805; Mougios V, 2003, J APPL PHYSIOL, V94, P476, DOI 10.1152/japplphysiol.00624.2002; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Murphy MP, 2004, BIOCHEM SOC T, V32, P1011, DOI 10.1042/BST0321011; Murphy MP, 2001, EXPERT OPIN BIOL TH, V1, P753, DOI 10.1517/14712598.1.5.753; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; NOBES CD, 1990, J BIOL CHEM, V265, P12903; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; O'Malley Y, 2006, J BIOL CHEM, V281, P39766, DOI 10.1074/jbc.M608268200; Ohnishi ST, 2005, J BIOENERG BIOMEMBR, V37, P1, DOI 10.1007/s10863-005-4117-y; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Roden M, 2004, NEWS PHYSIOL SCI, V19, P92, DOI 10.1152/nips.01459.2003; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; Schafer M, 2003, CIRC RES, V92, P1010, DOI 10.1161/01.RES.0000070882.81508.FC; Schrauwen P, 2004, DIABETES, V53, P1412, DOI 10.2337/diabetes.53.6.1412; Shadid S, 2006, DIABETOLOGIA, V49, P149, DOI 10.1007/s00125-005-0051-0; Tauskela JS, 2007, IDRUGS, V10, P399; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Yamagishi SI, 2001, J BIOL CHEM, V276, P25096, DOI 10.1074/jbc.M007383200; Ye G, 2004, DIABETES, V53, P1336, DOI 10.2337/diabetes.53.5.1336; Young ME, 2002, DIABETES, V51, P2587, DOI 10.2337/diabetes.51.8.2587	48	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2009	4	1							e4250	10.1371/journal.pone.0004250	http://dx.doi.org/10.1371/journal.pone.0004250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JC	19158951	Green Submitted, gold, Green Published			2022-12-25	WOS:000265482200007
J	Carbone, MA; Ayroles, JF; Yamamoto, A; Morozova, TV; West, SA; Magwire, MM; Mackay, TFC; Anholt, RRH				Carbone, Mary Anna; Ayroles, Julien F.; Yamamoto, Akihiko; Morozova, Tatiana V.; West, Steven A.; Magwire, Michael M.; Mackay, Trudy F. C.; Anholt, Robert R. H.			Overexpression of Myocilin in the Drosophila Eye Activates the Unfolded Protein Response: Implications for Glaucoma	PLOS ONE			English	Article								Background: Glaucoma is the world's second leading cause of bilateral blindness with progressive loss of vision due to retinal ganglion cell death. Myocilin has been associated with congenital glaucoma and 2-4% of primary open angle glaucoma (POAG) cases, but the pathogenic mechanisms remain largely unknown. Among several hypotheses, activation of the unfolded protein response (UPR) has emerged as a possible disease mechanism. Methodology/Principal Findings: We used a transgenic Drosophila model to analyze whole-genome transcriptional profiles in flies that express human wild- type or mutant MYOC in their eyes. The transgenic flies display ocular fluid discharge, reflecting ocular hypertension, and a progressive decline in their behavioral responses to light. Transcriptional analysis shows that genes associated with the UPR, ubiquitination, and proteolysis, as well as metabolism of reactive oxygen species and photoreceptor activity undergo altered transcriptional regulation. Following up on the results from these transcriptional analyses, we used immunoblots to demonstrate the formation of MYOC aggregates and showed that the formation of such aggregates leads to induction of the UPR, as evident from activation of the fluorescent UPR marker, xbp1-EGFP. Conclusions/Significance: Our results show that aggregation of MYOC in the endoplasmic reticulum activates the UPR, an evolutionarily conserved stress pathway that culminates in apoptosis. We infer from the Drosophila model that MYOC-associated ocular hypertension in the human eye may result from aggregation of MYOC and induction of the UPR in trabecular meshwork cells. This process could occur at a late age with wild- type MYOC, but might be accelerated by MYOC mutants to account for juvenile onset glaucoma.	[Carbone, Mary Anna; Ayroles, Julien F.; Yamamoto, Akihiko; Magwire, Michael M.; Mackay, Trudy F. C.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Yamamoto, Akihiko; Morozova, Tatiana V.; West, Steven A.; Anholt, Robert R. H.] N Carolina State Univ, Dept Zool, Raleigh, NC USA; [Carbone, Mary Anna; Ayroles, Julien F.; Yamamoto, Akihiko; Morozova, Tatiana V.; West, Steven A.; Magwire, Michael M.; Mackay, Trudy F. C.; Anholt, Robert R. H.] North Carolina State University, WM Keck Ctr Behavioral Biol, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Carbone, MA (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	anholt@unity.ncsu.edu	Anholt, Robert/S-5977-2019; West, Steven/AAG-4009-2019		National Institutes of Health [EY015873]; NATIONAL EYE INSTITUTE [R01EY015873] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by a grant from the National Institutes of Health grant EY015873 to RRHA and TFCM. The federal funding institute had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achary MS, 2006, BIOPHYS J, V91, P4329, DOI 10.1529/biophysj.106.085498; Acharya M, 2006, MOL VIS, V12, P399; Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; Affymetrix, 2001, MICR SUIT US GUID VE; Alward WLM, 1998, NEW ENGL J MED, V338, P1022, DOI 10.1056/NEJM199804093381503; Ashburner M., 1989, DROSOPHILA LAB HDB; Belmouden A, 2002, CLIN GENET, V62, P334, DOI 10.1034/j.1399-0004.2002.620415.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borras T, 2003, GENETICS, V163, P637; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bruttini M, 2003, ARCH OPHTHALMOL-CHIC, V121, P1034, DOI 10.1001/archopht.121.7.1034; Caballero M, 2001, BIOCHEM BIOPH RES CO, V282, P662, DOI 10.1006/bbrc.2001.4624; Challa P, 2002, J GLAUCOMA, V11, P416, DOI 10.1097/00061198-200210000-00008; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Colomb E, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9197; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Forman MS, 2003, TRENDS NEUROSCI, V26, P407, DOI 10.1016/S0166-2236(03)00197-8; Gibbs SM, 2001, J NEUROSCI, V21, P7705, DOI 10.1523/JNEUROSCI.21-19-07705.2001; Gobeil S, 2004, INVEST OPHTH VIS SCI, V45, P3560, DOI 10.1167/iovs.04-0300; Gobeil S, 2006, EXP EYE RES, V82, P1017, DOI 10.1016/j.exer.2005.11.002; Gould DB, 2006, MOL CELL BIOL, V26, P8427, DOI 10.1128/MCB.01127-06; Hart H, 2007, VET OPHTHALMOL, V10, P28, DOI 10.1111/j.1463-5224.2007.00517.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Izzotti A, 2006, MUTAT RES-REV MUTAT, V612, P105, DOI 10.1016/j.mrrev.2005.11.001; Jacobson N, 2001, HUM MOL GENET, V10, P117, DOI 10.1093/hmg/10.2.117; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Kramer Jamie M, 2003, Genet Mol Res, V2, P43; Kubota R, 1997, GENOMICS, V41, P360, DOI 10.1006/geno.1997.4682; LEE JA, 2007, MECH DEV; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; Liu YH, 2004, HUM MOL GENET, V13, P1193, DOI 10.1093/hmg/ddh128; Lopez-Garrido MP, 2006, MOL VIS, V12, P748; MacKay EO, 2008, VET OPHTHALMOL, V11, P177, DOI 10.1111/j.1463-5224.2008.00617.x; Mackay TEC, 2006, ANNU REV GENOM HUM G, V7, P339, DOI 10.1146/annurev.genom.7.080505.115758; Moreno TA, 2005, DEV BIOL, V288, P434, DOI 10.1016/j.ydbio.2005.09.050; Morissette J, 1998, NAT GENET, V19, P319, DOI 10.1038/1203; Mukhopadhyay A, 2002, MOL VIS, V8, P271; Naskar R, 2006, MOL VIS, V12, P1199; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Oliveros JC, 2007, VENNY INTERACTIVE TO; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Reddy ABM, 2004, MOL VIS, V10, P696; Richards JE, 1998, OPHTHALMOLOGY, V105, P1698, DOI 10.1016/S0161-6420(98)99041-8; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Sena DF, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.010777; Senatorov V, 2006, J NEUROSCI, V26, P11903, DOI 10.1523/JNEUROSCI.3020-06.2006; SHEPARD AR, 2007, HUM MOL GENET; Stoilova D, 1997, OPHTHALMIC GENET, V18, P109, DOI 10.3109/13816819709057124; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Tamm ER, 2002, PROG RETIN EYE RES, V21, P395, DOI 10.1016/S1350-9462(02)00010-1; Tan JCH, 2006, CURR OPIN OPHTHALMOL, V17, P168; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Wiggs JL, 1998, AM J HUM GENET, V63, P1549, DOI 10.1086/302098; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Yagi Yoshimasa, 2000, Molecular Cell Biology Research Communications, V4, P43, DOI 10.1006/mcbr.2000.0248; Yam GHT, 2007, INVEST OPHTH VIS SCI, V48, P1683, DOI 10.1167/iovs.06-0943; Yam GHF, 2007, AM J PATHOL, V170, P100, DOI 10.2353/ajpath.2007.060806	64	38	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2009	4	1							e4216	10.1371/journal.pone.0004216	http://dx.doi.org/10.1371/journal.pone.0004216			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IH	19148291	gold, Green Submitted, Green Published			2022-12-25	WOS:000265479900009
J	Bonadonna, F; Caro, SP; Brooke, MD				Bonadonna, Francesco; Caro, Samuel P.; Brooke, M. de L.			Olfactory Sex Recognition Investigated in Antarctic Prions	PLOS ONE			English	Article							ODOR RECOGNITION; BLUE PETRELS; SENSORY ECOLOGY; DISCRIMINATION; MECHANISM; NEST; COMMUNICATION; PACHYPTILA; NAVIGATION; SIGNATURE	Chemical signals can yield information about an animal such as its identity, social status or sex. Such signals have rarely been considered in birds, but recent results have shown that chemical signals are actually used by different bird species to find food and to recognize their home and nest. This is particularly true in petrels whose olfactory anatomy is among the most developed in birds. Recently, we have demonstrated that Antarctic prions, Pachyptila desolata, are also able to recognize and follow the odour of their partner in a Y-maze. However, the experimental protocol left unclear whether this choice reflected an olfactory recognition of a particular individual (i.e. partner) or a more general sex recognition mechanism. To test this second hypothesis, male and female birds' odours were presented simultaneously to 54 Antarctic prions in a Y-maze. Results showed random behaviour by the tested bird, independent of its sex or reproductive status. Present results do not support the possibility that Antarctic prions can distinguish the sex of a conspecific through its odour but indirectly support the hypothesis that they can distinguish individual odours.	[Caro, Samuel P.] CNRS, CEFE, Behav Ecol Grp, Montpellier, France; [Caro, Samuel P.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Brooke, M. de L.] Univ Cambridge, Dept Zool, Cambridge CB2 1TN, England	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of North Carolina; University of North Carolina Chapel Hill; University of Cambridge	Bonadonna, F (corresponding author), CNRS, CEFE, Behav Ecol Grp, Montpellier, France.	francesco.bonadonna@cefe.cnrs.fr	P, Samuel/A-5750-2008; Bonadonna, Francesco/A-7456-2008	P, Samuel/0000-0002-5405-7753; Bonadonna, Francesco/0000-0002-2702-5801	Institut Polaire Francais Paul Emile Victor; FRIA	Institut Polaire Francais Paul Emile Victor; FRIA(Fonds de la Recherche Scientifique - FNRS)	This work was supported by Institut Polaire Francais Paul Emile Victor (IPEV, Program no 354 to Francesco Bonadonna). S.P.Caro was a FRIA grant recipient. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, PHEROMONES ANIMAL BE; BANG BG, 1968, AUK, V85, P55; BANG BG, 1971, ACTA ANAT          S, V58, P1; Bonadonna F, 2004, ANIM BEHAV, V67, P893, DOI 10.1016/j.anbehav.2003.08.013; Bonadonna F, 2003, J EXP BIOL, V206, P3719, DOI 10.1242/jeb.00610; Bonadonna F, 2003, BEHAV ECOL SOCIOBIOL, V54, P174, DOI 10.1007/s00265-003-0610-7; Bonadonna F, 2002, J EXP BIOL, V205, P2519; Bonadonna F, 2001, J EXP BIOL, V204, P1485; Bonadonna F, 2004, SCIENCE, V306, P835, DOI 10.1126/science.1103001; BONADONNA F, 2008, ANN NEW YOR IN PRESS; Bonadonna F, 2007, J CHEM ECOL, V33, P1819, DOI 10.1007/s10886-007-9345-7; Bouchard S, 2001, J ZOOL, V254, P109, DOI 10.1017/S0952836901000607; BRETAGNOLLE V, 1990, AUK, V107, P305, DOI 10.2307/4087614; Brooke M, 2004, ALBATROSSES PETRELS; Burger BV, 2005, TOP CURR CHEM, V240, P231, DOI 10.1007/b98318; FERKIN MH, 1995, ANIM BEHAV, V49, P37, DOI 10.1016/0003-3472(95)80151-0; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; GENEVOIS F, 1994, ETHOL ECOL EVOL, V6, P377, DOI 10.1080/08927014.1994.9522988; GRUBB TC, 1974, ANIM BEHAV, V22, P192, DOI 10.1016/S0003-3472(74)80069-2; Hagelin JC., 2007, REPROD BEHAV PHYLOGE, V6B, P76; Hagelin JC, 2007, AUK, V124, P741, DOI 10.1642/0004-8038(2007)124[741:BOAOCS]2.0.CO;2; JACOB J, 1979, BIOCHEM SYST ECOL, V7, P149, DOI 10.1016/0305-1978(79)90024-3; Minguez E, 1997, ANIM BEHAV, V53, P701, DOI 10.1006/anbe.1996.0308; Mougeot F, 2000, ANIM BEHAV, V60, P647, DOI 10.1006/anbe.2000.1491; Nevitt GA, 2005, MAR ECOL PROG SER, V287, P292; Nevitt GA, 2005, BIOL LETT-UK, V1, P303, DOI 10.1098/rsbl.2005.0350; Nevitt GA, 2008, J EXP BIOL, V211, P1706, DOI 10.1242/jeb.015412; Roper TJ, 1999, ADV STUD BEHAV, V28, P247, DOI 10.1016/S0065-3454(08)60219-3; Soini HA, 2007, J CHEM ECOL, V33, P183, DOI 10.1007/s10886-006-9210-0; Vicario DS, 2001, ANIM BEHAV, V61, P805, DOI 10.1006/anbe.2000.1651; Warham J., 1996, BEHAV POPULATION BIO; Zelano B, 2002, AM NAT, V160, pS225, DOI 10.1086/342897	32	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4148	10.1371/journal.pone.0004148	http://dx.doi.org/10.1371/journal.pone.0004148			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FX	19127294	Green Published, gold, Green Submitted			2022-12-25	WOS:000265473300013
J	Hong, JJ; Reynolds, MR; Mattila, TL; Hage, A; Watkins, DI; Miller, CJ; Skinner, PJ				Hong, Jung Joo; Reynolds, Matthew R.; Mattila, Teresa L.; Hage, Aaron; Watkins, David I.; Miller, Christopher J.; Skinner, Pamela J.			Localized Populations of CD8(low/-) MHC Class I Tetramer(+) SIV-Specific T Cells in Lymphoid Follicles and Genital Epithelium	PLOS ONE			English	Article								CD8 T cells play an important role in controlling viral infections. We investigated the in situ localization of simian immunodeficiency virus (SIV)-specific T cells in lymph and genital tissues from SIV-infected macaques using MHC-class I tetramers. The majority of tetramer-binding cells localized in T cell zones and were CD8(+). Curiously, small subpopulations of tetramer-binding cells that had little to no surface CD8 were detected in situ both early and late post-infection, and in both vaginally and rectally inoculated macaques. These tetramer(+)CD8(low/-) cells were more often localized in apparent B cell follicles relative to T cell zones and more often found near or within the genital epithelium than the submucosa. Cells analyzed by flow cytometry showed similar populations of cells. Further immunohistological characterization revealed small populations of tetramer(+)CD20(-) cells inside B cell follicles and that tetramer(+) cells did not stain with gamma delta-TCR nor CD4 antibodies. Negative control tetramer staining indicated that tetramer(+)CD8(low/-) cells were not likely NK cells non-specifically binding to MHC tetramers. These findings have important implications for SIV-specific and other antigen-specific T cell function in these specific tissue locations, and suggest a model in which antigen-specific CD8+ T cells down modulate CD8 upon entering B cell follicles or the epithelial layer of tissues, or alternatively a model in which only antigen-specific CD8 T cells that down-modulate CD8 can enter B cell follicles or the epithelium.	[Hong, Jung Joo; Mattila, Teresa L.; Hage, Aaron; Skinner, Pamela J.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Reynolds, Matthew R.; Watkins, David I.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA; [Miller, Christopher J.] Univ Calif Davis, Davis, CA USA	University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis	Hong, JJ (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	skinn002@umn.edu		Skinner, Pamela/0000-0003-3388-1687	NIH [P51 RR00167-42, PAR-03-094]; National Center for Research Resources (NCRR) [P51 RR000167]; Wisconsin National Primate Research Center, University of Wisconsin-Madison; Research Facilities Improvement Program [RR15459-01, RR020141-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015459, C06RR020141, P51RR000167] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Wisconsin National Primate Research Center, University of Wisconsin-Madison; Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants P51 RR00167-42 and PAR-03-094. Additionally, this publication was made possible in part by Grant Number P51 RR000167 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), to the Wisconsin National Primate Research Center, University of Wisconsin-Madison. This research was conducted in part at a facility constructed with support from Research Facilities Improvement Program grant numbers RR15459-01 and RR020141-01. This publication's contents are solely the responsibility of the authors and do not necessarily represent the official views of NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Altman JD, 1998, SCIENCE, V280, P1821; Brenner M, 2006, J VIROL, V80, P4469, DOI 10.1128/JVI.80.9.4469-4481.2006; Connick E, 2007, J IMMUNOL, V178, P6975, DOI 10.4049/jimmunol.178.11.6975; GAN YH, 1995, CLIN EXP IMMUNOL, V102, P251; Genesca M, 2008, MUCOSAL IMMUNOL, V1, P219, DOI 10.1038/mi.2008.6; Genesca M, 2008, J VIROL, V82, P11181, DOI 10.1128/JVI.01433-08; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; Haigwood NL, 2004, AIDS REV, V6, P187; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kaufmann SHE, 1996, P NATL ACAD SCI USA, V93, P2272, DOI 10.1073/pnas.93.6.2272; Khanna KM, 2007, SCIENCE, V318, P116, DOI 10.1126/science.1146291; Komatsu H, 2003, CLIN EXP IMMUNOL, V134, P9, DOI 10.1046/j.1365-2249.2003.02266.x; Kuroda MJ, 1999, J IMMUNOL, V162, P5127; LANDOLFI MMT, 1993, J IMMUNOL, V151, P1086; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Mothe BR, 2002, J VIROL, V76, P875, DOI 10.1128/JVI.76.2.875-884.2002; Park JH, 2007, NAT IMMUNOL, V8, P1049, DOI 10.1038/ni1512; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Quigley MF, 2007, EUR J IMMUNOL, V37, P3352, DOI 10.1002/eji.200636746; Reynolds MR, 2005, J VIROL, V79, P9228, DOI 10.1128/JVI.79.14.9228-9235.2005; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Skinner PJ, 2000, J IMMUNOL, V165, P613, DOI 10.4049/jimmunol.165.2.613; SKINNER PJ, 2005, CURR PROTOC IMMUNOL, pCH17; Sun Y, 2006, J VIROL, V80, P10950, DOI 10.1128/JVI.01458-06; Veazey RS, 2003, J MED PRIMATOL, V32, P194, DOI 10.1034/j.1600-0684.2003.00025.x; Viola A, 1997, J EXP MED, V186, P1775, DOI 10.1084/jem.186.10.1775; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; Xiao ZG, 2007, J EXP MED, V204, P2667, DOI 10.1084/jem.20062376; Zamoyska R, 1998, CURR OPIN IMMUNOL, V10, P82, DOI 10.1016/S0952-7915(98)80036-8	31	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2009	4	1							e4131	10.1371/journal.pone.0004131	http://dx.doi.org/10.1371/journal.pone.0004131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FT	19122815	Green Submitted, Green Published, gold			2022-12-25	WOS:000265472900009
J	Fablet, M; Lerat, E; Rebollo, R; Horard, B; Burlet, N; Martinez, S; Brasset, E; Gilson, E; Vaury, C; Vieira, C				Fablet, Marie; Lerat, Emmanuelle; Rebollo, Rita; Horard, Beatrice; Burlet, Nelly; Martinez, Sonia; Brasset, Emilie; Gilson, Eric; Vaury, Chantal; Vieira, Cristina			Genomic environment influences the dynamics of the tirant LTR retrotransposon in Drosophila	FASEB JOURNAL			English	Article						chromatin; endogenous retrovirus; natural populations	ELEMENT COPY NUMBER; TRANSPOSABLE ELEMENTS; MELANOGASTER GENOME; NATURAL-POPULATIONS; SIMULANS; HETEROCHROMATIN; SEQUENCES; RETROVIRUSES; EXPRESSION; EVOLUTION	Combining genome sequence analysis and functional analysis, we show that some full-length copies of tirant are present in heterochromatic regions in Drosophila simulans and that when tested in vitro, these copies have a functional promoter. However, when inserted in heterochromatic regions, tirant copies are inactive in vivo, and only transcription of euchromatic copies can be detected. Thus, our data indicate that the localization of the element is a hallmark of its activity in vivo and raise the question of genomic invasions by transposable elements and the importance of their genomic integration sites.-Fablet, M., Lerat, E., Rebollo, R., Horard, B., Burlet, N., Martinez, S., Brasset, E., Gilson, E., Vaury, C., Vieira, C. Genomic environment influences the dynamics of the tirant LTR retrotransposon in Drosophila. FASEB J. 23, 1482-1489 (2009)	[Fablet, Marie; Lerat, Emmanuelle; Rebollo, Rita; Burlet, Nelly; Martinez, Sonia; Vieira, Cristina] Univ Lyon 1, CNRS, UMR5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Horard, Beatrice; Gilson, Eric] Univ Lyon 1, Fac Med Lyon Sud, CNRS, ENS Lyon,Lab Biol Mol Cellule,HCL,UMR 5161, Pierre Benite, France; [Brasset, Emilie; Vaury, Chantal] Clermont Univ, CNRS, UMR 6247, Fac Med,INSERM,U931, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA)	Vieira, C (corresponding author), Univ Lyon 1, CNRS, UMR5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France.	vieira@biomserv.univ-lyon1.fr	Vaury, Chantal/I-4658-2015; Vieira, Cristina/Q-3137-2017; Brasset, Emilie/J-6684-2015	Vaury, Chantal/0000-0002-7725-5760; Vieira, Cristina/0000-0003-3414-3993; LERAT, Emmanuelle/0000-0001-6757-8796; Brasset, Emilie/0000-0003-2479-7969; BURLET, Nelly/0000-0003-3231-4154; Rebollo, Rita/0000-0002-8138-5082	Centre National de la Recherche Scientifique [UMR 5558, GDR 2157]; ARC (ARECA program on epigenetic profiling)	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); ARC (ARECA program on epigenetic profiling)	We thank Christian Biemont for useful comments, and Monika Ghosh for reviewing the English text. The work in C. Vieira's laboratory was funded by the Centre National de la Recherche Scientifique (UMR 5558 and GDR 2157 on TEs). The work in E.G.'s laboratory was funded by ARC (ARECA program on epigenetic profiling).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Bergman CM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r112; Biemont C, 2005, CYTOGENET GENOME RES, V110, P25, DOI 10.1159/000084935; Biemont C, 2003, EVOLUTION, V57, P159, DOI 10.1111/j.0014-3820.2003.tb00225.x; Biemont C, 1997, GENETICA, V100, P161, DOI 10.1023/A:1018329528314; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Bonnivard E, 1997, GENET RES, V69, P197, DOI 10.1017/S0016672397002826; Busseau I, 2001, MOL BIOL EVOL, V18, P196, DOI 10.1093/oxfordjournals.molbev.a003793; CHARLESWORTH B, 1994, GENET RES, V64, P183, DOI 10.1017/S0016672300032845; CHARLESWORTH B, 1989, ANNU REV GENET, V23, P251, DOI 10.1146/annurev.ge.23.120189.001343; Costas J, 2001, J MOL EVOL, V52, P342, DOI 10.1007/s002390010164; DANIELS SB, 1986, J MOL EVOL, V23, P138, DOI 10.1007/BF02099908; Desset S, 1999, MOL BIOL EVOL, V16, P54, DOI 10.1093/oxfordjournals.molbev.a026038; Desset S, 2003, GENETICS, V164, P501; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; EICKBUSH DG, 1995, GENETICS, V139, P671; Fablet M, 2006, GENE, V375, P54, DOI 10.1016/j.gene.2006.02.008; Felsenstein J, 1989, CLADISTICS, V5, P3; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; Junakovic N, 1998, J MOL EVOL, V46, P661, DOI 10.1007/PL00006346; KAMINKER JS, 2002, GENOME BIOL, V0003; Kapitonov VV, 2003, P NATL ACAD SCI USA, V100, P6569, DOI 10.1073/pnas.0732024100; KIM A, 1994, P NATL ACAD SCI USA, V91, P1285, DOI 10.1073/pnas.91.4.1285; Kogan GL, 2003, MOL GENET GENOMICS, V269, P234, DOI 10.1007/s00438-003-0827-1; Lerat E, 2003, GENOME RES, V13, P1889, DOI 10.1101/gr.827603; Matyunina LV, 1996, P NATL ACAD SCI USA, V93, P7097, DOI 10.1073/pnas.93.14.7097; Mugnier N, 2005, MOL BIOL EVOL, V22, P747, DOI 10.1093/molbev/msi060; Mugnier N, 2008, GENE, V411, P87, DOI 10.1016/j.gene.2008.01.010; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; PRUDHOMME N, 1995, GENETICS, V139, P697; Sandmann T, 2006, NAT PROTOC, V1, P2839, DOI 10.1038/nprot.2006.383; Strohner R, 2004, MOL CELL BIOL, V24, P1791, DOI 10.1128/MCB.24.4.1791-1798.2004; Sun XP, 2003, GENOME RES, V13, P182, DOI 10.1101/gr.681703; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; VAURY C, 1989, CHROMOSOMA, V98, P215, DOI 10.1007/BF00329686; Vernhettes S, 1998, MOL BIOL EVOL, V15, P827, DOI 10.1093/oxfordjournals.molbev.a025988; Vieira C, 1999, MOL BIOL EVOL, V16, P1251, DOI 10.1093/oxfordjournals.molbev.a026215; Vieira C, 2004, GENETICA, V120, P115, DOI 10.1023/B:GENE.0000017635.34955.b5	39	10	10	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2009	23	5					1482	1489		10.1096/fj.08-123513	http://dx.doi.org/10.1096/fj.08-123513			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19141532				2022-12-25	WOS:000266651700024
J	Nader, N; Chrousos, GP; Kino, T				Nader, Nancy; Chrousos, George P.; Kino, Tomoshige			Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: potential physiological implications	FASEB JOURNAL			English	Article						brain-muscle-arnt-like protein 1; hypothalamic-pituitary-adrenal axis; GREs; GILZ; G6Pase; histone acetyltransferase	PITUITARY-ADRENAL AXIS; CLINICAL-IMPLICATIONS; NERVOUS-SYSTEM; GENE-EXPRESSION; DNA-BINDING; KAPPA-B; STRESS; INTERACTS; PROMOTER; DISEASES	Glucocorticoids, end products of the hypothalamic-pituitary-adrenal axis, influence functions of virtually all organs and tissues through the glucocorticoid receptor (GR). Circulating levels of glucocorticoids fluctuate naturally in a circadian fashion and regulate the transcriptional activity of GR in target tissues. The basic helix-loop-helix protein CLOCK, a histone acetyltransferase (HAT), and its heterodimer partner BMAL1 are self-oscillating transcription factors that generate circadian rhythms in both the central nervous system and periphery. We found that CLOCK/BMAL1 repressed GR-induced transcriptional activity in a HAT-activity-dependent fashion. In serum-shock-synchronized cells, transactivational activity of GR, accessed by mRNA expression of an endogenous-responsive gene, fluctuated spontaneously in a circadian fashion in reverse phase with CLOCK/BMAL1 mRNA expression. CLOCK and GR interacted with each other physically, and CLOCK suppressed binding of GR to its DNA recognition sequences by acetylating multiple lysine residues located in its hinge region. These findings indicate that CLOCK/BMAL1 functions as a reverse-phase negative regulator of glucocorticoid action in target tissues, possibly by antagonizing biological actions of diurnally fluctuating circulating glucocorticoids. Further, these results suggest that a peripheral target tissue circadian rhythm indirectly influences the functions of every organ and tissue inside the body through modulation of the ubiquitous and diverse actions of glucocorticoids.-Nader, N., Chrousos, G. P., Kino, T. Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: potential physiological implications. FASEB J. 23, 1572-1583 (2009)	[Nader, Nancy; Chrousos, George P.; Kino, Tomoshige] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Pediat Endocrinol, Program Reprod & Adult Endocrinol, NIH,Clin Res Ctr, Bethesda, MD 20892 USA; [Chrousos, George P.] Univ Athens, Sch Med, Dept Pediat 1, GR-11527 Athens, Greece	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Athens Medical School; National & Kapodistrian University of Athens	Kino, T (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Pediat Endocrinol, Program Reprod & Adult Endocrinol, NIH,Clin Res Ctr, Bldg 10,Rm 1-3140,10 Ctr Dr MSC 1109, Bethesda, MD 20892 USA.	kinot@mail.nih.gov	Nader, Nader/E-6358-2014	Nader, Nader/0000-0002-5744-7319	Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000618, ZIAHD000615, ZIAHD008732] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008732, Z01HD000615, Z01HD000618] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by the Intramural Research Program of Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH. We thank Drs. R. M. Evans (Salk Institute, La Jolla, CA, USA), G. L. Hager (National Cancer Institute, Bethesda, MD, USA), G. A. FitzGerald (University of Pennsylvania, Philadelphia, PA, USA), P. Sassone-Corsi (University of California, Irvine, CA, USA), and J. H. Segars (NIH, Bethesda, MD, USA) for providing plasmids and K. Zachman and Dr. T. Shibata for superb technical assistance.	Asselin-Labat ML, 2004, BLOOD, V104, P215, DOI 10.1182/blood-2003-12-4295; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Blind RD, 2008, J STEROID BIOCHEM, V109, P150, DOI 10.1016/j.jsbmb.2008.01.002; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Buijs RM, 2003, J ENDOCRINOL, V177, P17, DOI 10.1677/joe.0.1770017; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Chrousos G.P., 2001, ENDOCRINOLOGY METABO, V4th ed., P609; Chrousos GP, 2007, STRESS, V10, P213, DOI 10.1080/10253890701292119; Chrousos George P, 2005, Sci STKE, V2005, ppe48, DOI 10.1126/stke.3042005pe48; Chrousos GP, 2000, INT J OBESITY, V24, pS50, DOI 10.1038/sj.ijo.0801278; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Chrousos GP, 2000, ANN NY ACAD SCI, V917, P38, DOI 10.1111/j.1749-6632.2000.tb05371.x; Chrousos GP, 1998, ANN NY ACAD SCI, V851, P311, DOI 10.1111/j.1749-6632.1998.tb09006.x; Crofford LJ, 1997, J CLIN ENDOCR METAB, V82, P1279, DOI 10.1210/jc.82.4.1279; De Martino MU, 2004, MOL ENDOCRINOL, V18, P820, DOI 10.1210/me.2003-0341; Dickmeis T, 2007, PLOS BIOL, V5, P854, DOI 10.1371/journal.pbio.0050078; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Galon J, 2002, FASEB J, V16, P61, DOI 10.1096/fj.01-0245com; Green CB, 2003, SCIENCE, V301, P319, DOI 10.1126/science.1087824; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Ichijo T, 2005, J BIOL CHEM, V280, P42067, DOI 10.1074/jbc.M509338200; Ichijo T, 2008, MOL CELL ENDOCRINOL, V283, P19, DOI 10.1016/j.mce.2007.10.014; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Kino T, 2005, J CELL BIOL, V169, P885, DOI 10.1083/jcb.200409150; Kino T, 2004, ESSAYS BIOCHEM, V40, P137, DOI 10.1042/bse0400137; Kino T, 2003, J STEROID BIOCHEM, V85, P457, DOI 10.1016/S0960-0760(03)00218-8; Kino T, 2002, J VIROL, V76, P9724, DOI 10.1128/JVI.76.19.9724-9734.2002; KINO T, 2004, HDB STRESS BRAIN 1, P295; Kino T, 2007, MOL ENDOCRINOL, V21, P1552, DOI 10.1210/me.2006-0345; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Mirani M, 2002, J IMMUNOL, V169, P6361, DOI 10.4049/jimmunol.169.11.6361; Nascimento AS, 2006, J MOL BIOL, V360, P586, DOI 10.1016/j.jmb.2006.05.008; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Rosen J, 2005, ENDOCR REV, V26, P452, DOI 10.1210/er.2005-0002; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Schibler U, 2005, CELL METAB, V2, P278, DOI 10.1016/j.cmet.2005.10.001; Smit P, 2005, J CLIN ENDOCR METAB, V90, P2994, DOI 10.1210/jc.2004-2298; van Rossum EFC, 2005, TRENDS ENDOCRIN MET, V16, P445, DOI 10.1016/j.tem.2005.10.009; Vander Kooi BT, 2005, MOL ENDOCRINOL, V19, P3001, DOI 10.1210/me.2004-0497; Vgontzas AN, 1999, J CLIN ENDOCR METAB, V84, P2603, DOI 10.1210/jc.84.8.2603; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713	56	231	236	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2009	23	5					1572	1583		10.1096/fj.08-117697	http://dx.doi.org/10.1096/fj.08-117697			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19141540	Green Published			2022-12-25	WOS:000266651700032
J	Wu, Q; Hu, HX; Lan, JP; Emenari, C; Wang, ZY; Chang, KS; Huang, H; Yao, XB				Wu, Quan; Hu, Haixiang; Lan, Jianping; Emenari, Chibuzo; Wang, Zhiyong; Chang, Kang-sang; Huang, He; Yao, Xuebiao			PML3 Orchestrates the Nuclear Dynamics and Function of TIP60	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; RAR-ALPHA; BODIES; ACETYLATION; ONCOPROTEIN; RECEPTOR; P53; ACETYLTRANSFERASES; IDENTIFICATION; DEGRADATION	The promyelocytic leukemia (PML) protein is a major component to govern the PML nuclear body (NB) assembly and function. Although it is well defined that PML NB is a site recruiting sumoylated proteins, the mechanism by which PML protein regulates the process remains unclear. Here we show that PML3, a specific PML isoform, interacts with and recruits TIP60 to PML NBs. Our biochemical characterization demonstrates that PML3 physically interacts with TIP60 via its N-terminal 364 amino acids. Importantly, this portion of TIP60 is sufficient to target to the PMLNBs, suggesting that PML3-TIP60 interaction is sufficient for targeting TIP60 to the NBs. The PML3-TIP60 interaction is specific, since the region of TIP60 binding is not conserved in other PML isoforms. The physical interaction between PML3 and TIP60 protects TIP60 from Mdm2-mediated degradation, suggesting that PML3 competes with MDM2 for binding to TIP60. Fluorescence recovery after photobleaching analysis indicates that the PML3-TIP60 interaction modulates the nuclear body distribution and mobility of TIP60. Conversely, the distribution and mobility of TIP60 are perturbed in PML3-deficient cells, accompanied by aberrations in DNA damage-repairing response. Thus, PML3 orchestrates the distribution, dynamics, and function of TIP60. Our findings suggest a novel regulatory mechanism by which the PML3 and TIP60 tumor suppressors cooperate to ensure genomic stability.	[Yao, Xuebiao] Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China; [Yao, Xuebiao] Natl Lab Phys Sci Nanoscale, Hefei 230027, Peoples R China; [Hu, Haixiang] Airforce Gen Hosp, Dept Radiobiol, Beijing 100036, Peoples R China; [Lan, Jianping; Huang, He] Zhejiang Prov Peoples Hosp, Dept Hematol, Hangzhou 310014, Zhejiang, Peoples R China; [Lan, Jianping; Huang, He] Zhejiang Univ, Sch Med, Hangzhou 310014, Zhejiang, Peoples R China; [Wu, Quan; Emenari, Chibuzo] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA; [Chang, Kang-sang] MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA	Zhejiang Provincial People's Hospital; Zhejiang University; Morehouse School of Medicine; University of Texas System; UTMD Anderson Cancer Center	Yao, XB (corresponding author), Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China.	yaoxb@ustc.edu.cn	Yao, Xuebiao/P-5771-2014		National Institutes of Health/NCRR/RCM1 [G-12RR03034]; Chinese Academy of Science [KSCX1-YW-R65, KSCX2-YW-H-10]; Chinese 973 Project [2002CB713700, 2007CB914503]; Chinese 863 Project [2001AA215331, 2006AA02A247]; Anhui Science and Technology [08040102005]; Natural Science Foundation of China [39925018, 9050800290, 90813008];  [DK56292];  [CA92080];  [CA118948]; NATIONAL CANCER INSTITUTE [U54CA118948] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER	National Institutes of Health/NCRR/RCM1(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Chinese Academy of Science(Chinese Academy of Sciences); Chinese 973 Project(National Basic Research Program of China); Chinese 863 Project(National High Technology Research and Development Program of China); Anhui Science and Technology; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Grants DK56292, CA92080, and CA118948. The facilities used were supported in part by National Institutes of Health/NCRR/RCM1 Grant G-12RR03034. This work was also supported by Chinese Academy of Science Grants KSCX1-YW-R65 and KSCX2-YW-H-10, Chinese 973 Project Grants 2002CB713700 and 2007CB914503, Chinese 863 Project Grants 2001AA215331 and 2006AA02A247, Anhui Science and Technology Project Grant 08040102005, and Natural Science Foundation of China Grants 39925018 and 9050800290 (to X.Y. and 90813008 (to Z.W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ASCOLI CA, 1991, J CELL BIOL, V112, P785, DOI 10.1083/jcb.112.5.785; Borden KLB, 1996, P NATL ACAD SCI USA, V93, P1601, DOI 10.1073/pnas.93.4.1601; BORDEN KLB, 1995, EMBO J, V14, P1532, DOI 10.1002/j.1460-2075.1995.tb07139.x; Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; Cheng Z, 2008, ONCOGENE, V27, P931, DOI 10.1038/sj.onc.1210710; Col E, 2005, EMBO J, V24, P2634, DOI 10.1038/sj.emboj.7600734; Dechend R, 1999, ONCOGENE, V18, P3316, DOI 10.1038/sj.onc.1202717; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; Eskiw CH, 2003, J CELL SCI, V116, P4455, DOI 10.1242/jcs.00758; Fagioli M, 1998, ONCOGENE, V16, P2905, DOI 10.1038/sj.onc.1201811; FAGIOLI M, 1992, ONCOGENE, V7, P1083; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; Fu CH, 2005, ONCOGENE, V24, P5401, DOI 10.1038/sj.onc.1208714; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; Hodges M, 1998, AM J HUM GENET, V63, P297, DOI 10.1086/301991; Hofmann TG, 2003, CELL DEATH DIFFER, V10, P1290, DOI 10.1038/sj.cdd.4401313; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Kwek SSS, 2001, ONCOGENE, V20, P2587, DOI 10.1038/sj.onc.1204362; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Legube G, 2004, J BIOL CHEM, V279, P44825, DOI 10.1074/jbc.M407478200; Legube G, 2002, EMBO J, V21, P1704, DOI 10.1093/emboj/21.7.1704; Lemercier C, 2003, J BIOL CHEM, V278, P4713, DOI 10.1074/jbc.M211811200; Louria-Hayon I, 2003, J BIOL CHEM, V278, P33134, DOI 10.1074/jbc.M301264200; Maul GG, 2000, J STRUCT BIOL, V129, P278, DOI 10.1006/jsbi.2000.4239; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; MU ZM, 1994, MOL CELL BIOL, V14, P6858, DOI 10.1128/MCB.14.10.6858; Muller S, 1998, BLOOD, V92, P4308, DOI 10.1182/blood.V92.11.4308.423k36_4308_4316; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Salomoni P, 2008, CELL RES, V18, P620, DOI 10.1038/cr.2008.58; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Wu WS, 2003, J BIOL CHEM, V278, P12294, DOI 10.1074/jbc.M211849200; Xu ZX, 2005, MOL CELL, V17, P721, DOI 10.1016/j.molcel.2005.02.014; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752; Zhu HY, 2003, J BIOL CHEM, V278, P49286, DOI 10.1074/jbc.M308302200	47	21	24	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8738	8750		10.1074/jbc.M807590200	http://dx.doi.org/10.1074/jbc.M807590200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19150978	Green Published, hybrid			2022-12-25	WOS:000264397800058
J	Ramseger, R; White, R; Kroger, S				Ramseger, Rene; White, Robin; Kroeger, Stephan			Transmembrane Form Agrin-induced Process Formation Requires Lipid Rafts and the Activation of Fyn and MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED PROTEINS; NICOTINIC ACETYLCHOLINE-RECEPTOR; CULTURED HIPPOCAMPAL-NEURONS; SIGNAL-TRANSDUCTION; CORTICAL-NEURONS; TYROSINE KINASE; DEFICIENT MICE; NEUROMUSCULAR-JUNCTION; DENDRITIC FILOPODIA	Overexpression or clustering of the transmembrane form of the extracellular matrix heparan sulfate proteoglycan agrin (TM-agrin) induces the formation of highly dynamic filopodia-like processes on axons and dendrites from central and peripheral nervous system-derived neurons. Here we show that the formation of these processes is paralleled by a partitioning of TM-agrin into lipid rafts, that lipid rafts and transmembrane-agrin colocalize on the processes, that extraction of lipid rafts with methyl-beta-cyclodextrin leads to a dose-dependent reduction of process formation, that inhibition of lipid raft synthesis prevents process formation, and that the continuous presence of lipid rafts is required for the maintenance of the processes. Association of TM-agrin with lipid rafts results in the phosphorylation and activation of the Src family kinase Fyn and subsequently in the phosphorylation and activation of MAPK. Inhibition of Fyn or MAPK activation inhibits process formation. These results demonstrate that the formation of filopodia-like processes by TM-agrin is the result of the activation of a complex intracellular signaling cascade, supporting the hypothesis that TM-agrin is a receptor or coreceptor on neurons.	[Ramseger, Rene] Johannes Gutenberg Univ Mainz, Dept Physiol Chem, D-55128 Mainz, Germany; [White, Robin; Kroeger, Stephan] Johannes Gutenberg Univ Mainz, Dept Biol, D-55128 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Kroger, S (corresponding author), Univ Munich, Dept Physiol, Schillerstr 46, D-80336 Munich, Germany.	skroeger@lmu.de		Kroger, Stephan/0000-0002-4626-1690	Deutsche Forschungsgemeinschaft [Kr1039/7]; Deutsche Forschungsgemeinschaft Priority Program 1086 [Kr1039/9]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft Priority Program 1086(German Research Foundation (DFG))	Supported by Deutsche Forschungsgemeinschaft Grant Kr1039/7 and Deutsche Forschungsgemeinschaft Priority Program 1086 Grant Kr1039/9.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Annies M, 2006, MOL CELL NEUROSCI, V31, P515, DOI 10.1016/j.mcn.2005.11.005; Annies M, 2002, MOL CELL NEUROSCI, V20, P525, DOI 10.1006/mcne.2002.1125; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; Bose CM, 2000, J NEUROSCI, V20, P9086; Bruses JL, 2001, J NEUROSCI, V21, P504, DOI 10.1523/JNEUROSCI.21-02-00504.2001; Burgess RW, 2000, J CELL BIOL, V151, P41, DOI 10.1083/jcb.151.1.41; Campagna JA, 2006, NEUROSCIENCE, V138, P123, DOI 10.1016/j.neuroscience.2005.11.019; Chen L, 2006, J BIOL CHEM, V281, P24575, DOI 10.1074/jbc.M604147200; Denzer AJ, 1997, J CELL BIOL, V137, P671, DOI 10.1083/jcb.137.3.671; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Ferreira A, 1999, J CELL SCI, V112, P4729; Fiala JC, 1998, J NEUROSCI, V18, P8900; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Fuki IV, 2000, BIOCHEM J, V351, P607, DOI 10.1042/0264-6021:3510607; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; HALFTER W, 1987, J NEUROSCI, V7, P3712; Halfter W, 1997, J COMP NEUROL, V383, P1; Hambsch B, 2005, J BIOL CHEM, V280, P15888, DOI 10.1074/jbc.M414359200; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Harder T, 1999, EUR J IMMUNOL, V29, P556, DOI 10.1002/(SICI)1521-4141(199902)29:02<556::AID-IMMU556>3.0.CO;2-2; Hering H, 2003, J NEUROSCI, V23, P3262; Hilgenberg LGW, 1999, J NEUROSCI, V19, P7384, DOI 10.1523/JNEUROSCI.19-17-07384.1999; Hilgenberg LGW, 2004, J NEUROBIOL, V61, P289, DOI 10.1002/neu.20049; INOKUCHI J, 1987, CANCER LETT, V38, P23, DOI 10.1016/0304-3835(87)90196-0; Iwase T, 2005, J NEUROCHEM, V94, P1488, DOI 10.1111/j.1471-4159.2005.03290.x; Kammerer RA, 1999, EMBO J, V18, P6762, DOI 10.1093/emboj/18.23.6762; Karasewski L, 2003, J NEUROBIOL, V55, P14, DOI 10.1002/neu.10197; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Kim MJ, 2007, GLYCOBIOLOGY, V17, P231, DOI 10.1093/glycob/cwl069; Kim MJ, 2003, J NEUROBIOL, V55, P261, DOI 10.1002/neu.10213; Kolkova K, 2000, J NEUROSCI, V20, P2238; Kovacic B, 1998, J BIOL CHEM, V273, P35185; Kroger S, 2002, NEWS PHYSIOL SCI, V17, P207, DOI 10.1152/01390.2002; Kroger S, 1996, J NEUROBIOL, V29, P165; Kroger S, 1997, MOL CELL NEUROSCI, V10, P149, DOI 10.1006/mcne.1997.0651; Ksiazek I, 2007, J NEUROSCI, V27, P7183, DOI 10.1523/JNEUROSCI.1609-07.2007; Li WJ, 2005, J BIOL CHEM, V280, P6036, DOI 10.1074/jbc.M406546200; Li Z, 1999, J NEUROBIOL, V39, P547, DOI 10.1002/(SICI)1097-4695(19990615)39:4<547::AID-NEU8>3.0.CO;2-C; Lin S, 2008, J NEUROSCI, V28, P3333, DOI 10.1523/JNEUROSCI.5590-07.2008; Ma L, 2003, J NEUROSCI, V23, P3164; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Mantych KB, 2001, J NEUROSCI, V21, P6802, DOI 10.1523/JNEUROSCI.21-17-06802.2001; Marta CB, 2003, J NEUROSCI, V23, P5461; Mayer BJ, 2001, J CELL SCI, V114, P1253; McCroskery S, 2006, MOL CELL NEUROSCI, V33, P15, DOI 10.1016/j.mcn.2006.06.004; Nagafuku M, 2003, J BIOL CHEM, V278, P51920, DOI 10.1074/jbc.M307674200; Neumann FR, 2001, MOL CELL NEUROSCI, V17, P208, DOI 10.1006/mcne.2000.0932; Parnass Z, 2000, HIPPOCAMPUS, V10, P561, DOI 10.1002/1098-1063(2000)10:5<561::AID-HIPO6>3.3.CO;2-O; PLEIMAN CM, 1993, MOL CELL BIOL, V13, P5877, DOI 10.1128/MCB.13.9.5877; Resh MD, 1998, INT J BIOCHEM CELL B, V30, P1159, DOI 10.1016/S1357-2725(98)00089-2; RICKLES RJ, 1995, P NATL ACAD SCI USA, V92, P10909, DOI 10.1073/pnas.92.24.10909; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; SCHON A, 1989, BIOCHEMISTRY-US, V28, P5019, DOI 10.1021/bi00438a017; Serpinskaya AS, 1999, DEV BIOL, V205, P65, DOI 10.1006/dbio.1998.9112; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stetzkowski-Marden F, 2006, J LIPID RES, V47, P2121, DOI 10.1194/jlr.M600182-JLR200; Suzuki S, 2004, J CELL BIOL, V167, P1205, DOI 10.1083/jcb.200404106; Szczur K, 2006, BLOOD, V108, P4205, DOI 10.1182/blood-2006-03-013789; Tansey MG, 2000, NEURON, V25, P611, DOI 10.1016/S0896-6273(00)81064-8; Tatton L, 2003, J BIOL CHEM, V278, P4847, DOI 10.1074/jbc.M209321200; Tkachenko E, 2004, J CELL SCI, V117, P3189, DOI 10.1242/jcs.01190; Tkachenko E, 2002, J BIOL CHEM, V277, P19946, DOI 10.1074/jbc.M200841200; TSEN G, 1995, J BIOL CHEM, V270, P3392, DOI 10.1074/jbc.270.7.3392; Uhm CS, 2001, J NEUROSCI, V21, P9678, DOI 10.1523/JNEUROSCI.21-24-09678.2001; White R, 2008, J CELL BIOL, V181, P579, DOI 10.1083/jcb.200706164; Willmann R, 2006, EMBO J, V25, P4050, DOI 10.1038/sj.emboj.7601288; Wolven A, 1997, MOL BIOL CELL, V8, P1159, DOI 10.1091/mbc.8.6.1159; Wu CC, 1999, NEUROSCIENCE, V92, P665, DOI 10.1016/S0306-4522(99)00018-4; Zhu D, 2006, J NEUROSCI, V26, P4841, DOI 10.1523/JNEUROSCI.2807-05.2006; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	74	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7697	7705		10.1074/jbc.M806719200	http://dx.doi.org/10.1074/jbc.M806719200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19139104	hybrid, Green Published			2022-12-25	WOS:000264195600032
J	Gao, Y; Howard, A; Ban, K; Chandra, J				Gao, Yin; Howard, Adrienne; Ban, Kechen; Chandra, Joya			Oxidative Stress Promotes Transcriptional Up-regulation of Fyn in BCR-ABL1-expressing Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASES; SRC-FAMILY KINASES; PHILADELPHIA-CHROMOSOME; ROS PRODUCTION; DNA-DAMAGE; GC BOXES; BCR/ABL; GENE; ACTIVATION; REGION	Signaling initiated by the BCR-ABL1 kinase causes chronic myelogenous leukemia (CML). Recently, we reported that expression of Fyn, a Src kinase, is heightened in CML cells and patient specimens and confers in vitro and in vivo proliferative advantages. Fyn is regulated by redox, and because BCR-ABL1 raises intracellular oxidant levels, which have been implicated in CML progression, we explored the molecular regulation of Fyn. Here we identify the transcription factors that drive redox- and BCR-ABL1-dependent Fyn expression. Promoter deletion analysis in 293T, BaF3, BaF3-p210, and K562 cells identified the region essential for basal transcriptional activity. Mutation of Sp1 and Egr1 binding sites within the essential region diminished Fyn promoter activity and identified Egr1 as conferring redox sensitivity. Gel shift and chromatin immunoprecipitation assays confirmed the binding of Sp1 and Egr1 to the promoter fragments. Importantly, knockdown of Sp1 or Egr1 with small interference RNA or inhibition of Sp1 binding by mithramycin A repressed Fyn protein expression. Our work is the first to define transcription factors that are responsible for endogenous, oxidative stress-dependent and BCR-ABL1-dependent Fyn expression.	[Gao, Yin; Howard, Adrienne; Ban, Kechen; Chandra, Joya] Univ Texas MD Anderson Canc Ctr, Childrens Canc Hosp MD Anderson, Dept Pediat Res, Unit 853, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chandra, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Box 853,1515 Holcombe Blvd, Houston, TX 77030 USA.	jchandra@mdanderson.org	Chandra, Joya/ABC-7869-2021	Chandra, Joya/0000-0002-2077-9715	National Institutes of Health [RO1 CA 115811]; NATIONAL CANCER INSTITUTE [R01CA115811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA 115811 (to J.C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abe J, 1999, J BIOL CHEM, V274, P21003, DOI 10.1074/jbc.274.30.21003; Albertini V, 2006, NUCLEIC ACIDS RES, V34, P1721, DOI 10.1093/nar/gkl063; APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; Arlinghaus Ralph, 2004, Cancer Treat Res, V119, P239; Ban KC, 2008, BLOOD, V111, P2904, DOI 10.1182/blood-2007-05-091769; Berwanger B, 2002, CANCER CELL, V2, P377, DOI 10.1016/S1535-6108(02)00179-4; BONHAM K, 1993, ONCOGENE, V8, P1973; Chandra J, 1998, BLOOD, V92, P4220, DOI 10.1182/blood.V92.11.4220.423k49_4220_4229; Chang IS, 2007, BLOOD, V110, P994, DOI 10.1182/blood-2007-03-078303; COURTNEIDGE SA, 1993, DEVELOPMENT, P57; Dang CV, 2005, CELL CYCLE, V4, P1465, DOI 10.4161/cc.4.11.2121; DATTA R, 1993, P NATL ACAD SCI USA, V90, P2419, DOI 10.1073/pnas.90.6.2419; Deininger MWN, 2007, EXP HEMATOL, V35, P144, DOI 10.1016/j.exphem.2007.01.023; Doggrell SA, 2005, EXPERT OPIN INV DRUG, V14, P89, DOI 10.1517/13543784.14.1.89; Eiring AM, 2008, BLOOD, V111, P816, DOI 10.1182/blood-2007-05-090472; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Fukada T, 2001, J BIOL CHEM, V276, P25512, DOI 10.1074/jbc.M101354200; Furumoto Y, 2004, IMMUNOL RES, V30, P241, DOI 10.1385/IR:30:2:241; Guerzoni C, 2006, BLOOD, V107, P4080, DOI 10.1182/blood-2005-08-3181; Hauses M, 1998, J BIOL CHEM, V273, P31844, DOI 10.1074/jbc.273.48.31844; Hochhaus A, 2007, SEMIN HEMATOL, V44, pS15, DOI 10.1053/j.seminhematol.2006.12.002; Iervolino A, 2002, MOL CELL BIOL, V22, P2255, DOI 10.1128/MCB.22.7.2255-2266.2002; Juric D, 2007, J CLIN ONCOL, V25, P1341, DOI 10.1200/JCO.2006.09.3534; Kamath AV, 2008, CANCER CHEMOTH PHARM, V61, P365, DOI 10.1007/s00280-007-0478-8; Kim JH, 2005, BLOOD, V105, P1717, DOI 10.1182/blood-2004-03-0849; Koptyra M, 2006, BLOOD, V108, P319, DOI 10.1182/blood-2005-07-2815; Lee J, 2006, FASEB J, V20, P2375, DOI 10.1096/fj.06-5957fje; Legros L, 2004, BLOOD, V104, P495, DOI 10.1182/blood-2003-08-2695; Long J, 2007, CANCER CHEMOTH PHARM, V59, P527, DOI 10.1007/s00280-006-0295-5; Masutani H, 2000, INT J HEMATOL, V71, P25; MATSUZAWA Y, 1991, ONCOGENE, V6, P1561; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; Nowell PC, 2007, J CLIN INVEST, V117, P2033, DOI 10.1172/JCI31771; Nowicki MO, 2004, BLOOD, V104, P3746, DOI 10.1182/blood-2004-05-1941; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Penserga ETP, 2007, ONCOGENE, V26, P11, DOI 10.1038/sj.onc.1209756; Ritchie S, 2000, J BIOL CHEM, V275, P847, DOI 10.1074/jbc.275.2.847; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Sallmyr A, 2008, BLOOD, V111, P3173, DOI 10.1182/blood-2007-05-092510; Sanguinetti AR, 2003, BIOCHEM J, V376, P159, DOI 10.1042/BJ20030336; Sattler M, 2003, SEMIN HEMATOL, V40, P4, DOI 10.1053/shem.2003.50034; Sattler M, 2000, J BIOL CHEM, V275, P24273, DOI 10.1074/jbc.M002094200; Shah NP, 2003, ONCOGENE, V22, P7389, DOI 10.1038/sj.onc.1206942; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Sorensen KD, 2008, INT J CANCER, V122, P509, DOI 10.1002/ijc.23136; Stuart JR, 2005, ONCOGENE, V24, P8085, DOI 10.1038/sj.onc.1208953; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Trotta R, 2003, CANCER CELL, V3, P145, DOI 10.1016/S1535-6108(03)00020-5; UCHIUMI F, 1992, MOL CELL BIOL, V12, P3784, DOI 10.1128/MCB.12.9.3784	50	30	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7114	7125		10.1074/jbc.M804801200	http://dx.doi.org/10.1074/jbc.M804801200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19131339	hybrid, Green Published			2022-12-25	WOS:000263919000059
J	Griffero, F; Daga, A; Marubbi, D; Capra, MC; Melotti, A; Pattarozzi, A; Gatti, M; Bajetto, A; Porcile, C; Barbieri, F; Favoni, RE; Lo Casto, M; Zona, G; Spaziante, R; Florio, T; Corte, G				Griffero, Fabrizio; Daga, Antonio; Marubbi, Daniela; Capra, Maria Cristina; Melotti, Alice; Pattarozzi, Alessandra; Gatti, Monica; Bajetto, Adriana; Porcile, Carola; Barbieri, Federica; Favoni, Roberto E.; Lo Casto, Michele; Zona, Gianluigi; Spaziante, Renato; Florio, Tullio; Corte, Giorgio			Different Response of Human Glioma Tumor-initiating Cells to Epidermal Growth Factor Receptor Kinase Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER STEM-CELLS; BRAIN-TUMORS; IN-VITRO; NEURAL PRECURSORS; HUMAN MENINGIOMAS; GENE-EXPRESSION; SIDE-POPULATION; NERVOUS-SYSTEM; PROLIFERATION; EGF	Because a subpopulation of cancer stem cells (tumor-initiating cells, TICs) is believed to be responsible for the development, progression, and recurrence of many tumors, we evaluated the in vitro sensitivity of human glioma TICs to epidermal growth factor receptor (EGFR) kinase inhibitors (erlotinib and gefitinib) and possible molecular determinants for their effects. Cells isolated from seven glioblastomas (GBM 1-7) and grown using neural stem cell permissive conditions were characterized for in vivo tumorigenicity, expression of tumor stem cell markers (CD133, nestin), and multilineage differentiation properties, confirming that these cultures are enriched in TICs. TIC cultures were challenged with increasing concentrations of erlotinib and gefitinib, and their survival was evaluated after 1-4 days. In most cases, a time- and concentration-dependent cell death was observed, although GBM 2 was completely insensitive to both drugs, and GBM 7 was responsive only to the highest concentrations tested. Using a radioligand binding assay, we show that all GBM TICs express EGFR. Erlotinib and gefitinib inhibited EGFR and ERK1/2 phosphorylation/activation in all GBMs, irrespective of the antiproliferative response observed. However, under basal conditions GBM 2 showed a high Akt phosphorylation that was completely insensitive to both drugs, whereas GBM 7 was completely insensitive to gefitinib, and Akt inactivation occurred only for the highest erlotinib concentration tested, showing a precise relationship with the antiproliferative effects of the drug. Interestingly, in GBM 2, phosphatase and tensin homolog expression was significantly down-regulated, possibly accounting for the insensitivity to the drugs. In conclusion, glioma TICs are responsive to anti-EGFR drugs, but phosphatase and tensin homolog expression and Akt inhibition seem to be necessary for such effect.	[Florio, Tullio] Univ Genoa, Dept Oncol Biol & Genet, Pharmacol Lab, I-16132 Genoa, Italy; [Griffero, Fabrizio; Daga, Antonio; Capra, Maria Cristina; Melotti, Alice; Favoni, Roberto E.; Lo Casto, Michele; Corte, Giorgio] Natl Inst Canc Res, Dept Translat Oncol, I-16132 Genoa, Italy; [Zona, Gianluigi; Spaziante, Renato] Univ Genoa, Dept Neurosci Ophthalmol & Genet, I-16132 Genoa, Italy	University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Genoa	Florio, T (corresponding author), Univ Genoa, Dept Oncol Biol & Genet, Pharmacol Lab, Viale Benedetto 15,2, I-16132 Genoa, Italy.	tullio.florio@unige.it; giorgio.corte@istge.it	FLORIO, TULLIO/ABG-3182-2020; Barbieri, Federica/L-8753-2015; Daga, Antonio/Z-2417-2019; Florio, Tullio/A-2211-2012; Daga, Antonio/C-3041-2008; zona, gianluigi/AAF-8235-2021	Barbieri, Federica/0000-0001-8988-6896; Daga, Antonio/0000-0001-5845-8530; Florio, Tullio/0000-0002-2394-996X; Monica, Gatti/0000-0002-2016-0285; ZONA, GIANLUIGI/0000-0002-3577-7894	Fondazione Carige; MIUR-PRIN; Ministero della Salute	Fondazione Carige(Fondazione Carige); MIUR-PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Ministero della Salute(Ministry of Health, Italy)	This work was supported by grants from Fondazione Carige, MIUR-PRIN, and Ministero della Salute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arena S, 2004, J NEURO-ONCOL, V66, P155, DOI 10.1023/B:NEON.0000013498.19981.55; Bajetto A, 2007, NEURO-ONCOLOGY, V9, P3, DOI 10.1215/15228517-2006-023; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Castellino RC, 2007, NAT CLIN PRACT NEURO, V3, P682, DOI 10.1038/ncpneuro0661; Cho RW, 2008, CURR OPIN GENET DEV, V18, P48, DOI 10.1016/j.gde.2008.01.017; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Diehn M, 2006, J NATL CANCER I, V98, P1755, DOI 10.1093/jnci/djj505; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Dowlati A, 2004, MOL CANCER THER, V3, P459; Florio T, 2006, MOL PHARMACOL, V69, P539, DOI 10.1124/mol.105.015255; Florio T, 2008, ENDOCR-RELAT CANCER, V15, P583, DOI 10.1677/ERC-07-0271; Florio T, 2008, MOL CELL ENDOCRINOL, V286, P40, DOI 10.1016/j.mce.2007.08.012; Fukazawa H, 2002, MOL CANCER THER, V1, P303; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; GANGEMI RM, 2008, STEM CELLS, V23, P23; Gangemi RMR, 2006, EUR J NEUROSCI, V23, P325, DOI 10.1111/j.1460-9568.2005.04559.x; Gibson S, 1999, J BIOL CHEM, V274, P17612, DOI 10.1074/jbc.274.25.17612; Gritti A, 1999, J NEUROSCI, V19, P3287; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kari C, 2003, CANCER RES, V63, P1; Knobbe CB, 2002, NEURO-ONCOLOGY, V4, P196; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ma YH, 2008, J NEURO-ONCOL, V86, P31, DOI 10.1007/s11060-007-9439-7; Massa A, 2004, J BIOL CHEM, V279, P29004, DOI 10.1074/jbc.M403573200; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Ono M, 2004, MOL CANCER THER, V3, P465; Palmer TD, 1999, J NEUROSCI, V19, P8487; PAN MG, 1992, SCIENCE, V256, P1215, DOI 10.1126/science.256.5060.1215; Pattarozzi A, 2008, MOL PHARMACOL, V73, P191, DOI 10.1124/mol.107.039974; Pedersen MW, 2001, ANN ONCOL, V12, P745, DOI 10.1023/A:1011177318162; Preusser M, 2006, WIEN MED WOCHENSCHR, V156, P332, DOI 10.1007/s10354-006-0304-7; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Shmelkov SV, 2005, INT J BIOCHEM CELL B, V37, P715, DOI 10.1016/j.biocel.2004.08.010; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soeda A, 2008, J BIOL CHEM, V283, P10958, DOI 10.1074/jbc.M704205200; vanderValk P, 1997, ANN ONCOL, V8, P1023, DOI 10.1023/A:1008265905505; Vermeulen L, 2008, CELL DEATH DIFFER, V15, P947, DOI 10.1038/cdd.2008.20; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Woodburn JR, 1999, PHARMACOL THERAPEUT, V82, P241, DOI 10.1016/S0163-7258(98)00045-X; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Zhou YH, 2003, CLIN CANCER RES, V9, P3369	54	122	122	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7138	7148		10.1074/jbc.M807111200	http://dx.doi.org/10.1074/jbc.M807111200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19147502	hybrid, Green Published			2022-12-25	WOS:000263919000061
J	Razidlo, GL; Johnson, HJ; Stoeger, SM; Cowan, KH; Bessho, T; Lewis, RE				Razidlo, Gina L.; Johnson, Heidi J.; Stoeger, Scott M.; Cowan, Kenneth H.; Bessho, Tadayoshi; Lewis, Robert E.			KSR1 Is Required for Cell Cycle Reinitiation Following DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; INTERSTRAND CROSS-LINKS; DOUBLE-STRAND BREAKS; MAP KINASE; GENOTOXIC STRESS; MITOMYCIN-C; IN-VITRO; SUPPRESSOR; RAS; CHECKPOINT	KSR1 (kinase suppressor of Ras 1) is a molecular scaffold and positive regulator of the Raf/MEK/ERK phosphorylation cascade. KSR1 is required for maximal ERK activation induced by growth factors and by some cytotoxic agents. We show here that KSR1 is also required for maximal ERK activation induced by UV light, ionizing radiation, or the DNA interstrand cross-linking agent mitomycin C (MMC). We further demonstrate a role for KSR1 in the reinitiation of the cell cycle and proliferation following cell cycle arrest induced by MMC. Cells lacking KSR1 underwent but did not recover from MMC-induced G(2)/M arrest. Expression of KSR1 allowed KSR1(-/-) cells to re-enter the cell cycle following MMC treatment. However, cells expressing a mutated form of KSR1 unable to bind ERK did not recover from MMC-induced cell cycle arrest, demonstrating the requirement for the KSR1-ERK interaction. In addition, constitutive activation of ERK was not sufficient to promote cell cycle reinitiation in MMC-treated KSR1(-/-) cells. Only cells expressing KSR1 recovered from MMC-induced cell cycle arrest. Importantly, MMC-induced DNA damage was repaired in KSR1(-/-) cells, as determined by resolution of gamma-H2AX-containing foci. These data indicate that cell cycle reinitiation is not actively signaled in the absence of KSR1, even when DNA damage has been resolved. These data reveal a specific role for the molecular scaffold KSR1 and KSR1-mediated ERK signaling in the cellular response to DNA interstrand cross-links.	[Razidlo, Gina L.; Johnson, Heidi J.; Stoeger, Scott M.; Cowan, Kenneth H.; Bessho, Tadayoshi; Lewis, Robert E.] Univ Nebraska, Med Ctr, Eppley Inst, Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Lewis, RE (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst, Res Canc & Allied Dis, 987696 Nebraska Med Ctr, Omaha, NE 68198 USA.	rlewis@unmc.edu	Lewis, Robert E./H-3404-2019	Razidlo, Gina/0000-0002-9042-2738	National Institutes of Health [CA90400]; Nebraska Dept. of Health and Human Services; Cancer Center Support [CA036727]; Training Grant [CA009476]; National Science Foundation; University of Nebraska Medical Center Graduate Studies; NATIONAL CANCER INSTITUTE [P30CA036727, T32CA009476, R01CA090400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Dept. of Health and Human Services; Cancer Center Support; Training Grant; National Science Foundation(National Science Foundation (NSF)); University of Nebraska Medical Center Graduate Studies; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA90400 ( to R. E. L.). This work was also supported by a grant from the Nebraska Dept. of Health and Human Services ( to R. E. L.) and Cancer Center Support Grant CA036727.; Supported by Training Grant CA009476.; Supported by a predoctoral fellowship from the National Science Foundation.; Supported by a Widaman Fellowship from University of Nebraska Medical Center Graduate Studies.	Abbott DW, 1999, J BIOL CHEM, V274, P2732, DOI 10.1074/jbc.274.5.2732; Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; ATHERTONFESSLER S, 1993, MOL CELL BIOL, V13, P1675, DOI 10.1128/MCB.13.3.1675; BODE AM, 2003, SCI STKE, pRE2; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Chou SF, 2007, INVEST OPHTH VIS SCI, V48, P2009, DOI 10.1167/iovs.06-0835; Cipak L, 2006, NAT STRUCT MOL BIOL, V13, P729, DOI 10.1038/nsmb1120; De Silva IU, 2000, MOL CELL BIOL, V20, P7980, DOI 10.1128/MCB.20.21.7980-7990.2000; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Dronkert MLG, 2001, MUTAT RES-DNA REPAIR, V486, P217, DOI 10.1016/S0921-8777(01)00092-1; Dunphy William G., 1994, Trends in Cell Biology, V4, P202; FENECH M, 1985, MUTAT RES, V147, P29, DOI 10.1016/0165-1161(85)90015-9; Fisher LA, 2008, J BIOL CHEM, V283, P1275, DOI 10.1074/jbc.M708072200; Friedberg EC, 2005, DNA REPAIR MUTAGENES; KANO Y, 1981, MUTAT RES, V81, P365, DOI 10.1016/0027-5107(81)90123-8; Kim M, 2005, CANCER RES, V65, P3986, DOI 10.1158/0008-5472.CAN-03-2334; Kortum RL, 2006, MOL CELL BIOL, V26, P2202, DOI 10.1128/MCB.26.6.2202-2214.2006; Kortum RL, 2005, MOL CELL BIOL, V25, P7592, DOI 10.1128/MCB.25.17.7592-7604.2005; Kortum RL, 2004, MOL CELL BIOL, V24, P4407, DOI 10.1128/MCB.24.10.4407-4416.2004; Kuraoka I, 2000, J BIOL CHEM, V275, P26632, DOI 10.1074/jbc.C000337200; Lee SW, 2000, P NATL ACAD SCI USA, V97, P8302, DOI 10.1073/pnas.150024397; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Lozano J, 2003, CANCER RES, V63, P4232; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Matsumoto T, 1999, J BIOL CHEM, V274, P13954, DOI 10.1074/jbc.274.20.13954; Mckay MM, 2007, J BIOL CHEM, V282, P26225, DOI 10.1074/jbc.M702692200; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Muller J, 2001, MOL CELL, V8, P983, DOI 10.1016/S1097-2765(01)00383-5; Muller J, 2000, MOL CELL BIOL, V20, P5529, DOI 10.1128/MCB.20.15.5529-5539.2000; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Noll DM, 2006, CHEM REV, V106, P277, DOI 10.1021/cr040478b; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Pandey P, 1996, J BIOL CHEM, V271, P23775, DOI 10.1074/jbc.271.39.23775; PARKER LL, 1992, P NATL ACAD SCI USA, V89, P2917, DOI 10.1073/pnas.89.7.2917; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Peng CY, 1998, CELL GROWTH DIFFER, V9, P197; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; ROOTS R, 1985, INT J RADIAT ONCOL, V11, P259, DOI 10.1016/0360-3016(85)90147-6; Rothfuss A, 2004, MOL CELL BIOL, V24, P123, DOI 10.1128/MCB.24.1.123-134.2004; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; SETLOW RB, 1966, SCIENCE, V153, P379, DOI 10.1126/science.153.3734.379; SHIBUYA EK, 1992, EMBO J, V11, P3963, DOI 10.1002/j.1460-2075.1992.tb05490.x; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; Stewart S, 1999, MOL CELL BIOL, V19, P5523; Stiff T, 2005, EMBO J, V24, P199, DOI 10.1038/sj.emboj.7600504; Szatmari E, 2007, J NEUROSCI, V27, P11389, DOI 10.1523/JNEUROSCI.3473-07.2007; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; TOMASZ M, 1995, CHEM BIOL, V2, P575, DOI 10.1016/1074-5521(95)90120-5; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang RN, 2007, CELL, V128, P1119, DOI 10.1016/j.cell.2006.11.053; Wittinghofer A, 1998, BIOL CHEM, V379, P933; Wu D, 2006, ONCOGENE, V25, P1153, DOI 10.1038/sj.onc.1209148; Yan F, 2004, J CLIN INVEST, V114, P1272, DOI 10.1172/JCI200421022; Yan F, 2001, CANCER RES, V61, P8668; Yan Y, 2007, ONCOGENE, V26, P4689, DOI 10.1038/sj.onc.1210268; Yan Y, 2008, CANCER RES, V68, P5113, DOI 10.1158/0008-5472.CAN-07-5818; Yang J, 2003, MUTAT RES-REV MUTAT, V543, P31, DOI 10.1016/S1383-5742(02)00069-8; Yu W, 1998, CURR BIOL, V8, P56, DOI 10.1016/S0960-9822(98)70020-X; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	76	13	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6705	6715		10.1074/jbc.M806457200	http://dx.doi.org/10.1074/jbc.M806457200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19147494	Green Published, hybrid			2022-12-25	WOS:000263919000015
J	Lee, SJ; Yang, JW; Cho, IJ; Kim, WD; Cho, MK; Lee, CH; Kim, SG				Lee, S. J.; Yang, J. W.; Cho, I. J.; Kim, W. D.; Cho, M. K.; Lee, C. H.; Kim, S. G.			The gep oncogenes, G alpha(12) and G alpha(13), upregulate the transforming growth factor-beta 1 gene	ONCOGENE			English	Article						G alpha(12) members; transforming growth factor-beta 1; hepatic stellate cell; activating protein 1	HEPATIC STELLATE CELLS; KAPPA-B-ALPHA; LIVER FIBROSIS; G-PROTEINS; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION FACTOR; SIGNALING PATHWAYS; PROMOTER REGION; CIRRHOTIC LIVER; CANCER CELLS	Transforming growth factor-beta 1 (TGF beta 1) plays a role in neoplastic transformation and transdifferentiation. G alpha(12) and G alpha(13), referred to as the gep oncogenes, stimulate mitogenic pathways. Nonetheless, no information is available regarding their roles in the regulation of the TGF beta 1 gene and the molecules linking them to gene transcription. Knockdown or knockout experiments using murine embryonic fibroblasts and hepatic stellate cells indicated that a G alpha(12) and G alpha(13) deficiency reduced constitutive, auto-stimulatory or thrombin-inducible TGF beta 1 gene expression. In contrast, transfection of activated mutants of G alpha(12) and G alpha(13) enabled the knockout cells to promote TGF beta 1 induction. A promoter deletion analysis suggested that activating protein 1 (AP-1) plays a role in TGF beta 1 gene transactivation, which was corroborated by the observation that a deficiency of the G-proteins decreased the AP-1 activity, whereas their activation enhanced it. Moreover, mutation of the AP-1-binding site abrogated the ability of G alpha(12) and G alpha(13) to induce the TGF beta 1 gene. Transfection of a dominant-negative mutant of Rho or Rac, but not Cdc42, prevented gene transactivation and decreased AP-1 activity downstream of G alpha 12 and G alpha 13. In summary, G alpha 12 and G alpha 13 regulate the expression of the TGF beta 1 gene through an increase in Rho/Rac-dependent AP-1 activity, implying that the G-protein-coupled receptor (GPCR)-G alpha(12) pathway is involved in the TGF beta 1-mediated transdifferentiation process.	[Kim, S. G.] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul 151742, South Korea; [Lee, S. J.; Yang, J. W.; Cho, I. J.; Kim, W. D.; Cho, M. K.; Kim, S. G.] Seoul Natl Univ, Coll Pharm, Innovat Drug Res Ctr Metab & Inflammatory Dis, Seoul 151742, South Korea; [Cho, M. K.] Dongguk Univ, Coll Oriental Med, Kyungju, South Korea; [Lee, C. H.] Hanyang Univ, Coll Med, Inst Biomed Sci, Seoul 133791, South Korea; [Lee, C. H.] Hanyang Univ, Coll Med, Dept Pharmacol, Seoul 133791, South Korea	Seoul National University (SNU); Seoul National University (SNU); Dongguk University; Hanyang University; Hanyang University	Kim, SG (corresponding author), Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul 151742, South Korea.	sgk@snu.ac.kr		Kim, Wondong/0000-0001-9030-9164	Korea government (MEST), Korea [R11-2007-10701001-0]	Korea government (MEST), Korea(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	We thank Dr SC Brooks III for helpful discussion and English editing. This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government ( MEST) ( No. R11-2007-10701001-0), Korea.	Ankoma-Sey V, 2000, HEPATOLOGY, V31, P141, DOI 10.1002/hep.510310122; Bahr MJ, 1999, HEPATOLOGY, V29, P839, DOI 10.1002/hep.510290333; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bataller R, 2000, GASTROENTEROLOGY, V118, P1149, DOI 10.1016/S0016-5085(00)70368-4; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Byun HJ, 2006, J BIOL CHEM, V281, P34833, DOI 10.1074/jbc.M605483200; CHAN AML, 1993, MOL CELL BIOL, V13, P762, DOI 10.1128/MCB.13.2.762; Coulouarn C, 2008, HEPATOLOGY, V47, P2059, DOI 10.1002/hep.22283; Dhanasekaran N, 1996, CELL SIGNAL, V8, P235, DOI 10.1016/0898-6568(96)00048-4; DOKTER WHA, 1995, LEUKEMIA, V9, P425; Fiorucci S, 2004, HEPATOLOGY, V39, P365, DOI 10.1002/hep.20054; Fransvea E, 2008, HEPATOLOGY, V47, P1557, DOI 10.1002/hep.22201; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; Fujii T, 2005, J BIOL CHEM, V280, P23041, DOI 10.1074/jbc.M409397200; Gaca MDA, 2002, J HEPATOL, V36, P362, DOI 10.1016/S0168-8278(01)00285-9; George J, 2001, TOXICOLOGY, V156, P129, DOI 10.1016/S0300-483X(00)00352-8; George J, 1996, BBA-PROTEIN STRUCT M, V1292, P215, DOI 10.1016/0167-4838(95)00202-2; Giannelli G, 2005, GASTROENTEROLOGY, V129, P1375, DOI 10.1053/j.gastro.2005.09.055; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Graupera M, 2003, HEPATOLOGY, V37, P172, DOI 10.1053/jhep.2003.50004; Gu JL, 2002, P NATL ACAD SCI USA, V99, P9352, DOI 10.1073/pnas.102291599; JENKINS SA, 1985, J HEPATOL, V1, P489, DOI 10.1016/S0168-8278(85)80747-9; Kang KW, 2003, J BIOL CHEM, V278, P17368, DOI 10.1074/jbc.M300471200; Kang KW, 2002, FASEB J, V16, P1988, DOI 10.1096/fj.02-0406fje; Kang KW, 2002, CHEM-BIOL INTERACT, V139, P61, DOI 10.1016/S0009-2797(01)00286-1; Kaufmann R, 2007, J CELL PHYSIOL, V211, P699, DOI 10.1002/jcp.21027; Kawanabe Y, 2002, MOL PHARMACOL, V61, P277, DOI 10.1124/mol.61.2.277; Kelly P, 2007, BIOCHEMISTRY-US, V46, P6677, DOI 10.1021/bi700235f; Ki SH, 2007, J BIOL CHEM, V282, P1938, DOI 10.1074/jbc.M606080200; KIM SJ, 1989, J BIOL CHEM, V264, P402; Kumar RN, 2006, ONCOGENE, V25, P899, DOI 10.1038/sj.onc.1209132; Kuner R, 2002, EUR J NEUROSCI, V16, P2333, DOI 10.1046/j.1460-9568.2002.02402.x; Kurose H, 2003, LIFE SCI, V74, P155, DOI 10.1016/j.lfs.2003.09.003; Lee JS, 2007, HEPATOLOGY, V45, P817, DOI 10.1002/hep.21564; Mikula M, 2006, J CELL PHYSIOL, V209, P560, DOI 10.1002/jcp.20772; Molteni Agostino, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P451, DOI 10.2174/187152006778226521; Oklu R, 2000, BIOCHEM J, V352, P601, DOI 10.1042/0264-6021:3520601; Olaso E, 1997, HEPATOLOGY, V26, P634, DOI 10.1053/jhep.1997.v26.pm0009303493; Pinzani M, 1996, GASTROENTEROLOGY, V110, P534, DOI 10.1053/gast.1996.v110.pm8566602; Qi Z, 1999, P NATL ACAD SCI USA, V96, P2345, DOI 10.1073/pnas.96.5.2345; Radhika V, 2005, ONCOGENE, V24, P4597, DOI 10.1038/sj.onc.1208665; RHOADES KL, 1992, J BIOL CHEM, V267, P22102; SCHOOK LB, 1992, TOXICOL APPL PHARM, V116, P110, DOI 10.1016/0041-008X(92)90151-H; Smart DE, 2006, HEPATOLOGY, V44, P1432, DOI 10.1002/hep.21436; Solis-Herruzo JA, 1998, CELL SIGNAL, V10, P173, DOI 10.1016/S0898-6568(97)00036-3; Vogt S, 2003, J BIOL CHEM, V278, P28743, DOI 10.1074/jbc.M304570200; Weigert C, 2000, J AM SOC NEPHROL, V11, P2007, DOI 10.1681/ASN.V11112007; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; XU NZ, 1993, P NATL ACAD SCI USA, V90, P6741, DOI 10.1073/pnas.90.14.6741; XU NZ, 1994, BIOCHEM BIOPH RES CO, V201, P603, DOI 10.1006/bbrc.1994.1744; Yamaguchi Y, 2003, J BIOL CHEM, V278, P14936, DOI 10.1074/jbc.M301409200; Yoshiji H, 2007, CURR MED CHEM, V14, P2749, DOI 10.2174/092986707782360169; Yue JB, 2000, J BIOL CHEM, V275, P30765, DOI 10.1074/jbc.M000039200; Zhao SJ, 2008, CANCER RES, V68, P4221, DOI 10.1158/0008-5472.CAN-07-5123	54	20	21	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 5	2009	28	9					1230	1240		10.1038/onc.2008.488	http://dx.doi.org/10.1038/onc.2008.488			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	415AH	19151758				2022-12-25	WOS:000263906200007
J	Mattera, L; Escaffit, F; Pillaire, MJ; Selves, J; Tyteca, S; Hoffmann, JS; Gourraud, PA; Chevillard-Briet, M; Cazaux, C; Trouche, D				Mattera, L.; Escaffit, F.; Pillaire, M-J; Selves, J.; Tyteca, S.; Hoffmann, J-S; Gourraud, P-A; Chevillard-Briet, M.; Cazaux, C.; Trouche, D.			The p400/Tip60 ratio is critical for colorectal cancer cell proliferation through DNA damage response pathways	ONCOGENE			English	Article						colon cancer; apoptosis; chromatin; p400; Tip60	TIP60 HISTONE ACETYLTRANSFERASE; P53 PATHWAY; ACETYLATION; APOPTOSIS; COMPLEX; P400; HISTONE-DEACETYLASE-3; PROGRESSION; CHROMATIN; REPAIR	The Tip60 histone acetyltransferase belongs to a multi-molecular complex that contains many chromatin remodeling enzymes including the ATPase p400, a protein involved in nucleosomal incorporation of specific histone variants and that can directly or indirectly repress some Tip60-dependent pathways. Tip60 activity is critical for the cellular response to DNA damage and is affected during cancer progression. Here, we found that the ratio between Tip60 and p400 mRNAs is affected in most colorectal carcinoma. Strikingly, reversing the p400/Tip60 imbalance by Tip60 overexpression or the use of siRNAs resulted in increased apoptosis and decreased proliferation of colon-cancer-derived cells, suggesting that this ratio defect is important for cancer progression. Furthermore, we demonstrate that the p400/Tip60 ratio controls the oncogene-induced DNA damage response, a known anticancer barrier. Finally, we found that it is also critical for the response to 5-fluorouracil, a first-line treatment against colon cancer. Together, our data indicate that the p400/Tip60 ratio is critical for colon cancer cells proliferation and response to therapeutic drugs through the control of stress-response pathways.	[Trouche, D.] CNRS, LBCMCP, UMR 5088, F-31062 Toulouse, France; [Mattera, L.; Escaffit, F.; Pillaire, M-J; Selves, J.; Tyteca, S.; Hoffmann, J-S; Gourraud, P-A; Chevillard-Briet, M.; Cazaux, C.; Trouche, D.] Univ Toulouse, UPS, Toulouse, France; [Pillaire, M-J; Hoffmann, J-S; Cazaux, C.] CNRS, IPBS, F-31062 Toulouse, France; [Selves, J.] Fac Med Toulouse, INSERM, CPTP, F-31073 Toulouse, France; [Gourraud, P-A] Hop Toulouse, INSERM, Serv Epidemiol, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)	Trouche, D (corresponding author), CNRS, LBCMCP, UMR 5088, 118 Route Narbonne, F-31062 Toulouse, France.	dtrouche@cict.fr	Selves, Janick/M-7719-2014; Gourraud, Pierre-Antoine FD/O-3024-2015; Hoffmann, Jean-Sebastien/O-9183-2014; ESCAFFIT, Fabrice/AAE-4832-2021; Pillaire, Marie-Jeanne/P-1579-2014	Hoffmann, Jean-Sebastien/0000-0003-2222-354X; Pillaire, Marie-Jeanne/0000-0001-6866-7416; Trouche, Didier/0000-0003-1398-6481; Gourraud, Pierre-Antoine/0000-0003-1131-9554	ARC; Institut National du Cancer (INCa); Canceropole Grand Sud-Ouest (ACI 2004/2007); French Ministry of Science; 'Fondation de France'	ARC(Australian Research Council); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Canceropole Grand Sud-Ouest (ACI 2004/2007)(French National Research Agency (ANR)); French Ministry of Science; 'Fondation de France'(Fondation de France)	We thank Professor JF Beaulieu and K Helin for materials, Professor B Ducommun, Dr G Legube and Dr Y Canitrot for critical reading of the paper. We also acknowledge JJ Maoret, responsible person of the QPCR platform at IFR31 (INSERM), as well as S Mazeres (IPBS) and P Grosclaude (INSERM) for their help to format the data concerning tumor analysis. This work was supported by a grant to DT as a 'subvention libre' from the ARC and the Institut National du Cancer (INCa), Canceropole Grand Sud-Ouest (ACI 2004/2007, to CC). LM and ST were supported by studentships from the French Ministry of Science and the ARC, respectively, whereas FE was supported by a fellowship from the 'Fondation de France'.	Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Chan HM, 2005, GENE DEV, V19, P196, DOI 10.1101/gad.1280205; Escaffit F, 2007, MOL CELL BIOL, V27, P554, DOI 10.1128/MCB.00869-06; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; Gaughan L, 2001, J BIOL CHEM, V276, P46841, DOI 10.1074/jbc.M103710200; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Legube G, 2004, J BIOL CHEM, V279, P44825, DOI 10.1074/jbc.M407478200; Lleonart ME, 2006, ONCOL REP, V16, P603; Miremadi A, 2007, HUM MOL GENET, V16, pR28, DOI 10.1093/hmg/ddm021; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; Tyteca S, 2006, EMBO J, V25, P1680, DOI 10.1038/sj.emboj.7601066; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200	20	72	76	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	12					1506	1517		10.1038/onc.2008.499	http://dx.doi.org/10.1038/onc.2008.499			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	424AH	19169279				2022-12-25	WOS:000264537400003
J	Yeh, YH; Huang, YF; Lin, TY; Shieh, SY				Yeh, Y-H; Huang, Y-F; Lin, T-Y; Shieh, S-Y			The cell cycle checkpoint kinase CHK2 mediates DNA damage-induced stabilization of TTK/hMps1	ONCOGENE			English	Article						checkpoint; CHK2; TTK/hMps1	POLE BODY DUPLICATION; SPINDLE-CHECKPOINT; PROTEIN-KINASE; KINETOCHORE LOCALIZATION; CENTROSOME DUPLICATION; MITOTIC CHECKPOINT; HUMAN MPS1; CANCER-THERAPY; GENE MPS1; PHOSPHORYLATION	Cell cycle progression is monitored constantly to ensure faithful passage of genetic codes and genome stability. We have demonstrated previously that, upon DNA damage, TTK/hMps1 activates the checkpoint kinase CHK2 by phosphorylating CHK2 at Thr68. However, it remains to be determined whether and how TTK/hMps1 responds to DNA damage. In this report, we present evidence that TTK/hMps1 can be induced by DNA damage in normal human. broblasts. Interestingly, the induction depends on CHK2 because CHK2-targeting small interfering RNA or a CHK2 inhibitor abolishes the increase. Such induction is mediated through phosphorylation of TTK/hMps1 at Thr288 by CHK2 and requires the CHK2 SQ/TQ cluster domain/forkhead-associated domain. In cells, TTK/hMps1 phosphorylation at Thr288 is induced by DNA damage and forms nuclear foci, which colocalize partially with c-H2AX. Reexpression of TTK/hMps1 T288A mutant in TTK/hMps1-knockdown cells causes a defect in G2/M arrest, suggesting that phosphorylation at this site participates in the proper checkpoint execution. Our study uncovered a regulatory loop between TTK/hMps1 and CHK2 whereby DNA damage-activated CHK2 may facilitate the stabilization of TTK/hMps1, therefore maintaining the checkpoint control.	[Yeh, Y-H; Huang, Y-F; Lin, T-Y; Shieh, S-Y] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Huang, Y-F] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan	Academia Sinica - Taiwan; National Tsing Hua University	Shieh, SY (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Sect 2,Acad Rd, Taipei 115, Taiwan.	sy88@ibms.sinica.edu.tw	Shieh, Sheau-Yann/N-9512-2018	Shieh, Sheau-Yann/0000-0002-5351-4430	Academia Sinica; National Science Council of Taiwan	Academia Sinica(Academia Sinica - Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Academia Sinica and National Science Council of Taiwan to S-Y Shieh.	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Cui Y, 2008, ONCOGENE, V27, P3122, DOI 10.1038/sj.onc.1210972; de Carcer G, 2007, CURR MED CHEM, V14, P969, DOI 10.2174/092986707780362925; Dimitrova DS, 2000, EXP CELL RES, V254, P321, DOI 10.1006/excr.1999.4770; DOUVILLE EMJ, 1992, MOL CELL BIOL, V12, P2681, DOI 10.1128/MCB.12.6.2681; Enders GH, 2006, GENE, V371, P1, DOI 10.1016/j.gene.2005.11.017; Fischer MG, 2004, CURR BIOL, V14, P2019, DOI 10.1016/j.cub.2004.11.008; Fisk HA, 2004, CELL CYCLE, V3, P439; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Fisk HA, 2001, CELL, V106, P95, DOI 10.1016/S0092-8674(01)00411-1; He XW, 1998, J CELL SCI, V111, P1635; HOGG D, 1994, ONCOGENE, V9, P89; Hurley PJ, 2007, CELL CYCLE, V6, P414, DOI 10.4161/cc.6.4.3886; Iliakis G, 2003, ONCOGENE, V22, P5834, DOI 10.1038/sj.onc.1206682; Jaspersen SL, 2004, DEV CELL, V7, P263, DOI 10.1016/j.devcel.2004.07.006; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Kang JS, 2007, P NATL ACAD SCI USA, V104, P20232, DOI 10.1073/pnas.0710519105; Kasbek C, 2007, MOL BIOL CELL, V18, P4457, DOI 10.1091/mbc.E07-03-0283; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; LINDBERG RA, 1993, ONCOGENE, V8, P351; Mattison CP, 2007, J BIOL CHEM, V282, P30553, DOI 10.1074/jbc.M707063200; MILLS GB, 1992, J BIOL CHEM, V267, P16000; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Poss KD, 2004, GENE DEV, V18, P1527, DOI 10.1101/gad.1182604; Poss KD, 2002, DEVELOPMENT, V129, P5141; Shieh SY, 2000, GENE DEV, V14, P289; Straight PD, 2000, MOL BIOL CELL, V11, P3525, DOI 10.1091/mbc.11.10.3525; Stucke VM, 2004, CHROMOSOMA, V113, P1, DOI 10.1007/s00412-004-0288-2; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Wang HC, 2006, CANCER RES, V66, P1391, DOI 10.1158/0008-5472.CAN-05-3270; Ward IM, 2001, J BIOL CHEM, V276, P47755, DOI 10.1074/jbc.C100587200; Wei JH, 2005, J BIOL CHEM, V280, P7748, DOI 10.1074/jbc.M410152200; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745; Winey M, 2002, ONCOGENE, V21, P6161, DOI 10.1038/sj.onc.1205712; Xu XZ, 2002, MOL CELL BIOL, V22, P4419, DOI 10.1128/MCB.22.12.4419-4432.2002; Zhao Y, 2006, CURR BIOL, V16, P1764, DOI 10.1016/j.cub.2006.07.058	43	35	35	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	10					1366	1378		10.1038/onc.2008.477	http://dx.doi.org/10.1038/onc.2008.477			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	417ZC	19151762				2022-12-25	WOS:000264116000009
J	Garnier-Lhomme, M; Byrne, RD; Hobday, TMC; Gschmeissner, S; Woscholski, R; Poccia, DL; Dufourc, EJ; Larijani, B				Garnier-Lhomme, Marie; Byrne, Richard D.; Hobday, Tina M. C.; Gschmeissner, Stephen; Woscholski, Rudiger; Poccia, Dominic L.; Dufourc, Erick J.; Larijani, Banafshe			Nuclear Envelope Remnants: Fluid Membranes Enriched in STEROLS and Polyphosphoinositides	PLOS ONE			English	Article								Background: The cytoplasm of eukaryotic cells is a highly dynamic compartment where membranes readily undergo fission and fusion to reorganize the cytoplasmic architecture, and to import, export and transport various cargos within the cell. The double membrane of the nuclear envelope that surrounds the nucleus, segregates the chromosomes from cytoplasm and regulates nucleocytoplasmic transport through pores. Many details of its formation are still unclear. At fertilization the sperm devoid of nuclear envelope pores enters the egg. Although most of the sperm nuclear envelope disassembles, remnants of the envelope at the acrosomal and centriolar fossae do not and are subsequently incorporated into the newly forming male pronuclear envelope. Remnants are conserved from annelid to mammalian sperm. Methodology/Principal Findings: Using lipid mass spectrometry and a new application of deuterium solid-state NMR spectroscopy we have characterized the lipid composition and membrane dynamics of the sperm nuclear envelope remnants in isolated sperm nuclei. Conclusions/Significance: We report nuclear envelope remnants are relatively fluid membranes rich in sterols, devoid of sphingomyelin, and highly enriched in polyphosphoinositides and polyunsaturated phospholipids. The localization of the polybasic effector domain of MARCKS illustrates the non-nuclear aspect of the polyphosphoinositides. Based on their atypical biophysical characteristics and phospholipid composition, we suggest a possible role for nuclear envelope remnants in membrane fusion leading to nuclear envelope assembly.	[Garnier-Lhomme, Marie; Byrne, Richard D.; Hobday, Tina M. C.; Larijani, Banafshe] Canc Res UK, Lincolns Inn Fields Labs, Cell Biophys Lab, London, England; [Gschmeissner, Stephen] Canc Res UK, Lincolns Inn Fields Lab, Electron Microscopy Unit, London, England; [Garnier-Lhomme, Marie; Woscholski, Rudiger] Imperial Coll London, Div Cell & Molecular Biol, London, England; [Byrne, Richard D.; Poccia, Dominic L.] Amherst Coll, Dept Biol, Amherst, MA 01002 USA; [Garnier-Lhomme, Marie; Dufourc, Erick J.] Univ Bordeaux 1, CNRS, UMR 5248, ENITAB, IECB, Pessac, France	Cancer Research UK; Cancer Research UK; Imperial College London; Amherst College; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux	Garnier-Lhomme, M (corresponding author), Canc Res UK, Lincolns Inn Fields Labs, Cell Biophys Lab, London, England.	banafshe.larijani@cancer.org.uk	Larijani, Banafshe/H-3909-2015; DUFOURC, Erick Joel/AAA-4992-2020	Larijani, Banafshe/0000-0003-4735-1169; DUFOURC, Erick Joel/0000-0002-8221-9326; LHOMME, MARIE/0000-0002-6335-4506	Cancer Research UK; Amherst College Copeland Fellowship; H. Axel Schupf '57 Fund for Intellectual Life [Amherst College Faculty Research Award]; Medical Research Council [G0000138] Funding Source: researchfish; MRC [G0000138] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Amherst College Copeland Fellowship; H. Axel Schupf '57 Fund for Intellectual Life; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Cancer Research UK core funding, an Amherst College Copeland Fellowship for RDB and an Amherst College Faculty Research Award from the H. Axel Schupf '57 Fund for Intellectual Life to DLP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablan S, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-104; Ahn A, 2002, J VIROL, V76, P3267, DOI 10.1128/JVI.76.7.3267-3275.2002; Aussenac F, 2003, BIOCHEMISTRY-US, V42, P1383, DOI 10.1021/bi026717b; Barona T, 2005, J BIOL CHEM, V280, P41171, DOI 10.1074/jbc.M412863200; Beck JG, 2007, FASEB J, V21, P1714, DOI 10.1096/fj.06-7809com; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Brzustowicz MR, 1999, FEBS LETT, V451, P197, DOI 10.1016/S0014-5793(99)00567-0; BURNETT LJ, 1971, J CHEM PHYS, V55, P5829, DOI 10.1063/1.1675758; Byrne RD, 2005, BIOCHEM J, V387, P393, DOI 10.1042/BJ20040947; Byrne RD, 2007, CELL SIGNAL, V19, P913, DOI 10.1016/j.cellsig.2006.10.011; CAMERON LA, 1994, DEV BIOL, V162, P568, DOI 10.1006/dbio.1994.1110; CHANA RS, 1985, CHEM PHYS LIPIDS, V37, P345, DOI 10.1016/0009-3084(85)90088-X; Chen Z, 1997, BIOPHYS J, V73, P267, DOI 10.1016/S0006-3495(97)78067-6; Churchward MA, 2005, J CELL SCI, V118, P4833, DOI 10.1242/jcs.02601; Churchward MA, 2008, BIOPHYS J, V94, P3976, DOI 10.1529/biophysj.107.123984; COLLAS P, 1995, DEV BIOL, V169, P123, DOI 10.1006/dbio.1995.1132; Collas P, 1996, J CELL SCI, V109, P1275; COLLAS P, 1995, MOL REPROD DEV, V42, P106, DOI 10.1002/mrd.1080420114; Collas P, 1996, J CELL BIOL, V135, P1715, DOI 10.1083/jcb.135.6.1715; Collas P, 1996, EUR J CELL BIOL, V71, P22; COLWIN AL, 1961, J BIOPHYS BIOCHEM CY, V10, P255, DOI 10.1083/jcb.10.2.255; COORSSEN JR, 1990, BIOCHEM CELL BIOL, V68, P65, DOI 10.1139/o90-008; DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2; DECKER SJ, 1983, DEV BIOL, V96, P37, DOI 10.1016/0012-1606(83)90309-3; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; FRANKE WW, 1974, INT REV CYTOL, P71; FRANKLIN LE, 1965, J CELL BIOL, V25, P81, DOI 10.1083/jcb.25.2.81; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; GARNIERLHOMME M, 2007, LIPID QUANT IN PRESS; GARNIERLHOMME M, 2007, BIOCHIM BIOPHYS ACTA, V1786, P2516; Golebiewska U, 2006, BIOPHYS J, V91, P588, DOI 10.1529/biophysj.106.081562; Gray A, 1999, BIOCHEM J, V344, P929, DOI 10.1042/0264-6021:3440929; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; HOCHMUTH RM, 1983, SCIENCE, V220, P101, DOI 10.1126/science.6828875; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P349, DOI 10.1038/nrm1100; Irvine RF, 2006, BBA-MOL CELL BIOL L, V1761, P505, DOI 10.1016/j.bbalip.2006.02.008; John K, 2002, BIOPHYS J, V83, P1525, DOI 10.1016/S0006-3495(02)73922-2; KALINA M, 1977, J CELL BIOL, V74, P726, DOI 10.1083/jcb.74.3.726; KINSEY WH, 1980, J CELL BIOL, V87, P248, DOI 10.1083/jcb.87.1.248; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P2097, DOI 10.1021/bi0478502; Larijani B, 2000, LIPIDS, V35, P1289, DOI 10.1007/s11745-000-0645-4; Larijani B., 2007, SIGNAL TRANSDUCT, V7, P142, DOI [10.1002/sita.200600128, DOI 10.1002/SITA.200600128]; Larijani B, 2006, LIPIDS, V41, P925, DOI 10.1007/s11745-006-5045-2; LEONARD A, 1991, BIOCHIMIE, V73, P1295, DOI 10.1016/0300-9084(91)90092-F; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; LONGO FJ, 1968, J CELL BIOL, V39, P339, DOI 10.1083/jcb.39.2.339; Maxfield FR, 2002, J CLIN INVEST, V110, P891, DOI 10.1172/JCI200216500; MCCAUGHAN L, 1980, SCIENCE, V207, P1481, DOI 10.1126/science.7361101; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; Mobius W, 2002, J HISTOCHEM CYTOCHEM, V50, P43; Mukherjee S, 2004, ANNU REV CELL DEV BI, V20, P839, DOI 10.1146/annurev.cellbio.20.010403.095451; Mukherjee S, 1998, BIOPHYS J, V75, P1915, DOI 10.1016/S0006-3495(98)77632-5; Pettitt TR, 2006, J LIPID RES, V47, P1588, DOI 10.1194/jlr.D600004-JLR200; Radeva G, 2004, BIOCHEM J, V380, P219, DOI 10.1042/BJ20031348; RAND RP, 1968, BIOPHYS J, V8, P125, DOI 10.1016/S0006-3495(68)86479-3; Ribes E, 2004, MOL REPROD DEV, V68, P223, DOI 10.1002/mrd.20069; ROCHE Y, 2008, FASEB J; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Sot J, 2006, BIOPHYS J, V90, P903, DOI 10.1529/biophysj.105.067710; Takeuchi T, 2006, ACS CHEM BIOL, V1, P299, DOI 10.1021/cb600127m; WANG W, 2007, BIOPHYS J	63	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2009	4	1							e4255	10.1371/journal.pone.0004255	http://dx.doi.org/10.1371/journal.pone.0004255			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JD	19165341	gold, Green Published, Green Submitted			2022-12-25	WOS:000265482400003
J	Icard, V; Diaz, O; Scholtes, C; Perrin-Cocon, L; Ramiere, C; Bartenschlager, R; Penin, F; Lotteau, V; Andre, P				Icard, Vinca; Diaz, Olivier; Scholtes, Caroline; Perrin-Cocon, Laure; Ramiere, Christophe; Bartenschlager, Ralf; Penin, Francois; Lotteau, Vincent; Andre, Patrice			Secretion of Hepatitis C Virus Envelope Glycoproteins Depends on Assembly of Apolipoprotein B Positive Lipoproteins	PLOS ONE			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; LOW-DENSITY; LIPID DROPLET; CORE PROTEIN; HUMAN SERA; PARTICLES; ASSOCIATION; RESISTANCE; CULTURE; BINDING	The density of circulating hepatitis C virus (HCV) particles in the blood of chronically infected patients is very heterogeneous. The very low density of some particles has been attributed to an association of the virus with apolipoprotein B (apoB) positive and triglyceride rich lipoproteins (TRL) likely resulting in hybrid lipoproteins known as lipoviro-particles (LVP) containing the viral envelope glycoproteins E1 and E2, capsid and viral RNA. The specific infectivity of these particles has been shown to be higher than the infectivity of particles of higher density. The nature of the association of HCV particles with lipoproteins remains elusive and the role of apolipoproteins in the synthesis and assembly of the viral particles is unknown. The human intestinal Caco-2 cell line differentiates in vitro into polarized and apoB secreting cells during asymmetric culture on porous filters. By using this cell culture system, cells stably expressing E1 and E2 secreted the glycoproteins into the basal culture medium after one week of differentiation concomitantly with TRL secretion. Secreted glycoproteins were only detected in apoB containing density fractions. The E1-E2 and apoB containing particles were unique complexes bearing the envelope glycoproteins at their surface since apoB could be co-immunoprecipitated with E2-specific antibodies. Envelope protein secretion was reduced by inhibiting the lipidation of apoB with an inhibitor of the microsomal triglyceride transfer protein. HCV glycoproteins were similarly secreted in association with TRL from the human liver cell line HepG2 but not by Huh-7 and Huh-7.5 hepatoma cells that proved deficient for lipoprotein assembly. These data indicate that HCV envelope glycoproteins have the intrinsic capacity to utilize apoB synthesis and lipoprotein assembly machinery even in the absence of the other HCV proteins. A model for LVP assembly is proposed.	[Icard, Vinca; Diaz, Olivier; Scholtes, Caroline; Perrin-Cocon, Laure; Ramiere, Christophe; Lotteau, Vincent; Andre, Patrice] Univ Lyon, Lyon, France; [Icard, Vinca; Diaz, Olivier; Scholtes, Caroline; Perrin-Cocon, Laure; Ramiere, Christophe; Lotteau, Vincent; Andre, Patrice] Inserm, U851, Lyon, France; [Icard, Vinca; Diaz, Olivier; Scholtes, Caroline; Perrin-Cocon, Laure; Ramiere, Christophe; Lotteau, Vincent; Andre, Patrice] Univ Lyon 1, IFR128, Lyon, France; [Icard, Vinca; Scholtes, Caroline; Ramiere, Christophe; Lotteau, Vincent; Andre, Patrice] Hosp Civils Lyon, Lab Virol Nord, Lyon, France; [Bartenschlager, Ralf] Heidelberg Univ, Dept Mol Virol, D-6900 Heidelberg, Germany; [Penin, Francois] Inst Biol Chim Proteines, CNRS, UMR 5086, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ruprecht Karls University Heidelberg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Icard, V (corresponding author), Univ Lyon, Lyon, France.	patrice.andre@inserm.fr	Ramière, Christophe/M-8083-2014; lotteau, vincent/M-8143-2014; diaz, olivier/M-8112-2014; Perrin-Cocon, Laure A/M-8099-2014; André, Patrice/M-8139-2014; Scholtès, Caroline/B-9039-2011; Bartenschlager, Ralf/L-2582-2015	Ramière, Christophe/0000-0002-1981-7155; diaz, olivier/0000-0002-3451-9914; Perrin-Cocon, Laure A/0000-0003-0501-6733; André, Patrice/0000-0002-5834-7395; Scholtès, Caroline/0000-0003-0691-8480; Lotteau, Vincent/0000-0003-0997-3282; Bartenschlager, Ralf/0000-0001-5601-9307	ANRS Agence nationale de recherches sur le sida et les hepatites virales	ANRS Agence nationale de recherches sur le sida et les hepatites virales(ANRSFrench National Research Agency (ANR))	The work was supported by a grant from the ANRS Agence nationale de recherches sur le sida et les hepatites virales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Andre P, 2005, SEMIN LIVER DIS, V25, P93, DOI 10.1055/s-2005-864785; Appel N, 2006, J BIOL CHEM, V281, P9833, DOI 10.1074/jbc.R500026200; BARTOSCH B, 2007, 14 INT S HCV REL VIR; BRADLEY D, 1991, J MED VIROL, V34, P206, DOI 10.1002/jmv.1890340315; Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; Buhman KK, 2000, NAT MED, V6, P1341, DOI 10.1038/82153; Chandler CE, 2003, J LIPID RES, V44, P1887, DOI 10.1194/jlr.M300094-JLR200; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Chateau D, 2005, J CELL PHYSIOL, V202, P767, DOI 10.1002/jcp.20173; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Deforges S, 2004, J GEN VIROL, V85, P2515, DOI 10.1099/vir.0.80071-0; Delie F, 1997, CRIT REV THER DRUG, V14, P221; Diaz O, 2008, J MED VIROL, V80, P242, DOI 10.1002/jmv.21037; Diaz O, 2006, J GEN VIROL, V87, P2983, DOI 10.1099/vir.0.82033-0; Domitrovich AM, 2005, J BIOL CHEM, V280, P39802, DOI 10.1074/jbc.M510391200; Dubuisson J, 2002, TRENDS CELL BIOL, V12, P517, DOI 10.1016/S0962-8924(02)02383-8; Dupuy FP, 2005, J GENE MED, V7, P1158, DOI 10.1002/jgm.769; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; HIJIKATA M, 1993, J VIROL, V67, P1953, DOI 10.1128/JVI.67.4.1953-1958.1993; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Hussain MM, 1996, BBA-LIPID LIPID MET, V1300, P151, DOI 10.1016/0005-2760(96)00041-0; Lavie M, 2007, CURR ISSUES MOL BIOL, V9, P71; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; LINDENBACH BD, 2005, SCIENCE; Maillard P, 2001, J VIROL, V75, P8240, DOI 10.1128/JVI.75.17.8240-8250.2001; Mensenkamp AR, 2001, J HEPATOL, V35, P816, DOI 10.1016/S0168-8278(01)00249-5; Mensenkamp AR, 2001, ARTERIOSCL THROM VAS, V21, P1366, DOI 10.1161/hq0801.093864; Mirandola S, 2006, GASTROENTEROLOGY, V130, P1661, DOI 10.1053/j.gastro.2006.02.035; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316; Nielsen SU, 2008, J GEN VIROL, V89, P2507, DOI 10.1099/vir.0.2008/000083-0; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Nielsen SU, 2004, J GEN VIROL, V85, P1497, DOI 10.1099/vir.0.79967-0; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Pumeechockchai W, 2002, J MED VIROL, V68, P335, DOI 10.1002/jmv.10208; Rey FA, 2003, P NATL ACAD SCI USA, V100, P6899, DOI 10.1073/pnas.1332695100; Robertson B, 1998, ARCH VIROL, V143, P2493, DOI 10.1007/s007050050479; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Shelness GS, 2001, CURR OPIN LIPIDOL, V12, P151, DOI 10.1097/00041433-200104000-00008; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; THOMSSEN R, 1993, MED MICROBIOL IMMUN, V182, P329; THOMSSEN R, 1992, MED MICROBIOL IMMUN, V181, P293, DOI 10.1007/BF00198849; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	49	97	101	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4233	10.1371/journal.pone.0004233	http://dx.doi.org/10.1371/journal.pone.0004233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JB	19156195	Green Published, Green Submitted, gold			2022-12-25	WOS:000265482100005
J	Mavromatis, K; Ivanova, N; Anderson, I; Lykidis, A; Hooper, SD; Sun, H; Kunin, V; Lapidus, A; Hugenholtz, P; Patel, B; Kyrpides, NC				Mavromatis, Konstantinos; Ivanova, Natalia; Anderson, Iain; Lykidis, Athanasios; Hooper, Sean D.; Sun, Hui; Kunin, Victor; Lapidus, Alla; Hugenholtz, Philip; Patel, Bharat; Kyrpides, Nikos C.			Genome Analysis of the Anaerobic Thermohalophilic Bacterium Halothermothrix orenii	PLOS ONE			English	Article							SUCROSE-PHOSPHATE SYNTHASE; SEQUENCE; EXPRESSION; PURIFICATION; HALOPHILE; OXIDATION; PATHWAY; CLONING; GENE; AMYA	Halothermothirx orenii is a strictly anaerobic thermohalophilic bacterium isolated from sediment of a Tunisian salt lake. It belongs to the order Halanaerobiales in the phylum Firmicutes. The complete sequence revealed that the genome consists of one circular chromosome of 2578146 bps encoding 2451 predicted genes. This is the first genome sequence of an organism belonging to the Haloanaerobiales. Features of both Gram positive and Gram negative bacteria were identified with the presence of both a sporulating mechanism typical of Firmicutes and a characteristic Gram negative lipopolysaccharide being the most prominent. Protein sequence analyses and metabolic reconstruction reveal a unique combination of strategies for thermophilic and halophilic adaptation. H. orenii can serve as a model organism for the study of the evolution of the Gram negative phenotype as well as the adaptation under thermohalophilic conditions and the development of biotechnological applications under conditions that require high temperatures and high salt concentrations.	[Mavromatis, Konstantinos; Ivanova, Natalia; Anderson, Iain; Lykidis, Athanasios; Hooper, Sean D.; Sun, Hui; Kunin, Victor; Lapidus, Alla; Hugenholtz, Philip; Kyrpides, Nikos C.] DOE Joint Genome Inst, Walnut Creek, CA USA; [Patel, Bharat] Griffith Univ, Sch Biomol & Phys Sci, Microbial Gene Res & Resources Facil, Nathan, Qld 4111, Australia	United States Department of Energy (DOE); Griffith University	Mavromatis, K (corresponding author), DOE Joint Genome Inst, Walnut Creek, CA USA.	KMavrommatis@lbl.gov	Hugenholtz, Philip/AAD-9138-2019; Kyrpides, Nikos C./A-6305-2014; Lapidus, Alla L/I-4348-2013; Patel, Bharat/H-8050-2015	Hugenholtz, Philip/0000-0001-5386-7925; Kyrpides, Nikos C./0000-0002-6131-0462; Lapidus, Alla L/0000-0003-0427-8731; Kunin, Victor/0000-0002-8741-7866; Patel, Bharat/0000-0002-5332-1858; Ivanova, Natalia/0000-0002-5802-9485	US Department of Energy's Office of Science, Biological and Environmental Research Program; University of California, Lawrence Livermore National Laboratory under Contract [W-7405-Eng-48]; Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Los Alamos National Laboratory [DE-AC02-06NA25396]	US Department of Energy's Office of Science, Biological and Environmental Research Program(United States Department of Energy (DOE)); University of California, Lawrence Livermore National Laboratory under Contract(University of California System); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory)	The work presented in this article was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program and by the University of California, Lawrence Livermore National Laboratory under Contract No. W-7405-Eng-48, Lawrence Berkeley National Laboratory under contract No. DE-AC02-05CH11231 and Los Alamos National Laboratory under contract No. DE-AC02-06NA25396. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BOCH J, 1994, J BACTERIOL, V176, P5364; Brioukhanov AL, 2006, MICROBIOL-SGM, V152, P1671, DOI 10.1099/mic.0.28542-0; Bruggemann H, 2003, P NATL ACAD SCI USA, V100, P1316, DOI 10.1073/pnas.0335853100; CAYOL JL, 1994, INT J SYST BACTERIOL, V44, P534, DOI 10.1099/00207713-44-3-534; CHEN JS, 1974, BIOCHIM BIOPHYS ACTA, V352, P202, DOI 10.1016/0005-2736(74)90212-0; Chua TK, 2008, PLANT CELL, V20, P1059, DOI 10.1105/tpc.107.051193; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Cumino A, 2002, FEBS LETT, V517, P19, DOI 10.1016/S0014-5793(02)02516-4; de Champdore M, 2007, J R SOC INTERFACE, V4, P183, DOI 10.1098/rsif.2006.0174; Dervyn E, 2001, SCIENCE, V294, P1716, DOI 10.1126/science.1066351; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Gyan S, 2006, J BACTERIOL, V188, P7062, DOI 10.1128/JB.00601-06; Hickey DA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-117; Huynh F, 2005, ACTA CRYSTALLOGR F, V61, P116, DOI 10.1107/S174430910403091X; Kikuchi Y, 2006, APPL ENVIRON MICROB, V72, P7183, DOI 10.1128/AEM.01528-06; Kobayashi I, 2001, NUCLEIC ACIDS RES, V29, P3742, DOI 10.1093/nar/29.18.3742; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; LIOLIOS K, 2007, NUCL ACIDS RES DATAB, pD475; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Ludwig W, 2005, BERGEYS MANUAL SYSTE, V2, P49, DOI DOI 10.1007/978-0-387-21609-6_8; Lunn JE, 1999, PLANT MOL BIOL, V40, P297, DOI 10.1023/A:1006130802706; MARKOWITZ VM, 2007, NUCL ACIDS RES DATAB, pD528; Mijts BN, 2002, MICROBIOL-SGM, V148, P2343, DOI 10.1099/00221287-148-8-2343; Mijts BN, 2001, EXTREMOPHILES, V5, P61, DOI 10.1007/s007920000174; Muller FH, 2004, MOL MICROBIOL, V53, P1147, DOI 10.1111/j.1365-2958.2004.04193.x; Paredes CJ, 2005, NAT REV MICROBIOL, V3, P969, DOI 10.1038/nrmicro1288; PATEL BKC, 1995, FEMS MICROBIOL LETT, V134, P115, DOI 10.1016/0378-1097(95)00395-L; Podar M, 2006, CURR OPIN BIOTECH, V17, P250, DOI 10.1016/j.copbio.2006.05.002; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sivakumar N, 2006, FEBS LETT, V580, P2646, DOI 10.1016/j.febslet.2006.04.017; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tan TC, 2008, J MOL BIOL, V378, P852, DOI 10.1016/j.jmb.2008.02.041	35	51	229	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2009	4	1							e4192	10.1371/journal.pone.0004192	http://dx.doi.org/10.1371/journal.pone.0004192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IG	19145256	Green Published, gold			2022-12-25	WOS:000265479800003
J	Marshall, DC; Hill, KBR				Marshall, David C.; Hill, Kathy B. R.			Versatile Aggressive Mimicry of Cicadas by an Australian Predatory Katydid	PLOS ONE			English	Article								Background: In aggressive mimicry, a predator or parasite imitates a signal of another species in order to exploit the recipient of the signal. Some of the most remarkable examples of aggressive mimicry involve exploitation of a complex signal-response system by an unrelated predator species. Methodology/Principal Findings: We have found that predatory Chlorobalius leucoviridis katydids (Orthoptera: Tettigoniidae) can attract male cicadas (Hemiptera: Cicadidae) by imitating the species-specific wing-flick replies of sexually receptive female cicadas. This aggressive mimicry is accomplished both acoustically, with tegminal clicks, and visually, with synchronized body jerks. Remarkably, the katydids respond effectively to a variety of complex, species-specific Cicadettini songs, including songs of many cicada species that the predator has never encountered. Conclusions/Significance: We propose that the versatility of aggressive mimicry in C. leucoviridis is accomplished by exploiting general design elements common to the songs of many acoustically signaling insects that use duets in pair-formation. Consideration of the mechanism of versatile mimicry in C. leucoviridis may illuminate processes driving the evolution of insect acoustic signals, which play a central role in reproductive isolation of populations and the formation of species.	[Marshall, David C.; Hill, Kathy B. R.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA	University of Connecticut	Marshall, DC (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA.	david.marshall@uconn.edu		Marshall, David/0000-0003-3581-8884	National Science Foundation [DEB 04-22386, DEB 05-29679, DEB 07 20664]	National Science Foundation(National Science Foundation (NSF))	This study arose during research partially supported by the National Science Foundation under Grant Numbers NSF DEB 04-22386, DEB 05-29679 and DEB 07 20664 to Dr. Chris Simon (University of Connecticut). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RD, 1962, SYST ZOOL, V11, P53, DOI 10.2307/2411453; Alexander RD., 1967, MISCELLANEOUS PUBLIC, V133, P1; Bailey WJ, 2003, PHYSIOL ENTOMOL, V28, P157, DOI 10.1046/j.1365-3032.2003.00337.x; BELWOOD JJ, 1987, BAT PREDATION ITS IN, P64; BURK T, 1982, FLA ENTOMOL, V65, P90, DOI 10.2307/3494148; CARLSON AD, 1985, Q REV BIOL, V60, P415, DOI 10.1086/414564; Cooley JR, 2001, BEHAVIOUR, V138, P827, DOI 10.1163/156853901753172674; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; EBERHARD WG, 1977, SCIENCE, V198, P1173, DOI 10.1126/science.198.4322.1173; Gorochov A.V., 1988, CRETACEOUS BIOCOENOT, P145; Gwynne Darryl T., 1995, Journal of Orthoptera Research, V4, P203; GWYNNE DT, 1987, ANIM BEHAV, V35, P571, DOI 10.1016/S0003-3472(87)80283-X; HARTLEY JC, 1993, ZOOL J LINN SOC-LOND, V107, P155, DOI 10.1006/zjls.1993.1010; Heller K.-G., 1990, P130; HELVERSEN D, 1983, NEUROETHOLOGY BEHAV; Jost MC, 2006, MOL PHYLOGENET EVOL, V38, P510, DOI 10.1016/j.ympev.2005.10.004; Lakes-Harlan R, 2000, ZOOL-ANAL COMPLEX SY, V103, P31; LANE DH, 1995, SPECIATION RECOGNITI; LLOYD JE, 1990, FLA ENTOMOL, V73, P51, DOI 10.2307/3495329; LLOYD JE, 1984, FLA ENTOMOL, V67, P368, DOI 10.2307/3494715; LLOYD JE, 1975, SCIENCE, V187, P452, DOI 10.1126/science.187.4175.452; Marshall DC, 2008, MOL PHYLOGENET EVOL, V48, P1054, DOI 10.1016/j.ympev.2008.05.007; Moulds MS, 2005, REC AUST MUS, V57, P375, DOI 10.3853/j.0067-1975.57.2005.1447; Moulds MS., 1990, AUSTR CICADAS; Myers JG., 1929, INSECT SINGERS NATUR; Naskrecki P, 2000, THESIS U CONNECTICUT; Otte, 1983, ACADEMY NATURAL SCI, V22, P1; Otte D., 1974, Annual Rev Ecol Syst, V5, P385, DOI 10.1146/annurev.es.05.110174.002125; Ragge D.R, 1998, SONGS GRASSHOPPERS C; Rentz D.C.F., 1995, Journal of Orthoptera Research, V4, P199; Rentz D.C.F., 2001, TETTIGONIIDAE AUSTR, V3; Rentz D. C. F., 1996, GRASSHOPPER COUNTRY; Robinson D., 1990, P112; SAULGERSHENZ LS, 1993, AM ZOOL, V33, P139; SIMMONS LW, 1993, BEHAV ECOL, V4, P364, DOI 10.1093/beheco/4.4.364; Spooner John D., 1995, Journal of Orthoptera Research, V4, P127; STOWE MK, 1987, SCIENCE, V236, P964, DOI 10.1126/science.236.4804.964; VENCL FV, 1994, J INSECT BEHAV, V7, P843, DOI 10.1007/BF01997130; VERRELL PA, 1991, ETHOL ECOL EVOL, V3, P273, DOI 10.1080/08927014.1991.9525356; Walker T. J., 1964, Florida Entomologist, V47, P163, DOI 10.2307/3493290; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	41	35	37	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4185	10.1371/journal.pone.0004185	http://dx.doi.org/10.1371/journal.pone.0004185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142230	Green Published, gold, Green Submitted			2022-12-25	WOS:000265479700006
J	Aliabadian, M; Kaboli, M; Nijman, V; Vences, M				Aliabadian, Mansour; Kaboli, Mohammad; Nijman, Vincent; Vences, Miguel			Molecular Identification of Birds: Performance of Distance-Based DNA Barcoding in Three Genes to Delimit Parapatric Species	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; EVOLUTIONARY GENETICS; PHYLOGENY; HYBRIDIZATION; BUTTERFLIES; SPECIATION	Background: DNA barcoding based on the mitochondrial cytochrome oxidase subunit I gene (cox1 or COI) has been successful in species identification across a wide array of taxa but in some cases failed to delimit the species boundaries of closely allied allopatric species or of hybridising sister species. Methodology/Principal Findings: In this study we extend the sample size of prior studies in birds for cox1 (2776 sequences, 756 species) and target especially species that are known to occur parapatrically, and/or are known to hybridise, on a Holarctic scale. In order to obtain a larger set of taxa (altogether 2719 species), we include also DNA sequences of two other mitochondrial genes: cytochrome b (cob) ( 4614 sequences, 2087 species) and 16S (708 sequences, 498 species). Our results confirm the existence of a wide gap between intra- and interspecies divergences for both cox1 and cob, and indicate that distance-based DNA barcoding provides sufficient information to identify and delineate bird species in 98% of all possible pairwise comparisons. This DNA barcoding gap was not statistically influenced by the number of individuals sequenced per species. However, most of the hybridising parapatric species pairs have average divergences intermediate between intraspecific and interspecific distances for both cox1 and cob. Conclusions/Significance: DNA barcoding, if used as a tool for species discovery, would thus fail to identify hybridising parapatric species pairs. However, most of them can probably still assigned to known species by character-based approaches, although development of complementary nuclear markers will be necessary to account for mitochondrial introgression in hybridising species.	Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Aliabadian, Mansour] Univ Amsterdam, Zool Museum, Amsterdam, Netherlands; [Aliabadian, Mansour] Ferdowsi Univ Mashhad, Fac Sci, Dept Biol, Mashhad, Iran; [Kaboli, Mohammad] Univ Tehran, Fac Nat Resources, Dept Fishery & Environm, Tehran 14174, Iran; [Nijman, Vincent] Oxford Brookes Univ, Sch Social Sci & Law, Oxford OX3 0BP, England; [Vences, Miguel] Tech Univ Carolo Wilhelmina Braunschweig, Zool Inst, Div Evolutionary Biol, Braunschweig, Germany	University of Amsterdam; University of Amsterdam; Ferdowsi University Mashhad; University of Tehran; Oxford Brookes University; Braunschweig University of Technology	Aliabadian, M (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.	M.aliabadian@uva.nl	赵, 鹏/B-8401-2009; Aliabadian, Mansour/P-8373-2019; Vences, Miguel/E-5573-2010; Nijman, Vincent/AHD-8685-2022	Aliabadian, Mansour/0000-0002-3200-4853; Vences, Miguel/0000-0003-0747-0817; Nijman, Vincent/0000-0002-5600-4276	Ministry of Science, Research and Technology of the Islamic Republic of Iran	Ministry of Science, Research and Technology of the Islamic Republic of Iran	This work was partially funded by the Ministry of Science, Research and Technology of the Islamic Republic of Iran to MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliabadian M, 2007, CONTRIB ZOOL, V76, P197, DOI 10.1163/18759866-07603005; Aliabadian M, 2005, BIOL LETTERS, V1, P21, DOI 10.1098/rsbl.2004.0258; Aliabadian M, 2007, MOL PHYLOGENET EVOL, V42, P665, DOI 10.1016/j.ympev.2006.08.018; ALSTROM P, 2006, ACTA ZOOLOGICA SIN S, V52, P429; AVISE JC, 1986, PHILOS T ROY SOC B, V312, P325, DOI 10.1098/rstb.1986.0011; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; BARTON NH, 1989, NATURE, V341, P497, DOI 10.1038/341497a0; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Crochet PA, 2000, J EVOLUTION BIOL, V13, P47; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Dickinson EC., 2003, HOWARD MOORE COMPLET; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Haffer Juergen, 1992, Bulletin of the British Ornithologists' Club, V112, P250; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Helbig AJ, 1999, MOL PHYLOGENET EVOL, V11, P246, DOI 10.1006/mpev.1998.0571; Hogg ID, 2004, CAN J ZOOL, V82, P749, DOI [10.1139/z04-041, 10.1139/Z04-041]; Johns GC, 1998, MOL BIOL EVOL, V15, P1481, DOI 10.1093/oxfordjournals.molbev.a025875; Johnson NK, 2004, EVOLUTION, V58, P1122; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lemer S, 2007, CR BIOL, V330, P86, DOI 10.1016/j.crvi.2006.09.002; Liebers D, 2004, P ROY SOC B-BIOL SCI, V271, P893, DOI 10.1098/rspb.2004.2679; Mallet J, 2003, TRENDS ECOL EVOL, V18, P57, DOI 10.1016/S0169-5347(02)00061-7; Mallet J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-28; McCarthy EM, 2006, HDB AVIAN HYBRIDS WO; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Palumbi S., 1991, SIMPLE FOOLS GUIDE P; Roques S, 2006, GENE, V383, P12, DOI 10.1016/j.gene.2006.06.018; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8	41	79	98	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4119	10.1371/journal.pone.0004119	http://dx.doi.org/10.1371/journal.pone.0004119			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FX	19127298	Green Published, Green Submitted, gold			2022-12-25	WOS:000265473300004
J	Zarubica, A; Plazzo, AP; Stockl, M; Trombik, T; Hamon, Y; Muller, P; Pomorski, T; Herrmann, A; Chimini, G				Zarubica, Ana; Plazzo, Anna Pia; Stoeckl, Martin; Trombik, Tomasz; Hamon, Yannick; Mueller, Peter; Pomorski, Thomas; Herrmann, Andreas; Chimini, Giovanna			Functional implications of the influence of ABCA1 on lipid microenvironment at the plasma membrane: a biophysical study	FASEB JOURNAL			English	Article						FLIM; TfR; cholesterol; phosphatidylserine; FRAP	FLUORESCENCE LIFETIME; CHOLESTEROL EFFLUX; CELL-MEMBRANES; SURFACE; RAFTS; PHOSPHATIDYLSERINE; PHOSPHOLIPIDS; TRANSPORTER; VESICLES; ACTIVATION	The ABCA1 transporter orchestrates cellular lipid homeostasis by promoting the release of cholesterol to plasmatic acceptors. The molecular mechanism is, however, unknown. We report here on the biophysical analysis in living HeLa cells of the ABCA1 lipid microenvironment at the plasma membrane. The modifications of membrane attributes induced by ABCA1 were assessed at both the outer and inner leaflet by monitoring either the lifetime of membrane inserted fluorescent lipid analogues by fluorescence lifetime imaging microscopy (FLIM) or, respectively, the membrane translocation of cationic sensors. Analysis of the partitioning of dedicated probes in plasma membrane blebs vesiculated from these cells allowed visualization of ABCA1 partitioning into the liquid disordered-like phase and corroborated the idea that ABCA1 destabilizes the lipid arrangement at the membrane. Specificity was demonstrated by comparison with cells expressing an inactive transporter. The physiological relevance of these modifications was finally demonstrated by the reduced membrane mobility and function of transferrin receptors under the influence of an active ABCA1. Collectively, these data assess that the control of both transversal and lateral lipid distribution at the membrane is the primary function of ABCA1 and positions the effluxes of cholesterol from cell membranes downstream to the redistribution of the sterol into readily extractable membrane pools.-Zarubica, A., Plazzo, A. P., Stockl, M., Trombik, T., Hamon, Y., Muller, P., Pomorski, T., Herrmann, A., Chimini, G. Functional implications of the influence of ABCA1 on lipid microenvironment at the plasma membrane: a biophysical study. FASEB J. 23, 1775-1785 (2009)	[Zarubica, Ana; Trombik, Tomasz; Hamon, Yannick; Chimini, Giovanna] Univ Aix Marseille 2, Ctr Natl Rech Sci, Inst Natl Sante & Rech Med, Ctr Immunol Marseille Luminy, F-13288 Marseille 09, France; [Plazzo, Anna Pia; Stoeckl, Martin; Mueller, Peter; Pomorski, Thomas; Herrmann, Andreas] Humboldt Univ, Inst Biol Biophys, Berlin, Germany	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Humboldt University of Berlin	Chimini, G (corresponding author), Univ Aix Marseille 2, Ctr Natl Rech Sci, Inst Natl Sante & Rech Med, Ctr Immunol Marseille Luminy, Parc Sci Luminy Case 906, F-13288 Marseille 09, France.	chimini@ciml.univ-mrs.fr	Trombik, Tomasz/X-6504-2019; Stöckl, Martin/AAM-6743-2020; Trombik, Tomasz/AAP-2750-2021; HAMON, Yannick YH/N-5372-2016; Pomorski, Thomas Günther/G-4804-2014; HAMON, Yannick/S-3118-2019; Stöckl, Martin T/I-6554-2016	Stöckl, Martin/0000-0001-7986-9291; Trombik, Tomasz/0000-0003-3643-8381; HAMON, Yannick YH/0000-0002-7636-2310; Pomorski, Thomas Günther/0000-0002-4889-0829; HAMON, Yannick/0000-0002-7636-2310; Stöckl, Martin T/0000-0001-7986-9291				Alder-Baerens N, 2005, J BIOL CHEM, V280, P26321, DOI 10.1074/jbc.M413993200; Attie AD, 2007, TRENDS BIOCHEM SCI, V32, P172, DOI 10.1016/j.tibs.2007.02.001; Baumgart T, 2007, BBA-BIOMEMBRANES, V1768, P2182, DOI 10.1016/j.bbamem.2007.05.012; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Bortnick AE, 2000, J BIOL CHEM, V275, P28634, DOI 10.1074/jbc.M003407200; Chambenoit O, 2001, J BIOL CHEM, V276, P9955, DOI 10.1074/jbc.M010265200; Chattopadhyay A, 2002, J PHYS CHEM B, V106, P13002, DOI 10.1021/jp021801m; CHATTOPADHYAY A, 1993, BIOCHEMISTRY-US, V32, P3804, DOI 10.1021/bi00065a037; Combes V, 2005, AM J PATHOL, V166, P295, DOI 10.1016/S0002-9440(10)62253-5; de Almeida RFM, 2007, BIOPHYS J, V93, P539, DOI 10.1529/biophysj.106.098822; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Dufort L., 2007, HIGH DENSITY LIPOPRO, P113; Fielding PE, 2000, BIOCHEMISTRY-US, V39, P14113, DOI 10.1021/bi0004192; Gaus K, 2005, J CELL BIOL, V171, P121, DOI 10.1083/jcb.200505047; Gillotte KL, 1999, J BIOL CHEM, V274, P2021, DOI 10.1074/jbc.274.4.2021; Goodwin JS, 2005, BIOPHYS J, V89, P1398, DOI 10.1529/biophysj.104.055640; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; HO C, 1992, BIOCHIM BIOPHYS ACTA, V1104, P273, DOI 10.1016/0005-2736(92)90041-J; HO CJ, 1994, BBA-BIOMEMBRANES, V1193, P307, DOI 10.1016/0005-2736(94)90167-8; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Koseki M, 2007, J LIPID RES, V48, P299, DOI 10.1194/jlr.M600428-JLR200; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Lange Y, 2005, J BIOL CHEM, V280, P36126, DOI 10.1074/jbc.M507149200; Lange Y, 2007, BIOCHEMISTRY-US, V46, P2233, DOI 10.1021/bi6023397; Luciani MF, 1996, EMBO J, V15, P226, DOI 10.1002/j.1460-2075.1996.tb00353.x; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; Marchetti M, 2006, MOL BIOL CELL, V17, P2896, DOI 10.1091/mbc.E06-01-0076; Margineanu A, 2007, BIOPHYS J, V93, P2877, DOI 10.1529/biophysj.106.100743; McMullen TPW, 2000, BIOPHYS J, V79, P2056, DOI 10.1016/S0006-3495(00)76453-8; Meder D, 2006, P NATL ACAD SCI USA, V103, P329, DOI 10.1073/pnas.0509885103; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Radhakrishnan A, 2000, BIOCHEMISTRY-US, V39, P8119, DOI 10.1021/bi0005097; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; Rigot W, 2002, J LIPID RES, V43, P2077, DOI 10.1194/jlr.M200279-JLR200; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Sengupta P, 2008, BBA-BIOMEMBRANES, V1778, P20, DOI 10.1016/j.bbamem.2007.08.028; Smith JD, 2002, J BIOL CHEM, V277, P17797, DOI 10.1074/jbc.M201594200; Stockl M, 2008, J BIOL CHEM, V283, P30828, DOI 10.1074/jbc.M801418200; Tam SP, 2006, AM J PHYSIOL-CELL PH, V291, pC490, DOI 10.1152/ajpcell.00055.2006; Thymiakou E, 2007, BIOCHEMISTRY-US, V46, P11473, DOI 10.1021/bi700994m; Trompier D, 2006, J BIOL CHEM, V281, P20283, DOI 10.1074/jbc.M601072200; van Meer G, 2006, FEBS LETT, V580, P1171, DOI 10.1016/j.febslet.2005.12.019; Vaughan AM, 2003, J LIPID RES, V44, P1373, DOI 10.1194/jlr.M300078-JLR200; Williamson P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000729; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; YGUERABIDE J, 1982, BIOPHYS J, V40, P69, DOI 10.1016/S0006-3495(82)84459-7; Young SG, 1999, NAT GENET, V22, P316, DOI 10.1038/11878; Zha XH, 2001, J BIOL CHEM, V276, P39476, DOI 10.1074/jbc.M105067200; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	53	36	37	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1775	1785		10.1096/fj.08-122192	http://dx.doi.org/10.1096/fj.08-122192			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19151332				2022-12-25	WOS:000266652400018
J	Kimberley, FC; van Bostelen, L; Cameron, K; Hardenberg, G; Marquart, JA; Hahne, M; Medema, JP				Kimberley, Fiona C.; van Bostelen, Liesbeth; Cameron, Katherine; Hardenberg, Gijs; Marquart, J. Arnoud; Hahne, Michael; Medema, Jan Paul			The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking	FASEB JOURNAL			English	Article						proliferation; B cells; signaling; tumors; immunoglobulins	TUMOR-NECROSIS-FACTOR; B-CELL MATURATION; PROLIFERATION-INDUCING LIGAND; HIGH-AFFINITY RECEPTOR; TNF FAMILY; ACTIVATING FACTOR; CUTTING EDGE; T-CELL; IGA PRODUCTION; MYELOMA CELLS	A proliferation-inducing ligand (APRIL) (also known as TALL-2 and TRDL-1) is a member of the tumor necrosis factor (TNF) superfamily that has tumorigenic properties but is also important for the induction of humoral immune responses. APRIL binds two TNF receptors: transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) and B-cell maturation antigen (BCMA) as well as heparan sulfate proteoglycans (HSPGs). The aim of this study was to clarify the role of the HSPG interaction in canonical APRIL signaling, because it has been proposed to act as a docking site and also to play a role in direct signaling. In this study, we generated point mutants of soluble APRIL that lack either the capacity to bind HSPGs or TACI and BCMA and then tested the function of these mutants in mouse B-cell assays. In contrast to previous reports, we found that APRIL alone is sufficient to costimulate B-cell proliferation and drive IgA production and does not require artificial antibody cross-linking. We found no evidence that APRIL requires signaling through HSPGs but, notably, were able to show that binding of APRIL to HSPGs is crucial for mediating natural APRIL cross-linking to allow for optimal activation of murine B cells.-Kimberley, F. C., van Bostelen, L., Cameron, K., Hardenberg, G., Marquart, J. A., Hahne, M., Medema, J. P. The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking. FASEB J. 23, 1584-1595 (2009)	[Kimberley, Fiona C.; van Bostelen, Liesbeth; Cameron, Katherine; Hardenberg, Gijs; Medema, Jan Paul] Univ Amsterdam, LEXOR, Ctr Expt Mol Med, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Marquart, J. Arnoud] Univ Amsterdam, Dept Expt Vasc Med, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Hahne, Michael] CNRS, Inst Genet Mol Montpellier, UMR5535, Montpellier, France	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Medema, JP (corresponding author), Univ Amsterdam, LEXOR, Ctr Expt Mol Med, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.p.medema@amc.uva.nl		Medema, Jan Paul/0000-0003-3045-2924	TI-Pharma; Dutch Cancer Society [20032812, 2007-3750]; Stichting Vanderes; Fondation de France and Association pour la Recherche sur le Cancer	TI-Pharma; Dutch Cancer Society(KWF Kankerbestrijding); Stichting Vanderes; Fondation de France and Association pour la Recherche sur le Cancer	We thank the animal caretakers at the Academic Medical Center, University of Amsterdam. The work in this study was supported by TI-Pharma, Dutch Cancer Society grants 20032812 and 2007-3750, and Stichting Vanderes. M. H. is supported by the Fondation de France and Association pour la Recherche sur le Cancer. The authors declare no competing financial interests.	Baeg GH, 2004, DEV BIOL, V276, P89, DOI 10.1016/j.ydbio.2004.08.023; Belnoue E, 2008, BLOOD, V111, P2755, DOI 10.1182/blood-2007-09-110858; Benson MJ, 2008, J IMMUNOL, V180, P3655, DOI 10.4049/jimmunol.180.6.3655; Bischof D, 2006, BLOOD, V107, P3235, DOI 10.1182/blood-2005-01-0256; Bossen C, 2008, BLOOD, V111, P1004, DOI 10.1182/blood-2007-09-110874; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; Chiu A, 2007, BLOOD, V109, P729, DOI 10.1182/blood-2006-04-015958; Day ES, 2005, BIOCHEMISTRY-US, V44, P1919, DOI 10.1021/bi048227k; Deshayes F, 2004, ONCOGENE, V23, P3005, DOI 10.1038/sj.onc.1207350; Garner OB, 2008, IMMUNOLOGY, V125, P420, DOI 10.1111/j.1365-2567.2008.02856.x; Gorelik L, 2004, J IMMUNOL, V172, P762, DOI 10.4049/jimmunol.172.2.762; Grell M, 1998, P NATL ACAD SCI USA, V95, P570, DOI 10.1073/pnas.95.2.570; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; Hardenberg G, 2008, IMMUNOL CELL BIOL, V86, P530, DOI 10.1038/icb.2008.17; Hardenberg G, 2007, EUR J IMMUNOL, V37, P2900, DOI 10.1002/eji.200737210; He B, 2004, J IMMUNOL, V172, P3268, DOI 10.4049/jimmunol.172.5.3268; He B, 2003, J IMMUNOL, V171, P5215, DOI 10.4049/jimmunol.171.10.5215; Hendriks J, 2005, CELL DEATH DIFFER, V12, P637, DOI 10.1038/sj.cdd.4401647; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Hsu BL, 2002, J IMMUNOL, V168, P5993, DOI 10.4049/jimmunol.168.12.5993; Huard B, 2008, J CLIN INVEST, V118, P2887, DOI 10.1172/JCI33760; Hymowitz SG, 2005, J BIOL CHEM, V280, P7218, DOI 10.1074/jbc.M411714200; Ingold K, 2005, J EXP MED, V201, P1375, DOI 10.1084/jem.20042309; Kanswal S, 2008, J IMMUNOL, V181, P976, DOI 10.4049/jimmunol.181.2.976; Kern C, 2004, BLOOD, V103, P679, DOI 10.1182/blood-2003-02-0540; Kolfschoten GA, 2003, BIOCHEM PHARMACOL, V66, P1427, DOI 10.1016/S0006-2952(03)00493-3; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Liu YF, 2003, NATURE, V423, P49, DOI 10.1038/nature01543; Lopez-Fraga M, 2001, EMBO REP, V2, P945, DOI 10.1093/embo-reports/kve198; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; Moreaux J, 2004, BLOOD, V103, P3148, DOI 10.1182/blood-2003-06-1984; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; Ng LG, 2004, J IMMUNOL, V173, P807, DOI 10.4049/jimmunol.173.2.807; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Patel DR, 2004, J BIOL CHEM, V279, P16727, DOI 10.1074/jbc.M312316200; Pelekanou V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-76; Planelles L, 2007, HAEMATOLOGICA, V92, P1284, DOI 10.3324/haematol.10317; Planelles Lourdes, 2008, Curr Mol Med, V8, P829, DOI 10.2174/156652408786733711; Pradet-Balade B, 2002, EMBO J, V21, P5711, DOI 10.1093/emboj/cdf565; Rennert P, 2000, J EXP MED, V192, P1677, DOI 10.1084/jem.192.11.1677; Sakurai D, 2007, BLOOD, V109, P2961, DOI 10.1182/blood-2006-08-041772; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Shulga-Morskaya S, 2004, J IMMUNOL, V173, P2331, DOI 10.4049/jimmunol.173.4.2331; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Varfolomeev E, 2004, MOL CELL BIOL, V24, P997, DOI 10.1128/MCB.24.3.997-1006.2004; Wallweber HJA, 2004, J MOL BIOL, V343, P283, DOI 10.1016/j.jmb.2004.08.040; Wu YM, 2000, J BIOL CHEM, V275, P35478, DOI 10.1074/jbc.M005224200; Yaccoby S, 2008, LEUKEMIA, V22, P406, DOI 10.1038/sj.leu.2405048; Yang M, 2005, J IMMUNOL, V175, P2814, DOI 10.4049/jimmunol.175.5.2814; Yu G, 2000, NAT IMMUNOL, V1, P252, DOI 10.1038/79802	55	69	73	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2009	23	5					1584	1595		10.1096/fj.08-124669	http://dx.doi.org/10.1096/fj.08-124669			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19141538				2022-12-25	WOS:000266651700033
J	Huang, WY; Li, ZG; Rus, H; Wang, XY; Jose, PA; Chen, SY				Huang, Wen-Yan; Li, Zu-Guo; Rus, Horea; Wang, Xiaoyan; Jose, Pedro A.; Chen, Shi-You			RGC-32 Mediates Transforming Growth Factor-beta-induced Epithelial-Mesenchymal Transition in Human Renal Proximal Tubular Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNILATERAL URETERAL OBSTRUCTION; SMOOTH-MUSCLE DIFFERENTIATION; TGF-BETA; MYOFIBROBLAST TRANSITION; INTERSTITIAL FIBROSIS; N-CADHERIN; EXPRESSION; CANCER; SNAIL; TRANSCRIPTION	Epithelial-mesenchymal transition (EMT) occurs in several disease states, including renal fibrosis and carcinogenesis. Myo-fibroblasts produced from EMT of renal tubular cells are responsible for the deposition of extracellular matrix components in a large portion of renal interstitial fibrosis. Transforming growth factor-beta (TGF-beta) plays an essential role in the EMT of renal tubular cells, but the molecular mechanism governing this process remains largely unknown. In this study, we found that RGC-32 ( response gene to complement 32) is critical for TGF-beta-induced EMT of human renal proximal tubular cells (HPTCs). RGC-32 is not normally expressed in the HPTCs. However, TGF-beta stimulation markedly activates RGC-32 while inducing an EMT, as shown by the induction of smooth muscle alpha-actin (alpha-SMA) and extracellular matrix proteins collagen I and fibronectin, as well as the reduction of epithelial marker E-cadherin. TGF-beta function is mediated by several signaling pathways, but RGC-32 expression in HPTCs appears to be mainly regulated by Smad. Functionally, RGC-32 appears to mediate TGF-beta-induced EMT of HPTCs. Blockage of RGC-32 using short hairpin interfering RNA significantly inhibits TGF-beta induction of myofibroblast marker gene alpha-SMA while repressing the expression of E-cadherin. In contrast, overexpression of RGC-32 induces alpha-SMA expression while restoring E-cadherin. RGC-32 also inhibits the expression of another adherens junction protein, N-cadherin, suggesting that RGC-32 alone induces the phenotypic conversion of renal epithelial cells to myofibroblasts. Additional studies show that RGC-32 stimulates the production of extracellular matrix components fibronectin and collagen I. Mechanistically, RGC-32 induces EMT via the activation of other transcription factors such as Snail and Slug. RGC-32 knockdown inhibits the expression of Snail and Slug during TGF-beta-induced EMT. Taken together, our data demonstrate for the first time that RGC-32 plays a critical role in TGF-beta-induced EMT of renal tubular cells.	[Huang, Wen-Yan; Li, Zu-Guo; Chen, Shi-You] Univ Georgia, Coll Vet Med, Dept Physiol & Pharmacol, Athens, GA 30602 USA; [Huang, Wen-Yan] Fudan Univ, Childrens Hosp, Dept Pediat Nephrol, Shanghai 200032, Peoples R China; [Rus, Horea] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; [Huang, Wen-Yan; Wang, Xiaoyan; Jose, Pedro A.] Georgetown Univ, Med Ctr, Dept Pediat, Washington, DC 20057 USA	University System of Georgia; University of Georgia; Fudan University; University System of Maryland; University of Maryland Baltimore; Georgetown University	Chen, SY (corresponding author), Univ Georgia, Coll Vet Med, Dept Physiol & Pharmacol, 501 DW Brooks Dr, Athens, GA 30602 USA.	sc229@uga.edu	Rus, Horea/AAF-2583-2020; Wang, Xiaoyan/GOK-1663-2022	Wang, Xiaoyan/0000-0001-7406-5008	National Institutes of Health [HL093429, DK39308, HL23081]; American Heart Association [0765265U]; Chinese National Nature Science Foundation [30871177]; Veterans Administration Merit Award	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Chinese National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Veterans Administration Merit Award	This work was supported, in whole or in part, by National Institutes of Health Grants HL093429 ( to S.-Y.C.) and DK39308 and HL23081 ( to P.A.J.). This work was also supported by American Heart Association Beginning Grant-in-aid 0765265U ( to S.-Y.C.), Chinese National Nature Science Foundation Grant 30871177 ( to W.-Y.H.), and a Veterans Administration Merit Award ( to H. R.).	Badea T, 2002, J BIOL CHEM, V277, P502, DOI 10.1074/jbc.M109354200; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Boyer B, 2000, BIOCHEM PHARMACOL, V60, P1091, DOI 10.1016/S0006-2952(00)00427-5; Burns WC, 2006, J AM SOC NEPHROL, V17, P2484, DOI 10.1681/ASN.2006050525; Chen SY, 2006, J BIOL CHEM, V281, P1765, DOI 10.1074/jbc.M507771200; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; deCaestecker MP, 1997, J BIOL CHEM, V272, P13690, DOI 10.1074/jbc.272.21.13690; DELARCO JE, 1978, J CELL PHYSIOL, V94, P335, DOI 10.1002/jcp.1040940311; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Essawy M, 1997, NEPHROL DIAL TRANSPL, V12, P43, DOI 10.1093/ndt/12.1.43; Fan JM, 1999, KIDNEY INT, V56, P1455, DOI 10.1046/j.1523-1755.1999.00656.x; Fosbrink M, 2005, EXP MOL PATHOL, V78, P116, DOI 10.1016/j.yexmp.2004.11.001; Fosbrink M, 2005, IMMUNOL RES, V31, P37, DOI 10.1385/IR:31:1:37; HEWITSON TD, 1995, AM J NEPHROL, V15, P111, DOI 10.1159/000168813; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Lan HY, 2003, CURR OPIN NEPHROL HY, V12, P25, DOI 10.1097/00041552-200301000-00005; Lange-Sperandio B, 2007, AM J PATHOL, V171, P861, DOI 10.2353/ajpath.2007.061199; Leroy P, 2007, MOL BIOL CELL, V18, P1943, DOI 10.1091/mbc.E06-09-0823; Li FM, 2007, J BIOL CHEM, V282, P10133, DOI 10.1074/jbc.C600225200; Li JH, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014252.37680.E4; Li YJ, 2003, J CLIN INVEST, V112, P503, DOI 10.1172/JCI200317913; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Masszi A, 2003, AM J PHYSIOL-RENAL, V284, pF911, DOI 10.1152/ajprenal.00183.2002; Medici D, 2006, MOL BIOL CELL, V17, P1871, DOI 10.1091/mbc.E05-08-0767; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Prozialeck Walter C, 2004, BMC Physiol, V4, P10, DOI 10.1186/1472-6793-4-10; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Sanada H, 1999, HYPERTENSION, V33, P1036, DOI 10.1161/01.HYP.33.4.1036; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Savagner P, 1997, J CELL BIOL, V137, P1403, DOI 10.1083/jcb.137.6.1403; Schieppati A, 2005, KIDNEY INT, V68, pS7, DOI 10.1111/j.1523-1755.2005.09801.x; Schnaper HW, 2003, AM J PHYSIOL-RENAL, V284, pF243, DOI 10.1152/ajprenal.00300.2002; Strutz F, 2002, KIDNEY INT, V61, P1714, DOI 10.1046/j.1523-1755.2002.00333.x; Tomita K, 2000, CANCER RES, V60, P3650; Tsuchiya B, 2006, ARCH HISTOL CYTOL, V69, P135, DOI 10.1679/aohc.69.135; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang JW, 2002, J AM SOC NEPHROL, V13, P96, DOI 10.1681/ASN.V13196; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3	46	62	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9426	9432		10.1074/jbc.M900039200	http://dx.doi.org/10.1074/jbc.M900039200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19158077	hybrid, Green Published			2022-12-25	WOS:000264669100049
J	Ruiz-Duenas, FJ; Pogni, R; Morales, M; Giansanti, S; Mate, MJ; Romero, A; Martinez, MJ; Basosi, R; Martinez, AT				Ruiz-Duenas, Francisco J. y; Pogni, Rebecca; Morales, Maria; Giansanti, Stefania; Mate, Maria J.; Romero, Antonio; Jesus Martinez, Maria; Basosi, Riccardo; Martinez, Angel T.			Protein Radicals in Fungal Versatile Peroxidase CATALYTIC TRYPTOPHAN RADICAL IN BOTH COMPOUND I AND COMPOUND II AND STUDIES ON W164Y, W164H, AND W164S VARIANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-FIELD EPR; SITE-DIRECTED MUTAGENESIS; LIGNIN PEROXIDASE; MULTIFREQUENCY EPR; PLEUROTUS-ERYNGII; RIBONUCLEOTIDE REDUCTASE; ELECTRON-TRANSFER; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CYTOCHROME-C	Lignin-degrading peroxidases, a group of biotechnologically interesting enzymes, oxidize high redox potential aromatics via an exposed protein radical. Low temperature EPR of Pleurotus eryngii versatile peroxidase (VP) revealed, for the first time in a fungal peroxidase, the presence of a tryptophanyl radical in both the two-electron (VPI) and the one-electron (VPII) activated forms of the enzyme. Site-directed mutagenesis was used to substitute this tryptophan (Trp-164) by tyrosine and histidine residues. No changes in the crystal structure were observed, indicating that the modified behavior was due exclusively to the mutations introduced. EPR revealed the formation of tyrosyl radicals in both VPI and VPII of the W164Y variant. However, no protein radical was detected in the W164H variant, whose VPI spectrum indicated a porphyrin radical identical to that of the inactive W164S variant. Stopped-flow spectrophotometry showed that the W164Y mutation reduced 10-fold the apparent second-order rate constant for VPI reduction (k(2app)) by veratryl alcohol (VA), when compared with over 50-fold reduction in W164S, revealing some catalytic activity of the tyrosine radical. Its first-order rate constant (k(2)) was more affected than the dissociation constant (K-D2). Moreover, VPII reduction by VA was impaired by the above mutations, revealing that the Trp-164 radical was involved in catalysis by both VPI and VPII. The low first-order rate constant (k(3)) values were similar for the W164Y, W164H, and W164S variants, indicating that the tyrosyl radical in VPII was not able to oxidize VA (in contrast with that observed for VPI). VPII self-reduction was also suppressed, revealing that Trp-164 is involved in this autocatalytic process.	[Ruiz-Duenas, Francisco J. y; Morales, Maria; Mate, Maria J.; Romero, Antonio; Jesus Martinez, Maria; Martinez, Angel T.] CSIC, CIB, E-28040 Madrid, Spain; [Pogni, Rebecca; Giansanti, Stefania; Basosi, Riccardo] Univ Siena, Dept Chem, I-53100 Siena, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Siena	Pogni, R (corresponding author), CSIC, CIB, Ramiro de Maeztu 9, E-28040 Madrid, Spain.	pogni@unisi.it; ATMartinez@cib.csic.es	Basosi, Riccardo/E-7497-2011; Martínez, Angel T/G-7284-2017; Martinez, Maria Jesus/F-9147-2015; Romero, Antonio/K-5754-2014; Ruiz-Dueñas, Francisco J/L-9837-2015	Basosi, Riccardo/0000-0003-1026-7668; Martínez, Angel T/0000-0002-1584-2863; Martinez, Maria Jesus/0000-0003-2166-1097; Romero, Antonio/0000-0002-6990-6973; Ruiz-Dueñas, Francisco J/0000-0002-9837-5665	Spanish projects [BIO2005-03569, BIO2008-01533]; Italian Miur PRIN 2007; BIORENEW project of the European Union [NMP2-CT-2006-026456]	Spanish projects(Spanish Government); Italian Miur PRIN 2007(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); BIORENEW project of the European Union(European Commission)	This work was supported by the Spanish projects BIO2005-03569 and BIO2008-01533, Italian Miur PRIN 2007, and the BIORENEW project of the European Union (Contract NMP2-CT-2006-026456).	Aubert C, 1999, P NATL ACAD SCI USA, V96, P5423, DOI 10.1073/pnas.96.10.5423; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BENECKY MJ, 1993, BIOCHEMISTRY-US, V32, P11929, DOI 10.1021/bi00095a024; BERATAN DN, 1992, SCIENCE, V258, P1740, DOI 10.1126/science.1334572; Bleifuss G, 2001, BIOCHEMISTRY-US, V40, P15362, DOI 10.1021/bi010707d; Blodig W, 2001, J MOL BIOL, V305, P851, DOI 10.1006/jmbi.2000.4346; Blodig W, 1999, ARCH BIOCHEM BIOPHYS, V370, P86, DOI 10.1006/abbi.1999.1365; Camarero S, 1999, J BIOL CHEM, V274, P10324, DOI 10.1074/jbc.274.15.10324; Choinowski T, 1999, J MOL BIOL, V286, P809, DOI 10.1006/jmbi.1998.2507; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Detweiler CD, 2005, FREE RADICAL BIO MED, V38, P969, DOI 10.1016/j.freeradbiomed.2004.12.031; Doyle WA, 1998, BIOCHEMISTRY-US, V37, P15097, DOI 10.1021/bi981633h; Dunford H. B., 1999, HEME PEROXIDASES; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gelpke MDS, 2002, BIOCHEMISTRY-US, V41, P3498, DOI 10.1021/bi011930d; Gerini MF, 2003, BIOPHYS J, V84, P3883, DOI 10.1016/S0006-3495(03)75116-9; Gold MH, 2000, MET IONS BIOL SYST, V37, P559; Hammel KE, 2008, CURR OPIN PLANT BIOL, V11, P349, DOI 10.1016/j.pbi.2008.02.003; HO PS, 1983, J BIOL CHEM, V258, P4356; Ivancich A, 2001, BIOCHEMISTRY-US, V40, P6860, DOI 10.1021/bi002826j; Ivancich A, 2003, J AM CHEM SOC, V125, P14093, DOI 10.1021/ja035582+; Ivancich A, 1997, BIOCHEMISTRY-US, V36, P9356, DOI 10.1021/bi970886s; Johjima T, 1999, P NATL ACAD SCI USA, V96, P1989, DOI 10.1073/pnas.96.5.1989; Kersten P, 2007, FUNGAL GENET BIOL, V44, P77, DOI 10.1016/j.fgb.2006.07.007; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; Lendzian F, 2005, BBA-BIOENERGETICS, V1707, P67, DOI 10.1016/j.bbabio.2004.02.011; Martinez AT, 2002, ENZYME MICROB TECH, V30, P425, DOI 10.1016/S0141-0229(01)00521-X; Martinez AT, 2005, INT MICROBIOL, V8, P195; MCCONNELL HM, 1957, J PHYS CHEM-US, V61, P1018, DOI 10.1021/j150553a048; Mester T, 2001, J BIOL CHEM, V276, P22985, DOI 10.1074/jbc.M010739200; Miki Y, 2006, J FAC AGR KYUSHU U, V51, P99; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PELLETIER H, 1992, SCIENCE, V258, P1748, DOI 10.1126/science.1334573; Perez-Boada M, 2005, J MOL BIOL, V354, P385, DOI 10.1016/j.jmb.2005.09.047; Perez-Boada M, 2002, ENZYME MICROB TECH, V30, P518, DOI 10.1016/S0141-0229(02)00008-X; Pogni R, 2007, APPL MAGN RESON, V31, P509, DOI 10.1007/BF03166599; Pogni R, 2006, J BIOL CHEM, V281, P9517, DOI 10.1074/jbc.M510424200; Pogni R, 2005, BIOCHEMISTRY-US, V44, P4267, DOI 10.1021/bi047474l; Ruiz-Duenas FJ, 1999, MOL MICROBIOL, V31, P223, DOI 10.1046/j.1365-2958.1999.01164.x; Ruiz-Duenas FJ, 2008, BIOCHEMISTRY-US, V47, P1685, DOI 10.1021/bi7020298; Ruiz-Duenas FJ, 2007, BIOCHEMISTRY-US, V46, P66, DOI 10.1021/bi061542h; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Sasaki S, 2008, PHYTOCHEMISTRY, V69, P348, DOI 10.1016/j.phytochem.2007.08.020; Schoemaker H E, 1994, Bioorg Med Chem, V2, P509, DOI 10.1016/0968-0896(94)80021-9; SCHOEMAKER HE, 1990, RECL TRAV CHIM PAY B, V109, P255; SCHULZ CE, 1979, FEBS LETT, V103, P102, DOI 10.1016/0014-5793(79)81259-4; Schunemann V, 2004, J BIOL CHEM, V279, P10919, DOI 10.1074/jbc.M307884200; Smith AT, 1998, CURR OPIN CHEM BIOL, V2, P269, DOI 10.1016/S1367-5931(98)80069-0; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; UN S, 1995, J AM CHEM SOC, V117, P10713, DOI 10.1021/ja00148a013; Un S, 2001, J AM CHEM SOC, V123, P3048, DOI 10.1021/ja003650b; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	52	54	55	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7986	7994		10.1074/jbc.M808069200	http://dx.doi.org/10.1074/jbc.M808069200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19158088	Green Published, hybrid			2022-12-25	WOS:000264195600061
J	Contreras, L; Satrustegui, J				Contreras, Laura; Satrustegui, Jorgina			Calcium Signaling in Brain Mitochondria INTERPLAY OF MALATE ASPARTATE NADH SHUTTLE AND CALCIUM UNIPORTER/MITOCHONDRIAL DEHYDROGENASE PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; ALPHA-KETOGLUTARATE DEHYDROGENASE; GLYCEROL-PHOSPHATE DEHYDROGENASE; PERMEABILITY TRANSITION; OXIDATIVE-METABOLISM; GLYCEROL-3-PHOSPHATE DEHYDROGENASE; GLUTAMATE-DEHYDROGENASE; REDUCING EQUIVALENTS; GLUCOSE CONSUMPTION; SENSORY STIMULATION	Ca2+ signaling in mitochondria has been mainly attributed to Ca2+ entry to the matrix through the Ca2+ uniporter and activation of mitochondrial matrix dehydrogenases. However, mitochondria can also sense increases in cytosolic Ca2+ through a mechanism that involves the aspartate-glutamate carriers, extramitochondrial Ca2+ activation of the NADH malate-aspartate shuttle (MAS). Both pathways are linked through the shared substrate alpha-ketoglutarate (alpha KG). Here we have studied the interplay between the two pathways under conditions of Ca2+ activation. We show that alpha KG becomes limiting when Ca2+ enters in brain or heart mitochondria, but not liver mitochondria, resulting in a drop in alpha KG efflux through the oxoglutarate carrier and in a drop in MAS activity. Inhibition of alpha KG efflux and MAS activity by matrix Ca2+ in brain mitochondria was fully reversible upon Ca2+ efflux. Because of their differences in cytosolic calcium concentration requirements, the MAS and Ca2+ uniporter-mitochondrial dehydrogenase pathways are probably sequentially activated during a Ca2+ transient, and the inhibition of MAS at the center of the transient may provide an explanation for part of the increase in lactate observed in the stimulated brain in vivo.	[Satrustegui, Jorgina] Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, CSIC, E-28049 Madrid, Spain; CIBER Enfermedades Raras, Madrid 28049, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Satrustegui, J (corresponding author), Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, CSIC, C Nicolas Cabrera 1,Campus Cantoblanco, E-28049 Madrid, Spain.	jsatrustegui@cbm.uam.es	Contreras, Laura/A-2296-2015; Contreras, Laura/ABG-7620-2021; Satrustegui, Jorgina/R-6732-2019	Contreras, Laura/0000-0003-1157-4942; Satrustegui Gil Delgado, Jorgina/0000-0003-3377-2667	Ministerio de Educacion y Ciencia [BFU2005-C02-01, BFU2008-04084/BMC]; Comunidad de Madrid [S-GEN-0269-2006]; European Union [LSHM-CT-2006-518153]	Ministerio de Educacion y Ciencia(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); European Union(European Commission)	This work was supported by Ministerio de Educacion y Ciencia Grants BFU2005-C02-01 and BFU2008-04084/BMC, Comunidad de Madrid Grant S-GEN-0269-2006 MITOLAB-CM, and European Union Grant LSHM-CT-2006-518153. The costs of publication of this article were defrayed in part by the payment of page charges.	Atlante A, 1999, J NEUROCHEM, V73, P237, DOI 10.1046/j.1471-4159.1999.0730237.x; Bak LK, 2006, J CEREBR BLOOD F MET, V26, P1285, DOI 10.1038/sj.jcbfm.9600281; Begum L, 2002, BBA-GENE STRUCT EXPR, V1574, P283, DOI 10.1016/S0167-4781(01)00376-1; Berkich DA, 2007, J NEUROSCI RES, V85, P3367, DOI 10.1002/jnr.21500; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; BERNARDI P, 1990, EUR J BIOCHEM, V188, P91, DOI 10.1111/j.1432-1033.1990.tb15375.x; Bernardinelli Y, 2006, GLIA, V54, P460, DOI 10.1002/glia.20387; Caesar K, 2008, J PHYSIOL-LONDON, V586, P1337, DOI 10.1113/jphysiol.2007.144154; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Carobbio S, 2009, J BIOL CHEM, V284, P921, DOI 10.1074/jbc.M806295200; CEDERBAU.AI, 1973, ARCH BIOCHEM BIOPHYS, V158, P763, DOI 10.1016/0003-9861(73)90571-7; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; CHEESEMAN AJ, 1988, J NEUROCHEM, V50, P1559, DOI 10.1111/j.1471-4159.1988.tb03044.x; Contreras L, 2007, J BIOL CHEM, V282, P7098, DOI 10.1074/jbc.M610491200; Cruz NF, 2007, J NEUROSCI RES, V85, P3254, DOI 10.1002/jnr.21193; DAWSON AG, 1978, FEBS LETT, V91, P169, DOI 10.1016/0014-5793(78)81164-8; de Bari L, 2002, BIOCHEM J, V365, P391, DOI 10.1042/BJ20020139; del Arco A, 2002, EUR J BIOCHEM, V269, P3313, DOI 10.1046/j.1432-1033.2002.03018.x; Dienel GA, 2002, J CEREBR BLOOD F MET, V22, P1490, DOI 10.1097/01.WCB.0000034363.37277.89; Erakovic V, 2001, EPILEPSIA, V42, P181, DOI 10.1046/j.1528-1157.2001.4220181.x; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; Gellerich FN, 2008, J BIOL CHEM, V283, P30715, DOI 10.1074/jbc.M709555200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUNTER KK, 1994, J BIOENERG BIOMEMBR, V26, P471, DOI 10.1007/BF00762732; Gunter TE, 2004, FEBS LETT, V567, P96, DOI 10.1016/j.febslet.2004.03.071; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Hernandez-SanMiguel E, 2006, CELL CALCIUM, V40, P53, DOI 10.1016/j.ceca.2006.03.009; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4; Jalil MA, 2005, J BIOL CHEM, V280, P31333, DOI 10.1074/jbc.M505286200; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kasischke KA, 2008, J PHYSIOL-LONDON, V586, P1207, DOI 10.1113/jphysiol.2008.151373; LANOUE KF, 1974, J BIOL CHEM, V249, P7522; LANOUE KF, 1974, J BIOL CHEM, V249, P7514; LANOUE KF, 1974, ARCH BIOCHEM BIOPHYS, V161, P544, DOI 10.1016/0003-9861(74)90337-3; Lasorsa FM, 2003, J BIOL CHEM, V278, P38686, DOI 10.1074/jbc.M304988200; LEVEILLE PJ, 1980, BRAIN RES, V196, P287, DOI 10.1016/0006-8993(80)90397-2; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; MacDonald MJ, 1996, ARCH BIOCHEM BIOPHYS, V326, P79, DOI 10.1006/abbi.1996.0049; Madsen PL, 1999, J CEREBR BLOOD F MET, V19, P393, DOI 10.1097/00004647-199904000-00005; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Mangia S, 2007, J CEREBR BLOOD F MET, V27, P1055, DOI 10.1038/sj.jcbfm.9600401; Marmol P, 2009, J BIOL CHEM, V284, P515, DOI 10.1074/jbc.M806729200; MARTINEZ A, 1988, NEUROSCI LETT, V88, P336, DOI 10.1016/0304-3940(88)90234-0; MARTINEZSERRANO A, 1992, MOL BIOL CELL, V3, P235, DOI 10.1091/mbc.3.2.235; McCormack JG, 1999, CALCIUM AS A CELLULAR REGULATOR, P529; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; MCCORMACK JG, 1979, BIOCHEM J, V180, P533, DOI 10.1042/bj1800533; McKenna MC, 2006, BIOCHEM PHARMACOL, V71, P399, DOI 10.1016/j.bcp.2005.10.011; Monteith GR, 1999, AM J PHYSIOL-CELL PH, V276, pC1193, DOI 10.1152/ajpcell.1999.276.5.C1193; Moreau B, 2006, CURR BIOL, V16, P1672, DOI 10.1016/j.cub.2006.06.059; Nehlig A, 2007, GLIA, V55, P1238, DOI 10.1002/glia.20376; Nguyen NHT, 2003, J NEUROCHEM, V85, P831, DOI 10.1046/j.1471-4159.2003.01762.x; NICHOLLS DG, 1980, BIOCHEM J, V186, P833, DOI 10.1042/bj1860833; NICHOLLS DG, 1978, BIOCHEM J, V170, P511, DOI 10.1042/bj1700511; NICHOLS BJ, 1995, MOL CELL BIOCHEM, V149, P203, DOI 10.1007/BF01076578; O'Donnell JM, 2004, AM J PHYSIOL-HEART C, V286, pH2237, DOI 10.1152/ajpheart.01113.2003; O'Donnell JM, 1998, AM J PHYSIOL-HEART C, V274, pH467, DOI 10.1152/ajpheart.1998.274.2.H467; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Panov A, 2007, AM J PHYSIOL-CELL PH, V292, pC708, DOI 10.1152/ajpcell.00202.2006; Pardo B, 2006, J BIOL CHEM, V281, P1039, DOI 10.1074/jbc.M507270200; Patel AB, 2005, J NEUROSCI RES, V79, P128, DOI 10.1002/jnr.20311; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; POITRYYAMATE CL, 1995, J NEUROSCI, V15, P5179; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Ramos M, 2003, DEV BRAIN RES, V143, P33, DOI 10.1016/S0165-3806(03)00097-X; ROBERT R, 1983, METHODS ENZYMATIC AN, V3; ROLFE DFS, 1994, BBA-BIOENERGETICS, V1188, P405, DOI 10.1016/0005-2728(94)90062-0; RUNSWICK MJ, 1990, BIOCHEMISTRY-US, V29, P11033, DOI 10.1021/bi00502a004; RUTTER GA, 1992, BIOCHIM BIOPHYS ACTA, V1175, P107, DOI 10.1016/0167-4889(92)90016-5; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; Scholz TD, 1997, J MOL CELL CARDIOL, V29, P1605, DOI 10.1006/jmcc.1997.0394; SCHOLZ TD, 1995, PEDIATR RES, V38, P221, DOI 10.1203/00006450-199508000-00015; SLUSE FE, 1973, EUR J BIOCHEM, V32, P283, DOI 10.1111/j.1432-1033.1973.tb02609.x; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Tretter L, 2000, J NEUROSCI, V20, P8972; Villa A, 1998, BBA-BIOMEMBRANES, V1373, P347, DOI 10.1016/S0005-2736(98)00120-5; VITORICA J, 1985, BIOCHEM J, V225, P41, DOI 10.1042/bj2250041; Waagepetersen HS, 2008, NEUROCHEM RES, V33, P1610, DOI 10.1007/s11064-008-9695-8; WAN B, 1989, J BIOL CHEM, V264, P13430; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Watkins J, 2008, J PROTEOME RES, V7, P328, DOI 10.1021/pr070300g; WERNETTE ME, 1981, J BIOL CHEM, V256, P2767; Xu Y, 2007, J NEUROCHEM, V101, P120, DOI 10.1111/j.1471-4159.2006.04349.x; Yang SJ, 2003, BIOCHIMIE, V85, P581, DOI 10.1016/S0300-9084(03)00092-0	87	69	74	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7091	7099		10.1074/jbc.M808066200	http://dx.doi.org/10.1074/jbc.M808066200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19129175	hybrid, Green Published			2022-12-25	WOS:000263919000057
J	Hora, R; Bridges, DJ; Craig, A; Sharma, A				Hora, Rachna; Bridges, Daniel J.; Craig, Alister; Sharma, Amit			Erythrocytic Casein Kinase II Regulates Cytoadherence of Plasmodium falciparum-infected Red Blood Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTIDINE-RICH PROTEIN; MEMBRANE PROTEIN-1; SUBCELLULAR-LOCALIZATION; PHOSPHORYLATION; MALARIA; PFEMP1; LIGAND; SPECTRIN; PARASITE; RECEPTOR	Plasmodium falciparum malaria is a major human health scourge and a key cause of mortality. Its pathogenicity partly results from the phenomenon of "cytoadherence" mediated by the PfEMP1 (Plasmodium falciparum erythrocyte membrane protein 1) family. Extracellular domains of PfEMP1s are variable and bind various host endothelial receptors, whereas their cytoplasmic domains (VARCs) are relatively conserved. VARCs affix PfEMP1s in the human erythrocyte membrane by interacting with host cytoskeleton proteins and exported parasite proteins. Here, we provide in vitro and in vivo evidence for PfEMP1 phosphorylation (on VARC) and propose an important function for this modification. Specific inhibitors and enhancers have been used to identify erythrocytic casein kinase II (CKII) as the enzyme responsible for VARC modification activity. We have also delineated probable CKII target residues on VARC, which mainly reside in an N-terminal acidic cluster. Our data show that VARC phosphorylation alters its binding to parasite encoded knob-associated histidine-rich protein (KAHRP). Finally, we demonstrate reduced cytoadherence of infected RBCs to endothelial receptors like ICAM-1 and CSA (these contribute to cerebral and placental malaria, respectively) in response to their CKII inhibition. Collectively, this study furthers our understanding of VARC function, underscores the importance of erythrocytic CKII in cytoadherence, and suggests a possible new target for anti-cytoadherence molecules.	[Hora, Rachna; Sharma, Amit] Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, New Delhi 110067, India; [Bridges, Daniel J.; Craig, Alister] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Liverpool School of Tropical Medicine; University of Liverpool	Sharma, A (corresponding author), Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, Aruna Asaf Ali Rd, New Delhi 110067, India.	amit.icgeb@gmail.com		Hora, Rachna/0000-0002-6085-8389; Craig, Alister/0000-0003-0914-6164	MRC [G0400417] Funding Source: UKRI; Medical Research Council [G0400417] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ASSARAF YG, 1984, BIOCHEM J, V222, P815, DOI 10.1042/bj2220815; BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; Barragan A, 1999, BIOCHEM SOC T, V27, P487, DOI 10.1042/bst0270487; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; BERENDT AR, 1994, PARASITOLOGY, V108, P19; Brunati AM, 2000, BLOOD, V96, P1550, DOI 10.1182/blood.V96.4.1550.h8001550_1550_1557; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; CULVENOR JG, 1987, EXP PARASITOL, V63, P58, DOI 10.1016/0014-4894(87)90078-6; Dondorp AM, 2000, PARASITOL TODAY, V16, P228, DOI 10.1016/S0169-4758(00)01666-5; Faust M, 2000, CELL TISSUE RES, V301, P329, DOI 10.1007/s004410000256; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; Ghosh S, 2002, J CELL SCI, V115, P4107, DOI 10.1242/jcs.00102; Glenister FK, 2002, BLOOD, V99, P1060, DOI 10.1182/blood.V99.3.1060; HATHAWAY GM, 1984, J BIOL CHEM, V259, P7011; HATHAWAY GM, 1980, J BIOL CHEM, V255, P8038; Horrocks P, 2005, J CELL SCI, V118, P2507, DOI 10.1242/jcs.02381; KAMESHITA I, 1989, ANAL BIOCHEM, V183, P139, DOI 10.1016/0003-2697(89)90181-4; Lechuga MT, 2006, ACTA PSYCHOL, V123, P279, DOI 10.1016/j.actpsy.2006.01.006; LING E, 1988, J BIOL CHEM, V263, P2209; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Oh SS, 2000, MOL BIOCHEM PARASIT, V108, P237, DOI 10.1016/S0166-6851(00)00227-9; PATEL VP, 1981, J CELL BIOL, V88, P430, DOI 10.1083/jcb.88.2.430; Penrose KJ, 2004, J BIOL CHEM, V279, P22430, DOI 10.1074/jbc.M314340200; POLOGE LG, 1987, P NATL ACAD SCI USA, V84, P7139, DOI 10.1073/pnas.84.20.7139; Raha T, 2000, PROTEIN ENG, V13, P437, DOI 10.1093/protein/13.6.437; Ramya TNC, 2006, BIOCHEM BIOPH RES CO, V348, P579, DOI 10.1016/j.bbrc.2006.07.127; RUANGJIRACHUPORN W, 1991, PARASITOLOGY, V102, P325, DOI 10.1017/S003118200006426X; Sarno S, 2005, BBA-PROTEINS PROTEOM, V1754, P263, DOI 10.1016/j.bbapap.2005.07.043; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Voigt S, 2000, MOL BIOCHEM PARASIT, V110, P423, DOI 10.1016/S0166-6851(00)00281-4; Wagner LM, 2002, MOL VIS, V8, P394; Waller KL, 1999, J BIOL CHEM, V274, P23808, DOI 10.1074/jbc.274.34.23808; Waller KL, 2002, MOL BIOCHEM PARASIT, V119, P125, DOI 10.1016/S0166-6851(01)00395-4	37	32	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6260	6269		10.1074/jbc.M809756200	http://dx.doi.org/10.1074/jbc.M809756200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19131328	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000263742700029
J	Bachmaier, R; Aryee, DNT; Jug, G; Kauer, M; Kreppel, M; Lee, KA; Kovar, H				Bachmaier, R.; Aryee, D. N. T.; Jug, G.; Kauer, M.; Kreppel, M.; Lee, K. A.; Kovar, H.			O-GlcNAcylation is involved in the transcriptional activity of EWS-FLI1 in Ewing's sarcoma	ONCOGENE			English	Article						EWS-FLI1; Ewing's sarcoma; post-translational modification; O-GlcNAc; phosphorylation; transcription	RNA-POLYMERASE-II; DON 6-DIAZO-5-OXO-L-NORLEUCINE; N-ACETYLGLUCOSAMINE; TYROSINE KINASE; FUSION PROTEIN; PHASE-I; EWS; DOMAIN; PHOSPHORYLATION; GLYCOPROTEIN	The oncogene EWS-FLI1 encodes a chimeric transcription factor expressed in Ewing's sarcoma family tumors (ESFTs). EWS-FLI1 target gene expression is thought to drive ESFT pathogenesis and, therefore, inhibition of EWS-FLI1 activity holds high therapeutic promise. As the activity of many transcription factors is regulated by post-translational modi. cations, we studied the presence of modi. cations on EWS-FLI1. The immuno-purified fusion-protein was recognized by an antibody specific for O-linked beta-N-acetylglucosaminylation, and bound readily to a phosphoprotein-specific dye. Inhibition of Ser/Thr-specific phophatases increased EWS-FLI1 molecular weight and reduced its O-GlcNAc content, suggesting that phosphorylation and O-GlcNAcylation of EWS-FLI1 interact dynamically. By mutation analysis, O-GlcNAcylation was delineated to Ser/Thr residues of the amino-terminal EWS transcriptional-activation domain. Metabolic inhibition of the hexosamine biosynthetic pathway abrogated O-GlcNAcylation of EWS-FLI1 and interfered specifically with transcriptional activation of the EWS-FLI1 target Id2. These results suggest that drugs modulating glycosylation of EWS-FLI1 interfere functionally with its activity and might, therefore, constitute promising additions to the current ESFT chemotherapy.	[Bachmaier, R.; Aryee, D. N. T.; Jug, G.; Kauer, M.; Kreppel, M.; Kovar, H.] St Anna Kinder Krebsforsch, Childrens Canc Res Inst, A-1090 Vienna, Austria; [Lee, K. A.] Hong Kong Univ Sci & Technol, Dept Biol, Kowloon, Hong Kong, Peoples R China	Saint Anna Children's Hospital; Hong Kong University of Science & Technology	Kovar, H (corresponding author), St Anna Kinder Krebsforsch, Childrens Canc Res Inst, Kinderspitalgasse 6, A-1090 Vienna, Austria.	heinrich.kovar@ccri.at		Kovar, Heinrich/0000-0001-6873-9109	Austrian Science Fund (FWF) [P18046-B12]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported in part by Grant P18046-B12 of the Austrian Science Fund ( FWF).	Araya N, 2005, BIOCHEM BIOPH RES CO, V329, P653, DOI 10.1016/j.bbrc.2005.02.018; Aryee DNT, 2006, CANCER RES, V66, P9862, DOI 10.1158/0008-5472.CAN-05-4042; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Deloulme JC, 1997, J BIOL CHEM, V272, P27369, DOI 10.1074/jbc.272.43.27369; Guinamard R, 1997, SCAND J IMMUNOL, V45, P587, DOI 10.1046/j.1365-3083.1997.d01-447.x; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Kim J, 1999, P NATL ACAD SCI USA, V96, P14300, DOI 10.1073/pnas.96.25.14300; Kim J, 2000, FEBS LETT, V474, P121, DOI 10.1016/S0014-5793(00)01590-8; Kovar H, 2005, SEMIN CANCER BIOL, V15, P189, DOI 10.1016/j.semcancer.2005.01.004; LYNCH G, 1982, AM J CLIN ONCOL-CANC, V5, P541; Martin K, 2003, PROTEOMICS, V3, P1244, DOI 10.1002/pmic.200300445; Matsuoka Y, 2002, HYBRIDOMA HYBRIDOM, V21, P233, DOI 10.1089/153685902760213831; Ng KP, 2007, P NATL ACAD SCI USA, V104, P479, DOI 10.1073/pnas.0607007104; Ohlson J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni169; Petermann R, 1998, ONCOGENE, V17, P603, DOI 10.1038/sj.onc.1201964; RAHMAN A, 1985, INVEST NEW DRUG, V3, P369; SNOW CM, 1987, J CELL BIOL, V104, P1143, DOI 10.1083/jcb.104.5.1143; Spahn L, 2003, ONCOGENE, V22, P6819, DOI 10.1038/sj.onc.1206810; SULLIVAN MP, 1988, CANCER CHEMOTH PHARM, V21, P78, DOI 10.1007/BF00262746; Wang M, 1999, EXP CELL RES, V246, P38, DOI 10.1006/excr.1998.4280; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Zhang XK, 2005, J BIOCHEM, V137, P297, DOI 10.1093/jb/mvi032	24	39	40	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 5	2009	28	9					1280	1284		10.1038/onc.2008.484	http://dx.doi.org/10.1038/onc.2008.484			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	415AH	19151750	Green Accepted			2022-12-25	WOS:000263906200012
J	Khandrika, L; Lieberman, R; Koul, S; Kumar, B; Maroni, P; Chandhoke, R; Meacham, RB; Koul, HK				Khandrika, L.; Lieberman, R.; Koul, S.; Kumar, B.; Maroni, P.; Chandhoke, R.; Meacham, R. B.; Koul, H. K.			Hypoxia-associated p38 mitogen-activated protein kinase-mediated androgen receptor activation and increased HIF-1 alpha levels contribute to emergence of an aggressive phenotype in prostate cancer	ONCOGENE			English	Article						p38 MAPK; HIF-1 alpha; androgen independence; prostate cancer	ENDOTHELIAL GROWTH-FACTOR; INDUCIBLE FACTOR-1-ALPHA; MAP-KINASE; OXIDATIVE STRESS; VEGF EXPRESSION; CELL INVASION; LNCAP CELLS; IN-VITRO; ANGIOGENESIS; PATHWAY	Androgen receptor (AR) signaling is involved in the development and progression of prostate cancer. Tumor microvasculature contributes to continual exposure of prostate cancer cells to hypoxia-reoxygenation, however, the role of hypoxia-reoxygenation in prostate cancer progression and modulation of AR signaling is not understood. In this study, we evaluated the effects of hypoxia-reoxygenation in LNCaP cells, a line of hormone responsive human prostate cancer cells. Our results demonstrate that hypoxia-reoxygenation resulted in increased survival, higher clonogenicity and enhanced invasiveness of these cells. Moreover, hypoxia-reoxygenation was associated with an increased AR activity independent of androgens as well as increased hypoxia inducible factor (HIF-1 alpha) levels and activity. We also observed that the activation of p38 mitogen-activated protein (MAP) kinase pathway was an early response to hypoxia, and inhibition of p38 MAP kinase pathway by variety of approaches abolished hypoxia-reoxygenation induced increased AR activity as well as increased survival, clonogenicity and invasiveness. These results demonstrate a critical role for hypoxia-induced p38 MAP kinase pathway in androgen-independent AR activation in prostate cancer cells, and suggest that hypoxia-reoxygenation may select for aggressive androgen-independent prostate cancer phenotype.	[Khandrika, L.; Lieberman, R.; Koul, S.; Kumar, B.; Maroni, P.; Chandhoke, R.; Meacham, R. B.; Koul, H. K.] Univ Colorado, Denver & Hlth Sci Ctr, Sch Med,Program Urosci, Signal Transduct & Mol Urol Lab,Dep Surg,Div Urol, Aurora, CO 80045 USA; [Maroni, P.; Meacham, R. B.; Koul, H. K.] Univ Colorado, Denver & Hlth Sci Ctr, Ctr Comprehens Canc, Aurora, CO 80045 USA; [Koul, H. K.] Univ Colorado, Denver & Hlth Sci Ctr, Denver Vet Adm Med Ctr, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Koul, HK (corresponding author), Univ Colorado, Denver & Hlth Sci Ctr, Sch Med,Program Urosci, Signal Transduct & Mol Urol Lab,Dep Surg,Div Urol, Bldg P15 RC2,12700 E 19th Ave,Room 6001, Aurora, CO 80045 USA.	hari.koul@uchsc.edu	Kumar, Binod/K-3679-2013	Khandrika, Lakshmipathi/0000-0003-4438-9073	NIH/NCI-P20 [CA103680]; Student Cancer Research Fellowship Program; University of Colorado Cancer Center; Department of Surgery School of Medicine Academic Enrichment Funds; NATIONAL CANCER INSTITUTE [P20CA103680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054084] Funding Source: NIH RePORTER	NIH/NCI-P20(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Student Cancer Research Fellowship Program; University of Colorado Cancer Center; Department of Surgery School of Medicine Academic Enrichment Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported in part by NIH/NCI-P20 CA103680-Schwartz/Byers Program PI's ( H Koul, Pilot-Project PI), Student Cancer Research Fellowship Program ( H Koul, Preceptor), University of Colorado Cancer Center and Department of Surgery School of Medicine Academic Enrichment Funds ( H Koul). We thankfully acknowledge service provided by University of Colorado Cancer Center Flow Cytometry Core. We thank Dr Andrew Kung ( Dana-Faber Cancer Institute, Boston, MA, USA) for 3 x HRE luciferase plasmid, Dr Magnus Essand ( Uppsala University, Sweden) for AR responsive Luciferase Vector PSAe/TARPp and Professor Matthias Gaestel ( Institute of Biochemistry, Medical School, Hannover, Germany) for MK2 expression plasmids.	Akakura N, 2001, CANCER RES, V61, P6548; Asirvatham AJ, 2006, ENDOCRINOLOGY, V147, P257, DOI 10.1210/en.2005-0942; Baek SH, 2001, J CELL PHYSIOL, V188, P223, DOI 10.1002/jcp.1117; Berra E, 2000, CANCER METAST REV, V19, P139, DOI 10.1023/A:1026506011458; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Boddy JL, 2005, CLIN CANCER RES, V11, P7658, DOI 10.1158/1078-0432.CCR-05-0460; Butterworth KT, 2008, INT J CANCER, V123, P760, DOI 10.1002/ijc.23418; Calvani M, 2008, CANCER RES, V68, P285, DOI 10.1158/0008-5472.CAN-07-5564; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cheng WS, 2003, ENDOCRINOLOGY, V144, P3433, DOI 10.1210/en.2003-0121; Culig Z, 2006, J CELL BIOCHEM, V99, P373, DOI 10.1002/jcb.20898; Horii K, 2007, MOL CANCER RES, V5, P383, DOI 10.1158/1541-7786.MCR-06-0226; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Huggins C, 1941, CANCER RES, V1, P293; Kimbro KS, 2006, ENDOCR-RELAT CANCER, V13, P739, DOI 10.1677/erc.1.00728; Kokontis JM, 1998, MOL ENDOCRINOL, V12, P941, DOI 10.1210/me.12.7.941; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Kwon SJ, 2005, CLIN CANCER RES, V11, P7607, DOI 10.1158/1078-0432.CCR-05-0981; Luo Y, 2006, BJU INT, V98, P1315, DOI 10.1111/j.1464-410X.2006.06480.x; Maroni PD, 2005, J UROLOGY, V174, P757, DOI 10.1097/01.ju.0000164724.86631.6e; McDonald DM, 2003, NAT MED, V9, P713, DOI 10.1038/nm0603-713; Milosevic M, 2007, CANCER RES, V67, P6022, DOI 10.1158/0008-5472.CAN-07-0561; Miyazaki Y, 2008, INT J ONCOL, V32, P145; Mortimer HJ, 2007, PULM PHARMACOL THER, V20, P718, DOI 10.1016/j.pupt.2006.08.007; Murata M, 2006, J ORTHOP RES, V24, P1544, DOI 10.1002/jor.20168; Pages G, 2000, J BIOL CHEM, V275, P26484, DOI 10.1074/jbc.M002104200; Park SY, 2006, CANCER RES, V66, P5121, DOI 10.1158/0008-5472.CAN-05-1341; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Powell CS, 2004, AM J PHYSIOL-LUNG C, V286, pL826, DOI 10.1152/ajplung.00119.2003; REPESH LA, 1989, INVAS METAST, V9, P192; RIZZINO A, 1987, METHOD ENZYMOL, V146, P341; Shida Y, 2007, BIOCHEM BIOPH RES CO, V353, P744, DOI 10.1016/j.bbrc.2006.12.077; Sumbayev VV, 2005, ARCH BIOCHEM BIOPHYS, V436, P406, DOI 10.1016/j.abb.2005.02.021; Sung SY, 2006, CANCER RES, V66, P9519, DOI 10.1158/0008-5472.CAN-05-4375; Vleugel MM, 2005, J CLIN PATHOL, V58, P172, DOI 10.1136/jcp.2004.019885; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Xu L, 2006, ONCOGENE, V25, P2987, DOI 10.1038/sj.onc.1209337; Yoshino Y, 2006, INT J ONCOL, V29, P981; Zetter BR, 1998, ANNU REV MED, V49, P407, DOI 10.1146/annurev.med.49.1.407; Zhong H, 1998, CANCER RES, V58, P5280; Zhong H, 2000, CANCER RES, V60, P1541; Zoubeidi A, 2007, CANCER RES, V67, P10455, DOI 10.1158/0008-5472.CAN-07-2057	42	66	69	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 5	2009	28	9					1248	1260		10.1038/onc.2008.476	http://dx.doi.org/10.1038/onc.2008.476			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	415AH	19151763	Green Accepted			2022-12-25	WOS:000263906200009
J	Finkbeiner, MR; Astanehe, A; To, K; Fotovati, A; Davies, AH; Zhao, Y; Jiang, H; Stratford, AL; Shadeo, A; Boccaccio, C; Comoglio, P; Mertens, PR; Eirew, P; Raouf, A; Eaves, CJ; Dunn, SE				Finkbeiner, M. R.; Astanehe, A.; To, K.; Fotovati, A.; Davies, A. H.; Zhao, Y.; Jiang, H.; Stratford, A. L.; Shadeo, A.; Boccaccio, C.; Comoglio, P.; Mertens, P. R.; Eirew, P.; Raouf, A.; Eaves, C. J.; Dunn, S. E.			Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells	ONCOGENE			English	Article						YB-1; MET receptor; ChIP-on-chip; basal-like breast cancer; mammary progenitors	GROWTH-FACTOR RECEPTOR; BOX BINDING PROTEIN-1; BREAST-CANCER CELLS; EPITHELIAL STEM-CELLS; INVASIVE GROWTH; IN-VIVO; C-MET; EXPRESSION; HER-2; BINDING-PROTEIN-1	Basal-like breast cancers (BLBCs) are aggressive tumors with high relapse rates and poor survival. We recently reported that > 70% of primary BLBCs express the oncogenic transcription/translation factor Y-box binding protein-1 (YB-1) and silencing it with small interfering RNAs (siRNAs) attenuates the growth of BLBC cell lines. To understand the basis of these earlier findings, we profiled YB-1: DNA complexes by chromatin immunoprecipitation (ChIP)-on-chip. Several tumor growth-promoting genes such as MET, CD44, CD49f, WNT and NOTCH family members were identified. In addition, YB-1 and MET are coordinately expressed in BLBC cell lines, as well as in normal human mammary progenitor cells. MET was confirmed to be a YB-1 target through traditional ChIP and gel-shift assays. More specifically, YB-1 binds to -1018 bp on the MET promoter. Silencing YB-1 with siRNA decreased MET promoter activity, transcripts, as well as protein levels and signaling. Conversely, expressing wild-type YB-1 or a constitutively active mutant YB-1 (D102) increased MET expression. Finally, silencing YB-1 or MET attenuated anchorage-independent growth of BLBC cell lines. Together, these findings implicate MET as a target of YB-1 that work in concert to promote BLBC growth.	[Finkbeiner, M. R.; Astanehe, A.; To, K.; Fotovati, A.; Davies, A. H.; Zhao, Y.; Jiang, H.; Stratford, A. L.; Dunn, S. E.] Univ British Columbia, Dept Pediat, Lab Oncogen Res, Vancouver, BC V5Z 4H4, Canada; [Finkbeiner, M. R.; Astanehe, A.; To, K.; Fotovati, A.; Davies, A. H.; Zhao, Y.; Jiang, H.; Stratford, A. L.; Dunn, S. E.] Univ British Columbia, Dept Expt Med, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [Shadeo, A.] British Columbia Canc Agcy, Canc Genet & Dev Biol, Vancouver, BC V5Z 4E6, Canada; [Boccaccio, C.; Comoglio, P.] Univ Turin, Sch Med, Inst Canc Res & Treatment IRCC, Candiolo, Italy; [Mertens, P. R.] Univ Hosp Aachen, Div Nephrol & Clin Immunol, Aachen, Germany; [Eirew, P.; Raouf, A.; Eaves, C. J.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada	University of British Columbia; Child & Family Research Institute; University of British Columbia; British Columbia Cancer Agency; IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; RWTH Aachen University; RWTH Aachen University Hospital; British Columbia Cancer Agency	Dunn, SE (corresponding author), Univ British Columbia, Dept Pediat, Lab Oncogen Res, 950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	sedunn@interchange.ubc.ca	Boccaccio, Carla/AHE-7875-2022; Mertens, Peter/AAI-7310-2020	Boccaccio, Carla/0000-0003-2620-9083; Eaves, Connie/0000-0002-3452-1926; Shadeo, Ashleen/0000-0002-0866-0519; Comoglio, Paolo/0000-0002-7056-5328	Canadian Breast Cancer Research Alliance; National Institute of Health; Michael Smith Foundation; Canadian Institute for Health; Canadian Breast Cancer Foundation; US Department of Defense Breast Cancer Research; Terry Fox Foundation; National Cancer Institute of Canada; Canadian Imperial Bank of Commerce; Canadian Stem Cell Network Studentship	Canadian Breast Cancer Research Alliance; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael Smith Foundation(Michael Smith Foundation for Health Research); Canadian Institute for Health(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); US Department of Defense Breast Cancer Research(United States Department of Defense); Terry Fox Foundation; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Imperial Bank of Commerce; Canadian Stem Cell Network Studentship	This project was funded by the Canadian Breast Cancer Research Alliance (awarded to SED) and the National Institute of Health (RO1 awarded to SED). A Astanehe, K To and A Davies are recipients of Michael Smith Foundation for Health Research Graduate Studentships. A Astanehe and K To are recipients of Canadian Institute for Health Graduate Studentships. A Stratford holds a Canadian Breast Cancer Foundation Postdoctoral Fellowship. P Eirew is the recipient of the US Department of Defense Breast Cancer Research Program Studentship, the Terry Fox Foundation Research Studentship from the National Cancer Institute of Canada, the Canadian Imperial Bank of Commerce Interdisciplinary Award and the Canadian Stem Cell Network Studentship.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Boon EMJ, 2002, CANCER RES, V62, P5126; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Colozza M, 2007, ONCOLOGIST, V12, P253, DOI 10.1634/theoncologist.12-3-253; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dunn BK, 2007, EUR J CANCER PREV, V16, P232, DOI 10.1097/CEJ.0b013e328011ed2d; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; Gambarotta G, 1996, ONCOGENE, V13, P1911; Habibi G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2156; Kuwano M, 2004, MOL CANCER THER, V3, P1485; Lee C, 2008, CANCER RES, V68, P8661, DOI 10.1158/0008-5472.CAN-08-1082; Leo C, 2007, GYNECOL ONCOL, V104, P181, DOI 10.1016/j.ygyno.2006.07.040; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Okamoto T, 2000, ONCOGENE, V19, P6194, DOI 10.1038/sj.onc.1204029; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Sachs M, 2000, J CELL BIOL, V150, P1375, DOI 10.1083/jcb.150.6.1375; Shadeo A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1370; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stratford AL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1767; Stratford AL, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2202; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; To K, 2007, MOL PHARMACOL, V72, P641, DOI 10.1124/mol.107.036111; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; van Roeyen CRC, 2005, J AM SOC NEPHROL, V16, P2985, DOI 10.1681/ASN.2004111009; Welm AL, 2005, P NATL ACAD SCI USA, V102, P4324, DOI 10.1073/pnas.0500470102; Wu J, 2006, CANCER RES, V66, P4872, DOI 10.1158/0008-5472.CAN-05-3561; Yoshida S, 2004, J CLIN ENDOCR METAB, V89, P823, DOI 10.1210/jc.2003-030874; Zhao Y, 2007, STEM CELLS, V25, P1681, DOI 10.1634/stemcells.2006-0794	37	70	70	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	11					1421	1431		10.1038/onc.2008.485	http://dx.doi.org/10.1038/onc.2008.485			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	421JE	19151767				2022-12-25	WOS:000264354400003
J	Saharia, A; Stewart, SA				Saharia, A.; Stewart, S. A.			FEN1 contributes to telomere stability in ALT-positive tumor cells	ONCOGENE			English	Article						telomere; FEN1; genomic stability; ALT	REPLICATION FORK; DNA-REPLICATION; WRN HELICASE; COMPLEX; LENGTH; STRAND; MECHANISM; ENDS; STIMULATION; INHIBITION	Abrogation of telomere stability through loss-of-function mutations in telomere binding proteins contributes to genomic instability and cancer progression. Recently, Flap endonuclease 1 (FEN1) was shown to contribute to telomere stability in human cells that had not yet activated a telomere maintenance mechanism, suggesting that abrogation of FEN1 function influences the transformation process by compromising telomere stability and driving genomic instability. Here, we analyse the telomeres in human cancer cells following FEN1 depletion. We show that FEN1 is required for telomere stability in cells that rely on the alternative lengthening of telomere (ALT) mechanism. Indeed, FEN1 depletion resulted in telomere dysfunction, characterized by formation of telomere dysfunction-induced foci (TIFs) and end-to-end fusions in ALT-positive cells. In contrast, no telomere phenotype was observed in telomerase-positive cells on FEN1 depletion, suggesting that ongoing telomerase activity protected telomeres. In consonance with this, we found that expression of the catalytic component of telomerase (hTERT) but not an inactive allele rescued telomere dysfunction on FEN1 depletion in ALT cells. Our data suggest that mutations that arise in FEN1 affect telomere stability and genome fidelity by promoting telomere fusions and anaphase-bridge-breakage cycles, which further drive genome instability and thereby contribute to the transformation process.	[Stewart, S. A.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Saharia, A.; Stewart, S. A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Stewart, SA (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol & Med, Campus Box 8228,660 S Euclid Ave, St Louis, MO 63110 USA.	sheila.stewart@cellbiology.wustl.edu	Stewart, Sheila A/C-5213-2012		Sidney Kimmel Foundation for Cancer Research; Edward Mallinckrodt, Jr Foundation; Lucille P Markey Program	Sidney Kimmel Foundation for Cancer Research; Edward Mallinckrodt, Jr Foundation; Lucille P Markey Program	This work was supported by the Sidney Kimmel Foundation for Cancer Research and the Edward Mallinckrodt, Jr Foundation. AS was supported by the Lucille P Markey Program. SAS is a Sidney Kimmel Scholar. We are grateful to Yu Tao for helpwith statistical analyses and members of the Stewart Laboratory for valuable discussions.	Artandi SE, 2000, CURR OPIN GENET DEV, V10, P39, DOI 10.1016/S0959-437X(99)00047-7; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Forstemann K, 2000, NUCLEIC ACIDS RES, V28, P2690, DOI 10.1093/nar/28.14.2690; Fouche N, 2006, NUCLEIC ACIDS RES, V34, P6044, DOI 10.1093/nar/gkl757; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Grobelny JV, 2001, HUM MOL GENET, V10, P1953, DOI 10.1093/hmg/10.18.1953; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Kikuchi K, 2005, MOL CELL BIOL, V25, P6948, DOI 10.1128/MCB.25.16.6948-6955.2005; Kucherlapati M, 2007, ONCOGENE, V26, P6297, DOI 10.1038/sj.onc.1210453; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Londono-Vallejo JA, 2004, CANCER RES, V64, P2324, DOI 10.1158/0008-5472.CAN-03-4035; Marcand S, 1999, EMBO J, V18, P3509, DOI 10.1093/emboj/18.12.3509; Nabetani A, 2004, J BIOL CHEM, V279, P25849, DOI 10.1074/jbc.M312652200; Ohki R, 2004, NUCLEIC ACIDS RES, V32, P1627, DOI 10.1093/nar/gkh309; Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072; Parenteau J, 2002, GENETICS, V162, P1583; Parenteau J, 1999, MOL CELL BIOL, V19, P4143; Perrem K, 2001, MOL CELL BIOL, V21, P3862, DOI 10.1128/MCB.21.12.3862-3875.2001; Prasad R, 2000, J BIOL CHEM, V275, P4460, DOI 10.1074/jbc.275.6.4460; Saharia A, 2008, CURR BIOL, V18, P496, DOI 10.1016/j.cub.2008.02.071; Sharma S, 2004, MOL BIOL CELL, V15, P734, DOI 10.1091/mbc.E03-08-0567; Stewart SA, 2003, NAT GENET, V33, P492, DOI 10.1038/ng1127; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Zheng L, 2005, EMBO REP, V6, P83, DOI 10.1038/sj.embor.7400313; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599	35	32	34	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2009	28	8					1162	1167		10.1038/onc.2008.458	http://dx.doi.org/10.1038/onc.2008.458			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	412KE	19137021				2022-12-25	WOS:000263722900011
J	Sagara, J; Arata, T; Taniguchi, S				Sagara, Junji; Arata, Toshiaki; Taniguchi, Shunichiro			Scapinin, the Protein Phosphatase 1 Binding Protein, Enhances Cell Spreading and Motility by Interacting with the Actin Cytoskeleton	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; NUCLEAR ACTIN; RHO-GTPASES; MEMBRANE; DYNAMICS; FAMILY; DOMAIN; LINK	Scapinin, also named phactr3, is an actin and protein phosphatase 1 (PP1) binding protein, which is expressed in the adult brain and some tumor cells. At present, the role(s) of scapinin in the brain and tumors are poorly understood. We show that the RPEL-repeat domain of scapinin, which is responsible for its direct interaction with actin, inhibits actin polymerization in vitro. Next, we established a Hela cell line, where scapinin expression was induced by tetracycline. In these cells, expression of scapinin stimulated cell spreading and motility. Scapinin was colocalized with actin at the edge of spreading cells. To explore the roles of the RPEL-repeat and PP1-binding domains, we expressed wild-type and mutant scapinins as fusion proteins with green fluorescence protein (GFP) in Cos7 cells. Expression of GFP-scapinin (wild type) also stimulated cell spreading, but mutation in the RPEL-repeat domain abolished both the actin binding and the cell spreading activity. PP1-binding deficient mutants strongly induced cell retraction. Long and branched cytoplasmic processes were developed during the cell retraction. These results suggest that scapinin enhances cell spreading and motility through direct interaction with actin and that PP1 plays a regulatory role in scapinin-induced morphological changes.	Shinshu Univ, Sch Hlth Sci, Dept Biomed Lab Sci, Nagano, Japan; [Taniguchi, Shunichiro] Shinshu Univ, Grad Sch Med, Dept Mol Oncol, Matsumoto, Nagano, Japan; [Arata, Toshiaki] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Suita, Osaka 565, Japan	Shinshu University; Shinshu University; Osaka University	Sagara, J (corresponding author), Shinshu Univ, Sch Hlth Sci, Dept Biomed Lab Sci, Nagano, Japan.	sagaraj@shinshu-u.ac.jp			Minister of Education, Science and Culture, Japan [16570156]	Minister of Education, Science and Culture, Japan	This work was supported by a Grant-in aid 16570156 (to J. S.) from Minister of Education, Science and Culture, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Allen PB, 2004, P NATL ACAD SCI USA, V101, P7187, DOI 10.1073/pnas.0401673101; ARATA T, 1991, J BIOCHEM-TOKYO, V109, P335; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Cohen PTW, 2002, J CELL SCI, V115, P241; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; Favot L, 2005, FEBS LETT, V579, P100, DOI 10.1016/j.febslet.2004.11.054; FERNANDEZ A, 1990, J CELL BIOL, V111, P103, DOI 10.1083/jcb.111.1.103; Guettler S, 2008, MOL CELL BIOL, V28, P732, DOI 10.1128/MCB.01623-07; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Hofmann WA, 2004, NAT CELL BIOL, V6, P1094, DOI 10.1038/ncb1182; Kim TH, 2007, DEV CELL, V13, P87, DOI 10.1016/j.devcel.2007.04.018; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; Paavilainen VO, 2004, TRENDS CELL BIOL, V14, P386, DOI 10.1016/j.tcb.2004.05.002; Paunola E, 2002, FEBS LETT, V513, P92, DOI 10.1016/S0014-5793(01)03242-2; Percipalle P, 2006, J CELL BIOL, V172, P967, DOI 10.1083/jcb.200512083; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Posern G, 2004, EMBO J, V23, P3973, DOI 10.1038/sj.emboj.7600404; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sagara J, 2003, J BIOL CHEM, V278, P45611, DOI 10.1074/jbc.M305227200; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Worch S, 2006, CYTOGENET GENOME RES, V115, P23, DOI 10.1159/000094797; Wu XY, 2006, NAT CELL BIOL, V8, P756, DOI 10.1038/ncb1433; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x	31	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2009	4	1							e4247	10.1371/journal.pone.0004247	http://dx.doi.org/10.1371/journal.pone.0004247			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JC	19158953	Green Published, gold, Green Submitted			2022-12-25	WOS:000265482200004
J	Tiziani, S; Lodi, A; Khanim, FL; Viant, MR; Bunce, CM; Gunther, UL				Tiziani, Stefano; Lodi, Alessia; Khanim, Farhat L.; Viant, Mark R.; Bunce, Christopher M.; Guenther, Ulrich L.			Metabolomic Profiling of Drug Responses in Acute Myeloid Leukaemia Cell Lines	PLOS ONE			English	Article								Combined bezafibrate (BEZ) and medroxyprogesterone acetate (MPA) exert unexpected antileukaemic activities against acute myeloid leukaemia (AML) and these activities are associated with the generation of reactive oxygen species (ROS) within the tumor cells. Although the generation of ROS by these drugs is supported by preceding studies including our own, the interrelationship between the cellular effects of the drugs and ROS generation is not well understood. Here we report the use of NMR metabolomic profiling to further study the effect of BEZ and MPA on three AML cell lines and to shed light on the underlying mechanism of action. For this we focused on drug effects induced during the initial 24 hours of treatment prior to the onset of overt cellular responses and examined these in the context of basal differences in metabolic profiles between the cell lines. Despite their ultimately profound cellular effects, the early changes in metabolic profiles engendered by these drugs were less pronounced than the constitutive metabolic differences between cell types. Nonetheless, drug treatments engendered common metabolic changes, most markedly in the response to the combination of BEZ and MPA. These responses included changes to TCA cycle intermediates consistent with recently identified chemical actions of ROS. Notable amongst these was the conversion of alpha-ketoglutarate to succinate which was recapitulated by the treatment of cell extracts with exogenous hydrogen peroxide. These findings indicate that the actions of combined BEZ and MPA against AML cells are indeed mediated downstream of the generation of ROS rather than some hitherto unsuspected mechanism. Moreover, our findings demonstrate that metabolite profiles represent highly sensitive markers for genomic differences between cells and their responses to external stimuli. This opens new perspectives to use metabolic profiling as a tool to study the rational redeployment of drugs in new disease settings.	[Tiziani, Stefano; Lodi, Alessia; Guenther, Ulrich L.] Univ Birmingham, CR UK Inst Canc Studies, Birmingham, W Midlands, England; [Khanim, Farhat L.; Viant, Mark R.; Bunce, Christopher M.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University of Birmingham	Tiziani, S (corresponding author), Univ Birmingham, CR UK Inst Canc Studies, Henry Wellcome Bldg Biomol NMR Spect, Birmingham, W Midlands, England.	u.l.gunther@bham.ac.uk	Viant, Mark R/B-6339-2009	Viant, Mark R/0000-0001-5898-4119; Bunce, Chris/0000-0003-4084-8973	Marie Curie Transfer of Knowledge (ToK) award (MOTET); NERC Fellowship [NER/J/S/2002/00618]; Natural Environment Research Council [NER/J/S/2002/00618] Funding Source: researchfish	Marie Curie Transfer of Knowledge (ToK) award (MOTET)(European Commission); NERC Fellowship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Marie Curie Transfer of Knowledge (ToK) award (MOTET) and the NERC Fellowship (NER/J/S/2002/00618). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED N, 1995, LEUKEMIA RES, V19, P263, DOI 10.1016/0145-2126(94)00158-7; AUE WP, 1976, J CHEM PHYS, V64, P4226, DOI 10.1063/1.431994; Blaise BJ, 2007, P NATL ACAD SCI USA, V104, P19808, DOI 10.1073/pnas.0707393104; Brookes PS, 2006, FREE RADICAL BIO MED, V41, P41, DOI 10.1016/j.freeradbiomed.2006.03.019; Bunce CM, 1996, BBA-MOL CELL RES, V1311, P189, DOI 10.1016/0167-4889(96)00005-5; Bundy JG, 2007, GENOME RES, V17, P510, DOI 10.1101/gr.5662207; Bundy JG, 2006, CANCER RES, V66, P7606, DOI 10.1158/0008-5472.CAN-05-2999; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Cohen FJ, 2005, NAT REV DRUG DISCOV, V4, P78, DOI 10.1038/nrd1610; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; Fan TWM, 2005, METABOLOMICS, V1, P325, DOI 10.1007/s11306-005-0012-0; Fedotcheva NI, 2006, FREE RADICAL BIO MED, V41, P56, DOI 10.1016/j.freeradbiomed.2006.02.012; Fenton SL, 2003, LEUKEMIA, V17, P568, DOI 10.1038/sj.leu.2402843; FUKUDA M, 1981, P NATL ACAD SCI-BIOL, V78, P6299, DOI 10.1073/pnas.78.10.6299; Goldstone AH, 2001, BLOOD, V98, P1302, DOI 10.1182/blood.V98.5.1302; Gonzalez-Aragon D, 2007, BIOCHEM PHARMACOL, V73, P427, DOI 10.1016/j.bcp.2006.10.016; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Griffin JL, 2003, BBA-GEN SUBJECTS, V1619, P151, DOI 10.1016/S0304-4165(02)00475-0; Gunther UL, 2000, J MAGN RESON, V145, P201, DOI 10.1006/jmre.2000.2071; Hakumaki JM, 2003, TRENDS PHARMACOL SCI, V24, P146, DOI 10.1016/S0165-6147(03)00032-4; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Kettunen MI, 2005, PROG NUCL MAG RES SP, V47, P175, DOI 10.1016/j.pnmrs.2005.08.005; KHANIM F, 2008, RATIONAL REDEP UNPUB; LUCAS DL, 1983, J CLIN INVEST, V72, P1889, DOI 10.1172/JCI111152; Lutz NW, 2005, METABOLOMICS, V1, P251, DOI 10.1007/s11306-005-0005-z; Mailloux RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000690; Martin DS, 2000, CANCER RES, V60, P6776; Neves AA, 2006, BBA-REV CANCER, V1766, P242, DOI 10.1016/j.bbcan.2006.10.002; Parsons HM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-234; Scatena R, 1999, CELL DEATH DIFFER, V6, P781, DOI 10.1038/sj.cdd.4400551; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Serkova NJ, 2007, CURR OPIN MOL THER, V9, P572; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Thrippleton MJ, 2005, J MAGN RESON, V174, P97, DOI 10.1016/j.jmr.2005.01.012; Tiziani S, 2008, ANAL CHIM ACTA, V610, P80, DOI 10.1016/j.aca.2008.01.030; Wu HF, 2008, ANAL BIOCHEM, V372, P204, DOI 10.1016/j.ab.2007.10.002	38	98	102	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2009	4	1							e4251	10.1371/journal.pone.0004251	http://dx.doi.org/10.1371/journal.pone.0004251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JC	19158949	Green Published, gold, Green Submitted			2022-12-25	WOS:000265482200008
J	Finn, J; Tregenza, T; Norman, M				Finn, Julian; Tregenza, Tom; Norman, Mark			Preparing the Perfect Cuttlefish Meal: Complex Prey Handling by Dolphins	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; TURSIOPS-TRUNCATUS; FORAGING BEHAVIOR; SPECIALIZATION; CULTURES; WHALES	Dolphins are well known for their complex social and foraging behaviours. Direct underwater observations of wild dolphin feeding behaviour however are rare. At mass spawning aggregations of giant cuttlefish (Sepia apama) in the Upper Spencer Gulf in South Australia, a wild female Indo-Pacific bottlenose dolphin (Tursiops aduncus) was observed and recorded repeatedly catching, killing and preparing cuttlefish for consumption using a specific and ordered sequence of behaviours. Cuttlefish were herded to a sand substrate, pinned to the seafloor, killed by downward thrust, raised mid-water and beaten by the dolphin with its snout until the ink was released and drained. The deceased cuttlefish was then returned to the seafloor, inverted and forced along the sand substrate in order to strip the thin dorsal layer of skin off the mantle, thus releasing the buoyant calcareous cuttlebone. This stepped behavioural sequence significantly improves prey quality through 1) removal of the ink (with constituent melanin and tyrosine), and 2) the calcareous cuttlebone. Observations of foraging dolphin pods from above-water at this site (including the surfacing of intact clean cuttlebones) suggest that some or all of this prey handling sequence may be used widely by dolphins in the region. Aspects of the unique mass spawning aggregations of giant cuttlefish in this region of South Australia may have contributed to the evolution of this behaviour through both high abundances of spawning and weakened post-spawning cuttlefish in a small area (>10,000 animals on several kilometres of narrow rocky reef), as well as potential long-term and regular visitation by dolphin pods to this site.	[Norman, Mark] Museum Victoria, Melbourne, Vic, Australia; [Finn, Julian] La Trobe Univ, Dept Zool, Victoria, BC, Canada; [Tregenza, Tom] Univ Exeter, Sch Biosci, Ctr Ecol & Conservat, Exeter EX4 4QJ, Devon, England	Museum Victoria; University of Exeter	Finn, J (corresponding author), Museum Victoria, Melbourne, Vic, Australia.	jfinn@museum.vic.gov.au		Tregenza, Thomas/0000-0003-4182-2222	Hermon Slade Foundation; Australian Biological Resources Study; Australian Research Council; Royal Society [Fellowship]	Hermon Slade Foundation; Australian Biological Resources Study; Australian Research Council(Australian Research Council); Royal Society(Royal Society of London)	The authors wish to thank Tokyo Broadcasting System - Live Inc., Tony Bramley of Whyalla Diving Services, Graham Ross and Alpha Diving Products for assistance with this project. JF and MN wish to thank the following bodies for research funding support: Hermon Slade Foundation, Australian Biological Resources Study and the Australian Research Council. TT was funded by a Royal Society Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Connor RC, 2000, CETACEAN SOCIETIES, P91; Duffy-Echevarria EE, 2008, MAR MAMMAL SCI, V24, P202, DOI 10.1111/j.1748-7692.2007.00151.x; Gazda SK, 2005, P ROY SOC B-BIOL SCI, V272, P135, DOI 10.1098/rspb.2004.2937; Hall KC, 2002, MAR BIOL, V140, P533; Hanson Mark T., 1993, Aquatic Mammals, V19, P127; Kenward B, 2005, NATURE, V433, P121, DOI 10.1038/433121a; Krutzen M, 2005, P NATL ACAD SCI USA, V102, P8939, DOI 10.1073/pnas.0500232102; Lewis Jennifer S., 2003, Gulf of Mexico Science, V21, P92; Mann Janet, 2003, P236, DOI 10.1017/CBO9780511584022.010; MIMURA T, 1982, CHEM PHARM BULL, V30, P1381; Norman MD, 1999, P ROY SOC B-BIOL SCI, V266, P1347, DOI 10.1098/rspb.1999.0786; Nowacek DP, 2002, BEHAVIOUR, V139, P1125, DOI 10.1163/15685390260437290; PROTA G, 1981, COMP BIOCHEM PHYS B, V68, P415, DOI 10.1016/0305-0491(81)90149-8; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Rossbach KA, 1997, MAR MAMMAL SCI, V13, P498, DOI 10.1111/j.1748-7692.1997.tb00658.x; Sargeant BL, 2005, CAN J ZOOL, V83, P1400, DOI 10.1139/Z05-136; Smolker R, 1997, ETHOLOGY, V103, P454, DOI 10.1111/j.1439-0310.1997.tb00160.x; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Whitehead H, 2005, MAR MAMMAL SCI, V21, P58, DOI 10.1111/j.1748-7692.2005.tb01208.x; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415	20	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4217	10.1371/journal.pone.0004217	http://dx.doi.org/10.1371/journal.pone.0004217			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JB	19156212	Green Published, gold			2022-12-25	WOS:000265482100002
J	Ihm, Y; Sparks, WO; Lee, JH; Cao, HB; Carpenter, S; Wang, CZ; Ho, KM; Dobbs, D				Ihm, Yungok; Sparks, Wendy O.; Lee, Jae-Hyung; Cao, Haibo; Carpenter, Susan; Wang, Cai-Zhuang; Ho, Kai-Ming; Dobbs, Drena			Structural Model of the Rev Regulatory Protein from Equine Infectious Anemia Virus	PLOS ONE			English	Article							FELINE IMMUNODEFICIENCY VIRUS; HIV-1 REV; NUCLEAR-EXPORT; ACTIVATION DOMAIN; AMINO-ACIDS; BINDING; SEQUENCES; SUGGESTS; ELEMENT; FOLD	Rev is an essential regulatory protein in the equine infectious anemia virus (EIAV) and other lentiviruses, including HIV-1. It binds incompletely spliced viral mRNAs and shuttles them from the nucleus to the cytoplasm, a critical prerequisite for the production of viral structural proteins and genomic RNA. Despite its important role in production of infectious virus, the development of antiviral therapies directed against Rev has been hampered by the lack of an experimentally-determined structure of the full length protein. We have used a combined computational and biochemical approach to generate and evaluate a structural model of the Rev protein. The modeled EIAV Rev (ERev) structure includes a total of 6 helices, four of which form an anti-parallel four-helix bundle. The first helix contains the leucine-rich nuclear export signal (NES). An arginine-rich RNA binding motif, RRDRW, is located in a solvent-exposed loop region. An ERLE motif required for Rev activity is predicted to be buried in the core of modeled structure where it plays an essential role in stabilization of the Rev fold. This structural model is supported by existing genetic and functional data as well as by targeted mutagenesis of residues predicted to be essential for overall structural integrity. Our predicted structure should increase understanding of structure-function relationships in Rev and may provide a basis for the design of new therapies for lentiviral diseases.	[Cao, Haibo; Ho, Kai-Ming] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Sparks, Wendy O.; Carpenter, Susan] Iowa State Univ, Dept Vet Microbiol & Preventive Med, Ames, IA 50011 USA; [Lee, Jae-Hyung; Carpenter, Susan; Ho, Kai-Ming; Dobbs, Drena] Iowa State Univ, Bioinformat Computat Biol Program, Ames, IA 50011 USA; [Wang, Cai-Zhuang; Ho, Kai-Ming] Iowa State Univ, US DOE, Ames Lab, Ames, IA 50011 USA; [Dobbs, Drena] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Carpenter, Susan] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA	Iowa State University; Iowa State University; Iowa State University; Iowa State University; United States Department of Energy (DOE); Ames National Laboratory; Iowa State University; Washington State University	Ihm, Y (corresponding author), Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA.	yihm@spring8.or.jp	Lee, Jae-Hyung/E-6827-2011; Lee, Jae-Hyung/AAI-9813-2020	Dobbs, Drena/0000-0003-4404-9554; Lee, Jae-Hyung/0000-0002-5085-6988	NIH [CA97936]; Laurence H. Baker Center for Bioinformatics and Biological Statistics at Iowa State University; NATIONAL CANCER INSTITUTE [R01CA128568, R21CA097936] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Laurence H. Baker Center for Bioinformatics and Biological Statistics at Iowa State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank NIH grant CA97936 to S.C. and a grant from Laurence H. Baker Center for Bioinformatics and Biological Statistics at Iowa State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUER M, 1994, BIOCHEMISTRY-US, V33, P2988, DOI 10.1021/bi00176a031; Baccam P, 2003, J VIROL, V77, P12122, DOI 10.1128/JVI.77.22.12122-12131.2003; Battiste JL, 1996, SCIENCE, V273, P1547, DOI 10.1126/science.273.5281.1547; Belshan M, 2000, MOL CELL BIOL, V20, P3550, DOI 10.1128/MCB.20.10.3550-3557.2000; Belshan M, 1998, J VIROL, V72, P4421, DOI 10.1128/JVI.72.5.4421-4426.1998; Belshan M, 2001, VIROLOGY, V279, P185, DOI 10.1006/viro.2000.0696; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Cao HB, 2004, POLYMER, V45, P687, DOI 10.1016/j.polymer.2003.10.091; Chandonia JM, 2004, NUCLEIC ACIDS RES, V32, pD189, DOI 10.1093/nar/gkh034; Chung HK, 2001, J BIOL CHEM, V276, P18960, DOI 10.1074/jbc.M008996200; CORNISH VW, 1994, BIOCHEMISTRY-US, V33, P12022, DOI 10.1021/bi00206a003; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; CULLEN BR, 1992, MICROBIOL REV, V56, P375, DOI 10.1128/MMBR.56.3.375-394.1992; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; FRIDELL RA, 1993, J VIROL, V67, P7317, DOI 10.1128/JVI.67.12.7317-7323.1993; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Harris ME, 1998, MOL CELL BIOL, V18, P3889, DOI 10.1128/MCB.18.7.3889; Havlin RH, 2007, BIOCHEMISTRY-US, V46, P3586, DOI 10.1021/bi0622928; HEAPHY S, 1990, CELL, V60, P685, DOI 10.1016/0092-8674(90)90671-Z; Holm Liisa, 2006, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0505s14; Hope TJ, 1999, ARCH BIOCHEM BIOPHYS, V365, P186, DOI 10.1006/abbi.1999.1207; Hulsmeyer M, 2001, ACTA CRYSTALLOGR D, V57, P1334, DOI 10.1107/S0907444901009799; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; Lee JH, 2006, J VIROL, V80, P3844, DOI 10.1128/JVI.80.8.3844-3852.2006; Li H, 1997, PHYS REV LETT, V79, P765, DOI 10.1103/PhysRevLett.79.765; LYU PC, 1991, P NATL ACAD SCI USA, V88, P5317, DOI 10.1073/pnas.88.12.5317; MALIM MH, 1989, CELL, V58, P205, DOI 10.1016/0092-8674(89)90416-9; MANCUSO VA, 1994, J VIROL, V68, P1998, DOI 10.1128/JVI.68.3.1998-2001.1994; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; MIYAZAWA S, 1985, MACROMOLECULES, V18, P534, DOI 10.1021/ma00145a039; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Otero GC, 1998, J VIROL, V72, P7593, DOI 10.1128/JVI.72.9.7593-7597.1998; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sparks WO, 2008, J GEN VIROL, V89, P1043, DOI 10.1099/vir.0.83195-0; Stauber RH, 1998, VIROLOGY, V251, P38, DOI 10.1006/viro.1998.9295; Tang HL, 1999, ANNU REV GENET, V33, P133, DOI 10.1146/annurev.genet.33.1.133; Thomas SL, 1998, J VIROL, V72, P2935, DOI 10.1128/JVI.72.4.2935-2944.1998; Thomas SL, 1997, PROTEIN ENG, V10, P103, DOI 10.1093/protein/10.2.103; Truant R, 1999, MOL CELL BIOL, V19, P1210; Watts NR, 1998, J STRUCT BIOL, V121, P41, DOI 10.1006/jsbi.1998.3964; Weis K, 1998, TRENDS BIOCHEM SCI, V23, P185, DOI 10.1016/S0968-0004(98)01204-3; WINGFIELD PT, 1991, BIOCHEMISTRY-US, V30, P7527, DOI 10.1021/bi00244a023; Zanotti G, 2000, BBA-PROTEIN STRUCT M, V1478, P232, DOI 10.1016/S0167-4838(00)00040-6	49	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2009	4	1							e4178	10.1371/journal.pone.0004178	http://dx.doi.org/10.1371/journal.pone.0004178			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ID	19137065	Green Published, gold, Green Submitted			2022-12-25	WOS:000265479500009
J	Heslop, CL; Miller, GE; Hill, JS				Heslop, Claire L.; Miller, Gregory E.; Hill, John S.			Neighbourhood Socioeconomics Status Predicts Non-Cardiovascular Mortality in Cardiac Patients with Access to Universal Health Care	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; HDL-CHOLESTEROL; RISK-FACTOR; SURVIVAL; EVENTS; DEATH; RATES	Background: Although the Canadian health care system provides essential services to all residents, evidence suggests that socioeconomic gradients in disease outcomes still persist. The main objective of our study was to investigate whether mortality, from cardiovascular disease or other causes, varies by neighbourhood socioeconomic gradients in patients accessing the healthcare system for cardiovascular disease management. Methods and Findings: A cohort of 485 patients with angiographic evidence of coronary artery disease (CAD) and neighbourhood socioeconomic status information was followed for 13.3 years. Survival analyses were completed with adjustment for potentially confounding risk factors. There were 64 cases of cardiovascular mortality and 66 deaths from non-cardiovascular chronic diseases. No socioeconomic differentials in cardiovascular mortality were observed. However, lower neighbourhood employment, education, and median family income did predict an increased risk of mortality from non-cardiovascular chronic diseases. For each quintile decrease in neighbourhood socioeconomic status, non-cardiovascular mortality risk rose by 21-30%. Covariate-adjusted hazard ratios (95% confidence interval) for non-cardiovascular mortality were 1.21 (1.02-1.42), 1.21 (1.01-1.46), and 1.30 (1.06-1.60), for each quintile decrease in neighbourhood education, employment, and income, respectively. These patterns were primarily attributable to mortality from cancer. Estimated risks for mortality from cancer rose by 42% and 62% for each one quintile decrease in neighbourhood median income and employment rate, respectively. Although only baseline clinical information was collected and patient-level socioeconomic data were not available, our results suggest that environmental socioeconomic factors have a significant impact on CAD patient survival. Conclusions: Despite public health care access, CAD patients who reside in lower-socioeconomic neighbourhoods show increased vulnerability to non-cardiovascular chronic disease mortality, particularly in the domain of cancer. These findings prompt further research exploring mechanisms of neighbourhood effects on health, and ways they may be ameliorated.	[Hill, John S.] Univ British Columbia, James Hogg iCAPTURE Ctr Cardiovasc & Pulm Res, Providence Heart & Lung Inst,Dept Pathol & Lab Me, St Pauls Hosp,Atherosclerosis Specialty Lab, Vancouver, BC V5Z 1M9, Canada; [Miller, Gregory E.] Univ British Columbia, Fac Arts, Dept Psychol, Vancouver, BC V5Z 1M9, Canada	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of British Columbia	Heslop, CL (corresponding author), Univ British Columbia, James Hogg iCAPTURE Ctr Cardiovasc & Pulm Res, Providence Heart & Lung Inst,Dept Pathol & Lab Me, St Pauls Hosp,Atherosclerosis Specialty Lab, Vancouver, BC V5Z 1M9, Canada.	clheslop@interchange.ubc.ca			Canadian Institutes of Health Research [MD/PhD Studentship Award]; Heart and Stroke Foundation of British Columbia and Yukon; Heart and Stroke Foundation of Canada [McDonald Scholarship Award]; Providence Health Care Research Institute [MD/PhD Studentship Award]; Michael Smith Foundation for Health Research [senior graduate studentship]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of British Columbia and Yukon; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Providence Health Care Research Institute; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	The recruitment of study patients in 1993 to 1995 was funded by a research grant from the Canadian Institutes of Health Research, and subsequent analyses were funded by the Heart and Stroke Foundation of British Columbia and Yukon. GEM is supported by a McDonald Scholarship Award from the Heart and Stroke Foundation of Canada. CLH is supported by a Canadian Institutes of Health Research and Providence Health Care Research Institute MD/PhD Studentship Award, and a senior graduate studentship from the Michael Smith Foundation for Health Research. The authors received no specific funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER NE, 1993, JAMA-J AM MED ASSOC, V269, P3140, DOI 10.1001/jama.269.24.3140; AKRITAS MG, 1994, ANN STAT, V22, P1299, DOI 10.1214/aos/1176325630; Alter DA, 2006, ANN INTERN MED, V144, P82, DOI 10.7326/0003-4819-144-2-200601170-00005; Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; Chen E, 2006, HEALTH PSYCHOL, V25, P704, DOI 10.1037/0278-6133.25.6.704; Cohen S, 1999, J APPL SOC PSYCHOL, V29, P445, DOI 10.1111/j.1559-1816.1999.tb01396.x; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; Concato J, 1995, J CLIN EPIDEMIOL, V48, P1495, DOI 10.1016/0895-4356(95)00510-2; *CTR CHRON DIS PRE, 2005, CHRON DIS CLOCK EXPL; Demeter S, 2005, CAN MED ASSOC J, V173, P1173, DOI 10.1503/cmaj.050609; DRAGANO N, 2008, EUR J EPIDEMIOL; Francis MC, 2001, ATHEROSCLEROSIS, V155, P165, DOI 10.1016/S0021-9150(00)00528-1; Frohlich J, 2003, CLIN CHEM, V49, P1873, DOI 10.1373/clinchem.2003.022558; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; HAFT JI, 1988, CHEST, V94, P731, DOI 10.1378/chest.94.4.731; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hemingway H, 2000, J EPIDEMIOL COMMUN H, V54, P510, DOI 10.1136/jech.54.7.510; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; Lee KWJ, 2004, ATHEROSCLEROSIS, V176, P165, DOI 10.1016/j.atherosclerosis.2004.04.024; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Lemstra M, 2006, CAN J PUBLIC HEALTH, V97, P435, DOI 10.1007/BF03405223; Manderbacka K, 2006, J EPIDEMIOL COMMUN H, V60, P442, DOI 10.1136/jech.2005.041566; MCGRAIL KM, 2004, BRIT COLUMBIA HLTH A; MCGRAIL KM, 2008, INCOME RELATED INEQU; Morrison C, 1997, BMJ-BRIT MED J, V314, P541, DOI 10.1136/bmj.314.7080.541; MYLES J, 2000, NEIGHBOURHOOD INEQUA; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Peltonen M, 2000, AM J EPIDEMIOL, V151, P283, DOI 10.1093/oxfordjournals.aje.a010204; Petersen KL, 2008, PSYCHOSOM MED, V70, P646, DOI 10.1097/PSY.0b013e31817b8ee4; Roux AVD, 2002, DIABETES CARE, V25, P1976, DOI 10.2337/diacare.25.11.1976; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P399, DOI 10.1136/jech.52.6.399; *STAT CAN, 2005, 2001 POP CENS; Tonne C, 2005, CIRCULATION, V111, P3063, DOI 10.1161/CIRCULATIONAHA.104.496174; *U BRIT COL, HUM EARL LEARN PARTN; WEINBLATT E, 1978, NEW ENGL J MED, V299, P60, DOI 10.1056/NEJM197807132990202; WILLIAMS RB, 1992, JAMA-J AM MED ASSOC, V267, P520, DOI 10.1001/jama.267.4.520; Winkleby MA, 2003, J EPIDEMIOL COMMUN H, V57, P444, DOI 10.1136/jech.57.6.444; Winkleby M, 2006, AM J PUBLIC HEALTH, V96, P2145, DOI 10.2105/AJPH.2004.060970; World Health Organization, 1992, INT STAT CLASS DIS R	41	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4120	10.1371/journal.pone.0004120	http://dx.doi.org/10.1371/journal.pone.0004120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437FX	19127285	Green Submitted, Green Published, gold			2022-12-25	WOS:000265473300005
J	Levin, A; Hayouka, Z; Helfer, M; Brack-Werner, R; Friedler, A; Loyter, A				Levin, Aviad; Hayouka, Zvi; Helfer, Markus; Brack-Werner, Ruth; Friedler, Assaf; Loyter, Abraham			Peptides Derived from HIV-1 Integrase that Bind Rev Stimulate Viral Genome Integration	PLOS ONE			English	Article								Background: The human immunodeficiency virus type 1 (HIV-1) integrase protein (IN), catalyzes the integration of viral DNA into the host cell genome. IN catalyzes the first step of the integration process, namely the 3'-end processing in which IN removes a pGT dinucleotide from the 3' end of each viral long terminal repeat (LTR). Following nuclear import of the viral preintegration complex, the host chromosomal DNA becomes accessible to the viral cDNA and the second step of the integration process, namely the strand-transfer step takes place. This ordered sequence of events, centered on integration, is mandatory for HIV replication. Methodology/Principal Findings: Using an integrase peptide library, we selected two peptides, designated INr-1 and INr-2, which interact with the Rev protein and probably mediate the Rev-integrase interaction. Using an in-vitro assay system, we show that INr-1 and INr-2 are able to abrogate the inhibitory effects exerted by Rev and Rev-derived peptides on integrase activity. Both INr-1 and INr-2 were found to be cell-permeable and nontoxic, allowing a study of their effect in HIV-1-infected cultured cells. Interestingly, both INr peptides stimulated virus infectivity as estimated by production of the viral P24 protein, as well as by determination of the appearance of newly formed virus particles. Furthermore, kinetics studies revealed that the cell-permeable INr peptides enhance the integration process, as was indeed confirmed by direct determination of viral DNA integration by real-time PCR. Conclusions/Significance: The results of the present study raise the possibility that in HIV-infected cells, the Rev protein may be involved in the integration of proviral DNA by controlling/regulating the activity of the integrase. Release from such inhibition leads to stimulation of IN activity and multiple viral DNA integration events.	[Loyter, Abraham] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Hayouka, Zvi; Friedler, Assaf] Hebrew Univ Jerusalem, Inst Chem, IL-91905 Jerusalem, Israel; [Helfer, Markus; Brack-Werner, Ruth] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Virol, Neuherberg, Germany; [Brack-Werner, Ruth] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Clin Cooperat Grp Immune Monitoring, Neuherberg, Germany	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Levin, A (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	loyter@mail.ls.huji.ac.il	Brack-Werner, Ruth/M-4615-2014	Brack-Werner, Ruth/0000-0002-8651-9318	Israel Science Foundation, Israel Ministry of Health [888/05]; European Research Council; Austrian National Bank; Horowitz Foundation	Israel Science Foundation, Israel Ministry of Health(Israel Science Foundation); European Research Council(European Research Council (ERC)European Commission); Austrian National Bank; Horowitz Foundation	This work was supported in part by grants from the Israel Science Foundation, Israel Ministry of Health (grant no. 888/05) by starting grant from the European Research Council (ERC) (to A.F.) and Austrian National Bank (to A.L.), and by the Horowitz Foundation (to A.L. and A.F.).	Afanasieva TA, 2001, J NEUROVIROL, V7, P169; Armon-Omer A, 2008, J MOL BIOL, V376, P971, DOI 10.1016/j.jmb.2007.11.095; BABA M, 1988, P NATL ACAD SCI USA, V85, P6132, DOI 10.1073/pnas.85.16.6132; BRACKWERNER R, 1992, AIDS, V6, P273, DOI 10.1097/00002030-199203000-00003; BUKRINSKY MI, 1993, P NATL ACAD SCI USA, V90, P6125, DOI 10.1073/pnas.90.13.6125; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Chen AP, 2006, J BIOL CHEM, V281, P4173, DOI 10.1074/jbc.M510628200; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; CHESEBRO B, 1990, J VIROL, V64, P215, DOI 10.1128/JVI.64.1.215-221.1990; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; COFFIN JM, 1997, HIST INTRO GEN PROPE, P1; CRAIGIE R, 1991, NUCLEIC ACIDS RES, V19, P2729, DOI 10.1093/nar/19.10.2729; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; Depienne C, 2000, EXP CELL RES, V260, P387, DOI 10.1006/excr.2000.5016; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; FARNET CM, 1991, J VIROL, V65, P1910, DOI 10.1128/JVI.65.4.1910-1915.1991; Field FJ, 2002, BIOCHEM J, V368, P855, DOI 10.1042/BJ20020731; Fineberg K, 2003, BIOCHEMISTRY-US, V42, P2625, DOI 10.1021/bi0206199; Freed E. O., 2001, FIELDS VIROLOGY, P1971; Freed Eric O., 2001, Somatic Cell and Molecular Genetics, V26, P13, DOI 10.1023/A:1021070512287; Gelderblom HC, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-60; Guiot E, 2006, J BIOL CHEM, V281, P22707, DOI 10.1074/jbc.M602198200; Gummuluru S, 2000, J VIROL, V74, P10882, DOI 10.1128/JVI.74.23.10882-10891.2000; Haffar OK, 2000, J MOL BIOL, V299, P359, DOI 10.1006/jmbi.2000.3768; Hariton-Gazal E, 2005, BIOCHEMISTRY-US, V44, P11555, DOI 10.1021/bi050752b; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Heuer TS, 1998, BIOCHEMISTRY-US, V37, P6667, DOI 10.1021/bi972949c; Hwang Y, 2000, NUCLEIC ACIDS RES, V28, P4884, DOI 10.1093/nar/28.24.4884; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; Jenkins Y, 1998, J CELL BIOL, V143, P875, DOI 10.1083/jcb.143.4.875; Kelly J, 2008, VIROLOGY, V372, P300, DOI 10.1016/j.virol.2007.11.007; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; KOHLER F, 1989, PLANT MOL BIOL, V12, P189, DOI 10.1007/BF00020504; Kramer-Hammerle S, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-20; LI CKN, 1985, MOL IMMUNOL, V22, P321, DOI 10.1016/0161-5890(85)90168-3; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; MITSUYA H, 1988, SCIENCE, V240, P646, DOI 10.1126/science.2452480; NAKASHIMA H, 1989, ANTIVIR RES, V11, P233, DOI 10.1016/0166-3542(89)90033-8; Odawara T, 1998, J VIROL, V72, P5414, DOI 10.1128/JVI.72.7.5414-5424.1998; Pannecouque C, 2002, CURR BIOL, V12, P1169, DOI 10.1016/S0960-9822(02)00952-1; Paul TA, 2006, J VIROL, V80, P2941, DOI 10.1128/JVI.80.6.2941-2948.2006; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Rigourd M, 2000, J BIOL CHEM, V275, P26944; Rosenbluh J, 2007, J BIOL CHEM, V282, P15743, DOI 10.1074/jbc.M609864200; Rosenbluh J, 2006, ANAL BIOCHEM, V352, P157, DOI 10.1016/j.ab.2006.03.002; Sherman MP, 2002, MICROBES INFECT, V4, P67, DOI 10.1016/S1286-4579(01)01511-8; Tai CK, 2008, FRONT BIOSCI-LANDMRK, V13, P3083, DOI 10.2741/2910; TSURUO T, 1977, J VIROL, V23, P533, DOI 10.1128/JVI.23.3.533-542.1977; Van Maele B, 2006, TRENDS BIOCHEM SCI, V31, P98, DOI 10.1016/j.tibs.2005.12.002; Watts NR, 1998, J STRUCT BIOL, V121, P41, DOI 10.1006/jsbi.1998.3964; WOLFF B, 1995, EXP CELL RES, V217, P31, DOI 10.1006/excr.1995.1060; Wolff H, 2006, EXP CELL RES, V312, P443, DOI 10.1016/j.yexcr.2005.11.020; Wu YT, 2003, J VIROL, V77, P10376, DOI 10.1128/JVI.77.19.10376-10382.2003; Wu Yuntao, 2004, Retrovirology, V1, P13, DOI 10.1186/1742-4690-1-13; Wu YT, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-61; Yamamoto N, 2006, VIRUS GENES, V32, P105, DOI 10.1007/s11262-005-5851-2; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4	63	28	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4155	10.1371/journal.pone.0004155	http://dx.doi.org/10.1371/journal.pone.0004155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FX	19127291	Green Submitted, Green Published, gold			2022-12-25	WOS:000265473300018
J	Liberman, AC; Druker, J; Refojo, D; Holsboer, F; Arzt, E				Liberman, Ana C.; Druker, Jimena; Refojo, Damian; Holsboer, Florian; Arzt, Eduardo			Glucocorticoids inhibit GATA-3 phosphorylation and activity in T cells	FASEB JOURNAL			English	Article						GCs; T helper 2; p38 mitogen-activated protein kinase; interleukin 5	TRANSCRIPTION FACTOR GATA-3; NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; CYTOKINE GENE-EXPRESSION; DEVELOPING TH1 CELLS; C-JUN; INTERLEUKIN-5 GENE; IFN-GAMMA; ANTIINFLAMMATORY ACTION; MAPK PHOSPHATASE-1	Glucocorticoid (GC) immunosuppression and anti-inflammatory action involve the regulation of several transcription factors (TFs). GCs inhibit the acute production of T-helper (Th) 1 and Th2 cytokines but ultimately favor a shift toward Th2 phenotype. GCs inhibit the transcriptional activity of T-bet Th1 TF by a transrepression mechanism. Here we analyze GC regulation of GATA-3, the master driver of Th2 differentiation. We found that GCs inhibit GATA-3 transcriptional activity. We demonstrate that this mechanism does not involve physical interaction between the glucocorticoid receptor (GR) and GATA-3 or reduction of GATA-3 binding to DNA, as described previously for T-bet. Instead, GCs inhibit GATA-3 activity by inhibition of p38 mitogen-activated protein kinase induced GATA-3 phosphorylation. GCs also inhibit GATA-3 mRNA and protein expression. Finally, GATA-3 inhibition affects the interleukin-5 gene, a central Th2 cytokine. The IC50 of dexamethasone is 10 nM with a maximum effect at 100 nM. All inhibitory actions were blocked by the GR antagonist RU38486 (1 uM), proving the specificity of GR action. In view of the crucial role of GATA-3 in T-cell differentiation and inflammation, we propose that the mechanism of GATA-3 inhibition compared with that in T-bet may have relevant implications in understanding and modulating the anti-inflammatory and Th-regulatory properties of GCs. Liberman, A. C., Druker, J., Refojo, D., Holsboer, F., Arzt, E. Glucocorticoids inhibit GATA-3 phosphorylation and activity in T cells. FASEB J. 23, 1558-1571 (2009)	[Liberman, Ana C.; Druker, Jimena; Refojo, Damian; Arzt, Eduardo] Univ Buenos Aires, Lab Fisiol & Biol Mol, FCEN, Dept Fisiol & Biol Mol & Celular, RA-1428 Buenos Aires, DF, Argentina; [Liberman, Ana C.; Druker, Jimena; Refojo, Damian; Arzt, Eduardo] Consejo Nacl Invest Cient & Tecn, Inst Fisiol & Biol Mol & Neurosci, IFIBYNE, RA-1033 Buenos Aires, DF, Argentina; [Refojo, Damian; Holsboer, Florian] Max Planck Inst Psychiat, D-80804 Munich, Germany	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Max Planck Society	Arzt, E (corresponding author), Univ Buenos Aires, Lab Fisiol & Biol Mol, FCEN, Dept Fisiol & Biol Mol & Celular, Ciudad Univ, RA-1428 Buenos Aires, DF, Argentina.	earzt@fbmc.fcen.uba.ar		Refojo, Damian/0000-0002-9798-6413	Max Planck Society, Germany; University of Buenos Aires (UBA); CONICET; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina	Max Planck Society, Germany(Max Planck Society); University of Buenos Aires (UBA)(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT)	We thank Drs. Dietmar Spengler (Max Planck Institute of Psychiatry, Munich, Germany), Anuradha Ray (University of Pittsburgh School of Medicine, Pittsburgh, PA, USA), Jeffrey Leiden (Harvard Medical School and Center for Prevention of Cardiovascular Disease, Harvard School of Public Health, Boston, MA, USA), Takashi Yokota (Institute of Medical Science, University of Tokyo, Tokyo, Japan), and Tamara Tanos and Omar Cosso (Universidad de Buenos Aires and IFIBYNE-CONICET, Buenos Aires, Argentina) for providing the plasmids used in this work. This work was supported by grants from the Max Planck Society, Germany; and the University of Buenos Aires (UBA), the CONICET, and the Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina.	Adcock IM, 2001, PULM PHARMACOL THER, V14, P211, DOI 10.1006/pupt.2001.0283; Arthur JSC, 2000, FEBS LETT, V482, P44, DOI 10.1016/S0014-5793(00)02031-7; Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; Beck IM, 2008, EMBO J, V27, P1682, DOI 10.1038/emboj.2008.95; BETZ M, 1991, J IMMUNOL, V146, P108; Biola A, 2000, FEBS LETT, V487, P229, DOI 10.1016/S0014-5793(00)02297-3; BOUMPAS DT, 1993, ANN INTERN MED, V119, P1198, DOI 10.7326/0003-4819-119-12-199312150-00007; BRINKMANN V, 1995, J IMMUNOL, V155, P3322; Caelles C, 1997, GENE DEV, V11, P3351, DOI 10.1101/gad.11.24.3351; CALDENHOVEN E, 1995, MOL ENDOCRINOL, V9, P401, DOI 10.1210/me.9.4.401; Chen CH, 2000, J IMMUNOL, V165, P5597, DOI 10.4049/jimmunol.165.10.5597; Cho JY, 2003, INT IMMUNOL, V15, P1149, DOI 10.1093/intimm/dxg113; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; CIPPITELLI M, 1995, J BIOL CHEM, V270, P12548, DOI 10.1074/jbc.270.21.12548; Costas M, 1996, J CLIN INVEST, V98, P1409, DOI 10.1172/JCI118928; CUPPS TR, 1982, IMMUNOL REV, V65, P133, DOI 10.1111/j.1600-065X.1982.tb00431.x; DAYNES RA, 1989, EUR J IMMUNOL, V19, P2319, DOI 10.1002/eji.1830191221; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; De Bosscher K, 2000, J NEUROIMMUNOL, V109, P16, DOI 10.1016/S0165-5728(00)00297-6; Ferber IA, 1999, CLIN IMMUNOL, V91, P134, DOI 10.1006/clim.1999.4718; Furst R, 2007, FASEB J, V21, P74, DOI 10.1096/fj.06-6752com; Galon J, 2002, FASEB J, V16, P61, DOI 10.1096/fj.01-0245com; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; Gottlicher M, 1998, J MOL MED-JMM, V76, P480, DOI 10.1007/s001090050242; HAMID Q, 1991, J CLIN INVEST, V87, P1541, DOI 10.1172/JCI115166; Hendriks RW, 1999, EUR J IMMUNOL, V29, P1912, DOI 10.1002/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.3.CO;2-4; HO IC, 1991, EMBO J, V10, P1187, DOI 10.1002/j.1460-2075.1991.tb08059.x; Hwang ES, 2002, J IMMUNOL, V169, P248, DOI 10.4049/jimmunol.169.1.248; Hwang ES, 2005, J EXP MED, V202, P1289, DOI 10.1084/jem.20051044; Jee YK, 2005, J BIOL CHEM, V280, P23243, DOI 10.1074/jbc.M503659200; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Klein-Hessling S, 2003, J IMMUNOL, V170, P2956, DOI 10.4049/jimmunol.170.6.2956; Kovalovsky D, 2002, MOL ENDOCRINOL, V16, P1638, DOI 10.1210/me.16.7.1638; Kovalovsky D, 1998, EUR J IMMUNOL, V28, P2075; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Lasa M, 2001, MOL CELL BIOL, V21, P771, DOI 10.1128/MCB.21.3.771-780.2001; LAUE L, 1988, J STEROID BIOCHEM, V29, P591, DOI 10.1016/0022-4731(88)90156-2; LEE HJ, 1995, J BIOL CHEM, V270, P17541, DOI 10.1074/jbc.270.29.17196; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; LEE HJ, 1993, J IMMUNOL, V151, P6135; Liberman AC, 2007, FASEB J, V21, P1177, DOI 10.1096/fj.06-7452com; Maneechotesuwan K, 2007, J IMMUNOL, V178, P2491, DOI 10.4049/jimmunol.178.4.2491; Miyaura H, 2002, J IMMUNOL, V168, P1087, DOI 10.4049/jimmunol.168.3.1087; Mori A, 1997, BLOOD, V89, P2891, DOI 10.1182/blood.V89.8.2891; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Novac N, 2006, FASEB J, V20, P1074, DOI 10.1096/fj.05-5457com; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Paez-Pereda M, 2003, P NATL ACAD SCI USA, V100, P1034, DOI 10.1073/pnas.0237312100; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Pelaia G, 2001, BIOCHEM PHARMACOL, V62, P1719, DOI 10.1016/S0006-2952(01)00791-2; Quan A, 2001, J ALLERGY CLIN IMMUN, V108, P340; RAIDEN S, 1995, J CLIN IMMUNOL, V15, P242, DOI 10.1007/BF01540881; Ramirez F, 1998, Dev Immunol, V6, P233, DOI 10.1155/1998/73401; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; RUPPRECHT R, 1993, MOL ENDOCRINOL, V7, P597, DOI 10.1210/me.7.4.597; SAKAI DD, 1988, GENE DEV, V2, P1144, DOI 10.1101/gad.2.9.1144; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; SIEGEL MD, 1995, J BIOL CHEM, V270, P24548, DOI 10.1074/jbc.270.41.24548; Stranick KS, 1997, J BIOL CHEM, V272, P16453, DOI 10.1074/jbc.272.26.16453; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tanos T, 2005, J BIOL CHEM, V280, P18842, DOI 10.1074/jbc.M500620200; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; Zhang DH, 1999, IMMUNITY, V11, P473, DOI 10.1016/S1074-7613(00)80122-3; Zhang DH, 1998, J IMMUNOL, V161, P3817; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	68	58	60	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2009	23	5					1558	1571		10.1096/fj.08-121236	http://dx.doi.org/10.1096/fj.08-121236			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19124555				2022-12-25	WOS:000266651700031
J	Metchat, A; Akerfelt, M; Bierkamp, C; Delsinne, V; Sistonen, L; Alexandre, H; Christians, ES				Metchat, Aicha; Akerfelt, Malin; Bierkamp, Christiane; Delsinne, Virginie; Sistonen, Lea; Alexandre, Henri; Christians, Elisabeth S.			Mammalian Heat Shock Factor 1 Is Essential for Oocyte Meiosis and Directly Regulates Hsp90 alpha Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETED GENE DISRUPTION; MOUSE OOCYTES; TRANSCRIPTION FACTOR-1; DOWN-REGULATION; CYCLIN B1; MICE; HSF1; MATURATION; THERMOTOLERANCE; TRANSITION	Heat shock transcription factor 1 (HSF1) is the main regulator of the stress response that triggers the transcription of several genes encoding heat shock proteins (Hsps). Hsps act as molecular chaperones involved in protein folding, stability, and trafficking. HSF1 is highly expressed in oocytes and Hsf1 knock-out in mice revealed that in the absence of stress this factor plays an important role in female reproduction. We previously reported that Hsf1(-/-) females produce oocytes but no viable embryos. Consequently, we asked whether oocytes require HSF1 to regulate a particular set of Hsps necessary for them to develop. We find that Hsp90 alpha (Hspaa1) is the major HSF1-dependent chaperone inasmuch as Hsf1 knock-out resulted in Hsp90-depleted oocytes. These oocytes exhibited delayed germinal vesicle breakdown (or G(2)/M transition), partial meiosis I block, and defective asymmetrical division. To probe the role of Hsp90 alpha in this meiotic syndrome, we analyzed meiotic maturation in wildtype oocytes treated with a specific inhibitor of Hsp90, 17-allylamino-17-demethoxy-geldanamycin, and observed similar defects. At the molecular level we showed that, together with these developmental anomalies, CDK1 and MAPK, key meiotic kinases, were significantly disturbed. Thus, our data demonstrate that HSF1 is a maternal transcription factor essential for normal progression of meiosis.	[Metchat, Aicha; Bierkamp, Christiane; Christians, Elisabeth S.] Univ Toulouse, 4R3B3, Ctr Dev Biol, UPS,UMR5547, F-31062 Toulouse, France; [Akerfelt, Malin; Sistonen, Lea] Abo Akad Univ, Univ Turku, Turku Ctr Biotechnol, Dept Biol, FIN-20520 Turku, Finland; [Delsinne, Virginie; Alexandre, Henri] Univ Mons, Dept Biol, Fac Med Pharm, B-7000 Mons, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Abo Akademi University; University of Turku; University of Mons	Christians, ES (corresponding author), Univ Toulouse, 4R3B3, Ctr Dev Biol, UPS,UMR5547, 118 Route Narbonne, F-31062 Toulouse, France.	Elisabeth.Christians@cict.fr		Akerfelt, Malin/0000-0003-4810-7862; Sistonen, Lea/0000-0003-1341-2867				Anger M, 2005, BIOL REPROD, V72, P188, DOI 10.1095/biolreprod.104.035451; Chang YH, 2006, GENE DEV, V20, P836, DOI 10.1101/gad.366906; Choi TS, 1996, P NATL ACAD SCI USA, V93, P7032, DOI 10.1073/pnas.93.14.7032; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; Christians ES, 2006, HANDB EXP PHARM, V172, P139; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dale EC, 1997, CELL STRESS CHAPERON, V2, P87, DOI 10.1379/1466-1268(1997)002<0087:MKHSPG>2.3.CO;2; de Carcer G, 2004, CANCER RES, V64, P5106, DOI 10.1158/0008-5472.CAN-03-2214; Fisher DL, 2000, EMBO J, V19, P1516, DOI 10.1093/emboj/19.7.1516; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Garcia-Morales P, 2007, ONCOGENE, V26, P7185, DOI 10.1038/sj.onc.1210534; Hamatani T, 2008, REPRODUCTION, V135, P581, DOI 10.1530/REP-07-0430; Han SJ, 2006, CELL CYCLE, V5, P227, DOI 10.4161/cc.5.3.2395; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Huang L, 2001, MOL CELL BIOL, V21, P8575, DOI 10.1128/MCB.21.24.8575-8591.2001; Huang L, 2007, GENESIS, V45, P487, DOI 10.1002/dvg.20319; Hunt CR, 2004, MOL CELL BIOL, V24, P899, DOI 10.1128/MCB.24.2.899-911.2004; Inoue T, 2006, DEV GROWTH DIFFER, V48, P25, DOI [10.1111/j.1440-169x.2006.00841.x, 10.1111/j.1440-169X.2006.00841.x]; Inouye S, 2004, J BIOL CHEM, V279, P38701, DOI 10.1074/jbc.M405986200; Kanatsu-Shinohara M, 2000, BIOL REPROD, V63, P1610, DOI 10.1095/biolreprod63.6.1610; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Mehlmann LM, 2005, REPRODUCTION, V130, P791, DOI 10.1530/rep.1.00793; Nakai A, 2001, EMBO J, V20, P2885, DOI 10.1093/emboj/20.11.2885; Nomura N, 2007, BIOCHEM PHARMACOL, V73, P1528, DOI 10.1016/j.bcp.2007.01.022; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Salmand PA, 2008, BIOL REPROD, V79, P1092, DOI 10.1095/biolreprod.108.070334; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Takaki E, 2006, J BIOL CHEM, V281, P4931, DOI 10.1074/jbc.M506911200; Takaki E, 2007, J BIOL CHEM, V282, P37285, DOI 10.1074/jbc.M704562200; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Van Cauwenberge A, 2000, INT J DEV BIOL, V44, P409; VERLHAC MH, 1994, DEVELOPMENT, V120, P1017; Vitale AM, 2007, MOL REPROD DEV, V74, P608, DOI 10.1002/mrd.20648; Voss AK, 2000, DEVELOPMENT, V127, P1; Wang L, 2008, DEV BIOL, V313, P155, DOI 10.1016/j.ydbio.2007.10.009; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yan LJ, 2002, EMBO J, V21, P5164, DOI 10.1093/emboj/cdf528; Yu LZ, 2007, CELL CYCLE, V6, P330, DOI 10.4161/cc.6.3.3805; Zhang Y, 2002, J CELL BIOCHEM, V86, P376, DOI 10.1002/jcb.10232; Zheng H, 2004, J IMMUNOL, V173, P5929, DOI 10.4049/jimmunol.173.10.5929	45	69	75	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9521	9528		10.1074/jbc.M808819200	http://dx.doi.org/10.1074/jbc.M808819200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19158073	hybrid, Green Published			2022-12-25	WOS:000264669100058
J	Zhong, XM; Jin, Y				Zhong, Xiaomin; Jin, Ying			Critical Roles of Coactivator p300 in Mouse Embryonic Stem Cell Differentiation and Nanog Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR OCT-4; EPIGENETIC REGULATION; DISTINCT ROLES; SELF-RENEWAL; GENE; PLURIPOTENCY; CBP; PROTEIN; ACETYLTRANSFERASE; BINDING	p300 is a well known histone acetyltransferase and coactivator that plays pivotal roles in many physiological processes. Despite extensive research for the functions of p300 in embryogenesis and transcription regulation, its roles in regulating embryonic stem (ES) cell pluripotency are poorly understood. To address this issue, we investigated the self-renewal ability and early differentiation process in both wild-type mouse ES cells and ES cells derived from p300 knock-out (p300(-/-)) mice. We found that p300 ablation did not affect self-renewal capacity overtly when ES cells were maintained under undifferentiated conditions. However, the absence of p300 caused a significantly abnormal expression pattern of germ layer markers when differentiation was induced by embryoid body (EB) formation. Interestingly, the expression level of pluripotency marker Nanog but not Oct4 was markedly lower in EBs from p300(-/-) ES cells compared with that in EBs from wild-type ES cells. Exogenous expression of Nanog rescued abnormal expression of extra-embryonic endoderm marker partially but not mesoderm and ectoderm markers. Furthermore, we demonstrate that p300 was directly involved in modulating Nanog expression. Importantly, epigenetic modification of histone acetylation at the distal regulatory region of Nanog was found to be dependent on the presence of p300, which could contribute to the mechanism of regulating Nanog expression by p300. Collectively, our results show that p300 plays an important role in the differentiation process of ES cells and provide the first evidence for the involvement of p300 in regulating Nanog expression during differentiation, probably through epigenetic modification of histone on Nanog.	[Zhong, Xiaomin; Jin, Ying] Chinese Acad Sci, Shanghai Jiao Tong Univ, Shanghai Inst Biol Sci,Sch Med, Key Lab Stem Cell Biol,Inst Hlth Sci, Beijing 100000, Peoples R China; [Jin, Ying] Shanghai Jiao Tong Univ, Sch Med, Shanghai Stem Cell Inst, Beijing 100000, Peoples R China; [Zhong, Xiaomin] Chinese Acad Sci, Grad Sch, Beijing 100000, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Jin, Y (corresponding author), Inst Hlth Sci, 225 S Chongqing Rd, Shanghai 200025, Peoples R China.	yjin@sibs.ac.cn		, jin ying/0000-0003-0070-2048	National High Technology Research and Development Program of China [2006CB943901, 2007CB947904]; National Natural Science Foundation [3057907, 30730051]; Shanghai Leading Academic Discipline Project [S30201]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by National High Technology Research and Development Program of China Grants 2006CB943901 and 2007CB947904, National Natural Science Foundation Grants 3057907 and 30730051, and Shanghai Leading Academic Discipline Project Grant S30201. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.SC. Section 1734 solely to indicate this fact.	Bibikova M, 2008, CELL STEM CELL, V2, P123, DOI 10.1016/j.stem.2008.01.005; Brouillard F, 2003, J BIOL CHEM, V278, P39509, DOI 10.1074/jbc.M307123200; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chan HM, 2001, J CELL SCI, V114, P2363; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Desbaillets I, 2000, EXP PHYSIOL, V85, P645, DOI 10.1017/S0958067000021047; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Goodman RH, 2000, GENE DEV, V14, P1553; Hattori N, 2007, GENES CELLS, V12, P387, DOI 10.1111/j.1365-2443.2007.01058.x; Hough SR, 2006, STEM CELLS, V24, P1467, DOI 10.1634/stemcells.2005-0475; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; McManus KJ, 2003, MOL CELL BIOL, V23, P7611, DOI 10.1128/MCB.23.21.7611-7627.2003; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Partanen M, 1999, INT J DEV BIOL, V43, P487; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Roth JF, 2003, EMBO J, V22, P5186, DOI 10.1093/emboj/cdg473; Shimoda M, 2007, J CELL SCI, V120, P3859, DOI 10.1242/jcs.007856; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Suzuki Atsushi, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS114, DOI 10.1038/ncpcardio0442; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang R, 2005, J BIOL CHEM, V280, P11528, DOI 10.1074/jbc.M413930200; Wu DY, 2005, CELL RES, V15, P317, DOI 10.1038/sj.cr.7290300; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang ZH, 2007, FASEB J, V21, P3042, DOI 10.1096/fj.06-6914com	36	54	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9168	9175		10.1074/jbc.M805562200	http://dx.doi.org/10.1074/jbc.M805562200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19150979	Green Published, hybrid			2022-12-25	WOS:000264669100022
J	Asong, J; Wolfert, MA; Maiti, KK; Miller, D; Boons, GJ				Asong, Jinkeng; Wolfert, Margreet A.; Maiti, Kaustabh K.; Miller, Douglas; Boons, Geert-Jan			Binding and Cellular Activation Studies Reveal That Toll-like Receptor 2 Can Differentially Recognize Peptidoglycan from Gram-positive and Gram-negative Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-SYSTEM; SURFACE-PLASMON RESONANCE; STAPHYLOCOCCUS-AUREUS; EXPERIMENTAL-DESIGN; PROTEINS PGRPS; ACID; WALL; INFLAMMATION; FRAGMENTS; ENDOTOXIN	Although much progress has been made toward the identification of innate immune receptors, far less is known about how these receptors recognize specific microbial products. Such studies have been hampered by the need to purify compounds from microbial sources and a reliance on biological assays rather than direct binding to monitor recognition. We have employed surface plasmon resonance (SPR) binding studies using a wide range of well defined synthetic muropeptides derived from Gram-positive (lysine-containing) and Gram-negative (diaminopimelic acid (DAP)-containing) bacteria to demonstrate that Toll-like receptor 2 can recognize peptidoglycan (PGN). In the case of lysine-containing muropeptides, a limited number of compounds, which were derived from PGN remodeled by bacterial autolysins, was recognized. However, a wider range of DAP-containing muropeptides was bound with high affinity, and these compounds were derived from nascent and remodeled PGN. The difference in recognition of the two classes of muropeptides is proposed to be a strategy by the host to respond appropriately to Gram-negative and -positive bacteria, which produce vastly different quantities of PGN. It was also found that certain modifications of the carboxylic acids of isoglutamine and DAP can dramatically reduce binding, and thus, bacterial strains may employ such modifications to evade innate immune detection. Cellular activation studies employing highly purified PGN from Bacillus licheniformis, Bacillus subtilis, Escherichia coli, Lactobacillus plantarum, Micrococcus luteus, and Staphylococcus aureus support the structure binding relationship. The data firmly establish Toll-like receptor 2 as an innate immune sensor for PGN and provides an understanding of host-pathogen interactions at the molecular level.	[Asong, Jinkeng; Wolfert, Margreet A.; Maiti, Kaustabh K.; Miller, Douglas; Boons, Geert-Jan] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Boons, GJ (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	gjboons@ccrc.uga.edu	Boons, Geert-Jan P H/J-3211-2016; Wolfert, Margreet A/J-1726-2016	Boons, Geert-Jan P H/0000-0003-3111-5954; Wolfert, Margreet A/0000-0003-4864-0026	National Institutes of Health [GM065248]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065248, R01GM061761] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065248. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement"	Boneca IG, 2005, CURR OPIN MICROBIOL, V8, P46, DOI 10.1016/j.mib.2004.12.008; Chamaillard M, 2003, CELL MICROBIOL, V5, P581, DOI 10.1046/j.1462-5822.2003.00304.x; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Chowdhury AR, 2005, TETRAHEDRON LETT, V46, P1675, DOI 10.1016/j.tetlet.2005.01.062; Chowdhury AR, 2002, TETRAHEDRON LETT, V43, P7805; Darveau RP, 1998, CURR OPIN MICROBIOL, V1, P36, DOI 10.1016/S1369-5274(98)80140-9; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Doyle R.J., 2001, MOL MED MICROBIOLOGY, P137; Dziarski R, 2005, INFECT IMMUN, V73, P5212, DOI 10.1128/IAI.73.8.5212-5216.2005; Dziarski R, 2003, CELL MOL LIFE SCI, V60, P1793, DOI 10.1007/s00018-003-3019-6; Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011; Ganz T, 2003, BLOOD, V101, P2388, DOI 10.1182/blood-2002-07-2319; GHUYSEN JM, 1968, BACTERIOL REV, V32, P425, DOI 10.1128/MMBR.32.4_Pt_2.425-464.1968; Girardin SE, 2004, EUR J IMMUNOL, V34, P1777, DOI 10.1002/eji.200425095; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Guan RJ, 2004, P NATL ACAD SCI USA, V101, P17168, DOI 10.1073/pnas.0407856101; Guan RJ, 2007, TRENDS MICROBIOL, V15, P127, DOI 10.1016/j.tim.2007.01.006; Hawkins LD, 2004, CURR TOP MED CHEM, V4, P1147, DOI 10.2174/1568026043388123; Hoijer MA, 1997, EUR CYTOKINE NETW, V8, P375; Inamura S, 2006, ORG BIOMOL CHEM, V4, P232, DOI 10.1039/b511866b; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Iwaki D, 2002, J BIOL CHEM, V277, P24315, DOI 10.1074/jbc.M107057200; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; JANUSZ MJ, 1986, INFECT IMMUN, V52, P459, DOI 10.1128/IAI.52.2.459-467.1986; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; Karlsson R, 1997, J IMMUNOL METHODS, V200, P121, DOI 10.1016/S0022-1759(96)00195-0; Kumar S, 2005, J BIOL CHEM, V280, P37005, DOI 10.1074/jbc.M506385200; Lipschultz CA, 2000, METHODS, V20, P310, DOI 10.1006/meth.1999.0924; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Myhre AE, 2006, SHOCK, V25, P227, DOI 10.1097/01.shk.0000191378.55274.37; Myhre AE, 2004, INFECT IMMUN, V72, P1311, DOI 10.1128/IAI.72.3.1311-1317.2004; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; Rice TW, 2005, ANNU REV MED, V56, P225, DOI 10.1146/annurev.med.56.082103.104356; Roychowdhury A, 2005, CHEMBIOCHEM, V6, P2088, DOI 10.1002/cbic.200500181; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Smith TJ, 2000, MICROBIOL-UK, V146, P249, DOI 10.1099/00221287-146-2-249; Steiner H, 2004, IMMUNOL REV, V198, P83, DOI 10.1111/j.0105-2896.2004.0120.x; STROMINGER JL, 1967, SCIENCE, V156, P213, DOI 10.1126/science.156.3772.213; Swaminathan CP, 2006, P NATL ACAD SCI USA, V103, P684, DOI 10.1073/pnas.0507656103; Thomas CJ, 1999, J BIOL CHEM, V274, P29624, DOI 10.1074/jbc.274.42.29624; TIPPER DJ, 1967, BIOCHEMISTRY-US, V6, P921, DOI 10.1021/bi00855a036; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Wolfert MA, 2007, INFECT IMMUN, V75, P706, DOI 10.1128/IAI.01597-06; Yoshimura A, 1999, J IMMUNOL, V163, P1; Zhang YH, 2007, J AM CHEM SOC, V129, P5200, DOI 10.1021/ja068922a	47	73	74	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8634	8644		10.1074/jbc.M806633200	http://dx.doi.org/10.1074/jbc.M806633200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19164296	hybrid, Green Published			2022-12-25	WOS:000264397800048
J	Long, P; Mercer, A; Begum, R; Stephens, GJ; Sihra, TS; Jovanovic, JN				Long, Philip; Mercer, Audrey; Begum, Rahima; Stephens, Gary J.; Sihra, Talvinder S.; Jovanovic, Jasmina N.			Nerve Terminal GABA(A) Receptors Activate Ca2+/Calmodulin-dependent Signaling to Inhibit Voltage-gated Ca2+ Influx and Glutamate Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRESYNAPTIC IONOTROPIC RECEPTORS; CALCIUM-CHANNELS; TRANSMITTER RELEASE; PROTEIN-KINASE; SYNAPSIN-I; CALMODULIN ANTAGONISTS; CHLORIDE CONCENTRATION; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL-NEURONS; CA(V)2.1 CHANNELS	gamma-Aminobutyric acid type A (GABA(A)) receptors, a family of Cl--permeable ion channels, mediate fast synaptic inhibition as postsynaptically enriched receptors for gamma-aminobutyric acid at GABAergic synapses. Here we describe an alternative type of inhibition mediated by GABA(A) receptors present on neocortical glutamatergic nerve terminals and examine the underlying signaling mechanism(s). By monitoring the activity of the presynaptic CaM kinase II/synapsin I signaling pathway in isolated nerve terminals, we demonstrate that GABAA receptor activation correlated with an increase in basal intraterminal [Ca2+](i). Interestingly, this activation of GABAA receptors resulted in a reduction of subsequent depolarization-evoked Ca2+ influx, which thereby led to an inhibition of glutamate release. To investigate how the observed GABAA receptor-mediated modulation operates, we determined the sensitivity of this process to the Na-K-2Cl cotransporter 1 antagonist bumetanide, as well as substitution of Ca2+ with Ba2+, or Ca2+/calmodulin inhibition by W7. All of these treatments abolished the modulation by GABAA receptors. Application of selective antagonists of voltage-gated Ca2+ channels (VGCCs) revealed that the GABA(A) receptor-mediated modulation of glutamate release required the specific activity of L- and R-type VGCCs. Crucially, the inhibition of release by these receptors was abolished in terminals isolated from R-type VGCC knock-out mice. Together, our results indicate that a functional coupling between nerve terminal GABA(A) receptors and L- or R-type VGCCs is mediated by Ca2+/calmodulin-dependent signaling. This mechanism provides a GABA-mediated control of glutamatergic synaptic activity by a direct inhibition of glutamate release.	[Long, Philip; Mercer, Audrey; Begum, Rahima; Jovanovic, Jasmina N.] Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; [Stephens, Gary J.] Univ Reading, Sch Pharm, Dept Pharmacol, Reading RG6 6AP, Berks, England; [Sihra, Talvinder S.] UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London; University of London School of Pharmacy; University of Reading; University of London; University College London	Jovanovic, JN (corresponding author), Univ London, Sch Pharm, Dept Pharmacol, 29-39 Brunswick Sq, London WC1N 1AX, England.	jasmina.jovanovic@pharmacy.ac.uk	Stephens, Gary/J-3578-2014; Sihra, Talvinder S/A-4581-2009	Stephens, Gary/0000-0002-8966-4238; Mercer, Audrey/0000-0002-5086-2560	Royal Society UK and Biotechnology and Biological Sciences Research Council UK project; School of Pharmacy studentship; MRC [G0800498] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C507237/1] Funding Source: researchfish; Medical Research Council [G0800498] Funding Source: researchfish	Royal Society UK and Biotechnology and Biological Sciences Research Council UK project(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); School of Pharmacy studentship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Royal Society UK and Biotechnology and Biological Sciences Research Council UK project grants (to J.N.J.) and a School of Pharmacy studentship (to P.L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AUGUSTINE GJ, 1984, J PHYSIOL-LONDON, V346, P257, DOI 10.1113/jphysiol.1984.sp015020; Axmacher N, 2004, NEUROREPORT, V15, P329, DOI 10.1097/00001756-200402090-00024; Axmacher N, 2004, NEUROIMAGE, V22, P1014, DOI 10.1016/j.neuroimage.2004.02.009; Belenky MA, 2003, NEUROSCIENCE, V118, P909, DOI 10.1016/S0306-4522(03)00062-9; Bencsits E, 1999, J BIOL CHEM, V274, P19613, DOI 10.1074/jbc.274.28.19613; BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0; Billups D, 2002, J PHYSIOL-LONDON, V545, P183, DOI 10.1113/jphysiol.2002.024877; BONANNO G, 1987, SYNAPSE, V1, P254, DOI 10.1002/syn.890010306; CARBONE E, 1989, PROG BIOPHYS MOL BIO, V54, P31, DOI 10.1016/0079-6107(89)90008-4; CHAO SH, 1984, MOL PHARMACOL, V26, P75; CZERNIK AJ, 1991, METHOD ENZYMOL B, V201, P264; DECAMILLI P, 1983, J CELL BIOL, V96, P1337, DOI 10.1083/jcb.96.5.1337; DEUCHARS J, 1994, J PHYSIOL-LONDON, V478, P423, DOI 10.1113/jphysiol.1994.sp020262; DUDEL J, 1961, J PHYSIOL-LONDON, V155, P543, DOI 10.1113/jphysiol.1961.sp006646; DUNKLEY PR, 1988, BRAIN RES, V441, P59, DOI 10.1016/0006-8993(88)91383-2; DUNKLEY PR, 1986, BRAIN RES, V372, P115, DOI 10.1016/0006-8993(86)91464-2; ECCLES J. C., 1964, PROGR BRAIN RES, V12, P65, DOI 10.1016/S0079-6123(08)60618-4; ECCLES JC, 1963, J PHYSIOL-LONDON, V168, P500, DOI 10.1113/jphysiol.1963.sp007205; ECCLES JC, 1962, J PHYSIOL-LONDON, V160, P62, DOI 10.1113/jphysiol.1962.sp006835; ECCLES JC, 1961, J PHYSIOL-LONDON, V159, P147, DOI 10.1113/jphysiol.1961.sp006798; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Farrant M, 2007, PROG BRAIN RES, V160, P59, DOI 10.1016/S0079-6123(06)60005-8; Fassio A, 1999, J NEUROSCI RES, V57, P324, DOI 10.1002/(SICI)1097-4547(19990801)57:3<324::AID-JNR4>3.0.CO;2-Z; FUNG SC, 1983, NEUROSCI LETT, V42, P61, DOI 10.1016/0304-3940(83)90422-6; Gasparini S, 2001, J NEUROSCI, V21, P8715, DOI 10.1523/JNEUROSCI.21-22-08715.2001; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HIDAKA H, 1981, MOL PHARMACOL, V20, P571; HIDAKA H, 1983, METHOD ENZYMOL, V102, P185; HIDAKA H, 1981, P NATL ACAD SCI-BIOL, V78, P4354, DOI 10.1073/pnas.78.7.4354; HOPKINS MH, 1992, J ENZYM INHIB, V6, P125, DOI 10.3109/14756369209040743; Hughes DI, 2000, J NEUROSCI METH, V101, P107, DOI 10.1016/S0165-0270(00)00254-5; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jang IS, 2006, NEUROSCIENCE, V138, P25, DOI 10.1016/j.neuroscience.2005.11.001; Jang IS, 2005, NEUROSCIENCE, V135, P737, DOI 10.1016/j.neuroscience.2005.06.030; Jang IS, 2001, J NEUROSCI, V21, P5962, DOI 10.1523/JNEUROSCI.21-16-05962.2001; Jensen K, 1999, J NEUROPHYSIOL, V81, P1225, DOI 10.1152/jn.1999.81.3.1225; Jovanovic JN, 2001, J NEUROSCI, V21, P7944, DOI 10.1523/JNEUROSCI.21-20-07944.2001; Koga H, 2005, BRAIN RES, V1046, P24, DOI 10.1016/j.brainres.2005.03.026; Kullmann DM, 2005, PROG BIOPHYS MOL BIO, V87, P33, DOI 10.1016/j.pbiomolbio.2004.06.003; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Liu XB, 1996, P NATL ACAD SCI USA, V93, P7332, DOI 10.1073/pnas.93.14.7332; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; MCMAHON HT, 1991, J NEUROCHEM, V56, P86, DOI 10.1111/j.1471-4159.1991.tb02566.x; Menegon A, 2000, J CELL SCI, V113, P3573; Millan C, 2002, NEUROSCI LETT, V330, P29, DOI 10.1016/S0304-3940(02)00719-X; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MITCHELL PR, 1978, NATURE, V274, P904, DOI 10.1038/274904a0; Mody I, 2001, NEUROCHEM RES, V26, P907, DOI 10.1023/A:1012376215967; Mohler H, 2007, J NEUROCHEM, V102, P1, DOI 10.1111/j.1471-4159.2007.04454.x; NACHSHEN DA, 1982, J GEN PHYSIOL, V79, P1065, DOI 10.1085/jgp.79.6.1065; Newcomb R, 1998, BIOCHEMISTRY-US, V37, P15353, DOI 10.1021/bi981255g; NICHOLLS DG, 1986, NATURE, V321, P772, DOI 10.1038/321772a0; OLSEN RW, 1986, LIFE SCI, V39, P1969, DOI 10.1016/0024-3205(86)90320-6; PEARCE BR, 1982, EUR J PHARMACOL, V82, P131, DOI 10.1016/0014-2999(82)90501-5; Pereverzev A, 2002, MOL ENDOCRINOL, V16, P884, DOI 10.1210/me.16.4.884; Perkinton MS, 1998, J NEUROCHEM, V70, P1513; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pouzat C, 1999, J NEUROSCI, V19, P1675; Price GD, 2006, J NEUROSCI, V26, P11432, DOI 10.1523/JNEUROSCI.1660-06.2006; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; Rhee JS, 1999, J NEUROCHEM, V72, P800, DOI 10.1046/j.1471-4159.1999.0720800.x; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; Ruiz A, 2003, NEURON, V39, P961, DOI 10.1016/S0896-6273(03)00559-2; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Sieghart W, 2006, ADV PHARMACOL, V54, P231, DOI 10.1016/S1054-3589(06)54010-4; SIHRA TS, 1987, J NEUROCHEM, V49, P261, DOI 10.1111/j.1471-4159.1987.tb03424.x; SIHRA TS, 1992, J BIOL CHEM, V267, P1983; SIHRA TS, 1993, J NEUROCHEM, V61, P1220, DOI 10.1111/j.1471-4159.1993.tb13612.x; SIHRA TS, 1996, POSTTRANSLATIONAL MO, P67; Sik A, 1998, P NATL ACAD SCI USA, V95, P3245, DOI 10.1073/pnas.95.6.3245; Stell BM, 2007, J NEUROSCI, V27, P9022, DOI 10.1523/JNEUROSCI.1954-07.2007; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Tokunaga T, 2004, HIPPOCAMPUS, V14, P570, DOI 10.1002/hipo.10202; TOSELLI M, 1992, PFLUG ARCH EUR J PHY, V421, P59, DOI 10.1007/BF00374734; Trigo FF, 2007, J NEUROSCI, V27, P12452, DOI 10.1523/JNEUROSCI.3413-07.2007; Turecek R, 2002, P NATL ACAD SCI USA, V99, P13884, DOI 10.1073/pnas.212419699; Vazquez E, 1997, EUR J NEUROSCI, V9, P2009, DOI 10.1111/j.1460-9568.1997.tb01369.x; Wang G, 1999, J NEUROSCI, V19, P9235; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; Whiting PJ, 1999, NEUROCHEM INT, V34, P387, DOI 10.1016/S0197-0186(99)00048-0; Wu LG, 1998, P NATL ACAD SCI USA, V95, P4720, DOI 10.1073/pnas.95.8.4720; Xiao C, 2007, J PHYSIOL-LONDON, V580, P731, DOI 10.1113/jphysiol.2006.124099; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; ZHANG SLJ, 1993, SCIENCE, V259, P531, DOI 10.1126/science.8380942; ZHANG SLJ, 1995, J PHYSIOL-LONDON, V483, P583, DOI 10.1113/jphysiol.1995.sp020608	90	35	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8717	8728		10.1074/jbc.M805322200	http://dx.doi.org/10.1074/jbc.M805322200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19141616	Green Published, hybrid			2022-12-25	WOS:000264397800056
J	Yonetani, M; Nonaka, T; Masuda, M; Inukai, Y; Oikawa, T; Hisanaga, S; Hasegawa, M				Yonetani, Motokuni; Nonaka, Takashi; Masuda, Masami; Inukai, Yuki; Oikawa, Takayuki; Hisanaga, Shin-ichi; Hasegawa, Masato			Conversion of Wild-type alpha-Synuclein into Mutant-type Fibrils and Its Propagation in the Presence of A30P Mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL PARKINSONS-DISEASE; LEWY BODIES; GENE DUPLICATION; KINETIC-ANALYSIS; IN-VITRO; MUTATION; CONFORMATION; AGGREGATION; FILAMENTS; MECHANISM	Fibrillization or conformational change of alpha-synuclein is central in the pathogenesis of alpha-synucleinopathies, such as Parkinson disease. We found that the A30P mutant accelerates nucleation-dependent fibrillization of wild type (WT) alpha-synuclein. Electron microscopy observation and ultracentrifugation experiments revealed that shedding of fragments occurs from A30P fibrils and that these fragments accelerate fibrillization by serving as seeds. Immunochemical analysis using epitope-specific antibodies and biochemical analyses of protease-resistant cores demonstrated that A30P fibrils have a distinct conformation. Interestingly, WT fibrils formed with A30P seeds exhibited the same character as A30P fibrils, as did A30P fibrils formed with WT seeds, indicating that the A30P mutation affects the conformation and fibrillization of both WT and A30P. These effects of A30P mutation may explain the apparent conflict between the association of A30P with Parkinson disease and the slow fibrillization of A30P itself and therefore provide new insight into the molecular mechanisms of alpha-synucleinopathies.	[Hasegawa, Masato] Tokyo Metropolitan Org Med Res, Tokyo Inst Psychiat, Dept Mol Neurobiol, Setagaya Ku, Tokyo 1568585, Japan; [Yonetani, Motokuni; Masuda, Masami; Inukai, Yuki; Oikawa, Takayuki; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Mol Neurosci Lab, Hachioji, Tokyo 1920397, Japan	Tokyo Institute of Psychiatry; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan University	Hasegawa, M (corresponding author), Tokyo Metropolitan Org Med Res, Tokyo Inst Psychiat, Dept Mol Neurobiol, Setagaya Ku, 2-1-8 Kamikitazawa, Tokyo 1568585, Japan.	masato@prit.go.jp	Nonaka, Takashi/L-8572-2017	Nonaka, Takashi/0000-0002-0830-9403	Priority Areas, Research on Pathomechanisms of Brain Disorders; Ministry of Education, Culture, Sports, Science and Technology of Japan	Priority Areas, Research on Pathomechanisms of Brain Disorders; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas, Research on Pathomechanisms of Brain Disorders (to M. H.), a Grant-in-Aid for Scientific Research (B) (to M. H.), and a Grant-in-Aid for Scientific Research (C) (to M. H.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; Baba M, 1998, AM J PATHOL, V152, P879; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Biere AL, 2000, J BIOL CHEM, V275, P34574, DOI 10.1074/jbc.M005514200; Bussell R, 2001, J BIOL CHEM, V276, P45996, DOI 10.1074/jbc.M106777200; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Crowther RA, 2000, NEUROSCI LETT, V292, P128, DOI 10.1016/S0304-3940(00)01440-3; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Fuchs J, 2007, NEUROLOGY, V68, P916, DOI 10.1212/01.wnl.0000254458.17630.c5; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee JC, 2004, P NATL ACAD SCI USA, V101, P16466, DOI 10.1073/pnas.0407307101; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Masuda M, 2006, FEBS LETT, V580, P1775, DOI 10.1016/j.febslet.2006.02.032; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Naiki H, 1999, METHOD ENZYMOL, V309, P305; NAIKI H, 1991, LAB INVEST, V65, P104; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Nishioka K, 2006, ANN NEUROL, V59, P298, DOI 10.1002/ana.20753; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Raymond GJ, 1997, NATURE, V388, P285, DOI 10.1038/40876; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sandal M, 2008, PLOS BIOL, V6, P99, DOI 10.1371/journal.pbio.0060006; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	49	77	79	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7940	7950		10.1074/jbc.M807482200	http://dx.doi.org/10.1074/jbc.M807482200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19164293	hybrid, Green Published			2022-12-25	WOS:000264195600056
J	Du, M; Keeling, KM; Fan, LM; Liu, XL; Bedwell, DM				Du, Ming; Keeling, Kim M.; Fan, Liming; Liu, Xiaoli; Bedwell, David M.			Poly-L-aspartic Acid Enhances and Prolongs Gentamicin-mediated Suppression of the CFTR-G542X Mutation in a Cystic Fibrosis Mouse Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREMATURE STOP MUTATIONS; AMINOGLYCOSIDE ANTIBIOTICS; LYSOSOMAL PHOSPHOLIPIDOSIS; CFTR FUNCTION; INHIBITION; PROTECTION; MECHANISM; AMIKACIN	Aminoglycosides such as gentamicin have the ability to suppress translation termination at premature stop mutations, leading to a partial restoration of protein expression and function. This observation led to studies showing that this approach may provide a viable treatment for patients with genetic diseases such as cystic fibrosis that are caused by premature stop mutations. Although aminoglycoside treatment is sometimes associated with harmful side effects, several studies have shown that the co-administration of polyanions such as poly-L-aspartic acid (PAA) can both reduce toxicity and increase the intracellular aminoglycoside concentration. In the current study we examined how the co-administration of gentamicin with PAA influenced the readthrough of premature stop codons in cultured cells and a cystic fibrosis mouse model. Using a dual luciferase readthrough reporter system in cultured cells, we found that the co-administration of gentamicin with PAA increased readthrough 20-40% relative to cells treated with the same concentration of gentamicin alone. Using a Cftr(-/-) hCFTR-G542X mouse model, we found that PAA also increased the in vivo nonsense suppression induced by gentamicin. Following the withdrawal of gentamicin, PAA significantly prolonged the time interval during which readthrough could be detected, as shown by short circuit current measurements and immunofluorescence. Because the use of gentamicin to suppress disease-causing nonsense mutations will require their long term administration, the ability of PAA to reduce toxicity and increase both the level and duration of readthrough has important implications for this promising therapeutic approach.	[Bedwell, David M.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Bedwell, DM (corresponding author), Univ Alabama Birmingham, Dept Microbiol, BBRB 432,Box 8,1530 3rd Ave S, Birmingham, AL 35294 USA.	dbedwell@uab.edu	Liu, Xiaoli/HGE-7614-2022	Bedwell, David/0000-0002-6605-818X	NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK053090] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA13148] Funding Source: Medline; NIDDK NIH HHS [P50 DK53090] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barton-Davis ER, 1999, J CLIN INVEST, V104, P375, DOI 10.1172/JCI7866; BEAUCHAMP D, 1990, J PHARMACOL EXP THER, V255, P858; Bedwell DM, 1997, NAT MED, V3, P1280, DOI 10.1038/nm1197-1280; BROWN SA, 1988, ANTIMICROB AGENTS CH, V32, P595, DOI 10.1128/AAC.32.4.595; CARLIER MB, 1983, ANTIMICROB AGENTS CH, V23, P440, DOI 10.1128/AAC.23.3.440; Clancy JP, 2007, AM J RESP CELL MOL, V37, P57, DOI 10.1165/rcmb.2006-0173OC; Clancy JP, 2001, AM J RESP CRIT CARE, V163, P1683, DOI 10.1164/ajrccm.163.7.2004001; DEBROE ME, 1984, KIDNEY INT, V25, P643, DOI 10.1038/ki.1984.69; Du M, 2002, J MOL MED, V80, P595, DOI 10.1007/s00109-002-0363-1; Du M, 2008, P NATL ACAD SCI USA, V105, P2064, DOI 10.1073/pnas.0711795105; Du M, 2006, J MOL MED, V84, P573, DOI 10.1007/s00109-006-0045-5; Fan-Minogue H, 2008, RNA, V14, P148, DOI 10.1261/rna.805208; GILBERT DN, 1989, J INFECT DIS, V159, P945, DOI 10.1093/infdis/159.5.945; Grentzmann G, 1998, RNA, V4, P479; Howard M, 1996, NAT MED, V2, P467, DOI 10.1038/nm0496-467; Howard MT, 2004, ANN NEUROL, V55, P422, DOI 10.1002/ana.20052; HULKA GF, 1993, AM J OTOL, V14, P352; HUTCHIN T, 1994, ANTIMICROB AGENTS CH, V38, P2517, DOI 10.1128/AAC.38.11.2517; Keeling K. M., 2005, Current Pharmacogenomics, V3, P259, DOI 10.2174/157016005774913149; Keeling KM, 2002, J MOL MED-JMM, V80, P367, DOI 10.1007/s00109-001-0317-z; Keeling KM, 2001, HUM MOL GENET, V10, P291, DOI 10.1093/hmg/10.3.291; Kerem E, 2004, CURR OPIN PULM MED, V10, P547, DOI 10.1097/01.mcp.0000141247.22078.46; KISHORE BK, 1992, J PHARMACOL EXP THER, V262, P424; LAURENT G, 1982, BIOCHEM PHARMACOL, V31, P3861, DOI 10.1016/0006-2952(82)90303-3; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P1003, DOI 10.1128/AAC.43.5.1003; MOESTRUP SK, 1995, J CLIN INVEST, V96, P1404, DOI 10.1172/JCI118176; Politano L, 2003, Acta Myol, V22, P15; RAMSAMMY L, 1990, AM J PHYSIOL, V258, pC1141, DOI 10.1152/ajpcell.1990.258.6.C1141; RATCLIFF R, 1993, NAT GENET, V4, P35, DOI 10.1038/ng0593-35; Sandoval RM, 2004, AM J PHYSIOL-RENAL, V286, pF617, DOI 10.1152/ajprenal.00130.2003; Schmitz C, 2002, J BIOL CHEM, V277, P618, DOI 10.1074/jbc.M109959200; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Wagner KR, 2001, ANN NEUROL, V49, P706, DOI 10.1002/ana.1023.abs; WILLIAMS PD, 1986, J PHARMACOL EXP THER, V237, P919; Wilschanski M, 2000, AM J RESP CRIT CARE, V161, P860, DOI 10.1164/ajrccm.161.3.9904116; Wilschanski M, 2003, NEW ENGL J MED, V349, P1433, DOI 10.1056/NEJMoa022170	36	35	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6885	6892		10.1074/jbc.M806728200	http://dx.doi.org/10.1074/jbc.M806728200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19136563	hybrid, Green Published			2022-12-25	WOS:000263919000036
J	Jenei, ZA; Borthwick, K; Zammit, VA; Dixon, AM				Jenei, Zsuzsanna A.; Borthwick, Karen; Zammit, Victor A.; Dixon, Ann M.			Self-association of Transmembrane Domain 2 (TM2), but Not TM1, in Carnitine Palmitoyltransferase 1A ROLE OF GXXXG(A) MOTIFS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; RAT-LIVER MITOCHONDRIA; MALONYL-COA SENSITIVITY; FATTY-ACID OXIDATION; HELIX ASSOCIATION; CELL-FUNCTION; CPT-I; TOPOLOGY; DIMERIZATION; CARNITINE-PALMITOYLTRANSFERASE-1	Carnitine palmitoyltransferase 1 (CPT1) controls the rate of entry of long-chain fatty acids into the mitochondrial matrix for beta-oxidation and has been reported to exist as an oligomer. We have investigated the in vivo oligomerization of full-length rat CPT1A (rCPT1A) along with those of the N-terminal truncation/deletion mutants Delta(1-82), Delta(1-18), and Delta(19-30) expressed in yeast mitochondria. The data indicate that in liver mitochondria in vivo CPT1A exists as a hexamer but that during preparation and storage of mitochondria the order of oligomerization is rapidly reduced to the trimer, such that a mixture of hexamer and trimer is observed in isolated mitochondria in vitro. Mutants bearing deletions of different segments of the N terminus (including the more N-terminal of the two transmembrane domains) have the same pattern of oligomerization when expressed in yeast mitochondria. The self-association of the individual rCPT1A transmembrane (TM) domains (TM1, TM2) was also studied using the TOXCAT assay (which measures TM self-association in the Escherichia coli inner membrane). There was minimal self-association of the sequence corresponding to TM1 but significant self-association of TM2 in TOXCAT. Chemical cross-linking and analytical ultracentrifugation of a TM2-derived synthetic peptide showed oligomerization with a similar trimer/hexamer equilibrium to that observed for native rCPT1A in isolated mitochondria. Therefore, there was a correlation between the oligomerization behavior of TM2 peptide and that of the full-length protein. In silico molecular modeling of rCPT1A TM2 highlighted the favorable orientation of GXXXG and GXXXA motifs in the formation of the TM2 hexamer.	[Jenei, Zsuzsanna A.; Dixon, Ann M.] Univ Warwick, Warwick Med Sch, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Borthwick, Karen; Zammit, Victor A.] Univ Warwick, Warwick Med Sch, Clin Sci Res Inst, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick	Dixon, AM (corresponding author), Univ Warwick, Warwick Med Sch, Dept Chem, Coventry CV4 7AL, W Midlands, England.	ann.dixon@warwick.ac.uk	Jenei, Zsuzsanna/F-2028-2011; Dixon, Ann M/I-3696-2012	Dixon, Ann M/0000-0002-5261-304X	Diabetes UK; Warwick University Postgraduate Research Fellowship	Diabetes UK(Diabetes UK); Warwick University Postgraduate Research Fellowship	This work was supported by a Diabetes UK grant (to V.A.Z. and A. M. D.) and by a Warwick University Postgraduate Research Fellowship (to Z.J.). The costs of publication of this article were defrayed in part by the payment of page charges.	Adams PD, 1996, PROTEINS, V26, P257, DOI 10.1002/(SICI)1097-0134(199611)26:3<257::AID-PROT2>3.0.CO;2-B; ADAMS PD, 1995, NAT STRUCT BIOL, V2, P154, DOI 10.1038/nsb0295-154; Branstrom R, 2004, DIABETOLOGIA, V47, P277, DOI 10.1007/s00125-003-1299-x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN HF, 1995, J BIOL CHEM, V270, P14115, DOI 10.1074/jbc.270.23.14115; Dawson JP, 2002, J MOL BIOL, V316, P799, DOI 10.1006/jmbi.2001.5353; Ding FX, 2001, BIOCHEMISTRY-US, V40, P8945, DOI 10.1021/bi010394m; Drynan L, 1996, BIOCHEM J, V317, P791, DOI 10.1042/bj3170791; Faye A, 2005, BIOCHEM J, V387, P67, DOI 10.1042/BJ20041533; Faye A, 2007, J BIOL CHEM, V282, P26908, DOI 10.1074/jbc.M705418200; Fisher LE, 1999, J MOL BIOL, V293, P639, DOI 10.1006/jmbi.1999.3126; Fraser F, 1997, BIOCHEM J, V323, P711, DOI 10.1042/bj3230711; Fraser F, 1998, BIOCHEM J, V329, P225, DOI 10.1042/bj3290225; Jackson VN, 2000, J BIOL CHEM, V275, P38410, DOI 10.1074/jbc.M007722200; KOLODZIEJ MP, 1990, BIOCHEM J, V272, P421, DOI 10.1042/bj2720421; KOLODZIEJ MP, 1992, BIOCHEM J, V282, P415, DOI 10.1042/bj2820415; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Langosch D, 1996, J MOL BIOL, V263, P525, DOI 10.1006/jmbi.1996.0595; Lazarova T, 2004, BIOCHEMISTRY-US, V43, P12945, DOI 10.1021/bi0492051; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; Lopez-Vinas E, 2007, J BIOL CHEM, V282, P18212, DOI 10.1074/jbc.M700885200; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Melnyk RA, 2003, BIOPOLYMERS, V71, P675, DOI 10.1002/bip.10595; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Schneider D, 2004, J BIOL CHEM, V279, P9840, DOI 10.1074/jbc.M312749200; Schneider D, 2004, J MOL BIOL, V343, P799, DOI 10.1016/j.jmb.2004.08.083; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; STAROS JV, 1982, BIOCHEMISTRY-US, V21, P3950, DOI 10.1021/bi00260a008; Turkaly P, 1999, FEBS LETT, V460, P241, DOI 10.1016/S0014-5793(99)01354-X; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; ZAMMIT VA, 1989, BIOCHEM J, V263, P89, DOI 10.1042/bj2630089; Zammit VA, 1999, PROG LIPID RES, V38, P199, DOI 10.1016/S0163-7827(99)00002-8; Zammit VA, 1998, LIPIDS, V33, P371, DOI 10.1007/s11745-998-0217-7; Zammit VA, 1999, BIOCHEM J, V343, P505, DOI 10.1042/0264-6021:3430505; Zammit VA, 1997, ADV ENZYME REGUL, V37, P295, DOI 10.1016/S0065-2571(96)00015-5; Zammit VA, 2008, IUBMB LIFE, V60, P347, DOI 10.1002/iub.78	43	26	27	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6988	6997		10.1074/jbc.M808487200	http://dx.doi.org/10.1074/jbc.M808487200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19136561	Green Published, hybrid			2022-12-25	WOS:000263919000047
J	Chaturvedi, D; Gao, X; Cohen, MS; Taunton, J; Patel, TB				Chaturvedi, D.; Gao, X.; Cohen, M. S.; Taunton, J.; Patel, T. B.			Rapamycin induces transactivation of the EGFR and increases cell survival	ONCOGENE			English	Article						mTOR; rapamycin; transactivation; EGFR; c-Src; apoptosis	GROWTH-FACTOR RECEPTOR; RIBOSOMAL S6 KINASE; MAMMALIAN TARGET; CANCER-CELLS; CARDIAC-HYPERTROPHY; PROTEIN-KINASE; SIGNAL-TRANSDUCTION; MTOR; PATHWAY; AKT	The mammalian target of rapamycin (mTOR) signa ling network regulates cell growth, proliferation and cell survival. Deregulated activation of this pathway is a common event in diverse human diseases such as cancers, cardiac hypertrophy, vascular restenosis and nephrotic hypertrophy. Although mTOR inhibitor, rapamycin, has been widely used to inhibit the aberrant signaling due to mTOR activation that plays a major role in hyperproliferative diseases, in some cases rapamycin does not attenuate the cell proliferation and survival. Thus, we studied the mechanism(s) by which cells may confer resistance to rapamycin. Our data show that in a variety of cell types the mTOR inhibitor rapamycin activates extracellularly regulated kinases (Erk1/2) signa ling. Rapamycin-mediated activation of the Erk1/2 signaling requires (a) the epidermal growth factor receptor (EGFR), (b) its tyrosine kinase activity and (c) intact autophosphorylation sites on the receptor. Rapamycin treatment increases tyrosine phosphorylation of EGFR without the addition of growth factor and this transactivation of receptor involves activation of c-Src. We also show that rapamycin treatment triggers activation of cell survival signaling pathway by activating the prosurvival kinases Erk1/2 and p90RSK. These studies provide a novel paradigm by which cells escape the apoptotic actions of rapamycin and its derivatives that inhibit the mTOR pathway.	[Chaturvedi, D.; Gao, X.; Patel, T. B.] Loyola Univ, Med Ctr, Stritch Sch Med, Dept Pharmacol & Expt Therapeut, Maywood, IL 60153 USA; [Cohen, M. S.; Taunton, J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	Loyola University Chicago; University of California System; University of California San Francisco	Chaturvedi, D (corresponding author), Loyola Univ, Med Ctr, Stritch Sch Med, Dept Pharmacol & Expt Therapeut, 2160 S 1st Ave,Bldg 101,Rm 2716, Maywood, IL 60153 USA.	dchaturvedi@lumc.edu			American Heart Association-SDG [AHA-ID-0830411Z]; NIH [GM071434, GM 079226, GM73181]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079226, R01GM073181, R01GM071434] Funding Source: NIH RePORTER	American Heart Association-SDG(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to Dr PJ Bertics for providing us with the B82L cells, the EGFR cDNA and EGFR antibodies and to Ms Kuldeep Patel for the immunocytochemical analyses. This study was supported by American Heart Association-SDG AHA-ID-0830411Z ( to DC) and NIH Grants GM071434 ( to JT), GM 079226 and GM73181 ( to TBP).	Abraham RT, 1998, CURR OPIN IMMUNOL, V10, P330, DOI 10.1016/S0952-7915(98)80172-6; Arteaga CL, 1997, J BIOL CHEM, V272, P23247, DOI 10.1074/jbc.272.37.23247; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Azzariti A, 2008, BIOCHEM PHARMACOL, V75, P1035, DOI 10.1016/j.bcp.2007.11.018; Banko JL, 2006, J NEUROSCI, V26, P2167, DOI 10.1523/JNEUROSCI.5196-05.2006; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Boluyt MO, 2004, CARDIOVASC DRUG THER, V18, P257, DOI 10.1023/B:CARD.0000041245.61136.56; Chaturvedi D, 2006, MOL CELL BIOL, V26, P4586, DOI 10.1128/MCB.01422-05; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Costa LJ, 2007, UROLOGY, V69, P596, DOI 10.1016/j.urology.2007.01.053; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; Dormond O, 2007, J BIOL CHEM, V282, P23679, DOI 10.1074/jbc.M700563200; Dummler BA, 2005, J BIOL CHEM, V280, P13304, DOI 10.1074/jbc.M408194200; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Fumarola C, 2005, CELL DEATH DIFFER, V12, P1344, DOI 10.1038/sj.cdd.4401660; Galanis E, 2005, J CLIN ONCOL, V23, P5294, DOI 10.1200/JCO.2005.23.622; Goudar RK, 2005, MOL CANCER THER, V4, P101; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Huang S, 2003, CURR OPIN PHARMACOL, V3, P371, DOI 10.1016/S1471-4892(03)00071-7; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jin W, 2007, CANCER RES, V67, P3192, DOI 10.1158/0008-5472.CAN-06-3526; Kiley SC, 2007, AM J PHYSIOL-RENAL, V293, pF895, DOI 10.1152/ajprenal.00227.2007; Kris MG, 2007, J CLIN ONCOL, V25, p18s; Kudo N, 1996, BBA-LIPID LIPID MET, V1301, P67, DOI 10.1016/0005-2760(96)00013-6; Li J, 1999, J BIOL CHEM, V274, P11209, DOI 10.1074/jbc.274.16.11209; LORENZ MC, 1995, J BIOL CHEM, V270, P27531, DOI 10.1074/jbc.270.46.27531; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; Metro G, 2006, REV RECENT CLIN TRIA, V1, P1, DOI 10.2174/157488706775246157; Milton DT, 2007, CANCER-AM CANCER SOC, V110, P599, DOI 10.1002/cncr.22816; Myers AP, 2004, MOL CELL BIOL, V24, P4255, DOI 10.1128/MCB.24.10.4255-4266.2004; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Parry TJ, 2005, EUR J PHARMACOL, V524, P19, DOI 10.1016/j.ejphar.2005.09.042; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Saito Y, 2001, MOL CELL BIOL, V21, P6387, DOI 10.1128/MCB.21.19.6387-6394.2001; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sharma S, 2006, CARDIOLOGY, V105, P128, DOI 10.1159/000090550; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; VanderWeele DJ, 2004, MOL CANCER THER, V3, P1605; Vega F, 2006, CANCER RES, V66, P6589, DOI 10.1158/0008-5472.CAN-05-3018; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	61	41	44	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 5	2009	28	9					1187	1196		10.1038/onc.2008.490	http://dx.doi.org/10.1038/onc.2008.490			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	415AH	19151764	Green Accepted, Green Submitted			2022-12-25	WOS:000263906200003
J	Raimundo, N; Vanharanta, S; Aaltonen, LA; Hovatta, I; Suomalainen, A				Raimundo, N.; Vanharanta, S.; Aaltonen, L. A.; Hovatta, I.; Suomalainen, A.			Downregulation of SRF-FOS-JUNB pathway in fumarate hydratase deficiency and in uterine leiomyomas	ONCOGENE			English	Article						leiomyoma; mitochondria; fumarate hydratase; expression microarray; serum response factor	SERUM-RESPONSE FACTOR; RENAL-CELL CANCER; GENE-EXPRESSION; HEREDITARY LEIOMYOMATOSIS; GLUCOCORTICOID-RECEPTOR; TARGETED INACTIVATION; MITOCHONDRIAL DISEASE; HYPOXIA PATHWAY; KREBS CYCLE; PUR-BETA	Defects of metabolic enzymes result in a variety of manifestations not logically explained by the primary metabolic function. Dominant defects of fumarate hydratase (FH) result in predisposition to cutaneous and uterine leiomyomas, and renal cell cancer. FH is a metabolic enzyme of the tricarboxylic acid cycle, and its tumor-suppressor mechanism is not fully understood. We compared the consequences of FH deficiency and respiratory chain (RC) deficiency using global expression pattern of diploid primary fibroblasts. This approach utilized the information that RC defects do not seem to predispose to tumorigenesis, and the aim was to identify FH-specific signaling effects that might have relevance to tumor formation. These results were then compared to global expression patterns of FH-deficient and sporadic uterine leiomyoma data sets. We show here that FH-deficient fibroblasts share a common transcriptional fingerprint with FH-deficient and sporadic leiomyomas, highlighting the downregulation of serum response factor (SRF)-regulated transcripts, particularly the FOS-JUNB pathway. We confirmed the downregulation of this pathway at transcriptional and protein level. SRF has a fundamental function in the differentiation of smooth muscle progenitor cells, and its downregulation both in diploid FH-deficient primary fibroblasts and in leiomyomas suggests an early function in the mechanism of uterine leiomyoma formation in FH deficiency. Concordantly, the phosphorylated form of SRF, known to activate transcription, is undetectable in leiomyomas whereas clearly detected in several nuclei in the differentiated myometrium. A similar transcriptional SRF-pathway fingerprint in FH-deficient and sporadic leiomyomas emphasizes the potential importance of this pathway in primary events leading to leiomyomatosis.	[Raimundo, N.; Hovatta, I.; Suomalainen, A.] Univ Helsinki, Res Program Mol Neurol, FIN-00290 Helsinki, Finland; [Vanharanta, S.; Aaltonen, L. A.] Univ Helsinki, Res Program Genome Scale Biol, FIN-00290 Helsinki, Finland; [Vanharanta, S.; Aaltonen, L. A.; Hovatta, I.] Univ Helsinki, Dept Med Genet, FIN-00290 Helsinki, Finland; [Hovatta, I.] Natl Publ Hlth Inst, Dept Mol Med, Helsinki, Finland; [Hovatta, I.] Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, Helsinki, Finland; [Suomalainen, A.] Univ Helsinki, Cent Hosp, Dept Neurol, FIN-00290 Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital	Suomalainen, A (corresponding author), Univ Helsinki, Res Program Mol Neurol, Room c523B,Haartmaninkatu 8, FIN-00290 Helsinki, Finland.	Anu.wartiovaara@helsinki.fi	Aaltonen, Lauri/A-5375-2010; Raimundo, Nuno/AAD-9498-2020; Hovatta, Iiris/D-6871-2012; Raimundo, Nuno/E-8357-2010	Aaltonen, Lauri/0000-0001-6839-4286; Raimundo, Nuno/0000-0002-5988-9129; Hovatta, Iiris/0000-0002-5990-7892; Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195	Helsinki Biomedical Graduate School; Sigrid Juselius Foundation; Centre of Excellence program of Academy of Finland; University of Helsinki; EMBO Young Investigator Program	Helsinki Biomedical Graduate School; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Centre of Excellence program of Academy of Finland(Academy of Finland); University of Helsinki; EMBO Young Investigator Program(European Molecular Biology Organization (EMBO))	We thank Heli Lehtonen for providing the paraffin sections and Markus Innila for skillful immunohistochemistry. The following funding sources are gratefully acknowledged: Helsinki Biomedical Graduate School (NR), Sigrid Juselius Foundation ( AS and LA), Centre of Excellence program of Academy of Finland and University of Helsinki ( AS and LA) and EMBO Young Investigator Program ( AS).; Financial support: Academy of Finland, Helsinki University, Sigrid Juselius Foundation ( for AS), Helsinki Biomedical Graduate School ( for NR).	Al Refae M, 2007, NAT CLIN PRACT ONCOL, V4, P256, DOI 10.1038/ncponc0773; Alam NA, 2003, HUM MOL GENET, V12, P1241, DOI 10.1093/hmg/ddg148; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Arslan AA, 2005, HUM REPROD, V20, P852, DOI 10.1093/humrep/deh698; Balza RO, 2006, J BIOL CHEM, V281, P6498, DOI 10.1074/jbc.M509487200; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; BOURGERON T, 1994, J CLIN INVEST, V93, P2514, DOI 10.1172/JCI117261; Campione E, 2007, J INVEST DERMATOL, V127, P2271, DOI 10.1038/sj.jid.5700851; Carlini LE, 2002, J BIOL CHEM, V277, P8682, DOI 10.1074/jbc.M109754200; Carvajal-Carmona LG, 2006, J CLIN ENDOCR METAB, V91, P3071, DOI 10.1210/jc.2006-0183; CATALA F, 1995, MOL CELL BIOL, V15, P4585; Chai J, 2002, J PHYSIOL PHARMACOL, V53, P147; Chebotaev D, 2007, MOL CARCINOGEN, V46, P732, DOI 10.1002/mc.20349; Du KL, 2004, J BIOL CHEM, V279, P17578, DOI 10.1074/jbc.M400961200; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eng C, 2003, NAT REV CANCER, V3, P193, DOI 10.1038/nrc1013; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Heidenreich O, 1999, J BIOL CHEM, V274, P14434, DOI 10.1074/jbc.274.20.14434; Hoffman PJ, 2004, FERTIL STERIL, V82, P639, DOI 10.1016/j.fertnstert.2004.01.047; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; JANKNECHT R, 1992, EMBO J, V11, P1045, DOI 10.1002/j.1460-2075.1992.tb05143.x; Kelm RJ, 2003, J BIOL CHEM, V278, P38749, DOI 10.1074/jbc.M306163200; Le PP, 2005, PLOS GENET, V1, P159, DOI 10.1371/journal.pgen.0010016; Loeffen J, 2005, J INHERIT METAB DIS, V28, P799, DOI 10.1007/s10545-005-0044-7; Maradin M, 2006, J INHERIT METAB DIS, V29, P683, DOI 10.1007/s10545-006-0321-0; Marshall P, 2001, J BIOL CHEM, V276, P20719, DOI 10.1074/jbc.M102100200; MISRA RP, 1994, J BIOL CHEM, V269, P25483; Mittelstadt PR, 2003, MOL ENDOCRINOL, V17, P1534, DOI 10.1210/me.2002-0429; Parlakian A, 2004, MOL CELL BIOL, V24, P5281, DOI 10.1128/MCB.24.12.5281-5289.2004; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Pollard P, 2005, J PATHOL, V205, P41, DOI 10.1002/path.1686; Pollard PJ, 2007, CANCER CELL, V11, P311, DOI 10.1016/j.ccr.2007.02.005; Pollard PJ, 2003, ANN MED, V35, P632, DOI 10.1080/07853890310018458; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Raimundo N, 2008, BBA-MOL BASIS DIS, V1782, P287, DOI 10.1016/j.bbadis.2008.01.008; Remes AM, 2004, J MOL MED, V82, P550, DOI 10.1007/s00109-004-0563-y; RIVERA VM, 1993, MOL CELL BIOL, V13, P6260, DOI 10.1128/MCB.13.10.6260; Rustin P, 1997, BBA-MOL BASIS DIS, V1361, P185, DOI 10.1016/S0925-4439(97)00035-5; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Shozu M, 2004, CANCER RES, V64, P4677, DOI 10.1158/0008-5472.CAN-03-0560; Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102; Vanharanta S, 2006, HUM MOL GENET, V15, P97, DOI 10.1093/hmg/ddi431; Walker CL, 2005, SCIENCE, V308, P1589, DOI 10.1126/science.1112063; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Wei JJ, 2005, MODERN PATHOL, V18, P179, DOI 10.1038/modpathol.3800283; Weinhold B, 2000, EMBO J, V19, P5835, DOI 10.1093/emboj/19.21.5835; Ylisaukko-oja SK, 2006, EUR J HUM GENET, V14, P880, DOI 10.1038/sj.ejhg.5201630; Zhang SX, 2005, J BIOL CHEM, V280, P19115, DOI 10.1074/jbc.M413793200	52	22	22	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 5	2009	28	9					1261	1273		10.1038/onc.2008.472	http://dx.doi.org/10.1038/onc.2008.472			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	415AH	19151755				2022-12-25	WOS:000263906200010
J	Wolfe, DN; Buboltz, AM; Harvill, ET				Wolfe, Daniel N.; Buboltz, Anne M.; Harvill, Eric T.			Inefficient Toll-Like Receptor-4 Stimulation Enables Bordetella parapertussis to Avoid Host Immunity	PLOS ONE			English	Article							CELL PERTUSSIS-VACCINE; LIPID-A; WHOLE-CELL; SIGNAL-TRANSDUCTION; MEDIATED CLEARANCE; YERSINIA-PESTIS; IN-VITRO; LIPOPOLYSACCHARIDE; BRONCHISEPTICA; INFECTIONS	The recognition of bacterial lipopolysaccharide (LPS) by host Toll-like receptor (TLR)4 is a crucial step in developing protective immunity against several gram negative bacterial pathogens. Bordetella bronchiseptica and B. pertussis stimulate robust TLR4 responses that are required to control the infection, but a close relative, B. parapertussis, poorly stimulates this receptor, and TLR4 deficiency does not affect its course of infection. This led us to hypothesize that inefficient TLR4 stimulation enables B. parapertussis to evade host immunity. In a mouse model of infection, B. parapertussis grew rapidly in the lungs, but no measurable increase in TLR4-mediated cytokine, chemokine, or leukocyte responses were observed over the first few days of infection. Delivery of a TLR4 stimulant in the inoculum resulted in a robust inflammatory response and a 10- to 100-fold reduction of B. parapertussis numbers. As we have previously shown, B. parapertussis grows efficiently during the first week of infection even in animals passively immunized with antibodies. We show that this evasion of antibody-mediated clearance is dependent on the lack of TLR4 stimulation by B. parapertussis as co-inoculation with a TLR4 agonist resulted in 10,000-fold lower B. parapertussis numbers on day 3 in antibody-treated wild type, but not TLR4-deficient, mice. Together, these results indicate that inefficient TLR4 stimulation by B. parapertussis enables it to avoid host immunity and grow to high numbers in the respiratory tract of naive and immunized hosts.	[Wolfe, Daniel N.; Buboltz, Anne M.; Harvill, Eric T.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Buboltz, Anne M.] Penn State Univ, Grad Program Biochem Microbiol & Molecular Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wolfe, DN (corresponding author), Penn State Univ, Coll Informat Sci & Technol, University Pk, PA 16802 USA.	harvill@psu.edu		Russell, Anne/0000-0003-4533-5069; Harvill, Eric/0000-0001-8893-2133	NIH [AI 053075]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053075] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by NIH grant AI 053075 (E.T.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2002, J IMMUNOL, V169, P3155, DOI 10.4049/jimmunol.169.6.3155; ARICO B, 1987, J BACTERIOL, V169, P2847, DOI 10.1128/jb.169.6.2847-2853.1987; Barnard A, 1996, IMMUNOLOGY, V87, P372, DOI 10.1046/j.1365-2567.1996.497560.x; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; Bernheiden M, 2001, J ENDOTOXIN RES, V7, P447, DOI 10.1179/096805101101533061; Biswas SK, 2007, J IMMUNOL, V179, P4083, DOI 10.4049/jimmunol.179.6.4083; Carbonetti NH, 2005, INFECT IMMUN, V73, P2698, DOI 10.1128/IAI.73.5.2698-2703.2005; Caroff M, 2001, J ENDOTOXIN RES, V7, P63, DOI 10.1177/09680519010070011101; *CDCP, 2002, JAMA-J AM MED ASSOC, P977; Celentano LP, 2005, PEDIATR INFECT DIS J, V24, P761, DOI 10.1097/01.inf.0000177282.53500.77; Cherry J. D., 2004, TXB PEDIAT INFECT DI; COTTER PA, 1994, INFECT IMMUN, V62, P3381, DOI 10.1128/IAI.62.8.3381-3390.1994; David S, 2004, VACCINE, V22, P1892, DOI 10.1016/j.vaccine.2003.11.005; de Melker HE, 2000, EMERG INFECT DIS, V6, P348, DOI 10.3201/eid0604.000404; Dixon DR, 2005, J DENT RES, V84, P584, DOI 10.1177/154405910508400702; Ernst RK, 2006, J BACTERIOL, V188, P191, DOI 10.1128/JB.188.1.191-201.2006; GOODNOW RA, 1980, MICROBIOL REV, V44, P722, DOI 10.1128/MMBR.44.4.722-738.1980; Hajjar AM, 2006, INFECT IMMUN, V74, P6730, DOI 10.1128/IAI.00934-06; Heininger U, 1998, VACCINE, V16, P1255, DOI 10.1016/S0264-410X(97)00078-9; Heininger U, 2002, INFECT IMMUN, V70, P3777, DOI 10.1128/IAI.70.7.3777-3784.2002; Higgins SC, 2003, J IMMUNOL, V171, P3119, DOI 10.4049/jimmunol.171.6.3119; Kawahara K, 2002, INFECT IMMUN, V70, P4092, DOI 10.1128/IAI.70.8.4092-4098.2002; Kawasaki K, 2004, J ENDOTOXIN RES, V10, P439, DOI 10.1179/096805104225006264; Kawasaki K, 2004, J BIOL CHEM, V279, P20044, DOI 10.1074/jbc.M401275200; Kielian T, 2007, J IMMUNOL, V178, P4528, DOI 10.4049/jimmunol.178.7.4528; Kirimanjeswara GS, 2005, J CLIN INVEST, V115, P3594, DOI 10.1172/JCI24609; Kirimanjeswara GS, 2003, INFECT IMMUN, V71, P1719, DOI 10.1128/IAI.71.4.1719-1724.2003; Kirimanjeswara GS, 2005, J IMMUNOL, V175, P7504, DOI 10.4049/jimmunol.175.11.7504; Knirel YA, 2005, BIOCHEMISTRY-US, V44, P1731, DOI 10.1021/bi048430f; Lee JY, 2005, BIOCHEM PHARMACOL, V70, P1231, DOI 10.1016/j.bcp.2005.07.020; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Liese JG, 2003, ARCH DIS CHILD, V88, P684, DOI 10.1136/adc.88.8.684; Mann PB, 2005, INFECT IMMUN, V73, P8144, DOI 10.1128/IAI.73.12.8144-8152.2005; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pilione MR, 2006, INFECT IMMUN, V74, P1043, DOI 10.1128/IAI.74.2.1043-1049.2006; Preston A, 2006, J BIOL CHEM, V281, P18135, DOI 10.1074/jbc.M513904200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rebeil R, 2004, MOL MICROBIOL, V52, P1363, DOI 10.1111/j.1365-2958.2004.04059.x; Schurr JR, 2005, INFECT IMMUN, V73, P532, DOI 10.1128/IAI.73.1.532-545.2005; Skowronski DM, 2002, J INFECT DIS, V185, P1448, DOI 10.1086/340280; Stehr K, 1998, PEDIATRICS, V101, P1, DOI 10.1542/peds.101.1.1; Supajatura V, 2001, J IMMUNOL, V167, P2250, DOI 10.4049/jimmunol.167.4.2250; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; van den Akker WMR, 1998, MICROBIOL-SGM, V144, P1527, DOI 10.1099/00221287-144-6-1527; VanderZee A, 1997, J BACTERIOL, V179, P6609, DOI 10.1128/jb.179.21.6609-6617.1997; von Konig CHW, 2002, LANCET INFECT DIS, V2, P744, DOI 10.1016/S1473-3099(02)00452-8; Watanabe Mineo, 2004, Expert Rev Anti Infect Ther, V2, P447, DOI 10.1586/14787210.2.3.447; Willems RJL, 1998, VACCINE, V16, P410, DOI 10.1016/S0264-410X(97)80919-X; Wolfe DN, 2005, INFECT IMMUN, V73, P6508, DOI 10.1128/IAI.73.10.6508-6513.2005	52	23	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2009	4	1							e4280	10.1371/journal.pone.0004280	http://dx.doi.org/10.1371/journal.pone.0004280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JE	19169359	Green Submitted, Green Published, gold			2022-12-25	WOS:000265482800010
J	Cui, XQ; Loraine, AE				Cui, Xiangqin; Loraine, Ann E.			Consistency Analysis of Redundant Probe Sets on Affymetrix Three-Prime Expression Arrays and Applications to Differential mRNA Processing	PLOS ONE			English	Article							GENE-EXPRESSION; MICROARRAYS; NETAFFX; TESTS; CALL	Affymetrix three-prime expression microarrays contain thousands of redundant probe sets that interrogate different regions of the same gene. Differential expression analysis methods rarely consider probe redundancy, which can lead to inaccurate inference about overall gene expression or cause investigators to overlook potentially valuable information about differential regulation of variant mRNA products. We investigated the behaviour and consistency of redundant probe sets in a publicly-available data set containing samples from mouse brain amygdala and hippocampus and asked how applying filtering methods to the data affected consistency of results obtained from redundant probe sets. A genome-based filter that screens and groups probe sets according to their overlapping genomic alignments significantly improved redundant probe set consistency. Screening based on qualitative Present-Absent calls from MAS5 also improved consistency. However, even after applying these filters, many redundant probe sets showed significant fold-change differences relative to each other, suggesting differential regulation of alternative transcript production. Visual inspection of these loci using an interactive genome visualization tool (igb.bioviz.org) exposed thirty putative examples of differential regulation of alternative splicing or polyadenylation across brain regions in mouse. This work demonstrates how P/A-call and genome-based filtering can improve consistency among redundant probe sets while at the same time exposing possible differential regulation of RNA processing pathways across sample types.	Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA; [Loraine, Ann E.] Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC USA	University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Charlotte	Cui, XQ (corresponding author), Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA.	aloraine@uncc.edu		Cui, Xiangqin/0000-0003-0621-9313	NIH/NCI [U54 CA100949]; NATIONAL CANCER INSTITUTE [U54CA100949] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by NIH/NCI U54 CA100949. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix, 2002, STAT ALG DESCR DOC; Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.2307/1165312; Cline MS, 2005, BIOINFORMATICS, V21, pI107, DOI 10.1093/bioinformatics/bti1010; CUI X, 2006, GLOBAL CORRELATION A, P223; Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018; D'mello Veera, 2006, Appl Bioinformatics, V5, P249, DOI 10.2165/00822942-200605040-00007; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Gautier L, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-111; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jongeneel CV, 2005, GENOME RES, V15, P1007, DOI 10.1101/gr.4041005; Kennedy PE, 1996, COMMUN STAT-SIMUL C, V25, P923, DOI 10.1080/03610919608813350; Li H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-188; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Lu J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-108; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; *NAT CANC I, 2008, CANC GEN ATL DAT POR; Perez-Iratxeta C, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-183; Ponder CA, 2007, GENES BRAIN BEHAV, V6, P736, DOI 10.1111/j.1601-183X.2007.00306.x; Sandberg R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-48; Stalteri MA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-13; Yang HU, 2007, BIOINFORMATICS, V23, P38, DOI 10.1093/bioinformatics/btl548; Zhang JH, 2005, GENOMICS, V85, P297, DOI 10.1016/j.ygeno.2004.11.004	26	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2009	4	1							e4229	10.1371/journal.pone.0004229	http://dx.doi.org/10.1371/journal.pone.0004229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JD	19165320	Green Published, Green Submitted, gold			2022-12-25	WOS:000265482400001
J	Chang, DK; Lin, CT; Wu, CH; Wu, HC				Chang, De-Kuan; Lin, Chin-Tarng; Wu, Chien-Hsun; Wu, Han-Chung			A Novel Peptide Enhances Therapeutic Efficacy of Liposomal Anti-Cancer Drugs in Mice Models of Human Lung Cancer	PLOS ONE			English	Article							STERICALLY STABILIZED LIPOSOMES; SOLID TUMORS; CHEMOTHERAPEUTIC-AGENTS; DOXORUBICIN DOXIL; SMALL-CELL; DELIVERY; PHARMACOKINETICS; EPITOPE; PHAGE; ACCUMULATION	Lung cancer is the leading cause of cancer-related mortality worldwide. The lack of tumor specificity remains a major drawback for effective chemotherapies and results in dose-limiting toxicities. However, a ligand-mediated drug delivery system should be able to render chemotherapy more specific to tumor cells and less toxic to normal tissues. In this study, we isolated a novel peptide ligand from a phage-displayed peptide library that bound to non-small cell lung cancer (NSCLC) cell lines. The targeting phage bound to several NSCLC cell lines but not to normal cells. Both the targeting phage and the synthetic peptide recognized the surgical specimens of NSCLC with a positive rate of 75% ( 27 of 36 specimens). In severe combined immunodeficiency (SCID) mice bearing NSCLC xenografts, the targeting phage specifically bound to tumor masses. The tumor homing ability of the targeting phage was inhibited by the cognate synthetic peptide, but not by a control or a WTY-mutated peptide. When the targeting peptide was coupled to liposomes carrying doxorubicin or vinorelbine, the therapeutic index of the chemotherapeutic agents and the survival rates of mice with human lung cancer xenografts markedly increased. Furthermore, the targeting liposomes increased drug accumulation in tumor tissues by 5.7-fold compared with free drugs and enhanced cancer cell apoptosis resulting from a higher concentration of bioavailable doxorubicin. The current study suggests that this tumor-specific peptide may be used to create chemotherapies specifically targeting tumor cells in the treatment of NSCLC and to design targeted gene transfer vectors or it may be used one in the diagnosis of this malignancy.	[Chang, De-Kuan; Wu, Chien-Hsun; Wu, Han-Chung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Chang, De-Kuan; Lin, Chin-Tarng; Wu, Han-Chung] Natl Taiwan Univ, Coll Med, Inst Pathol, Taipei, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Chang, DK (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan.	hcw0928@gate.sinica.edu.tw	Wu, Han-Chung/B-1209-2011	Wu, Han-Chung/0000-0002-5185-1169	Academia Sinica [5202402020-0]; National Science Council [NSC-96-2323-B-002-015, NSC96-3114-P-001-006-Y02]	Academia Sinica(Academia Sinica - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by Research Grants from Academia Sinica (#5202402020-0 to HCW) and National Science Council (NSC-96-2323-B-002-015 and NSC96-3114-P-001-006-Y02 to HCW).	Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Allen TM, 2002, NAT REV CANCER, V2, P750, DOI 10.1038/nrc903; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Bosslet K, 1998, CANCER RES, V58, P1195; BOUCHER Y, 1990, CANCER RES, V50, P4478; BOYLE P, 2000, EPIDEMIOLOGY LUNG CA, P13; Chen YC, 2007, CLIN VACCINE IMMUNOL, V14, P404, DOI 10.1128/CVI.00249-06; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Colbern GT, 1999, J LIPOSOME RES, V9, P523, DOI 10.3109/08982109909035551; Dharap SS, 2005, P NATL ACAD SCI USA, V102, P12962, DOI 10.1073/pnas.0504274102; DMello F, 1997, VIROLOGY, V237, P319, DOI 10.1006/viro.1997.8774; Drummond DC, 1999, PHARMACOL REV, V51, P691; Duncan R, 2006, NAT REV CANCER, V6, P688, DOI 10.1038/nrc1958; GABIZON A, 1994, CANCER RES, V54, P987; Gabizon A, 1997, DRUGS, V54, P15, DOI 10.2165/00003495-199700544-00005; Harrington KJ, 2001, CLIN CANCER RES, V7, P243; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Hu W, 2003, LANCET ONCOL, V4, P721, DOI 10.1016/S1470-2045(03)01277-4; HUANG SK, 1992, CANCER RES, V52, P6774; Jain RK, 1996, ANN BIOMED ENG, V24, P457, DOI 10.1007/BF02648108; Jain RK, 2001, ADV DRUG DELIVER REV, V46, P149, DOI 10.1016/S0169-409X(00)00131-9; Kirpotin D, 1997, BIOCHEMISTRY-US, V36, P66, DOI 10.1021/bi962148u; Laginha KM, 2005, CLIN CANCER RES, V11, P6944, DOI 10.1158/1078-0432.CCR-05-0343; Lee TY, 2007, CANCER RES, V67, P10958, DOI 10.1158/0008-5472.CAN-07-2233; Lee TY, 2004, CANCER RES, V64, P8002, DOI 10.1158/0008-5472.CAN-04-1948; LI B, 1995, SCIENCE, V270, P1657, DOI 10.1126/science.270.5242.1657; Liu IJ, 2004, J INFECT DIS, V190, P797, DOI 10.1086/422753; Lo A, 2008, MOL CANCER THER, V7, P579, DOI 10.1158/1535-7163.MCT-07-2359; Marina NM, 2002, CLIN CANCER RES, V8, P413; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Mayer LD, 1997, J PHARMACOL EXP THER, V280, P1406; MINNA JD, 1982, CANCER PRINCIPLES PR, P396; Muggia F, 2001, EUR J CANCER, V37, pS15; PAPAHADJOPOULOS D, 1991, P NATL ACAD SCI USA, V88, P11460, DOI 10.1073/pnas.88.24.11460; Park JW, 2002, BREAST CANCER RES, V4, P93; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Pastorino F, 2006, CANCER RES, V66, P10073, DOI 10.1158/0008-5472.CAN-06-2117; Rajotte D, 1998, J CLIN INVEST, V102, P430, DOI 10.1172/JCI3008; Safra T, 2000, ANN ONCOL, V11, P1029, DOI 10.1023/A:1008365716693; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Schiller JH, 2001, ONCOLOGY-BASEL, V61, P3, DOI 10.1159/000055386; SIEGAL T, 1995, J NEUROSURG, V83, P1029, DOI 10.3171/jns.1995.83.6.1029; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; SPETH PAJ, 1988, CLIN PHARMACOKINET, V15, P15, DOI 10.2165/00003088-198815010-00002; Vaage J, 1997, BRIT J CANCER, V75, P482, DOI 10.1038/bjc.1997.84; Vasey PA, 1999, CLIN CANCER RES, V5, P83; Wu H, 2006, J CANC MOL, V2, P57; Wu HC, 2003, J GEN VIROL, V84, P2771, DOI 10.1099/vir.0.19228-0; YUAN F, 1995, CANCER RES, V55, P3752	49	112	122	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2009	4	1							e4171	10.1371/journal.pone.0004171	http://dx.doi.org/10.1371/journal.pone.0004171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ID	19137069	Green Published, gold			2022-12-25	WOS:000265479500002
J	Palacios, R; Gazave, E; Goni, J; Piedrafita, G; Fernando, O; Navarro, A; Villoslada, P				Palacios, Ricardo; Gazave, Elodie; Goni, Joaquin; Piedrafita, Gabriel; Fernando, Olga; Navarro, Arcadi; Villoslada, Pablo			Allele-Specific Gene Expression Is Widespread Across the Genome and Biological Processes	PLOS ONE			English	Article								Allelic specific gene expression (ASGE) appears to be an important factor in human phenotypic variability and as a consequence, for the development of complex traits and diseases. In order to study ASGE across the human genome, we have performed a study in which genotyping was coupled with an analysis of ASGE by screening 11,500 SNPs using the Mapping 10 K Array to identify differential allelic expression. We found that from the 5,133 SNPs that were suitable for analysis ( heterozygous in our sample and expressed in peripheral blood mononuclear cells), 2,934 (57%) SNPs had differential allelic expression. Such SNPs were equally distributed along human chromosomes and biological processes. We validated the presence or absence of ASGE in 18 out 20 SNPs (90%) randomly selected by real time PCR in 48 human subjects. In addition, we observed that SNPs close to -but not included in- segmental duplications had increased levels of ASGE. Finally, we found that transcripts of unknown function or non-coding RNAs, also display ASGE: from a total of 2,308 intronic SNPs, 1510 (65%) SNPs underwent differential allelic expression. In summary, ASGE is a widespread mechanism in the human genome whose regulation seems to be far more complex than expected.	[Goni, Joaquin; Piedrafita, Gabriel; Villoslada, Pablo] Univ Navarra, Ctr Appl Med Res CIMA, Neuroimmunol Lab, E-31080 Pamplona, Spain; [Gazave, Elodie; Fernando, Olga; Navarro, Arcadi] Univ Pompeu Fabra, Unitat Biol Evolut, Barcelona, Spain; [Goni, Joaquin] Univ Navarra, Dept Phys & Appl Math, E-31080 Pamplona, Spain; [Fernando, Olga] Univ Nova Lisboa, ITQB, P-1200 Lisbon, Portugal; [Navarro, Arcadi] ICREA, Barcelona, Spain; [Navarro, Arcadi] CIBERESP, Barcelona, Spain; [Villoslada, Pablo] Hosp Clin Barcelona, IDIBAPS, Dept Neurol, Barcelona, Spain	University of Navarra; Pompeu Fabra University; University of Navarra; Universidade Nova de Lisboa; ICREA; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Palacios, R (corresponding author), Univ Navarra, Ctr Appl Med Res CIMA, Neuroimmunol Lab, E-31080 Pamplona, Spain.	pvilloslada@clinic.ub.es	Piedrafita, Gabriel/A-4529-2013; Navarro, Arcadi/F-1592-2011; Villoslada, Pablo/AAF-9547-2019	Piedrafita, Gabriel/0000-0001-8701-1084; Navarro, Arcadi/0000-0003-2162-8246; Gazave, Elodie/0000-0002-6972-7051; Villoslada, Pablo/0000-0002-8735-6119	Ministerio de Ciencia y Tecnologia, Spain [BFU2006 15413-C02-01]; National Institute of Bioinformatics; Genoma Espana; Government of Navarra; Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/15856/2005]; Spanish Ministry of Health [FIS PI060117]; CIMA UTE; ICREA Funding Source: Custom	Ministerio de Ciencia y Tecnologia, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Institute of Bioinformatics; Genoma Espana; Government of Navarra; Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); CIMA UTE; ICREA(ICREA)	This work was supported by grants from the Spanish Ministry of Health (FIS PI060117), by the CIMA UTE project to PV, by a grant to A.N. from the Ministerio de Ciencia y Tecnologia (Spain, BFU2006 15413-C02-01) and by the National Institute of Bioinformatics (www.inab.org), a platform of Genoma Espana. JG was supported by the Government of Navarra and OF was supported by a PhD fellowship (SFRH/BD/15856/2005) from the Fundacao para a Ciencia e a Tecnologia, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bray NJ, 2003, AM J HUM GENET, V73, P152, DOI 10.1086/376578; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Constancia M, 1998, GENOME RES, V8, P881, DOI 10.1101/gr.8.9.881; Cowles CR, 2002, NAT GENET, V32, P432, DOI 10.1038/ng992; Craig IW, 2004, ANN HUM GENET, V68, P269, DOI 10.1046/j.1529-8817.2004.00098.x; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Erdmann VA, 2000, NUCLEIC ACIDS RES, V28, P197, DOI 10.1093/nar/28.1.197; Frith MC, 2006, PLOS GENET, V2, P504, DOI 10.1371/journal.pgen.0020023; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Hsu L, 2005, BIOSTATISTICS, V6, P211, DOI 10.1093/biostatistics/kxi004; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Kantarci OH, 2008, ARCH NEUROL-CHICAGO, V65, P349, DOI 10.1001/archneurol.2007.66; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pastinen T, 2005, HUM MOL GENET, V14, P3963, DOI 10.1093/hmg/ddi420; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Yan H, 2002, NAT GENET, V30, P25, DOI 10.1038/ng799; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545	31	43	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4150	10.1371/journal.pone.0004150	http://dx.doi.org/10.1371/journal.pone.0004150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FX	19127300	Green Submitted, Green Published, gold			2022-12-25	WOS:000265473300014
J	Yoder, L				Yoder, Lane			Explicit Logic Circuits Discriminate Neural States	PLOS ONE			English	Article							OPPONENT-COLORS THEORY; QUANTITATIVE ASPECTS; RECEPTIVE-FIELDS; HUE; ODORANTS; NEURONS	The magnitude and apparent complexity of the brain's connectivity have left explicit networks largely unexplored. As a result, the relationship between the organization of synaptic connections and how the brain processes information is poorly understood. A recently proposed retinal network that produces neural correlates of color vision is refined and extended here to a family of general logic circuits. For any combination of high and low activity in any set of neurons, one of the logic circuits can receive input from the neurons and activate a single output neuron whenever the input neurons have the given activity state. The strength of the output neuron's response is a measure of the difference between the smallest of the high inputs and the largest of the low inputs. The networks generate correlates of known psychophysical phenomena. These results follow directly from the most cost-effective architectures for specific logic circuits and the minimal cellular capabilities of excitation and inhibition. The networks function dynamically, making their operation consistent with the speed of most brain functions. The networks show that well-known psychophysical phenomena do not require extraordinarily complex brain structures, and that a single network architecture can produce apparently disparate phenomena in different sensory systems.	Univ Hawaii, Dept Math, Honolulu, HI 96822 USA	University of Hawaii System	Yoder, L (corresponding author), Univ Hawaii, Dept Math, Honolulu, HI 96822 USA.	LDYoder@gmail.com						[Anonymous], 1998, NEURAL NETWORKS BRAI; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; BOYNTON RM, 1965, J OPT SOC AM, V55, P78, DOI 10.1364/JOSA.55.000078; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Eggermann E, 2003, J NEUROSCI, V23, P1557; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Grosch W, 2001, CHEM SENSES, V26, P533, DOI 10.1093/chemse/26.5.533; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; HURVICH LM, 1955, J OPT SOC AM, V45, P602, DOI 10.1364/JOSA.45.000602; JAMESON D, 1955, J OPT SOC AM, V45, P546, DOI 10.1364/JOSA.45.000546; JELLINEK JS, 1979, J SOC COSMET CHEM, V30, P253; KANDEL ER, 2000, PRINCIPLES NEURAL SC, P160; Koch Christof, 1999, P1; KUPFERMANN I, 1969, SCIENCE, V164, P847, DOI 10.1126/science.164.3881.847; LAING DG, 1989, PHYSIOL BEHAV, V46, P809, DOI 10.1016/0031-9384(89)90041-3; LAING DG, 1994, HDB OLFACTION GUSTAT, P283; LAING DG, 1991, HUMAN SENSE SMELL, P246; LANTHORN T, 1984, EXP BRAIN RES, V53, P431; McCulloch W. S., 1943, B MATH BIOPHYS, VBMB-5, P115, DOI DOI 10.1007/BF02478259; MOSKOWITZ HR, 1977, SENS PROCESS, V1, P212; Niimura Y, 2003, P NATL ACAD SCI USA, V100, P12235, DOI 10.1073/pnas.1635157100; Purdy DM, 1931, AM J PSYCHOL, V43, P541, DOI 10.2307/1415157; VONBEZOLD W, 1873, ANN PHYS CHEM, V150, P221; Wiltrout C, 2003, BEHAV NEUROSCI, V117, P236, DOI 10.1037/0735-7044.117.2.236; Yoder L, 2005, COLOR RES APPL, V30, P252, DOI 10.1002/col.20121; ZADEH LA, 1962, P IRE, V50, P856, DOI 10.1109/JRPROC.1962.288302	28	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4154	10.1371/journal.pone.0004154	http://dx.doi.org/10.1371/journal.pone.0004154			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FX	19127299	Green Published, gold, Green Submitted			2022-12-25	WOS:000265473300017
J	Renko, K; Hofmann, PJ; Stoedter, M; Hollenbach, B; Behrends, T; Kohrle, J; Schweizer, U; Schomburg, L				Renko, Kostja; Hofmann, Peter J.; Stoedter, Mette; Hollenbach, Birgit; Behrends, Thomas; Koehrle, Josef; Schweizer, Ulrich; Schomburg, Lutz			Down-regulation of the hepatic selenoprotein biosynthesis machinery impairs selenium metabolism during the acute phase response in mice	FASEB JOURNAL			English	Article						trace element; LPS; translation; transport; critical illness	REAL-TIME PCR; EXPRESSION; LIVER; SELENOCYSTEINE; SEPSIS; PLASMA; GENE; SUPPLEMENTATION; CYTOKINES; KIDNEY	The acute-phase response (APR) is characterized by an impaired metabolism of the essential trace element selenium (Se). Moreover, low-Se concentrations correlate to mortality risk in sepsis. Therefore, we analyzed the expression of the central Se transport and storage protein selenoprotein P (Sepp1) during an APR in mice. Serum Se and Sepp1 concentrations declined in parallel after injection of lipopolysaccharide to 50 and 39% of control-injected littermates, respectively. This negative APR proceeded largely independent from hepatic Sepp1 transcript concentrations. Instead, we identified a set of hepatic transcripts involved in Se metabolism, which declined coordinately during the APR, including the selenocysteine-specific elongation factor (EFsec), selenophosphate-synthetase 2 (Sephs2), selenocysteine-tRNA[Ser]Sec synthase (SecS), and phosphoseryl-tRNA[Ser]Sec kinase (Pstk). Pstk reacted most strongly and qualified as a new limiting factor for Sepp1 biosynthesis in siRNA-mediated knockdown experiments in hepatocytes in culture. Analogous experiments were performed with mice transgenic for hepatocyte-specific human Sepp1 cDNA to verify this hypothesis. Similar kinetics and effect sizes of Sepp1 expression were observed as before in wild-type mice. We conclude that hepatic translation of Sepp1 mRNA is specifically impaired during the APR. This deficit disrupts regular Se metabolism, transport, and supply to peripheral tissues and likely aggravates the pathological status.-Renko, K., Hofmann, P. J., Stoedter, M., Hollenbach, B., Behrends, T., Kohrle, J., Schweizer, U., Schomburg, L. Down-regulation of the hepatic selenoprotein biosynthesis machinery impairs selenium metabolism during the acute phase response in mice. FASEB J. 23, 1758-1765 (2009)	[Renko, Kostja; Hofmann, Peter J.; Stoedter, Mette; Hollenbach, Birgit; Behrends, Thomas; Koehrle, Josef; Schweizer, Ulrich; Schomburg, Lutz] Charite, Inst Expt Endocrinol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schomburg, L (corresponding author), Charite, Inst Expt Endocrinol, Augustenburger Pl 1, D-13353 Berlin, Germany.	lutz.schomburg@charite.de	Schomburg, Lutz/D-8096-2013; Köhrle, Josef/AAH-6438-2020; Schweizer, Ulrich/E-8105-2013	Schomburg, Lutz/0000-0001-9445-1555; Köhrle, Josef/0000-0002-9187-9078; Schweizer, Ulrich/0000-0003-1380-4780	Deutsche Forschungsgemeinschaft DFG [Scho849/2-2, GraKo1208]; Charite Berlin; Deutsche Krebshilfe [10-1792SchoII]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Charite Berlin; Deutsche Krebshilfe(Deutsche Krebshilfe)	Financial support was provided by the Deutsche Forschungsgemeinschaft DFG (Scho849/2-2, GraKo1208), Charite Berlin (personal grant to L.S.), and Deutsche Krebshilfe (10-1792SchoII). The excellent technical assistance of Silke Kappler, Katja Schreiber, and Vartiter Seher is gratefully acknowledged.	Agay D, 2005, BURNS, V31, P366, DOI 10.1016/j.burns.2004.11.010; Angstwurm MWA, 2007, CRIT CARE MED, V35, P118, DOI 10.1097/01.CCM.0000251124.83436.0E; Angstwurm MWA, 1999, CRIT CARE MED, V27, P1807, DOI 10.1097/00003246-199909000-00017; Arthur JR, 2003, J NUTR, V133, p1457S, DOI 10.1093/jn/133.5.1457S; Becker S, 2006, BIOCHEM BIOPH RES CO, V339, P833, DOI 10.1016/j.bbrc.2005.11.105; BERGER MM, 1992, CLIN NUTR, V11, P75, DOI 10.1016/0261-5614(92)90014-H; Berry MJ, 2001, BIOFACTORS, V14, P17, DOI 10.1002/biof.5520140104; Broome CS, 2004, AM J CLIN NUTR, V80, P154; Burk RF, 2005, ANNU REV NUTR, V25, P215, DOI 10.1146/annurev.nutr.24.012003.132120; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; Carlson BA, 2004, J BIOL CHEM, V279, P8011, DOI 10.1074/jbc.M310470200; Deicher R, 2006, EUR J CLIN INVEST, V36, P301, DOI 10.1111/j.1365-2362.2006.01633.x; Dreher I, 1997, J BIOL CHEM, V272, P29364, DOI 10.1074/jbc.272.46.29364; Dumitrescu AM, 2005, NAT GENET, V37, P1247, DOI 10.1038/ng1654; Forceville X, 1998, CRIT CARE MED, V26, P1536, DOI 10.1097/00003246-199809000-00021; Gao Y, 2006, CYTOKINE, V33, P246, DOI 10.1016/j.cyto.2006.02.005; Gromer S, 2005, CELL MOL LIFE SCI, V62, P2414, DOI 10.1007/s00018-005-5143-y; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; HAWKER FH, 1990, CRIT CARE MED, V18, P442, DOI 10.1097/00003246-199004000-00020; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Hollenbach B, 2008, J TRACE ELEM MED BIO, V22, P24, DOI 10.1016/j.jtemb.2007.11.003; Hurwitz BE, 2007, ARCH INTERN MED, V167, P148, DOI 10.1001/archinte.167.2.148; Maehira F, 2002, CLIN CHIM ACTA, V316, P137, DOI 10.1016/S0009-8981(01)00744-6; Mishra V, 2007, CLIN NUTR, V26, P41, DOI 10.1016/j.clnu.2006.10.003; Nichol C, 1998, CLIN CHEM, V44, P1764; Olson GE, 2008, J BIOL CHEM, V283, P6854, DOI 10.1074/jbc.M709945200; Olson GE, 2007, J BIOL CHEM, V282, P12290, DOI 10.1074/jbc.M611403200; Papp LV, 2006, MOL CELL BIOL, V26, P4895, DOI 10.1128/MCB.02284-05; Pattyn F, 2006, NUCLEIC ACIDS RES, V34, pD684, DOI 10.1093/nar/gkj155; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Powell-Tuck J, 2007, P NUTR SOC, V66, P16, DOI 10.1017/S0029665107005253; Rayman MP, 2002, P NUTR SOC, V61, P203, DOI 10.1079/PNS2002153; Reddi AS, 2001, KIDNEY INT, V59, P1342, DOI 10.1046/j.1523-1755.2001.0590041342.x; Renko K, 2008, BIOCHEM J, V409, P741, DOI 10.1042/BJ20071172; Riese C, 2006, ENDOCRINOLOGY, V147, P5883, DOI 10.1210/en.2006-0689; Sattar N, 1997, ANN CLIN BIOCHEM, V34, P437, DOI 10.1177/000456329703400419; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Schomburg L, 2007, CRIT CARE MED, V35, P995, DOI 10.1097/01.CCM.0000257479.88792.A5; Schweizer U, 2005, BIOCHEM J, V386, P221, DOI 10.1042/BJ20041973; Squires JE, 2007, MOL CELL BIOL, V27, P7848, DOI 10.1128/MCB.00793-07; Stamoulis I, 2007, DIGEST DIS SCI, V52, P1595, DOI 10.1007/s10620-006-9462-0; Xu XM, 2005, J BIOL CHEM, V280, P41568, DOI 10.1074/jbc.M506696200; Xu XM, 2007, BIOCHEM J, V404, P115, DOI 10.1042/BJ20070165	43	113	118	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1758	1765		10.1096/fj.08-119370	http://dx.doi.org/10.1096/fj.08-119370			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19136613				2022-12-25	WOS:000266652400016
J	Couturier, J; Koh, CS; Zaffagnini, M; Winger, AM; Gualberto, JM; Corbier, C; Decottignies, P; Jacquot, JP; Lemaire, SD; Didierjean, C; Rouhier, N				Couturier, Jeremy; Koh, Cha San; Zaffagnini, Mirko; Winger, Alison M.; Gualberto, Jose Manuel; Corbier, Catherine; Decottignies, Paulette; Jacquot, Jean-Pierre; Lemaire, Stephane D.; Didierjean, Claude; Rouhier, Nicolas			Structure-Function Relationship of the Chloroplastic Glutaredoxin S12 with an Atypical WCSYS Active Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR SOLUTION STRUCTURE; ESCHERICHIA-COLI GLUTAREDOXIN; IRON-SULFUR CLUSTER; MIXED DISULFIDE; BIOCHEMICAL-CHARACTERIZATION; MONOTHIOL GLUTAREDOXINS; PLANT GLUTAREDOXIN; THIOREDOXIN; PROTEIN; BINDING	Glutaredoxins (Grxs) are efficient catalysts for the reduction of mixed disulfides in glutathionylated proteins, using glutathione or thioredoxin reductases for their regeneration. Using GFP fusion, we have shown that poplar GrxS12, which possesses a monothiol (WCSYS32)-W-28 active site, is localized in chloroplasts. In the presence of reduced glutathione, the recombinant protein is able to reduce in vitro substrates, such as hydroxyethyldisulfide and dehydroascorbate, and to regenerate the glutathionylated glyceraldehyde-3-phosphate dehydrogenase. Although the protein possesses two conserved cysteines, it is functioning through a monothiol mechanism, the conserved C terminus cysteine (Cys(87)) being dispensable, since the C87S variant is fully active in all activity assays. Biochemical and crystallographic studies revealed that Cys(87) exhibits a certain reactivity, since its pK(a) is around 5.6. Coupled with thiol titration, fluorescence, and mass spectrometry analyses, the resolution of poplar GrxS12 x-ray crystal structure shows that the only oxidation state is a glutathionylated derivative of the active site cysteine (Cys(29)) and that the enzyme does not form inter-or intramolecular disulfides. Contrary to some plant Grxs, GrxS12 does not incorporate an iron-sulfur cluster in its wild-type form, but when the active site is mutated into YCSYS, it binds a [2Fe-2S] cluster, indicating that the single Trp residue prevents this incorporation.	[Koh, Cha San; Didierjean, Claude] Nancy Univ, Fac Sci & Tech, CNRS,UHP, LCM3B,Equipe Biocristallog, F-54506 Vandoeuvre Les Nancy, France; [Couturier, Jeremy; Winger, Alison M.; Jacquot, Jean-Pierre; Rouhier, Nicolas] Nancy Univ, Fac Sci, IFR GEEF 110, Unite Mixte Rech UHP INRA Interact Arbres Microor, F-54506 Vandoeuvre Les Nancy, France; [Zaffagnini, Mirko; Lemaire, Stephane D.] Univ Paris 11, Inst Biotechnol Plantes, F-91405 Orsay, France; [Gualberto, Jose Manuel] CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France; [Corbier, Catherine] Nancy Univ, Fac Sci & Tech, Equipe PB2P, URAFPA, F-54506 Vandoeuvre Les Nancy, France; [Decottignies, Paulette] Univ Paris 11, CNRS, UMR 8619, Inst Biochim & Biophys Mol & Cellulaire, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; INRAE; Universite de Lorraine; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Didierjean, C (corresponding author), Nancy Univ, Fac Sci & Tech, CNRS,UHP, LCM3B,Equipe Biocristallog, BP 239, F-54506 Vandoeuvre Les Nancy, France.	Claude.Didierjean@lcm3b.uhp-nancy.fr; nrouhier@scbiol.uhp-nancy.fr	Gualberto, José/I-5016-2015; Couturier, Jérémy/AAF-6588-2020; Jacquot, Jean-Pierre/A-1571-2012; DIDIERJEAN, Claude/L-1493-2013; Lemaire, Stéphane D/A-3530-2008	Gualberto, José/0000-0002-7296-2618; Couturier, Jérémy/0000-0003-3127-2669; Jacquot, Jean-Pierre/0000-0003-4975-8587; DIDIERJEAN, Claude/0000-0002-3176-8974; Lemaire, Stéphane D/0000-0001-6442-0547; Rouhier, Nicolas/0000-0002-2036-7884; Zaffagnini, Mirko/0000-0001-5115-0859	Agence Nationale de la Recherche [GNP05010G, JC07_204825, JC-45751]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche Grants GNP05010G and JC07_204825 ( to N.R. and J.C.) and Grant JC-45751 ( to M.Z. and S. D. L.).	Aslund F, 1996, J BIOL CHEM, V271, P6736, DOI 10.1074/jbc.271.12.6736; Augusto LA, 2003, BIOCHEMISTRY-US, V42, P3929, DOI 10.1021/bi0268394; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bandyopadhyay S, 2008, EMBO J, V27, P1122, DOI 10.1038/emboj.2008.50; Belli G, 2002, J BIOL CHEM, V277, P37590, DOI 10.1074/jbc.M201688200; BUSHWELLER JH, 1994, J MOL BIOL, V235, P1585, DOI 10.1006/jmbi.1994.1108; BUSHWELLER JH, 1992, BIOCHEMISTRY-US, V31, P9288, DOI 10.1021/bi00153a023; Comini MA, 2008, J BIOL CHEM, V283, P27785, DOI 10.1074/jbc.M802010200; DeLano W, 2002, PYMOL 0 99; Dos Santos CV, 2007, FEBS LETT, V581, P4371, DOI 10.1016/j.febslet.2007.07.081; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng YG, 2006, BIOCHEMISTRY-US, V45, P7998, DOI 10.1021/bi060444t; Fernandes AP, 2005, J BIOL CHEM, V280, P24544, DOI 10.1074/jbc.M500678200; Gama F, 2008, PHYSIOL PLANTARUM, V133, P599, DOI 10.1111/j.1399-3054.2008.01097.x; Hashemy SI, 2007, J BIOL CHEM, V282, P14428, DOI 10.1074/jbc.M700927200; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; Johansson C, 2007, J BIOL CHEM, V282, P3077, DOI 10.1074/jbc.M608179200; Jung CH, 1996, ARCH BIOCHEM BIOPHYS, V335, P61, DOI 10.1006/abbi.1996.0482; Kleywegt GJ, 1997, ACTA CRYSTALLOGR D, V53, P179, DOI 10.1107/S0907444996012279; KRAUSE G, 1991, J BIOL CHEM, V266, P4056; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemaire SD, 2004, PHOTOSYNTH RES, V79, P305, DOI 10.1023/B:PRES.0000017174.60951.74; Lillig CH, 1999, J BIOL CHEM, V274, P7695, DOI 10.1074/jbc.274.12.7695; Mansoor SE, 2004, BIOCHEMISTRY-US, V43, P9426, DOI 10.1021/bi036259m; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Melchers J, 2007, J BIOL CHEM, V282, P8678, DOI 10.1074/jbc.M608140200; Mesecke N, 2008, BIOCHEMISTRY-US, V47, P1452, DOI 10.1021/bi7017865; Morel M, 2008, NEW PHYTOL, V180, P391, DOI 10.1111/j.1469-8137.2008.02498.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NIKKOLA M, 1991, J BIOL CHEM, V266, P16105; Nordstrand K, 1999, J MOL BIOL, V286, P541, DOI 10.1006/jmbi.1998.2444; Nordstrand K, 2000, J MOL BIOL, V303, P423, DOI 10.1006/jmbi.2000.4145; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; Rouhier N, 2004, CELL MOL LIFE SCI, V61, P1266, DOI 10.1007/s00018-004-3410-y; Rouhier N, 2002, FEBS LETT, V511, P145, DOI 10.1016/S0014-5793(01)03302-6; Rouhier N, 2008, ANNU REV PLANT BIOL, V59, P143, DOI 10.1146/annurev.arplant.59.032607.092811; Rouhier N, 2006, J EXP BOT, V57, P1685, DOI 10.1093/jxb/erl001; Rouhier N, 2007, P NATL ACAD SCI USA, V104, P7379, DOI 10.1073/pnas.0702268104; Saviano M, 2000, BIOPOLYMERS, V53, P200, DOI 10.1002/(SICI)1097-0282(200002)53:2<200::AID-BIP10>3.0.CO;2-L; SCHENK PM, 1995, BIOTECHNIQUES, V19, P196; SODANO P, 1991, J MOL BIOL, V221, P1311; Srinivasan U, 1997, BIOCHEMISTRY-US, V36, P3199, DOI 10.1021/bi962017t; Su D, 2007, BIOCHEMISTRY-US, V46, P6903, DOI 10.1021/bi700152b; Sun CH, 1998, J MOL BIOL, V280, P687, DOI 10.1006/jmbi.1998.1913; Tamarit J, 2003, J BIOL CHEM, V278, P25745, DOI 10.1074/jbc.M303477200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; XIA TH, 1992, PROTEIN SCI, V1, P310; Yang YW, 1998, BIOCHEMISTRY-US, V37, P17145, DOI 10.1021/bi9806504; Zaffagnini M, 2008, J BIOL CHEM, V283, P8868, DOI 10.1074/jbc.M709567200; Zaffagnini M, 2007, FEBS J, V274, P212, DOI 10.1111/j.1742-4658.2006.05577.x	52	71	71	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9299	9310		10.1074/jbc.M807998200	http://dx.doi.org/10.1074/jbc.M807998200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19158074	hybrid, Green Published			2022-12-25	WOS:000264669100036
J	Duan, XY; Yang, Y; Chen, YH; Arenz, J; Rangi, GK; Zhao, XL; Ye, H				Duan, Xinyuan; Yang, Yan; Chen, Yu-Hung; Arenz, Jacqueline; Rangi, Gurdish K.; Zhao, Xiaolan; Ye, Hong			Architecture of the Smc5/6 Complex of Saccharomyces cerevisiae Reveals a Unique Interaction between the Nse5-6 Subcomplex and the Hinge Regions of Smc5 and Smc6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; DNA-REPAIR COMPLEX; SUMO LIGASE; YEAST; CHROMOSOME; PROTEINS; DAMAGE; SEGREGATION; COMPONENT; KLEISIN	The evolutionarily conserved structural maintenance of chromosome (SMC) proteins forms the core structures of three multisubunit complexes as follows: cohesin, condensin, and the Smc5/6 complex. These complexes play crucial roles in different aspects of chromosomal organization, duplication, and segregation. Although the architectures of cohesin and condensin are better understood, that of the more recently identified Smc5/6 complex remains to be elucidated. We have previously shown that the Smc5/6 complex of Saccharomyces cerevisiae contains Smc5, Smc6, and six non-SMC elements (Nse1-6). In this study, we investigated the architecture of the budding yeast Smc5/6 complex employing the yeast two-hybrid assay as well as in vitro biochemical approaches using purified recombinant proteins. These analyses revealed that Smc5 and Smc6 associate with each other at their hinge regions and constitute the backbone of the complex, whereas the Nse1-6 subunits form three distinct subcomplexes/entities that interact with different regions of Smc5 and Smc6. The Nse1, -3, and -4 subunits form a stable subcomplex that binds to the head and the adjacent coiled-coil region of Smc5. Nse2 binds to the middle of the coiled-coil region of Smc5. Nse5 and Nse6 interact with each other and, as a heterodimer, bind to the hinge regions of Smc5 and Smc6. These findings provide new insights into the structures of the Smc5/6 complex and lay the foundation for further investigations into the mechanism of its functions.	[Yang, Yan; Chen, Yu-Hung; Arenz, Jacqueline; Zhao, Xiaolan] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Duan, Xinyuan; Rangi, Gurdish K.; Ye, Hong] Univ Louisville, James Graham Brown Canc Ctr, Sch Med, Louisville, KY 40202 USA; [Chen, Yu-Hung] Cornell Univ, Grad Sch Med Sci, Program Biochem, New York, NY 10021 USA; [Chen, Yu-Hung] Cornell Univ, Grad Sch Med Sci, Program Cell, New York, NY 10021 USA; [Chen, Yu-Hung] Cornell Univ, Grad Sch Med Sci, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; University of Louisville; Cornell University; Cornell University; Cornell University	Zhao, XL (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA.	zhaox1@mskcc.org; hong.ye@louisville.edu		Zhao, Xiaolan/0000-0002-8302-6905	National Institutes of Health [R01GM079516, R01GM080670]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080670, R01GM079516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM079516 (toH.Y.), R01GM080670 (to X.Z.), and 5P20 RR 018733 ( Center of Biomedical Research Excellence in Molecular Targets grant to the James Graham Brown Cancer Center at the University of Louisville in Kentucky). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alber F, 2008, ANNU REV BIOCHEM, V77, P443, DOI 10.1146/annurev.biochem.77.060407.135530; Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Beasley M, 2002, GENOME RES, V12, P1201, DOI 10.1101/gr107302; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; Cobbe N, 2004, MOL BIOL EVOL, V21, P332, DOI 10.1093/molbev/msh023; Cost GJ, 2006, GENETICS, V172, P2185, DOI 10.1534/genetics.105.053876; Golemis E A, 1997, Methods Mol Biol, V63, P197; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hu B, 2005, MOL MICROBIOL, V55, P1735, DOI 10.1111/j.1365-2958.2005.04531.x; Jaspersen SL, 2004, ANNU REV CELL DEV BI, V20, P1, DOI 10.1146/annurev.cellbio.20.022003.114106; Lee KM, 2006, DNA REPAIR, V5, P138, DOI 10.1016/j.dnarep.2005.08.003; Lehmann AR, 2005, DNA REPAIR, V4, P309, DOI 10.1016/j.dnarep.2004.07.009; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Mc Intyre J, 2007, EMBO J, V26, P3783, DOI 10.1038/sj.emboj.7601793; Murray JM, 2008, NAT REV MOL CELL BIO, V9, P177, DOI 10.1038/nrm2309; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Palecek J, 2006, J BIOL CHEM, V281, P36952, DOI 10.1074/jbc.M608004200; Pebernard S, 2006, MOL CELL BIOL, V26, P1617, DOI 10.1128/MCB.26.5.1617-1630.2006; Pebernard S, 2008, EMBO J, V27, P3011, DOI 10.1038/emboj.2008.220; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; Sergeant J, 2005, MOL CELL BIOL, V25, P172, DOI 10.1128/MCB.25.1.172-184.2005; Strom L, 2007, CURR OPIN CELL BIOL, V19, P344, DOI 10.1016/j.ceb.2007.04.003; Taylor EM, 2008, MOL CELL BIOL, V28, P1197, DOI 10.1128/MCB.00767-07; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	30	67	67	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8507	8515		10.1074/jbc.M809139200	http://dx.doi.org/10.1074/jbc.M809139200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19141609	hybrid, Green Published			2022-12-25	WOS:000264397800035
J	Fukushima, K; Matsumura, I; Ezoe, S; Tokunaga, M; Yasumi, M; Satoh, Y; Shibayama, H; Tanaka, H; Iwama, A; Kanakura, Y				Fukushima, Kentaro; Matsumura, Itaru; Ezoe, Sachiko; Tokunaga, Masahiro; Yasumi, Masato; Satoh, Yusuke; Shibayama, Hirohiko; Tanaka, Hirokazu; Iwama, Atsushi; Kanakura, Yuzuru			FIP1L1-PDGFR alpha Imposes Eosinophil Lineage Commitment on Hematopoietic Stem/Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; CYTOKINE-DEPENDENT GROWTH; ACTIVATED PROTEIN-KINASE; PROTOONCOGENE C-KIT; HYPEREOSINOPHILIC SYNDROME; RECEPTOR-ALPHA; IN-VIVO; CATALYTIC DOMAIN; FUSION GENE; STEM-CELLS	Although leukemogenic tyrosine kinases (LTKs) activate a common set of downstream molecules, the phenotypes of leukemia caused by LTKs are rather distinct. Here we report the molecular mechanism underlying the development of hypereosinophilic syndrome/chronic eosinophilic leukemia by FIP1L1-PDGFR alpha. When introduced into c-Kit(high)Sca-1(+)Lineage(-) cells, FIP1L1-PDGFR alpha conferred cytokine-independent growth on these cells and enhanced their self-renewal, whereas it did not immortalize common myeloid progenitors in in vitro replating assays and transplantation assays. Importantly, FIP1L1-PDGFR alpha but not TEL-PDGFR beta enhanced the development of Gr-1(+)IL-5R alpha(+) eosinophil progenitors from c-Kit(high)Sca-1(+)Lineage(-) cells. FIP1L1-PDGFR alpha also promoted eosinophil development from common myeloid progenitors. Furthermore, when expressed in megakaryocyte/erythrocyte progenitors and common lymphoid progenitors, FIP1L1-PDGFR alpha not only inhibited differentiation toward erythroid cells, megakaryocytes, and B-lymphocytes but aberrantly developed eosinophil progenitors from megakaryocyte/erythrocyte progenitors and common lymphoid progenitors. As for the mechanism of FIP1L1-PDGFR alpha-induced eosinophil development, FIP1L1-PDGFR alpha was found to more intensely activate MEK1/2 and p38MAPK than TEL-PDGFR beta. In addition, a MEK1/2 inhibitor and a p38MAPK inhibitor suppressed FIP1L1-PDGFR alpha-promoted eosinophil development. Also, reverse transcription-PCR analysis revealed that FIP1L1-PDGFR alpha augmented the expression of C/EBP alpha, GATA-1, and GATA-2, whereas it hardly affected PU.1 expression. In addition, short hairpin RNAs against C/EBP alpha and GATA-2 and GATA-3KRR, which can act as a dominant-negative form over all GATA members, inhibited FIP1L1-PDGFR alpha-induced eosinophil development. Furthermore, FIP1L1-PDGFR alpha and its downstream Ras inhibited PU.1 activity in luciferase assays. Together, these results indicate that FIP1L1-PDGFR alpha enhances eosinophil development by modifying the expression and activity of lineage-specific transcription factors through Ras/MEK and p38MAPK cascades.	[Fukushima, Kentaro; Matsumura, Itaru; Ezoe, Sachiko; Tokunaga, Masahiro; Yasumi, Masato; Satoh, Yusuke; Shibayama, Hirohiko; Tanaka, Hirokazu; Kanakura, Yuzuru] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka 5650871, Japan; [Ezoe, Sachiko] Osaka Univ Hosp, Med Ctr Translat Res, Suita, Osaka 5650871, Japan; [Iwama, Atsushi] Chiba Univ, Grad Sch Med, Chiba 2608670, Japan	Osaka University; Osaka University; Chiba University	Ezoe, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	sezoe@bldon.med.osaka-u.ac.jp			Ministry of Education, Science, Sports, and Culture and Technology of Japan	Ministry of Education, Science, Sports, and Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Science, Sports, and Culture and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abkowitz JL, 2000, BLOOD, V96, P3399, DOI 10.1182/blood.V96.10.3399.h8003399_3399_3405; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Arcasoy MO, 2001, EUR J HAEMATOL, V67, P77, DOI 10.1034/j.1600-0609.2001.t01-1-00491.x; Bene MC, 1998, BLOOD, V92, P596, DOI 10.1182/blood.V92.2.596.414k05_596_599; Blair A, 1998, BLOOD, V92, P4325, DOI 10.1182/blood.V92.11.4325; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Buitenhuis M, 2008, BLOOD, V111, P112, DOI 10.1182/blood-2006-07-037572; Buitenhuis N, 2007, CANCER RES, V67, P3759, DOI 10.1158/0008-5472.CAN-06-4183; Capovilla M, 2008, EUR J HAEMATOL, V80, P81, DOI 10.1111/j.1600-0609.2007.00973.x; Cools J, 2003, CANCER CELL, V3, P459, DOI 10.1016/S1535-6108(03)00108-9; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Doornbos RP, 1999, J BIOL CHEM, V274, P8589, DOI 10.1074/jbc.274.13.8589; Du J, 2002, J BIOL CHEM, V277, P43481, DOI 10.1074/jbc.M204777200; Duan W, 2004, J IMMUNOL, V172, P7053, DOI 10.4049/jimmunol.172.11.7053; Ezoe S, 2005, J BIOL CHEM, V280, P13163, DOI 10.1074/jbc.M413461200; Ezoe S, 2002, BLOOD, V100, P3512, DOI 10.1182/blood-2002-04-1177; Fritsche-Polanz R, 2001, BRIT J HAEMATOL, V113, P357, DOI 10.1046/j.1365-2141.2001.02783.x; FURITSU T, 1993, J CLIN INVEST, V92, P1736, DOI 10.1172/JCI116761; Griffin JH, 2003, P NATL ACAD SCI USA, V100, P7830, DOI 10.1073/pnas.0932698100; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; HOHAUS S, 1995, MOL CELL BIOL, V15, P5830; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Hsu CL, 2007, BLOOD, V110, P1420, DOI 10.1182/blood-2007-02-071761; Huang S, 1999, BLOOD, V94, P2595, DOI 10.1182/blood.V94.8.2595.420k37_2595_2604; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; IKEDA H, 1991, BLOOD, V78, P2962; Iwasaki H, 2005, J EXP MED, V201, P1891, DOI 10.1084/jem.20050548; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Jovanovic JV, 2007, BLOOD, V109, P4635, DOI 10.1182/blood-2006-10-050054; Kampen GT, 2000, BLOOD, V95, P1911, DOI 10.1182/blood.V95.6.1911; Klion AD, 2003, BLOOD, V101, P4660, DOI 10.1182/blood-2003-01-0006; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; La Starza R, 2005, HAEMATOLOGICA, V90, P596; Levis M, 2001, BLOOD, V98, P885, DOI 10.1182/blood.V98.3.885; Longley BJ, 1999, P NATL ACAD SCI USA, V96, P1609, DOI 10.1073/pnas.96.4.1609; Longley BJ, 1996, NAT GENET, V12, P312, DOI 10.1038/ng0396-312; Matsumura I, 2000, BLOOD, V96, P2440; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; McNagny K, 2002, J EXP MED, V195, pf43, DOI 10.1084/jem.20020636; McNagny KM, 2003, BLOOD, V101, P1103, DOI 10.1182/blood-2002-04-1050; McPherson T, 2006, BRIT J DERMATOL, V155, P824, DOI 10.1111/j.1365-2133.2006.07416.x; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Okitsu Y, 2007, BIOCHEM BIOPH RES CO, V364, P383, DOI 10.1016/j.bbrc.2007.10.031; Ono R, 2005, MOL CELL BIOL, V25, P10965, DOI 10.1128/MCB.25.24.10965-10978.2005; Querfurth E, 2000, GENE DEV, V14, P2515, DOI 10.1101/gad.177200; Radomska HS, 2006, J EXP MED, V203, P371, DOI 10.1084/jem.20052242; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Robyn J, 2006, BRIT J HAEMATOL, V132, P286, DOI 10.1111/j.1365-2141.2005.05863.x; Roufosse F, 2003, ANNU REV MED, V54, P169, DOI 10.1146/annurev.med.54.101601.152431; Roufosse FE, 2003, NEW ENGL J MED, V348, P2687; Segawa K, 2009, J ENDOCRINOL, V200, P107, DOI 10.1677/JOE-08-0376; Semerad CL, 1999, IMMUNITY, V11, P153, DOI 10.1016/S1074-7613(00)80090-4; Simon HU, 1999, NEW ENGL J MED, V341, P1112, DOI 10.1056/NEJM199910073411503; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; SMITH VM, 1995, J BIOL CHEM, V270, P1515, DOI 10.1074/jbc.270.4.1515; Stover EH, 2005, BLOOD, V106, P3206, DOI 10.1182/blood-2005-05-1932; Stover EH, 2006, P NATL ACAD SCI USA, V103, P8078, DOI 10.1073/pnas.0601192103; Sutherland HJ, 1996, BLOOD, V87, P4754, DOI 10.1182/blood.V87.11.4754.bloodjournal87114754; Tanaka H, 2006, STEM CELLS, V24, P2592, DOI 10.1634/stemcells.2005-0434; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Wong CK, 2002, CLIN EXP IMMUNOL, V128, P483, DOI 10.1046/j.1365-2249.2002.01880.x; Yamada Y, 2006, BLOOD, V107, P4071, DOI 10.1182/blood-2005-08-3153; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	69	27	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7719	7732		10.1074/jbc.M807489200	http://dx.doi.org/10.1074/jbc.M807489200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19147501	Green Published, hybrid			2022-12-25	WOS:000264195600034
J	Murata, T; Sato, Y; Nakayama, S; Kudoh, A; Iwahori, S; Isomura, H; Tajima, M; Hishiki, T; Ohshima, T; Hijikata, M; Shimotohno, K; Tsurumi, T				Murata, Takayuki; Sato, Yoshitaka; Nakayama, Sanae; Kudoh, Ayumi; Iwahori, Satoko; Isomura, Hiroki; Tajima, Masako; Hishiki, Takayuki; Ohshima, Takayuki; Hijikata, Makoto; Shimotohno, Kunitada; Tsurumi, Tatsuya			TORC2, a Coactivator of cAMP-response Element-binding Protein, Promotes Epstein-Barr Virus Reactivation from Latency through Interaction with Viral BZLF1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG TERMINAL REPEAT; SWITCH GENE BZLF1; LYTIC SWITCH; SIGNAL-TRANSDUCTION; CYCLOSPORINE-A; CELL-LINE; CREB; REPLICATION; IDENTIFICATION; TRANSCRIPTION	Reactivation of the Epstein-Barr virus from latency is dependent on expression of the viral BZLF1 protein. The BZLF1 promoter (Zp) normally exhibits only low basal activity but is activated in response to chemical inducers such as 12-O-tetradecanoylphorbol-13-acetate and calcium ionophore. We found here that Transducer of Regulated cAMP-response Element-binding Protein (CREB) (TORC) 2 enhances Zp activity 10-fold and more than 100-fold with co-expression of the BZLF1 protein. Mutational analysis of Zp revealed that the activation by TORC is dependent on ZII and ZIII cis elements, binding sites for CREB family transcriptional factors and the BZLF1 protein, respectively. Immunoprecipitation, chromatin immunoprecipitation, and reporter assay using Gal4-luc and Gal4BD-BZLF1 fusion protein indicate that TORC2 interacts with BZLF1, and that the complex is efficiently recruited onto Zp. These observations clearly indicate that TORC2 activates the promoter through interaction with the BZLF1 protein as well as CREB family transcriptional factors. Induction of the lytic replication resulted in the translocation of TORC2 from cytoplasm to viral replication compartments in nuclei, and furthermore, activation of Zp by TORC2 was augmented by calcium-regulated phosphatase, calcineurin. Silencing of endogenous TORC2 gene expression by RNA interference decreased the levels of the BZLF1 protein in response to 12-O-tetradecanoylphorbol-13-acetate/ionophore. Based on these results, we conclude that Epstein-Barr virus exploits the calcineurin-TORC signaling pathway through interactions between TORC and the BZLF1 protein in reactivation from latency.	[Murata, Takayuki; Sato, Yoshitaka; Nakayama, Sanae; Kudoh, Ayumi; Iwahori, Satoko; Isomura, Hiroki; Tsurumi, Tatsuya] Aichi Canc Ctr, Res Inst, Div Virol, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Hishiki, Takayuki] Teikyo Univ, Sch Med, Cent Clin Lab, Tokyo 1730003, Japan; [Hishiki, Takayuki; Shimotohno, Kunitada] Chiba Inst Technol, Res Inst, Chiba 2750016, Japan; [Hishiki, Takayuki; Shimotohno, Kunitada] Keio Univ, Sch Med, Ctr Integrated Med Res, Shinjuku Ku, Tokyo 1608582, Japan; [Hishiki, Takayuki; Ohshima, Takayuki] Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Sakyo Ku, Kyoto 6068507, Japan	Aichi Cancer Center; Teikyo University; Chiba Institute of Technology; Keio University; Kyoto University	Tsurumi, T (corresponding author), Aichi Canc Ctr, Res Inst, Div Virol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	ttsurumi@aichi-cc.jp	Iwahori, Satoko/L-1948-2019; Sato, Yoshitaka/P-9728-2015; Murata, Takayuki/I-2621-2013	Sato, Yoshitaka/0000-0002-8541-6413; Murata, Takayuki/0000-0001-7228-0839; OHSHIMA, Takayuki/0000-0002-1501-6430	Ministry of Education, Science, Sports, Culture, and Technology of Japan [20012056, 19041078, 20390137, 20790362]	Ministry of Education, Science, Sports, Culture, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for Scientific Research from Ministry of Education, Science, Sports, Culture, and Technology of Japan Grants 20012056, 19041078, and 20390137 (to T. T.) and 20790362 (to T. M.).	Adamson AL, 1999, J VIROL, V73, P6551, DOI 10.1128/JVI.73.8.6551-6558.1999; Amon W, 2005, REV MED VIROL, V15, P149, DOI 10.1002/rmv.456; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Bryant H, 2002, J VIROL, V76, P10290, DOI 10.1128/JVI.76.20.10290-10298.2002; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Daikoku T, 2006, J BIOL CHEM, V281, P11422, DOI 10.1074/jbc.M510314200; Daikoku T, 2005, J VIROL, V79, P3409, DOI 10.1128/JVI.79.6.3409-3418.2005; Daikoku T, 2004, J BIOL CHEM, V279, P54817, DOI 10.1074/jbc.M405911200; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; Deng Z, 2001, J VIROL, V75, P10334, DOI 10.1128/JVI.75.21.10334-10347.2001; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Ego T, 2005, ONCOGENE, V24, P1914, DOI 10.1038/sj.onc.1208394; FLEMINGTON E, 1990, J VIROL, V64, P1217, DOI 10.1128/JVI.64.3.1217-1226.1990; FLEMINGTON E, 1990, J VIROL, V64, P1227, DOI 10.1128/JVI.64.3.1227-1232.1990; GOLDFELD AE, 1995, VIROLOGY, V209, P225, DOI 10.1006/viro.1995.1247; Gruffat H, 2002, EMBO REP, V3, P141, DOI 10.1093/embo-reports/kvf031; Hishiki T, 2007, J BIOL CHEM, V282, P28335, DOI 10.1074/jbc.M702656200; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Kanamori M, 2000, VIRUS GENES, V20, P117, DOI 10.1023/A:1008110312661; Koga H, 2004, J BIOL CHEM, V279, P52978, DOI 10.1074/jbc.M409021200; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kudoh A, 2005, J BIOL CHEM, V280, P8156, DOI 10.1074/jbc.M411405200; Kudoh A, 2003, J VIROL, V77, P851, DOI 10.1128/JVI.77.2.851-861.2003; Kuraishy AI, 2007, P NATL ACAD SCI USA, V104, P10175, DOI 10.1073/pnas.0704170104; LANG D, 1992, NUCLEIC ACIDS RES, V20, P3287, DOI 10.1093/nar/20.13.3287; Liu PF, 1998, J VIROL, V72, P8230, DOI 10.1128/JVI.72.10.8230-8239.1998; Liu SF, 1997, VIROLOGY, V228, P11, DOI 10.1006/viro.1996.8371; Liu SF, 1997, EMBO J, V16, P143, DOI 10.1093/emboj/16.1.143; MONTALVO EA, 1995, J VIROL, V69, P4158, DOI 10.1128/JVI.69.7.4158-4165.1995; Morrison TE, 2004, VIROLOGY, V328, P219, DOI 10.1016/j.virol.2004.07.020; Murata T, 2006, J BIOL CHEM, V281, P20788, DOI 10.1074/jbc.M600563200; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; RUF IK, 1995, J VIROL, V69, P7648, DOI 10.1128/JVI.69.12.7648-7657.1995; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Siu YT, 2006, J VIROL, V80, P7052, DOI 10.1128/JVI.00103-06; Speck SH, 1997, TRENDS MICROBIOL, V5, P399, DOI 10.1016/S0966-842X(97)01129-3; TAKADA K, 1991, VIRUS GENES, V5, P147, DOI 10.1007/BF00571929; Tatsumi Y, 2006, J CELL SCI, V119, P3128, DOI 10.1242/jcs.03031; TAYLOR N, 1991, J VIROL, V65, P4033, DOI 10.1128/JVI.65.8.4033-4041.1991; Tsurumi T, 2005, REV MED VIROL, V15, P3, DOI 10.1002/rmv.441; Wu FY, 2003, J VIROL, V77, P1481, DOI 10.1128/JVI.77.2.1481-1500.2003; Xu W, 2007, EMBO J, V26, P2890, DOI 10.1038/sj.emboj.7601734; Zerby D, 1999, MOL CELL BIOL, V19, P1617; ZHANG Q, 1994, MOL CELL BIOL, V14, P1929, DOI 10.1128/MCB.14.3.1929	45	32	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8033	8041		10.1074/jbc.M808466200	http://dx.doi.org/10.1074/jbc.M808466200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19164291	Green Published, hybrid			2022-12-25	WOS:000264195600066
J	Wilkinson, TA; Januszyk, K; Phillips, ML; Tekeste, SS; Zhang, M; Miller, JT; Le Grice, SFJ; Clubb, RT; Chow, SA				Wilkinson, Thomas A.; Januszyk, Kurt; Phillips, Martin L.; Tekeste, Shewit S.; Zhang, Min; Miller, Jennifer T.; Le Grice, Stuart F. J.; Clubb, Robert T.; Chow, Samson A.			Identifying and Characterizing a Functional HIV-1 Reverse Transcriptase-binding Site on Integrase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROVIRAL DNA FORMATION; VIRAL NUCLEIC-ACIDS; DOUBLE-STRANDED DNA; PREINTEGRATION COMPLEXES; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; IN-VITRO; NONDIVIDING CELLS; GENETIC-ANALYSIS	Integrase (IN) from human immunodeficiency virus, type 1 (HIV-1) exerts pleiotropic effects in the viral replication cycle. Besides integration, IN mutations can impact nuclear import, viral maturation, and reverse transcription. IN and reverse transcriptase (RT) interact in vitro, and the IN C-terminal domain (CTD) is both necessary and sufficient for binding RT. We used nuclear magnetic resonance spectroscopy to identify a putative RT-binding surface on the IN CTD, and surface plasmon resonance to obtain kinetic parameters and the binding affinity for the IN-RT interaction. An IN K258A substitution that disrupts reverse transcription in infected cells is located at the putative RT-binding surface, and we found that this substitution substantially weakens IN CTD-RT interactions. We also identified two additional IN amino acid substitutions located at the putative RT-binding surface (W243E and V250E) that significantly impair viral replication in tissue culture. These results strengthen the notion that IN-RT interactions are biologically relevant during HIV-1 replication and also provide insights into this interaction at the molecular level.	[Wilkinson, Thomas A.; Tekeste, Shewit S.; Zhang, Min; Chow, Samson A.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Januszyk, Kurt; Phillips, Martin L.; Clubb, Robert T.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Miller, Jennifer T.; Le Grice, Stuart F. J.] NCI, HIV Drug Resistance Program, NIH, Frederick, MD 21702 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chow, SA (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, CHS 23-133,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	schow@mednet.ucla.edu	zhang, min/C-6300-2011		National Institutes of Health [CA68859, AI077386]; UCLA AIDS Institute; UCLA Center for AIDS Researc [AI28697]; State of California Universitywide AIDS Research Program [CC95 LA 137, 05-LA-021]; Intramural Research Program of the Center for Cancer Research; NCI; National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA068859, ZIABC010493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052217, R21AI077386, P30AI028697] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA AIDS Institute; UCLA Center for AIDS Researc; State of California Universitywide AIDS Research Program; Intramural Research Program of the Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants CA68859 and AI077386 (to S. A. C.). This work was also supported by the UCLA AIDS Institute, UCLA Center for AIDS Research (AI28697 to T. A. W.), State of California Universitywide AIDS Research Program Grants CC95 LA 137 (to T. A. W.) and 05-LA-021 (to S. A. C.), and by the Intramural Research Program of the Center for Cancer Research, NCI, National Institutes of Health (to S. F. J. L.).	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Ao ZJ, 2007, J BIOL CHEM, V282, P13456, DOI 10.1074/jbc.M610546200; Appa RS, 2001, J BIOL CHEM, V276, P45848, DOI 10.1074/jbc.M107365200; Brown P. O., 1997, P161; Bukovsky A, 1996, J VIROL, V70, P6820, DOI 10.1128/JVI.70.10.6820-6825.1996; BUKRINSKY MI, 1993, P NATL ACAD SCI USA, V90, P6125, DOI 10.1073/pnas.90.13.6125; Cereseto A, 2005, EMBO J, V24, P3070, DOI 10.1038/sj.emboj.7600770; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Cohn E. J., 1943, PROTEINS AMINO ACIDS, P370; De Luca L, 2003, BIOCHEM BIOPH RES CO, V310, P1083, DOI 10.1016/j.bbrc.2003.09.120; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deprez E, 2000, BIOCHEMISTRY-US, V39, P9275, DOI 10.1021/bi000397j; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; Divita G, 1995, BIOCHEMISTRY-US, V34, P16337, DOI 10.1021/bi00050a014; Dobard CW, 2007, J VIROL, V81, P10037, DOI 10.1128/JVI.00519-07; ELLISON V, 1995, J BIOL CHEM, V270, P3320, DOI 10.1074/jbc.270.7.3320; ENGELMAN A, 1993, EMBO J, V12, P3269, DOI 10.1002/j.1460-2075.1993.tb05996.x; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; FARNET CM, 1991, J VIROL, V65, P1910, DOI 10.1128/JVI.65.4.1910-1915.1991; Farnet CM, 1997, CELL, V88, P483, DOI 10.1016/S0092-8674(00)81888-7; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Gleenberg IO, 2005, J BIOL CHEM, V280, P21987, DOI 10.1074/jbc.M414679200; Hamamoto S, 2006, J VIROL, V80, P5670, DOI 10.1128/JVI.02471-05; Hehl EA, 2004, J VIROL, V78, P5056, DOI 10.1128/JVI.78.10.5056-5067.2004; HEINZINGER NK, 1994, P NATL ACAD SCI USA, V91, P7311, DOI 10.1073/pnas.91.15.7311; Herschhorn A, 2008, BIOCHEM J, V412, P163, DOI 10.1042/BJ20071279; Heuer TS, 1998, BIOCHEMISTRY-US, V37, P6667, DOI 10.1021/bi972949c; Holmes-Son M L, 2001, Adv Genet, V43, P33, DOI 10.1016/S0065-2660(01)43003-3; HU SC, 1986, J VIROL, V60, P267, DOI 10.1128/JVI.60.1.267-274.1986; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Lai LL, 2001, J VIROL, V75, P11365, DOI 10.1128/JVI.75.23.11365-11372.2001; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Leavitt AD, 1996, J VIROL, V70, P721, DOI 10.1128/JVI.70.2.721-728.1996; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; Lian L. Y., 1993, NMR MACROMOLECULES P, P153; Lin CW, 2003, J VIROL, V77, P5030, DOI 10.1128/JVI.77.8.5030-5036.2003; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; LODI PJ, 1995, BIOCHEMISTRY-US, V34, P9826, DOI 10.1021/bi00031a002; Lu R, 2005, J VIROL, V79, P10356, DOI 10.1128/JVI.79.16.10356-10368.2005; Lu R, 2005, J VIROL, V79, P2493, DOI 10.1128/JVI.79.4.2493-2505.2005; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; LUTZKE RAP, 1994, NUCLEIC ACIDS RES, V22, P4125, DOI 10.1093/nar/22.20.4125; MASUDA T, 1995, J VIROL, V69, P6687, DOI 10.1128/JVI.69.11.6687-6696.1995; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; Oz I, 2002, BIOCHEM J, V361, P557, DOI 10.1042/0264-6021:3610557; Padow M, 2003, J VIROL, V77, P11050, DOI 10.1128/JVI.77.20.11050-11059.2003; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Podtelezhnikov AA, 2003, BIOPOLYMERS, V68, P110, DOI 10.1002/bip.10217; Quillent C, 1996, VIROLOGY, V219, P29, DOI 10.1006/viro.1996.0219; RODGERS DW, 1995, P NATL ACAD SCI USA, V92, P1222, DOI 10.1073/pnas.92.4.1222; SHIN CG, 1994, J VIROL, V68, P1633, DOI 10.1128/JVI.68.3.1633-1642.1994; Tasara T, 2001, FEBS LETT, V507, P39, DOI 10.1016/S0014-5793(01)02945-3; Temiz NA, 2002, PROTEINS, V49, P61, DOI 10.1002/prot.10183; Tsurutani N, 2000, J VIROL, V74, P4795, DOI 10.1128/JVI.74.10.4795-4806.2000; VANGENT DC, 1993, EMBO J, V12, P3261, DOI 10.1002/j.1460-2075.1993.tb05995.x; VINK C, 1993, NUCLEIC ACIDS RES, V21, P1419, DOI 10.1093/nar/21.6.1419; Violot S, 2003, J VIROL, V77, P12507, DOI 10.1128/JVI.77.23.12507-12522.2003; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Wu XY, 1999, J VIROL, V73, P2126, DOI 10.1128/JVI.73.3.2126-2135.1999; Zhu K, 2004, J VIROL, V78, P5045, DOI 10.1128/JVI.78.10.5045-5055.2004	65	51	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7931	7939		10.1074/jbc.M806241200	http://dx.doi.org/10.1074/jbc.M806241200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19150986	Green Published, hybrid			2022-12-25	WOS:000264195600055
J	Hou, R; Sibinga, NES				Hou, Rong; Sibinga, Nicholas E. S.			Atrophin Proteins Interact with the Fat1 Cadherin and Regulate Migration and Orientation in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PATHWAY; HISTONE DEACETYLASE; PROTOCADHERIN FAT1; ACTIN DYNAMICS; GENE FAT; DROSOPHILA; GROWTH; TRANSCRIPTION; MORPHOGENESIS; PROLIFERATION	Fat1, an atypical cadherin induced robustly after arterial injury, has significant effects on mammalian vascular smooth muscle cell (VSMC) growth and migration. The related Drosophila protein Fat interacts genetically and physically with Atrophin, a protein essential for development and control of cell polarity. We hypothesized that interactions between Fat1 and mammalian Atrophin (Atr) proteins might contribute to Fat1 effects on VSMCs. Like Fat1, mammalian Atr expression increased after arterial injury and in VSMCs stimulated with growth and chemotactic factors including angiotensin II, basic fibroblast growth factor, and platelet-derived growth factor BB. Two distinct Atr2 transcripts, atr2L and atr2S, were identified by Northern analysis; in VSMCs, atr2S mRNA expression was more responsive to stimuli. By immunocytochemistry, Fat1 and Atrs colocalized at cell-cell junctions, in the perinuclear area, and in the nucleus. In coimmunoprecipitation studies, Fat1 interacted with both Atr1 and Atr2; these interactions required Fat1 amino acids 4300-4400 and an intact Atro-box in the Atrs. Knock-down of Atrs by small interfering RNA did not affect VSMC growth but had complex effects on migration, which was impaired by Atr1 knockdown, enhanced by Atr2 L knockdown, and unchanged when both Atr2S and Atr2L were depleted. Enhanced migration caused by Atr2L knockdown required Fat1 expression. Similarly, orientation of cells after monolayer denudation was impaired in cells with Atr1 knockdown but enhanced in cells selectively depleted of Atr2L. Together these findings suggest that Fat1 and Atrs act in concert after vascular injury but show further that distinct Atr isoforms have disparate effects on VSMC directional migration.	[Sibinga, Nicholas E. S.] Albert Einstein Coll Med, Dept Med, Div Cardiovasc, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Sibinga, NES (corresponding author), Albert Einstein Coll Med, Dept Med, Div Cardiovasc, Forchheimer G46,1300 Morris Pk Ave, Bronx, NY 10461 USA.	nsibinga@aecom.yu.edu	Sibinga, Nicholas/GOJ-8544-2022	Sibinga, Nicholas/0000-0003-4838-910X	NATIONAL CANCER INSTITUTE [R01CA086289] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088104, R01HL067944] Funding Source: NIH RePORTER; NCI NIH HHS [CA086289] Funding Source: Medline; NHLBI NIH HHS [R01 HL088104, HL67944] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Braun GS, 2007, J BIOL CHEM, V282, P22823, DOI 10.1074/jbc.M701758200; BRYANT PJ, 1988, DEV BIOL, V129, P541, DOI 10.1016/0012-1606(88)90399-5; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Castillejo-Lopez C, 2004, J BIOL CHEM, V279, P24034, DOI 10.1074/jbc.M313878200; Charroux B, 2006, DEV BIOL, V291, P278, DOI 10.1016/j.ydbio.2005.12.012; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Ciani L, 2003, MOL CELL BIOL, V23, P3575, DOI 10.1128/MCB.23.10.3575-3582.2003; Erkner A, 2002, DEVELOPMENT, V129, P1119; Fanto M, 2003, DEVELOPMENT, V130, P763, DOI 10.1242/dev.00304; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Hou R, 2006, J CELL BIOL, V173, P417, DOI 10.1083/jcb.200508121; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Khan FA, 1996, NEUROBIOL DIS, V3, P121, DOI 10.1006/nbdi.1996.0012; Magg T, 2005, EXP CELL RES, V307, P100, DOI 10.1016/j.yexcr.2005.03.006; MAJESKY MW, 1992, CIRC RES, V71, P759, DOI 10.1161/01.RES.71.4.759; Matsui S, 2008, J DERMATOL SCI, V51, P207, DOI 10.1016/j.jdermsci.2008.04.006; Mercure MZ, 2008, AM J PHYSIOL-CELL PH, V294, pC1465, DOI 10.1152/ajpcell.90638.2007; Moeller MJ, 2004, EMBO J, V23, P3769, DOI 10.1038/sj.emboj.7600380; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; Nakaya K, 2007, ONCOGENE, V26, P5300, DOI 10.1038/sj.onc.1210330; Plaster N, 2007, DEV DYNAM, V236, P1891, DOI 10.1002/dvdy.21196; Riley BE, 2006, GENE DEV, V20, P2183, DOI 10.1101/gad.1436506; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; SAVANI RC, 1995, J CLIN INVEST, V95, P1158, DOI 10.1172/JCI117764; Shen YG, 2007, J BIOL CHEM, V282, P5037, DOI 10.1074/jbc.M610274200; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; Tanoue T, 2005, J CELL SCI, V118, P2347, DOI 10.1242/jcs.02398; Tanoue T, 2004, J CELL BIOL, V165, P517, DOI 10.1083/jcb.200403006; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Tyler DM, 2007, DEV BIOL, V305, P187, DOI 10.1016/j.ydbio.2007.02.004; Waerner T, 2001, CELL GROWTH DIFFER, V12, P201; Wang L, 2006, GENE DEV, V20, P525, DOI 10.1101/gad.1393506; Willecke M, 2006, CURR BIOL, V16, P2090, DOI 10.1016/j.cub.2006.09.005; Wood JD, 2000, J CELL BIOL, V150, P939, DOI 10.1083/jcb.150.5.939; Zhang CL, 2006, GENE DEV, V20, P1308, DOI 10.1101/gad.1413606; Zhang S, 2002, CELL, V108, P45, DOI 10.1016/S0092-8674(01)00630-4; Zoltewicz JS, 2004, DEVELOPMENT, V131, P3, DOI 10.1242/dev.00908	37	33	40	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6955	6965		10.1074/jbc.M809333200	http://dx.doi.org/10.1074/jbc.M809333200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19131340	Green Published, hybrid			2022-12-25	WOS:000263919000043
J	Lichti-Kaiser, K; Xu, CS; Staudinger, JL				Lichti-Kaiser, Kristin; Xu, Chenshu; Staudinger, Jeff L.			Cyclic AMP-dependent Protein Kinase Signaling Modulates Pregnane x Receptor Activity in a Species-specific Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSTITUTIVE-ANDROSTANE RECEPTOR; CYP3A4 GENE-EXPRESSION; NUCLEAR RECEPTORS; CROSS-TALK; MEDIATED INDUCTION; DRUG-INTERACTIONS; METABOLISM; PATHWAYS; MOUSE; CAMP	Pregnane x receptor is a ligand-activated transcription factor that regulates drug-inducible expression of several key cytochrome P450 enzymes and drug transporter proteins in liver and intestine in a species-specific manner. Activation of this receptor modulates several key biochemical pathways, including gluconeogenesis, beta-oxidation of fatty acids, fatty acid uptake, cholesterol homeostasis, and lipogenesis. It is of current interest to determine whether the interaction between pregnane x receptor and these key biochemical pathways is evolutionarily conserved. We show here that activation of the cyclic AMP-dependent protein kinase signaling pathway synergizes with pregnane x receptor-mediated gene activation in mouse hepatocytes. Conversely, cyclic AMP-dependent protein kinase signaling has a repressive effect upon pregnane x receptor-mediated gene activation in rat and human hepatocytes. We show that the human pregnane x receptor protein can serve as an effective substrate for catalytically active cyclic AMP-dependent protein kinase in vitro. Metabolic labeling of the protein in vivo indicates that human pregnane x receptor exists as a phosphoprotein and that activation of cyclic AMP-dependent protein kinase signaling modulates the phosphorylation status of pregnane x receptor. Activation of cyclic AMP-dependent protein kinase signaling also modulates the interactions of pregnane x receptor with protein cofactors. Our results define the species-specific impact of cyclic AMP-dependent protein kinase signaling on pregnane x receptor and provide a molecular explanation of cyclic AMP-dependent protein kinase-mediated repression of human pregnane x receptor activity. Taken together, our results identify a novel mode of regulation of pregnane x receptor activity and highlight prominent functional differences in the process across species.	[Lichti-Kaiser, Kristin; Xu, Chenshu; Staudinger, Jeff L.] Univ Kansas, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA	University of Kansas	Staudinger, JL (corresponding author), Univ Kansas, Dept Pharmacol & Toxicol, 1251Wescoe Hall Dr,5044 Malott Hall, Lawrence, KS 66045 USA.	stauding@ku.edu	Xu, Chenshu/F-7864-2014		National Institutes of Health [R01-DK068443]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-DK068443.	Aitken AE, 2006, ANNU REV PHARMACOL, V46, P123, DOI 10.1146/annurev.pharmtox.46.120604.141059; BEAVO JA, 1974, P NATL ACAD SCI USA, V71, P3580, DOI 10.1073/pnas.71.9.3580; Brobst DE, 2004, J PHARMACOL EXP THER, V310, P528, DOI 10.1124/jpet.103.064329; Ding XS, 2005, BIOCHEM PHARMACOL, V69, P867, DOI 10.1016/j.bcp.2004.11.025; Ding XS, 2005, J PHARMACOL EXP THER, V312, P849, DOI 10.1124/jpet.104.076331; Ding X, 2006, J BIOL CHEM, V281, P26540, DOI 10.1074/jbc.M600931200; Dowless MS, 2005, EUR J PHARMACOL, V512, P9, DOI 10.1016/j.ejphar.2005.02.022; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Galisteo M, 1999, J PHARMACOL EXP THER, V290, P1270; Gonzalez FJ, 2008, TOXICOLOGY, V246, P2, DOI 10.1016/j.tox.2007.09.030; Goodwin B, 2002, ANNU REV PHARMACOL, V42, P1, DOI 10.1146/annurev.pharmtox.42.111901.111051; Kim SK, 2007, PHARMACOL THERAPEUT, V113, P88, DOI 10.1016/j.pharmthera.2006.07.004; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Kodama S, 2004, MOL CELL BIOL, V24, P7931, DOI 10.1128/MCB.24.18.7931-7940.2004; Kodama S, 2006, DRUG METAB REV, V38, P75, DOI 10.1080/03602530600569851; Kodama S, 2007, BIOCHEM J, V407, P373, DOI 10.1042/BJ20070481; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Lichti-Kaiser K, 2008, DRUG METAB DISPOS, V36, P1538, DOI 10.1124/dmd.108.021774; Lin WW, 2008, J BIOL CHEM, V283, P30650, DOI 10.1074/jbc.M806132200; Ma X, 2007, DRUG METAB DISPOS, V35, P194, DOI 10.1124/dmd.106.012831; Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638; Marc N, 2000, EUR J BIOCHEM, V267, P963, DOI 10.1046/j.1432-1327.2000.01083.x; Miao J, 2006, J BIOL CHEM, V281, P14537, DOI 10.1074/jbc.M510713200; Moore LB, 2002, MOL ENDOCRINOL, V16, P977, DOI 10.1210/me.16.5.977; Nakamura K, 2007, J BIOL CHEM, V282, P9768, DOI 10.1074/jbc.M610072200; Rochette-Egly C, 2003, CELL SIGNAL, V15, P355, DOI 10.1016/S0898-6568(02)00115-8; Scheer N, 2008, J CLIN INVEST, V118, P3228, DOI 10.1172/JCI35483; SIDHU JS, 1995, J BIOL CHEM, V270, P12762, DOI 10.1074/jbc.270.21.12762; Sidhu JS, 1996, J PHARMACOL EXP THER, V276, P238; Staudinger JL, 2008, MOL PHARMACEUT, V5, P17, DOI 10.1021/mp700098c; Staudinger JL, 2003, DRUG METAB DISPOS, V31, P523, DOI 10.1124/dmd.31.5.523; Teng S, 2005, J PHARMACOL EXP THER, V312, P841, DOI 10.1124/jpet.104.076141; Willson TM, 2002, NAT REV DRUG DISCOV, V1, P259, DOI 10.1038/nrd753; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Zhou C, 2006, J CLIN INVEST, V116, P2280, DOI 10.1172/JCI26283; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200	36	45	46	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6639	6649		10.1074/jbc.M807426200	http://dx.doi.org/10.1074/jbc.M807426200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19141612	Green Published, hybrid			2022-12-25	WOS:000263919000008
J	Cheng, HT; Megha; London, E				Cheng, Hui-Ting; Megha; London, Erwin			Preparation and Properties of Asymmetric Vesicles That Mimic Cell Membranes EFFECT UPON LIPID RAFT FORMATION AND TRANSMEMBRANE HELIX ORIENTATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIQUID-ORDERED DOMAINS; GPI-ANCHORED PROTEINS; DETERGENT-RESISTANT; PHASE-TRANSITIONS; MODEL MEMBRANES; PHOSPHATIDYLCHOLINE VESICLES; FLUORESCENCE CORRELATION; TRANSBILAYER MOVEMENT; CHOLESTEROL; BILAYERS	A methyl-beta-cyclodextrin-induced lipid exchange technique was devised to prepare small unilamellar vesicles with stable asymmetric lipid compositions. Asymmetric vesicles that mimic biological membranes were prepared with sphingomyelin (SM) or SM mixed with 1-palmitoyl-2-oleoyl-phosphatidylcholine (POPC) as the predominant lipids in the outer leaflet and dioleoylphosphatidylcholine (DOPC), POPC, 1-palmitoyl-2-oleoylphosphatidyl- L-serine (POPS), or POPS mixed with 1-palmitoyl2- oleoyl-phosphatidylethanolamine (POPE) in the inner leaflet. Fluorescence-based assays were developed to confirm lipid asymmetry. Cholesterol was introduced into these vesicles using a second methyl-beta-cyclodextrin exchange step. In asymmetric vesicles composed of SM outside, DOPC inside (SMo/DOPCi) or SM outside, 2:1 mol:mol POPE:POPS inside (SMo/2:1 POPE:POPSi) the outer leaflet SM formed an ordered state with a thermal stability similar to that in pure SM vesicles and significantly greater than that in symmetric vesicles with the same overall lipid composition. Analogous behavior was observed in vesicles containing cholesterol. This shows that an asymmetric lipid distribution like that in eukaryotic plasma membranes can be conducive to ordered domain (raft) formation. Furthermore asymmetric vesicles containing similar to 25 mol % cholesterol formed ordered domains more thermally stable than those in asymmetric vesicles lacking cholesterol, showing that the crucial ability of cholesterol to stabilize ordered domain formation is likely to contribute to ordered domain formation in cell membranes. Additional studies demonstrated that hydrophobic helix orientation is affected by lipid asymmetry with asymmetry favoring formation of the transmembrane configuration. The ability to form asymmetric vesicles represents an important improvement in model membrane studies and should find many applications in the future.	[Cheng, Hui-Ting; Megha; London, Erwin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	London, E (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	Erwin.London@stonybrook.edu			National Institutes of Health [GM48596]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM48596. The costs of publication of this article were defrayed in part by the payment of page charges.	Ahmed SN, 1997, BIOCHEMISTRY-US, V36, P10944, DOI 10.1021/bi971167g; Anderson TG, 2004, BIOCHEMISTRY-US, V43, P2251, DOI 10.1021/bi0358869; Antignani A, 2006, CURR OPIN CELL BIOL, V18, P685, DOI 10.1016/j.ceb.2006.10.004; Ayuyan AG, 2008, BIOPHYS J, V94, P2654, DOI 10.1529/biophysj.107.118596; Bakht O, 2007, BIOPHYS J, V93, P4307, DOI 10.1529/biophysj.107.114967; Bakht Omar, 2007, V398, P29, DOI 10.1007/978-1-59745-513-8_4; BARSUKOV LI, 1980, BIOCHIM BIOPHYS ACTA, V598, P153, DOI 10.1016/0005-2736(80)90273-4; BECK A, 1993, CHEM PHYS LIPIDS, V66, P135, DOI 10.1016/0009-3084(93)90038-5; Bjorkqvist YJE, 2005, BIOPHYS J, V88, P4054, DOI 10.1529/biophysj.104.054718; BLOJ B, 1981, MOL CELL BIOCHEM, V40, P163; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown DA, 1997, BIOCHEM BIOPH RES CO, V240, P1, DOI 10.1006/bbrc.1997.7575; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Caputo GA, 2003, BIOCHEMISTRY-US, V42, P3275, DOI 10.1021/bi026697d; Chiantia S, 2006, CHEMPHYSCHEM, V7, P2409, DOI 10.1002/cphc.200600464; Chiantia S, 2006, BIOPHYS J, V90, P4500, DOI 10.1529/biophysj.106.081026; Collins MD, 2008, P NATL ACAD SCI USA, V105, P124, DOI 10.1073/pnas.0702970105; Crane JM, 2005, LANGMUIR, V21, P1377, DOI 10.1021/la047654w; Crane JM, 2004, BIOPHYS J, V86, P2965, DOI 10.1016/S0006-3495(04)74347-7; DAWIDOWICZ EA, 1976, BIOCHIM BIOPHYS ACTA, V455, P621, DOI 10.1016/0005-2736(76)90036-5; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Du H, 1998, PHOTOCHEM PHOTOBIOL, V68, P141, DOI 10.1562/0031-8655(1998)068<0141:PACADA>2.3.CO;2; EASTMAN SJ, 1991, BIOCHEMISTRY-US, V30, P1740, DOI 10.1021/bi00221a002; EVERETT J, 1986, J BIOL CHEM, V261, P6725; Fastenberg ME, 2003, BIOCHEMISTRY-US, V42, P12376, DOI 10.1021/bi034718d; Feigenson GW, 2001, BIOPHYS J, V80, P2775, DOI 10.1016/S0006-3495(01)76245-5; Fidorra M, 2006, BIOPHYS J, V90, P4437, DOI 10.1529/biophysj.105.077107; Fujita K, 2007, BIOCHEMISTRY-US, V46, P5185, DOI 10.1021/bi6024758; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Heerklotz H, 2003, J MOL BIOL, V329, P793, DOI 10.1016/S0022-2836(03)00504-7; HOPE MJ, 1989, BIOCHEMISTRY-US, V28, P4181, DOI 10.1021/bi00436a009; HUANG C, 1978, P NATL ACAD SCI USA, V75, P308, DOI 10.1073/pnas.75.1.308; HUANG CH, 1969, BIOCHEMISTRY-US, V8, P344, DOI 10.1021/bi00829a048; Johnston I, 2008, BBA-BIOMEMBRANES, V1778, P185, DOI 10.1016/j.bbamem.2007.09.021; Kahya N, 2006, MOL MEMBR BIOL, V23, P29, DOI 10.1080/09687860500489099; Kaiser RD, 1998, BIOCHEMISTRY-US, V37, P8180, DOI 10.1021/bi980064a; Kiessling V, 2006, BIOPHYS J, V91, P3313, DOI 10.1529/biophysj.106.091421; Korlach J, 1999, P NATL ACAD SCI USA, V96, P8461, DOI 10.1073/pnas.96.15.8461; KOYNOVA R, 1995, BBA-LIPID LIPID MET, V1255, P213, DOI 10.1016/0005-2760(94)00202-A; Koynova R, 1998, BBA-REV BIOMEMBRANES, V1376, P91, DOI 10.1016/S0304-4157(98)00006-9; KOYNOVA R, 1994, CHEM PHYS LIPIDS, V69, P1, DOI 10.1016/0009-3084(94)90024-8; Krishnakumar SS, 2007, J MOL BIOL, V374, P671, DOI 10.1016/j.jmb.2007.09.037; Krishnakumar SS, 2007, J MOL BIOL, V374, P1251, DOI 10.1016/j.jmb.2007.10.032; LACOWICZ J, 1999, PRINCIPLES FLUORESCE, P298; LENTZ BR, 1976, BIOCHEMISTRY-US, V15, P4521, DOI 10.1021/bi00665a029; Lerch-Bader M, 2008, P NATL ACAD SCI USA, V105, P4127, DOI 10.1073/pnas.0711580105; Leventis R, 2001, BIOPHYS J, V81, P2257, DOI 10.1016/S0006-3495(01)75873-0; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; LONDON E, 1981, BIOCHIM BIOPHYS ACTA, V649, P89, DOI 10.1016/0005-2736(81)90012-2; London E, 2005, BBA-MOL CELL RES, V1746, P203, DOI 10.1016/j.bbamcr.2005.09.002; LONDON E, 1978, ANAL BIOCHEM, V88, P203, DOI 10.1016/0003-2697(78)90412-8; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; London M, 2004, J BIOL CHEM, V279, P9997, DOI 10.1074/jbc.M309992200; Malewicz B, 2005, BIOPHYS J, V88, P2670, DOI 10.1529/biophysj.104.057059; Megha M, 2006, J BIOL CHEM, V281, P21903, DOI 10.1074/jbc.M600395200; Nybond S, 2005, BBA-BIOMEMBRANES, V1718, P61, DOI 10.1016/j.bbamem.2005.10.009; Ottico E, 2003, J LIPID RES, V44, P2142, DOI 10.1194/jlr.M300247-JLR200; Pautot S, 2003, P NATL ACAD SCI USA, V100, P10718, DOI 10.1073/pnas.1931005100; PRENDERGAST FG, 1981, BIOCHEMISTRY-US, V20, P7333, DOI 10.1021/bi00529a002; Ramstedt B, 1999, EUR J BIOCHEM, V266, P997, DOI 10.1046/j.1432-1327.1999.00938.x; Ramstedt B, 2006, BBA-BIOMEMBRANES, V1758, P1945, DOI 10.1016/j.bbamem.2006.05.020; Ren JH, 1997, BIOCHEMISTRY-US, V36, P10213, DOI 10.1021/bi9709295; Rinia HA, 2001, FEBS LETT, V501, P92, DOI 10.1016/S0014-5793(01)02636-9; Samsonov AV, 2001, BIOPHYS J, V81, P1486, DOI 10.1016/S0006-3495(01)75803-1; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SCHMIDT CF, 1978, NATURE, V271, P775, DOI 10.1038/271775a0; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Shahidullah K, 2008, J MOL BIOL, V379, P704, DOI 10.1016/j.jmb.2008.04.026; Shaikh SR, 2004, BIOPHYS J, V87, P1752, DOI 10.1529/biophysj.104.044552; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Shogomori H, 2003, BIOL CHEM, V384, P1259, DOI 10.1515/BC.2003.139; Sohn HW, 2008, J IMMUNOL, V180, P793, DOI 10.4049/jimmunol.180.2.793; Sohn HW, 2006, P NATL ACAD SCI USA, V103, P8143, DOI 10.1073/pnas.0509858103; Sot J, 2006, BIOPHYS J, V90, P903, DOI 10.1529/biophysj.105.067710; SRIPADA PK, 1987, J LIPID RES, V28, P710; Tanhuanpaa K, 1999, J BIOL CHEM, V274, P35359, DOI 10.1074/jbc.274.50.35359; UNTRACHT SH, 1977, J BIOL CHEM, V252, P4449; Veatch SL, 2007, P NATL ACAD SCI USA, V104, P17650, DOI 10.1073/pnas.0703513104; Veatch SL, 2006, BIOPHYS J, V90, P4428, DOI 10.1529/biophysj.105.080283; Veatch SL, 2003, BIOPHYS J, V85, P3074, DOI 10.1016/S0006-3495(03)74726-2; VERKLEIJ AJ, 1973, BIOCHIM BIOPHYS ACTA, V323, P178, DOI 10.1016/0005-2736(73)90143-0; Wang JW, 2004, BIOCHEMISTRY-US, V43, P1010, DOI 10.1021/bi035696y; Wang TY, 2000, BIOPHYS J, V79, P919, DOI 10.1016/S0006-3495(00)76347-8; Wang TY, 2001, BIOCHEMISTRY-US, V40, P13031, DOI 10.1021/bi0112311; Wang TY, 2001, BIOPHYS J, V81, P2762, DOI 10.1016/S0006-3495(01)75919-X; Wenz JJ, 2003, BIOCHEMISTRY-US, V42, P14267, DOI 10.1021/bi035759c; Xu XL, 2001, J BIOL CHEM, V276, P33540, DOI 10.1074/jbc.M104776200; Xu XL, 2000, BIOCHEMISTRY-US, V39, P843, DOI 10.1021/bi992543v; Young RM, 2003, J BIOL CHEM, V278, P20746, DOI 10.1074/jbc.M211402200	90	130	130	2	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6079	6092		10.1074/jbc.M806077200	http://dx.doi.org/10.1074/jbc.M806077200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19129198	hybrid, Green Published			2022-12-25	WOS:000263742700010
J	Chen, X; Guo, X; Zhang, H; Xiang, Y; Chen, J; Yin, Y; Cai, X; Wang, K; Wang, G; Ba, Y; Zhu, L; Wang, J; Yang, R; Zhang, Y; Ren, Z; Zen, K; Zhang, J; Zhang, CY				Chen, X.; Guo, X.; Zhang, H.; Xiang, Y.; Chen, J.; Yin, Y.; Cai, X.; Wang, K.; Wang, G.; Ba, Y.; Zhu, L.; Wang, J.; Yang, R.; Zhang, Y.; Ren, Z.; Zen, K.; Zhang, J.; Zhang, C-Y			Role of miR-143 targeting KRAS in colorectal tumorigenesis	ONCOGENE			English	Article						microRNA; colorectal cancer; miR-143; KRAS	MICRORNA TARGETS; EXPRESSION; CANCER; CELLS; SUPPRESSOR; TISSUES; PCR	Dysregulated expression of microRNAs ( miRNAs) is associated with a variety of diseases, including colorectal cancer. Bycomparing more than 200 miRNAs in 13 pairs of matched colorectal cancer and normal adjacent tissue samples through qRT-PCR and microarray analysis, we found a widespread disruption of miRNA expression during colorectal tumorigenesis. In particular, among a panel of presumed targets generated by in silico analysis that may interact with these aberrantly expressed miRNAs, KRAS oncogene has been further experimentally validated as the target of miR-143. First, an inverse correlation between KRAS protein and miR-143 in vivo was found. Second, KRAS expression in Lovo cells was significantly abolished by treatment with miR-143 mimic, whereas miR-143 inhibitor increased KRAS protein level. Third, luciferase reporter assay confirmed that miR-143 directly recognize the 30-untranslated region of KRAS transcripts. Four, Lovo cells treated with miR-143 inhibitor showed a stimulated cell proliferation, whereas miR-143 overexpression had an opposite effect. Finally, inhibition of KRAS expression by miR-143 inhibits constitutive phosphorylation of ERK1/2. Taken together, the present study provides the first evidences that miR-143 is significant in suppressing colorectal cancer cell growth through inhibition of KRAS translation.	[Chen, X.; Guo, X.; Zhang, H.; Xiang, Y.; Chen, J.; Yin, Y.; Cai, X.; Wang, K.; Wang, G.; Zhu, L.; Wang, J.; Yang, R.; Zhang, Y.; Ren, Z.; Zen, K.; Zhang, J.; Zhang, C-Y] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Diabet Ctr, Nanjing 210093, Jiangsu, Peoples R China; [Zhang, H.] Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China; [Ba, Y.] Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China; [Zen, K.] Nanjing Univ, Jiangsu CDC, Joint Inst Virol, Nanjing 210093, Jiangsu, Peoples R China	Nanjing University; Nanjing Medical University; Tianjin Medical University; Nanjing University	Zhang, CY (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Diabet Ctr, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China.	kzen@nju.edu.cn; jfzhang@nju.edu.cn; cyzhang@nju.edu.cn	殷, 媛/GSE-4523-2022; CHEN, JIAO/GZA-5784-2022; zhang, jiani/GVS-2052-2022; chen, JJ/HGB-6029-2022; Yin, Yuan/AAG-1707-2020	/0000-0002-0420-4508				Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Michael MZ, 2003, MOL CANCER RES, V1, P882; Michor F, 2005, SEMIN CANCER BIOL, V15, P484, DOI 10.1016/j.semcancer.2005.06.005; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293	26	458	491	3	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	10					1385	1392		10.1038/onc.2008.474	http://dx.doi.org/10.1038/onc.2008.474			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	417ZC	19137007				2022-12-25	WOS:000264116000011
J	Langmesser, S; Franken, P; Feil, S; Emmenegger, Y; Albrecht, U; Feil, R				Langmesser, Sonja; Franken, Paul; Feil, Susanne; Emmenegger, Yann; Albrecht, Urs; Feil, Robert			cGMP-Dependent Protein Kinase Type I Is Implicated in the Regulation of the Timing and Quality of Sleep and Wakefulness	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; EYE-MOVEMENT SLEEP; MALE-MICE LACKING; SUPRACHIASMATIC NUCLEUS; RAT; GENE; BRAIN; EXPRESSION; INHIBITOR; FRAGMENTATION	Many effects of nitric oxide (NO) are mediated by the activation of guanylyl cyclases and subsequent production of the second messenger cyclic guanosine-3',5'-monophosphate (cGMP). cGMP activates cGMP-dependent protein kinases (PRKGs), which can therefore be considered downstream effectors of NO signaling. Since NO is thought to be involved in the regulation of both sleep and circadian rhythms, we analyzed these two processes in mice deficient for cGMP-dependent protein kinase type I (PRKG1) in the brain. Prkg1 mutant mice showed a strikingly altered distribution of sleep and wakefulness over the 24 hours of a day as well as reductions in rapid-eye-movement sleep (REMS) duration and in non-REM sleep (NREMS) consolidation, and their ability to sustain waking episodes was compromised. Furthermore, they displayed a drastic decrease in electroencephalogram (EEG) power in the delta frequency range (1-4 Hz) under baseline conditions, which could be normalized after sleep deprivation. In line with the re-distribution of sleep and wakefulness, the analysis of wheel-running and drinking activity revealed more rest bouts during the activity phase and a higher percentage of daytime activity in mutant animals. No changes were observed in internal period length and phase-shifting properties of the circadian clock while chi-squared periodogram amplitude was significantly reduced, hinting at a less robust oscillator. These results indicate that PRKG1 might be involved in the stabilization and output strength of the circadian oscillator in mice. Moreover, PRKG1 deficiency results in an aberrant pattern, and consequently a reduced quality, of sleep and wakefulness, possibly due to a decreased wake-promoting output of the circadian system impinging upon sleep.	[Albrecht, Urs] Univ Fribourg, Dept Med, Div Biochem, CH-1700 Fribourg, Switzerland; [Franken, Paul; Emmenegger, Yann] Univ Lausanne, Ctr Integrative Genom, CH-1015 Lausanne, Switzerland; [Feil, Susanne; Feil, Robert] Univ Tubingen, Interfak Inst Biochem, D-72074 Tubingen, Germany	University of Fribourg; University of Lausanne; Eberhard Karls University of Tubingen	Langmesser, S (corresponding author), Univ Fribourg, Dept Med, Div Biochem, CH-1700 Fribourg, Switzerland.	urs.albrecht@unifr.ch	Albrecht, Urs/A-9831-2011; Feil, Susanne/AAF-7032-2019; Feil, Robert/B-8918-2014; Franken, Paul/A-9633-2018	Albrecht, Urs/0000-0002-0663-8676; Feil, Robert/0000-0002-7335-4841; Franken, Paul/0000-0002-2500-2921	University of Lausanne [3100A0-111974]; NIH [MH67752]; Universitat Tubingen [1774-0-0]; Deutsche Forschungsgemeinschaft; VolkswagenStiftung; Swiss National Science Foundation [3100A0-115984]; State of Fribourg; FP6 Integrated Programm EUCLOCK; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067752] Funding Source: NIH RePORTER	University of Lausanne; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Universitat Tubingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); VolkswagenStiftung(Volkswagen); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); State of Fribourg; FP6 Integrated Programm EUCLOCK; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	PF was supported by the University of Lausanne, an SNSF grant (3100A0-111974) and an NIH grant (MH67752). SF: Dr. Karl Kuhn-Stiftung and fortune-Programm der Medizinischen Fakultat der Universitat Tubingen (grant #1774-0-0). RF: Deutsche Forschungsgemeinschaft and VolkswagenStiftung. UA: Swiss National Science Foundation (3100A0-115984), State of Fribourg and FP6 Integrated Programm EUCLOCK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino PV, 2007, P NATL ACAD SCI USA, V104, P9834, DOI 10.1073/pnas.0703388104; Aschoff, 1965, CIRCADIAN CLOCKS, P95; Borbely AA, 1998, HORM RES, V49, P114, DOI 10.1159/000023156; Burlet S, 1997, NEUROSCI LETT, V226, P131, DOI 10.1016/S0304-3940(97)00247-4; Burlet S, 1999, NEUROSCIENCE, V92, P627, DOI 10.1016/S0306-4522(99)00031-7; Cavas M, 2006, PROG NEURO-PSYCHOPH, V30, P56, DOI 10.1016/j.pnpbp.2005.06.013; Chen LC, 2003, BRAIN RES, V973, P214, DOI 10.1016/S0006-8993(03)02484-3; Cudeiro J, 2000, SLEEP, V23, P829; Dzoljic MR, 1996, BRAIN RES, V718, P145, DOI 10.1016/0006-8993(96)00102-3; Easton A, 2004, SLEEP, V27, P1307, DOI 10.1093/sleep/27.7.1307; EDGAR DM, 1993, J NEUROSCI, V13, P1065; El-Husseini AED, 1999, J CHEM NEUROANAT, V17, P45, DOI 10.1016/S0891-0618(99)00023-X; Feil R, 2005, REV NEUROSCIENCE, V16, P23; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Feil S, 2005, NEUROSCIENCE, V135, P863, DOI 10.1016/j.neuroscience.2005.06.051; Ferreyra GA, 2001, AM J PHYSIOL-REG I, V280, pR1348, DOI 10.1152/ajpregu.2001.280.5.R1348; Franken P, 2006, P NATL ACAD SCI USA, V103, P7118, DOI 10.1073/pnas.0602006103; FRANKEN P, 1991, AM J PHYSIOL, V261, pR198, DOI 10.1152/ajpregu.1991.261.1.R198; Franken P, 1999, SLEEP, V22, P155; Franken P, 1998, AM J PHYSIOL-REG I, V275, pR1127, DOI 10.1152/ajpregu.1998.275.4.R1127; Gillette MU, 2002, CELL TISSUE RES, V309, P99, DOI 10.1007/s00441-002-0576-1; Hars B, 1999, BRAIN RES, V816, P209, DOI 10.1016/S0006-8993(98)01183-4; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Huber R, 2007, SLEEP, V30, P129, DOI 10.1093/sleep/30.2.129; Jud C, 2005, BIOL PROCED ONLINE, V7, P101, DOI 10.1251/bpo109; Kalinchuk AV, 2006, J NEUROCHEM, V99, P483, DOI 10.1111/j.1471-4159.2006.04077.x; KAPAS L, 1994, BRAIN RES, V664, P189, DOI 10.1016/0006-8993(94)91969-0; Kapas L, 1996, BRAIN RES BULL, V41, P293, DOI 10.1016/S0361-9230(96)00227-4; Kriegsfeld LJ, 2001, J BIOL RHYTHM, V16, P142, DOI 10.1177/074873001129001845; Kriegsfeld LJ, 1999, J BIOL RHYTHM, V14, P20, DOI 10.1177/074873099129000407; Kuhbandner S, 2000, GENESIS, V28, P15, DOI 10.1002/1526-968X(200009)28:1<15::AID-GENE20>3.0.CO;2-C; Kunieda T, 2008, CIRC RES, V102, P607, DOI 10.1161/CIRCRESAHA.107.162230; Lax P, 1998, AM J PHYSIOL-REG I, V275, pR580, DOI 10.1152/ajpregu.1998.275.2.R580; Marino J, 2003, J NEUROSCI, V23, P4299; McKenna JT, 2007, NEUROSCIENCE, V146, P1462, DOI 10.1016/j.neuroscience.2007.03.009; Mongrain V, 2007, SLEEP, V30, P773, DOI 10.1093/sleep/30.6.773; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Obal F, 2003, FRONT BIOSCI-LANDMRK, V8, pD520, DOI 10.2741/1033; Oster H, 2003, CURR BIOL, V13, P725, DOI 10.1016/S0960-9822(03)00252-5; Perlis ML, 2001, J SLEEP RES, V10, P93, DOI 10.1046/j.1365-2869.2001.00247.x; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; Raizen DM, 2008, NATURE, V451, P569, DOI 10.1038/nature06535; Revermann M, 2002, NEUROSCI LETT, V334, P119, DOI 10.1016/S0304-3940(02)01118-7; Ribeiro AC, 2005, AM J PHYSIOL-REG I, V289, pR521, DOI 10.1152/ajpregu.00605.2004; Ribeiro AC, 2005, BRAIN RES, V1049, P25, DOI 10.1016/j.brainres.2005.04.067; Ribeiro AC, 2000, AM J PHYSIOL-REG I, V278, pR1048, DOI 10.1152/ajpregu.2000.278.4.R1048; Rosenwasser AM, 2005, ALCOHOL, V36, P69, DOI 10.1016/j.alcohol.2005.07.001; Schlossmann J, 2003, ANN MED, V35, P21, DOI 10.1080/07853890310004093; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stenberg D, 2007, CELL MOL LIFE SCI, V64, P1187, DOI 10.1007/s00018-007-6530-3; Tischkau SA, 2004, NEURON, V43, P539, DOI 10.1016/j.neuron.2004.07.027; Tischkau SA, 2003, J NEUROSCI, V23, P7543; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Weber S, 2007, CIRC RES, V101, P1096, DOI 10.1161/CIRCRESAHA.107.154351; Wegener JW, 2002, CIRC RES, V90, P18, DOI 10.1161/hh0102.103222; Williams JA, 1997, J NEUROSCI, V17, P420, DOI 10.1523/JNEUROSCI.17-01-00420.1997; Zhdanova IV, 1999, J BIOL RHYTHM, V14, P307, DOI 10.1177/074873099129000722	58	41	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4238	10.1371/journal.pone.0004238	http://dx.doi.org/10.1371/journal.pone.0004238			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JB	19156199	Green Submitted, Green Published, gold			2022-12-25	WOS:000265482100010
J	Houard, X; Ollivier, V; Louedec, L; Michel, JB; Back, M				Houard, Xavier; Ollivier, Veronique; Louedec, Liliane; Michel, Jean-Baptiste; Back, Magnus			Differential inflammatory activity across human abdominal aortic aneurysms reveals neutrophil-derived leukotriene B-4 as a major chemotactic factor released from the intraluminal thrombus	FASEB JOURNAL			English	Article						lipoxygenase; granulocyte; eicosanoids; leukotriene receptors	MURAL THROMBUS; 5-LIPOXYGENASE PATHWAY; POLYMORPHONUCLEAR LEUKOCYTES; ARTERIAL-WALL; ATHEROSCLEROSIS; RECEPTORS; RECRUITMENT; INVOLVEMENT; EXPRESSION; EVOLUTION	Development and progression of acquired abdominal aortic aneurysms (AAAs) have been associated with different inflammatory mediators. The aim of the present study was to elucidate the topology and the potential mechanisms linking the leukotriene pathway to human AAAs. Human aneurysmal lesions were obtained from 24 patients undergoing surgery, and the intraluminal thrombus was separated from the vascular wall. Histological examination revealed major expression of the leukotriene-producing enzymes 5-lipoxygenase and LTA(4) hydrolase, as well as the two receptors for leukotriene B-4 (BLT1R and BLT2R), corresponding to neutrophils in the luminal part of the thrombus. In contrast, in the vascular wall, the leukotriene pathway mainly localized in macrophage-rich adventitial areas. Furthermore, conditioned media of the intraluminal thrombus contained significantly higher concentrations of leukotriene B-4 than that derived from the vascular wall, which were significantly correlated to other neutrophil-derived mediators, such as elastase/alpha(1)-antitrypsin complexes, myeloperoxidase, and MMP9/NGAL complexes. Finally, the neutrophil-chemotactic activity of the conditioned media from the intraluminal thrombus exhibited major inhibition by antagonists of the leukotriene B-4 receptors. Taken together, these results indicate neutrophil-derived leukotriene B-4 as a major neutrophil chemotactic factor released from the intraluminal thrombus of human AAAs and suggest that targeting BLT receptors may represent a potential medical therapeutic strategy in the prevention of AAA progression in humans.-Houard, X., Ollivier, V., Louedec, L., Michel, J.-B., Back, M. Differential inflammatory activity across human abdominal aortic aneurysms reveals neutrophil-derived leukotriene B-4 as a major chemotactic factor released from the intraluminal thrombus. FASEB J. 23, 1376-1383 (2009)	[Houard, Xavier; Ollivier, Veronique; Louedec, Liliane; Michel, Jean-Baptiste; Back, Magnus] Univ Paris 07, Bichat Claude Bernard Hosp, INSERM, Cardiovasc Hematol Bioengn & Remodeling U698, Paris, France; [Back, Magnus] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden; [Back, Magnus] Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Michel, JB (corresponding author), Hop X Bichat, INSERM, Cardiovasc Hematol Bioengn & Remodeling U698, 46 Rue Henri Huchard, F-75877 Paris 18, France.	jean-baptiste.michel@inserm.fr	Michel, Jean-Baptiste/AAH-9336-2020; Ollivier, Véronique/AAA-2241-2022; Back, Magnus/E-4879-2011	Back, Magnus/0000-0003-0853-5141; Ollivier, Veronique/0000-0003-1318-1712	Fondation Lefoulon-Delalande; French National Academy of Medicine; French-Swedish Foundation; Leducq Foundation; Fondation pour la Recherche Medicale; European Union	Fondation Lefoulon-Delalande; French National Academy of Medicine; French-Swedish Foundation; Leducq Foundation(Leducq Foundation); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Union(European Commission)	X.H. was supported by the Fondation Lefoulon-Delalande, and M. B. was supported by the French National Academy of Medicine and the French-Swedish Foundation. This study was supported by grants from the Leducq Foundation, the Fondation pour la Recherche Medicale, and the European Union "Fighting Aneurysmal Disease." We thank Dr. Uriel Sebbag and Dr. Tonino Palombi (Centre Cardiologique du Nord, St. Denis, France) for providing us with aneurysmal samples.	Adolph R, 1997, J VASC SURG, V25, P916, DOI 10.1016/S0741-5214(97)70223-4; Ahluwalia N, 2007, J IMMUNOL, V179, P691, DOI 10.4049/jimmunol.179.1.691; Alexander JJ, 2004, J SURG RES, V117, P163, DOI 10.1016/j.jss.2003.11.011; Back M, 2005, P NATL ACAD SCI USA, V102, P17501, DOI 10.1073/pnas.0505845102; Back M, 2007, CIRC RES, V100, P946, DOI 10.1161/01.RES.0000264498.60702.0d; Back M, 2008, CURR ATHEROSCLER REP, V10, P244, DOI 10.1007/s11883-008-0038-7; Back M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001351; BORGEAT P, 1976, J BIOL CHEM, V251, P7816; BREZINSKI DA, 1992, CIRCULATION, V86, P56, DOI 10.1161/01.CIR.86.1.56; Brink C, 2003, PHARMACOL REV, V55, P195, DOI 10.1124/pr.55.1.8; Cao RY, 2007, PROSTAG OTH LIPID M, V84, P34, DOI 10.1016/j.prostaglandins.2007.03.005; Carrell TWG, 2006, VASCULAR, V14, P9, DOI 10.2310/6670.2006.00008; Cipollone F, 2005, ARTERIOSCL THROM VAS, V25, P1665, DOI 10.1161/01.ATV.0000172632.96987.2d; de Gaetano G, 1999, HAEMOSTASIS, V29, P41; Eliason JL, 2005, CIRCULATION, V112, P232, DOI 10.1161/CIRCULATIONAHA.104.517391; Folkesson M, 2007, THROMB HAEMOSTASIS, V98, P427, DOI 10.1160/TH06-11-0638; Fontaine V, 2004, AM J PATHOL, V164, P2077, DOI 10.1016/S0002-9440(10)63766-2; Fontaine V, 2002, AM J PATHOL, V161, P1701, DOI 10.1016/S0002-9440(10)64447-1; Gacko M, 1998, CLIN CHIM ACTA, V271, P171, DOI 10.1016/S0009-8981(97)00246-5; GADALETA D, 1994, SURGERY, V116, P847; Hannawa KK, 2005, CIRCULATION, V112, P241, DOI 10.1161/CIRCULATIONAHA.105.535625; Hayashi S, 2000, CIRCULATION, V102, P1710, DOI 10.1161/01.CIR.102.14.1710; Hobeika MJ, 2007, J VASC SURG, V45, P849, DOI 10.1016/j.jvs.2006.09.066; Houard X, 2007, J PATHOL, V212, P20, DOI 10.1002/path.2148; Kazi M, 2003, J VASC SURG, V38, P1283, DOI 10.1016/S0741-5214(03)00791-2; Leclercq A, 2007, J LEUKOCYTE BIOL, V82, P1420, DOI 10.1189/jlb.1106671; Lindholt JS, 2008, VASC ENDOVASC SURG, V42, P329, DOI 10.1177/1538574408315205; Michel JB, 2007, ARTERIOSCL THROM VAS, V27, P1259, DOI 10.1161/ATVBAHA.106.137851; Mtairag EM, 2002, ARTERIOSCL THROM VAS, V22, P1824, DOI 10.1161/01.ATV.0000037102.31086.F4; Pagano MB, 2007, P NATL ACAD SCI USA, V104, P2855, DOI 10.1073/pnas.0606091104; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Sakalihasan N, 1996, J VASC SURG, V24, P127, DOI 10.1016/S0741-5214(96)70153-2; Sakata K, 2004, BRIT J PHARMACOL, V141, P449, DOI 10.1038/sj.bjp.0705641; Sarda-Mantel L, 2006, ARTERIOSCL THROM VAS, V26, P2153, DOI 10.1161/01.ATV.0000237605.25666.13; Spanbroek R, 2003, P NATL ACAD SCI USA, V100, P1238, DOI 10.1073/pnas.242716099; Touat Z, 2006, AM J PATHOL, V168, P1022, DOI 10.2353/ajpath.2006.050868; Trottier MD, 2008, P NATL ACAD SCI USA, V105, P2028, DOI 10.1073/pnas.0712003105; Vicioso MA, 1998, EUR CYTOKINE NETW, V9, P247; WRIGHT SD, 1988, P NATL ACAD SCI USA, V85, P7734, DOI 10.1073/pnas.85.20.7734; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099	42	89	92	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2009	23	5					1376	1383		10.1096/fj.08-116202	http://dx.doi.org/10.1096/fj.08-116202			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19136615				2022-12-25	WOS:000266651700014
J	Legardinier, S; Legrand, B; Raguenes-Nicol, C; Bondon, A; Hardy, S; Tascon, C; Le Rumeur, E; Hubert, JF				Legardinier, Sebastien; Legrand, Baptiste; Raguenes-Nicol, Celine; Bondon, Arnaud; Hardy, Serge; Tascon, Christophe; Le Rumeur, Elisabeth; Hubert, Jean-Francois			A Two-amino Acid Mutation Encountered in Duchenne Muscular Dystrophy Decreases Stability of the Rod Domain 23 (R23) Spectrin-like Repeat of Dystrophin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN STRUCTURES; CONFORMATIONAL UNIT; CONTAINING FRAGMENT; ERYTHROID SPECTRIN; STRUCTURAL REPEATS; BETA-DYSTROGLYCAN; POINT MUTATIONS; TANDEM REPEATS; ALPHA-SPECTRIN; GENE	Lack of functional dystrophin causes severe Duchenne muscular dystrophy. The subsarcolemmal location of dystrophin, as well as its association with both cytoskeleton and membrane, suggests a role in the mechanical regulation of muscular membrane stress. In particular, phenotype rescue in a Duchenne muscular dystrophy mice model has shown that some parts of the central rod domain of dystrophin, constituted by 24 spectrin-like repeats, are essential. In this study, we made use of rare missense pathogenic mutations in the dystrophin gene and analyzed the biochemical properties of the isolated repeat 23 bearing single or double mutations E2910V and N2912D found in muscle dystrophy with severity grading. No dramatic effect on secondary and tertiary structure of the repeat was found in mutants compared with wild type as revealed by circular dichroism and NMR. Thermal and chemical unfolding data from circular dichroism and tryptophan fluorescence show significant decrease of stability for the mutants, and stopped-flow spectroscopy shows decreased refolding rates. The most deleterious single mutation is the N2912D replacement, although we observe additive effects of the two mutations on repeat stability. Based on three-dimensional structures built by homology molecular modeling, we discuss the modifications of the mutation-induced repeat stability. We conclude that the main forces involved in repeat stability are electrostatic inter-helix interactions that are disrupted following mutations. This study represents the first analysis at the protein level of the consequences of missense mutations in the human dystrophin rod domain. Our results suggest that it may participate in mechanical weakening of dystrophin-deficient muscle.	[Legardinier, Sebastien; Legrand, Baptiste; Raguenes-Nicol, Celine; Bondon, Arnaud; Tascon, Christophe; Le Rumeur, Elisabeth; Hubert, Jean-Francois] Univ Rennes 1, CNRS, UMR Interact Cellulaires & Mol 6026, Fac Med,Equipe RMN & Interact Lipides Prot,IFR 14, F-35043 Rennes, France; [Hardy, Serge] Univ Rennes 1, CNRS, UMR Genet & Dev 6061, Fac Med,IFR 140, F-35043 Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Hubert, JF (corresponding author), Univ Rennes 1, CNRS, UMR Interact Cellulaires & Mol 6026, Fac Med,Equipe RMN & Interact Lipides Prot,IFR 14, CS 34317, F-35043 Rennes, France.	jfhubert@univ-rennes1.fr	Raguenes-Nicol, Celine/I-2693-2015; Legrand, Baptiste/ABB-2552-2021	Raguenes-Nicol, Celine/0000-0001-8428-9558; bondon, arnaud/0000-0002-9229-6317; Legrand, Baptiste/0000-0001-8931-7757	Association Francaise Contre les Myopathies	Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported in part by the Association Francaise Contre les Myopathies. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; An XL, 2006, J BIOL CHEM, V281, P10527, DOI 10.1074/jbc.M513725200; Baker RD, 2001, LIFETIME DATA ANAL, V7, P65, DOI 10.1023/A:1009677227030; Batey S, 2005, J MOL BIOL, V349, P1045, DOI 10.1016/j.jmb.2005.04.028; Beroud C, 2007, HUM MUTAT, V28, P196, DOI 10.1002/humu.20428; Calvert R, 1996, BIOPHYS J, V71, P1605, DOI 10.1016/S0006-3495(96)79363-3; Chaturvedi LS, 2001, EXP MOL MED, V33, P251, DOI 10.1038/emm.2001.41; DARRAS BT, 1988, AM J HUM GENET, V43, P620; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; Ervasti JM, 1993, CURR OPIN CELL BIOL, V5, P82, DOI 10.1016/S0955-0674(05)80012-2; Feng JN, 2002, MOL GENET METAB, V77, P119, DOI 10.1016/S1096-7192(02)00153-1; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; Hnia K, 2007, BIOCHEM J, V401, P667, DOI 10.1042/BJ20061051; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hofstra RMW, 2004, HUM MUTAT, V23, P57, DOI 10.1002/humu.10283; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KAHANA E, 1994, J MOL BIOL, V235, P1271, DOI 10.1006/jmbi.1994.1080; KAHANA E, 1995, BIOCHEMISTRY-US, V34, P8110, DOI 10.1021/bi00025a017; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1990, J BIOL CHEM, V265, P4560; Kusunoki H, 2004, J MOL BIOL, V344, P495, DOI 10.1016/j.jmb.2004.09.019; Kusunoki H, 2004, STRUCTURE, V12, P645, DOI 10.1016/j.str.2004.02.022; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Le Rumeur E, 2003, J BIOL CHEM, V278, P5993, DOI 10.1074/jbc.M207321200; Legardinier S, 2008, BBA-PROTEINS PROTEOM, V1784, P672, DOI 10.1016/j.bbapap.2007.12.014; LENK U, 1994, NEUROMUSCULAR DISORD, V4, P411, DOI 10.1016/0960-8966(94)90080-9; Long F, 2007, PROTEIN SCI, V16, P2519, DOI 10.1110/ps.073115307; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MACDONALD RI, 1994, P NATL ACAD SCI USA, V91, P1299, DOI 10.1073/pnas.91.4.1299; MacDonald RI, 2001, BIOCHEMISTRY-US, V40, P3974, DOI 10.1021/bi0025159; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Mendell JR, 2001, NEUROLOGY, V57, P645, DOI 10.1212/WNL.57.4.645; Norwood FLM, 2000, STRUCTURE, V8, P481, DOI 10.1016/S0969-2126(00)00132-5; PARRY DAD, 1992, BIOPHYS J, V61, P858, DOI 10.1016/S0006-3495(92)81893-3; PRIOR TW, 1995, HUM MUTAT, V5, P263, DOI 10.1002/humu.1380050312; ROBERTS RG, 1994, HUM MUTAT, V4, P1, DOI 10.1002/humu.1380040102; Saadat L, 2006, BBA-PROTEINS PROTEOM, V1764, P943, DOI 10.1016/j.bbapap.2006.02.012; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schnell JR, 2005, PROTEIN SCI, V14, P2421, DOI 10.1110/ps.051528905; SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4; SIPPL MJ, 1993, J COMPUT AID MOL DES, V7, P473, DOI 10.1007/BF02337562; SPEICHER DW, 1984, NATURE, V311, P177, DOI 10.1038/311177a0; White S, 2002, AM J HUM GENET, V71, P365, DOI 10.1086/341942; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; WINDER SJ, 1995, FEBS LETT, V369, P27, DOI 10.1016/0014-5793(95)00398-S; WINOGRAD E, 1991, P NATL ACAD SCI USA, V88, P10788, DOI 10.1073/pnas.88.23.10788; ZHOU NE, 1992, J BIOL CHEM, V267, P2664	55	27	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8822	8832		10.1074/jbc.M805846200	http://dx.doi.org/10.1074/jbc.M805846200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19158079	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000264397800065
J	Legesse-Miller, A; Elemento, O; Pfau, SJ; Forman, JJ; Tavazoie, S; Coller, HA				Legesse-Miller, Aster; Elemento, Olivier; Pfau, Sarah J.; Forman, Joshua J.; Tavazoie, Saeed; Coller, Hilary A.			let-7 Overexpression Leads to an Increased Fraction of Cells in G(2)/M, Direct Down-regulation of Cdc34, and Stabilization of Wee1 Kinase in Primary Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER CELLS; MICRORNAS; TRANSFORMATION; PROLIFERATION; EXPRESSION; PROGNOSIS; PATHWAYS; TARGETS; GROWTH; GENES	microRNAs play a critically important role in a wide array of biological processes including those implicated in cancer, neuro-degenerative and metabolic disorders, and viral infection. Although we have begun to understand microRNA biogenesis and function, experimental demonstration of their functional effects and the molecular mechanisms by which they function remains a challenge. Members of the let-7/miR-98 family play a critical role in cell cycle control with respect to differentiation and tumorigenesis. In this study, we show that exogenous addition of pre-let-7 in primary human fibroblasts results in a decrease in cell number and an increased fraction of cells in the G(2)/M cell cycle phase. Combining microarray techniques with DNA sequence analysis to identify potential let-7 targets, we discovered 838 genes with a let-7 binding site in their 3'-untranslated region that were down-regulated upon overexpression of let-7b. Among these genes is cdc34, the ubiquitin-conjugating enzyme of the Skp1/cullin/F-box (SCF) complex. Cdc34 protein levels are strongly down-regulated by let-7 overexpression. Reporter assays demonstrated direct regulation of the cdc34 3'-untranslated region by let-7. We hypothesized that low Cdc34 levels would result in decreased SCF activity, stabilization of the SCF target Wee1, and G(2)/M accumulation. Consistent with this hypothesis, small interfering RNA-mediated down-regulation of Wee1 reversed the G(2)/M phenotype induced by let-7 overexpression. We conclude that Cdc34 is a functional target of let-7 and that let-7 induces down-regulation of Cdc34, stabilization of the Wee1 kinase, and an increased fraction of cells in G(2)/M in primary fibroblasts.	[Legesse-Miller, Aster; Elemento, Olivier; Pfau, Sarah J.; Forman, Joshua J.; Tavazoie, Saeed; Coller, Hilary A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Elemento, Olivier; Tavazoie, Saeed] Princeton Univ, Lewis Sigler Inst Integrat Gen, Princeton, NJ 08544 USA	Princeton University; Princeton University	Coller, HA (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	hcoller@princeton.edu		Forman, Joshua/0000-0001-7762-0062; Pfau, Sarah/0000-0001-7528-0666	National Institutes of Health [R01 GM081686]; PhRMA Foundation [2007RSGl9572]; NIGMS Center of Excellence [P50 GM071508]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086465, P50GM071508, R01GM081686] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PhRMA Foundation; NIGMS Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01 GM081686. This work was also supported in part by Grant 2007RSGl9572 from the PhRMA Foundation ( to H. A. C.) and by National Institutes of Health Grant P50 GM071508 from the NIGMS Center of Excellence ( to H. A. C., A. L. and S. T.). The costs of publication of this article were defrayed in part by the payment of page charges.	Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Inamura K, 2007, LUNG CANCER, V58, P392, DOI 10.1016/j.lungcan.2007.07.013; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Michael WM, 1998, SCIENCE, V282, P1886, DOI 10.1126/science.282.5395.1886; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	23	91	95	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6605	6609		10.1074/jbc.C900002200	http://dx.doi.org/10.1074/jbc.C900002200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19126550	Green Published, hybrid			2022-12-25	WOS:000263919000004
J	Perlmutter, JD; Braun, AR; Sachs, JN				Perlmutter, Jason D.; Braun, Anthony R.; Sachs, Jonathan N.			Curvature Dynamics of alpha-Synuclein Familial Parkinson Disease Mutants MOLECULAR SIMULATIONS OF THE MICELLE- AND BILAYER-BOUND FORMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA COMPONENT; LIPID-BILAYERS; SECONDARY STRUCTURE; MEMBRANE-BINDING; LINKED MUTATIONS; FIBRIL FORMATION; PROTEIN; HELIX; PATHOGENESIS; AGGREGATION	alpha-Synuclein remains a protein of interest due to its propensity to form fibrillar aggregates in neurodegenerative disease and its putative function in synaptic vesicle regulation. Herein, we present a series of atomistic molecular dynamics simulations of wild-type alpha-synuclein and three Parkinson disease familial mutants (A30P, A53T, and E46K) in two distinct environments. First, in order to match recent NMR experiments, we have simulated each protein bound to an SDS detergent micelle. Second, in order to connect more closely to the true biological environment, we have simulated the proteins bound to a 1,2-dioleoyl-sn-glycero-3-phosphoserine lipid bilayer. In the micelle-bound case, we find that the wild type and all of the variants of alpha-synuclein flatten the underlying micelle, decreasing its surface area. A30P is known to lessen alpha-synuclein/membrane affinity and, consistent with experiment, destabilizes the simulated secondary structure. In the case of A53T, our simulations reveal a range of stabilizing hydrogen bonds that form with the threonine. In both environments, the E46K mutation, which is known to increase bilayer affinity, leads to an additional hydrogen bond between the protein and either the detergent or lipid. Simulations indicate that alpha S and its variants are less dynamic in the bilayer than in the micelle. Furthermore, the simulations of the mutants suggest how changes in the structure and dynamics of alpha-synuclein may affect its biological role.	[Perlmutter, Jason D.; Braun, Anthony R.; Sachs, Jonathan N.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Sachs, JN (corresponding author), 312 Church St SE,7-126 Hasselmo Hall, Minneapolis, MN 55455 USA.	jnsachs@umn.edu		Perlmutter, Jason/0000-0003-2855-2360; Braun, Anthony/0000-0002-9942-3390				Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; Bortolus M, 2008, J AM CHEM SOC, V130, P6690, DOI 10.1021/ja8010429; Buck M, 2006, BIOPHYS J, V90, pL36, DOI 10.1529/biophysj.105.078154; Bussell R, 2005, PROTEIN SCI, V14, P862, DOI 10.1110/ps.041255905; Bussell R, 2004, BIOCHEMISTRY-US, V43, P4810, DOI 10.1021/bi036135+; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; Choi W, 2004, FEBS LETT, V576, P363, DOI 10.1016/j.febslet.2004.09.038; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Drescher M, 2008, J AM CHEM SOC, V130, P7796, DOI 10.1021/ja801594s; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Garg G, 2005, J PHYS CHEM B, V109, P1340, DOI 10.1021/jp0472663; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Irizarry MC, 1996, J NEUROPATH EXP NEUR, V55, P889, DOI 10.1097/00005072-199608000-00004; IWAI A, 1995, BIOCHEMISTRY-US, V34, P10139, DOI 10.1021/bi00032a006; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kamp F, 2006, J BIOL CHEM, V281, P9251, DOI 10.1074/jbc.M512292200; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Kucerka N, 2008, BIOPHYS J, V95, P2792, DOI 10.1529/biophysj.107.122465; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lee HJ, 2002, J BIOL CHEM, V277, P671, DOI 10.1074/jbc.M107045200; Leontiadou H, 2004, BIOPHYS J, V86, P2156, DOI 10.1016/S0006-3495(04)74275-7; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; McLean PJ, 2000, J BIOL CHEM, V275, P8812, DOI 10.1074/jbc.275.12.8812; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mihajlovic M, 2008, PROTEINS, V70, P761, DOI 10.1002/prot.21558; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Narayanan V, 2001, BIOCHEMISTRY-US, V40, P9927, DOI 10.1021/bi002952n; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Ohkubo YZ, 2008, STRUCTURE, V16, P72, DOI 10.1016/j.str.2007.10.021; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Pitman MC, 2004, BIOCHEMISTRY-US, V43, P15318, DOI 10.1021/bi048231w; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rueda M, 2007, P NATL ACAD SCI USA, V104, P796, DOI 10.1073/pnas.0605534104; Sachs JN, 2003, CHEM PHYS LIPIDS, V126, P211, DOI 10.1016/j.chemphyslip.2003.08.001; Sachs JN, 2006, ANNU REV BIOCHEM, V75, P707, DOI 10.1146/annurev.biochem.75.110105.142336; SEGREST JP, 1974, FEBS LETT, V38, P247, DOI 10.1016/0014-5793(74)80064-5; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tarek M, 2005, BIOPHYS J, V88, P4045, DOI 10.1529/biophysj.104.050617; Tsigelny IF, 2007, FEBS J, V274, P1862, DOI 10.1111/j.1742-4658.2007.05733.x; Ulmer TS, 2005, J BIOL CHEM, V280, P43179, DOI 10.1074/jbc.M507624200; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Yavich L, 2004, J NEUROSCI, V24, P11165, DOI 10.1523/JNEUROSCI.2559-04.2004; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	65	81	81	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7177	7189		10.1074/jbc.M808895200	http://dx.doi.org/10.1074/jbc.M808895200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19126542	Green Published, hybrid			2022-12-25	WOS:000263919000065
J	Kaminska, M; Havrylenko, S; Decottignies, P; Gillet, S; Le Marechal, P; Negrutskii, B; Mirande, M				Kaminska, Monika; Havrylenko, Svitlana; Decottignies, Paulette; Gillet, Sylvie; Le Marechal, Pierre; Negrutskii, Boris; Mirande, Marc			Dissection of the Structural Organization of the Aminoacyl-tRNA Synthetase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; MACROMOLECULAR COMPLEXES; POLYPEPTIDE COMPONENTS; P43 COMPONENT; PURIFICATION; RABBIT; SHEEP; IDENTIFICATION; ASSEMBLAGE; LIVER	The spatio-temporal organization of proteins within the cytoplasm of eukaryotic cells rests in part on the assembly of stable and transient multiprotein complexes. Here we examined the assembly of the multiaminoacyl-tRNA synthetase complex (MARS) in human cells. This complex contains nine aminoacyl-tRNA synthetases and three auxiliary proteins and is a hallmark of metazoan species. Isolation of the complexes has been performed by tandem affinity purification from human cells in culture. To understand the rules of assembly of this particle, expression of the three nonsynthetase components of MARS, p18, p38, and p43, was blocked by stable small interfering RNA silencing. The lack of these components was not lethal for the cells, but cell growth was slightly reduced. The residual complexes that could form in vivo in the absence of the auxiliary proteins were isolated by tandem affinity purification. From the repertoire of the subcomplexes that could be isolated, a comprehensive map of protein-protein interactions mediating complex assembly is deduced. The data are consistent with a structural role of the three nonsynthetase components of MARS, with p38 connecting two subcomplexes that may form in the absence of p38.	[Kaminska, Monika; Havrylenko, Svitlana; Mirande, Marc] CNRS, Lab Enzymol & Biochim Struct, F-91190 Gif Sur Yvette, France; [Havrylenko, Svitlana; Negrutskii, Boris] Inst Mol Biol & Genet, UA-03143 Kiev, Ukraine; [Decottignies, Paulette; Gillet, Sylvie; Le Marechal, Pierre] Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, CNRS, UMR 8619, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Mirande, M (corresponding author), CNRS, Lab Enzymol & Biochim Struct, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France.	Mirande@lebs.cnrs-gif.fr	Gillet, Sylvie/A-3227-2017; Negrutskii, Boris/G-6439-2016	Gillet, Sylvie/0000-0002-3732-4696; Negrutskii, Boris/0000-0001-5974-1629	CNRS; Association pour la Recherche sur le Cancer; La Ligue	CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); La Ligue	This work was supported by grants from the CNRS, the Association pour la Recherche sur le Cancer, and "La Ligue."	Barton GM, 2002, P NATL ACAD SCI USA, V99, P14943, DOI 10.1073/pnas.242594499; BEC G, 1989, J BIOL CHEM, V264, P21131; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; CIRAKOGLU B, 1985, EUR J BIOCHEM, V151, P101, DOI 10.1111/j.1432-1033.1985.tb09074.x; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Han JM, 2006, J BIOL CHEM, V281, P38663, DOI 10.1074/jbc.M605211200; Jiang SL, 2005, FEBS LETT, V579, P6049, DOI 10.1016/j.febslet.2005.09.062; JOHNSON DL, 1981, P NATL ACAD SCI-BIOL, V78, P4059, DOI 10.1073/pnas.78.7.4059; JOHNSON DL, 1980, J BIOL CHEM, V255, P4362; Kaminska M, 2001, BIOCHEMISTRY-US, V40, P14309, DOI 10.1021/bi015670b; KAO J, 1994, J BIOL CHEM, V269, P9774; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Kim JY, 2002, P NATL ACAD SCI USA, V99, P7912, DOI 10.1073/pnas.122110199; Ko YG, 2001, J BIOL CHEM, V276, P23028, DOI 10.1074/jbc.M101544200; Kunst CB, 1997, NAT GENET, V15, P91, DOI 10.1038/ng0197-91; KUSTER B, 2002, NATURE, V415, P141; Lee YN, 2004, IMMUNITY, V20, P145, DOI 10.1016/S1074-7613(04)00020-2; Mansilla F, 2002, BIOCHEM J, V365, P669, DOI 10.1042/BJ20011681; MIRANDE M, 1982, J BIOL CHEM, V257, P1056; MIRANDE M, 1982, J BIOL CHEM, V257, P1049; MIRANDE M, 2005, AMINOACYL TRNA SYNTH, P298; MOTORIN YA, 1988, FEBS LETT, V238, P262, DOI 10.1016/0014-5793(88)80492-7; Negrutskii BS, 1999, J BIOL CHEM, V274, P4545, DOI 10.1074/jbc.274.8.4545; Norcum MT, 1998, PROTEIN SCI, V7, P79, DOI 10.1002/pro.5560070108; NORCUM MT, 1991, J BIOL CHEM, V266, P15398; Park BJ, 2005, CELL, V120, P209, DOI 10.1016/j.cell.2004.11.054; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; Quevillon S, 1997, J BIOL CHEM, V272, P32573, DOI 10.1074/jbc.272.51.32573; Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003; Rho SB, 1999, P NATL ACAD SCI USA, V96, P4488, DOI 10.1073/pnas.96.8.4488; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Robinson JC, 2000, J MOL BIOL, V304, P983, DOI 10.1006/jmbi.2000.4242; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Shalak V, 2001, J BIOL CHEM, V276, P23769, DOI 10.1074/jbc.M100489200; Shalak V, 2007, J BIOL CHEM, V282, P10935, DOI 10.1074/jbc.M611737200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SIHAG RK, 1983, J BIOL CHEM, V258, P1846; Wolfe CL, 2005, J BIOL CHEM, V280, P38870, DOI 10.1074/jbc.M502759200	39	51	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6053	6060		10.1074/jbc.M809636200	http://dx.doi.org/10.1074/jbc.M809636200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19131329	hybrid			2022-12-25	WOS:000263742700007
J	Tomaru, T; Steger, DJ; Lefterova, MI; Schupp, M; Lazar, MA				Tomaru, Takuya; Steger, David J.; Lefterova, Martina I.; Schupp, Michael; Lazar, Mitchell A.			Adipocyte-specific Expression of Murine Resistin Is Mediated by Synergism between Peroxisome Proliferator-activated Receptor gamma and CCAAT/Enhancer-binding Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 DIABETES-MELLITUS; RNA-POLYMERASE-II; PPAR-GAMMA; INSULIN-RESISTANCE; ADIPOSE-TISSUE; 3T3-L1 ADIPOCYTES; C/EBP-ALPHA; TRANSCRIPTIONAL REGULATION; GLUCOSE-HOMEOSTASIS; HUMAN GENOME	Resistin antagonizes insulin action in mouse, making it a potential therapeutic target for treating metabolic diseases such as diabetes. To better understand how mouse resistin gene (Retn) expression is restricted to fat tissue, we identified an adipocyte-specific enhancer located similar to 8.8-kb upstream of the transcription start site. This region contains a binding site for the master adipogenic regulator peroxisome proliferator-activated receptor gamma (PPAR gamma), and binds endogenous PPAR gamma together with its partner retinoid-X receptor alpha(RXR alpha). It also contains three binding sites for CCAAT/enhancer-binding protein (C/EBP), and is bound by endogenous C/EBP alpha and C/EBP beta in adipocytes. Exogenous expression of PPAR gamma/RXR alpha and C/EBP alpha in non-adipocyte cells synergistically drives robust expression from the enhancer. Although PPAR gamma ligands repress Retn transcription in adipocytes, rosiglitazone paradoxically stimulates the enhancer activity, suggesting that the enhancer is not directly involved in negative regulation. Unlike expression of Retn in mouse, human resistin (RETN) is expressed primarily in macrophages. Interestingly, the region homologous to the mouse Retn enhancer in the human gene contains all three C/EBP elements, but is not conserved for the sequence bound by PPAR gamma. Furthermore, it displays little or no binding by PPAR gamma in vitro. Taken together, the data suggest that a composite enhancer binding both PPAR gamma and C/EBP factors confers adipocyte-specific expression to Retn in mouse, and its absence from the human gene may explain the lack of adipocyte expression in humans.	[Lazar, Mitchell A.] Univ Penn, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Lazar, MA (corresponding author), Univ Penn, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, 700 CRB,415 Curie Blvd, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Lazar, Mitchell A/AAF-3738-2019	Schupp, Michael/0000-0003-3720-1052	National Institutes of Health [P01 DK49210]; Picower Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Picower Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK P01 DK49210 ( to M. A. L.). This work was also supported by the Picower Foundation.	Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CHAWLA A, 1993, J BIOL CHEM, V268, P16265; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; Chung SS, 2006, BIOCHEM BIOPH RES CO, V348, P253, DOI 10.1016/j.bbrc.2006.07.048; Clarke SL, 1997, BIOCHEM BIOPH RES CO, V240, P99, DOI 10.1006/bbrc.1997.7627; Conneely KN, 2004, DIABETOLOGIA, V47, P1782, DOI 10.1007/s00125-004-1537-x; DELEGEANE AM, 1987, MOL CELL BIOL, V7, P3994, DOI 10.1128/MCB.7.11.3994; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Farmer SR, 2008, GENE DEV, V22, P1269, DOI 10.1101/gad.1681308; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Hartman HB, 2002, J BIOL CHEM, V277, P19754, DOI 10.1074/jbc.M201451200; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Hollenberg AN, 1997, J BIOL CHEM, V272, P5283, DOI 10.1074/jbc.272.8.5283; Hwang CS, 1996, P NATL ACAD SCI USA, V93, P873, DOI 10.1073/pnas.93.2.873; Jonke J, 2002, OBES RES, V10, P1; Jung HS, 2005, METABOLISM, V54, P314, DOI 10.1016/j.metabol.2004.05.019; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kamin D, 2005, J CLIN ENDOCR METAB, V90, P3423, DOI 10.1210/jc.2005-0287; Kielstein JT, 2003, AM J KIDNEY DIS, V42, P62, DOI 10.1016/S0272-6386(03)00409-8; LAUER MN, 2002, J CLIN ENDOCR METAB, V87, P2407; Lazar MA, 2007, HORM METAB RES, V39, P710, DOI 10.1055/s-2007-985897; Lee JH, 2003, J CLIN ENDOCR METAB, V88, P4848, DOI 10.1210/jc.2003-030519; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045; Li Y, 2002, MOL ENDOCRINOL, V16, P1040, DOI 10.1210/me.16.5.1040; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; MACDOUGALD OA, 1994, J BIOL CHEM, V269, P19041; MACDOUGALD OA, 1995, J BIOL CHEM, V270, P647, DOI 10.1074/jbc.270.2.647; McTernan CL, 2002, LANCET, V359, P46, DOI 10.1016/S0140-6736(02)07281-1; McTernan PG, 2002, J CLIN ENDOCR METAB, V87, P2407, DOI 10.1210/jc.87.5.2407; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Nishikata I, 2003, BLOOD, V102, P3323, DOI 10.1182/blood-2002-12-3944; Osawa H, 2004, AM J HUM GENET, V75, P678, DOI 10.1086/424761; Osawa H, 2005, BIOCHEM BIOPH RES CO, V335, P596, DOI 10.1016/j.bbrc.2005.07.122; Osawa H, 2008, CLIN ENDOCRINOL, V69, P74, DOI 10.1111/j.1365-2265.2007.03154.x; Osawa H, 2007, DIABETES CARE, V30, P1501, DOI 10.2337/dc06-1936; PARK EA, 1990, MOL CELL BIOL, V10, P6264, DOI 10.1128/MCB.10.12.6264; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Rajala MW, 2003, J CLIN INVEST, V111, P225, DOI 10.1172/JCI200316521; Rajala MW, 2002, MOL ENDOCRINOL, V16, P1920, DOI 10.1210/me.2002-0048; Rangwala SM, 2004, DIABETES, V53, P1937, DOI 10.2337/diabetes.53.8.1937; Reaven G, 2004, RECENT PROG HORM RES, V59, P207, DOI 10.1210/rp.59.1.207; Roh TY, 2007, GENOME RES, V17, P74, DOI 10.1101/gr.5767907; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Savage DB, 2001, DIABETES, V50, P2199, DOI 10.2337/diabetes.50.10.2199; SAWADOGO M, 1988, J BIOL CHEM, V263, P11985; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seo JB, 2003, MOL ENDOCRINOL, V17, P1522, DOI 10.1210/me.2003-0028; Smith SR, 2003, DIABETES, V52, P1611, DOI 10.2337/diabetes.52.7.1611; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Steppan CM, 2001, P NATL ACAD SCI USA, V98, P502, DOI 10.1073/pnas.98.2.502; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Vidal-Puig A, 2001, CLIN ENDOCRINOL, V55, P437, DOI 10.1046/j.1365-2265.2001.01377.x; Wang H, 2002, J CLIN ENDOCR METAB, V87, P2520, DOI 10.1210/jc.87.6.2520; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; WILLIAMS SC, 1991, GENE DEV, V5, P1553, DOI 10.1101/gad.5.9.1553; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350; Yang RZ, 2003, BIOCHEM BIOPH RES CO, V310, P927, DOI 10.1016/j.bbrc.2003.09.093; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168	73	55	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6116	6125		10.1074/jbc.M808407200	http://dx.doi.org/10.1074/jbc.M808407200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19126543	Green Published, hybrid			2022-12-25	WOS:000263742700014
J	Woo, HH; Zhou, Y; Yi, X; David, CL; Zheng, W; Gilmore-Hebert, M; Kluger, HM; Ulukus, EC; Baker, T; Stoffer, JB; Chambers, SK				Woo, H-H; Zhou, Y.; Yi, X.; David, C. L.; Zheng, W.; Gilmore-Hebert, M.; Kluger, H. M.; Ulukus, E. C.; Baker, T.; Stoffer, J. B.; Chambers, S. K.			Regulation of non-AU-rich element containing c-fms proto-oncogene expression by HuR in breast cancer	ONCOGENE			English	Article						breast cancer; c-fms proto-oncogene; post-transcriptional regulation; HuR	MESSENGER-RNA STABILITY; STIMULATING FACTOR-1 RECEPTOR; CSF-1 RECEPTOR; BINDING PROTEIN; POSTTRANSCRIPTIONAL REGULATION; CYCLOOXYGENASE-2 EXPRESSION; MONOCYTIC DIFFERENTIATION; QUANTITATIVE-ANALYSIS; CROSS-LINKING; CARCINOMA	The role of RNA-binding proteins in cancer biology is recognized increasingly. The nucleocytoplasmic shuttling and AU-rich RNA-binding protein HuR stabilizes several cancer-related target mRNAs. The proto-oncogene c-fms, whose 3'untranslated region (3'UTR) is not AU-rich, is associated with poor prognosis in breast cancer. Using a large breast-cancer tissue array (N=670), we found nuclear HuR expression to be associated with nodal metastasis and independently with poor survival (P=0.03, RR 1.45), as well as to be co-expressed with c-fms in the breast tumors (P=0.0007). We described c-fms mRNA as a direct target of HuR in vivo, and that HuR bound specifically to a 69-nt region containing 'CUU' motifs in 3'UTR c-fms RNA. Overexpressing or silencing HuR significantly up-or down-regulated c-fms RNA expression, respectively. We also found that known glucocorticoid stimulation of c-fms RNA and protein is largely dependent on the presence of HuR. HuR, by binding to the 69-nt wild type, but not mutant, c-fms sequence can regulate reporter gene expression post-transcriptionally. We are the first to describe that HuR can regulate gene expression by binding non-AU-rich sequences in 3'UTR c-fms RNA. Collectively, our findings suggest that HuR plays a supportive role for c-fms in breast cancer progression by binding a 69-nt element in its 3'UTR, thus regulating its expression.	[Woo, H-H; Zhou, Y.; Yi, X.; David, C. L.; Zheng, W.; Baker, T.; Stoffer, J. B.; Chambers, S. K.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85724 USA; [Gilmore-Hebert, M.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Ulukus, E. C.] Dokuz Eylul Univ, Izmir, Turkey	Arizona Center Cancer Care; University of Arizona; Yale University; Dokuz Eylul University	Chambers, SK (corresponding author), Univ Arizona, Arizona Canc Ctr, POB 245024, Tucson, AZ 85724 USA.	schambers@azcc.arizona.edu			Department of Defense [DAMD 17-02-1-0633]; Susan G Komen Breast Cancer Foundation; Breast Cancer Alliance	Department of Defense(United States Department of Defense); Susan G Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Breast Cancer Alliance	This work was supported by Department of Defense Grant DAMD 17-02-1-0633 ( to SKC), and in part by the Susan G Komen Breast Cancer Foundation and by the Breast Cancer Alliance ( to HMK). We thank Joan A Steitz for providing the GST plasmids, and Ite A Laird-Offringa for providing purified HuR protein.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; ALLEGRA JC, 1979, CANCER RES, V39, P1447; Apponi LH, 2007, MOL CELL BIOL, V27, P6569, DOI 10.1128/MCB.00881-07; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Camp RL, 2003, CANCER RES, V63, P1445; Camp RL, 2000, LAB INVEST, V80, P1943, DOI 10.1038/labinvest.3780204; Chambers SK, 1997, CLIN CANCER RES, V3, P999; Chambers SK, 2004, AM J OBSTET GYNECOL, V190, P974, DOI 10.1016/j.ajog.2004.01.021; CHAMBERS SK, 1993, EXP HEMATOL, V21, P1328; CHAMBERS SK, 1994, STEROIDS, V59, P514, DOI 10.1016/0039-128X(94)90069-8; Chen CYA, 2002, MOL CELL BIOL, V22, P7268, DOI 10.1128/MCB.22.20.7268-7278.2002; COUSSENS L, 1986, NATURE, V320, P277, DOI 10.1038/320277a0; De Boer P, 2006, RNA, V12, P263, DOI 10.1261/rna.2257606; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; de Silanes IL, 2003, ONCOGENE, V22, P7146, DOI 10.1038/sj.onc.1206862; Denkert C, 2004, CLIN CANCER RES, V10, P5580, DOI 10.1158/1078-0432.CCR-04-0070; Erkinheimo TL, 2003, CANCER RES, V63, P7591; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Gallouzi IE, 2001, SCIENCE, V294, P1895, DOI 10.1126/science.1064693; GOTT JM, 1991, BIOCHEMISTRY-US, V30, P6290, DOI 10.1021/bi00239a030; Heinonen M, 2005, CANCER RES, V65, P2157, DOI 10.1158/0008-5472.CAN-04-3765; Ide H, 2002, P NATL ACAD SCI USA, V99, P14404, DOI 10.1073/pnas.222537099; Kacinski BM, 2001, J SOC GYNECOL INVEST, V8, P114, DOI 10.1016/S1071-5576(01)00092-2; KACINSKI BM, 1991, ONCOGENE, V6, P941; Kluger HM, 2004, CLIN CANCER RES, V10, P173, DOI 10.1158/1078-0432.CCR-0699-3; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Maher MG, 1998, CLIN CANCER RES, V4, P1851; Meisner NC, 2004, CHEMBIOCHEM, V5, P1432, DOI 10.1002/cbic.200400219; Moore MJ, 2002, CELL, V108, P431, DOI 10.1016/S0092-8674(02)00645-1; Nabors LB, 2001, CANCER RES, V61, P2154; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; SAPI E, 1995, ONCOGENE, V10, P529; Sapi E, 1996, CANCER RES, V56, P5704; STOLOW DT, 1990, MOL CELL BIOL, V10, P5937, DOI 10.1128/MCB.10.11.5937; Sureban SM, 2007, GASTROENTEROLOGY, V132, P1055, DOI 10.1053/j.gastro.2006.12.031; Toy EP, 2005, CLIN EXP METASTAS, V22, P1, DOI 10.1007/s10585-005-0718-4; Urlaub H, 2000, J BIOL CHEM, V275, P41458, DOI 10.1074/jbc.M007434200; WEBER B, 1989, MOL CELL BIOL, V9, P769, DOI 10.1128/MCB.9.2.769; Wein G, 2003, EUR J BIOCHEM, V270, P350, DOI 10.1046/j.1432-1033.2003.03396.x; Yeap BB, 2002, J BIOL CHEM, V277, P27183, DOI 10.1074/jbc.M202883200	42	29	30	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 5	2009	28	9					1176	1186		10.1038/onc.2008.469	http://dx.doi.org/10.1038/onc.2008.469			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	415AH	19151756				2022-12-25	WOS:000263906200002
J	Kallio, JM; Hakulinen, N; Kallio, JP; Niemi, MH; Karkkainen, S; Rouvinen, J				Kallio, Johanna M.; Hakulinen, Nina; Kallio, Juha P.; Niemi, Merja H.; Karkkainen, Susanna; Rouvinen, Juha			The Contribution of Polystyrene Nanospheres towards the Crystallization of Proteins	PLOS ONE			English	Article							ATOMIC-RESOLUTION STRUCTURE; TRICHODERMA-REESEI; HETEROGENEOUS NUCLEATION; CRYSTAL-STRUCTURES; HYDROPHOBIN; EXPRESSION; GROWTH; HFBII	Background: Protein crystallization is a slow process of trial and error and limits the amount of solved protein structures. Search of a universal heterogeneous nucleant is an effort to facilitate crystallizability of proteins. Methodology: The effect of polystyrene nanospheres on protein crystallization were tested with three commercial proteins: lysozyme, xylanase, xylose isomerase, and with five research target proteins: hydrophobins HFBI and HFBII, laccase, sarcosine dimethylglycine N-methyltransferase (SDMT), and anti-testosterone Fab fragment 5F2. The use of nanospheres both in screening and as an additive for known crystallization conditions was studied. In screening, the addition of an aqueous solution of nanosphere to the crystallization drop had a significant positive effect on crystallization success in comparison to the control screen. As an additive in hydrophobin crystallization, the nanospheres altered the crystal packing, most likely due to the amphiphilic nature of hydrophobins. In the case of laccase, nanospheres could be used as an alternative for streak-seeding, which insofar had remained the only technique to produce high-diffracting crystals. With methyltransferase SDMT the nanospheres, used also as an additive, produced fewer, larger crystals in less time. Nanospheres, combined with the streak-seeding method, produced single 5F2 Fab crystals in shorter equilibration times. Conclusions: All in all, the use of nanospheres in protein crystallization proved to be beneficial, both when screening new crystallization conditions to promote nucleation and when used as an additive to produce better quality crystals, faster. The polystyrene nanospheres are easy to use, commercially available and close to being inert, as even with amphiphilic proteins only the crystal packing is altered and the nanospheres do not interfere with the structure and function of the protein.	[Kallio, Johanna M.; Hakulinen, Nina; Kallio, Juha P.; Niemi, Merja H.; Karkkainen, Susanna; Rouvinen, Juha] Univ Joensuu, Dept Chem, FIN-80101 Joensuu, Finland	University of Eastern Finland	Kallio, JM (corresponding author), Univ Joensuu, Dept Chem, POB 111, FIN-80101 Joensuu, Finland.	juha.rouvinen@joensuu.fi	Kallio, Juha/AAE-4318-2021; Hakanpää, Johanna M/A-6958-2011	Hakanpää, Johanna M/0000-0003-0110-1439; Hakulinen, Nina/0000-0003-4471-7188; Kallio, Juha Pekka/0000-0003-3092-4012; Rouvinen, Juha/0000-0003-1843-5718; Kallio, Johanna/0000-0001-7330-8928	MaBio-project by European Social Fund; State Provincial Office of Eastern Finland; Department of Education and culture; Academy of Finland [115085]; National Graduate School in Informational and Structural Biology; Sigrid Juselius Foundation; European Community, Research Infrastructure Action [RII3-CT-2004-506008]	MaBio-project by European Social Fund; State Provincial Office of Eastern Finland; Department of Education and culture; Academy of Finland(Academy of Finland); National Graduate School in Informational and Structural Biology; Sigrid Juselius Foundation(Sigrid Juselius Foundation); European Community, Research Infrastructure Action(European Commission)	Funding from MaBio-project by European Social Fund and the State Provincial Office of Eastern Finland, Department of Education and culture (J.M.K.), the Academy of Finland, Project 115085 (N.H., J.P.K.), and the National Graduate School in Informational and Structural Biology (M.H.N.) is gratefully acknowledged. This work was also supported by the Sigrid Juselius Foundation. The support of the European Community, Research Infrastructure Action under the FP6 "Structuring the European Research Area Specific Programme" to the EMBL Hamburg Outstation, Contract Number RII3-CT-2004-506008, is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERTON G, 1945, J BIOL CHEM, V157, P43; Bergfors T, 2003, J STRUCT BIOL, V142, P66, DOI 10.1016/S1047-8477(03)00039-X; CARRELL HL, 1989, P NATL ACAD SCI USA, V86, P4440, DOI 10.1073/pnas.86.12.4440; Chayen NE, 2006, P NATL ACAD SCI USA, V103, P597, DOI 10.1073/pnas.0504860102; D'Arcy A, 2003, ACTA CRYSTALLOGR D, V59, P1343, DOI 10.1107/S0907444903009430; D'Arcy A, 2007, ACTA CRYSTALLOGR D, V63, P550, DOI 10.1107/S0907444907007652; Fermani S, 2001, J CRYST GROWTH, V224, P327, DOI 10.1016/S0022-0248(01)00797-7; Georgieva DG, 2007, ACTA CRYSTALLOGR D, V63, P564, DOI 10.1107/S0907444907007810; Hakanpaa J, 2004, J BIOL CHEM, V279, P534, DOI 10.1074/jbc.M309650200; Hakanpaa J, 2004, ACTA CRYSTALLOGR D, V60, P163, DOI 10.1107/S0907444903024430; Hakanpaa J, 2006, PROTEIN SCI, V15, P2129, DOI 10.1110/ps.062326706; Hakulinen N, 2008, J STRUCT BIOL, V162, P29, DOI 10.1016/j.jsb.2007.12.003; Hakulinen N, 2006, BIOCHEM BIOPH RES CO, V350, P929, DOI 10.1016/j.bbrc.2006.09.144; Ireton GC, 2004, ACTA CRYSTALLOGR D, V60, P601, DOI 10.1107/S0907444903029664; Kallio JM, 2007, J BIOL CHEM, V282, P28733, DOI 10.1074/jbc.M704238200; Kiiskinen LL, 2004, MICROBIOL-SGM, V150, P3065, DOI 10.1099/mic.0.27147-0; Linse S, 2007, P NATL ACAD SCI USA, V104, P8691, DOI 10.1073/pnas.0701250104; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCPHERSON A, 1988, SCIENCE, V239, P385, DOI 10.1126/science.239.4838.385; NakariSetala T, 1996, EUR J BIOCHEM, V235, P248, DOI 10.1111/j.1432-1033.1996.00248.x; NakariSetala T, 1997, EUR J BIOCHEM, V248, P415, DOI 10.1111/j.1432-1033.1997.00415.x; Nyyssola A, 2001, APPL ENVIRON MICROB, V67, P2044, DOI 10.1128/AEM.67.5.2044-2050.2001; Pechkova E, 2005, ACTA CRYSTALLOGR D, V61, P809, DOI 10.1107/S0907444905006566; Pechkova E, 2004, TRENDS BIOTECHNOL, V22, P117, DOI 10.1016/j.tibtech.2004.01.011; Pechkova E, 2001, J CRYST GROWTH, V231, P599, DOI 10.1016/S0022-0248(01)01450-6; Thakur AS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001091; TORRONEN A, 1994, EMBO J, V13, P2493, DOI 10.1002/j.1460-2075.1994.tb06536.x	27	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2009	4	1							e4198	10.1371/journal.pone.0004198	http://dx.doi.org/10.1371/journal.pone.0004198			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IG	19145241	Green Submitted, Green Published, gold			2022-12-25	WOS:000265479800005
J	Ling, DJ; Song, HJ; Garza, D; Neufeld, TP; Salvaterra, PM				Ling, Daijun; Song, Ho-Juhn; Garza, Dan; Neufeld, Thomas P.; Salvaterra, Paul M.			Abeta42-Induced Neurodegeneration via an Age-Dependent Autophagic-Lysosomal Injury in Drosophila	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; PROTEIN-DEGRADATION; AMYLOID-BETA; TOXICITY; NEURONS; MACROAUTOPHAGY; BIOGENESIS; EXPRESSION; PATHWAY; PLAQUES	The mechanism of widespread neuronal death occurring in Alzheimer's disease (AD) remains enigmatic even after extensive investigation during the last two decades. Amyloid beta 42 peptide (A beta(1-42)) is believed to play a causative role in the development of AD. Here we expressed human A beta(1-42) and amyloid beta 40 (A beta(1-40)) in Drosophila neurons. A beta(1-42) but not A beta(1-40) causes an extensive accumulation of autophagic vesicles that become increasingly dysfunctional with age. A beta(1-42)-induced impairment of the degradative function, as well as the structural integrity, of post-lysosomal autophagic vesicles triggers a neurodegenerative cascade that can be enhanced by autophagy activation or partially rescued by autophagy inhibition. Compromise and leakage from post-lysosomal vesicles result in cytosolic acidification, additional damage to membranes and organelles, and erosive destruction of cytoplasm leading to eventual neuron death. Neuronal autophagy initially appears to play a pro-survival role that changes in an age-dependent way to a pro-death role in the context of A beta(1-42) expression. Our in vivo observations provide a mechanistic understanding for the differential neurotoxicity of A beta(1-42) and A beta(1-40), and reveal an A beta(1-42)-induced death execution pathway mediated by an age-dependent autophagic-lysosomal injury.	[Salvaterra, Paul M.] Beckman Res Inst City Hope, Div Neurosci, Duarte, CA USA; [Salvaterra, Paul M.] Beckman Res Inst City Hope, Grad Sch Biol Sci, Duarte, CA USA; [Song, Ho-Juhn; Garza, Dan] Novartis Inst Biomed Rese, Dept Dev & Mol Pathway, Cambridge, MA USA; [Neufeld, Thomas P.] Univ Minnesota, Dept Genet, Minneapolis, MN 55455 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Novartis; University of Minnesota System; University of Minnesota Twin Cities	Ling, DJ (corresponding author), Beckman Res Inst City Hope, Div Neurosci, Duarte, CA USA.	psalv@coh.org		Neufeld, Thomas/0000-0001-5659-4811	American Health Assistant Foundation; Sidell-Kagan Foundation; John Douglas French Alzheimer's Foundation [fellowship]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062509] Funding Source: NIH RePORTER	American Health Assistant Foundation; Sidell-Kagan Foundation; John Douglas French Alzheimer's Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the American Health Assistant Foundation and Sidell-Kagan Foundation to P.M.S. and a fellowship from the John Douglas French Alzheimer's Foundation to D.L. (2005 2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Boland Barry, 2006, Molecular Aspects of Medicine, V27, P503, DOI 10.1016/j.mam.2006.08.009; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; Drachman DA, 2007, CURR NEUROL NEUROSCI, V7, P265, DOI 10.1007/s11910-007-0040-4; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Florez-McClure ML, 2007, AUTOPHAGY, V3, P569, DOI 10.4161/auto.4776; Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hariri M, 2000, MOL BIOL CELL, V11, P255, DOI 10.1091/mbc.11.1.255; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lajoie P, 2005, J CELL SCI, V118, P1991, DOI 10.1242/jcs.02324; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Martinez-Vicente M, 2005, EXP GERONTOL, V40, P622, DOI 10.1016/j.exger.2005.07.005; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2006, TRENDS NEUROSCI, V29, P528, DOI 10.1016/j.tins.2006.07.003; PICKFORD F, 2008, J CLIN INVEST; Pramatarova A, 2006, MOL CELL BIOL, V26, P1510, DOI 10.1128/MCB.26.4.1510-1517.2006; Pulipparacharuvil S, 2005, J CELL SCI, V118, P3663, DOI 10.1242/jcs.02502; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rodriguez-Enriquez S, 2006, AUTOPHAGY, V2, P39, DOI 10.4161/auto.2229; Rubinszfein DC, 2005, AUTOPHAGY, V1, P11, DOI 10.4161/auto.1.1.1513; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rudnicki DD, 2008, J NEUROPATH EXP NEUR, V67, P366, DOI 10.1097/NEN.0b013e31816b4aee; Salvaterra Paul M., 2001, Gene Expression Patterns, V1, P73, DOI 10.1016/S1567-133X(01)00011-4; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Shacka JJ, 2008, FRONT BIOSCI-LANDMRK, V13, P718, DOI 10.2741/2714; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Vellai T, 2007, AUTOPHAGY, V3, P461, DOI 10.4161/auto.4282; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Wong E.S., 2008, HUM MOL GENET; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082	42	131	141	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2009	4	1							e4201	10.1371/journal.pone.0004201	http://dx.doi.org/10.1371/journal.pone.0004201			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IG	19145255	Green Published, Green Submitted, gold			2022-12-25	WOS:000265479800007
J	Uchimura, A; Hidaka, Y; Hirabayashi, T; Hirabayashi, M; Yagi, T				Uchimura, Arikuni; Hidaka, Yuko; Hirabayashi, Takahiro; Hirabayashi, Masumi; Yagi, Takeshi			DNA Polymerase delta Is Required for Early Mammalian Embryogenesis	PLOS ONE			English	Article								Background: In eukaryotic cells, DNA polymerase delta ( Pol delta), whose catalytic subunit p125 is encoded in the Pold1 gene, plays a central role in chromosomal DNA replication, repair, and recombination. However, the physiological role of the Pol delta in mammalian development has not been thoroughly investigated. Methodology/Principal Findings: To examine this role, we used a gene targeting strategy to generate two kinds of Pold1 mutant mice: Pol delta-null ( Pold1(-/-)) mice and D400A exchanged Pol delta (Pold1(exo/exo)) mice. The D400A exchange caused deficient 3'-5' exonuclease activity in the Pol delta protein. In Pol delta-null mice, heterozygous mice developed normally despite a reduction in Pold1 protein quantity. In contrast, homozygous Pold1(-/-) mice suffered from peri-implantation lethality. Although Pold1(-/-) blastocysts appeared normal, their in vitro culture showed defects in outgrowth proliferation and DNA synthesis and frequent spontaneous apoptosis, indicating Pol delta participates in DNA replication during mouse embryogenesis. In Pold1(exo/exo) mice, although heterozygous Pold1(exo/+) mice were normal and healthy, Pold1(exo/exo) and Pold1(exo/-) mice suffered from tumorigenesis. Conclusions: These results clearly demonstrate that DNA polymerase delta is essential for mammalian early embryogenesis and that the 3'-5' exonuclease activity of DNA polymerase delta is dispensable for normal development but necessary to suppress tumorigenesis.	[Uchimura, Arikuni; Hirabayashi, Takahiro; Yagi, Takeshi] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Hidaka, Yuko] Neo Morgan Lab Inc, Tokyo, Japan; [Hirabayashi, Masumi] Natl Inst Physiol Sci, Okazaki, Aichi, Japan	Osaka University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Uchimura, A (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan.	uchimura@fbs.osaka-u.ac.jp	Hirabayashi, Masumi/C-8935-2019	Hirabayashi, Masumi/0000-0002-1059-5883; Uchimura, Arikuni/0000-0003-2435-7082	Ministry of Education, Culture, Sports, Science and Technology, Japan; National Institute for Physiological Sciences, Japan; Neo-Morgan Laboratory Inc	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute for Physiological Sciences, Japan; Neo-Morgan Laboratory Inc	This work was supported by a Grant-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (T.Y.), a grant from the Co-operative Study Program of National Institute for Physiological Sciences, Japan, and Neo-Morgan Laboratory Inc. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLOW PW, 1972, J EMBRYOL EXP MORPH, V27, P447; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; Burgers PMJ, 2001, J BIOL CHEM, V276, P43487, DOI 10.1074/jbc.R100056200; FRANCESCONI S, 1993, NUCLEIC ACIDS RES, V21, P3821, DOI 10.1093/nar/21.16.3821; Fukui T, 2004, GENES CELLS, V9, P179, DOI 10.1111/j.1356-9597.2004.00716.x; Garcia JS, 2004, NUCLEIC ACIDS RES, V32, P3005, DOI 10.1093/nar/gkh623; GARDNER RL, 1983, INT REV EXP PATHOL, V24, P63; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Goldsby RE, 2002, P NATL ACAD SCI USA, V99, P15560, DOI 10.1073/pnas.232340999; Goldsby RE, 2001, NAT MED, V7, P638, DOI 10.1038/88963; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Kamel D, 1997, BIOL REPROD, V57, P1367, DOI 10.1095/biolreprod57.6.1367; Larsen E, 2003, MOL CELL BIOL, V23, P5346, DOI 10.1128/MCB.23.15.5346-5353.2003; Le Cam L, 2004, MOL CELL BIOL, V24, P6467, DOI 10.1128/MCB.24.14.6467-6475.2004; Li L, 2005, GENETICS, V170, P569, DOI 10.1534/genetics.104.040295; MORRISON A, 1993, EMBO J, V12, P1467, DOI 10.1002/j.1460-2075.1993.tb05790.x; ORNITZ DM, 1991, P NATL ACAD SCI USA, V88, P698, DOI 10.1073/pnas.88.3.698; Pavlov YI, 2006, INT REV CYTOL, V255, P41, DOI 10.1016/S0074-7696(06)55002-8; Plaster N, 2006, CELL DEATH DIFFER, V13, P223, DOI 10.1038/sj.cdd.4401747; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; SIMON M, 1991, EMBO J, V10, P2165, DOI 10.1002/j.1460-2075.1991.tb07751.x; Sugo N, 2000, EMBO J, V19, P1397, DOI 10.1093/emboj/19.6.1397; Taniguchi M, 1998, NUCLEIC ACIDS RES, V26, P679, DOI 10.1093/nar/26.2.679; Ueno M, 2005, MOL CELL BIOL, V25, P10528, DOI 10.1128/MCB.25.23.10528-10532.2005; VARMUZA S, 1988, DEVELOPMENT, V102, P127; Venkatesan RN, 2007, MOL CELL BIOL, V27, P7669, DOI 10.1128/MCB.00002-07; Venkatesan RN, 2006, J BIOL CHEM, V281, P4486, DOI 10.1074/jbc.M510245200; Vidal F, 1998, MOL REPROD DEV, V51, P274, DOI 10.1002/(SICI)1098-2795(199811)51:3&lt;274::AID-MRD6&gt;3.0.CO;2-M; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Wittschieben J, 2000, CURR BIOL, V10, P1217, DOI 10.1016/S0960-9822(00)00725-9; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; Yoshida K, 2001, MOL CELL BIOL, V21, P4598, DOI 10.1128/MCB.21.14.4598-4603.2001	39	35	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2009	4	1							e4184	10.1371/journal.pone.0004184	http://dx.doi.org/10.1371/journal.pone.0004184			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IG	19145245	gold, Green Submitted, Green Published			2022-12-25	WOS:000265479800002
J	Huang, XX; Lu, B; Yu, WB; Fang, Q; Liu, L; Zhuang, K; Shen, TT; Wang, HB; Tian, P; Zhang, LQ; Chen, ZW				Huang, Xiaoxing; Lu, Bin; Yu, Wenbo; Fang, Qing; Liu, Li; Zhuang, Ke; Shen, Tingting; Wang, Haibo; Tian, Po; Zhang, Linqi; Chen, Zhiwei			A Novel Replication-Competent Vaccinia Vector MVTT Is Superior to MVA for Inducing High Levels of Neutralizing Antibody via Mucosal Vaccination	PLOS ONE			English	Article								Mucosal vaccination offers great advantage for inducing protective immune response to prevent viral transmission and dissemination. Here, we report our findings of a head-to-head comparison of two viral vectors modified vaccinia Ankara (MVA) and a novel replication-competent modified vaccinia Tian Tan (MVTT) for inducing neutralizing antibodies (Nabs) via intramuscular and mucosal vaccinations in mice. MVTT is an attenuated variant of the wild-type VTT, which was historically used as a smallpox vaccine for millions of Chinese people. The spike glycoprotein (S) of SARS-CoV was used as the test antigen after the S gene was constructed in the identical genomic location of two vectors to generate vaccine candidates MVTT-S and MVA-S. Using identical doses, MVTT-S induced lower levels (similar to 2-3-fold) of anti- SARS-CoV neutralizing antibodies (Nabs) than MVA-S through intramuscular inoculation. MVTT-S, however, was capable of inducing consistently 20-to-100-fold higher levels of Nabs than MVA-S when inoculated via either intranasal or intraoral routes. These levels of MVTT-S-induced Nab responses were substantially (similar to 10-fold) higher than that induced via the intramuscular route in the same experiments. Moreover, pre-exposure to the wild-type VTT via intranasal or intraoral route impaired the Nab response via the same routes of MVTT-S vaccination probably due to the pre-existing anti- VTT Nab response. The efficacy of intranasal or intraoral vaccination, however, was still 20-to-50-fold better than intramuscular inoculation despite the subcutaneous pre-exposure to wild-type VTT. Our data have implications for people who maintain low levels of anti-VTT Nabs after historical smallpox vaccination. MVTT is therefore an attractive live viral vector for mucosal vaccination.	[Huang, Xiaoxing; Lu, Bin; Yu, Wenbo; Fang, Qing; Zhuang, Ke; Shen, Tingting; Wang, Haibo; Tian, Po] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Modern Virol Res Ctr & AIDS Ctr, Hubei, Peoples R China; [Yu, Wenbo; Liu, Li; Wang, Haibo; Chen, Zhiwei] Univ Hong Kong, Li Ka Shing Fac Med, AIDS Inst, Hong Kong, Peoples R China; [Zhang, Linqi] Chinese Acad Med Sci, Inst Pathogen Biol, AIDS Res Ctr, Beijing, Peoples R China; [Zhang, Linqi] Tsinghua Univ, Comprehensive AIDS Res Ctr, Beijing, Peoples R China	Wuhan University; University of Hong Kong; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Tsinghua University	Huang, XX (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Modern Virol Res Ctr & AIDS Ctr, Hubei, Peoples R China.	zchenai@hku.hk	Tang, Xian/C-5535-2015; Liu, Li/ABA-8315-2020; ZHANG, LIN/GYD-9123-2022; Chen, Zhiwei/B-7793-2019	Liu, Li/0000-0003-2566-7357; Chen, Zhiwei/0000-0002-4511-2888; Yu, Wenbo/0000-0002-9237-272X	National Basic Research Program of China [2006CB504208]; HK-RGC [762208]; University Development Fund of the University of Hong Kong to its AIDS Institute	National Basic Research Program of China(National Basic Research Program of China); HK-RGC(Hong Kong Research Grants Council); University Development Fund of the University of Hong Kong to its AIDS Institute	This work was supported by the National Basic Research Program of China (the 973 project 2006CB504208), HK-RGC 762208 and the University Development Fund of the University of Hong Kong to its AIDS Institute. Sponsors were not involved in the study.	Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Antonis AFG, 2007, VACCINE, V25, P4818, DOI 10.1016/j.vaccine.2007.04.002; Ba L, 2007, APPL MICROBIOL BIOT, V76, P1131, DOI 10.1007/s00253-007-1073-y; Belyakov IM, 1998, J VIROL, V72, P8264, DOI 10.1128/JVI.72.10.8264-8272.1998; Bisht H, 2004, P NATL ACAD SCI USA, V101, P6641, DOI 10.1073/pnas.0401939101; BROCHIER B, 1991, NATURE, V354, P520, DOI 10.1038/354520a0; Chen ZW, 2008, JAIDS-J ACQ IMM DEF, V47, P412, DOI 10.1097/QAI.0b013e3181651bb2; Chen ZW, 2005, J VIROL, V79, P2678, DOI 10.1128/JVI.79.5.2678-2688.2005; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; Earl PL, 2003, J VIROL, V77, P10684, DOI 10.1128/JVI.77.19.10684-10688.2003; Fang Q, 2005, VIROLOGY, V335, P242, DOI 10.1016/j.virol.2005.02.014; Gallwitz S, 2003, J CLIN MICROBIOL, V41, P4068, DOI 10.1128/JCM.41.9.4068-4070.2003; Gherardi MM, 2005, J GEN VIROL, V86, P2925, DOI 10.1099/vir.0.81181-0; Gomez CE, 2007, VACCINE, V25, P2863, DOI 10.1016/j.vaccine.2006.09.090; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hanke T, 2007, J GEN VIROL, V88, P1, DOI 10.1099/vir.0.82493-0; HENDERSON DA, 1976, SCI AM, V235, P25, DOI 10.1038/scientificamerican1076-25; Heymann DL, 2004, INT J INFECT DIS, V8, pS15, DOI 10.1016/j.ijid.2004.09.005; HOU YT, 1985, J GEN VIROL, V66, P1819, DOI 10.1099/0022-1317-66-8-1819; HU SL, 1986, NATURE, V320, P537, DOI 10.1038/320537a0; Huang XG, 2007, VACCINE, V25, P8874, DOI 10.1016/j.vaccine.2007.08.066; Davies DH, 2007, PROTEOMICS, V7, P1678, DOI 10.1002/pmic.200600926; KANTOR J, 1992, CANCER RES, V52, P6917; Karkhanis LU, 2007, CURR PHARM DESIGN, V13, P2015; Kreijtz JHCM, 2007, J INFECT DIS, V195, P1598, DOI 10.1086/517614; LIU GQ, 1990, SCI CHINA SER B, V33, P188; Liu V J, 1989, Proc Chin Acad Med Sci Peking Union Med Coll, V4, P215; Mackett M, 1992, Biotechnology, V24, P495; McCurdy LH, 2004, CLIN INFECT DIS, V38, P1749, DOI 10.1086/421266; Meseda CA, 2005, VIROLOGY, V339, P164, DOI 10.1016/j.virol.2005.06.002; MOSS B, 1992, CURR TOP MICROBIOL, V158, P25; Naito T, 2007, J GEN VIROL, V88, P61, DOI 10.1099/vir.0.82216-0; NAM J H, 2007, Acta Virol, V51, P125; Ober BT, 2002, J VIROL, V76, P7713, DOI 10.1128/JVI.76.15.7713-7723.2002; Olszewska W, 2004, VACCINE, V23, P215, DOI 10.1016/j.vaccine.2004.05.015; PAOLETTI E, 1995, DEV BIOL STAND, V84, P159; Sauri MA, 2002, NEW ENGL J MED, V347, P689; Slifka Mark K, 2005, Med Immunol, V4, P2, DOI 10.1186/1476-9433-4-2; Smith JM, 2004, AIDS RES HUM RETROV, V20, P1335, DOI 10.1089/aid.2004.20.1335; SULLIVAN V, 1987, J GEN VIROL, V68, P2587, DOI 10.1099/0022-1317-68-10-2587; Weyer J, 2007, VACCINE, V25, P4213, DOI 10.1016/j.vaccine.2007.02.084; Wyatt LS, 2004, AIDS RES HUM RETROV, V20, P645, DOI 10.1089/0889222041217428; YILMA TD, 1989, VACCINE, V7, P484, DOI 10.1016/0264-410X(89)90266-1; Zhu WJ, 2007, J VIROL METHODS, V144, P17, DOI 10.1016/j.jviromet.2007.03.012	44	37	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2009	4	1							e4180	10.1371/journal.pone.0004180	http://dx.doi.org/10.1371/journal.pone.0004180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IE	19159014	Green Submitted, Green Published, gold			2022-12-25	WOS:000265479600001
J	Xia, XH; Holcik, M				Xia, Xuhua; Holcik, Martin			Strong Eukaryotic IRESs Have Weak Secondary Structure	PLOS ONE			English	Article								Background: The objective of this work was to investigate the hypothesis that eukaryotic Internal Ribosome Entry Sites (IRES) lack secondary structure and to examine the generality of the hypothesis. Methodology/Principal Findings: IRESs of the yeast and the fruit fly are located in the 5'UTR immediately upstream of the initiation codon. The minimum folding energy (MFE) of 60 nt RNA segments immediately upstream of the initiation codons was calculated as a proxy of secondary structure stability. MFE of the reverse complements of these 60 nt segments was also calculated. The relationship between MFE and empirically determined IRES activity was investigated to test the hypothesis that strong IRES activity is associated with weak secondary structure. We show that IRES activity in the yeast and the fruit fly correlates strongly with the structural stability, with highest IRES activity found in RNA segments that exhibit the weakest secondary structure. Conclusions: We found that a subset of eukaryotic IRESs exhibits very low secondary structure in the 5'-UTR sequences immediately upstream of the initiation codon. The consistency in results between the yeast and the fruit fly suggests a possible shared mechanism of cap-independent translation initiation that relies on an unstructured RNA segment.	Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Xia, Xuhua] Univ Ottawa, Ctr Advanced Res Environm Genom, Ottawa, ON, Canada; [Xia, Xuhua] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON K1N 6N5, Canada; [Holcik, Martin] Childrens Hosp East Ontario, Apoptosis Res Ctr, Ottawa, ON, Canada; [Holcik, Martin] Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada; [Holcik, Martin] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1N 6N5, Canada	University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa	Xia, XH (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	martin@arc.cheo.ca	Holcik, Martin/E-5372-2011; Holcik, Martin/AAC-6660-2019; Xia, Xuhua/E-5264-2010	Holcik, Martin/0000-0002-1922-5299; Xia, Xuhua/0000-0002-3092-7566	Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research (CIHR)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird SD, 2007, NUCLEIC ACIDS RES, V35, P4664, DOI 10.1093/nar/gkm483; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Boehringer D, 2005, STRUCTURE, V13, P1695, DOI 10.1016/j.str.2005.08.008; Dorokhov YL, 2002, P NATL ACAD SCI USA, V99, P5301, DOI 10.1073/pnas.082107599; DOUDNA JA, 2007, TRANSLATIONAL CONTRO, P129; Elroy-Stein O., 2007, TRANSLATIONAL CONTRO, P155; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; Hernandez G, 2004, RNA, V10, P1783, DOI 10.1261/rna.7154104; Hernandez G, 2008, TRENDS BIOCHEM SCI, V33, P58, DOI 10.1016/j.tibs.2007.11.002; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; KOZAK M, 2007, GENE, V5, P5; Kozak M, 2007, J CELL BIOCHEM, V102, P280, DOI 10.1002/jcb.21464; Mitchell SA, 2003, MOL CELL, V11, P757, DOI 10.1016/S1097-2765(03)00093-5; Nevins TA, 2003, J BIOL CHEM, V278, P3572, DOI 10.1074/jbc.M206781200; SCHULER M, 2006, NAT STRUCT MOL BIOL, V19, P19; Terenin IM, 2005, MOL CELL BIOL, V25, P7879, DOI 10.1128/MCB.25.17.7879-7888.2005; Vazquez-Pianzola P, 2007, CELL DEATH DIFFER, V14, P286, DOI 10.1038/sj.cdd.4401990; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; XIA X, 2000, DATA ANAL MOL BIOL E; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	23	41	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2009	4	1							e4136	10.1371/journal.pone.0004136	http://dx.doi.org/10.1371/journal.pone.0004136			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FV	19125192	Green Published, gold, Green Submitted			2022-12-25	WOS:000265473100010
J	Dowdy, DW; Lourenco, MC; Cavalcante, SC; Saraceni, V; King, B; Golub, JE; Bishai, D; Durovni, B; Chaisson, RE; Dorman, SE				Dowdy, David W.; Lourenco, Maria C.; Cavalcante, Solange C.; Saraceni, Valeria; King, Bonnie; Golub, Jonathan E.; Bishai, David; Durovni, Betina; Chaisson, Richard E.; Dorman, Susan E.			Impact and Cost-Effectiveness of Culture for Diagnosis of Tuberculosis in HIV-Infected Brazilian Adults	PLOS ONE			English	Article								Background: Culture of Mycobacterium tuberculosis currently represents the closest "gold standard" for diagnosis of tuberculosis (TB), but operational data are scant on the impact and cost-effectiveness of TB culture for human immunodeficiency (HIV-) infected individuals in resource-limited settings. Methodology/Principal Findings: We recorded costs, laboratory results, and dates of initiating TB therapy in a centralized TB culture program for HIV- infected patients in Rio de Janeiro, Brazil, constructing a decision-analysis model to estimate the incremental cost-effectiveness of TB culture from the perspective of a public-sector TB control program. Of 217 TB suspects presenting between January 2006 and March 2008, 33 (15%) had culture-confirmed active tuberculosis; 23 (70%) were smear-negative. Among smear- negative, culture-positive patients, 6 (26%) began TB therapy before culture results were available, 11 (48%) began TB therapy after culture result availability, and 6 ( 26%) did not begin TB therapy within 180 days of presentation. The cost per negative culture was US$ 17.52 (solid media)-$23.50 ( liquid media). Per 1,000 TB suspects and compared with smear alone, TB culture with solid media would avert an estimated eight TB deaths (95% simulation interval [SI]: 4, 15) and 37 disability-adjusted life years (DALYs) ( 95% SI: 13, 76), at a cost of $36( 95% SI: $25, $50) per TB suspect or $962 (95% SI: $469, $2642) per DALY averted. Replacing solid media with automated liquid culture would avert one further death (95% SI: 21, 4) and eight DALYs (95% SI: 24, 23) at $2751 per DALY 95% SI: $680, dominated). The cost-effectiveness of TB culture was more sensitive to characteristics of the existing TB diagnostic system than to the accuracy or cost of TB culture. Conclusions/Significance: TB culture is potentially effective and cost-effective for HIV- positive patients in resource-constrained settings. Reliable transmission of culture results to patients and integration with existing systems are essential.	[Dowdy, David W.; King, Bonnie; Golub, Jonathan E.; Chaisson, Richard E.; Dorman, Susan E.] Johns Hopkins Univ Hosp, Sch Med, Ctr TB Res, Baltimore, MD 21287 USA; [Dowdy, David W.; Golub, Jonathan E.; Chaisson, Richard E.] Johns Hopkins Univ Hosp, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21287 USA; [Lourenco, Maria C.] Fundacao Oswaldo Cruz, Mycobacteriol Lab, Rio De Janeiro, Brazil; [Cavalcante, Solange C.; Saraceni, Valeria; Durovni, Betina] Municipal Hlth Secretariat, Communicable Dis Program, Rio De Janeiro, Brazil; [Bishai, David] Johns Hopkins Univ Hosp, Bloomberg Sch Publ Hlth, Dept Populat & Family Hlth Sci, Baltimore, MD 21287 USA; [Chaisson, Richard E.; Dorman, Susan E.] Johns Hopkins Univ Hosp, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Medicine; Fundacao Oswaldo Cruz; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Medicine	Dowdy, DW (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	dsusan1@jhmi.edu	, David Bishai/GRO-4211-2022	Bishai, David/0000-0003-0714-9062	Bill & Melinda Gates Foundation [19790-01]; Foundation for Innovative New Diagnostics; National Institutes of Health [5 T32 GMO7309, K24 AI 16137, K23 AI 51528]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI016137, K23AI051528, R01AI016137, R22AI016137] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Foundation for Innovative New Diagnostics; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Bill & Melinda Gates Foundation (Grant 19790-01), the Foundation for Innovative New Diagnostics, and the National Institutes of Health (Medical Scientist Training Program Award 5 T32 GMO7309 to DWD; K24 AI 16137 to REC, and K23 AI 51528 to SED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert H, 2004, INT J TUBERC LUNG D, V8, P240; [Anonymous], 2001, MACR HLTH INV HLTH E; [Anonymous], 2007, GLOB TUB CONTR SURV; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Apers L, 2003, INT J TUBERC LUNG D, V7, P376; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Burgess AL, 2001, AIDS, V15, P1875, DOI 10.1097/00002030-200109280-00018; *CENTR INT AG, 2007, WORLD FACTB; Cohen GM, 2007, AIDS, V21, pS81, DOI 10.1097/01.aids.0000279710.47298.5c; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; DELLALATTA P, 2004, CLIN MICROBIOLOGY PR, P7114; Dowdy DW, 2008, P NATL ACAD SCI USA, V105, P11293, DOI 10.1073/pnas.0800965105; Dowdy DW, 2006, AIDS, V20, P751, DOI 10.1097/01.aids.0000216376.07185.cc; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847; Hudson CP, 2000, INT J TUBERC LUNG D, V4, P240; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; Keeler Emmett, 2006, Nature, V444 Suppl 1, P49, DOI 10.1038/nature05446; Marras TK, 2007, THORAX, V62, P661, DOI 10.1136/thx.2006.070797; McGrath EE, 2007, LANCET, V370, P28, DOI 10.1016/S0140-6736(07)61044-7; MOHAN CI, 2005, THESIS J HOPKINS BLO; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Moulton LH, 2007, CLIN TRIALS, V4, P190, DOI 10.1177/1740774507076937; Page K, 2006, REICHMAN HERSHFELDS, P371; Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656; Russell LB, 1996, JAMA-J AM MED ASSOC, V276, P1172, DOI 10.1001/jama.276.14.1172; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Styblo K, 1991, EPIDEMIOLOGY TUBERCU; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; SUTHERLAND I, 1982, TUBERCLE, V63, P255, DOI 10.1016/S0041-3879(82)80013-5; Thomsen VO, 2002, SCAND J INFECT DIS, V34, P648, DOI 10.1080/00365540210147813; Wang JY, 2007, DIAGN MICR INFEC DIS, V59, P395, DOI 10.1016/j.diagmicrobio.2007.06.010; WHO, 2007, GLOB TB DAT; Woods GL, 2002, INFECT DIS CLIN N AM, V16, P127, DOI 10.1016/S0891-5520(03)00049-7	34	45	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4057	10.1371/journal.pone.0004057	http://dx.doi.org/10.1371/journal.pone.0004057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19129940	Green Published, Green Submitted, gold			2022-12-25	WOS:000265466000017
J	Huang, W; Eum, SY; Andras, IE; Hennig, B; Toborek, M				Huang, Wen; Eum, Sung Yong; Andras, Ibolya E.; Hennig, Bernhard; Toborek, Michal			PPAR alpha and PPAR gamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities	FASEB JOURNAL			English	Article						peroxisome proliferator-activated receptor; human immunodeficiency virus-1; brain endothelial cells; blood-brain barrier	BLOOD-BRAIN-BARRIER; PROLIFERATOR-ACTIVATED-RECEPTOR; TAT-INDUCED ALTERATIONS; CEREBROSPINAL-FLUID; MONOCYTE MIGRATION; ADHESION MOLECULE; ENDOTHELIAL-CELLS; ZONULA OCCLUDENS; DISRUPTION; EXPRESSION	The blood-brain barrier (BBB) plays an important role in HIV trafficking into the brain and the development of the central nervous system complications in HIV infection. Tight junctions are the main structural and functional elements that regulate the BBB integrity. Exposure of human brain microvascular endothelial cells (hCMEC/D3 cell line) to HIV-infected monocytes resulted in decreased expression of tight junction proteins, such as junctional adhesion molecule-A (JAM)-A, occludin, and zonula occludens (ZO)-1. Control experiments involved exposure to uninfected monocytes. Alterations of tight junction protein expression were associated with increased endothelial permeability and elevated transendothelial migration of HIV-infected monocytes across an in vitro model of the BBB. Notably, overexpression of the peroxisome proliferator-activated receptor (PPAR)alpha or PPAR gamma attenuated HIV-mediated dysregulation of tight junction proteins. With the use of exogenous PPAR gamma agonists and silencing of PPAR alpha or PPAR gamma, these protective effects were connected to down-regulation of matrix metalloproteinase (MMP) and proteasome activities. Indeed, the HIV-induced decrease in the expression of JAM-A and occludin was restored by inhibition of MMP activity. Moreover, both MMP and proteasome inhibitors attenuated HIV-mediated altered expression of ZO-1. The present data indicate that down-regulation of MMP and proteasome activities constitutes a novel mechanism of PPAR-induced protections against HIV-induced disruption of brain endothelial cells.-Huang, W., Eum, S. Y., Andras, I. E., Hennig, B., Toborek, M. PPAR alpha and PPAR gamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities. FASEB J. 23, 1596-1606 (2009)	[Toborek, Michal] Univ Kentucky, Med Ctr, Mol Neurosci & Vasc Biol Lab, Dept Neurosurg, Lexington, KY 40536 USA; [Hennig, Bernhard] Univ Kentucky, Coll Agr, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Toborek, M (corresponding author), Univ Kentucky, Med Ctr, Mol Neurosci & Vasc Biol Lab, Dept Neurosurg, 593 Wethington Bldg,900 S Limestone, Lexington, KY 40536 USA.	michal.toborek@uky.edu			 [MH-63022];  [MH-072567];  [NS-39254]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063022, R01MH072567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039254] Funding Source: NIH RePORTER	; ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants MH-63022, MH-072567, and NS-39254. PYK-JRCSF was obtained through the AIDS Research and Reference Reagent Program, National Institute on Aging, National Institutes of Health.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Andras IE, 2008, MOL PHARMACOL, V73, P1424, DOI 10.1124/mol.107.042028; Andras IE, 2005, J CEREBR BLOOD F MET, V25, P1159, DOI 10.1038/sj.jcbfm.9600115; Avison MJ, 2002, TRENDS NEUROSCI, V25, P468, DOI 10.1016/S0166-2236(02)02234-8; Banks WA, 2006, CURR HIV RES, V4, P259, DOI 10.2174/157016206777709447; Boven LA, 2000, NEUROPATH APPL NEURO, V26, P356, DOI 10.1046/j.1365-2990.2000.00255.x; Cabrero A., 2002, Current Drug Targets - Inflammation and Allergy, V1, P243, DOI 10.2174/1568010023344616; CANN AJ, 1990, J VIROL, V64, P4735, DOI 10.1128/JVI.64.10.4735-4742.1990; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; Conant K, 1999, ANN NEUROL, V46, P391, DOI 10.1002/1531-8249(199909)46:3<391::AID-ANA15>3.0.CO;2-0; D Kanmogne G, 2007, J CEREBR BLOOD F MET, V27, P123, DOI 10.1038/sj.jcbfm.9600330; Dallasta LM, 1999, AM J PATHOL, V155, P1915, DOI 10.1016/S0002-9440(10)65511-3; Dueck M, 2007, VIROLOGY, V361, P1, DOI 10.1016/j.virol.2007.01.018; Ebnet K, 2000, J BIOL CHEM, V275, P27979; Eugenin EA, 2006, J NEUROSCI, V26, P1098, DOI 10.1523/JNEUROSCI.3863-05.2006; FIGUEIREDOPEREIRA ME, 1994, J NEUROCHEM, V63, P1578; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Garcia-Bueno B, 2005, BIOL PSYCHIAT, V57, P885, DOI 10.1016/j.biopsych.2005.01.007; Girao H, 2007, J CELL BIOCHEM, V102, P719, DOI 10.1002/jcb.21351; Haorah J, 2007, J NEUROCHEM, V101, P566, DOI 10.1111/j.1471-4159.2006.04393.x; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hayes MM, 2002, J BIOL CHEM, V277, P16913, DOI 10.1074/jbc.M200875200; Huang W, 2008, J NEUROCHEM, V107, P497, DOI 10.1111/j.1471-4159.2008.05626.x; Israelian-Konaraki Zarmen, 2005, Cardiol Rev, V13, P240, DOI 10.1097/01.crd.0000137255.54390.12; Kamin D, 2005, J CLIN ENDOCR METAB, V90, P3423, DOI 10.1210/jc.2005-0287; Kintscher U, 2000, EUR J PHARMACOL, V401, P259, DOI 10.1016/S0014-2999(00)00461-1; Krebs F C, 2000, Adv Pharmacol, V49, P315; Lemoine M, 2006, AIDS, V20, P387, DOI 10.1097/01.aids.0000206503.01536.11; Li AC, 2006, ANNU REV PHARMACOL, V46, P1, DOI 10.1146/annurev.pharmtox.46.120604.141247; Liuzzi GM, 2000, J NEUROVIROL, V6, P156, DOI 10.3109/13550280009013159; Lopez-Herrera A, 2005, BBA-MOL BASIS DIS, V1741, P55, DOI 10.1016/j.bbadis.2004.12.001; Louie JL, 2002, EXP EYE RES, V75, P271, DOI 10.1006/exer.2002.2022; Lui WY, 2005, J CELL PHYSIOL, V203, P564, DOI 10.1002/jcp.20254; Lytle C, 2005, INFLAMM BOWEL DIS, V11, P231, DOI 10.1097/01.MIB.0000160805.46235.eb; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Marx N, 1999, ARTERIOSCL THROM VAS, V19, P546, DOI 10.1161/01.ATV.19.3.546; McCoig C, 2004, PEDIATR INFECT DIS J, V23, P114, DOI 10.1097/01.inf.0000109247.67480.7a; Muranaka K, 2006, INVEST OPHTH VIS SCI, V47, P4547, DOI 10.1167/iovs.05-1432; Nagasawa M, 2007, BIOCHEM PHARMACOL, V74, P1738, DOI 10.1016/j.bcp.2007.08.020; Nakamuta S, 2008, J NEUROVIROL, V14, P186, DOI 10.1080/13550280801993630; Pascale JM, 1997, CLIN DIAGN LAB IMMUN, V4, P474, DOI 10.1128/CDLI.4.4.474-477.1997; Pereira AMM, 2005, CLIN EXP METASTAS, V22, P285, DOI 10.1007/s10585-005-8672-8; Persidsky Y, 1997, J IMMUNOL, V158, P3499; Persidsky Y, 2001, J NEUROIMMUNOL, V114, P57, DOI 10.1016/S0165-5728(00)00454-9; Persidsky Y, 2006, IMMUNOL REV, V213, P180, DOI 10.1111/j.1600-065X.2006.00440.x; Persidsky Y, 2006, BLOOD, V107, P4770, DOI 10.1182/blood-2005-11-4721; Piccinini M, 2003, CURR DRUG TARGETS, V4, P657; Ramirez SH, 2008, J IMMUNOL, V180, P1854, DOI 10.4049/jimmunol.180.3.1854; REDDY MM, 1989, J CLIN LAB ANAL, V3, P199, DOI 10.1002/jcla.1860030402; Reijerkerk A, 2006, FASEB J, V20, P2550, DOI 10.1096/fj.06-6099fje; Rhodes R H, 1991, Pathol Annu, V26 Pt 2, P247; Rizzo G, 2006, CURR OPIN PHARMACOL, V6, P421, DOI 10.1016/j.coph.2006.03.012; Rumbaugh J, 2006, FASEB J, V20, P1736, DOI 10.1096/fj.05-5619fje; Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057; SINGER EJ, 1994, J ACQ IMMUN DEF SYND, V7, P265; Sixt SU, 2007, AM J PHYSIOL-LUNG C, V292, pL1280, DOI 10.1152/ajplung.00140.2006; Sporer B, 1998, J INFECT DIS, V178, P854, DOI 10.1086/515342; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Takaki K, 2006, INFLAMM RES, V55, P10, DOI 10.1007/s00011-005-0002-8; Toborek M, 2005, CELL MOL NEUROBIOL, V25, P181, DOI 10.1007/s10571-004-1383-x; van Wijk JPH, 2005, ANN INTERN MED, V143, P337, DOI 10.7326/0003-4819-143-5-200509060-00009; Varley CL, 2006, J CELL PHYSIOL, V208, P407, DOI 10.1002/jcp.20676; Vieira O, 2000, FASEB J, V14, P532, DOI 10.1096/fasebj.14.3.532; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wu DT, 2000, J NEUROVIROL, V6, pS82; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Zhong Y, 2008, J NEUROSCI, V28, P7788, DOI 10.1523/JNEUROSCI.0061-08.2008; Zozulya AL, 2007, J IMMUNOL, V178, P520, DOI 10.4049/jimmunol.178.1.520	69	90	94	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2009	23	5					1596	1606		10.1096/fj.08-121624	http://dx.doi.org/10.1096/fj.08-121624			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19141539	Green Published			2022-12-25	WOS:000266651700034
J	Crawford, J; Grujic, O; Bruic, E; Czjzek, M; Grigg, ME; Boulanger, MJ				Crawford, Joanna; Grujic, Ognjen; Bruic, Ekaterina; Czjzek, Mirjam; Grigg, Michael E.; Boulanger, Martin J.			Structural Characterization of the Bradyzoite Surface Antigen (BSR4) from Toxoplasma gondii, a Unique Addition to the Surface Antigen Glycoprotein 1-related Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY SOLUTION; MACROMOLECULAR STRUCTURES; CRYSTAL-STRUCTURE; SCATTERING; ENCEPHALITIS; DIFFRACTION; ALIGNMENT; PROTEINS	Toxoplasma gondii is an obligate intracellular protozoan parasite that infects nearly one-third of the human population. The success of T. gondii is based on its complex life cycle; a lytic tachyzoite form disseminates infection, whereas an encysted bradyzoite form establishes a latent, chronic infection. Persistence and transmissibility is central to the survival of the parasite and is, in part, mediated by a family of antigenically distinct surface antigen glycoprotein (SAG)-related sequences (SRS) adhesins that play a dual role in host cell attachment and host immune evasion. More than 160 members of the SRS family have been identified with only the tachyzoite-expressed SAG1 structurally characterized. Here we report the first structural description of the bradyzoite adhesin BSR4 using x-ray crystallography and small angle x-ray scattering. The 1.90-angstrom crystal structure of BSR4 reveals an architecture comprised of tandem beta sandwich domains organized in a head to tail fashion with the N-terminal domain responsible for dimer formation. A restructured topology in BSR4 results in a ligand-binding site that is significantly reorganized in both structure and chemistry relative to SAG1, consistent with BSR4 binding a distinct physiological ligand. The small angle x-ray scattering solution structure of BSR4 highlights a potentially important structural role for the interdomain polymorphic linker that imparts significant flexibility that may promote structural adaptation during ligand binding. This study reveals an unexpected level of structural diversity within the SRS superfamily and provides important insight into the role of these virulence factors.	[Crawford, Joanna; Grujic, Ognjen; Bruic, Ekaterina; Boulanger, Martin J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Czjzek, Mirjam] Univ Paris 06, CNRS, Stn Biol Roscoff, UMR7139, F-29682 Roscoff, France; [Grigg, Michael E.] NIAID, Mol Parasitol Unit, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	University of Victoria; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Boulanger, MJ (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	mboulang@uvic.ca	Crawford, Joanna/F-9135-2013	Crawford, Joanna/0000-0003-0786-6889	Canadian Institutes for Health Research; Intramural Research Program of the NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI001017, ZIAAI001017] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Intramural Research Program of the NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a research grant from the Canadian Institutes for Health Research (to M.J.B.) and by the Intramural Research Program of the NIAID, National Institutes of Health (to M.E.G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barragan A, 2002, J EXP MED, V195, P1625, DOI 10.1084/jem.20020258; Bergmann A, 2000, J APPL CRYSTALLOGR, V33, P1212, DOI 10.1107/S0021889800008372; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Boothroyd JC, 1998, INT J PARASITOL, V28, P3, DOI 10.1016/S0020-7519(97)00182-3; Caiolfa VR, 2007, J CELL BIOL, V179, P1067, DOI 10.1083/jcb.200702151; Carruthers VB, 2007, CURR OPIN MICROBIOL, V10, P82; CESBRONDELAUW MF, 1994, J BIOL CHEM, V269, P16217; Channon JY, 2000, INFECT IMMUN, V68, P4822, DOI 10.1128/IAI.68.8.4822-4826.2000; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Di Costanzo L, 2007, J MOL BIOL, V366, P481, DOI 10.1016/j.jmb.2006.11.023; Dubey JP, 1998, INT J PARASITOL, V28, P1019, DOI 10.1016/S0020-7519(98)00023-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Graille M, 2005, J MOL BIOL, V354, P447, DOI 10.1016/j.jmb.2005.09.028; Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800; Grujic O, 2008, ACTA CRYSTALLOGR F, V64, P425, DOI 10.1107/S1744309108010920; Guinier A., 1955, SMALL ANGLE SCATTERI; He XL, 2002, NAT STRUCT BIOL, V9, P606, DOI 10.1038/nsb819; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Jackson M. H., 1989, Advances in Parasitology, V28, P55, DOI 10.1016/S0065-308X(08)60331-0; Jacquet A, 2001, MOL BIOCHEM PARASIT, V116, P35, DOI 10.1016/S0166-6851(01)00297-3; Jung C, 2004, INT J PARASITOL, V34, P285, DOI 10.1016/j.ijpara.2003.12.004; KOCH MHJ, 1983, NUCL INSTRUM METHODS, V208, P461, DOI 10.1016/0167-5087(83)91169-9; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lekutis C, 2000, EXP PARASITOL, V96, P89, DOI 10.1006/expr.2000.4556; Lekutis C, 2001, INT J PARASITOL, V31, P1285, DOI 10.1016/S0020-7519(01)00261-2; LUFT BJ, 1984, JAMA-J AM MED ASSOC, V252, P913, DOI 10.1001/jama.252.7.913; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; MCCABE RE, 1983, EUR J CLIN MICROBIOL, V2, P95, DOI 10.1007/BF02001573; MCDONALD JC, 1990, J INFECT DIS, V161, P769, DOI 10.1093/infdis/161.4.769; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NUSSENBLATT RB, 1994, JAMA-J AM MED ASSOC, V271, P304, DOI 10.1001/jama.271.4.304; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petoukhov MV, 2002, BIOPHYS J, V83, P3113, DOI 10.1016/S0006-3495(02)75315-0; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; SILVEIRA C, 1988, AM J OPHTHALMOL, V106, P362, DOI 10.1016/0002-9394(88)90382-0; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Westmeyer GG, 2004, J BIOL CHEM, V279, P53205, DOI 10.1074/jbc.M410378200	44	26	28	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9192	9198		10.1074/jbc.M808714200	http://dx.doi.org/10.1074/jbc.M808714200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19155215	Green Published, hybrid			2022-12-25	WOS:000264669100025
J	Varmeh, S; Manfredi, JJ				Varmeh, Shohreh; Manfredi, James J.			Inappropriate Activation of Cyclin-dependent Kinases by the Phosphatase Cdc25b Results in Premature Mitotic Entry and Triggers a p53-dependent Checkpoint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENE-INDUCED SENESCENCE; DNA-DAMAGE RESPONSE; CELL-CYCLE; TUMOR-SUPPRESSOR; AURORA-A; MITOSIS; PHOSPHORYLATION; TRANSITION; P53; PROTEIN	The dual specificity phosphatase Cdc25B is capable of inhibiting cellular proliferation, and this occurs in a manner dependent upon its catalytic activity. Here it is shown that this is accompanied by inappropriate cyclin-dependent kinase activation and premature mitotic entry, leading to both p53-dependent and independent checkpoints. Forced expression of Cdc25B inappropriately upregulated the activity of Cdk1 and Cdk2, by reducing levels of inhibitory phosphorylation. In cells lacking p14ARF, p53 is induced, and components of the ATM and ATR pathways are activated. Cdc25B triggers cell cycle arrest in the G1 and G2 phases that is p53- and p21-dependent and is inhibited by caffeine. Cdc25B also causes cells with an S phase DNA content to enter mitosis prematurely in a p53- independent manner. Synchronization of cells with aphidicolin results in these cells undergoing apoptosis. Thus, inappropriate cell cycle progression and premature mitotic entry via dysregulation of cyclin-dependent kinases results in activation of both p53 dependent and independent responses. Because Cdc25B is known to have oncogenic activity, this provides insight into the multistep nature of cancer development and why there is p53 loss during tumorigenesis.	[Varmeh, Shohreh; Manfredi, James J.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Manfredi, JJ (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, Box 1130, New York, NY 10029 USA.	james.manfredi@mssm.edu			NCI [R01 CA86001]; Dept. of Defense Breast Cancer Research Program [W81XWH-05-1-0305]; NATIONAL CANCER INSTITUTE [R01CA086001] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dept. of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA86001 from the NCI. This work was also supported by Dept. of Defense Breast Cancer Research Program Grant W81XWH-05-1-0305. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Borgne A, 1996, J BIOL CHEM, V271, P27847, DOI 10.1074/jbc.271.44.27847; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Cazales M, 2005, CELL CYCLE, V4, P1233, DOI 10.4161/cc.4.9.1964; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Dutertre S, 2004, J CELL SCI, V117, P2523, DOI 10.1242/jcs.01108; Ferguson AM, 2005, MOL CELL BIOL, V25, P2853, DOI 10.1128/MCB.25.7.2853-2860.2005; Furuno N, 1999, J CELL BIOL, V147, P295, DOI 10.1083/jcb.147.2.295; Gabrielli BG, 1996, J CELL SCI, V109, P1081; Gabrielli BG, 1997, J BIOL CHEM, V272, P28607, DOI 10.1074/jbc.272.45.28607; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; GALAKTIONOV K, 1995, GENE DEV, V9, P1046, DOI 10.1101/gad.9.9.1046; GALAKTIONOV K, 1995, SCIENCE, V269, P1575, DOI 10.1126/science.7667636; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; Goldstone S, 2001, ONCOGENE, V20, P921, DOI 10.1038/sj.onc.1204177; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; Guadagno TM, 1996, CELL, V84, P73, DOI 10.1016/S0092-8674(00)80994-0; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Karlsson C, 1999, J CELL BIOL, V146, P573, DOI 10.1083/jcb.146.3.573; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; Kudo Y, 1997, JPN J CANCER RES, V88, P947, DOI 10.1111/j.1349-7006.1997.tb00313.x; Lammer C, 1998, J CELL SCI, V111, P2445; Lincoln AJ, 2002, NAT GENET, V30, P446, DOI 10.1038/ng856; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Lowe SW, 1999, ENDOCR-RELAT CANCER, V6, P45, DOI 10.1677/erc.0.0060045; Ma ZQ, 1999, ONCOGENE, V18, P4564, DOI 10.1038/sj.onc.1202809; MEIJER L, 1991, EMBO J, V10, P1545, DOI 10.1002/j.1460-2075.1991.tb07674.x; MILLAR JBA, 1991, P NATL ACAD SCI USA, V88, P10500, DOI 10.1073/pnas.88.23.10500; Miyata H, 2000, CLIN CANCER RES, V6, P4859; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nishijima H, 1997, J CELL BIOL, V138, P1105, DOI 10.1083/jcb.138.5.1105; Royds JA, 2006, CELL DEATH DIFFER, V13, P1017, DOI 10.1038/sj.cdd.4401913; Sambrook J, 2001, MOL CLONING LAB MANU; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; Uto K, 2004, EMBO J, V23, P3386, DOI 10.1038/sj.emboj.7600328; Varmeh-Ziaie S, 2007, J BIOL CHEM, V282, P24633, DOI 10.1074/jbc.M703105200; Wilborn M, 2001, BIOCHEMISTRY-US, V40, P14200, DOI 10.1021/bi015638h; Xu X, 1996, J BIOL CHEM, V271, P5118; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	53	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9475	9488		10.1074/jbc.M900037200	http://dx.doi.org/10.1074/jbc.M900037200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19136558	Green Published, hybrid			2022-12-25	WOS:000264669100054
J	Wies, E; Hahn, AS; Schmidt, K; Viebahn, C; Rohland, N; Lux, A; Schellhorn, T; Holzer, A; Jung, JU; Neipel, F				Wies, Effi; Hahn, Alexander S.; Schmidt, Katharina; Viebahn, Cornelia; Rohland, Nadine; Lux, Anja; Schellhorn, Tim; Holzer, Angela; Jung, Jae U.; Neipel, Frank			The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON REGULATORY FACTOR; EPSTEIN-BARR-VIRUS; HHV8 ASSOCIATED DISEASES; TRANSCRIPTION FACTOR; EFFUSION LYMPHOMA; DNA-SEQUENCES; SIGNAL-TRANSDUCTION; CASTLEMANS-DISEASE; INDUCED APOPTOSIS; VIRAL-INFECTION	Kaposi's sarcoma-associated herpesvirus encodes four genes with homology to the family of interferon regulatory factors (IRFs). At least one of these viral IRFs, vIRF-3, is expressed in latently Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma (PEL) cells and is essential for the survival of PEL cells. We now report that vIRF-3 interacts with cellular IRF-5, thereby inhibiting binding of IRF-5 to interferon-responsive promoter elements. Consequently, vIRF-3 blocked IRF-5-mediated promoter activation. A central double helix motif present in vIRF-3 was sufficient to abrogate both DNA binding and transcriptional transactivation by IRF-5. Upon DNA damage or activation of the interferon or Toll-like receptor pathways, cytoplasmic IRF-5 has been reported to be translocated to the nucleus, which results in induction of both p53-independent apoptosis and p21-mediated cell cycle arrest. We report here that IRF-5 is present in the nuclei of PEL cells without interferon stimulation. Silencing of vIRF-3 expression in PEL cells was accompanied by increased sensitivity to interferon-mediated apoptosis and up-regulation of IRF-5 target genes. In addition, vIRF-3 antagonized IRF-5-mediated activation of the p21 promoter. The data presented here indicate that vIRF-3 contributes to immune evasion and sustained proliferation of PEL cells by releasing IRF-5 from transcription complexes.	[Schellhorn, Tim; Holzer, Angela; Neipel, Frank] Univ Klinikum Erlangen, Inst Virol, D-91054 Erlangen, Germany; [Jung, Jae U.] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA USA	University of Erlangen Nuremberg; University of Southern California	Neipel, F (corresponding author), Univ Klinikum Erlangen, Inst Virol, Schlossgarten 4, D-91054 Erlangen, Germany.	Frank.Neipel@viro.med.uni-erlangen.de	Hahn, Alexander/ABE-5642-2021	Hahn, Alexander/0000-0003-4171-2744; Schmidt, Katharina/0000-0003-2797-9952; Lux, Anja/0000-0001-9475-2147	Deutsche Forschungsgemeinschaft [SFB 643]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 643 and Graduate School 1071, " Viruses of the Immune System," the IZKF Erlangen, the European Community research project TargetHerpes, and the Mainzer Akademie der Wissenschaften und der Literatur. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arvanitakis L, 1996, BLOOD, V88, P2648, DOI 10.1182/blood.V88.7.2648.bloodjournal8872648; Balkhi MY, 2008, MOL CELL BIOL, V28, P7296, DOI 10.1128/MCB.00662-08; Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200; Barnes BJ, 2003, CANCER RES, V63, P6424; Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Birkmann A, 2001, J VIROL, V75, P11583, DOI 10.1128/JVI.75.23.11583-11593.2001; Cannon JS, 2000, J VIROL, V74, P10187, DOI 10.1128/JVI.74.21.10187-10193.2000; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Cheng TF, 2006, J IMMUNOL, V176, P7462, DOI 10.4049/jimmunol.176.12.7462; Couzinet A, 2008, P NATL ACAD SCI USA, V105, P2556, DOI 10.1073/pnas.0712295105; Cunningham C, 2003, J GEN VIROL, V84, P1471, DOI 10.1099/vir.0.19015-0; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Esteban M, 2003, J GEN VIROL, V84, P1463, DOI 10.1099/vir.0.19014-0; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Harada H, 1998, BIOCHIMIE, V80, P641, DOI 10.1016/S0300-9084(99)80017-0; Hengge UR, 2002, LANCET INFECT DIS, V2, P281, DOI 10.1016/S1473-3099(02)00263-3; Hengge UR, 2002, LANCET INFECT DIS, V2, P344, DOI 10.1016/S1473-3099(02)00288-8; Hu GD, 2005, CANCER RES, V65, P7403, DOI 10.1158/0008-5472.CAN-05-0583; Hu GD, 2006, EXPERT REV ANTICANC, V6, P775, DOI 10.1586/14737140.6.5.775; Hui DJ, 2003, J BIOL CHEM, V278, P39477, DOI 10.1074/jbc.M305038200; Joo CH, 2007, J VIROL, V81, P8282, DOI 10.1128/JVI.00235-07; Kliche S, 2001, MOL CELL, V7, P833, DOI 10.1016/S1097-2765(01)00227-1; Kovaleva M, 2006, J VIROL, V80, P8510, DOI 10.1128/JVI.00420-06; Lee H, 1998, NAT MED, V4, P435, DOI 10.1038/nm0498-435; Lin RT, 2005, J BIOL CHEM, V280, P3088, DOI 10.1074/jbc.M408452200; Lubyova B, 2004, J BIOL CHEM, V279, P7643, DOI 10.1074/jbc.M309485200; Lubyova B, 2007, J BIOL CHEM, V282, P31944, DOI 10.1074/jbc.M706430200; MANCL ME, 2005, J BIOL CHEM, P21090; Martin HJ, 2007, J VIROL, V81, P9748, DOI 10.1128/JVI.01122-07; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Moore PS, 2003, ANNU REV MICROBIOL, V57, P609, DOI 10.1146/annurev.micro.57.030502.090824; Mori T, 2002, ONCOGENE, V21, P2914, DOI 10.1038/sj.onc.1205459; Munoz-Fontela C, 2007, J VIROL, V81, P1511, DOI 10.1128/JVI.01816-06; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Rivas C, 2001, J VIROL, V75, P429, DOI 10.1128/JVI.75.1.429-438.2001; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Schulz TF, 2006, J PATHOL, V208, P187, DOI 10.1002/path.1904; Seo T, 2004, ONCOGENE, V23, P6146, DOI 10.1038/sj.onc.1207807; Shin YC, 2006, J VIROL, V80, P2257, DOI 10.1128/JVI.80.5.2257-2266.2006; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Swanton C, 1997, NATURE, V390, P184, DOI 10.1038/36606; Szremska AP, 2003, BLOOD, V102, P4159, DOI 10.1182/blood-2003-03-0915; TAKAOKA A, 2008, CANC SCI; Wessely R, 2003, HUM MOL GENET, V12, P177, DOI 10.1093/hmg/ddg018; Wies E, 2008, BLOOD, V111, P320, DOI 10.1182/blood-2007-05-092288; Xu DS, 2008, J VIROL, V82, P6251, DOI 10.1128/JVI.00163-08; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104; Zhang LL, 2007, J BIOL CHEM, V282, P5790, DOI 10.1074/jbc.M606284200; Zhang LW, 2004, J VIROL, V78, P12987, DOI 10.1128/JVI.78.23.12987-12995.2004; Zhang LW, 2001, SEMIN CANCER BIOL, V11, P445, DOI 10.1006/scbi.2001.0411; Zimring JC, 1998, J VIROL, V72, P701, DOI 10.1128/JVI.72.1.701-707.1998	54	58	58	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8525	8538		10.1074/jbc.M809252200	http://dx.doi.org/10.1074/jbc.M809252200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19129183	hybrid, Green Published			2022-12-25	WOS:000264397800037
J	Anyatonwu, G; Joseph, SK				Anyatonwu, Georgia; Joseph, Suresh K.			Surface Accessibility and Conformational Changes in the N-terminal Domain of Type I Inositol Trisphosphate Receptors STUDIES USING CYSTEINE SUBSTITUTION MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING SITE; 1,4,5-TRISPHOSPHATE RECEPTOR; FUNCTIONAL-PROPERTIES; ANION CHANNEL; IP3 RECEPTORS; PORE; PHOSPHORYLATION; ORGANIZATION; EXPRESSION; LOCATION	To identify surface-accessible residues and monitor conformational changes of the type I inositol 1,4,5-trisphosphate receptor protein in membranes, we have introduced 10 cysteine substitutions into the N-terminal ligand-binding domain. The reactivity of these mutants with progressively larger maleimide-polyethylene glycol derivatives (MPEG) was measured using a gel shift assay of tryptic fragments. The results indicate that the mutations fall into four categories as follows: sites that are highly accessible based on reactivity with the largest 20-kDa MPEG (S2C); sites that are moderately accessible based on reactivity only with 5-kDa MPEG (S6C, S7C, A189C, and S277C); sites whose accessibility is markedly enhanced by Ca2+ (S171C, S277C, and A575C); and sites that are inaccessible irrespective of incubation conditions (S217C, A245C, and S436C). The stimulation of accessibility induced by Ca2+ at the S277C site occurred with an EC50 of 0.8 mu M and was mimicked by Sr2+ but not Ba2+. Inositol 1,4,5-trisphosphate alone did not affect reactivity of any of the mutants in the presence or absence of Ca2+. The data are interpreted using crystal structures and EM reconstructions of the receptor. Our data identify N-terminal regions of the protein that become exposed upon Ca2+ binding and suggest possible orientations of the suppressor and ligand-binding domains that have implications for the mechanism of gating of the channel.	[Anyatonwu, Georgia; Joseph, Suresh K.] Thomas Jefferson Univ, Dept Pathol, Philadelphia, PA 19107 USA	Jefferson University	Joseph, SK (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Rm 230A JAH,1020 Locust St, Philadelphia, PA 19107 USA.	suresh.joseph@efferson.edu			National Institutes of Health [DK34804, T32-AA07463]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK34804 (to S. K. J.) and T32-AA07463 (training grant to G. A.). The costs of publication of this article were defrayed in part by the payment of page charges.	Bai GR, 2006, BIOCHEM BIOPH RES CO, V348, P1319, DOI 10.1016/j.bbrc.2006.07.208; Bauer PJ, 2005, BIOCHEMISTRY-US, V44, P1624, DOI 10.1021/bi0478749; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Boehning D, 2000, J BIOL CHEM, V275, P21492, DOI 10.1074/jbc.M001724200; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Bultynck G, 2004, BIOCHEM J, V381, P87, DOI 10.1042/BJ20040072; Chan J, 2007, J MOL BIOL, V373, P1269, DOI 10.1016/j.jmb.2007.08.057; da Fonseca PCA, 2003, P NATL ACAD SCI USA, V100, P3936, DOI 10.1073/pnas.0536251100; Desai SA, 1997, P NATL ACAD SCI USA, V94, P2045, DOI 10.1073/pnas.94.5.2045; Fernandez-Cobo M, 1999, CYTOKINE, V11, P216, DOI 10.1006/cyto.1998.0422; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Guo ZY, 2005, BIOCHEMISTRY-US, V44, P6537, DOI 10.1021/bi047409b; Hamada K, 2003, J BIOL CHEM, V278, P52881, DOI 10.1074/jbc.M309743200; Hamada K, 2002, J BIOL CHEM, V277, P21115, DOI 10.1074/jbc.C200244200; Howorka S, 2000, J BIOL CHEM, V275, P37876, DOI 10.1074/jbc.M003838200; Howorka S, 2000, J AM CHEM SOC, V122, P2411, DOI 10.1021/ja993221h; Jiang QX, 2002, EMBO J, V21, P3575, DOI 10.1093/emboj/cdf380; Joseph SK, 2006, BIOCHEM J, V393, P575, DOI 10.1042/BJ20050889; Joseph SK, 2005, CELL CALCIUM, V38, P539, DOI 10.1016/j.ceca.2005.07.007; Joseph SK, 1997, J BIOL CHEM, V272, P1579, DOI 10.1074/jbc.272.3.1579; JOSEPH SK, 1995, BIOCHEM J, V307, P859, DOI 10.1042/bj3070859; Kasri NN, 2004, MOL PHARMACOL, V66, P276, DOI 10.1124/mol.66.2.276; Khan MT, 2007, J BIOL CHEM, V282, P32983, DOI 10.1074/jbc.M705183200; Lee B, 2006, DEVELOPMENT, V133, P4355, DOI 10.1242/dev.02624; LIN JK, 1987, BIOTECHNOL BIOENG, V29, P976, DOI 10.1002/bit.260290809; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; MARSHALL ICB, 1994, BIOCHEM J, V301, P591, DOI 10.1042/bj3010591; Merzlyak PG, 1999, BIOPHYS J, V77, P3023, DOI 10.1016/S0006-3495(99)77133-X; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Movileanu L, 2001, J GEN PHYSIOL, V117, P239, DOI 10.1085/jgp.117.3.239; NAKAGAWA T, 1991, P NATL ACAD SCI USA, V88, P6244, DOI 10.1073/pnas.88.14.6244; Patel S, 1999, CELL CALCIUM, V25, P247, DOI 10.1054/ceca.1999.0021; Peyronnet O, 2002, BBA-BIOMEMBRANES, V1567, P113, DOI 10.1016/S0005-2736(02)00605-3; Ramos-Franco J, 1999, J GEN PHYSIOL, V114, P243, DOI 10.1085/jgp.114.2.243; Ramos-Franco J, 1998, BIOPHYS J, V75, P834, DOI 10.1016/S0006-3495(98)77572-1; Riley AM, 2002, J BIOL CHEM, V277, P40290, DOI 10.1074/jbc.M206925200; Sabirov RZ, 2004, BIOPHYS J, V87, P1672, DOI 10.1529/biophysj.104.043174; Sato C, 2004, J MOL BIOL, V336, P155, DOI 10.1016/j.jmb.2003.11.024; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; Serysheva II, 2003, J BIOL CHEM, V278, P21319, DOI 10.1074/jbc.C300148200; Srikanth S, 2004, BIOPHYS J, V86, P3634, DOI 10.1529/biophysj.104.040121; Tanimura A, 2004, J BIOL CHEM, V279, P38095, DOI 10.1074/jbc.C400312200; Taylor CW, 2004, TRENDS BIOCHEM SCI, V29, P210, DOI 10.1016/j.tibs.2004.02.010; Ternovsky VI, 2004, FEBS LETT, V576, P433, DOI 10.1016/j.febslet.2004.09.051; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316	52	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8093	8102		10.1074/jbc.M806932200	http://dx.doi.org/10.1074/jbc.M806932200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19141613	hybrid, Green Published			2022-12-25	WOS:000264195600072
J	Green, JA; Berrier, AL; Pankov, R; Yamada, KM				Green, J. Angelo; Berrier, Allison L.; Pankov, Roumen; Yamada, Kenneth M.			beta(1) Integrin Cytoplasmic Domain Residues Selectively Modulate Fibronectin Matrix Assembly and Cell Spreading through Talin and Akt-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; FOCAL ADHESIONS; BETA-1 SUBUNIT; ACTIVATION; BINDING; BETA-1-INTEGRIN; PHOSPHORYLATION; FIBRILLOGENESIS; IDENTIFICATION; LAMININ-10/11	The integrin beta(1) cytoplasmic domain (tail) serves as a scaffold for numerous intracellular proteins. The mechanisms by which the tail coordinates these proteins to facilitate extracellular matrix assembly and cell spreading are not clear. This study demonstrates that the beta(1) cytoplasmic domain can regulate cell spreading on fibronectin and fibronectin matrix assembly through Akt- and talin-dependent mechanisms, respectively. To identify these mechanisms, we characterized GD25 cells expressing the beta(1) integrin cytoplasmic domain mutants W775A and R760A. Although cell spreading appears normal in R760A mutant-integrin cells compared with wild type, it is inhibited in W775A mutant cells. In contrast, both mutant cell lines show defective fibronectin matrix assembly. Inhibition of cell spreading, but not matrix assembly, in the W775A mutant cells is due to a specific defect in Akt-1 activation. In addition, we find that both W775A and R760A mutant integrins have reduced surface expression of the 9EG7 epitope that correlates with reduced recruitment of talin to beta(1) integrin cytoplasmic complexes. Down-regulation of talin with small interfering RNA or expression of green fluorescent protein-talin head domain inhibits matrix assembly in beta(1) wild-type cells, mimicking the defect seen with the W775A and R760A mutant cells. These results demonstrate distinct mechanisms by which integrins regulate cell spreading and matrix assembly through the beta(1) integrin cytoplasmic tail.	[Green, J. Angelo; Berrier, Allison L.; Pankov, Roumen; Yamada, Kenneth M.] NIDCR, NIH, Lab Cell & Dev Biol, Bethesda, MD 20892 USA; [Berrier, Allison L.] Louisiana State Univ, Hlth Sci Ctr, Sch Dent, Dept Oral & Craniofacial Biol, New Orleans, LA 70119 USA; [Pankov, Roumen] Sofia Univ St Kliment Ohridski, Fac Biol, Dept Cytol Histol & Embryol, Sofia 1164, Bulgaria	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Sofia	Green, JA (corresponding author), NIDCR, NIH, Lab Cell & Dev Biol, Bethesda, MD 20892 USA.	angelo.green@nih.gov; kenneth.yamada@nih.gov	Pankov, Roumen G/B-3284-2014; Pankov, Roumen/AAK-3205-2021	Pankov, Roumen G/0000-0002-3157-3659; Pankov, Roumen/0000-0002-3157-3659; Yamada, Kenneth/0000-0003-1512-6805	NIDCR; National Institutes of Health; National Center on Minority Health and Health Disparities; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000718] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Intramural Research Program of the NIDCR, National Institutes of Health, and the National Center on Minority Health and Health Disparities. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Bodeau AL, 2001, J CELL SCI, V114, P2795; Bouaouina M, 2008, J BIOL CHEM, V283, P6118, DOI 10.1074/jbc.M709527200; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; Delcommenne M, 1999, METH MOL B, V129, P19; FASSLER R, 1995, J CELL BIOL, V128, P979, DOI 10.1083/jcb.128.5.979; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Gu JG, 2002, J BIOL CHEM, V277, P19922, DOI 10.1074/jbc.M200383200; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; HAYASHI Y, 1990, J CELL BIOL, V110, P175, DOI 10.1083/jcb.110.1.175; Humphries MJ, 2004, BIOCHEM SOC T, V32, P822, DOI 10.1042/BST0320822; Humphries MJ, 2004, BIOCHEM SOC T, V32, P407, DOI 10.1042/BST0320407; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Kaapa A, 1999, EXP CELL RES, V250, P524, DOI 10.1006/excr.1999.4533; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; LEWIS JM, 1995, MOL BIOL CELL, V6, P151, DOI 10.1091/mbc.6.2.151; Lim J, 2007, MOL BIOL CELL, V18, P976, DOI 10.1091/mbc.E06-09-0813; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; MIEKKA SI, 1982, THROMB RES, V27, P1, DOI 10.1016/0049-3848(82)90272-9; MOULD AP, 1995, FEBS LETT, V363, P118, DOI 10.1016/0014-5793(95)00301-O; OTOOLE TE, 1995, J BIOL CHEM, V270, P8553, DOI 10.1074/jbc.270.15.8553; Pankov R, 2003, J BIOL CHEM, V278, P18671, DOI 10.1074/jbc.M300879200; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; RESZKA AA, 1992, J CELL BIOL, V117, P1321, DOI 10.1083/jcb.117.6.1321; Retta SF, 1998, MOL BIOL CELL, V9, P715, DOI 10.1091/mbc.9.4.715; Sechler JL, 1996, J CELL BIOL, V134, P573, DOI 10.1083/jcb.134.2.573; Somanath PR, 2007, J BIOL CHEM, V282, P22964, DOI 10.1074/jbc.M700241200; Sondermann H, 1999, CELL ADHES COMMUN, V7, P43, DOI 10.3109/15419069909034391; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takahashi S, 2007, J CELL BIOL, V178, P167, DOI 10.1083/jcb.200703021; Tran H, 2002, J CELL SCI, V115, P2031; Vignoud L, 1997, J CELL SCI, V110, P1421; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; Wennerberg K, 1998, J CELL SCI, V111, P1117; YLANNE J, 1993, J CELL BIOL, V122, P223, DOI 10.1083/jcb.122.1.223; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zamir E, 1999, J CELL SCI, V112, P1655; Zhang QH, 1999, J BIOL CHEM, V274, P368, DOI 10.1074/jbc.274.1.368; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765	45	27	28	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8148	8159		10.1074/jbc.M805934200	http://dx.doi.org/10.1074/jbc.M805934200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19144637	Green Published, hybrid			2022-12-25	WOS:000264195600077
J	Stuttmann, J; Lechner, E; Guerois, R; Parker, JE; Nussaume, L; Genschik, P; Noel, LD				Stuttmann, Johannes; Lechner, Esther; Guerois, Raphael; Parker, Jane E.; Nussaume, Laurent; Genschik, Pascal; Noel, Laurent D.			COP9 Signalosome- and 26S Proteasome-dependent Regulation of SCFTIR1 Accumulation in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; F-BOX PROTEIN; NEUROSPORA CIRCADIAN CLOCK; PLANT DEVELOPMENT; AUXIN; CUL1; COP9/SIGNALOSOME; DEGRADATION; COMPLEXES; FAMILY	Ubiquitination and proteasome-mediated degradation of proteins are crucial for eukaryotic physiology and development. The largest class of E3 ubiquitin ligases is made up of the cullin-RING ligases (CRLs), which themselves are positively regulated through conjugation of the ubiquitin-like peptide RUB/NEDD8 to cullins. RUB modification is antagonized by the COP9 signalosome (CSN), an evolutionarily conserved eight-subunit complex that is essential in most eukaryotes and cleaves RUB from cullins. The CSN behaves genetically as an activator of CRLs, although it abolishes CRL activity in vitro. This apparent paradox was recently reconciled in different organisms, as the CSN was shown to prevent autocatalytic degradation of several CRL substrate adaptors. We tested for such a mechanism in the model plant Arabidopsis by measuring the impact of a newly identified viable csn2 mutant on the activity and stability of SCFTIR1, a receptor to the phytohormone auxin and probably the best characterized plant CRL. Our analysis reveals that not only the F-box protein TIR1 but also relevant cullins are destabilized in csn2 and other Arabidopsis csn mutants. These results provide an explanation for the auxin resistance of csn mutants. We further observed in vivo a post-translational modification of TIR1 dependent on the proteasome inhibitor MG-132 and provide evidence for proteasome-mediated degradation of TIR1, CUL1, and ASK1 (Arabidopsis SKP1 homolog). These results are consistent with CSN-dependent protection of Arabidopsis CRLs from autocatalytic degradation, as observed in other eukaryotes, and provide evidence for antagonist roles of the CSN and 26S proteasome in modulating accumulation of the plant CRL SCFTIR1.	[Stuttmann, Johannes; Nussaume, Laurent; Noel, Laurent D.] Univ Aix Marseille 2, CEN Cadarache, CNR,CEA, Inst Biol Environm & Biotechnol,UMR 6191, F-13108 St Paul Les Durance, France; [Stuttmann, Johannes; Parker, Jane E.] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Lechner, Esther; Genschik, Pascal] CNRS, Inst Biol Mol Plantes, UPR 2357, F-67084 Strasbourg, France; [Guerois, Raphael] CEA, Inst Biol & Technol Saclay, Lab Biol Struct & Radiobiol, F-91191 Gif Sur Yvette, France; [Guerois, Raphael] CNRS, URA 2096, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Aix-Marseille Universite; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Noel, LD (corresponding author), INRA, CNRS, UMR 2594 441, Lab Interact Plantes Microorganismes, F-31326 Castanet Tolosan, France.	laurent.noel@toulouse.inra.fr	NUSSAUME, Laurent/AAB-8312-2020; NUSSAUME, Laurent/AAA-5980-2022; noel, laurent/A-4885-2009; , raph/AAF-4380-2019	NUSSAUME, Laurent/0000-0002-9445-2563; noel, laurent/0000-0002-0110-1423; Stuttmann, Johannes/0000-0002-6207-094X; GENSCHIK, Pascal/0000-0002-4107-5071	Deutsche Forschungsgemeinschaft [SFB 635]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by Grant SFB 635 from the Deutsche Forschungsgemeinschaft during work performed at the Max-Plank-Institut fur Zuchtungsforschung.	Alonso JM, 2003, P NATL ACAD SCI USA, V100, P2992, DOI 10.1073/pnas.0438070100; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Austin MJ, 2002, SCIENCE, V295, P2077, DOI 10.1126/science.1067747; Bernhardt A, 2006, PLANT J, V47, P591, DOI 10.1111/j.1365-313X.2006.02810.x; Bornstein G, 2006, P NATL ACAD SCI USA, V103, P11515, DOI 10.1073/pnas.0603921103; Busch S, 2007, P NATL ACAD SCI USA, V104, P8089, DOI 10.1073/pnas.0702108104; Caspari T, 2000, MOL CELL BIOL, V20, P1254, DOI 10.1128/MCB.20.4.1254-1262.2000; Chen HD, 2006, PLANT CELL, V18, P1991, DOI 10.1105/tpc.106.043224; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Cope Gregory A., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-1; Denti S, 2006, J BIOL CHEM, V281, P32188, DOI 10.1074/jbc.M604746200; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dieterle M, 2005, PLANT J, V41, P386, DOI 10.1111/j.1365-313X.2004.02302.x; Dohmann EMN, 2005, PLANT CELL, V17, P1967, DOI 10.1105/tpc.105.032870; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Figueroa P, 2005, PLANT CELL, V17, P1180, DOI 10.1105/tpc.105.031989; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Gingerich DJ, 2005, J BIOL CHEM, V280, P18810, DOI 10.1074/jbc.M413247200; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 2003, PLANT CELL, V15, P1310, DOI 10.1105/tpc.010884; Gusmaroli G, 2007, PLANT CELL, V19, P564, DOI 10.1105/tpc.106.047571; He Q, 2005, BIOCHEM SOC T, V33, P953, DOI 10.1042/BST0330953; He Q, 2005, GENE DEV, V19, P1518, DOI 10.1101/gad.1322205; Hellmann H, 2003, EMBO J, V22, P3314, DOI 10.1093/emboj/cdg335; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kwok SF, 1998, PLANT CELL, V10, P1779, DOI 10.1105/tpc.10.11.1779; Lau S, 2008, PLANT CELL, V20, P1738, DOI 10.1105/tpc.108.060418; Lechner E, 2006, CURR OPIN PLANT BIOL, V9, P631, DOI 10.1016/j.pbi.2006.09.003; Lee JH, 2008, PLANT CELL, V20, P152, DOI 10.1105/tpc.107.055418; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Luke-Glaser S, 2007, MOL CELL BIOL, V27, P4526, DOI 10.1128/MCB.01724-06; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Manzano C, 2008, PLANT MOL BIOL, V68, P145, DOI 10.1007/s11103-008-9358-9; MISERA S, 1994, MOL GEN GENET, V244, P242, DOI 10.1007/BF00285451; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; Moon J, 2007, PLANT PHYSIOL, V143, P684, DOI 10.1104/pp.106.091439; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Mundt KE, 2002, MOL BIOL CELL, V13, P493, DOI 10.1091/mbc.01-10-0521; MURRAY JM, 1992, NUCLEIC ACIDS RES, V20, P2673, DOI 10.1093/nar/20.11.2673; Noel LD, 2007, PLANT CELL, V19, P4061, DOI 10.1105/tpc.107.051896; Oshikawa K, 2003, BIOCHEM BIOPH RES CO, V303, P1209, DOI 10.1016/S0006-291X(03)00501-1; Parry G, 2004, SEMIN CELL DEV BIOL, V15, P221, DOI 10.1016/j.semcdb.2003.12.003; Peng ZH, 2001, DEVELOPMENT, V128, P4277; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scheel H, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-71; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Schweitzer K, 2007, EMBO J, V26, P1532, DOI 10.1038/sj.emboj.7601600; Serino G, 2003, ANNU REV PLANT BIOL, V54, P165, DOI 10.1146/annurev.arplant.54.031902.134847; Serino G, 2003, PLANT CELL, V15, P719, DOI 10.1105/tpc.009092; Shen WH, 2002, MOL BIOL CELL, V13, P1916, DOI 10.1091/mbc.E02-02-0077; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Thomann A, 2005, PLANT J, V43, P437, DOI 10.1111/j.1365-313X.2005.02467.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang KLC, 2004, NATURE, V428, P945, DOI 10.1038/nature02516; Wee S, 2005, NAT CELL BIOL, V7, P387, DOI 10.1038/ncb1241; Weigel D, 2002, ARABIDOPSIS LAB MANU, P24; Witte CP, 2004, PLANT MOL BIOL, V55, P135, DOI 10.1007/s11103-004-0501-y; Wolf DA, 2003, NAT CELL BIOL, V5, P1029, DOI 10.1038/ncb1203-1029; Wu JT, 2005, NAT CELL BIOL, V7, P1014, DOI 10.1038/ncb1301; Yan N, 2000, PLANT PHYSIOL, V124, P1828, DOI 10.1104/pp.124.4.1828; Zhang WJ, 2008, P NATL ACAD SCI USA, V105, P8470, DOI 10.1073/pnas.0804144105; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou CS, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-7	78	46	49	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7920	7930		10.1074/jbc.M809069200	http://dx.doi.org/10.1074/jbc.M809069200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19147500	Green Published, hybrid			2022-12-25	WOS:000264195600054
J	Chen, YL; Chen, YH; Lin, YC; Tsai, KC; Chiu, HT				Chen, Yi-Lin; Chen, Yi-Hsine; Lin, Yu-Chin; Tsai, Kuo-Chung; Chiu, Hsien-Tai			Functional Characterization and Substrate Specificity of Spinosyn Rhamnosyltransferase by in Vitro Reconstitution of Spinosyn Biosynthetic Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DTDP-GLUCOSE 4,6-DEHYDRATASE; ENTERICA SEROVAR TYPHIMURIUM; L-RHAMNOSE BIOSYNTHESIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SACCHAROPOLYSPORA-SPINOSA; SALMONELLA-ENTERICA; MANNOSE 4,6-DEHYDRATASE; GENE-CLUSTER; GLYCOSYLTRANSFERASES	Spinosyn, a potent insecticide, is a novel tetracyclic polyketide decorated with D-forosamine and tri-O-methyl-L-rhamnose. Spinosyn rhamnosyltransferase (SpnG) is a key biocatalyst with unique sequence identity and controls the biosynthetic maturation of spinosyn. The rhamnose is critical for the spinosyn insecticidal activity and cell wall biosynthesis of the spinosyn producer, Saccharopolyspora spinosa. In this study, we have functionally expressed and characterized SpnG and the three enzymes, Gdh, Epi, and Kre, responsible for dTDP-L-rhamnose biosynthesis in S. spinosa by purified enzymes from Escherichia coli. Most notably, the substrate specificity of SpnG was thoroughly characterized by kinetic and inhibition experiments using various NDP sugar analogs made by an in situ combination of NDP-sugar-modifying enzymes. SpnG was found to exhibit striking substrate promiscuity, yielding corresponding glycosylated variants. Moreover, the critical residues presumably involved in catalytic mechanism of Gdh and SpnG were functionally evaluated by site-directed mutagenesis. The information gained from this study has provided important insight into molecular recognition and mechanism of the enzymes, especially SpnG. The results have made possible the structure-activity characterization of SpnG, as well as the use of SpnG or its engineered form to serve as a combinatorial tool to make spinosyn analogs with altered biological activities and potency.	[Chen, Yi-Lin; Chen, Yi-Hsine; Lin, Yu-Chin; Tsai, Kuo-Chung; Chiu, Hsien-Tai] Natl Tsing Hua Univ, Dept Biol Sci & Technol, Hsinchu 300, Taiwan	National Tsing Hua University	Chiu, HT (corresponding author), Natl Tsing Hua Univ, Dept Biol Sci & Technol, 75 Po Ai St, Hsinchu 300, Taiwan.	chiu@mail.nctu.edu.tw			National Science Council, Taiwan [NSC90-2113-M-009-014, NSC89-2113-M-009-036]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council, Taiwan, Grants NSC90-2113-M-009-014 and NSC89-2113-M-009-036 ( to H.- T. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALEX T, 2005, Patent No. 2005044979; Allard STM, 2004, J BIOL CHEM, V279, P2211, DOI 10.1074/jbc.M310134200; Allard STM, 2001, J MOL BIOL, V307, P283, DOI 10.1006/jmbi.2000.4470; Baltz RH, 2006, NAT BIOTECHNOL, V24, P1533, DOI 10.1038/nbt1265; Bode HB, 2007, ANGEW CHEM INT EDIT, V46, P2147, DOI 10.1002/anie.200604671; Bolam DN, 2007, P NATL ACAD SCI USA, V104, P5336, DOI 10.1073/pnas.0607897104; Borisova SA, 2004, J AM CHEM SOC, V126, P6534, DOI 10.1021/ja049967j; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Creemer LC, 1998, J ANTIBIOT, V51, P795, DOI 10.7164/antibiotics.51.795; Gerratana B, 2001, BIOCHEMISTRY-US, V40, P9187, DOI 10.1021/bi0108249; Graninger M, 2002, APPL ENVIRON MICROB, V68, P3708, DOI 10.1128/AEM.68.8.3708-3715.2002; Graninger M, 1999, J BIOL CHEM, V274, P25069, DOI 10.1074/jbc.274.35.25069; Gross JW, 2000, BIOCHEMISTRY-US, V39, P13633, DOI 10.1021/bi001963d; Gross JW, 2001, BIOCHEMISTRY-US, V40, P12497, DOI 10.1021/bi011138c; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kirst Herbert A., 2002, Current Topics in Medicinal Chemistry, V2, P675, DOI 10.2174/1568026023393615; KISER T, 2000, PRACTICAL STREPTOMYC, P117; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lopez O, 2005, GREEN CHEM, V7, P431, DOI 10.1039/b500733j; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu W, 2005, CHEM BIOL, V12, P527, DOI 10.1016/j.chembiol.2005.02.016; Madduri K, 2001, J IND MICROBIOL BIOT, V27, P399, DOI 10.1038/sj.jim.7000180; Madduri K, 2001, J BACTERIOL, V183, P5632, DOI 10.1128/JB.183.19.5632-5638.2001; Martin CJ, 2003, ORG BIOMOL CHEM, V1, P4144, DOI 10.1039/b310740j; Meyers CLF, 2004, BIOCHEMISTRY-US, V43, P15022, DOI 10.1021/bi048457z; Minami A, 2007, J AM CHEM SOC, V129, P5102, DOI 10.1021/ja0685250; Mittler M, 2007, J MOL BIOL, V372, P67, DOI 10.1016/j.jmb.2007.06.005; Mulichak AM, 2004, BIOCHEMISTRY-US, V43, P5170, DOI 10.1021/bi036130c; Mulichak AM, 2003, P NATL ACAD SCI USA, V100, P9238, DOI 10.1073/pnas.1233577100; Mulichak AM, 2001, STRUCTURE, V9, P547, DOI 10.1016/S0969-2126(01)00616-5; Naundorf A, 1996, CARBOHYD RES, V285, P141, DOI 10.1016/S0008-6215(96)90180-9; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; Sambrook J, 2001, MOL CLONING LAB MANU; Somoza JR, 2000, STRUCTURE, V8, P123, DOI 10.1016/S0969-2126(00)00088-5; Thibodeaux CJ, 2007, NATURE, V446, P1008, DOI 10.1038/nature05814; Thoden JB, 2002, J BIOL CHEM, V277, P27528, DOI 10.1074/jbc.M204413200; Waldron C, 2001, CHEM BIOL, V8, P487, DOI 10.1016/S1074-5521(01)00029-1; Walsh CT, 2006, NATURE, V443, P285, DOI 10.1038/443285a; Wu BY, 2001, BIOCHEM BIOPH RES CO, V285, P364, DOI 10.1006/bbrc.2001.5137; Yuan YQ, 2005, J AM CHEM SOC, V127, P14128, DOI 10.1021/ja053704n; Zhang CS, 2006, SCIENCE, V313, P1291, DOI 10.1126/science.1130028	43	35	37	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7352	7363		10.1074/jbc.M808441200	http://dx.doi.org/10.1074/jbc.M808441200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19126547	Green Published, hybrid			2022-12-25	WOS:000263919000081
J	Huergo, LF; Merrick, M; Monteiro, RA; Chubatsu, LS; Steffens, MBR; Pedrosa, FO; Souza, EM				Huergo, Luciano F.; Merrick, Mike; Monteiro, Rose A.; Chubatsu, Leda S.; Steffens, Maria B. R.; Pedrosa, Fabio O.; Souza, Emanuel M.			In Vitro Interactions between the P-II Proteins and the Nitrogenase Regulatory Enzymes Dinitrogenase Reductase ADP-ribosyltransferase (DraT) and Dinitrogenase Reductase-activating Glycohydrolase (DraG) in Azospirillum brasilense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PROTEIN; BACTERIUM RHODOBACTER-CAPSULATUS; ADENYLATE ENERGY-CHARGE; AMTB-GLNK COMPLEX; RHODOSPIRILLUM-RUBRUM; ESCHERICHIA-COLI; MEMBRANE SEQUESTRATION; POSTTRANSLATIONAL REGULATION; ACETYLGLUTAMATE-KINASE; CRYSTAL-STRUCTURE	The activity of the nitrogenase enzyme in the diazotroph Azospirillum brasilense is reversibly inactivated by ammonium through ADP-ribosylation of the nitrogenase NifH subunit. This process is catalyzed by DraT and is reversed by DraG, and the activities of both enzymes are regulated according to the levels of ammonium through direct interactions with the P-II proteins GlnB and GlnZ. We have previously shown that DraG interacts with GlnZ both in vivo and in vitro and that DraT interacts with GlnB in vivo. We have now characterized the influence of P-II uridylylation status and the P-II effectors (ATP, ADP, and 2-oxoglutarate) on the in vitro formation of DraT-GlnB and DraG-GlnZ complexes. We observed that both interactions are maximized when P-II proteins are de-uridylylated and when ADP is present. The DraT-GlnB complex formed in vivo was purified to homogeneity in the presence of ADP. The stoichiometry of the DraT-GlnB complex was determined by three independent approaches, all of which indicated a 1: 1 stoichiometry (DraT monomer: GlnB trimer). Our results suggest that the intracellular fluctuation of the P-II ligands ATP, ADP, and 2-oxoglutarate play a key role in the post-translational regulation of nitrogenase activity.	[Huergo, Luciano F.; Monteiro, Rose A.; Chubatsu, Leda S.; Steffens, Maria B. R.; Pedrosa, Fabio O.; Souza, Emanuel M.] Univ Fed Parana, Dept Biochem & Mol Biol, BR-81531900 Curitiba, Parana, Brazil; [Merrick, Mike] John Innes Ctr Plant Sci Res, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England	Universidade Federal do Parana; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Huergo, LF (corresponding author), Univ Fed Parana, Dept Biochem & Mol Biol, CP 19046, BR-81531900 Curitiba, Parana, Brazil.	huergo@ufpr.br	de Souza, Emanuel Maltempi/C-1920-2013; Pedrosa, Fabio 0/C-1938-2013; Chubatsu, Leda S./H-2603-2012	de Souza, Emanuel Maltempi/0000-0003-1546-9218; Chubatsu, Leda S./0000-0002-8687-2816; Huergo, Luciano/0000-0002-7587-9510; Monteiro, Rose Adele/0000-0001-8226-0700	CNPq; Fundacao Araucaria; Biotechnology and Biological Sciences Research Council (UK)	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by CNPq and Fundacao Araucaria.; Supported by a PDJ fellowship from the CNPq-Brazil.; Received support from the Biotechnology and Biological Sciences Research Council (UK).	Araujo LM, 2008, BRAZ J MED BIOL RES, V41, P289, DOI 10.1590/S0100-879X2008000400006; Araujo MS, 2004, PROTEIN EXPRES PURIF, V33, P19, DOI 10.1016/j.pep.2003.08.024; ATKINSON MR, 1994, J BIOL CHEM, V269, P28288; BURRIS RH, 1991, J BIOL CHEM, V266, P9339; Carr PD, 1996, ACTA CRYSTALLOGR D, V52, P93, DOI 10.1107/S0907444995007293; CHAPMAN AG, 1971, J BACTERIOL, V108, P1072, DOI 10.1128/JB.108.3.1072-1086.1971; Conroy MJ, 2007, P NATL ACAD SCI USA, V104, P1213, DOI 10.1073/pnas.0610348104; de Zamaroczy M, 1998, MOL MICROBIOL, V29, P449, DOI 10.1046/j.1365-2958.1998.00938.x; deZamaroczy M, 1996, J BACTERIOL, V178, P4143, DOI 10.1128/jb.178.14.4143-4149.1996; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; Durand A, 2006, J BIOL CHEM, V281, P29558, DOI 10.1074/jbc.M602477200; Espinosa J, 2006, MOL MICROBIOL, V61, P457, DOI 10.1111/j.1365-2958.2006.05231.x; Forchhammer K, 2004, FEMS MICROBIOL REV, V28, P319, DOI 10.1016/j.femsre.2003.11.001; Forchhammer K, 1999, MOL MICROBIOL, V33, P338, DOI 10.1046/j.1365-2958.1999.01477.x; Forchhammer K, 2008, TRENDS MICROBIOL, V16, P65, DOI 10.1016/j.tim.2007.11.004; Huergo LF, 2006, MOL MICROBIOL, V59, P326, DOI 10.1111/j.1365-2958.2005.04944.x; Huergo LF, 2005, FEMS MICROBIOL LETT, V253, P47, DOI 10.1016/j.femsle.2005.09.026; Huergo LF, 2005, ARCH MICROBIOL, V183, P209, DOI 10.1007/s00203-005-0763-z; Huergo LF, 2007, MOL MICROBIOL, V66, P1523, DOI 10.1111/j.1365-2958.2007.06016.x; Huergo LF, 2006, FEBS LETT, V580, P5232, DOI 10.1016/j.febslet.2006.08.054; Jiang P, 1998, BIOCHEMISTRY-US, V37, P12782, DOI 10.1021/bi980667m; Jiang P, 2007, BIOCHEMISTRY-US, V46, P12979, DOI 10.1021/bi701062t; Jiang P, 2007, BIOCHEMISTRY-US, V46, P4117, DOI 10.1021/bi0620508; KAMBEROV ES, 1995, J BIOL CHEM, V270, P17797, DOI 10.1074/jbc.270.30.17797; Leigh JA, 2007, ANNU REV MICROBIOL, V61, P349, DOI 10.1146/annurev.micro.61.080706.093409; LI J, 1987, J BACTERIOL, V169, P231, DOI 10.1128/jb.169.1.231-237.1987; Llacer JL, 2007, P NATL ACAD SCI USA, V104, P17644, DOI 10.1073/pnas.0705987104; LOWERY RG, 1988, J BIOL CHEM, V263, P16714; Mizuno Y, 2007, J BIOL CHEM, V282, P35733, DOI 10.1074/jbc.M707127200; Nordlund S, 2000, PROKARYOTIC NITROGEN FIXATION, P149; PAUL TD, 1984, BIOCHEM J, V224, P961, DOI 10.1042/bj2240961; Pawlowski A, 2003, J BACTERIOL, V185, P5240, DOI 10.1128/JB.185.17.5240-5247.2003; Ponnuraj RK, 2005, FEBS LETT, V579, P5751, DOI 10.1016/j.febslet.2005.09.057; SAARI LL, 1984, J BIOL CHEM, V259, P5502; SENIOR PJ, 1975, J BACTERIOL, V123, P407, DOI 10.1128/JB.123.2.407-418.1975; Strosser J, 2004, MOL MICROBIOL, V54, P132, DOI 10.1111/j.1365-2958.2004.04247.x; Teixeira PF, 2008, MICROBIOL-SGM, V154, P2336, DOI 10.1099/mic.0.2008/017533-0; Tezcan FA, 2005, SCIENCE, V309, P1377, DOI 10.1126/science.1115653; Tremblay PL, 2008, J BACTERIOL, V190, P1588, DOI 10.1128/JB.01643-07; Tremblay PL, 2007, J BACTERIOL, V189, P5850, DOI 10.1128/JB.00680-07; UPCHURCH RG, 1980, J BACTERIOL, V143, P274, DOI 10.1128/JB.143.1.274-284.1980; Van Dommelen A, 2002, MOL GENET GENOMICS, V266, P813, DOI 10.1007/s00438-001-0598-5; Wang H, 2005, FEMS MICROBIOL LETT, V253, P273, DOI 10.1016/j.femsle.2005.09.049; Wolfe DM, 2007, J BACTERIOL, V189, P6861, DOI 10.1128/JB.00759-07; Xu YB, 1998, J MOL BIOL, V282, P149, DOI 10.1006/jmbi.1998.1979; Xu YB, 2001, EUR J BIOCHEM, V268, P2028, DOI 10.1046/j.1432-1327.2001.02074.x; Yildiz O, 2007, EMBO J, V26, P589, DOI 10.1038/sj.emboj.7601492; Zhang YP, 2006, MICROBIOL-SGM, V152, P2075, DOI 10.1099/mic.0.28903-0; Zhang YP, 1997, FEMS MICROBIOL LETT, V152, P195, DOI 10.1111/j.1574-6968.1997.tb10428.x; Zhu Y, 2006, J BACTERIOL, V188, P1866, DOI 10.1128/JB.188.5.1866-1874.2006	50	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6674	6682		10.1074/jbc.M807378200	http://dx.doi.org/10.1074/jbc.M807378200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19131333	Green Published, hybrid			2022-12-25	WOS:000263919000011
J	Nijstad, N; Wiersma, H; Gautier, T; van der Giet, M; Maugeais, C; Tietge, UJF				Nijstad, Niels; Wiersma, Harmen; Gautier, Thomas; van der Giet, Markus; Maugeais, Cyrille; Tietge, Uwe J. F.			Scavenger Receptor BI-mediated Selective Uptake Is Required for the Remodeling of High Density Lipoprotein by Endothelial Lipase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; PHOSPHOLIPASE A(2); SR-BI; CHOLESTERYL ESTER; HDL CHOLESTEROL; TARGETED MUTATION; APOA-I; METABOLISM; MICE; ATHEROSCLEROSIS	Endothelial lipase (EL) is a negative regulator of high density lipoprotein (HDL) cholesterol plasma levels, and scavenger receptor BI (SR-BI) is involved in remodeling of HDL. The present study investigates the requirement of SR-BI for the effects of EL- mediated phospholipid hydrolysis on HDL metabolism in vivo. In vitro, selective uptake from EL- modified HDL was 129% higher than selective uptake from control HDL in SR-BI-overexpressing cells (p = 0.01). In vivo overexpression of human EL by means of recombinant adenovirus decreased HDL plasma levels significantly (p < 0.01). Fast protein liquid chromatography analysis and agarose gel electrophoresis revealed that EL expression resulted in the generation of small pre-beta HDL particles in wild-type mice, whereas in SR-BI-/- mice small HDL were preferentially removed. In kinetic experiments the fractional catabolic rate (FCR) of HDL cholesteryl ester increased by 110% (p < 0.001), and the FCR of HDL apolipoproteins increased by 64% (p < 0.001) in response to EL overexpression in wild-type mice. In SR-BI-/- mice a similar increase in the HDL apolipoprotein FCR occurred (p < 0.001); however, there was no further increase in HDL cholesteryl ester catabolism. The apparent whole body selective uptake was increased 3-fold by EL in wild-type mice (p < 0.001), whereas there was no selective uptake in SR-BI knock-out mice. EL overexpression increased hepatic selective uptake as well as holoparticle uptake (each p < 0.01) in wild-typemice, whereas in SR-BI knock-out mice only holoparticle uptake increased (p < 0.01). Our results indicate that SR-BI-mediated selective uptake of HDL cholesteryl ester is essential for the remodeling of large alpha-migrating HDL particles by EL.	[Nijstad, Niels; Wiersma, Harmen; Gautier, Thomas; Tietge, Uwe J. F.] Univ Groningen, Univ Med Ctr Groningen, Pediat Lab, Ctr Liver Digest & Metab Dis, NL-9713 GZ Groningen, Netherlands; [van der Giet, Markus] Charite, Med Klin 4, D-12203 Berlin, Germany; [Maugeais, Cyrille] Roche Pharmaceut, CH-4070 Basel, Switzerland	University of Groningen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Roche Holding	Tietge, UJF (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Pediat Lab, Ctr Liver Digest & Metab Dis, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	u_tietge@yahoo.com	Gautier, Thomas/Q-5371-2018	Gautier, Thomas/0000-0003-1119-7382; van der Giet, Markus/0000-0003-3590-5451	Netherlands Organization for Scientific Research [917-56-358]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by Netherlands Organization for Scientific Research VIDI Grant 917-56-358 ( to U. J. F. T.). The costs of publication of this article were defrayed in part by the payment of page charges.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Assmann G, 2004, CIRCULATION, V109, P8, DOI 10.1161/01.CIR.0000131512.50667.46; Brundert M, 2005, ARTERIOSCL THROM VAS, V25, P143, DOI 10.1161/01.ATV.0000149381.16166.c6; Caiazza D, 2004, BIOCHEMISTRY-US, V43, P11898, DOI 10.1021/bi049776t; GLASS C, 1985, J BIOL CHEM, V260, P744; Hirata K, 1999, J BIOL CHEM, V274, P14170, DOI 10.1074/jbc.274.20.14170; Hurt-Camejo E, 2001, CIRC RES, V89, P298, DOI 10.1161/hh1601.095598; Ishida T, 2003, J CLIN INVEST, V111, P347, DOI [10.1172/JCI200316306, 10.1172/JCI16306]; Jacquet S, 2005, CELL MOL LIFE SCI, V62, P2508, DOI 10.1007/s00018-005-5194-0; Jaye M, 1999, NAT GENET, V21, P424, DOI 10.1038/7766; Ji Y, 1999, J BIOL CHEM, V274, P33398, DOI 10.1074/jbc.274.47.33398; Jin WJ, 2003, J CLIN INVEST, V111, P357, DOI [10.1172/JCI16146, 10.1172/JCI200316146]; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658; Ma K, 2003, P NATL ACAD SCI USA, V100, P2748, DOI 10.1073/pnas.0438039100; Martinez LO, 2003, NATURE, V421, P75, DOI 10.1038/nature01250; Maugeais C, 2003, CIRCULATION, V108, P2121, DOI 10.1161/01.CIR.0000092889.24713.DC; McCoy MG, 2002, J LIPID RES, V43, P921; Out R, 2004, J LIPID RES, V45, P2088, DOI 10.1194/jlr.M400191-JLR200; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; RADER DJ, 2002, ARTERIOSCLER THROMB, V22, P1213; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Rosengren B, 2006, ARTERIOSCL THROM VAS, V26, P1579, DOI 10.1161/01.ATV.0000221231.56617.67; Skropeta D, 2007, J LIPID RES, V48, P2047, DOI 10.1194/jlr.M700248-JLR200; Tietge UJF, 2000, J BIOL CHEM, V275, P10077, DOI 10.1074/jbc.275.14.10077; Tietge UJF, 2003, AM J PHYSIOL-ENDOC M, V285, pE403, DOI 10.1152/ajpendo.00576.2002; Tietge UJF, 2002, ARTERIOSCL THROM VAS, V22, P1213, DOI 10.1161/01.ATV.0000023228.90866.29; Tietge UJF, 2008, J LIPID RES, V49, P563, DOI 10.1194/jlr.M700276-JLR200; Trigatti BL, 2003, ARTERIOSCL THROM VAS, V23, P1732, DOI 10.1161/01.ATV.0000091363.28501.84; Varban ML, 1998, P NATL ACAD SCI USA, V95, P4619, DOI 10.1073/pnas.95.8.4619; Vassiliou G, 2004, ARTERIOSCL THROM VAS, V24, P1669, DOI 10.1161/01.ATV.0000134295.09932.60; Webb NR, 2005, CURR OPIN LIPIDOL, V16, P341, DOI 10.1097/01.mol.0000169355.20395.55; Webb NR, 2004, J LIPID RES, V45, P1666, DOI 10.1194/jlr.M400026-JLR200	33	50	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6093	6100		10.1074/jbc.M807683200	http://dx.doi.org/10.1074/jbc.M807683200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19136670	hybrid			2022-12-25	WOS:000263742700011
J	Zhou, Q; Geahlen, RL				Zhou, Q.; Geahlen, R. L.			The protein-tyrosine kinase Syk interacts with TRAF-interacting protein TRIP in breast epithelial cells	ONCOGENE			English	Article						Syk; tyrosine kinase; breast cancer; tumor necrosis factor; TRIP; NF-kappa B	KAPPA-B ACTIVATION; TUMOR-NECROSIS-FACTOR; ANTIGEN RECEPTOR; CANCER CELLS; LOCALIZES; LYN	The nonreceptor, protein-tyrosine kinase Syk is a suppressor of breast cancer progression whose expression is inversely correlated with the invasive behavior of cancer cells. In contrast, Syk has a positive function in murine mammary tumor virus-mediated tumorigenesis. A yeast two-hybrid screen using a library from human mammary gland identified tumor necrosis factor (TNF) receptor-associated factor-interacting protein (TRIP) as an Syk-binding partner. This interaction is mediated by the C-terminal region of TRIP and is enhanced by the treatment of cells with TNF and the tyrosine phosphorylation of Syk. Syk and TRIP have opposing functions in TNF-signaling pathways. Syk enhances the activation of nuclear factor-kappa B by TNF and this is antagonized by TRIP. The overexpression of TRIP sensitizes cells to TNF-induced apoptosis, an effect that can be reversed by the coexpression of Syk.	[Zhou, Q.; Geahlen, R. L.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Zhou, Q.; Geahlen, R. L.] Purdue Univ, Purdue Canc Ctr, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Geahlen, RL (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, Hansen Life Sci Res Bldg,201 S Univ St, W Lafayette, IN 47907 USA.	geahlen@purdue.edu		Geahlen, Robert/0000-0001-8400-2924	NATIONAL CANCER INSTITUTE [R01CA115465] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA115465, R01 CA115465-03, CA115465] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Besse A, 2007, BIOCHEM BIOPH RES CO, V359, P660, DOI 10.1016/j.bbrc.2007.05.149; Coopman PJP, 2000, NATURE, V406, P742, DOI 10.1038/35021086; Eliopoulos AG, 2006, J BIOL CHEM, V281, P1371, DOI 10.1074/jbc.M506790200; Katz E, 2005, J EXP MED, V201, P431, DOI 10.1084/jem.20041471; Keshvara LM, 1998, J IMMUNOL, V161, P5276; Kurosaki T, 2000, CURR OPIN IMMUNOL, V12, P276, DOI 10.1016/S0952-7915(00)00087-X; Latour S, 2001, CURR OPIN IMMUNOL, V13, P299, DOI 10.1016/S0952-7915(00)00219-3; Lee SY, 1997, J EXP MED, V185, P1275, DOI 10.1084/jem.185.7.1275; Lu J, 2006, J BIOL CHEM, V281, P8806, DOI 10.1074/jbc.M507305200; Ma H, 2001, J IMMUNOL, V166, P1507, DOI 10.4049/jimmunol.166.3.1507; Moon KD, 2005, J BIOL CHEM, V280, P1543, DOI 10.1074/jbc.M407805200; Moroni M, 2004, CANCER RES, V64, P7346, DOI 10.1158/0008-5472.CAN-03-3520; Peters JD, 1996, J BIOL CHEM, V271, P4755; Regamey A, 2003, J EXP MED, V198, P1959, DOI 10.1084/jem.20031187; Salomoni P, 2006, TRENDS CELL BIOL, V16, P97, DOI 10.1016/j.tcb.2005.12.002; Takada Y, 2004, J IMMUNOL, V173, P1066, DOI 10.4049/jimmunol.173.2.1066; Toyama T, 2003, CANCER LETT, V189, P97, DOI 10.1016/S0304-3835(02)00463-9; Ulanova M, 2005, AM J PHYSIOL-LUNG C, V288, pL497, DOI 10.1152/ajplung.00246.2004; Wang L, 2005, CANCER RES, V65, P10289, DOI 10.1158/0008-5472.CAN-05-2231; Wilson J, 2002, SEMIN CANCER BIOL, V12, P113, DOI 10.1006/scbi.2001.0419; Zhou F, 2006, MOL CELL BIOL, V26, P3478, DOI 10.1128/MCB.26.9.3478-3491.2006; Zyss D, 2005, CANCER RES, V65, P10872, DOI 10.1158/0008-5472.CAN-05-1270	22	42	43	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	10					1348	1356		10.1038/onc.2008.493	http://dx.doi.org/10.1038/onc.2008.493			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	417ZC	19151749	Green Accepted			2022-12-25	WOS:000264116000007
J	Zubia, A; Ropero, S; Otaegui, D; Ballestar, E; Fraga, MF; Boix-Chornet, M; Berdasco, M; Martinez, A; Coll-Mulet, L; Gil, J; Cossio, FP; Esteller, M				Zubia, A.; Ropero, S.; Otaegui, D.; Ballestar, E.; Fraga, M. F.; Boix-Chornet, M.; Berdasco, M.; Martinez, A.; Coll-Mulet, L.; Gil, J.; Cossio, F. P.; Esteller, M.			Identification of (1H)-pyrroles as histone deacetylase inhibitors with antitumoral activity	ONCOGENE			English	Article						angiogenesis; cancer; computational modeling; epigenetics; histones; histone deacetylase inhibitors	HUMAN HDAC8; MECHANISMS; DISCOVERY; DISEASE; SAHA	Histone deacetylases (HDACs) play a key role in the regulation of gene expression and chromatin structure, and drugs targeting these enzymes might have an important impact in the treatment of human cancer. Herein, we report the characterization of (1H)-pyrroles as a new subfamily of HDAC inhibitors obtained by computational modeling of class-I human HDACs. From a functional standpoint, (1H)-pyrroles are powerful inductors of acetylation of histones H3 and H4, and restore the expression of growth-inhibitory genes. From a cellular view, these compounds cause a marked decrease in the viability of cancer cells in vitro and in vivo, associated with a cell-cycle arrest at G2/M and an inhibition of angiogenesis. Thus, (1H)-pyrroles emerge as a novel group of HDAC inhibitors with promising antitumoral features.	[Zubia, A.; Otaegui, D.; Cossio, F. P.] Univ Pais Vasco Euskal Herriko Unibertsitatea, Sch Chem Quim Kim Fak, Donostia San Sebastian, Euskadi, Spain; [Ropero, S.; Ballestar, E.; Fraga, M. F.; Boix-Chornet, M.; Berdasco, M.; Esteller, M.] Spanish Natl Canc Res Ctr CNIO, Canc Epigenet Lab, Madrid, Spain; [Zubia, A.] IkerChem SL, San Sebastian, Spain; [Ropero, S.; Ballestar, E.; Berdasco, M.; Esteller, M.] Bellvitge Inst Biomed Res IDIBELL, PEBC, Barcelona, Catalonia, Spain; [Ropero, S.; Ballestar, E.; Berdasco, M.; Esteller, M.] ICO, Barcelona, Catalonia, Spain; [Ropero, S.] Univ Alcala de Henares, Fac Med, Dept Bioquim & Biol Mol, Madrid, Spain; [Martinez, A.] CSIC, Inst Cajal, Dept Cell Biol & Neuroanat, E-28002 Madrid, Spain; [Coll-Mulet, L.; Gil, J.] Univ Barcelona, IDIBELL, Dept Ciencias Fisiol 2, Barcelona, Catalonia, Spain; [Esteller, M.] ICREA, Barcelona, Catalonia, Spain	University of Basque Country; Centro Nacional de Investigaciones Oncologicas (CNIO); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Universidad de Alcala; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; ICREA	Esteller, M (corresponding author), Hosp Duran & Reynals, PEBC, 3rd Floor,Av Gran Via Hosp 199-203, Barcelona 08907, Catalonia, Spain.	mesteller@iconcologia.net	Fraga, Mario F/H-7824-2017; Esteller, Manel/L-5956-2014; Martinez, Alfredo/GQH-5998-2022; Ballestar, Esteban/ABG-8561-2020	Fraga, Mario F/0000-0001-8450-2603; Esteller, Manel/0000-0003-4490-6093; Martinez, Alfredo/0000-0003-4882-4044; Otaegui Ansa, Dorleta/0000-0002-8215-354X; Gil, Joan/0000-0002-3686-3903; ZUBIA OLASCOAGA, AIZPEA/0000-0002-0657-801X; Cossio, Fernando P./0000-0002-4526-2122; Ballestar, Esteban/0000-0002-1400-2440	Consolider [CSD2006-49]; Spanish Association Against Cancer (AECC); SMARTER, Ikerchem Ltd.; Universidad del Pais Vasco-Euskal Herriko Unibertsitatea [UE07/16]; Gobierno Vasco-Eusko Jaurlaritza [9/UPV00170.215-13548]; Spanish Ministerio de Educacion y Ciencia [CTQ2007-67528/BQU];  [SAF2007-00027-65134]; ICREA Funding Source: Custom	Consolider(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Association Against Cancer (AECC); SMARTER, Ikerchem Ltd.; Universidad del Pais Vasco-Euskal Herriko Unibertsitatea; Gobierno Vasco-Eusko Jaurlaritza(Basque Government); Spanish Ministerio de Educacion y Ciencia(Spanish Government); ; ICREA(ICREA)	This work was supported by Grants SAF2007-00027-65134, Consolider CSD2006-49, the Spanish Association Against Cancer (AECC), FP6 Grant SMARTER, Ikerchem Ltd., The Universidad del Pais Vasco-Euskal Herriko Unibertsitatea (Grant UE07/16), the Gobierno Vasco-Eusko Jaurlaritza (Grant 9/UPV00170.215-13548) and the Spanish Ministerio de Educacion y Ciencia (CTQ2007-67528/BQU). SR is a 'Ramon y Cajal' Researcher. ME is an ICREA Research Professor.	Balakin KV, 2007, ANTI-CANCER AGENT ME, V7, P576, DOI 10.2174/187152007781668698; Chiorazzi N., 2005, NEW ENGL J MED, V352, P804, DOI [10.1056/NEJMra041720, DOI 10.1056/NEJMRA041720, 10.1002/9781444300857.ch36]; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim JH, 2001, COMPOS INTERFACE, V7, P443, DOI 10.1163/156855400750262932; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; MAIER T, 2006, Patent No. 2006105979; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; Massa S, 2001, J MED CHEM, V44, P2069, DOI 10.1021/jm015515v; Richardson B, 2007, NAT CLIN PRACT RHEUM, V3, P521, DOI 10.1038/ncprheum0573; Sadri-Vakili G, 2006, NAT CLIN PRACT NEURO, V2, P330, DOI 10.1038/ncpneuro0199; Somoza JR, 2004, STRUCTURE, V12, P1325, DOI 10.1016/j.str.2004.04.012; Vannini A, 2004, P NATL ACAD SCI USA, V101, P15064, DOI 10.1073/pnas.0404603101; Villar-Garea A, 2004, INT J CANCER, V112, P171, DOI 10.1002/ijc.20372; Vivanco S, 2000, J AM CHEM SOC, V122, P6078, DOI 10.1021/ja9945360; Wang DF, 2004, J MED CHEM, V47, P3409, DOI 10.1021/jm0498497	19	19	19	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	11					1477	1484		10.1038/onc.2008.501	http://dx.doi.org/10.1038/onc.2008.501			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	421JE	19169274				2022-12-25	WOS:000264354400009
J	Wu, DY; Raymond, J; Wu, M; Chatterji, S; Ren, QH; Graham, JE; Bryant, DA; Robb, F; Colman, A; Tallon, LJ; Badger, JH; Madupu, R; Ward, NL; Eisen, JA				Wu, Dongying; Raymond, Jason; Wu, Martin; Chatterji, Sourav; Ren, Qinghu; Graham, Joel E.; Bryant, Donald A.; Robb, Frank; Colman, Albert; Tallon, Luke J.; Badger, Jonathan H.; Madupu, Ramana; Ward, Naomi L.; Eisen, Jonathan A.			Complete Genome Sequence of the Aerobic CO-Oxidizing Thermophile Thermomicrobium roseum	PLOS ONE			English	Article							LONG-CHAIN DIOLS; CHLOROFLEXUS-AURANTIACUS; SIGNAL-TRANSDUCTION; CHLOROBIUM-TEPIDUM; SALINIBACTER-RUBER; EARLY EVOLUTION; BACILLUS; PATHWAY; PROTEIN; ENZYMES	In order to enrich the phylogenetic diversity represented in the available sequenced bacterial genomes and as part of an "Assembling the Tree of Life" project, we determined the genome sequence of Thermomicrobium roseum DSM 5159. T. roseum DSM 5159 is a red-pigmented, rod-shaped, Gram-negative extreme thermophile isolated from a hot spring that possesses both an atypical cell wall composition and an unusual cell membrane that is composed entirely of long-chain 1,2-diols. Its genome is composed of two circular DNA elements, one of 2,006,217 bp (referred to as the chromosome) and one of 919,596 bp (referred to as the megaplasmid). Strikingly, though few standard housekeeping genes are found on the megaplasmid, it does encode a complete system for chemotaxis including both chemosensory components and an entire flagellar apparatus. This is the first known example of a complete flagellar system being encoded on a plasmid and suggests a straightforward means for lateral transfer of flagellum-based motility. Phylogenomic analyses support the recent rRNA-based analyses that led to T. roseum being removed from the phylum Thermomicrobia and assigned to the phylum Chloroflexi. Because T. roseum is a deep-branching member of this phylum, analysis of its genome provides insights into the evolution of the Chloroflexi. In addition, even though this species is not photosynthetic, analysis of the genome provides some insight into the origins of photosynthesis in the Chloroflexi. Metabolic pathway reconstructions and experimental studies revealed new aspects of the biology of this species. For example, we present evidence that T. roseum oxidizes CO aerobically, making it the first thermophile known to do so. In addition, we propose that glycosylation of its carotenoids plays a crucial role in the adaptation of the cell membrane to this bacterium's thermophilic lifestyle. Analyses of published metagenomic sequences from two hot springs similar to the one from which this strain was isolated, show that close relatives of T. roseum DSM 5159 are present but have some key differences from the strain sequenced.	[Wu, Dongying; Wu, Martin; Chatterji, Sourav; Eisen, Jonathan A.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Eisen, Jonathan A.] Univ Calif Davis, Sect Evolut & Ecol, Davis, CA USA; [Eisen, Jonathan A.] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA USA; [Raymond, Jason] Lawrence Livermore Natl Lab, Microb Syst Div, Biosci Directorate, Livermore, CA USA; [Graham, Joel E.; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Robb, Frank; Colman, Albert] Univ Maryland, Biotechnol Inst, Baltimore, MD USA; [Ren, Qinghu; Tallon, Luke J.; Badger, Jonathan H.; Madupu, Ramana; Ward, Naomi L.] J Craig Venter Inst, Rockville, MD USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Maryland; University of Maryland Baltimore; J. Craig Venter Institute	Wu, DY (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	jaeisen@ucdavis.edu	Eisen, Jonathan A./H-2706-2019	Eisen, Jonathan A./0000-0002-0159-2197; Robb, Frank/0000-0001-5833-6496; Wu, Martin/0000-0003-3093-4077	National Science Foundation [0228651, MCB-0519743, MCB0605301]	National Science Foundation(National Science Foundation (NSF))	The project is supported by the National Science Foundation Assembling the Tree of Life Grant No. 0228651 rewarded to Jonathan A. Eisen and Naomi Ward; the National Science Foundation Photosystem I: Biogenesis, Broken Symmetry, and Hydrogenase Chimeras Grant No. MCB-0519743 rewarded to Donald A. Bryant; National Science Foundation Interspecies Metabolic Complementation in Geothermal Microbial Mats Grant No. MCB0605301 awarded to Frank Robb and Albert Colman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashida H, 2003, SCIENCE, V302, P286, DOI 10.1126/science.1086997; Atomi H, 2002, J BIOSCI BIOENG, V94, P497, DOI 10.1016/S1389-1723(02)80186-4; Badger JH, 2005, INT J SYST EVOL MICR, V55, P1021, DOI 10.1099/ijs.0.63510-0; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; BASSHAM JA, 1950, J BIOL CHEM, V185, P781; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Bhaya D, 2007, ISME J, V1, P703, DOI 10.1038/ismej.2007.46; BLANKENSHIP RE, 1992, PHOTOSYNTH RES, V33, P91, DOI 10.1007/BF00039173; Bryant DA, 2007, SCIENCE, V317, P523, DOI 10.1126/science.1143236; Bryant DA, 2006, TRENDS MICROBIOL, V14, P488, DOI 10.1016/j.tim.2006.09.001; Caspi R, 2006, NUCLEIC ACIDS RES, V34, pD511, DOI 10.1093/nar/gkj128; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; Chatterji S, 2008, LECT N BIOINFORMAT, V4955, P17; DI MASCIO P, 1991, AM J CLIN NUTR, V53, pS194, DOI 10.1093/ajcn/53.1.194S; DRACHEVA S, 1991, BIOCHEMISTRY-US, V30, P11451, DOI 10.1021/bi00112a012; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen JA, 2000, CURR OPIN MICROBIOL, V3, P475, DOI 10.1016/S1369-5274(00)00125-9; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; EUGESTER C, 1995, CAROTENOIDS A, V1, P71; Falke JJ, 1997, ANNU REV CELL DEV BI, V13, P457, DOI 10.1146/annurev.cellbio.13.1.457; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Garrity G. M., 2001, BERGEYS MANUAL SYSTE, P447; GISH W, 2004, WU BLAST; GRAHAM JE, 2008, THESIS PENNSYLVANIA; Gruszecki WI, 2005, BBA-MOL BASIS DIS, V1740, P108, DOI 10.1016/j.bbadis.2004.11.015; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAMAMOTO T, 1994, MOL MICROBIOL, V14, P939, DOI 10.1111/j.1365-2958.1994.tb01329.x; Hanson TE, 2001, P NATL ACAD SCI USA, V98, P4397, DOI 10.1073/pnas.081610398; Howe K, 2002, BIOINFORMATICS, V18, P1546, DOI 10.1093/bioinformatics/18.11.1546; Hugenholtz P, 2004, INT J SYST EVOL MICR, V54, P2049, DOI 10.1099/ijs.0.03028-0; Hugenholtz P, 2002, GENOME BIOL, V3; HUSSAIN H, 1994, MOL MICROBIOL, V12, P153, DOI 10.1111/j.1365-2958.1994.tb01004.x; JACKSON TJ, 1973, INT J SYST BACTERIOL, V23, P28, DOI 10.1099/00207713-23-1-28; JURGENS UJ, 1987, ARCH MICROBIOL, V148, P72, DOI 10.1007/BF00429651; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; King GM, 2007, NAT REV MICROBIOL, V5, P107, DOI 10.1038/nrmicro1595; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; Knoll AH, 2003, GEOBIOLOGY, V1, P3, DOI 10.1046/j.1472-4669.2003.00002.x; KRINSKY NI, 1989, FREE RADICAL BIO MED, V7, P617, DOI 10.1016/0891-5849(89)90143-3; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; Lobry JR, 1996, SCIENCE, V272, P745, DOI 10.1126/science.272.5262.745; Lutnaes BF, 2002, J NAT PROD, V65, P1340, DOI 10.1021/np020125c; MACDONALD H, 1985, MOL GEN GENET, V200, P328, DOI 10.1007/BF00425444; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Maresca JA, 2007, P NATL ACAD SCI USA, V104, P11784, DOI 10.1073/pnas.0702984104; Maresca JA, 2006, J BACTERIOL, V188, P6217, DOI 10.1128/JB.00766-06; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; McBride MJ, 2001, ANNU REV MICROBIOL, V55, P49, DOI 10.1146/annurev.micro.55.1.49; MCMANUS JD, 1992, J BIOL CHEM, V267, P6531; MERKEL GJ, 1980, CAN J MICROBIOL, V26, P556, DOI 10.1139/m80-097; Mongodin EF, 2005, P NATL ACAD SCI USA, V102, P18147, DOI 10.1073/pnas.0509073102; POND JL, 1987, J BACTERIOL, V169, P1328, DOI 10.1128/jb.169.3.1328-1330.1987; POND JL, 1986, SCIENCE, V231, P1134, DOI 10.1126/science.231.4742.1134; RAGSDALE SW, 1991, CRIT REV BIOCHEM MOL, V26, P261, DOI 10.3109/10409239109114070; Ren QH, 2005, PLOS COMPUT BIOL, V1, P190, DOI 10.1371/journal.pcbi.0010027; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Salzberg SL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r23; Santiago B, 1997, J BACTERIOL, V179, P6053, DOI 10.1128/jb.179.19.6053-6060.1997; Sekowska A, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-8; Seshadri R, 2005, SCIENCE, V307, P105, DOI 10.1126/science.1102226; STRAUSS G, 1993, EUR J BIOCHEM, V215, P633, DOI 10.1111/j.1432-1033.1993.tb18074.x; Swartz TH, 2005, EXTREMOPHILES, V9, P345, DOI 10.1007/s00792-005-0451-6; Tabita FR, 2007, MICROBIOL MOL BIOL R, V71, P576, DOI 10.1128/MMBR.00015-07; Tsuchiya T, 2005, FEBS LETT, V579, P2125, DOI 10.1016/j.febslet.2005.02.066; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Ward DM, 1998, MICROBIOL MOL BIOL R, V62, P1353, DOI 10.1128/MMBR.62.4.1353-1370.1998; Wisniewska A, 2006, ACTA BIOCHIM POL, V53, P475; WOOD HG, 1989, AUTOTROPHIC BACTERIA, P33; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188; Wu M, 2005, PLOS GENET, V1, P563, DOI 10.1371/journal.pgen.0010065; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724	74	80	201	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2009	4	1							e4207	10.1371/journal.pone.0004207	http://dx.doi.org/10.1371/journal.pone.0004207			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IH	19148287	Green Published, gold			2022-12-25	WOS:000265479900001
J	Hospedales, T; Vijayakumar, S				Hospedales, Timothy; Vijayakumar, Sethu			Multisensory Oddity Detection as Bayesian Inference	PLOS ONE			English	Article							CUE COMBINATION; TEXTURE; INFORMATION; PERCEPTION; VISION; INTEGRATION; SIGNALS; SLANT; TOUCH	A key goal for the perceptual system is to optimally combine information from all the senses that may be available in order to develop the most accurate and unified picture possible of the outside world. The contemporary theoretical framework of ideal observer maximum likelihood integration (MLI) has been highly successful in modelling how the human brain combines information from a variety of different sensory modalities. However, in various recent experiments involving multisensory stimuli of uncertain correspondence, MLI breaks down as a successful model of sensory combination. Within the paradigm of direct stimulus estimation, perceptual models which use Bayesian inference to resolve correspondence have recently been shown to generalize successfully to these cases where MLI fails. This approach has been known variously as model inference, causal inference or structure inference. In this paper, we examine causal uncertainty in another important class of multi-sensory perception paradigm - that of oddity detection and demonstrate how a Bayesian ideal observer also treats oddity detection as a structure inference problem. We validate this approach by showing that it provides an intuitive and quantitative explanation of an important pair of multi-sensory oddity detection experiments involving cues across and within modalities - for which MLI previously failed dramatically, allowing a novel unifying treatment of within and cross modal multisensory perception. Our successful application of structure inference models to the new 'oddity detection' paradigm, and the resultant unified explanation of across and within modality cases provide further evidence to suggest that structure inference may be a commonly evolved principle for combining perceptual information in the brain.	[Hospedales, Timothy; Vijayakumar, Sethu] Univ Edinburgh, Sch Informat, Inst Percept Act & Behav, Edinburgh, Midlothian, Scotland	University of Edinburgh	Hospedales, T (corresponding author), Univ Edinburgh, Sch Informat, Inst Percept Act & Behav, Edinburgh, Midlothian, Scotland.	t.hospedales@ed.ac.uk		Hospedales, Timothy/0000-0003-4867-7486	Neuroinformatics Doctoral Training Center (Neuroinformatics DTC) at the University of Edinburgh; Royal Academy of Engineering in Learning Robotics [fellowship]; Microsoft Research	Neuroinformatics Doctoral Training Center (Neuroinformatics DTC) at the University of Edinburgh; Royal Academy of Engineering in Learning Robotics; Microsoft Research(Microsoft)	TMH was supported by the Neuroinformatics Doctoral Training Center (Neuroinformatics DTC) at the University of Edinburgh. SV is supported by a fellowship of the Royal Academy of Engineering in Learning Robotics, co-sponsored by Microsoft Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; BARSHALOM Y, 1975, AUTOMATICA, V11, P451, DOI 10.1016/0005-1098(75)90021-7; Battaglia PW, 2003, J OPT SOC AM A, V20, P1391, DOI 10.1364/JOSAA.20.001391; Bresciani JP, 2006, J VISION, V6, P554, DOI 10.1167/6.5.2; ERNST M, 2005, BAYESIAN VIEW MULTIM, P105; Ernst MO, 2007, J VISION, V7, DOI 10.1167/7.5.7; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Geiger D, 1996, ARTIF INTELL, V82, P45, DOI 10.1016/0004-3702(95)00014-3; Gepshtein S, 2003, CURR BIOL, V13, P483, DOI 10.1016/S0960-9822(03)00133-7; Gepshtein S, 2005, J VISION, V5, P1013, DOI 10.1167/5.11.7; Hairston WD, 2003, J COGNITIVE NEUROSCI, V15, P20, DOI 10.1162/089892903321107792; Hillis JM, 2004, J VISION, V4, P967, DOI 10.1167/4.12.1; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; HOSPEDALES T, 2007, INT JOINT C ART INT; Hospedales TM, 2008, IEEE T PATTERN ANAL, V30, P2140, DOI 10.1109/TPAMI.2008.25; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Knill DC, 1998, VISION RES, V38, P1683, DOI 10.1016/S0042-6989(97)00325-8; Knill DC, 2003, VISION RES, V43, P2539, DOI 10.1016/S0042-6989(03)00458-9; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; KNILL DC, 2007, J VIS, V7; Knill DC, 1996, PERCEPTION BAYESIAN; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Kording KP, 2004, P NATL ACAD SCI USA, V101, P9839, DOI 10.1073/pnas.0308394101; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Landy MS, 2001, J OPT SOC AM A, V18, P2307, DOI 10.1364/JOSAA.18.002307; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; MacKay D. J. C., 2003, INFORM THEORY INFERE; MACKAY DJC, 1992, NEURAL COMPUT, V4, P415, DOI [10.1162/neco.1992.4.3.415, 10.1162/neco.1992.4.3.448]; Macmillan N. A., 2005, DETECTION THEORY USE; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Roach NW, 2006, P ROY SOC B-BIOL SCI, V273, P2159, DOI 10.1098/rspb.2006.3578; Sato Y, 2007, NEURAL COMPUT, V19, P3335, DOI 10.1162/neco.2007.19.12.3335; Shams L, 2005, NEUROREPORT, V16, P1923, DOI 10.1097/01.wnr.0000187634.68504.bb; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Wallace MT, 2004, EXP BRAIN RES, V158, P252, DOI 10.1007/s00221-004-1899-9	37	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2009	4	1							e4205	10.1371/journal.pone.0004205	http://dx.doi.org/10.1371/journal.pone.0004205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IG	19145254	Green Published, gold, Green Submitted			2022-12-25	WOS:000265479800011
J	Berrocal, M; Marcos, D; Sepulveda, MR; Perez, M; Avila, J; Mata, AM				Berrocal, Maria; Marcos, Daniel; Rosario Sepulveda, M.; Perez, Mar; Avila, Jesus; Mata, Ana M.			Altered Ca2+ dependence of synaptosomal plasma membrane Ca2+-ATPase in human brain affected by Alzheimer's disease	FASEB JOURNAL			English	Article						neurodegeneration; amyloid; beta-peptide; postmortem; activity	BETA-PROTEIN; LIPID RAFTS; HIPPOCAMPAL-NEURONS; ATPASE ACTIVITY; CALCIUM PUMPS; NA+/K+-ATPASE; PIG BRAIN; CHOLESTEROL; CEREBELLUM; HOMEOSTASIS	High-affinity Ca2+ transport ATPases play a crucial role in controlling cytosolic Ca2+. The amyloid beta-peptide (A beta) is a neurotoxic agent found in affected neurons in Alzheimer's disease (AD) that has been implicated in dysregulation of Ca2+ homeostasis. Using kinetic assays, we have shown that the Ca2+ dependencies of intracellular Ca2+-ATPase (SERCA and SPCA) activity are the same in human AD and normal brain but that of plasma membrane Ca2+-ATPase (PMCA) is different. The addition of A beta to normal brain decreases the PMCA activity measured at pCa 5.5, resulting in the same Ca2+ dependency as that seen in AD brain, whereas the addition of A beta to AD brain has no effect on PMCA activity. A beta also decreases the activity of PMCA purified from pig cerebrum, the effect being isoform specific. The level of inhibition of purified PMCA caused by A beta is reduced by cholesterol, and the level of inhibition of PMCA activity by A beta in the raft fraction of pig synaptosomal membranes is lower than for the nonraft fraction. We conclude that the effect of A beta on PMCA activity could be important in amyloid toxicity, resulting in cytoplasmic Ca2+ dysregulation and could explain the different Ca2+ dependencies of PMCA activity observed in normal and AD brain.-Berrocal, M., Marcos, D., Sepulveda, M. R., Perez, M., A Avila, J., Mata, A. M. Altered Ca2+ dependence of synaptosomal plasma membrane Ca2+-ATPase in human brain affected by Alzheimer's disease. FASEB J. 23, 1826-1834 (2009)	[Berrocal, Maria; Marcos, Daniel; Rosario Sepulveda, M.; Mata, Ana M.] Univ Extremadura, Fac Ciencias, Dept Bioquim & Biol Mol & Genet, E-06071 Badajoz, Spain; [Perez, Mar; Avila, Jesus] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Madrid, Spain	Universidad de Extremadura; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Mata, AM (corresponding author), Univ Extremadura, Fac Ciencias, Dept Bioquim & Biol Mol & Genet, Avda Elvas S-N, E-06071 Badajoz, Spain.	anam@unex.es	Sepulveda, M. Rosario/L-4907-2014; Avila, Jesus/I-2610-2015; Berrocal Carrillo, María/H-1527-2018; Mata, Ana M./J-8460-2014; Marcos, Daniel/J-9730-2014; Mar, Perez/Y-2055-2019	Sepulveda, M. Rosario/0000-0002-2375-5866; Avila, Jesus/0000-0002-6288-0571; Berrocal Carrillo, María/0000-0003-0684-3853; Mata, Ana M./0000-0002-2887-7854; Marcos, Daniel/0000-0002-1007-1780; Mar, Perez/0000-0002-8477-9554				ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; Arispe N, 2002, FASEB J, V16, P1526, DOI 10.1096/fj.02-0829com; Arispe N, 2007, BBA-BIOMEMBRANES, V1768, P1952, DOI 10.1016/j.bbamem.2007.03.014; Avdulov NA, 1997, J NEUROCHEM, V69, P1746; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; Dante S, 2006, EUR BIOPHYS J BIOPHY, V35, P523, DOI 10.1007/s00249-006-0062-x; Dickey CA, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-7; Esposito C, 2006, J PEPT SCI, V12, P766, DOI 10.1002/psc.811; Fallon L, 2002, J BIOL CHEM, V277, P486, DOI 10.1074/jbc.M109806200; HUGHES G, 1994, BIOCHEMISTRY-US, V33, P4745, DOI 10.1021/bi00182a001; Ji SR, 2002, J BIOL CHEM, V277, P6273, DOI 10.1074/jbc.M104146200; Kakio A, 2001, J BIOL CHEM, V276, P24985, DOI 10.1074/jbc.M100252200; Mall S, 2006, J BIOL CHEM, V281, P36597, DOI 10.1074/jbc.M606869200; MARK RJ, 1995, J NEUROSCI, V15, P6239; Mark RJ, 1997, BRAIN RES, V756, P205, DOI 10.1016/S0006-8993(97)00196-0; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; MCWHIRTER JM, 1987, BIOCHEM J, V245, P713, DOI 10.1042/bj2450713; Palacios J, 2003, BBA-BIOMEMBRANES, V1611, P197, DOI 10.1016/S0005-2736(03)00057-9; Parkin ET, 1999, J NEUROCHEM, V72, P1534, DOI 10.1046/j.1471-4159.1999.721534.x; Salvador JM, 2001, J BIOCHEM-TOKYO, V129, P621, DOI 10.1093/oxfordjournals.jbchem.a002899; Salvador JM, 1998, ARCH BIOCHEM BIOPHYS, V351, P272, DOI 10.1006/abbi.1997.0562; Salvador JM, 1996, BIOCHEM J, V315, P183, DOI 10.1042/bj3150183; Sepulveda MR, 2007, J NEUROCHEM, V103, P1009, DOI 10.1111/j.1471-4159.2007.04794.x; Sepulveda MR, 2006, J BIOL CHEM, V281, P447, DOI 10.1074/jbc.M506950200; Sepulveda MR, 2005, J NEUROCHEM, V95, P673, DOI 10.1111/j.1471-4159.2005.03401.x; Sepulveda MR, 2004, BBA-BIOMEMBRANES, V1665, P75, DOI 10.1016/j.bbamem.2004.06.016; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Strehler EE, 2007, ANN NY ACAD SCI, V1099, P226, DOI 10.1196/annals.1387.023; VERBOOMEN H, 1992, BIOCHEM J, V286, P591, DOI 10.1042/bj2860591; Waschuk SA, 2001, J BIOL CHEM, V276, P33561, DOI 10.1074/jbc.M103598200; Wuytack F, 2002, CELL CALCIUM, V32, P279, DOI 10.1016/S0143416002001847; Yagyu K, 2001, J NEUROCHEM, V78, P569, DOI 10.1046/j.1471-4159.2001.00446.x; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yip CM, 2001, J MOL BIOL, V311, P723, DOI 10.1006/jmbi.2001.4881	38	48	49	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2009	23	6					1826	1834		10.1096/fj.08-121459	http://dx.doi.org/10.1096/fj.08-121459			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19144698	Green Submitted			2022-12-25	WOS:000266652400023
J	Corbetta, S; Gualdoni, S; Ciceri, G; Monari, M; Zuccaro, E; Tybulewicz, VLJ; de Curtis, I				Corbetta, Sara; Gualdoni, Sara; Ciceri, Gabriele; Monari, Marta; Zuccaro, Emanuela; Tybulewicz, Victor L. J.; de Curtis, Ivan			Essential role of Rac1 and Rac3 GTPases in neuronal development	FASEB JOURNAL			English	Article						hippocampus; hilar mossy cells; dendritic spines; axons	MOUSE DENTATE GYRUS; MOSSY CELLS; RHO FAMILY; SYNAPTIC CONNECTIONS; HIPPOCAMPAL-NEURONS; RHESUS-MONKEY; MIGRATION; PROTEINS; MICE; IDENTIFICATION	Rac GTPases are members of the Rho family regulating the actin cytoskeleton and implicated in neuronal development. Ubiquitous Rac1 and neuron-specific Rac3 GTPases are coexpressed in the developing mammalian brain. We used Cre-mediated conditional deletion of Rac1 in neurons combined with knockout of neuron-specific Rac3 to study the role of these GTPases in neural development. We found that lack of both genes causes motor behavioral defects, epilepsy, and premature death of mice. Deletion of either GTPase does not produce evident phenotypes. Double-knockout mice show specific defects in the development of the hippocampus. Selective impairment of the dorsal hilus of double-knockout animals is associated with alteration in the formation of the hippocampal circuitry. Axonal pathways to and from the dorsal hilus are affected because of the deficit of hilar mossy cells. Moreover, analysis of Rac function in hippocampal cultures shows that spine formation is strongly hampered only in neurons lacking both Rac proteins. These findings show for the first time that both Rac1 and Rac3 are important for the development of the nervous system, wherein they play complementary roles during late stages of neuronal and brain development.-Corbetta, S., Gualdoni, S., Ciceri, G., Monari, M., Zuccaro, E., Tybulewicz, V. L. J., de Curtis, I. Essential role of Rac1 and Rac3 GTPases in neuronal development. FASEB J. 23, 1347-1357 (2009)	[Corbetta, Sara; Gualdoni, Sara; Ciceri, Gabriele; Monari, Marta; Zuccaro, Emanuela; de Curtis, Ivan] Ist Sci San Raffaele, Cell Adhes Unit, I-20132 Milan, Italy; [Corbetta, Sara; Gualdoni, Sara; Ciceri, Gabriele; Monari, Marta; Zuccaro, Emanuela; de Curtis, Ivan] San Raffaele Univ, Milan, Italy; [Tybulewicz, Victor L. J.] Natl Inst Med Res, Ridgeway, Div Immune Cell Biol, London NW7 1AA, England	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; MRC National Institute for Medical Research	de Curtis, I (corresponding author), Ist Sci San Raffaele, Cell Adhes Unit, Via Olgettina 58, I-20132 Milan, Italy.	decurtis.ivan@hsr.it		Tybulewicz, Victor/0000-0003-2439-0798; monari, marta/0000-0003-4071-270X; Ciceri, Gabriele/0000-0002-8481-9771; DE CURTIS, Ivanmatteo/0000-0002-7651-1515	Telethon-Italy [GGP05051]; Fondazione Cariplo; Medical Research Council [MC_U117527252] Funding Source: researchfish; MRC [MC_U117527252] Funding Source: UKRI	Telethon-Italy(Fondazione Telethon); Fondazione Cariplo(Fondazione Cariplo); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Laura Croci, the personnel of the Alembic facility, Claudia Asperti, and Fabio Monzani for technical help. This work was supported by Telethon-Italy (Grant GGP05051) and by Fondazione Cariplo. We thank Jamey Marth (University of California, San Diego, CA, USA) for SynI-Cre mice; Louis Reichardt (University of California, San Francisco, CA, USA) for the pEGFP-Cre plasmid; and Virginia Lee (University of Pennsylvania School of Medicine, Philadelphia, PA, USA), Richard Palmiter (University of Washington School of Medicine, Seattle, WA, USA), and Flavia Valtorta (University Vita-Salute San Raffaele, Milan, Italy) for antibodies. We also thank Marco de Curtis, Jacopo Meldolesi, Anna Mondino, Flavia Valtorta, and Larry Wrabetz for helpful discussions.	Albertinazzi C, 1998, J CELL BIOL, V142, P815, DOI 10.1083/jcb.142.3.815; ANGEVINE JAY B., 1965, EXP NEUROL SUPPL, V2, P1; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Bolis A, 2003, EUR J NEUROSCI, V18, P2417, DOI 10.1046/j.1460-9568.2003.02938.x; Chen L, 2007, J NEUROSCI, V27, P3884, DOI 10.1523/JNEUROSCI.3509-06.2007; Cho YJ, 2005, MOL CELL BIOL, V25, P5777, DOI 10.1128/MCB.25.13.5777-5785.2005; Corbetta S, 2005, MOL CELL BIOL, V25, P5763, DOI 10.1128/MCB.25.13.5763-5776.2005; Corbetta S, 2008, BEHAV BRAIN RES, V186, P246, DOI 10.1016/j.bbr.2007.08.019; De Curtis I, 2008, DEV NEUROSCI-BASEL, V30, P47, DOI 10.1159/000109851; DIDSBURY J, 1989, J BIOL CHEM, V264, P16378; FROTSCHER M, 1991, J COMP NEUROL, V312, P145, DOI 10.1002/cne.903120111; Fujise N, 1999, BRAIN RES, V816, P500, DOI 10.1016/S0006-8993(98)01202-5; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Gualdoni S, 2007, BIOL CELL, V99, P455, DOI 10.1042/BC20060119; Haataja L, 1997, J BIOL CHEM, V272, P20384, DOI 10.1074/jbc.272.33.20384; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HARIHARAN IK, 1995, EMBO J, V14, P292, DOI 10.1002/j.1460-2075.1995.tb07003.x; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; Li G, 2008, DEV NEUROSCI-BASEL, V30, P255, DOI 10.1159/000110347; Liu Y, 1996, EXP BRAIN RES, V108, P389; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Malosio ML, 1997, J NEUROSCI, V17, P6717; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; NOWAKOWSKI RS, 1981, J COMP NEUROL, V196, P129, DOI 10.1002/cne.901960110; NOWAKOWSKI RS, 1979, J NEUROCYTOL, V8, P697, DOI 10.1007/BF01206671; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Philips A, 2003, BIOL CELL, V95, P295, DOI 10.1016/S0248-4900(03)00052-2; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Ratzliff ADH, 2002, TRENDS NEUROSCI, V25, P140, DOI 10.1016/S0166-2236(00)02122-6; RIBAK CE, 1985, J NEUROCYTOL, V14, P835, DOI 10.1007/BF01170832; Rico B, 2004, NAT NEUROSCI, V7, P1059, DOI 10.1038/nn1317; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; VALTORTA F, 1988, NEUROSCIENCE, V24, P593, DOI 10.1016/0306-4522(88)90353-3; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	40	65	65	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2009	23	5					1347	1357		10.1096/fj.08-121574	http://dx.doi.org/10.1096/fj.08-121574			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19126596				2022-12-25	WOS:000266651700011
J	Armishaw, C; Jensen, AA; Balle, T; Clark, RJ; Harpsoe, K; Skonberg, C; Liljefors, T; Stromgaard, K				Armishaw, Christopher; Jensen, Anders A.; Balle, Thomas; Clark, Richard J.; Harpsoe, Kasper; Skonberg, Christian; Liljefors, Tommy; Stromgaard, Kristian			Rational Design of alpha-Conotoxin Analogues Targeting alpha 7 Nicotinic Acetylcholine Receptors IMPROVED ANTAGONISTIC ACTIVITY BY INCORPORATION OF PROLINE DERIVATIVES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; BINDING PROTEIN; LIGAND-BINDING; PEPTIDE ANTAGONIST; CONUS-GEOGRAPHUS; ACCURATE DOCKING; IMI; NMR; REVEALS; SUBTYPE	Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels that belong to the superfamily of Cys loop receptors. Valuable insight into the orthosteric ligand binding to nAChRs in recent years has been obtained from the crystal structures of acetylcholine-binding proteins (AChBPs) that share significant sequence homology with the aminoterminal domains of the nAChRs. alpha-Conotoxins, which are isolated from the venom of carnivorous marine snails, selectively inhibit the signaling of neuronal nAChR subtypes. Co-crystal structures of alpha-conotoxins in complex with AChBP show that the side chain of a highly conserved proline residue in these toxins is oriented toward the hydrophobic binding pocket in the AChBP but does not have direct interactions with this pocket. In this study, we have designed and synthesized analogues of alpha-conotoxins ImI and PnIA[A10L], by introducing a range of substituents on the Pro6 residue in these toxins to probe the importance of this residue for their binding to the nAChRs. Pharmacological characterization of the toxin analogues at the alpha(7) nAChR shows that although polar and charged groups on Pro6 result in analogues with significantly reduced antagonistic activities, analogues with aromatic and hydrophobic substituents in the Pro6 position exhibit moderate activity at the receptor. Interestingly, introduction of a 5-(R)-phenyl substituent at Pro6 in alpha-conotoxin ImI gives rise to a conotoxin analogue with a significantly higher binding affinity and antagonistic activity at the alpha(7) nAChR than those exhibited by the native conotoxin.	[Armishaw, Christopher; Jensen, Anders A.; Balle, Thomas; Harpsoe, Kasper; Liljefors, Tommy; Stromgaard, Kristian] Univ Copenhagen, Dept Med Chem, Fac Pharmaceut Sci, DK-2100 Copenhagen O, Denmark; [Skonberg, Christian] Univ Copenhagen, Dept Pharmaceut & Analyt Chem, Fac Pharmaceut Sci, DK-2100 Copenhagen O, Denmark; [Clark, Richard J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	University of Copenhagen; University of Copenhagen; University of Queensland	Jensen, AA (corresponding author), Univ Copenhagen, Dept Med Chem, Fac Pharmaceut Sci, Univ Sparken 2, DK-2100 Copenhagen O, Denmark.	aaj@farma.ku.dk; krst@farma.ku.dk	Jensen, Anders/AAJ-3335-2020; Stromgaard, Kristian/E-3380-2010; Clark, Richard J/G-8848-2012; Harpsøe, Kasper/V-6870-2018; Skonberg, Christian/D-2381-2010	Jensen, Anders/0000-0002-7927-5052; Clark, Richard J/0000-0002-6807-5426; Harpsøe, Kasper/0000-0002-9326-9644; Balle, Thomas/0000-0002-0233-8350; Stromgaard, Kristian/0000-0003-2206-4737	Drug Research Academy; Faculty of Pharmaceutical Sciences, University of Copenhagen	Drug Research Academy; Faculty of Pharmaceutical Sciences, University of Copenhagen	This work was supported in part by post-doctoral grants from the Drug Research Academy, Faculty of Pharmaceutical Sciences, University of Copenhagen (to C. A. and K. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Armishaw CJ, 2006, J BIOL CHEM, V281, P14136, DOI 10.1074/jbc.M512419200; Armishaw CJ, 2005, CURR PROTEIN PEPT SC, V6, P221, DOI 10.2174/1389203054065437; Azam L, 2005, J BIOL CHEM, V280, P80, DOI 10.1074/jbc.M406281200; Boulegue C, 2006, J MOL BIOL, V358, P846, DOI 10.1016/j.jmb.2006.02.031; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Bretscher LE, 2001, J AM CHEM SOC, V123, P777, DOI 10.1021/ja005542v; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buczek O, 2005, CELL MOL LIFE SCI, V62, P3067, DOI 10.1007/s00018-005-5283-0; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Celie PHN, 2005, J BIOL CHEM, V280, P26457, DOI 10.1074/jbc.M414476200; Clark RJ, 2006, J BIOL CHEM, V281, P23254, DOI 10.1074/jbc.M604550200; Cromer BA, 2002, TRENDS BIOCHEM SCI, V27, P280, DOI 10.1016/S0968-0004(02)02092-3; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dowell C, 2003, J NEUROSCI, V23, P8445; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Dutertre S, 2006, BIOCHEM PHARMACOL, V72, P661, DOI 10.1016/j.bcp.2006.03.027; Dutton JL, 2002, J BIOL CHEM, V277, P48849, DOI 10.1074/jbc.M208842200; Ellison M, 2004, BIOCHEMISTRY-US, V43, P16019, DOI 10.1021/bi048918g; Ellison M, 2003, J BIOL CHEM, V278, P757, DOI 10.1074/jbc.M204565200; Everhart D, 2004, BIOCHEMISTRY-US, V43, P2732, DOI 10.1021/bi036180h; FAINZILBER M, 1994, BIOCHEMISTRY-US, V33, P9523, DOI 10.1021/bi00198a018; Feuerbach D, 2005, NEUROPHARMACOLOGY, V48, P215, DOI 10.1016/j.neuropharm.2004.10.003; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gehrmann J, 1999, J MED CHEM, V42, P2364, DOI 10.1021/jm990114p; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; GRAY WR, 1993, PROTEIN SCI, V2, P1732, DOI 10.1002/pro.5560021017; GRAY WR, 1981, J BIOL CHEM, V256, P4734; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2002, J BIOL CHEM, V277, P41299, DOI 10.1074/jbc.C200462200; Hansen SB, 2004, J BIOL CHEM, V279, P24197, DOI 10.1074/jbc.M402452200; Hogg RC, 2003, J BIOL CHEM, V278, P26908, DOI 10.1074/jbc.M212628200; Hogg RC, 1999, J BIOL CHEM, V274, P36559, DOI 10.1074/jbc.274.51.36559; Hu SH, 1996, STRUCTURE, V4, P417, DOI 10.1016/S0969-2126(96)00047-0; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Jacobsen RB, 1999, BIOCHEMISTRY-US, V38, P13310, DOI 10.1021/bi9907476; Jensen AA, 2003, MOL PHARMACOL, V64, P865, DOI 10.1124/mol.64.4.865; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; JOHNSON DS, 1995, MOL PHARMACOL, V48, P194; Kang TS, 2007, BIOCHEMISTRY-US, V46, P3338, DOI 10.1021/bi061969o; Kasheverov IE, 2006, FEBS J, V273, P4470, DOI 10.1111/j.1742-4658.2006.05453.x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lamthanh H, 1999, FEBS LETT, V454, P293, DOI 10.1016/S0014-5793(99)00831-5; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Laube B, 2002, TRENDS PHARMACOL SCI, V23, P519, DOI 10.1016/S0165-6147(02)02138-7; Livett BG, 2006, TOXICON, V48, P810, DOI 10.1016/j.toxicon.2006.07.023; Lopez-Vera E, 2008, BIOCHEMISTRY-US, V47, P1741, DOI 10.1021/bi701934m; Loughnan M, 1998, J BIOL CHEM, V273, P15667, DOI 10.1074/jbc.273.25.15667; Lukas RJ, 1999, PHARMACOL REV, V51, P397; Luo S, 1999, BIOCHEMISTRY-US, V38, P14542, DOI 10.1021/bi991252j; Luo SQ, 1998, J NEUROSCI, V18, P8571; Maslennikov IV, 1999, FEBS LETT, V444, P275, DOI 10.1016/S0014-5793(99)00069-1; McIntosh JM, 2002, J BIOL CHEM, V277, P33610, DOI 10.1074/jbc.M205102200; MCINTOSH JM, 1994, J BIOL CHEM, V269, P16733; MCINTOSH M, 1982, ARCH BIOCHEM BIOPHYS, V218, P329, DOI 10.1016/0003-9861(82)90351-4; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; MYERS RA, 1991, BIOCHEMISTRY-US, V30, P9370, DOI 10.1021/bi00102a034; Nicke A, 2003, J BIOL CHEM, V278, P3137, DOI 10.1074/jbc.M210280200; O'Mara M, 2005, BIOPHYS J, V88, P3286, DOI 10.1529/biophysj.104.051664; Quiram PA, 1998, J BIOL CHEM, V273, P11001, DOI 10.1074/jbc.273.18.11001; Quiram PA, 2000, J BIOL CHEM, V275, P4889, DOI 10.1074/jbc.275.7.4889; Quiram PA, 1998, J BIOL CHEM, V273, P11007, DOI 10.1074/jbc.273.18.11007; Reeves DC, 2002, MOL MEMBR BIOL, V19, P11, DOI 10.1080/09687680110110048; Rogers JP, 1999, BIOCHEMISTRY-US, V38, P3874, DOI 10.1021/bi9826254; Sabey K, 1999, MOL PHARMACOL, V55, P58, DOI 10.1124/mol.55.1.58; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sandall DW, 2003, BIOCHEMISTRY-US, V42, P6904, DOI 10.1021/bi034043e; Satkunanathan N, 2005, BRAIN RES, V1059, P149, DOI 10.1016/j.brainres.2005.08.009; Schrodinger L., 2008, MAESTRO VERSION 8 5; SCHRODINGER LLC, 2008, PRIME VERSION 2 0; SCHRODINGER LLC, 2008, MACROMODEL VERSION 9; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sher E, 2004, CURR TOP MED CHEM, V4, P283, DOI 10.2174/1568026043451393; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Tamaki M, 2001, J ORG CHEM, V66, P3593, DOI 10.1021/jo005625u; Tamamura H, 2005, J MED CHEM, V48, P3280, DOI 10.1021/jm050009h; Trudell JR, 2002, BBA-BIOMEMBRANES, V1565, P91, DOI 10.1016/S0005-2736(02)00512-6; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; WOODY RW, 1995, METHOD ENZYMOL, V246, P34; Xiao YX, 2004, BIOORG MED CHEM LETT, V14, P1845, DOI 10.1016/j.bmcl.2003.09.105; Xiao YX, 2004, J PHARMACOL EXP THER, V310, P98, DOI 10.1124/jpet.104.066787; Xiao YX, 1998, MOL PHARMACOL, V54, P322, DOI 10.1124/mol.54.2.322	88	42	46	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9498	9512		10.1074/jbc.M806136200	http://dx.doi.org/10.1074/jbc.M806136200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19131337	hybrid, Green Published			2022-12-25	WOS:000264669100056
J	Hoe, HS; Fu, ZY; Makarova, A; Lee, JY; Lu, CY; Feng, L; Pajoohesh-Ganji, A; Matsuoka, Y; Hyman, BT; Ehlers, MD; Vicini, S; Pak, DTS; Rebeck, GW				Hoe, Hyang-Sook; Fu, Zhanyan; Makarova, Alexandra; Lee, Ji-Yun; Lu, Congyi; Feng, Li; Pajoohesh-Ganji, Ahdeah; Matsuoka, Yasuji; Hyman, Bradley T.; Ehlers, Michael D.; Vicini, Stefano; Pak, Daniel T. S.; Rebeck, G. William			The Effects of Amyloid Precursor Protein on Postsynaptic Composition and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMDA RECEPTOR SUBUNITS; SYNAPTIC PLASTICITY; DIFFERENTIAL ROLES; NR2A SUBUNIT; APP; ENDOCYTOSIS; TRAFFICKING; EXPRESSION; LOCALIZATION; ACTIVATION	The amyloid precursor protein (APP) is cleaved to produce the Alzheimer disease-associated peptide A beta, but the normal functions of uncleaved APP in the brain are unknown. We found that APP was present in the postsynaptic density of central excitatory synapses and coimmunoprecipitated with N-methyl-D-aspartate receptors (NMDARs). The presence of APP in the postsynaptic density was supported by the observation that NMDARs regulated trafficking and processing of APP; overexpression of the NR1 subunit increased surface levels of APP, whereas activation of NMDARs decreased surface APP and promoted production of A beta. We transfected APP or APP RNA interference into primary neurons and used electrophysiological techniques to explore the effects of APP on postsynaptic function. Reduction of APP decreased (and overexpression of APP increased) NMDAR whole cell current density and peak amplitude of spontaneous miniature excitatory postsynaptic currents. The increase in NMDAR current by APP was due to specific recruitment of additional NR2B-containing receptors. Consistent with these findings, immunohistochemical experiments demonstrated that APP increased the surface levels and decreased internalization of NR2B subunits. These results demonstrate a novel physiological role of postsynaptic APP in enhancing NMDAR function.	[Pajoohesh-Ganji, Ahdeah; Rebeck, G. William] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20057 USA; [Fu, Zhanyan; Lu, Congyi; Feng, Li; Vicini, Stefano] Georgetown Univ, Med Ctr, Dept Physiol & Biophys, Washington, DC 20057 USA; [Lee, Ji-Yun; Pak, Daniel T. S.] Georgetown Univ, Med Ctr, Dept Pharmacol, Washington, DC 20057 USA; [Matsuoka, Yasuji] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20057 USA; [Makarova, Alexandra; Hyman, Bradley T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGeneral Inst Neurodegenerat Disorders, Charlestown, MA 02129 USA; [Ehlers, Michael D.] Duke Univ, Med Ctr, Dept Neurobiol, Howard Hughes Med Inst, Durham, NC 27710 USA	Georgetown University; Georgetown University; Georgetown University; Georgetown University; Harvard University; Massachusetts General Hospital; Duke University; Howard Hughes Medical Institute	Rebeck, GW (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, 3970 Reservoir Rd NW, Washington, DC 20057 USA.	gwr2@georgetown.edu	Feng, Li Rebekah/Y-9204-2019; Feng, Li Rebekah/A-5678-2009; Rebeck, George William/J-2192-2012; Lu, Congyi/G-3984-2013; Lee, Ji-Yun/F-8127-2013	Feng, Li Rebekah/0000-0003-0445-4088; Rebeck, George William/0000-0001-6276-248X; Lee, Ji-Yun/0000-0002-4053-6577; Vicini, Stefano/0000-0001-8671-5194	National Institutes of Health Grants [AG14473, NS48085, AG032330]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047700, R01NS048085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R29AG014473, R01AG012406, R01AG014473, R03AG032330, R37AG012406] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG14473 ( to G. W. R.), NS48085 ( to D. T. S. P.), NS047700 ( to S. V.), AG12406 ( to B. T. H.), AG032330 ( to H. S. H.). This work is also supported by the Alzheimer's Research Fund in memory of Bill and Marie Drach. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anliker B, 2006, NEURODEGENER DIS, V3, P239, DOI 10.1159/000095262; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Fox CJ, 2006, HIPPOCAMPUS, V16, P907, DOI 10.1002/hipo.20230; Fu ZY, 2007, J NEUROCHEM, V100, P118, DOI 10.1111/j.1471-4159.2006.04195.x; Fu ZY, 2005, J PHYSIOL-LONDON, V563, P867, DOI 10.1113/jphysiol.2004.079467; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; Hoe HS, 2005, MOL CELL BIOL, V25, P9259, DOI 10.1128/MCB.25.21.9259-9268.2005; Hoogenraad CC, 2005, NAT NEUROSCI, V8, P906, DOI 10.1038/nn1487; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; *I LAB RES COMM CA, 1996, GUID CAR US LAB AN; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; KIM TW, 1995, MOL BRAIN RES, V32, P36, DOI 10.1016/0169-328X(95)00328-P; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Lesne S, 2005, J NEUROSCI, V25, P9367, DOI 10.1523/JNEUROSCI.0849-05.2005; LI GL, 1995, J NEUROTRAUM, V12, P269, DOI 10.1089/neu.1995.12.269; Losi G, 2003, J PHYSIOL-LONDON, V548, P21, DOI 10.1113/jphysiol.2002.034918; Luo JH, 2002, NEUROPHARMACOLOGY, V42, P306, DOI 10.1016/S0028-3908(01)00188-5; Lyckman AW, 1998, J BIOL CHEM, V273, P11100, DOI 10.1074/jbc.273.18.11100; Marcello E, 2007, J NEUROSCI, V27, P1682, DOI 10.1523/JNEUROSCI.3439-06.2007; MarquezSterling NR, 1997, J NEUROSCI, V17, P140, DOI 10.1523/JNEUROSCI.17-01-00140.1997; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Perez-Otano I, 2006, NAT NEUROSCI, V9, P611, DOI 10.1038/nn1680; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; Prybylowski K, 2004, J BIOL CHEM, V279, P9673, DOI 10.1074/jbc.R300029200; Prybylowski K, 2002, J NEUROSCI, V22, P8902; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Scott DB, 2004, J NEUROSCI, V24, P7096, DOI 10.1523/JNEUROSCI.0780-04.2004; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; Wang B, 2007, P NATL ACAD SCI USA, V104, P14140, DOI 10.1073/pnas.0704070104; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Weitlauf C, 2005, J NEUROSCI, V25, P8386, DOI 10.1523/JNEUROSCI.2388-05.2005	48	83	85	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8495	8506		10.1074/jbc.M900141200	http://dx.doi.org/10.1074/jbc.M900141200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19164281	Green Published, hybrid			2022-12-25	WOS:000264397800034
J	Mahoney, CM; Morgan, MR; Harrison, A; Humphries, MJ; Bass, MD				Mahoney, Claire M.; Morgan, Mark R.; Harrison, Andrew; Humphries, Martin J.; Bass, Mark D.			Therapeutic Ultrasound Bypasses Canonical Syndecan-4 Signaling to Activate Rac1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTENSITY PULSED ULTRASOUND; CUTANEOUS WOUND REPAIR; NF-KAPPA-B; CELL-ADHESION; CYCLOOXYGENASE-2 EXPRESSION; ALPHA(5)BETA(1) INTEGRIN; DIRECTIONAL MIGRATION; HUMAN OSTEOBLASTS; IN-VITRO; FIBRONECTIN	The application of pulsed, low intensity ultrasound is emerging as a potent therapy for the treatment of complex bone fractures and tissue damage. Ultrasonic stimuli accelerate fracture healing by up to 40% and enhance tendon and ligament healing by promoting cell proliferation, migration, and matrix synthesis through an unresolved mechanism. Ultrasound treatment also induces closure of nonunion fractures, at a success rate (85% of cases) similar to that of surgical intervention (68-96%) while avoiding the complications associated with surgery. The regulation of cell adhesion necessary for wound healing depends on cooperative engagement of the extracellular matrix receptors, integrin and syndecan, as exemplified by the wound healing defects observed in syndecan-and integrin-knock-out mice. This report distinguishes the influence of ultrasound on signals downstream of the prototypic fibronectin receptors, alpha(5)beta(1) integrin and syndecan-4, which cooperate to regulate Rac1 and RhoA. Ultrasonic stimulation fails to activate integrins or induce cell spreading on poor, electrostatic ligands. By contrast, ultrasound treatment overcomes the necessity of engagement or expression of syndecan-4 during the process of focal adhesion formation, which normally requires simultaneous engagement of both receptors. Ultrasound exerts an influence downstream of syndecan-4 and PKC alpha to specifically activate Rac1, itself a critical regulator of tissue repair, and to a lesser extent RhoA. The ability of ultrasound to bypass syndecan-4 signaling, which is known to facilitate efficient tissue repair, explains the reduction in healing times observed in ultrasound-treated patients. By substituting for one of the key axes of adhesion-dependent signaling, ultrasound therapy has considerable potential as a clinical technique.	[Humphries, Martin J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Harrison, Andrew] Smith & Nephew, York YO10 5DF, N Yorkshire, England	University of Manchester; Smith & Nephew	Humphries, MJ (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	martin.humphries@manchester.ac.uk		Humphries, Martin/0000-0002-4331-6967; Morgan, Mark/0000-0001-7728-9883	Wellcome Trust [045225, 074941]; Biotechnology and Biological Sciences Research Council; University of Manchester Strategic Fund	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Manchester Strategic Fund	This work was supported by Wellcome Trust Grants 045225 and 074941 (to M.J.H.). The Bioimaging Facility microscopes used in this study were purchased with grants from the Biotechnology and Biological Sciences Research Council, Wellcome Trust, and the University of Manchester Strategic Fund. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALKURDI D, 2008, COCHRANE DB SYST REV, V1; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Azuma Y, 2001, J BONE MINER RES, V16, P671, DOI 10.1359/jbmr.2001.16.4.671; Bass MD, 2008, J CELL BIOL, V181, P1013, DOI 10.1083/jcb.200711129; Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076; BASS MD, 2007, EUR PHYS J E, V3, P372; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bhadriraju K, 2007, EXP CELL RES, V313, P3616, DOI 10.1016/j.yexcr.2007.07.002; Bloom L, 1999, MOL BIOL CELL, V10, P1521, DOI 10.1091/mbc.10.5.1521; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; CAVANI A, 1993, J INVEST DERMATOL, V101, P600, DOI 10.1111/1523-1747.ep12366057; Chakravarti R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-83; Chen YJ, 2003, FEBS LETT, V554, P154, DOI 10.1016/S0014-5793(03)01157-8; Coe APF, 2001, J BIOL CHEM, V276, P35854, DOI 10.1074/jbc.M103639200; COUCHMAN JR, 1983, J CELL BIOL, V96, P177, DOI 10.1083/jcb.96.1.177; DANEN EHJ, 1995, J BIOL CHEM, V270, P21612, DOI 10.1074/jbc.270.37.21612; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Doan N, 1999, J ORAL MAXIL SURG, V57, P409, DOI 10.1016/S0278-2391(99)90281-1; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Gallo R, 1996, J INVEST DERMATOL, V107, P676, DOI 10.1111/1523-1747.ep12365571; Gebauer D, 2005, ULTRASOUND MED BIOL, V31, P1391, DOI 10.1016/j.ultrasmedbio.2005.06.002; Grenache DG, 2007, J INVEST DERMATOL, V127, P455, DOI 10.1038/sj.jid.5700611; Grose R, 2002, DEVELOPMENT, V129, P2303; Hassanain HH, 2005, SURGERY, V137, P92, DOI 10.1016/j.surg.2004.06.012; HECKMAN JD, 1994, J BONE JOINT SURG AM, V76A, P26, DOI 10.2106/00004623-199401000-00004; Hsu HC, 2007, CELL SIGNAL, V19, P2317, DOI 10.1016/j.cellsig.2007.07.006; HUMPHRIES MJ, 1986, J CELL BIOL, V103, P2637, DOI 10.1083/jcb.103.6.2637; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; Koo BK, 2006, J MOL BIOL, V355, P651, DOI 10.1016/j.jmb.2005.09.087; Kristiansen TK, 1997, J BONE JOINT SURG AM, V79A, P961, DOI 10.2106/00004623-199707000-00002; MAKAREM R, 1994, J BIOL CHEM, V269, P4005; Matthews HK, 2008, DEVELOPMENT, V135, P1771, DOI 10.1242/dev.017350; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Mould AP, 1998, BIOCHEM J, V331, P821, DOI 10.1042/bj3310821; Ng COY, 2003, ULTRASOUND MED BIOL, V29, P1501, DOI 10.1016/S0301-5629(03)01018-4; Orr AW, 2008, CIRC RES, V103, P671, DOI 10.1161/CIRCRESAHA.108.182097; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Parvizi J, 2002, J ORTHOPAED RES, V20, P51, DOI 10.1016/S0736-0266(01)00069-9; Praemer A., 1992, MUSCULOSKELETAL COND, P85; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Saoncella S, 2004, J BIOL CHEM, V279, P47172, DOI 10.1074/jbc.C400299200; Stepp MA, 2002, J CELL SCI, V115, P4517, DOI 10.1242/jcs.00128; Sun D, 2006, DRUG RESIST UPDATE, V9, P274, DOI 10.1016/j.drup.2006.12.001; Tang CH, 2007, J BIOL CHEM, V282, P25406, DOI 10.1074/jbc.M701001200; Tang CH, 2006, MOL PHARMACOL, V69, P2047, DOI 10.1124/mol.105.022160; Tscharntke M, 2007, J CELL SCI, V120, P1480, DOI 10.1242/jcs.03426; Wang FS, 2004, BONE, V35, P114, DOI 10.1016/j.bone.2004.02.012; Warden SJ, 2006, AM J SPORT MED, V34, P1094, DOI 10.1177/0363546505286139; WOODS A, 1986, EMBO J, V5, P665, DOI 10.1002/j.1460-2075.1986.tb04265.x; Yang KH, 1996, J ORTHOP RES, V14, P802, DOI 10.1002/jor.1100140518; Zhou SX, 2008, CELL SIGNAL, V20, P695, DOI 10.1016/j.cellsig.2007.12.005; Zhou SX, 2004, J BIOL CHEM, V279, P54463, DOI 10.1074/jbc.M404786200; Zweers MC, 2007, J INVEST DERMATOL, V127, P467, DOI 10.1038/sj.jid.5700546	55	27	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8889	8900		10.1074/jbc.M804281200	http://dx.doi.org/10.1074/jbc.M804281200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19147498	hybrid, Green Published			2022-12-25	WOS:000264397800072
J	Ishii, H; Du, H; Zhang, Z; Henderson, A; Sen, R; Pazin, MJ				Ishii, Haruhiko; Du, Hansen; Zhang, Zhaoqing; Henderson, Angus; Sen, Ranjan; Pazin, Michael J.			Mi2 beta Shows Chromatin Enzyme Specificity by Erasing a DNase I-hypersensitive Site Established by ACF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN GENE; TRANSCRIPTIONAL ACTIVATION; REMODELING COMPLEX; NUCLEOSOMAL DNA; HISTONE DEACETYLASE; FUNCTIONAL DIFFERENCES; REGULATORY PROTEINS; BINDING PROTEINS; B-CELLS; ENHANCER	ATP-dependent chromatin-remodeling enzymes are linked to changes in gene expression; however, it is not clear how the multiple remodeling enzymes found in eukaryotes differ in function and work together. In this report, we demonstrate that the ATP-dependent remodeling enzymes ACF and Mi2 beta can direct consecutive, opposing chromatin-remodeling events, when recruited to chromatin by different transcription factors. In a cell-free system based on the immunoglobulin heavy chain gene enhancer, we show that TFE3 induces a DNase I-hypersensitive site in an ATP-dependent reaction that requires ACF following transcription factor binding to chromatin. In a second step, PU.1 directs Mi2 beta to erase an established DNase I-hypersensitive site, in an ATP-dependent reaction subsequent to PU.1 binding to chromatin, whereas ACF will not support erasure. Erasure occurred without displacing the transcription factor that initiated the site. Other tested enzymes were unable to erase the DNase I-hypersensitive site. Establishing and erasing the DNase I-hypersensitive site required transcriptional activation domains from TFE3 and PU.1, respectively. Together, these results provide important new mechanistic insight into the combinatorial control of chromatin structure.	[Du, Hansen; Sen, Ranjan; Pazin, Michael J.] NIA, Lab Cellular & Mol Biol, NIH, Baltimore, MD 21224 USA; [Ishii, Haruhiko] Brandeis Univ, Grad Program Biophys & Struct Biol, Waltham, MA 02454 USA; [Zhang, Zhaoqing; Pazin, Michael J.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Henderson, Angus] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Brandeis University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Pazin, MJ (corresponding author), NIA, Lab Cellular & Mol Biol, NIH, 251 Bayview Blvd, Baltimore, MD 21224 USA.	pazinm@mail.nih.gov		Pazin, Michael/0000-0002-7561-3640; Ishii, Haruhiko/0000-0002-1593-096X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038925, R01GM061011, R29GM038925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000374, ZIAAG000377, ZIAAG000524] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA AG000524-05] Funding Source: Medline; NIGMS NIH HHS [GM61011, GM38925] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aalfs JD, 2001, J BIOL CHEM, V276, P34270, DOI 10.1074/jbc.M104163200; ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; Alen C, 2002, MOL CELL, V10, P1441, DOI 10.1016/S1097-2765(02)00778-5; Armstrong JA, 1996, MOL CELL BIOL, V16, P5634; ARTANDI SE, 1995, NUCLEIC ACIDS RES, V23, P3865, DOI 10.1093/nar/23.19.3865; BECKMANN H, 1990, GENE DEV, V4, P167, DOI 10.1101/gad.4.2.167; Boyer LA, 2000, J BIOL CHEM, V275, P18864, DOI 10.1074/jbc.M002810200; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Brehm A, 2000, EMBO J, V19, P4332, DOI 10.1093/emboj/19.16.4332; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Cirillo LA, 1999, MOL CELL, V4, P961, DOI 10.1016/S1097-2765(00)80225-7; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Corey LL, 2003, GENE DEV, V17, P1392, DOI 10.1101/gad.1071803; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Erman B, 1996, EMBO J, V15, P4665, DOI 10.1002/j.1460-2075.1996.tb00843.x; ERNST P, 1995, IMMUNITY, V2, P427, DOI 10.1016/1074-7613(95)90024-1; Fan HY, 2003, MOL CELL, V11, P1311, DOI 10.1016/S1097-2765(03)00192-8; Fisher RC, 1998, MOL CELL BIOL, V18, P4347, DOI 10.1128/MCB.18.7.4347; Flaus A, 2003, MOL CELL BIOL, V23, P7767, DOI 10.1128/MCB.23.21.7767-7779.2003; FYODOROV DV, 2002, CURR PROTOC MOL BIOL, pCH21; Hakimi MA, 2002, NATURE, V418, P994, DOI 10.1038/nature01024; Hall DB, 2002, J BIOL CHEM, V277, P46043, DOI 10.1074/jbc.M208911200; Ikeda K, 1999, MOL CELL BIOL, V19, P855; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Ishii H, 2004, J BIOL CHEM, V279, P7331, DOI 10.1074/jbc.M308973200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JENUWEIN T, 1993, GENE DEV, V7, P2016, DOI 10.1101/gad.7.10.2016; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kal AJ, 2000, GENE DEV, V14, P1058; Kassabov SR, 2003, MOL CELL, V11, P391, DOI 10.1016/S1097-2765(03)00039-X; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Klemsz MJ, 1996, MOL CELL BIOL, V16, P390; Langst G, 1998, EMBO J, V17, P3135, DOI 10.1093/emboj/17.11.3135; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Linderson Y, 2004, EMBO REP, V5, P291, DOI 10.1038/sj.embor.7400089; Lusser A, 2003, BIOESSAYS, V25, P1192, DOI 10.1002/bies.10359; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; MILLS FC, 1983, NATURE, V306, P809, DOI 10.1038/306809a0; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; NELSEN B, 1993, SCIENCE, V261, P82, DOI 10.1126/science.8316859; Nikolajczyk BS, 1997, MOL CELL BIOL, V17, P3527, DOI 10.1128/MCB.17.7.3527; Pazin MJ, 1997, SCIENCE, V276, P809, DOI 10.1126/science.276.5313.809; PAZIN MJ, 1994, SCIENCE, V266, P2007, DOI 10.1126/science.7801129; Pazin MJ, 1996, GENE DEV, V10, P37, DOI 10.1101/gad.10.1.37; Pazin MJ, 1998, J BIOL CHEM, V273, P34653, DOI 10.1074/jbc.273.51.34653; Pazin MJ, 1998, CHROMATIN PRACTICAL, P173; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; PINA B, 1990, CELL, V60, P719, DOI 10.1016/0092-8674(90)90087-U; Polach KJ, 1996, J MOL BIOL, V258, P800, DOI 10.1006/jmbi.1996.0288; PONGUBALA JMR, 1992, MOL CELL BIOL, V12, P368, DOI 10.1128/MCB.12.1.368; Pongubala JMR, 1997, P NATL ACAD SCI USA, V94, P127, DOI 10.1073/pnas.94.1.127; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Rao E, 1997, J BIOL CHEM, V272, P6722, DOI 10.1074/jbc.272.10.6722; Rekhtman N, 2003, MOL CELL BIOL, V23, P7460, DOI 10.1128/MCB.23.21.7460-7474.2003; Ryan MP, 1998, MOL CELL BIOL, V18, P1774, DOI 10.1128/MCB.18.4.1774; Sakai E, 1999, P NATL ACAD SCI USA, V96, P1526, DOI 10.1073/pnas.96.4.1526; SERWE M, 1993, EMBO J, V12, P2321, DOI 10.1002/j.1460-2075.1993.tb05886.x; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Stopka T, 2003, P NATL ACAD SCI USA, V100, P14097, DOI 10.1073/pnas.2336105100; Suzuki M, 2003, ONCOGENE, V22, P8688, DOI 10.1038/sj.onc.1207182; Tian G, 1999, MOL CELL BIOL, V19, P2946; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; VARGAWEISZ PD, 1995, EMBO J, V14, P2209, DOI 10.1002/j.1460-2075.1995.tb07215.x; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; WECHSLER DS, 1994, MOL CELL BIOL, V14, P4097, DOI 10.1128/MCB.14.6.4097; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yudkovsky N, 1999, GENE DEV, V13, P2369, DOI 10.1101/gad.13.18.2369; ZARET KS, 1984, CELL, V38, P29, DOI 10.1016/0092-8674(84)90523-3; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	79	5	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7533	7541		10.1074/jbc.M807617200	http://dx.doi.org/10.1074/jbc.M807617200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19158090	hybrid, Green Published			2022-12-25	WOS:000264195600016
J	Maron, BA; Zhang, YY; Handy, DE; Beuve, A; Tang, SS; Loscalzo, J; Leopold, JA				Maron, Bradley A.; Zhang, Ying-Yi; Handy, Diane E.; Beuve, Annie; Tang, Shiow-Shih; Loscalzo, Joseph; Leopold, Jane A.			Aldosterone Increases Oxidant Stress to Impair Guanylyl Cyclase Activity by Cysteinyl Thiol Oxidation in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; NITRIC-OXIDE; HEART-FAILURE; VASODILATOR DYSFUNCTION; SULFENIC ACID; ACTIVATION; EXPRESSION; NO; SUPEROXIDE; PEROXYNITRITE	Hyperaldosteronism is associated with impaired endothelium-dependent vascular reactivity owing to increased reactive oxygen species and decreased bioavailable nitric oxide (NO center dot); however, the effects of aldosterone on vasodilatory signaling pathways in vascular smooth muscle cells (VSMC) remain unknown. Soluble guanylyl cyclase (GC) is a heterodimer that is activated by NO center dot to convert cytosolic GTP to cGMP, a second messenger required for normal VSMC relaxation. Here, we show that aldosterone (10(-9)-10(-7) mol/liter) diminishes GC activity by activating NADPH oxidase in bovine aortic VSMC to increase reactive oxygen species levels and induce oxidative posttranslational modification(s) of Cys-122, a beta(1)-subunit cysteinyl residue demonstrated previously to modulate NO center dot sensing by GC. In VSMC treated with aldosterone, Western immunoblotting detected evidence of GC beta(1)-subunit disulfide bonding, whereas mass spectrometry analysis of a homologous peptide containing the Cys-122-bearing sequence exposed to conditions of increased oxidant stress confirmed cysteinyl sulfinic acid (m/z 435), sulfonic acid (m/z 443), and disulfide (m/z 836) bond formation. The functional effect of these modifications was examined by transfecting COS-7 cells with wild-type GC or mutant GC containing an alanine substitution at Cys-122 (C122A). Exposure to aldosterone or hydrogen peroxide (H2O2) significantly decreased cGMP levels in cells expressing wild-type GC. In contrast, aldosterone or H2O2 did not influence cGMP levels in cells expressing the mutant C122A GC, confirming that oxidative modification of Cys-122 specifically impairs GC activity. These findings demonstrate that pathophysiologically relevant concentrations of aldosterone increase oxidant stress to convert GC to an NO center dot-insensitive state, resulting in disruption of normal vasodilatory signaling pathways in VSMC.	[Maron, Bradley A.; Zhang, Ying-Yi; Handy, Diane E.; Tang, Shiow-Shih; Loscalzo, Joseph; Leopold, Jane A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Cardiovasc Div, Boston, MA 02115 USA; [Beuve, Annie] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Rutgers State University New Brunswick; Rutgers State University Medical Center	Leopold, JA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Cardiovasc Div, 77 Ave Louis Pasteur,NRB 0630K, Boston, MA 02115 USA.	jleopold@partners.org	Loscalzo, Joseph/ABD-8980-2021	Handy, Diane/0000-0002-4310-8527	National Institutes of Health [HL089771, HL61795, NO1HV28178, HL5897, PO1HL815876, HL081110]; American Heart Association grant-in-aid; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028178] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089771, K02HL081110, R01HL061795, R01HL058976, P01HL081587, R37HL061795] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association grant-in-aid(American Heart Association); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL089771 (to A.B.), HL61795, NO1HV28178, HL58976, and PO1HL81587 (to J.L.), and HL081110 (to J.A.L.). This work was also supported by an American Heart Association grant-in-aid (to J.A.L.) The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ahokas RA, 2005, CIRCULATION, V111, P51, DOI 10.1161/01.CIR.0000151516.84238.37; Bauersachs J, 1998, CARDIOVASC RES, V37, P772, DOI 10.1016/S0008-6363(97)00250-2; BRANDWEIN HJ, 1981, J BIOL CHEM, V256, P2958; Duprez DA, 1998, EUR HEART J, V19, P1371, DOI 10.1053/euhj.1998.1099; Farquharson CAJ, 2000, CIRCULATION, V101, P594, DOI 10.1161/01.CIR.101.6.594; Friebe A, 1997, BIOCHEMISTRY-US, V36, P1194, DOI 10.1021/bi962047w; Gerassimou C, 2007, BRIT J PHARMACOL, V150, P1084, DOI 10.1038/sj.bjp.0707179; Gladwin MT, 2006, J CLIN INVEST, V116, P2330, DOI 10.1172/JCI29807; Goldstein S, 2005, CHEM REV, V105, P2457, DOI 10.1021/cr0307087; Handy DE, 2005, J BIOL CHEM, V280, P15518, DOI 10.1074/jbc.M501452200; Heumuller S, 2008, HYPERTENSION, V51, P211, DOI 10.1161/HYPERTENSIONAHA.107.100214; IGNARRO LJ, 1982, BIOCHIM BIOPHYS ACTA, V718, P49, DOI 10.1016/0304-4165(82)90008-3; Jiang BB, 1999, HYPERTENSION, V34, P574, DOI 10.1161/01.HYP.34.4.574; Kloss S, 2000, HYPERTENSION, V35, P43; Koesling D, 1999, METHODS, V19, P485, DOI 10.1006/meth.1999.0891; Leopold JA, 2007, NAT MED, V13, P189, DOI 10.1038/nm1545; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; Mastroberardino PG, 2008, FREE RADICAL BIO MED, V45, P971, DOI 10.1016/j.freeradbiomed.2008.06.018; Melichar VO, 2004, P NATL ACAD SCI USA, V101, P16671, DOI 10.1073/pnas.0405509101; Mingone CJ, 2006, AM J PHYSIOL-LUNG C, V291, pL337, DOI 10.1152/ajplung.00482.2005; Mulsch A, 1997, BRIT J PHARMACOL, V120, P681, DOI 10.1038/sj.bjp.0700982; MULSCH A, 1989, N-S ARCH PHARMACOL, V339, P568, DOI 10.1007/BF00167263; Munzel T, 2005, ARTERIOSCL THROM VAS, V25, P1551, DOI 10.1161/01.ATV.0000168896.64927.bb; MURAD F, 1981, ADV CYCL NUCL RES<D>, V14, P229; RADI R, 1991, J BIOL CHEM, V266, P4244; Ruetten H, 1999, CIRC RES, V85, P534, DOI 10.1161/01.RES.85.6.534; Saurin AT, 2004, P NATL ACAD SCI USA, V101, P17982, DOI 10.1073/pnas.0404762101; Sayed N, 2007, P NATL ACAD SCI USA, V104, P12312, DOI 10.1073/pnas.0703944104; Shetty V, 2007, J AM SOC MASS SPECTR, V18, P1544, DOI 10.1016/j.jasms.2007.05.013; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SIMONS JM, 1990, FREE RADICAL BIO MED, V8, P251, DOI 10.1016/0891-5849(90)90070-Y; Srikanth R, 2007, J AM SOC MASS SPECTR, V18, P1499, DOI 10.1016/j.jasms.2007.05.011; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Struthers AD, 2004, MOL CELL ENDOCRINOL, V217, P239, DOI 10.1016/j.mce.2003.10.024; Sun Y, 2002, AM J PATHOL, V161, P1773, DOI 10.1016/S0002-9440(10)64454-9; SWEDBERG K, 1990, CIRCULATION, V82, P1730, DOI 10.1161/01.CIR.82.5.1730; UshioFukai M, 1996, J BIOL CHEM, V271, P23317, DOI 10.1074/jbc.271.38.23317; WALDMAN SA, 1991, METHODS ENZYMOL, V195, P391; Walford GA, 2004, J BIOL CHEM, V279, P4425, DOI 10.1074/jbc.M310582200; Weber KT, 2003, J LAB CLIN MED, V142, P71, DOI 10.1016/S0022-2143(03)00062-3; Weber KT, 2001, NEW ENGL J MED, V345, P1689, DOI 10.1056/NEJMra000050; Weber M, 2001, FREE RADICAL BIO MED, V31, P1360, DOI 10.1016/S0891-5849(01)00706-7; Welch GN, 1998, P ASSOC AM PHYSICIAN, V110, P22	43	75	77	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7665	7672		10.1074/jbc.M809460200	http://dx.doi.org/10.1074/jbc.M809460200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19141618	Green Published, hybrid			2022-12-25	WOS:000264195600028
J	Baltus, GA; Kowalski, MP; Tutter, AV; Kadam, S				Baltus, Gretchen A.; Kowalski, Michael P.; Tutter, Antonin V.; Kadam, Shilpa			A Positive Regulatory Role for the mSin3A-HDAC Complex in Pluripotency through Nanog and Sox2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSION; HISTONE DEACETYLASE; GENE-EXPRESSION; DIFFERENTIATION; ACETYLATION; NETWORK; OCT4	Large networks of proteins govern embryonic stem (ES) cell pluripotency. Recent analysis of the critical pluripotency factors Oct4 and Nanog has identified their interaction with multiple transcriptional repression complexes, including members of the mSin3A-HDAC complex, suggesting that these factors could be involved in the regulation of Oct4/Nanog function. mSin3A is critical for embryonic development, but the mechanism by which the mSin3A-HDAC complex is able to regulate ES cell pluripotency is undefined. Herein we show that the mSin3A-HDAC complex positively regulates Nanog expression in ES cells through Sox2, a critical ES cell transcription factor and regulator of Nanog. We have identified the mSin3A-HDAC complex to be present at the Nanog promoter only under proliferating conditions concurrent with histone acetylation. We find that Sox2 associates with mSin3A-HDAC complex members both in vitro and in vivo, similar to the interactions found between Oct4/Nanog and the mSin3A-HDAC complex. Knockdown of mSin3A-HDAC complex members or HDAC inhibitor treatment reduces Nanog expression, and overexpression of mSin3A-HDAC complex subunits stimulates Nanog expression. Our data demonstrate that the mSin3A-HDAC complex can positively regulate Nanog expression under proliferating conditions and that this activity is complementary to mSin3A-mediated p53-dependent silencing of Nanog during differentiation.	[Baltus, Gretchen A.; Kowalski, Michael P.; Tutter, Antonin V.; Kadam, Shilpa] Novartis Inst Biomed Res, Dept Dev & Mol Pathways, Cambridge, MA 02139 USA	Novartis	Kadam, S (corresponding author), Novartis Inst Biomed Res, Dept Dev & Mol Pathways, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	shilpa.kadam@novartis.com						Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cowley SM, 2005, MOL CELL BIOL, V25, P6990, DOI 10.1128/MCB.25.16.6990-7004.2005; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gu PL, 2005, MOL CELL BIOL, V25, P8507, DOI 10.1128/MCB.25.19.8507-8519.2005; Imai Y, 2004, MOL CELL BIOL, V24, P1033, DOI 10.1128/MCB.24.3.1033-1043.2004; Johnson BV, 2006, CURR OPIN GENET DEV, V16, P447, DOI 10.1016/j.gde.2006.08.012; KAESER MD, 2006, CURR OPIN GENE DEV, V5, P508; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kasler Herbert G., 2006, P129; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; McCool KW, 2007, J BIOL CHEM, V282, P6696, DOI 10.1074/jbc.M609519200; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Thevenet L, 2004, EMBO J, V23, P3336, DOI 10.1038/sj.emboj.7600352; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001	34	51	53	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6998	7006		10.1074/jbc.M807670200	http://dx.doi.org/10.1074/jbc.M807670200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19139101	hybrid, Green Published			2022-12-25	WOS:000263919000048
J	Gong, ZH; Cho, YW; Kim, JE; Ge, K; Chen, JJ				Gong, Zihua; Cho, Young-Wook; Kim, Ja-Eun; Ge, Kai; Chen, Junjie			Accumulation of Pax2 Transactivation Domain Interaction Protein (PTIP) at Sites of DNA Breaks via RNF8-dependent Pathway Is Required for Cell Survival after DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRCT-DOMAIN; BINDING; MDC1; PHOSPHORYLATION; REPAIR; P53	Genomic stability in eukaryotic cells is maintained by the coordination of multiple cellular events including cell cycle checkpoint, DNA repair, transcription, and apoptosis after DNA damage. Pax2 transactivation domain interaction protein (PTIP), a protein that contains six BRCT domains, has been implicated in DNA damage response. In this study we showed that recruitment of PTIP to damaged chromatin depends on DNA damage signaling proteins gamma H2AX center dot MDC1 center dot RNF8, which in turn facilitates sustained localization of PA1 (PTIP-associated protein 1) to sites of DNA break. Similar to PTIP, depletion of PA1 increases cellular sensitivity to ionizing radiation. Furthermore, we demonstrated that the N-terminal PA1 binding domain and the C-terminal focus-localization domain of PTIP are critical for PTIP function in DNA damage repair. Interestingly, although PTIP and PA1 associate with MLL (mixed lineage leukemia) complexes and participate in transcriptional regulation, this function of PTIP center dot PA1 in DNA damage response is likely to be independent of the MLL complexes. Taken together, we propose that a subset of PTIP center dot PA1 complex is recruited to DNA damage sites via the RNF8-dependent pathway and is required for cell survival in response to DNA damage.	[Gong, Zihua; Kim, Ja-Eun; Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; [Cho, Young-Wook; Ge, Kai] NIDDK, Nucl Receptor Biol Sect, Clin Endocrinol Branch, NIH, Bethesda, MD 20892 USA; [Kim, Ja-Eun] Kyung Hee Univ, Sch Med, Dept Pharmacol, Seoul 130701, South Korea	Yale University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Kyung Hee University	Chen, JJ (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA.	Junjie.chen@yale.edu	Kim, Ja-Eun/AAI-1896-2020; Ge, Kai/H-2810-2019; Cho, Young-Wook/F-8269-2011	Kim, Ja-Eun/0000-0002-9132-1277; Ge, Kai/0000-0002-7442-5138; 	National Institutes of Health [CA089239, CA092312, CA100109]; NATIONAL CANCER INSTITUTE [R01CA100109, R01CA092312, R01CA089239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075017, ZIADK047055, ZIADK075003, Z01DK047055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA089239, CA092312, and CA100109 (to J. C.).	Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Chini C, 2006, ONCOGENE, V25, P4165, DOI 10.1038/sj.onc.1209447; Cho EA, 2003, MOL CELL BIOL, V23, P1666, DOI 10.1128/MCB.23.5.1666-1673.2003; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Jowsey PA, 2004, J BIOL CHEM, V279, P55562, DOI 10.1074/jbc.M411021200; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lechner MS, 2000, NUCLEIC ACIDS RES, V28, P2741, DOI 10.1093/nar/28.14.2741; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; Munoz IM, 2007, NUCLEIC ACIDS RES, V35, P5312, DOI 10.1093/nar/gkm493; Patel SR, 2007, DEV CELL, V13, P580, DOI 10.1016/j.devcel.2007.09.004; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	26	62	68	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7284	7293		10.1074/jbc.M809158200	http://dx.doi.org/10.1074/jbc.M809158200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19124460	Green Published, hybrid			2022-12-25	WOS:000263919000075
J	Gropler, MC; Harris, TE; Hall, AM; Wolins, NE; Gross, RW; Han, XL; Chen, ZJ; Finck, BN				Gropler, Matthew C.; Harris, Thurl E.; Hall, Angela M.; Wolins, Nathan E.; Gross, Richard W.; Han, Xianlin; Chen, Zhouji; Finck, Brian N.			Lipin 2 Is a Liver-enriched Phosphatidate Phosphohydrolase Enzyme That Is Dynamically Regulated by Fasting and Obesity in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE-METABOLISM; HEPATIC GLUCONEOGENESIS; BIOLOGICAL SAMPLES; MASS-SPECTROMETRY; COACTIVATOR PGC-1; MAJEED-SYNDROME; MUTANT MOUSE; MUTATION; EXPRESSION; LPIN2	Lipin 1 is a bifunctional intracellular protein that regulates fatty acid metabolism in the nucleus via interactions with DNA-bound transcription factors and at the endoplasmic reticulum as a phosphatidic acid phosphohydrolase enzyme (PAP-1) to catalyze the penultimate step in triglyceride synthesis. However, livers of 8-day-old mice lacking lipin 1 (fld mice) exhibited normal PAP-1 activity and a 20-fold increase in triglyceride levels. We sought to further analyze the hepatic lipid profile of these mice by electrospray ionization mass spectrometry. Surprisingly, hepatic content of phosphatidate, the substrate of PAP-1 enzymes, was markedly diminished in fld mice. Similarly, other phospholipids derived from phosphatidate, phosphatidylglycerol and cardiolipin, were also depleted. Another member of the lipin family (lipin 2) is enriched in liver, and hepatic lipin 2 protein content was markedly increased by lipin 1 deficiency, food deprivation, and obesity, often independent of changes in steady-state mRNA levels. Importantly, RNAi against lipin 2 markedly reduced PAP-1 activity in hepatocytes from both wild type and fld mice and suppressed triglyceride synthesis under conditions of high fatty acid availability. Collectively, these data suggest that lipin 2 plays an important role as a hepatic PAP-1 enzyme.	[Gropler, Matthew C.; Hall, Angela M.; Wolins, Nathan E.; Gross, Richard W.; Han, Xianlin; Chen, Zhouji; Finck, Brian N.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Harris, Thurl E.] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA	Washington University (WUSTL); University of Virginia	Finck, BN (corresponding author), Washington Univ, Sch Med, Dept Med, 660 S Euclid Ave,Box 8031, St Louis, MO 63110 USA.	bfinck@wustl.edu		Hall, Angela Marie/0000-0003-0006-7910; Finck, Brian/0000-0001-5411-3674	National Institutes of Health [R01 DK078187, R01 HL73939, R01 DK52753, R01 DK28312, P01 HL57278]; Digestive Diseases Research Core Center (National Institutes of Health) [P30 DK52574]; Clinical Nutrition Research Unit Core Center (National Institutes of Health) [P30 DK56341]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278, R01HL073939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078187, R01DK028312, P30DK056341, P30DK052574, R01DK052753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Diseases Research Core Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Nutrition Research Unit Core Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK078187 ( to B. N. F.), R01 HL73939 ( to Z. C.), R01s DK52753 and DK28312 ( to J. C. Lawrence, Jr. ( deceased)), and P01 HL57278 ( to R. W. G. and X. H.). This work was also supported, in part, by the Digestive Diseases Research Core Center ( National Institutes of Health Grant P30 DK52574) and the Clinical Nutrition Research Unit Core Center (National Institutes of Health Grant P30 DK56341) at the Washington University School of Medicine.	Al-Mosawi ZS, 2007, ARTHRITIS RHEUM, V56, P960, DOI 10.1002/art.22431; Aulchenko YS, 2007, DIABETES, V56, P3020, DOI 10.2337/db07-0338; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Chen ZJ, 2008, ARTERIOSCL THROM VAS, V28, P1738, DOI 10.1161/ATVBAHA.108.171538; Chen ZJ, 2000, J BIOL CHEM, V275, P32807, DOI 10.1074/jbc.M004913200; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Ferguson PJ, 2005, J MED GENET, V42, P551, DOI 10.1136/jmg.2005.030759; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Gonzalez-Baro MR, 2007, AM J PHYSIOL-GASTR L, V292, pG1195, DOI 10.1152/ajpgi.00553.2006; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han XL, 2001, ANAL BIOCHEM, V295, P88, DOI 10.1006/abio.2001.5178; Han XL, 2004, ANAL BIOCHEM, V330, P317, DOI 10.1016/j.ab.2004.04.004; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; LANGNER CA, 1989, J BIOL CHEM, V264, P7994; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Manmontri B, 2008, J LIPID RES, V49, P1056, DOI 10.1194/jlr.M800013-JLR200; Mileykovskaya E, 2005, BIOCHEMISTRY-MOSCOW+, V70, P154, DOI 10.1007/s10541-005-0095-2; MOSTAFA N, 1993, BIOCHIM BIOPHYS ACTA, V1169, P189, DOI 10.1016/0005-2760(93)90205-N; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Rehnmark S, 1998, J LIPID RES, V39, P2209; Reue K, 1996, J LIPID RES, V37, P1387; Reue K, 2000, J LIPID RES, V41, P1067; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	31	55	59	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6763	6772		10.1074/jbc.M807882200	http://dx.doi.org/10.1074/jbc.M807882200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19136718	Green Published, hybrid			2022-12-25	WOS:000263919000021
J	Yang, SL; Cao, Q; Zhou, KC; Feng, YJ; Wang, YZ				Yang, S. L.; Cao, Q.; Zhou, K. C.; Feng, Y. J.; Wang, Y. Z.			Transient receptor potential channel C3 contributes to the progression of human ovarian cancer	ONCOGENE			English	Article						TRPC channels; ovarian epithelium cancer; proliferation; Ca2+/calmodulin-dependent kinase II; M phase	CAPACITATIVE CA2+ ENTRY; PROTEIN KINASE-II; CELL-PROLIFERATION; MAMMALIAN-CELLS; TRPC3 CHANNELS; CYTOSTATIC FACTOR; EPITHELIAL-CELLS; CALCIUM; EXPRESSION; ACTIVATION	Ovarian cancer (OC) is the leading cause of death from gynecological malignancy. However, the mechanism by which OC develops remains largely unknown. Increases in cytosolic free Ca2+ ([Ca2+](i)) can result in different physiological changes including cell growth, differentiation and death. The transient receptor potential (TRP) C channels are nonselective cation channels with permeability to Ca2(+). Here we report that TRPC3 channels promote human OC growth. The TRPC3 protein levels in human OC specimens were greatly increased than those in normal ovarian specimens. Downregulating TRPC3 expression in SKOV3 cells, a human OC cell line, led to reduction of proliferation, suppression in epidermal growth factor-induced Ca2+ in flux, dephosphorylation of Cdc2 and CaMKII alpha and prolonged progression through M phase of these cells. Further, decreased the expression of TRPC3 suppressed the tumor formation generated by injecting SKOV3 cells in nude mice. Together, our results suggest that increased activity of TRPC3 channels is necessary for the development of OCs. Oncogene (2009) 28, 1320-1328; doi:10.1038/onc.2008.475; published online 19 January 2009	[Yang, S. L.; Zhou, K. C.; Wang, Y. Z.] Shanghai Inst Biol Sci, Inst Neurosci, Lab Neural Signal Transduct, State Key Lab Neurosci, Shanghai 200031, Peoples R China; [Yang, S. L.; Zhou, K. C.; Wang, Y. Z.] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China; [Cao, Q.; Feng, Y. J.] Fudan Univ, Med Ctr, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Fudan University	Wang, YZ (corresponding author), Shanghai Inst Biol Sci, Inst Neurosci, Lab Neural Signal Transduct, State Key Lab Neurosci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	yzwang@ion.ac.cn			973 Program [2006CB806600]; National Natural Science Foundation of China [30711120566, 30621062, U0632006]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Q Hu and HL Yao for technical support and B Shen for reading the article. This work was supported by grants from the 973 Program (2006CB806600), projects 30711120566, 30621062, U0632006 from the National Natural Science Foundation of China and project B117 from Shanghai Leading Academic Discipline Project.	Auersperg N, 1998, SEMIN ONCOL, V25, P281; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Cook SJ, 2006, CELL CALCIUM, V39, P101, DOI 10.1016/j.ceca.2005.10.014; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Eder P, 2005, PFLUG ARCH EUR J PHY, V451, P99, DOI 10.1007/s00424-005-1434-2; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; FONG YL, 1989, J BIOL CHEM, V264, P16759; Hansen DV, 2006, P NATL ACAD SCI USA, V103, P608, DOI 10.1073/pnas.0509549102; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hurst RS, 1998, FEBS LETT, V422, P333, DOI 10.1016/S0014-5793(98)00035-0; Hussain MM, 2003, J CLIN ONCOL, V21, P4356, DOI 10.1200/JCO.2003.04.136; Jia YC, 2007, NAT NEUROSCI, V10, P559, DOI 10.1038/nn1870; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; KAO JPY, 1990, J CELL BIOL, V111, P183, DOI 10.1083/jcb.111.1.183; Kohn EC, 1996, CANCER RES, V56, P569; Lintschinger B, 2000, J BIOL CHEM, V275, P27799; Liu JJ, 2005, CURR BIOL, V15, P1458, DOI 10.1016/j.cub.2005.07.030; LORCA T, 1993, NATURE, V366, P270, DOI 10.1038/366270a0; Maihle N J, 2002, Cancer Treat Res, V107, P247; Minaguchi T, 2006, CANCER RES, V66, P11677, DOI 10.1158/0008-5472.CAN-06-2240; Mochida S, 2007, NATURE, V449, P336, DOI 10.1038/nature06121; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Nicosia SV, 2003, HEMATOL ONCOL CLIN N, V17, P927, DOI 10.1016/S0889-8588(03)00056-X; Odell AF, 2005, J BIOL CHEM, V280, P37974, DOI 10.1074/jbc.M503646200; POPPER LD, 1993, CELL CALCIUM, V14, P209, DOI 10.1016/0143-4160(93)90068-H; Psyrri A, 2005, CLIN CANCER RES, V11, P8637, DOI 10.1158/1078-0432.CCR-05-1436; Rauh NR, 2005, NATURE, V437, P1048, DOI 10.1038/nature04093; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Rosenberg P, 2004, P NATL ACAD SCI USA, V101, P9387, DOI 10.1073/pnas.0308179101; Rosker C, 2004, J BIOL CHEM, V279, P13696, DOI 10.1074/jbc.M308108200; Schultze-Mosgau A, 2000, MOL HUM REPROD, V6, P435, DOI 10.1093/molehr/6.5.435; Smyth JT, 2006, J BIOL CHEM, V281, P11712, DOI 10.1074/jbc.M510541200; Thebault S, 2006, CANCER RES, V66, P2038, DOI 10.1158/0008-5472.CAN-05-0376; Thebault S, 2005, J CELL PHYSIOL, V204, P320, DOI 10.1002/jcp.20301; TOMBES RM, 1989, J CELL BIOL, V109, P627, DOI 10.1083/jcb.109.2.627; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Xu NH, 2003, BIOCHEM BIOPH RES CO, V306, P737, DOI 10.1016/S0006-291X(03)01061-1; Yang H, 2005, J BIOL CHEM, V280, P32230, DOI 10.1074/jbc.M504553200; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101; Yu Y, 2003, AM J PHYSIOL-CELL PH, V284, pC316, DOI 10.1152/ajpcell.00125.2002; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7; Zitt C, 1997, J CELL BIOL, V138, P1333, DOI 10.1083/jcb.138.6.1333	49	96	101	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	10					1320	1328		10.1038/onc.2008.475	http://dx.doi.org/10.1038/onc.2008.475			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	417ZC	19151765				2022-12-25	WOS:000264116000004
J	Honda, M; Eriksson, KS; Zhang, SW; Tanaka, S; Lin, L; Salehi, A; Hesla, PE; Maehlen, J; Gaus, SE; Yanagisawa, M; Sakurai, T; Taheri, S; Tsuchiya, K; Honda, Y; Mignot, E				Honda, Makoto; Eriksson, Krister S.; Zhang, Shengwen; Tanaka, Susumu; Lin, Ling; Salehi, Ahmad; Hesla, Per Egil; Maehlen, Jan; Gaus, Stephanie E.; Yanagisawa, Masashi; Sakurai, Takeshi; Taheri, Shahrad; Tsuchiya, Kuniaki; Honda, Yutaka; Mignot, Emmanuel			IGFBP3 Colocalizes with and Regulates Hypocretin (Orexin)	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-3; GENE-EXPRESSION; LATERAL HYPOTHALAMUS; CEREBROSPINAL-FLUID; HUMAN NARCOLEPSY; TRANSGENIC MICE; KNOCKOUT MICE; CANCER CELLS; GROWTH; NEURONS	Background: The sleep disorder narcolepsy is caused by a vast reduction in neurons producing the hypocretin (orexin) neuropeptides. Based on the tight association with HLA, narcolepsy is believed to result from an autoimmune attack, but the cause of hypocretin cell loss is still unknown. We performed gene expression profiling in the hypothalamus to identify novel genes dysregulated in narcolepsy, as these may be the target of autoimmune attack or modulate hypocretin gene expression. Methodology/Principal Findings: We used microarrays to compare the transcriptome in the posterior hypothalamus of (1) narcoleptic versus control postmortem human brains and (2) transgenic mice lacking hypocretin neurons versus wild type mice. Hypocretin was the most downregulated gene in human narcolepsy brains. Among many additional candidates, only one, insulin-like growth factor binding protein 3 (IGFBP3), was downregulated in both human and mouse models and co-expressed in hypocretin neurons. Functional analysis indicated decreased hypocretin messenger RNA and peptide content, and increased sleep in transgenic mice overexpressing human IGFBP3, an effect possibly mediated through decreased hypocretin promotor activity in the presence of excessive IGFBP3. Although we found no IGFBP3 autoantibodies nor a genetic association with IGFBP3 polymorphisms in human narcolepsy, we found that an IGFBP3 polymorphism known to increase serum IGFBP3 levels was associated with lower CSF hypocretin-1 in normal individuals. Conclusions/Significance: Comparison of the transcriptome in narcolepsy and narcolepsy model mouse brains revealed a novel dysregulated gene which colocalized in hypocretin cells. Functional analysis indicated that the identified IGFBP3 is a new regulator of hypocretin cell physiology that may be involved not only in the pathophysiology of narcolepsy, but also in the regulation of sleep in normal individuals, most notably during adolescence. Further studies are required to address the hypothesis that excessive IGFBP3 expression may initiate hypocretin cell death and cause narcolepsy.	[Tanaka, Susumu] Tokyo Inst Psychiat, Sleep Disorder Res Project, Tokyo, Japan; [Honda, Makoto; Eriksson, Krister S.; Zhang, Shengwen; Lin, Ling; Gaus, Stephanie E.; Mignot, Emmanuel] Stanford Univ, Ctr Narcolepsy, Palo Alto, CA USA; [Salehi, Ahmad] Stanford Univ, Dept Neurol, Palo Alto, CA USA; [Hesla, Per Egil; Maehlen, Jan] Univ Oslo, Dept Pathol, N-0316 Oslo, Norway; [Yanagisawa, Masashi] Univ Texas, Dept Molecular Genet, Dallas, TX USA; [Sakurai, Takeshi] Kanagawa Univ, Dept Molecular Neurosci & Integrative Physiol, Kanazawa, Ishikawa, Japan; [Taheri, Shahrad] Univ Bristol, Lab Integrative Neurosci & Endocrinol, Bristol BS8 1TH, Avon, England; [Tsuchiya, Kuniaki] Tokyo Metropolitan Matsuzawa Hosp, Tokyo, Japan; [Honda, Yutaka] Neuropsychiat Inst, Japan Somnol Ctr, Tokyo, Japan; [Mignot, Emmanuel] Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA USA	Tokyo Institute of Psychiatry; Stanford University; Stanford University; University of Oslo; University of Texas System; University of Texas Dallas; Kanagawa University; University of Bristol; Howard Hughes Medical Institute; Stanford University	Honda, M (corresponding author), Tokyo Inst Psychiat, Sleep Disorder Res Project, Tokyo, Japan.	honda@prit.go.jp; mignot@stanford.edu	Tanaka, Susumu/AAC-4739-2019; Salehi, Ahmad/H-2746-2019; Taheri, Shahrad/O-9721-2016	Tanaka, Susumu/0000-0003-4804-7839; Salehi, Ahmad/0000-0001-8257-3280; Taheri, Shahrad/0000-0001-8314-1500; Zhang, Shengwen/0000-0001-7318-3870	NIH [MH073435]; Ministry of Education, Science, Sports and Culture; Science Research on Priority Areas Comprehensive Genomics; Uehara Memorial Foundation; Howard Hughes Medical Institute;  [19390310];  [1739034]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073435] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Science Research on Priority Areas Comprehensive Genomics; Uehara Memorial Foundation(Uehara Memorial Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH-MH073435 to E. Mignot and by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research 19390310, 1739034 and Science Research on Priority Areas Comprehensive Genomics and in part by Uehara Memorial Foundation to M. Honda. E. Mignot (Investigator) is funded by the Howard Hughes Medical Institute.	Beilharz EJ, 1998, MOL BRAIN RES, V59, P119, DOI 10.1016/S0169-328X(98)00122-3; Bhattacharyya N, 2006, J BIOL CHEM, V281, P24588, DOI 10.1074/jbc.M509463200; Blouin AM, 2005, NEUROLOGY, V65, P1189, DOI 10.1212/01.wnl.0000175219.01544.c8; Broberger C, 1998, J COMP NEUROL, V402, P460; Bunn RC, 2005, PEDIATR RES, V58, P89, DOI 10.1203/01.PDR.0000156369.62787.96; Carskadon MA, 2004, ANN NY ACAD SCI, V1021, P276, DOI 10.1196/annals.1308.032; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chou TC, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-19-j0003.2001; Coyle AJ, 1999, J EXP MED, V190, P895, DOI 10.1084/jem.190.7.895; Crocker A, 2005, NEUROLOGY, V65, P1184, DOI 10.1212/01.WNL.0000168173.71940.ab; Fang Peng, 2004, Novartis Found Symp, V262, P215; Franz H, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r112; Hakansson ML, 1999, J NEUROENDOCRINOL, V11, P653; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Jernstrom H, 2001, CANCER EPIDEM BIOMAR, V10, P377; Katsuki H, 2004, NEUROBIOL DIS, V15, P61, DOI 10.1016/j.nbd.2003.09.003; Kim HS, 2004, CANCER RES, V64, P2229, DOI 10.1158/0008-5472.CAN-03-1675; Lee KW, 2005, J BIOL CHEM, V280, P16942, DOI 10.1074/jbc.M412757200; Lee KW, 2004, J BIOL CHEM, V279, P469, DOI 10.1074/jbc.M307316200; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Lin L, 2002, PEPTIDES, V23, P2203, DOI 10.1016/S0196-9781(02)00251-6; Mai J.K., 1997, ATLAS HUMAN BRAIN; Mandel S, 2005, ANN NY ACAD SCI, V1053, P356, DOI 10.1196/annals.1344.031; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Modric T, 2001, ENDOCRINOLOGY, V142, P1958, DOI 10.1210/en.142.5.1958; Ning Y, 2006, MOL ENDOCRINOL, V20, P2173, DOI 10.1210/me.2005-0196; Obal F, 2001, REV NEUROL-FRANCE, V157, pS12; Paxinos G., 1995, ATLAS HUMAN BRAINSTE; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Reti IM, 2002, J NEUROCHEM, V82, P1561, DOI 10.1046/j.1471-4159.2002.01141.x; Sakurai T, 1999, J BIOL CHEM, V274, P17771, DOI 10.1074/jbc.274.25.17771; Sakurai T, 1998, CELL, V92, pU29; Santer FR, 2006, CANCER RES, V66, P3024, DOI 10.1158/0008-5472.CAN-05-2013; Scammell TE, 2006, SLEEP, V29, P601, DOI 10.1093/sleep/29.5.601; Schneider HJ, 2003, EUR J ENDOCRINOL, V149, P377, DOI 10.1530/eje.0.1490377; Silha JV, 2005, ENDOCRINOLOGY, V146, P1523, DOI 10.1210/en.2004-0905; Silha JV, 2002, AM J PHYSIOL-ENDOC M, V283, pE937, DOI 10.1152/ajpendo.00014.2002; Taheri S, 2004, SLEEP, V27, P243; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Thannickal TC, 2003, BRAIN PATHOL, V13, P340; Tomita H, 2004, BIOL PSYCHIAT, V55, P346, DOI 10.1016/j.biopsych.2003.10.013; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vogel-Hopker A, 2002, DEVELOPMENT, V129, P983; Zhang SW, 2007, J PHYSIOL-LONDON, V581, P649, DOI 10.1113/jphysiol.2007.129510	46	54	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2009	4	1							e4254	10.1371/journal.pone.0004254	http://dx.doi.org/10.1371/journal.pone.0004254			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JC	19158946	gold, Green Submitted, Green Published			2022-12-25	WOS:000265482200010
J	Dupouy, S; Viardot-Foucault, V; Alifano, M; Souaze, F; Plu-Bureau, G; Chaouat, M; Lavaur, A; Hugol, D; Gespach, C; Gompel, A; Forgez, P				Dupouy, Sandra; Viardot-Foucault, Veronique; Alifano, Marco; Souaze, Frederique; Plu-Bureau, Genevieve; Chaouat, Marc; Lavaur, Anne; Hugol, Danielle; Gespach, Christian; Gompel, Anne; Forgez, Patricia			The Neurotensin Receptor-1 Pathway Contributes to Human Ductal Breast Cancer Progression	PLOS ONE			English	Article								Background: The neurotensin (NTS) and its specific high affinity G protein coupled receptor, the NT1 receptor (NTSR1), are considered to be a good candidate for one of the factors implicated in neoplastic progression. In breast cancer cells, functionally expressed NT1 receptor coordinates a series of transforming functions including cellular migration and invasion. Methods and Results: we investigated the expression of NTS and NTSR1 in normal human breast tissue and in invasive ductal breast carcinomas (IDCs) by immunohistochemistry and RT-PCR. NTS is expressed and up-regulated by estrogen in normal epithelial breast cells. NTS is also found expressed in the ductal and invasive components of IDCs. The high expression of NTSR1 is associated with the SBR grade, the size of the tumor, and the number of metastatic lymph nodes. Furthermore, the NTSR1 high expression is an independent factor of prognosis associated with the death of patients. Conclusion: these data support the activation of neurotensinergic deleterious pathways in breast cancer progression.	[Dupouy, Sandra; Viardot-Foucault, Veronique; Souaze, Frederique; Gespach, Christian; Gompel, Anne; Forgez, Patricia] UPMC, Hop St Antoine, INSERM, CDR St Antoine EQ 5, Paris, France; [Viardot-Foucault, Veronique; Plu-Bureau, Genevieve; Lavaur, Anne; Gompel, Anne] Univ Paris 05, AP HP, Hotel Dieu Paris, Unite Gynecol, Paris, France; [Alifano, Marco] Univ Paris 05, AP HP, Hotel Dieu Paris, Serv Chirurg Thorac, Paris, France; [Chaouat, Marc] Hop Rotschild, AP HP, Serv Chirurg Plastique, Paris, France; [Hugol, Danielle] Univ Paris 05, AP HP, Hotel Dieu Paris, Dept Anatomo Pathol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Rothschild - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Dupouy, S (corresponding author), UPMC, Hop St Antoine, INSERM, CDR St Antoine EQ 5, Paris, France.	patricia.forgez@inserm.fr	Gompel, Anne/AAV-3132-2020; Souazé, Frédérique/K-7937-2015; souazé, frédérique/AAE-6478-2021; Alifano, Marco/AAN-7800-2020; FORGEZ, Patricia/N-2960-2018	Frederique, Souaze/0000-0003-0476-2603	INSERM; UPMC; ARC Association pour la Recherche sur le Cancer [3543]; LNC (Ligue Nationale Contre le cancer) [75/00-RS/40, 07/75-85]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); UPMC; ARC Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); LNC (Ligue Nationale Contre le cancer)	This work has been supported by INSERM, UPMC and a Grant from ARC (Association pour la Recherche sur le Cancer # 3543) and LNC (Ligue Nationale Contre le cancer) # 75/00-RS/40 and 07/75-85 France. Sandra Dupouy was supported by the Ligue nationale contre le cancer.	ALEXANDER MJ, 1993, ENDOCRINOLOGY, V133, P1809, DOI 10.1210/en.133.4.1809; ALEXANDER MJ, 1994, J COMP NEUROL, V345, P496, DOI 10.1002/cne.903450403; Althuis MD, 2005, INT J EPIDEMIOL, V34, P405, DOI 10.1093/ije/dyh414; ANDERSSON S, 1977, ACTA PHYSIOL SCAND, V100, P231, DOI 10.1111/j.1748-1716.1977.tb05941.x; ARMSTRONG MJ, 1986, AM J PHYSIOL, V251, pG823, DOI 10.1152/ajpgi.1986.251.6.G823; BACA I, 1982, DIGESTION, V23, P174, DOI 10.1159/000198725; Chang JC, 2003, LANCET, V362, P362, DOI 10.1016/S0140-6736(03)14023-8; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Dong ZZ, 1998, AM J PHYSIOL-GASTR L, V274, pG535, DOI 10.1152/ajpgi.1998.274.3.G535; Ehlers RA, 2000, BIOCHEM BIOPH RES CO, V269, P704, DOI 10.1006/bbrc.2000.2335; Evers BM, 2006, PEPTIDES, V27, P2424, DOI 10.1016/j.peptides.2006.01.028; Ginestier C, 2006, CLIN CANCER RES, V12, P4533, DOI 10.1158/1078-0432.CCR-05-2339; GOMPEL A, 1986, J CLIN ENDOCR METAB, V63, P1174, DOI 10.1210/jcem-63-5-1174; Hassan S, 2004, REGUL PEPTIDES, V120, P155, DOI 10.1016/j.regpep.2004.03.004; KAPUSCINSKI M, 1990, J CLIN ENDOCR METAB, V70, P100, DOI 10.1210/jcem-70-1-100; Leyton J, 2002, EUR J PHARMACOL, V442, P179, DOI 10.1016/S0014-2999(02)01539-X; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; REINECKE M, 1985, PROG HISTOCHEM CYTOC, V16, P1; Rostene WH, 1997, FRONT NEUROENDOCRIN, V18, P115, DOI 10.1006/frne.1996.0146; Somai S, 2002, BIOCHEM BIOPH RES CO, V295, P482, DOI 10.1016/S0006-291X(02)00703-9; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Souaze F, 2006, CARCINOGENESIS, V27, P708, DOI 10.1093/carcin/bgi269; Souaze F, 1997, J BIOL CHEM, V272, P10087; Souaze F, 2006, CANCER RES, V66, P6243, DOI 10.1158/0008-5472.CAN-06-0450; Toy-Miou-Leong M, 2004, J BIOL CHEM, V279, P12636, DOI 10.1074/jbc.M303384200; VITA N, 1993, FEBS LETT, V317, P139, DOI 10.1016/0014-5793(93)81509-X; Wang QD, 2006, NEOPLASIA, V8, P781, DOI 10.1593/neo.06259; Watters JJ, 1998, J NEUROSCI, V18, P6672; Zhao DZ, 2004, J BIOL CHEM, V279, P43547, DOI 10.1074/jbc.M401453200; Zhao DZ, 2003, AM J PHYSIOL-CELL PH, V284, pC1397, DOI 10.1152/ajpcell.00328.2002	30	70	78	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2009	4	1							e4223	10.1371/journal.pone.0004223	http://dx.doi.org/10.1371/journal.pone.0004223			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IZ	19156213	gold, Green Published, Green Submitted			2022-12-25	WOS:000265481900005
J	Jackson, JC; Higgins, LA; Lin, XR				Jackson, Jennifer C.; Higgins, Laura A.; Lin, Xiaorong			Conidiation Color Mutants of Aspergillus fumigatus Are Highly Pathogenic to the Heterologous Insect Host Galleria mellonella	PLOS ONE			English	Article							CANDIDA-ALBICANS MUTANTS; CRYPTOCOCCUS-NEOFORMANS; CAENORHABDITIS-ELEGANS; MELANIN BIOSYNTHESIS; PIGMENT BIOSYNTHESIS; VIRULENCE FACTORS; MODEL; GENE; LARVAE; SYSTEM	The greater wax moth Galleria mellonella has been widely used as a heterologous host for a number of fungal pathogens including Candida albicans and Cryptococcus neoformans. A positive correlation in pathogenicity of these yeasts in this insect model and animal models has been observed. However, very few studies have evaluated the possibility of applying this heterologous insect model to investigate virulence traits of the filamentous fungal pathogen Aspergillus fumigatus, the leading cause of invasive aspergillosis. Here, we have examined the impact of mutations in genes involved in melanin biosynthesis on the pathogenicity of A. fumigatus in the G. mellonella model. Melanization in A. fumigatus confers bluish-grey color to conidia and is a known virulence factor in mammal models. Surprisingly, conidial color mutants in B5233 background that have deletions in the defined six-gene cluster required for DHN-melanin biosynthesis caused enhanced insect mortality compared to the parent strain. To further examine and confirm the relationship between melanization defects and enhanced virulence in the wax moth model, we performed random insertional mutagenesis in the Af293 genetic background to isolate mutants producing altered conidia colors. Strains producing conidia of previously identified colors and of novel colors were isolated. Interestingly, these color mutants displayed a higher level of pathogenicity in the insect model compared to the wild type. Although some of the more virulent color mutants showed increased resistance to hydrogen peroxide, overall phenotypic characterizations including secondary metabolite production, metalloproteinase activity, and germination rate did not reveal a general mechanism accountable for the enhanced virulence of these color mutants observed in the insect model. Our observations indicate instead, that exacerbated immune response of the wax moth induced by increased exposure of PAMPs (pathogen-associated molecular patterns) may cause self-damage that results in increased mortality of larvae infected with the color mutants. The current study underscores the limitations of using this insect model for inferring the pathogenic potential of A. fumigatus strains in mammals, but also points to the importance of understanding the innate immunity of the insect host in providing insights into the pathogenicity level of different fungal strains in this model. Additionally, our observations that melanization defective color mutants demonstrate increased virulence in the insect wax moth, suggest the potential of using melanization defective mutants of native insect fungal pathogens in the biological control of insect populations.	[Jackson, Jennifer C.; Higgins, Laura A.; Lin, Xiaorong] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Jackson, JC (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	xlin@mail.bio.tamu.edu	Lin, Xiaorong/ABC-4163-2021	Lin, Xiaorong/0000-0002-3390-8387	Biology Department of Texas A & M University	Biology Department of Texas A & M University	Startup fund to XL from Biology Department of Texas A & M University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altincicek B, 2007, INFECT IMMUN, V75, P175, DOI 10.1128/IAI.01385-06; Balajee SA, 2006, EUKARYOT CELL, V5, P1705, DOI 10.1128/EC.00162-06; Bergin D, 2005, INFECT IMMUN, V73, P4161, DOI 10.1128/IAI.73.7.4161-4170.2005; Bergin D, 2003, MICROBES INFECT, V5, P1389, DOI 10.1016/j.micinf.2003.09.019; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; Brennan M, 2002, FEMS IMMUNOL MED MIC, V34, P153, DOI 10.1111/j.1574-695X.2002.tb00617.x; Brush L, 1999, FUNGAL GENET BIOL, V28, P190, DOI 10.1006/fgbi.1999.1176; Buchanan KL, 1998, EMERG INFECT DIS, V4, P71, DOI 10.3201/eid0401.980109; Burgos A, 2008, PEDIATRICS, V121, pE1286, DOI 10.1542/peds.2007-2117; Casadevall A, 2005, INFECT IMMUN, V73, P3829, DOI 10.1128/IAI.73.7.3829-3832.2005; Casadevall A, 2003, CURR OPIN MICROBIOL, V6, P332, DOI 10.1016/S1369-5274(03)00082-1; Casadevall A, 2000, CURR OPIN MICROBIOL, V3, P354, DOI 10.1016/S1369-5274(00)00103-X; Cotter G, 2000, FEMS IMMUNOL MED MIC, V27, P163, DOI 10.1111/j.1574-695X.2000.tb01427.x; Dadachova E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000457; DEHOOG GS, 1993, ANTON LEEUW INT J G, V63, P105, DOI 10.1007/BF00872386; DIXON DM, 1987, J MED VET MYCOL, V25, P97; Dunphy GB, 2003, CAN J MICROBIOL, V49, P514, DOI 10.1139/W03-064; Fuchs BB, 2006, CURR OPIN MICROBIOL, V9, P346, DOI 10.1016/j.mib.2006.06.004; Fujii I, 2004, J BIOL CHEM, V279, P44613, DOI 10.1074/jbc.M406758200; Golebiowski M, 2008, INSECT BIOCHEM MOLEC, V38, P619, DOI 10.1016/j.ibmb.2008.03.005; Gomez BL, 2003, CURR OPIN INFECT DIS, V16, P91, DOI 10.1097/00001432-200304000-00005; Hamilton A J, 1996, Curr Top Med Mycol, V7, P19; Held KG, 2007, APPL ENVIRON MICROB, V73, P7622, DOI 10.1128/AEM.01000-07; HILL HZ, 1992, BIOESSAYS, V14, P49, DOI 10.1002/bies.950140111; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; Jacobson ES, 2005, MED MYCOL, V43, P327, DOI 10.1080/13693780412331271081; Jahn B, 1997, INFECT IMMUN, V65, P5110, DOI 10.1128/IAI.65.12.5110-5117.1997; Jahn B, 2000, INFECT IMMUN, V68, P3736, DOI 10.1128/IAI.68.6.3736-3739.2000; Jahn B, 2002, CELL MICROBIOL, V4, P793, DOI 10.1046/j.1462-5822.2002.00228.x; Kavanagh K, 2004, FEMS MICROBIOL REV, V28, P101, DOI 10.1016/j.femsre.2003.09.002; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Langfelder K, 1998, MED MICROBIOL IMMUN, V187, P79, DOI 10.1007/s004300050077; Langfelder K, 2003, FUNGAL GENET BIOL, V38, P143, DOI 10.1016/S1087-1845(02)00526-1; Leger RJS, 2000, APPL ENVIRON MICROB, V66, P320, DOI 10.1128/AEM.66.1.320-324.2000; Lionakis MS, 2005, MED MYCOL, V43, pS111, DOI 10.1080/13693780400020030; London R, 2006, FEMS YEAST RES, V6, P567, DOI 10.1111/j.1567-1364.2006.00056.x; Lumbreras Carlos, 2003, Revista Iberoamericana de Micologia, V20, P79; Luther K, 2007, CELL MICROBIOL, V9, P368, DOI 10.1111/j.1462-5822.2006.00796.x; Magill SS, 2008, EXPERT OPIN PHARMACO, V9, P193, DOI 10.1517/14656566.9.2.193 ; Marr KA, 2002, INFECT DIS CLIN N AM, V16, P875, DOI 10.1016/S0891-5520(02)00035-1; Momany M, 2000, MICROBIOL-UK, V146, P3279, DOI 10.1099/00221287-146-12-3279; Mowlds P, 2008, MICROBES INFECT, V10, P628, DOI 10.1016/j.micinf.2008.02.011; Mowlds P, 2008, MYCOPATHOLOGIA, V165, P5, DOI 10.1007/s11046-007-9069-9; Mullins ED, 2001, PHYTOPATHOLOGY, V91, P173, DOI 10.1094/PHYTO.2001.91.2.173; Mylonakis E, 2005, INFECT IMMUN, V73, P3833, DOI 10.1128/IAI.73.7.3833-3841.2005; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Mylonakis E, 2002, P NATL ACAD SCI USA, V99, P15675, DOI 10.1073/pnas.232568599; Mylonakis E, 2007, PLOS PATHOG, V3, P859, DOI 10.1371/journal.ppat.0030101; Mylonakis E, 2008, MYCOPATHOLOGIA, V165, P1, DOI 10.1007/s11046-007-9082-z; Mylonakis Eleftherios, 2003, Expert Rev Anti Infect Ther, V1, P167, DOI 10.1586/14787210.1.1.167; NAPPI AJ, 1993, PIGM CELL RES, V6, P117, DOI 10.1111/j.1600-0749.1993.tb00590.x; Nappi AJ, 1995, EUR J CELL BIOL, V68, P450; Nosanchuk JD, 1999, MOL CELL BIOL, V19, P745; Park SY, 2007, INFECT IMMUN, V75, P1861, DOI 10.1128/IAI.01473-06; Poulsen M, 2002, BEHAV ECOL SOCIOBIOL, V52, P151, DOI 10.1007/s00265-002-0489-8; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; RATCLIFFE NA, 1985, IMMUNOL LETT, V10, P253, DOI 10.1016/0165-2478(85)90100-2; Reeves EP, 2004, MYCOPATHOLOGIA, V158, P73, DOI 10.1023/B:MYCO.0000038434.55764.16; Rementeria Aitor, 2005, Revista Iberoamericana de Micologia, V22, P1, DOI 10.1016/S1130-1406(05)70001-2; Renwick J, 2006, MYCOPATHOLOGIA, V161, P377, DOI 10.1007/s11046-006-0021-1; Revankar SG, 2007, MYCOSES, V50, P91, DOI 10.1111/j.1439-0507.2006.01331.x; Sadd BM, 2006, P ROY SOC B-BIOL SCI, V273, P2571, DOI 10.1098/rspb.2006.3574; SAKEMI S, 1995, J ANTIBIOT, V48, P134, DOI 10.7164/antibiotics.48.134; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Steinbach WJ, 2003, CLIN INFECT DIS, V37, pS157, DOI 10.1086/376523; Sugui JA, 2005, APPL ENVIRON MICROB, V71, P1798, DOI 10.1128/AEM.71.4.1798-1802.2005; Sugumaran M, 2000, ARCH BIOCHEM BIOPHYS, V379, P252, DOI 10.1006/abbi.2000.1884; Swanson MS, 2000, ANNU REV MICROBIOL, V54, P567, DOI 10.1146/annurev.micro.54.1.567; Tang RJ, 2005, INFECT IMMUN, V73, P8219, DOI 10.1128/IAI.73.12.8219-8225.2005; TAYLOR RL, 1969, J INVERTEBR PATHOL, V14, P427, DOI 10.1016/0022-2011(69)90178-5; Thompson JE, 2000, J BIOL CHEM, V275, P34867, DOI 10.1074/jbc.M006659200; Tojo S, 2000, J INSECT PHYSIOL, V46, P1129, DOI 10.1016/S0022-1910(99)00223-1; Tournu H, 2005, CURR DRUG TARGETS, V6, P909, DOI 10.2174/138945005774912690; Tsai HF, 1999, J BACTERIOL, V181, P6469, DOI 10.1128/JB.181.20.6469-6477.1999; Tsai HF, 1997, MOL MICROBIOL, V26, P175, DOI 10.1046/j.1365-2958.1997.5681921.x; Tsai HF, 2001, J BIOL CHEM, V276, P29292, DOI 10.1074/jbc.M101998200; Tsai HF, 1998, J BACTERIOL, V180, P3031, DOI 10.1128/JB.180.12.3031-3038.1998; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Unsold IA, 2005, MICROBIOL-SGM, V151, P1499, DOI 10.1099/mic.0.27759-0; Vaideeswar P, 2004, J Postgrad Med, V50, P21; WANG YL, 1995, INFECT IMMUN, V63, P3131, DOI 10.1128/IAI.63.8.3131-3136.1995; Wheeler M H, 1988, Curr Top Med Mycol, V2, P338; Whitten MMA, 2004, J IMMUNOL, V172, P2177, DOI 10.4049/jimmunol.172.4.2177	84	81	99	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2009	4	1							e4224	10.1371/journal.pone.0004224	http://dx.doi.org/10.1371/journal.pone.0004224			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IZ	19156203	Green Published, Green Submitted, gold			2022-12-25	WOS:000265481900006
J	Cameron, EZ; Dalerum, F				Cameron, Elissa Z.; Dalerum, Fredrik			A Trivers-Willard Effect in Contemporary Humans: Male-Biased Sex Ratios among Billionaires	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; BOVINE EMBRYOS; OFFSPRING SEX; BIRTH; SONS; BLASTOCYST; INVESTMENT; ADJUSTMENT; HYPOTHESIS; DAUGHTERS	Background: Natural selection should favour the ability of mothers to adjust the sex ratio of offspring in relation to the offspring's potential reproductive success. In polygynous species, mothers in good condition would be advantaged by giving birth to more sons. While studies on mammals in general provide support for the hypothesis, studies on humans provide particularly inconsistent results, possibly because the assumptions of the model do not apply. Methodology/Principal Findings: Here, we take a subset of humans in very good condition: the Forbe's billionaire list. First, we test if the assumptions of the model apply, and show that mothers leave more grandchildren through their sons than through their daughters. We then show that billionaires have 60% sons, which is significantly different from the general population, consistent with our hypothesis. However, women who themselves are billionaires have fewer sons than women having children with billionaires, suggesting that maternal testosterone does not explain the observed variation. Furthermore, paternal masculinity as indexed by achievement, could not explain the variation, since there was no variation in sex ratio between self-made or inherited billionaires. Conclusions/Significance: Humans in the highest economic bracket leave more grandchildren through sons than through daughters. Therefore, adaptive variation in sex ratios is expected, and human mothers in the highest economic bracket do give birth to more sons, suggesting similar sex ratio manipulation as seen in other mammals.	[Cameron, Elissa Z.; Dalerum, Fredrik] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa	University of Pretoria	Cameron, EZ (corresponding author), Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa.	ezcameron@zoology.up.ac.za	Cameron, Elissa Z/E-4280-2010; Cameron, Elissa/B-8053-2014; Dalerum, Fredrik/M-6068-2017	Cameron, Elissa/0000-0002-9243-0547; Dalerum, Fredrik/0000-0001-9737-8242	University of Pretoria Research Development Fund	University of Pretoria Research Development Fund	University of Pretoria Research Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Al-Ayadhi LY, 2004, SAUDI MED J, V25, P711; Almond D, 2007, P ROY SOC B-BIOL SCI, V274, P2491, DOI 10.1098/rspb.2007.0524; Barker DJP, 1998, MOTHER BABIES HLTH L; Bartlett MS., 1936, J R STAT SOC, V3, P185; BORGERHOFFMULDE.M, 1998, HUM NATURE, V9, P119; BROOKS AA, 1995, EARLY HUM DEV, V42, P29, DOI 10.1016/0378-3782(95)01637-I; Cameron EZ, 2008, P ROY SOC B-BIOL SCI, V275, P323, DOI 10.1098/rspb.2007.1401; Cameron EZ, 2004, P ROY SOC B-BIOL SCI, V271, P1723, DOI 10.1098/rspb.2004.2773; Catalano RA, 2003, HUM REPROD, V18, P1972, DOI 10.1093/humrep/deg370; Dupanloup I, 2003, J MOL EVOL, V57, P85, DOI 10.1007/s00239-003-2458-x; Freese J, 1999, AM J SOCIOL, V104, P1704, DOI 10.1086/210221; Gibson MA, 2003, P ROY SOC B-BIOL SCI, V270, pS108, DOI 10.1098/rsbl.2003.0031; GOMENDIO M, 1990, NATURE, V343, P261, DOI 10.1038/343261a0; Grant VJ, 2008, BIOL REPROD, V78, P812, DOI 10.1095/biolreprod.107.066050; Grant V. J., 1998, MATERNAL PERSONALITY; Grant VJ, 2003, HUM BIOL, V75, P917, DOI 10.1353/hub.2004.0005; Gutierrez-Adan A, 2001, REPROD FERT DEVELOP, V13, P361, DOI 10.1071/RD00039; GutierrezAdan A, 1996, THERIOGENOLOGY, V46, P515, DOI 10.1016/0093-691X(96)00173-2; Helle S, 2008, ANIM BEHAV, V75, P1031, DOI 10.1016/j.anbehav.2007.08.015; Helle S, 2008, J THEOR BIOL, V252, P773, DOI 10.1016/j.jtbi.2008.02.032; Hewison AJM, 1999, TRENDS ECOL EVOL, V14, P229, DOI 10.1016/S0169-5347(99)01592-X; Hopcroft RL, 2006, EVOL HUM BEHAV, V27, P104, DOI 10.1016/j.evolhumbehav.2005.07.004; James WH, 1996, J THEOR BIOL, V180, P271, DOI 10.1006/jtbi.1996.0102; Kanazawa S, 2005, J THEOR BIOL, V235, P583, DOI 10.1016/j.jtbi.2005.02.010; Kanazawa S, 2005, J THEOR BIOL, V233, P589, DOI 10.1016/j.jtbi.2004.11.009; Kankova S, 2007, NATURWISSENSCHAFTEN, V94, P122, DOI 10.1007/s00114-006-0166-2; Keller MC, 2001, EVOL HUM BEHAV, V22, P343, DOI 10.1016/S1090-5138(01)00075-7; Larson MA, 2001, P NATL ACAD SCI USA, V98, P9677, DOI 10.1073/pnas.171305398; Lazarus J, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P287, DOI 10.1017/CBO9780511542053.015; Leimar O, 1996, BEHAV ECOL, V7, P316, DOI 10.1093/beheco/7.3.316; Luna M, 2007, FERTIL STERIL, V87, P519, DOI 10.1016/j.fertnstert.2006.06.058; Mathews F, 2008, P ROY SOC B-BIOL SCI, V275, P1661, DOI 10.1098/rspb.2008.0105; MYERS JH, 1978, AM NAT, V112, P381, DOI 10.1086/283280; Nevison C, 1997, APPL ANIM BEHAV SCI, V51, P285, DOI 10.1016/S0168-1591(96)01111-2; Phillips DIW, 2001, BRIT MED J, V322, P771, DOI 10.1136/bmj.322.7289.771; Potts M, 1997, POPUL DEV REV, V23, P1, DOI 10.2307/2137459; Rickard IJ, 2007, P ROY SOC B-BIOL SCI, V274, P2981, DOI 10.1098/rspb.2007.1051; Sheldon BC, 2004, AM NAT, V163, P40, DOI 10.1086/381003; Stein AD, 2000, HUM BIOL, V72, P641; Tovee MJ, 2001, P ROY SOC B-BIOL SCI, V268, P1007, DOI 10.1098/rspb.2001.1618; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; WHITE RE, 2006, ENTREPRENEURS EVOLUT	44	47	49	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4195	10.1371/journal.pone.0004195	http://dx.doi.org/10.1371/journal.pone.0004195			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142225	Green Published, Green Submitted, gold			2022-12-25	WOS:000265479700015
J	Kau, JH; Sun, DS; Huang, HH; Wong, MS; Lin, HC; Chang, HH				Kau, Jyh-Hwa; Sun, Der-Shan; Huang, Hsin-Hsien; Wong, Ming-Show; Lin, Hung-Chi; Chang, Hsin-Hou			Role of Visible Light-Activated Photocatalyst on the Reduction of Anthrax Spore-Induced Mortality in Mice	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; ESCHERICHIA-COLI; BACTERICIDAL ACTIVITY; LETHAL TOXIN; INACTIVATION; TIO2; DISINFECTION; DESTRUCTION; GERMINATION; RESISTANCE	Background: Photocatalysis of titanium dioxide (TiO2) substrates is primarily induced by ultraviolet light irradiation. Anion-doped TiO2 substrates were shown to exhibit photocatalytic activities under visible-light illumination, relative environmentally-friendly materials. Their anti-spore activity against Bacillus anthracis, however, remains to be investigated. We evaluated these visible-light activated photocatalysts on the reduction of anthrax spore-induced pathogenesis. Methodology/Principal Findings: Standard plating method was used to determine the inactivation of anthrax spore by visible light-induced photocatalysis. Mouse models were further employed to investigate the suppressive effects of the photocatalysis on anthrax toxin- and spore-mediated mortality. We found that anti-spore activities of visible light illuminated nitrogen- or carbon-doped titania thin films significantly reduced viability of anthrax spores. Even though the spore-killing efficiency is only approximately 25%, our data indicate that spores from photocatalyzed groups but not untreated groups have a less survival rate after macrophage clearance. In addition, the photocatalysis could directly inactivate lethal toxin, the major virulence factor of B. anthracis. In agreement with these results, we found that the photocatalyzed spores have tenfold less potency to induce mortality in mice. These data suggest that the photocatalysis might injury the spores through inactivating spore components. Conclusion/Significance: Photocatalysis induced injuries of the spores might be more important than direct killing of spores to reduce pathogenicity in the host.	[Kau, Jyh-Hwa; Huang, Hsin-Hsien; Lin, Hung-Chi] Natl Def Med Ctr, Inst Prevent Med, Taipei, Taiwan; [Sun, Der-Shan; Chang, Hsin-Hou] Tzu Chi Univ, Inst Mol Biol & Human Genet, Hualien, Taiwan; [Sun, Der-Shan; Chang, Hsin-Hou] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Wong, Ming-Show] Natl Dong Hwa Univ, Dept Mat Sci & Engn, Hualien, Taiwan	National Defense Medical Center; Tzu Chi University; Tzu Chi University; National Dong Hwa University	Kau, JH (corresponding author), Natl Def Med Ctr, Inst Prevent Med, Taipei, Taiwan.	hhchang@mail.tcu.edu.tw	Chang, Hsin-Hou/B-6225-2012	Chang, Hsin-Hou/0000-0002-8731-3485	National Science Council of Taiwan ROC [94-2216-E-259-002, 94-2120-M-259-003, 95-2314-B-320-009-MY3, 095-2811-B-320-001]	National Science Council of Taiwan ROC(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council of Taiwan ROC under grant no. NSC 94-2216-E-259-002, NSC 94-2120-M-259-003, NSC 95-2314-B-320-009-MY3 and 095-2811-B-320-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051; Bekbolet M, 1996, CHEMOSPHERE, V32, P959, DOI 10.1016/0045-6535(95)00359-2; Bizani D, 2004, APPL MICROBIOL BIOT, V65, P158, DOI 10.1007/s00253-004-1570-1; Carrera M, 2007, J APPL MICROBIOL, V102, P303, DOI 10.1111/j.1365-2672.2006.03111.x; Chang HH, 2000, J BIOMED SCI, V7, P42, DOI 10.1159/000025428; Chang HH, 2006, J BIOTECHNOL, V126, P277, DOI 10.1016/j.jbiotec.2006.04.038; Chang JC, 2005, J BIOMED SCI, V12, P881, DOI 10.1007/s11373-005-9021-2; CHENG CL, 2009, J BIOMED SC IN PRESS, V16; Christopher GW, 1997, JAMA-J AM MED ASSOC, V278, P412, DOI 10.1001/jama.278.5.412; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Cote CK, 2005, MICROB PATHOGENESIS, V38, P209, DOI 10.1016/j.micpath.2005.02.001; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Dixon TC, 2000, CELL MICROBIOL, V2, P453, DOI 10.1046/j.1462-5822.2000.00067.x; Driks A, 1999, MICROBIOL MOL BIOL R, V63, P1; DROBNIEWSKI FA, 1993, CLIN MICROBIOL REV, V6, P324, DOI 10.1128/CMR.6.4.324-338.1993; Elahifard MR, 2007, J AM CHEM SOC, V129, P9552, DOI 10.1021/ja072492m; Fouet A, 2006, CURR OPIN MICROBIOL, V9, P160, DOI 10.1016/j.mib.2006.02.009; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Guidi-Rontani C, 1999, MOL MICROBIOL, V31, P9, DOI 10.1046/j.1365-2958.1999.01137.x; Guidi-Rontani C, 2001, MOL MICROBIOL, V42, P931, DOI 10.1046/j.1365-2958.2001.02695.x; Hamburg MA, 2002, TRENDS BIOTECHNOL, V20, P296, DOI 10.1016/S0167-7799(02)01989-3; Hu C, 2006, J PHYS CHEM B, V110, P4066, DOI 10.1021/jp0564400; IRELAND JC, 1993, APPL ENVIRON MICROB, V59, P1668, DOI 10.1128/AEM.59.5.1668-1670.1993; Iwasaki M, 2000, J COLLOID INTERF SCI, V224, P202, DOI 10.1006/jcis.1999.6694; Kau JH, 2005, J INFECT DIS, V192, P1465, DOI 10.1086/491477; Kau JH, 2002, CURR MICROBIOL, V44, P106, DOI 10.1007/s00284-001-0059-8; Kort R, 2005, APPL ENVIRON MICROB, V71, P3556, DOI 10.1128/AEM.71.7.3556-3564.2005; Kudva IT, 2005, INFECT IMMUN, V73, P5685, DOI 10.1128/IAI.73.9.5685-5696.2005; Leahy MB, 1997, J VIROL, V71, P8352, DOI 10.1128/JVI.71.11.8352-8356.1997; LI E, 1975, APPL MICROBIOL, V30, P354, DOI 10.1128/AEM.30.3.354-361.1975; Li Q, 2007, ENVIRON SCI TECHNOL, V41, P5050, DOI 10.1021/es062753c; Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; RUSSELL AD, 1990, CLIN MICROBIOL REV, V3, P99, DOI 10.1128/CMR.3.2.99-119.1990; Sagripanti JL, 1996, APPL ENVIRON MICROB, V62, P545, DOI 10.1128/AEM.62.2.545-551.1996; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Shieh KJ, 2006, NANOMED-NANOTECHNOL, V2, P121, DOI 10.1016/j.nano.2006.04.001; Sun DS, 2007, J THROMB HAEMOST, V5, P2291, DOI 10.1111/j.1538-7836.2007.02754.x; Sun DS, 2005, J BIOMED SCI, V12, P321, DOI 10.1007/s11373-005-0979-6; Wang H, 2006, J PHYS-CONDENS MAT, V18, P421, DOI 10.1088/0953-8984/18/2/006; Weber MHW, 2002, PHILOS T R SOC B, V357, P895, DOI 10.1098/rstb.2002.1078; Whitney EAS, 2003, EMERG INFECT DIS, V9, P623; Wong MS, 2006, APPL ENVIRON MICROB, V72, P6111, DOI 10.1128/AEM.02580-05; Yang MC, 2004, THIN SOLID FILMS, V469, P1, DOI 10.1016/j.tsf.2004.06.189; Yang TS, 2004, SURF SCI, V548, P75, DOI 10.1016/j.susc.2003.10.044; Zan L, 2007, J PHOTOCH PHOTOBIO B, V86, P165, DOI 10.1016/j.jphotobiol.2006.09.002	47	39	39	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2009	4	1							e4167	10.1371/journal.pone.0004167	http://dx.doi.org/10.1371/journal.pone.0004167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GB	19132100	Green Submitted, gold, Green Published			2022-12-25	WOS:000265473700006
J	Alcina, A; Fedetz, M; Ndagire, D; Fernandez, O; Leyva, L; Guerrero, M; Abad-Grau, MM; Arnal, C; Delgado, C; Lucas, M; Izquierdo, G; Matesanz, F				Alcina, Antonio; Fedetz, Maria; Ndagire, Dorothy; Fernandez, Oscar; Leyva, Laura; Guerrero, Miguel; Abad-Grau, Maria M.; Arnal, Carmen; Delgado, Concepcion; Lucas, Miguel; Izquierdo, Guillermo; Matesanz, Fuencisla			IL2RA/CD25 Gene Polymorphisms: Uneven Association with Multiple Sclerosis (MS) and Type 1 Diabetes (T1D)	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE PTPN22; INTERLEUKIN-7 RECEPTOR; AUTOIMMUNE-DISEASES; FC RECEPTOR-LIKE-3; FUNCTIONAL VARIANT; POPULATION; FAMILIES; LOCUS; FCRL3; RISK	Background: IL-2 receptor (IL2R) alpha is the specific component of the high affinity IL2R system involved in the immune response and in the control of autoimmunity. Methods and Results: Here we perform a replication and fine mapping of the IL2RA gene region analyzing 3 SNPs previously associated with multiple sclerosis (MS) and 5 SNPs associated with type 1 diabetes (T1D) in a collection of 798 MS patients and 927 matched Caucasian controls from the south of Spain. We observed association with MS in 6 of 8 SNPs. The rs1570538, at the 3'-UTR extreme of the gene, previously reported to have a weak association with MS, is replicated here (P = 0.032). The most associated T1D SNP (rs41295061) was not associated with MS in the present study. However, the rs35285258, belonging to another independent group of SNPs associated with T1D, showed the maximal association in this study but different risk allele. We replicated the association of only one (rs2104286) of the two IL2RA SNPs identified in the recently performed genome-wide association study of MS. Conclusions: These findings confirm and extend the association of this gene with MS and reveal a genetic heterogeneity of the associated polymorphisms and risk alleles between MS and T1D suggesting different immunopathological roles of IL2RA in these two diseases.	[Fedetz, Maria; Ndagire, Dorothy; Matesanz, Fuencisla] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Fernandez, Oscar; Leyva, Laura; Guerrero, Miguel] Hosp Carlos Haya, Inst Neuroci Clin, Serv Neurol, Malaga, Spain; [Abad-Grau, Maria M.] Univ Granada, Dept Lenguajes Sist Informat, Granada, Spain; [Arnal, Carmen] Hosp Virgen Nieves, Serv Neurol, Granada, Spain; [Delgado, Concepcion] Ctr Region Transfus Sanguinea Granada Almeria, Granada, Spain; [Lucas, Miguel] Hosp Virgen Macarena, Serv Biol Mol, Seville, Spain; [Izquierdo, Guillermo] Hosp Virgen Macarena, Unidad Esclerosis Multiple, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Hospital Carlos Haya; University of Granada; Hospital Universitario Virgen de las Nieves; Hospital Universitario Virgen Macarena; Hospital Universitario Virgen Macarena	Alcina, A (corresponding author), CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain.	pulgoso@ipb.csic.es	Matesanz, Fuencisla/F-3715-2016; Alcina, Antonio/T-1893-2017; Leyva, Laura/B-5574-2019; Abad Grau, María del Mar/B-2172-2012; Leyva, Laura/R-2187-2019	Matesanz, Fuencisla/0000-0002-9429-1819; Alcina, Antonio/0000-0001-7294-0948; Leyva, Laura/0000-0003-0620-9625; Abad Grau, María del Mar/0000-0001-8470-9719; Leyva, Laura/0000-0003-0620-9625	Ministerio de Educacion y Ciencia [PN-SAF2006-02023, TIN2007-67418-C03-03]; Junta de Andalucia [P07-CVI-02551]; Servicio Andaluz de Salud de la Junta de Andalucia [PI0168/2007]; Fundacion IMABIS [fellowship]; AECI-Ministerio de Asuntos Exteriores [fellowship]	Ministerio de Educacion y Ciencia(Spanish Government); Junta de Andalucia(Junta de Andalucia); Servicio Andaluz de Salud de la Junta de Andalucia(Junta de Andalucia); Fundacion IMABIS; AECI-Ministerio de Asuntos Exteriores	Financial support for the study was provided by the Ministerio de Educacion y Ciencia (grants PN-SAF2006-02023 and TIN2007-67418-C03-03) and Junta de Andalucia (P07-CVI-02551) to A. Alcina and Servicio Andaluz de Salud de la Junta de Andalucia (grant PI0168/2007) to F. Matesanz. Maria Fedetz is a holder of a fellowship from Fundacion IMABIS. Dorothy Ndagire is a holder of AECI-Ministerio de Asuntos Exteriores fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2007, J NEUROL, V254, P1736, DOI 10.1007/s00415-007-0602-z; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Barcellos LF, 2006, LANCET NEUROL, V5, P924, DOI 10.1016/S1474-4422(06)70552-X; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Corporaal S, 2002, CLIN RHEUMATOL, V21, P108, DOI 10.1007/PL00011215; Dideberg V, 2007, HUM MOL GENET, V16, P3008, DOI 10.1093/hmg/ddm259; Fernandez O, 2008, TISSUE ANTIGENS, V71, P426, DOI 10.1111/j.1399-0039.2008.01016.x; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Karni A, 1999, NEUROLOGY, V53, P883, DOI 10.1212/WNL.53.4.883; Kochi Y, 2005, NAT GENET, V37, P478, DOI 10.1038/ng1540; Kristjansdottir G, 2008, J MED GENET, V45, P362, DOI 10.1136/jmg.2007.055012; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Lindsey JW, 2005, AM J MED GENET A, V135A, P53, DOI 10.1002/ajmg.a.30702; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Matesanz F, 2008, J NEUROIMMUNOL, V195, P146, DOI 10.1016/j.jneuroim.2008.01.004; Matesanz Fuencisla, 2007, N Engl J Med, V357, P2200; Matesanz F, 2007, J NEUROL, V254, P682, DOI 10.1007/s00415-006-0416-4; McElroy JP, 2008, CURR TOP MICROBIOL, V318, P45; Murayama A, 2006, EMBO J, V25, P1081, DOI 10.1038/sj.emboj.7601012; Owen CJ, 2007, J CLIN ENDOCR METAB, V92, P1106, DOI 10.1210/jc.2006-2183; Pitzalis M, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-3; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Qu HQ, 2007, DIABETES, V56, P1174, DOI 10.2337/db06-1555; Ramagopolan SV, 2007, LANCET NEUROL, V6, P604, DOI 10.1016/S1474-4422(07)70132-1; Rueda B, 2006, ARTHRITIS RHEUM, V54, P3815, DOI 10.1002/art.22271; Sawcer S, 2008, LANCET NEUROL, V7, P567, DOI 10.1016/S1474-4422(08)70122-4; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843	33	58	63	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2009	4	1							e4137	10.1371/journal.pone.0004137	http://dx.doi.org/10.1371/journal.pone.0004137			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FV	19125193	Green Published, gold			2022-12-25	WOS:000265473100011
J	Hoegg, MB; Browman, DT; Resek, ME; Robbins, SM				Hoegg, Maja B.; Browman, Duncan T.; Resek, Mary E.; Robbins, Stephen M.			Distinct Regions within the Erlins Are Required for Oligomerization and Association with High Molecular Weight Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE MICRODOMAINS; SPFH DOMAIN; REGGIE/FLOTILLIN PROTEINS; ENDOPLASMIC-RETICULUM; RAFT ASSOCIATION; MAMMALIAN-CELLS; CHOLESTEROL; FAMILY; PALMITOYLATION; MYRISTOYLATION	The group of stomatin/prohibitin/flotillin/HflK/C (SPFH) domain-containing proteins comprise members of diverse subcellular localization and function. Association with detergent-resistant membranes (DRMs) and the propensity to form oligomers are two common properties of SPFH domain proteins and likely important for the function of these proteins. Our laboratory recently discovered two novel members of this protein group, which, based on their endoplasmic reticulum (ER) localization and association with DRMs, were named ER lipid raft-associated protein (erlin)-1 and -2. Here we characterized erlin oligomerization and identified domains within the erlins responsible for oligomerization and DRM association. Using co-immunoprecipitation and sucrose density gradient centrifugation approaches on endogenous and ectopically expressed erlin proteins, we found that they formed homo- and hetero-oligomers and were part of large multimeric complexes. These properties were independent of their DRM association. By analyzing truncation and point mutants of erlin-2 we discovered that interaction between erlin monomers (oligomerization) and association with high molecular weight complexes require distinct regions within the protein. Although oligomerization and DRM association were mediated by a region immediately downstream of the SPFH domain (residues 228-300), integration into high molecular weight complexes was absolutely dependent on a phenylalanine residue C-terminal of this region (Phe-305), which lies within a short stretch of hydrophobic residues. Our data demonstrate that lower order oligomerization and incorporation into multimeric complexes are two separate biochemical properties of the erlins, because they are mediated by distinct regions.	[Hoegg, Maja B.; Browman, Duncan T.; Resek, Mary E.; Robbins, Stephen M.] Univ Calgary, So Alberta Canc Res Inst, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Resek, Mary E.; Robbins, Stephen M.] Univ Calgary, So Alberta Canc Res Inst, Dept Oncol, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Robbins, SM (corresponding author), Hlth Res Innovat Ctr, Room 2AA22,3330 Hosp Dr,NW, Calgary, AB T2N 4N1, Canada.	srobbins@ucalgary.ca		Robbins, Stephen/0000-0001-7475-1665	Canadian Institutes of Health Research; Alberta Cancer Foundation Legacy Funds	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation Legacy Funds	This work was supported in part by grants from the Canadian Institutes of Health Research and the Alberta Cancer Foundation Legacy Funds. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Christis C, 2008, FEBS J, V275, P4700, DOI 10.1111/j.1742-4658.2008.06590.x; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Ikegawa S, 1999, CYTOGENET CELL GENET, V85, P227, DOI 10.1159/000015298; Kasashima K, 2006, J BIOL CHEM, V281, P36401, DOI 10.1074/jbc.M605260200; Kokubo H, 2003, BRAIN RES, V965, P83, DOI 10.1016/S0006-8993(02)04140-9; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Li N, 2000, BIOCHEM BIOPH RES CO, V279, P487, DOI 10.1006/bbrc.2000.3935; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Pearce MMP, 2007, J BIOL CHEM, V282, P20104, DOI 10.1074/jbc.M701862200; Pol A, 2005, MOL BIOL CELL, V16, P2091, DOI 10.1091/mbc.E04-08-0737; Polyak MJ, 2002, BLOOD, V99, P3256, DOI 10.1182/blood.V99.9.3256; Rivera-Milla E, 2006, CELL MOL LIFE SCI, V63, P343, DOI 10.1007/s00018-005-5434-3; ROBBINS SM, 1995, MOL CELL BIOL, V15, P3507; Snyers L, 1998, J BIOL CHEM, V273, P17221, DOI 10.1074/jbc.273.27.17221; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Sprenger RR, 2006, BIOCHEM J, V400, P401, DOI 10.1042/BJ20060355; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Tavernarakis N, 1999, TRENDS BIOCHEM SCI, V24, P425, DOI 10.1016/S0968-0004(99)01467-X; Umlauf E, 2006, J BIOL CHEM, V281, P23349, DOI 10.1074/jbc.M513720200	24	23	24	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7766	7776		10.1074/jbc.M809127200	http://dx.doi.org/10.1074/jbc.M809127200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19131330	Green Published, hybrid			2022-12-25	WOS:000264195600038
J	Hornakova, T; Staerk, J; Royer, Y; Flex, E; Tartaglia, M; Constantinescu, SN; Knoops, L; Renauld, JC				Hornakova, Tekla; Staerk, Judith; Royer, Yohan; Flex, Elisabetta; Tartaglia, Marco; Constantinescu, Stefan N.; Knoops, Laurent; Renauld, Jean-Christophe			Acute Lymphoblastic Leukemia-associated JAK1 Mutants Activate the Janus Kinase/STAT Pathway via Interleukin-9 Receptor alpha Homodimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL LEUKEMIA; TYROSINE KINASE; POLYCYTHEMIA-VERA; CYTOKINE RECEPTOR; THYMIC LYMPHOMAS; GAMMA-CHAIN; MYELOPROLIFERATIVE DISORDERS; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; EXPRESSION	Activating mutations in JAK1 have been reported in acute lymphoblastic leukemias, but little is known about the mechanisms involved in their constitutive activation. Here, we studied the ability of JAK1 V658F and A634D to activate the Janus kinase (JAK)/STAT pathway upon ectopic expression in HEK293 cells alone or together with the other components of the interleukin-9 receptor complex (IL-9R alpha, gamma c, and JAK3). Expression of JAK1 mutants alone failed to trigger STAT activation, but co-expression of the IL-9R alpha chain promoted JAK1 mutant phosphorylation and STAT activation. Mutation of the FERM domain of JAK1, which is critical for cytokine receptor association, or of the single tyrosine of IL-9R alpha involved in STAT recruitment abolished this activity, indicating that JAK1 mutants need to associate with a functional IL-9R alpha to activate STAT factors. Several lines of evidence indicated that IL-9R alpha homodimerization was involved in this process. IL-9R alpha variants with mutations of the JAK-interacting BOX1 region not only failed to promote JAK1 activation but also acted as dominant negative forms reverting the effect of wild-type IL-9R alpha. Coimmunoprecipitation experiments also showed the formation of IL-9R alpha homodimers. Interestingly, STAT activation was partially inhibited by expression of gamma c, suggesting that overlapping residues are involved in IL-9R alpha homodimerization and IL-9R alpha/gamma c heterodimerization. Co-expression of wild-type JAK3 partially reverted the inhibition by gamma c, indicating that JAK3 cooperates with JAK1 mutants within the IL-9 receptor complex. Similar results were observed with IL-2R beta. Taken together, our results show that IL-9R alpha and IL-2R beta homodimers efficiently mediate constitutive activation of ALL-associated JAK1 mutants.	[Hornakova, Tekla; Staerk, Judith; Royer, Yohan; Constantinescu, Stefan N.; Knoops, Laurent; Renauld, Jean-Christophe] Univ Catholique Louvain, Ludwig Inst Canc Res, Brussels Branch, B-1200 Brussels, Belgium; [Hornakova, Tekla; Staerk, Judith; Royer, Yohan; Constantinescu, Stefan N.; Knoops, Laurent; Renauld, Jean-Christophe] Univ Catholique Louvain, Duve Inst, B-1200 Brussels, Belgium; [Flex, Elisabetta; Tartaglia, Marco] Ist Super Sanita, I-00161 Rome, Italy; [Knoops, Laurent] Clin Univ St Luc, Div Hematol, B-1200 Brussels, Belgium	Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; Istituto Superiore di Sanita (ISS); Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Renauld, JC (corresponding author), Univ Catholique Louvain, Ludwig Inst Canc Res, Brussels Branch, Ave Hippocrate 74, B-1200 Brussels, Belgium.	renauld@bru.licr.org	Tartaglia, Marco/K-2955-2018; Constantinescu, Stefan N/E-5277-2012; Flex, Elisabetta/A-5958-2017; Renauld, Jean-Christophe/B-7268-2012	Tartaglia, Marco/0000-0001-7736-9672; Flex, Elisabetta/0000-0002-6802-1356; Constantinescu, Stefan N./0000-0002-8599-2699; Renauld, Jean-Christophe/0000-0003-1736-2131; Staerk, Judith/0000-0001-8698-6998	Belgian State, Prime Minister's Office, Science Policy Programming; Actions de Recherche Concertees of the Communaute Francaise de Belgique; Foundation Salus Sanguinis; Atlantic Philanthropies/Ludwig Institute for Cancer Research Ltd. Clinical Discovery Program; operation Televie	Belgian State, Prime Minister's Office, Science Policy Programming; Actions de Recherche Concertees of the Communaute Francaise de Belgique; Foundation Salus Sanguinis; Atlantic Philanthropies/Ludwig Institute for Cancer Research Ltd. Clinical Discovery Program; operation Televie	This work was supported in part by the Belgian Programme on Interuniversity Poles of Attraction initiated by the Belgian State, Prime Minister's Office, Science Policy Programming, by the Actions de Recherche Concertees of the Communaute Francaise de Belgique, by Foundation Salus Sanguinis, Atlantic Philanthropies/Ludwig Institute for Cancer Research Ltd. Clinical Discovery Program, and the operation Televie.	Baba H, 2002, EUR J HAEMATOL, V68, P362, DOI 10.1034/j.1600-0609.2002.00653.x; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; Demoulin JB, 2000, CANCER RES, V60, P3971; Demoulin JB, 1996, MOL CELL BIOL, V16, P4710; DRUEZ C, 1990, J IMMUNOL, V145, P2494; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Fischer M, 2003, LEUKEMIA, V17, P2513, DOI 10.1038/sj.leu.2403123; Flex E, 2008, J EXP MED, V205, P751, DOI 10.1084/jem.20072182; Gerland K, 2000, MOL CELL ENDOCRINOL, V168, P1, DOI 10.1016/S0303-7207(00)00314-2; Haan C, 2001, J BIOL CHEM, V276, P37451, DOI 10.1074/jbc.M106135200; Hideshima T, 2004, BLOOD, V104, P607, DOI 10.1182/blood-2004-01-0037; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jeong EG, 2008, CLIN CANCER RES, V14, P3716, DOI 10.1158/1078-0432.CCR-07-4839; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; KAWAMURA M, 1994, P NATL ACAD SCI USA, V91, P6374, DOI 10.1073/pnas.91.14.6374; KELLEHER K, 1991, BLOOD, V77, P1436; Knoops L, 2004, GROWTH FACTORS, V22, P207, DOI 10.1080/08977190410001720879; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Liu XD, 2000, ANAL BIOCHEM, V280, P20, DOI 10.1006/abio.2000.4478; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; Lu XH, 2008, J BIOL CHEM, V283, P5258, DOI 10.1074/jbc.M707125200; Malka Y, 2008, J BIOL CHEM, V283, P33569, DOI 10.1074/jbc.M803125200; MERZ H, 1991, BLOOD, V78, P1311; NAKARAI T, 1994, J EXP MED, V180, P241, DOI 10.1084/jem.180.1.241; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; Peelman F, 2006, J BIOL CHEM, V281, P15496, DOI 10.1074/jbc.M512622200; RENAULD JC, 1992, P NATL ACAD SCI USA, V89, P5690, DOI 10.1073/pnas.89.12.5690; RENAULD JC, 1994, ONCOGENE, V9, P1327; RENAULD JC, 1995, BLOOD, V85, P1300, DOI 10.1182/blood.V85.5.1300.bloodjournal8551300; Saharinen P, 2000, MOL CELL BIOL, V20, P3387, DOI 10.1128/MCB.20.10.3387-3395.2000; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; UYTTENHOVE C, 1991, J EXP MED, V173, P519, DOI 10.1084/jem.173.2.519; Vainchenker William, 2005, Hematology Am Soc Hematol Educ Program, P195; VINK A, 1993, EUR J IMMUNOL, V23, P1134, DOI 10.1002/eji.1830230523; Walters DK, 2006, CANCER CELL, V10, P65, DOI 10.1016/j.ccr.2006.06.002; Wernig G, 2008, BLOOD, V111, P3751, DOI 10.1182/blood-2007-07-102186	41	57	60	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6773	6781		10.1074/jbc.M807531200	http://dx.doi.org/10.1074/jbc.M807531200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19139102	hybrid, Green Published			2022-12-25	WOS:000263919000022
J	Zhang, Y; Inouye, M				Zhang, Yonglong; Inouye, Masayori			The Inhibitory Mechanism of Protein Synthesis by YoeB, an Escherichia coli Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; TRANSLATION INITIATION; RIBONUCLEIC ACID; STRUCTURAL BASIS; TOLUENE; SITE; RIBOSOMES; CLEAVAGE; BACTERIA; BINDING	YoeB is a toxin encoded by the yefM-yoeB antitoxin-toxin operon in the Escherichia coli genome. Here we show that YoeB, a highly potent protein synthesis inhibitor, specifically blocks translation initiation. In in vivo primer extension experiments using two different mRNAs, a major band was detected after YoeB induction at three bases downstream of the initiation codon at 2.5 min. An identical band was also detected in in vitro toeprinting experiments after the addition of YoeB to the reaction mixtures containing 70 S ribosomes and the same mRNAs, even in the absence of tRNA(f)(Met). Notably, this band was not detected in the presence of YoeB alone, indicating that YoeB by itself does not have endoribonuclease activity under the conditions used. The 70 S ribosomes increased upon YoeB induction, and YoeB was found to be specifically associated with 50 S subunits. Using tetracycline and hygromycin B, we demonstrated that YoeB binds to the 50 S ribosomal subunit in 70 S ribosomes and interacts with the A site leading to mRNA cleavage at this site. As a result, the 3'-end portion of the mRNA was released from ribosomes, and translation initiation was effectively inhibited. These results demonstrate that YoeB primarily inhibits translation initiation.	[Zhang, Yonglong; Inouye, Masayori] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Inouye, M (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.	inouye@umdnj.edu			National Institutes of Health [RO1GM081567]; Takara Bio Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takara Bio Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant RO1GM081567 and by a grant from Takara Bio Inc.	Aoki H, 2002, ANTIMICROB AGENTS CH, V46, P1080, DOI 10.1128/AAC.46.4.1080-1085.2002; Baker KE, 2003, MOL MICROBIOL, V47, P75, DOI 10.1046/j.1365-2958.2003.03292.x; Brandi L, 2006, P NATL ACAD SCI USA, V103, P39, DOI 10.1073/pnas.0507740102; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Cherny I, 2004, J BIOL CHEM, V279, P8252, DOI 10.1074/jbc.M308263200; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Du HS, 1998, J BIOL CHEM, V273, P20494, DOI 10.1074/jbc.273.32.20494; HALEGOUA S, 1976, EUR J BIOCHEM, V69, P163, DOI 10.1111/j.1432-1033.1976.tb10869.x; HALEGOUA S, 1976, J BACTERIOL, V126, P183, DOI 10.1128/JB.126.1.183-191.1976; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; Hesterkamp T, 1997, J BIOL CHEM, V272, P21865, DOI 10.1074/jbc.272.35.21865; Moll I, 2002, BIOCHEM BIOPH RES CO, V297, P1021, DOI 10.1016/S0006-291X(02)02333-1; MOSES RE, 1970, P NATL ACAD SCI USA, V67, P674, DOI 10.1073/pnas.67.2.674; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; PETERSON RL, 1971, J BACTERIOL, V107, P585, DOI 10.1128/JB.107.2.585-588.1971; RAJBHANDARY UL, 1969, J BIOL CHEM, V244, P1104; SARMIENTOS P, 1983, CELL, V32, P1337, DOI 10.1016/0092-8674(83)90314-8; Swaney SM, 1998, ANTIMICROB AGENTS CH, V42, P3251, DOI 10.1128/AAC.42.12.3251; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; Vila-Sanjurjo A, 2004, NAT STRUCT MOL BIOL, V11, P1054, DOI 10.1038/nsmb850; Zhang JJ, 2002, J BACTERIOL, V184, P5323, DOI 10.1128/JB.184.19.5323-5329.2002; Zhang YL, 2005, J BIOL CHEM, V280, P26080, DOI 10.1074/jbc.M502050200; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	24	80	83	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6627	6638		10.1074/jbc.M808779200	http://dx.doi.org/10.1074/jbc.M808779200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19124462	hybrid, Green Published			2022-12-25	WOS:000263919000007
J	Mukherjee, A; Morosky, SA; Shen, L; Weber, CR; Turner, JR; Kim, KS; Wang, TY; Coyne, CB				Mukherjee, Amitava; Morosky, Stefanie A.; Shen, Le; Weber, Christopher R.; Turner, Jerrold R.; Kim, Kwang Sik; Wang, Tianyi; Coyne, Carolyn B.			Retinoic Acid-induced Gene-1 (RIG-I) Associates with the Actin Cytoskeleton via Caspase Activation and Recruitment Domain-dependent Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTESTINAL EPITHELIAL-CELLS; RECEPTOR-RELATED PROTEIN-1; HEPATITIS-C VIRUS; TIGHT JUNCTIONS; POLIOVIRUS RECEPTOR; ADAPTER PROTEIN; ENTRY; RECOGNITION; MEDIATOR	The actin cytoskeleton serves as a barrier that protects mammalian cells from environmental pathogens such as bacteria, fungi, and viruses. Several components of antimicrobial signaling pathways have been shown to associate directly with the actin cytoskeleton, indicating that the cytoskeleton may also serve as a platform for immune-associated molecules. Here we report that retinoic acid-induced gene-I (RIG-I), an important viral RNA recognition molecule, is associated with the actin cytoskeleton and localizes predominantly to actin-enriched membrane ruffles in non-polarized epithelial cells. Subcellular localization and fractionation experiments revealed that the association between RIG-I and the actin cytoskeleton was mediated by its N-terminal caspase activation and recruitment domains (CARDs), which were necessary and sufficient to induce cytoskeletal association. We also show that RIG-I plays a role in cellular migration, as ectopic expression of RIG-I enhanced cellular migration in a wound healing assay and depletion of endogenous RIG-I significantly reduced wound healing. We further show that in both cultured intestinal epithelial cells (IEC) and human colon and small intestine biopsies, RIG-I is enriched at apico-lateral cell junctions and colocalizes with markers of the tight junction. Depolymerization of the actin cytoskeleton in polarized IEC led to the rapid relocalization of RIG-I and to the induction of type I interferon signaling. These data provide evidence that RIG-I is associated with the actin cytoskeleton in non-polarized epithelial cells and with the junctional complex in polarized IECs and human intestine and colon biopsies and may point to a physiological role for RIG-I in the regulation of cellular migration.	[Mukherjee, Amitava; Morosky, Stefanie A.; Coyne, Carolyn B.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Wang, Tianyi] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Shen, Le; Weber, Christopher R.; Turner, Jerrold R.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Kim, Kwang Sik] Johns Hopkins Univ, Sch Med, Div Pediat Infect Dis, Baltimore, MD 21287 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Chicago; Johns Hopkins University	Coyne, CB (corresponding author), S313 Biomed Sci Tower,3500 Terrace St, Pittsburgh, PA 15261 USA.	coynec2@pitt.edu	Turner, Jerrold/H-1502-2019; Mukherjee, Amitava/AAK-4002-2020; Shen, Le/E-7866-2010; Turner, Jerrold R/A-6895-2009	Mukherjee, Amitava/0000-0001-5603-5147; Turner, Jerrold R/0000-0003-0627-9455; Weber, Christopher/0000-0002-2117-3184	University of Pittsburgh School of Medicine, Dept. of Cell Biology and Physiology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK067887, R01DK061931, R56DK094954, R01DK068271] Funding Source: NIH RePORTER	University of Pittsburgh School of Medicine, Dept. of Cell Biology and Physiology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by faculty development funding from the University of Pittsburgh School of Medicine, Dept. of Cell Biology and Physiology. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Are AF, 2000, EXP CELL RES, V256, P533, DOI 10.1006/excr.2000.4830; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Coyne CB, 2004, J BIOL CHEM, V279, P48079, DOI 10.1074/jbc.M409061200; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hershberg RM, 2002, AM J PHYSIOL-GASTR L, V283, pG833, DOI 10.1152/ajpgi.00208.2002; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Krummenacher C, 1998, J VIROL, V72, P7064, DOI 10.1128/JVI.72.9.7064-7074.1998; Kustermans G, 2005, BIOCHEM J, V387, P531, DOI 10.1042/BJ20041318; Legrand-Poels S, 2007, J CELL SCI, V120, P1299, DOI 10.1242/jcs.03424; Li JY, 2008, J CELL BIOL, V181, P321, DOI 10.1083/jcb.200711082; Li JY, 2007, NAT CELL BIOL, V9, P276, DOI 10.1038/ncb1541; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Mattagajasingh SN, 2000, J BIOL CHEM, V275, P30573, DOI 10.1074/jbc.M004578200; McDonald C, 2005, J BIOL CHEM, V280, P40301, DOI 10.1074/jbc.M508538200; MCNEIL PL, 2001, TURR PROTOC CELL BIO; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mitic LL, 1998, ANNU REV PHYSIOL, V60, P121, DOI 10.1146/annurev.physiol.60.1.121; Nemeth ZH, 2004, J CELL PHYSIOL, V200, P71, DOI 10.1002/jcp.10477; NUSRAT A, 1995, P NATL ACAD SCI USA, V92, P10629, DOI 10.1073/pnas.92.23.10629; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Wang Y, 2007, CELL RES, V17, P858, DOI 10.1038/cr.2007.81; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang NN, 2008, P NATL ACAD SCI USA, V105, P10553, DOI 10.1073/pnas.0804895105	35	42	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6486	6494		10.1074/jbc.M807547200	http://dx.doi.org/10.1074/jbc.M807547200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19122199	hybrid, Green Published			2022-12-25	WOS:000263742700051
J	Uemura, T; Shiozaki, K; Yamaguchi, K; Miyazaki, S; Satomi, S; Kato, K; Sakuraba, H; Miyagi, T				Uemura, T.; Shiozaki, K.; Yamaguchi, K.; Miyazaki, S.; Satomi, S.; Kato, K.; Sakuraba, H.; Miyagi, T.			Contribution of sialidase NEU1 to suppression of metastasis of human colon cancer cells through desialylation of integrin beta 4	ONCOGENE			English	Article						sialidase; integrin beta 4; sialic acid; metastasis; invasion; MMP-7	MEMBRANE-ASSOCIATED SIALIDASE; TYPE-1 MATRIX-METALLOPROTEINASE; PLASMA-MEMBRANE; LYSOSOMAL SIALIDASE; APOPTOSIS SUPPRESSION; COLORECTAL-CANCER; GLYCOSYLATION; EXPRESSION; PROGRESSION; LAMININ-5	We previously found an inverse relationship between sialidase Neu1 expression and metastatic potential of murine cancer cells. To elucidate the mechanism underlying the cellular events, the human sialidase gene NEU1 was overexpressed or silenced in colon cancer HT-29 cells. When NEU1-overexpressing cells were injected transsplenically into mice, in vivo liver metastasis was significantly reduced. NEU1 suppressed cell migration, invasion and adhesion in vitro, whereas the silencing resulted in the opposite. One of the major molecular changes by NEU1 was decreased sialylation of integrin beta 4, assessed by PNA- and MAL-II-lectin blotting of immunoprecipitates with anti-integrin beta 4 antibody. The desialylation was accompanied by decreased phosphorylation of the integrin followed by attenuation of focal adhesion kinase and Erk1/2 pathway. Moreover, NEU1 caused downregulation of matrix metalloproteinase-7, overexpression of which is associated with cancer metastasis. Treatment of the cells with GalNAc-alpha-O-benzyl, an inhibitor of O-glycosylation, showed increased PNA-positive integrin beta 4 with its decreased phosphorylation, indicating that sialic acid removal from the integrin O-glycans results in the decreased phosphorylation. Biotinylation and immunofluorescence staining exhibited some NEU1 molecules to be at the cell surface accessible to the integrin. These results suggest that NEU1 is important in regulation of integrin beta 4-mediated signaling, leading to suppression of metastasis.	[Uemura, T.; Shiozaki, K.; Yamaguchi, K.; Kato, K.; Miyagi, T.] Miyagi Canc Ctr, Res Inst, Div Biochem, Natori, Miyagi 9811293, Japan; [Uemura, T.; Shiozaki, K.; Yamaguchi, K.; Kato, K.; Miyagi, T.] JST, CREST, Kawaguchi, Saitama, Japan; [Uemura, T.; Miyazaki, S.; Satomi, S.] Tohoku Univ, Grad Sch Med, Dept Adv Surg Sci & Technol, Sendai, Miyagi 980, Japan; [Sakuraba, H.] Meiji Pharmaceut Univ, Dept Analyt Biochem, Tokyo, Japan	Miyagi Cancer Center; Japan Science & Technology Agency (JST); Tohoku University; Meiji Pharmaceutical University	Miyagi, T (corresponding author), Miyagi Canc Ctr, Res Inst, Div Biochem, 47-1 Nodayama, Natori, Miyagi 9811293, Japan.	miyagi-ta173@pref.miyagi.jp		Shiozaki, Kazuhiro/0000-0002-0523-838X	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We appreciate the expert technical assistance of Ms Setsuko Moriya. This study was supported in part by Grants-in-Aid for Scientific Research on Priority Areas Cancer from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; Duca L, 2007, J BIOL CHEM, V282, P12484, DOI 10.1074/jbc.M609505200; Fukushima Y, 1998, INT J CANCER, V76, P63, DOI 10.1002/(SICI)1097-0215(19980330)76:1<63::AID-IJC11>3.0.CO;2-H; GALJART NJ, 1988, CELL, V54, P755, DOI 10.1016/S0092-8674(88)90999-3; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Giannelli G, 2002, CLIN EXP METASTAS, V19, P217, DOI 10.1023/A:1015579204607; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Hinek A, 2006, J BIOL CHEM, V281, P3698, DOI 10.1074/jbc.M508736200; Huet G, 1998, J CELL BIOL, V141, P1311, DOI 10.1083/jcb.141.6.1311; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kakugawa Y, 2002, P NATL ACAD SCI USA, V99, P10718, DOI 10.1073/pnas.152597199; Kato K, 2006, BIOCHEM J, V394, P647, DOI 10.1042/BJ20050737; Kato T, 2001, INT J CANCER, V92, P797, DOI 10.1002/ijc.1268; Koshikawa N, 2005, J BIOL CHEM, V280, P88, DOI 10.1074/jbc.M411824200; LI K, 1992, J CHROMATOGR-BIOMED, V579, P209, DOI 10.1016/0378-4347(92)80384-3; Liang F, 2006, J BIOL CHEM, V281, P27526, DOI 10.1074/jbc.M605633200; Lohi J, 2001, INT J CANCER, V94, P763, DOI 10.1002/ijc.1539; Mimori K, 2004, CLIN CANCER RES, V10, P8243, DOI 10.1158/1078-0432.CCR-04-0849; Miyagi T, 2003, GLYCOCONJUGATE J, V20, P189, DOI 10.1023/B:GLYC.0000024250.48506.bf; MIYAGI T, 1984, EUR J BIOCHEM, V141, P75, DOI 10.1111/j.1432-1033.1984.tb08159.x; MIYAGI T, 1994, FEBS LETT, V349, P255, DOI 10.1016/0014-5793(94)00682-2; Miyagi T., 2007, COMPREHENSIVE GLYCOS, V3, P297; Miyagi T, 2008, BBA-GEN SUBJECTS, V1780, P532, DOI 10.1016/j.bbagen.2007.09.016; Monti E, 2002, NEUROCHEM RES, V27, P649, DOI 10.1023/A:1020276000901; Remacle AG, 2006, J BIOL CHEM, V281, P16897, DOI 10.1074/jbc.M600295200; Remy L, 2006, CANCER RES, V66, P11228, DOI 10.1158/0008-5472.CAN-06-1187; Sawada M, 2002, INT J CANCER, V97, P180, DOI 10.1002/ijc.1598; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Shiomi T, 2003, CANCER METAST REV, V22, P145, DOI 10.1023/A:1023039230052; TRAINER DL, 1998, INT J CANCER, V41, P287; Ueno S, 2006, J BIOL CHEM, V281, P7756, DOI 10.1074/jbc.M509668200; Wu YI, 2004, J BIOL CHEM, V279, P8278, DOI 10.1074/jbc.M311870200; Xia YP, 1996, J CELL BIOL, V132, P727, DOI 10.1083/jcb.132.4.727; Yamaguchi K, 2005, BIOCHEM J, V390, P85, DOI 10.1042/BJ20050017; Zeng ZS, 2002, CLIN CANCER RES, V8, P144	35	138	143	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 5	2009	28	9					1218	1229		10.1038/onc.2008.471	http://dx.doi.org/10.1038/onc.2008.471			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	415AH	19151752				2022-12-25	WOS:000263906200006
J	Gonzalez, L; Zambrano, A; Lazaro-Trueba, I; Lopez, E; Gonzalez, JJA; Martin-Perez, J; Aranda, A				Gonzalez, L.; Zambrano, A.; Lazaro-Trueba, I.; Lopez, E.; Gonzalez, J. J. A.; Martin-Perez, J.; Aranda, A.			Activation of the unliganded estrogen receptor by prolactin in breast cancer cells	ONCOGENE			English	Article						prolactin; estrogen receptor; transcriptional activation; breast cancer cells	CYCLIN D1; C-MYC; MAMMARY-GLAND; GROWTH-FACTOR; PROGESTERONE-RECEPTOR; ENDOCRINE RESISTANCE; HORMONE RECEPTORS; TYROSINE KINASE; GENE-EXPRESSION; IN-VIVO	Both prolactin (PRL) and estrogen (E2) are involved in the pathogenesis and progression of mammary neoplasia, but the mechanisms by which these hormones interact to exert their effects in breast cancer cells are not well understood. We show here that PRL is able to activate the unliganded estrogen receptor (ER). In breast cancer cells, PRL activates a reporter plasmid containing estrogen response elements (EREs) and induces the ER target gene pS2. These actions are blocked by the antagonist ICI 182,780, showing that ER is required for the PRL-mediated effect. Moreover, PRL leads to phosphorylation of ER alpha in serine-118 (P-ER alpha), a modification related to the potentiation of ligand-independent transcriptional activation. In addition, PRL mimics the effect of E2 on target gene expression by inducing cyclical recruitment of ER alpha and P-ER alpha to ERE-containing promoters, resulting in recruitment of co-activators and acetylation of histone H3. Finally, PRL induces expression of c-Myc and Cyclin D1 and leads to increased cell proliferation, which is specifically antagonized by ICI 182,780 or ERa depletion. These results show that ligand-independent ER alpha activation appears to be an important component of the proliferative and transcriptional actions of PRL in breast cancer cells.	[Martin-Perez, J.; Aranda, A.] CSIC, Inst Invest Biomed, E-28029 Madrid, Spain; Univ Autonoma Madrid, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid	Martin-Perez, J (corresponding author), CSIC, Inst Invest Biomed, Arturo Duperier 4, E-28029 Madrid, Spain.	jmartin@iib.uam.es; aaranda@iib.uam.es	Zambrano, Alberto/A-1580-2013; Aranda, Ana/ABG-8820-2020; Zambrano, Alberto/Q-6188-2019; Martin-Perez, Jorge/A-3522-2008	Zambrano, Alberto/0000-0001-5677-2999; Aranda, Ana/0000-0002-8338-9589; Zambrano, Alberto/0000-0001-5677-2999; Martin-Perez, Jorge/0000-0002-2292-0057; Gonzalez, Lorena/0000-0002-0575-7833	Ministerio de Educacion y Ciencia [SAF2006-00371, BFU2007-62402]; Fondo de Investigaciones Sanitarias [RD06/0020/0036, PIO40682]; Fundacion MMA; CRESCENDO [FP6-018652]	Ministerio de Educacion y Ciencia(Spanish Government); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fundacion MMA; CRESCENDO(European Commission)	This work was supported by grants SAF2006-00371 and BFU2007-62402 from the Ministerio de Educacion y Ciencia, RD06/0020/0036 and PIO40682 from the Fondo de Investigaciones Sanitarias, by a grant from the Fundacion MMA and by the EU Project CRESCENDO (FP6-018652).	Acosta JJ, 2003, MOL ENDOCRINOL, V17, P2268, DOI 10.1210/me.2002-0422; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Bourdeau V, 2004, MOL ENDOCRINOL, V18, P1411, DOI 10.1210/me.2003-0441; Brockman JL, 2002, MOL ENDOCRINOL, V16, P774, DOI 10.1210/me.16.4.774; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Butt AJ, 2005, ENDOCR-RELAT CANCER, V12, pS47, DOI 10.1677/erc.1.00993; CAMPBELL GS, 1994, P NATL ACAD SCI USA, V91, P5232, DOI 10.1073/pnas.91.12.5232; Carroll JS, 2002, CANCER RES, V62, P3126; Chen DS, 2002, ONCOGENE, V21, P4921, DOI 10.1038/sj.onc.1205420; Chen DS, 2000, MOL CELL, V6, P127, DOI 10.1016/S1097-2765(00)00014-9; CLEVENGER CV, 1995, AM J PATHOL, V146, P695; Clevenger CV, 2003, ENDOCR REV, V24, P1, DOI 10.1210/er.2001-0036; Dong J, 2006, J BIOL CHEM, V281, P18825, DOI 10.1074/jbc.M512826200; Eeckhoute J, 2006, GENE DEV, V20, P2513, DOI 10.1101/gad.1446006; FABRIS G, 1987, J STEROID BIOCHEM, V27, P171, DOI 10.1016/0022-4731(87)90307-4; Fowler AM, 2004, FASEB J, V18, P81, DOI 10.1096/fj.03-0038com; FUH G, 1995, J BIOL CHEM, V270, P13133, DOI 10.1074/jbc.270.22.13133; GINSBURG E, 1995, CANCER RES, V55, P2591; Gutzman JH, 2005, MOL ENDOCRINOL, V19, P1765, DOI 10.1210/me.2004-0339; Gutzman JH, 2004, MOL ENDOCRINOL, V18, P3064, DOI 10.1210/me.2004-0187; Gutzman JH, 2004, J STEROID BIOCHEM, V88, P69, DOI 10.1016/j.jsbmb.2003.10.008; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Holst F, 2007, NAT GENET, V39, P655, DOI 10.1038/ng2006; JOHNSTON SRD, 1995, CANCER RES, V55, P3331; Jonas BA, 2004, J BIOL CHEM, V279, P54676, DOI 10.1074/jbc.M410128200; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Likhite VS, 2006, MOL ENDOCRINOL, V20, P3120, DOI 10.1210/me.2006-0068; Lipfert L, 2006, MOL ENDOCRINOL, V20, P516, DOI 10.1210/me.2005-0190; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; McNeil CM, 2006, J STEROID BIOCHEM, V102, P147, DOI 10.1016/j.jsbmb.2006.09.028; Medunjanin S, 2005, J BIOL CHEM, V280, P33006, DOI 10.1074/jbc.M506758200; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; Murphy L, 2004, CLIN CANCER RES, V10, P1354, DOI 10.1158/1078-0432.CCR-03-0112; Murphy LC, 2006, J STEROID BIOCHEM, V102, P139, DOI 10.1016/j.jsbmb.2006.09.021; MURPHY LJ, 1984, CANCER RES, V44, P1963; MUSGROVE EA, 1994, P NATL ACAD SCI USA, V91, P8022, DOI 10.1073/pnas.91.17.8022; MUSGROVE EA, 1993, MOL CELL BIOL, V13, P3577, DOI 10.1128/MCB.13.6.3577; Neilson LM, 2007, MOL ENDOCRINOL, V21, P2218, DOI 10.1210/me.2007-0173; NUNEZ AM, 1989, EMBO J, V8, P823, DOI 10.1002/j.1460-2075.1989.tb03443.x; Ormandy CJ, 1997, J CLIN ENDOCR METAB, V82, P3692, DOI 10.1210/jc.82.11.3692; Park KJ, 2005, MOL CELL, V18, P71, DOI 10.1016/j.molcel.2005.03.006; Reynolds C, 1997, ENDOCRINOLOGY, V138, P5555, DOI 10.1210/en.138.12.5555; Santos MDL, 2007, ENDOCR-RELAT CANCER, V14, P1021, DOI 10.1677/ERC-07-0144; Schroeder MD, 2002, MOL ENDOCRINOL, V16, P45, DOI 10.1210/me.16.1.45; SHAFIE S, 1977, CANCER RES, V37, P792; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Touraine P, 1998, J CLIN ENDOCR METAB, V83, P667, DOI 10.1210/jc.83.2.667; Tworoger SS, 2006, CANCER LETT, V243, P160, DOI 10.1016/j.canlet.2006.01.032; Vicent GP, 2006, MOL CELL, V24, P367, DOI 10.1016/j.molcel.2006.10.011; Wang Y, 2007, CANCER RES, V67, P3698, DOI 10.1158/0008-5472.CAN-06-4000; Weitsman GE, 2006, CANCER RES, V66, P10162, DOI 10.1158/0008-5472.CAN-05-4111; Wijayaratne AL, 2001, J BIOL CHEM, V276, P35684, DOI 10.1074/jbc.M101097200; Wu RC, 2005, ENDOCR REV, V26, P393, DOI 10.1210/er.2004-0018; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776	57	51	56	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	10					1298	1308		10.1038/onc.2008.473	http://dx.doi.org/10.1038/onc.2008.473			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	417ZC	19169277	Green Submitted			2022-12-25	WOS:000264116000002
J	Morioka, Y; Monypenny, J; Matsuzaki, T; Shi, S; Alexander, DB; Kitayama, H; Noda, M				Morioka, Y.; Monypenny, J.; Matsuzaki, T.; Shi, S.; Alexander, D. B.; Kitayama, H.; Noda, M.			The membrane-anchored metalloproteinase regulator RECK stabilizes focal adhesions and anterior-posterior polarity in fibroblasts	ONCOGENE			English	Article						cell adhesion; AP polarity; chemotaxis; MMPs; RAS; fibronectin	CELL-MIGRATION; MATRIX-METALLOPROTEINASE; RHO-GTPASES; FIBRONECTIN; BINDING; PROTEIN; FIBRILLOGENESIS; CYTOSKELETON; CHEMOTAXIS; MOTILITY	Accumulating evidence indicates that Reversion-inducing cysteine-rich protein with Kazal motifs (RECK), a membrane-anchored matrix metalloproteinase regulator, plays crucial roles in mammalian development and tumor suppression. Its mechanisms of action at the single cell level, however, remain largely unknown. In mouse fibroblasts, RECK is abundant around the perinuclear region, membrane ruffles and cell surface. Cells lacking Reck show decreased spreading, ambiguous anterior-posterior (AP) polarity, and increased speed and decreased directional persistence in migration; these characteristics are also found in transformed fibroblasts and fibrosarcoma cells with low RECK expression. RECK-deficient cells fail to form discrete focal adhesions, have increased levels of GTP-bound Rac1 and Cdc42, and a marked decrease in the level of detyrosinated tubulin, a hallmark of stabilized microtubules. RECK-deficient cells also show elevated gelatinolytic activity and decreased fibronectin fibrils. The phenotype of RECK-deficient cells is largely suppressed when the cells are plated on fibronectin-coated substrates. These findings suggest that RECK regulates pericellular extracellular matrix degradation, thereby allowing the cells to form proper cell-substrate adhesions and to maintain AP polarity during migration; this mechanism is compromised in malignant cells.	[Morioka, Y.; Matsuzaki, T.; Shi, S.; Kitayama, H.; Noda, M.] Kyoto Univ, Grad Sch Med, Dept Mol Oncol, Sakyo Ku, Kyoto 6068501, Japan; [Monypenny, J.] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Sakyo Ku, Kyoto 6068501, Japan; [Shi, S.] Harbin Inst Technol, Dept Life Sci & Engn, Harbin 150006, Peoples R China; [Alexander, D. B.] Nagoya City Univ, Grad Sch Med Sci, Dept Mol Toxicol, Mizuho Ku, Nagoya, Aichi, Japan	Kyoto University; Kyoto University; Harbin Institute of Technology; Nagoya City University	Noda, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Mol Oncol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	mnoda@virus.kyoto-u.ac.jp			JSPS; MEXT	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We are grateful to Dr Susan Creig for the GFP-vinculin expression vector, to Drs Shuh Narumiya, Alicia Arroyo and Motoharu Seiki for critical reading of the paper, and to the anonymous reviewer for suggesting the use of GM130 for analysing cell polarity. We also thank Emi Nishimoto, Takashi Kawai, Aiko Nishimoto and Aki Miyazaki for their technical and secretarial assistance, Akira Omura for his technical advice and So-ichiro Noda for his help in data analysis. This work was supported by JSPS Grant-in-Aid for Creative Scientific Research and MEXT Grant-in-Aid on Priority Areas.	Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Arora PD, 2003, EXP CELL RES, V286, P366, DOI 10.1016/S0014-4827(03)00096-X; Auge F, 2003, BIOORG MED CHEM LETT, V13, P1783, DOI 10.1016/S0960-894X(03)00214-2; COUTU MD, 1988, P NATL ACAD SCI USA, V85, P8535, DOI 10.1073/pnas.85.22.8535; Dunn G A, 1983, Agents Actions Suppl, V12, P14; Echizenya M, 2005, ONCOGENE, V24, P5850, DOI 10.1038/sj.onc.1208733; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; Kawashima S, 2008, J NEUROCHEM, V104, P376, DOI 10.1111/j.1471-4159.2007.04977.x; Kondo S, 2007, J CELL SCI, V120, P849, DOI 10.1242/jcs.03388; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Mellor H, 2004, CURR BIOL, V14, pR434, DOI 10.1016/j.cub.2004.05.038; Miki T, 2007, J BIOL CHEM, V282, P12341, DOI 10.1074/jbc.M610948200; Muraguchi T, 2007, NAT NEUROSCI, V10, P838, DOI 10.1038/nn1922; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NODA M, 1983, P NATL ACAD SCI-BIOL, V80, P5602, DOI 10.1073/pnas.80.18.5602; Noda M, 2003, CANCER METAST REV, V22, P167, DOI 10.1023/A:1023043315031; Noda M, 2007, CANCER SCI, V98, P1659, DOI 10.1111/j.1349-7006.2007.00588.x; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Sieg DJ, 1999, J CELL SCI, V112, P2677; Simizu S, 2005, CANCER RES, V65, P7455, DOI 10.1158/0008-5472.CAN-04-4446; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; Takino T, 2006, EXP CELL RES, V312, P1381, DOI 10.1016/j.yexcr.2006.01.008; Wittmann T, 2001, J CELL SCI, V114, P3795; ZICHA D, 1991, J CELL SCI, V99, P769	30	38	39	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	11					1454	1464		10.1038/onc.2008.486	http://dx.doi.org/10.1038/onc.2008.486			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	421JE	19169281	Green Submitted			2022-12-25	WOS:000264354400006
J	Ragone, G; Bresin, A; Piermarini, F; Lazzeri, C; Picchio, MC; Remotti, D; Kang, SM; Cooper, MD; Croce, CM; Narducci, MG; Russo, G				Ragone, G.; Bresin, A.; Piermarini, F.; Lazzeri, C.; Picchio, M. C.; Remotti, D.; Kang, S-M; Cooper, M. D.; Croce, C. M.; Narducci, M. G.; Russo, G.			The Tcl1 oncogene defines secondary hair germ cells differentiation at catagen-telogen transition and affects stem-cell marker CD34 expression	ONCOGENE			English	Article						Tcl1; hair follicle; bulge cells; secondary hair germ cells; stem-cells; transient-amplifying cells	CHRONIC LYMPHOCYTIC-LEUKEMIA; LABEL-RETAINING CELLS; T-CELL; SELF-RENEWAL; COMPREHENSIVE GUIDE; MOUSE; SKIN; GENE; DISTINCT; CLASSIFICATION	Overexpression of the TCL1 gene family plays a role in the onset of T-cell leukemias in mice and in humans. The Tcl1 gene is tightly regulated during early embryogenesis in which it participates in embryonic stem (ES)-cells proliferation and during lymphoid differentiation. Here, we provide evidences that Tcl1 is also important in mouse hair follicle (HF) and skin homeostasis. We found that Tcl1(-/-) adult mice exhibit hair loss, leading to alopecia with extensive skin lesions. By analysing Tcl1 expression in the wild-type (wt) skin through different stages of hair differentiation, we observe high levels in the secondary hair germ (HG) cells and hair bulges, during early anagen and catagen-telogen transition phases. The loss of Tcl1 does not result in apparent skin morphological defects during embryonic development and at birth, but its absence causes a reduction of proliferation in anagen HFs. Importantly, we show the that absence of Tcl1 induces a significant loss of the stem-cell marker CD34 (but not alpha 6-integrin) expression in the bulge cells, which is necessary to maintain stem-cell characteristics. Therefore, our findings indicate that Tcl1 gene(s) might have important roles in hair formation, by its involvement in cycling and self-renewal of transient amplifying (TA) and stem-cell (SC) populations.	[Ragone, G.; Bresin, A.; Piermarini, F.; Lazzeri, C.; Picchio, M. C.; Narducci, M. G.; Russo, G.] Ist Ricovero & Cura Carattere Sci, Ist Dermopat Immacolata, Mol Oncol Lab, I-167 Rome, Italy; [Remotti, D.] Azienda Osped San Camillo Forlanini, Dept Pathol, Rome, Italy; [Kang, S-M] Emory Univ, Sch Med, Dept Microbiol, Atlanta, GA USA; [Kang, S-M] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA; [Cooper, M. D.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Croce, C. M.] Ohio State Univ, Coll Med, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet,Human Canc Gen, Columbus, OH 43210 USA	IRCCS Istituto Dermopatico dell'Immacolata (IDI); Azienda Ospedaliera San Camillo-Forlanini; Emory University; Emory University; Emory University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Russo, G (corresponding author), Ist Ricovero & Cura Carattere Sci, Ist Dermopat Immacolata, Mol Oncol Lab, Via Monti Creta 104, I-167 Rome, Italy.	russo@idi.it	Narducci, Maria Grazia/L-3093-2018; Young, Richard A/F-6495-2012; bresin, antonella/AAG-7189-2020; Russo, Giandomenico/K-9566-2016	Narducci, Maria Grazia/0000-0002-9066-186X; Young, Richard A/0000-0001-8855-8647; Russo, Giandomenico/0000-0002-7718-9687; Narducci, Maria Grazia/0000-0002-8877-4611; BRESIN, antonella/0000-0003-3954-5481	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Bichi R, 2002, P NATL ACAD SCI USA, V99, P6955, DOI 10.1073/pnas.102181599; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; CHASE HB, 1954, PHYSIOL REV, V34, P113, DOI 10.1152/physrev.1954.34.1.113; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Di-Poi N, 2005, MOL CELL BIOL, V25, P1696, DOI 10.1128/MCB.25.5.1696-1712.2005; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; French SW, 2007, CANCER LETT, V248, P198, DOI 10.1016/j.canlet.2006.07.006; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Glover CH, 2006, PLOS COMPUT BIOL, V2, P1463, DOI 10.1371/journal.pcbi.0020158; Hallas C, 1999, P NATL ACAD SCI USA, V96, P14418, DOI 10.1073/pnas.96.25.14418; Hoyer KK, 2002, P NATL ACAD SCI USA, V99, P14392, DOI 10.1073/pnas.212410199; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kang SM, 2005, BLOOD, V105, P1288, DOI 10.1182/blood-2004-04-1453; Kunstle G, 2002, MOL CELL BIOL, V22, P1513, DOI 10.1128/MCB.22.5.1513-1525.2002; Laine J, 2000, MOL CELL, V6, P395, DOI 10.1016/S1097-2765(00)00039-3; Laine J, 2002, J BIOL CHEM, V277, P3743, DOI 10.1074/jbc.M107069200; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Morris RJ, 1999, J INVEST DERMATOL, V112, P470, DOI 10.1046/j.1523-1747.1999.00537.x; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Murayama K, 2007, ONCOGENE, V26, P4882, DOI 10.1038/sj.onc.1210274; Narducci MG, 1997, CANCER RES, V57, P5452; Narducci MG, 2002, P NATL ACAD SCI USA, V99, P11712, DOI 10.1073/pnas.182412399; Narducci MG, 1997, ONCOGENE, V15, P919, DOI 10.1038/sj.onc.1201246; Narducci MG, 2000, CANCER RES, V60, P2095; Panteleyev AA, 2000, AM J PATHOL, V157, P1071, DOI 10.1016/S0002-9440(10)64621-4; Panteleyev AA, 2001, J CELL SCI, V114, P3419; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; PAUS R, 1994, J INVEST DERMATOL, V103, P143, DOI 10.1111/1523-1747.ep12392542; PAUS R, 1990, BRIT J DERMATOL, V122, P777, DOI 10.1111/j.1365-2133.1990.tb06266.x; PAUS R, 1994, BRIT J DERMATOL, V131, P177; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; RUSSO G, 1988, CELL, V53, P137, DOI 10.1016/0092-8674(88)90495-3; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Takizawa J, 1998, JPN J CANCER RES, V89, P712, DOI 10.1111/j.1349-7006.1998.tb03275.x; Teitell M, 1999, P NATL ACAD SCI USA, V96, P9809, DOI 10.1073/pnas.96.17.9809; Tiede S, 2007, EUR J CELL BIOL, V86, P355, DOI 10.1016/j.ejcb.2007.03.006; Trempus CS, 2007, CANCER RES, V67, P4173, DOI 10.1158/0008-5472.CAN-06-3128; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; VIRGILIO L, 1994, P NATL ACAD SCI USA, V91, P12530, DOI 10.1073/pnas.91.26.12530; Virgilio L, 1998, P NATL ACAD SCI USA, V95, P3885, DOI 10.1073/pnas.95.7.3885; Yang ZZ, 2005, MOL CELL BIOL, V25, P10407, DOI 10.1128/MCB.25.23.10407-10418.2005; Yu H, 2006, AM J PATHOL, V168, P1879, DOI 10.2353/ajpath.2006.051170; Zanesi N, 2006, CANCER RES, V66, P915, DOI 10.1158/0008-5472.CAN-05-3426	46	7	7	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	10					1329	1338		10.1038/onc.2008.489	http://dx.doi.org/10.1038/onc.2008.489			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	417ZC	19169282	Green Published			2022-12-25	WOS:000264116000005
J	Shorning, BY; Zabkiewicz, J; McCarthy, A; Pearson, HB; Winton, DJ; Sansom, OJ; Ashworth, A; Clarke, AR				Shorning, Boris Y.; Zabkiewicz, Joanna; McCarthy, Afshan; Pearson, Helen B.; Winton, Douglas J.; Sansom, Owen J.; Ashworth, Alan; Clarke, Alan R.			Lkb1 Deficiency Alters Goblet and Paneth Cell Differentiation in the Small Intestine	PLOS ONE			English	Article							PEUTZ-JEGHERS-SYNDROME; TUMOR-SUPPRESSOR; NOTCH; EXPRESSION; KINASE; CRE; ACTIVATION; POLARITY; LOCUS; FATE	The Lkb1 tumour suppressor is a multitasking kinase participating in a range of physiological processes. We have determined the impact of Lkb1 deficiency on intestinal homeostasis, particularly focussing on secretory cell differentiation and development since we observe strong expression of Lkb1 in normal small intestine Paneth and goblet cells. We crossed mice bearing an Lkb1 allele flanked with LoxP sites with those carrying a Cyp1a1-specific inducible Cre recombinase. Lkb1 was efficiently deleted from the epithelial cells of the mouse intestine after intraperitoneal injection of the inducing agent beta-naphthoflavone. Bi-allelic loss of Lkb1 led to the perturbed development of Paneth and goblet cell lineages. These changes were characterised by the lack of Delta ligand expression in Lkb1-deficient secretory cells and a significant increase in the levels of the downstream Notch signalling effector Hes5 but not Hes1. Our data show that Lkb1 is required for the normal differentiation of secretory cell lineages within the intestine, and that Lkb1 deficiency modulates Notch signalling modulation in post-mitotic cells.	[Clarke, Alan R.] Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales; [Zabkiewicz, Joanna] Cardiff Univ, Sch Med, Dept Haematol, Cardiff, S Glam, Wales; [McCarthy, Afshan; Ashworth, Alan] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London, England; [Pearson, Helen B.] Peter MacCallum Canc Inst, Res Div, Cell Cycle & Canc Genet Lab, Melbourne, Vic, Australia; [Sansom, Owen J.] Beatson Inst Canc Res, Garscube Estate, Glasgow, Lanark, Scotland; [Winton, Douglas J.] Canc Res UK, Dept Oncol, Cambridge, England	Cardiff University; Cardiff University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Peter Maccallum Cancer Center; Beatson Institute; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Shorning, BY (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales.	clarkear@Cardiff.ac.uk	Clarke, Alan R/A-6256-2008; clarke, alan r/P-2820-2014	Sansom, Owen J./0000-0001-9540-3010; Clarke, Alan/0000-0002-4281-426X; Pearson, Helen/0000-0002-3284-0843	Cancer Research UK; The Wales Gene Park and Breakthrough Breast Cancer	Cancer Research UK(Cancer Research UK); The Wales Gene Park and Breakthrough Breast Cancer	Cancer Research UK, The Wales Gene Park and Breakthrough Breast Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bayraktar J, 2006, J CELL SCI, V119, P711, DOI 10.1242/jcs.02789; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hemminki A, 1997, NAT GENET, V15, P87, DOI 10.1038/ng0197-87; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Katajisto P, 2008, NAT GENET, V40, P455, DOI 10.1038/ng.98; Kemp R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh090; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Marignani PA, 2001, J BIOL CHEM, V276, P32415, DOI 10.1074/jbc.C100207200; Mirouse V, 2007, J CELL BIOL, V177, P387, DOI 10.1083/jcb.200702053; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Pearson HB, 2008, CANCER RES, V68, P2223, DOI 10.1158/0008-5472.CAN-07-5169; Rowan A, 2000, J PATHOL, V192, P203; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sapir A, 2005, DEVELOPMENT, V132, P123, DOI 10.1242/dev.01546; SATOH Y, 1990, J ELECTRON MICR TECH, V16, P69, DOI 10.1002/jemt.1060160109; SELZMAN HM, 1962, J CELL BIOL, V15, P136, DOI 10.1083/jcb.15.1.136; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SPICER SS, 1967, J HISTOCHEM CYTOCHEM, V15, P225, DOI 10.1177/15.4.225; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Tomlinson IPM, 1997, J MED GENET, V34, P1007, DOI 10.1136/jmg.34.12.1007; TROUGHTON WD, 1969, J CELL BIOL, V41, P251, DOI 10.1083/jcb.41.1.251; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wang ZJ, 1999, J PATHOL, V188, P9, DOI 10.1002/(SICI)1096-9896(199905)188:1<9::AID-PATH326>3.0.CO;2-E; Yoo LI, 2002, NAT REV CANCER, V2, P529, DOI 10.1038/nrc843; Zecchini V, 2005, GENE DEV, V19, P1686, DOI 10.1101/gad.341705	34	49	49	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2009	4	1							e4264	10.1371/journal.pone.0004264	http://dx.doi.org/10.1371/journal.pone.0004264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JD	19165340	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000265482400010
J	Johnston, C; Orem, J; Okuku, F; Kalinaki, M; Saracino, M; Katongole-Mbidde, E; Sande, M; Ronald, A; McAdam, K; Huang, ML; Drolette, L; Selke, S; Wald, A; Corey, L; Casper, C				Johnston, Christine; Orem, Jackson; Okuku, Fred; Kalinaki, Mary; Saracino, Misty; Katongole-Mbidde, Edward; Sande, Merle; Ronald, Allan; McAdam, Keith; Huang, Meei-Li; Drolette, Linda; Selke, Stacy; Wald, Anna; Corey, Lawrence; Casper, Corey			Impact of HIV Infection and Kaposi Sarcoma on Human Herpesvirus-8 Mucosal Replication and Dissemination in Uganda	PLOS ONE			English	Article								Introduction: Kaposi sarcoma (KS) is the leading cause of cancer in Uganda and occurs in people with and without HIV. Human herpesvirus-8 (HHV-8) replication is important both in transmission of HHV-8 and progression to KS. We characterized the sites and frequency of HHV-8 detection in Ugandans with and without HIV and KS. Methods: Participants were enrolled into one of four groups on the basis of HIV and KS status (HIV negative/KS negative, HIV positive/KS negative, HIV negative/KS positive, and HIV positive/KS positive). Participants collected oral swabs daily and clinicians collected oral swabs, anogenital swabs, and plasma samples weekly over 4 weeks. HHV-8 DNA at each site was quantified by polymerase chain reaction (PCR). Results: 78 participants collected a total of 2063 orals swabs and 358 plasma samples. Of these, 428 (21%) oral swabs and 96 (27%) plasma samples had detectable HHV-8 DNA. HHV-8 was detected more frequently in both the oropharynx of persons with KS (24 (57%) of 42 persons with KS vs. 8 (22%) of 36 persons without, p = 0.002) and the peripheral blood (30 (71%) of 42 persons with KS vs. 8 (22%) of 36 persons without, p<0.001). In a multivariate model, HHV-8 viremia was more frequent among men (IRR = 3.3, 95% CI = 1.7-6.2, p<0.001), persons with KS (IRR = 3.9, 95% CI = 1.7-9.0, p = 0.001) and persons with HIV infection (IRR= 1.7, 95% CI = 1.0-2.7, p = 0.03). Importantly, oral HHV-8 detection predicted the subsequent HHV-8 viremia. HHV-8 viremia was significantly more common when HHV-8 DNA was detected from the oropharynx during the week prior than when oral HHV-8 was not detected (RR = 3.3, 95% CI = 1.8-5.9 p<0.001). Genital HHV-8 detection was rare (9 (3%) of 272 swabs). Conclusions: HHV-8 detection is frequent in the oropharynx and peripheral blood of Ugandans with endemic and epidemic KS. Replication at these sites is highly correlated, and viremia is increased in men and those with HIV. The high incidence of HHV-8 replication at multiple anatomic sites may be an important factor leading to and sustaining the high prevalence of KS in Uganda.	[Johnston, Christine; Sande, Merle; Wald, Anna; Corey, Lawrence; Casper, Corey] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Saracino, Misty; Huang, Meei-Li; Drolette, Linda; Selke, Stacy; Wald, Anna; Corey, Lawrence] Univ Washington, Seattle, WA 98195 USA; [Wald, Anna; Casper, Corey] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Johnston, Christine; Wald, Anna; Corey, Lawrence; Casper, Corey] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA USA; [Orem, Jackson; Okuku, Fred; Kalinaki, Mary; Katongole-Mbidde, Edward] Makerere Univ, Mulago Hosp, Uganda Canc Inst, Kampala, Uganda; [Katongole-Mbidde, Edward] Uganda Virus Res Inst, Entebbe, Uganda; [Sande, Merle; Ronald, Allan; McAdam, Keith] Makerere Univ, Mulago Hosp, Infect Dis Inst, Kampala, Uganda; [Sande, Merle; Ronald, Allan] Acad Alliance AIDS Care Africa, Kampala, Uganda	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Makerere University; Mulago National Referral Hospital; Uganda Virus Research Institute; Makerere University; Mulago National Referral Hospital	Johnston, C (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	cjohnsto@u.washington.edu	Wald, Anna/B-6272-2012; Corey, Lawrence/AAE-1796-2020	Wald, Anna/0000-0003-3486-6438; Corey, Lawrence/0000-0002-2179-2436; Ronald, Allan/0000-0002-5746-3490; Johnston, Christine/0000-0002-3073-0843	Early Detection Initiative; Fred Hutchinson Cancer Research Center; Joel Meyers Infectious Disease Scholarship; Clinical Scientist Development Award; Doris Duke Charitable Foundation; National Institutes of Health [K23 A154162, K24 A1071113]; National Center for Research Resources [K30 RR022293]; NATIONAL CENTER FOR RESEARCH RESOURCES [K30RR022293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, K23AI079394] Funding Source: NIH RePORTER	Early Detection Initiative; Fred Hutchinson Cancer Research Center; Joel Meyers Infectious Disease Scholarship; Clinical Scientist Development Award(American Heart Association); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Early Detection Initiative, Fred Hutchinson Cancer Research Center (LC) Joel Meyers Infectious Disease Scholarship Grant, Fred Hutchinson Cancer Research Center (CJ) Clinical Scientist Development Award, Doris Duke Charitable Foundation (CC), National Institutes of Health: K23 A154162 (CC), K24 A1071113 (AW), National Center for Research Resources K30 RR022293 (CJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2002, AIDS, V16, P2073, DOI 10.1097/00002030-200210180-00013; Beral V, 1991, AIDS, V5 Suppl 2, pS99, DOI 10.1097/00002030-199101001-00014; Campbell TB, 2003, CLIN INFECT DIS, V36, P1144, DOI 10.1086/374599; Casper C, 2004, JAIDS-J ACQ IMM DEF, V35, P233, DOI 10.1097/00126334-200403010-00003; Casper C, 2002, J INFECT DIS, V185, P990, DOI 10.1086/339605; Casper C, 2008, J INFECT DIS, V198, P23, DOI 10.1086/588820; Casper C, 2007, J INFECT DIS, V195, P30, DOI 10.1086/509621; Chandran B, 1998, VIROLOGY, V243, P208, DOI 10.1006/viro.1998.9055; Cottoni F, 1996, ACTA DERM-VENEREOL, V76, P59; Foster CB, 2000, BLOOD, V96, P2562; Gandhi M, 2004, J DENT RES, V83, P639, DOI 10.1177/154405910408300811; Gao SJ, 1996, NAT MED, V2, P925, DOI 10.1038/nm0896-925; Gondos A, 2005, BRIT J CANCER, V92, P1808, DOI 10.1038/sj.bjc.6602540; Grundhoff A, 2004, J CLIN INVEST, V113, P124, DOI 10.1172/JCI200417803; Guttman-Yassky E, 2004, J INFECT DIS, V189, P2023, DOI 10.1086/386308; Guttman-Yassky E, 2007, DIAGN MICR INFEC DIS, V57, P387, DOI 10.1016/j.diagmicrobio.2006.09.012; HUANG YQ, 1995, LANCET, V345, P759, DOI 10.1016/S0140-6736(95)90641-X; KROWN SE, 1989, J CLIN ONCOL, V7, P1201, DOI 10.1200/JCO.1989.7.9.1201; Lampinen TM, 2000, J INFECT DIS, V181, P1785, DOI 10.1086/315426; Laney AS, 2007, AIDS, V21, P1541, DOI 10.1097/QAD.0b013e3282202b7d; LOTHE F, 1963, ACTA PATHOL MICROB S, V161, P1; Magaret AS, 2007, J CLIN MICROBIOL, V45, P1618, DOI 10.1128/JCM.01405-06; Mayama S, 1998, INT J CANCER, V77, P817, DOI 10.1002/(SICI)1097-0215(19980911)77:6&lt;817::AID-IJC2&gt;3.0.CO;2-X; Mbulaiteye S, 2006, J INFECT DIS, V193, P1250, DOI 10.1086/503052; Moore PS, 1998, AM J EPIDEMIOL, V147, P217, DOI 10.1093/oxfordjournals.aje.a009440; Nsubuga MM, 2008, CANCER LETT, V263, P182, DOI 10.1016/j.canlet.2007.12.025; Pauk J, 2000, NEW ENGL J MED, V343, P1369, DOI 10.1056/NEJM200011093431904; Plancoulaine S, 2003, J INFECT DIS, V187, P1944, DOI 10.1086/375345; Plancoulaine S, 2000, LANCET, V356, P1062, DOI 10.1016/S0140-6736(00)02729-X; Ryncarz AJ, 1999, J CLIN MICROBIOL, V37, P1941, DOI 10.1128/JCM.37.6.1941-1947.1999; Simpson GR, 1996, LANCET, V348, P1133, DOI 10.1016/S0140-6736(96)07560-5; Taylor MM, 2004, J INFECT DIS, V190, P484, DOI 10.1086/421466; Vieira J, 1997, J VIROL, V71, P7083, DOI 10.1128/JVI.71.9.7083-7087.1997; Wabinga HR, 2000, BRIT J CANCER, V82, P1585, DOI 10.1054/bjoc.1999.1071; Wald A, 2000, NEW ENGL J MED, V342, P844, DOI 10.1056/NEJM200003233421203; WALD A, 1995, NEW ENGL J MED, V333, P770, DOI 10.1056/NEJM199509213331205; Wald A, 2002, J INFECT DIS, V186, pS34, DOI 10.1086/342969; Wawer MJ, 2001, SEX TRANSM DIS, V28, P77, DOI 10.1097/00007435-200102000-00003; WHITBY D, 1995, LANCET, V346, P799, DOI 10.1016/S0140-6736(95)91619-9	39	41	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2009	4	1							e4222	10.1371/journal.pone.0004222	http://dx.doi.org/10.1371/journal.pone.0004222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JA	19156206	gold, Green Published, Green Submitted			2022-12-25	WOS:000265482000001
J	Agudelo, WA; Galindo, JF; Ortiz, M; Villaveces, JL; Daza, EE; Patarroyo, ME				Agudelo, William A.; Galindo, Johan F.; Ortiz, Marysol; Villaveces, Jose L.; Daza, Edgar E.; Patarroyo, Manuel E.			Variations in the Electrostatic Landscape of Class II Human Leukocyte Antigen Molecule Induced by Modifications in the Myelin Basic Protein Peptide: A Theoretical Approach	PLOS ONE			English	Article								The receptor-ligand interactions involved in the formation of the complex between Class II Major Histocompatibility Complex molecules and antigenic peptides, which are essential for establishing an adaptive immunological response, were analyzed in the Class II Human Leukocyte Antigen (HLA) - Myelin Basic Protein (MBP) peptide complex (HLA-DR beta 1*1501-MBP) using a multipolar molecular electrostatic potential approach. The Human Leukocyte Antigen - peptide complex system was divided into four pockets together with their respective peptide fragment and the corresponding occupying amino acid was replaced by each of the remaining 19 amino acids. Partial atomic charges were calculated by a quantum chemistry approach at the Hatree Fock/3-21*G level, to study the behavior of monopole, dipole and quadrupole electrostatic multipolar moments. Two types of electrostatic behavior were distinguished in the pockets' amino acids: "anchoring'' located in Pocket 1 and 4, and "recognition'' located in Pocket 4 and 7. According to variations in the electrostatic landscape, pockets were ordered as: Pocket 1>Pocket 9 >> Pocket 4 approximate to Pocket 7 which is in agreement with the binding ability reported for Class II Major Histocompatibility Complex pockets. In the same way, amino acids occupying the polymorphic positions beta 13R, beta 26F, beta 28D, beta 9W, beta 74A, beta 47F and beta 57D were shown to be key for this Receptor-Ligand interaction. The results show that the multipolar molecular electrostatic potential approach is appropriate for characterizing receptor-ligand interactions in the MHC-antigenic peptide complex, which could have potential implications for synthetic vaccine design.	[Galindo, Johan F.; Ortiz, Marysol; Patarroyo, Manuel E.] Fdn Inst Inmunol Colombia, Grp Biomatemat, Bogota, Colombia; [Agudelo, William A.; Galindo, Johan F.; Ortiz, Marysol; Villaveces, Jose L.; Daza, Edgar E.] Univ Nacl Colombia, Ctr Investigac Sistemas Complejos CEIBA, Bogota, Colombia; [Villaveces, Jose L.] Univ Andes, Ctr Investigac Sistemas Complejos CEIBA, Grp Quim Teorica, Bogota, Colombia	Universidad Nacional de Colombia; Universidad de los Andes (Colombia)	Agudelo, WA (corresponding author), Fdn Inst Inmunol Colombia, Grp Biomatemat, Bogota, Colombia.	mepatarr@gmail.com	; Patarroyo, Manuel-Elkin/S-1422-2017	Galindo, Johan/0000-0001-9968-362X; Patarroyo, Manuel-Elkin/0000-0002-1119-6040	Colciencias [RC-2008]	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	Supported by Colciencias contract RC-2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON G, 1994, IMMUNOL TODAY, V15, P58, DOI 10.1016/0167-5699(94)90134-1; Balbin A, 2006, BIOCHIMIE, V88, P1307, DOI 10.1016/j.biochi.2006.05.009; BATCHRACH S, 1994, REV COMPUTATIONAL CH, V5, pCH3; Cardenas C, 2005, BIOCHEM BIOPH RES CO, V330, P1162, DOI 10.1016/j.bbrc.2005.03.102; Cardenas C, 2005, J STRUCT BIOL, V149, P38, DOI 10.1016/j.jsb.2004.08.003; Cardenas C, 2004, BIOCHEM BIOPH RES CO, V323, P1265, DOI 10.1016/j.bbrc.2004.08.225; Cardenas C, 2007, J MOL GRAPH MODEL, V25, P605, DOI 10.1016/j.jmgm.2006.04.005; Cifuentes G, 2008, MED CHEM, V4, P278, DOI 10.2174/157340608784325160; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Frisch M. J., 2001, GAUSSIAN 98 REVISION; Garcia JE, 2006, CLIN MICROBIOL REV, V19, P686, DOI 10.1128/CMR.00063-05; HAMMER J, 1993, CELL, V74, P197, DOI 10.1016/0092-8674(93)90306-B; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Khandogin J, 2004, PROTEINS, V56, P724, DOI 10.1002/prot.20171; Krogsgaard M, 2000, J EXP MED, V191, P1395, DOI 10.1084/jem.191.8.1395; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; Marsh SG, 2000, HLA FACTS BOOK; Patarroyo ME, 2008, J CELL MOL MED, V12, P1915, DOI 10.1111/j.1582-4934.2008.00174.x; Patarroyo ME, 2006, IMMUNOGENETICS, V58, P598, DOI 10.1007/s00251-006-0128-z; Patarroyo ME, 2004, CHEMBIOCHEM, V5, P1588, DOI 10.1002/cbic.200400116; PATARROYO ME, 2008, ACCOUNTS CHEM RES, V41, P357; Reche PA, 2003, J MOL BIOL, V331, P623, DOI 10.1016/S0022-2836(03)00750-2; RODRIGUEZ LE, 2008, CHEM REV IN PRESS; Saito K, 2004, MICROBIOL IMMUNOL, V48, P53, DOI 10.1111/j.1348-0421.2004.tb03487.x; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Schafroth HD, 2004, PROTEINS, V54, P534, DOI 10.1002/prot.10608; Smith KJ, 1998, J EXP MED, V188, P1511, DOI 10.1084/jem.188.8.1511; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Southwood S, 1998, J IMMUNOL, V160, P3363; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Suarez CF, 2006, IMMUNOGENETICS, V58, P542, DOI 10.1007/s00251-006-0127-0; Svensson AC, 1996, IMMUNOGENETICS, V43, P304, DOI 10.1007/BF02440998; Tukey JW, 1977, EXPLORATORY DATA ANA; VOGT AB, 1994, J IMMUNOL, V153, P1665; WUCHERPFENNIG KW, 1994, J EXP MED, V179, P279, DOI 10.1084/jem.179.1.279	37	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2009	4	1							e4164	10.1371/journal.pone.0004164	http://dx.doi.org/10.1371/journal.pone.0004164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GB	19132105	Green Submitted, Green Published, gold			2022-12-25	WOS:000265473700003
J	Rollin, J; Blechet, C; Regina, S; Tenenhaus, A; Guyetant, S; Gidrol, X				Rollin, Jerome; Blechet, Claire; Regina, Sandra; Tenenhaus, Arthur; Guyetant, Serge; Gidrol, Xavier			The Intracellular Localization of ID2 Expression Has a Predictive Value in Non Small Cell Lung Cancer	PLOS ONE			English	Article								Background: ID2 is a member of a subclass of transcription regulators belonging to the general bHLH (basic-helix-loop-helix) family of transcription factors. In normal cells, ID2 is responsible for regulating the balance between proliferation and differentiation. More recent studies have demonstrated that ID2 is involved in tumor progression in several cancer types such as prostate or breast. Methodology/Principal Findings: In this work, we investigated, for the first time, the relationship between the expression of ID2 in non-small cell lung cancer (NSCLC) patients and the clinicopathological features and prognosis of these patients. Immunohistochemistry was performed on tissue microarrays, which included 62 NSCLC tumors. In malignant tissues, ID2 expression has been detected in both the nuclear and cytoplasmic compartments, but we have demonstrated that only nuclear expression of ID2 is inversely correlated with the differentiation grade of the tumor (p = 0.007). Interestingly, among patients with poorly differentiated tumors, high nuclear expression of ID2 was an independent and unfavorable prognostic factor for survival (p = 0.036). Conclusions: These results suggest that ID2 could be involved in tumor dedifferentiation processes of NSCLC, and could be used as prognostic marker for patients with poorly differentiated tumors.	[Tenenhaus, Arthur; Gidrol, Xavier] CEA, IRCM, DSV, Lab Explorat Fonctionnelle Genomes, Evry, France; [Blechet, Claire; Regina, Sandra; Guyetant, Serge] INSERM, U618, IFR 135, Tours, France; [Blechet, Claire; Guyetant, Serge] Bretonneau Hosp, Lab Anat Pathol, Tours, France; [Regina, Sandra] Trousseau Hosp, Serv Hematol Hemostase, Tours, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Tours; CHU Tours	Rollin, J (corresponding author), CEA, IRCM, DSV, Lab Explorat Fonctionnelle Genomes, Evry, France.	xavier.gidrol@cea.fr	Jerome, Rollin/K-2157-2019	Gidrol, Xavier/0000-0002-4233-3749				Baghdoyan S, 2005, J BIOL CHEM, V280, P15836, DOI 10.1074/jbc.M414216200; Beasley MB, 2005, SEMIN ROENTGENOL, V40, P90, DOI 10.1053/j.ro.2005.01.001; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Coppe JP, 2004, CLIN CANCER RES, V10, P2044, DOI 10.1158/1078-0432.CCR-03-0933; Daibata M, 2004, INT J CANCER, V108, P845, DOI 10.1002/ijc.11647; Ettinger David S, 2006, J Natl Compr Canc Netw, V4, P548; Hua H, 2007, ENDOCRINE, V32, P329, DOI 10.1007/s12020-008-9039-0; Itahana Y, 2003, CANCER RES, V63, P7098; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; JEN Y, 1992, GENE DEV, V6, P1466, DOI 10.1101/gad.6.8.1466; Kamalian L, 2008, CLIN CANCER RES, V14, P2318, DOI 10.1158/1078-0432.CCR-07-4716; Kleeff J, 1998, CANCER RES, V58, P3769; KREIDER BL, 1992, SCIENCE, V255, P1700, DOI 10.1126/science.1372755; Kurooka H, 2005, J BIOL CHEM, V280, P4313, DOI 10.1074/jbc.M412614200; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lasorella A, 2006, P NATL ACAD SCI USA, V103, P4976, DOI 10.1073/pnas.0600168103; Lasorella A, 2005, MOL CELL BIOL, V25, P3563, DOI 10.1128/MCB.25.9.3563-3574.2005; Lasorella A, 2002, CANCER RES, V62, P301; Liu CJ, 2002, MOL CELL BIOL, V22, P2893, DOI 10.1128/MCB.22.9.2893-2905.2002; Melnikova IN, 1999, EXP CELL RES, V247, P94, DOI 10.1006/excr.1998.4330; Nishimori H, 2002, ONCOGENE, V21, P8302, DOI 10.1038/sj.onc.1206025; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Stighall M, 2005, INT J CANCER, V115, P403, DOI 10.1002/ijc.20875; Vielh P, 2005, CRIT REV ONCOL HEMAT, V53, P193, DOI 10.1016/j.critrevonc.2004.10.007; Wilson JW, 2001, CANCER RES, V61, P8803; WILSON RB, 1991, MOL CELL BIOL, V11, P6185, DOI 10.1128/MCB.11.12.6185; Yokota Y, 2001, ONCOGENE, V20, P8290, DOI 10.1038/sj.onc.1205090; Yuen HF, 2006, MODERN PATHOL, V19, P931, DOI 10.1038/modpathol.3800602	30	25	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2009	4	1							e4158	10.1371/journal.pone.0004158	http://dx.doi.org/10.1371/journal.pone.0004158			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FZ	19129913	gold, Green Published, Green Submitted			2022-12-25	WOS:000265473500006
J	Hu, W; Metselaar, J; Ben, LH; Cravens, PD; Singh, MP; Frohman, EM; Eagar, TN; Racke, MK; Kieseier, BC; Stuve, O				Hu, Wei; Metselaar, Josbert; Ben, Li-Hong; Cravens, Petra D.; Singh, Mahendra P.; Frohman, Elliot M.; Eagar, Todd N.; Racke, Michael K.; Kieseier, Bernd C.; Stueve, Olaf			PEG Minocycline-Liposomes Ameliorate CNS Autoimmune Disease	PLOS ONE			English	Article								Background: Minocycline is an oral tetracycline derivative with good bioavailability in the central nervous system (CNS). Minocycline, a potent inhibitor of matrix metalloproteinase (MMP)-9, attenuates disease activity in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). Potential adverse effects associated with long-term daily minocycline therapy in human patients are concerning. Here, we investigated whether less frequent treatment with long-circulating polyethylene glycol (PEG) minocycline liposomes are effective in treating EAE. Findings: Performing in vitro time kinetic studies of PEG minocycline-liposomes in human peripheral blood mononuclear cells (PBMCs), we determined that PEG minocycline-liposome preparations stabilized with CaCl2 are effective in diminishing MMP-9 activity. Intravenous injections of PEG minocycline-liposomes every five days were as effective in ameliorating clinical EAE as daily intraperitoneal injections of minocycline. Treatment of animals with PEG minocycline-liposomes significantly reduced the number of CNS-infiltrating leukocytes, and the overall expression of MMP-9 in the CNS. There was also a significant suppression of MMP-9 expression and proteolytic activity in splenocytes of treated animals, but not in CNS-infiltrating leukocytes. Thus, leukocytes gaining access to the brain and spinal cord require the same absolute amount of MMP-9 in all treatment groups, but minocycline decreases the absolute cell number. Conclusions: Our data indicate that less frequent injections of PEG minocycline-liposomes are an effective alternative pharmacotherapy to daily minocycline injections for the treatment of CNS autoimmune diseases. Also, inhibition of MMP-9 remains a promising treatment target in EAE and patients with MS.			Hu, W (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA.	bernd.kieseier@uni-duesseldorf.de; olaf.stuve@va.gov			Dallas VA Research Corporation; VISN 17, Department of Veterans Affairs [New Investigator Award]; Department of Veterans Affairs [Merit Review Award]; National Multiple Sclerosis Society [RG3427A8/T, RG2969B7/T]; Viragh Family Foundation	Dallas VA Research Corporation; VISN 17, Department of Veterans Affairs(US Department of Veterans Affairs); Department of Veterans Affairs(US Department of Veterans Affairs); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Viragh Family Foundation	OS was supported by a Start-up Grant from the Dallas VA Research Corporation, a New Investigator Award from VISN 17, Department of Veterans Affairs, a Merit Review Award from the Department of Veterans Affairs, Research Grants from National Multiple Sclerosis Society (NMSS; RG3427A8/T, and RG2969B7/T), and a grant from the Viragh Family Foundation. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brundula V, 2002, BRAIN, V125, P1297, DOI 10.1093/brain/awf133; DAVIES MG, 1989, BRIT MED J, V298, P1523, DOI 10.1136/bmj.298.6686.1523-c; Gocke AR, 2007, J IMMUNOL, V178, P1341, DOI 10.4049/jimmunol.178.3.1341; Harel L, 1996, ANN PHARMACOTHER, V30, P481, DOI 10.1177/106002809603000509; Keilhoff G, 2007, DEV NEUROBIOL, V67, P1382, DOI 10.1002/dneu.20384; Kieseier BC, 1998, BRAIN, V121, P159, DOI 10.1093/brain/121.1.159; KLOPPENBURG M, 1994, ARTHRITIS RHEUM, V37, P629, DOI 10.1002/art.1780370505; Langevitz P, 2000, DRUG SAFETY, V22, P405, DOI 10.2165/00002018-200022050-00007; Leppert D, 1996, ANN NEUROL, V40, P846, DOI 10.1002/ana.410400606; LEPPERT D, 1995, J IMMUNOL, V154, P4379; MATSUURA T, 1992, LANCET, V340, P1553, DOI 10.1016/0140-6736(92)92810-3; Metselaar Josbert M, 2005, Expert Opin Drug Deliv, V2, P465, DOI 10.1517/17425247.2.3.465; Metz LM, 2004, ANN NEUROL, V55, P756, DOI 10.1002/ana.20111; Nessler S, 2002, ANN NEUROL, V52, P689, DOI 10.1002/ana.10353; Pelletier F, 2003, EUR J DERMATOL, V13, P396; Popovic N, 2002, ANN NEUROL, V51, P215, DOI 10.1002/ana.10092; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Stueve O, 2008, DRUGS, V68, P73, DOI 10.2165/00003495-200868010-00005; Stuve O, 2006, J CLIN INVEST, V116, P1037, DOI 10.1172/JCI25805; Stuve O, 1996, ANN NEUROL, V40, P853, DOI 10.1002/ana.410400607; Stuve O, 1997, J NEUROIMMUNOL, V80, P38, DOI 10.1016/S0165-5728(97)00134-3; Stuve O, 2002, J IMMUNOL, V169, P6720, DOI 10.4049/jimmunol.169.12.6720; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051	25	40	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4151	10.1371/journal.pone.0004151	http://dx.doi.org/10.1371/journal.pone.0004151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FX	19127301	Green Published, gold, Green Submitted			2022-12-25	WOS:000265473300015
J	McClain, CR; Lundsten, L; Ream, M; Barry, J; DeVogelaere, A				McClain, Craig R.; Lundsten, Lonny; Ream, Micki; Barry, James; DeVogelaere, Andrew			Endemicity, Biogeography, Composition, and Community Structure On a Northeast Pacific Seamount	PLOS ONE			English	Article								The deep ocean greater than 1 km covers the majority of the earth's surface. Interspersed on the abyssal plains and continental slope are an estimated 14000 seamounts, topographic features extending 1000 m off the seafloor. A variety of hypotheses are posited that suggest the ecological, evolutionary, and oceanographic processes on seamounts differ from those governing the surrounding deep sea. The most prominent and oldest of these hypotheses, the seamount endemicity hypothesis (SMEH), states that seamounts possess a set of isolating mechanisms that produce highly endemic faunas. Here, we constructed a faunal inventory for Davidson Seamount, the first bathymetric feature to be characterized as a 'seamount', residing 120 km off the central California coast in approximately 3600 m of water (Fig 1). We find little support for the SMEH among megafauna of a Northeast Pacific seamount; instead, finding an assemblage of species that also occurs on adjacent continental margins. A large percentage of these species are also cosmopolitan with ranges extending over much of the Pacific Ocean Basin. Despite the similarity in composition between the seamount and non-seamount communities, we provide preliminary evidence that seamount communities may be structured differently and potentially serve as source of larvae for suboptimal, non-seamount habitats.	[McClain, Craig R.; Lundsten, Lonny; Barry, James] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA; [Ream, Micki] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [DeVogelaere, Andrew] Monterey Bay Natl Marine Sanctuary, Monterey, CA USA	Monterey Bay Aquarium Research Institute; Stanford University; National Oceanic Atmospheric Admin (NOAA) - USA	McClain, CR (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA USA.	cmcclain@mbari.org		Lundsten, Lonny/0000-0002-7464-7443; McClain, Craig/0000-0003-0574-428X	NOAA'S Office of Ocean Exploration, the Monterey Bay National Marine Sanctuary, the Monterey Bay Aquarium Research Institute [200002, 900703, 900608, Postdoctoral Fellowship]; Save the Earth Foundation; David and Lucile Packard Foundation; Monterey Bay National Marine Sanctuary Foundation	NOAA'S Office of Ocean Exploration, the Monterey Bay National Marine Sanctuary, the Monterey Bay Aquarium Research Institute; Save the Earth Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Monterey Bay National Marine Sanctuary Foundation	This work was supported NOAA'S Office of Ocean Exploration, the Monterey Bay National Marine Sanctuary, the Monterey Bay Aquarium Research Institute (projects 200002, 900703, 900608), the Save the Earth Foundation, and the David and Lucile Packard Foundation. CRM was supported by a Monterey Bay Aquarium Research Institute Postdoctoral Fellowship and a grant from the Monterey Bay National Marine Sanctuary Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 1996, PROG OCEANOGR, V38, P95, DOI 10.1016/S0079-6611(96)00011-0; Braby CE, 2007, DEEP-SEA RES PT I, V54, P1773, DOI 10.1016/j.dsr.2007.05.014; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Cairns Stephen D., 2007, Proceedings of the California Academy of Sciences, V58, P511; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; Cartes JE, 2004, DEEP-SEA RES PT I, V51, P263, DOI 10.1016/j.dsr.2003.10.001; de Forges BR, 2000, NATURE, V405, P944, DOI 10.1038/35016066; FROESE R, 2004, SEAMOUNTS BIODIVERSI, P25; Gage J. D., 1991, DEEP SEA BIOL NATURA; Gaston KJ, 1996, OIKOS, V75, P479, DOI 10.2307/3545889; Gaston KJ, 1996, TRENDS ECOL EVOL, V11, P197, DOI 10.1016/0169-5347(96)10027-6; Gaston KJ, 1998, PHILOS T R SOC B, V353, P219, DOI 10.1098/rstb.1998.0204; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; Haddock SHD, 2004, HYDROBIOLOGIA, V530, P549, DOI 10.1007/s10750-004-2653-9; Harbison GR, 2001, B MAR SCI, V68, P299; Holt Robert D., 1993, P77; HUBBS CARL L., 1959, PACIFIC SCI, V13, P311; Jetz W, 2002, SCIENCE, V297, P1548, DOI 10.1126/science.1072779; Johnston PA, 2004, ARCH FISH MAR RES, V51, P305; Koslow JA, 2001, MAR ECOL PROG SER, V213, P111, DOI 10.3354/meps213111; LUNDSTEN L, MARINE ECOLOGY PROGR; LUNDSTEN L, 2007, BIOGEOGRAPHY DISTRIB, P73; MCCLAIN CR, 2007, GUEST EDITORIAL SEAM, P1; O'Hara TD, 2007, GLOBAL ECOL BIOGEOGR, V16, P720, DOI 10.1111/j.1466-8238.2007.00329.x; Rex MA, 2005, AM NAT, V165, P163, DOI 10.1086/427226; RIZK S, 2006, SEAMOUNT INFLUENCES; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Roberts S, 2004, FRONT ECOL ENVIRON, V2, P123, DOI 10.2307/3868237; ROGERS AD, 1994, ADV MAR BIOL, V30, P304; Samadi S, 2006, MAR BIOL, V149, P1463, DOI 10.1007/s00227-006-0306-4; SCHLINING B, 2006, P MAR TECHN SOC I EL, P1; Stocks K., 2004, SEAMOUNTS BIODIVERSI, P17; STONE G, 2003, DEF OC END C SAN LUC, P43; Vermeij GJ, 2004, Frontiers of Biogeography: New Directions in the Geography of Nature, P239; Webb TJ, 2003, AM NAT, V161, P553, DOI 10.1086/368296; WILSON RR, 1987, SEAMOUNTS ISLANDS AT, P227; Worm B, 2003, P NATL ACAD SCI USA, V100, P9884, DOI 10.1073/pnas.1333941100	37	83	86	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4141	10.1371/journal.pone.0004141	http://dx.doi.org/10.1371/journal.pone.0004141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FX	19127302	Green Submitted, gold, Green Published			2022-12-25	WOS:000265473300008
J	Ansorge, HL; Meng, XM; Zhang, GY; Veit, G; Sun, M; Klement, JF; Beason, DP; Soslowsky, LJ; Koch, M; Birk, DE				Ansorge, Heather L.; Meng, Xianmin; Zhang, Guiyun; Veit, Guido; Sun, Mei; Klement, John F.; Beason, David P.; Soslowsky, Louis J.; Koch, Manuel; Birk, David E.			Type XIV Collagen Regulates Fibrillogenesis PREMATURE COLLAGEN FIBRIL GROWTH AND TISSUE DYSFUNCTION IN NULL MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERLEUKIN-6 KNOCKOUT MICE; FETAL BOVINE SKIN; DIFFERENTIAL EXPRESSION; MECHANICAL-PROPERTIES; CONNECTIVE TISSUES; MESSENGER-RNA; TENDON; LUMICAN; MODEL; DECORIN	Type XIV collagen is a fibril-associated collagen with an interrupted triple helix. This collagen interacts with the fibril surface and has been implicated as a regulator of fibrillogenesis; however, a specific role has not been elucidated. Functional roles for type XIV collagen were defined utilizing a new type XIV collagen-deficient mouse line. This line was produced using a conventional targeted knock-out approach. Col14a1(-/-) mice were devoid of type XIV collagen, whereas heterozygous mice had reduced synthesis. Both mutant Col14a1 genotypes were viable with a grossly normal phenotype; however, mature skin exhibited altered mechanical properties. Prior to evaluating tendon fibrillogenesis in type XIV collagen-deficient mice, the developmental expression patterns were analyzed in wild-type flexor digitorum longus (FDL) tendons. Analyses of mRNA and protein expression indicated tissue-specific temporal expression that was associated with the early stages in fibrillogenesis. Ultrastructural analyses of wild-type and null tendons demonstrated premature fibril growth and larger fibril diameters in tendons from null mice at postnatal day 4 (P4). However, fibril structure in mature tendons was normal. Biomechanical studies established a direct structure/function relationship with reduced strength in P7-null tendons. However, the biomechanical properties in P60 tendons were comparable in null and wild-type mice. Our results indicate a regulatory function for type XIV collagen in early stages of collagen fibrillogenesis with tissue differences.	[Sun, Mei; Birk, David E.] Univ S Florida, Coll Med, Dept Pathol & Cell Biol, Tampa, FL 33612 USA; [Ansorge, Heather L.; Beason, David P.; Soslowsky, Louis J.] Univ Penn, McKay Orthopaed Res Lab, Philadelphia, PA 19104 USA; [Meng, Xianmin; Zhang, Guiyun] Thomas Jefferson Univ, Dept Pathol, Philadelphia, PA 19107 USA; [Meng, Xianmin; Zhang, Guiyun] Thomas Jefferson Univ, Dept Anat & Cell Biol, Philadelphia, PA 19107 USA; [Klement, John F.] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [Veit, Guido; Koch, Manuel] Univ Cologne, Fac Med, Ctr Biochem, D-50923 Cologne, Germany; [Koch, Manuel] Univ Cologne, Fac Med, Dept Dermatol, D-50923 Cologne, Germany; [Koch, Manuel] Univ Cologne, Fac Med, Ctr Mol Med Cologne, D-50923 Cologne, Germany	State University System of Florida; University of South Florida; University of Pennsylvania; Jefferson University; Jefferson University; Jefferson University; University of Cologne; University of Cologne; University of Cologne	Birk, DE (corresponding author), Univ S Florida, Coll Med, Dept Pathol & Cell Biol, 12901 Bruce B Downs Blvd,MDC11, Tampa, FL 33612 USA.	dbirk@health.usf.edu	Koch, Manuel/AAG-9914-2021; Veit, Guido/C-9596-2009; Birk, David/I-4072-2012	Koch, Manuel/0000-0002-2962-7814; Veit, Guido/0000-0002-6758-2696; Birk, David/0000-0002-4865-9088	National Institutes of Health [AR044745]; NEI [EY05129]; NIAMS [AR050950]; NATIONAL EYE INSTITUTE [R01EY005129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050950, R01AR044745] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR044745 from NIAMS, Grant EY05129 from NEI, and Grant AR050950 from NIAMS, supporting the Penn Center for Musculoskeletal Disorders. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Berthod F, 1997, J INVEST DERMATOL, V108, P737, DOI 10.1111/1523-1747.ep12292122; Birk DE, 2005, TOP CURR CHEM, V247, P185, DOI 10.1007/b103823; BIRK DE, 1995, DEV DYNAM, V202, P229, DOI 10.1002/aja.1002020303; Birk DE, 1997, EUR J CELL BIOL, V72, P352; BIRK DE, 1986, J CELL BIOL, V103, P231, DOI 10.1083/jcb.103.1.231; BROWN JC, 1993, J CELL BIOL, V120, P557, DOI 10.1083/jcb.120.2.557; CASTAGNOLA P, 1992, EUR J CELL BIOL, V59, P340; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Christner PJ, 2006, J INVEST DERMATOL, V126, P595, DOI 10.1038/sj.jid.5700100; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; DERWIN KA, 1994, J BIOMECH, V27, P1277, DOI 10.1016/0021-9290(94)90281-X; Derwin KA, 1999, J BIOMECH ENG-T ASME, V121, P598, DOI 10.1115/1.2800859; DUBLET B, 1991, J BIOL CHEM, V266, P6853; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; Favata M, 2006, SCARLESS HEALING FET; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; Gerecke DR, 2004, MATRIX BIOL, V22, P593, DOI 10.1016/j.matbio.2003.11.004; Goh KL, 2005, BBA-GEN SUBJECTS, V1722, P183, DOI 10.1016/j.bbagen.2004.12.004; Gordon MK, 1990, CURR OPIN CELL BIOL, V2, P833, DOI 10.1016/0955-0674(90)90080-X; Gordon MK, 1996, DEV DYNAM, V206, P49, DOI 10.1002/(SICI)1097-0177(199605)206:1<49::AID-AJA5>3.3.CO;2-T; Grant ME, 2002, COLLAGEN FAMILY STRU, P159, DOI DOI 10.1002/0471221929.CH2; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; KEENE DR, 1991, J CELL BIOL, V113, P971, DOI 10.1083/jcb.113.4.971; KOCH M, 1995, J CELL BIOL, V130, P1005, DOI 10.1083/jcb.130.4.1005; Koch M, 2006, J BIOL CHEM, V281, P21546, DOI 10.1074/jbc.M604131200; KONTGEN F, 1993, METHOD ENZYMOL, V225, P878; LETHIAS C, 1993, J INVEST DERMATOL, V101, P92, DOI 10.1111/1523-1747.ep12360433; Lin TW, 2006, J BIOMECH, V39, P61, DOI 10.1016/j.jbiomech.2004.11.009; Lin TW, 2005, J BIOMECH, V38, P99, DOI 10.1016/j.jbiomech.2004.03.008; LUNSTRUM GP, 1991, J CELL BIOL, V113, P963, DOI 10.1083/jcb.113.4.963; Meng XM, 2003, J INVEST DERMATOL, V121, P720, DOI 10.1046/j.1523-1747.2003.12515.x; NISHIYAMA T, 1994, J BIOL CHEM, V269, P28193; Niyibizi C, 1995, MATRIX BIOL, V14, P743, DOI 10.1016/S0945-053X(05)80017-4; Nurminskaya MV, 1998, ARCH BIOCHEM BIOPHYS, V350, P1, DOI 10.1006/abbi.1997.0498; PARRY DAD, 1978, PROC R SOC SER B-BIO, V203, P305, DOI 10.1098/rspb.1978.0107; Robinson PS, 2005, J BIOMECH ENG-T ASME, V127, P181, DOI 10.1115/1.1835363; Robinson PS, 2004, ANN BIOMED ENG, V32, P924, DOI 10.1023/B:ABME.0000032455.78459.56; SHAW LM, 1991, TRENDS BIOCHEM SCI, V16, P191, DOI 10.1016/0968-0004(91)90074-6; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; Veit G, 2006, J BIOL CHEM, V281, P27461, DOI 10.1074/jbc.M603147200; WALCHLI C, 1994, J CELL SCI, V107, P669; WALCHLI C, 1993, EUR J BIOCHEM, V212, P483, DOI 10.1111/j.1432-1033.1993.tb17685.x; Young BB, 2000, DEV DYNAM, V217, P430, DOI 10.1002/(SICI)1097-0177(200004)217:4<430::AID-DVDY10>3.0.CO;2-5; Young BB, 2002, J CELL BIOCHEM, V87, P208, DOI 10.1002/jcb.10290; Zhang CM, 2005, CHINESE J ASTRON AST, V5, P21, DOI 10.1088/1009-9271/5/S1/21; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhang GY, 2003, J ANAT, V202, P411, DOI 10.1046/j.1469-7580.2003.00174.x	48	116	121	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8427	8438		10.1074/jbc.M805582200	http://dx.doi.org/10.1074/jbc.M805582200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19136672	Green Published, hybrid			2022-12-25	WOS:000264397800027
J	Carrithers, MD; Chatterjee, G; Carrithers, LM; Offoha, R; Iheagwara, U; Rahner, C; Graham, M; Waxman, SG				Carrithers, Michael D.; Chatterjee, Gouri; Carrithers, Lisette M.; Offoha, Roosevelt; Iheagwara, Uzoma; Rahner, Christoph; Graham, Morven; Waxman, Stephen G.			Regulation of Podosome Formation in Macrophages by a Splice Variant of the Sodium Channel SCN8A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-SCLEROSIS; CALCIUM; RELEASE; COMPLEX; DYNAMIN; PROTEIN; PROTRUSIONS; EXPRESSION; PHENYTOIN; MIGRATION	Voltage-gated sodium channels initiate electrical signaling in excitable cells such as muscle and neurons. They also are expressed in non-excitable cells such as macrophages and neoplastic cells. Previously, in macrophages, we demonstrated expression of SCN8A, the gene that encodes the channel NaV1.6, and intracellular localization of NaV1.6 to regions near F-actin bundles, particularly at areas of cell attachment. Here we show that a splice variant of NaV1.6 regulates cellular invasion through its effects on podosome and invadopodia formation in macrophages and melanoma cells. cDNA sequence analysis of SCN8A from THP-1 cells, a human monocyte-macrophage cell line, confirmed the expression of a full-length splice variant that lacks exon 18. Immunoelectron microscopy demonstrated NaV1.6-positive staining within the electron dense podosome rosette structure. Pharmacologic antagonism with tetrodotoxin (TTX) in differentiated THP-1 cells or absence of functional NaV1.6 through a naturally occurring mutation (med) in mouse peritoneal macrophages inhibited podosome formation. Agonist-mediated activation of the channel with veratridine caused release of sodium from cationic vesicular compartments, uptake by mitochondria, and mitochondrial calcium release through the Na/Ca exchanger. Invasion by differentiated THP-1 and HTB-66 cells, an invasive melanoma cell line, through extracellular matrix was inhibited by TTX. THP-1 invasion also was inhibited by small hairpin RNA knockdown of SCN8A. These results demonstrate that a variant of NaV1.6 participates in the control of podosome and invadopodia formation and suggest that intracellular sodium release mediated by NaV1.6 may regulate cellular invasion of macrophages and melanoma cells.	[Carrithers, Michael D.; Chatterjee, Gouri; Carrithers, Lisette M.; Offoha, Roosevelt; Iheagwara, Uzoma; Waxman, Stephen G.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; [Rahner, Christoph; Graham, Morven] Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell Biol, Madison, WI 53792 USA; [Carrithers, Michael D.] Univ Wisconsin, Sch Med & Publ Hlth, Program Human & Translat Immunol, Madison, WI 53792 USA; [Waxman, Stephen G.] Vet Adm Connecticut Healthcare, Ctr Neurosci & Neuroregenerat Res, Hamden, CT 06518 USA	Yale University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Carrithers, MD (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol, 600 N Highland Ave, Madison, WI 53792 USA.	carrithers@neurology.wisc.edu	Waxman, Stephen/Z-2507-2019	Waxman, Stephen/0000-0001-5718-7177	National Institutes of Health; National Multiple Sclerosis Society; Nancy Davis Foundation; Dana Foundation award in Clinical Hypotheses in Neuroimmunology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS047457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Nancy Davis Foundation; Dana Foundation award in Clinical Hypotheses in Neuroimmunology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by the National Institutes of Health. This work was also supported by the National Multiple Sclerosis Society, the Nancy Davis Foundation, and a Dana Foundation award in Clinical Hypotheses in Neuroimmunology (to M. D. C.).	BAKER PF, 1971, J PHYSIOL-LONDON, V218, P709, DOI 10.1113/jphysiol.1971.sp009641; Bechtold DA, 2004, ANN NEUROL, V55, P607, DOI 10.1002/ana.20045; Black JA, 2007, ANN NEUROL, V62, P21, DOI 10.1002/ana.21172; Blumenstein Y, 2004, J PHYSIOL-LONDON, V556, P121, DOI 10.1113/jphysiol.2003.056168; Bruzzaniti A, 2005, MOL BIOL CELL, V16, P3301, DOI 10.1091/mbc.e04-12-1117; BURGESS DL, 1995, NAT GENET, V10, P461, DOI 10.1038/ng0895-461; Calle Y, 2006, EUR J CELL BIOL, V85, P151, DOI 10.1016/j.ejcb.2005.09.003; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Carrithers MD, 2007, J IMMUNOL, V178, P7822, DOI 10.4049/jimmunol.178.12.7822; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chellaiah M, 2000, J CELL BIOL, V148, P665, DOI 10.1083/jcb.148.4.665; CHEN WT, 1989, J EXP ZOOL, V251, P167, DOI 10.1002/jez.1402510206; Craner MJ, 2005, GLIA, V49, P220, DOI 10.1002/glia.20112; Evans JG, 2006, EUR J CELL BIOL, V85, P145, DOI 10.1016/j.ejcb.2005.08.006; Evans JG, 2003, J CELL BIOL, V161, P697, DOI 10.1083/jcb.200212037; Fraser SP, 2003, J CELL PHYSIOL, V195, P479, DOI 10.1002/jcp.10312; GAVAZZI I, 1989, J CELL SCI, V94, P85; Ghersi G, 2006, CANCER RES, V66, P4652, DOI 10.1158/0008-5472.CAN-05-1245; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; LEBLANC N, 1990, SCIENCE, V248, P372, DOI 10.1126/science.2158146; Lo AC, 2003, J NEUROPHYSIOL, V90, P3566, DOI 10.1152/jn.00434.2003; LOWE DA, 1976, NATURE, V260, P337, DOI 10.1038/260337a0; McNiven MA, 2004, FRONT BIOSCI-LANDMRK, V9, P1944, DOI 10.2741/1348; MIYAUCHI A, 1990, J CELL BIOL, V111, P2543, DOI 10.1083/jcb.111.6.2543; Nikolaeva MA, 2005, J NEUROSCI, V25, P9960, DOI 10.1523/JNEUROSCI.2003-05.2005; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Oh Y, 1998, NEUROREPORT, V9, P1267, DOI 10.1097/00001756-199805110-00002; Plummer NW, 1997, J BIOL CHEM, V272, P24008, DOI 10.1074/jbc.272.38.24008; Smith KJ, 2007, BRAIN PATHOL, V17, P230, DOI 10.1111/j.1750-3639.2007.00066.x; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; Tsuboi S, 2007, J IMMUNOL, V178, P2987, DOI 10.4049/jimmunol.178.5.2987; Waxman SG, 2008, NAT CLIN PRACT NEURO, V4, P159, DOI 10.1038/ncpneuro0735; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823	34	87	96	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8114	8126		10.1074/jbc.M801892200	http://dx.doi.org/10.1074/jbc.M801892200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19136557	hybrid, Green Published			2022-12-25	WOS:000264195600074
J	Liao, CP; Lasbury, ME; Wang, SH; Zhang, C; Durant, PJ; Murakami, Y; Matsufuji, S; Lee, CH				Liao, Chung-Ping; Lasbury, Mark E.; Wang, Shao-Hung; Zhang, Chen; Durant, Pamela J.; Murakami, Yasuko; Matsufuji, Senya; Lee, Chao-Hung			Pneumocystis Mediates Overexpression of Antizyme Inhibitor Resulting in Increased Polyamine Levels and Apoptosis in Alveolar Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL-MEMBRANE DEPOLARIZATION; DL-ALPHA-DIFLUOROMETHYLORNITHINE; ORNITHINE-DECARBOXYLASE; HELICOBACTER-PYLORI; CARINII PNEUMONIA; RAT MODEL; INTRACELLULAR-LOCALIZATION; SACCHAROMYCES-CEREVISIAE; FLUORESCENT-PROBE; CELLS	Pneumocystis pneumonia (PcP) is the most common opportunistic disease in immunocompromised patients. Alveolar macrophages are responsible for the clearance of Pneumocystis organisms; however, they undergo a high rate of apoptosis during PcP due to increased intracellular polyamine levels. In this study, the sources of polyamines and mechanisms of polyamine increase and polyamine-induced apoptosis were investigated. The level of ornithine decarboxylase (ODC) was elevated in alveolar macrophages, and the number of alveolar macrophages that took up exogenous polyamines was increased 20-fold during PcP. Monocytes, B lymphocytes, and CD8+ T lymphocytes that were recruited into the lung during PcP expressed high levels of ornithine decarboxylase, suggesting that these cells are sources of polyamines. Both protein and mRNA levels of antizyme inhibitor (AZI) were increased in alveolar macrophages during PcP. This AZI overexpression correlated with increased polyamine uptake by alveolar macrophages, because AZI expression knockdown decreased the polyamine uptake ability of these cells. AZI expression knockdown also decreased the apoptosis rate of alveolar macrophages. Pneumocystis organisms and zymosan A were found to induce AZI overexpression in alveolar macrophages, suggesting that beta-glucan, which is the major component of the Pneumocystis cell wall, induces AZI overexpression. The levels of mRNA, protein, and activity of polyamine oxidase were increased in alveolar macrophages during PcP, indicating that the H2O2 generated during polyamine catabolism caused alveolar macrophages to undergo apoptosis. Taken together, results of this study indicate that Pneumocystis organisms induce AZI overexpression in alveolar macrophages, leading to increased polyamine synthesis and uptake and apoptosis rate of these cells.	[Liao, Chung-Ping; Lasbury, Mark E.; Wang, Shao-Hung; Zhang, Chen; Durant, Pamela J.; Lee, Chao-Hung] Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Murakami, Yasuko] Musashino Univ, Sch Pharm, Dept Genet & Mol Biol, Nishi Tokyo 2028585, Japan; [Matsufuji, Senya] Jikei Univ, Sch Med, Dept Mol Biol, Tokyo 1058461, Japan	Indiana University System; Indiana University-Purdue University Indianapolis; Jikei University	Lee, CH (corresponding author), Indiana Univ, Sch Med, Dept Pathol & Lab Med, 1120 South Dr,FH419, Indianapolis, IN 46202 USA.	chlee@iupui.edu	Liao, Chung-Ping/E-2344-2015; wang, shaohung/E-4017-2015	Liao, Chung-Ping/0000-0001-8787-7291; wang, shaohung/0000-0002-6824-0372	National Institutes of Health [RO1 HL65170, RO1 AI062259]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL65170 and RO1 AI062259. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aouida M, 2004, BIOCHEM J, V384, P47, DOI 10.1042/BJ20040392; Aziz SM, 1998, J PHARMACEUT BIOMED, V17, P307, DOI 10.1016/S0731-7085(98)00016-8; BARTLETT MS, 1988, J CLIN MICROBIOL, V26, P1100, DOI 10.1128/JCM.26.6.1100-1102.1988; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Bussiere FI, 2005, J BIOL CHEM, V280, P2409, DOI 10.1074/jbc.C400498200; Chaturvedi R, 2004, J BIOL CHEM, V279, P40161, DOI 10.1074/jbc.M401370200; Chaturvedi R, 2007, INFECT IMMUN, V75, P4305, DOI 10.1128/IAI.00578-07; Cheng Y, 2005, J BIOL CHEM, V280, P22492, DOI 10.1074/jbc.C500122200; Chin K, 1996, ANTIMICROB AGENTS CH, V40, P2318, DOI 10.1128/AAC.40.10.2318; CLARKSON AB, 1988, ANTIMICROB AGENTS CH, V32, P1158, DOI 10.1128/AAC.32.8.1158; Cullis PM, 1999, CHEM BIOL, V6, P717, DOI 10.1016/S1074-5521(00)80019-8; ERWIN BG, 1983, BIOCHEM BIOPH RES CO, V114, P944, DOI 10.1016/0006-291X(83)90651-4; EZEKOWITZ RAB, 1991, NATURE, V351, P155, DOI 10.1038/351155a0; FLEURY J, 1985, ACTA CYTOL, V29, P721; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Heiskala M, 1999, EMBO J, V18, P1214, DOI 10.1093/emboj/18.5.1214; Hoet PHM, 2000, AM J PHYSIOL-LUNG C, V278, pL417, DOI 10.1152/ajplung.2000.278.3.L417; Huang L, 2004, EMERG INFECT DIS, V10, P1721, DOI 10.3201/eid1010.030994; Jung MH, 2000, GENOMICS, V69, P281, DOI 10.1006/geno.2000.6338; Kaur N, 2008, J MED CHEM, V51, P1393, DOI 10.1021/jm070794t; Keren-Paz A, 2006, ONCOGENE, V25, P5163, DOI 10.1038/sj.onc.1209521; Kim SW, 2006, J CELL SCI, V119, P2853, DOI 10.1242/jcs.02966; KUFE DW, 1984, CANCER RES, V44, P4281; Lasbury ME, 2007, J BIOL CHEM, V282, P11009, DOI 10.1074/jbc.M611686200; Lasbury ME, 2006, J IMMUNOL, V176, P6443, DOI 10.4049/jimmunol.176.11.6443; Lasbury ME, 2003, J EUKARYOT MICROBIOL, V50, P630, DOI 10.1111/j.1550-7408.2003.tb00658.x; Lasbury ME, 2003, CLIN DIAGN LAB IMMUN, V10, P293, DOI 10.1128/CDLI.10.2.293-302.2003; Limper AH, 1997, J CLIN INVEST, V99, P2110, DOI 10.1172/JCI119384; Liu GY, 2006, APOPTOSIS, V11, P1773, DOI 10.1007/s10495-006-9512-2; MATSUFUJI S, 1990, J BIOCHEM, V107, P87, DOI 10.1093/oxfordjournals.jbchem.a123018; MATSUFUJI S, 1990, J BIOCHEM-TOKYO, V108, P365, DOI 10.1093/oxfordjournals.jbchem.a123207; Merali S, 1999, J BIOL CHEM, V274, P21017, DOI 10.1074/jbc.274.30.21017; MITCHELL JLA, 1994, BIOCHEM J, V299, P19, DOI 10.1042/bj2990019; Murakami Y, 1996, J BIOL CHEM, V271, P3340, DOI 10.1074/jbc.271.7.3340; Nahimana A, 2004, ANTIMICROB AGENTS CH, V48, P4301, DOI 10.1128/AAC.48.11.4301-4305.2004; Nilsson JA, 2005, CANCER CELL, V7, P433, DOI 10.1016/j.ccr.2005.03.036; Oredsson SM, 2003, BIOCHEM SOC T, V31, P366, DOI 10.1042/BST0310366; PHAIR J, 1990, NEW ENGL J MED, V322, P161, DOI 10.1056/NEJM199001183220304; Roy UKB, 2008, MOL CARCINOGEN, V47, P538, DOI 10.1002/mc.20414; Schipper RG, 2004, J HISTOCHEM CYTOCHEM, V52, P1259, DOI 10.1369/jhc.4C6389.2004; Schipper RG, 2000, SEMIN CANCER BIOL, V10, P55, DOI 10.1006/scbi.2000.0308; Soulet D, 2004, J BIOL CHEM, V279, P49355, DOI 10.1074/jbc.M401287200; Soulet D, 2002, BIOCHEM J, V367, P347, DOI 10.1042/BJ20020764; Steele C, 2003, J EXP MED, V198, P1677, DOI 10.1084/jem.20030932; Stein CR, 2004, EMERG INFECT DIS, V10, P1760, DOI 10.3201/eid1010.040362; SUZUKI O, 1984, EXPERIENTIA, V40, P838, DOI 10.1007/BF01951981; Uemura T, 2007, J BIOL CHEM, V282, P7733, DOI 10.1074/jbc.M611105200; VERMA DS, 1982, CANCER RES, V42, P3046; Wang SH, 2008, MICROBES INFECT, V10, P334, DOI 10.1016/j.micinf.2007.12.014; Wang YL, 2006, J BIOCHEM, V139, P17, DOI 10.1093/jb/mvj021; Xu HX, 2004, CANCER RES, V64, P8521, DOI 10.1158/0008-5472.CAN-04-3511; Zhang C, 2006, INFECT IMMUN, V74, P1857, DOI 10.1128/IAI.74.3.1857-1864.2006	53	17	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8174	8184		10.1074/jbc.M805787200	http://dx.doi.org/10.1074/jbc.M805787200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19158080	Green Published, hybrid			2022-12-25	WOS:000264195600079
J	Liavonchanka, A; Rudolph, MG; Tittmann, K; Hamberg, M; Feussner, I				Liavonchanka, Alena; Rudolph, Markus G.; Tittmann, Kai; Hamberg, Mats; Feussner, Ivo			On the Mechanism of a Polyunsaturated Fatty Acid Double Bond Isomerase from Propionibacterium acnes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONJUGATED LINOLEIC-ACID; ALGA PTILOTA-FILICINA; BUTYRIVIBRIO-FIBRISOLVENS; DIPHOSPHATE ISOMERASE; SUBSTRATE; FLAVOPROTEINS; BIOSYNTHESIS; BACTERIA; STEREOSPECIFICITY; BIOHYDROGENATION	The catalytic mechanism of Propionibacterium acnes polyunsaturated fatty acid isomerase (PAI) is explored by kinetic, spectroscopic, and thermodynamic studies. The PAI-catalyzed double bond isomerization takes place by selective removal of the pro-R hydrogen from C-11 followed by suprafacial transfer of this hydrogen to C-9 as shown by conversion of C-9-deuterated substrate isotopologs. Data on the midpoint potential, photoreduction, and cofactor replacement suggest PAI to operate via an ionic mechanism with the formation of FADH(2) and linoleic acid carbocation as intermediates. In line with this proposal, no radical intermediates were detected neither by stopped flow absorption nor by EPR spectroscopy. The substrate preference toward free fatty acids is determined by the interaction between Arg-88 and Phe-193, and the reaction rate is strongly affected by replacement of these amino acids, indicating that the efficiency of the hydrogen transfer relies on a fixed distance between the free carboxyl group and the N-5 atom of FAD. Combining data obtained for PAI from the structural studies and experiments described here suggests that at least two different prototypical active site geometries exist among polyunsaturated fatty acid double bond isomerases.	[Liavonchanka, Alena] Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, D-377077 Gottingen, Germany; [Tittmann, Kai; Feussner, Ivo] Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Bioanalyt, D-377077 Gottingen, Germany; [Rudolph, Markus G.] Univ Gottingen, Inst Microbiol & Genet, Dept Biol Struct, D-377077 Gottingen, Germany; [Hamberg, Mats] Karolinska Inst, Dept Med Biochem & Biophys, Div Chem 2, SE-17177 Stockholm, Sweden	University of Gottingen; University of Gottingen; University of Gottingen; Karolinska Institutet	Feussner, I (corresponding author), Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, Justus von Liebig Weg 11, D-377077 Gottingen, Germany.	ifeussn@gwdg.de	Feussner, Ivo/H-9320-2013	Feussner, Ivo/0000-0002-9888-7003; Rudolph, Markus/0000-0003-0447-1101; Hamberg, Mats/0000-0002-8910-7810	international master/Ph.D. program Molecular Biology; International Max Planck Research School in Molecular Biology, Goettingen	international master/Ph.D. program Molecular Biology; International Max Planck Research School in Molecular Biology, Goettingen	Supported by a Georg-Christoph-Lichtenberg stipend from the international master/Ph.D. program Molecular Biology and the International Max Planck Research School in Molecular Biology, Goettingen.	Basran J, 2003, J BIOL CHEM, V278, P43973, DOI 10.1074/jbc.M305983200; Basran J, 2001, J BIOL CHEM, V276, P24581, DOI 10.1074/jbc.M101178200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bornemann S, 2002, NAT PROD REP, V19, P761, DOI 10.1039/b108916c; Chapman S.K., 1999, FLAVOPROTEIN PROTOCO; Christie WW, 1998, LIPIDS, V33, P343, DOI 10.1007/s11745-998-0214-x; Devillard E, 2007, J BACTERIOL, V189, P2566, DOI 10.1128/JB.01359-06; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; Hamberg M, 2005, FEBS J, V272, P736, DOI 10.1111/j.1742-4658.2004.04510.x; Hornung E, 2005, BBA-MOL CELL BIOL L, V1738, P105, DOI 10.1016/j.bbalip.2005.11.004; Hornung E, 2002, EUR J BIOCHEM, V269, P4852, DOI 10.1046/j.1432-1033.2002.03184.x; KEPLER CR, 1970, J BIOL CHEM, V245, P3612; KEPLER CR, 1971, J BIOL CHEM, V246, P2765; Kittleman W, 2007, BIOCHEMISTRY-US, V46, P8401, DOI 10.1021/bi700286a; Liavonchanka A, 2006, P NATL ACAD SCI USA, V103, P2576, DOI 10.1073/pnas.0510144103; Liavonchanka A, 2006, ACTA CRYSTALLOGR F, V62, P153, DOI 10.1107/S1744309106001229; Liavonchanka A, 2008, CHEMBIOCHEM, V9, P1867, DOI 10.1002/cbic.200800141; MASSEY V, 1994, J BIOL CHEM, V269, P22459; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P9, DOI 10.1021/bi00594a002; MINNAERT K, 1965, BIOCHIM BIOPHYS ACTA, V110, P42, DOI 10.1016/S0926-6593(65)80093-5; Muh U, 1996, BIOCHEMISTRY-US, V35, P11710, DOI 10.1021/bi9601363; Murthy YVSN, 1997, METHOD ENZYMOL, V280, P436; Ogawa J, 2005, J BIOSCI BIOENG, V100, P355, DOI 10.1263/jbb.100.355; Rothman SC, 2007, BIOCHEMISTRY-US, V46, P5437, DOI 10.1021/bi0616347; Saenger AK, 2005, BIOCHEMISTRY-US, V44, P16043, DOI 10.1021/bi051048y; SCHROEPF.GJ, 1965, J BIOL CHEM, V240, P54; Wallace RJ, 2007, J LIPID RES, V48, P2247, DOI 10.1194/jlr.M700271-JLR200; Wise ML, 1997, BIOCHEMISTRY-US, V36, P2985, DOI 10.1021/bi962158v; WISE ML, 1994, BIOCHEMISTRY-US, V33, P15223, DOI 10.1021/bi00255a002	29	24	27	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8005	8012		10.1074/jbc.M809060200	http://dx.doi.org/10.1074/jbc.M809060200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19164287	Green Published, hybrid			2022-12-25	WOS:000264195600063
J	Lin, Y; Liu, XJ; Cheng, YH; Yang, J; Huo, YQ; Zhang, CX				Lin, Ying; Liu, Xiaojun; Cheng, Yunhui; Yang, Jian; Huo, Yuqing; Zhang, Chunxiang			Involvement of MicroRNAs in Hydrogen Peroxide-mediated Gene Regulation and Cellular Injury Response in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; NEOINTIMA FORMATION; GROWTH; AP-1; EXPRESSION; CANCER; DEATH; PDCD4; IDENTIFICATION; PROLIFERATION	MicroRNAs (miRNAs) comprise a novel class of endogenous, small, noncoding RNAs that negatively regulate similar to 30% of genes in a cell via degradation or translational inhibition of their target mRNAs. However, the effects of reactive oxygen species (ROS) on miRNA expression and the roles of miRNAs in ROS-mediated gene regulation and biological functions of vascular cells are unclear. Using microarray analysis, we demonstrated that miRNAs are aberrantly expressed in vascular smooth muscle cells (VSMCs) after treatment with hydrogen peroxide (H2O2). H2O2-mediated up-regulation of microRNA-21 (miR-21) was further confirmed by quantitative real-time PCR. To determine the potential roles of miRNAs in H2O2-mediated gene regulation and cellular effects, miR-21 expression was down-regulated by miR-21 inhibitor and up-regulated by pre-miR-21. H2O2-induced VSMC apoptosis and death were increased by miR-21 inhibitor and decreased by pre-miR-21. Programmed cell death 4 (PDCD4) was a direct target of miR-21 that was involved in miR-21-mediated effects on VSMCs. Pre-miR-21-mediated protective effect on VSMC apoptosis and death was blocked via adenovirus-mediated overexpression of PDCD4 without the miR-21 binding site. Moreover, activator protein 1 was a downstream signaling molecule of PDCD4 in miR-21-modulated VSMCs. The results suggest that miRNAs in VSMCs are sensitive to H2O2 stimulation. miRN-21 participates in H2O2-mediated gene regulation and cellular injury response through PDCD4 and the activator protein 1 pathway. miRNAs might play a role in vascular diseases related to ROS.	[Lin, Ying; Liu, Xiaojun; Cheng, Yunhui; Yang, Jian; Zhang, Chunxiang] Univ Med & Dent New Jersey, RNA, Newark, NJ 07103 USA; [Lin, Ying; Liu, Xiaojun; Cheng, Yunhui; Yang, Jian; Zhang, Chunxiang] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Anesthesiol, Cardiovasc Res Lab, Newark, NJ 07103 USA; [Huo, Yuqing] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Minnesota System; University of Minnesota Twin Cities	Zhang, CX (corresponding author), 185 S Orange Ave,MSB E548, Newark, NJ 07101 USA.	zhangc3@umdnj.edu	Liu, Xiaojun/C-1650-2009; Cheng, Yunhui/D-3922-2012; zhang, xiang chun/HCH-7063-2022; Cheng, Yunhui/A-4683-2011	Liu, Xiaojun/0000-0003-4758-7040; zhang, xiang chun/0000-0001-8303-6495; 	National Institutes of Health [HL080133]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080133] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL080133.	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonomini F, 2008, HISTOL HISTOPATHOL, V23, P381, DOI 10.14670/HH-23.381; Cerda S, 1997, MUTAT RES-REV MUTAT, V386, P141, DOI 10.1016/S1383-5742(96)00050-6; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Cho MA, 2007, J ENDOCRINOL, V195, P255, DOI 10.1677/JOE-06-0193; Delles C, 2008, ANTIOXID REDOX SIGN, V10, P1061, DOI 10.1089/ars.2007.2008; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gao XL, 2004, BIOPOLYMERS, V73, P579, DOI 10.1002/bip.20005; Halbeisen RE, 2008, CELL MOL LIFE SCI, V65, P798, DOI 10.1007/s00018-007-7447-6; Hwang SK, 2007, GENE THER, V14, P1353, DOI 10.1038/sj.gt.3302983; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Karin M, 2001, IUBMB LIFE, V52, P17; Kong Yong, 2005, GeoActa, V3, P62; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu ZM, 2005, J BIOL CHEM, V280, P14700, DOI 10.1074/jbc.M500322200; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Lyle AN, 2006, PHYSIOLOGY, V21, P269, DOI 10.1152/physiol.00004.2006; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Mangat R, 2006, AM J PHYSIOL-HEART C, V291, pH854, DOI 10.1152/ajpheart.01205.2005; McCormick ML, 2007, ARTERIOSCL THROM VAS, V27, P461, DOI 10.1161/01.ATV.0000257552.94483.14; Movahed A, 1996, CAN J CARDIOL, V12, P138; Napoli C, 2001, J CELL BIOCHEM, V82, P674, DOI 10.1002/jcb.1198; Pasquinelli AE, 2005, CURR OPIN GENET DEV, V15, P200, DOI 10.1016/j.gde.2005.01.002; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shi Y, 2001, CIRCULATION, V103, P2408; Son Seok Man, 2004, Curr Diab Rep, V4, P247; Tardif Jean-Claude, 2002, Am J Cardiovasc Drugs, V2, P323, DOI 10.2165/00129784-200202050-00005; Vandenbroucke K, 2008, MOL BIOL EVOL, V25, P507, DOI 10.1093/molbev/msm276; Weigel AL, 2002, FREE RADICAL BIO MED, V33, P1419, DOI 10.1016/S0891-5849(02)01082-1; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433; Yoo PS, 2006, WORLD J GASTROENTERO, V12, P4937, DOI 10.3748/wjg.v12.i31.4937; ZAUG AJ, 1986, SCIENCE, V231, P470, DOI 10.1126/science.3941911; Zhang CX, 2008, CLIN SCI, V114, P699, DOI 10.1042/CS20070211; Zhang CX, 2004, J EXP MED, V199, P763, DOI 10.1084/jem.20031619; Zhang Li-Jun, 2008, Acta Zootaxonomica Sinica, V33, P147	43	189	216	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7903	7913		10.1074/jbc.M806920200	http://dx.doi.org/10.1074/jbc.M806920200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19158092	Green Published, hybrid			2022-12-25	WOS:000264195600052
J	Burgess, STG; Shen, C; Ferguson, LA; O'Neill, GT; Docherty, K; Hunter, N; Goldmann, W				Burgess, Stewart T. G.; Shen, Cuicui; Ferguson, Laura A.; O'Neill, Gerard T.; Docherty, Kevin; Hunter, Nora; Goldmann, Wilfred			Identification of Adjacent Binding Sites for the YY1 and E4BP4 Transcription Factors in the Ovine PrP (Prion) Gene Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN GENE; MESSENGER-RNA; EXPRESSION; POLYMORPHISMS; ACCUMULATION; ACTIVATION; REGULATOR; SURVIVAL; ELEMENT	The PrP gene encodes the cellular isoform of the prion protein (PrPc) which has been shown to be crucial to the development of transmissible spongiform encephalopathies (TSEs). PrP knock-out mice, which do not express endogenous PrPc, exhibit resistance to TSE disease. The regulation of PrP gene expression represents, therefore, a crucial factor in the development of TSEs. Two sequence motifs in the PrP promoter (positions -287 to -263 from transcriptional start) were previously reported as being highly conserved, and it was suggested that they represent binding sites for as yet unidentified transcription factors. To test this hypothesis, binding of nuclear proteins was analyzed by electrophoretic mobility shift assays using ovine or murine cells and tissues with radiolabeled DNA probes containing the conserved motif sequences. Specific binding was observed to both motifs, and polymorphic variants of these motifs exhibited differential binding. Two proteins bound to these motifs were identified as the Yin Yang 1 (YY1) (motif 1) and E4BP4 (motif 2) transcription factors. Functional promoter analysis of four different promoter variants revealed that motif 1 (YY1) was associated with inhibitory activity in the context of the PrP promoter, whereas motif 2 (E4BP4) was linked to a slight enhancing activity. This represents the first demonstration of binding of nuclear factors to two highly conserved DNA sequence motifs within mammalian PrP promoters. The action of these factors on the PrP promoter is haplotype-specific, leading us to propose that the prion protein expression pattern and, with it, the distribution of TSE infectivity may be associated with PrP promoter genotype.	[Burgess, Stewart T. G.; Shen, Cuicui; O'Neill, Gerard T.; Hunter, Nora; Goldmann, Wilfred] Univ Edinburgh, Neuropathogenesis Div, Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; [Ferguson, Laura A.; Docherty, Kevin] Univ Aberdeen, Sch Med Sci, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Shen, Cuicui] China Agr Univ, Coll Vet Med, Natl Inst Anim TSEs, Beijing 100094, Peoples R China; [Burgess, Stewart T. G.; Shen, Cuicui; O'Neill, Gerard T.; Hunter, Nora; Goldmann, Wilfred] Univ Edinburgh, Neuropathogenesis Div, RDSVS, Roslin EH25 9PS, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Aberdeen; China Agricultural University; University of Edinburgh	Goldmann, W (corresponding author), Univ Edinburgh, Neuropathogenesis Div, Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland.	wilfred.goldmann@roslin.ed.ac.uk		Docherty, Kevin/0000-0001-6765-2060; burgess, stewart/0000-0002-9268-7641	United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) [00A1D06533, CPA1741]; BBSRC [BBS/E/D/05241340, BBS/E/A/00001651] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/A/00001651, BBS/E/D/05241340] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) Grant 00A1D06533, Roslin ISPG Programme 3 "The Biology of Neurodegenerative Disease," and BBSRC China Partnering Award CPA1741.	Baier M, 2008, INT J DEV NEUROSCI, V26, P821, DOI 10.1016/j.ijdevneu.2008.07.001; Cagampang FRA, 1999, NEUROSCIENCE, V91, P1201, DOI 10.1016/S0306-4522(99)00092-5; Cowell IG, 2002, BIOESSAYS, V24, P1023, DOI 10.1002/bies.10176; Dupre SM, 2008, ENDOCRINOLOGY, V149, P5527, DOI 10.1210/en.2008-0834; Dyer KD, 2001, LIFE SCI, V69, P201, DOI 10.1016/S0024-3205(01)01104-3; Ericsson J, 1999, J BIOL CHEM, V274, P14508, DOI 10.1074/jbc.274.20.14508; Freshney RI., 1987, CULTURE ANIMAL CELLS; GAMBETTI P, 1993, BRIT MED BULL, V49, P980, DOI 10.1093/oxfordjournals.bmb.a072657; Haigh CL, 2007, J MOL BIOL, V368, P915, DOI 10.1016/j.jmb.2007.02.086; Hu W, 2007, ACTA NEUROL SCAND, V116, P75, DOI 10.1111/j.1600-0404.2007.00868.x; HYDEDERUYSCHER RP, 1995, NUCLEIC ACIDS RES, V23, P4457, DOI 10.1093/nar/23.21.4457; Ikushima S, 1997, P NATL ACAD SCI USA, V94, P2609, DOI 10.1073/pnas.94.6.2609; Inoue S, 1997, J VET MED SCI, V59, P175, DOI 10.1292/jvms.59.175; Jamieson E, 2001, NEUROREPORT, V12, P3567, DOI 10.1097/00001756-200111160-00039; Johansson E, 1998, J BIOL CHEM, V273, P29816, DOI 10.1074/jbc.273.45.29816; JOHN HA, 1994, HUM GENE THER, V5, P283, DOI 10.1089/hum.1994.5.3-283; Johnson RT, 2005, LANCET NEUROL, V4, P635, DOI 10.1016/S1474-4422(05)70192-7; Kretzschmar HA, 1997, J NEURAL TRANSM-SUPP, P191; MANSON JC, 1994, NEURODEGENERATION, V3, P331; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; MCKNIGHT SL, 1991, SCI AM, V264, P54, DOI 10.1038/scientificamerican0491-54; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Montagna P, 2005, SLEEP MED REV, V9, P339, DOI 10.1016/j.smrv.2005.02.001; Nishimura Y, 2001, J BIOL CHEM, V276, P19921, DOI 10.1074/jbc.M010332200; NOVAK K, 2006, J NEUROCHEM, V96, P1696; O'Neill GT, 2005, J ANIM BREED GENET, V122, P86, DOI 10.1111/j.1439-0388.2005.00520.x; O'Neill GT, 2003, J ANIM BREED GENET, V120, P114, DOI 10.1046/j.1439-0388.2003.00381.x; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Premzl M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-1; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Romey MC, 2000, J BIOL CHEM, V275, P3561, DOI 10.1074/jbc.275.5.3561; Saeki K, 1996, BIOCHEM BIOPH RES CO, V219, P47, DOI 10.1006/bbrc.1996.0179; Sander P, 2005, J BIOL CHEM, V280, P37408, DOI 10.1074/jbc.M506361200; Schneider K, 2007, J ENDODONT, V33, P110, DOI 10.1016/j.joen.2006.11.010; SETO E, 1993, NATURE, V365, P462, DOI 10.1038/365462a0; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Spencer VA, 2003, METHODS, V31, P67, DOI 10.1016/S1046-2023(03)00089-6; Tobler I, 1996, NATURE, V380, P639, DOI 10.1038/380639a0; WEISSMANN C, 2003, BRIT MED B SERIES EX, P321; WESTAWAY D, 1994, P NATL ACAD SCI USA, V91, P6418, DOI 10.1073/pnas.91.14.6418; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; Yu YL, 2002, J BIOL CHEM, V277, P27144, DOI 10.1074/jbc.M200924200; Zambrano N, 1997, BIOCHEM J, V328, P293, DOI 10.1042/bj3280293; Zomosa-Signoret V, 2008, VET RES, V39, DOI 10.1051/vetres:2007048	45	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6716	6724		10.1074/jbc.M807065200	http://dx.doi.org/10.1074/jbc.M807065200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19129193	hybrid, Green Published			2022-12-25	WOS:000263919000016
J	Cormier, A; Clement, MJ; Knossow, M; Lachkar, S; Savarin, P; Toma, F; Sobel, A; Gigant, B; Curmi, PA				Cormier, Anthony; Clement, Marie-Jeanne; Knossow, Marcel; Lachkar, Sylvie; Savarin, Philippe; Toma, Flavio; Sobel, Andre; Gigant, Benoit; Curmi, Patrick A.			The PN2-3 Domain of Centrosomal P4.1-associated Protein Implements a Novel Mechanism for Tubulin Sequestration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; SECONDARY STRUCTURE PREDICTION; STATHMIN FAMILY PROTEINS; NMR-SPECTROSCOPY; CIRCULAR-DICHROISM; GTPASE ACTIVITY; CHEMICAL-SHIFT; BINDING; COMPLEX; CPAP	Microtubules are cytoskeletal components involved in multiple cell functions such as mitosis, motility, or intracellular traffic. In vivo, these polymers made of alpha beta-tubulin nucleate mostly from the centrosome to establish the interphasic microtubule network or, during mitosis, the mitotic spindle. Centrosomal P4.1-associated protein (CPAP; also named CENPJ) is a centrosomal protein involved in the assembly of centrioles and important for the centrosome function. This protein contains a microtubule-destabilizing region referred to as PN2-3. Here we decrypt the microtubule destabilization activity of PN2-3 at the molecular level and show that it results from the sequestration of tubulin by PN2-3 in a non-polymerizable 1: 1 complex. We also map the tubulin/PN2-3 interaction both on the PN2-3 sequence and on the tubulin surface. NMR and CD data on free PN2-3 in solution show that this is an intrinsically unstructured protein that comprises a 23-amino acid residue alpha-helix. This helix is embedded in a 76-residue region that interacts strongly with tubulin. The interference of PN2-3 with well characterized tubulin properties, namely GTPase activity, nucleotide exchange, vinblastine-induced self-assembly, and stathmin family protein binding, highlights the beta subunit surface located at the intermolecular longitudinal interface when tubulin is embedded in a microtubule as a tubulin/PN2-3 interaction area. These findings characterize the PN2-3 fragment of CPAP as a protein with an unprecedented tubulin sequestering mechanism distinct from that of stathmin family proteins.	[Cormier, Anthony; Knossow, Marcel; Gigant, Benoit] CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; [Clement, Marie-Jeanne; Savarin, Philippe; Toma, Flavio; Curmi, Patrick A.] Univ Evry Val DEssonne, INSERM, UMR829, Lab Struct Activite Biomol Normales & Pathol, F-91025 Evry, France; [Lachkar, Sylvie; Sobel, Andre] Univ Paris 06, Inst Fer Moulin, INSERM, UMR839, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Gigant, B (corresponding author), CNRS, Lab Enzymol & Biochim Struct, Batiment 34,1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	gigant@lebs.cnrs-gif.fr; pcurmi@univ-evry.fr	CURMI, Patrick/G-4036-2013	CURMI, Patrick A./0000-0001-5045-8501; Gigant, Benoit/0000-0002-5946-6759	INSERM; CNRS; Association pour la Recherche sur le Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by INSERM, CNRS, Association pour la Recherche sur le Cancer (to P.A.C. and A.S.), and Association Francaise contre les Myopathies (to A.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Amayed P, 2000, BIOCHEMISTRY-US, V39, P12295, DOI 10.1021/bi000279w; BAI R, 1990, J BIOL CHEM, V265, P17141; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Bevington PR, 1992, DATA REDUCTION ERROR; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAPLOW M, 1980, ARCH BIOCHEM BIOPHYS, V203, P404, DOI 10.1016/0003-9861(80)90193-9; CARLIER MF, 1987, BIOCHEMISTRY-US, V26, P4428, DOI 10.1021/bi00388a036; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Charbaut E, 2001, J BIOL CHEM, V276, P16146, DOI 10.1074/jbc.M010637200; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Cho JH, 2006, BIOCHEM BIOPH RES CO, V339, P742, DOI 10.1016/j.bbrc.2005.11.074; Clement MJ, 2008, BIOMOL NMR ASSIGN, V2, P115, DOI 10.1007/s12104-008-9099-3; Clement MJ, 2005, BIOCHEMISTRY-US, V44, P14616, DOI 10.1021/bi0512492; Cormier A, 2008, EMBO REP, V9, P1101, DOI 10.1038/embor.2008.171; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DAVIDPFEUTY T, 1979, J BIOL CHEM, V254, P1696; DETRICH HW, 1978, BIOCHEMISTRY-US, V17, P3900, DOI 10.1021/bi00612a002; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; Hsu WB, 2008, EXP CELL RES, V314, P2591, DOI 10.1016/j.yexcr.2008.05.012; Hung LY, 2000, MOL CELL BIOL, V20, P7813, DOI 10.1128/MCB.20.20.7813-7825.2000; Hung LY, 2004, MOL BIOL CELL, V15, P2697, DOI 10.1091/mbc.E04-02-0121; Jourdain I, 2004, BIOCHEM J, V378, P877, DOI 10.1042/BJ20031413; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; KNELLER DG, 1990, J MOL BIOL, V214, P171, DOI 10.1016/0022-2836(90)90154-E; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Martin SR, 2008, METHOD CELL BIOL, V84, P263, DOI 10.1016/S009l-679X(07)84010-6; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Sambrook J., 1989, MOL CLONING LAB MANU; Schiebel E, 2000, CURR OPIN CELL BIOL, V12, P113, DOI 10.1016/S0955-0674(99)00064-2; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Steinmetz MO, 2007, J STRUCT BIOL, V158, P137, DOI 10.1016/j.jsb.2006.07.018; Steinmetz MO, 2000, EMBO J, V19, P572, DOI 10.1093/emboj/19.4.572; STULTZ CM, 1993, PROTEIN SCI, V2, P305; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Wang CG, 2007, BIOCHEMISTRY-US, V46, P10595, DOI 10.1021/bi701147f; WEISENBE.RC, 1970, BIOCHEMISTRY-US, V9, P4110, DOI 10.1021/bi00823a012; WEISENBERG RC, 1968, BIOCHEMISTRY-US, V7, P4466, DOI 10.1021/bi00852a043; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	47	39	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6909	6917		10.1074/jbc.M808249200	http://dx.doi.org/10.1074/jbc.M808249200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19131341	Green Published, hybrid			2022-12-25	WOS:000263919000038
J	Larue, K; Kimber, MS; Ford, R; Whitfield, C				Larue, Kane; Kimber, Matthew S.; Ford, Robert; Whitfield, Chris			Biochemical and Structural Analysis of Bacterial O-antigen Chain Length Regulator Proteins Reveals a Conserved Quaternary Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL REGIONS; GROUP-1 CAPSULAR POLYSACCHARIDES; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; SHIGELLA-FLEXNERI; PSEUDOMONAS-AERUGINOSA; CONFORMATIONAL FLEXIBILITY; 3-DIMENSIONAL STRUCTURE; ALTERNATIVE PATHWAY; POLYACRYLAMIDE GELS	Lipopolysaccharide (LPS) is a major component of the Gram-negative outer membrane and is an important virulence determinant. The O-antigen polysaccharide of the LPS molecule provides protection from host defenses, and the length of O-antigen chains plays a pivotal role. In the Wzy-dependent O-antigen biosynthesis pathway, the integral inner membrane protein Wzz determines the O-antigen chain length. How these proteins function is currently unknown, but the hypothesis includes activities such as a "molecular ruler" or a "molecular stopwatch," and other possibilities may exist. Wzz homologs are membrane proteins with two transmembrane helices that flank a large periplasmic domain. Recent x-ray crystallographic studies of the periplasmic portions of Wzz proteins found multiple oligomeric forms, with quaternary structures favoring the "molecular ruler" interpretation. Here, we have studied full-length Wzz proteins with the transmembrane portions embedded in lipid membranes. Using electron microscopy and image analysis we find a unique hexameric state rather than differing oligomeric forms. The data suggest that in vivo Wzz proteins determine O-antigen chain length via subtle structure-function relationships at the level of primary, secondary, or tertiary structure within the context of a hexameric complex.	[Larue, Kane; Kimber, Matthew S.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Ford, Robert] Univ Manchester, Fac Life Sci, Manchester M60 1QD, Lancs, England	University of Guelph; University of Manchester	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca	Kimber, Matthew/Q-8144-2019	Kimber, Matthew/0000-0001-9454-5586; Ford, Robert/0000-0002-0958-1505	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; Amer AO, 2001, MICROBIOL-SGM, V147, P3015, DOI 10.1099/00221287-147-11-3015; Amor PA, 1997, MOL MICROBIOL, V26, P145, DOI 10.1046/j.1365-2958.1997.5631930.x; AMOS LA, 1983, PROG BIOPHYS MOL BIO, V39, P183, DOI 10.1016/0079-6107(83)90017-2; Anderson MS, 2000, FEMS MICROBIOL LETT, V191, P169, DOI 10.1111/j.1574-6968.2000.tb09335.x; BASTIN DA, 1993, MOL MICROBIOL, V7, P725, DOI 10.1111/j.1365-2958.1993.tb01163.x; BATCHELOR RA, 1992, J BACTERIOL, V174, P5228, DOI 10.1128/JB.174.16.5228-5236.1992; BATCHELOR RA, 1991, J BACTERIOL, V173, P5699, DOI 10.1128/jb.173.18.5699-5704.1991; Becker A, 1998, J BACTERIOL, V180, P395, DOI 10.1128/JB.180.2.395-399.1998; BINOTTO J, 1991, CAN J MICROBIOL, V37, P474, DOI 10.1139/m91-078; Collins RF, 2006, J BIOL CHEM, V281, P2144, DOI 10.1074/jbc.M508078200; Collins RF, 2007, P NATL ACAD SCI USA, V104, P2390, DOI 10.1073/pnas.0607763104; Daniels C, 2002, ENVIRON MICROBIOL, V4, P883, DOI 10.1046/j.1462-2920.2002.00288.x; Daniels C, 1999, MOL MICROBIOL, V34, P181, DOI 10.1046/j.1365-2958.1999.01591.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dodgson C, 1996, J BACTERIOL, V178, P1895, DOI 10.1128/jb.178.7.1895-1902.1996; Doublet P, 2002, J BIOL CHEM, V277, P37339, DOI 10.1074/jbc.M204465200; Franco AV, 1998, J BACTERIOL, V180, P2670, DOI 10.1128/JB.180.10.2670-2675.1998; GROSSMAN N, 1987, J BACTERIOL, V169, P856, DOI 10.1128/jb.169.2.856-863.1987; Guo H, 2006, PROTEIN EXPRES PURIF, V48, P49, DOI 10.1016/j.pep.2006.01.015; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; JOINER KA, 1988, ANNU REV MICROBIOL, V42, P201, DOI 10.1146/annurev.mi.42.100188.001221; KASTOWSKY M, 1992, J BACTERIOL, V174, P4798, DOI 10.1128/JB.174.14.4798-4806.1992; Klee SR, 1997, J BACTERIOL, V179, P2421, DOI 10.1128/jb.179.7.2421-2425.1997; LAM JS, 1992, J BACTERIOL, V174, P7159, DOI 10.1128/jb.174.22.7159-7167.1992; Lee DC, 2008, EMBO J, V27, P1758, DOI 10.1038/emboj.2008.97; Lobedanz S, 2007, P NATL ACAD SCI USA, V104, P4612, DOI 10.1073/pnas.0610160104; Ludtke SJ, 2001, J MOL BIOL, V314, P253, DOI 10.1006/jmbi.2001.5133; Marolda CL, 2008, J BACTERIOL, V190, P2128, DOI 10.1128/JB.01746-07; Marolda CL, 2006, J BACTERIOL, V188, P5124, DOI 10.1128/JB.00461-06; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; MORONA R, 1995, J BACTERIOL, V177, P1059, DOI 10.1128/jb.177.4.1059-1068.1995; Morona R, 2000, MICROBIOL-UK, V146, P1, DOI 10.1099/00221287-146-1-1; Mosser G, 2001, MICRON, V32, P517, DOI 10.1016/S0968-4328(00)00047-0; MUNFORD RS, 1980, J BACTERIOL, V144, P630, DOI 10.1128/JB.144.2.630-640.1980; Murray GL, 2006, J BACTERIOL, V188, P2735, DOI 10.1128/JB.188.7.2735-2739.2006; Murray GL, 2003, MOL MICROBIOL, V47, P1395, DOI 10.1046/j.1365-2958.2003.03383.x; Olivares-Illana V, 2008, PLOS BIOL, V6, P1321, DOI 10.1371/journal.pbio.0060143; PALVA ET, 1980, EUR J BIOCHEM, V107, P137, DOI 10.1111/j.1432-1033.1980.tb04634.x; PANGBURN MK, 1989, J IMMUNOL, V142, P2766; PANGBURN MK, 1989, J IMMUNOL, V142, P2759; Price NP, 2005, GLYCOBIOLOGY, V15, p29R, DOI 10.1093/glycob/cwi065; Purins L, 2008, MICROBIOL-SGM, V154, P1104, DOI 10.1099/mic.0.2007/014225-0; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Saldias MS, 2008, MICROBIOL-SGM, V154, P440, DOI 10.1099/mic.0.2007/013136-0; Tang KH, 2007, BIOCHEMISTRY-US, V46, P11744, DOI 10.1021/bi701181r; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; Tocilj A, 2008, NAT STRUCT MOL BIOL, V15, P130, DOI 10.1038/nsmb.1374; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Valvano MA, 2003, FRONT BIOSCI-LANDMRK, V8, pS452, DOI 10.2741/1079; Wang L, 1996, J BACTERIOL, V178, P2598, DOI 10.1128/jb.178.9.2598-2604.1996; WANG L, 1994, J BACTERIOL, V176, P4348, DOI 10.1128/jb.176.14.4348-4356.1994; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wugeditsch T, 2001, J BIOL CHEM, V276, P2361, DOI 10.1074/jbc.M009092200; Yeager M, 1999, Methods Enzymol, V294, P135; Zgurskaya HI, 2000, J BACTERIOL, V182, P4264, DOI 10.1128/JB.182.15.4264-4267.2000; Zgurskaya HI, 1999, J MOL BIOL, V285, P409, DOI 10.1006/jmbi.1998.2313	61	56	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7395	7403		10.1074/jbc.M809068200	http://dx.doi.org/10.1074/jbc.M809068200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19129185	Green Published, hybrid			2022-12-25	WOS:000263919000085
J	Mirnikjoo, B; Balasubramanian, K; Schroit, AJ				Mirnikjoo, Banafsheh; Balasubramanian, Krishnakumar; Schroit, Alan J.			Mobilization of Lysosomal Calcium Regulates the Externalization of Phosphatidylserine during Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; FREE CA2+; CELLS; MITOCHONDRIAL; EXPOSURE; TRANSLOCATION; INTRANUCLEAR; PLATELETS; INCREASE; SURFACE	A hallmark of apoptotic cells is the Ca2+ dependent appearance of phosphatidylserine (PS) at the cell surface as a result of its redistribution from the inner-to-outer plasma membrane leaflet. Although endoplasmic reticulum and mitochondrial Ca2+ are known to participate in apoptosis, their role in PS externalization has not been established. In this study, several organelle-specific fluorescent markers and Ca2+-sensitive probes were used to identify the source of Ca2+ critical to PS externalization. By employing Rhod-2AM, fluorescein-labeled high molecular weight dextran, and Calcium Green 1, we provide evidence that lysosomes respond to apoptotic stimuli by releasing their luminal Ca2+ to the cytosol. Cells treated with the cytosolic phospholipase A(2) inhibitor, cPLA2 alpha, had no effect on caspase activation but exhibited a significant decrease in lysosomal Ca2+ release and externalization of PS in response to apoptotic stimuli. Similarly, cells depleted of lysosomal Ca2+ underwent programmed cell death yet failed to externalize PS. These data indicate that although Ca2+ release from other intracellular organelles to the cytosol is adequate for apoptosis, the release of Ca2+ from lysosomes is critical for PS externalization.	[Mirnikjoo, Banafsheh; Balasubramanian, Krishnakumar; Schroit, Alan J.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Schroit, AJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	aschroit@mdanderson.org			National Institutes of Health [CA-98527]; Foundation and by Department of Defense Breast Cancer Research Program [W81XWH-06-1-0347]; NATIONAL CANCER INSTITUTE [R01CA098527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation and by Department of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-98527 (to A.J.S.). This work was also supported in part by a grant from the John Q. Gaines Foundation and by Department of Defense Breast Cancer Research Program Grant W81XWH-06-1-0347 ( to B. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Balasubramanian K, 2007, J BIOL CHEM, V282, P18357, DOI 10.1074/jbc.M700202200; Bassik MC, 2004, EMBO J, V23, P1207, DOI 10.1038/sj.emboj.7600104; BELLOMO G, 1992, CANCER RES, V52, P1342; Bevers EM, 1999, BBA-MOL CELL BIOL L, V1439, P317, DOI 10.1016/S1388-1981(99)00110-9; Bratton DL, 1997, J BIOL CHEM, V272, P26159, DOI 10.1074/jbc.272.42.26159; Burlando B, 2002, AM J PHYSIOL-CELL PH, V283, pC1461, DOI 10.1152/ajpcell.00429.2001; Castedo M, 1996, J IMMUNOL, V157, P512; Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; Draper DW, 2004, J IMMUNOL, V172, P2416, DOI 10.4049/jimmunol.172.4.2416; FADOK VA, 1992, J IMMUNOL, V148, P2207; Gerasimenko JV, 1998, CURR BIOL, V8, P1335, DOI 10.1016/S0960-9822(07)00565-9; Grimsley C, 2003, TRENDS CELL BIOL, V13, P648, DOI 10.1016/j.tcb.2003.10.004; Hallett MB, 1999, J IMMUNOL METHODS, V232, P77, DOI 10.1016/S0022-1759(99)00167-2; Hampton MB, 1996, FEBS LETT, V399, P277, DOI 10.1016/S0014-5793(96)01341-5; Heemskerk JWM, 1997, BLOOD, V90, P2615, DOI 10.1182/blood.V90.7.2615.2615_2615_2625; Keij JF, 2000, CYTOMETRY, V39, P203, DOI 10.1002/(SICI)1097-0320(20000301)39:3<203::AID-CYTO5>3.0.CO;2-Z; Kong SK, 1997, ONCOLOGY-BASEL, V54, P55; Marchi B, 2004, AQUAT TOXICOL, V66, P197, DOI 10.1016/j.aquatox.2003.09.003; Ravichandran KS, 2003, CELL, V113, P817, DOI 10.1016/S0092-8674(03)00471-9; ROE MW, 1990, CELL CALCIUM, V11, P63, DOI 10.1016/0143-4160(90)90060-8; Sahu SK, 2007, ARCH BIOCHEM BIOPHYS, V462, P103, DOI 10.1016/j.abb.2007.04.002; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Sims PJ, 2001, THROMB HAEMOSTASIS, V86, P266; SMEETS EF, 1994, BBA-BIOMEMBRANES, V1195, P281, DOI 10.1016/0005-2736(94)90268-2; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; WILLIAMSON P, 1992, BIOCHEMISTRY-US, V31, P6355, DOI 10.1021/bi00142a027; Zhou QS, 2002, BLOOD, V99, P4030, DOI 10.1182/blood-2001-12-0271; Zunkler BJ, 2004, BIOCHEM PHARMACOL, V67, P1437, DOI 10.1016/j.bcp.2003.12.011	30	34	34	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6918	6923		10.1074/jbc.M805288200	http://dx.doi.org/10.1074/jbc.M805288200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19126538	Green Published, hybrid			2022-12-25	WOS:000263919000039
J	Nogami, K; Nishiya, K; Saenko, EL; Takeyama, M; Ogiwara, K; Yoshioka, A; Shima, M				Nogami, Keiji; Nishiya, Katsumi; Saenko, Evgueni L.; Takeyama, Masahiro; Ogiwara, Kenichi; Yoshioka, Akira; Shima, Midori			Identification of Plasmin-interactive Sites in the Light Chain of Factor VIII Responsible for Proteolytic Cleavage at Lys(36)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR-VIII; ACTIVATED PROTEIN-C; FACTOR-IXA; A1 SUBUNIT; FACTOR XA; HEAVY-CHAIN; CATALYZED CLEAVAGE; A2 SUBUNITS; FACTOR-VA; INACTIVATION	We have recently reported that plasmin likely associates with the factor VIII light chain to proteolyze at Lys(36) within the A1 domain. In this study, we determined that the rate of plasmin-catalyzed inactivation on the forms of factor VIIIa containing A1-(1-336) and (1722)A3C1C2, reflecting Lys36 cleavage, was reduced by similar to 60%, compared with those containing (1649)A3C1C2 and (1690)A3C1C2. SDS-PAGE analysis revealed that Lys36 cleavage of factor VIIIa with (1722)A3C1C2 was markedly slower than those with (1649)A3C1C2 and (1690)A3C1C2. Surface plasmon resonance-based assays, using active site-modified anhydro-plasmin (Ah-plasmin) showed that (1722)A3C1C2 bound to Ah-plasmin with an similar to 3-fold lower affinity than (1649)A3C1C2 or (1690)A3C1C2 (K-d, 176, 68.2, and 60.3 nM, respectively). Recombinant A3 bound to Ah-plasmin (K-d, 44.2 nM), whereas C2 failed to bind, confirming the presence of a plasmin-binding site within N terminus of A3. Furthermore, the Glu-Gly-Arg active sitem-odified factor IXa also blocked (1722)A3C1C2 binding to Ah-plasmin by similar to 95%, supporting the presence of another plasmin-binding site overlapping the factor IXa-binding site in A3. In keeping with a major contribution of the lysine-binding sites in plasmin for interaction with the factor VIII light chain, analysis of the A3 sequence revealed two regions involving clustered lysine residues in 1690-1705 and 1804-1818. Two peptides based on these regions blocked (1649)A3C1C2 binding to Ah-plasmin by similar to 60% and plasmin-catalyzed Lys36 cleavage of factor VIIIa with A1-(1-336) by similar to 80%. Our findings indicate that an extended surface, centered on residues 1690-1705 and 1804 1818 within the A3 domain, contributes to a unique plasmin-interactive site that promotes plasmin docking during cofactor inactivation by cleavage at Lys(36).	[Nogami, Keiji; Nishiya, Katsumi; Takeyama, Masahiro; Ogiwara, Kenichi; Yoshioka, Akira; Shima, Midori] Nara Med Univ, Dept Pediat, Nara 6348522, Japan; [Saenko, Evgueni L.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	Nara Medical University; University System of Maryland; University of Maryland Baltimore	Nogami, K (corresponding author), Nara Med Univ, Dept Pediat, 840 Shijo Cho, Nara 6348522, Japan.	roc-noga@naramed-u.ac.jp	Ogiwara, Kenichi/ABD-7067-2021	Ogiwara, Kenichi/0000-0002-3046-6915				BACHMANN F, 2000, HEMOSTASIS THROMBOSI, P275; Bovenschen N, 2003, J BIOL CHEM, V278, P9370, DOI 10.1074/jbc.M212053200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DONATH MJSH, 1995, J BIOL CHEM, V270, P3648, DOI 10.1074/jbc.270.8.3648; EATON D, 1986, BIOCHEMISTRY-US, V25, P505, DOI 10.1021/bi00350a035; FAY PJ, 1986, BIOCHIM BIOPHYS ACTA, V871, P268, DOI 10.1016/0167-4838(86)90208-6; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; Fay PJ, 2001, J BIOL CHEM, V276, P12434, DOI 10.1074/jbc.M009539200; Jenkins PV, 2004, BIOCHEMISTRY-US, V43, P5094, DOI 10.1021/bi036289p; Kalafatis M, 2001, J BIOL CHEM, V276, P18614, DOI 10.1074/jbc.M007134200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPHEAR BJ, 1992, BLOOD, V80, P3120; Lapan KA, 1997, J BIOL CHEM, V272, P2082; Lenting PJ, 1996, J BIOL CHEM, V271, P1935, DOI 10.1074/jbc.271.4.1935; LOLLAR P, 1988, J BIOL CHEM, V263, P10451; MANGEL WF, 1990, SCIENCE, V248, P69, DOI 10.1126/science.2108500; MANN KG, 1990, BLOOD, V76, P1; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; Nogami K, 2003, J BIOL CHEM, V278, P1634, DOI 10.1074/jbc.M209811200; Nogami K, 2004, J BIOL CHEM, V279, P15763, DOI 10.1074/jbc.M400568200; Nogami K, 2003, J BIOL CHEM, V278, P16502, DOI 10.1074/jbc.M213044200; Nogami K, 2008, BBA-PROTEINS PROTEOM, V1784, P753, DOI 10.1016/j.bbapap.2008.01.019; Nogami K, 2007, J BIOL CHEM, V282, P5287, DOI 10.1074/jbc.M607816200; O'Brien LM, 2000, BLOOD, V95, P1714, DOI 10.1182/blood.V95.5.1714.005k40_1714_1720; OBrien LM, 1997, BLOOD, V90, P3943, DOI 10.1182/blood.V90.10.3943; OMAR MN, 1987, J BIOL CHEM, V262, P9750; Pemberton S, 1997, BLOOD, V89, P2413, DOI 10.1182/blood.V89.7.2413; Pipe SW, 1997, P NATL ACAD SCI USA, V94, P11851, DOI 10.1073/pnas.94.22.11851; Pryzdial ELG, 1999, J BIOL CHEM, V274, P8500, DOI 10.1074/jbc.274.13.8500; RAMAKRISHNAN V, 1991, BIOCHEMISTRY-US, V30, P3963, DOI 10.1021/bi00230a023; REGAN LM, 1995, J BIOL CHEM, V270, P8546, DOI 10.1074/jbc.270.15.8546; REGAN LM, 1994, J BIOL CHEM, V269, P9445; Rosenblum MEK, 2002, J BIOL CHEM, V277, P11664, DOI 10.1074/jbc.M200037200; Samis JA, 2000, BLOOD, V95, P943, DOI 10.1182/blood.V95.3.943.003k34_943_951; SHIMA M, 1993, THROMB HAEMOSTASIS, V69, P240; Takeshima K, 2003, THROMB HAEMOSTASIS, V89, P788, DOI 10.1055/s-0037-1613463; TULINSKY A, 1988, PROTEINS, V3, P85, DOI 10.1002/prot.340030203; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0; WU TP, 1991, BIOCHEMISTRY-US, V30, P10589, DOI 10.1021/bi00107a030; Zhong DG, 1998, BLOOD, V92, P136, DOI 10.1182/blood.V92.1.136.413k35_136_142	41	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6934	6945		10.1074/jbc.M802224200	http://dx.doi.org/10.1074/jbc.M802224200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19126539	Green Published, hybrid			2022-12-25	WOS:000263919000041
J	Toth, M; Chow, JW; Mobashery, S; Vakulenko, SB				Toth, Marta; Chow, Joseph W.; Mobashery, Shahriar; Vakulenko, Sergei B.			Source of Phosphate in the Enzymic Reaction as a Point of Distinction among Aminoglycoside 2 ''-Phosphotransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-SEQUENCE ANALYSIS; GENTAMICIN RESISTANCE GENE; MYCOBACTERIUM-TUBERCULOSIS; KINETIC MECHANISM; ESCHERICHIA-COLI; ANTIBIOTICS; SPECIFICITY; APH(2'')-IB; ENZYMES; IIIA	Aminoglycoside 2 ''-phosphotransferases are clinically important enzymes that cause high levels of resistance to aminoglycoside antibiotics by the organisms that harbor them. These enzymes phosphorylate aminoglycosides, and the modified antibiotics show significant reduction in the binding ability to target the bacterial ribosome. This report presents a detailed characterization of the antibiotic resistance profile and the aminoglycoside and nucleotide triphosphate substrate profiles of four common aminoglycoside 2 ''-phosphotransferases widely distributed in clinically important Gram-positive microorganisms. Although the antibiotic resistance phenotypes exhibited by these enzymes are similar, their aminoglycoside and nucleotide triphosphate substrate profiles are distinctive. Contrary to the dogma that these enzymes use ATP as the source of phosphate in their reactions, two of the four aminoglycoside 2 ''-phosphotransferases utilize GTP as the phosphate donor. Of the other two enzymes, one exhibits preference for ATP, and the other can utilize either ATP or GTP as nucleotide triphosphate substrate. A new nomenclature for these enzymes is put forth that takes into account the differences among these enzymes based on their respective substrate preferences. These nucleotide triphosphate preferences should have ramifications for understanding of the evolution, selection, and dissemination of the genes for these important resistance enzymes.	[Toth, Marta; Mobashery, Shahriar; Vakulenko, Sergei B.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Chow, Joseph W.] Merck Res Labs, Dept Infect Dis Clin Res, N Wales, PA 19454 USA	University of Notre Dame; Merck & Company	Vakulenko, SB (corresponding author), Univ Notre Dame, Dept Chem & Biochem, 417 Nieuwland Sci Hall, Notre Dame, IN 46556 USA.	svakulen@nd.edu	Chow, Joseph W/W-4164-2017	Chow, Joseph W/0000-0002-5934-5877	National Institutes of Health [AI 057393]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI 057393.	Akova M, 1999, ANTIMICROB AGENTS CH, V43, P1298, DOI 10.1128/AAC.43.5.1298; Azucena E, 1997, J AM CHEM SOC, V119, P2317, DOI 10.1021/ja964278w; Badarau A, 2008, J BIOL CHEM, V283, P7638, DOI 10.1074/jbc.M709645200; BAKER CN, 1985, J CLIN MICROBIOL, V22, P212, DOI 10.1128/JCM.22.2.212-215.1985; BENVENISTE R, 1973, P NATL ACAD SCI USA, V70, P2276, DOI 10.1073/pnas.70.8.2276; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; Chow JW, 1997, ANTIMICROB AGENTS CH, V41, P511, DOI 10.1128/AAC.41.3.511; Chow JW, 2001, ANTIMICROB AGENTS CH, V45, P2691, DOI 10.1128/AAC.45.10.2691-2694.2001; Clinical and Laboratory Standards Institute, 2006, METH DIL ANT SUSC TE, V7; Craig W, 1996, ANTIBIOTICS LAB MED, P296; Craig W A, 1990, Scand J Infect Dis Suppl, V74, P63; CRAIG WA, 1987, ANN INTERN MED, V106, P900, DOI 10.7326/0003-4819-106-6-900; Daigle DM, 1999, CHEM BIOL, V6, P99, DOI 10.1016/S1074-5521(99)80006-4; DRUSANO GL, 1988, ANTIMICROB AGENTS CH, V32, P289, DOI 10.1128/AAC.32.3.289; EBERT SC, 1990, INFECT CONT HOSP EP, V11, P319; FERRETTI JJ, 1986, J BACTERIOL, V167, P631, DOI 10.1128/jb.167.2.631-638.1986; FOSTER TJ, 1983, MICROBIOL REV, V47, P361, DOI 10.1128/MMBR.47.3.361-409.1983; Gilbert DN, 2005, PRINCIPLES PRACTICE, P328; Gillespie SH, 2002, ANTIMICROB AGENTS CH, V46, P267, DOI 10.1128/AAC.46.2.267-274.2002; Heinzl B, 2002, PEDIATR PULM, V33, P32, DOI 10.1002/ppul.10019; Kao SJ, 2000, ANTIMICROB AGENTS CH, V44, P2876, DOI 10.1128/AAC.44.10.2876-2879.2000; Kim C, 2004, BIOCHEMISTRY-US, V43, P2373, DOI 10.1021/bi036095+; Llano-Sotelo B, 2002, CHEM BIOL, V9, P455, DOI 10.1016/S1074-5521(02)00125-4; MCDONALD PJ, 1977, J INFECT DIS, V135, P217, DOI 10.1093/infdis/135.2.217; MCKAY GA, 1995, J BIOL CHEM, V270, P24686, DOI 10.1074/jbc.270.42.24686; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; MOORE RD, 1987, J INFECT DIS, V155, P93, DOI 10.1093/infdis/155.1.93; Nicolau DP, 1999, ANTIMICROBIAL, P621; Schatz A, 1944, P SOC EXP BIOL MED, V57, P244, DOI 10.3181/00379727-57-14769; SHAW KJ, 1993, ANTIMICROB AGENTS CH, V37, P708, DOI 10.1128/AAC.37.4.708; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; Toth M, 2007, BIOCHEMISTRY-US, V46, P5570, DOI 10.1021/bi6024512; Tsai SF, 1998, ANTIMICROB AGENTS CH, V42, P1229, DOI 10.1128/AAC.42.5.1229; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; VANPELT JE, 1984, ARCH BIOCHEM BIOPHYS, V230, P250, DOI 10.1016/0003-9861(84)90106-1; WAKSMAN SA, 1949, ANN NY ACAD SCI, V52, P750, DOI 10.1111/j.1749-6632.1949.tb53965.x; WAKSMAN SA, 1949, SCIENCE, V109, P305, DOI 10.1126/science.109.2830.305; WOODCOCK J, 1991, EMBO J, V10, P3099, DOI 10.1002/j.1460-2075.1991.tb07863.x; Wright GD, 1998, ADV EXP MED BIOL, V456, P27	39	31	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6690	6696		10.1074/jbc.M808148200	http://dx.doi.org/10.1074/jbc.M808148200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19158087	Green Published, hybrid			2022-12-25	WOS:000263919000013
J	Huang, JN; Ren, T; Guan, H; Jiang, YX; Cheng, H				Huang, Jiannan; Ren, Tong; Guan, Hui; Jiang, Yixing; Cheng, Hua			HTLV-1 Tax Is a Critical Lipid Raft Modulator That Hijacks I kappa B Kinases to the Microdomains for Persistent Activation of NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA-VIRUS TYPE-1; T-CELL-ACTIVATION; LYMPHOTROPIC-VIRUS; C-THETA; IKK-ALPHA; IMMUNOLOGICAL SYNAPSE; PHYSICAL ASSOCIATION; TRANSFORMING PROTEIN; MEMBRANE RAFTS; PKC-THETA	Upon T cell activation, I kappa B kinases (IKKs) are transiently recruited to the plasma membrane-associated lipid raft microdomains for activation of NF-kappa B in promoting T cell proliferation. Retroviral Tax proteins from human T cell leukemia virus type 1 and type 2 (HTLV-1 and -2) are capable of activating IKK, yet only HTLV-1 infection causes T cell leukemia, which correlates with persistent activation of NF-kappa B induced by Tax1. Here, we show that the Tax proteins exhibit differential modes of IKK activation. The subunits of IKK are constitutively present in lipid rafts in activated forms in HTLV-1-infected T cells that express Tax. Disruption of lipid rafts impairs I kappa B kinase activation by Tax1. We also show that the cytoplasmic Tax1 protein persistently resides in the Golgi-associated lipid raft microdomains. Tax1 directs lipid raft translocation of IKK through selective interaction with IKK gamma and accordingly, depletion of IKK gamma impairs Tax1-directed lipid raft recruitment of IKK alpha and IKK beta. In contrast, Tax2 activates NF-kappa B in a manner independent of lipid raft recruitment of IKK. These findings indicate that Tax1 actively recruits IKK to the lipid raft microdomains for persistent activation of NF-kappa B, thereby contributing to HTLV-1 oncogenesis.	[Huang, Jiannan; Ren, Tong; Guan, Hui; Jiang, Yixing; Cheng, Hua] Penn State Univ, Coll Med, Penn State Canc Inst, Hershey, PA 17033 USA; [Jiang, Yixing; Cheng, Hua] Penn State Univ, Coll Med, Dept Med, Hershey, PA 17033 USA; [Cheng, Hua] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Cheng, H (corresponding author), C6818,500 Univ Dr, Hershey, PA 17033 USA.	hcheng@hmc.psu.edu			Penn State Hershey Cancer Institute	Penn State Hershey Cancer Institute	This work was supported by the Penn State Hershey Cancer Institute. The costs of publication of this article were defrayed in part by the payment of page charges.	Alefantis T, 2003, J BIOL CHEM, V278, P21814, DOI 10.1074/jbc.M211576200; Baur AS, 1997, IMMUNITY, V6, P283, DOI 10.1016/S1074-7613(00)80331-3; Bi K, 2001, NAT IMMUNOL, V2, P556, DOI 10.1038/88765; Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; Burton M, 2000, J VIROL, V74, P2351, DOI 10.1128/JVI.74.5.2351-2364.2000; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Cheng H, 2005, MOL CELL BIOL, V25, P44, DOI 10.1128/MCB.25.1.44-59.2005; Chu ZL, 1999, J BIOL CHEM, V274, P15297, DOI 10.1074/jbc.274.22.15297; Chu ZL, 1998, J BIOL CHEM, V273, P15891, DOI 10.1074/jbc.273.26.15891; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Demarchi F, 1996, J VIROL, V70, P4427, DOI 10.1128/JVI.70.7.4427-4437.1996; Drevot P, 2002, EMBO J, V21, P1899, DOI 10.1093/emboj/21.8.1899; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Fenard D, 2005, J IMMUNOL, V175, P6050, DOI 10.4049/jimmunol.175.9.6050; Feng X, 2003, J VIROL, V77, P13389, DOI 10.1128/JVI.77.24.13389-13395.2003; Feuer G, 2005, ONCOGENE, V24, P5996, DOI 10.1038/sj.onc.1208971; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Geleziunas R, 1998, MOL CELL BIOL, V18, P5157, DOI 10.1128/MCB.18.9.5157; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; Gupta N, 2003, MOL BIOL CELL, V14, P432, DOI 10.1091/mbc.02-05-0078; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; Harhaj EW, 1999, J BIOL CHEM, V274, P22911, DOI 10.1074/jbc.274.33.22911; Harhaj NS, 2007, J BIOL CHEM, V282, P4185, DOI 10.1074/jbc.M611031200; He HT, 2008, EMBO REP, V9, P525, DOI 10.1038/embor.2008.78; Jin DY, 1999, J BIOL CHEM, V274, P17402, DOI 10.1074/jbc.274.25.17402; Khoshnan A, 2000, J IMMUNOL, V165, P6933, DOI 10.4049/jimmunol.165.12.6933; KIYOKAWA T, 1985, VIROLOGY, V147, P462, DOI 10.1016/0042-6822(85)90149-7; Krautkramer E, 2004, J VIROL, V78, P4085, DOI 10.1128/JVI.78.8.4085-4097.2004; Lamsoul I, 2005, MOL CELL BIOL, V25, P10391, DOI 10.1128/MCB.25.23.10391-10406.2005; Li XH, 1999, J BIOL CHEM, V274, P34417, DOI 10.1074/jbc.274.48.34417; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; Lindwasser OW, 2002, P NATL ACAD SCI USA, V99, P13037, DOI 10.1073/pnas.212409999; Luftig M, 2004, P NATL ACAD SCI USA, V101, P141, DOI 10.1073/pnas.2237183100; Manna SK, 2000, J IMMUNOL, V164, P5156, DOI 10.4049/jimmunol.164.10.5156; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Meertens L, 2004, J BIOL CHEM, V279, P43307, DOI 10.1074/jbc.M400497200; Nejmeddine M, 2005, J BIOL CHEM, V280, P29653, DOI 10.1074/jbc.M502639200; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; Pise-Masison CA, 1998, J VIROL, V72, P1165, DOI 10.1128/JVI.72.2.1165-1170.1998; Richard V, 2001, AM J PATHOL, V158, P2219, DOI 10.1016/S0002-9440(10)64694-9; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rousso I, 2000, P NATL ACAD SCI USA, V97, P13523, DOI 10.1073/pnas.240459697; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; SALGHETTI S, 1995, P NATL ACAD SCI USA, V92, P349, DOI 10.1073/pnas.92.2.349; Stilo R, 2004, J BIOL CHEM, V279, P34323, DOI 10.1074/jbc.M402244200; Sun SC, 1999, ONCOGENE, V18, P6948, DOI 10.1038/sj.onc.1203220; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; TANAKA A, 1990, P NATL ACAD SCI USA, V87, P1071, DOI 10.1073/pnas.87.3.1071; Uhlik M, 1998, J BIOL CHEM, V273, P21132, DOI 10.1074/jbc.273.33.21132; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Wang JK, 2000, P NATL ACAD SCI USA, V97, P394, DOI 10.1073/pnas.97.1.394; Wu XF, 2007, EMBO REP, V8, P510, DOI 10.1038/sj.embor.7400931; Xiao GT, 2001, EMBO J, V20, P6805, DOI 10.1093/emboj/20.23.6805; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yin MJ, 1998, CELL, V93, P875, DOI 10.1016/S0092-8674(00)81447-6; Zheng YH, 2001, CURR BIOL, V11, P875, DOI 10.1016/S0960-9822(01)00237-8; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	59	47	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6208	6217		10.1074/jbc.M806390200	http://dx.doi.org/10.1074/jbc.M806390200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19129196	hybrid			2022-12-25	WOS:000263742700024
J	Lei, H; Kazlauskas, A				Lei, Hetian; Kazlauskas, Andrius			Growth Factors Outside of the Platelet-derived Growth Factor (PDGF) Family Employ Reactive Oxygen Species/Src Family Kinases to Activate PDGF Receptor alpha and Thereby Promote Proliferation and Survival of Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; FACTOR-BETA RECEPTOR; RETINAL-DETACHMENT; SIGNAL-TRANSDUCTION; C-SRC; TYROSINE KINASES; OXIDATIVE STRESS; CLINICAL FACTORS; ANGIOTENSIN-II; PROTEIN-KINASE	The vitreous contains a plethora of growth factors that are strongly implicated in the formation of fibroproliferative diseases such as proliferative vitreoretinopathy. Although platelet-derived growth factors (PDGFs) are present in the vitreous, vitreal growth factors outside of the PDGF family activated the PDGF alpha receptor (PDGFR alpha) and promoted disease progression in a rabbit model of proliferative vitreoretinopathy (H. Lei, G. Velez, P. Hovland, T. Hirose, D. Gilbertson, and A. Kazlauskas (2008) submitted for publication.) In this report we investigated the mechanism by which non-PDGFs activated PDGFR alpha. We found that non-PDGFs increased the cellular level of reactive oxygen species (ROS) and that this event was necessary and sufficient for phosphorylation of PDGFR alpha. We speculated that the underlying mechanism was ROS-mediated inhibition of phosphotyrosine phosphatases, which antagonize receptor autophosphorylation. However, this did not appear to be the case. Non-PDGFs promoted tyrosine phosphorylation of catalytically inactive PDGFR alpha, and thereby indicated that at least one additional tyrosine kinase was involved. Indeed, preventing expression or blocking the kinase activity of Src family kinases suppressed non-PDGF-dependent tyrosine phosphorylation of PDGFR alpha. Thus non-PDGFs increased the level of ROS, which activated Src family kinases and resulted in phosphorylation of PDGFR alpha. Finally, although non-PDGFs induced only modest phosphorylation of PDGFR alpha, proliferation and survival of cells in response to non-PDGFs was significantly enhanced by expression of PDGFR alpha. These studies reveal a novel mechanism for activation of PDGFR alpha that appears capable of enhancing the responsiveness of cells to growth factors outside of the PDGF family.	[Lei, Hetian; Kazlauskas, Andrius] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute	Kazlauskas, A (corresponding author), 20 Staniford St, Boston, MA 02114 USA.	ak@eri.harvard.edu		Lei, Hetian/0000-0003-4091-1936	National Institutes of Health [EY012509]; NATIONAL EYE INSTITUTE [R01EY012509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY012509 (to A. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abe J, 1997, J BIOL CHEM, V272, P20389, DOI 10.1074/jbc.272.33.20389; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Andrews A, 1999, INVEST OPHTH VIS SCI, V40, P2683; Asaria RHY, 2004, BRIT J OPHTHALMOL, V88, P1439, DOI 10.1136/bjo.2003.040402; Avrov K, 2003, EXP CELL RES, V291, P426, DOI 10.1016/j.yexcr.2003.08.001; Bae YS, 2000, J BIOL CHEM, V275, P10527, DOI 10.1074/jbc.275.14.10527; Banerjee S, 2007, INVEST OPHTH VIS SCI, V48, P2203, DOI 10.1167/iovs.06-1358; Baroni SS, 2006, NEW ENGL J MED, V354, P2667; BAUDOUIN C, 1993, OPHTHALMIC RES, V25, P52, DOI 10.1159/000267221; Campochiaro PA, 1997, ARCH OPHTHALMOL-CHIC, V115, P237, DOI 10.1001/archopht.1997.01100150239014; Campochiaro PA, 1996, PROG RETIN EYE RES, V15, P547, DOI 10.1016/1350-9462(96)00012-2; CUI J, 2008, EXP EYE RES IN PRESS; Cui JZ, 2007, EYE, V21, P200, DOI 10.1038/sj.eye.6702169; Dieudonne SC, 2004, INVEST OPHTH VIS SCI, V45, P4113, DOI 10.1167/iovs.04-0643; Dolloff NG, 2007, CANCER RES, V67, P555, DOI 10.1158/0008-5472.CAN-06-2593; Emaduddin M, 2008, P NATL ACAD SCI USA, V105, P2358, DOI 10.1073/pnas.0712176105; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Gelderloos JA, 1998, J BIOL CHEM, V273, P5908, DOI 10.1074/jbc.273.10.5908; GLASER BM, 1987, OPHTHALMOLOGY, V94, P327; Hansen K, 1996, EMBO J, V15, P5299, DOI 10.1002/j.1460-2075.1996.tb00915.x; Harada C, 2006, PROG RETIN EYE RES, V25, P149, DOI 10.1016/j.preteyeres.2005.09.001; HARDWICK JS, 1995, P NATL ACAD SCI USA, V92, P4527, DOI 10.1073/pnas.92.10.4527; Heeneman S, 2000, J BIOL CHEM, V275, P15926, DOI 10.1074/jbc.M909616199; Herrlich A, 1998, P NATL ACAD SCI USA, V95, P8985, DOI 10.1073/pnas.95.15.8985; Hinton DR, 2002, EYE, V16, P422, DOI 10.1038/sj.eye.6700190; Ikuno Y, 2000, INVEST OPHTH VIS SCI, V41, P3107; Ikuno Y, 2002, INVEST OPHTH VIS SCI, V43, P483; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Kita T, 2007, DIABETES, V56, P1421, DOI 10.2337/db06-1644; KLINGHOFFER AR, 1995, J BIOL CHEM, V270, P22208; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; La Heij EC, 2002, AM J OPHTHALMOL, V134, P367, DOI 10.1016/S0002-9394(02)01536-2; LAQUA H, 1975, AM J OPHTHALMOL, V80, P602, DOI 10.1016/0002-9394(75)90390-6; Lashkari K, 1999, INVEST OPHTH VIS SCI, V40, P149; Lei HT, 2007, INVEST OPHTH VIS SCI, V48, P2335, DOI 10.1167/iovs.06-0965; Lei HT, 2004, CIRC RES, V94, P902, DOI 10.1161/01.RES.0000124979.46214.E3; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; LINSEMAN DA, 1995, J BIOL CHEM, V270, P12563, DOI 10.1074/jbc.270.21.12563; Liou G, 2002, MOL VIS, V8, P494; Liu YL, 2007, FASEB J, V21, P2725, DOI 10.1096/fj.06-8058com; MAA MC, 1995, P NATL ACAD SCI USA, V92, P6981, DOI 10.1073/pnas.92.15.6981; Matsuoka H, 2004, J BIOL CHEM, V279, P5975, DOI 10.1074/jbc.M311278200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Mukherjee S, 2007, INVEST OPHTH VIS SCI, V48, P1892, DOI 10.1167/iovs.06-1095; NAGASAKI H, 1991, RETINA-J RET VIT DIS, V11, P204, DOI 10.1097/00006982-199111020-00002; NAKAGAWA M, 1995, INVEST OPHTH VIS SCI, V36, P2388; Oshima Y, 2002, GENE THER, V9, P1214, DOI 10.1038/sj.gt.3301789; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Reigstad LJ, 2005, FEBS J, V272, P5723, DOI 10.1111/j.1742-4658.2005.04989.x; ROBBINS SG, 1994, INVEST OPHTH VIS SCI, V35, P3649; Rosenkranz S, 1999, GROWTH FACTORS, V16, P201, DOI 10.3109/08977199909002130; RYAN SJ, 1993, AM J OPHTHALMOL, V115, P1; Siegbahn A, 2008, ARTERIOSCL THROM VAS, V28, P135, DOI 10.1161/ATVBAHA.107.155754; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tanimoto T, 2004, CIRC RES, V94, P1050, DOI 10.1161/01.RES.0000126404.41421.BE; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Veracini L, 2006, J CELL SCI, V119, P2921, DOI 10.1242/jcs.03015; Wan XS, 2003, RADIAT RES, V160, P622, DOI 10.1667/3099; YOSHINO Y, 1989, RETINA-J RET VIT DIS, V9, P97, DOI 10.1097/00006982-198909020-00004; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zheng YP, 2003, JPN J OPHTHALMOL, V47, P158, DOI 10.1016/S0021-5155(02)00698-6	64	76	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6329	6336		10.1074/jbc.M808426200	http://dx.doi.org/10.1074/jbc.M808426200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19126548	Green Published, hybrid			2022-12-25	WOS:000263742700036
J	Sagara, M; Kawasaki, Y; Iemura, S; Natsume, T; Takai, Y; Akiyama, T				Sagara, M.; Kawasaki, Y.; Iemura, S-i; Natsume, T.; Takai, Y.; Akiyama, T.			Asef2 and Neurabin2 cooperatively regulate actin cytoskeletal organization and are involved in HGF-induced cell migration	ONCOGENE			English	Article						APC; Asef2; Neurabin2/Spinophilin; HGF; filopodia; migration	TUMOR-SUPPRESSOR APC; EXCHANGE FACTOR; BINDING-PROTEIN; SPINOPHILIN; DOMAIN; CDC42; IDENTIFICATION; ACTIVATION; RELEASE; CANCER	The tumor suppressor adenomatous polyposis coli (APC) is mutated in sporadic and familial colorectal tumors. APC interacts with the Rac1- and Cdc42-specific guanine-nucleotide exchange factors (GEF), Asef and Asef2, which contain an APC-binding region (ABR) in addition to Dbl homology, Pleckstrin homology (PH) and Src homology 3 (SH3) domains. APC stimulates the GEF activity of Asef and Asef2, and thereby regulates cell adhesion and migration. Here we show that Asef2, but not Asef, interacts with Neurabin2/Spinophilin, a scaffold protein that binds to Filamentous actin (F-actin). In response to hepatocyte growth factor (HGF) treatment of HeLa cells, Asef2, Neurabin2 and APC were induced to accumulate and colocalize in lamellipodia and membrane ruffles. Neurabin2 did not affect the GEF activity of Asef2. RNA interference experiments showed that Asef2, Neurabin2 and APC are involved in HGF-induced cell migration. Furthermore, knockdown of Neurabin2 resulted in the suppression of Asef2-induced filopodia formation. These results suggest that Asef2, Neurabin2 and APC cooperatively regulate actin cytoskeletal organization and are required for HGF-induced cell migration.	[Akiyama, T.] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, Tokyo 1130032, Japan; [Iemura, S-i; Natsume, T.] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Tokyo, Japan; [Takai, Y.] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol, Kobe, Hyogo 657, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Kobe University	Akiyama, T (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	akiyama@iam.u-tokyo.ac.jp	Natsume, Tohru/M-7627-2018	Natsume, Tohru/0000-0002-1510-2582	Japan Society for the Promotion of Science for Young Scientists	Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Scientific Research on Priority Areas and the Organization for Pharmaceutical Safety and Research, Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists, and in part by Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), MEXT, Japan.	Akiyama T, 2006, ONCOGENE, V25, P7538, DOI 10.1038/sj.onc.1210063; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Buchsbaum RJ, 2003, J BIOL CHEM, V278, P18833, DOI 10.1074/jbc.M207876200; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Futter M, 2005, P NATL ACAD SCI USA, V102, P3489, DOI 10.1073/pnas.0409802102; Hamann MJ, 2007, MOL CELL BIOL, V27, P1380, DOI 10.1128/MCB.01608-06; Itoh RE, 2008, J CELL SCI, V121, P2635, DOI 10.1242/jcs.028647; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Kawasaki Y, 2007, ONCOGENE, V26, P7620, DOI 10.1038/sj.onc.1210574; Kawasaki Y, 2003, NAT CELL BIOL, V5, P211, DOI 10.1038/ncb937; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Mitin N, 2007, NAT STRUCT MOL BIOL, V14, P814, DOI 10.1038/nsmb1290; Murayama K, 2007, J BIOL CHEM, V282, P4238, DOI 10.1074/jbc.C600234200; Muroya K, 2007, BIOCHEM BIOPH RES CO, V355, P85, DOI 10.1016/j.bbrc.2007.01.131; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Polakis P, 2000, GENE DEV, V14, P1837; Ryan XZP, 2005, NEURON, V47, P85, DOI 10.1016/j.neuron.2005.05.013; Sarrouilhe D, 2006, BIOCHIMIE, V88, P1099, DOI 10.1016/j.biochi.2006.04.010; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Schuler H, 2008, FEBS J, V275, P59, DOI 10.1111/j.1742-4658.2007.06171.x; SU LK, 1995, CANCER RES, V55, P2972; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017	31	22	25	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	10					1357	1365		10.1038/onc.2008.478	http://dx.doi.org/10.1038/onc.2008.478			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	417ZC	19151759				2022-12-25	WOS:000264116000008
J	Herz, HM; Woodfield, SE; Chen, ZH; Bolduc, C; Bergmann, A				Herz, Hans-Martin; Woodfield, Sarah E.; Chen, Zhihong; Bolduc, Clare; Bergmann, Andreas			Common and Distinct Genetic Properties of ESCRT-II Components in Drosophila	PLOS ONE			English	Article								Background: Genetic studies in yeast have identified class E vps genes that form the ESCRT complexes required for protein sorting at the early endosome. In Drosophila, mutations of the ESCRT-II component vps25 cause endosomal defects leading to accumulation of Notch protein and increased Notch pathway activity. These endosomal and signaling defects are thought to account for several phenotypes. Depending on the developmental context, two different types of overgrowth can be detected. Tissue predominantly mutant for vps25 displays neoplastic tumor characteristics. In contrast, vps25 mutant clones in a wild-type background trigger hyperplastic overgrowth in a non-autonomous manner. In addition, vps25 mutant clones also promote apoptotic resistance in a non-autonomous manner. Principal Findings: Here, we genetically characterize the remaining ESCRT-II components vps22 and vps36. Like vps25, mutants of vps22 and vps36 display endosomal defects, accumulate Notch protein and - when the tissue is predominantly mutant - show neoplastic tumor characteristics. However, despite these common phenotypes, they have distinct non-autonomous phenotypes. While vps22 mutations cause strong non-autonomous overgrowth, they do not affect apoptotic resistance. In contrast, vps36 mutations increase apoptotic resistance, but have little effect on non-autonomous proliferation. Further characterization reveals that although all ESCRT-II mutants accumulate Notch protein, only vps22 and vps25 mutations trigger Notch activity. Conclusions/Significance: The ESCRT-II components vps22, vps25 and vps36 display common and distinct genetic properties. Our data redefine the role of Notch for hyperplastic and neoplastic overgrowth in these mutants. While Notch is required for hyperplastic growth, it appears to be dispensable for neoplastic transformation.	[Herz, Hans-Martin; Woodfield, Sarah E.; Chen, Zhihong; Bolduc, Clare; Bergmann, Andreas] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Genes & Development Grad Program, Houston, TX USA; [Woodfield, Sarah E.] Baylor Coll Med, Grad Program Developmental Biol, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Herz, HM (corresponding author), Stowers Inst Med Res, Kansas City, MO USA.	abergman@mdanderson.org	Herz, Hans-Martin/N-2594-2018; Woodfield, Sarah/AEW-0563-2022	Herz, Hans-Martin/0000-0003-4780-9176; Bolduc, Clare/0000-0002-1321-6017	National Institute of General Medical Sciences, NIH [R01 GM081543]; Robert A. Welch Foundation [G-1496]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081543] Funding Source: NIH RePORTER	National Institute of General Medical Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by grant number R01 GM081543 from the National Institute of General Medical Sciences. The content is solely the responsibility of the authors and does not represent the official views of the NIGMS or NIH. A.B. gratefully acknowledges support by the Robert A. Welch Foundation (G-1496). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Chao JL, 2004, DEVELOPMENT, V131, P3839, DOI 10.1242/dev.01258; de Gassart A, 2004, TRAFFIC, V5, P896, DOI 10.1111/j.1600-0854.2004.00223.x; DECELIS JF, 1991, P NATL ACAD SCI USA, V88, P632, DOI 10.1073/pnas.88.2.632; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Fan Y, 2008, TRENDS CELL BIOL, V18, P467, DOI 10.1016/j.tcb.2008.08.001; Fan Y, 2008, DEV CELL, V14, P399, DOI 10.1016/j.devcel.2008.01.003; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Fujimuro M, 1997, EUR J BIOCHEM, V249, P427, DOI 10.1111/j.1432-1033.1997.00427.x; Gonzallez-Gaitan M, 2003, NAT REV MOL CELL BIO, V4, P213, DOI 10.1038/nrm1053; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738; Herz HM, 2006, DEVELOPMENT, V133, P1871, DOI 10.1242/dev.02356; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hierro A, 2004, NATURE, V431, P221, DOI 10.1038/nature02914; Irion U, 2007, NATURE, V445, P554, DOI 10.1038/nature05503; Jekely G, 2003, EMBO REP, V4, P1163, DOI 10.1038/sj.embor.7400019; Kamura T, 2001, J BIOL CHEM, V276, P16528, DOI 10.1074/jbc.M010142200; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Krempler A, 2002, J BIOL CHEM, V277, P43216, DOI 10.1074/jbc.M207662200; Le Roy C, 2005, DEV CELL, V9, P167, DOI 10.1016/j.devcel.2005.07.007; Lee TV, 2008, DEVELOPMENT, V135, P43, DOI 10.1242/dev.011288; Li LM, 1996, CELL, V85, P319, DOI 10.1016/S0092-8674(00)81111-3; Li LM, 1997, CELL, V88, P143, DOI 10.1016/S0092-8674(00)81866-8; Lin SY, 1998, J GASTROEN HEPATOL, V13, P1111, DOI 10.1111/j.1440-1746.1998.tb00585.x; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Menut L, 2007, GENETICS, V177, P1667, DOI 10.1534/genetics.107.078360; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Pornillos O, 2002, TRENDS CELL BIOL, V12, P569, DOI 10.1016/S0962-8924(02)02402-9; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Reynolds-Kenneally J, 2005, DEV BIOL, V285, P38, DOI 10.1016/j.ydbio.2005.05.038; Schmidt AE, 1999, J BIOL CHEM, V274, P21981, DOI 10.1074/jbc.274.31.21981; Seto ES, 2006, J CELL BIOL, V173, P95, DOI 10.1083/jcb.200510123; Seto ES, 2004, TRENDS CELL BIOL, V14, P45, DOI 10.1016/j.tcb.2003.11.004; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Srivastava M, 2007, CELL DEATH DIFFER, V14, P92, DOI 10.1038/sj.cdd.4401931; Stowers RS, 1999, GENETICS, V152, P1631; Sun ZJ, 1997, ONCOGENE, V15, P3121, DOI 10.1038/sj.onc.1201521; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Tsai YC, 2004, GENESIS, V39, P141, DOI 10.1002/gene.20035; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Wagner KU, 2003, MOL CELL BIOL, V23, P150, DOI 10.1128/MCB.23.1.150-162.2003; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Xu DB, 2005, DEVELOPMENT, V132, P2125, DOI 10.1242/dev.01790; Yu SY, 2002, DEVELOPMENT, V129, P3269	53	32	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2009	4	1							e4165	10.1371/journal.pone.0004165	http://dx.doi.org/10.1371/journal.pone.0004165			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GB	19132102	Green Published, Green Submitted, gold			2022-12-25	WOS:000265473700004
J	Sturlan, S; Sachet, M; Baumann, S; Kuznetsova, I; Spittler, A; Bergmann, M				Sturlan, Sanda; Sachet, Monika; Baumann, Suzann; Kuznetsova, Irina; Spittler, Andreas; Bergmann, Michael			Influenza A Virus Induces an Immediate Cytotoxic Activity in All Major Subsets of Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article								Background: A replication defective influenza A vaccine virus (delNS1 virus) was developed. Its attenuation is due to potent stimulation of the innate immune system by the virus. Since the innate immune system can also target cancer cells, we reasoned that delNS1 virus induced immune-stimulation should also lead to the induction of innate cytotoxic effects towards cancer cells. Methodology/Principal Findings: Peripheral blood mononuclear cells (PBMCs), isolated CD56+, CD3+, CD14+ and CD19+ subsets and different combinations of the above subsets were stimulated by delNS1, wild type (wt) virus or heat inactivated virus and co-cultured with tumor cell lines in the presence or absence of antibodies against the interferon system. Stimulation of PBMCs by the delNS1 virus effectively induced cytotoxicity against different cancer cell lines. Surprisingly, virus induced cytotoxicity was exerted by all major subtypes of PBMCs including CD56+, CD3+, CD14+ and CD19+ cells. Virus induced cytotoxicity in CD3+, CD14+ and CD19+ cells was dependent on virus replication, whereas virus induced cytotoxicity in CD56+ cells was only dependent on the binding of the virus. Virus induced cytotoxicity of isolated cell cultures of CD14+, CD19+ or CD56+ cells could be partially blocked by antibodies against type I and type II (IFN) interferon. In contrast, virus induced cytotoxicity in the complete PBMC preparation could not be inhibited by blocking type I or type II IFN, indicating a redundant system of activation in whole blood. Conclusions/Significance: Our data suggest that apart from their well known specialized functions all main subsets of peripheral blood cells also initially exert a cytotoxic effect upon virus stimulation. This closely links the innate immune system to the adaptive immune response and renders delNS1 virus a potential therapeutic tool for viro-immunotherapy of cancer.	[Sturlan, Sanda; Sachet, Monika; Baumann, Suzann; Kuznetsova, Irina; Spittler, Andreas; Bergmann, Michael] Med Univ Vienna, Dept Surg, Div Gen Surg, Vienna, Austria	Medical University of Vienna	Sturlan, S (corresponding author), Med Univ Vienna, Dept Surg, Div Gen Surg, Vienna, Austria.	michael.bergmann@meduniwien.ac.at	Bergmann, Michael/GZK-7700-2022	Spittler, Andreas/0000-0003-2657-6836; Bergmann, Michael/0000-0001-8529-1166	EU [518281]	EU(European Commission)	The work was supported by the grant of the EU-commission Nr. 518281. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann M, 2000, J VIROL, V74, P6203, DOI 10.1128/JVI.74.13.6203-6206.2000; Chaperot L, 2006, J IMMUNOL, V176, P248, DOI 10.4049/jimmunol.176.1.248; Chawla-Sarkar M, 2002, J IMMUNOL, V169, P847, DOI 10.4049/jimmunol.169.2.847; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Draghi M, 2007, J IMMUNOL, V178, P2688, DOI 10.4049/jimmunol.178.5.2688; Efferson CL, 2006, J VIROL, V80, P383, DOI 10.1128/JVI.80.1.383-394.2006; Egorov A, 1998, J VIROL, V72, P6437, DOI 10.1128/JVI.72.8.6437-6441.1998; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; He XS, 2004, J CLIN INVEST, V114, P1812, DOI 10.1172/JCI200422797; Hicks Amy M, 2006, Cancer Immun, V6, P11; Hicks AM, 2006, P NATL ACAD SCI USA, V103, P7753, DOI 10.1073/pnas.0602382103; Kemp TJ, 2004, J IMMUNOL, V173, P892, DOI 10.4049/jimmunol.173.2.892; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Mailliard RB, 2003, J IMMUNOL, V171, P2366, DOI 10.4049/jimmunol.171.5.2366; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Mozdzanowska K, 2000, J IMMUNOL, V164, P2635, DOI 10.4049/jimmunol.164.5.2635; Oh S, 2000, J VIROL, V74, P7738, DOI 10.1128/JVI.74.17.7738-7744.2000; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rothenfusser S, 2001, EUR J IMMUNOL, V31, P3525, DOI 10.1002/1521-4141(200112)31:12<3525::AID-IMMU3525>3.0.CO;2-5; Stanford MM, 2008, CURR OPIN MOL THER, V10, P32; Stary G, 2007, J EXP MED, V204, P1441, DOI 10.1084/jem.20070021; Stasakova J, 2005, J GEN VIROL, V86, P185, DOI 10.1099/vir.0.80422-0; Talon J, 2000, P NATL ACAD SCI USA, V97, P4309, DOI 10.1073/pnas.070525997; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Ullrich E, 2008, CYTOKINE GROWTH F R, V19, P79, DOI 10.1016/j.cytogfr.2007.10.009; Urosevic M, 2007, J CLIN INVEST, V117, P2834, DOI 10.1172/JCI32077; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Washburn B, 2003, J IMMUNOL, V170, P1814, DOI 10.4049/jimmunol.170.4.1814; Woo Y, 2006, CURR OPIN INVEST DR, V7, P549	33	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2009	4	1							e4122	10.1371/journal.pone.0004122	http://dx.doi.org/10.1371/journal.pone.0004122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FV	19125202	Green Published, Green Submitted, gold			2022-12-25	WOS:000265473100002
J	Ji, SR; Ma, L; Bai, CJ; Shi, JM; Li, HY; Potempa, LA; Filep, JG; Zhao, J; Wu, Y				Ji, Shang-Rong; Ma, Le; Bai, Cai-Juan; Shi, Jing-Ming; Li, Hai-Yun; Potempa, Lawrence A.; Filep, Janos G.; Zhao, Jing; Wu, Yi			Monomeric C-reactive protein activates endothelial cells via interaction with lipid raft microdomains	FASEB JOURNAL			English	Article						atherosclerosis; inflammation; protein-membrane interaction	INTEGRAL MEMBRANE-PROTEIN; HUMAN NEUTROPHILS; PENTAMERIC SYMMETRY; CAVEOLAE; ATHEROSCLEROSIS; EXPRESSION; RECEPTORS; ADHESION; DOMAIN; MICE	Emerging evidence indicates that in addition to native pentameric C-reactive protein (CRP), monomeric CRP (mCRP) also plays an active role in inflammation associated with cardiovascular diseases. mCRP activates endothelial cells, one of the critical events in cardiovascular diseases; however, the underlying molecular mechanisms are incompletely understood. Here we report that association of mCRP with human aortic and coronary artery endothelial cells is predominantly due to membrane insertion rather than binding to the surface proteins Fc gamma Rs and proteoglycans. We identify lipid rafts as the preferential membrane microdomains for mCRP anchorage. mCRP binding depends on membrane cholesterol content and is synergistically mediated by the putative cholesterol binding consensus sequence of CRP (aa 35-47) and the C-terminal octapeptide ( aa 199-206). Conversely, disrupting lipid rafts with methyl-beta cyclodextrin or nystatin abrogated mCRP-induced cytokine release, reactive oxygen species generation, and adhesion molecule expression in endothelial cells. Furthermore, ex vivo treatment of rabbit thoracic aorta and carotid artery segments with nystatin prevented mCRP-induced IL-8 release. Our data identify mCRP-lipid raft interaction as an important mechanism in mediating cellular responses to mCRP and lend further support to the notion of mCRP regulation of endothelial cell function during inflammation.-Ji, S.-R., Ma, L., Bai, C.-J., Shi, J.-M., Li, H.-Y., Potempa, L. A., Filep, J. G., Zhao, J., Wu, Y. Monomeric C-reactive protein activates endothelial cells via interaction with lipid raft microdomains. FASEB J. 23, 1806-1816 (2009)	[Ji, Shang-Rong; Ma, Le; Bai, Cai-Juan; Shi, Jing-Ming; Li, Hai-Yun; Zhao, Jing; Wu, Yi] Lanzhou Univ, Inst Biophys, MOE Key Lab Arid & Grassland Ecol, Lanzhou 730000, Peoples R China; [Potempa, Lawrence A.] Acphazin Inc, Deerfield, IL USA; [Filep, Janos G.] Univ Montreal, Res Ctr, Maisonneuve Rosemont Hosp, Montreal, PQ, Canada	Lanzhou University; Universite de Montreal	Wu, Y (corresponding author), Lanzhou Univ, Inst Biophys, MOE Key Lab Arid & Grassland Ecol, Life Sci Bldg,Room 227, Lanzhou 730000, Peoples R China.	wuy@lzu.edu.cn	Shi, Jing-Ming/ACS-3321-2022	Shi, Jing-Ming/0000-0002-8185-3130; Wu, Yi/0000-0003-0365-5590; Li, Haiyun/0000-0002-7458-7399; Ji, Shang-Rong/0000-0001-8595-3756	National Natural Science Foundation of China [30500087, 30670475, 30770451, 30870495]; National Natural Science Foundation of China; Canadian Institutes of Health Research [30711120578]; Fonds de la Recherche en Sante du Quebec; National Natural Science Foundation; Research Fund for the Doctoral Program of Higher Education [20070730015]; Program for New Century Excellent Talents in University [NCET-070392, NCET-05-0884]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by grants from the National Natural Science Foundation of China (30500087, 30670475, 30770451, 30870495), National Natural Science Foundation of China-Canadian Institutes of Health Research (30711120578), Fonds de la Recherche en Sante du Quebec-National Natural Science Foundation, the Research Fund for the Doctoral Program of Higher Education (20070730015), and Program for New Century Excellent Talents in University (NCET-070392, NCET-05-0884).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ciubotaru I, 2005, EXP BIOL MED, V230, P762, DOI 10.1177/153537020523001010; Derham BK, 2002, BIOCHEM J, V368, P865, DOI 10.1042/BJ20020924; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Epand RM, 2005, J MOL BIOL, V345, P339, DOI 10.1016/j.jmb.2004.10.064; FRA AM, 1994, J BIOL CHEM, V269, P30745; Girard-Egrot A, 2004, J MOL BIOL, V335, P321, DOI 10.1016/j.jmb.2003.10.028; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; Heuertz RM, 2005, INT J BIOCHEM CELL B, V37, P320, DOI 10.1016/j.biocel.2004.07.002; Ji SR, 2007, FASEB J, V21, P284, DOI 10.1096/fj.06-6722com; Ji SR, 2006, ARTERIOSCL THROM VAS, V26, P935, DOI 10.1161/01.ATV.0000206211.21895.73; Ji SR, 2006, INT J BIOCHEM CELL B, V38, P648, DOI 10.1016/j.biocel.2005.11.004; Khreiss T, 2004, CIRCULATION, V110, P2713, DOI 10.1161/01.CIR.0000146846.00816.DD; Khreiss T, 2005, CIRC RES, V97, P690, DOI 10.1161/01.RES.0000183881.11739.CB; Khreiss T, 2004, CIRCULATION, V109, P2016, DOI 10.1161/01.CIR.0000125527.41598.68; Khreiss T, 2002, J BIOL CHEM, V277, P40775, DOI 10.1074/jbc.M205378200; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; POTEMPA LA, 1987, MOL IMMUNOL, V24, P531, DOI 10.1016/0161-5890(87)90028-9; Schlegel A, 1999, J BIOL CHEM, V274, P22660, DOI 10.1074/jbc.274.32.22660; Schwedler SB, 2006, AM J KIDNEY DIS, V47, P212, DOI 10.1053/j.ajkd.2005.10.028; Schwedler SB, 2005, CIRCULATION, V112, P1016, DOI 10.1161/CIRCULATIONAHA.105.556530; Schwedler SB, 2003, NEPHROL DIAL TRANSPL, V18, P2300, DOI 10.1093/ndt/gfg407; Sengelov H, 1998, J LEUKOCYTE BIOL, V63, P563, DOI 10.1002/jlb.63.5.563; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Singh SK, 2008, ANN MED, V40, P110, DOI 10.1080/07853890701749225; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Tamai R, 2005, INFECT IMMUN, V73, P6290, DOI 10.1128/IAI.73.10.6290-6298.2005; Taylor KE, 2007, IMMUNOLOGY, V120, P404, DOI 10.1111/j.1365-2567.2006.02516.x; Verma S, 2006, CIRCULATION, V113, P2135; Volanakis JE, 2001, MOL IMMUNOL, V38, P189, DOI 10.1016/S0161-5890(01)00042-6; Wu Y, 2002, BIOCHEMISTRY-MOSCOW+, V67, P1377, DOI 10.1023/A:1021862027061; YING SC, 1992, MOL IMMUNOL, V29, P677, DOI 10.1016/0161-5890(92)90205-C	35	102	113	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1806	1816		10.1096/fj.08-116962	http://dx.doi.org/10.1096/fj.08-116962			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19136614				2022-12-25	WOS:000266652400021
J	Chen, T; Li, M; Ding, Y; Zhang, LS; Xi, Y; Pan, WJ; Tao, DL; Wang, JY; Li, L				Chen, Ting; Li, Meng; Ding, Yu; Zhang, Le-shuai; Xi, Ying; Pan, Wei-jun; Tao, Dong-lei; Wang, Ji-yong; Li, Lin			Identification of Zinc-finger BED Domain-containing 3 (Zbed3) as a Novel Axin-interacting Protein That Activates Wnt/beta-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL-KINASE MECHANISM; BETA-CATENIN; NEGATIVE REGULATOR; WNT; PATHWAY; PHOSPHORYLATION; COMPLEX; TRANSDUCTION; EXPRESSION; STABILITY	Axin, a key modulator of the Wnt/beta-catenin pathway, acts as a scaffold protein in phosphorylating and degrading cytoplasmic beta-catenin. Canonical Wnt proteins appear to stabilize beta-catenin by inducing the interaction of LRP5/6 with Axin. This interaction requires the phosphorylation of the Ser or Thr residues in the PPPP(S/T)PX(T/S) motifs at the intracellular domain of LRP5/6. In this work, we identified a novel Axin-interacting protein, zinc-finger BED domain-containing 3 (Zbed3), by yeast two-hybrid screening. The interaction was confirmed in co-immunoprecipitation experiment in mammalian cells and in vitro pulldown assays. Moreover, we found Zbed3 also contains a PPPPSPT motif, which is crucial to its binding to Axin. The Ser and Thr residues in the motif appear to be also phosphorylated by glycogen synthase kinase 3 beta (GSK3 beta) and the CKI family kinases, as GSK3 beta and CKI epsilon could enhance the interaction of Zbed3 with Axin. Mutation of the Ser (SA) or Thr (TA) residue to Ala in the motif markedly impaired its ability to interact with Axin. Expressing Zbed3, but not these mutants, led to inhibition of GSK3 beta-mediated beta-catenin phosphorylation, cytoplasmic beta-catenin accumulation, and activation of lymphoid enhancer binding factor-1-dependent reporter gene transcription. Furthermore, knockdown of Zbed3 with RNA interference attenuated Wnt-induced beta-catenin accumulation, lymphoid enhancer binding factor-1-dependent luciferase reporter activity, and the Wnt target gene expression. These results together indicate that Zbed3 is a novel Axin-binding protein that is involved in Wnt/beta-catenin signaling modulation.	[Chen, Ting; Li, Meng; Ding, Yu; Zhang, Le-shuai; Xi, Ying; Pan, Wei-jun; Tao, Dong-lei; Wang, Ji-yong; Li, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China.	lli@sibs.ac.cn	Zhang, Leshuai/C-8077-2012; Ding, Yu/A-2949-2013; li, li/HII-4157-2022; Li, Li/AEM-3636-2022; LI, LI/GVS-5344-2022	Le, Shuai/0000-0003-3748-5454	Ministry of Science and Technology of China [2007CB914500 and 2007CB947100]; Natural Science Foundation of China [30821065, 30600305]; Science and Technology Commission of Shanghai Municipality; Chinese Academy of Sciences	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by Ministry of Science and Technology of China Grants 2007CB914500 and 2007CB947100, by Natural Science Foundation of China Grants 30821065 ( to L. L.) and 30600305 ( to J. W.), and by Science and Technology Commission of Shanghai Municipality and Chinese Academy of Sciences grants.	Baig-Lewis S, 2007, DEV BIOL, V306, P94, DOI 10.1016/j.ydbio.2007.03.005; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen HJ, 2006, GENE DEV, V20, P1933, DOI 10.1101/gad.1411206; Chia IV, 2005, MOL CELL BIOL, V25, P4371, DOI 10.1128/MCB.25.11.4371-4376.2005; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Dahmen RP, 2001, CANCER RES, V61, P7039; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Harte D, 1998, J NONLINEAR SCI, V8, P581, DOI 10.1007/s003329900060; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Kusano S, 2002, MOL CELL BIOL, V22, P6393, DOI 10.1128/MCB.22.18.6393-6405.2002; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Pan WJ, 2004, CELL RES, V14, P324, DOI 10.1038/sj.cr.7290232; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PLATT T, 1972, EXPT MOL GENETICS, P352; Polakis P, 2000, GENE DEV, V14, P1837; Salahshor S, 2005, J CLIN PATHOL, V58, P225, DOI 10.1136/jcp.2003.009506; Shiomi K, 2003, CURR BIOL, V13, P73, DOI 10.1016/S0960-9822(02)01398-2; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	39	35	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6683	6689		10.1074/jbc.M807753200	http://dx.doi.org/10.1074/jbc.M807753200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19141611	Green Published, hybrid			2022-12-25	WOS:000263919000012
J	Song, WF; Liu, G; Bosworth, CA; Walker, JR; Megaw, GA; Lazrak, A; Abraham, E; Sullender, WM; Matalon, S				Song, Weifeng; Liu, Gang; Bosworth, Charles A.; Walker, John R.; Megaw, George A.; Lazrak, Ahmed; Abraham, Edward; Sullender, Wayne M.; Matalon, Sadis			Respiratory Syncytial Virus Inhibits Lung Epithelial Na+ Channels by Up-regulating Inducible Nitric-oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ALVEOLAR MACROPHAGES; BIOPHYSICAL PROPERTIES; SODIUM-CHANNELS; PROTEIN; GENE; EXPRESSION; INFECTION; CELL; ACTIVATION	Respiratory syncytial virus (RSV) infection has been shown to reduce Na+-driven alveolar fluid clearance in BALB/ c mice in vivo. To investigate the cellular mechanisms by which RSV inhibits amiloride-sensitive epithelial Na+ channels (ENaC), the main pathways through which Na+ ions enter lung epithelial cells, we infected human Clara-like lung (H441) cells with RSV that expresses green fluorescent protein (rRA2). 3-6 days later patch clamp recordings showed that infected cells (i.e. cells expressing green fluorescence; GFP(+)) had significantly lower whole-cell amiloride-sensitive currents and single channel activity (NPo) as compared with non-infected (GFP(-)), non-inoculated, or cells infected with UV-inactivated RSV. Both alpha and beta ENaC mRNA levels were significantly reduced in GFP(+) cells as measured by real-time reverse transcription-PCR. Infection with RSV increased expression of the inducible nitric-oxide synthase (iNOS) and nitrite concentration in the culture medium; nuclear translocation of NF-kappa B p65 subunit and NF-kappa B activation were also up-regulated. iNOS up-regulation in GFP(+) cells was prevented by knocking down I kappa B kinase gamma before infection. Furthermore, pretreatment of H441 cells with the specific iNOS inhibitor 1400W (1 mu M) resulted in a doubling of the amiloride-sensitive Na+ current in GFP(+) cells. Additionally, preincubation of H441 cells with A77-1726 (20 mu M), a de novo UTP synthesis inhibitor, and 1400W completely reversed the RSV inhibition of amiloride-sensitive currents in GFP(+) cells. Thus, both UTP- and iNOS-generated reactive species contribute to ENaC down-regulation in RSV-infected airway epithelial cells.	[Song, Weifeng; Bosworth, Charles A.; Walker, John R.; Lazrak, Ahmed; Matalon, Sadis] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL 35233 USA; [Liu, Gang; Abraham, Edward] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35233 USA; [Megaw, George A.; Sullender, Wayne M.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35233 USA; [Sullender, Wayne M.; Matalon, Sadis] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35233 USA; [Matalon, Sadis] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35233 USA; [Bosworth, Charles A.; Lazrak, Ahmed; Matalon, Sadis] Univ Alabama Birmingham, Ctr Free Radical Biol, Birmingham, AL 35233 USA; [Matalon, Sadis] Univ Alabama Birmingham, Ctr Lung Injury & Repair, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Matalon, S (corresponding author), Univ Alabama Birmingham, Dept Anesthesiol, 224 BMR 2,901 19th St S, Birmingham, AL 35205 USA.	sadis@uab.edu		, Gang/0000-0002-6999-7633; Liu, Gang/0000-0003-2615-131X; Lazrak, Ahmed/0000-0002-4127-1937	National Institutes of Health [HL-31197, HL-51173]; NIEHS, Public Health Service [U01ES015676, 1U54NS063739]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL031197, R01HL051173, R01HL031197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES015676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS, Public Health Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)United States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-31197 and HL- 51173 and Grants U01ES015676 and 1U54NS063739 (NIEHS, Public Health Service). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Bebok Z, 2002, J BIOL CHEM, V277, P43041, DOI 10.1074/jbc.M203154200; Burnstock G, 2000, J PHARMACOL EXP THER, V295, P862; Campbell DL, 1996, J GEN PHYSIOL, V108, P277, DOI 10.1085/jgp.108.4.277; Cartee TL, 2003, J VIROL, V77, P7352, DOI 10.1128/JVI.77.13.7352-7360.2003; Chen L, 2006, J BIOL CHEM, V281, P9190, DOI 10.1074/jbc.M513231200; CHEN L, 2008, AM J RESP C IN PRESS; Chen L, 2008, AM J RESP CELL MOL, V39, P150, DOI 10.1165/rcmb.2008-0005OC; Chen XJ, 2004, AM J PHYSIOL-LUNG C, V287, pL366, DOI 10.1152/ajplung.00011.2004; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; Davis IC, 2007, AM J RESP CELL MOL, V37, P379, DOI 10.1165/rcmb.2007-0142OC; Davis IC, 2007, AM J PHYSIOL-LUNG C, V293, pL281, DOI 10.1152/ajplung.00458.2006; Davis IC, 2006, AM J RESP CRIT CARE, V173, P673, DOI 10.1164/rccm.200508-1200OC; Davis IC, 2004, AM J PHYSIOL-LUNG C, V286, pL112, DOI 10.1152/ajplung.00218.2003; Dowell SF, 1996, J INFECT DIS, V174, P456, DOI 10.1093/infdis/174.3.456; Eckardt-Michel J, 2008, J VIROL, V82, P3236, DOI 10.1128/JVI.01887-07; Eu JP, 1999, BIOCHEM PHARMACOL, V57, P1079, DOI 10.1016/S0006-2952(98)00360-8; Feelisch M, 2002, FASEB J, V16, P1775, DOI 10.1096/fj.02-0363com; Fuentes S, 2007, J VIROL, V81, P8361, DOI 10.1128/JVI.02717-06; Guo Y, 1998, AM J PHYSIOL-LUNG C, V274, pL369, DOI 10.1152/ajplung.1998.274.3.L369; Guo Z, 2007, FASEB J, V21, P535, DOI 10.1096/fj.06-6739com; Haeberle HA, 2002, J INFECT DIS, V186, P1199, DOI 10.1086/344644; Hammer J, 1997, PEDIATR PULM, V23, P176, DOI 10.1002/(SICI)1099-0496(199703)23:3<176::AID-PPUL2>3.0.CO;2-M; Hardy RW, 1999, J VIROL, V73, P170, DOI 10.1128/JVI.73.1.170-176.1999; Hardy RW, 1998, J VIROL, V72, P520, DOI 10.1128/JVI.72.1.520-526.1998; Hickman-Davis J, 1999, P NATL ACAD SCI USA, V96, P4953, DOI 10.1073/pnas.96.9.4953; Jain L, 1998, AM J PHYSIOL-LUNG C, V274, pL475, DOI 10.1152/ajplung.1998.274.4.L475; Janssen R, 2007, J VIROL, V81, P5958, DOI 10.1128/JVI.02220-06; Karron RA, 2005, J INFECT DIS, V191, P1093, DOI 10.1086/427813; Kochva U, 2003, PROTEIN SCI, V12, P2668, DOI 10.1110/ps.03151103; Kulaksiz H, 2002, P NATL ACAD SCI USA, V99, P6796, DOI 10.1073/pnas.102171199; Kunzelmann K, 2000, P NATL ACAD SCI USA, V97, P10282, DOI 10.1073/pnas.160041997; Kunzelmann K, 2004, J BIOL CHEM, V279, P48760, DOI 10.1074/jbc.M409747200; Kunzelmann K, 2007, J VIROL, V81, P3714, DOI 10.1128/JVI.02621-06; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lazrak A, 2000, AM J PHYSIOL-CELL PH, V279, pC762, DOI 10.1152/ajpcell.2000.279.3.C762; Lazrak A, 2003, AM J PHYSIOL-LUNG C, V285, pL443, DOI 10.1152/ajplung.00412.2002; Lazrak A, 2002, AM J PHYSIOL-LUNG C, V282, pL650, DOI 10.1152/ajplung.00370.2001; Lazrak A, 2000, AM J PHYSIOL-LUNG C, V278, pL848, DOI 10.1152/ajplung.2000.278.4.L848; Lindell DM, 2008, EUR J IMMUNOL, V38, P2168, DOI 10.1002/eji.200838155; LING BN, 1989, AM J PHYSIOL, V256, pF1094, DOI 10.1152/ajprenal.1989.256.6.F1094; Liu G, 2008, FASEB J, V22, P2285, DOI 10.1096/fj.07-101816; Liu G, 2007, J IMMUNOL, V179, P4125, DOI 10.4049/jimmunol.179.6.4125; Matalon S, 2002, J APPL PHYSIOL, V93, P1852, DOI 10.1152/japplphysiol.01241.2001; Matalon S, 1999, ANNU REV PHYSIOL, V61, P627, DOI 10.1146/annurev.physiol.61.1.627; MBIGUINO A, 1991, J VIROL METHODS, V31, P161, DOI 10.1016/0166-0934(91)90154-R; Nara M, 2000, AM J PHYSIOL-CELL PH, V279, pC1938, DOI 10.1152/ajpcell.2000.279.6.C1938; Nifli AP, 2005, J DAIRY RES, V72, P44, DOI 10.1017/S0022029905001172; PATTNAIK AK, 1992, CELL, V69, P1011, DOI 10.1016/0092-8674(92)90619-N; Pribul PK, 2008, J VIROL, V82, P4441, DOI 10.1128/JVI.02541-07; ROBERTS SR, 1995, J VIROL, V69, P2667, DOI 10.1128/JVI.69.4.2667-2673.1995; Shijubo N, 2000, ANN NY ACAD SCI, V923, P268; Smyth RL, 2006, LANCET, V368, P312, DOI 10.1016/S0140-6736(06)69077-6; Stockando JD, 2000, J BIOL CHEM, V275, P25760, DOI 10.1074/jbc.M003615200; SULLENDER WM, 1990, VIROLOGY, V178, P195, DOI 10.1016/0042-6822(90)90394-7; Sullender WM, 2000, CLIN MICROBIOL REV, V13, P1, DOI 10.1128/CMR.13.1.1-15.2000; Tsuruta Y, 2007, J IMMUNOL, V179, P7079, DOI 10.4049/jimmunol.179.10.7079; Tsutsumi H, 1999, J LEUKOCYTE BIOL, V66, P99, DOI 10.1002/jlb.66.1.99; Whitehead SS, 1999, J VIROL, V73, P3438, DOI 10.1128/JVI.73.4.3438-3442.1999; XIE QW, 1994, J BIOL CHEM, V269, P4705; YU QZ, 1995, J VIROL, V69, P2412, DOI 10.1128/JVI.69.4.2412-2419.1995; Zaman K, 2006, MOL PHARMACOL, V70, P1435, DOI 10.1124/mol.106.023242; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002; Zhang YH, 2003, J VIROL, V77, P5933, DOI 10.1128/JVI.77.10.5933-5947.2003; Zhang YH, 2001, J VIROL, V75, P9044, DOI 10.1128/JVI.75.19.9044-9058.2001	65	42	44	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7294	7306		10.1074/jbc.M806816200	http://dx.doi.org/10.1074/jbc.M806816200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19131335	hybrid, Green Published			2022-12-25	WOS:000263919000076
J	Miloushev, VZ; Levine, JA; Arbing, MA; Hunt, JF; Pitt, GS; Palmer, AG				Miloushev, Vesselin Z.; Levine, Joshua A.; Arbing, Mark A.; Hunt, John F.; Pitt, Geoffrey S.; Palmer, Arthur G., III			Solution Structure of the Na(V)1.2 C-terminal EF-hand Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL INACTIVATION; MOLECULAR-STRUCTURE DETERMINATION; PROTEIN-STRUCTURE DETERMINATION; CALCIUM-FREE CALMODULIN; TONIC-CLONIC SEIZURES; LONG-QT SYNDROME; SLOW INACTIVATION; DIPOLAR COUPLINGS; RESONANCE ASSIGNMENTS; CARDIAC EXCITABILITY	Voltage-gated sodium channels initiate the rapid upstroke of action potentials in many excitable tissues. Mutations within intracellular C-terminal sequences of specific channels underlie a diverse set of channelopathies, including cardiac arrhythmias and epilepsy syndromes. The three-dimensional structure of the C-terminal residues 1777-1882 of the human Na(V)1.2 voltage-gated sodium channel has been determined in solution by NMR spectroscopy at pH 7.4 and 290.5 K. The ordered structure extends from residues Leu-1790 to Glu-1868 and is composed of four alpha-helices separated by two short anti-parallel beta-strands; a less well defined helical region extends from residue Ser-1869 to Arg-1882, and a disordered N-terminal region encompasses residues 1777-1789. Although the structure has the overall architecture of a paired EF-hand domain, the Na(V)1.2 C-terminal domain does not bind Ca2+ through the canonical EF-hand loops, as evidenced by monitoring H-1, N-15 chemical shifts during a Ca2+ titration. Backbone chemical shift resonance assignments and Ca2+ titration also were performed for the Na(V)1.5 (1773-1878) isoform, demonstrating similar secondary structure architecture and the absence of Ca2+ binding by the EF-hand loops. Clinically significant mutations identified in the C-terminal region of Na(V)1 sodium channels cluster in the helix I-IV interface and the helix II-III interhelical segment or in helices III and IV of the Na(V)1.2 (1777-1882) structure.	[Miloushev, Vesselin Z.; Palmer, Arthur G., III] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Levine, Joshua A.] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Arbing, Mark A.; Hunt, John F.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Pitt, Geoffrey S.] Duke Univ, Div Cardiol, Dept Med, Med Ctr, Durham, NC 27710 USA	Columbia University; Columbia University; Columbia University; Duke University	Palmer, AG (corresponding author), 701 West 168th St,Box 36, New York, NY 10032 USA.	agp6@columbia.edu	Pitt, Geoffrey/L-4927-2019	Pitt, Geoffrey/0000-0003-2246-0289	National Institutes of Health [R01 HL71165, MSTP 5T32 GM07367, R01 GM59273]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059273, U54GM074958, T32GM007367, P50GM062413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL71165 (to G. S. P.), MSTP 5T32 GM07367 (to V.Z.M.), and R01 GM59273 (to A. G. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abriel H, 2000, CIRCULATION, V102, P921; Abriel H, 2005, TRENDS CARDIOVAS MED, V15, P35, DOI 10.1016/j.tcm.2005.01.001; Ackerman MJ, 2001, JAMA-J AM MED ASSOC, V286, P2264, DOI 10.1001/jama.286.18.2264; Alekov AK, 2001, EUR J NEUROSCI, V13, P2171, DOI 10.1046/j.0953-816x.2001.01590.x; An RH, 1998, CIRC RES, V83, P141, DOI 10.1161/01.RES.83.2.141; BABITCH J, 1990, NATURE, V346, P321, DOI 10.1038/346321b0; BABITCH JA, 1987, J THEOR BIOL, V127, P451, DOI 10.1016/S0022-5193(87)80142-X; Bezzina C, 1999, CIRC RES, V85, P1206; Biekofsky RR, 1998, BIOCHEMISTRY-US, V37, P7617, DOI 10.1021/bi9800449; Biswas S, 2008, J GEN PHYSIOL, V131, P197, DOI 10.1085/jgp.200709863; Brugada J, 1999, EUROPACE, V1, P156, DOI 10.1053/eupc.1999.0033; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Casini S, 2007, CARDIOVASC RES, V76, P418, DOI 10.1016/j.cardiores.2007.08.005; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chou JJ, 2000, J BIOMOL NMR, V18, P101, DOI 10.1023/A:1008358318863; Chou KC, 2000, ANAL BIOCHEM, V286, P1, DOI 10.1006/abio.2000.4757; Cicero DO, 2006, J MAGN RESON, V180, P222, DOI 10.1016/j.jmr.2006.02.016; Cormier JW, 2002, J BIOL CHEM, V277, P9233, DOI 10.1074/jbc.M110204200; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deschenes I, 1999, CIRCULATION, V100, P278; Doreleijers JF, 1999, J BIOMOL NMR, V14, P123, DOI 10.1023/A:1008335423527; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Findeisen M, 2007, MAGN RESON CHEM, V45, P175, DOI 10.1002/mrc.1941; Fletcher CM, 1996, J BIOMOL NMR, V8, P292, DOI 10.1007/BF00410328; Fujiwara T, 2003, BRAIN, V126, P531, DOI 10.1093/brain/awg053; GAO ZH, 1993, J BIOL CHEM, V268, P20096; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Glaaser IW, 2006, J BIOL CHEM, V281, P24015, DOI 10.1074/jbc.M605473200; Goldin AL, 2003, CURR OPIN NEUROBIOL, V13, P284, DOI 10.1016/S0959-4388(03)00065-5; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; GUNTERT P, 1991, Journal of Biomolecular NMR, V1, P447, DOI 10.1007/BF02192866; HAZES B, 1988, PROTEIN ENG, V2, P119, DOI 10.1093/protein/2.2.119; Hilber K, 2001, J BIOL CHEM, V276, P27831, DOI 10.1074/jbc.M101933200; Houdusse A, 1996, STRUCTURE, V4, P21, DOI 10.1016/S0969-2126(96)00006-8; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Kim J, 2004, J BIOL CHEM, V279, P45004, DOI 10.1074/jbc.M407286200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Makita N, 2002, CIRCULATION, V106, P1269, DOI 10.1161/01.CIR.0000027139.42087.B6; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; MAUNE JF, 1992, J BIOL CHEM, V267, P5286; Mori M, 2000, BIOCHEMISTRY-US, V39, P1316, DOI 10.1021/bi9912600; Motoike HK, 2004, J GEN PHYSIOL, V123, P155, DOI 10.1085/jgp.200308929; Mumenthaler C, 1997, J BIOMOL NMR, V10, P351, DOI 10.1023/A:1018383106236; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Permi P, 2000, J BIOMOL NMR, V17, P43, DOI 10.1023/A:1008372624615; Pitt B, 2007, CIRCULATION, V115, P2976, DOI 10.1161/CIRCULATIONAHA.106.670109; Pitt GS, 2007, CARDIOVASC RES, V73, P641, DOI 10.1016/j.cardiores.2006.10.019; QU YS, 1995, J BIOL CHEM, V270, P25696, DOI 10.1074/jbc.270.43.25696; Rhodes TH, 2005, J PHYSIOL-LONDON, V569, P433, DOI 10.1113/jphysiol.2005.094326; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Rivolta I, 2001, J BIOL CHEM, V276, P30623, DOI 10.1074/jbc.M104471200; Rohl CA, 1999, BIOCHEMISTRY-US, V38, P855, DOI 10.1021/bi9823380; Rusconi R, 2007, J NEUROSCI, V27, P11037, DOI 10.1523/JNEUROSCI.3515-07.2007; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shah VN, 2006, P NATL ACAD SCI USA, V103, P3592, DOI 10.1073/pnas.0507397103; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Spampanato J, 2004, J NEUROSCI, V24, P10022, DOI 10.1523/JNEUROSCI.2034-04.2004; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Tan HL, 2002, NATURE, V415, P442, DOI 10.1038/415442a; Tateyama M, 2004, BIOPHYS J, V86, P1843, DOI 10.1016/S0006-3495(04)74251-4; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Terrenoire C, 2007, J CARDIOVASC ELECTR, V18, P900, DOI 10.1111/j.1540-8167.2007.00838.x; The YK, 2006, BIOPHYS J, V90, P3511, DOI 10.1529/biophysj.105.073072; Tikhonov DB, 2007, BIOPHYS J, V93, P1557, DOI 10.1529/biophysj.106.100248; TJANDRA N, 1995, EUR J BIOCHEM, V230, P1014, DOI 10.1111/j.1432-1033.1995.tb20650.x; Ulbricht W, 2005, PHYSIOL REV, V85, P1271, DOI 10.1152/physrev.00024.2004; Vilin YY, 1999, BIOPHYS J, V77, P1384, DOI 10.1016/S0006-3495(99)76987-0; Wang DW, 2000, CIRC RES, V87, pE37, DOI 10.1161/01.RES.87.8.e37; WILMOT CM, 1990, PROTEIN ENG, V3, P479, DOI 10.1093/protein/3.6.479; Wilson MA, 2000, J MOL BIOL, V301, P1237, DOI 10.1006/jmbi.2000.4029; Wingo TL, 2004, NAT STRUCT MOL BIOL, V11, P219, DOI 10.1038/nsmb737; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xu XP, 2002, BIOPOLYMERS, V65, P408, DOI 10.1002/bip.10276; Young KA, 2005, J PHYSIOL-LONDON, V565, P349, DOI 10.1113/jphysiol.2004.081422; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	82	36	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6446	6454		10.1074/jbc.M807401200	http://dx.doi.org/10.1074/jbc.M807401200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19129176	hybrid, Green Published			2022-12-25	WOS:000263742700047
J	Hagos, EG; Ghaleb, AM; Dalton, WB; Bialkowska, AB; Yang, VW				Hagos, E. G.; Ghaleb, A. M.; Dalton, W. B.; Bialkowska, A. B.; Yang, V. W.			Mouse embryonic fibroblasts null for the Kruppel-like factor 4 gene are genetically unstable	ONCOGENE			English	Article						aneuploidy; centrosome amplification; cell cycle; chromosome aberrations; gamma-H2AX; KLF4	GASTRIC-CANCER DEVELOPMENT; CENTROSOME AMPLIFICATION; CYCLIN-E; CHROMOSOMAL INSTABILITY; TRANSCRIPTION FACTORS; CELL-PROLIFERATION; TUMOR-SUPPRESSOR; DNA-DAMAGE; ANEUPLOIDY; P53	Kruppel-like factor 4 (KLF4) is a zinc-finger transcription factor with tumor suppressive activity in colorectal cancer. Here, we investigated whether KLF4 is involved in maintaining genetic stability in mouse embryonic fibroblasts (MEFs) isolated from mice wild type (+/+), heterozygous (+/-), or homozygous (-/-) for the Klf4 alleles. Compared to Klf4(+/+) and Klf4(+/-) MEFs, Klf4(-/-) MEFs had both a higher level of apoptosis and rate of proliferation. Quantification of chromosome numbers showed that Klf4(-/-) MEFs were aneuploid. A higher number of Klf4(-/-) MEFs exhibited gamma-H2AX foci and had higher amounts of gamma-H2AX compared to controls. Cytogenetic analysis demonstrated the presence of numerous chromosome aberrations including dicentric chromosomes, chromatid breaks, and double minute chromosomes in Klf4(-/-) cells but in few, if any, Klf4(+/+) or Klf4(+/-) MEFs. Approximately 25% of Klf4(-/-) MEFs exhibited centrosome amplification in contrast to the less than 5% of Klf4(+/+) or Klf4(+/-) MEFs. Finally, only Klf4(-/-) MEFs were capable of anchorage-independent growth. Taken together, these findings demonstrate that MEFs null for the Klf4 alleles are genetically unstable, as evidenced by the presence of aneuploidy, chromosome aberration and centrosome amplification. The results support a crucial role for KLF4 in maintaining genetic stability and as a tumor suppressor.	[Hagos, E. G.; Ghaleb, A. M.; Dalton, W. B.; Bialkowska, A. B.; Yang, V. W.] Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA; [Yang, V. W.] Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Emory University; Emory University	Yang, VW (corresponding author), Emory Univ, Sch Med, Dept Med, Div Digest Dis, 201 Whitehead Res Bldg,615 Michael St, Atlanta, GA 30322 USA.	vyang@emory.edu	, ehagos/AAY-8486-2020; Dalton, William/M-7944-2017	Dalton, William/0000-0002-1314-0534	National Institutes of Health [DK52230, DK64399, CA84197]; NIH National Research Service Award [CA130308]; Emory Biochemistry, Cell and Developmental Biology (BCDB) training grant; NATIONAL CANCER INSTITUTE [R01CA084197, F32CA130308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064399, R01DK052230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory Biochemistry, Cell and Developmental Biology (BCDB) training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr Klaus Kaestner and Dr Jonathan Katz for providing the Klf4<SUP>+/-</SUP> mice. This work was in part supported by grants from the National Institutes of Health ( DK52230, DK64399, and CA84197). EGH was an Emory Fellowships in Research and Science Teaching ( FIRST) fellow. AMG was the recipient of a NIH National Research Service Award ( CA130308). WBD was supported in part by an Emory Biochemistry, Cell and Developmental Biology (BCDB) training grant.	Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Chen XM, 2003, J MOL BIOL, V326, P665, DOI 10.1016/S0022-2836(02)01449-3; Chen XM, 2001, J BIOL CHEM, V276, P30423, DOI 10.1074/jbc.M101194200; Chng WJ, 2008, BLOOD, V111, P1603, DOI 10.1182/blood-2007-06-097774; D'Assoro AB, 2002, ONCOGENE, V21, P6146, DOI 10.1038/sj.onc.1205772; Dalton WB, 2007, CANCER RES, V67, P11487, DOI 10.1158/0008-5472.CAN-07-5162; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; Dang DT, 2000, FEBS LETT, V476, P203, DOI 10.1016/S0014-5793(00)01727-0; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Fukasawa K, 1997, ONCOGENE, V15, P1295, DOI 10.1038/sj.onc.1201482; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Gartel AL, 2002, MOL CANCER THER, V1, P639; Ghadimi BM, 2000, GENE CHROMOSOME CANC, V27, P183, DOI 10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P; Ghaleb AM, 2007, ONCOGENE, V26, P2365, DOI 10.1038/sj.onc.1210022; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Ghaleb AM, 2007, CANCER RES, V67, P7147, DOI 10.1158/0008-5472.CAN-07-1302; Ghaleb AM, 2008, CURR COLORECT CANC R, V4, P59, DOI 10.1007/s11888-008-0011-4; Hanashiro K, 2008, ONCOGENE, V27, P5288, DOI 10.1038/onc.2008.161; HARVEY M, 1993, ONCOGENE, V8, P2457; Hinchcliffe EH, 2002, ONCOGENE, V21, P6154, DOI 10.1038/sj.onc.1205826; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kanai M, 2006, CLIN CANCER RES, V12, P6395, DOI 10.1158/1078-0432.CCR-06-1034; Katz JP, 2005, GASTROENTEROLOGY, V128, P935, DOI 10.1053/j.gastro.2005.02.022; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kawamura K, 2004, CANCER RES, V64, P4800, DOI 10.1158/0008-5472.CAN-03-3908; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; KIRSCHNER MW, 1986, NATURE, V324, P621, DOI 10.1038/324621a0; LEE JJ, 1990, ANAL BIOCHEM, V189, P1, DOI 10.1016/0003-2697(90)90036-9; LEE JM, 1994, ONCOGENE, V9, P3731; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lingle WL, 1999, AM J PATHOL, V155, P1941, DOI 10.1016/S0002-9440(10)65513-7; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Mayer F, 2003, ONCOGENE, V22, P3859, DOI 10.1038/sj.onc.1206469; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Salisbury JL, 2004, J MAMMARY GLAND BIOL, V9, P275, DOI 10.1023/B:JOMG.0000048774.27697.30; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Takada Y, 2007, ONCOGENE, V26, P1201, DOI 10.1038/sj.onc.1209906; Tarapore P, 2002, ONCOGENE, V21, P6234, DOI 10.1038/sj.onc.1205707; Tarapore P, 2001, ONCOGENE, V20, P3173, DOI 10.1038/sj.onc.1204424; Tarapore P, 2002, CELL CYCLE, V1, P75, DOI 10.4161/cc.1.1.103; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Weaver BAA, 2007, CANCER RES, V67, P10103, DOI 10.1158/0008-5472.CAN-07-2266; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Wei DY, 2005, CANCER RES, V65, P2746, DOI 10.1158/0008-5472.CAN-04-3619; Yoon HS, 2005, ONCOGENE, V24, P4017, DOI 10.1038/sj.onc.1208576; Yoon HS, 2004, J BIOL CHEM, V279, P5035, DOI 10.1074/jbc.M307631200; Yoon HS, 2003, J BIOL CHEM, V278, P2101, DOI 10.1074/jbc.M211027200; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067	62	34	35	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 5	2009	28	9					1197	1205		10.1038/onc.2008.465	http://dx.doi.org/10.1038/onc.2008.465			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	415AH	19137014	Green Accepted			2022-12-25	WOS:000263906200004
J	Mahller, YY; Williams, JP; Baird, WH; Mitton, B; Grossheim, J; Saeki, Y; Cancelas, JA; Ratner, N; Cripe, TP				Mahller, Yonatan Y.; Williams, Jon P.; Baird, William H.; Mitton, Bryan; Grossheim, Jonathan; Saeki, Yoshinaga; Cancelas, Jose A.; Ratner, Nancy; Cripe, Timothy P.			Neuroblastoma Cell Lines Contain Pluripotent Tumor Initiating Cells That Are Susceptible to a Targeted Oncolytic Virus	PLOS ONE			English	Article								Background: Although disease remission can frequently be achieved for patients with neuroblastoma, relapse is common. The cancer stem cell theory suggests that rare tumorigenic cells, resistant to conventional therapy, are responsible for relapse. If true for neuroblastoma, improved cure rates may only be achieved via identification and therapeutic targeting of the neuroblastoma tumor initiating cell. Based on cues from normal stem cells, evidence for tumor populating progenitor cells has been found in a variety of cancers. Methodology/Principal Findings: Four of eight human neuroblastoma cell lines formed tumorspheres in neural stem cell media, and all contained some cells that expressed neurogenic stem cell markers including CD133, ABCG2, and nestin. Three lines tested could be induced into multi-lineage differentiation. LA-N-5 spheres were further studied and showed a verapamil-sensitive side population, relative resistance to doxorubicin, and CD133+ cells showed increased sphere formation and tumorigenicity. Oncolytic viruses, engineered to be clinically safe by genetic mutation, are emerging as next generation anticancer therapeutics. Because oncolytic viruses circumvent typical drug-resistance mechanisms, they may represent an effective therapy for chemotherapy-resistant tumor initiating cells. A Nestin-targeted oncolytic herpes simplex virus efficiently replicated within and killed neuroblastoma tumor initiating cells preventing their ability to form tumors in athymic nude mice. Conclusions/Significance: These results suggest that human neuroblastoma contains tumor initiating cells that may be effectively targeted by an oncolytic virus.	[Baird, William H.; Mitton, Bryan; Cripe, Timothy P.] Cincinnati Childrens Hosp, Med Ctr, Div Hematol & Oncol, Cincinnati, OH USA; [Mahller, Yonatan Y.; Williams, Jon P.; Baird, William H.; Cancelas, Jose A.; Ratner, Nancy; Cripe, Timothy P.] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol, Cincinnati, OH USA; [Grossheim, Jonathan] Cincinnati Childrens Hosp Med Ctr, Div Pathol, Cincinnati, OH USA; [Mahller, Yonatan Y.; Baird, William H.; Mitton, Bryan] Univ Cincinnati, Coll Med, Physician Scientist Training Program, Cincinnati, OH 45221 USA; [Mahller, Yonatan Y.; Baird, William H.] Univ Cincinnati, Coll Med, Graduate Program Mol & Dev Biol, Cincinnati, OH 45221 USA; [Saeki, Yoshinaga] Ohio State Univ, Dept Neurol Surg, Dardinger Lab NeuroOncol & Neurosci, Columbus, OH 43210 USA; [Saeki, Yoshinaga] Ohio State Univ, Comprehensive Canc Ctr, Columbus, OH 43210 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Mahller, YY (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Hematol & Oncol, Cincinnati, OH USA.	timothy.cripe@cchmc.org	Williams, Jon/AAP-2761-2020; Cancelas, Jose/AAR-9324-2020	RATNER, NANCY/0000-0001-5030-9354	Cincinnati Children's Hospital Medical Center Division of Hematology/Oncology; TeeOffAgainstCancer.org; NIH [R01-CA114004, R21-CA133663]; NATIONAL CANCER INSTITUTE [T32CA117846, R21CA133663, R01CA114004] Funding Source: NIH RePORTER	Cincinnati Children's Hospital Medical Center Division of Hematology/Oncology; TeeOffAgainstCancer.org; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Cincinnati Children's Hospital Medical Center Division of Hematology/Oncology, by TeeOffAgainstCancer.org, and NIH grants R01-CA114004 and R21-CA133663 to TPC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adusumilli PS, 2006, J GENE MED, V8, P603, DOI 10.1002/jgm.877; Aghi M, 2005, ONCOGENE, V24, P7802, DOI 10.1038/sj.onc.1209037; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bapat SA, 2007, SEMIN CANCER BIOL, V17, P204, DOI 10.1016/j.semcancer.2006.05.001; Bez A, 2003, BRAIN RES, V993, P18, DOI 10.1016/j.brainres.2003.08.061; BRODEUR G, 2001, PRINCIPLES PRACTICE, P896; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Chojnacki A, 2003, J NEUROSCI, V23, P1730; Dontu G, 2005, STEM CELL REV, V1, P207, DOI 10.1385/SCR:1:3:207; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Fukuhara H, 2005, CANCER RES, V65, P10663, DOI 10.1158/0008-5472.CAN-05-2534; George RE, 2006, J CLIN ONCOL, V24, P2891, DOI 10.1200/JCO.2006.05.6986; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Hadnagy A, 2006, EXP CELL RES, V312, P3701, DOI 10.1016/j.yexcr.2006.08.030; Hansford LM, 2007, CANCER RES, V67, P11234, DOI 10.1158/0008-5472.CAN-07-0718; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Islam MO, 2005, NEUROSCI RES, V52, P75, DOI 10.1016/j.neures.2005.01.013; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Kambara H, 2005, CANCER RES, V65, P2832, DOI 10.1158/0008-5472.CAN-04-3227; Kanemura Y, 2002, J NEUROSCI RES, V69, P869, DOI 10.1002/jnr.10377; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Keshelava N, 1998, CANCER RES, V58, P5396; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Li H, 2007, CLIN CANCER RES, V13, P316, DOI 10.1158/1078-0432.CCR-06-1625; Lin E, 2004, CANCER GENE THER, V11, P643, DOI 10.1038/sj.cgt.7700733; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Luo L, 2006, INT J HEMATOL, V84, P123, DOI 10.1532/IJH97.A10503; Mahller YY, 2007, MOL THER, V15, P279, DOI 10.1038/sj.mt.6300038; Mahller YY, 2006, PEDIATR BLOOD CANCER, V46, P745, DOI 10.1002/pbc.20565; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Nagato M, 2005, J NEUROSCI RES, V80, P456, DOI 10.1002/jnr.20442; Olshan AF, 2000, NEUROBLASTOMA, P33; Parikh NS, 2005, PEDIATR BLOOD CANCER, V44, P469, DOI 10.1002/pbc.20268; Polyak K, 2006, NAT MED, V12, P296, DOI 10.1038/nm1379; Prabhakar S, 2007, CANCER GENE THER, V14, P460, DOI 10.1038/sj.cgt.7701037; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ribacka C, 2008, CURR GENE THER, V8, P88, DOI 10.2174/156652308784049372; ROSS RA, 1983, J NATL CANCER I, V71, P741; Ross RA, 2007, SEMIN CANCER BIOL, V17, P241, DOI 10.1016/j.semcancer.2006.04.006; Sakariassen PO, 2007, NEOPLASIA, V9, P882, DOI 10.1593/neo.07658; Sales-Pardo I, 2006, BLOOD, V108, P1774, DOI 10.1182/blood-2006-03-013615; Salmaggi A, 2006, GLIA, V54, P850, DOI 10.1002/glia.20414; SHEN Y, 2006, CANCER GENE THER, V7, P7; SHIMADA H, 1984, J NATL CANCER I, V73, P405, DOI 10.1093/jnci/73.2.405; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Singh SK, 2003, CANCER RES, V63, P5821; Staud F, 2005, INT J BIOCHEM CELL B, V37, P720, DOI 10.1016/j.biocel.2004.11.004; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; TERADA K, 2006, GENE THER, V19, P19; Thomas SK, 2004, J BIOL CHEM, V279, P27994, DOI 10.1074/jbc.M312663200; Walton JD, 2004, NEOPLASIA, V6, P838, DOI 10.1593/neo.04310; Wang JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003769; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Williams JP, 2008, CELL STEM CELL, V3, P658, DOI 10.1016/j.stem.2008.10.003; Zhou F C, 1998, Wound Repair Regen, V6, P337, DOI 10.1046/j.1524-475X.1998.60409.x	64	113	118	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4235	10.1371/journal.pone.0004235	http://dx.doi.org/10.1371/journal.pone.0004235			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JB	19156211	Green Submitted, gold, Green Published			2022-12-25	WOS:000265482100007
J	Kim, TS; Braciale, TJ				Kim, Taeg S.; Braciale, Thomas J.			Respiratory Dendritic Cell Subsets Differ in Their Capacity to Support the Induction of Virus-Specific Cytotoxic CD8(+) T Cell Responses	PLOS ONE			English	Article							ANTIGEN-PRESENTING FUNCTIONS; LYMPH-NODE; INFLUENZA-VIRUS; VIRAL IMMUNITY; LUNG; MIGRATION; ACTIVATION; INFECTION; CD4; RECRUITMENT	Dendritic cells located at the body surfaces, e. g. skin, respiratory and gastrointestinal tract, play an essential role in the induction of adaptive immune responses to pathogens and inert antigens present at these surfaces. In the respiratory tract, multiple subsets of dendritic cells ( RDC) have been identified in both the normal and inflamed lungs. While the importance of RDC in antigen transport from the inflamed or infected respiratory tract to the lymph nodes draining this site is well recognized, the contribution of individual RDC subsets to this process and the precise role of migrant RDC within the lymph nodes in antigen presentation to T cells is not clear. In this report, we demonstrate that two distinct subsets of migrant RDC - exhibiting the CD103(+) and CD11b(hi) phenotype, respectively - are the primary DC presenting antigen to naive CD4(+) and CD8(+) T lymphocytes in the draining nodes in response to respiratory influenza virus infection. Furthermore, the migrant CD103(+) RDC subset preferentially drives efficient proliferation and differentiation of naive CD8(+) T cells responding to infection into effector cells, and only the CD103(+) RDC subset can present to naive CD8(+) T cells non-infectious viral vaccine introduced into the respiratory tract. These results identify CD103(+) and CD11b(hi) RDC as critical regulators of the adaptive immune response to respiratory tract infection and potential targets in the design of mucosal vaccines.	[Kim, Taeg S.; Braciale, Thomas J.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22903 USA; [Braciale, Thomas J.] Univ Virginia, Dept Microbiol & Pathol, Charlottesville, VA 22903 USA	University of Virginia; University of Virginia	Kim, TS (corresponding author), Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22903 USA.	tjb2r@virginia.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037293] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL033391, R01 HL033391-27] Funding Source: Medline; NIAID NIH HHS [R01 AI037293] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Beaty SR, 2007, J IMMUNOL, V178, P1882, DOI 10.4049/jimmunol.178.3.1882; Belz GT, 2007, NAT IMMUNOL, V8, P1060, DOI 10.1038/ni1505; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; BEVAN MJ, 1976, J IMMUNOL, V117, P2233; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; CARBONE FR, 1990, J EXP MED, V171, P377, DOI 10.1084/jem.171.2.377; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; del Rio ML, 2007, J IMMUNOL, V178, P6861, DOI 10.4049/jimmunol.178.11.6861; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Diacovo TG, 2005, J EXP MED, V202, P687, DOI 10.1084/jem.20051035; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Geiss GK, 2001, J VIROL, V75, P4321, DOI 10.1128/JVI.75.9.4321-4331.2001; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Grayson MH, 2006, ANN ALLERG ASTHMA IM, V96, P643, DOI 10.1016/S1081-1206(10)61061-7; Hao XL, 2008, J VIROL, V82, P4908, DOI 10.1128/JVI.02367-07; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Hintzen G, 2006, J IMMUNOL, V177, P7346, DOI 10.4049/jimmunol.177.10.7346; Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Lambrecht BN, 2003, NAT REV IMMUNOL, V3, P994, DOI 10.1038/nri1249; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Lawrence CW, 2005, J IMMUNOL, V174, P5332, DOI 10.4049/jimmunol.174.9.5332; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Legge KL, 2003, IMMUNITY, V18, P265, DOI 10.1016/S1074-7613(03)00023-2; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Martin P, 2002, BLOOD, V99, P1282, DOI 10.1182/blood.V99.4.1282; MCWILLIAM AS, 1994, J EXP MED, V179, P1331, DOI 10.1084/jem.179.4.1331; Moron G, 2002, J EXP MED, V195, P1233, DOI 10.1084/jem.20011930; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Roman E, 2002, J EXP MED, V196, P957, DOI 10.1084/jem.20021052; Sallusto F, 2000, IMMUNOL REV, V177, P134, DOI 10.1034/j.1600-065X.2000.17717.x; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Stevens WW, 2007, J IMMUNOL METHODS, V327, P63, DOI 10.1016/j.jim.2007.07.011; Stumbles PA, 2003, APMIS, V111, P741, DOI 10.1034/j.1600-0463.2003.11107806.x; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Vermaelen K, 2004, CYTOM PART A, V61A, P170, DOI 10.1002/cyto.a.20064; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Villadangos JA, 2005, SEMIN IMMUNOL, V17, P262, DOI 10.1016/j.smim.2005.05.015; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; von Garnier C, 2005, J IMMUNOL, V175, P1609, DOI 10.4049/jimmunol.175.3.1609; Wikstrom ME, 2007, IMMUNOL CELL BIOL, V85, P182, DOI 10.1038/sj.icb.7100039; XIA WJ, 1995, J EXP MED, V181, P1275, DOI 10.1084/jem.181.4.1275; Yoneyama H, 2005, J EXP MED, V202, P425, DOI 10.1084/jem.20041961; Yoneyama H, 2004, INT IMMUNOL, V16, P915, DOI 10.1093/intimm/dxh093; Yoon H, 2007, J IMMUNOL, V179, P391, DOI 10.4049/jimmunol.179.1.391; Zammit DJ, 2006, IMMUNITY, V24, P439, DOI 10.1016/j.immuni.2006.01.015	55	205	207	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2009	4	1							e4204	10.1371/journal.pone.0004204	http://dx.doi.org/10.1371/journal.pone.0004204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IG	19145246	Green Published, Green Submitted, gold			2022-12-25	WOS:000265479800010
J	Serwanga, J; Shafer, LA; Pimego, E; Auma, B; Watera, C; Rowland, S; Yirrell, D; Pala, P; Grosskurth, H; Whitworth, J; Gotch, F; Kaleebu, P				Serwanga, Jennifer; Shafer, Leigh Anne; Pimego, Edward; Auma, Betty; Watera, Christine; Rowland, Samantha; Yirrell, David; Pala, Pietro; Grosskurth, Heiner; Whitworth, Jimmy; Gotch, Frances; Kaleebu, Pontiano			Host HLA B*Allele-Associated Multi-Clade Gag T-Cell Recognition Correlates with Slow HIV-1 Disease Progression in Antiretroviral Therapy-Naive Ugandans	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VIRAL LOAD; HIV-1-INFECTED INDIVIDUALS; IMMUNE-RESPONSES; CD4 DECLINE; PROVIRAL LOAD; LARGE COHORT; SET-POINT; INFECTION; REPLICATION	Background: Some HIV infected individuals remain asymptomatic for protracted periods of time in the absence of antiretroviral therapy (ART). Virological control, CD4 T cell loss and HIV-specific responses are some of the key interrelated determinants of HIV-1 disease progression. In this study, possible interactions between viral load, CD4 T cell slopes, host genetics and HIV-specific IFN-gamma responses were evaluated in chronically HIV-1-infected adults. Methodolology/Principal Findings: Multilevel regression modeling was used to stratify clade A or D HIV-infected individuals into disease progression groups based on CD4 T cell slopes. ELISpot assays were used to quantify the frequency and magnitude of HIV-induced IFN-gamma responses in 7 defined rapid progressors (RPs) and 14 defined slow progressors (SPs) at a single time point. HLA typing was performed using reference strand conformational analysis (RSCA). Although neither the breadth nor the magnitude of the proteome-wide HIV-specific IFN-gamma response correlated with viral load, slow disease progression was associated with over-representation of host immunogenetic protective HLA B* alleles (10 of 14 SPs compared to 0 of 7; p = 0.004, Fisher's Exact) especially B*57 and B*5801, multiclade Gag T-cell targeting (71%, 10 of 14 SPs compared to 14%, 1 of 7 RPs); p = 0.029, Fisher's Exact test and evident virological control (3.65 compared to 5.46 log10 copies/mL in SPs and RPs respectively); p < 0.001, unpaired student's t-test Conclusions: These data are consistent with others that associated protection from HIV disease with inherent host HLA B allele-mediated ability to induce broader Gag T-cell targeting coupled with apparent virological control. These immunogenetic features of Gag-specific immune response which could influence disease progression may provide useful insight in future HIV vaccine design.	[Serwanga, Jennifer; Shafer, Leigh Anne; Pimego, Edward; Auma, Betty; Watera, Christine; Pala, Pietro; Grosskurth, Heiner; Whitworth, Jimmy; Kaleebu, Pontiano] Uganda Virus Res Inst, MRC, Uganda Res Unit AIDS, Entebbe, Uganda; [Rowland, Samantha; Gotch, Frances] Imperial Coll, Chelsea & Westminster Hosp, Dept Immunol, London, England; [Yirrell, David] Ninewells Hosp, Dept Med Microbiol, Dundee, Scotland	Uganda Virus Research Institute; Imperial College London; University of Dundee	Serwanga, J (corresponding author), Uganda Virus Res Inst, MRC, Uganda Res Unit AIDS, Entebbe, Uganda.	jennifer.serwanga@mrcuganda.org		Grosskurth, Heiner/0000-0001-9960-7280	Wellcome Trust, UK [059437]; NIH [ROIA/146254.01]; MRC [G0501957, MC_U950081327] Funding Source: UKRI; Medical Research Council [G0501957, MC_U950081327] Funding Source: researchfish	Wellcome Trust, UK(Wellcome Trust); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by programme grant 059437 from the Wellcome Trust, UK, and NIH grant ROIA/146254.01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Arguello JR, 1998, TISSUE ANTIGENS, V52, P57, DOI 10.1111/j.1399-0039.1998.tb03024.x; Barugahare B, 2005, J VIROL, V79, P4132, DOI 10.1128/JVI.79.7.4132-4139.2005; Bennett MS, 2008, J INFECT DIS, V197, P390, DOI 10.1086/525281; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2005, P NATL ACAD SCI USA, V102, P4512, DOI 10.1073/pnas.0408773102; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Bratt G, 1998, AIDS, V12, P729, DOI 10.1097/00002030-199807000-00009; Brumme ZL, 2008, AIDS, V22, P1277, DOI 10.1097/QAD.0b013e3283021a8c; Chopera DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000033; Choudhary SK, 2007, J VIROL, V81, P8838, DOI 10.1128/JVI.02663-06; Coplan PM, 2005, J INFECT DIS, V191, P1427, DOI 10.1086/428450; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Ferrari G, 2008, AIDS RES HUM RETROV, V24, P20; Foxall RB, 2008, J VIROL, V82, P9795, DOI 10.1128/JVI.01217-08; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Frahm N, 2005, J VIROL, V79, P10218, DOI 10.1128/JVI.79.16.10218-10225.2005; Frahm N, 2007, J IMMUNOL, V179, P6638, DOI 10.4049/jimmunol.179.10.6638; Frater AJ, 2007, J VIROL, V81, P6742, DOI 10.1128/JVI.00022-07; Geldmacher C, 2007, J VIROL, V81, P2440, DOI 10.1128/JVI.01847-06; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Gupta SB, 2006, JAIDS-J ACQ IMM DEF, V42, P135, DOI 10.1097/01.qai.0000223017.01568.e7; Honeyborne I, 2007, J VIROL, V81, P3667, DOI 10.1128/JVI.02689-06; Jiao Y, 2006, JAIDS-J ACQ IMM DEF, V42, P263, DOI 10.1097/01.qai.0000221692.00091.a2; Kaleebu P, 2002, J INFECT DIS, V185, P1244, DOI 10.1086/340130; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Kebba A, 2004, AIDS RES HUM RETROV, V20, P67, DOI 10.1089/088922204322749512; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kiwanuka N, 2008, J INFECT DIS, V197, P707, DOI 10.1086/527416; Lazaryan A, 2006, J VIROL, V80, P6056, DOI 10.1128/JVI.02119-05; Lepri AC, 1998, EPIDEMIOL INFECT, V121, P369, DOI 10.1017/S095026889800140X; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Lopez M, 2008, AIDS RES HUM RETROV, V24, P1185, DOI 10.1089/aid.2008.0006; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; Maness NJ, 2008, J VIROL, V82, P5245, DOI 10.1128/JVI.00292-08; Matthews PC, 2008, J VIROL, V82, P8548, DOI 10.1128/JVI.00580-08; McAdam S, 1998, AIDS, V12, P571, DOI 10.1097/00002030-199806000-00005; McKinnon LR, 2005, JAIDS-J ACQ IMM DEF, V40, P245, DOI 10.1097/01.qai.0000184858.16447.04; Navis M, 2007, J IMMUNOL, V179, P3133, DOI 10.4049/jimmunol.179.5.3133; Ngumbela KC, 2008, AIDS RES HUM RETROV, V24, P72, DOI 10.1089/aid.2007.0124; Novitsky V, 2003, J VIROL, V77, P882, DOI 10.1128/JVI.77.2.882-890.2003; Novitsky VA, 2006, VIROLOGY, V349, P142, DOI 10.1016/j.virol.2006.02.006; O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1; Ostrowski MA, 2001, J INFECT DIS, V184, P1268, DOI 10.1086/324005; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Patke DS, 2002, J INFECT DIS, V186, P1177, DOI 10.1086/343811; Peretz Y, 2005, J VIROL, V79, P4908, DOI 10.1128/JVI.79.8.4908-4917.2005; Peretz Y, 2008, AIDS, V22, P1222, DOI 10.1097/QAD.0b013e3283021a76; Rutebemberwa A, 2004, AIDS RES HUM RETROV, V20, P763, DOI 10.1089/0889222041524643; Schellens IMM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002745; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Streeck H, 2008, J EXP MED, V205, P1789, DOI 10.1084/jem.20080281; Troyer RM, 2005, J VIROL, V79, P9006, DOI 10.1128/JVI.79.14.9006-9018.2005; Tsegaye A, 2007, AIDS, V21, P369, DOI 10.1097/QAD.0b013e32801222e3; Valentine LE, 2008, J VIROL, V82, P575, DOI 10.1128/JVI.00275-07; van Benthem BHB, 2002, AIDS, V16, P919, DOI 10.1097/00002030-200204120-00012; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; Wang B, 2002, VIROLOGY, V304, P246, DOI 10.1006/viro.2002.1706; Yirrell DL, 2002, AIDS, V16, P279, DOI 10.1097/00002030-200201250-00018; YIRRELL DL, 2007, EPIDEMIOL INFECT, V9, P1	63	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4188	10.1371/journal.pone.0004188	http://dx.doi.org/10.1371/journal.pone.0004188			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142234	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000265479700009
J	Qin, W; Ho, L; Wang, J; Peskind, E; Pasinetti, GM				Qin, Weiping; Ho, Lap; Wang, Jun; Peskind, Elaine; Pasinetti, Giulio Maria			S100A7, a Novel Alzheimer's Disease Biomarker with Non-Amyloidogenic alpha-Secretase Activity Acts via Selective Promotion of ADAM-10	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PRECURSOR PROTEIN; GAMMA; ADAM10; ASSAY; HIPPOCAMPAL; CLEAVAGE	Alzheimer's disease (AD) is the most common cause of dementia among older people. At present, there is no cure for the disease and as of now there are no early diagnostic tests for AD. There is an urgency to develop a novel promising biomarker for early diagnosis of AD. Using surface-enhanced laser desorption ionization-mass spectrometry SELDI-(MS) proteomic technology, we identified and purified a novel 11.7-kDa metal-binding protein biomarker whose content is increased in the cerebrospinal fluid (CSF) and in the brain of AD dementia subjects as a function of clinical dementia. Following purification and protein-sequence analysis, we identified and classified this biomarker as S100A7, a protein known to be involved in immune responses. Using an adenoviral- S100A7 expression system, we continued to examine the potential role of S100A7 in AD amyloid neuropathology in in vitro model of AD. We found that the expression of exogenous S100A7 in primary cortico-hippocampal neuron cultures derived from Tg2576 transgenic embryos inhibits the generation of beta-amyloid (A beta)(1-42) and A beta(1-40) peptides, coincidental with a selective promotion of "non- amyloidogenic'' alpha-secretase activity via promotion of ADAM (a disintegrin and metalloproteinase)-10. Finally, a selective expression of human S100A7 in the brain of transgenic mice results in significant promotion of alpha-secretase activity. Our study for the first time suggests that S100A7 may be a novel biomarker of AD dementia and supports the hypothesis that promotion of S100A7 expression in the brain may selectively promote alpha-secretase activity in the brain of AD precluding the generation of amyloidogenic peptides. If in the future we find that S1000A7 protein content in CSF is sensitive to drug intervention experimentally and eventually in the clinical setting, S100A7 might be developed as novel surrogate index (biomarker) of therapeutic efficacy in the characterization of novel drug agents for the treatment of AD.	[Qin, Weiping; Ho, Lap; Wang, Jun; Pasinetti, Giulio Maria] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Pasinetti, Giulio Maria] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Ho, Lap; Wang, Jun; Pasinetti, Giulio Maria] James J Peters Vet Affairs Med Ctr, GCRC, Bronx, NY USA; [Peskind, Elaine] Univ Washington, Sch Med, Seattle, WA 98195 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; University of Washington; University of Washington Seattle	Qin, W (corresponding author), Mt Sinai Sch Med, Dept Psychiat, New York, NY USA.	giulio.pasinetti@mssm.edu		Pasinetti, Giulio/0000-0002-1524-5196	James J. Peters VA GRECC Program; NIA [AG02219]; NATIONAL INSTITUTE ON AGING [P01AG002219, P50AG005136] Funding Source: NIH RePORTER	James J. Peters VA GRECC Program; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	These studies were supported by James J. Peters VA GRECC Program and NIA AG02219 to GMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinson TMJ, 2004, EUR J BIOCHEM, V271, P2539, DOI 10.1111/j.1432-1033.2004.04184.x; Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Bonafe JL, 1998, ARCH DERMATOL, V134, P1300, DOI 10.1001/archderm.134.10.1300; BOSMAN GJCGM, 1991, NEUROBIOL AGING, V12, P13, DOI 10.1016/0197-4580(91)90033-G; Burns M, 2003, J NEUROSCI, V23, P5645; Bussiere T, 2003, J COMP NEUROL, V463, P281, DOI 10.1002/cne.10760; Castellani RJ, 2006, ACTA NEUROPATHOL, V111, P503, DOI 10.1007/s00401-006-0071-y; Cheng HJ, 2000, METH MOL B, V124, P313; Colciaghi F, 2002, MOL MED, V8, P67, DOI 10.1007/BF03402076; Desdouits-Magnen J, 1998, J NEUROCHEM, V70, P524; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Ghanbari H, 1998, J CLIN LAB ANAL, V12, P285, DOI 10.1002/(SICI)1098-2825(1998)12:5<285::AID-JCLA6>3.0.CO;2-5; Gustaw KA, 2008, J NEUROCHEM, V106, P1350, DOI 10.1111/j.1471-4159.2008.05477.x; HEINONEN O, 1994, ARCH NEUROL-CHICAGO, V51, P799, DOI 10.1001/archneur.1994.00540200075019; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; JOHNSON VA, 1990, TECHNIQUES HIV RES, P71; Keating CD, 2005, P NATL ACAD SCI USA, V102, P2263, DOI 10.1073/pnas.0500024102; Kelley KA, 1999, AM J PATHOL, V155, P995, DOI 10.1016/S0002-9440(10)65199-1; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lee Hyoung-gon, 2006, Current Alzheimer Research, V3, P75, DOI 10.2174/156720506775697124; Leuner K, 2007, J NEURAL TRANSM-SUPP, P207; McLendon C, 2000, FASEB J, V14, P2383; Mills J, 1997, J NEUROSCI, V17, P9415; Mills J, 1999, NEUROSCIENCE, V94, P1333, DOI 10.1016/S0306-4522(99)00381-4; Mobbs CV, 2004, NEUROCHEM RES, V29, P1093, DOI 10.1023/B:NERE.0000023596.49140.e0; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; *NAT I AG ALZH DIS, PREV COSTS ALZH DIS; NybergHoffman C, 1997, NAT MED, V3, P808, DOI 10.1038/nm0797-808; Pinnix I, 2001, J BIOL CHEM, V276, P481, DOI 10.1074/jbc.M005968200; PIRTTILA T, 1992, J NEUROL SCI, V107, P160, DOI 10.1016/0022-510X(92)90284-R; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Qin WP, 2003, J BIOL CHEM, V278, P50970, DOI 10.1074/jbc.M307699200; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Steinerman JR, 2007, CURR NEUROL NEUROSCI, V7, P381, DOI 10.1007/s11910-007-0059-6; Takeuchi M, 2007, MED HYPOTHESES, V69, P1358, DOI 10.1016/j.mehy.2006.12.017; Thompson PM, 2004, NEUROIMAGE, V22, P1754, DOI 10.1016/j.neuroimage.2004.03.040; Ward M, 2007, EXPERT REV MOL DIAGN, V7, P635, DOI 10.1586/14737159.7.5.635; Watson PH, 1998, INT J BIOCHEM CELL B, V30, P567, DOI 10.1016/S1357-2725(97)00066-6	41	53	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2009	4	1							e4183	10.1371/journal.pone.0004183	http://dx.doi.org/10.1371/journal.pone.0004183			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IE	19159013	gold, Green Submitted, Green Published			2022-12-25	WOS:000265479600002
J	Bull, JJ; Harcombe, WR				Bull, James J.; Harcombe, William R.			Population Dynamics Constrain the Cooperative Evolution of Cross-Feeding	PLOS ONE			English	Article							ALTRUISM; MODEL	Cross-feeding is the exchange of nutrients among species of microbes. It has two potential evolutionary origins, one as an exchange of metabolic wastes or byproducts among species, the other as a form of cooperation known as reciprocal altruism. This paper explores the conditions favoring the origin of cooperative cross-feeding between two species. There is an extensive literature on the evolution of cooperation, and some of the requirements for the evolution of cooperative cross-feeding follow from this prior work-specifically the requirement that interactions be limited to small groups of individuals, such as colonies in a spatially structured environment. Evolution of cooperative cross- feeding by a species also requires that cross-feeding from the partner species already exists, so that the cooperating mutant will automatically be reciprocated for its actions. Beyond these considerations, some unintuitive dynamical constraints apply. In particular, the benefit of cooperative cross- feeding applies only in the range of intermediate cell densities. At low density, resource concentrations are too low to offset the cost of cooperation. At high density, resources shared by both species become limiting, and the two species become competitors. These considerations suggest that the evolution of cooperative cross-feeding in nature may be more challenging than for other types of cooperation. However, the principles identified here may enable the experimental evolution of cross- feeding, as born out by a recent study.	[Bull, James J.; Harcombe, William R.] Univ Texas Austin, Austin, TX 78712 USA; [Bull, James J.] Univ Texas, Inst Cellular & Mol Biol, Austin, TX USA; [Bull, James J.] Univ Texas, Ctr Computat Biol & Bioinformat, Austin, TX USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Bull, JJ (corresponding author), Univ Texas Austin, Austin, TX 78712 USA.	bull@mail.utexas.edu			NIH [GM57756]; NSF [Predoctoral Fellowship]; University of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057756] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); University of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by NIH GM57756 to JJB; by an NSF Predoctoral Fellowship to WRH. JJB is also supported as the Miescher Regents Professor at the University of Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHAO L, 1981, P NATL ACAD SCI-BIOL, V78, P6324, DOI 10.1073/pnas.78.10.6324; Darwin C., 1877, DIFFERENT FORMS FLOW; Eigen M, 1979, THE HYPERCYCLE, P60; Foster KR, 2006, J EVOLUTION BIOL, V19, P1283, DOI 10.1111/j.1420-9101.2005.01073.x; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Maynard Smith J., 1982, pi; Nadell CD, 2008, PLOS BIOL, V6, P171, DOI 10.1371/journal.pbio.0060014; Overmann J, 2002, ARCH MICROBIOL, V177, P201, DOI 10.1007/s00203-001-0377-z; Pernthaler A, 2008, P NATL ACAD SCI USA, V105, P7052, DOI 10.1073/pnas.0711303105; Rawlings DE, 2007, MICROBIOL-SGM, V153, P315, DOI 10.1099/mic.0.2006/001206-0; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; SCHAFFER WM, 1978, AM NAT, V112, P250, DOI 10.1086/283268; Schink B, 2002, ANTON LEEUW INT J G, V81, P257, DOI 10.1023/A:1020579004534; Schink B, 1991, PROKARYOTES, P276; SMITH J. M., 1964, Nature, V201, P1145, DOI 10.1038/2011145a0; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; West SA, 2003, P ROY SOC B-BIOL SCI, V270, P37, DOI 10.1098/rspb.2002.2209; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461	22	56	56	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2009	4	1							e4115	10.1371/journal.pone.0004115	http://dx.doi.org/10.1371/journal.pone.0004115			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FT	19127304	Green Published, Green Submitted, gold			2022-12-25	WOS:000265472900002
J	Nishida, K; Kamizato, M; Kawai, T; Masuda, K; Takeo, K; Teshima-Kondo, S; Tanahashi, T; Rokutan, K				Nishida, Kensei; Kamizato, Mai; Kawai, Tomoko; Masuda, Kiyoshi; Takeo, Keiko; Teshima-Kondo, Shigetada; Tanahashi, Toshihito; Rokutan, Kazuhito			Interleukin-18 is a crucial determinant of vulnerability of the mouse rectum to psychosocial stress	FASEB JOURNAL			English	Article						intestinal mucosal barrier; goblet cells; MUC2; inflammatory cytokines; Notch 1	IRRITABLE-BOWEL-SYNDROME; INDUCED COLITIS; CELLS; MUC2; INFLAMMATION; COLON; IL-18; DIFFERENTIATION; CANCER; CORTICOSTERONE	Psychosocial factors are important determinants of disease manifestations, treatment efficacy, and prognosis of functional and inflammatory bowel disorders. Isolation of C57BL/6J mice from their 4 brothers growing in the same cage reduced goblet cells and MUC2 expression with a peak on day 8 in the rectum, but not in the colon. Gene expression analysis using a whole mouse genome microarray showed that the stress induced a 10-fold larger change in the gene expression in the rectum (722 genes) than in the colon (72 genes). The Ingenuity Pathway Analysis (IPA) application organized the rectum-specific 711 genes into stress response-related pathways. Nuclear factor-kappa B-related cytokine networks constructed with IPA showed selective up-regulation of interleukin (IL)-18 mRNA expression, which was also confirmed by real-time polymerase chain reaction. The stress produced active forms of caspase 1, IL-18, and a negative regulator for goblet cells, Notch 1, only in the rectum. IL-18-knockout mouse rectum had significantly increased goblet cells and MUC2 mucin, compared with wild-type mouse rectum. The absence of IL-18 completely blocked the stress-induced changes in gene expression and the goblet cell responses in the rectum. Thus, IL-18 may be a crucial determinant for the vulnerability of the rectum to psychosocial stress.-Nishida, K., Kamizato, M., Kawai, T., Masuda, K., Takeo, K., Teshima-Kondo, S., Tanahashi, T., Rokutan, K. Interleukin-18 is a crucial determinant of vulnerability of the mouse rectum to psychosocial stress. FASEB J. 23, 1797-1805 (2009)	[Nishida, Kensei; Kamizato, Mai; Kawai, Tomoko; Masuda, Kiyoshi; Takeo, Keiko; Teshima-Kondo, Shigetada; Tanahashi, Toshihito; Rokutan, Kazuhito] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Stress Sci, Tokushima 7708503, Japan	Tokushima University	Rokutan, K (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Stress Sci, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	rokutan16@basic.med.tokushima-u.ac.jp	Nishida, Kensei/AAF-2829-2020	Kawai, Tomoko/0000-0001-8137-0334; Nishida, Kensei/0000-0003-2314-785X				Bitton A, 2008, GUT, V57, P1386, DOI 10.1136/gut.2007.134817; Boraschi D, 2006, EUR CYTOKINE NETW, V17, P224; Bowers SL, 2008, BRAIN BEHAV IMMUN, V22, P105, DOI 10.1016/j.bbi.2007.07.012; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Castagliuolo I, 1998, AM J PHYSIOL-GASTR L, V274, pG1094, DOI 10.1152/ajpgi.1998.274.6.G1094; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Gareau MG, 2007, GUT, V56, P1522, DOI 10.1136/gut.2006.117176; HATCH A, 1963, SCIENCE, V142, P507, DOI 10.1126/science.142.3591.507; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Ishikura T, 2003, J GASTROEN HEPATOL, V18, P960, DOI 10.1046/j.1440-1746.2003.03097.x; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kawahara T, 2004, J IMMUNOL, V172, P3051, DOI 10.4049/jimmunol.172.5.3051; Kraneveld AD, 2008, EUR J PHARMACOL, V585, P361, DOI 10.1016/j.ejphar.2008.02.095; LESUFFLEUR T, 1990, CANCER RES, V50, P6334; Lidell ME, 2003, J BIOL CHEM, V278, P13944, DOI 10.1074/jbc.M210069200; Ludwiczek O, 2005, EUR CYTOKINE NETW, V16, P27; Mawdsley JE, 2005, GUT, V54, P1481, DOI 10.1136/gut.2005.064261; Mawdsley JE, 2006, GASTROENTEROLOGY, V131, P410, DOI 10.1053/j.gastro.2006.05.017; Nakanishi K, 2001, CYTOKINE GROWTH F R, V12, P53, DOI 10.1016/S1359-6101(00)00015-0; Ng AYN, 2002, GASTROENTEROLOGY, V122, P1455, DOI 10.1053/gast.2002.32990; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Pfeiffer CJ, 2001, J PHYSIOLOGY-PARIS, V95, P81, DOI 10.1016/S0928-4257(01)00012-2; Ricci-Vitiani L, 2008, GUT, V57, P538, DOI 10.1136/gut.2007.127837; ROBERTSON DAF, 1989, GUT, V30, P623, DOI 10.1136/gut.30.5.623; Sekiyama A, 2005, IMMUNITY, V22, P669, DOI 10.1016/j.immuni.2005.04.006; Sivakumar PV, 2002, GUT, V50, P812, DOI 10.1136/gut.50.6.812; SOWDEN J, 1993, DIFFERENTIATION, V53, P67, DOI 10.1111/j.1432-0436.1993.tb00647.x; Spiller R, 2007, GUT, V56, P1770, DOI 10.1136/gut.2007.119446; Sugama S, 2008, BRAIN RES REV, V58, P85, DOI 10.1016/j.brainresrev.2007.11.003; Ten Hove T, 2001, GASTROENTEROLOGY, V121, P1372, DOI 10.1053/gast.2001.29579; Tytgat KMAJ, 1996, BIOCHEM BIOPH RES CO, V224, P397, DOI 10.1006/bbrc.1996.1039; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Van Klinken BJW, 1999, GUT, V44, P387, DOI 10.1136/gut.44.3.387; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Wallon C, 2008, GUT, V57, P50, DOI 10.1136/gut.2006.117549; Wei EK, 2004, INT J CANCER, V108, P433, DOI 10.1002/ijc.11540; Weiss IC, 2004, BEHAV BRAIN RES, V152, P279, DOI 10.1016/j.bbr.2003.10.015; Wiercinska-Drapalo A, 2005, WORLD J GASTROENTERO, V11, P605, DOI 10.3748/wjg.v11.i4.605; Yamamoto H, 2003, BIOCHEM BIOPH RES CO, V300, P813, DOI 10.1016/S0006-291X(02)02935-2; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718	42	13	13	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1797	1805		10.1096/fj.08-125005	http://dx.doi.org/10.1096/fj.08-125005			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19141531				2022-12-25	WOS:000266652400020
J	Reddy, MK; Labhasetwar, V				Reddy, Maram K.; Labhasetwar, Vinod			Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury	FASEB JOURNAL			English	Article						antioxidant enzymes; blood-brain barrier; biodegradable polymers; sustained release; nanomedicine	FOCAL CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; ARTERY OCCLUSION; RAT; PATHOPHYSIOLOGY; INFLAMMATION; THERAPY; ISCHEMIA/REPERFUSION; OVEREXPRESSION; ANTIOXIDANTS	Excessive production of reactive oxygen species (ROS) after cerebral ischemia and reperfusion is implicated in brain damage through different cellular and molecular mechanisms, and it is further aggravated by impaired cellular antioxidant defense systems under ischemic conditions. Therapeutic strategies based on exogenous delivery of the native form of superoxide dismutase (SOD), a free radical scavenger, are limited because of its short half-life (similar to 6 min) in vivo and poor permeability across the blood-brain-barrier (BBB). We encapsulated SOD in biodegradable poly(D, L-lactide co-glycolide) nanoparticles (SOD-NPs) and tested their efficacy in a rat focal cerebral ischemia-reperfusion injury model. We hypothesized that localized brain delivery of SOD-NPs would sustain the protective effect of SOD by neutralizing the deleterious effects of ROS formed following ischemia-reperfusion. SOD-NPs were administered at the time of reperfusion via the intracarotid route to maximize their localization in the brain. Animals receiving SOD-NPs (10,000 U of SOD/kg) demonstrated a 65% reduction in infarct volume, whereas an equivalent dose of SOD in solution (SOD-Sol) increased it by 25% over saline control (P<0.001; data at 6 h following reperfusion). Control NPs alone or mixed with SOD-Sol were ineffective in reducing infract volume, with results similar to saline control, indicating the protective effect of the encapsulated enzyme. SOD-NPs maintained BBB integrity, thereby preventing edema, reduced the level of ROS formed following reperfusion, and protected neurons from undergoing apoptosis. Animals treated with SOD-NPs demonstrated greater survival than those with saline control (75% vs. 0% at 28 days) and later regained most vital neurological functions. SOD-NPs may be an effective treatment option in conjunction with a thrombolytic agent for stroke patients.-Reddy, M. K., Labhasetwar, V. Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury. FASEB J. 23, 1384-1395 (2009)	[Reddy, Maram K.; Labhasetwar, Vinod] Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44195 USA; [Labhasetwar, Vinod] Univ Nebraska Med Ctr, Dept Pharmaceut Sci, Omaha, NE USA	Cleveland Clinic Foundation; University of Nebraska System; University of Nebraska Medical Center	Labhasetwar, V (corresponding author), Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, ND-20,9500 Euclid Ave, Cleveland, OH 44195 USA.	labhasv@ccf.org	Labhasetwar, Vinod/J-9660-2016	Labhasetwar, Vinod/0000-0001-7950-1542	University of Nebraska Medical Center, Omaha, NE	University of Nebraska Medical Center, Omaha, NE	This work was supported by grants from the Cleveland Clinic and a Technology Advancement grant from the University of Nebraska Medical Center, Omaha, NE (to V. L.). We thank Ms. Melissa Jedlicka for proofreading the manuscript.	Anderson HA, 2002, CELL DEATH DIFFER, V9, P616, DOI 10.1038/sj.cdd.4401013; Buonocore G, 2007, SEMIN FETAL NEONAT M, V12, P287, DOI 10.1016/j.siny.2007.01.020; Collard CD, 2001, ANESTHESIOLOGY, V94, P1133, DOI 10.1097/00000542-200106000-00030; Cuzzocrea S, 2001, PHARMACOL REV, V53, P135; Davda J, 2002, INT J PHARM, V233, P51, DOI 10.1016/S0378-5173(01)00923-1; Davda J, 2005, J BIOMED NANOTECHNOL, V1, P74, DOI 10.1166/jbn.2005.010; Francis JW, 1997, EXP NEUROL, V146, P435, DOI 10.1006/exnr.1997.6547; Goldstein LB, 2007, CIRCULATION, V116, P1504, DOI 10.1161/CIRCULATIONAHA.106.670885; Goto H, 2007, J NEUROTRAUM, V24, P745, DOI 10.1089/neu.2006.0183; Gursoy-Ozdemir Y, 2000, STROKE, V31, P1974, DOI 10.1161/01.STR.31.8.1974; HAUN SE, 1991, STROKE, V22, P655, DOI 10.1161/01.STR.22.5.655; HE YY, 1993, AM J PHYSIOL, V265, pH252, DOI 10.1152/ajpheart.1993.265.1.H252; Heiss WD, 1999, STROKE, V30, P1486, DOI 10.1161/01.STR.30.7.1486; IMAIZUMI S, 1990, STROKE, V21, P1312, DOI 10.1161/01.STR.21.9.1312; Jean WC, 1998, NEUROSURGERY, V43, P1382, DOI 10.1097/00006123-199812000-00076; Juttler E, 2006, NAT CLIN PRACT CARD, V3, P656, DOI 10.1038/ncpcardio0721; Kim DW, 2005, MOL CELLS, V19, P88; Kitagawa K, 2001, J CEREBR BLOOD F MET, V21, P1199, DOI 10.1097/00004647-200110000-00008; Kuroda S, 1997, CLIN NEUROSCI, V4, P199; LABHASETWAR V, 2008, Patent No. 7332159; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Maier CM, 2006, ANN NEUROL, V59, P929, DOI 10.1002/ana.20850; Margaill I, 2005, FREE RADICAL BIO MED, V39, P429, DOI 10.1016/j.freeradbiomed.2005.05.003; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Muhl D, 2006, J THROMB THROMBOLYS, V22, P221, DOI 10.1007/s11239-006-9035-2; Pan J, 2007, NEURORADIOLOGY, V49, P93, DOI 10.1007/s00234-006-0183-z; Perera MN, 2006, J CLIN NEUROSCI, V13, P1, DOI 10.1016/j.jocn.2005.07.005; Plekhanova OS, 2006, B EXP BIOL MED+, V142, P304, DOI 10.1007/s10517-006-0352-4; Prabha S, 2002, INT J PHARM, V244, P105, DOI 10.1016/S0378-5173(02)00315-0; Rao KS, 2008, BIOMATERIALS, V29, P4429, DOI 10.1016/j.biomaterials.2008.08.004; Reddy MK, 2008, APPL BIOCHEM BIOTECH, V151, P565, DOI 10.1007/s12010-008-8232-1; Rosenberg Gary A, 2007, Neurosurg Focus, V22, pE4; Saleh A, 2004, BRAIN, V127, P1670, DOI 10.1093/brain/awh191; Schmid-Elsaesser R, 1998, STROKE, V29, P2162, DOI 10.1161/01.STR.29.10.2162; Shimamura M, 2004, CIRCULATION, V109, P424, DOI 10.1161/01.CIR.0000109496.82683.49; Sinha J, 2001, BIOMED PHARMACOTHER, V55, P264, DOI 10.1016/S0753-3322(01)00060-9; SLIVKA A, 1995, STROKE, V26, P1061, DOI 10.1161/01.STR.26.6.1061; Smi CK, 2004, DEV BRAIN RES, V152, P11, DOI [10.1016/j.devbrainres.2004.05.004, 10.1016/j.debrainres.2004.05.004]; Sugawara T, 2002, J NEUROSCI, V22, P209, DOI 10.1523/JNEUROSCI.22-01-00209.2002; Tsubokawa T, 2007, STROKE, V38, P1057, DOI 10.1161/01.STR.0000257978.70312.1d; Veronese FM, 2002, ADV DRUG DELIVER REV, V54, P587, DOI 10.1016/S0169-409X(02)00029-7; Warner DS, 2004, J EXP BIOL, V207, P3221, DOI 10.1242/jeb.01022; Yasui K, 2006, INFLAMM RES, V55, P359, DOI 10.1007/s00011-006-5195-y; Zambaux MF, 1998, J CONTROL RELEASE, V50, P31, DOI 10.1016/S0168-3659(97)00106-5	46	199	214	3	62	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2009	23	5					1384	1395		10.1096/fj.08-116947	http://dx.doi.org/10.1096/fj.08-116947			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19124559				2022-12-25	WOS:000266651700015
J	Heupel, WM; Muller, T; Efthymiadis, A; Schmidt, E; Drenckhahn, D; Waschke, J				Heupel, Wolfgang-Moritz; Mueller, Thomas; Efthymiadis, Athina; Schmidt, Enno; Drenckhahn, Detlev; Waschke, Jens			Peptides Targeting the Desmoglein 3 Adhesive Interface Prevent Autoantibody-induced Acantholysis in Pemphigus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAYS; STRUCTURAL BASIS; CELL ADHESION; VULGARIS; CADHERIN; DISEASE; DISSOCIATION; PLAKOGLOBIN; ENDOCYTOSIS; INHIBITION	Pemphigus vulgaris (PV) autoantibodies directly inhibit desmoglein (Dsg) 3-mediated transinteraction. Because cellular signaling also seems to be required for PV pathogenesis, it is important to characterize the role of direct inhibition in pemphigus acantholysis to allow establishment of new therapeutic approaches. Therefore, we modeled the Dsg1 and Dsg3 sequences into resolved cadherin structures and predicted peptides targeting the adhesive interface of both Dsg3 and Dsg1. In atomic force microscopy single molecule experiments, the self-designed cyclic single peptide specifically blocked homophilic Dsg3 and Dsg1 transinteraction, whereas a tandem peptide (TP) consisting of two combined single peptides did not. TP did not directly block binding of pemphigus IgG to their target Dsg antigens but prevented PV-IgG-induced inhibition of Dsg3 transinteraction in cell-free (atomic force microscopy) and cell-based (laser tweezer) experiments, indicating stabilization of Dsg3 bonds. Similarly, PV-IgG-mediated acantholysis and disruption of Dsg3 localization in HaCaT keratinocytes was partially blocked by TP. This is the first evidence that direct inhibition of Dsg3 binding is important for PV pathogenesis and that peptidomimetics stabilizing Dsg transinteraction may provide a novel approach for PV treatment.	[Waschke, Jens] Univ Wurzburg, Dept Anat & Cell Biol, D-97070 Wurzburg, Germany; [Mueller, Thomas] Univ Wurzburg, Dept Mol Plant Physiol & Biophys, D-97082 Wurzburg, Germany; [Schmidt, Enno] Univ Wurzburg, Dept Dermatol, D-97082 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Drenckhahn, D (corresponding author), Univ Wurzburg, Dept Anat & Cell Biol, Koellikerstr 6, D-97070 Wurzburg, Germany.	drenckhahn@uni-wuerzburg.de; jens.waschke@mail.uni-wuerzburg.de	Schmidt, Enno/C-4008-2009; Heupel, Wolfgang-Moritz/B-7788-2009	Schmidt, Enno/0000-0002-1206-8913; Mueller, Thomas/0000-0003-1862-7357	Deutsche Forschungsgemeinschaft [SFB 487, TP B5, B2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by grants from the Deutsche Forschungsgemeinschaft (Grants SFB 487, TP B5, and B2) and the IZKF Wurzburg (Grant TP A-51). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; Billet SE, 2006, AUTOIMMUNITY, V39, P617, DOI 10.1080/08916930600972099; Caldelari R, 2001, J CELL BIOL, V153, P823, DOI 10.1083/jcb.153.4.823; Calkins CC, 2006, J BIOL CHEM, V281, P7623, DOI 10.1074/jbc.M512447200; Chernyavsky AI, 2007, J BIOL CHEM, V282, P13804, DOI 10.1074/jbc.M611365200; Delva E, 2008, J BIOL CHEM, V283, P18303, DOI 10.1074/jbc.M710046200; He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957; Heupel WM, 2008, J IMMUNOL, V181, P1825, DOI 10.4049/jimmunol.181.3.1825; Ishii K, 2005, J INVEST DERMATOL, V124, P939, DOI 10.1111/j.0022-202X.2005.23714.x; JONES JCR, 1984, P NATL ACAD SCI-BIOL, V81, P2781, DOI 10.1073/pnas.81.9.2781; Lanza A, 2008, J BIOL CHEM, V283, P8736, DOI 10.1074/jbc.M702186200; Muller EJ, 2008, J INVEST DERMATOL, V128, P501, DOI 10.1038/sj.jid.5701248; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Posy S, 2008, J MOL BIOL, V378, P954, DOI 10.1016/j.jmb.2008.02.063; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Sharma P, 2007, J DERMATOL SCI, V48, P1, DOI 10.1016/j.jdermsci.2007.05.005; Spindler V, 2007, AM J PATHOL, V171, P906, DOI 10.2353/ajpath.2007.070028; Stanley JR, 2006, NEW ENGL J MED, V355, P1800, DOI 10.1056/NEJMra061111; Syed SEH, 2002, BIOCHEM J, V362, P317, DOI 10.1042/0264-6021:3620317; Tong JC, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-30; Tselepis C, 1998, P NATL ACAD SCI USA, V95, P8064, DOI 10.1073/pnas.95.14.8064; Tsukasaki Y, 2007, J MOL BIOL, V367, P996, DOI 10.1016/j.jmb.2006.12.022; Tsunoda K, 2003, J IMMUNOL, V170, P2170, DOI 10.4049/jimmunol.170.4.2170; Waschke J, 2005, J CLIN INVEST, V115, P3157, DOI 10.1172/JCI23475; Waschke J, 2008, HISTOCHEM CELL BIOL, V130, P21, DOI 10.1007/s00418-008-0420-0; Waschke J, 2006, J CELL BIOL, V175, P721, DOI 10.1083/jcb.200605125; Williams G, 2002, J BIOL CHEM, V277, P4361, DOI 10.1074/jbc.M109185200; Williamson L, 2006, EMBO J, V25, P3298, DOI 10.1038/sj.emboj.7601224; Yamamoto Y, 2007, J BIOL CHEM, V282, P17866, DOI 10.1074/jbc.M607963200	30	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8589	8595		10.1074/jbc.M808813200	http://dx.doi.org/10.1074/jbc.M808813200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19164289	Green Published, hybrid			2022-12-25	WOS:000264397800043
J	Garapaty, S; Xu, CF; Trojer, P; Mahajan, MA; Neubert, TA; Samuels, HH				Garapaty, Shivani; Xu, Chong-Feng; Trojer, Patrick; Mahajan, Muktar A.; Neubert, Thomas A.; Samuels, Herbert H.			Identification and Characterization of a Novel Nuclear Protein Complex Involved in Nuclear Hormone Receptor-mediated Gene Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE-4 METHYLTRANSFERASE COMPLEX; ACTIVATING SIGNAL COINTEGRATOR-2; RETINOIC ACID; IN-VIVO; TRANSCRIPTIONAL REGULATION; HISTONE METHYLTRANSFERASE; INTERACTING PROTEIN; COACTIVATOR ASC-2; BINDING PROTEIN; CARCINOMA-CELLS	NRC/NCoA6 plays an important role in mediating the effects of ligand-bound nuclear hormone receptors as well as other transcription factors. NRC interacting factor 1 (NIF-1) was cloned as a novel factor that interacts in vivo with NRC. Although NIF-1 does not directly interact with nuclear hormone receptors, it enhances activation by nuclear hormone receptors presumably through its interaction with NRC. To further understand the cellular and biological function of NIF-1, we identified NIF-1-associated proteins by in-solution proteolysis followed by mass spectrometry. The identified components revealed factors involved in histone methylation and cell cycle control and include Ash2L, RbBP5, WDR5, HCF-1, DBC-1, and EMSY. Although the NIF-1 complex contains Ash2L, RbBP5, and WDR5, suggesting that the complex might methylate histone H3-Lys-4, we found that the complex contains a H3 methyltransferase activity that modifies a residue other than H3-Lys-4. The identified components form at least two distinctly sized NIF-1 complexes. DBC-1 and EMSY were identified as integral components of an NIF-1 complex of similar to 1.5 MDa and were found to play an important role in the regulation of nuclear receptor-mediated transcription. Stimulation of the Sox9 and HoxA1 genes by retinoic acid receptor-alpha was found to require both DBC-1 andEMSYin addition to NIF-1 for maximal transcriptional activation. Interestingly, NRC was not identified as a component of the NIF-1 complex, suggesting that NIF-1 and NRC do not exist as stable in vitro purified complexes, although the separate NIF-1 and NRC complexes appear to functionally interact in the cell.	[Garapaty, Shivani; Xu, Chong-Feng; Mahajan, Muktar A.; Neubert, Thomas A.; Samuels, Herbert H.] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; [Trojer, Patrick] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	New York University; New York University	Samuels, HH (corresponding author), NYU, Sch Med, Dept Pharmacol, MSB 424,550 1st Ave, New York, NY 10016 USA.	herbert.samuels@nyumc.org		Mahajan, Muktar/0000-0003-1024-6808	NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK016636, R01DK016636, R37DK016636] Funding Source: NIH RePORTER; NCI NIH HHS [P30CA016087-239025] Funding Source: Medline; NCRR NIH HHS [1S10 RR017990-01] Funding Source: Medline; NIDDK NIH HHS [DK16636] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Afonja O, 2002, ONCOGENE, V21, P7850, DOI 10.1038/sj.onc.1205985; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Antonson P, 2003, MOL CELL BIOL, V23, P1260, DOI 10.1128/MCB.23.4.1260-1268.2003; Belakavadi M, 2006, REV PHYSIOL BIOCH P, V156, P23, DOI 10.1007/s10254-005-0002-7; Caira F, 2000, J BIOL CHEM, V275, P5308, DOI 10.1074/jbc.275.8.5308; Caslini C, 2007, CANCER RES, V67, P7275, DOI 10.1158/0008-5472.CAN-06-2369; Chen YH, 2006, CANCER RES, V66, P8749, DOI 10.1158/0008-5472.CAN-06-0581; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Crawford BD, 2006, ACS CHEM BIOL, V1, P495, DOI 10.1021/cb600367v; DeCerbo J, 2005, CURR OPIN CELL BIOL, V17, P302, DOI 10.1016/j.ceb.2005.04.008; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Endl E, 2000, EXP CELL RES, V257, P231, DOI 10.1006/excr.2000.4888; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Garapaty S, 2008, J BIOL CHEM, V283, P6806, DOI 10.1074/jbc.M706986200; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; Haber DA, 2003, CELL, V115, P507, DOI 10.1016/S0092-8674(03)00933-4; Hamaguchi M, 2002, P NATL ACAD SCI USA, V99, P13647, DOI 10.1073/pnas.212516099; Hong SH, 2004, J BIOL CHEM, V279, P16996, DOI 10.1074/jbc.M311752200; Huang Y, 2006, STRUCTURE, V14, P703, DOI 10.1016/j.str.2006.01.007; Hughes-Davies L, 2003, CELL, V115, P523, DOI 10.1016/S0092-8674(03)00930-9; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Ko L, 2000, P NATL ACAD SCI USA, V97, P6212, DOI 10.1073/pnas.97.11.6212; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KRISTIE TM, 1993, J BIOL CHEM, V268, P6525; Lee HI, 2008, BIOCHEM BIOPH RES CO, V368, P298, DOI 10.1016/j.bbrc.2008.01.082; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee S, 2006, P NATL ACAD SCI USA, V103, P15392, DOI 10.1073/pnas.0607313103; Lee SK, 2000, MOL ENDOCRINOL, V14, P915, DOI 10.1210/me.14.6.915; Lee SK, 1999, J BIOL CHEM, V274, P34283, DOI 10.1074/jbc.274.48.34283; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu ZR, 2002, MOL CELL BIOL, V22, P5443, DOI 10.1128/MCB.22.15.5443-5450.2002; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; Mahajan MA, 2005, ENDOCR REV, V26, P583, DOI 10.1210/er.2004-0012; Mahajan MA, 2004, MOL CELL BIOL, V24, P4994, DOI 10.1128/MCB.24.11.4994-5004.2004; Mahajan MA, 2002, MOL CELL BIOL, V22, P6883, DOI 10.1128/MCB.22.19.6883-6894.2002; Mahajan MA, 2000, MOL CELL BIOL, V20, P5048, DOI 10.1128/MCB.20.14.5048-5063.2000; Mahajan Muktar A, 2008, Nucl Recept Signal, V6, pe002, DOI 10.1621/nrs.06002; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Narayanan A, 2007, P NATL ACAD SCI USA, V104, P10835, DOI 10.1073/pnas.0704351104; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Patel SR, 2007, DEV CELL, V13, P580, DOI 10.1016/j.devcel.2007.09.004; Qi C, 2004, J BIOL CHEM, V279, P33696, DOI 10.1074/jbc.M401266200; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Trauernicht AM, 2007, MOL ENDOCRINOL, V21, P1526, DOI 10.1210/me.2007-0064; Trotter Kevin W, 2008, Nucl Recept Signal, V6, pe004, DOI 10.1621/nrs.06004; Tsai CC, 2004, VITAM HORM, V68, P93; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116; Yeom SY, 2006, MOL CELL BIOL, V26, P4553, DOI 10.1128/MCB.01412-05; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P11574, DOI 10.1073/pnas.0704946104; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zhu YJ, 2000, J BIOL CHEM, V275, P13510, DOI 10.1074/jbc.275.18.13510	62	63	75	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7542	7552		10.1074/jbc.M805872200	http://dx.doi.org/10.1074/jbc.M805872200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19131338	Green Published, hybrid			2022-12-25	WOS:000264195600017
J	Meng, H; Zhang, XJ; Hankenson, KD; Wang, MM				Meng, He; Zhang, Xiaojie; Hankenson, Kurt D.; Wang, Michael M.			Thrombospondin 2 Potentiates Notch3/Jagged1 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NOTCH1 EXTRACELLULAR DOMAIN; HUMAN LUNG CANCERS; ALAGILLE-SYNDROME; HUMAN JAGGED1; IN-VIVO; RECEPTOR; CELLS; EXPRESSION; MUTATIONS; PATHWAY	Extracellular thrombospondins (TSP or THBS) and the Notch family of transmembrane receptors share a role in multiple, overlapping cellular functions and participate in developmental signaling and pathological reactions to tissue injury. We demonstrate that TSP2, but not TSP1, enhances the potency of Notch3 signal transduction. In addition, TSP2 reduces cancer cell proliferation in a Notch-ligand dependent fashion. The loss of TSP2 in knock-out mice reduces Notch target gene expression. TSP2 binds directly to Notch3 and Jagged1. TSP1 also binds to Notch3 and Jagged1; however, only TSP2 augments the interaction between Notch3 and Jagged1. These studies demonstrate that the diverse functions of TSP2 may also include a role as an intermediary protein that facilitates transcellular receptor-ligand interactions.	[Meng, He; Zhang, Xiaojie; Wang, Michael M.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Wang, Michael M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Hankenson, Kurt D.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Pennsylvania	Wang, MM (corresponding author), 7629 Med Sci Bldg 2,Box 5622,1137 Catherine St, Ann Arbor, MI 48109 USA.	micwang@umich.edu	Hankenson, Kurt/AFS-9417-2022; Hankenson, Kurt/ABI-1547-2020	Hankenson, Kurt/0000-0001-6361-143X; 	NIAMS NIH HHS [AR049682] Funding Source: Medline; NINDS NIH HHS [NS054724, NS052681] Funding Source: Medline; Wellcome Trust [1000990] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS054724, R21NS052681] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; Aho S, 1998, MATRIX BIOL, V17, P401, DOI 10.1016/S0945-053X(98)90100-7; Albizu L, 2007, J MED CHEM, V50, P4976, DOI 10.1021/jm061404q; Armstrong LC, 2003, MATRIX BIOL, V22, P63, DOI 10.1016/S0945-053X(03)00005-2; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Campos AH, 2002, CIRC RES, V91, P999, DOI 10.1161/01.RES.0000044944.99984.25; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Chen H, 1996, J BIOL CHEM, V271, P15993, DOI 10.1074/jbc.271.27.15993; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Dang L, 2006, ONCOGENE, V25, P487, DOI 10.1038/sj.onc.1209074; Dang TP, 2000, J NATL CANCER I, V92, P1355, DOI 10.1093/jnci/92.16.1355; Eiraku M, 2005, NAT NEUROSCI, V8, P873, DOI 10.1038/nn1492; Haruki N, 2005, CANCER RES, V65, P3555, DOI 10.1158/0008-5472.CAN-04-3132; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kazuno M, 1999, EUR J CANCER, V35, P502, DOI 10.1016/S0959-8049(98)00374-8; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; Kunnimalaiyaan M, 2006, J BIOL CHEM, V281, P39819, DOI 10.1074/jbc.M603578200; Kyriakides TR, 1998, J CELL BIOL, V140, P419, DOI 10.1083/jcb.140.2.419; Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5; Li JL, 2005, CANCER CELL, V8, P1, DOI 10.1016/j.ccr.2005.06.013; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Miyamoto A, 2006, J BIOL CHEM, V281, P10089, DOI 10.1074/jbc.M600298200; Monet M, 2007, HUM MOL GENET, V16, P982, DOI 10.1093/hmg/ddm042; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; Oshika Y, 1998, CLIN CANCER RES, V4, P1785; Park JT, 2006, CANCER RES, V66, P6312, DOI 10.1158/0008-5472.CAN-05-3610; Sakamoto K, 2002, J BIOL CHEM, V277, P29399, DOI 10.1074/jbc.M203727200; Saxena MT, 2001, J BIOL CHEM, V276, P40268, DOI 10.1074/jbc.M107234200; SCHULTZCHERRY S, 1995, J BIOL CHEM, V270, P7304, DOI 10.1074/jbc.270.13.7304; Sriuranpong V, 2001, CANCER RES, V61, P3200; Tokunaga T, 1999, BRIT J CANCER, V79, P354, DOI 10.1038/sj.bjc.6690056; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yamaguchi N, 2008, CANCER RES, V68, P1881, DOI 10.1158/0008-5472.CAN-07-1597; Yang ZT, 2001, J BIOL CHEM, V276, P8403, DOI 10.1074/jbc.M008925200; Zhang YM, 2007, BIOCHEM BIOPH RES CO, V355, P245, DOI 10.1016/j.bbrc.2007.01.151	47	47	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7866	7874		10.1074/jbc.M803650200	http://dx.doi.org/10.1074/jbc.M803650200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19147503	Green Published, hybrid			2022-12-25	WOS:000264195600048
J	MacKinnon, MA; Curwin, AJ; Gaspard, GJ; Suraci, AB; Fernandez-Murray, JP; McMaster, CR				MacKinnon, Melissa A.; Curwin, Amy J.; Gaspard, Gerard J.; Suraci, Alison B.; Fernandez-Murray, J. Pedro; McMaster, Christopher R.			The Kap60-Kap95 Karyopherin Complex Directly Regulates Phosphatidylcholine Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; EARLY EMBRYONIC LETHALITY; SACCHAROMYCES-CEREVISIAE; CHOLINE-KINASE; NUCLEAR-LOCALIZATION; MEMBRANE-BINDING; ALPHA; GENE; EXPRESSION; YEAST	Phosphatidylcholine is the major phospholipid in eukaryotic cells. There are two main pathways for the synthesis of phosphatidylcholine: the CDP-choline pathway present in all eukaryotes and the phosphatidylethanolamine methylation pathway present in mammalian hepatocytes and some single celled eukaryotes, including the yeast Saccharomyces cerevisiae. In S. cerevisiae, the rate-determining step in the synthesis of phosphatidylcholine via the CDP-choline pathway is catalyzed by Pct1. Pct1 converts phosphocholine and CTP to CDP-choline and pyrophosphate. In this study, we determined that Pct1 is in the nucleoplasm and at endoplasmic reticulum and nuclear membranes. Pct1 directly interacts with the alpha-importin Kap60 via a bipartite basic region in Pct1, and this region of Pct1 was required for its entry into the nucleus. Pct1 also interacted with the beta-importin Kap95 in cell extracts, implying a model whereby Pct1 interacts with Kap60 and Kap95 with this tripartite complex transiting the nuclear pore. Exclusion of Pct1 from the nucleus by elimination of its nuclear localization signal or by decreasing Kap60 function did not affect the level of phosphatidylcholine synthesis. Diminution of Kap95 function resulted in almost complete ablation of phosphatidylcholine synthesis under conditions where Pct1 was extranuclear. The beta-importin Kap95 is a direct regulator membrane synthesis.	[McMaster, Christopher R.] Dalhousie Univ, Atlantic Res Ctr, Dept Pediat, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Atlantic Res Ctr, Dept Biochem & Mol Biol, Halifax, NS B3H 4H7, Canada	Dalhousie University; Dalhousie University	McMaster, CR (corresponding author), Dalhousie Univ, Atlantic Res Ctr, Dept Pediat, Halifax, NS B3H 4H7, Canada.	christopher.mcmaster@dal.ca	Curwin, Amy/O-8816-2015	Curwin, Amy/0000-0003-1086-2483; McMaster, Christopher/0000-0003-0822-5776	Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes for Health Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrews BJ, 2003, NAT BIOTECHNOL, V21, P1297, DOI 10.1038/nbt1103-1297; Aoyama C, 2000, J LIPID RES, V41, P452; Attard GS, 2000, P NATL ACAD SCI USA, V97, P9032, DOI 10.1073/pnas.160260697; Bai C, 1997, METHOD ENZYMOL, V283, P141; Banchio C, 2003, J BIOL CHEM, V278, P32457, DOI 10.1074/jbc.M304810200; Bogan MJ, 2005, J BIOL CHEM, V280, P19613, DOI 10.1074/jbc.M414028200; BOURMANN HA, 2003, BIOCHEMISTRY-US, V42, P3054; BOURMANN HA, 2006, MOL BIOL CELL, V17, P1006; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; Cui Z, 1996, J BIOL CHEM, V271, P14668, DOI 10.1074/jbc.271.25.14668; Davies SMA, 2001, BIOCHEMISTRY-US, V40, P10522, DOI 10.1021/bi010904c; Friesen JA, 2001, PROTEIN EXPRES PURIF, V21, P141, DOI 10.1006/prep.2000.1354; Gehrig K, 2008, MOL BIOL CELL, V19, P237, DOI 10.1091/mbc.E07-02-0179; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Henneberry AL, 1999, BIOCHEM J, V339, P291, DOI 10.1042/0264-6021:3390291; Henneberry AL, 2000, J BIOL CHEM, V275, P29808, DOI 10.1074/jbc.M005786200; Henneberry AL, 2002, MOL BIOL CELL, V13, P3148, DOI 10.1091/mbc.01-11-0540; Henneberry AL, 2001, MOL BIOL CELL, V12, P511, DOI 10.1091/mbc.12.3.511; Howe AG, 2002, J BIOL CHEM, V277, P44100, DOI 10.1074/jbc.M206643200; Jackowski S, 2005, J BIOL CHEM, V280, P853, DOI 10.1074/jbc.R400031200; Karim M, 2003, BBA-MOL CELL BIOL L, V1633, P1, DOI 10.1016/S1388-1981(03)00067-2; Kim KH, 1999, J BIOL CHEM, V274, P9531, DOI 10.1074/jbc.274.14.9531; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Lagace TA, 2005, BIOCHEM J, V392, P449, DOI 10.1042/BJ20051021; Lagace TA, 2005, MOL BIOL CELL, V16, P1120, DOI 10.1091/mbc.E04-10-0874; Lagace TA, 2002, MOL CELL BIOL, V22, P4851, DOI 10.1128/MCB.22.13.4851-4862.2002; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Loewen CJR, 2007, J CELL BIOL, V179, P467, DOI 10.1083/jcb.200708205; MCMASTER CR, 1994, J BIOL CHEM, V269, P14776; McMaster CR, 2004, TOP CURR GENET, V6, P5; Newton AC, 2004, TRENDS PHARMACOL SCI, V25, P175, DOI 10.1016/j.tips.2004.02.010; Northwood IC, 1999, J BIOL CHEM, V274, P26240, DOI 10.1074/jbc.274.37.26240; Peter C, 2008, J BIOL CHEM, V283, P5296, DOI 10.1074/jbc.M706586200; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Sher RB, 2006, J BIOL CHEM, V281, P4938, DOI 10.1074/jbc.M512578200; Soto A, 2008, J BIOL CHEM, V283, P10079, DOI 10.1074/jbc.M800502200; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; Stevens SY, 2001, NAT STRUCT BIOL, V8, P947, DOI 10.1038/nsb1101-947; Strahl T, 2005, J CELL BIOL, V171, P967, DOI 10.1083/jcb.200504104; Taneva SG, 2005, BIOCHEMISTRY-US, V44, P9382, DOI 10.1021/bi050679p; Taneva S, 2008, J BIOL CHEM, V283, P28137, DOI 10.1074/jbc.M802595200; Wang LM, 2005, MOL CELL BIOL, V25, P3357, DOI 10.1128/MCB.25.8.3357-3363.2005; WANG YL, 1993, J BIOL CHEM, V268, P5899; WANG YL, 1995, J BIOL CHEM, V270, P354, DOI 10.1074/jbc.270.1.354; Williams JG, 1998, J BIOL CHEM, V273, P13482, DOI 10.1074/jbc.273.22.13482; Wu GS, 2008, J BIOL CHEM, V283, P1456, DOI 10.1074/jbc.M708766200; Xie MT, 2004, J BIOL CHEM, V279, P28817, DOI 10.1074/jbc.M403311200; Yu Y, 2002, J BIOL CHEM, V277, P34978, DOI 10.1074/jbc.M205316200	51	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7376	7384		10.1074/jbc.M809117200	http://dx.doi.org/10.1074/jbc.M809117200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19141610	Green Published, hybrid			2022-12-25	WOS:000263919000083
J	Pamuklar, Z; Federico, L; Liu, SY; Umezu-Goto, M; Dong, AP; Panchatcharam, M; Fulerson, Z; Berdyshev, E; Natarajan, V; Fang, XJ; Van Meeteren, LA; Moolenaar, WH; Mills, GB; Morris, AJ; Smyth, SS				Pamuklar, Zehra; Federico, Lorenzo; Liu, Shuying; Umezu-Goto, Makiko; Dong, Anping; Panchatcharam, Manikandan; Fulerson, Zachary; Berdyshev, Evgeny; Natarajan, Viswanathan; Fang, Xianjun; Van Meeteren, Laurens A.; Moolenaar, Wouter H.; Mills, Gordon B.; Morris, Andrew J.; Smyth, Susan S.			Autotaxin/Lysopholipase D and Lysophosphatidic Acid Regulate Murine Hemostasis and Thrombosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; PLATELET SHAPE CHANGE; MYOSIN LIGHT-CHAIN; GLANZMANN THROMBASTHENIA; LYSOPHOSPHOLIPASE-D; AUTOTAXIN; ACTIVATION; RECEPTORS; KINASE; BLOOD	The lipid mediator lysophosphatidic acid (LPA) is a potent regulator of vascular cell function in vitro, but its physiologic role in the cardiovasculature is largely unexplored. To address the role of LPA in regulating platelet function and thrombosis, we investigated the effects of LPA on isolated murine platelets. Although LPA activates platelets from the majority of human donors, we found that treatment of isolated murine platelets with physiologic concentrations of LPA attenuated agonist-induced aggregation. Transgenic overexpression of autotaxin/lysophospholipase D (Enpp2), the enzyme necessary for production of the bulk of biologically active LPA in plasma, elevated circulating LPA levels and induced a bleeding diathesis and attenuation of thrombosis in mice. Intravascular administration of exogenous LPA recapitulated the prolonged bleeding time observed in Enpp2-Tg mice. Enpp2(+/-) mice, which have similar to 50% normal plasma LPA levels, were more prone to thrombosis. Plasma autotaxin associated with platelets during aggregation and concentrated in arterial thrombus, and activated but not resting platelets bound recombinant autotaxin/lysoPLD in an integrin-dependent manner. These results identify a novel pathway in which LPA production by autotaxin/lysoPLD regulates murine hemostasis and thrombosis and suggest that binding of autotaxin/lysoPLD to activated platelets may provide a mechanism to localize LPA production.	[Pamuklar, Zehra; Federico, Lorenzo; Dong, Anping; Panchatcharam, Manikandan; Fulerson, Zachary; Morris, Andrew J.; Smyth, Susan S.] Gill Heart Inst, Div Cardiovasc Med, Lexington, KY USA; [Federico, Lorenzo; Smyth, Susan S.] Univ Kentucky, Dept Pharmacol, Lexington, KY 40536 USA; [Morris, Andrew J.] Univ Kentucky, Dept Biochem, Lexington, KY 40536 USA; [Liu, Shuying; Umezu-Goto, Makiko; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Berdyshev, Evgeny; Natarajan, Viswanathan] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Fang, Xianjun] Virginia Commonwealth Univ, Sch Med, Dept Biochem, Richmond, VA 23298 USA; [Van Meeteren, Laurens A.; Moolenaar, Wouter H.] Netherlands Canc Inst, Div Cellular Biochem, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Smyth, Susan S.] US Dept Vet Affairs, Med Ctr, Lexington, KY 40511 USA	University of Kentucky; University of Kentucky; University of Texas System; UTMD Anderson Cancer Center; University of Chicago; Virginia Commonwealth University; Netherlands Cancer Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center	Smyth, SS (corresponding author), Gill Heart Inst, Div Cardiovasc Med, 900 S Limestone St,326 CTW Bldg, Lexington, KY USA.	SusanSmyth@uky.edu	Van Meeteren, Laurens A./AGQ-6139-2022; Morris, Andrew/B-7869-2010; van Meeteren, Laurens/A-9890-2008	van Meeteren, Laurens/0000-0001-9885-0668; Panchatcharam, Manikandan/0000-0002-7691-8948	National Institutes of Health [HL070304, HL078663, HL074219, CA096496, GM050388, HL79396, P30 CA16672, PO1 CA64602]; NATIONAL CANCER INSTITUTE [P50CA098258, P01CA064602, R01CA096496, P30CA016672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024598] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL079396, R01HL078663, R01HL074219, R01HL079396, K08HL070304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL070304, HL078663, and HL074219 ( to S. S. S.), CA096496 and GM050388 to A. J. M.), HL79396 ( to V. N.), and P30 CA16672 and PO1 CA64602 ( to G. B. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amisten S, 2008, THROMB RES, V122, P47, DOI 10.1016/j.thromres.2007.08.014; Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; Blue R, 2008, BLOOD, V111, P1248, DOI 10.1182/blood-2007-08-105544; Borna C, 2005, THROMB J, V3, DOI 10.1186/1477-9560-3-10; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Chen X, 2003, SCAND J CLIN LAB INV, V63, P497, DOI 10.1080/00365510310003265; Choi JW, 2008, BBA-MOL CELL BIOL L, V1781, P531, DOI 10.1016/j.bbalip.2008.03.004; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Cimpean A, 2004, BIOCHEM J, V381, P71, DOI 10.1042/BJ20040465; COLLER BS, 1991, BLOOD, V78, P2603; DEJANA E, 1979, THROMB RES, V15, P191, DOI 10.1016/0049-3848(79)90064-1; Denis CV, 2007, ARTERIOSCL THROM VAS, V27, P728, DOI 10.1161/01.ATV.0000259359.52265.62; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; Emeis JJ, 2007, J THROMB HAEMOST, V5, P670, DOI 10.1111/j.1538-7836.2007.02408.x; Georas SN, 2007, CLIN EXP ALLERGY, V37, P311, DOI 10.1111/j.1365-2222.2006.02626.x; GERRARD JM, 1979, AM J PATHOL, V96, P423; GERRARD JM, 1984, BIOCHIM BIOPHYS ACTA, V795, P487, DOI 10.1016/0005-2760(84)90177-2; Guieu R, 2001, J INVEST MED, V49, P56, DOI 10.2310/6650.2001.34091; Haseruck N, 2004, BLOOD, V103, P2585, DOI 10.1182/blood-2003-04-1127; Hla T, 2001, SCIENCE, V294, P1875, DOI 10.1126/science.1065323; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Lee Z, 2008, MOL BIOL CELL, V19, P5435, DOI 10.1091/mbc.E08-03-0316; Li ZY, 2003, BLOOD, V101, P4423, DOI 10.1182/blood-2002-10-3210; Maddux BA, 2006, AM J PHYSIOL-ENDOC M, V290, pE746, DOI 10.1152/ajpendo.00298.2005; Maschberger P, 2000, J BIOL CHEM, V275, P19159, DOI 10.1074/jbc.M910257199; MOOLENAAR WH, 1992, COLD SPRING HARB SYM, V57, P163, DOI 10.1101/SQB.1992.057.01.021; Morris AJ, 2007, METHOD ENZYMOL, V434, P89, DOI 10.1016/S0076-6879(07)34005-6; Nylander S, 2006, THROMB RES, V117, P543, DOI 10.1016/j.thromres.2005.04.026; Olorundare OE, 2001, BLOOD, V98, P117, DOI 10.1182/blood.V98.1.117; Pamuklar Z, 2008, ARTERIOSCL THROM VAS, V28, P555, DOI 10.1161/ATVBAHA.107.151837; Pandey D, 2007, BLOOD CELL MOL DIS, V38, P269, DOI 10.1016/j.bcmd.2007.01.002; Retzer M, 2000, CELL SIGNAL, V12, P645, DOI 10.1016/S0898-6568(00)00108-X; Retzer M, 2000, FEBS LETT, V466, P70, DOI 10.1016/S0014-5793(99)01762-7; Rother E, 2003, CIRCULATION, V108, P741, DOI 10.1161/01.CIR.0000083715.37658.C4; SCHUMACHER KA, 1972, N-S ARCH PHARMACOL, V275, P373, DOI 10.1007/BF00501126; Siess W, 1999, P NATL ACAD SCI USA, V96, P6931, DOI 10.1073/pnas.96.12.6931; Siess W, 2004, J CELL BIOCHEM, V92, P1086, DOI 10.1002/jcb.20108; Smyth SS, 2000, THROMB HAEMOSTASIS, V84, P1103; Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Tokumura A, 2002, BIOCHEM J, V365, P617, DOI 10.1042/BJ20020348; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2005, J BIOL CHEM, V280, P21155, DOI 10.1074/jbc.M413183200; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Wang X, 2005, J THROMB HAEMOST, V3, P695, DOI 10.1111/j.1538-7836.2005.01236.x; Watanabe N, 2007, J CLIN GASTROENTEROL, V41, P616, DOI 10.1097/01.mcg.0000225642.90898.0e; Westrick RJ, 2007, ARTERIOSCL THROM VAS, V27, P2079, DOI 10.1161/ATVBAHA.107.142810	48	106	111	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7385	7394		10.1074/jbc.M807820200	http://dx.doi.org/10.1074/jbc.M807820200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19139100	hybrid, Green Published			2022-12-25	WOS:000263919000084
J	Wang, G; Olczak, A; Forsberg, LS; Maier, RJ				Wang, Ge; Olczak, Adriana; Forsberg, Lennart S.; Maier, Robert J.			Oxidative Stress-induced Peptidoglycan Deacetylase in Helicobacter pylori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINE DEACETYLASE; DNA-DAMAGE; STREPTOCOCCUS-PNEUMONIAE; NEISSERIA-MENINGITIDIS; LYSOZYME RESISTANCE; HOST COLONIZATION; VIRULENCE FACTOR; GASTRIC-MUCOSA; PROTEINS; MUTANTS	Structural modification of peptidoglycan (PG) is one of the mechanisms that pathogenic bacteria use to evade the host innate immune system. For the noninvasive human gastric pathogen Helicobacter pylori, PG delivery to the host cells is one trigger of the immune response. H. pylori HP310 was markedly up-expressed upon cell exposure to oxidative stress. However, disruption of HP310 did not produce a phenotype distinguishable from the parent, including oxidative stress resistance characteristics. HP310 shows very weak homology to a known gene pgdA encoding PG deacetylase in Streptococcous pneumoniae. PGs from wild type H. pylori and the HP310 mutant were purified and analyzed by matrix-assisted laser desorption ionization time-of-flight and high pressure liquid chromatography. The parent strain PG is partially deacetylated, whereas several major PG-deacetylated muropeptides are absent or significantly reduced in the HP310 mutant. PG deacetylase activity was directly demonstrated by use of pure PG and HP310 protein by measuring the release of acetic acid. The Gram-negative bacterium H. pylori is highly resistant to lysozyme (up to 50 mg/ml), but the HP310 mutant is less resistant to lysozyme compared with the parent strain. Complementation of an hp310 strain with the wild type gene restored lysozyme resistance. The purified PG from the mutant is more susceptible to lysozyme (0.3 mg/ml) digestion than the wild type PG. The PG deacetylation appears to confer lysozyme resistance to escape immune detection. HP310 is representative of anew subfamily of bacterial PG deacetylases.	[Wang, Ge; Olczak, Adriana; Maier, Robert J.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Forsberg, Lennart S.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Maier, RJ (corresponding author), Univ Georgia, Dept Microbiol, 815 Biol Sci Bldg, Athens, GA 30602 USA.	rmaier@uga.edu			University of Georgia Foundation; Department of Energy [DE-FG02-93ER20097]	University of Georgia Foundation; Department of Energy(United States Department of Energy (DOE))	This work was supported by the University of Georgia Foundation and in part by Department of Energy Grant DE-FG02-93ER20097 ( to Complex Carbohydrate Research Center).	Alamuri P, 2004, MOL MICROBIOL, V53, P1397, DOI 10.1111/j.1365-2958.2004.04190.x; Antignac A, 2003, J BIOL CHEM, V278, P31521, DOI 10.1074/jbc.M304749200; Baik SC, 1996, CANCER RES, V56, P1279; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; Boneca IG, 2005, CURR OPIN MICROBIOL, V8, P46, DOI 10.1016/j.mib.2004.12.008; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Caufrier F, 2003, CARBOHYD RES, V338, P687, DOI 10.1016/S0008-6215(03)00002-8; DAVIES GR, 1994, GUT, V35, P179, DOI 10.1136/gut.35.2.179; Dillard JP, 2005, INFECT IMMUN, V73, P5697, DOI 10.1128/IAI.73.9.5697-5705.2005; Ding SZ, 2007, INFECT IMMUN, V75, P4030, DOI 10.1128/IAI.00172-07; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720, DOI 10.1128/CMR.10.4.720; Fukushima T, 2005, J BACTERIOL, V187, P1287, DOI 10.1128/JB.187.4.1287-1292.2005; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Harris AG, 2003, MICROBIOL-SGM, V149, P665, DOI 10.1099/mic.0.26012-0; HASH JH, 1967, J BACTERIOL, V93, P1201, DOI 10.1128/JB.93.3.1201-1202.1967; Hebert L, 2007, INFECT IMMUN, V75, P5390, DOI 10.1128/IAI.00571-07; Loughlin MF, 2003, INFECT IMMUN, V71, P2022, DOI 10.1128/IAI.71.4.2022-2031.2003; McGee DJ, 1999, CURR TOP MICROBIOL, V241, P155; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Meyrand M, 2007, MICROBIOL-SGM, V153, P3275, DOI 10.1099/mic.0.2007/005835-0; Nardone G, 2004, ALIMENT PHARM THER, V20, P261, DOI 10.1111/j.1365-2036.2004.02075.x; O'Rourke EJ, 2003, P NATL ACAD SCI USA, V100, P2789, DOI 10.1073/pnas.0337641100; Olczak AA, 2002, J BACTERIOL, V184, P3186, DOI 10.1128/JB.184.12.3186-3193.2002; Olczak ANA, 2005, FREE RADICAL RES, V39, P1173, DOI 10.1080/10715760500306729; Park AM, 2004, FREE RADICAL BIO MED, V36, P1126, DOI 10.1016/j.freeradbiomed.2004.02.001; Psylinakis E, 2005, J BIOL CHEM, V280, P30856, DOI 10.1074/jbc.M407426200; Seyler RW, 2001, INFECT IMMUN, V69, P4034, DOI 10.1128/IAI.69.6.4034-4040.2001; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Vollmer W, 2002, INFECT IMMUN, V70, P7176, DOI 10.1128/IAI.70.12.7176-7178.2002; Wang G, 2005, MOL MICROBIOL, V58, P166, DOI 10.1111/j.1365-2958.2005.04833.x; Wang G, 2004, INFECT IMMUN, V72, P1391, DOI 10.1128/IAI.72.3.1391-1396.2004; Wang G, 2006, BBA-GEN SUBJECTS, V1760, P1596, DOI 10.1016/j.bbagen.2006.05.005; Wang G, 2006, INFECT IMMUN, V74, P6839, DOI 10.1128/IAI.00991-06; Wang G, 2006, MOL MICROBIOL, V61, P847, DOI 10.1111/j.1365-2958.2006.05302.x	38	44	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6790	6800		10.1074/jbc.M808071200	http://dx.doi.org/10.1074/jbc.M808071200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19147492	Green Published, hybrid			2022-12-25	WOS:000263919000024
J	Nakano, A; Koinuma, D; Miyazawa, K; Uchida, T; Saitoh, M; Kawabata, M; Hanai, J; Akiyama, H; Abe, M; Miyazono, K; Matsumoto, T; Imamura, T				Nakano, Ayako; Koinuma, Daizo; Miyazawa, Keiji; Uchida, Takafumi; Saitoh, Masao; Kawabata, Masahiro; Hanai, Jun-ichi; Akiyama, Hirotada; Abe, Masahiro; Miyazono, Kohei; Matsumoto, Toshio; Imamura, Takeshi			Pin1 Down-regulates Transforming Growth Factor-beta (TGF-beta) Signaling by Inducing Degradation of Smad Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; BREAST-CANCER; DEPENDENT DEGRADATION; CELL-MEMBRANE; I RECEPTOR; PATHWAYS; PHOSPHORYLATION; SMURF2; MECHANISM; BMP	Transforming growth factor-beta (TGF-beta) is crucial in numerous cellular processes, such as proliferation, differentiation, migration, and apoptosis. TGF-beta signaling is transduced by intracellular Smad proteins that are regulated by the ubiquitin-proteasome system. Smad ubiquitin regulatory factor 2 (Smurf2) prevents TGF-beta and bone morphogenetic protein signaling by interacting with Smads and inducing their ubiquitin-mediated degradation. Here we identified Pin1, a peptidylprolyl cis-trans isomerase, as a novel protein binding Smads. Pin1 interacted with Smad2 and Smad3 but not Smad4; this interaction was enhanced by the phosphorylation of (S/T) P motifs in the Smad linker region. (S/T) P motif phosphorylation also enhanced the interaction of Smad2/3 with Smurf2. Pin1 reduced Smad2/3 protein levels in a manner dependent on its peptidyl-prolyl cis-trans isomerase activity. Knockdown of Pin1 increased the protein levels of endogenous Smad2/3. In addition, Pin1 both enhanced the interaction of Smurf2 with Smads and enhanced Smad ubiquitination. Pin1 inhibited TGF-beta-induced transcription and gene expression, suggesting that Pin1 negatively regulates TGF-beta signaling by down-regulating Smad2/3 protein levels via induction of Smurf2-mediated ubiquitin-proteasomal degradation.	[Nakano, Ayako; Koinuma, Daizo; Kawabata, Masahiro; Hanai, Jun-ichi; Imamura, Takeshi] Japanese Fdn Canc Res, Inst Canc, Div Biochem, Tokyo 1358550, Japan; [Nakano, Ayako; Abe, Masahiro; Matsumoto, Toshio] Univ Tokushima, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Tokushima 7708503, Japan; [Miyazawa, Keiji; Saitoh, Masao; Miyazono, Kohei] Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Tokyo 1130033, Japan; [Uchida, Takafumi; Akiyama, Hirotada] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan	Japanese Foundation for Cancer Research; Tokushima University; University of Tokyo; Tohoku University	Imamura, T (corresponding author), Japanese Fdn Canc Res, Inst Canc, Div Biochem, Tokyo 1358550, Japan.	timamura-ind@umin.ac.jp	Koinuma, Daizo/Y-8716-2018; MIYAZAWA, KEIJI/I-9713-2014	Koinuma, Daizo/0000-0001-5611-2122; Uchida, Takafumi/0000-0003-3665-4906	KAKENHI; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science Forum	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science Forum	This research was supported by KAKENHI (grants-in-aid for scientific research) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This study was carried out as a part of "Ground Research Announcement for Space Utilization" promoted by the Japan Science Forum.	Akiyama H, 2005, BIOCHEM BIOPH RES CO, V336, P521, DOI 10.1016/j.bbrc.2005.08.130; Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Aubin J, 2004, GENE DEV, V18, P1482, DOI 10.1101/gad.1202604; Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Chen SY, 2006, MOL CELL BIOL, V26, P929, DOI 10.1128/MCB.26.3.929-939.2006; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Fukunaga E, 2008, J BIOL CHEM, V283, P35660, DOI 10.1074/jbc.M710496200; Grimm OH, 2002, NAT CELL BIOL, V4, P519, DOI 10.1038/ncb812; Hayashi M, 2008, J BIOL CHEM, V283, P565, DOI 10.1074/jbc.M708154200; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Kuratomi G, 2005, BIOCHEM J, V386, P461, DOI 10.1042/BJ20040738; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2003, GENE DEV, V17, P2993, DOI 10.1101/gad.1167003; Matsuura I, 2005, BIOCHEMISTRY-US, V44, P12546, DOI 10.1021/bi050560g; Murakami G, 2003, MOL BIOL CELL, V14, P2809, DOI 10.1091/mbc.E02-07-0441; Nishihara A, 1998, GENES CELLS, V3, P613, DOI 10.1046/j.1365-2443.1998.00217.x; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Wulf G, 2004, EMBO J, V23, P3397, DOI 10.1038/sj.emboj.7600323; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Yoshida-Koide U, 2004, BIOCHEM BIOPH RES CO, V313, P475, DOI 10.1016/j.bbrc.2003.11.138; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	37	87	90	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6109	6115		10.1074/jbc.M804659200	http://dx.doi.org/10.1074/jbc.M804659200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19122240	hybrid			2022-12-25	WOS:000263742700013
J	Preston, RJS; Tran, S; Johnson, JA; Ainle, FN; Harmon, S; White, B; Smith, OP; Jenkins, PV; Dahlback, B; O'Donnell, JS				Preston, Roger J. S.; Tran, Sinh; Johnson, Jennifer A.; Ainle, Fionnuala Ni; Harmon, Shona; White, Barry; Smith, Owen P.; Jenkins, P. Vince; Dahlback, Bjorn; O'Donnell, James S.			Platelet Factor 4 Impairs the Anticoagulant Activity of Activated Protein C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BRAIN ENDOTHELIUM; FACTOR-VA; MEDIATED CLEAVAGES; BINDING-PROPERTIES; COFACTOR ACTIVITY; S DEFICIENCY; GLA DOMAIN; IN-VIVO; INACTIVATION; RECEPTOR	Platelet factor 4 (PF4) is an abundant platelet alpha-granule chemokine released following platelet activation. PF4 interacts with thrombomodulin and the gamma-carboxyglutamic acid (Gla) domain of protein C, thereby enhancing activated protein C (APC) generation by the thrombin-thrombomodulin complex. However, the protein C Gla domain not only mediates protein C activation in vivo, but also plays a critical role in modulating the diverse functional properties of APC once generated. In this study we demonstrate that PF4 significantly inhibits APC anticoagulant activity. PF4 inhibited both protein S-dependentAPC anticoagulant function in plasma and protein S-dependent factor Va (FVa) proteolysis 3- to 5-fold, demonstrating that PF4 impairs protein S cofactor enhancement of APC anticoagulant function. Using recombinant factor Va variants FVa-R506Q/R679Q and FVa-R306Q/R679Q, PF4 was shown to impair APC proteolysis of FVa at position Arg(306) by 3-fold both in the presence and absence of protein S. These data suggest that PF4 contributes to the poorly understood APC resistance phenotype associated with activated platelets. Finally, despite PF4 binding to the APC Gla domain, we show that APC in the presence of PF4 retains its ability to initiate PAR-1-mediated cytoprotective signaling. In summary, we propose that PF4 acts as a critical regulator of APC generation, but also differentially targets APC toward cytoprotective, rather than anticoagulant function at sites of vascular injury with concurrent platelet activation.	[Preston, Roger J. S.; Johnson, Jennifer A.; Ainle, Fionnuala Ni; Harmon, Shona; O'Donnell, James S.] St James Hosp, Haemostasis Res Grp, Inst Mol Med, Trin Coll Dublin, Dublin 8, Ireland; [Tran, Sinh; Dahlback, Bjorn] Lund Univ, Univ Hosp, Dept Lab Med, Wallenberg Lab, SE-20502 Malmo, Sweden; [White, Barry; Jenkins, P. Vince; O'Donnell, James S.] St James Hosp, Natl Ctr Hereditary Coagulat Disorders, Dublin 8, Ireland; [Smith, Owen P.] Our Ladys Childrens Hosp Crumlin, Dept Haematol, Dublin 12, Ireland	Trinity College Dublin; Lund University; Skane University Hospital; Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin	Preston, RJS (corresponding author), St James Hosp, Haemostasis Res Grp, Inst Mol Med, Trin Coll Dublin, Dublin 8, Ireland.	prestonr@tcd.ie	O'Donnell, James/A-6171-2009; Smith, Owen/AAU-8929-2020	O'Donnell, James/0000-0003-0309-3313; Preston, Roger/0000-0003-0108-4077; Jenkins, P. Vincent/0000-0001-5301-464X; Dahlback, Bjorn/0000-0003-1546-0328; Ni Ainle, Fionnuala/0000-0003-0163-792X	Health Research Board Ireland Postdoctoral Fellowship [RP/2006/44]; Health Research Board Ph. D. Scholarship; Children's Medical and Research Foundation Award [RP348]; Science Foundation Ireland President of Ireland Young Researcher Award [06/Y12/0925]	Health Research Board Ireland Postdoctoral Fellowship; Health Research Board Ph. D. Scholarship; Children's Medical and Research Foundation Award; Science Foundation Ireland President of Ireland Young Researcher Award(Science Foundation Ireland)	This work was supported by a Health Research Board Ireland Postdoctoral Fellowship (RP/2006/44 to R.J.S.P.), a Health Research Board Ph.D. Scholarship (to J.A.J.), a Children's Medical and Research Foundation Award (RP348 to O.P.S. and F.N.A.), and a Science Foundation Ireland President of Ireland Young Researcher Award (06/Y12/0925, to J.S.O.D.).	Bae JS, 2007, J BIOL CHEM, V282, P9251, DOI 10.1074/jbc.M610547200; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; CAMIRE RM, 1995, J BIOL CHEM, V270, P20794, DOI 10.1074/jbc.270.35.20794; Camire RM, 1998, BLOOD, V91, P2818, DOI 10.1182/blood.V91.8.2818.2818_2818_2829; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; COMP PC, 1984, J CLIN INVEST, V74, P2082, DOI 10.1172/JCI111632; Dahlback B, 2005, FEBS LETT, V579, P3310, DOI 10.1016/j.febslet.2005.03.001; Domotor E, 2003, BLOOD, V101, P4797, DOI 10.1182/blood-2002-12-3680; Dudek AZ, 1997, J BIOL CHEM, V272, P31785, DOI 10.1074/jbc.272.50.31785; Eslin DE, 2004, BLOOD, V104, P3173, DOI 10.1182/blood-2003-11-3994; Esmon CT, 1999, HAEMATOLOGICA, V84, P363; FAY PJ, 1991, J BIOL CHEM, V266, P20139; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Fukudome K, 1998, J EXP MED, V187, P1029, DOI 10.1084/jem.187.7.1029; Griffin JH, 2007, J THROMB HAEMOST, V5, P73, DOI 10.1111/j.1538-7836.2007.02491.x; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; HANDIN RI, 1976, J BIOL CHEM, V251, P4273; JANE SM, 1989, J CLIN INVEST, V83, P222, DOI 10.1172/JCI113862; KALAFATIS M, 1993, J BIOL CHEM, V268, P27246; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Kowalska MA, 2007, BLOOD, V110, P1903, DOI 10.1182/blood-2007-03-081901; McDonald JF, 1997, BIOCHEMISTRY-US, V36, P5120, DOI 10.1021/bi9626160; Mosnier LO, 2007, J BIOL CHEM, V282, P33022, DOI 10.1074/jbc.M705824200; Mosnier LO, 2004, BLOOD, V104, P1740, DOI 10.1182/blood-2004-01-0110; Mosnier LO, 2003, BIOCHEM J, V373, P65, DOI 10.1042/BJ20030341; Norstrom EA, 2003, J BIOL CHEM, V278, P24904, DOI 10.1074/jbc.M303829200; Oliver JA, 2002, BLOOD, V100, P539, DOI 10.1182/blood.V100.2.539; Preston RJS, 2006, J BIOL CHEM, V281, P28850, DOI 10.1074/jbc.M604966200; Regan LM, 1997, J BIOL CHEM, V272, P26279, DOI 10.1074/jbc.272.42.26279; REITSMA PH, 1993, THROMB HAEMOSTASIS, V69, P77; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; ROSING J, 1995, J BIOL CHEM, V270, P27852, DOI 10.1074/jbc.270.46.27852; SCHWARZ HP, 1984, BLOOD, V64, P1297; SELIGSOHN U, 1984, NEW ENGL J MED, V310, P559, DOI 10.1056/NEJM198403013100904; Sere KM, 2004, BLOOD, V104, P3624, DOI 10.1182/blood-2004-03-1146; SLUNGAARD A, 1994, J BIOL CHEM, V269, P25549; Slungaard A, 2005, INT J BIOCHEM CELL B, V37, P1162, DOI 10.1016/j.biocel.2004.12.003; Slungaard A, 2003, BLOOD, V102, P146, DOI 10.1182/blood-2002-11-3529; Smirnov MD, 1998, J BIOL CHEM, V273, P9031, DOI 10.1074/jbc.273.15.9031; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; STERN DM, 1986, J BIOL CHEM, V261, P713; Taube J, 1999, BLOOD, V93, P3792, DOI 10.1182/blood.V93.11.3792.411k06_3792_3797; Tran S, 2008, J BIOL CHEM, V283, P6648, DOI 10.1074/jbc.M708036200; WALKER FJ, 1979, BIOCHIM BIOPHYS ACTA, V571, P333, DOI 10.1016/0005-2744(79)90103-7; WALKER FJ, 1980, J BIOL CHEM, V255, P5521	45	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5869	5875		10.1074/jbc.M804703200	http://dx.doi.org/10.1074/jbc.M804703200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19129181	Green Published, hybrid			2022-12-25	WOS:000263560600050
J	Kim, DJ; Angel, JM; Sano, S; DiGiovanni, J				Kim, D. J.; Angel, J. M.; Sano, S.; DiGiovanni, J.			Constitutive activation and targeted disruption of signal transducer and activator of transcription 3 (Stat3) in mouse epidermis reveal its critical role in UVB-induced skin carcinogenesis	ONCOGENE			English	Article						Stat3; skin carcinogenesis; UVB	SQUAMOUS-CELL CARCINOMAS; NUCLEOTIDE EXCISION-REPAIR; INDUCED CUTANEOUS DAMAGE; KINASE-C-EPSILON; EPITHELIAL CARCINOGENESIS; MEDIATED ACTIVATION; TUMOR-DEVELOPMENT; PROMOTION STAGES; HAIRLESS MOUSE; DNA-DAMAGE	In this study, the potential role of Stat3 in UVB-induced skin carcinogenesis was examined using skin-specific gain and loss of function transgenic mice, that is, K5.Stat3C and K5Cre.Stat3(fl/fl) mice, respectively. The epidermis of Stat3-deficient mice was highly sensitive to UVB-induced apoptosis, whereas the epidermis of K5.Stat3C mice was more resistant to UVB-induced apoptosis. In particular, the status of Stat3 influenced the survival of ultraviolet-photoproduct cells, including those located in the hair follicles. K5.Stat3C mice exhibited significantly increased epidermal proliferation and hyperplasia in response to UVB irradiation, whereas Stat3-deficient mice showed reduced epidermal proliferation and hyperplasia. Expression of target genes regulated by Stat3, such as cyclin D1 and Bcl-x(L), was increased in epidermis of both control and UVB-irradiated K5.Stat3C mice, and downregulated in epidermis of both control and UVB-irradiated K5Cre.Stat3(fl/fl) mice. Following UVB irradiation, the formation of skin tumors in K5.Stat3C mice was accelerated and both the incidence and multiplicity of skin tumors were significantly greater than wild-type controls. In contrast, Stat3-deficient mice were resistant to UVB skin carcinogenesis. These results show that Stat3 plays an important role in the development of UVB-induced skin tumors through its effects on both survival and proliferation of keratinocytes during carcinogenesis.	[Kim, D. J.; Angel, J. M.; DiGiovanni, J.] Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Div Sci Pk Res, Smithville, TX USA; [Sano, S.] Osaka Univ, Grad Sch Med, Dept Dermatol, Osaka, Japan	University of Texas System; UTMD Anderson Cancer Center; Osaka University	DiGiovanni, J (corresponding author), MD Anderson, Sci Pk,1808 Pk Rd 1C,POB 389, Smithville, TX 78957 USA.	jdigiova@mdanderson.org		KIM, DAE/0000-0002-7977-9955	NCI NIH HHS [R01 CA076520, CA105345, U01 CA105345, P30 CA016672, CA76520, CA16672, R01 CA076520-02] Funding Source: Medline; NIEHS NIH HHS [P30 ES007784, P30 ES007784-12, ES07784] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA076520, U01CA105345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ahsan H, 2005, BIOCHEM BIOPH RES CO, V333, P241, DOI 10.1016/j.bbrc.2005.05.106; Alvarez JV, 2005, CANCER RES, V65, P5054, DOI 10.1158/0008-5472.CAN-04-4281; Aziz MH, 2007, CANCER RES, V67, P1385, DOI 10.1158/0008-5472.CAN-06-3350; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chan KS, 2008, ONCOGENE, V27, P1087, DOI 10.1038/sj.onc.1210726; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Chan KS, 2004, CANCER RES, V64, P2382, DOI 10.1158/0008-5472.CAN-03-3197; Cooper SJ, 2003, MOL CANCER RES, V1, P848; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Daya-Grosjean L, 2005, MUTAT RES-FUND MOL M, V571, P43, DOI 10.1016/j.mrfmmm.2004.11.013; de Gruijl FR, 2001, J PHOTOCH PHOTOBIO B, V63, P19, DOI 10.1016/S1011-1344(01)00199-3; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; Frank David A, 2003, Cancer Treat Res, V115, P267; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Grad JM, 2000, CURR OPIN ONCOL, V12, P543, DOI 10.1097/00001622-200011000-00006; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; Hill LL, 1999, SCIENCE, V285, P898, DOI 10.1126/science.285.5429.898; Ichihashi M, 2003, TOXICOLOGY, V189, P21, DOI 10.1016/S0300-483X(03)00150-1; Kataoka K, 2008, CARCINOGENESIS, V29, P1108, DOI 10.1093/carcin/bgn061; Kim AL, 2002, PHOTOCHEM PHOTOBIOL, V75, P58, DOI 10.1562/0031-8655(2002)075<0058:SSAOCE>2.0.CO;2; Kim AL, 2002, BIOCHEM BIOPH RES CO, V298, P377, DOI 10.1016/S0006-291X(02)02435-X; Kim DJ, 2007, MOL CARCINOGEN, V46, P725, DOI 10.1002/mc.20342; Kraemer KH, 1997, P NATL ACAD SCI USA, V94, P11, DOI 10.1073/pnas.94.1.11; Leslie K, 2006, CANCER RES, V66, P2544, DOI 10.1158/0008-5472.CAN-05-2203; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li DL, 2001, FASEB J, V15, P2533, DOI 10.1096/fj.01-0172fje; Li L, 2002, J BIOL CHEM, V277, P17397, DOI 10.1074/jbc.M109962200; LIPPKE JA, 1981, P NATL ACAD SCI-BIOL, V78, P3388, DOI 10.1073/pnas.78.6.3388; Masuda M, 2002, CANCER RES, V62, P3351; Melnikova VO, 2005, MUTAT RES-FUND MOL M, V571, P91, DOI 10.1016/j.mrfmmm.2004.11.015; MITCHELL DL, 1989, PHOTOCHEM PHOTOBIOL, V49, P805, DOI 10.1111/j.1751-1097.1989.tb05578.x; Nijhof JGW, 2007, CARCINOGENESIS, V28, P792, DOI 10.1093/carcin/bgl213; Noonan FP, 2000, CANCER RES, V60, P3738; Pena JC, 1997, CELL GROWTH DIFFER, V8, P619; Robles AI, 1998, GENE DEV, V12, P2469, DOI 10.1101/gad.12.16.2469; Sano S, 2005, CANCER RES, V65, P5720, DOI 10.1158/0008-5472.CAN-04-4359; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Sano S, 2008, J DERMATOL SCI, V50, P1, DOI 10.1016/j.jdermsci.2007.05.016; Sarasin A, 1999, MUTAT RES-FUND MOL M, V428, P5, DOI 10.1016/S1383-5742(99)00025-3; SETLOW RB, 1966, J MOL BIOL, V17, P237, DOI 10.1016/S0022-2836(66)80105-5; Shen YH, 2001, P NATL ACAD SCI USA, V98, P1543, DOI 10.1073/pnas.041588198; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Umeda J, 2003, FASEB J, V17, P610, DOI 10.1096/fj.02-0597com; Wheeler DL, 2004, CANCER RES, V64, P7756, DOI 10.1158/0008-5472.CAN-04-1881	48	60	62	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 19	2009	28	7					950	960		10.1038/onc.2008.453	http://dx.doi.org/10.1038/onc.2008.453			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	408TH	19137019	Green Accepted			2022-12-25	WOS:000263457400002
J	Joppa, LN; Loarie, SR; Pimm, SL				Joppa, Lucas N.; Loarie, Scott R.; Pimm, Stuart L.			On Population Growth Near Protected Areas	PLOS ONE			English	Article								Background: Protected areas are the first, and often only, line of defense in efforts to conserve biodiversity. They might be detrimental or beneficial to rural communities depending on how they alter economic opportunities and access to natural resources. As such, protected areas may attract or repel human settlement. Disproportionate increases in population growth near protected area boundaries may threaten their ability to conserve biodiversity. Methodology/Principal Findings: Using decadal population datasets, we analyze population growth across 45 countries and 304 protected areas. We find no evidence for population growth near protected areas to be greater than growth of rural areas in the same country. Furthermore, we argue that what growth does occur near protected areas likely results from a general expansion of nearby population centers. Conclusions/Significance: Our results contradict those from a recent study by Wittemyer et al., who claim overwhelming evidence for increased human population growth near protected areas. To understand the disagreement, we re-analyzed the protected areas in Wittemyer et al.'s paper. Their results are simply artifacts of mixing two incompatible datasets. Protected areas may experience unusual population pressures near their edges; indeed, individual case studies provide examples. There is no evidence, however, of a general pattern of disproportionate population growth near protected areas.	[Joppa, Lucas N.; Pimm, Stuart L.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Loarie, Scott R.] Carnegie Inst, Dept Glob Ecol, Stanford, CA USA	Duke University; Carnegie Institution for Science	Joppa, LN (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	StuartPimm@me.com	pimm, stuart/ABF-1082-2020		National Science Foundation [Graduate Research Fellowship]; NASA [Earth Systems Sciences Graduate Fellowship]	National Science Foundation(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	LNJ is supported by a National Science Foundation Graduate Research Fellowship. SRL is supported by a NASA Earth Systems Sciences Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; Anderson A., 2006, APPL NATURES DESIGN; [Anonymous], 2013, THE FUTURE OF NATURE, DOI DOI 10.12987/9780300188479-039; CIESIN (Center for International Earth Science Information NEtweok - Columbia University) IFPRI (International Food Policy Research Institute) The World Bank CIAT (Centro Internacional de Agricultura Tropical), GLOB RUR URB MAPP PR; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; Loarie SR, 2007, TRENDS ECOL EVOL, V22, P630, DOI 10.1016/j.tree.2007.08.018; Myers N., 2004, NEW CONSUMERS INFLUE; PELUSO NL, 1993, GLOBAL ENVIRON CHANG, V3, P199, DOI 10.1016/0959-3780(93)90006-7; Pimm SL, 2001, SCIENCE, V293, P2207, DOI 10.1126/science.1061626; Scherl LM, 2004, OPPORTUNITIES LIMITA; *UNEP CTR INT EART, 2004, AFR POP DISTR DAT; *UNEP INT CTR TROP, 2004, LAT AM POP DISTR DAT; *UNEP WORLD CONS M, 2003, WORLD DAT PROT AR; United Nations (UN) Population Division, 2007, WORLD URB PROSP 2007; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900	18	71	72	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2009	4	1							e4279	10.1371/journal.pone.0004279	http://dx.doi.org/10.1371/journal.pone.0004279			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JE	19169358	Green Published, Green Submitted, gold			2022-12-25	WOS:000265482800009
J	Slater, BJ; Liu, KJ; Kwan, MD; Quarto, N; Longaker, MT				Slater, Bethany J.; Liu, Karen J.; Kwan, Matthew D.; Quarto, Natalina; Longaker, Michael T.			Cranial Osteogenesis and Suture Morphology in Xenopus laevis: A Unique Model System for Studying Craniofacial Development	PLOS ONE			English	Article								Background: The tremendous diversity in vertebrate skull formation illustrates the range of forms and functions generated by varying genetic programs. Understanding the molecular basis for this variety may provide us with insights into mechanisms underlying human craniofacial anomalies. In this study, we provide evidence that the anuran Xenopus laevis can be developed as a simplified model system for the study of cranial ossification and suture patterning. The head structures of Xenopus undergo dramatic remodelling during metamorphosis; as a result, tadpole morphology differs greatly from the adult bony skull. Because of the extended larval period in Xenopus, the molecular basis of these alterations has not been well studied. Methodology/Principal Findings: We examined late larval, metamorphosing, and post-metamorphosis froglet stages in intact and sectioned animals. Using micro-computed tomography (mCT) and tissue staining of the frontoparietal bone and surrounding cartilage, we observed that bone formation initiates from lateral ossification centers, proceeding from posterior-to-anterior. Histological analyses revealed midline abutting and posterior overlapping sutures. To determine the mechanisms underlying the large-scale cranial changes, we examined proliferation, apoptosis, and proteinase activity during remodelling of the skull roof. We found that tissue turnover during metamorphosis could be accounted for by abundant matrix metalloproteinase (MMP) activity, at least in part by MMP-1 and -13. Conclusion: A better understanding of the dramatic transformation from cartilaginous head structures to bony skull during Xenopus metamorphosis may provide insights into tissue remodelling and regeneration in other systems. Our studies provide some new molecular insights into this process.	[Slater, Bethany J.; Kwan, Matthew D.; Quarto, Natalina; Longaker, Michael T.] Stanford Univ, Sch Med, Div Plast & Reconstruct Surg, Hagey Lab Pediat Regenerat Med, Stanford, CA 94305 USA; [Longaker, Michael T.] Stanford Univ, Sch Med, Dept Surg, Hagey Lab Pediat Regenerative Med, Stanford, CA 94305 USA; [Liu, Karen J.] Kings Coll London, Dept Craniofac Dev, London, England; [Quarto, Natalina] Univ Naples Federico II, Dept Structural & Funct Biol, Naples, Italy	Stanford University; Stanford University; University of London; King's College London; University of Naples Federico II	Slater, BJ (corresponding author), Stanford Univ, Sch Med, Div Plast & Reconstruct Surg, Hagey Lab Pediat Regenerat Med, Stanford, CA 94305 USA.	karen.liu@kcl.ac.uk; Longaker@stanford.edu	Liu, Karen/F-2870-2010	Liu, Karen/0000-0002-2483-2165				Amsterdam A, 1999, GENE DEV, V13, P2713, DOI 10.1101/gad.13.20.2713; CANNATELLA DC, 1993, SYST BIOL, V42, P476, DOI 10.2307/2992485; CAROL C, 1996, J MORPHOL, V229, P121; Chipman AD, 2002, EVOL DEV, V4, P86, DOI 10.1046/j.1525-142X.2002.01064.x; COULY GF, 1993, DEVELOPMENT, V117, P409; de Beer G., 1937, DEV VERTEBRATE SKULL; Fujimoto K, 2007, DEV GROWTH DIFFER, V49, P131, DOI 10.1111/j.1440-169x.2007.00916.x; Geisler R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-11; GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014; Gross JB, 2005, J EXP ZOOL PART B, V304B, P169, DOI 10.1002/jez.b.21028; Gross JB, 2004, DEV DYNAM, V230, P100, DOI 10.1002/dvdy.20036; Gross JB, 2006, J ANAT, V209, P401, DOI 10.1111/j.1469-7580.2006.00608.x; Hanken J, 2005, J ANAT, V207, P437, DOI 10.1111/j.1469-7580.2005.00481.x; HANKEN J, 1988, J MORPHOL, V195, P247, DOI 10.1002/jmor.1051950303; Hanken J., 1993, SKULL; Harrison M, 2004, DEV DYNAM, V231, P214, DOI 10.1002/dvdy.20113; Hasebe T, 2006, CELL TISSUE RES, V324, P105, DOI 10.1007/s00441-005-0099-7; Holmbeck K, 2003, J CELL BIOL, V163, P661, DOI 10.1083/jcb.200307061; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; JENNIFER Y, 2002, EVOLUTION, V56, P2484; Lenton KA, 2005, CURR TOP DEV BIOL, V66, P287, DOI 10.1016/S0070-2153(05)66009-7; Miura S, 2008, BONE, V43, P901, DOI 10.1016/j.bone.2008.07.005; Morriss-Kay GM, 2001, J ANAT, V199, P143; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; NIEWKOOP P.D., 1994, NORMAL TABLE XENOPUS; NODEN DM, 1986, J CRAN GENET DEV BIO, P15; Ogawa O, 2003, ACTA NEUROPATHOL, V105, P524, DOI 10.1007/s00401-003-0684-3; Olsson L, 1996, J MORPHOL, V229, P105, DOI 10.1002/(SICI)1097-4687(199607)229:1<105::AID-JMOR7>3.0.CO;2-2; Opperman LA, 2000, DEV DYNAM, V219, P472, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F; ORAHILLY R, 1972, AM J ANAT, V134, P291, DOI 10.1002/aja.1001340303; PATERSON NF, Q J MICROSCOPIAL S S, V2, P161; Quarto N, 2005, CELLS TISSUES ORGANS, V181, P109, DOI 10.1159/000091100; RICE DP, 2008, FRONTIERS ORAL BIOL; Ritman EL, 2004, ANNU REV BIOMED ENG, V6, P185, DOI 10.1146/annurev.bioeng.6.040803.140130; Sanchez-Villagra MR, 2008, EVOL DEV, V10, P519, DOI 10.1111/j.1525-142X.2008.00267.x; SANSOM IJ, 1992, SCIENCE, V256, P1308, DOI 10.1126/science.1598573; SEDRA SN, VERH KON AKAD WETENS, V51, P1; TRUEB L, 1992, J MORPHOL, V214, P1, DOI 10.1002/jmor.1052140102; Trueb L, 2000, J MORPHOL, V243, P75, DOI 10.1002/(SICI)1097-4687(200001)243:1<75::AID-JMOR4>3.0.CO;2-L; WANG Z, 1993, J BIOL CHEM, V268, P16270; Yelick PC, 2002, CRIT REV ORAL BIOL M, V13, P308, DOI 10.1177/154411130201300402	41	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2009	4	1							e3914	10.1371/journal.pone.0003914	http://dx.doi.org/10.1371/journal.pone.0003914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IZ	19156194	Green Published, Green Submitted, gold			2022-12-25	WOS:000265481900001
J	Driscoll, CA; Yamaguchi, N; Bar-Gal, GK; Roca, AL; Luo, SJ; Macdonald, DW; O'Brien, SJ				Driscoll, Carlos A.; Yamaguchi, Nobuyuki; Bar-Gal, Gila Kahila; Roca, Alfred L.; Luo, Shujin; Macdonald, David W.; O'Brien, Stephen J.			Mitochondrial Phylogeography Illuminates the Origin of the Extinct Caspian Tiger and Its Relationship to the Amur Tiger	PLOS ONE			English	Article							GENOME; DNA; ALIGNMENT; NUMT	The Caspian tiger (Panthera tigris virgata) flourished in Central Asian riverine forest systems in a range disjunct from that of other tigers, but was driven to extinction in 1970 prior to a modern molecular evaluation. For over a century naturalists puzzled over the taxonomic validity, placement, and biogeographic origin of this enigmatic animal. Using ancient-DNA (aDNA) methodology, we generated composite mtDNA haplotypes from twenty wild Caspian tigers from throughout their historic range sampled from museum collections. We found that Caspian tigers carry a major mtDNA haplotype differing by only a single nucleotide from the monomorphic haplotype found across all contemporary Amur tigers (P. t. altaica). Phylogeographic analysis with extant tiger subspecies suggests that less than 10,000 years ago the Caspian/Amur tiger ancestor colonized Central Asia via the Gansu Corridor (Silk Road) from eastern China then subsequently traversed Siberia eastward to establish the Amur tiger in the Russian Far East. The conservation implications of these findings are far reaching, as the observed genetic depletion characteristic of modern Amur tigers likely reflects these founder migrations and therefore predates human influence. Also, due to their evolutionary propinquity, living Amur tigers offer an appropriate genetic source should reintroductions to the former range of the Caspian tiger be implemented.	[Driscoll, Carlos A.; Yamaguchi, Nobuyuki; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Tubney, Oxon, England; [Driscoll, Carlos A.; Luo, Shujin; O'Brien, Stephen J.] NCI, Lab Genom Diversity, Bethesda, MD 20892 USA; [Bar-Gal, Gila Kahila] Hebrew Univ Jerusalem, Fac Agr Food & Environm Quality Sci, Koret Sch Vet Med, IL-91905 Jerusalem, Israel; [Roca, Alfred L.] NCI Frederick, SAIC Frederick, Lab Genom Diversity, Frederick, MD USA; [Roca, Alfred L.] Univ Illinois, Dept Animal Sci, Urbana, IL USA	University of Oxford; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Hebrew University of Jerusalem; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Illinois System; University of Illinois Urbana-Champaign	Driscoll, CA (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Tubney, Oxon, England.	bigscience@ncifcrf.gov; obrien@ncifcrf.gov	OBRIEN, STEPHEN/ABD-1346-2020; Yamaguchi, Nobuyuki/AAN-4884-2020	Yamaguchi, Nobuyuki/0000-0002-6492-6588; Driscoll, Carlos/0000-0003-2392-505X; OBRIEN, STEPHEN/0000-0001-7857-0757; Roca, Alfred/0000-0001-9217-5593	National Cancer Institute, National Institutes of Health [N01-CO-12400]; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC005385] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400. The contents of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1999, ICZN INT COD ZOOL NO, Vxxix, px306; Avise J.C., 2004, MOL MARKERS NATURAL; AVISE JC, 1989, SCIENCE, V243, P646, DOI 10.1126/science.243.4891.646; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; CAN OE, 2004, STATUS CONSERVATION, P8; Cooper A, 2000, SCIENCE, V289, P1139; Culver M, 2000, J HERED, V91, P186, DOI 10.1093/jhered/91.3.186; HEMMER H, 1987, TIGERS WORLD BIOL BI; Heptner V. H., 1972, CARNIVORES HYENAS CA; HERRINGTON SJ, 1987, TIGERS WORLD BIOL BI; Hilzheimer M., 1905, Zoologischer Anzeiger, Vxxviii, P594; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; ILLIGER C, 1815, ABHANDLUNGEN PHYS KL, V1804-1811, P39; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kim JH, 2006, GENE, V366, P292, DOI 10.1016/j.gene.2005.08.023; KITCHENER A, 1999, RIDING TIGER TIGER C; Kitchener AC, 2000, ANIM CONSERV, V3, P113, DOI 10.1111/j.1469-1795.2000.tb00236.x; Linnaeus C., 1758, SYSTEMA NATURAE PER, V1; Lopez JV, 1996, GENOMICS, V33, P229, DOI 10.1006/geno.1996.0188; Luo SJ, 2008, CURR BIOL, V18, P592, DOI 10.1016/j.cub.2008.03.053; Luo SJ, 2004, PLOS BIOL, V2, P2275, DOI 10.1371/journal.pbio.0020442; Marris E, 2007, NATURE, V450, P152, DOI 10.1038/450152a; MAY RM, 1990, NATURE, V347, P129, DOI 10.1038/347129a0; MAZAK V, 1968, Mammalia, V32, P104, DOI 10.1515/mamm.1968.32.1.104; MAZAK V, 1983, TIGER PANTHERA TIGRI, V1758; MAZAK V, 1981, MAMMALIAN SPECIES, V152, P1, DOI DOI 10.2307/3504004; NOWELL K, 1996, WILD CATS STATUS SUR, pR24; O'Brien SJ, 2005, ANNU REV GENOM HUM G, V6, P407, DOI 10.1146/annurev.genom.6.080604.162151; OBRIEN SJ, 1991, SCIENCE, V251, P1187, DOI 10.1126/science.251.4998.1187; POCOCK R. I., 1929, JOUR BOMBAY NAT HIST SOC, V33, P505; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rozen S, 2000, Methods Mol Biol, V132, P365; Russello MA, 2004, CONSERV GENET, V5, P707, DOI 10.1007/s10592-004-1860-2; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Schwarz E., 1912, Annals & Magazine of Natural History Series 8, V10; SEIDENSTICKER J, 1999, RIDING TIGER TIGER C, pR19; Smith J.L.D., 1987, P97; SUNQUIST ME, 1999, RIDING TIGER TIGER C; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Temminck C, 1844, FAUNA JAPONICA, P25; WEI L, 2008, MOL BIOL REP; WEI LW, 2008, EF551002 GENBANK; Wu XB, 2007, GENOME, V50, P252, DOI 10.1139/G06-143	44	39	44	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4125	10.1371/journal.pone.0004125	http://dx.doi.org/10.1371/journal.pone.0004125			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142238	Green Submitted, gold, Green Published			2022-12-25	WOS:000265479700002
J	Watanabe, K; Morishima, Y; Toigawa, M; Hata, Y				Watanabe, Kana; Morishima, Yu; Toigawa, Masahito; Hata, Yoshio			Experience-Driven Axon Retraction in the Pharmacologically Inactivated Visual Cortex Does Not Require Synaptic Transmission	PLOS ONE			English	Article								Background: Experience during early postnatal development plays an important role in the refinement of specific neural connections in the brain. In the mammalian visual system, altered visual experiences induce plastic adaptation of visual cortical responses and guide rearrangements of afferent axons from the lateral geniculate nucleus. Previous studies using visual deprivation demonstrated that the afferents serving an open eye significantly retract when cortical neurons are pharmacologically inhibited by applying a gamma-aminobutyric acid type A receptor agonist, muscimol, whereas those serving a deprived eye are rescued from retraction, suggesting that presynaptic activity can lead to the retraction of geniculocortical axons in the absence of postsynaptic activity. Because muscimol application suppresses the spike activity of cortical neurons leaving transmitter release intact at geniculocortical synapses, local synaptic interaction may underlie the retraction of active axons in the inhibited cortex. Method and Findings: New studies reported here determined whether experience-driven axon retraction can occur in the visual cortex inactivated by blocking synaptic inputs. We inactivated the primary visual cortex of kittens by suppressing synaptic transmission with cortical injections of botulinum neurotoxin type E, which cleaves a synaptic protein, SNAP-25, and blocks transmitter release, and examined the geniculocortical axon morphology in the animals with normal vision and those deprived of vision binocularly. We found that afferent axons in the animals with normal vision showed a significant retraction in the inactivated cortex, as similarly observed in the muscimol-treated cortex, whereas the axons in the binocularly deprived animals were preserved. Conclusions: Therefore, the experience-driven axon retraction in the inactivated cortex can proceed in the absence of synaptic transmission. These results suggest that presynaptic mechanisms play an important role in the experience-driven refinement of geniculocortical axons.	[Watanabe, Kana; Morishima, Yu; Toigawa, Masahito; Hata, Yoshio] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Div Integrat Biosci, Yonago, Tottori, Japan	Tottori University	Watanabe, K (corresponding author), Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Div Integrat Biosci, Yonago, Tottori, Japan.	yhata@med.tottori-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [17023033]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas- Elucidation of neural network function in the brain from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 17023033) to Y.H.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONINI A, 1993, J NEUROSCI, V13, P3549; Antonini A, 1996, J COMP NEUROL, V369, P64; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; Caleo M, 2007, J NEUROSCI, V27, P4530, DOI 10.1523/JNEUROSCI.0772-07.2007; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Costantin L, 2005, J NEUROSCI, V25, P1943, DOI 10.1523/JNEUROSCI.4402-04.2005; Davletov B, 2005, TRENDS NEUROSCI, V28, P446, DOI 10.1016/j.tins.2005.06.001; Elliott RC, 2001, J NEUROSCI RES, V66, P83, DOI 10.1002/jnr.1199; Hansel C, 1997, EUR J NEUROSCI, V9, P2309, DOI 10.1111/j.1460-9568.1997.tb01648.x; Haruta M, 2007, CURR BIOL, V17, P37, DOI 10.1016/j.cub.2006.10.064; Hata Y, 1999, NEURON, V22, P375, DOI 10.1016/S0896-6273(00)81097-1; HATA Y, 1994, SCIENCE, V265, P1732, DOI 10.1126/science.8085163; Hata Y, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-03-j0002.2000; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; HILL DR, 1981, NATURE, V290, P149, DOI 10.1038/290149a0; Ichisaka S, 2003, NEUROSCIENCE, V117, P361, DOI 10.1016/S0306-4522(02)00771-6; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; NEEDLER MC, 1984, BRAIN RES, V308, P347, DOI 10.1016/0006-8993(84)91076-X; REITER HO, 1986, EXP BRAIN RES, V65, P182; REITER HO, 1988, P NATL ACAD SCI USA, V85, P3623, DOI 10.1073/pnas.85.10.3623; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Shimegi S, 2003, J NEUROPHYSIOL, V90, P4027, DOI 10.1152/jn.00313.2003; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WORLEY PF, 1991, P NATL ACAD SCI USA, V88, P5106, DOI 10.1073/pnas.88.12.5106; Yamauchi T, 2000, EUR J NEUROSCI, V12, P3433, DOI 10.1046/j.1460-9568.2000.00248.x; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	29	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4193	10.1371/journal.pone.0004193	http://dx.doi.org/10.1371/journal.pone.0004193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142221	Green Submitted, gold, Green Published			2022-12-25	WOS:000265479700013
J	Richer, MJ; Lavallee, DJ; Shanina, I; Horwitz, MS				Richer, Martin J.; Lavallee, Danielle J.; Shanina, Iryna; Horwitz, Marc S.			Toll-Like Receptor 3 Signaling on Macrophages Is Required for Survival Following Coxsackievirus B4 Infection	PLOS ONE			English	Article								Toll-like receptor 3 (TLR3) has been proposed to play a central role in the early recognition of viruses by sensing double stranded RNA, a common intermediate of viral replication. However, several reports have demonstrated that TLR3 signaling is either dispensable or even harmful following infection with certain viruses. Here, we asked whether TLR3 plays a role in the response to coxsackievirus B4 (CB4), a prevalent human pathogen that has been associated with pancreatitis, myocarditis and diabetes. We demonstrate that TLR3 signaling on macrophages is critical to establish protective immunity to CB4. TLR3 deficient mice produced reduced pro-inflammatory mediators and are unable to control viral replication at the early stages of infection resulting in severe cardiac damage. Intriguingly, the absence of TLR3 did not affect the activation of several key innate and adaptive cellular effectors. This suggests that in the absence of TLR3 signaling on macrophages, viral replication outpaces the developing adaptive immune response. We further demonstrate that the MyD88-dependent signaling pathways are not only unable to compensate for the loss of TLR3, they are also dispensable in the response to this RNA virus. Our results demonstrate that TLR3 is not simply part of a redundant system of viral recognition, but rather TLR3 plays an essential role in recognizing the molecular signatures associated with specific viruses including CB4.	[Richer, Martin J.; Lavallee, Danielle J.; Shanina, Iryna; Horwitz, Marc S.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Richer, MJ (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada.	mhorwitz@interchange.ubc.ca			Canadian Institute of Health Research; Michael Smith Foundation for Health Research	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	Canadian Institute of Health Research and Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Ashkar AA, 2004, J INFECT DIS, V190, P1841, DOI 10.1086/425079; Barral PM, 2007, J VIROL, V81, P3677, DOI 10.1128/JVI.01360-06; Bertinchant JP, 1996, CLIN BIOCHEM, V29, P587, DOI 10.1016/S0009-9120(96)00105-1; Boehme KW, 2006, J IMMUNOL, V177, P7094, DOI 10.4049/jimmunol.177.10.7094; Carpentier PA, 2007, GLIA, V55, P239, DOI 10.1002/glia.20450; DAFFIS S, 2008, J VIROL; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Fuse K, 2005, CIRCULATION, V112, P2276, DOI 10.1161/CIRCULATIONAHA.105.536433; Georgel P, 2007, VIROLOGY, V362, P304, DOI 10.1016/j.virol.2006.12.032; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Gowen BB, 2006, J IMMUNOL, V177, P6301, DOI 10.4049/jimmunol.177.9.6301; Hardarson HS, 2007, AM J PHYSIOL-HEART C, V292, pH251, DOI 10.1152/ajpheart.00398.2006; Herbein G, 2000, P SOC EXP BIOL MED, V223, P241, DOI 10.1046/j.1525-1373.2000.22335.x; Herbst-Kralovetz MM, 2006, J VIROL, V80, P9988, DOI 10.1128/JVI.01099-06; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Horwitz MS, 2000, NAT MED, V6, P693, DOI 10.1038/76277; Horwitz MS, 1998, NAT MED, V4, P781, DOI 10.1038/nm0798-781; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Jung A, 2008, J VIROL, V82, P196, DOI 10.1128/JVI.01640-07; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; KLAVINSKIS LS, 1989, J GEN VIROL, V70, P3317, DOI 10.1099/0022-1317-70-12-3317; Kumar A, 2006, IMMUNOLOGY, V117, P11, DOI 10.1111/j.1365-2567.2005.02258.x; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Lore K, 2003, J IMMUNOL, V171, P4320, DOI 10.4049/jimmunol.171.8.4320; Lowenstein CJ, 1996, J CLIN INVEST, V97, P1837, DOI 10.1172/JCI118613; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; McCartney SA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000108; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Richer MJ, 2008, DIABETES, V57, P1302, DOI 10.2337/db07-1460; Richer MJ, 2006, CLIN IMMUNOL, V121, P339, DOI 10.1016/j.clim.2006.07.009; Richer MJ, 2008, FRONT BIOSCI-LANDMRK, V13, P4241, DOI 10.2741/3002; Rose NR, 2008, CURR TOP MICROBIOL, V323, P293; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Serreze DV, 2000, DIABETES, V49, P708, DOI 10.2337/diabetes.49.5.708; Suh HS, 2007, J VIROL, V81, P9838, DOI 10.1128/JVI.00792-07; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tam PE, 2006, VIRAL IMMUNOL, V19, P133, DOI 10.1089/vim.2006.19.133; Taylor DO, 2007, J HEART LUNG TRANSPL, V26, P769, DOI 10.1016/j.healun.2007.06.004; Triantafilou K, 2005, CELL MICROBIOL, V7, P1117, DOI 10.1111/j.1462-5822.2005.00537.x; Triantafilou K, 2004, J VIROL, V78, P11313, DOI 10.1128/JVI.78.20.11313-11320.2004; Ure DR, 2005, INT IMMUNOL, V17, P569, DOI 10.1093/intimm/dxh236; Wada H, 2001, CIRCULATION, V103, P743; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; WEBB SR, 1976, J EXP MED, V143, P1239, DOI 10.1084/jem.143.5.1239; WEINZIERL AO, J VIROL; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang Y, 2007, P NATL ACAD SCI USA, V104, P7253, DOI 10.1073/pnas.0611506104; YOON JW, 1979, NEW ENGL J MED, V300, P1173, DOI 10.1056/NEJM197905243002102; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhou SH, 2005, EUR J IMMUNOL, V35, P822, DOI 10.1002/eji.200425730	52	107	109	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2009	4	1							e4127	10.1371/journal.pone.0004127	http://dx.doi.org/10.1371/journal.pone.0004127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FT	19122812	Green Submitted, Green Published, gold			2022-12-25	WOS:000265472900007
J	Tozuka, Y; Wada, E; Wada, K				Tozuka, Yusuke; Wada, Etsuko; Wada, Keiji			Diet-induced obesity in female mice leads to peroxidized lipid accumulations and impairment of hippocampal neurogenesis during the early life of their offspring	FASEB JOURNAL			English	Article						lactation; neural progenitor cells; hight-fat diet; metabolic abnormalities; oxidative stress; brain development	NEURAL PRECURSOR CELLS; HIGH-FAT DIET; SYNAPTIC PLASTICITY; ADULT NEUROGENESIS; INSULIN-RESISTANCE; OXIDATIVE STRESS; CHOLINE AVAILABILITY; CIRCULATING LEVELS; PROGENITOR CELLS; MILK-COMPOSITION	Maternal obesity may affect the child's long-term development and health. However, there is little information about the involvement of maternal obesity in the brain development of offspring. Here, we investigated the effects of maternal obesity on the hippocampal formation of offspring. Adult female mice were fed either a normal diet (ND, 4% fat) or a high-fat diet (HFD, 32% fat) 6 wk before mating and throughout pregnancy and the majority of lactation. We found that infants from HFD-fed dams (HFD offspring) showed obesity and hyperlipidemia during suckling. In HFD offspring, lipid peroxidation was promoted in serum and the hippocampal dentate gyrus, where neurogenesis takes place throughout postnatal life. Using a BrdU-pulse labeling study, we showed that malondialdehyde, a product of peroxidized lipids, reduced the proliferation of hippocampal progenitor cells in vitro and that neurogenesis in HFD offspring during postnatal development was similarly lowered relative to the ND animals. These results indicated that maternal obesity impairs hippocampal progenitor cell division and neuronal production in young offspring possibly due to metabolic and oxidative changes.-Tozuka, Y., Wada, E., Wada, K. Diet-induced obesity in female mice leads to peroxidized lipid accumulations and impairment of hippocampal neurogenesis during the early life of their offspring. FASEB J. 23, 1920-1934 (2009)	[Tozuka, Yusuke; Wada, Etsuko; Wada, Keiji] Natl Ctr Neurol & Psychiat, Dept Degenerat Neurol Dis, Natl Inst Neurosci, Tokyo 1878502, Japan; [Tozuka, Yusuke] Japan Assoc Adv Med Equipment, Tokyo, Japan; [Tozuka, Yusuke; Wada, Etsuko; Wada, Keiji] Japan Sci & Technol Agcy, Saitama, Japan	National Center for Neurology & Psychiatry - Japan; Japan Science & Technology Agency (JST)	Wada, K (corresponding author), Natl Ctr Neurol & Psychiat, Dept Degenerat Neurol Dis, Natl Inst Neurosci, 4-1-1 Ogawahigasi, Tokyo 1878502, Japan.	wada@ncnp.go.jp			Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Masayuki Sekiguchi (NCNP), Satoshi Nagamine (NCNP), Tomohiro Kabuta (NCNP), H. Akiko Popiel (NCNP), Daisuke Yamada (CNP), and Motoko Maekawa (RIKEN) for informative discussions and insightful comments. We are also grateful to Hisae Kikuchi ( NCNP), Mami Kumon (NCNP), and Noboru Ohsawa (Waseda University) for technical assistance. This work was supported in part by grants-in-aid for scientific research from the Ministry of Health, Labour and Welfare of Japan; grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; and a grant from the Japan Science and Technology Agency.	Andersen RE, 2000, CAN MED ASSOC J, V163, P1461; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Bick-Sander A, 2006, P NATL ACAD SCI USA, V103, P3852, DOI 10.1073/pnas.0502644103; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Casolini P, 2007, J NEUROSCI, V27, P7041, DOI 10.1523/JNEUROSCI.1074-07.2007; Cerf ME, 2005, AM J PHYSIOL-REG I, V288, pR1122, DOI 10.1152/ajpregu.00335.2004; Cetina I, 2008, CURR OPIN CLIN NUTR, V11, P297, DOI 10.1097/MCO.0b013e3282f795e6; Chan O, 2001, ENDOCRINOLOGY, V142, P4872, DOI 10.1210/en.142.11.4872; Chang GQ, 2008, J NEUROSCI, V28, P12107, DOI 10.1523/JNEUROSCI.2642-08.2008; CHAPMAN RH, 1979, DEV PSYCHOBIOL, V12, P255, DOI 10.1002/dev.420120309; Craciunescu CN, 2003, J NUTR, V133, P3614, DOI 10.1093/jn/133.11.3614; Cserjesi R, 2007, APPETITE, V49, P675, DOI 10.1016/j.appet.2007.04.001; DACOSTA THM, 1993, BIOCHEM J, V290, P557, DOI 10.1042/bj2900557; DelPrado M, 1997, J NUTR, V127, P458, DOI 10.1093/jn/127.3.458; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; Ferezou-Viala J, 2007, AM J PHYSIOL-REG I, V293, pR1056, DOI 10.1152/ajpregu.00117.2007; Fukuda S, 2003, J NEUROSCI, V23, P9357; Giedzinski E, 2005, RADIAT RES, V164, P540, DOI 10.1667/RR3369.1; Glenn MJ, 2007, EUR J NEUROSCI, V25, P2473, DOI 10.1111/j.1460-9568.2007.05505.x; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Herrera DG, 2003, P NATL ACAD SCI USA, V100, P7919, DOI 10.1073/pnas.1230907100; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Innis SM, 2005, PLACENTA, V26, pS70, DOI 10.1016/j.placenta.2005.01.005; Jones HN, 2007, PLACENTA, V28, P763, DOI 10.1016/j.placenta.2007.05.002; Jones HN, 2009, FASEB J, V23, P271, DOI 10.1096/fj.08-116889; Kabuta T, 2006, J BIOL CHEM, V281, P30524, DOI 10.1074/jbc.M603337200; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lee HH, 2006, BRAIN DEV-JPN, V28, P147, DOI 10.1016/j.braindev.2005.05.007; Limoli CL, 2004, RADIAT RES, V161, P17, DOI 10.1667/RR3112; Lindqvist A, 2006, EUR J NEUROL, V13, P1385, DOI 10.1111/j.1468-1331.2006.01500.x; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Maekawa M, 2005, GENES CELLS, V10, P1001, DOI 10.1111/j.1365-2443.2005.00893.x; Manganas LN, 2007, SCIENCE, V318, P980, DOI 10.1126/science.1147851; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; Mohn A, 2005, J CLIN ENDOCR METAB, V90, P2653, DOI 10.1210/jc.2004-2178; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Muhlhausler BS, 2006, FASEB J, V20, P1257, DOI 10.1096/fj.05-5241fje; NAEYE RL, 1990, AM J CLIN NUTR, V52, P273, DOI 10.1093/ajcn/52.2.273; NICHOLAS KR, 1991, COMP BIOCHEM PHYS A, V98, P535, DOI 10.1016/0300-9629(91)90443-G; Nishimoto M, 2007, GLIA, V55, P317, DOI 10.1002/glia.20461; Nixon K, 2004, J NEUROSCI, V24, P9714, DOI 10.1523/JNEUROSCI.3063-04.2004; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; OhkiHamazaki H, 1997, NATURE, V390, P165, DOI 10.1038/36568; Oike Y, 2005, NAT MED, V11, P400, DOI 10.1038/nm1214; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Sarafidis PA, 2007, J HUM HYPERTENS, V21, P12, DOI 10.1038/sj.jhh.1002103; Sava V, 2007, TOXICOL SCI, V98, P187, DOI 10.1093/toxsci/kfm093; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Shankar K, 2008, AM J PHYSIOL-REG I, V294, pR528, DOI 10.1152/ajpregu.00316.2007; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V291, pE792, DOI 10.1152/ajpendo.00078.2006; Stranahan AM, 2008, HIPPOCAMPUS, V18, P1085, DOI 10.1002/hipo.20470; Stranahan AM, 2008, NAT NEUROSCI, V11, P309, DOI 10.1038/nn2055; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Sun AY, 2001, J BIOMED SCI, V8, P37, DOI 10.1007/BF02255969; Tanaka Y, 2009, CEREB CORTEX, V19, P2181, DOI 10.1093/cercor/bhn238; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Tripathy D, 2003, DIABETES, V52, P2882, DOI 10.2337/diabetes.52.12.2882; Trottier G, 1998, ENDOCRINOLOGY, V139, P3704, DOI 10.1210/en.139.9.3704; Wong-Goodrich SJE, 2008, NEUROBIOL DIS, V30, P255, DOI 10.1016/j.nbd.2008.01.008; Wong-Goodrich SJE, 2008, BRAIN RES, V1237, P153, DOI 10.1016/j.brainres.2008.08.074; Woollett LA, 2005, AM J CLIN NUTR, V82, P1155, DOI 10.1093/ajcn/82.6.1155; Wu AG, 2004, EUR J NEUROSCI, V19, P1699, DOI 10.1111/j.1460-9568.2004.03246.x; Yamaguchi Y, 2006, NITRIC OXIDE-BIOL CH, V15, P380, DOI 10.1016/j.niox.2006.04.264; Yamato M, 2007, FEBS J, V274, P3855, DOI 10.1111/j.1742-4658.2007.05914.x; Yang JL, 2006, HIPPOCAMPUS, V16, P431, DOI 10.1002/hipo.20181; YOGMAN MW, 1985, AM J CLIN NUTR, V42, P352, DOI 10.1093/ajcn/42.2.352; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhang WJ, 2008, ACTA NEUROL SCAND, V117, P205, DOI 10.1111/j.1600-0404.2007.00928.x	76	126	129	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1920	1934		10.1096/fj.08-124784	http://dx.doi.org/10.1096/fj.08-124784			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19158155				2022-12-25	WOS:000266652400031
J	Halligan, KE; Jourd'heuil, FL; Jourd'heuil, D				Halligan, Katharine E.; Jourd'heuil, Frances L.; Jourd'heuil, David			Cytoglobin Is Expressed in the Vasculature and Regulates Cell Respiration and Proliferation via Nitric Oxide Dioxygenation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE GUANYLATE-CYCLASE; MITOCHONDRIAL RESPIRATION; HUMAN NEUROGLOBIN; CONSUMPTION; ACTIVATION; NO; SENSITIVITY; INHIBITION; MYOGLOBIN; PROTECTS	Disposition of the second messenger nitric oxide (NO) in mammalian tissues occurs through multiple pathways including dioxygenation by erythrocyte hemoglobin and red muscle myoglobin. Metabolism by a putative NO dioxygenase activity in non-striated tissues has also been postulated, but the exact nature of this activity is unknown. In the present study, we tested the hypothesis that cytoglobin, a newly discovered hexacoordinated globin, participates in cell-mediated NO consumption. Stable expression of small hairpin RNA targeting cytoglobin in fibroblasts resulted in decreased NO consumption and intracellular nitrate production. These cells were more sensitive to NO-induced inhibition of cell respiration and proliferation, which could be restored by re-expression of human cytoglobin. We also demonstrated cytoglobin expression in adventitial fibroblasts as well as vascular smooth muscle cells from various species including human and found that cytoglobin was expressed in the adventitia and media of intact rat aorta. These results indicate that cytoglobin contributes to cell-mediated NO dioxygenation and represents an important NO sink in the vascular wall.	[Halligan, Katharine E.; Jourd'heuil, Frances L.; Jourd'heuil, David] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA	Albany Medical College	Jourd'heuil, D (corresponding author), Albany Med Coll, Ctr Cardiovasc Sci, 47 New Scotland Ave MC8, Albany, NY 12208 USA.	jourdhd@mail.amc.edu		Jourd'heuil, David/0000-0002-6555-5061	National Institutes of Health [CA-89366]; NATIONAL CANCER INSTITUTE [R01CA089366] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-89366 from the NCI ( to D. J.). This work was also supported by Philip Morris USA, Inc. and Philip Morris International ( to D. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bellamy TC, 2002, J BIOL CHEM, V277, P31801, DOI 10.1074/jbc.M205936200; Borutaite V, 2001, AM J PHYSIOL-HEART C, V281, pH2256, DOI 10.1152/ajpheart.2001.281.6.H2256; Bove PF, 2006, FREE RADICAL BIO MED, V41, P515, DOI 10.1016/j.freeradbiomed.2006.05.011; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; CLARKSON RB, 1995, BBA-GEN SUBJECTS, V1243, P496, DOI 10.1016/0304-4165(94)00181-V; Coffey MJ, 2001, P NATL ACAD SCI USA, V98, P8006, DOI 10.1073/pnas.141136098; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; Fago A, 2004, J BIOL CHEM, V279, P44417, DOI 10.1074/jbc.M407126200; Feelisch M, 2002, FASEB J, V16, P1775, DOI 10.1096/fj.02-0363com; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; Gardner PR, 2006, J INORG BIOCHEM, V100, P542, DOI 10.1016/j.jinorgbio.2005.12.012; Gardner PR, 2001, FREE RADICAL BIO MED, V31, P191, DOI 10.1016/S0891-5849(01)00569-X; Godecke A, 2003, J BIOL CHEM, V278, P21761, DOI 10.1074/jbc.M302573200; Griffiths C, 2001, J PHYSIOL-LONDON, V536, P855, DOI 10.1111/j.1469-7793.2001.00855.x; Griffiths C, 2002, BIOCHEM J, V362, P459, DOI 10.1042/0264-6021:3620459; Hamdane D, 2003, J BIOL CHEM, V278, P51713, DOI 10.1074/jbc.M309396200; Jourd'heuil D, 2003, J BIOL CHEM, V278, P15720, DOI 10.1074/jbc.M300203200; Kawada N, 2001, J BIOL CHEM, V276, P25318, DOI 10.1074/jbc.M102630200; Kim-Shapiro DB, 2006, ARTERIOSCL THROM VAS, V26, P697, DOI 10.1161/01.ATV.0000204350.44226.9a; LANCASTER JR, 1994, P NATL ACAD SCI USA, V91, P8137, DOI 10.1073/pnas.91.17.8137; Liao JC, 1999, P NATL ACAD SCI USA, V96, P8757, DOI 10.1073/pnas.96.15.8757; Lu Q, 2007, J CELL PHYSIOL, V212, P827, DOI 10.1002/jcp.21079; Nakatani K, 2004, LAB INVEST, V84, P91, DOI 10.1038/labinvest.3700013; O'Donnell VB, 1999, J BIOL CHEM, V274, P20083, DOI 10.1074/jbc.274.29.20083; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Palacios-Callender M, 2007, P NATL ACAD SCI USA, V104, P18508, DOI 10.1073/pnas.0709440104; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Rodriguez-Juarez F, 2007, BIOCHEM J, V405, P223, DOI 10.1042/BJ20070033; Schmidt K, 2004, FEBS LETT, V577, P199, DOI 10.1016/j.febslet.2004.10.010; Schmidt M, 2004, J BIOL CHEM, V279, P8063, DOI 10.1074/jbc.M310540200; Schmidt M, 2005, NEUROSCI LETT, V374, P207, DOI 10.1016/j.neulet.2004.10.071; Shivapurkar N, 2008, CANCER RES, V68, P7448, DOI 10.1158/0008-5472.CAN-08-0565; Smagghe BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002039; Thomas DD, 2004, P NATL ACAD SCI USA, V101, P8894, DOI 10.1073/pnas.0400453101; Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.98.1.355; Torres J, 2000, FEBS LETT, V475, P263, DOI 10.1016/S0014-5793(00)01682-3; Trent JT, 2002, J BIOL CHEM, V277, P19538, DOI 10.1074/jbc.M201934200; Xu R, 2006, MOL THER, V13, P1093, DOI 10.1016/j.ymthe.2005.11.027; ZHAO XJ, 1995, BIOCHEM BIOPH RES CO, V212, P1054, DOI 10.1006/bbrc.1995.2076	39	83	88	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8539	8547		10.1074/jbc.M808231200	http://dx.doi.org/10.1074/jbc.M808231200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19147491	Green Published, hybrid			2022-12-25	WOS:000264397800038
J	Thoreen, CC; Kang, SA; Chang, JW; Liu, QS; Zhang, JM; Gao, Y; Reichling, LJ; Sim, TB; Sabatini, DM; Gray, NS				Thoreen, Carson C.; Kang, Seong A.; Chang, Jae Won; Liu, Qingsong; Zhang, Jianming; Gao, Yi; Reichling, Laurie J.; Sim, Taebo; Sabatini, David M.; Gray, Nathanael S.			An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR 4E-BINDING PROTEIN-1; CAP-DEPENDENT TRANSLATION; INITIATION-FACTOR 4E; KINASE-ACTIVITY; AMINO-ACIDS; EARLY G1; PHOSPHORYLATION; 4E-BP1; MEDIATE; COMPLEX	The mammalian target of rapamycin (mTOR) kinase is the catalytic subunit of two functionally distinct complexes, mTORC1 and mTORC2, that coordinately promote cell growth, proliferation, and survival. Rapamycin is a potent allosteric mTORC1 inhibitor with clinical applications as an immunosuppressant and anti-cancer agent. Here we find that Torin1, a highly potent and selective ATP-competitive mTOR inhibitor that directly inhibits both complexes, impairs cell growth and proliferation to a far greater degree than rapamycin. Surprisingly, these effects are independent of mTORC2 inhibition and are instead because of suppression of rapamycin-resistant functions of mTORC1 that are necessary for cap-dependent translation and suppression of autophagy. These effects are at least partly mediated by mTORC1-dependent and rapamycin-resistant phosphorylation of 4E-BP1. Our findings challenge the assumption that rapamycin completely inhibits mTORC1 and indicate that direct inhibitors of mTORC1 kinase activity may be more successful than rapamycin at inhibiting tumors that depend on mTORC1.	[Thoreen, Carson C.; Kang, Seong A.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Thoreen, Carson C.; Kang, Seong A.; Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Sabatini, David M.] MIT, Koch Ctr Integrat Canc Res, Cambridge, MA 02139 USA; [Chang, Jae Won; Liu, Qingsong; Zhang, Jianming; Sim, Taebo; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Dept Canc Biol,Dana Farber Canc Inst, Boston, MA 02115 USA; [Gao, Yi; Reichling, Laurie J.] Invitrogen Corp, Madison, WI 53719 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Thermo Fisher Scientific	Sabatini, DM (corresponding author), Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	Liu, Qingsong/AFS-0714-2022; Chang, Jae Won/AAN-4139-2020; 刘, 青松/AEM-1932-2022	Liu, Qingsong/0000-0002-7829-2547; 刘, 青松/0000-0002-7829-2547; Zhang, Jianming/0000-0001-6326-3906; /0000-0002-1446-7256	National Institutes of Health [R01 AI47389, R01 CA103866]; Dana Farber Cancer Institute; Barr Foundation; Damon Runyon Cancer Research Foundation; Keck Foundation; LAM Foundation; Department of Defense [W81XWH-07-1-0448]; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA129105, R01CA103866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Farber Cancer Institute; Barr Foundation; Damon Runyon Cancer Research Foundation; Keck Foundation(W.M. Keck Foundation); LAM Foundation; Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI47389 and R01 CA103866. This work was also supported by start-up funding from the Dana Farber Cancer Institute, the Barr Foundation, and the Damon Runyon Cancer Research Foundation (to N. S. G.), Keck Foundation, LAM Foundation, and Department of Defense Grant W81XWH-07-1-0448 (to D. M. S.), and a fellowship from the American Cancer Society (to S. A. K.).	ALBERS MW, 1993, J BIOL CHEM, V268, P22825; Ali SM, 2005, J BIOL CHEM, V280, P19445, DOI 10.1074/jbc.C500125200; Averous J, 2008, ONCOGENE, V27, P1106, DOI 10.1038/sj.onc.1210715; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Choi KM, 2003, J BIOL CHEM, V278, P19667, DOI 10.1074/jbc.M301142200; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Herbert TP, 2002, J BIOL CHEM, V277, P11591, DOI 10.1074/jbc.M110367200; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Jiang H, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-2; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Pedersen S, 1997, EUR J BIOCHEM, V247, P449, DOI 10.1111/j.1432-1033.1997.00449.x; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; ROSENWALD IB, 1993, MOL CELL BIOL, V13, P7358, DOI 10.1128/MCB.13.12.7358; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Sehgal SN, 2003, TRANSPLANT P, V35, p7S, DOI 10.1016/S0041-1345(03)00211-2; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Shor B, 2008, CANCER RES, V68, P2934, DOI 10.1158/0008-5472.CAN-07-6487; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Tee AR, 2002, MOL CELL BIOL, V22, P1674, DOI 10.1128/MCB.22.6.1674-1683.2002; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005	43	1322	1369	1	95	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8023	8032		10.1074/jbc.M900301200	http://dx.doi.org/10.1074/jbc.M900301200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19150980	Green Published, hybrid			2022-12-25	WOS:000264195600065
J	Contreras, X; Schweneker, M; Chen, CS; McCune, JM; Deeks, SG; Martin, J; Peterlin, BM				Contreras, Xavier; Schweneker, Marc; Chen, Ching-Shih; McCune, Joseph M.; Deeks, Steven G.; Martin, Jeffrey; Peterlin, B. Matija			Suberoylanilide Hydroxamic Acid Reactivates HIV from Latently Infected Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; HISTONE DEACETYLASE INHIBITORS; ACTIVE ANTIRETROVIRAL THERAPY; P-TEFB; HEXAMETHYLENE BISACETAMIDE; TERMINAL DOMAIN; 7SK SNRNP; IN-VIVO	Human immunodeficiency virus (HIV) persists in a latent form in infected individuals treated effectively with highly active antiretroviral therapy (HAART). In part, these latent proviruses account for the rebound in viral replication observed after treatment interruption. A major therapeutic challenge is to purge this reservoir. In this study, we demonstrate that suberoylanilide hydroxamic acid (SAHA) reactivates HIV from latency in chronically infected cell lines and primary cells. Indeed, P-TEFb, a critical transcription cofactor for HIV, is released and then recruited to the viral promoter upon stimulation with SAHA. The phosphatidylinositol 3-kinase/Akt pathway is involved in the initiation of these events. Using flow cytometry-based single cell analysis of protein phosphorylation, we demonstrate that SAHA activates this pathway in several subpopulations of T cells, including memory T cells that are the major viral reservoir in peripheral blood. Importantly, SAHA activates HIV replication in peripheral blood mononuclear cells from individuals treated effectively with HAART. Thus SAHA, which is a Food and Drug Administration-approved drug, might be considered to accelerate the decay of the latent reservoir in HAART-treated infected humans.	[Contreras, Xavier; Peterlin, B. Matija] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Schweneker, Marc; McCune, Joseph M.] Univ Calif San Francisco, Div Expt Med, San Francisco Gen Hosp, San Francisco, CA 94143 USA; [Deeks, Steven G.] Univ Calif San Francisco, Div HIV AIDS, San Francisco Gen Hosp, San Francisco, CA 94143 USA; [Martin, Jeffrey] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco Gen Hosp, San Francisco, CA 94143 USA; [Chen, Ching-Shih] Ohio State Univ, Coll Pharm, Div Med Chem, Columbus, OH 43210 USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University System of Ohio; Ohio State University	Peterlin, BM (corresponding author), Univ Calif San Francisco, Dept Med, 533 Parnassus Ave,Rm U432,Box 0703, San Francisco, CA 94143 USA.	matija.peterlin@ucsf.edu	contreras, xavier/ABA-3533-2020	contreras, xavier/0000-0003-0748-6923	National Institutes of Health [AI49104, AI058708, R01 AI40312, AI47062, DPI OD00329]; University of California, San Francisco; Center for AIDS Research Grants [P30 AI027763, P30 MH59037, CC99-SF-001]; Clinical and Translational Research Institute [UL1 RR024131]; National Institutes of Health Roadmap for Medical Research; California Foundation for AIDS Research; University-wide AIDS Research Program [F05-GI-219]; Burroughs Wellcome Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040312, R01AI047062, P01AI058708, P30AI027763, R01AI049104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH059037] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000329] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Francisco(University of California System); Center for AIDS Research Grants; Clinical and Translational Research Institute; National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Foundation for AIDS Research; University-wide AIDS Research Program; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants AI49104 and AI058708 ( to B. M. P.) and R01 AI40312 and AI47062 ( to J. M. M.). This work was also supported by the University of California, San Francisco, Center for AIDS Research Grants P30 AI027763, P30 MH59037, and CC99-SF-001 and the University of California, San Francisco, Clinical and Translational Research Institute Grant UL1 RR024131, a component of the National Institutes of Health Roadmap for Medical Research.; Supported by a grant from the California Foundation for AIDS Research.; Supported by the University-wide AIDS Research Program Grant F05-GI-219.; Recipient of National Institutes of Health Grant DPI OD00329 Director's Pioneer Award Program, part of the National Institutes of Health Roadmap for Medical Research) and the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research.	ANDREEFF M, 1992, BLOOD, V80, P2604; ANTONI BA, 1994, VIROLOGY, V202, P684, DOI 10.1006/viro.1994.1390; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Bark-Jones SJ, 2006, ONCOGENE, V25, P1775, DOI 10.1038/sj.onc.1209205; BEDNARIK DP, 1990, EMBO J, V9, P1157, DOI 10.1002/j.1460-2075.1990.tb08222.x; Casse C, 1999, J BIOL CHEM, V274, P16097, DOI 10.1074/jbc.274.23.16097; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Choudhary SK, 2008, J INFECT DIS, V197, P1162, DOI 10.1086/529525; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1999, NAT MED, V5, P651, DOI 10.1038/9498; CLOUSE KA, 1989, J IMMUNOL, V142, P431; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Contreras X, 2006, FUTURE VIROL, V1, P733, DOI 10.2217/17460794.1.6.733; Countryman JK, 2008, J VIROL, V82, P4706, DOI 10.1128/JVI.00116-08; Duvic M, 2007, BLOOD, V109, P31, DOI 10.1182/blood-2006-06-025999; Fantin VR, 2008, CANCER RES, V68, P3785, DOI 10.1158/0008-5472.CAN-07-6091; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; Ganesh L, 2003, NATURE, V426, P853, DOI 10.1038/nature02171; He NH, 2006, MOL CELL BIOL, V26, P7068, DOI 10.1128/MCB.00778-06; Ishida T, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-69; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Klichko V, 2006, J VIROL, V80, P4570, DOI 10.1128/JVI.80.9.4570-4579.2006; Korin YD, 2002, J VIROL, V76, P8118, DOI 10.1128/JVI.76.16.8118-8123.2002; Krueger BJ, 2008, NUCLEIC ACIDS RES, V36, P2219, DOI 10.1093/nar/gkn061; Kulkosky J, 2001, BLOOD, V98, P3006, DOI 10.1182/blood.V98.10.3006; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Lenasi T, 2008, CELL HOST MICROBE, V4, P123, DOI 10.1016/j.chom.2008.05.016; Li NN, 2008, P NATL ACAD SCI USA, V105, P4796, DOI 10.1073/pnas.0712051105; Li QT, 2005, J BIOL CHEM, V280, P28819, DOI 10.1074/jbc.M502712200; Liu Y, 2006, J BIOL CHEM, V281, P31359, DOI 10.1074/jbc.M604478200; Marcello A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-7; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Nunnari G, 2005, EXPERT OPIN BIOL TH, V5, P1421, DOI 10.1517/14712598.5.11.1421; PEREZ VL, 1991, J IMMUNOL, V147, P3145; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Rahmani M, 2003, ONCOGENE, V22, P6231, DOI 10.1038/sj.onc.1206646; Ramalingam SS, 2007, CLIN CANCER RES, V13, P3605, DOI 10.1158/1078-0432.CCR-07-0162; Richon VM, 1996, P NATL ACAD SCI USA, V93, P5705, DOI 10.1073/pnas.93.12.5705; Schweneker M, 2008, J IMMUNOL, V180, P6490, DOI 10.4049/jimmunol.180.10.6490; Scripture-Adams DD, 2002, J VIROL, V76, P13077, DOI 10.1128/JVI.76.24.13077-13082.2002; Sedaghat AR, 2008, P NATL ACAD SCI USA, V105, P4832, DOI 10.1073/pnas.0711372105; Siegel DS, 1998, P NATL ACAD SCI USA, V95, P162, DOI 10.1073/pnas.95.1.162; Stellbrink HJ, 2002, AIDS, V16, P1479, DOI 10.1097/00002030-200207260-00004; VLACH J, 1993, J GEN VIROL, V74, P2401, DOI 10.1099/0022-1317-74-11-2401; Wang FX, 2005, J CLIN INVEST, V115, P128, DOI 10.1172/JCI200522574; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yik JHN, 2005, J BIOL CHEM, V280, P16368, DOI 10.1074/jbc.M500912200	53	231	236	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6782	6789		10.1074/jbc.M807898200	http://dx.doi.org/10.1074/jbc.M807898200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19136668	Green Published, hybrid			2022-12-25	WOS:000263919000023
J	Curwin, AJ; Fairn, GD; McMaster, CR				Curwin, Amy J.; Fairn, Gregory D.; McMaster, Christopher R.			Phospholipid Transfer Protein Sec14 Is Required for Trafficking from Endosomes and Regulates Distinct trans-Golgi Export Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL-TRANSFER PROTEIN; SACCHAROMYCES-CEREVISIAE; BINDING-PROTEIN; GTPASE ARL3P; YEAST; COMPLEX; PHOSPHATIDYLCHOLINE; DOMAIN; MUTANTS; ACETYLATION	A protein known to regulate both lipid metabolism and vesicular transport is the phosphatidylcholine/phosphatidylinositol transfer protein Sec14 of Saccharomyces cerevisiae. Sec14 is thought to globally affect secretion from the trans-Golgi. The results from a synthetic genetic array screen for genes whose inactivation impaired growth of cells with a temperature-sensitive SEC14 allele implied Sec14 regulates transport into and out of the Golgi. This prompted us to examine the role of Sec14 in various vesicular transport pathways. We determined that Sec14 function was required for the route followed by Bgl2, whereas trafficking of other secreted proteins, including Hsp150, Cts1, Scw4, Scw10, Exg1, Cis3, and Ygp1, still occurred, indicating Sec14 regulates specific trans-Golgi export pathways. Upon diminution of Sec14 function, the v-SNARE Snc1 accumulated in endosomes and the trans-Golgi. Its accumulation in endosomes is consistent with Sec14 being required for transport from endosomes to the trans-Golgi. Sec14 was also required for trafficking of Ste3 and the lipophilic dye FM4-64 from the plasma membrane to the vacuole at the level of the endosome. The combined genetic and cell biology data are consistent with regulation of endosome trafficking being a major role for Sec14. We further determined that lipid ligand occupancy differentially regulates Sec14 functions.	[McMaster, Christopher R.] Dalhousie Univ, Atlantic Res Ctr, Dept Pediat, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Atlantic Res Ctr, Dept Biochem & Mol Biol, Halifax, NS B3H 4H7, Canada	Dalhousie University; Dalhousie University	McMaster, CR (corresponding author), Dalhousie Univ, Atlantic Res Ctr, Dept Pediat, Halifax, NS B3H 4H7, Canada.	christopher.mcmaster@dal.ca	Curwin, Amy/O-8816-2015	Curwin, Amy/0000-0003-1086-2483; McMaster, Christopher/0000-0003-0822-5776; Fairn, Greg/0000-0001-6508-168X	Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes for Health Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BANKAITIS VA, 1989, J CELL BIOL, V108, P1271, DOI 10.1083/jcb.108.4.1271; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Behnia R, 2004, NAT CELL BIOL, V6, P405, DOI 10.1038/ncb1120; Cai HQ, 2005, J CELL BIOL, V171, P823, DOI 10.1083/jcb.200505145; Chang HJ, 2002, GENETICS, V162, P29; Chen LY, 2000, J CELL BIOL, V151, P731, DOI 10.1083/jcb.151.3.731; Chen SH, 2005, MOL BIOL CELL, V16, P178, DOI 10.1091/mbc.E04-03-0258; CLEVES AE, 1991, CELL, V64, P789, DOI 10.1016/0092-8674(91)90508-V; Curwin AJ, 2008, FUTURE LIPIDOL, V3, P399, DOI 10.2217/17460875.3.4.399; D'Angelo I, 2006, EMBO REP, V7, P174, DOI 10.1038/sj.embor.7400602; de Graaf P, 2004, MOL BIOL CELL, V15, P2038, DOI 10.1091/mbc.E03-12-0862; Demmel L, 2008, MOL BIOL CELL, V19, P1991, DOI 10.1091/mbc.E06-10-0937; Fairn GD, 2005, METHODS, V36, P102, DOI 10.1016/j.ymeth.2004.11.005; Fairn GD, 2007, P NATL ACAD SCI USA, V104, P15352, DOI 10.1073/pnas.0705571104; Fernandez JP, 2005, J BIOL CHEM, V280, P8544, DOI 10.1074/jbc.M413999200; Goldstein A, 1975, Methods Enzymol, V42, P504; Gurunathan S, 2002, EMBO J, V21, P602, DOI 10.1093/emboj/21.4.602; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Harsay E, 2002, J CELL BIOL, V156, P271, DOI 10.1083/jcb.200109077; Henneberry AL, 2001, MOL BIOL CELL, V12, P511, DOI 10.1091/mbc.12.3.511; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kostenko EV, 2005, J BIOL CHEM, V280, P2807, DOI 10.1074/jbc.M411139200; Kozminski KG, 2006, TRAFFIC, V7, P1224, DOI 10.1111/j.1600-0854.2006.00467.x; Lafourcade C, 2004, MOL CELL BIOL, V24, P3815, DOI 10.1128/MCB.24.9.3815-3826.2004; Li XM, 2002, J CELL BIOL, V157, P63, DOI 10.1083/jcb.200201037; Liang Y, 2007, MOL BIOL CELL, V18, P2533, DOI 10.1091/mbc.e07-03-0221; Lustgarten V, 1999, MOL CELL BIOL, V19, P4480; Morozova N, 2006, NAT CELL BIOL, V8, P1263, DOI 10.1038/ncb1489; Mousley CJ, 2007, BBA-MOL CELL BIOL L, V1771, P727, DOI 10.1016/j.bbalip.2007.04.002; Panic B, 2003, CURR BIOL, V13, P405, DOI 10.1016/S0960-9822(03)00091-5; PattonVogt JL, 1997, J BIOL CHEM, V272, P20873, DOI 10.1074/jbc.272.33.20873; Phillips SE, 2006, CRIT REV BIOCHEM MOL, V41, P21, DOI 10.1080/10409230500519573; Phillips SE, 1999, MOL CELL, V4, P187, DOI 10.1016/S1097-2765(00)80366-4; Reggiori F, 2003, J BIOL CHEM, V278, P5009, DOI 10.1074/jbc.M210436200; Robinson M, 2006, MOL BIOL CELL, V17, P1845, DOI 10.1091/mbc.E05-09-0832; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Sciorra VA, 2005, MOL BIOL CELL, V16, P776, DOI 10.1091/mbc.e04-08-0700; Setty SRG, 2004, NAT CELL BIOL, V6, P414, DOI 10.1038/ncb1121; Sha BD, 1998, NATURE, V391, P506, DOI 10.1038/35179; Sirokmany G, 2006, J BIOL CHEM, V281, P6096, DOI 10.1074/jbc.M510619200; SKINNER HB, 1995, P NATL ACAD SCI USA, V92, P112, DOI 10.1073/pnas.92.1.112; Sreenivas A, 1998, J BIOL CHEM, V273, P16635, DOI 10.1074/jbc.273.27.16635; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Ueda S, 2004, CELL SIGNAL, V16, P899, DOI 10.1016/j.cellsig.2004.01.007; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Welti S, 2007, J MOL BIOL, V366, P551, DOI 10.1016/j.jmb.2006.11.055; Xie ZG, 1998, P NATL ACAD SCI USA, V95, P12346, DOI 10.1073/pnas.95.21.12346; Xie ZH, 2001, MOL BIOL CELL, V12, P1117, DOI 10.1091/mbc.12.4.1117	50	56	56	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7364	7375		10.1074/jbc.M808732200	http://dx.doi.org/10.1074/jbc.M808732200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19129178	Green Published, hybrid			2022-12-25	WOS:000263919000082
J	Park, SW; Liu, PP; Forouhar, F; Vlot, AC; Tong, L; Tietjen, K; Klessig, DF				Park, Sang-Wook; Liu, Po-Pu; Forouhar, Farhad; Vlot, A. Corina; Tong, Liang; Tietjen, Klaus; Klessig, Daniel F.			Use of a Synthetic Salicylic Acid Analog to Investigate the Roles of Methyl Salicylate and Its Esterases in Plant Disease Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; TOBACCO-MOSAIC-VIRUS; ARABIDOPSIS-THALIANA; INNATE IMMUNITY; TRANSLOCATED SIGNAL; PATHOGEN RESISTANCE; BINDING PROTEIN-2; JASMONIC ACID; DEFENSE; INDUCTION	We previously demonstrated that salicylic acid-binding protein 2 (SABP2) of tobacco is an integral component of systemic acquired resistance (SAR). SABP2 is a methyl salicylate (MeSA) esterase that has high affinity for SA, which feedback inhibits its esterase activity. MeSA esterase activity is required in distal, healthy tissue of pathogen-infected plants to hydrolyze MeSA, which functions as a long-distance, phloem-mobile SAR signal; this hydrolysis releases the biologically active defense hormone SA. In this study, we examined the inhibitory interaction of SA with SABP2, and identified a synthetic SA analog, 2,2,2,2'-tetra-fluoroacetophenone (tetraFA) that, like SA, competitively inhibits the activity of SABP2 and targets esterases, which utilize MeSA as a substrate. However, in contrast to SA, tetraFA does not induce downstream defense responses and, therefore, is effective in planta at blocking SAR development in tobacco mosaic virus (TMV)-infected tobacco and Pseudomonas syringae-infected Arabidopsis. These results confirm the importance of SABP2 and MeSA for SAR development in tobacco and establish similar roles for MeSA and the orthologs of SABP2 in Arabidopsis. Moreover, they demonstrate that tetraFA can be used to determine whether MeSA and its corresponding esterase(s) play a role in SAR signaling in other plant species. In planta analyses using tetraFA, in conjunction with leaf detachment assays and MeSA quantification, were used to assess the kinetics with which MeSA is generated in pathogen-infected leaves, transmitted through the phloem, and processed in the distal healthy leaves. In TMV-infected tobacco, these studies revealed that critical amounts of MeSA are generated, transmitted, and processed between 48 and 72 h post primary infection.	[Park, Sang-Wook; Liu, Po-Pu; Vlot, A. Corina; Klessig, Daniel F.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Forouhar, Farhad; Tong, Liang] Columbia Univ, NE Struct Genom Consortium, Dept Biol Sci, New York, NY 10027 USA; [Tietjen, Klaus] Bayer Crop Sci, Aktiengesell R F BF, D-40764 Monheim, Germany	Cornell University; Boyce Thompson Institute for Plant Research; Columbia University; Bayer AG; Bayer CropScience	Klessig, DF (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	dfk8@cornell.edu	Bruening, Stefan/B-8505-2011; Vlot-Schuster, Corina/M-7351-2014	Vlot-Schuster, Corina/0000-0002-8146-6018; Tong, Liang/0000-0002-0563-6468	National Institutes of Health [P50 GM62413]; National Science Foundation [IOS-0525360]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM062413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant Protein Structure Initiative P50 GM62413 ( to L. T.). This work was also supported by National Science Foundation Grant IOS-0525360 ( to D. F. K.).	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Ament K, 2004, PLANT PHYSIOL, V135, P2025, DOI 10.1104/pp.104.048694; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chaturvedi R, 2008, PLANT J, V54, P106, DOI 10.1111/j.1365-313X.2007.03400.x; CHEN ZX, 1993, SCIENCE, V262, P1883, DOI 10.1126/science.8266079; Cui J, 2005, P NATL ACAD SCI USA, V102, P1791, DOI 10.1073/pnas.0409450102; de Torres-Zabala M, 2007, EMBO J, V26, P1434, DOI 10.1038/sj.emboj.7601575; DEAN RA, 1986, PHYTOPATHOLOGY, V76, P966, DOI 10.1094/Phyto-76-966; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Dempsey DA, 1999, CRIT REV PLANT SCI, V18, P547, DOI 10.1080/07352689991309397; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Du H, 1997, PLANT PHYSIOL, V113, P1319, DOI 10.1104/pp.113.4.1319; Dudareva N, 1998, PLANT PHYSIOL, V116, P599, DOI 10.1104/pp.116.2.599; DURNER J, 1995, P NATL ACAD SCI USA, V92, P11312, DOI 10.1073/pnas.92.24.11312; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; ENYEDI AJ, 1992, P NATL ACAD SCI USA, V89, P2480, DOI 10.1073/pnas.89.6.2480; Forouhar F, 2005, P NATL ACAD SCI USA, V102, P1773, DOI 10.1073/pnas.0409227102; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; GILLESPIE RJ, 1992, INORG CHEM, V31, P1960, DOI 10.1021/ic00036a045; Guo AL, 2000, PLANT J, V21, P409, DOI 10.1046/j.1365-313x.2000.00692.x; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; JENNS AE, 1979, PHYTOPATHOLOGY, V69, P753, DOI 10.1094/Phyto-69-753; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Koo YJ, 2007, PLANT MOL BIOL, V64, P1, DOI 10.1007/s11103-006-9123-x; Kumar D, 2003, P NATL ACAD SCI USA, V100, P16101, DOI 10.1073/pnas.0307162100; Maldonado AM, 2002, NATURE, V419, P399, DOI 10.1038/nature00962; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Nandi A, 2004, PLANT CELL, V16, P465, DOI 10.1105/tpc.016907; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Pallas JA, 1996, PLANT J, V10, P281, DOI 10.1046/j.1365-313X.1996.10020281.x; Park SW, 2007, SCIENCE, V318, P113, DOI 10.1126/science.1147113; Seskar M, 1998, PLANT PHYSIOL, V116, P387, DOI 10.1104/pp.116.1.387; Shulaev V, 1997, NATURE, V385, P718, DOI 10.1038/385718a0; SHULAEV V, 1995, PLANT CELL, V7, P1691, DOI 10.1105/tpc.7.10.1691; Slaymaker DH, 2002, P NATL ACAD SCI USA, V99, P11640, DOI 10.1073/pnas.182427699; Truman W, 2007, P NATL ACAD SCI USA, V104, P1075, DOI 10.1073/pnas.0605423104; VERNOOIJ B, 1994, PLANT CELL, V6, P959, DOI 10.1105/tpc.6.7.959; Vlot AC, 2008, PLANT J, V56, P445, DOI 10.1111/j.1365-313X.2008.03618.x; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; YALPANI N, 1991, PLANT CELL, V3, P809, DOI 10.1105/tpc.3.8.809; Yang Y, 2008, PLANT PHYSIOL, V147, P1034, DOI 10.1104/pp.108.118224	44	68	75	2	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7307	7317		10.1074/jbc.M807968200	http://dx.doi.org/10.1074/jbc.M807968200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19131332	Green Published, hybrid			2022-12-25	WOS:000263919000077
J	Rigutto, S; Hoste, C; Grasberger, H; Milenkovic, M; Communi, D; Dumont, JE; Corvilain, B; Miot, F; De Deken, X				Rigutto, Sabrina; Hoste, Candice; Grasberger, Helmut; Milenkovic, Milutin; Communi, David; Dumont, Jacques E.; Corvilain, Bernard; Miot, Francoise; De Deken, Xavier			Activation of Dual Oxidases Duox1 and Duox2 DIFFERENTIAL REGULATION MEDIATED BY cAMP-DEPENDENT PROTEIN KINASE AND PROTEIN KINASE C-DEPENDENT PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN THYROID-CELLS; CONGENITAL HYPOTHYROIDISM; NADPH OXIDASE; HYDROGEN-PEROXIDE; H2O2-GENERATING SYSTEM; MATURATION FACTOR; H2O2 GENERATION; TSH RECEPTOR; GENE; MUTATIONS	Dual oxidases were initially identified as NADPH oxidases producing H2O2 necessary for thyroid hormone biosynthesis. The crucial role of Duox2 has been demonstrated in patients suffering from partial iodide organification defect caused by bi-allelic mutations in the DUOX2 gene. However, the Duox1 function in thyroid remains elusive. We optimized a functional assay by co-expressing Duox1 or Duox2 with their respective maturation factors, DuoxA1 and DuoxA2, to compare their intrinsic enzymatic activities under stimulation of the major signaling pathways active in the thyroid in relation to their membrane expression. We showed that basal activity of both Duox isoenzymes depends on calcium and functional EF-hand motifs. However, the two oxidases are differentially regulated by activation of intracellular signaling cascades. Duox1 but not Duox2 activity is stimulated by forskolin (EC50 = 0.1 mu M) via protein kinase A-mediated Duox1 phosphorylation on serine 955. In contrast, phorbol esters induce Duox2 phosphorylation via protein kinase C activation associated with high H2O2 generation (phorbol 12-myristate 13-acetate EC50 = 0.8 nM). These results were confirmed in human thyroid cells, suggesting that Duox1 is also involved in thyroid hormonogenesis. Our data provide, for the first time, detailed insights into the mechanisms controlling the activation of Duox1-2 proteins and reveal additional phosphorylation-mediated regulation.	[Rigutto, Sabrina; Hoste, Candice; Milenkovic, Milutin; Communi, David; Dumont, Jacques E.; Corvilain, Bernard; Miot, Francoise; De Deken, Xavier] Univ Libre Bruxelles, IRIBHM, Hop Erasme, B-1070 Brussels, Belgium; [Corvilain, Bernard] Univ Libre Bruxelles, Dept Endocrinol, Hop Erasme, B-1070 Brussels, Belgium; [Grasberger, Helmut] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Chicago	Rigutto, S (corresponding author), Univ Libre Bruxelles, IRIBHM, Campus Erasme,Bat C,808 Route Lenn, B-1070 Brussels, Belgium.	sabrina.rigutto@ulb.ac.be	Grasberger, Helmut/C-4148-2015	Grasberger, Helmut/0000-0002-4065-4418	Fonds National pour la Recherche Medicale; Actions de Recherches Concertees de la Communaute Francaise de Belgique; Fonds National de la Recherche Scientifique; Fondation Van Buren; Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture; Cancer Research Foundation; American Thyroid Association	Fonds National pour la Recherche Medicale(Fonds de la Recherche Scientifique - FNRS); Actions de Recherches Concertees de la Communaute Francaise de Belgique; Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Fondation Van Buren; Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture(Fonds de la Recherche Scientifique - FNRS); Cancer Research Foundation; American Thyroid Association	This work was supported by the "Fonds National pour la Recherche Medicale," "Actions de Recherches Concertees de la Communaute Francaise de Belgique," the "Fonds National de la Recherche Scientifique," and the Fondation Van Buren.; Recipients of a fellowship from the "Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture."; Recipient of research grants from the Cancer Research Foundation and the American Thyroid Association.	ALLGEIER A, 1994, J BIOL CHEM, V269, P13733; Ameziane-El-Hassani R, 2005, J BIOL CHEM, V280, P30046, DOI 10.1074/jbc.M500516200; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Banfi B, 2004, J BIOL CHEM, V279, P46065, DOI 10.1074/jbc.M403046200; Banfi B, 2004, J BIOL CHEM, V279, P18583, DOI 10.1074/jbc.M310268200; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; BENARD B, 1971, UNION MED CAN, V100, P701; BUCHLER W, 1990, EUR J BIOCHEM, V188, P253, DOI 10.1111/j.1432-1033.1990.tb15397.x; Cheng GJ, 2004, J BIOL CHEM, V279, P34250, DOI 10.1074/jbc.M400660200; CORVILAIN B, 1994, J CLIN ENDOCR METAB, V79, P152, DOI 10.1210/jc.79.1.152; CORVILAIN B, 1991, ENDOCRINOLOGY, V128, P779, DOI 10.1210/endo-128-2-779; DARCANGELO D, 1995, J CLIN ENDOCR METAB, V80, P1136, DOI 10.1210/jc.80.4.1136; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; De Deken X, 2002, EXP CELL RES, V273, P187, DOI 10.1006/excr.2001.5444; Dumont J E, 1971, Vitam Horm, V29, P287; DUPUY C, 1989, EUR J BIOCHEM, V185, P597, DOI 10.1111/j.1432-1033.1989.tb15155.x; DUPUY C, 1986, BIOCHEM BIOPH RES CO, V141, P839, DOI 10.1016/S0006-291X(86)80249-2; DUPUY C, 1988, FEBS LETT, V233, P74, DOI 10.1016/0014-5793(88)81358-9; Dupuy C, 1999, J BIOL CHEM, V274, P37265, DOI 10.1074/jbc.274.52.37265; DUPUY C, 1991, J BIOL CHEM, V266, P3739; El Hassani RA, 2005, AM J PHYSIOL-GASTR L, V288, pG933, DOI 10.1152/ajpgi.00198.2004; Geiszt M, 2003, J BIOL CHEM, V278, P20006, DOI 10.1074/jbc.M301289200; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Grasberger H, 2007, MOL ENDOCRINOL, V21, P1408, DOI 10.1210/me.2007-0018; Grasberger H, 2006, J BIOL CHEM, V281, P18269, DOI 10.1074/jbc.C600095200; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Jagnandan D, 2007, J BIOL CHEM, V282, P6494, DOI 10.1074/jbc.M608966200; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Luxen S, 2008, CANCER RES, V68, P1037, DOI 10.1158/0008-5472.CAN-07-5782; Maruo Y, 2008, J CLIN ENDOCR METAB, V93, P4261, DOI 10.1210/jc.2008-0856; MINAMIDE LS, 1990, ANAL BIOCHEM, V190, P66, DOI 10.1016/0003-2697(90)90134-U; Moreno JC, 2002, NEW ENGL J MED, V347, P95, DOI 10.1056/NEJMoa012752; Moreno Jose C., 2007, V10, P99, DOI 10.1159/000106822; NUNEZ J, 1982, VITAM HORM, V39, P175, DOI 10.1016/S0083-6729(08)61137-1; Ohye H, 2008, THYROID, V18, P561, DOI 10.1089/thy.2007.0258; Pachucki J, 2004, MOL CELL ENDOCRINOL, V214, P53, DOI 10.1016/j.mce.2003.11.026; Pacquelet S, 2008, J BIOL CHEM, V283, P24649, DOI 10.1074/jbc.M709108200; Pfarr N, 2006, CLIN ENDOCRINOL, V65, P810, DOI 10.1111/j.1365-2265.2006.02672.x; RASPE E, 1991, MOL CELL ENDOCRINOL, V81, P175, DOI 10.1016/0303-7207(91)90216-F; Rigutto S, 2007, EXP CELL RES, V313, P3892, DOI 10.1016/j.yexcr.2007.06.011; ROGER P, 1988, J CLIN ENDOCR METAB, V66, P1158, DOI 10.1210/jcem-66-6-1158; ROGER PP, 1982, MOL CELL ENDOCRINOL, V26, P165, DOI 10.1016/0303-7207(82)90014-4; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200; UHLER MD, 1987, J BIOL CHEM, V262, P15202; Varela V, 2006, CLIN CHEM, V52, P182, DOI 10.1373/clinchem.2005.058321; Vassart G, 1995, ANN NY ACAD SCI, V766, P23, DOI 10.1111/j.1749-6632.1995.tb26645.x; Vigone Maria Cristina, 2005, Hum Mutat, V26, P395; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; Zamproni I, 2008, J CLIN ENDOCR METAB, V93, P605, DOI 10.1210/jc.2007-2020	51	156	159	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6725	6734		10.1074/jbc.M806893200	http://dx.doi.org/10.1074/jbc.M806893200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19144650	hybrid, Green Published			2022-12-25	WOS:000263919000017
J	Hakim, O; John, S; Ling, JQ; Biddie, SC; Hoffman, AR; Hager, GL				Hakim, Ofir; John, Sam; Ling, Jian Qun; Biddie, Simon C.; Hoffman, Andrew R.; Hager, Gordon L.			Glucocorticoid Receptor Activation of the Ciz1-Lcn2 Locus by Long Range Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLOBIN GENE; NUCLEAR-ORGANIZATION; CHROMATIN; GENOME; EXPRESSION; MECHANISMS; REVEALS; SITES; CELLS	The cellular response to glucocorticoid receptor (GR) activation involves a highly orchestrated series of regulatory actions influenced at multiple levels by a variety of mechanisms including the action of transcription factors and chromatin modifiers. Because the majority of GR binding sites (glucocorticoid-responsive elements (GREs)) are distant from promoters, it is likely that interactions at a distance play an important role in GR action. To determine whether long range chromosomal associations play a role in transcription regulation by GR, we utilized a chromosome conformation capture-based technique (associated chromosome trap) to identify unknown, remote sequences that interact with the GR-induced Lipocalin2 (Lcn2) gene. Our screen revealed that the Lcn2 GRE interacts with the Ciz1 gene, nearly 30 kb upstream. Ciz1 was subsequently found to be a novel GR-responsive gene. The GRE proximal to the Lcn2 promoter apparently functions to regulate both the Lcn2 gene and the distal Ciz1 gene. Using quantitative chromosome conformation capture, we find that a loop structure is organized between these two genes. This structure is hormone-independent and present only in cell types where the genes are active. The strong correlation between gene expression and loop structure in different cell lines suggests that high order interactions play a role in determining tissue-specific gene regulation.	[Hakim, Ofir; John, Sam; Biddie, Simon C.; Hager, Gordon L.] NCI, LRBGE, NIH, Bethesda, MD 20892 USA; [Ling, Jian Qun; Hoffman, Andrew R.] Palo Alto Hlth Care Syst, Dept Vet Affairs, Palo Alto, CA 94304 USA; [Ling, Jian Qun; Hoffman, Andrew R.] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Hager, GL (corresponding author), NCI, LRBGE, NIH, Bldg 41,B602, Bethesda, MD 20892 USA.	hagerg@exchange.nih.gov	Hakim, Ofir/A-6239-2012	Hakim, Ofir/0000-0003-0063-2721; Biddie, Simon/0000-0002-8253-0253	National Institutes of Health; NCI; Center for Cancer Research; NATIONAL CANCER INSTITUTE [Z01BC005450, ZIABC005450, ZIABC010027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by a National Institutes of Health grant from the Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research.	BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Fraser P, 2006, CURR OPIN GENET DEV, V16, P490, DOI 10.1016/j.gde.2006.08.002; Gao H, 2008, MOL ENDOCRINOL, V22, P10, DOI 10.1210/me.2007-0121; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Hager GL, 2004, BBA-GENE STRUCT EXPR, V1677, P46, DOI 10.1016/j.bbaexp.2003.09.016; HANKINSON O, 1979, P NATL ACAD SCI USA, V76, P373, DOI 10.1073/pnas.76.1.373; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; JOHN S, 2009, ENDOCRINOLO IN PRESS; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Johnson TA, 2008, MOL BIOL CELL, V19, P3308, DOI 10.1091/mbc.E08-02-0123; Ling JQ, 2007, PEDIATR RES, V61, p11R, DOI 10.1203/pdr.0b013e31804575db; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Magee JA, 2006, ENDOCRINOLOGY, V147, P590, DOI 10.1210/en.2005-1001; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Muller WG, 2007, J CELL BIOL, V177, P957, DOI 10.1083/jcb.200703157; RICHARDSON UI, 1981, ENDOCRINOLOGY, V108, P281, DOI 10.1210/endo-108-1-281; Schoneveld OJLM, 2004, BBA-GENE STRUCT EXPR, V1680, P114, DOI 10.1016/j.bbaexp.2004.09.004; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Voss TC, 2006, MOL ENDOCRINOL, V20, P2641, DOI 10.1210/me.2006-0091; Walker D, 1999, METHODS, V19, P386, DOI 10.1006/meth.1999.0874; WASYLYK B, 1983, CELL, V32, P503, DOI 10.1016/0092-8674(83)90470-1; Wurtele H, 2006, CHROMOSOME RES, V14, P477, DOI 10.1007/s10577-006-1075-0; Xu M, 2008, J CELL BIOL, V181, P615, DOI 10.1083/jcb.200710053; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891; 2007, CURR OPIN GENET DEV, V17, P456; 2007, CURR OPIN CELL BIOL, V19, P317	35	56	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6048	6052		10.1074/jbc.C800212200	http://dx.doi.org/10.1074/jbc.C800212200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19124469	Green Published, hybrid			2022-12-25	WOS:000263742700006
J	Silva, JP; Lelianova, V; Hopkins, C; Volynski, KE; Ushkaryov, Y				Silva, John-Paul; Lelianova, Vera; Hopkins, Colin; Volynski, Kirill E.; Ushkaryov, Yuri			Functional Cross-interaction of the Fragments Produced by the Cleavage of Distinct Adhesion G-protein-coupled Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-LATROTOXIN-BINDING; CHONDROITIN SULFATE; STORED CA2+; HUMAN EMR2; GPS MOTIF; CD97; LATROPHILIN; EXPRESSION; FAMILY; EXOCYTOSIS	The unusual adhesion G-protein-coupled receptors (aGPCRs) contain large extracellular N-terminal domains, which resemble cell-adhesion receptors, and C-terminal heptahelical domains, which may couple to G-proteins. These receptors are cleaved post-translationally between these domains into two fragments (NTF and CTF). Using the aGPCR latrophilin 1, we previously demonstrated that the fragments behave as independent cell-surface proteins. Upon binding the agonist, alpha-latrotoxin (LTX), latrophilin fragments reassemble and induce intracellular signaling. Our observations raised important questions: is the aGPCR signaling mediated by reassembled fragments or by any non-cleaved receptors? Also, can the fragments originating from distinct aGPCRs form hybrid complexes? To answer these questions, we created two types of chimerical constructs. One contained the CTF of latrophilin joined to the NTF of another aGPCR, EMR2; the resulting protein did not bind LTX but, similar to latrophilin, could couple to G-proteins. In another construct, the NTF of latrophilin was fused with the C terminus of neurexin; this chimera bound LTX but could not signal via G-proteins. Both constructs were efficiently cleaved in cells. When the two constructs were co-expressed, their fragments could cross-interact, as shown by immunoprecipitation. Furthermore, LTXN4C induced intracellular Ca2+ signaling only in cells expressing both constructs but not each individual construct. Finally, we demonstrated that fragments of unrelated aGPCRs can be cross-immunoprecipitated from live tissues. Thus, (i) aGPCR fragments behave as independent proteins, (ii) the complementary fragments from distinct aGPCRs can cross-interact, and (iii) these cross-complexes are functionally active. This unusual cross-assembly of aGPCR fragments could couple cell-surface interactions to multiple signaling pathways.	[Silva, John-Paul; Lelianova, Vera; Hopkins, Colin; Volynski, Kirill E.; Ushkaryov, Yuri] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London SW7 2AZ, England	Imperial College London	Ushkaryov, Y (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Exhibit Rd, London SW7 2AZ, England.	y.ushkaryov@imperial.ac.uk	Ushkaryov, Yuri/AAQ-2985-2020	Ushkaryov, Yuri/0000-0002-5712-8297; Volynski, Kirill/0000-0001-8208-1905	The Wellcome Trust [GR074359]; Biotechnology and Biological Sciences Research Council [BB/D523078]; MRC [G0600089] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D523078/1] Funding Source: researchfish; Medical Research Council [G0600089] Funding Source: researchfish	The Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by project grants from The Wellcome Trust (Grant GR074359) and the Biotechnology and Biological Sciences Research Council ( Grant BB/D523078) ( to Y. U. and C. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ashton AC, 2001, J BIOL CHEM, V276, P44695, DOI 10.1074/jbc.M108088200; BAUD V, 1995, GENOMICS, V26, P334, DOI 10.1016/0888-7543(95)80218-B; Bjarnadottir TK, 2007, CELL MOL LIFE SCI, V64, P2104, DOI 10.1007/s00018-007-7067-1; Capogna M, 2003, J NEUROSCI, V23, P4044; Chang GW, 2003, FEBS LETT, V547, P145, DOI 10.1016/S0014-5793(03)00695-1; Davies JQ, 2007, J BIOL CHEM, V282, P27343, DOI 10.1074/jbc.M704096200; Davletov BA, 1998, EMBO J, V17, P3909, DOI 10.1093/emboj/17.14.3909; Davletov BA, 1996, J BIOL CHEM, V271, P23239, DOI 10.1074/jbc.271.38.23239; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gray JX, 1996, J IMMUNOL, V157, P5438; Haitina T, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-43; HAMANN J, 1995, J IMMUNOL, V155, P1942; Hamann J, 1998, EUR J IMMUNOL, V28, P1701, DOI 10.1002/(SICI)1521-4141(199805)28:05<1701::AID-IMMU1701>3.0.CO;2-2; Hamann J, 1996, J EXP MED, V184, P1185, DOI 10.1084/jem.184.3.1185; Hayflick JS, 2000, J RECEPT SIGNAL TR R, V20, P119, DOI 10.3109/10799890009150640; Huang Y, 2008, MOL CELL BIOCHEM, V308, P133, DOI 10.1007/s11010-007-9621-4; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Krasnoperov V, 2002, J BIOL CHEM, V277, P46518, DOI 10.1074/jbc.M206415200; Krasnoperov V, 1999, J BIOL CHEM, V274, P3590, DOI 10.1074/jbc.274.6.3590; Krasnoperov VG, 1997, NEURON, V18, P925, DOI 10.1016/S0896-6273(00)80332-3; Kwakkenbos MJ, 2005, J LEUKOCYTE BIOL, V77, P112, DOI 10.1189/jlb.0704402; Lelianova VG, 1997, J BIOL CHEM, V272, P21504, DOI 10.1074/jbc.272.34.21504; Lin HH, 2004, J BIOL CHEM, V279, P31823, DOI 10.1074/jbc.M402974200; Lin HH, 2000, GENOMICS, V67, P188, DOI 10.1006/geno.2000.6238; Little KD, 2004, MOL BIOL CELL, V15, P2375, DOI 10.1091/mbc.E03-12-0886; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; Qian YM, 1999, IMMUNOLOGY, V98, P303; Rahman MA, 1999, PHILOS T ROY SOC B, V354, P379, DOI 10.1098/rstb.1999.0390; Stacey M, 2003, BLOOD, V102, P2916, DOI 10.1182/blood-2002-11-3540; Volynski KE, 2004, EMBO J, V23, P4423, DOI 10.1038/sj.emboj.7600443; Volynski KE, 2003, J BIOL CHEM, V278, P31058, DOI 10.1074/jbc.M210395200; Volynski KE, 2000, J BIOL CHEM, V275, P41175, DOI 10.1074/jbc.M005857200; Wei W, 2007, J BIOL CHEM, V282, P21729, DOI 10.1074/jbc.M703218200; Xu L, 2006, P NATL ACAD SCI USA, V103, P9023, DOI 10.1073/pnas.0602681103	35	51	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6495	6506		10.1074/jbc.M806979200	http://dx.doi.org/10.1074/jbc.M806979200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19124473	Green Published, hybrid			2022-12-25	WOS:000263742700052
J	Tan, M; Walwyn, WM; Evans, CJ; Xie, CW				Tan, Miao; Walwyn, Wendy M.; Evans, Christopher J.; Xie, Cui-Wei			p38 MAPK and beta-Arrestin 2 Mediate Functional Interactions between Endogenous mu-Opioid and alpha(2A)-Adrenergic Receptors in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MORPHINE-TOLERANCE; DESENSITIZATION; KINASE; TRAFFICKING; ACTIVATION; INTERNALIZATION; ENDOCYTOSIS; HETERODIMERIZATION; PHOSPHORYLATION; OLIGOMERIZATION	Formation of receptor complexes between mu-opioid and alpha(2A)-adrenergic receptors has been demonstrated in transfected cells. The functional significance and underlying mechanisms of such receptor interactions remain to be determined in neuronal systems. We examined functional interactions between endogenous mu and alpha(2A) receptors in mouse dorsal root ganglion neurons. Acute application of the mu agonist [D-Ala(2), N-MePhe(4), Gly-ol(5)] enkephalin (DAMGO) or the alpha(2) agonist clonidine inhibited voltage-gated Ca2+ currents in these neurons. Prolonged treatment with either DAMGO or clonidine induced a mutual cross-desensitization between mu and alpha(2A) receptor-mediated current inhibition. The cross-desensitization was closely associated with simultaneous internalization of mu and alpha(2A) receptors. Morphine, a mu agonist triggering little mu receptor endocytosis, induced neither cross-desensitization nor internalization of alpha(2A) receptors. Furthermore, inhibition of p38 MAPK prevented the cross-desensitization as well as cointernalization of mu and alpha(2A) receptors. Changes in receptor trafficking profiles suggested that p38 MAPK activity was required for initiating mu receptor internalization and maintaining possible mu-alpha(2A) association during their cointernalization. Finally, the mu-alpha(2A) cross-desensitization was absent in dorsal root ganglion neurons lacking beta-arrestin 2. These findings demonstrated p38 MAPK- and beta-arrestin 2-dependent cross-regulation between neuronal mu and alpha(2A) receptors. By promoting receptor cross-desensitization and cointernalization, such functional interactions may serve as negative feedback mechanisms triggered by prolonged agonist exposure to modulate the signaling of functionally related G protein-coupled receptors.	[Tan, Miao; Walwyn, Wendy M.; Evans, Christopher J.; Xie, Cui-Wei] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Xie, CW (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci, 760 Westwood Plaza,Box 77, Los Angeles, CA 90024 USA.	cxie@mednet.ucla.edu		Walwyn, Wendy/0000-0001-8101-2844	NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005010] Funding Source: NIH RePORTER; NIDA NIH HHS [P50DA05010, P50 DA005010] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Afify EA, 1998, MOL BRAIN RES, V54, P24, DOI 10.1016/S0169-328X(97)00315-X; Arttamangkul S, 2006, J NEUROSCI, V26, P4118, DOI 10.1523/JNEUROSCI.0303-06.2006; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Borgland SL, 2003, J BIOL CHEM, V278, P18776, DOI 10.1074/jbc.M300525200; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Connor M, 2004, BRIT J PHARMACOL, V143, P685, DOI 10.1038/sj.bjp.0705938; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DeGraff JL, 1999, J BIOL CHEM, V274, P11253, DOI 10.1074/jbc.274.16.11253; Fairbanks CA, 1999, J PHARMACOL EXP THER, V288, P1107; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Hasbi A, 2007, BIOCHEMISTRY-US, V46, P12997, DOI 10.1021/bi701436w; He L, 2002, CELL, V108, P271, DOI 10.1016/S0092-8674(02)00613-X; Hein L, 1999, ANN NY ACAD SCI, V881, P265, DOI 10.1111/j.1749-6632.1999.tb09368.x; Jordan BA, 2003, MOL PHARMACOL, V64, P1317, DOI 10.1124/mol.64.6.1317; Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Koch T, 1998, J BIOL CHEM, V273, P13652, DOI 10.1074/jbc.273.22.13652; Kummer JL, 1997, J BIOL CHEM, V272, P20490, DOI 10.1074/jbc.272.33.20490; Lakhlani PP, 1997, P NATL ACAD SCI USA, V94, P9950, DOI 10.1073/pnas.94.18.9950; Law PY, 2000, MOL PHARMACOL, V58, P388, DOI 10.1124/mol.58.2.388; Law PY, 2005, J BIOL CHEM, V280, P11152, DOI 10.1074/jbc.M500171200; Mace T, 2005, EMBO J, V24, P3235, DOI 10.1038/sj.emboj.7600799; Maldonado R, 1997, NEUROSCI BIOBEHAV R, V21, P91, DOI 10.1016/0149-7634(95)00061-5; Marie N, 2006, CELL SIGNAL, V18, P1815, DOI 10.1016/j.cellsig.2006.03.015; Martini L, 2007, CURR OPIN NEUROBIOL, V17, P556, DOI 10.1016/j.conb.2007.10.004; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; McLaughlin NJD, 2006, J IMMUNOL, V176, P7039, DOI 10.4049/jimmunol.176.11.7039; Nasser Y, 2006, J COMP NEUROL, V495, P529, DOI 10.1002/cne.20898; OSSIPOV MH, 1990, J PHARMACOL EXP THER, V255, P1107; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; Pfeiffer M, 2003, J BIOL CHEM, V278, P51630, DOI 10.1074/jbc.M307095200; Qiu Y, 2003, J BIOL CHEM, V278, P36733, DOI 10.1074/jbc.M305857200; Rozenfeld R, 2007, FASEB J, V21, P2455, DOI 10.1096/fj.06-7793com; Stone LS, 2004, NEUROSCI LETT, V361, P265, DOI 10.1016/j.neulet.2003.12.065; Stone LS, 1997, J NEUROSCI, V17, P7157; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Tan M, 2003, J NEUROSCI, V23, P10292; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; Uddin S, 2000, J BIOL CHEM, V275, P27634; Underwood DC, 2000, AM J PHYSIOL-LUNG C, V279, pL895, DOI 10.1152/ajplung.2000.279.5.L895; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Walwyn WM, 2006, NEUROSCIENCE, V142, P493, DOI 10.1016/j.neuroscience.2006.06.021; Walwyn W, 2007, J NEUROSCI, V27, P5092, DOI 10.1523/JNEUROSCI.1157-07.2007; Walwyn WM, 2004, NEUROSCIENCE, V123, P111, DOI 10.1016/j.neuroscience.2003.08.060; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Williams JP, 2007, ANESTH ANALG, V105, P998, DOI 10.1213/01.ane.0000278865.11991.9d; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157; Zhang YQ, 2004, BIOCHEM SOC T, V32, P856, DOI 10.1042/BST0320856	51	47	51	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6270	6281		10.1074/jbc.M806742200	http://dx.doi.org/10.1074/jbc.M806742200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19126537	Green Published, hybrid			2022-12-25	WOS:000263742700030
J	Zu, LX; He, JH; Jiang, HF; Xu, C; Pu, SS; Xu, GH				Zu, Luxia; He, Jinhan; Jiang, Hongfeng; Xu, Chong; Pu, Shenshen; Xu, Guoheng			Bacterial Endotoxin Stimulates Adipose Lipolysis via Toll-Like Receptor 4 and Extracellular Signal-regulated Kinase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; HORMONE-SENSITIVE LIPASE; PRIMARY RAT ADIPOCYTES; NF-KAPPA-B; FACTOR-ALPHA; LIPID-METABOLISM; PROTEIN-KINASE; TRIGLYCERIDE LIPASE; INSULIN-RESISTANCE; IN-VITRO	Bacterial endotoxin/lipopolysaccharide elicits inflammatory responses and also elevates circulating levels of free fatty acids (FFAs) and impairs insulin sensitivity. Serum FFA elevation in acute endotoxemia has long been thought to be due to endotoxin dysregulating lipid disposal and counterregulatory hormones and cytokines. Here, we investigated the direct lipolysis effect of endotoxin in rodents and in isolated primary adipocytes. Endotoxin increases lipolysis in vivo in adipose tissues, elevates circulating FFA level, induces insulin resistance in rats, and directly stimulates chronic lipolysis in vitro in adipocytes. The lipolytic action of endotoxin is mediated via its lipid A moiety and is blocked by anti-endotoxin peptides. Neither adipocytokine secretion nor nuclear factor-kappa B activation is involved in endotoxin-induced lipolysis. Different from catecholamine, endotoxin stimulates lipolysis without elevating cAMP production and activating protein kinase A and protein kinase C. Instead, endotoxin induces phosphorylation of Raf-1, MEK1/2, and ERK1/2. Upon inhibition of ERK1/2 but not JNK and p38 MAPK, endotoxin-stimulated lipolysis ceases. Endotoxin causes perilipin down-regulation and phosphorylation and increases the activity and protein levels of hormone-sensitive lipase and adipose triglyceride lipase but does not induce hormone-sensitive lipase translocation to intracellular lipid droplets. In TLR4 (Toll-like receptor 4)-deficient mice and adipocytes, endotoxin fails to increase in vivo and in vitro lipolysis. These findings suggest that endotoxin stimulates lipolysis via TLR4 and ERK1/2 signaling in adipocytes. The lipolytic action of endotoxin liberates FFA efflux from adipocytes to the bloodstream, which is a possible basis for systemic FFA elevation and insulin resistance in endotoxemia or Gram-negative bacterial infection.	[Zu, Luxia; He, Jinhan; Jiang, Hongfeng; Xu, Chong; Pu, Shenshen; Xu, Guoheng] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100191, Peoples R China; [Zu, Luxia; Xu, Chong; Pu, Shenshen; Xu, Guoheng] Minist Educ China, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China	Peking University; Ministry of Education, China	Xu, GH (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	xug@bjmu.edu.cn	jiang, hongfeng/I-6188-2013		National Basic Research Program of China [2009CB941603, 2006CB503903]; National Natural Science Foundation of China [30890042, 30770803, 30670779]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2009CB941603 and 2006CB503903 and National Natural Science Foundation of China Grants 30890042, 30770803, and 30670779. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ajuwon KM, 2004, AM J PHYSIOL-REG I, V287, pR608, DOI 10.1152/ajpregu.00192.2004; ARNER P, 2002, DIABETES METAB RE S2, V18, P5; BELFRAGE P, 1969, J LIPID RES, V10, P341; Berg AH, 2004, AM J PHYSIOL-ENDOC M, V287, pE1178, DOI 10.1152/ajpendo.00002.2004; Bhor VM, 2005, MOL BIOSYST, V1, P213, DOI 10.1039/b500756a; FEINGOLD KR, 1992, J LIPID RES, V33, P1765; FONG YM, 1990, J CLIN INVEST, V85, P1896, DOI 10.1172/JCI114651; Fricke K, 2004, ENDOCRINOLOGY, V145, P4940, DOI 10.1210/en.2004-0803; GORIN E, 1990, ENDOCRINOLOGY, V126, P2973; GREEN A, 1994, ENDOCRINOLOGY, V134, P2581, DOI 10.1210/en.134.6.2581; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; Guan HP, 2002, NAT MED, V8, P1122, DOI 10.1038/nm780; HAMBLETON J, 1995, J EXP MED, V182, P147, DOI 10.1084/jem.182.1.147; He JH, 2006, BBA-MOL CELL BIOL L, V1761, P247, DOI 10.1016/j.bbalip.2006.02.001; HIKAWYJYEVICH I, 1977, J SURG RES, V23, P106, DOI 10.1016/0022-4804(77)90197-4; Jiang HF, 2007, BBA-MOL CELL BIOL L, V1771, P66, DOI 10.1016/j.bbalip.2006.10.004; Jiang Z, 2004, INT IMMUNOPHARMACOL, V4, P527, DOI 10.1016/j.intimp.2004.02.004; Kawasaki M, 2004, BIOSCI BIOTECH BIOCH, V68, P72, DOI 10.1271/bbb.68.72; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Laurencikiene J, 2007, J LIPID RES, V48, P1069, DOI 10.1194/jlr.M600471-JLR200; Londos C, 2005, BIOCHIMIE, V87, P45, DOI 10.1016/j.biochi.2004.12.010; Londos C, 1999, ANN NY ACAD SCI, V892, P155, DOI 10.1111/j.1749-6632.1999.tb07794.x; Matthews CK, 1996, BIOCHEMISTRY-US, P819; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; NONOGAKI K, 1994, ENDOCRINOLOGY, V135, P2644, DOI 10.1210/en.135.6.2644; POND CM, 1995, J LIPID RES, V36, P2219; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Ren TT, 2006, J MOL ENDOCRINOL, V37, P175, DOI 10.1677/jme.1.02061; Robidoux J, 2006, J BIOL CHEM, V281, P37794, DOI 10.1074/jbc.M605572200; Ryden M, 2002, J BIOL CHEM, V277, P1085, DOI 10.1074/jbc.M109498200; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; SPITZER JA, 1990, CELL CALCIUM, V11, P405, DOI 10.1016/0143-4160(90)90052-V; SPITZER JA, 1986, CIRC SHOCK, V18, P21; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; van Hall G, 2003, J CLIN ENDOCR METAB, V88, P3005, DOI 10.1210/jc.2002-021687; VIRKAMAKI A, 1994, ENDOCRINOLOGY, V134, P2072, DOI 10.1210/en.134.5.2072; WEINSTEIN SL, 1992, J BIOL CHEM, V267, P14955; Xu GH, 2006, BBA-MOL CELL BIOL L, V1761, P83, DOI 10.1016/j.bbalip.2005.12.005; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zu LX, 2008, MOL PHARMACOL, V73, P215, DOI 10.1124/mol.107.039479	44	102	114	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5915	5926		10.1074/jbc.M807852200	http://dx.doi.org/10.1074/jbc.M807852200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19122198	hybrid			2022-12-25	WOS:000263560600055
J	Sabado, RL; Kavanagh, DG; Kaufmann, DE; Fru, K; Babcock, E; Rosenberg, E; Walker, B; Lifson, J; Bhardwaj, N; Larsson, M				Sabado, Rachel Lubong; Kavanagh, Daniel G.; Kaufmann, Daniel E.; Fru, Karlhans; Babcock, Ethan; Rosenberg, Eric; Walker, Bruce; Lifson, Jeffrey; Bhardwaj, Nina; Larsson, Marie			In Vitro Priming Recapitulates In Vivo HIV-1 Specific T Cell Responses, Revealing Rapid Loss of Virus Reactive CD4(+) T Cells in Acute HIV-1 Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DENDRITIC CELLS; CROSS-PRESENTATION; CD8(+); VACCINE; LYMPHOCYTES; ACTIVATION; MATURATION; INDUCTION; ANTIGENS	Background: The requirements for priming of HIV-specific T cell responses initially seen in infected individuals remain to be defined. Activation of T cell responses in lymph nodes requires cell-cell contact between T cells and DCs, which can give concurrent activation of T cells and HIV transmission. Methodology: The study aim was to establish whether DCs pulsed with HIV-1 could prime HIV-specific T cell responses and to characterize these responses. Both infectious and aldrithiol-2 inactivated noninfectious HIV-1 were compared to establish efficiencies in priming and the type of responses elicited. Findings: Our findings show that both infectious and inactivated HIV-1 pulsed DCs can prime HIV-specific responses from naive T cells. Responses included several CD4(+) and CD8(+) T cell epitopes shown to be recognized in vivo by acutely and chronically infected individuals and some CD4(+) T cell epitopes not identified previously. Follow up studies of acute and recent HIV infected samples revealed that these latter epitopes are among the earliest recognized in vivo, but the responses are lost rapidly, presumably through activation-induced general CD4(+) T cell depletion which renders the newly activated HIV-specific CD4(+) T cells prime targets for elimination. Conclusion: Our studies highlight the ability of DCs to efficiently prime naive T cells and induce a broad repertoire of HIV-specific responses and also provide valuable insights to the pathogenesis of HIV-1 infection in vivo.	[Babcock, Ethan; Bhardwaj, Nina] NYU, Sch Med, New York, NY 10003 USA; [Kavanagh, Daniel G.; Kaufmann, Daniel E.; Rosenberg, Eric; Walker, Bruce] Harvard Univ, Sch Med, Massachusetts Gen Hosp, PARC, Charlestown, MA USA; [Lifson, Jeffrey] NCI, NIH, SAIC Fredrick Inc, Frederick, MD USA; [Fru, Karlhans; Larsson, Marie] Linkoping Univ, Dept Clin & Expt Med, S-58183 Linkoping, Sweden	New York University; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Linkoping University	Sabado, RL (corresponding author), NYU, Sch Med, New York, NY 10003 USA.	marla@imk.liu.se		Larsson, Marie/0000-0002-4524-0177; Bhardwaj, Nina/0000-0003-1865-4187	The Swedish Research Council; The Swedish, Physicians against AIDS research Foundation; The Swedish International Development Cooperation Agency; SIDA SARC; VINNMER for Vinnova; Linkoping University hospital research Fund; C ALF; The Swedish Society of Medicine; Emerald Foundation; Burroughs Wellcome; Elizabeth Glaser Pediatric AIDS Foundation; Bill and Melinda Gates Foundation; Center for HIV/AIDS Vaccine Initiative (CHAVI); NIH [AI52731, AI55274, AI61684, AI57127, AI44628]; National Cancer Institute, National Institutes of Health [N01-CO-12400]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI044628, R01AI052731, R01AI061684, R21AI055274, R01AI044628, F32AI058457, P01AI057127, R37AI052731] Funding Source: NIH RePORTER	The Swedish Research Council(Swedish Research Council); The Swedish, Physicians against AIDS research Foundation; The Swedish International Development Cooperation Agency; SIDA SARC; VINNMER for Vinnova(Vinnova); Linkoping University hospital research Fund; C ALF; The Swedish Society of Medicine; Emerald Foundation; Burroughs Wellcome(Burroughs Wellcome Fund); Elizabeth Glaser Pediatric AIDS Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Center for HIV/AIDS Vaccine Initiative (CHAVI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	All below funders have provided funding for performing this study. This work has been supported by grants through: ML: AI52731, The Swedish Research Council, The Swedish, Physicians against AIDS research Foundation, The Swedish International Development Cooperation Agency; SIDA SARC, VINNMER for Vinnova, Linkoping University hospital research Fund, C ALF, and The Swedish Society of Medicine. NB: Emerald Foundation, Burroughs Wellcome, Elizabeth Glaser Pediatric AIDS Foundation, Bill and Melinda Gates Foundation and the Center for HIV/AIDS Vaccine Initiative (CHAVI) and NIH grants AI52731, AI55274, AI61684, AI57127, and AI44628. JL: with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400. The content of this publication does not necessarily reflect the views of policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Addo MM, 2001, P NATL ACAD SCI USA, V98, P1781, DOI 10.1073/pnas.98.4.1781; Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Addo MM, 2002, AIDS, V16, P1071, DOI 10.1097/00002030-200205030-00015; BEBENEK K, 1992, J BIOL CHEM, V267, P3589; BEBENEK K, 1993, MOL PHARMACOL, V43, P57; BEBENEK K, 1989, J BIOL CHEM, V264, P16948; BERZOFSKY JA, 1988, NATURE, V334, P706, DOI 10.1038/334706a0; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brown SA, 2003, J IMMUNOL, V171, P4140, DOI 10.4049/jimmunol.171.8.4140; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Buseyne F, 2001, NAT MED, V7, P344, DOI 10.1038/85493; Cavrois M, 2007, PLOS PATHOG, V3, P38, DOI 10.1371/journal.ppat.0030004; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Engelmayer J, 2001, J VIROL, V75, P2142, DOI 10.1128/JVI.75.5.2142-2153.2001; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; Frank I, 2003, JAIDS-J ACQ IMM DEF, V34, P7, DOI 10.1097/00126334-200309010-00002; Gauduin MC, 2006, J EXP MED, V203, P2661, DOI 10.1084/jem.20060134; Granelli-Piperno A, 2004, P NATL ACAD SCI USA, V101, P7669, DOI 10.1073/pnas.0402431101; Gruber A, 2000, BLOOD, V96, P1327, DOI 10.1182/blood.V96.4.1327.h8001327_1327_1333; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Huang XL, 2003, J INFECT DIS, V187, P315, DOI 10.1086/346054; Jabbari A, 2006, J EXP MED, V203, P919, DOI 10.1084/jem.20052237; Karlsson H, 2004, INFECT IMMUN, V72, P2671, DOI 10.1128/IAI.72.5.2671-2678.2004; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kaufmann DE, 2004, J VIROL, V78, P4463, DOI 10.1128/JVI.78.9.4463-4477.2004; Kent SJ, 1997, J IMMUNOL, V158, P807; Larsson M, 2003, CURR TOP MICROBIOL, V276, P261; Larsson M, 2002, AIDS, V16, P1319, DOI 10.1097/00002030-200207050-00003; LARSSON M, 2004, SPRINGER SEMIN IMMUN; Lichterfeld M, 2007, J VIROL, V81, P4199, DOI 10.1128/JVI.01388-06; Lore K, 2005, J EXP MED, V201, P2023, DOI 10.1084/jem.20042413; Lu W, 2004, NAT MED, V10, P1359, DOI 10.1038/nm1147; Lu W, 2003, NAT MED, V9, P27, DOI 10.1038/nm806; Macagno A, 2007, TRENDS IMMUNOL, V28, P227, DOI 10.1016/j.it.2007.03.008; Malhotra U, 2003, J VIROL, V77, P2663, DOI 10.1128/JVI.77.4.2663-2674.2003; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Muthumani K, 2005, INT IMMUNOL, V17, P103, DOI 10.1093/intimm/dxh190; Okoye A, 2007, J EXP MED, V204, P2171, DOI 10.1084/jem.20070567; OTT DE, 1995, J VIROL, V69, P2443, DOI 10.1128/JVI.69.4.2443-2450.1995; Palmer BE, 2005, J IMMUNOL, V175, P8415, DOI 10.4049/jimmunol.175.12.8415; Palmer BE, 2004, J IMMUNOL, V172, P3337, DOI 10.4049/jimmunol.172.5.3337; Pantaleo G, 1997, P NATL ACAD SCI USA, V94, P9848, DOI 10.1073/pnas.94.18.9848; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Rosenberg ES, 1998, AIDS RES HUM RETROV, V14, pS143; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Sabado RL, 2007, EUR J IMMUNOL, V37, P1752, DOI 10.1002/eji.200636981; Saito H, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1621; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Smed-Sorensen A, 2004, BLOOD, V104, P2810, DOI 10.1182/blood-2003-07-2314; Thomas JA, 2007, J VIROL, V81, P4367, DOI 10.1128/JVI.02357-06; Walsh SR, 2003, CURR HIV RES, V1, P205, DOI 10.2174/1570162033485285; Wilson CC, 1999, J IMMUNOL, V162, P3070; Wilson CC, 2001, J VIROL, V75, P4195, DOI 10.1128/JVI.75.9.4195-4207.2001; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598; Yu XG, 2005, AIDS, V19, P1449, DOI 10.1097/01.aids.0000183126.32077.c8; Zarling AL, 1999, J IMMUNOL, V162, P5197; Zaunders JJ, 2005, BLOOD, V106, P1660, DOI 10.1182/blood-2005-01-0206; Zaunders JJ, 2006, J VIROL, V80, P10162, DOI 10.1128/JVI.00249-06	63	37	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2009	4	1							e4256	10.1371/journal.pone.0004256	http://dx.doi.org/10.1371/journal.pone.0004256			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JD	19165342	Green Published, gold, Green Submitted			2022-12-25	WOS:000265482400004
J	Sowa, NA; Vadakkan, KI; Zylka, MJ				Sowa, Nathaniel A.; Vadakkan, Kunjumon I.; Zylka, Mark J.			Recombinant Mouse PAP Has pH-Dependent Ectonucleotidase Activity and Acts through A(1)-Adenosine Receptors to Mediate Antinociception	PLOS ONE			English	Article							PROSTATIC ACID-PHOSPHATASE; ADENOSINE KINASE-INHIBITOR; SITE-DIRECTED MUTAGENESIS; NEUROPATHIC PAIN; SPINAL MICROGLIA; THERMAL HYPERALGESIA; ALLODYNIA; ENZYME; SPECIFICITY; NOCICEPTION	Prostatic acid phosphatase (PAP) is expressed in nociceptive neurons and functions as an ectonucleotidase. When injected intraspinally, the secretory isoforms of human and bovine PAP protein have potent and long-lasting antinociceptive effects that are dependent on A(1)-adenosine receptor (A(1)R) activation. In this study, we purified the secretory isoform of mouse (m) PAP using the baculovirus expression system to determine if recombinant mPAP also had antinociceptive properties. We found that mPAP dephosphorylated AMP, and to a much lesser extent, ADP at neutral pH (pH 7.0). In contrast, mPAP dephosphorylated all purine nucleotides (AMP, ADP, ATP) at an acidic pH (pH 5.6). The transmembrane isoform of mPAP had similar pH-dependent ectonucleotidase activity. A single intraspinal injection of mPAP protein had long-lasting (three day) antinociceptive properties, including antihyperalgesic and antiallodynic effects in the Complete Freund's Adjuvant (CFA) inflammatory pain model. These antinociceptive effects were transiently blocked by the A1R antagonist 8-cyclopentyl-1,3-dipropylxanthine (CPX), suggesting mPAP dephosphorylates nucleotides to adenosine to mediate antinociception just like human and bovine PAP. Our studies indicate that PAP has species-conserved antinociceptive effects and has pH-dependent ectonucleotidase activity. The ability to metabolize nucleotides in a pH-dependent manner could be relevant to conditions like inflammation where tissue acidosis and nucleotide release occur. Lastly, our studies demonstrate that recombinant PAP protein can be used to treat chronic pain in animal models.	[Sowa, Nathaniel A.; Vadakkan, Kunjumon I.; Zylka, Mark J.] Univ N Carolina, Dept Cell & Mol Physiol, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Sowa, NA (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA.	zylka@med.unc.edu	Vadakkan, Kunjumon/A-3254-2008	Vadakkan, Kunjumon/0000-0002-2721-6931	UNC; The Sloan Foundation; The Searle Scholars Program; The Klingenstein Foundation; The Whitehall Foundation; Rita Allen Foundation [Milton E. Cassel Scholar]; NINDS [R01NS060725, F30NS063507]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060725, F30NS063507] Funding Source: NIH RePORTER	UNC; The Sloan Foundation(Alfred P. Sloan Foundation); The Searle Scholars Program; The Klingenstein Foundation(Klingenstein Philanthropies); The Whitehall Foundation; Rita Allen Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by UNC startup funds, grants to M.J.Z. from The Sloan Foundation, The Searle Scholars Program, The Klingenstein Foundation, The Whitehall Foundation, Rita Allen Foundation and NINDS (R01NS060725), a grant to N.A.S. from NINDS (F30NS063507). M.J.Z. is a Rita Allen Foundation Milton E. Cassel Scholar. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Belfrage M, 1999, ANESTH ANALG, V89, P136, DOI 10.1097/00000539-199907000-00023; Burch PA, 2004, PROSTATE, V60, P197, DOI 10.1002/pros.20040; Burch PA, 2000, CLIN CANCER RES, V6, P2175; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; Cunha TM, 2004, BRAZ J MED BIOL RES, V37, P401, DOI 10.1590/S0100-879X2004000300018; DODD J, 1983, COLD SPRING HARB SYM, V48, P685, DOI 10.1101/SQB.1983.048.01.072; DORR RT, 1993, DRUGS, V45, P177, DOI 10.2165/00003495-199345020-00003; DZIEMBOR E, 1971, ACTA BIOCHIM POL, V18, P249; DZIEMBORGRYSZKIEWICZ E, 1978, B ACAD POL SCI BIOL, V26, P815; Eisenach JC, 2003, PAIN, V105, P65, DOI 10.1016/S0304-3959(03)00158-1; Fairbanks CA, 2003, ADV DRUG DELIVER REV, V55, P1007, DOI 10.1016/S0169-409X(03)00101-7; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hayashida Masakazu, 2005, J Anesth, V19, P225, DOI 10.1007/s00540-005-0310-8; HOLTON P, 1959, J PHYSIOL-LONDON, V145, P494, DOI 10.1113/jphysiol.1959.sp006157; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Jakob CG, 2000, PROSTATE, V42, P211, DOI 10.1002/(SICI)1097-0045(20000215)42:3<211::AID-PROS7>3.0.CO;2-U; Jarvis MF, 2002, PHARMACOL BIOCHEM BE, V73, P573, DOI 10.1016/S0091-3057(02)00840-7; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; KEIL GJ, 1992, LIFE SCI, V51, pPL171, DOI 10.1016/0024-3205(92)90566-8; KNYIHARCSILLIK E, 1986, J HISTOCHEM CYTOCHEM, V34, P363, DOI 10.1177/34.3.3005391; LAM KW, 1973, CLIN CHEM, V19, P483; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lavand'homme PM, 1999, PAIN, V80, P31, DOI 10.1016/S0304-3959(98)00193-6; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nakagawa T, 2007, NEUROSCIENCE, V147, P445, DOI 10.1016/j.neuroscience.2007.03.045; OSTANIN K, 1994, J BIOL CHEM, V269, P8971; OSTROWSKI WS, 1994, CLIN CHIM ACTA, V226, P121, DOI 10.1016/0009-8981(94)90209-7; POON A, 1995, EUR J PHARMACOL, V286, P177, DOI 10.1016/0014-2999(95)00444-P; Poon A, 1998, PAIN, V74, P235, DOI 10.1016/S0304-3959(97)00186-3; PORVARI KS, 1994, J BIOL CHEM, V269, P22642; Quintero IB, 2007, CANCER RES, V67, P6549, DOI 10.1158/0008-5472.CAN-07-1651; REPPERT SM, 1991, MOL ENDOCRINOL, V5, P1037, DOI 10.1210/mend-5-8-1037; Rodriguez-Nunez A, 2000, BRAIN DEV-JPN, V22, P427, DOI 10.1016/S0387-7604(00)00172-8; ROIKO K, 1990, GENE, V89, P223, DOI 10.1016/0378-1119(90)90009-G; Sawynok J, 2007, Handb Exp Pharmacol, P309; SCHNEIDER G, 1993, EMBO J, V12, P2609, DOI 10.1002/j.1460-2075.1993.tb05921.x; Stucky CL, 2004, PAIN, V109, P36, DOI 10.1016/j.pain.2004.01.007; SYKOVA E, 1990, BRAIN RES, V512, P181, DOI 10.1016/0006-8993(90)90625-L; SYKOVA E, 1988, CIBA F SYMP, V139, P220; Tozaki-Saitoh H, 2008, J NEUROSCI, V28, P4949, DOI 10.1523/JNEUROSCI.0323-08.2008; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; VIHKO P, 1978, CLIN CHEM, V24, P1783; VIHKO P, 1979, INVEST UROL, V16, P349; VIHKO P, 1993, P NATL ACAD SCI USA, V90, P799, DOI 10.1073/pnas.90.3.799; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie John A., 2008, P661, DOI 10.1007/978-0-387-77232-5_22; Wu WP, 2005, PAIN, V113, P395, DOI 10.1016/j.pain.2004.11.020; Zucchini S, 2008, CURR OPIN INVEST DR, V9, P396; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024	52	34	35	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2009	4	1							e4248	10.1371/journal.pone.0004248	http://dx.doi.org/10.1371/journal.pone.0004248			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JC	19158948	Green Published, gold, Green Submitted			2022-12-25	WOS:000265482200005
J	Aabye, MG; Ravn, P; PrayGod, G; Jeremiah, K; Mugomela, A; Jepsen, M; Faurholt, D; Range, N; Friis, H; Changalucha, J; Andersen, AB				Aabye, Martine G.; Ravn, Pernille; PrayGod, George; Jeremiah, Kidola; Mugomela, Apolinary; Jepsen, Maria; Faurholt, Daniel; Range, Nyagosya; Friis, Henrik; Changalucha, John; Andersen, Aase B.			The Impact of HIV Infection and CD4 Cell Count on the Performance of an Interferon Gamma Release Assay in Patients with Pulmonary Tuberculosis	PLOS ONE			English	Article							WHOLE-BLOOD; LATENT TUBERCULOSIS; SKIN-TEST; T-CELLS; ACTIVE TUBERCULOSIS; INDIVIDUALS; SENSITIVITY; DIAGNOSIS; ADULTS; PREVALENCE	Background: The performance of the tuberculosis specific Interferon Gamma Release Assays (IGRAs) has not been sufficiently documented in tuberculosis-and HIV-endemic settings. This study evaluated the sensitivity of the QuantiFERON TB-Gold In-Tube (QFT-IT) in patients with culture confirmed pulmonary tuberculosis (PTB) in a TB-and HIV-endemic population and the effect of HIV-infection and CD4 cell count on test performance. Methodology/Principal Findings: 161 patients with sputum culture confirmed PTB were subjected to HIV- and QFT-IT testing and measurement of CD4 cell count. The QFT-IT was positive in 74% (119/161; 95% CI: 67-81%). Sensitivity was higher in HIV-negative (75/93) than in HIV-positive (44/68) patients (81% vs. 65%, p = 0.02) and increased with CD4 cell count in HIV-positive patients (test for trend p = 0.03). 23 patients (14%) had an indeterminate result and this proportion decreased with increasing CD4 cell count in HIV-positive patients (test for trend p = 0.03). Low CD4 cell count (<300 cells/ml) did not account for all QFT-IT indeterminate nor all negative results. Sensitivity when excluding indeterminate results was 86% (95% CI: 81-92%) and did not differ between HIV-negative and HIV-positive patients (88 vs. 83%, p = 0.39). Conclusions/Significance: Sensitivity of the QFT-IT for diagnosing active PTB infection was reasonable when excluding indeterminate results and in HIV-negative patients. However, since the test missed more than 10% of patients, its potential as a rule-out test for active TB disease is limited. Furthermore, test performance is impaired by low CD4 cell count in HIV-positive patients and possibly by other factors as well in both HIV-positive and HIV-negative patients. This might limit the potential of the test in populations where HIV-infection is prevalent.	[Andersen, Aase B.] Univ Copenhagen, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Ravn, Pernille] Univ Copenhagen, Herlev Hosp, Unit Infect Dis Q, DK-1168 Copenhagen, Denmark; [PrayGod, George; Jeremiah, Kidola; Changalucha, John] Mwanza Med Res Ctr, Natl Inst Med Res, Mwanza, Tanzania; [Mugomela, Apolinary] Bugando Med Ctr, Zonal TB Reference Lab, Mwanza, Tanzania; [Jepsen, Maria; Faurholt, Daniel; Friis, Henrik] Univ Copenhagen, Fac Life Sci, Dept Human Nutr, Frederiksberg, Denmark; [Range, Nyagosya] Muhimbili Med Res Ctr, Natl Inst Med Res, Dar Es Salaam, Tanzania	Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; National Institute of Medical Research; University of Copenhagen; National Institute of Medical Research	Aabye, MG (corresponding author), Univ Copenhagen, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark.	martine@aabye.com	Friis, Henrik/N-2047-2014; Faurholt-Jepsen, Daniel/D-9453-2012; Friis, Henrik/P-2891-2019; Faurholt-Jepsen, Daniel/M-6324-2019; PrayGod, George/L-7098-2018	Friis, Henrik/0000-0002-2848-2940; Faurholt-Jepsen, Daniel/0000-0001-8561-0155; Friis, Henrik/0000-0002-2848-2940; Faurholt-Jepsen, Daniel/0000-0001-8561-0155; Jeremiah, Kidola/0000-0001-7900-9689; Andersen, Aase Bengaard/0000-0003-4779-7603; PrayGod, George/0000-0002-0329-4839	Danish Council for Medical Research	Danish Council for Medical Research	The study was funded by the Danish Council for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken AM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-66; BAKIR M, 2008, ANN INTERN MED; Balcells ME, 2008, INT J INFECT DIS, V12, P645, DOI 10.1016/j.ijid.2008.03.005; Brock I, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-56; Carrara S, 2004, CLIN INFECT DIS, V38, P754, DOI 10.1086/381754; Chee CBE, 2008, J CLIN MICROBIOL, V46, P1935, DOI 10.1128/JCM.02403-07; de Leon DP, 2008, J RHEUMATOL, V35, P776; DIEL R, 2008, CHEST; Dosanjh DPS, 2008, ANN INTERN MED, V148, P325, DOI 10.7326/0003-4819-148-5-200803040-00003; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; Harada Nobuyuki, 2004, Kekkaku, V79, P725; Jafari C, 2008, EUR RESPIR J, V31, P261, DOI 10.1183/09031936.00096707; Jafari C, 2006, AM J RESP CRIT CARE, V174, P1048, DOI 10.1164/rccm.200604-465OC; Jones S, 2007, INT J TUBERC LUNG D, V11, P1190; Kanunfre KA, 2008, CLIN VACCINE IMMUNOL, V15, P1028, DOI 10.1128/CVI.00026-08; Karam F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001441; Kobashi Y, 2008, INTERNAL MED, V47, P237, DOI 10.2169/internalmedicine.47.0389; Lalvani A, 2004, CLIN INFECT DIS, V38, P757, DOI 10.1086/381763; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; LUETKEMEYER AF, 2007, AM J RESP CRIT CARE; Mandalakas AM, 2008, INT J TUBERC LUNG D, V12, P417; Mazurek GH, 2007, CLIN INFECT DIS, V45, P837, DOI 10.1086/521107; Menzies D, 2008, ANN INTERN MED, V148, P398, DOI 10.7326/0003-4819-148-5-200803040-00011; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Nakaoka H, 2006, EMERG INFECT DIS, V12, P1383, DOI 10.3201/eid1209.051606; Pai M, 2007, INFECTION, V35, P98, DOI 10.1007/s15010-007-6114-z; PAI M, 2008, ANN INTERN MED; Palaci M, 2007, J CLIN MICROBIOL, V45, P4064, DOI 10.1128/JCM.01780-07; Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217; Raby E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002489; Ramarokoto H, 2002, INT J TUBERC LUNG D, V6, P909; Rangaka MX, 2007, AM J RESP CRIT CARE, V175, P514, DOI 10.1164/rccm.200610-1439OC; Range N, 2007, ANN TROP MED PARASIT, V101, P343, DOI 10.1179/136485907X176373; Rathman G, 2003, INT J TUBERC LUNG D, V7, P942; Ruhwald M, 2007, MICROBES INFECT, V9, P806, DOI 10.1016/j.micinf.2007.02.021; Stephan C, 2008, AIDS, V22, P2471, DOI 10.1097/QAD.0b013e3283188415; Tsiouris SJ, 2006, J CLIN MICROBIOL, V44, P2844, DOI 10.1128/JCM.02411-05; *US FDA, 2007, PREM APPR DAT QUANT; Veerapathran A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001850; Vincenti D, 2007, CLIN EXP IMMUNOL, V150, P91, DOI 10.1111/j.1365-2249.2007.03462.x; WHO, 2004, INT POL COLL TB HIV; *WHO, 2005, COUNTR PROF UN REP T; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2	43	73	74	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2009	4	1							e4220	10.1371/journal.pone.0004220	http://dx.doi.org/10.1371/journal.pone.0004220			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IZ	19156218	gold, Green Published, Green Submitted			2022-12-25	WOS:000265481900003
J	Martinand-Mari, C; Maury, B; Rousset, F; Sahuquet, A; Mennessier, G; Rochal, S; Lorman, V; Mangeat, P; Baghdiguian, S				Martinand-Mari, Camille; Maury, Benoit; Rousset, Francois; Sahuquet, Alain; Mennessier, Gerard; Rochal, Sergei; Lorman, Vladimir; Mangeat, Paul; Baghdiguian, Stephen			Topological Control of Life and Death in Non-Proliferative Epithelia	PLOS ONE			English	Article								Programmed cell death is one of the most fascinating demonstrations of the plasticity of biological systems. It is classically described to act upstream of and govern major developmental patterning processes (e. g. inter-digitations in vertebrates, ommatidia in Drosophila). We show here the first evidence that massive apoptosis can also be controlled and coordinated by a pre-established pattern of a specific 'master cell' population. This new concept is supported by the development and validation of an original model of cell patterning. Ciona intestinalis eggs are surrounded by a three-layered follicular organization composed of 60 elongated floating extensions made of as many outer and inner cells, and indirectly spread through an extracellular matrix over 1200 test cells. Experimental and selective ablation of outer and inner cells results in the abrogation of apoptosis in respective remaining neighbouring test cells. In addition incubation of outer/inner follicular cell-depleted eggs with a soluble extract of apoptotic outer/inner cells partially restores apoptosis to apoptotic-defective test cells. The 60 inner follicular cells were thus identified as 'apoptotic master' cells which collectively are induction sites for programmed cell death of the underlying test cells. The position of apoptotic master cells is controlled by topological constraints exhibiting a tetrahedral symmetry, and each cell spreads over and can control the destiny of 20 smaller test cells, which leads to optimized apoptosis signalling.	[Martinand-Mari, Camille; Maury, Benoit; Rousset, Francois; Baghdiguian, Stephen] Univ Montpellier 2, Inst Sci Evolut, CNRS, UMR 5554, Montpellier, France; [Sahuquet, Alain; Mangeat, Paul] Univ Montpellier 2, CNRS 5327, CRBM, UMR, F-34095 Montpellier, France; [Mennessier, Gerard; Lorman, Vladimir] Univ Montpellier 2, CNRS 5207, LPTA, UMR, F-34095 Montpellier, France; [Rochal, Sergei] S Fed Univ, Fac Phys, Rostov Na Donu, Russia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Southern Federal University	Martinand-Mari, C (corresponding author), Univ Montpellier 2, Inst Sci Evolut, CNRS, UMR 5554, Montpellier, France.	stbaghdi@univ-montp2.fr	Rousset, Francois/GRJ-3980-2022; Rousset, Francois/C-7360-2008; Rochal, Sergei/AAY-3323-2020	Rousset, Francois/0000-0003-4670-0371; Rousset, Francois/0000-0003-4670-0371; Rochal, Sergei/0000-0001-6135-0440; Baghdiguian, Stephen/0000-0002-2992-9708	programme interdisciplinaire Interface Physique Chimie Biologie; CNRS; Comite Herault de la Ligue Nationale Contre le Cancer	programme interdisciplinaire Interface Physique Chimie Biologie; CNRS(Centre National de la Recherche Scientifique (CNRS)); Comite Herault de la Ligue Nationale Contre le Cancer	Funding was from programme interdisciplinaire Interface Physique Chimie Biologie : soutien a la prise de risque du CNRS and Comite Herault de la Ligue Nationale Contre le Cancer to SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHULER EL, 1994, PHYS REV LETT, V72, P2671, DOI 10.1103/PhysRevLett.72.2671; Baghdiguian S, 2007, SEMIN CANCER BIOL, V17, P147, DOI 10.1016/j.semcancer.2006.11.005; Bates WR, 2004, ZOOL SCI, V21, P553, DOI 10.2108/zsj.21.553; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Chambon JP, 2007, DEVELOPMENT, V134, P1203, DOI 10.1242/dev.002220; Chambon JP, 2002, DEVELOPMENT, V129, P3105; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Coucouvanis E, 1999, DEVELOPMENT, V126, P535; Cox DR, 1974, THEORETICAL STAT; Coxeter H. S. M., 1969, INTRO GEOMETRY; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; ERBER T, 1991, J PHYS A-MATH GEN, V24, pL1369, DOI 10.1088/0305-4470/24/23/008; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Golstein P, 2003, NAT REV MOL CELL BIO, V4, P798, DOI 10.1038/nrm1224; Jeffery WR, 2002, MECH DEVELOP, V118, P111, DOI 10.1016/S0925-4773(02)00236-8; Lauzon RJ, 2007, DEV BIOL, V301, P92, DOI 10.1016/j.ydbio.2006.08.055; Lorman VL, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.185502; Maury B, 2006, DEV BIOL, V289, P152, DOI 10.1016/j.ydbio.2005.10.021; Morris JR, 1996, PHYS REV B, V53, pR1740, DOI 10.1103/PhysRevB.53.R1740; Satoh N, 2003, TRENDS GENET, V19, P376, DOI 10.1016/S0168-9525(03)00144-6; Satoh N., 1994, DEV BIOL ASCIDIANS; SLOANE NJA, 2004, SPHERICAL CODES NICE; SUGINO YM, 1987, J EXP ZOOL, V242, P205, DOI 10.1002/jez.1402420212; Takada N, 2005, APOPTOSIS, V10, P1211, DOI 10.1007/s10495-005-1391-4; TAMMES PML, 1930, REC TRAV BOT NEERL, P1; Tarallo R, 2004, DEV DYNAM, V230, P251, DOI 10.1002/dvdy.20055; Tarnai T, 2002, STRUCT CHEM, V13, P289, DOI 10.1023/A:1015859822819; Terajima D, 2003, CELL DEATH DIFFER, V10, P749, DOI 10.1038/sj.cdd.4401223; Thompson D. W., 1917, GROWTH FORM; Thomson JJ, 1904, PHILOS MAG, V7, P237, DOI 10.1080/14786440409463107; Vinson JP, 2005, GENOME RES, V15, P1127, DOI 10.1101/gr.3722605; Voskoboynik A, 2004, J EXP BIOL, V207, P2409, DOI 10.1242/jeb.01045	34	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2009	4	1							e4202	10.1371/journal.pone.0004202	http://dx.doi.org/10.1371/journal.pone.0004202			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IG	19145253	Green Published, gold, Green Submitted			2022-12-25	WOS:000265479800008
J	Hirose, T; Satoh, D; Kurihara, H; Kusaka, C; Hirose, H; Akimoto, K; Matsusaka, T; Ichikawa, I; Noda, T; Ohno, S				Hirose, Tomonori; Satoh, Daisuke; Kurihara, Hidetake; Kusaka, Chiho; Hirose, Hiroko; Akimoto, Kazunori; Matsusaka, Taiji; Ichikawa, Iekuni; Noda, Tetsuo; Ohno, Shigeo			An Essential Role of the Universal Polarity Protein, aPKC lambda, on the Maintenance of Podocyte Slit Diaphragms	PLOS ONE			English	Article								Glomerular visceral epithelial cells (podocytes) contain interdigitated processes that form specialized intercellular junctions, termed slit diaphragms, which provide a selective filtration barrier in the renal glomerulus. Analyses of disease-causing mutations in familial nephrotic syndromes and targeted mutagenesis in mice have revealed critical roles of several proteins in the assembly of slit diaphragms. The nephrin-podocin complex is the main constituent of slit diaphragms. However, the molecular mechanisms regulating these proteins to maintain the slit diaphragms are still largely unknown. Here, we demonstrate that the PAR3-atypical protein kinase C (aPKC) -PAR6 beta cell polarity proteins co-localize to the slit diaphragms with nephrin. Furthermore, selective depletion of aPKC lambda in mouse podocytes results in the disassembly of slit diaphragms, a disturbance in apico-basal cell polarity, and focal segmental glomerulosclerosis (FSGS). The aPKC-PAR3 complex associates with the nephrin-podocin complex in podocytes through direct interaction between PAR3 and nephrin, and the kinase activity of aPKC is required for the appropriate distribution of nephrin and podocin in podocytes. These observations not only establish a critical function of the polarity proteins in the maintenance of slit diaphragms, but also imply their potential involvement in renal failure in FSGS.	[Hirose, Tomonori; Satoh, Daisuke; Kusaka, Chiho; Hirose, Hiroko; Akimoto, Kazunori; Ohno, Shigeo] Yokohama City Univ, Grad Sch Med Sci, Dept Mol Biol, Kanagawa, Japan; [Kurihara, Hidetake] Juntendo Univ, Sch Med, Dept Anat, Tokyo, Japan; [Matsusaka, Taiji] Tokai Univ, Sch Med, Inst Med Sci, Hiratsuka, Kanagawa 25912, Japan; [Ichikawa, Iekuni] Tokai Univ, Sch Med, Dept Bioeth, Hiratsuka, Kanagawa 25912, Japan; [Noda, Tetsuo] Japanese Fdn Canc Res, Canc Inst, Dept Cell Biol, Tokyo, Japan; [Ohno, Shigeo] Yokohama City Univ, Advanced Med Res Ctr, Yokohama, Kanagawa, Japan	Yokohama City University; Juntendo University; Tokai University; Tokai University; Japanese Foundation for Cancer Research; Yokohama City University	Hirose, T (corresponding author), Yokohama City Univ, Grad Sch Med Sci, Dept Mol Biol, Kanagawa, Japan.	ohnos@med.yokohama-cu.ac.jp	Ohno, Shigeo/B-1768-2010; Noda, Tetsuo/B-1667-2016; Hirose, Tomonori/M-8872-2019; Hirose, Tomonori/F-6015-2010	Ohno, Shigeo/0000-0002-1294-5269; Hirose, Tomonori/0000-0003-2428-0919; Hirose, Tomonori/0000-0003-2428-0919	Yokohama City University Center of Excellence Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Japan Society for the Promotion of Science; Mitsubishi Foundation	Yokohama City University Center of Excellence Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mitsubishi Foundation	This work was supported by the Yokohama City University Center of Excellence Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT). This work was also supported in part by grants from the Japan Society for the Promotion of Science, by grants from MEXT, and by the Mitsubishi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2005, J AM SOC NEPHROL, V16, P2257, DOI 10.1681/ASN.2004121134; Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; Feng W, 2008, J BIOL CHEM, V283, P23440, DOI 10.1074/jbc.M802482200; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Hartleben B, 2008, J BIOL CHEM, V283, P23033, DOI 10.1074/jbc.M803143200; Hirabayashi S, 2005, LAB INVEST, V85, P1528, DOI 10.1038/labinvest.3700347; Hirose T, 2006, DEVELOPMENT, V133, P1389, DOI 10.1242/dev.02294; Huber TB, 2003, HUM MOL GENET, V12, P3397, DOI 10.1093/hmg/ddg360; Iden S, 2006, EMBO REP, V7, P1239, DOI 10.1038/sj.embor.7400819; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Johnstone DB, 2006, NAT CLIN PRACT NEPHR, V2, P271, DOI 10.1038/ncpneph0180; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Kerjaschki D, 2001, J CLIN INVEST, V108, P1583, DOI 10.1172/JCI200114629; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; KURIHARA H, 1992, AM J PATHOL, V141, P805; Lee DBN, 2006, AM J PHYSIOL-RENAL, V290, pF20, DOI 10.1152/ajprenal.00052.2005; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; MUNDLOS S, 1993, DEVELOPMENT, V119, P1329; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Reiser J, 2000, J AM SOC NEPHROL, V11, P1, DOI 10.1681/ASN.V1111; SCHNABEL E, 1990, J CELL BIOL, V111, P1255, DOI 10.1083/jcb.111.3.1255; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI200112849; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Simons M, 2001, AM J PATHOL, V159, P1069, DOI 10.1016/S0002-9440(10)61782-8; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Tryggvason K, 1999, J AM SOC NEPHROL, V10, P2440; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6; Yuan HP, 2002, AM J PHYSIOL-RENAL, V282, pF585, DOI 10.1152/ajprenal.00290.2001	38	55	57	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4194	10.1371/journal.pone.0004194	http://dx.doi.org/10.1371/journal.pone.0004194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142224	Green Published, gold, Green Submitted			2022-12-25	WOS:000265479700014
J	Tuvim, MJ; Evans, SE; Clement, CG; Dickey, BF; Gilbert, BE				Tuvim, Michael J.; Evans, Scott E.; Clement, Cecilia G.; Dickey, Burton F.; Gilbert, Brian E.			Augmented Lung Inflammation Protects against Influenza A Pneumonia	PLOS ONE			English	Article								Background: Influenza pneumonia causes high mortality every year, and pandemic episodes kill millions of people. Influenza-related mortality has been variously ascribed to an ineffective host response that fails to limit viral replication, an excessive host inflammatory response that results in lung injury and impairment of gas exchange, or to bacterial superinfection. We sought to determine whether lung inflammation promoted or impaired host survival in influenza pneumonia. Methods and Findings: To distinguish among these possible causes of influenza-related death, we induced robust lung inflammation by exposing mice to an aerosolized bacterial lysate prior to challenge with live virus. The treatment induced expression of the inflammatory cytokines IL-6 and TNF in bronchoalveolar lavage fluid 8- and 40-fold greater, respectively, than that caused by lethal influenza infection. Yet, this augmented inflammation was associated with striking resistance to host mortality (0% vs 90% survival, p = 0.0001) and reduced viral titers (p = 0.004). Bacterial superinfection of virus infected lungs was not observed. When mice were repeatedly exposed to the bacterial lysate, as would be clinically desirable during an influenza epidemic, there was no tachyphylaxis of the induced viral resistance. When the bacterial lysate was administered after the viral challenge, there was still some mortality benefit, and when ribavirin was added to the aerosolized bacterial lysate, host survival was synergistically improved (0% vs 93.3% survival, p < 0.0001). Conclusions: Together, these data indicate that innate immune resistance to influenza can be effectively stimulated, and suggest that ineffective rather than excessive inflammation is the major cause of mortality in influenza pneumonia.	[Tuvim, Michael J.; Evans, Scott E.; Clement, Cecilia G.; Dickey, Burton F.] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA; [Tuvim, Michael J.; Evans, Scott E.; Dickey, Burton F.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Lung Inflammat & Infect, Houston, TX USA; [Gilbert, Brian E.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Baylor College of Medicine	Evans, SE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA.	seevans@mdanderson.org	Clement, Cecilia/AAP-1141-2020	Tuvim, Michael/0000-0001-8126-7716; Dickey, Burton/0000-0002-4780-1847; Evans, Scott/0000-0003-4503-0644	Virology Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health [N01-AI-15437]; National Center for Research Resources, National Institutes of Health [KL2-RR-02419]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002419] Funding Source: NIH RePORTER	Virology Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by contract N01-AI-15437 from the Virology Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health to Dr. Gilbert. Dr Evans is supported by KL2-RR-02419 from the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Brundage JF, 2006, LANCET INFECT DIS, V6, P303, DOI 10.1016/S1473-3099(06)70466-2; Budd A, 2007, ANTIMICROB AGENTS CH, V51, P2965, DOI 10.1128/AAC.00219-07; Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07; Clement CG, 2008, AM J RESP CRIT CARE, V177, P1322, DOI 10.1164/rccm.200607-1038OC; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; Fang LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002268; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Garcia-Sastre A, 2006, EMERG INFECT DIS, V12, P44, DOI 10.3201/eid1201.051186; GILBERT BE, 1992, ANTIVIR RES, V17, P33, DOI 10.1016/0166-3542(92)90088-M; Gilbert BE, 2008, ANTIVIR RES, V78, P223, DOI 10.1016/j.antiviral.2008.01.005; Hayden FG, 2006, J INFECT DIS, V194, pS119, DOI 10.1086/507552; Hillman MR, 2002, VACCINE, V20, P3055, DOI 10.1016/S0264-410X(02)00300-6; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Joos Ladina, 2005, Proc Am Thorac Soc, V2, P445, DOI 10.1513/pats.200508-097JS; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kim KD, 2007, NAT MED, V13, P1248, DOI 10.1038/nm1633; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; Moghaddam SJ, 2008, AM J RESP CELL MOL, V38, P629, DOI 10.1165/rcmb.2007-0366OC; Rothberg MB, 2008, AM J MED, V121, P258, DOI 10.1016/j.amjmed.2007.10.040; Salomon R, 2007, P NATL ACAD SCI USA, V104, P12479, DOI 10.1073/pnas.0705289104; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Wang JP, 2007, CELL MICROBIOL, V9, P1641, DOI 10.1111/j.1462-5822.2007.00961.x; World Health Organization, 2004, WORLD HLTH REP 2004; WYDE PR, 1977, INFECT IMMUN, V15, P221, DOI 10.1128/IAI.15.1.221-229.1977; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105	30	82	86	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2009	4	1							e4176	10.1371/journal.pone.0004176	http://dx.doi.org/10.1371/journal.pone.0004176			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ID	19137067	gold, Green Published			2022-12-25	WOS:000265479500007
J	Flowers, S; Nagl, NG; Beck, GR; Moran, E				Flowers, Stephen; Nagl, Norman G., Jr.; Beck, George R., Jr.; Moran, Elizabeth			Antagonistic Roles for BRM and BRG1 SWI/SNF Complexes in Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEXES; MURINE MC3T3-E1 CELLS; OSTEOBLAST DIFFERENTIATION; CYCLE CONTROL; EXPRESSION; GENE; SUBUNITS; BONE; TRANSCRIPTION; ACETYLATION	The mammalian SWI/SNF chromatin-remodeling complex is essential for the multiple changes in gene expression that occur during differentiation. However, the basis within the complex for specificity in effecting positive versus negative changes in gene expression has only begun to be elucidated. The catalytic core of the complex can be either of two closely related ATPases, BRM or BRG1, with the potential that the choice of alternative subunits is a key determinant of specificity. Short hairpin RNA-mediated depletion of the ATPases was used to explore their respective roles in the well characterized multistage process of osteoblast differentiation. The results reveal an unexpected role for BRM-specific complexes. Instead of impeding differentiation as was seen with BRG1 depletion, depletion of BRM caused accelerated progression to the differentiation phenotype. Multiple tissue-specific differentiation markers, including the tightly regulated late stage marker osteocalcin, become constitutively up-regulated in BRM-depleted cells. Chromatin immunoprecipitation analysis of the osteocalcin promoter as a model for the behavior of the complexes indicates that the promoter is a direct target of both BRM- and BRG1-containing complexes. BRG1 complexes, which are required for activation, are associated with the promoter well before induction, but the concurrent presence of BRM- specific complexes overrides their activation function. BRM- specific complexes are present only on the repressed promoter and are required for association of the corepressor HDAC1. These findings reveal an unanticipated degree of specialization of function linked with the choice of ATPase and suggest a new paradigm for the roles of the alternative subunits during differentiation.	[Flowers, Stephen; Moran, Elizabeth] Univ Med & Dent New Jersey, Univ Hosp Canc Ctr, New Jersey Med Sch, Dept Orthopaed, Newark, NJ 07103 USA; [Nagl, Norman G., Jr.] Temple Univ, Sch Med, Fels Inst Canc Res, Philadelphia, PA 19140 USA; [Beck, George R., Jr.] Emory Univ, Sch Med, Div Endocrinol Metab & Lipids, Atlanta, GA 30322 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Emory University	Moran, E (corresponding author), NJMS UH Canc Ctr, G-1200,205 S Orange Ave, Newark, NJ 07101 USA.	MoranEL@umdnj.edu	Beck, George/AAO-2117-2020		National Institutes of Health [GM073257]; USPSH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073257] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPSH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM073257 from the USPSH ( to E. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beck GR, 2001, CELL GROWTH DIFFER, V12, P61; Beck GR, 1998, J CELL BIOCHEM, V68, P269, DOI 10.1002/(SICI)1097-4644(19980201)68:2<269::AID-JCB13>3.0.CO;2-A; Beck GR, 2003, EXP CELL RES, V288, P288, DOI 10.1016/S0014-4827(03)00213-1; Blais A, 2007, CURR OPIN CELL BIOL, V19, P658, DOI 10.1016/j.ceb.2007.10.003; Brodeur MR, 2008, J BONE MINER RES, V23, P326, DOI 10.1359/JBMR.071022; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Choi JY, 1996, J CELL BIOCHEM, V61, P609, DOI 10.1002/(SICI)1097-4644(19960616)61:4<609::AID-JCB15>3.3.CO;2-Q; Das AV, 2007, J BIOL CHEM, V282, P35187, DOI 10.1074/jbc.M706742200; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Glaros S, 2007, ONCOGENE, V26, P7058, DOI 10.1038/sj.onc.1210514; Griffin CT, 2008, DEVELOPMENT, V135, P493, DOI 10.1242/dev.010090; Inoue H, 2002, J BIOL CHEM, V277, P41674, DOI 10.1074/jbc.M205961200; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Klochendler-Yeivin A, 2002, CURR OPIN GENET DEV, V12, P73, DOI 10.1016/S0959-437X(01)00267-2; Lee HW, 2006, MOL ENDOCRINOL, V20, P2432, DOI 10.1210/me.2006-0061; Lee JS, 2006, J BONE MINER RES, V21, P921, DOI 10.1359/JBMR.060303; MARSHALL TW, 2003, CURR OPIN GENE DEV, V13, P136; Matsumoto S, 2006, DEV BIOL, V289, P372, DOI 10.1016/j.ydbio.2005.10.044; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Montecino M, 2007, BIOCHEM CELL BIOL, V85, P419, DOI 10.1139/O07-070; Nagl NG, 2006, CANCER RES, V66, P1289, DOI 10.1158/0008-5472.CAN-05-3427; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; Nightingale KP, 2007, J BIOL CHEM, V282, P4408, DOI 10.1074/jbc.M606773200; QUARLES LD, 1992, J BONE MINER RES, V7, P683; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Reyes-Botella C, 2002, CELL PHYSIOL BIOCHEM, V12, P359, DOI 10.1159/000067906; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Smith CL, 2005, CURR TOP DEV BIOL, V65, P115; Stein GS, 1996, PHYSIOL REV, V76, P593, DOI 10.1152/physrev.1996.76.2.593; Strobeck MW, 2002, J BIOL CHEM, V277, P4782, DOI 10.1074/jbc.M109532200; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Villagra A, 2006, J BIOL CHEM, V281, P22695, DOI 10.1074/jbc.M511640200; Wang F, 2004, J BIOL CHEM, V279, P46733, DOI 10.1074/jbc.M409002200; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang XM, 2004, BIOCHEM J, V383, P319, DOI 10.1042/BJ20040524; YACIUK P, 1991, MOL CELL BIOL, V11, P5389, DOI 10.1128/MCB.11.11.5389; Yang XL, 2002, TRENDS MOL MED, V8, P340, DOI 10.1016/S1471-4914(02)02340-7	42	75	79	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10067	10075		10.1074/jbc.M808782200	http://dx.doi.org/10.1074/jbc.M808782200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19144648	hybrid, Green Published			2022-12-25	WOS:000264892900049
J	Unno, H; Yamashita, S; Ikeda, Y; Sekiguchi, S; Yoshida, N; Yoshimura, T; Kusunoki, M; Nakayama, T; Nishino, T; Hemmi, H				Unno, Hideaki; Yamashita, Satoshi; Ikeda, Yosuke; Sekiguchi, Shin-ya; Yoshida, Norie; Yoshimura, Tohru; Kusunoki, Masami; Nakayama, Toru; Nishino, Tokuzo; Hemmi, Hisashi			New Role of Flavin as a General Acid-Base Catalyst with No Redox Function in Type 2 Isopentenyl-diphosphate Isomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; STAPHYLOCOCCUS-AUREUS; THERMUS-THERMOPHILUS; MECHANISM; COFACTOR; PYROPHOSPHATE; BIOSYNTHESIS; INACTIVATION; FLAVOENZYMES; VERSATILITY	Using FMN and a reducing agent such as NAD(P) H, type 2 isopentenyl-diphosphate isomerase catalyzes isomerization between isopentenyl diphosphate and dimethylallyl diphosphate, both of which are elemental units for the biosynthesis of highly diverse isoprenoid compounds. Although the flavin cofactor is expected to be integrally involved in catalysis, its exact role remains controversial. Here we report the crystal structures of the substrate-free and complex forms of type 2 isopentenyl-diphosphate isomerase from the thermoacidophilic archaeon Sulfolobus shibatae, not only in the oxidized state but also in the reduced state. Based on the active-site structures of the reduced FMN-substrate-enzyme ternary complexes, which are in the active state, and on the data from site-directed mutagenesis at highly conserved charged or polar amino acid residues around the active site, we demonstrate that only reduced FMN, not amino acid residues, can catalyze proton addition/elimination required for the isomerase reaction. This discovery is the first evidence for this long suspected, but previously unobserved, role of flavins just as a general acid-base catalyst without playing any redox roles, and thereby expands the known functions of these versatile coenzymes.	[Sekiguchi, Shin-ya; Yoshida, Norie; Yoshimura, Tohru; Hemmi, Hisashi] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Unno, Hideaki] Nagasaki Univ, Fac Engn, Dept Appl Chem, Nagasaki 8528521, Japan; [Yamashita, Satoshi; Ikeda, Yosuke; Nakayama, Toru; Nishino, Tokuzo] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan; [Kusunoki, Masami] Osaka Univ, Inst Prot Res, Res Ctr Struct & Funct Prote, Suita, Osaka 5650871, Japan	Nagoya University; Nagasaki University; Tohoku University; Osaka University	Hemmi, H (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	hhemmi@agr.nagoya-u.ac.jp	Hideaki, UNNO/ABG-9471-2020; Hemmi, Hisashi/I-6868-2014	Hideaki, UNNO/0000-0001-5917-269X; Hemmi, Hisashi/0000-0002-9538-809X	Ministry of Education, Culture, Sports, Science and Technology of Japan [15370049, 18780053]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part Ministry of Education, Culture, Sports, Science and Technology of Japan by Grants-in-aid for Scientific Research 15370049 (to T. N.) and 18780053 (to H. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barkley SJ, 2004, ORG LETT, V6, P5019, DOI 10.1021/ol0477273; Bornemann S, 2002, NAT PROD REP, V19, P761, DOI 10.1039/b108916c; Christianson DW, 2007, SCIENCE, V316, P60, DOI 10.1126/science.1141630; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; de Ruyck J, 2005, BIOCHEM BIOPH RES CO, V338, P1515, DOI 10.1016/j.bbrc.2005.10.114; de Ruyck J, 2008, BIOCHEMISTRY-US, V47, P9051, DOI 10.1021/bi801159x; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hemmi H, 2004, BIOCHEM BIOPH RES CO, V322, P905, DOI 10.1016/j.bbrc.2004.08.013; Hoshino T, 2006, BIOORGAN MED CHEM, V14, P6555, DOI 10.1016/j.bmc.2006.06.011; Johnston JB, 2007, J AM CHEM SOC, V129, P7740, DOI 10.1021/ja072501r; Kaneda K, 2001, P NATL ACAD SCI USA, V98, P932, DOI 10.1073/pnas.020472198; Kao CL, 2005, ORG LETT, V7, P5677, DOI 10.1021/ol0524050; Kittleman W, 2007, BIOCHEMISTRY-US, V46, P8401, DOI 10.1021/bi700286a; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuzuyama T, 2003, NAT PROD REP, V20, P171, DOI 10.1039/b109860h; Laupitz R, 2004, CHEM BIODIVERS, V1, P1367, DOI 10.1002/cbdv.200490099; Lennon BW, 1999, PROTEIN SCI, V8, P2366; Ludwig ML, 1997, BIOCHEMISTRY-US, V36, P1259, DOI 10.1021/bi962180o; Macheroux Peter, 2005, BMC Biochem, V6, P26, DOI 10.1186/1471-2091-6-26; Maclean J, 2003, STRUCTURE, V11, P1499, DOI 10.1016/j.str.2003.11.005; Mansoorabadi SO, 2007, J ORG CHEM, V72, P6329, DOI 10.1021/jo0703092; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Miller SM, 2004, NAT STRUCT MOL BIOL, V11, P497, DOI 10.1038/nsmb0604-497; Miura R, 2001, CHEM REC, V1, P183, DOI 10.1002/tcr.1007; MUEHLBACHER M, 1988, BIOCHEMISTRY-US, V27, P7315, DOI 10.1021/bi00419a021; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RamosValdivia AC, 1997, NAT PROD REP, V14, P591, DOI 10.1039/np9971400591; REARDON JE, 1986, BIOCHEMISTRY-US, V25, P5609, DOI 10.1021/bi00367a040; Rothman SC, 2008, J AM CHEM SOC, V130, P4906, DOI 10.1021/ja7108954; Rothman SC, 2007, BIOCHEMISTRY-US, V46, P5437, DOI 10.1021/bi0616347; Soltero-Higgin M, 2004, NAT STRUCT MOL BIOL, V11, P539, DOI 10.1038/nsmb772; Steinbacher S, 2003, J MOL BIOL, V329, P973, DOI 10.1016/S0022-2836(03)00527-8; Thibodeaux CJ, 2008, BIOCHEMISTRY-US, V47, P2547, DOI 10.1021/bi701467g; Yamashita S, 2004, EUR J BIOCHEM, V271, P1087, DOI 10.1111/j.1432-1033.2004.04010.x; Zheng W, 2007, J MOL BIOL, V366, P1447, DOI 10.1016/j.jmb.2006.12.055	39	38	40	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9160	9167		10.1074/jbc.M808438200	http://dx.doi.org/10.1074/jbc.M808438200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19158086	Green Published, hybrid			2022-12-25	WOS:000264669100021
J	Zhu, DH; Wu, J; Spee, C; Ryan, SJ; Hinton, DR				Zhu, DanHong; Wu, Jian; Spee, Christine; Ryan, Stephen J.; Hinton, David R.			BMP4 Mediates Oxidative Stress-induced Retinal Pigment Epithelial Cell Senescence and Is Overexpressed in Age-related Macular Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NORMAL HUMAN FIBROBLASTS; PROTEIN-KINASE PATHWAY; MAP KINASE; IN-VITRO; SIGNALING PATHWAYS; ARPE-19 CELLS; GROWTH ARREST; UV-RADIATION; EXPRESSION; P53	The retinal pigment epithelium is a primary site of pathology in age-related macular degeneration. Oxidative stress and senescence are both thought to be important mediators of macular degeneration pathogenesis. We demonstrate here that bone morphogenetic protein-4 is highly expressed in the retinal pigment epithelium and adjacent extracellular matrix of patients with dry age-related macular degeneration. In vitro studies revealed that sublethal oxidative stress increased bone morphogenetic protein-4 expression in retinal pigment epithelial cells, and both bone morphogenetic protein-4 and persistent mild oxidative stress can induce retinal pigment epithelial cell senescence through p53-p21(Cip1/WAF1)-Rb pathway. We further demonstrate that bone morphogenetic protein-4 acts as a mediator in oxidative stress-induced senescence and that this mediator function is via Smad and the p38 signaling pathway to increase and activate p53 and p21(Cip1/WAF1) and decrease phospho-Rb. Oxidative stress-induced senescence can be blocked by Chordin-like, an antagonist of bone morphogenetic protein-4, or SB203580, a phospho-p38 inhibitor. Our results suggest that oxidative stress and bone morphogenetic protein-4 may interact to promote retinal pigment epithelial cell senescence and that bone morphogenetic protein-4 may represent a novel therapeutic target to inhibit the progressive effects of oxidative stress and senescence in dry age-related macular degeneration.	[Zhu, DanHong; Wu, Jian; Hinton, David R.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Zhu, DanHong; Spee, Christine; Ryan, Stephen J.; Hinton, David R.] Univ So Calif, Keck Sch Med, Arnold & Mabel Beckman Macular Res Ctr, Los Angeles, CA 90033 USA; [Zhu, DanHong; Spee, Christine; Ryan, Stephen J.; Hinton, David R.] Univ So Calif, Keck Sch Med, Doheny Eye Inst, Los Angeles, CA 90033 USA; [Ryan, Stephen J.] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; Doheny Eye Institute; University of Southern California; University of Southern California	Hinton, DR (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol, 2011 Zonal Ave,HMR209, Los Angeles, CA 90033 USA.	dhinton@usc.edu			National Institutes of Health [EY01545]; Core [EY03040]; NATIONAL EYE INSTITUTE [R01EY001545, P30EY003040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Core(Luxembourg National Research Fund); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part by National Institutes of Health Grants EY01545 (to S. J. R.) and Core grant EY03040.	Afshari CA, 1996, CELL GROWTH DIFFER, V7, P979; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Barnouin K, 2002, J BIOL CHEM, V277, P13761, DOI 10.1074/jbc.M111123200; Bensaad K, 2005, NAT MED, V11, P1278, DOI 10.1038/nm1205-1278; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Chan CC, 2008, OPHTHALMIC RES, V40, P124, DOI 10.1159/000119862; Chen QM, 1998, BIOCHEM J, V332, P43, DOI 10.1042/bj3320043; Chretien A, 2008, FREE RADICAL BIO MED, V44, P1732, DOI 10.1016/j.freeradbiomed.2008.01.026; Colavitti R, 2005, IUBMB LIFE, V57, P277, DOI 10.1080/15216540500091890; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Cuadrado A, 2007, EMBO J, V26, P2115, DOI 10.1038/sj.emboj.7601657; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; EL DW, 1993, CELL, V75, P817; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724; Glotin AL, 2008, FREE RADICAL BIO MED, V44, P1348, DOI 10.1016/j.freeradbiomed.2007.12.023; Goswami M, 2001, DEV BIOL, V236, P259, DOI 10.1006/dbio.2001.0338; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Holz FG, 2004, AM J OPHTHALMOL, V137, P504, DOI 10.1016/j.ajo.2003.11.026; Honda S, 2001, INVEST OPHTH VIS SCI, V42, P2419; Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kendall SE, 2005, MOL CELL BIOL, V25, P7711, DOI 10.1128/MCB.25.17.7711-7724.2005; Kimura N, 2000, J BIOL CHEM, V275, P17647, DOI 10.1074/jbc.M908622199; King A, 2004, PHOTOCHEM PHOTOBIOL, V79, P470, DOI 10.1562/LE-03-17.1; Klein ML, 2008, OPHTHALMOLOGY, V115, P1026, DOI 10.1016/j.ophtha.2007.08.030; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; Lopez PF, 1996, INVEST OPHTH VIS SCI, V37, P855; Matsunaga H, 1999, INVEST OPHTH VIS SCI, V40, P197; Mishima K, 1999, INVEST OPHTH VIS SCI, V40, P1590; Muller F, 2007, DEVELOPMENT, V134, P3483, DOI 10.1242/dev.02884; Nagata Y, 2007, MACROMOLECULES, V40, P6, DOI 10.1021/ma062007s; Nakayama N, 2001, DEV BIOL, V232, P372, DOI 10.1006/dbio.2001.0200; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Ng KP, 2008, MOL CELL PROTEOMICS, V7, P1397, DOI 10.1074/mcp.M700525-MCP200; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Nordgaard CL, 2006, INVEST OPHTH VIS SCI, V47, P815, DOI 10.1167/iovs.05-0976; Pardali K, 2005, J CELL PHYSIOL, V204, P260, DOI 10.1002/jcp.20304; Pouliot F, 2002, J ENDOCRINOL, V172, P187, DOI 10.1677/joe.0.1720187; Roth F, 2004, GRAEF ARCH CLIN EXP, V242, P710, DOI 10.1007/s00417-004-0976-x; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sakuta H, 2001, SCIENCE, V293, P111, DOI 10.1126/science.1058379; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; SARKS SH, 1976, BRIT J OPHTHALMOL, V60, P324, DOI 10.1136/bjo.60.5.324; SCHATZ H, 1975, International Ophthalmology Clinics, V15, P169, DOI 10.1097/00004397-197501510-00014; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Seomun Y, 2005, MOL VIS, V11, P764; Severino J, 2000, EXP CELL RES, V257, P162, DOI 10.1006/excr.2000.4875; She QB, 2000, J BIOL CHEM, V275, P20444, DOI 10.1074/jbc.M001020200; Shen JK, 2007, HISTOL HISTOPATHOL, V22, P1301, DOI 10.14670/HH-22.1301; Smith RT, 2006, INVEST OPHTH VIS SCI, V47, P5495, DOI 10.1167/iovs.05-1318; Sorescu GP, 2004, CIRC RES, V95, P773, DOI 10.1161/01.RES.0000145728.22878.45; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Timmers C, 2007, MOL CELL BIOL, V27, P65, DOI 10.1128/MCB.02147-06; Wachi H, 2005, CLIN BIOCHEM, V38, P643, DOI 10.1016/j.clinbiochem.2005.04.006; Weigel AL, 2002, FREE RADICAL BIO MED, V33, P1419, DOI 10.1016/S0891-5849(02)01082-1; WHEATLEY HM, 1995, ARCH OPHTHALMOL-CHIC, V113, P103, DOI 10.1001/archopht.1995.01100010105028; Yu JD, 2004, J BIOL CHEM, V279, P42211, DOI 10.1074/jbc.M408223200; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zeng YX, 1996, ONCOGENE, V12, P1557; Zhu XY, 1996, J CELL BIOL, V133, P391, DOI 10.1083/jcb.133.2.391	70	67	71	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9529	9539		10.1074/jbc.M809393200	http://dx.doi.org/10.1074/jbc.M809393200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19158083	Green Published, hybrid			2022-12-25	WOS:000264669100059
J	Temme, C; Weissbach, R; Lilie, H; Wilson, C; Meinhart, A; Meyer, S; Golbik, R; Schierhorn, A; Wahle, E				Temme, Claudia; Weissbach, Rebekka; Lilie, Hauke; Wilson, Clive; Meinhart, Anton; Meyer, Sylke; Golbik, Ralph; Schierhorn, Angelika; Wahle, Elmar			The Drosophila melanogaster Gene cg(4930) Encodes a High Affinity Inhibitor for Endonuclease G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOTIC DNA-DEGRADATION; POLY(A)-BINDING PROTEIN; CRYSTAL-STRUCTURE; CELL-DEATH; NUCLEASE; COMPLEX; RIBONUCLEASE; INVOLVEMENT; GENERATION; IMMUNITY	Endonuclease G (EndoG) is a mitochondrial enzyme believed to be released during apoptosis to participate in the degradation of nuclear DNA. This paper describes a Drosophila protein, EndoGI, which inhibits EndoG specifically. EndoG and EndoGI associate with subpicomolar affinity, forming a 2: 1 complex in which dimeric EndoG is bound by two tandemly repeated homologous domains of monomeric EndoGI. Binding appears to involve the active site of EndoG. EndoGI is present in the cell nucleus at micromolar concentrations. Upon induction of apoptosis, levels of the inhibitor appear to be reduced, and it is relocalized to the cytoplasm. EndoGI, encoded by the predicted open reading frame cg4930, is expressed throughout Drosophila development. Flies homozygous for a hypomorphic EndoGI mutation have a strongly reduced viability, which is modulated by genetic background and diet. We propose that EndoGI protects the cell against low levels of EndoG outside mitochondria.	[Golbik, Ralph; Schierhorn, Angelika; Wahle, Elmar] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Germany; [Wilson, Clive] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; [Meinhart, Anton] Max Planck Inst Med Res, Dept Biomol Mechanisms, D-69120 Heidelberg, Germany	Martin Luther University Halle Wittenberg; University of Oxford; Max Planck Society	Wahle, E (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, Kurt Mothes Str 3, D-06120 Halle, Germany.	ewahle@biochemtech.uni-halle.de	Meinhart, Anton/M-9647-2014	Wahle, Elmar/0000-0003-2504-0677	Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by grants from the Deutsche Forschungsgemeinschaft and the Fonds der Chemischen Industrie ( to E. W.).	Acevedo SF, 2007, GENETICS, V177, P239, DOI 10.1534/genetics.107.072280; Bahi N, 2006, J BIOL CHEM, V281, P22943, DOI 10.1074/jbc.M601025200; Benoit B, 1999, NUCLEIC ACIDS RES, V27, P3771, DOI 10.1093/nar/27.19.3771; Bonisch C, 2007, J BIOL CHEM, V282, P21818, DOI 10.1074/jbc.M702998200; Buttner S, 2007, CELL CYCLE, V6, P1072, DOI 10.4161/cc.6.9.4218; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Carr S, 2000, STRUCTURE, V8, P949, DOI 10.1016/S0969-2126(00)00186-6; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; COTE J, 1993, SCIENCE, V261, P765, DOI 10.1126/science.7688144; Cymerman IA, 2008, NUCLEIC ACIDS RES, V36, P1369, DOI 10.1093/nar/gkm1169; David KK, 2006, CELL DEATH DIFFER, V13, P1147, DOI 10.1038/sj.cdd.4401787; Dickson KA, 2005, PROG NUCLEIC ACID RE, V80, P349, DOI 10.1016/S0079-6603(05)80009-1; Fic W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000253; Franke I, 1999, J BIOL CHEM, V274, P825, DOI 10.1074/jbc.274.2.825; Fronz K, 2008, J BIOL CHEM, V283, P20408, DOI 10.1074/jbc.M802329200; GERSCHENSON M, 1995, NUCLEIC ACIDS RES, V23, P88, DOI 10.1093/nar/23.1.88; Ghosh M, 2007, J BIOL CHEM, V282, P5682, DOI 10.1074/jbc.M605986200; HARTLEY RW, 1989, TRENDS BIOCHEM SCI, V14, P450, DOI 10.1016/0968-0004(89)90104-7; Huang KJ, 2006, P NATL ACAD SCI USA, V103, P8995, DOI 10.1073/pnas.0603445103; Huang KJ, 2002, J BIOL CHEM, V277, P21071, DOI 10.1074/jbc.M201785200; Irvine RA, 2005, MOL CELL BIOL, V25, P294, DOI 10.1128/MCB.25.1.294-302.2005; Ishihara Y, 2006, J BIOL CHEM, V281, P6726, DOI 10.1074/jbc.M510382200; Kalinowska M, 2005, APOPTOSIS, V10, P821, DOI 10.1007/s10495-005-0410-9; Kerwitz Y, 2003, EMBO J, V22, P3705, DOI 10.1093/emboj/cdg347; Korner CG, 1998, EMBO J, V17, P5427, DOI 10.1093/emboj/17.18.5427; Kuhlmann UC, 1999, FEBS LETT, V463, P1, DOI 10.1016/S0014-5793(99)01499-4; LaGrandeur TE, 1998, EMBO J, V17, P1487, DOI 10.1093/emboj/17.5.1487; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Miller MD, 1996, PROTEIN SCI, V5, P24; Mukae N, 2002, GENE DEV, V16, P2662, DOI 10.1101/gad.1022802; MUOPASTOR AM, 1997, J MOL BIOL, V268, P589; Niikura Y, 2007, J CELL BIOL, V178, P283, DOI 10.1083/jcb.200702134; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Parrish JZ, 2006, CHROMOSOMA, V115, P89, DOI 10.1007/s00412-005-0038-0; Parrish JZ, 2003, EMBO J, V22, P3451, DOI 10.1093/emboj/cdg320; Parrish JZ, 2003, MOL CELL, V11, P987, DOI 10.1016/S1097-2765(03)00095-9; Rudolph T, 1999, DROSOPHILA INF SERV, V82, P99; Samejima K, 2005, NAT REV MOL CELL BIO, V6, P677, DOI 10.1038/nrm1715; Sauter C, 2003, NUCLEIC ACIDS RES, V31, P4091, DOI 10.1093/nar/gkg480; Schafer P, 2004, J MOL BIOL, V338, P217, DOI 10.1016/j.jmb.2004.02.069; Temme C, 2004, EMBO J, V23, P2862, DOI 10.1038/sj.emboj.7600273; van Loo G, 2001, CELL DEATH DIFFER, V8, P1136, DOI 10.1038/sj.cdd.4400944; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Widlak P, 2005, J CELL BIOCHEM, V94, P1078, DOI 10.1002/jcb.20409; Widlak P, 2001, J BIOL CHEM, V276, P48404, DOI 10.1074/jbc.M108461200; Zhao TB, 2007, J BIOL CHEM, V282, P12104, DOI 10.1074/jbc.M611006200	47	34	34	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8337	8348		10.1074/jbc.M808319200	http://dx.doi.org/10.1074/jbc.M808319200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19129189	Green Published, hybrid			2022-12-25	WOS:000264397800018
J	Wang, ZC; Wijewickrama, GT; Peng, KW; Dietz, BM; Yuan, L; van Breemen, RB; Bolton, JL; Thatcher, GRJ				Wang, Zhican; Wijewickrama, Gihani T.; Peng, Kuan-wei; Dietz, Birgit M.; Yuan, Long; van Breemen, Richard B.; Bolton, Judy L.; Thatcher, Gregory R. J.			Estrogen Receptor alpha Enhances the Rate of Oxidative DNA Damage by Targeting an Equine Estrogen Catechol Metabolite to the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; POSTMENOPAUSAL HORMONE-THERAPY; RANDOMIZED CONTROLLED-TRIAL; TANDEM MASS-SPECTROMETRY; SINGLE-STRAND BREAKS; SCREENING MAMMOGRAPHY; GENE-EXPRESSION; PLUS PROGESTIN; IN-VITRO; CARCINOGENESIS	Exposure to estrogens increases the risk of breast and endometrial cancer. It is proposed that the estrogen receptor ( ER) may contribute to estrogen carcinogenesis by transduction of the hormonal signal and as a "Trojan horse" concentrating genotoxic estrogen metabolites in the nucleus to complex with DNA, enhancing DNA damage. 4-Hydroxyequilenin (4-OHEN), the major catechol metabolite of equine estrogens present in estrogen replacement formulations, autoxidizes to a redox-cycling quinone that has been shown to cause DNA damage. 4-OHEN was found to be an estrogen of nanomolar potency in cell culture using a luciferase reporter assay and, using a chromatin immunoprecipitation assay, was found to activate ER alpha binding to estrogen-responsive genes in MCF-7 cells. DNA damage was measured in cells by comparing ER alpha(+) versus ER alpha(-) cells and 4-OHEN versus menadione, a reactive oxygen species (ROS)-generating, but non-estrogenic, quinone. 4-OHEN selectively induced DNA damage in ER alpha(+) cells, whereas menadione-induced damage was not dependent on cellular ER status. The rate of 4-OHEN-induced DNA damage was significantly enhanced in ER alpha(+) cells, whereas ER status had no effect on the rate of menadione-induced damage. Imaging of ROSinduced by 4-OHEN showed accumulation selective for the nucleus of ER alpha(+) cells within 5 min, whereas in ER alpha(-) or menadione-treated cells, no selectivity was observed. These data support ER alpha acting as a Trojan horse concentrating 4-OHEN in the nucleus to accelerate the rate of ROS generation and thereby amplify DNA damage. The Trojan horse mechanism may be of general importance beyond estrogen genotoxins.	[Wang, Zhican; Wijewickrama, Gihani T.; Peng, Kuan-wei; Dietz, Birgit M.; Yuan, Long; van Breemen, Richard B.; Bolton, Judy L.; Thatcher, Gregory R. J.] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy MC 781, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bolton, JL (corresponding author), 833 S Wood St, Chicago, IL 60612 USA.	judyb@uic.edu; thatcher@uic.edu	Yuan, Long/H-9552-2013; van Breemen, Richard/AAO-2875-2020	Yuan, Long/0000-0003-1863-2308; van Breemen, Richard/0000-0003-2016-0063	National Institutes of Health [CA130037]; NATIONAL CANCER INSTITUTE [R01CA130037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA130037 ( to J. L. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bocchinfuso WP, 1997, J MAMMARY GLAND BIOL, V2, P323, DOI 10.1023/A:1026339111278; Bocchinfuso WP, 1999, CANCER RES, V59, P1869; Bolton JL, 2002, TOXICOLOGY, V177, P55, DOI 10.1016/S0300-483X(02)00195-6; Bolton JL, 1998, CHEM RES TOXICOL, V11, P1113, DOI 10.1021/tx9801007; Bolton JL, 2008, CHEM RES TOXICOL, V21, P93, DOI 10.1021/tx700191p; Burczynski ME, 2000, CANCER RES, V60, P908; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Cavalieri EL, 1997, P NATL ACAD SCI USA, V94, P10937, DOI 10.1073/pnas.94.20.10937; Cavalieri E, 2006, BBA-REV CANCER, V1766, P63, DOI 10.1016/j.bbcan.2006.03.001; Chang MS, 2007, ENDOCRINOLOGY, V148, P4793, DOI 10.1210/en.2006-1568; Chen YM, 1998, CHEM RES TOXICOL, V11, P1105, DOI 10.1021/tx980083l; Chen YM, 2000, CHEM RES TOXICOL, V13, P342, DOI 10.1021/tx990186j; CHO HS, 1991, MOL ENDOCRINOL, V5, P1323, DOI 10.1210/mend-5-9-1323; Cobleigh MA, 1999, JAMA-J AM MED ASSOC, V281, P1528, DOI 10.1001/jama.281.16.1528; COLDITZ GA, 1995, NEW ENGL J MED, V332, P1589, DOI 10.1056/NEJM199506153322401; Collins AR, 1997, MUTAT RES-FUND MOL M, V375, P183, DOI 10.1016/S0027-5107(97)00013-4; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Embrechts J, 2003, J AM SOC MASS SPECTR, V14, P482, DOI 10.1016/S1044-0305(03)00130-2; Feigelson HS, 1996, CARCINOGENESIS, V17, P2279, DOI 10.1093/carcin/17.11.2279; Fischer WH, 2001, MUTAGENESIS, V16, P209, DOI 10.1093/mutage/16.3.209; Flototto T, 2001, HORM METAB RES, V33, P451, DOI 10.1055/s-2001-16936; Gaikwad NW, 2008, INT J CANCER, V122, P1949, DOI 10.1002/ijc.23329; Glass AG, 2007, JNCI-J NATL CANCER I, V99, P1152, DOI 10.1093/jnci/djm059; Grodstein F, 1997, NEW ENGL J MED, V336, P1769, DOI 10.1056/NEJM199706193362501; HAN XL, 1995, CARCINOGENESIS, V16, P2571, DOI 10.1093/carcin/16.10.2571; Harrington WR, 2006, MOL ENDOCRINOL, V20, P491, DOI 10.1210/me.2005-0186; Henderson BE, 2000, CARCINOGENESIS, V21, P427, DOI 10.1093/carcin/21.3.427; Hua YS, 2001, J AM SOC MASS SPECTR, V12, P80, DOI 10.1016/S1044-0305(00)00191-4; JEFCOATE CR, 2000, J NATL CANC I MONOGR; Kerlikowske K, 2007, JNCI-J NATL CANCER I, V99, P1335, DOI 10.1093/jnci/djm111; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; LI JJ, 1995, CANCER RES, V55, P4347; Liehr JG, 2000, ENDOCR REV, V21, P40, DOI 10.1210/er.21.1.40; Liu XM, 2003, CHEM RES TOXICOL, V16, P832, DOI 10.1021/tx030004s; Liu XM, 2002, CHEM RES TOXICOL, V15, P512, DOI 10.1021/tx0101649; LUPULESCU A, 1995, CANCER INVEST, V13, P287, DOI 10.3109/07357909509094464; Mitra K, 2002, J AM CHEM SOC, V124, P1862, DOI 10.1021/ja017344p; Mobley JA, 2004, CARCINOGENESIS, V25, P3, DOI 10.1093/carcin/bgg175; Mueck AO, 2003, CLIMACTERIC, V6, P221, DOI 10.1080/713605415; NANDI S, 1995, P NATL ACAD SCI USA, V92, P3650, DOI 10.1073/pnas.92.9.3650; *NIH, 1981, NIH GUID LAB US CHEM; NUTTER LM, 1992, J BIOL CHEM, V267, P2474; Okamoto Y, 2008, CHEM RES TOXICOL, V21, P1120, DOI 10.1021/tx700428m; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Pisha E, 2001, CHEM RES TOXICOL, V14, P82, DOI 10.1021/tx000168y; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Rosenberg LU, 2006, CANCER EPIDEM BIOMAR, V15, P2482, DOI 10.1158/1055-9965.EPI-06-0489; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Service RF, 1998, SCIENCE, V279, P1631, DOI 10.1126/science.279.5357.1631; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sharma U, 2004, BIOORG MED CHEM LETT, V14, P3829, DOI 10.1016/j.bmcl.2004.04.064; Shen L, 1998, CHEM RES TOXICOL, V11, P94, DOI 10.1021/tx970181r; Shen L, 1997, CARCINOGENESIS, V18, P1093, DOI 10.1093/carcin/18.5.1093; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Stopper H, 2003, MUTAGENESIS, V18, P243, DOI 10.1093/mutage/18.3.243; UBEZIO P, 1994, FREE RADICAL BIO MED, V16, P509, DOI 10.1016/0891-5849(94)90129-5; VOGEL VG, 1993, BREAST CANCER RES TR, V28, P195, DOI 10.1007/BF00666431; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Zhang F, 2001, CHEM RES TOXICOL, V14, P1654, DOI 10.1021/tx010158c; Zhang FG, 1999, CHEM RES TOXICOL, V12, P204, DOI 10.1021/tx980217v; Zhang QA, 2008, CHEM RES TOXICOL, V21, P1509, DOI 10.1021/tx8001737; Zumoff B, 1998, P SOC EXP BIOL MED, V217, P30	64	17	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8624	8633		10.1074/jbc.M807860200	http://dx.doi.org/10.1074/jbc.M807860200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19158089	Green Published, hybrid			2022-12-25	WOS:000264397800047
J	Zaia, KA; Reimer, RJ				Zaia, Kimberly A.; Reimer, Richard J.			Synaptic Vesicle Protein NTT4/XT1 (SLC6A17) Catalyzes Na+-coupled Neutral Amino Acid Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; GLUTAMATE-GLUTAMINE CYCLE; NEUROTRANSMITTER TRANSPORTER; ORPHAN TRANSPORTER; V7-3 SLC6A15; RAT-BRAIN; FAMILY; LOCALIZATION; PROLINE; TRANSMISSION	The SLC6 family of structurally related, Na+-dependent transporter proteins is responsible for presynaptic reuptake of the majority of neurotransmitters. Within this family are a number of orphan transporters, including NTT4/XT1 (SLC6A17), a protein first identified over 15 years ago. NTT4/XT1 is expressed exclusively in the nervous system and specifically on synaptic vesicles in glutamatergic and some GABAergic neurons. Despite extensive efforts by a number of groups, no substrate has been reported for NTT4/XT1. Here we use a combination of molecular manipulations to increase expression of the NTT4/XT1 protein at the plasma membrane and to directly demonstrate that it catalyzes neutral amino acid transport. The substrate profile of the NTT4/XT1-dependent activity is similar to that of the closely related B(0)AT2/SBAT1 (SLC6A15), including a submillimolar apparent affinity for proline and leucine and a low millimolar apparent affinity for glutamine. The transport activity is Na+-dependent and Cl--independent and is inhibited by low pH as is SLC6A15, suggesting redundant roles for these proteins. This characterization of NTT4/XT1 offers important insights into neurotransmitter metabolism as well as the mechanistic differences among the structurally related, but functionally divergent, SLC6 proteins.	Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Grad Program Neurosci, Stanford, CA 94305 USA	Stanford University; Stanford University	Reimer, RJ (corresponding author), P211 MSLS,1201 Welch Rd, Stanford, CA 94305 USA.	rjreimer@stanford.edu			National Institutes of Health [K02 NS045634.]; National Defense Science and Engineering Graduate fellowship; The Dana Foundation Brain and Immuno- Imaging; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS045634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science and Engineering Graduate fellowship; The Dana Foundation Brain and Immuno- Imaging; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant K02 NS045634. This work was also supported by a National Defense Science and Engineering Graduate fellowship ( to K. A. Z.) and a grant from The Dana Foundation Brain and Immuno- Imaging ( to R. J. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement"	Albrecht J, 2007, FRONT BIOSCI-LANDMRK, V12, P332, DOI 10.2741/2067; Aubrey KR, 2000, MOL PHARMACOL, V58, P129, DOI 10.1124/mol.58.1.129; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Broer A, 2006, BIOCHEM J, V393, P421, DOI 10.1042/BJ20051273; Broer A, 2004, J BIOL CHEM, V279, P24467, DOI 10.1074/jbc.M400904200; Broer S, 2006, NEUROCHEM INT, V48, P559, DOI 10.1016/j.neuint.2005.11.021; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Cohen SM, 1997, BRAIN RES, V761, P271, DOI 10.1016/S0006-8993(97)00352-1; Conti F, 2006, NEUROCHEM INT, V48, P459, DOI 10.1016/j.neuint.2005.11.016; Drgonova J, 2007, BRAIN RES, V1183, P10, DOI 10.1016/j.brainres.2007.09.001; Edwards RH, 2007, NEURON, V55, P835, DOI 10.1016/j.neuron.2007.09.001; ELMESTIKAWY S, 1994, J NEUROCHEM, V62, P445; Farmer MK, 2000, GENOMICS, V70, P241, DOI 10.1006/geno.2000.6387; Ferguson SM, 2003, J NEUROSCI, V23, P9697; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Garcia-Espinosa MA, 2007, J NEUROCHEM, V100, P1458, DOI 10.1111/j.1471-4159.2006.04332.x; Grossman TR, 2002, FEBS LETT, V527, P125, DOI 10.1016/S0014-5793(02)03194-0; Kam K, 2007, J NEUROSCI, V27, P9192, DOI 10.1523/JNEUROSCI.1198-07.2007; LIU QR, 1993, FEBS LETT, V315, P114, DOI 10.1016/0014-5793(93)81145-P; Masson J, 1999, EUR J NEUROSCI, V11, P1349, DOI 10.1046/j.1460-9568.1999.00540.x; MCGALE EHF, 1977, J NEUROCHEM, V29, P291, DOI 10.1111/j.1471-4159.1977.tb09621.x; McKenna MC, 2007, J NEUROSCI RES, V85, P3347, DOI 10.1002/jnr.21444; PAPINI E, 1995, J BIOL CHEM, V270, P1332, DOI 10.1074/jbc.270.3.1332; Parra LA, 2008, MOL PHARMACOL, V74, P1521, DOI 10.1124/mol.108.050005; POZZAN T, 1984, J CELL BIOL, V99, P628, DOI 10.1083/jcb.99.2.628; Sambrook J, 2001, MOL CLONING LAB MANU; Sur C, 2007, CURR DRUG TARGETS, V8, P643, DOI 10.2174/138945007780618535; Takanaga H, 2005, BIOCHEM BIOPH RES CO, V337, P892, DOI 10.1016/j.bbrc.2005.09.128; Thompson GA, 1996, PHARMACOL THERAPEUT, V72, P25, DOI 10.1016/S0163-7258(96)00097-6; Wreden CC, 2005, J BIOL CHEM, V280, P1408, DOI 10.1074/jbc.M411295200; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	33	31	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8439	8448		10.1074/jbc.M806407200	http://dx.doi.org/10.1074/jbc.M806407200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19147495	Green Published, hybrid			2022-12-25	WOS:000264397800028
J	Irigoyen, N; Garriga, D; Navarro, A; Verdaguer, N; Rodriguez, JF; Caston, JR				Irigoyen, Nerea; Garriga, Damia; Navarro, Aitor; Verdaguer, Nuria; Rodriguez, Jose F.; Caston, Jose R.			Autoproteolytic Activity Derived from the Infectious Bursal Disease Virus Capsid Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC NECROSIS VIRUS; RNA-SILENCING SUPPRESSION; ICOSAHEDRAL VIRUSES; MATURATION PROCESS; CRYSTAL-STRUCTURE; MOLECULAR SWITCH; STRUCTURAL BASIS; SITE; CLEAVAGE; VP2	Viral capsids are envisioned as vehicles to deliver the viral genome to the host cell. They are nonetheless dynamic protective shells, as they participate in numerous processes of the virus cycle such as assembly, genome packaging, binding to receptors, and uncoating among others. In so doing, they undergo large scale conformational changes. Capsid proteins with essential enzymatic activities are being described more frequently. Here we show that the precursor (pVP2) of the capsid protein VP2 of the infectious bursal disease virus (IBDV), an avian double-stranded RNA virus, has autoproteolytic activity. The pVP2 C-terminal region is first processed by the viral protease VP4. VP2 Asp-431, lying in a flexible loop preceding the C-terminal most alpha-helix, is responsible for the endopeptidase activity that cleaves the Ala-441-Phe-442 bond to generate the mature VP2 polypeptide. The D431N substitution abrogates the endopeptidase activity without introducing a significant conformational change, as deduced from the three-dimensional structure of the mutant protein at 3.1 angstrom resolution. Combinations of VP2 polypeptides containing mutations affecting either the cleavage or the catalytic site revealed that pVP2 proteolytic processing is the result of a monomolecular cis-cleavage reaction. The D431N mutation does not affect the assembly of the VP2 trimers that constitute the capsid building block. Although VP2 D431N trimers are capable of assembling both pentamers and hexamers, expression of a polyprotein gene harboring the D431N mutation does not result in the assembly of IBDV virus-like particles. Reverse genetics analyses demonstrate that pVP2 self-processing is essential for the assembly of an infectious IBDV progeny.	[Caston, Jose R.] CSIC, Ctr Nacl Biotecnol, Dpto Estruct Macromol, Madrid 28049, Spain; [Irigoyen, Nerea; Rodriguez, Jose F.] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid 28049, Spain; [Garriga, Damia; Verdaguer, Nuria] CSIC, Inst Biol Mol Barcelona, E-08028 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Caston, JR (corresponding author), CSIC, Ctr Nacl Biotecnol, Dpto Estruct Macromol, C Darwin 3, Madrid 28049, Spain.	jrcaston@cnb.csic.es	Irigoyen, Nerea/CAJ-2485-2022; Rodríguez, José F/T-8500-2017; Caston, Jose/AAB-8825-2021; Irigoyen, Nerea/A-7925-2017; Caston, Jose R/L-5896-2014	Irigoyen, Nerea/0000-0001-6346-3369; Rodríguez, José F/0000-0001-7944-5341; Caston, Jose/0000-0003-2350-9048; Irigoyen, Nerea/0000-0001-6346-3369; Caston, Jose R/0000-0003-2350-9048; Navarro Nieto, Aitor/0000-0002-1051-9290; Verdaguer, Nuria/0000-0001-8826-7129; Garriga, Damia/0000-0003-0410-538X	Spanish Direccion General de Investigacion (MEC) [BIO2006-09407, BFU2005-02376, BFU2005-06487]	Spanish Direccion General de Investigacion (MEC)(Spanish Government)	This work was supported by Spanish Direccion General de Investigacion (MEC) Grants BIO2006-09407, BFU2005-02376, and BFU2005-06487.	Ahlquist P, 2005, CURR BIOL, V15, pR465, DOI 10.1016/j.cub.2005.06.016; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker TS, 1999, MICROBIOL MOL BIOL R, V63, P862, DOI 10.1128/MMBR.63.4.862-922.1999; BLANC A, 1994, MOL CELL BIOL, V14, P2664, DOI 10.1128/MCB.14.4.2664; Bothner B, 2005, VIROLOGY, V334, P17, DOI 10.1016/j.virol.2005.01.017; Bottcher B, 1997, J VIROL, V71, P325; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Canady MA, 2000, J MOL BIOL, V299, P573, DOI 10.1006/jmbi.2000.3723; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Caston Jose R., 2008, P133; Caston JR, 2001, J VIROL, V75, P10815, DOI 10.1128/JVI.75.22.10815-10828.2001; Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005; Chen HY, 2008, EMBO REP, V9, P754, DOI 10.1038/embor.2008.118; CHENG RH, 1994, STRUCTURE, V2, P271; Chevalier C, 2004, J VIROL, V78, P3296, DOI 10.1128/JVI.78.7.3296-3303.2004; Chevalier C, 2002, J VIROL, V76, P2384, DOI 10.1128/JVI.76.5.2384-2392.2002; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; Da Costa B, 2002, J VIROL, V76, P2393, DOI 10.1128/JVI.76.5.2393-2402.2002; DELMAS B, 2005, VIRUS TAXONOMY, P561; Dobos Peter, 1995, Annual Review of Fish Diseases, V5, P25, DOI 10.1016/0959-8030(95)00003-8; EARL PL, 1993, CURRENT PROTOCOLS MO; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Arias A, 1998, J GEN VIROL, V79, P1047, DOI 10.1099/0022-1317-79-5-1047; FernandezArias A, 1997, J VIROL, V71, P8014; GALLAGHER TM, 1988, J VIROL, V62, P3399, DOI 10.1128/JVI.62.9.3399-3406.1988; Galloux M, 2007, J BIOL CHEM, V282, P20774, DOI 10.1074/jbc.M701048200; Garriga D, 2007, P NATL ACAD SCI USA, V104, P20540, DOI 10.1073/pnas.0704447104; Garriga D, 2006, J VIROL, V80, P6895, DOI 10.1128/JVI.00368-06; Gorbalenya AE, 2002, J MOL BIOL, V324, P47, DOI 10.1016/S0022-2836(02)01033-1; Hanzlik TN, 1997, ADV VIRUS RES, V48, P101, DOI 10.1016/S0065-3527(08)60287-0; Hjalmarsson A, 1999, J VIROL, V73, P3484, DOI 10.1128/JVI.73.4.3484-3490.1999; Lee CC, 2006, J STRUCT BIOL, V155, P74, DOI 10.1016/j.jsb.2006.02.014; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, V5, P27; Lombardo E, 1999, J VIROL, V73, P6973, DOI 10.1128/JVI.73.8.6973-6983.1999; Luque D, 2007, J VIROL, V81, P6869, DOI 10.1128/JVI.00077-07; MACBETH KJ, 1995, P NATL ACAD SCI USA, V92, P8994, DOI 10.1073/pnas.92.19.8994; MACBETH KJ, 1995, J VIROL, V69, P3458, DOI 10.1128/JVI.69.6.3458-3464.1995; Maraver A, 2003, J VIROL, V77, P6438, DOI 10.1128/JVI.77.11.6438-6449.2003; Martinez-Torrecuadrada JL, 2000, VIROLOGY, V278, P322, DOI 10.1006/viro.2000.0559; Morillas M, 2008, J MOL BIOL, V376, P721, DOI 10.1016/j.jmb.2007.11.055; Ona A, 2004, VIROLOGY, V322, P135, DOI 10.1016/j.virol.2004.01.025; Pan JH, 2007, P NATL ACAD SCI USA, V104, P7385, DOI 10.1073/pnas.0611599104; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; Sanchez AB, 1999, VIROLOGY, V262, P190, DOI 10.1006/viro.1999.9910; Saugar I, 2005, STRUCTURE, V13, P1007, DOI 10.1016/j.str.2005.04.012; Schneemann A, 1998, ADV VIRUS RES, V50, P381, DOI 10.1016/S0065-3527(08)60812-X; Tang JH, 2005, J MOL RECOGNIT, V18, P158, DOI 10.1002/jmr.724; Taylor DJ, 2005, PROTEIN SCI, V14, P401, DOI 10.1110/ps.041054605; Taylor DJ, 2002, J VIROL, V76, P9972, DOI 10.1128/JVI.76.19.9972-9980.2002; van den Berg TP, 2000, REV SCI TECH OIE, V19, P527; Villanueva RA, 2004, J VIROL, V78, P13829, DOI 10.1128/JVI.78.24.13829-13838.2004; WARD GA, 1995, P NATL ACAD SCI USA, V92, P6773, DOI 10.1073/pnas.92.15.6773; Xu HT, 2004, VIROLOGY, V322, P199, DOI 10.1016/j.virol.2004.01.024; ZLOTNICK A, 1994, J BIOL CHEM, V269, P13680	54	35	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8064	8072		10.1074/jbc.M808942200	http://dx.doi.org/10.1074/jbc.M808942200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19144647	Green Published, hybrid			2022-12-25	WOS:000264195600069
J	Champaiboon, C; Sappington, KJ; Guenther, BD; Ross, KF; Herzberg, MC				Champaiboon, Chantrakorn; Sappington, Kaia J.; Guenther, Brian D.; Ross, Karen F.; Herzberg, Mark C.			Calprotectin S100A9 Calcium-binding Loops I and II Are Essential for Keratinocyte Resistance to Bacterial Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSIBLE ANTIMICROBIAL ACTIVITY; EPITHELIAL-CELLS; ARACHIDONIC-ACID; INTERMEDIATE-FILAMENTS; HUMAN NEUTROPHILS; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; PROTEIN FAMILY; CA2+ BINDING; MRP14	Epithelial cells expressing calprotectin, a heterodimer of S100A8 and S100A9 proteins, are more resistant to bacterial invasion. To determine structural motifs that affect resistance to bacterial invasion, mutations were constructed in S100A9 targeting the calcium-binding loops I and II (E36Q, E78Q, E36Q, E78Q) and the Cterminus (S100A91-99 and S100A91-112), which contains putative antimicrobial zinc-binding and phosphorylation sites. The S100A8 and mutated S100A9 encoding plasmids were transfected into calprotectin-negative KB carcinoma cells. All transfected cells (except KB-sham) expressed 27E10-reactive heterodimers. In bacterial invasion assays with Listeria monocytogenes and Salmonella enterica serovar Typhimurium (Salmonella typhimurium), cell lines expressing S100A8 in complex with S100A9E36Q, S100A9E78Q, S100A91-99, or S100A91-112 mutants or the S100A91-114 (full-length) calprotectin resisted bacterial invasion better than KB-sham. When compared with KB-S100A8/A91-114, cells expressing truncated S100A91-99 or S100A91-112 with S100A8 also showed increased resistance to bacterial invasion. In contrast, glutamic acid residues 36 and 78 in calcium-binding loops I and II promote resistance in epithelial cells, because cells expressing S100A9E36Q, E78Q with S100A8 were unable to resist bacterial invasion. Mutations in S100A9 E36Q, E78Q were predicted to cause loss of the calcium-induced positive face in calprotectin, reducing interactions with microtubules and appearing to be crucial for keratinocyte resistance to bacterial invasion.	[Champaiboon, Chantrakorn; Sappington, Kaia J.; Guenther, Brian D.; Ross, Karen F.; Herzberg, Mark C.] Univ Minnesota, Sch Dent, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Herzberg, MC (corresponding author), 17-164 Moos Tower,515 Delaware St SE, Minneapolis, MN 55455 USA.	mcherzb@umn.edu			National Institutes of Health [R01DE11831]; Royal Thai Government; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011831] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Thai Government; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DE11831 (NIDCR). This work was also supported by a scholarship from the Royal Thai Government. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Buechau AS, 2007, J INVEST DERMATOL, V127, P2596, DOI 10.1038/sj.jid.5700946; CARLSTROM G, 1993, J MOL BIOL, V231, P415, DOI 10.1006/jmbi.1993.1291; Clohessy PA, 1996, J LEUKOCYTE BIOL, V60, P674, DOI 10.1002/jlb.60.5.674; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Cuida M, 1997, EUR J ORAL SCI, V105, P228, DOI 10.1111/j.1600-0722.1997.tb00205.x; DALE I, 1985, AM J CLIN PATHOL, V84, P24, DOI 10.1093/ajcp/84.1.24; DALE I, 1983, EUR J BIOCHEM, V134, P1, DOI 10.1111/j.1432-1033.1983.tb07522.x; EDGEWORTH J, 1989, NATURE, V342, P189, DOI 10.1038/342189a0; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; GOEBELER M, 1995, BIOCHEM J, V309, P419, DOI 10.1042/bj3090419; Gottsch JD, 1999, INFECT IMMUN, V67, P6631; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAMMER HB, 1995, CLIN EXP RHEUMATOL, V13, P59; Hatakeyama T, 2004, EUR J BIOCHEM, V271, P3765, DOI 10.1111/j.1432-1033.2004.04318.x; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Hessian PA, 2001, EUR J BIOCHEM, V268, P353, DOI 10.1046/j.1432-1327.2001.01894.x; Ishikawa K, 2000, ACTA CRYSTALLOGR D, V56, P559, DOI 10.1107/S0907444900002833; Itou H, 2002, J MOL BIOL, V316, P265, DOI 10.1006/jmbi.2001.5340; Johne B, 1997, J CLIN PATHOL-MOL PA, V50, P113; Kerkhoff C, 1999, J BIOL CHEM, V274, P32672, DOI 10.1074/jbc.274.46.32672; KLIGMAN D, 1988, TRENDS BIOCHEM SCI, V13, P437, DOI 10.1016/0968-0004(88)90218-6; Korndorfer IP, 2007, J MOL BIOL, V370, P887, DOI 10.1016/j.jmb.2007.04.065; Lee KC, 2007, J INVEST DERMATOL, V127, P945, DOI 10.1038/sj.jid.5700663; Leslie CC, 2004, BIOCHEM CELL BIOL, V82, P1, DOI 10.1139/o03-080; Leukert N, 2005, BIOL CHEM, V386, P429, DOI 10.1515/BC.2005.051; Leukert N, 2006, J MOL BIOL, V359, P961, DOI 10.1016/j.jmb.2006.04.009; Loomans HJ, 1998, J INFECT DIS, V177, P812, DOI 10.1086/517816; Lusitani D, 2003, INFECT IMMUN, V71, P4711, DOI 10.1128/IAI.71.8.4711-4716.2003; Malik S, 2008, PROTEINS, V73, P28, DOI 10.1002/prot.22037; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; MAUNE JF, 1992, BIOCHEMISTRY-US, V31, P7779, DOI 10.1021/bi00149a006; MIYASAKI KT, 1993, J DENT RES, V72, P517, DOI 10.1177/00220345930720020801; MURTHY ARK, 1993, J IMMUNOL, V151, P6291; Nisapakultorn K, 2001, INFECT IMMUN, V69, P4242, DOI 10.1128/IAI.69.7.4242-4247.2001; Nisapakultorn K, 2001, INFECT IMMUN, V69, P3692, DOI 10.1128/IAI.69.6.3692-3696.2001; Nordahl EA, 2005, J BIOL CHEM, V280, P34832, DOI 10.1074/jbc.M507249200; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; Propper C, 1999, J BIOL CHEM, V274, P183, DOI 10.1074/jbc.274.1.183; Rammes A, 1997, J BIOL CHEM, V272, P9496; Roseth AG, 1999, SCAND J GASTROENTERO, V34, P50; Ross KF, 2001, INFECT IMMUN, V69, P3248, DOI 10.1128/IAI.69.5.3248-3254.2001; ROTH J, 1993, BLOOD, V82, P1875; Rudney JD, 2006, ARCH ORAL BIOL, V51, P291, DOI 10.1016/j.archoralbio.2005.09.003; Rustandi RR, 2002, BIOCHEMISTRY-US, V41, P788, DOI 10.1021/bi0118308; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SOHNLE PG, 1991, J INFECT DIS, V163, P187, DOI 10.1093/infdis/163.1.187; SOHNLE PG, 1991, J INFECT DIS, V164, P137, DOI 10.1093/infdis/164.1.137; Sohnle PG, 2000, ANTIMICROB AGENTS CH, V44, P139, DOI 10.1128/AAC.44.1.139-142.2000; Sohnle PG, 1996, J INFECT DIS, V174, P1369, DOI 10.1093/infdis/174.6.1369; Sohnle PG, 2000, J INFECT DIS, V182, P1272, DOI 10.1086/315810; Sopalla C, 2002, BIOL CHEM, V383, P1895, DOI 10.1515/BC.2002.213; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; Striz I, 2004, PHYSIOL RES, V53, P245; Vallely KM, 2002, BIOCHEMISTRY-US, V41, P12670, DOI 10.1021/bi020365r; vandenBos C, 1996, J IMMUNOL, V156, P1247; WATT KWK, 1983, IMMUNOLOGY, V48, P79; Zaia AA, 2009, MUCOSAL IMMUNOL, V2, P43, DOI 10.1038/mi.2008.63; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297	59	54	61	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7078	7090		10.1074/jbc.M806605200	http://dx.doi.org/10.1074/jbc.M806605200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19122197	Green Published, hybrid			2022-12-25	WOS:000263919000056
J	Connaris, H; Crocker, PR; Taylor, GL				Connaris, Helen; Crocker, Paul R.; Taylor, Garry L.			Enhancing the Receptor Affinity of the Sialic Acid-binding Domain of Vibrio cholerae Sialidase through Multivalency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; CATALYTIC EFFICIENCY; CARBOHYDRATE; RECOGNITION; LECTINS; MODULES; ENHANCEMENT; ENERGY	Many glycoside hydrolases possess carbohydrate-binding modules (CBMs) that help target these enzymes to appropriate substrates and increase their catalytic efficiency. The Vibrio cholerae sialidase contains two CBMs, one of which is designated as a family CBM40 module and has been shown through structural and calorimetry studies to recognize the alpha-anomer of sialic acid with a K-D of similar to 30 mu M at 37 degrees C. The affinity of this V. cholerae CBM40 module for sialic acid is one of the highest reported for recognition of a monosaccharide by a CBM. As Nature often increases a weak substrate affinity through multi-valency, we have explored the potential of developing reagents with an increased affinity for sialic acid receptors through linking CBM40 modules together. The V. cholerae CBM40 was sub-cloned and crystallized in the presence of sialyllactose confirming its ability to recognize sialic acid. Calorimetry revealed that this CBM40 demonstrated specificity to alpha(2,3)-, alpha(2,6)-, and alpha(2,8)-linked sialosides. Polypeptides containing up to four CBM40 modules in tandem were created to determine if an increase in affinity to sialic acid could be achieved through an avidity effect. Using SPR and a multivalent alpha(2,3)-sialyllactose ligand, we show that increasing the number of linked modules does increase the affinity for sialic acid. The four-CBM40 module protein has a 700- to 1500-fold increase in affinity compared with the single-CBM40 module. Varying the linker length of amino acids between each CBM40 module had little effect on the binding of these polypeptides. Finally, fluorescence-activated cell sorting analysis demonstrated that a green fluorescent protein fused to three CBM40 modules bound to subpopulations of human leukocytes. These studies lay the foundation for creating high affinity, multivalent CBMs that could have broad application in glycobiology.	[Connaris, Helen; Taylor, Garry L.] Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland; [Crocker, Paul R.] Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland	University of St Andrews; University of Dundee	Connaris, H (corresponding author), Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland.	hc6@st-and.ac.uk; glt2@st-and.ac.uk	Taylor, Garry/G-3017-2014	Crocker, Paul/0000-0001-6230-0293	Biotechnology and Biological Sciences Research Council; European Synchrotron Radiation Facility; European Union; MRC [G0500367] Funding Source: UKRI; Medical Research Council [G0500367] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Synchrotron Radiation Facility; European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Biotechnology and Biological Sciences Research Council. The staff at the European Synchrotron Radiation Facility and the European Union provided funds for access to the facility. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ambrosi M, 2005, ORG BIOMOL CHEM, V3, P1476, DOI 10.1039/b411555b; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; BIDDISON WE, 2001, CURR PROTOC CELL BIO, pCH2; Boraston AB, 2002, MOL MICROBIOL, V43, P187, DOI 10.1046/j.1365-2958.2002.02730.x; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2007, BIOCHEMISTRY-US, V46, P11352, DOI 10.1021/bi701317g; CORFIELD T, 1992, GLYCOBIOLOGY, V2, P509, DOI 10.1093/glycob/2.6.509; CRENNELL S, 1994, STRUCTURE, V2, P535, DOI 10.1016/S0969-2126(00)00053-8; Crocker PR, 2002, CURR OPIN STRUC BIOL, V12, P609, DOI 10.1016/S0959-440X(02)00375-5; Ehrhardt C, 2004, ADV DRUG DELIVER REV, V56, P527, DOI 10.1016/j.addr.2003.10.029; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guillen D, 2007, APPL ENVIRON MICROB, V73, P3833, DOI 10.1128/AEM.02628-06; KAMERLING JP, 1982, BIOCHIM BIOPHYS ACTA, V714, P351, DOI 10.1016/0304-4165(82)90344-0; Lee RT, 2000, GLYCOCONJUGATE J, V17, P543, DOI 10.1023/A:1011070425430; Lehmann F, 2006, CELL MOL LIFE SCI, V63, P1331, DOI 10.1007/s00018-005-5589-y; Lis H, 1998, CHEM REV, V98, P637, DOI 10.1021/cr940413g; Liu HT, 2009, PROTEIN EXPRES PURIF, V63, P102, DOI 10.1016/j.pep.2008.09.008; Lundquist JJ, 2002, CHEM REV, V102, P555, DOI 10.1021/cr000418f; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; MANDAL C, 1990, EXPERIENTIA, V46, P433, DOI 10.1007/BF01954221; McCartney L, 2004, ANAL BIOCHEM, V326, P49, DOI 10.1016/j.ab.2003.11.011; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moustafa I, 2004, J BIOL CHEM, V279, P40819, DOI 10.1074/jbc.M404965200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Poon GMK, 2007, BIOCHEM SOC T, V35, P1574, DOI 10.1042/BST0351574; ROGERS CM, 1978, GUT, V19, P587, DOI 10.1136/gut.19.7.587; Sacchettini JC, 2001, BIOCHEMISTRY-US, V40, P3009, DOI 10.1021/bi002544j; Vyas NK, 2002, BIOCHEMISTRY-US, V41, P13575, DOI 10.1021/bi0261387; Williams DH, 2004, J MOL BIOL, V340, P373, DOI 10.1016/j.jmb.2004.04.056; Williams DH, 2004, ANGEW CHEM INT EDIT, V43, P6596, DOI 10.1002/anie.200300644; Williams DH, 2003, J MOL BIOL, V329, P389, DOI 10.1016/S0022-2836(03)00428-5	31	32	42	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7339	7351		10.1074/jbc.M807398200	http://dx.doi.org/10.1074/jbc.M807398200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19124471	Green Published, hybrid			2022-12-25	WOS:000263919000080
J	Sun, P; Nallar, SC; Kalakonda, S; Lindner, DJ; Martin, SS; Kalvakolanu, DV				Sun, P.; Nallar, S. C.; Kalakonda, S.; Lindner, D. J.; Martin, S. S.; Kalvakolanu, D. V.			GRIM-19 inhibits v-Src-induced cell motility by interfering with cytoskeletal restructuring	ONCOGENE			English	Article						interferon; cytoskeleton; oncogenes; metastasis; growth suppression	REGULATORY GENE-PRODUCT; RETINOIC ACID; MATRIX-METALLOPROTEINASE; TYROSINE PHOSPHORYLATION; SIGNAL TRANSDUCER; STAT3 ACTIVATION; DEATH; ACTIN; CORTACTIN; PROTEIN	GRIM-19 (Gene associated with Retinoid-Interferon-induced Mortality 19) is a novel tumor suppressor regulated by interferon/retinoid combination. We have recently shown that GRIM-19 inhibits v-Src-induced oncogenic transformation and metastatic behavior of cells. Oncogenic v-Src induces cell motility by cytoskeletal remodeling, especially the formation of podosomes and. Here, we show that GRIM-19 inhibited the v-Src-induced cell motility by inhibiting cytoskeletal remodeling, that is, podosome formation. We also show that the N terminus of GRIM-19 played a major role in this process and identified critical residues in this region. More importantly, we show that tumor-associated GRIM-19 mutations disrupted its ability to inhibit v-Src-induced cell motility. These actions appear to occur independently of STAT3, a known target of GRIM-19-mediated inhibition. Lastly, tumor-associated GRIM-19 mutants significantly lost their ability to control v-Src-induced metastases in vivo, indicating the biological and pathological significance of these observations.	[Sun, P.; Nallar, S. C.; Kalakonda, S.; Martin, S. S.; Kalvakolanu, D. V.] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Sun, P.; Kalvakolanu, D. V.] Univ Maryland, Grad Program Life Sci, Baltimore, MD 21201 USA; [Lindner, D. J.] Cleveland Clin, Lerner Res Inst, Taussig Canc Ctr, Cleveland, OH 44106 USA; [Lindner, D. J.] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA; [Sun, P.; Nallar, S. C.; Kalakonda, S.; Kalvakolanu, D. V.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Maryland; University of Maryland Baltimore	Kalvakolanu, DV (corresponding author), Univ Maryland, Sch Med, Greenebaum Canc Ctr, 660 W Redwood St,Howard Hall Room 324, Baltimore, MD 21201 USA.	dkalvako@umaryland.edu	Lindner, Daniel/ABB-5440-2020		National Cancer Institute [CA105005]; NATIONAL CANCER INSTITUTE [R01CA105005] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	DVK thanks National Cancer Institute (CA105005) for the grant support.	Alchanati I, 2006, ONCOGENE, V25, P7138, DOI 10.1038/sj.onc.1209708; Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Hakak Y, 2000, ONCOGENE, V19, P3164, DOI 10.1038/sj.onc.1203655; Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.e02-11-0753; Huang C, 1997, J BIOL CHEM, V272, P13911, DOI 10.1074/jbc.272.21.13911; Itoh M, 2006, ONCOGENE, V25, P1195, DOI 10.1038/sj.onc.1209149; Jonasch E, 2001, ONCOLOGIST, V6, P34, DOI 10.1634/theoncologist.6-1-34; Kalakonda S, 2007, AM J PATHOL, V171, P1352, DOI 10.2353/ajpath.2007.070241; Kalakonda S, 2007, CANCER RES, V67, P6212, DOI 10.1158/0008-5472.CAN-07-0031; Kolla V, 1996, J BIOL CHEM, V271, P10508, DOI 10.1074/jbc.271.18.10508; Lindner DJ, 1997, CLIN CANCER RES, V3, P931; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; Ma XR, 2001, J BIOL CHEM, V276, P24843, DOI 10.1074/jbc.M100380200; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Maximo V, 2005, BRIT J CANCER, V92, P1892, DOI 10.1038/sj.bjc.6602547; Mizutani K, 2002, CANCER RES, V62, P669; MONSKY WL, 1993, CANCER RES, V53, P3159; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Scott LA, 2004, MOL CELL BIOL, V24, P1540, DOI 10.1128/MCB.24.4.1540-1559.2004; Seo T, 2002, J VIROL, V76, P8797, DOI 10.1128/JVI.76.17.8797-8807.2002; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Tehrani S, 2006, MOL BIOL CELL, V17, P2882, DOI 10.1091/mbc.E06-03-0187; Wittmann T, 2001, J CELL SCI, V114, P3795; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Zhang J, 2003, P NATL ACAD SCI USA, V100, P9342, DOI 10.1073/pnas.1633516100; Zhang L, 2008, CLIN CANCER RES, V14, P559, DOI 10.1158/1078-0432.CCR-07-1176	33	17	22	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	10					1339	1347		10.1038/onc.2008.480	http://dx.doi.org/10.1038/onc.2008.480			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	417ZC	19151760	Green Accepted			2022-12-25	WOS:000264116000006
J	Zagurovskaya, M; Shareef, MM; Das, A; Reeves, A; Gupta, S; Sudol, M; Bedford, MT; Prichard, J; Mohiuddin, M; Ahmed, MM				Zagurovskaya, M.; Shareef, M. M.; Das, A.; Reeves, A.; Gupta, S.; Sudol, M.; Bedford, M. T.; Prichard, J.; Mohiuddin, M.; Ahmed, M. M.			EGR-1 forms a complex with YAP-1 and upregulates Bax expression in irradiated prostate carcinoma cells	ONCOGENE			English	Article						EGR-1; YAP-1; Bax; prostate cancer; radiation	YES-ASSOCIATED PROTEIN; IONIZING-RADIATION; APOPTOSIS; TRANSCRIPTION; P53; CANCER; DOMAIN; GENE; RESISTANCE; INDUCTION	In this study, we investigated the functional role of early growth response-1 (Egr1 gene) in the regulation of radiation-induced clonogenic inhibition and apoptosis in p53 wild-type and mutant prostate cancer cells 22Rv1 and DU145, respectively. 22Rv1 cells were more sensitive to irradiation compared with DU145 cells, and the sensitivity was enhanced by overexpression of EGR-1 in both cells. Dominant-negative EGR-1 mutant (dnEGR-1) or repressor of EGR-1, NGFIA binding protein 1 (NAB1), increased radioresistance of these cells. Significant activation of caspases 3 and 9 and Bcl2-associated X (Bax) with increased poly(ADP-ribose) polymerase (PARP) cleavage and cytochrome c release was observed in radiation-exposed EGR-1 overexpressing cells. Gel shift analysis and chloramphenicol acetyl transferase (CAT) reporter assays indicate that EGR-1 transactivates the promoter of the Bax gene. Interaction of EGR-1 and Yes kinase-associated protein 1 (YAP-1) through the WW domain of YAP-1 enhances the transcriptional activity of EGR-1 on the Bax promoter as shown by chromatin immunoprecipitation and reporter assays. Irradiation of PC3 cell xenografts that were treated with adenoviral EGR-1 showed significant regression in tumor volume. These findings establish the radiation-induced pro-apoptotic action of EGR-1, in a p53-independent manner, by directly transactivating Bax, and prove that alters the B-cell CLL/lymphoma 2 (Bcl-2)/Bax ratio as one of the mechanisms resulting in significant activation of caspases, leading to cell death through the novel interaction of EGR-1 with YAP-1.	[Das, A.] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA USA; [Bedford, M. T.] Univ Texas, MD Anderson Canc Ctr, Dept Carcinogenesis, Smithville, TX USA; [Prichard, J.] Weis Ctr Res, Geisinger Clin, Dept Pathol, Danville, PA 17822 USA; [Mohiuddin, M.] Geisinger Med Clin, Geisinger Fox Chase Canc Ctr, Wilkes Barre, PA USA; [Ahmed, M. M.] Fox Chase Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19111 USA	Virginia Commonwealth University; University of Texas System; UTMD Anderson Cancer Center; Fox Chase Cancer Center; Geisinger Medical Center; Fox Chase Cancer Center	Ahmed, MM (corresponding author), Univ Miami, Sylvester Comprehens Canc Ctr, Miller Sch Med, Dept Radiat Oncol, Miami, FL 33136 USA.	amansoor@med.miami.edu	Bedford, Mark T/E-7856-2011; Das, Anindita/K-8003-2013; Ahmed, Mansoor/AAK-5988-2020	Das, Anindita/0000-0003-4422-7277; 	NIH [RO1 CA78471, DK62345]; PCRP-DOD [PC 970526, WB1XWH-04-1-0039]; Pennsylvania Department of Health [SAP4100037378]; Welch Foundation [G-1495]; NATIONAL CANCER INSTITUTE [R01CA078471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK062345] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PCRP-DOD; Pennsylvania Department of Health; Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants, NIH (RO1 CA78471), PCRP-DOD (PC 970526) and Charlotte Geyer foundation to MMA; post-doctoral training grant, PCRP-DOD (WB1XWH-04-1-0039) to MZ; NIH (DK62345) and Pennsylvania Department of Health Grant (SAP4100037378) to MMS and Welch Foundation Grant (G-1495) to MTB.	Abdulkadir SA, 2001, HUM PATHOL, V32, P935, DOI 10.1053/hupa.2001.27102; Abdulkadir SA, 2001, NAT MED, V7, P101, DOI 10.1038/83231; Ahmed MM, 1997, J BIOL CHEM, V272, P33056, DOI 10.1074/jbc.272.52.33056; Ahmed MM, 1996, J BIOL CHEM, V271, P29231, DOI 10.1074/jbc.271.46.29231; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; BUTTYAN R, 1988, MOL ENDOCRINOL, V2, P650, DOI 10.1210/mend-2-7-650; Das A, 2001, J BIOL CHEM, V276, P3279, DOI 10.1074/jbc.M008454200; DATTA R, 1992, P NATL ACAD SCI USA, V89, P10149, DOI 10.1073/pnas.89.21.10149; DAY ML, 1993, CANCER RES, V53, P5597; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Eid MA, 1998, CANCER RES, V58, P2461; Espejo Alexsandra, 2004, Methods Mol Biol, V264, P173; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; KYPRIANOU N, 1994, WORLD J UROL, V12, P299; LEE JM, 1993, P NATL ACAD SCI USA, V90, P5742, DOI 10.1073/pnas.90.12.5742; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; MATHENY C, 1994, J BIOL CHEM, V269, P8176; Nair P, 1997, J BIOL CHEM, V272, P20131, DOI 10.1074/jbc.272.32.20131; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Shareef MM, 2007, CANCER RES, V67, P11811, DOI 10.1158/0008-5472.CAN-07-0722; Strano S, 2007, MOL CELL, V27, P863, DOI 10.1016/j.molcel.2007.09.004; SUDOL M, 1994, ONCOGENE, V9, P2145; SUDOL M, 1995, J BIOL CHEM, V270, P14733, DOI 10.1074/jbc.270.24.14733; Svaren J, 2000, J BIOL CHEM, V275, P38524, DOI 10.1074/jbc.M005220200; Tsujimoto Y, 1998, GENES CELLS, V3, P697, DOI 10.1046/j.1365-2443.1998.00223.x; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030	29	77	80	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2009	28	8					1121	1131		10.1038/onc.2008.461	http://dx.doi.org/10.1038/onc.2008.461			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	412KE	19137013				2022-12-25	WOS:000263722900007
J	Chiori, R; Jager, M; Denker, E; Wincker, P; Da Silva, C; Le Guyader, H; Manuel, M; Queinnec, E				Chiori, Roxane; Jager, Muriel; Denker, Elsa; Wincker, Patrick; Da Silva, Corinne; Le Guyader, Herve; Manuel, Michael; Queinnec, Eric			Are Hox Genes Ancestrally Involved in Axial Patterning? Evidence from the Hydrozoan Clytia hemisphaerica (Cnidaria)	PLOS ONE			English	Article								Background: The early evolution and diversification of Hox-related genes in eumetazoans has been the subject of conflicting hypotheses concerning the evolutionary conservation of their role in axial patterning and the pre-bilaterian origin of the Hox and ParaHox clusters. The diversification of Hox/ParaHox genes clearly predates the origin of bilaterians. However, the existence of a "Hox code'' predating the cnidarian-bilaterian ancestor and supporting the deep homology of axes is more controversial. This assumption was mainly based on the interpretation of Hox expression data from the sea anemone, but growing evidence from other cnidarian taxa puts into question this hypothesis. Methodology/Principal Findings: Hox, ParaHox and Hox-related genes have been investigated here by phylogenetic analysis and in situ hybridisation in Clytia hemisphaerica, an hydrozoan species with medusa and polyp stages alternating in the life cycle. Our phylogenetic analyses do not support an origin of ParaHox and Hox genes by duplication of an ancestral ProtoHox cluster, and reveal a diversification of the cnidarian HOX9-14 genes into three groups called A, B, C. Among the 7 examined genes, only those belonging to the HOX9-14 and the CDX groups exhibit a restricted expression along the oralaboral axis during development and in the planula larva, while the others are expressed in very specialised areas at the medusa stage. Conclusions/Significance: Cross species comparison reveals a strong variability of gene expression along the oral-aboral axis and during the life cycle among cnidarian lineages. The most parsimonious interpretation is that the Hox code, collinearity and conservative role along the antero-posterior axis are bilaterian innovations.	[Chiori, Roxane; Jager, Muriel; Le Guyader, Herve; Manuel, Michael; Queinnec, Eric] Univ Paris 06, CNRS, UPMC, MNHN,IRD,UMR 7138,Case 05, Paris, France; [Denker, Elsa] Sars Int Ctr Marine Mol Biol, Bergen, Norway; [Wincker, Patrick; Da Silva, Corinne] Genoscope, Ctr Natl Sequencage, Evry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay	Chiori, R (corresponding author), Univ Paris 06, CNRS, UPMC, MNHN,IRD,UMR 7138,Case 05, Paris, France.	eric.queinnec@snv.jussieu.fr		DA SILVA, Corinne/0000-0002-7618-7831; Denker, Elsa/0000-0002-7092-1038	French Ministry of Research; Consortium National de Recherche en Genomique; Genoscope; GIS Institut de la Genomique Marine [PhD fellowship]	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Consortium National de Recherche en Genomique; Genoscope; GIS Institut de la Genomique Marine	This work was supported by the French Ministry of Research (ACI jeunes chercheurs and ANR NT_NV_52), the Consortium National de Recherche en Genomique, the Genoscope and the GIS Institut de la Genomique Marine. RC was supported by a PhD fellowship from the GIS Institut de la Genomique Marine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; AERNE BL, 1995, DEV BIOL, V169, P547, DOI 10.1006/dbio.1995.1168; Alfaro ME, 2003, MOL BIOL EVOL, V20, P255, DOI 10.1093/molbev/msg028; ARENDT D, 1994, NATURE, V371, P26, DOI 10.1038/371026a0; Arnone MI, 2006, DEV BIOL, V300, P63, DOI 10.1016/j.ydbio.2006.07.037; Averof M, 1997, NATURE, V388, P682, DOI 10.1038/41786; Balavoine G, 2002, MOL PHYLOGENET EVOL, V24, P366, DOI 10.1016/S1055-7903(02)00237-3; Banerjee-Basu S, 2001, NUCLEIC ACIDS RES, V29, P3258, DOI 10.1093/nar/29.15.3258; BRIDGE D, 1995, MOL BIOL EVOL, V12, P679; Brooke NM, 1998, NATURE, V392, P920, DOI 10.1038/31933; CARROLL SB, 1995, NATURE, V376, P479, DOI 10.1038/376479a0; Cartwright P, 1999, P NATL ACAD SCI USA, V96, P2183, DOI 10.1073/pnas.96.5.2183; Chevalier S, 2006, DEV GENES EVOL, V216, P709, DOI 10.1007/s00427-006-0103-6; Chourrout D, 2006, NATURE, V442, P684, DOI 10.1038/nature04863; Collins AG, 2006, SYST BIOL, V55, P97, DOI 10.1080/10635150500433615; Collins AG, 1998, P NATL ACAD SCI USA, V95, P15458, DOI 10.1073/pnas.95.26.15458; Coutinho CC, 2003, MECH DEVELOP, V120, P429, DOI 10.1016/S0925-4773(03)00007-8; de Jong DM, 2006, DEV BIOL, V298, P632, DOI 10.1016/j.ydbio.2006.07.034; De Robertis EM, 2008, CELL, V132, P185, DOI 10.1016/j.cell.2008.01.003; Denker E, 2008, DEV BIOL, V315, P99, DOI 10.1016/j.ydbio.2007.12.023; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Ferrier DEK, 2003, INT J DEV BIOL, V47, P605; Ferrier DEK, 2002, MOL PHYLOGENET EVOL, V24, P412, DOI 10.1016/S1055-7903(02)00204-X; Ferrier DEK, 2001, EVOL DEV, V3, P263, DOI 10.1046/j.1525-142x.2001.003004263.x; Ferrier DEK, 2001, NAT REV GENET, V2, P33, DOI 10.1038/35047605; Finnerty JR, 2004, SCIENCE, V304, P1335, DOI 10.1126/science.1091946; Finnerty JR, 1997, BIOL BULL-US, V193, P62, DOI 10.2307/1542736; Finnerty JR, 1999, EVOL DEV, V1, P16, DOI 10.1046/j.1525-142x.1999.99010.x; Finnerty JR, 2003, EVOL DEV, V5, P331, DOI 10.1046/j.1525-142X.2003.03041.x; Freitas R, 2006, NATURE, V442, P1033, DOI 10.1038/nature04984; Freund JN, 1998, BIOCHEM CELL BIOL, V76, P957, DOI 10.1139/bcb-76-6-957; Frobius AC, 2006, DEV GENES EVOL, V216, P81, DOI 10.1007/s00427-005-0049-0; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; Gauchat D, 2000, P NATL ACAD SCI USA, V97, P4493, DOI 10.1073/pnas.97.9.4493; Gellon G, 1998, BIOESSAYS, V20, P116, DOI 10.1002/(SICI)1521-1878(199802)20:2<116::AID-BIES4>3.3.CO;2-N; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; Guder C, 2006, ONCOGENE, V25, P7450, DOI 10.1038/sj.onc.1210052; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hayward DC, 2001, DEV GENES EVOL, V211, P10; Hill A, 2003, MOL PHYLOGENET EVOL, V28, P529, DOI 10.1016/S1055-7903(03)00062-9; HSIEHLI HM, 1995, MECH DEVELOP, V50, P177, DOI 10.1016/0925-4773(94)00334-J; Hudson C, 2001, MECH DEVELOP, V100, P189, DOI 10.1016/S0925-4773(00)00528-1; Hughes CL, 2002, EVOL DEV, V4, P459, DOI 10.1046/j.1525-142X.2002.02034.x; Jakob W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000694; Kamm K, 2006, CURR BIOL, V16, P920, DOI 10.1016/j.cub.2006.03.036; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; Kourakis MJ, 2000, J EXP ZOOL, V288, P175, DOI 10.1002/1097-010X(20000815)288:2<175::AID-JEZ8>3.0.CO;2-N; Kuhn K, 1999, J EXP ZOOL, V285, P63, DOI 10.1002/(SICI)1097-010X(19990415)285:1<63::AID-JEZ8>3.0.CO;2-X; Kuhn K, 1996, MOL PHYLOGENET EVOL, V6, P30, DOI 10.1006/mpev.1996.0055; Kulakova MA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-61; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Larroux C, 2007, CURR BIOL, V17, P706, DOI 10.1016/j.cub.2007.03.008; Le Gouar M, 2003, GENE EXPR PATTERNS, V3, P35, DOI 10.1016/S1567-133X(02)00091-1; Lee PN, 2006, SEMIN CELL DEV BIOL, V17, P157, DOI 10.1016/j.semcdb.2006.05.002; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; MANUEL M, 2008, C R BIOL IN PRESS; Marques AC, 2004, INVERTEBR BIOL, V123, P23; Martindale MQ, 2005, NAT REV GENET, V6, P917, DOI 10.1038/nrg1725; Masuda-Nakagawa LM, 2000, DEV GENES EVOL, V210, P151, DOI 10.1007/s004270050022; Mazza ME, 2007, J EXP ZOOL PART B, V308B, P494, DOI 10.1002/jez.b.21158; Medina M, 2001, P NATL ACAD SCI USA, V98, P9707, DOI 10.1073/pnas.171316998; MILES A, 1992, P ROY SOC B-BIOL SCI, V248, P159, DOI 10.1098/rspb.1992.0057; Miljkovic-Licina M, 2007, DEVELOPMENT, V134, P1191, DOI 10.1242/dev.02804; MILLER DJ, 1993, NATURE, V365, P215, DOI 10.1038/365215b0; Minguillon C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r12; Mokady O, 1998, P NATL ACAD SCI USA, V95, P3673, DOI 10.1073/pnas.95.7.3673; Momose T, 2008, DEVELOPMENT, V135, P2105, DOI 10.1242/dev.021543; Monteiro AS, 2006, EVOL DEV, V8, P174, DOI 10.1111/j.1525-142X.2006.00087.x; MURTHA MT, 1991, P NATL ACAD SCI USA, V88, P10711, DOI 10.1073/pnas.88.23.10711; Offield MF, 1996, DEVELOPMENT, V122, P983; Pang K, 2008, DEV GENES EVOL, V218, P307, DOI 10.1007/s00427-008-0222-3; Peterson KJ, 2007, EVOL DEV, V9, P405, DOI 10.1111/j.1525-142X.2007.00179.x; Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716; Ruvkun G, 1998, SCIENCE, V282, P2033, DOI 10.1126/science.282.5396.2033; Ryan JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000153; Ryan JF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r64; SCHIERWATER B, 1991, J EXP ZOOL, V260, P413, DOI 10.1002/jez.1402600316; Schierwater B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002457; SCHUMMER M, 1992, EMBO J, V11, P1815, DOI 10.1002/j.1460-2075.1992.tb05233.x; Seo HC, 2004, NATURE, V431, P67, DOI 10.1038/nature02709; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Weiss JB, 1998, GENE DEV, V12, P3591, DOI 10.1101/gad.12.22.3591; Yanze N, 2001, DEV BIOL, V236, P89, DOI 10.1006/dbio.2001.0299	85	63	65	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4231	10.1371/journal.pone.0004231	http://dx.doi.org/10.1371/journal.pone.0004231			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JB	19156208	Green Published, gold, Green Submitted			2022-12-25	WOS:000265482100003
J	Ng, LFP; Chow, A; Sun, YJ; Kwek, DJC; Lim, PL; Dimatatac, F; Ng, LC; Ooi, EE; Choo, KH; Her, Z; Kourilsky, P; Leo, YS				Ng, Lisa F. P.; Chow, Angela; Sun, Yong-Jiang; Kwek, Dyan J. C.; Lim, Poh-Lian; Dimatatac, Frederico; Ng, Lee-Ching; Ooi, Eng-Eong; Choo, Khar-Heng; Her, Zhisheng; Kourilsky, Philippe; Leo, Yee-Sin			IL-1 beta, IL-6, and RANTES as Biomarkers of Chikungunya Severity	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; NATURAL-KILLER-CELLS; INDIAN-OCEAN; RHEUMATOID-ARTHRITIS; INTENSIVE-CARE; GROWTH-FACTOR; RISK-FACTORS; VIRUS; OUTBREAK; SEPSIS	Background: Little is known about the immunopathogenesis of Chikungunya virus. Circulating levels of immune mediators and growth factors were analyzed from patients infected during the first Singaporean Chikungunya fever outbreak in early 2008 to establish biomarkers associated with infection and/or disease severity. Methods and Findings: Adult patients with laboratory-confirmed Chikungunya fever infection, who were referred to the Communicable Disease Centre/Tan Tock Seng Hospital during the period from January to February 2008, were included in this retrospective study. Plasma fractions were analyzed using a multiplex-microbead immunoassay. Among the patients, the most common clinical features were fever (100%), arthralgia (90%), rash (50%) and conjunctivitis (40%). Profiles of 30 cytokines, chemokines, and growth factors were able to discriminate the clinical forms of Chikungunya from healthy controls, with patients classified as non-severe and severe disease. Levels of 8 plasma cytokines and 4 growth factors were significantly elevated. Statistical analysis showed that an increase in IL-1b, IL-6 and a decrease in RANTES were associated with disease severity. Conclusions: This is the first comprehensive report on the production of cytokines, chemokines, and growth factors during acute Chikungunya virus infection. Using these biomarkers, we were able to distinguish between mild disease and more severe forms of Chikungunya fever, thus enabling the identification of patients with poor prognosis and monitoring of the disease.	[Ng, Lisa F. P.; Kwek, Dyan J. C.; Her, Zhisheng; Kourilsky, Philippe] ASTAR, Singapore Immunol Network, Singapore, Singapore; [Chow, Angela; Sun, Yong-Jiang; Lim, Poh-Lian; Dimatatac, Frederico; Leo, Yee-Sin] Tan Tock Seng Hosp, Communicable Dis Ctr, Singapore, Singapore; [Ng, Lee-Ching] Environm Hlth Inst, Singapore, Singapore; [Ooi, Eng-Eong] DSO Natl Lab, Singapore, Singapore; [Choo, Khar-Heng] ASTAR, Inst Infocomm Res, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Tan Tock Seng Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R)	Ng, LFP (corresponding author), ASTAR, Singapore Immunol Network, Singapore, Singapore.	lisa_ng@immunol.astar.edu.sg; Yee_Sin_Leo@ttsh.com.sg		Chow, Angela/0000-0002-4063-736X; Ng, Lisa/0000-0003-4071-5222; Ooi, Eng Eong/0000-0002-0520-1544	Singapore Immunology Network; Biomedical Research Council at the Agency for Science, Technology and Research (A*STAR); Communicable Disease Centre, Tan Tock Seng Hospital	Singapore Immunology Network(Agency for Science Technology & Research (A*STAR)); Biomedical Research Council at the Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Communicable Disease Centre, Tan Tock Seng Hospital	This work was supported by core grants provided by the Singapore Immunology Network, Biomedical Research Council at the Agency for Science, Technology and Research (A*STAR); and the Communicable Disease Centre, Tan Tock Seng Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 2007, EMERG INFECT DIS, V13, P147, DOI 10.3201/eid1301.060617; Aird WC, 2003, MAYO CLIN PROC, V78, P869, DOI 10.4065/78.7.869; Asquith DL, 2007, CURR OPIN RHEUMATOL, V19, P246, DOI 10.1097/BOR.0b013e3280eec78c; Avila-Aguero ML, 2004, CYTOKINE, V27, P173, DOI 10.1016/j.cyto.2004.05.007; Beltrame A, 2007, EMERG INFECT DIS, V13, P1264, DOI 10.3201/eid1308.070161; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bonn D, 2006, LANCET INFECT DIS, V6, P543, DOI 10.1016/S1473-3099(06)70559-X; Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013; Chevillon C, 2008, TRENDS MICROBIOL, V16, P80, DOI 10.1016/j.tim.2007.12.003; Churchman SM, 2008, RHEUMATOLOGY, V47, P753, DOI 10.1093/rheumatology/ken053; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Dalbeth N, 2002, ARTHRITIS RHEUM, V46, P1763, DOI 10.1002/art.10410; Dash PK, 2007, VECTOR-BORNE ZOONOT, V7, P519, DOI 10.1089/vbz.2007.7272; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; ECONOMOPOULOU A, 2008, EPIDEMIOL INFECT, V11, P1; Ellis M, 2005, BRIT J HAEMATOL, V128, P482, DOI 10.1111/j.1365-2141.2004.05350.x; Enserink M, 2007, SCIENCE, V317, P1485, DOI 10.1126/science.317.5844.1485a; FELDMANN M, 1990, ANN RHEUM DIS, P480; Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060; GIRI JG, 1995, J LEUKOCYTE BIOL, V57, P763, DOI 10.1002/jlb.57.5.763; Hansmann L, 2008, CLIN IMMUNOL, V127, P252, DOI 10.1016/j.clim.2008.01.014; Hasebe F, 2002, J MED VIROL, V67, P370, DOI 10.1002/jmv.10085; Jiang Y, 2005, AM J RESP CRIT CARE, V171, P850, DOI 10.1164/rccm.200407-857OC; John CC, 2006, J INFECT DIS, V194, P837, DOI 10.1086/506623; KENDALL DG, 1982, ENCY STAT SCI, V8, P417; Lakshmi V, 2008, CLIN INFECT DIS, V46, P1436, DOI 10.1086/529444; Lee N, 2006, EMERG INFECT DIS, V12, P1790, DOI 10.3201/eid1211.060574; Lee YR, 2007, VIRUS RES, V126, P216, DOI 10.1016/j.virusres.2007.03.003; Leelarasamee Amorn, 2004, Journal of the Medical Association of Thailand, V87, P464; Levi M, 2004, J THROMB HAEMOST, V2, P2094, DOI 10.1111/j.1538-7836.2004.01004.x; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; McQuitty L, 1996, EDUC PSYCHOL MEAS, V26, P825; *MIN HLTH SING, UPD CHIK FEV CAS 5; *MIN HLTH SING, CHIK FEV CAS DET CLI; OKA Y, 1983, J CLIN INVEST, V72, P249, DOI 10.1172/JCI110964; Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610; Perez AB, 2004, J MED VIROL, V73, P230, DOI 10.1002/jmv.20080; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; *PROMED MAIL, CHIK 07 SING PROMED; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; RUBIN LA, 1985, J IMMUNOL, V135, P3172; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089; Taubitz W, 2007, CLIN INFECT DIS, V45, pE1, DOI 10.1086/518701; Toivanen A, 2008, CURR OPIN RHEUMATOL, V20, P486, DOI 10.1097/BOR.0b013e328303220b; Vanderschueren S, 2000, CRIT CARE MED, V28, P1871, DOI 10.1097/00003246-200006000-00031; Wang E, 2006, J CLIN MICROBIOL, V44, P4000, DOI 10.1128/JCM.00175-06; Wong CK, 2004, CLIN EXP IMMUNOL, V136, P95, DOI 10.1111/j.1365-2249.2004.02415.x; Ziegler SA, 2008, AM J TROP MED HYG, V79, P133, DOI 10.4269/ajtmh.2008.79.133	57	207	215	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4261	10.1371/journal.pone.0004261	http://dx.doi.org/10.1371/journal.pone.0004261			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JB	19156204	Green Submitted, gold, Green Published			2022-12-25	WOS:000265482100015
J	Jin, HJ; Tyler-Smith, C; Kim, W				Jin, Han-Jun; Tyler-Smith, Chris; Kim, Wook			The Peopling of Korea Revealed by Analyses of Mitochondrial DNA and Y-Chromosomal Markers	PLOS ONE			English	Article							CONTROL REGION SEQUENCES; POPULATION HISTORY; ETHNIC POPULATIONS; GENETIC-STRUCTURE; STRS HAPLOTYPES; EAST-ASIA; PHYLOGENETIC ANALYSIS; DUAL ORIGINS; MTDNA; DIVERSITY	Background: The Koreans are generally considered a northeast Asian group because of their geographical location. However, recent findings from Y chromosome studies showed that the Korean population contains lineages from both southern and northern parts of East Asia. To understand the genetic history and relationships of Korea more fully, additional data and analyses are necessary. Methodology and Results: We analyzed mitochondrial DNA (mtDNA) sequence variation in the hypervariable segments I and II (HVS-I and HVS-II) and haplogroup-specific mutations in coding regions in 445 individuals from seven east Asian populations (Korean, Korean-Chinese, Mongolian, Manchurian, Han (Beijing), Vietnamese and Thais). In addition, published mtDNA haplogroup data (N=3307), mtDNA HVS-I sequences (N=2313), Y chromosome haplogroup data (N=1697) and Y chromosome STR data (N=2713) were analyzed to elucidate the genetic structure of East Asian populations. All the mtDNA profiles studied here were classified into subsets of haplogroups common in East Asia, with just two exceptions. In general, the Korean mtDNA profiles revealed similarities to other northeastern Asian populations through analysis of individual haplogroup distributions, genetic distances between populations or an analysis of molecular variance, although a minor southern contribution was also suggested. Reanalysis of Y-chromosomal data confirmed both the overall similarity to other northeastern populations, and also a larger paternal contribution from southeastern populations. Conclusion: The present work provides evidence that peopling of Korea can be seen as a complex process, interpreted as an early northern Asian settlement with at least one subsequent male-biased southern-to-northern migration, possibly associated with the spread of rice agriculture.	[Kim, Wook] Dankook Univ, Dept Biol Sci, Cheonan, South Korea; [Jin, Han-Jun; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England	Dankook University; Wellcome Trust Sanger Institute	Jin, HJ (corresponding author), Dankook Univ, Dept Biol Sci, Cheonan, South Korea.	wookkim@dankook.ac.kr			Conservation Technology Research and Development; National Research Institute of Cultural Heritage of Cultural Heritage Administration, Republic of Korea; Koguryo Research Foundation, Republic of Korea; The Wellcome Trust	Conservation Technology Research and Development; National Research Institute of Cultural Heritage of Cultural Heritage Administration, Republic of Korea; Koguryo Research Foundation, Republic of Korea; The Wellcome Trust(Wellcome TrustEuropean Commission)	This study, which forms a part of the project, has been achieved with the support of Conservation Technology Research and Development project, which has been hosted by National Research Institute of Cultural Heritage of Cultural Heritage Administration, Republic of Korea. This work was supported by grant from the Koguryo Research Foundation, Republic of Korea. CTS was supported by The Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Brandstatter A, 2006, INT J LEGAL MED, V120, P310, DOI 10.1007/s00414-006-0114-x; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; CHOI ML, 2001, SEOUL J KOREAN STUD, V14, P117; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Derenko MV, 2003, ANN HUM GENET, V67, P391, DOI 10.1046/j.1469-1809.2003.00035.x; DERENKO MV, 2004, RUSSIAN J GENET, V40, P1562; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; EXCOFFIER L, 1992, GENETICS, V131, P479; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; Goedde H W, 1987, Gene Geogr, V1, P177; Hammer MF, 2006, J HUM GENET, V51, P47, DOI 10.1007/s10038-005-0322-0; HAN YH, 1995, ALTAI KOREAN PENINSU; Hara Masaaki, 2007, Legal Medicine, V9, P161, DOI 10.1016/j.legalmed.2006.11.002; Hong S. S, 1993, MOL CELLS, V3, P457; Hong SB, 2006, KOREAN J GENETIC, V28, P1; Huang TY, 2008, FORENSIC SCI INT, V174, P249, DOI 10.1016/j.forsciint.2007.06.003; Hwang JH, 2007, FORENSIC SCI INT, V168, P73, DOI 10.1016/j.forsciint.2006.01.014; Jin Han Jun, 1999, Korean Journal of Biological Sciences, V3, P393; Jin HJ, 2003, HUM GENET, V114, P27, DOI 10.1007/s00439-003-1019-0; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; KIM K, 1970, ITS PEOPLE CULTURES; Kim W, 2000, J HUM GENET, V45, P76, DOI 10.1007/s100380050015; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Kong QP, 2003, HUM GENET, V113, P391, DOI 10.1007/s00439-003-1004-7; Kwak KD, 2005, INT J LEGAL MED, V119, P195, DOI 10.1007/s00414-004-0518-4; Lee H, 2006, INT J LEGAL MED, V120, P5, DOI 10.1007/s00414-005-0005-6; Li H, 2007, AM J PHYS ANTHROPOL, V134, P481, DOI 10.1002/ajpa.20690; Marrero AR, 2007, HUM HERED, V64, P160, DOI 10.1159/000102989; Maruyama S, 2003, INT J LEGAL MED, V117, P218, DOI 10.1007/s00414-003-0379-2; NEI M, 1993, MOL BIOL EVOL, V10, P927; Powell GT, 2007, FORENSIC SCI INT-GEN, V1, P115, DOI 10.1016/j.fsigen.2007.01.015; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Quintana-Murci L, 2008, P NATL ACAD SCI USA, V105, DOI 10.1073/pnas.0711467105; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; SAHA N, 1992, AM J PHYS ANTHROPOL, V88, P27, DOI 10.1002/ajpa.1330880104; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schneider S., 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Shi H, 2005, AM J HUM GENET, V77, P408, DOI 10.1086/444436; Sokal RR, 1998, HUM BIOL, V70, P1; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; TURNER CG, 1990, AM J PHYS ANTHROPOL, V82, P295, DOI 10.1002/ajpa.1330820308; Underhill PA, 2003, COLD SPRING HARB SYM, V68, P487, DOI 10.1101/sqb.2003.68.487; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4; Wells Spencer, 2002, JOURNEY MAN GENETIC; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; Wen B, 2005, MOL BIOL EVOL, V22, P725, DOI 10.1093/molbev/msi055; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Yan Jiangwei, 2007, Legal Medicine, V9, P196, DOI 10.1016/j.legalmed.2006.11.016; Yao YG, 2002, AM J PHYS ANTHROPOL, V118, P63, DOI 10.1002/ajpa.10052; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Yao YG, 2004, MOL BIOL EVOL, V21, P2265, DOI 10.1093/molbev/msh238; Yong RYY, 2006, FORENSIC SCI INT, V159, P244, DOI 10.1016/j.forsciint.2005.05.010; Zalloua PA, 2008, AM J HUM GENET, V82, P873, DOI 10.1016/j.ajhg.2008.01.020; Zhang Qingxia, 2006, Legal Medicine, V8, P300, DOI 10.1016/j.legalmed.2006.07.001; Zhang YJ, 2005, FORENSIC SCI INT, V149, P267, DOI 10.1016/j.forsciint.2004.07.012; Zhang YJ, 2007, FORENSIC SCI INT, V173, P197, DOI 10.1016/j.forsciint.2006.12.017	66	70	71	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2009	4	1							e4210	10.1371/journal.pone.0004210	http://dx.doi.org/10.1371/journal.pone.0004210			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437IH	19148289	Green Published, gold, Green Submitted			2022-12-25	WOS:000265479900004
J	Wang, AL; Lukas, TJ; Yuan, M; Du, N; Tso, MO; Neufeld, AH				Wang, Ai Ling; Lukas, Thomas J.; Yuan, Ming; Du, Nga; Tso, Mark O.; Neufeld, Arthur H.			Autophagy and Exosomes in the Aged Retinal Pigment Epithelium: Possible Relevance to Drusen Formation and Age-Related Macular Degeneration	PLOS ONE			English	Article								Age-related macular degeneration (AMD) is a major cause of loss of central vision in the elderly. The formation of drusen, an extracellular, amorphous deposit of material on Bruch's membrane in the macula of the retina, occurs early in the course of the disease. Although some of the molecular components of drusen are known, there is no understanding of the cell biology that leads to the formation of drusen. We have previously demonstrated increased mitochondrial DNA (mtDNA) damage and decreased DNA repair enzyme capabilities in the rodent RPE/choroid with age. In this study, we found that drusen in AMD donor eyes contain markers for autophagy and exosomes. Furthermore, these markers are also found in the region of Bruch's membrane in old mice. By in vitro modeling increased mtDNA damage induced by rotenone, an inhibitor of mitochondrial complex I, in the RPE, we found that the phagocytic activity was not altered but that there were: 1) increased autophagic markers, 2) decreased lysosomal activity, 3) increased exocytotic activity and 4) release of chemoattractants. Exosomes released by the stressed RPE are coated with complement and can bind complement factor H, mutations of which are associated with AMD. We speculate that increased autophagy and the release of intracellular proteins via exosomes by the aged RPE may contribute to the formation of drusen. Molecular and cellular changes in the old RPE may underlie susceptibility to genetic mutations that are found in AMD patients and may be associated with the pathogenesis of AMD in the elderly.	[Wang, Ai Ling; Lukas, Thomas J.; Yuan, Ming; Du, Nga; Tso, Mark O.; Neufeld, Arthur H.] Northwestern Univ, Sch Med, Dept Ophthalmol, Forsythe Lab Invest Aging Retina, Chicago, IL 60611 USA	Northwestern University	Wang, AL (corresponding author), Northwestern Univ, Sch Med, Dept Ophthalmol, Forsythe Lab Invest Aging Retina, Chicago, IL 60611 USA.	a-neufeld@northwestern.edu			NIH [EY12017]; Forsythe Foundation; RPB; NATIONAL EYE INSTITUTE [R01EY012017] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Forsythe Foundation; RPB(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grant EY12017, a generous gift from the Forsythe Foundation and an unrestricted grant from RPB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOK D, 1993, J CELL SCI, P189; BOULTON M, 1994, BRIT J OPHTHALMOL, V78, P125, DOI 10.1136/bjo.78.2.125; Chang YG, 2007, J CELL SCI, V120, P3053, DOI 10.1242/jcs.006361; Chen HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002339; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Deretic V, 2008, SCI AM, V298, P74, DOI 10.1038/scientificamerican0508-74; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Finnemann SC, 1999, J EXP MED, V190, P861, DOI 10.1084/jem.190.6.861; Fischer R, 2006, CHEMBIOCHEM, V7, P1428, DOI 10.1002/cbic.200600209; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Li J, 2005, J NEUROCHEM, V92, P462, DOI 10.1111/j.1471-4159.2004.02872.x; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; McCray BA, 2008, NEUROSIGNALS, V16, P75, DOI 10.1159/000109761; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; Nordgaard CL, 2008, INVEST OPHTH VIS SCI, V49, P2848, DOI 10.1167/iovs.07-1352; Olver Christine, 2007, V43, P99, DOI 10.1007/978-1-4020-5943-8_7; Ping JA, 2004, J CHROMATOGR B, V805, P297, DOI 10.1016/j.jchromb.2004.03.008; Rakoczy PE, 2002, AM J PATHOL, V161, P1515, DOI 10.1016/S0002-9440(10)64427-6; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Spencer KL, 2008, HUM MOL GENET, V17, P1821, DOI 10.1093/hmg/ddn075; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Teshima K, 2005, ANAL BIOCHEM, V338, P12, DOI 10.1016/j.ab.2004.12.007; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Umeda S, 2005, FASEB J, V19, P1683, DOI 10.1096/fj.04-3525fje; Wang AL, 2008, MOL VIS, V14, P644	34	239	252	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2009	4	1							e4160	10.1371/journal.pone.0004160	http://dx.doi.org/10.1371/journal.pone.0004160			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FZ	19129916	gold, Green Submitted, Green Published			2022-12-25	WOS:000265473500007
J	Wan, QH; Zeng, CJ; Ni, XW; Pan, HJ; Fang, SG				Wan, Qiu-Hong; Zeng, Chang-Jun; Ni, Xiao-Wei; Pan, Hui-Juan; Fang, Sheng-Guo			Giant Panda Genomic Data Provide Insight into the Birth-and-Death Process of Mammalian Major Histocompatibility Complex Class II Genes	PLOS ONE			English	Article							CATTLE MHC; EVOLUTION; ORGANIZATION; SEQUENCE; FERTILIZATION; SIMILARITY; REGION; MOUSE	To gain an understanding of the genomic structure and evolutionary history of the giant panda major histocompatibility complex (MHC) genes, we determined a 636,503-bp nucleotide sequence spanning the MHC class II region. Analysis revealed that the MHC class II region from this rare species contained 26 loci (17 predicted to be expressed), of which 10 are classical class II genes (1 DRA, 2 DRB, 2 DQA, 3 DQB, 1 DYB, 1 DPA, and 2 DPB) and 4 are non-classical class II genes (1 DOA, 1 DOB, 1 DMA, and 1 DMB). The presence of DYB, a gene specific to ruminants, prompted a comparison of the giant panda class II sequence with those of humans, cats, dogs, cattle, pigs, and mice. The results indicated that birth and death events within the DQ and DRB-DY regions led to major lineage differences, with absence of these regions in the cat and in humans and mice respectively. The phylogenetic trees constructed using all expressed alpha and beta genes from marsupials and placental mammals showed that: (1) because marsupials carry loci corresponding to DR, DP, DO and DM genes, those subregions most likely developed before the divergence of marsupials and placental mammals, approximately 150 million years ago (MYA); ( 2) conversely, the DQ and DY regions must have evolved later, but before the radiation of placental mammals (100 MYA). As a result, the typical genomic structure of MHC class II genes for the giant panda is similar to that of the other placental mammals and corresponds to BTNL2 similar to DR1 similar to DQ similar to DR2 similar to DY similar to DO_box similar to DP similar to COL11A2. Over the past 100 million years, there has been birth and death of mammalian DR, DQ, DY, and DP genes, an evolutionary process that has brought about the current species-specific genomic structure of the MHC class II region. Furthermore, facing certain similar pathogens, mammals have adopted intra-subregion (DR and DQ) and inter-subregion (between DQ and DP) convergent evolutionary strategies for their alpha and beta genes, respectively.	[Wan, Qiu-Hong; Zeng, Chang-Jun; Ni, Xiao-Wei; Pan, Hui-Juan; Fang, Sheng-Guo] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Wan, Qiu-Hong; Zeng, Chang-Jun; Ni, Xiao-Wei; Pan, Hui-Juan; Fang, Sheng-Guo] Minist Ed, Key Lab Conserv Genet & Reproduct Biol Endanger, Hangzhou, Peoples R China; [Wan, Qiu-Hong; Zeng, Chang-Jun; Ni, Xiao-Wei; Pan, Hui-Juan; Fang, Sheng-Guo] State Conserv Ctr Gene Resources Endangered, Hangzhou, Peoples R China	Zhejiang University	Wan, QH (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	sgfang@mail.hz.zj.cn			National Basic Research Program of China (973 program) [2007CB411600]; State Forestry Administration of P. R. China	National Basic Research Program of China (973 program)(National Basic Research Program of China); State Forestry Administration of P. R. China	This work was supported by a grant from the National Basic Research Program of China (973 program) (No. 2007CB411600) and a special grant from the State Forestry Administration of P. R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ando A, 2006, ANIM SCI J, V77, P127, DOI 10.1111/j.1740-0929.2006.00331.x; Ballingall KT, 2004, IMMUNOGENETICS, V55, P748, DOI 10.1007/s00251-004-0641-x; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Belov K, 2006, PLOS BIOL, V4, P317, DOI 10.1371/journal.pbio.0040046; BENTON MJ, 1990, J MOL EVOL, V30, P409, DOI 10.1007/BF02101113; BENTON MJ, 1993, PHYLOGENY MAJOR TETR; Bourque G, 2004, GENOME RES, V14, P507, DOI 10.1101/gr.1975204; Bray N, 2003, GENOME RES, V13, P97, DOI 10.1101/gr.789803; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Childers CP, 2006, ANIM GENET, V37, P121, DOI 10.1111/j.1365-2052.2005.01395.x; Debenham SL, 2005, GENOMICS, V85, P48, DOI 10.1016/j.ygeno.2004.09.009; Ellis SA, 1999, IMMUNOL REV, V167, P159, DOI 10.1111/j.1600-065X.1999.tb01389.x; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fernandez N, 1999, HUM REPROD UPDATE, V5, P234, DOI 10.1093/humupd/5.3.234; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Fukami-Kobayashi K, 2005, P NATL ACAD SCI USA, V102, P9230, DOI 10.1073/pnas.0500770102; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Gorer PA, 1936, BRIT J EXP PATHOL, V17, P42; Hu JC, 2001, RES GIANT PANDA; Huang Y, 2004, BIOINFORMATICS, V20, P460, DOI 10.1093/bioinformatics/btg429; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUGHES AL, 1990, MOL BIOL EVOL, V7, P491; HUGHES AL, 1989, MOL BIOL EVOL, V6, P559; Kaufman J, 1999, NATURE, V401, P923, DOI 10.1038/44856; Kielan-Jaworowska Z., 1992, Historical Biology, V6, P185; KLEIN J, 1990, IMMUNOGENETICS, V31, P217, DOI 10.1007/BF00204890; KLEIN J, 1986, NATURAL HIST MAJOR H; Kumanovics A, 2003, ANNU REV IMMUNOL, V21, P629, DOI 10.1146/annurev.immunol.21.090501.080116; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lum JK, 2000, MOL BIOL EVOL, V17, P1417, DOI 10.1093/oxfordjournals.molbev.a026242; McCluskey J, 1999, Rev Immunogenet, V1, P3; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; OBER C, 1993, J REPROD IMMUNOL, V25, P195, DOI 10.1016/0165-0378(93)90063-N; Reusch TBH, 2001, NATURE, V414, P300, DOI 10.1038/35104547; Roberts SC, 2003, NAT GENET, V35, P103, DOI 10.1038/ng1231; ROWEN L, 1998, SEQUENCE MOUSE MAJOR; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Skarstein F, 2005, BEHAV ECOL SOCIOBIOL, V57, P374, DOI 10.1007/s00265-004-0860-z; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; State Forestry Administration, 2006, 3 NAT SURV REP GIANT; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Takahashi K, 2000, J HERED, V91, P198, DOI 10.1093/jhered/91.3.198; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Theodor JM, 2004, J PALEONTOL, V78, P39, DOI 10.1666/0022-3360(2004)078<0039:MCDEAT>2.0.CO;2; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; TROWSDALE J, 1995, IMMUNOGENETICS, V41, P1, DOI 10.1007/BF00188427; XIE Z, 2007, 2007 INT STUDBOOK GI; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yuhki N, 2003, GENOME RES, V13, P1169, DOI 10.1101/gr.976103; Zeng C. J., 2005, CYTOGENET GENOME RES, V109, p534H, DOI [10. 1159/000084222, DOI 10.1159/000084222]; Zeng CJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-315; ZHAO XM, GIANT PANDAS NATURAL	57	27	33	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4147	10.1371/journal.pone.0004147	http://dx.doi.org/10.1371/journal.pone.0004147			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FX	19127303	gold, Green Submitted, Green Published			2022-12-25	WOS:000265473300012
J	Liao, JJ; Huang, MC; Fast, K; Gundling, K; Yadav, M; Van Brocklyn, JR; Wabl, MR; Goetzl, EJ				Liao, Jia-Jun; Huang, Mei-Chuan; Fast, Katharine; Gundling, Katherine; Yadav, Mahesh; Van Brocklyn, James R.; Wabl, Matthias R.; Goetzl, Edward J.			Immunosuppressive human anti-lymphocyte autoantibodies specific for the type 1 sphingosine 1-phosphate receptor	FASEB JOURNAL			English	Article						inflammation; chemotaxis; sphingolipid; G protein-coupled	LYMPHOCYTE EGRESS; ANTIBODIES; SPHINGOSINE-1-PHOSPHATE; S1P; ACTIVATION; IDENTIFICATION; SPHINGOLIPIDS; AGONIST; CELLS	Anti-lymphocyte antibodies (Abs) that suppress T-cell chemotactic and other responses to sphingosine 1-phosphate (S1P), but not to chemokines, were found in a lymphopenic patient with recurrent infections. Lymphocyte type 1 S1P receptor (S1P(1)) that transduces S1P chemotactic stimulation was recognized by patient Abs in Western blots of T cells, S1P(1) transfectants, and S1P(1)-hemagglutinin purified by monoclonal anti-hemagglutinin Ab absorption. The amino terminus of S1P(1), but not any extracellular loop, prevented anti-S1P(1) Ab suppression of S1P(1) signaling and T-cell chemotaxis to S1P. Human purified anti-S1P(1) Abs decreased mouse blood lymphocyte levels by a mean of 72%, suppressed mouse T-cell chemotaxis to S1P in vivo, and significantly reduced the severity of dextran sodium sulfate-induced colitis in mice. Human Abs to the amino terminus of S1P(1) suppress T-cell trafficking sufficiently to impair host defense and provide therapeutic immunosuppression.-Liao, J.- J., Huang, M.-C., Fast, K., Gundling, K., Yadav, M., Van Brocklyn, J. R., Wabl, M. R., Goetzl, E. J. Immunosuppressive human anti-lymphocyte autoantibodies specific for the type 1 sphingosine 1-phosphate receptor. FASEB J. 23, 1786-1796 (2009)	[Goetzl, Edward J.] Univ Calif San Francisco, Med Ctr, Dept Med, San Francisco, CA 94143 USA; [Wabl, Matthias R.; Goetzl, Edward J.] Univ Calif San Francisco, Dept Microbiol Immunol, San Francisco, CA 94143 USA; [Van Brocklyn, James R.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University System of Ohio; Ohio State University	Goetzl, EJ (corresponding author), Univ Calif San Francisco, Med Ctr, Dept Med, Rm UB8B,UCSF Box 0711,533 Parnassus & 4th Ave, San Francisco, CA 94143 USA.	edward.goetzl@ucsf.edu	Van Brocklyn, Jim/A-9733-2010		National Institutes of Health (NIH) [RO-1, HL-31809, RO1 AI041570]; Rainin Post-Doctoral Training Fund; NIH [T32 AG000212]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000212] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rainin Post-Doctoral Training Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	These studies were made possible by RO-1 grant HL-31809 from the National Institutes of Health (NIH) (E.J.G.), NIH grant RO1 AI041570 (M.R.W.), and the Rainin Post-Doctoral Training Fund (M.Y.). K. F. is supported by the UCSF Geriatric Program Training Grant T32 AG000212 from NIH.	Chun J, 2007, SCIENCE, V316, P208, DOI 10.1126/science.1142239; Dorsam G, 2003, J IMMUNOL, V171, P3500, DOI 10.4049/jimmunol.171.7.3500; Fieger CB, 2005, FASEB J, V19, P1926, DOI 10.1096/fj.05-4476fje; Fina D, 2008, GASTROENTEROLOGY, V134, P1038, DOI 10.1053/j.gastro.2008.01.041; Fujiwara Y, 2007, J BIOL CHEM, V282, P2374, DOI 10.1074/jbc.M609648200; GILBREATH MJ, 1983, CLIN EXP IMMUNOL, V51, P232; Gonzalez-Cabrera PJ, 2008, MOL PHARMACOL, V74, P1308, DOI 10.1124/mol.108.049783; Graeler M, 2002, FASEB J, V16, P1874, DOI 10.1096/fj.02-0548com; Graeler MH, 2003, J BIOL CHEM, V278, P27737, DOI 10.1074/jbc.C300147200; Grahler MH, 2005, J IMMUNOL, V174, P1997; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; GRIGGI T, 1994, SCAND J IMMUNOL, V40, P77, DOI 10.1111/j.1365-3083.1994.tb03436.x; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hale JJ, 2004, BIOORG MED CHEM LETT, V14, P3351, DOI 10.1016/j.bmcl.2004.02.106; Igarashi J, 2000, J BIOL CHEM, V275, P32363, DOI 10.1074/jbc.M003075200; Kohno T, 2002, FASEB J, V16, P983, DOI 10.1096/fj.01-0809com; Lebman DA, 2008, J LIPID RES, V49, P1388, DOI 10.1194/jlr.R800008-JLR200; Li X, 2008, BLOOD, V111, P3489, DOI 10.1182/blood-2007-05-092148; Lobo PI, 2008, J IMMUNOL, V180, P1780, DOI 10.4049/jimmunol.180.3.1780; LOBO PI, 1981, TRANSPLANTATION, V32, P233, DOI 10.1097/00007890-198109000-00010; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; MIMURA T, 1990, J EXP MED, V172, P653, DOI 10.1084/jem.172.2.653; MINOTA S, 1987, J IMMUNOL, V139, P3644; Olivera A, 2005, J IMMUNOL, V174, P1153, DOI 10.4049/jimmunol.174.3.1153; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Przybylowski P, 1999, TRANSPLANTATION, V67, P258, DOI 10.1097/00007890-199901270-00012; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; SPIEGEL S, 1995, J MEMBRANE BIOL, V146, P225; STRICKER RB, 1987, NATURE, V327, P710, DOI 10.1038/327710a0; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; WARREN RQ, 1988, CLIN EXP IMMUNOL, V73, P168; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41	36	12	12	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1786	1796		10.1096/fj.08-124891	http://dx.doi.org/10.1096/fj.08-124891			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19158154	Green Published			2022-12-25	WOS:000266652400019
J	Garantziotis, S; Li, ZW; Potts, EN; Kimata, K; Zhuo, LS; Morgan, DL; Savani, RC; Noble, PW; Foster, WM; Schwartz, DA; Hollingsworth, JW				Garantziotis, Stavros; Li, Zhuowei; Potts, Erin N.; Kimata, Koji; Zhuo, Lisheng; Morgan, Daniel L.; Savani, Rashmin C.; Noble, Paul W.; Foster, W. Michael; Schwartz, David A.; Hollingsworth, John W.			Hyaluronan Mediates Ozone-induced Airway Hyperresponsiveness in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTER-ALPHA-INHIBITOR; LUNG INFLAMMATION; HEAVY-CHAINS; MORTALITY; HEALTH; INJURY; TSG-6; CD44; BRONCHOCONSTRICTION; POLLUTION	Ozone is a common urban environmental air pollutant and significantly contributes to hospitalizations for respiratory illness. The mechanisms, which regulate ozone-induced broncho-constriction, remain poorly understood. Hyaluronan was recently shown to play a central role in the response to noninfectious lung injury. Therefore, we hypothesized that hyaluronan contributes to airway hyperreactivity (AHR) after exposure to ambient ozone. Using an established model of ozone-induced airways disease, we characterized the role of hyaluronan in airway hyperresponsiveness. The role of hyaluronan in response to ozone was determined by using therapeutic blockade, genetically modified animals, and direct challenge to hyaluronan. Ozone-exposed mice demonstrate enhanced AHR associated with elevated hyaluronan levels in the lavage fluid. Mice deficient in either CD44 (the major receptor for hyaluronan) or inter-alpha-trypsin inhibitor (molecule that facilitates hyaluronan binding) show similar elevations in hyaluronan but are protected from ozone-induced AHR. Mice pretreated with hyaluronan-binding peptide are protected from the development of ozone-induced AHR. Overexpression of hyaluronan enhances the airway response to ozone. Intratracheal instillation of endotoxin-free low molecular weight hyaluronan induces AHR dependent on CD44, whereas instillation of high molecular weight hyaluronan protects against ozone-induced AHR. In conclusion, we demonstrate that hyaluronan mediates ozone-induced AHR, which is dependent on the fragment size and both CD44 and inter-alpha-trypsin inhibitor. These data support the conclusion that pulmonary matrix can contribute to the development of airway hyperresponsiveness.	[Garantziotis, Stavros; Morgan, Daniel L.] NIEHS, NIH, Res Triangle Pk, NC 27709 USA; [Li, Zhuowei; Potts, Erin N.; Noble, Paul W.; Foster, W. Michael; Hollingsworth, John W.] Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Durham, NC 27710 USA; [Kimata, Koji; Zhuo, Lisheng] Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan; [Savani, Rashmin C.] Univ Texas SW Med Ctr Dallas, Div Pulm & Vasc Biol, Dallas, TX 75390 USA; [Savani, Rashmin C.] Univ Texas SW Med Ctr Dallas, Div Neonatal Perinatal Med, Dallas, TX 75390 USA; [Schwartz, David A.] Natl Jewish Med & Res Ctr, Div Pulm Med, Denver, CO 80206 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; Aichi Medical University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Jewish Health	Hollingsworth, JW (corresponding author), DUMC Box 103004, Durham, NC 27710 USA.	holli017@mc.duke.edu	Garantziotis, Stavros/A-6903-2009; Rashmin C. Savani, MBChB/AAG-2041-2021	Garantziotis, Stavros/0000-0003-4007-375X; Rashmin C. Savani, MBChB/0000-0002-9533-5422	National Institutes of Health [ES11961]; NIEHS [ES16126]; NHLBI [HL91335, HL62472, HL73896]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073896, R01HL062472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016126, ZIAES102605, P30ES011961] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES11961 and ES16126 from the NIEHS, Grants HL91335, HL62472, and HL73896 from the NHLBI, and grants from the NIEHS (Intramural Research Program). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bai KJ, 2005, AM J RESP CRIT CARE, V172, P92, DOI 10.1164/rccm.200405-652OC; Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372; Deed R, 1997, INT J CANCER, V71, P251, DOI 10.1002/(SICI)1097-0215(19970410)71:2<251::AID-IJC21>3.0.CO;2-J; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Gryparis A, 2004, AM J RESP CRIT CARE, V170, P1080, DOI 10.1164/rccm.200403-333OC; Hollingsworth John W, 2007, Proc Am Thorac Soc, V4, P240, DOI 10.1513/pats.200701-023AW; Hollingsworth JW, 2005, AM J RESP CRIT CARE, V171, P806, DOI 10.1164/rccm.200407-953OC; Hollingsworth JW, 2004, AM J RESP CRIT CARE, V170, P126, DOI 10.1164/rccm.200311-1499OC; HOLLINGSWORTH JW, 2007, AM J RESP CELL MOL B, V120, P121; Hubbell BJ, 2005, ENVIRON HEALTH PERSP, V113, P73, DOI 10.1289/ehp.7186; Ito K, 2005, EPIDEMIOLOGY, V16, P446, DOI 10.1097/01.ede.0000165821.90114.7f; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; KATSOUYANNI K, 1995, EUR RESPIR J, V8, P1030; Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; Levy JI, 2005, EPIDEMIOLOGY, V16, P458, DOI 10.1097/01.ede.0000165820.08301.b3; Petrigni G, 2006, PULM PHARMACOL THER, V19, P166, DOI 10.1016/j.pupt.2005.03.002; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; SAHU S, 1978, BIOCHEM J, V173, P565, DOI 10.1042/bj1730565; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Savani RC, 2000, AM J RESP CELL MOL, V23, P475, DOI 10.1165/ajrcmb.23.4.3944; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; SCHMUT O, 1994, OPHTHALMIC RES, V26, P340, DOI 10.1159/000267499; Scuri M, 2001, AM J RESP CRIT CARE, V164, P1855, DOI 10.1164/ajrccm.164.10.2011115; Skerrett SJ, 2004, AM J PHYSIOL-LUNG C, V287, pL143, DOI 10.1152/ajplung.00030.2004; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Wang Q, 2002, AM J PATHOL, V161, P2219, DOI 10.1016/S0002-9440(10)64498-7; WIESTER MJ, 1988, TOXICOL APPL PHARM, V96, P140, DOI 10.1016/0041-008X(88)90256-6; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200; Zhuo LS, 2004, J BIOL CHEM, V279, P38079, DOI 10.1074/jbc.R300039200; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	32	94	96	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11309	11317		10.1074/jbc.M802400200	http://dx.doi.org/10.1074/jbc.M802400200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19164299	hybrid, Green Published			2022-12-25	WOS:000265494500035
J	Lain, E; Carnejac, S; Escher, P; Wilson, MC; Lomo, T; Gajendran, N; Brenner, HR				Lain, Enzo; Carnejac, Soizic; Escher, Pascal; Wilson, Marieangela C.; Lomo, Terje; Gajendran, Nadesan; Brenner, Hans Rudolf			A Novel Role for Embigin to Promote Sprouting of Motor Nerve Terminals at the Neuromuscular Junction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; CELL-ADHESION MOLECULE; N-CAM; IMMUNOGLOBULIN SUPERFAMILY; SKELETAL-MUSCLE; SYNAPSE FORMATION; MESSENGER-RNAS; BASIGIN CD147; SCHWANN-CELLS; MICE	Adult skeletal muscle accepts ectopic innervation by foreign motor axons only after section of its own nerve, suggesting that the formation of new neuromuscular junctions is promoted by muscle denervation. With the aim to identify new proteins involved in neuromuscular junction formation we performed an mRNA differential display on innervated versus denervated adult rat muscles. We identified transcripts encoding embigin, a transmembrane protein of the immunoglobulin superfamily (IgSF) class of cell adhesion molecules to be strongly regulated by the state of innervation. In innervated muscle it is preferentially localized to neuromuscular junctions. Forced overexpression in innervated muscle of a full-length embigin transgene, but not of an embigin fragment lacking the intracellular domain, promotes nerve terminal sprouting and the formation of additional acetylcholine receptor clusters at synaptic sites without affecting terminal Schwann cell number or morphology, and it delays the retraction of terminal sprouts following re-innervation of denervated endplates. Conversely, knockdown of embigin by RNA interference in wild-type muscle accelerates terminal sprout retraction, both by itself and synergistically with deletion of neural cell adhesion molecule. These findings indicate that embigin enhances neural cell adhesion molecule-dependent neuromuscular adhesion and thereby modulates neuromuscular junction formation and plasticity.	[Brenner, Hans Rudolf] Univ Basel, Dept Biomed, Inst Physiol, CH-4056 Basel, Switzerland; [Wilson, Marieangela C.] Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England; [Lomo, Terje] Univ Oslo, Dept Physiol, N-0317 Oslo, Norway	University of Basel; University of Bristol; University of Oslo	Brenner, HR (corresponding author), Univ Basel, Dept Biomed, Inst Physiol, Klingelbergstr 50, CH-4056 Basel, Switzerland.	Hans-Rudolf.Brenner@unibas.ch		Wilson, Marieangela/0000-0001-6218-3533; , Nadesan/0000-0002-7463-4220	Swiss National Science Foundation; Swiss Foundation for Research on Muscle Diseases; Kanton Basel-Stadt	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Foundation for Research on Muscle Diseases; Kanton Basel-Stadt	This work was supported by grants from the Swiss National Science Foundation, the Swiss Foundation for Research on Muscle Diseases, and by the Kanton Basel-Stadt. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Besse F, 2007, J CELL BIOL, V177, P843, DOI 10.1083/jcb.200701111; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; Bowen DC, 1998, DEV BIOL, V199, P309, DOI 10.1006/dbio.1998.8936; BROWN MC, 1977, NATURE, V265, P459, DOI 10.1038/265459a0; BROWN MC, 1979, NATURE, V282, P724, DOI 10.1038/282724a0; BROWN MC, 1981, ANNU REV NEUROSCI, V4, P17, DOI 10.1146/annurev.ne.04.030181.000313; BURG MA, 1995, J NEUROSCI RES, V41, P49, DOI 10.1002/jnr.490410107; Cotman SL, 1999, EXP CELL RES, V249, P54, DOI 10.1006/excr.1999.4463; COVAULT J, 1986, J CELL BIOL, V102, P731, DOI 10.1083/jcb.102.3.731; COVAULT J, 1986, J CELL BIOL, V102, P716, DOI 10.1083/jcb.102.3.716; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Fan QW, 1998, DEV GROWTH DIFFER, V40, P277; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; GATCHALIAN CL, 1989, J CELL BIOL, V108, P1873, DOI 10.1083/jcb.108.5.1873; Hayworth CR, 2006, J NEUROSCI, V26, P6873, DOI 10.1523/JNEUROSCI.1086-06.2006; Herbst R, 2002, DEVELOPMENT, V129, P5449, DOI 10.1242/dev.00112; Hinkle CL, 2006, J NEUROBIOL, V66, P1378, DOI 10.1002/neu.20257; HUANG RP, 1990, DIFFERENTIATION, V45, P76, DOI 10.1111/j.1432-0436.1990.tb00460.x; HUANG RP, 1993, DEV BIOL, V155, P307, DOI 10.1006/dbio.1993.1030; Jones G, 1997, P NATL ACAD SCI USA, V94, P2654, DOI 10.1073/pnas.94.6.2654; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; Ksiazek I, 2007, J NEUROSCI, V27, P7183, DOI 10.1523/JNEUROSCI.1609-07.2007; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Lomo T, 2003, J NEUROCYTOL, V32, P835, DOI 10.1023/B:NEUR.0000020627.18156.b1; LOMO T, 1978, J PHYSIOL-LONDON, V275, P391, DOI 10.1113/jphysiol.1978.sp012196; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Meier T, 1998, EUR J NEUROSCI, V10, P3141, DOI 10.1046/j.1460-9568.1998.00320.x; Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054; MOORE SE, 1985, EMBO J, V4, P623, DOI 10.1002/j.1460-2075.1985.tb03675.x; Moscoso LM, 1998, J NEUROSCI, V18, P1465; Muramatsu T, 2003, HISTOL HISTOPATHOL, V18, P981, DOI 10.14670/HH-18.981; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; O'Malley JP, 1999, J NEUROBIOL, V38, P270, DOI 10.1002/(SICI)1097-4695(19990205)38:2<270::AID-NEU9>3.0.CO;2-F; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; SANES JR, 1986, J CELL BIOL, V102, P420, DOI 10.1083/jcb.102.2.420; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SON YJ, 1995, NEURON, V14, P125, DOI 10.1016/0896-6273(95)90246-5; SON YJ, 1995, NEURON, V14, P133, DOI 10.1016/0896-6273(95)90247-3; Storms SD, 1996, EXP CELL RES, V223, P385, DOI 10.1006/excr.1996.0093; Walsh FS, 1997, ANNU REV CELL DEV BI, V13, P425, DOI 10.1146/annurev.cellbio.13.1.425; Walsh FS, 2000, MOL CELL NEUROSCI, V15, P244, DOI 10.1006/mcne.1999.0815; WEHRLEHALLER B, 1993, J CELL SCI, V106, P597; WIGSTON DJ, 1989, J NEUROSCI, V9, P639; Wilson MC, 2005, J BIOL CHEM, V280, P27213, DOI 10.1074/jbc.M411950200; Windisch A, 1998, J PHYSIOL-LONDON, V510, P623, DOI 10.1111/j.1469-7793.1998.623bk.x; WITZEMANN V, 1989, FEBS LETT, V242, P419, DOI 10.1016/0014-5793(89)80514-9; WITZEMANN V, 1991, J CELL BIOL, V114, P125, DOI 10.1083/jcb.114.1.125	47	27	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8921	8930		10.1074/jbc.M809491200	http://dx.doi.org/10.1074/jbc.M809491200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19164284	Green Published, hybrid			2022-12-25	WOS:000264397800075
J	Suwan, K; Choocheep, K; Hatano, S; Kongtawelert, P; Kimata, K; Watanabe, H				Suwan, Keittisak; Choocheep, Kanyamas; Hatano, Sonoko; Kongtawelert, Prachya; Kimata, Koji; Watanabe, Hideto			Versican/PG-M Assembles Hyaluronan into Extracellular Matrix and Inhibits CD44-mediated Signaling toward Premature Senescence in Embryonic Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; CREST CELL-MIGRATION; CHONDROITIN SULFATE; PG-M/VERSICAN; LEUKOCYTE ADHESION; TUMOR-CELLS; PROLIFERATION; PROTEOGLYCAN; BINDING; DOMAIN	Versican/PG-M is a large chondroitin sulfate proteoglycan of the extracellular matrix which interacts with hyaluronan at the N-terminal G1 domain, composed of A, B, and B' subdomains. Recently, we generated knock-in mice Cspg2(Delta 3/Delta 3), whose versican, without the A subdomain, has decreased hyaluronan ( HA) binding affinity, thereby exhibiting reduced deposition of versican in the extracellular matrix. Here, we show that the Cspg2(Delta 3/Delta 3) fibroblasts within 20 passages proliferate more slowly and acquire senescence. Whereas the extracellular matrix of the wild type fibroblasts exhibited a network structure of hyaluronan and versican, that of the Cspg2(Delta 3/Delta 3) fibroblasts exhibited similar to 35 and similar to 85% deposition of versican and HA, without such a structure. The Cspg2(Delta 3/Delta 3) fibroblasts showed a substantial increase of ERK1/2 phosphorylation and expression of senescence markers p53, p21, and p16. Treatment of wild type fibroblasts with hyaluronidase and exogenous hyaluronan enhanced ERK1/2 phosphorylation, and treatment with an anti-CD44 antibody that blocks HA-CD44 interaction inhibited the phosphorylation. These results demonstrate that versican is essential for matrix assembly involving hyaluronan and that diminished versican deposition increases free hyaluronan fragments that interact with CD44 and increase phosphorylation of ERK1/2, leading to cellular senescence.	[Suwan, Keittisak; Choocheep, Kanyamas; Hatano, Sonoko; Kimata, Koji; Watanabe, Hideto] Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan; [Suwan, Keittisak; Choocheep, Kanyamas; Kongtawelert, Prachya] Chiang Mai Univ, Thailand Excellence Ctr Tissue Engn, Fac Med, Dept Biochem, Chiang Mai 50200, Thailand	Aichi Medical University; Chiang Mai University	Watanabe, H (corresponding author), Karimata 21, Nagakute, Aichi 4801195, Japan.	wannabee@aichi-med-u.ac.jp		Suwan, Keittisak/0000-0001-6542-5841; Watanabe, Hideto/0000-0001-5291-0696; kongtawelert, prachya/0000-0002-5963-2796	Scientific Research B and C KAKENHI	Scientific Research B and C KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research B and C KAKENHI ( to H. W.) and Grants- in- aid for Priority Areas ( to H. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aspberg A, 1999, J BIOL CHEM, V274, P20444, DOI 10.1074/jbc.274.29.20444; ASPBERG A, 1995, P NATL ACAD SCI USA, V92, P10590, DOI 10.1073/pnas.92.23.10590; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; BRAUNEWELL KH, 1995, EUR J NEUROSCI, V7, P805, DOI 10.1111/j.1460-9568.1995.tb00683.x; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Cattaruzza S, 2004, FASEB J, V18, P779, DOI 10.1096/fj.03-0660fje; Cheng CH, 2006, GENE DEV, V20, P1715, DOI 10.1101/gad.1430906; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Domenzain C, 2003, BBA-MOL CELL RES, V1642, P107, DOI 10.1016/S0167-4889(03)00104-6; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; Hinek A, 2004, AM J PATHOL, V164, P119, DOI 10.1016/S0002-9440(10)63103-3; HOGAN B, 1994, MANIPULATING MOUSE E, P260; Isogai Z, 2002, J BIOL CHEM, V277, P4565, DOI 10.1074/jbc.M110583200; Ito T, 2004, KIDNEY INT, V65, P823, DOI 10.1111/j.1523-1755.2004.00457.x; Kamiya N, 2006, J BIOL CHEM, V281, P2390, DOI 10.1074/jbc.M509341200; KIMATA K, 1985, J EMBRYOL EXP MORPH, V89, P243; LANDOLT RM, 1995, DEVELOPMENT, V121, P2303; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Matsumoto K, 2003, J BIOL CHEM, V278, P41205, DOI 10.1074/jbc.M305060200; Matsumoto K, 2006, J BIOL CHEM, V281, P18257, DOI 10.1074/jbc.M510330200; Mazzucato M, 2002, FASEB J, V16, P1903, DOI 10.1096/fj.02-0382com; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Olin AI, 2001, J BIOL CHEM, V276, P1253, DOI 10.1074/jbc.M006783200; Perissinotto D, 2000, DEVELOPMENT, V127, P2823; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sheng W, 2005, MOL BIOL CELL, V16, P1330, DOI 10.1091/mbc.e04-04-0295; SHINOMURA T, 1993, J BIOL CHEM, V268, P14461; Suwiwat S, 2004, CLIN CANCER RES, V10, P2491, DOI 10.1158/1078-0432.CCR-03-0146; Tsatas D, 2002, J CLIN NEUROSCI, V9, P282, DOI 10.1054/jocn.2001.1063; Tsujii M, 2006, HISTOL HISTOPATHOL, V21, P511, DOI 10.14670/HH-21.511; van der Voort R, 1999, J BIOL CHEM, V274, P6499, DOI 10.1074/jbc.274.10.6499; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Wu YJ, 2004, J CELL SCI, V117, P2227, DOI 10.1242/jcs.01057; YAMAGATA M, 1994, J CELL SCI, V107, P2581; YAMAGATA M, 1986, J BIOL CHEM, V261, P3526; Zhang Y, 1998, J BIOL CHEM, V273, P21342, DOI 10.1074/jbc.273.33.21342; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x	40	41	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8596	8604		10.1074/jbc.M806927200	http://dx.doi.org/10.1074/jbc.M806927200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19164294	Green Published, hybrid			2022-12-25	WOS:000264397800044
J	Brice, SE; Alford, CW; Cowart, LA				Brice, Sarah E.; Alford, Charlene W.; Cowart, L. Ashley			Modulation of Sphingolipid Metabolism by the Phosphatidylinositol-4-phosphate Phosphatase Sac1p through Regulation of Phosphatidylinositol in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN PROTEINS SLM1; DE-NOVO; HEAT-STRESS; SERINE PALMITOYLTRANSFERASE; ACTIN CYTOSKELETON; LIPID PHOSPHATASE; FREE SPHINGOSINE; PLASMA-MEMBRANE; DISTINCT ROLES; YEAST	Sphingolipids and phosphoinositides both play signaling roles in Saccharomyces cerevisiae. Although previous data indicate independent functions for these two classes of lipids, recent genetic studies have suggested interactions between phosphatidylinositol (PtdIns) phosphate effectors and sphingolipid biosynthetic enzymes. The present study was undertaken to further define the effects of phosphatidylinositol 4-phosphate (PtdIns(4)P) metabolism on cell sphingolipid metabolism. The data presented indicate that deletion of SAC1, a gene encoding a PtdIns(4) P phosphatase, increased levels of most sphingolipid species, including sphingoid bases, sphingoid base phosphates, and phytoceramide. In contrast, sac1 Delta dramatically reduced inositol phosphosphingolipids, which result from the addition of a PtdIns-derived phosphoinositol head group to ceramides through Aur1p. Deletion of SAC1 decreased PtdIns dramatically in both steady-state and pulse labeling studies, suggesting that the observed effects on sphingolipids may result from modulation of the availability of PtdIns as a substrate for Aur1p. Supporting this hypothesis, acute attenuation of PtdIns(4) P production through Stt4p immediately increased PtdIns and subsequently reduced sphingoid bases. This reduction was overcome by the inhibition of Aur1p. Moreover, modulation of sphingoid bases through perturbation of PtdIns(4) P metabolism initiated sphingolipid-dependent biological effects, supporting the biological relevance for this route of regulating sphingolipids. These findings suggest that, in addition to potential signaling effects of PtdInsP effectors on sphingolipid metabolism, PtdIns kinases may exert substantial effects on cell sphingolipid profiles at a metabolic level through modulation of PtdIns available as a substrate for complex sphingolipid synthesis.	[Brice, Sarah E.; Alford, Charlene W.; Cowart, L. Ashley] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Cowart, L. Ashley] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Cowart, LA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	cowartl@musc.edu			Centers of Biomedical Research Excellence in lipidomics and pathobiology at the Medical University of South Carolina	Centers of Biomedical Research Excellence in lipidomics and pathobiology at the Medical University of South Carolina(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by the Centers of Biomedical Research Excellence in lipidomics and pathobiology at the Medical University of South Carolina	Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232; Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015; Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bultynck G, 2006, MOL CELL BIOL, V26, P4729, DOI 10.1128/MCB.01973-05; Cameroni E, 2006, J BIOL CHEM, V281, P38139, DOI 10.1074/jbc.M601060200; Cerbon J, 2005, BIOCHEM J, V388, P169, DOI 10.1042/BJ20040475; Choi JY, 2006, BIOCHEM SOC T, V34, P404, DOI 10.1042/BST0340404; Chung N, 2000, J BIOL CHEM, V275, P17229, DOI 10.1074/jbc.C000229200; Chung NJ, 2001, J BIOL CHEM, V276, P35614, DOI 10.1074/jbc.M105653200; Cowart LA, 2007, J BIOL CHEM, V282, P12330, DOI 10.1074/jbc.M700685200; Cowart LA, 2006, BIOCHEM J, V393, P733, DOI 10.1042/BJ20050643; Cutler NS, 1997, J BIOL CHEM, V272, P27671, DOI 10.1074/jbc.272.44.27671; Daquinag A, 2007, MOL CELL BIOL, V27, P633, DOI 10.1128/MCB.00461-06; Desrivieres S, 2002, BIOCHEM J, V366, P945, DOI 10.1042/BJ20020429; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; Fadri M, 2005, MOL BIOL CELL, V16, P1883, DOI 10.1091/mbc.e04-07-0564; Fischl AS, 2000, METHOD ENZYMOL, V311, P123; Foti M, 2001, MOL BIOL CELL, V12, P2396, DOI 10.1091/mbc.12.8.2396; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Han GS, 2002, J BIOL CHEM, V277, P47709, DOI 10.1074/jbc.M207996200; HEIDLER SA, 1995, ANTIMICROB AGENTS CH, V39, P2765, DOI 10.1128/AAC.39.12.2765; Kitagaki H, 2007, BBA-BIOMEMBRANES, V1768, P2849, DOI 10.1016/j.bbamem.2007.07.019; LESTER RL, 1993, ADV LIPID RES, V26, P253; Levine TP, 2000, MOL BIOL CELL, V11, P2267, DOI 10.1091/mbc.11.7.2267; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Mao CG, 1997, J BIOL CHEM, V272, P28690, DOI 10.1074/jbc.272.45.28690; MERRILL AH, 1988, ANAL BIOCHEM, V171, P373, DOI 10.1016/0003-2697(88)90500-3; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Mousley CJ, 2006, BIOCHEM SOC T, V34, P346, DOI 10.1042/BST0340346; Muhua L, 1998, NATURE, V393, P487, DOI 10.1038/31014; Nagiec MM, 1998, J BIOL CHEM, V273, P19437, DOI 10.1074/jbc.273.31.19437; Obeid LA, 2002, BBA-MOL CELL BIOL L, V1585, P163, DOI 10.1016/S1388-1981(02)00337-2; PINTO WJ, 1992, J BACTERIOL, V174, P2575, DOI 10.1128/jb.174.8.2575-2581.1992; Rivas MP, 1999, MOL BIOL CELL, V10, P2235, DOI 10.1091/mbc.10.7.2235; Routt SM, 2005, TRAFFIC, V6, P1157, DOI 10.1111/j.1600-0854.2005.00350.x; SAHEKI S, 1985, ANAL BIOCHEM, V148, P277, DOI 10.1016/0003-2697(85)90229-5; Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200; Sims KJ, 2004, BIOCHEM CELL BIOL, V82, P45, DOI 10.1139/o03-086; SMITH ER, 1995, J BIOL CHEM, V270, P18749, DOI 10.1074/jbc.270.32.18749; SYCHROVA H, 1985, FEBS LETT, V183, P21, DOI 10.1016/0014-5793(85)80945-5; Tabuchi M, 2006, MOL CELL BIOL, V26, P5861, DOI 10.1128/MCB.02403-05; Tahirovic S, 2005, TRAFFIC, V6, P116, DOI 10.1111/j.1600-0854.2004.00255.x; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; Wells GB, 1998, J BIOL CHEM, V273, P7235, DOI 10.1074/jbc.273.13.7235; WU WI, 1995, J BIOL CHEM, V270, P13171, DOI 10.1074/jbc.270.22.13171	48	49	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7588	7596		10.1074/jbc.M808325200	http://dx.doi.org/10.1074/jbc.M808325200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19139096	Green Published, hybrid			2022-12-25	WOS:000264195600021
J	Brookheart, RT; Michel, CI; Listenberger, LL; Ory, DS; Schaffer, JE				Brookheart, Rita T.; Michel, Carlos I.; Listenberger, Laura L.; Ory, Daniel S.; Schaffer, Jean E.			The Non-coding RNA gadd7 Is a Regulator of Lipid-induced Oxidative and Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PALMITATE-INDUCED APOPTOSIS; UNFOLDED PROTEIN RESPONSE; FATTY-ACID OXIDATION; LIPOTOXIC CELL-DEATH; HEPATIC STEATOSIS; NAD(P)H OXIDASE; LIVER-INJURY; RAT-HEART; EXPRESSION; OBESITY	In obesity and diabetes, an imbalance in fatty acid uptake and fatty acid utilization leads to excess accumulation of lipid in non-adipose tissues. This lipid overload is associated with cellular dysfunction and cell death, which contribute to organ failure, a phenomenon termed lipotoxicity. To elucidate the molecular mechanism of lipid-mediated cell death, we generated and characterized a mutant Chinese hamster ovary cell line that is resistant to palmitate-induced cell death. In this mutant, random insertion of a retroviral promoter trap has disrupted the gene for the non-coding RNA, growth arrested DNA-damage inducible gene 7 (gadd7). Here we report that gadd7 is induced by lipotoxic stress in a reactive oxygen species (ROS)-dependent fashion and is necessary for both lipid-and general oxidative stress-mediated cell death. Depletion of gadd7 by mutagenesis or short hairpin RNA knockdown significantly reduces lipid and nonlipid induced ROS. Furthermore, depletion of gadd7 delays and diminishes ROS-induced endoplasmic reticulum stress. Together these data are the first to implicate a non-coding RNA in a feed-forward loop with oxidative stress and its induction of the endoplasmic reticulum stress response.	[Brookheart, Rita T.; Michel, Carlos I.; Listenberger, Laura L.; Ory, Daniel S.; Schaffer, Jean E.] Cardiovasc Res Ctr, Dept Internal Med, St Louis, MO 63110 USA; [Ory, Daniel S.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Schaffer, Jean E.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Schaffer, JE (corresponding author), Cardiovasc Res Ctr, Dept Internal Med, Box 8086,660 S Euclid Ave, St Louis, MO 63110 USA.	jschaff@wustl.edu			National Institutes of Health [DK064989]; Burroughs Wellcome Foundation [1005935]; Predoctoral Fellowship [DK077583]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK077583, R01DK064989, R56DK064989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Predoctoral Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK064989 (to J.E.S.) and Predoctoral Fellowship DK077583 (to R.T.B.). This work was also supported by Burroughs Wellcome Foundation Grant 1005935 (to J.E.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S.C.Section 1734 solely to indicate this fact.	Belke DD, 2000, AM J PHYSIOL-ENDOC M, V279, pE1104, DOI 10.1152/ajpendo.2000.279.5.E1104; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Borradaile NM, 2006, MOL BIOL CELL, V17, P770, DOI 10.1091/mbc.E05-08-0742; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Cacicedo JM, 2005, DIABETES, V54, P1838, DOI 10.2337/diabetes.54.6.1838; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Christoffersen C, 2003, ENDOCRINOLOGY, V144, P3483, DOI 10.1210/en.2003-0242; Crawford DR, 1996, ARCH BIOCHEM BIOPHYS, V329, P137, DOI 10.1006/abbi.1996.0202; Crawford DR, 1996, ARCH BIOCHEM BIOPHYS, V325, P256, DOI 10.1006/abbi.1996.0032; Darmaun D, 2005, DIABETES, V54, P190, DOI 10.2337/diabetes.54.1.190; Finck BN, 2003, P NATL ACAD SCI USA, V100, P1226, DOI 10.1073/pnas.0336724100; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Hollander MC, 1996, NUCLEIC ACIDS RES, V24, P1589, DOI 10.1093/nar/24.9.1589; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Inagaki S, 2005, GENES CELLS, V10, P1163, DOI 10.1111/j.1365-2443.2005.00910.x; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Ji J, 2005, EXP TOXICOL PATHOL, V56, P369, DOI 10.1016/j.etp.2005.02.003; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Leichman JG, 2006, AM J CLIN NUTR, V84, P336; Lin R, 2007, ONCOGENE, V26, P851, DOI 10.1038/sj.onc.1209846; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Mazumder PK, 2004, DIABETES, V53, P2366, DOI 10.2337/diabetes.53.9.2366; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Nollen EAA, 2002, J CELL SCI, V115, P2809; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Sorensen S, 2006, J BIOL CHEM, V281, P468, DOI 10.1074/jbc.M507071200; Szczepaniak LS, 2003, MAGN RESON MED, V49, P417, DOI 10.1002/mrm.10372; TIEDGE H, 1993, J NEUROSCI, V13, P2382, DOI 10.1523/JNEUROSCI.13-06-02382.1993; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Wang D, 2006, ENDOCRINOLOGY, V147, P943, DOI 10.1210/en.2005-0570; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Xu WM, 2004, NAT CELL BIOL, V6, P1129, DOI 10.1038/ncb1188; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; Ye G, 2004, DIABETES, V53, P1336, DOI 10.2337/diabetes.53.5.1336; Young ME, 2002, DIABETES, V51, P2587, DOI 10.2337/diabetes.51.8.2587; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200	45	65	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7446	7454		10.1074/jbc.M806209200	http://dx.doi.org/10.1074/jbc.M806209200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19150982	hybrid, Green Published			2022-12-25	WOS:000264195600008
J	Filip, AM; Klug, J; Cayli, S; Frohlich, S; Henke, T; Lacher, P; Eickhoff, R; Bulau, P; Linder, M; Carlsson-Skwirut, C; Leng, L; Bucala, R; Kraemer, S; Bernhagen, J; Meinhardt, A				Filip, Ana-Maria; Klug, Joerg; Cayli, Sevil; Froehlich, Suada; Henke, Tamara; Lacher, Philipp; Eickhoff, Regina; Bulau, Patrick; Linder, Monika; Carlsson-Skwirut, Christine; Leng, Lin; Bucala, Richard; Kraemer, Sandra; Bernhagen, Juergen; Meinhardt, Andreas			Ribosomal Protein S19 Interacts with Macrophage Migration Inhibitory Factor and Attenuates Its Pro-inflammatory Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR MIF; RHEUMATOID-ARTHRITIS; CYTOKINE; CELLS; BINDING; SITE; LINK; PURIFICATION; RECRUITMENT; RECEPTOR	Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine that has been implicated in the pathogenesis of inflammatory disorders such as infection, sepsis, and autoimmune disease. MIF exists preformed in cytoplasmic pools and exhibits an intrinsic tautomerase and oxidoreductase activity. MIF levels are elevated in the serum of animals and patients with infection or different inflammatory disorders. To elucidate how MIF actions are controlled, we searched for endogenous MIF-interacting proteins with the potential to interfere with key MIF functions. Using in vivo biotin-tagging and endogenous co-immunoprecipitation, the ribosomal protein S19 (RPS19) was identified as a novel MIF binding partner. Surface plasmon resonance and pulldown experiments with wild type and mutant MIF revealed a direct physical interaction of the two proteins (K-D = 1.3 x 10(-6) M). As RPS19 is released in inflammatory lesions by apoptotic cells, we explored whether it affects MIF function and inhibits its binding to receptors CD74 and CXCR2. Low doses of RPS19 were found to strongly inhibit MIF-CD74 interaction. Furthermore, RPS19 significantly compromised CXCR2-dependent MIF-triggered adhesion of monocytes to endothelial cells under flow conditions. We, therefore, propose that RPS19 acts as an extracellular negative regulator of MIF.	[Filip, Ana-Maria; Klug, Joerg; Cayli, Sevil; Froehlich, Suada; Henke, Tamara; Lacher, Philipp; Eickhoff, Regina; Meinhardt, Andreas] Univ Giessen, Dept Anat & Cell Biol, Reprod Biol Unit, D-35385 Giessen, Germany; [Bulau, Patrick] Univ Giessen, Med Clin 2, D-35385 Giessen, Germany; [Linder, Monika] Univ Giessen, Dept Biochem, D-35385 Giessen, Germany; [Carlsson-Skwirut, Christine] Karolinska Inst, Astrid Lindgren Childrens Hosp, Paediat Endocrinol Unit, Dept Woman & Child Hlth, S-17116 Stockholm, Sweden; [Carlsson-Skwirut, Christine] St Gorans Univ Hosp, S-17116 Stockholm, Sweden; [Leng, Lin; Bucala, Richard] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Kraemer, Sandra; Bernhagen, Juergen] Rhein Westfal TH Aachen, Univ Hosp, Inst Biochem, Dept Biochem & Mol Cell Biol, D-52074 Aachen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen; Karolinska Institutet; Saint Goran's Hospital; Yale University; RWTH Aachen University; RWTH Aachen University Hospital	Meinhardt, A (corresponding author), Univ Giessen, Dept Anat & Cell Biol, Reprod Biol Unit, Aulweg 123, D-35385 Giessen, Germany.	andreas.meinhardt@anatomie.med.uni-giessen.de	Meinhardt, Andreas/B-3688-2009; Cayli, Sevil/V-2342-2019	Bulau, Patrick/0000-0002-7121-2954; Cayli, Sevil/0000-0003-2465-5389; Leng, Lin/0000-0002-0605-358X	Deutsche Forschungsgemeinschaft [1323/2-4]; University Medical Centre Giessen and Marburg; SFB [542/TP A7]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University Medical Centre Giessen and Marburg; SFB(Austrian Science Fund (FWF))	This work was supported by Deutsche Forschungsgemeinschaft Grants Me 1323/2-4 (to A. M.) and SFB 542/TP A7 (J. B.) and a research grant of the University Medical Centre Giessen and Marburg (to A. M.).	Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Baugh JA, 2002, CRIT CARE MED, V30, pS27, DOI 10.1097/00003246-200201001-00004; Bendrat K, 1997, BIOCHEMISTRY-US, V36, P15356, DOI 10.1021/bi971153a; Berndt K, 2008, MOL CELL BIOCHEM, V307, P265, DOI 10.1007/s11010-007-9578-3; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bucala R, 2005, DRUG NEWS PERSPECT, V18, P417, DOI 10.1358/dnp.2005.18.7.939345; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Chatterjee M, 2006, CANCER RES, V66, P1181, DOI 10.1158/0008-5472.CAN-04-2962; Chiocchetti A, 2005, HAEMATOLOGICA, V90, P1453; Da Costa L, 2003, BLOOD, V101, P5039, DOI 10.1182/blood-2002-12-3878; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Degryse B, 2003, FEBS LETT, V553, P11, DOI 10.1016/S0014-5793(03)01027-5; Denkinger CM, 2003, J IMMUNOL, V170, P1274, DOI 10.4049/jimmunol.170.3.1274; Gregory JL, 2006, J IMMUNOL, V177, P8072, DOI 10.4049/jimmunol.177.11.8072; GU J, 1994, BIOTECHNIQUES, V17, P257; Hoi Alberta Y., 2007, Inflammation & Allergy Drug Targets, V6, P183, DOI 10.2174/187152807781696455; Hoi AY, 2006, J IMMUNOL, V177, P5687, DOI 10.4049/jimmunol.177.8.5687; Jung H, 2008, J BIOL CHEM, V283, P32669, DOI 10.1074/jbc.M806225200; Kamir D, 2008, J IMMUNOL, V180, P8250, DOI 10.4049/jimmunol.180.12.8250; KIM M, 2003, THESIS PHILIPPS U MA; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kleemann R, 2000, EUR J BIOCHEM, V267, P7183, DOI 10.1046/j.1432-1327.2000.01823.x; Lan HY, 1997, J EXP MED, V185, P1455, DOI 10.1084/jem.185.8.1455; Leech M, 1998, ARTHRITIS RHEUM-US, V41, P910, DOI 10.1002/1529-0131(199805)41:5<910::AID-ART19>3.0.CO;2-E; Leech M, 2000, ARTHRITIS RHEUM, V43, P827, DOI 10.1002/1529-0131(200004)43:4<827::AID-ANR13>3.0.CO;2-K; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Ni J, 2000, ANN NY ACAD SCI, V923, P25; Nishimura T, 2001, J BIOCHEM-TOKYO, V129, P445, DOI 10.1093/oxfordjournals.jbchem.a002876; Nishiura H, 1996, J BIOL CHEM, V271, P878, DOI 10.1074/jbc.271.2.878; Nishiura H, 1998, LAB INVEST, V78, P1615; Orru S, 2007, MOL CELL PROTEOMICS, V6, P382, DOI 10.1074/mcp.M600156-MCP200; Pan JH, 2004, CIRCULATION, V109, P3149, DOI 10.1161/01.CIR.0000134704.84454.D2; RISCHITOR G, 2005, THESIS PHILIPPS U MA; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Sambrook J., 2001, MOL CLONING; Santos L, 2001, CLIN EXP IMMUNOL, V123, P309, DOI 10.1046/j.1365-2249.2001.01423.x; SHERMAN F, 1985, BIOESSAYS, V3, P27, DOI 10.1002/bies.950030108; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Soulet F, 2001, BIOCHEM BIOPH RES CO, V289, P591, DOI 10.1006/bbrc.2001.5960; Stosic-Grujicic S, 2008, J CELL PHYSIOL, V215, P665, DOI 10.1002/jcp.21346; Swope M, 1998, EMBO J, V17, P3534, DOI 10.1093/emboj/17.13.3534; Swope MD, 1999, REV PHYSIOL BIOCH P, V139, P1, DOI 10.1007/BFb0033647; Thiele M, 2005, ANTIOXID REDOX SIGN, V7, P1234, DOI 10.1089/ars.2005.7.1234; WEBER C, 1993, EUR J IMMUNOL, V23, P852, DOI 10.1002/eji.1830230413; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; Xiao F, 2005, MOL ENDOCRINOL, V19, P2964, DOI 10.1210/me.2004-0408	48	49	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7977	7985		10.1074/jbc.M808620200	http://dx.doi.org/10.1074/jbc.M808620200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19155217	hybrid, Green Published			2022-12-25	WOS:000264195600060
J	Sommers, JA; Rawtani, N; Gupta, R; Bugreev, DV; Mazin, AV; Cantor, SB; Brosh, RM				Sommers, Joshua A.; Rawtani, Nina; Gupta, Rigu; Bugreev, Dmitry V.; Mazin, Alexander V.; Cantor, Sharon B.; Brosh, Robert M.			FANCJ Uses Its Motor ATPase to Destabilize Protein-DNA Complexes, Unwind Triplexes, and Inhibit RAD51 Strand Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOLOGOUS RECOMBINATION; BREAST-CANCER; NUCLEOPROTEIN FILAMENTS; SUBSTRATE-SPECIFICITY; GENOMIC STABILITY; SYNDROME HELICASE; REPLICATION-FORK; BINDING PROTEIN; RECQ HELICASES; IN-VIVO	Mutations in the FANCJ helicase predispose individuals to breast cancer and are genetically linked to the Fanconi anemia (FA) complementation group J.FA is a chromosomal instability disorder characterized by multiple congenital anomalies, progressive bone marrow failure, and high cancer risk. FANCJ has been proposed to function downstream of FANCD2 monoubi-quitination, a critical event in the FA pathway. Evidence supports a role for FANCJ in a homologous recombination pathway of double strand break repair. In an effort to understand the molecular functions of FANCJ, we have investigated the ability of purified FANCJ recombinant protein to use its motor ATPase function for activities in addition to unwinding of conventional duplex DNA substrates. These efforts have led to the discovery that FANCJ ATP hydrolysis can be used to destabilize protein-DNA complexes and unwind triple helix alternate DNA structures. These novel catalytic functions of FANCJ may be important for its role in cellular DNA repair, recombination, or resolving DNA structural obstacles to replication. Consistent with this, we show that FANCJ can inhibit RAD51 strand exchange, an activity that is likely to be important for its role in controlling DNA repair through homologous recombination.	[Sommers, Joshua A.; Rawtani, Nina; Gupta, Rigu; Brosh, Robert M.] NIA, Lab Mol Gerontol, NIH, Natl Inst Hlth Biomed Res Ctr, Baltimore, MD 21224 USA; [Bugreev, Dmitry V.; Mazin, Alexander V.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA; [Bugreev, Dmitry V.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk 630090, Russia; [Cantor, Sharon B.] Univ Massachusetts, Sch Med, Womens Canc Program, UMass Mem Canc Ctr,Dept Canc Biol, Worcester, MA 01605 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Drexel University; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; University of Massachusetts System; University of Massachusetts Worcester; University Massachusetts Worcester Hospital	Brosh, RM (corresponding author), NIA, Lab Mol Gerontol, NIH, Natl Inst Hlth Biomed Res Ctr, 251 Bayview Dr,Suite 100,Rm 06B125, Baltimore, MD 21224 USA.	broshr@mail.nih.gov	Brosh, Robert/AAR-6124-2020		National Institutes of Health Intramural Research Program; NIA; National Institutes of Health [CA100839, MH084119]; Fanconi Anemia Research Fund; Leukemia and Lymphoma Society Scholar Award [1054-09]; NATIONAL CANCER INSTITUTE [R01CA100839, R56CA100839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH084119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000741, ZIAAG000753] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fanconi Anemia Research Fund; Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program; NIA, National Institutes of Health; and National Institutes of Health Grants CA100839 and MH084119. This work was also supported by the Fanconi Anemia Research Fund (to R.M.B.) and by Leukemia and Lymphoma Society Scholar Award 1054-09 (to A.V.M.).	Amitani I, 2006, MOL CELL, V23, P143, DOI 10.1016/j.molcel.2006.05.009; BEDINGER P, 1983, CELL, V34, P115, DOI 10.1016/0092-8674(83)90141-1; Bissler JJ, 2007, FRONT BIOSCI-LANDMRK, V12, P4536, DOI 10.2741/2408; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Brosh RM, 2001, J BIOL CHEM, V276, P3024, DOI 10.1074/jbc.M006784200; Brosh RM, 2007, NUCLEIC ACIDS RES, V35, P7527, DOI 10.1093/nar/gkm1008; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Byrd AK, 2006, NUCLEIC ACIDS RES, V34, P3020, DOI 10.1093/nar/gkl369; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cheung I, 2002, NAT GENET, V31, P405, DOI [10.1038/ng928, 10.1038/417405a]; Eoff RL, 2005, BIOCHEM SOC T, V33, P1474, DOI 10.1042/BST0331474; Flores MJ, 2005, MOL MICROBIOL, V57, P1664, DOI 10.1111/j.1365-2958.2005.04753.x; Gacy AM, 1998, MOL CELL, V1, P583, DOI 10.1016/S1097-2765(00)80058-1; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; Greenberger JS, 2006, EXP HEMATOL, V34, P46; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Gupta R, 2007, BLOOD, V110, P2390, DOI 10.1182/blood-2006-11-057273; Gupta R, 2006, NUCLEIC ACIDS RES, V34, P6673, DOI 10.1093/nar/gkl964; Hacker KJ, 1997, BIOCHEMISTRY-US, V36, P14080, DOI 10.1021/bi971644v; HENDRICKSON WA, 1989, P NATL ACAD SCI USA, V86, P2190, DOI 10.1073/pnas.86.7.2190; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; Kaplan DL, 2000, J MOL BIOL, V301, P285, DOI 10.1006/jmbi.2000.3965; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Krasilnikova MM, 2004, MOL CELL BIOL, V24, P2286, DOI 10.1128/MCB.24.6.2286-2295.2004; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Kumaraswamy E, 2007, MOL CELL BIOL, V27, P6733, DOI 10.1128/MCB.00961-07; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levitus M, 2006, CELL ONCOL, V28, P3; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Lusser A, 2003, BIOESSAYS, V25, P1192, DOI 10.1002/bies.10359; Mackintosh SG, 2006, NUCLEIC ACIDS RES, V34, P4154, DOI 10.1093/nar/gkl501; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Peng M, 2007, EMBO J, V26, P3238, DOI 10.1038/sj.emboj.7601754; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Sharma S, 2004, MOL BIOL CELL, V15, P734, DOI 10.1091/mbc.E03-08-0567; Sharma S, 2006, BIOCHEM J, V398, P319, DOI 10.1042/BJ20060450; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wang GL, 2004, P NATL ACAD SCI USA, V101, P13448, DOI 10.1073/pnas.0405116101; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07	49	83	84	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7505	7517		10.1074/jbc.M809019200	http://dx.doi.org/10.1074/jbc.M809019200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19150983	Green Published, hybrid			2022-12-25	WOS:000264195600014
J	Kawashima, N; Yoon, SJ; Itoh, K; Nakayama, K				Kawashima, Nagako; Yoon, Seon-Joo; Itoh, Kohji; Nakayama, Ken-ichi			Tyrosine Kinase Activity of Epidermal Growth Factor Receptor Is Regulated by GM3 Binding through Carbohydrate to Carbohydrate Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLCNAC TERMINI; CELLS; OLIGOSACCHARIDES; PHOSPHORYLATION; GANGLIOSIDE; GLYCOSYNAPSE; CDNA; GENE	Epidermal growth factor receptor (EGFR), an N-glycosylated transmembrane protein with an intracellular kinase domain, undergoes dimerization by ligand binding resulting in activation of the kinase domain and phosphorylation. Ganglioside GM3 containing sialyllactose inhibits the tyrosine kinase activity of EGFR through carbohydrate to carbohydrate interactions (CCI) between N-glycans with GlcNAc termini on EGFR and oligosaccharides on GM3. In this study, we provide further evidence for CCI between EGFR and GM3. (i) In vitro and in situ, the inhibitory effect of GM3 on EGFR tyrosine kinase was much higher in A431 cells upon exposure of the GlcNAc termini of the N-glycans to glycosidase treatment (neuraminidase and beta-galactosidase) than in untreated A431 cells. Furthermore, the GM3-mediated inhibition was abrogated by co-incubation with N-glycan containing terminal GlcNAc. (ii) In situ, inhibition of EGFR phosphorylation by GM3 was not observed in alpha-mannosidase IB (ManIB)-knocked down A431 cells that accumulate high mannose- type N-glycans. (iii) EGFR binding to GM3 was enhanced in glycosidase-treated cells that accumulated GlcNAc termini, whereas GM3 did not bind to EGFR from ManIB-knocked down cells that accumulated high mannose- type N-glycans. These results indicate that GM3-mediated inhibition of EGFR phosphorylation is caused by interaction of GM3 with GlcNAc-terminated N-glycan on EGFR.	[Kawashima, Nagako; Nakayama, Ken-ichi] Natl Inst Adv Ind Sci & Technol, Hlth Technol Res Ctr, Kagawa 7610395, Japan; [Yoon, Seon-Joo] Univ Washington, Pacific NW Res Inst, Div Biomembrane Res, Seattle, WA 98122 USA; [Yoon, Seon-Joo] Univ Washington, Dept Microbiol, Seattle, WA 98122 USA; [Kawashima, Nagako; Itoh, Kohji] Univ Tokushima, Grad Sch Pharmaceut Sci, Inst Med Resources, Dept Med Biotechnol, Tokushima 7708505, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Tokushima University	Nakayama, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Hlth Technol Res Ctr, Kagawa 7610395, Japan.	k-nakayama@aist.go.jp						BLANKEN WM, 1985, ANAL BIOCHEM, V145, P322, DOI 10.1016/0003-2697(85)90369-0; BREMER EG, 1986, J BIOL CHEM, V261, P2434; Fernandes H, 2001, J BIOL CHEM, V276, P5375, DOI 10.1074/jbc.M005599200; Gu JG, 2004, GLYCOBIOLOGY, V14, P177, DOI 10.1093/glycob/cwh016; Haga Y, 2008, CARBOHYD RES, V343, P3034, DOI 10.1016/j.carres.2008.09.002; Hakomori S, 2004, GLYCOCONJUGATE J, V21, P125, DOI 10.1023/B:GLYC.0000044844.95878.cf; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P225, DOI 10.1073/pnas.012540899; Hakomori S, 2004, AN ACAD BRAS CIENC, V76, P553, DOI 10.1590/S0001-37652004000300010; HERSCOVICS A, 1994, J BIOL CHEM, V269, P9864; KATO K, 2006, GLYCOCONJ J, V23, P639; Miljan EA, 2002, J BIOL CHEM, V277, P10108, DOI 10.1074/jbc.M111669200; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Sato Y, 2001, J BIOL CHEM, V276, P11956, DOI 10.1074/jbc.M008551200; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Takahashi M, 2003, GLYCOCONJUGATE J, V20, P207, DOI 10.1023/B:GLYC.0000024252.63695.5c; TOMIYA N, 1988, ANAL BIOCHEM, V171, P73, DOI 10.1016/0003-2697(88)90126-1; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Wang XQ, 2002, J BIOL CHEM, V277, P47028, DOI 10.1074/jbc.M208257200; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103; Yoon SJ, 2006, GLYCOCONJUGATE J, V23, P639, DOI 10.1007/s10719-006-9001-4; ZHOU QG, 1994, J BIOL CHEM, V269, P1959	23	86	90	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6147	6155		10.1074/jbc.M808171200	http://dx.doi.org/10.1074/jbc.M808171200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19124464	hybrid			2022-12-25	WOS:000263742700017
J	Gustafson, TL; Wellberg, E; Laffin, B; Schilling, L; Metz, RP; Zahnow, CA; Porter, WW				Gustafson, T. L.; Wellberg, E.; Laffin, B.; Schilling, L.; Metz, R. P.; Zahnow, C. A.; Porter, W. W.			Ha-Ras transformation of MCF10A cells leads to repression of Singleminded-2s through NOTCH and C/EBP beta	ONCOGENE			English	Article						Singleminded-2s; NOTCH; C/EBP-beta; mammary gland	ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR RECEPTOR; SINGLE-MINDED GENE; HUMAN-BREAST; TRANSCRIPTION FACTOR; TRANSGENIC MICE; ONCOGENIC RAS; SELF-RENEWAL; MAMMARY; EXPRESSION	We have previously shown that Singleminded-2s (SIM2s), a member of the basic helix-loop-helix Per-Arnt-Sim (bHLH/PAS) family of transcription factors, is downregulated in breast cancer samples and has tumor suppressor activity. However, the mechanism by which SIM2s is repressed in breast cancer cells has not been determined. In this study, we show that transformation of MCF10A cells by Harvey-Ras (Ha-Ras) induces CCAAT/enhance binding protein beta (C/EBP beta) and activates the NOTCH signaling pathway to block SIM2s gene expression. NOTCH-mediated repression acts through a C-repeat binding factor 1 (CBF1)-independent mechanism, as introduction of CBF1 had no effect on SIM2s expression. Consistent with C/ebp beta-dependent inhibition of SIM2s, C/ebp beta(-/-) mouse mammary glands express high levels of SIM2s and reestablishment of C/ebp beta isoforms decreased SIM2s mRNA levels in C/ebp beta immortalized mammary epithelial cell lines. These studies illustrate a novel pathway of tumor suppressor gene silencing in Ha-Ras-transformed breast epithelial cells and identify SIM2s as a target of C/EBP beta and NOTCH signaling.	[Gustafson, T. L.; Wellberg, E.; Laffin, B.; Schilling, L.; Metz, R. P.; Porter, W. W.] Texas A&M Univ, Dept Integrat Biosci, Coll Vet Med, College Stn, TX 77843 USA; [Zahnow, C. A.] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Dept Oncol, Baltimore, MD USA	Texas A&M University System; Texas A&M University College Station; Johns Hopkins University; Johns Hopkins Medicine	Porter, WW (corresponding author), Texas A&M Univ, Dept Integrat Biosci, Coll Vet Med, College Stn, TX 77843 USA.	wporter@cvm.tamu.edu	Wellberg, Elizabeth/AFQ-6450-2022	Metz, Richard/0000-0002-9876-3385	National Cancer Institute [RO1CA111551, R01CA113795]; Howard Hughes Medical Institute Predoctoral Fellowship; NATIONAL CANCER INSTITUTE [R01CA113795, R01CA111551] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute Predoctoral Fellowship(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Bryan and Alana Welm (Huntsman Cancer Institute, Salt Lake City, UT, USA) for the Ha-Ras parent construct, Jeff Rosen (Baylor College of Medicine, Houston, TX, USA) for providing the C/ebpb<SUP>-/-</SUP> mammary glands and Michael Lewis (Baylor College of Medicine, Houston, TX, USA) for critical reading of the paper. We also thank Keelan Anderson for technical assistance. This work was supported by awards from the National Cancer Institute RO1CA111551 (WWP), R01CA113795 (CAZ) and Howard Hughes Medical Institute Predoctoral Fellowship (TG).	Aleman MJ, 2005, P NATL ACAD SCI USA, V102, P12765, DOI 10.1073/pnas.0505484102; Arias AM, 2002, CURR OPIN GENET DEV, V12, P524, DOI 10.1016/S0959-437X(02)00336-2; Baldwin BR, 2004, MOL CELL BIOL, V24, P3682, DOI 10.1128/MCB.24.9.3682-3691.2004; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; CREWS S, 1992, J EXP ZOOL, V261, P234, DOI 10.1002/jez.1402610303; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Deyoung MP, 2002, ANTICANCER RES, V22, P3149; Dunn KL, 2005, BIOCHEM CELL BIOL, V83, P1, DOI 10.1139/O04-121; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Grimm SL, 2003, J MAMMARY GLAND BIOL, V8, P191, DOI 10.1023/A:1025900908026; Halvorsen OJ, 2007, CLIN CANCER RES, V13, P892, DOI 10.1158/1078-0432.CCR-06-1207; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Khleif SN, 1999, J IMMUNOTHER, V22, P155, DOI 10.1097/00002371-199903000-00007; Kiaris H, 2004, AM J PATHOL, V165, P695, DOI 10.1016/S0002-9440(10)63333-0; Kwak HI, 2007, CARCINOGENESIS, V28, P259, DOI 10.1093/carcin/bgl122; Laffin B, 2008, MOL CELL BIOL, V28, P1936, DOI 10.1128/MCB.01701-07; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Liu SL, 2005, BREAST CANCER RES, V7, P86, DOI 10.1186/bcr1021; Martinez-Lacaci I, 2000, INT J CANCER, V88, P44, DOI 10.1002/1097-0215(20001001)88:1<44::AID-IJC7>3.0.CO;2-8; Metz RP, 2006, J BIOL CHEM, V281, P10839, DOI 10.1074/jbc.M508858200; Milde-Langosch K, 2003, BREAST CANCER RES TR, V79, P175, DOI 10.1023/A:1023929504884; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; NIELSEN LL, 1991, CANCER RES, V51, P3762; Sansone P, 2007, STEM CELLS, V25, P807, DOI 10.1634/stemcells.2006-0442; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Shim M, 2005, CANCER RES, V65, P861; Shuman JD, 2004, MOL CELL BIOL, V24, P7380, DOI 10.1128/MCB.24.17.7380-7391.2004; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Sundaram MV, 2005, GENE DEV, V19, P1825, DOI 10.1101/gad.1330605; von Lintig FC, 2000, BREAST CANCER RES TR, V62, P51, DOI 10.1023/A:1006491619920; Weijzen S, 2002, NAT MED, V8, P979, DOI 10.1038/nm754; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Zahnow CA, 2002, BREAST CANCER RES, V4, P109, DOI 10.1186/bcr428; Zahnow CA, 1997, J NATL CANCER I, V89, P1887, DOI 10.1093/jnci/89.24.1887; Zahnow CA, 2001, CANCER RES, V61, P261; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299	39	21	21	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2009	28	12					1561	1568		10.1038/onc.2008.497	http://dx.doi.org/10.1038/onc.2008.497			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	424AH	19169276	Green Accepted			2022-12-25	WOS:000264537400008
J	Zhao, Y; Lin, B; Darflinger, R; Zhang, YK; Holterman, MJ; Skidgel, RA				Zhao, Yong; Lin, Brian; Darflinger, Robert; Zhang, Yongkang; Holterman, Mark J.; Skidgel, Randal A.			Human Cord Blood Stem Cell-Modulated Regulatory T Lymphocytes Reverse the Autoimmune-Caused Type 1 Diabetes in Nonobese Diabetic (NOD) Mice	PLOS ONE			English	Article								Background: The deficit of pancreatic islet beta cells caused by autoimmune destruction is a crucial issue in type 1 diabetes (T1D). It is essential to fundamentally control the autoimmunity for treatment of T1D. Regulatory T cells (Tregs) play a pivotal role in maintaining self-tolerance through their inhibitory impact on autoreactive effector T cells. An abnormality of Tregs is associated with initiation of progression of T1D. Methodology/Principal Findings: Here, we report that treatment of established autoimmune-caused diabetes in NOD mice with purified autologous CD4(+)CD62L(+) Tregs co-cultured with human cord blood stem cells (CB-SC) can eliminate hyperglycemia, promote islet beta-cell regeneration to increase beta-cell mass and insulin production, and reconstitute islet architecture. Correspondingly, treatment with CB-SC-modulated CD4(+)CD62L(+) Tregs (mCD4CD62L Tregs) resulted in a marked reduction of insulitis, restored Th1/Th2 cytokine balance in blood, and induced apoptosis of infiltrated leukocytes in pancreatic islets. Conclusions/Significance: These data demonstrate that treatment with mCD4CD62L Tregs can reverse overt diabetes, providing a novel strategy for the treatment of type 1 diabetes as well as other autoimmune diseases.	[Zhao, Yong; Lin, Brian; Darflinger, Robert] Univ Illinois, Dept Med, Chicago, IL 60680 USA; [Zhang, Yongkang; Skidgel, Randal A.] Univ Illinois, Dept Pharm, Chicago, IL 60680 USA; [Holterman, Mark J.] Univ Illinois, Dept Surg, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Zhao, Y (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60680 USA.	yongzhao@uic.edu			Illinois Regenerative Medicine Institute	Illinois Regenerative Medicine Institute	This work was supported by University start-up funding (Y.Zhao) and Stem cell research grant from the Illinois Regenerative Medicine Institute (M.J.H). M.J.H. contributed to the writing of manuscript and provision of reagents/materials. The funders had no role in study design, data collection and analysis, or decision to publish.	Abdi R, 2008, DIABETES, V57, P1759, DOI 10.2337/db08-0180; Ablamunits V, 2007, ANN NY ACAD SCI, V1103, P19, DOI 10.1196/annals.1394.006; ALLEN JS, 2008, DIABETES; Bayry J, 2008, NAT REV IMMUNOL, V8, DOI 10.1038/nri2138-c1; BLUESTONE JA, 2008, J CLIN IMMUNOL; Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; Bour-Jordan H, 2007, J IMMUNOL, V179, P1004, DOI 10.4049/jimmunol.179.2.1004; Bresson D, 2006, J CLIN INVEST, V116, P1371, DOI 10.1172/JCI27191; Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Brusko T, 2007, DIABETES, V56, P604, DOI 10.2337/db06-1248; Chatenoud L, 2005, EXPERT OPIN BIOL TH, V5, pS73, DOI 10.1517/14712598.5.1.S73; Chatenoud L, 2005, INT REV IMMUNOL, V24, P247, DOI 10.1080/08830180590934994; Gombert JM, 1996, CR ACAD SCI III-VIE, V319, P125; Goudy KS, 2003, J IMMUNOL, V171, P2270, DOI 10.4049/jimmunol.171.5.2270; Huang YM, 2008, DIABETES, V57, P2360, DOI 10.2337/db08-0356; JIN Y, 2008, CLIN IMMUNOL; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li Q, 2008, P NATL ACAD SCI USA, V105, P12439, DOI 10.1073/pnas.0806439105; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Marleau AM, 2008, J IMMUNOL, V180, P5235, DOI 10.4049/jimmunol.180.8.5235; Meier JJ, 2006, DIABETOLOGIA, V49, P1838, DOI 10.1007/s00125-006-0308-2; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Perruche S, 2008, NAT MED, V14, P528, DOI 10.1038/nm1749; Pop SM, 2005, J EXP MED, V201, P1333, DOI 10.1084/jem.20042398; Ricordi C, 2008, LANCET, V372, P27, DOI 10.1016/S0140-6736(08)60984-8; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; Roncarolo MG, 2003, J AUTOIMMUN, V20, P269, DOI 10.1016/S0896-8411(03)00047-7; Schneider A, 2008, J IMMUNOL, V181, P7350, DOI 10.4049/jimmunol.181.10.7350; Staeva-Vieira T, 2007, CLIN EXP IMMUNOL, V148, P17, DOI 10.1111/j.1365-2249.2007.03328.x; Summers KL, 2006, CLIN IMMUNOL, V121, P81, DOI 10.1016/j.clim.2006.05.015; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Tritt M, 2008, DIABETES, V57, P113, DOI 10.2337/db06-1700; Trucco M, 2005, J CLIN INVEST, V115, P5, DOI 10.1172/JCI200523935; Wan YSY, 2006, IMMUNOL REV, V212, P114, DOI 10.1111/j.0105-2896.2006.00407.x; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415; You S, 2004, P NATL ACAD SCI USA, V101, P14580, DOI 10.1073/pnas.0404870101; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009; Zhao Y, 2003, P NATL ACAD SCI USA, V100, P2426, DOI 10.1073/pnas.0536882100; Zhao Y, 2007, IMMUNOL LETT, V108, P78, DOI 10.1016/j.imlet.2006.10.007; Zhao Y, 2006, EXP CELL RES, V312, P2454, DOI 10.1016/j.yexcr.2006.04.008; ZHOU Q, 2008, NATURE	43	61	69	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2009	4	1							e4226	10.1371/journal.pone.0004226	http://dx.doi.org/10.1371/journal.pone.0004226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IZ	19156219	Green Published, Green Submitted, gold			2022-12-25	WOS:000265481900008
J	Mostowy, S; Tham, TN; Danckaert, A; Guadagnini, S; Boisson-Dupuis, S; Pizarro-Cerda, J; Cossart, P				Mostowy, Serge; Tham, To Nam; Danckaert, Anne; Guadagnini, Stephanie; Boisson-Dupuis, Stephanie; Pizarro-Cerda, Javier; Cossart, Pascale			Septins Regulate Bacterial Entry into Host Cells	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; PROTEIN; INVASION; INTERNALIN; INIB; SUFFICIENT; ACTIVATION; PATTERNS; RECEPTOR; 3-KINASE	Background: Septins are conserved GTPases that form filaments and are required in many organisms for several processes including cytokinesis. We previously identified SEPT9 associated with phagosomes containing latex beads coated with the Listeria surface protein InIB. Methodology/Principal Findings: Here, we investigated septin function during entry of invasive bacteria in non-phagocytic mammalian cells. We found that SEPT9, and its interacting partners SEPT2 and SEPT11, are recruited as collars next to actin at the site of entry of Listeria and Shigella. SEPT2-depletion by siRNA decreased bacterial invasion, suggesting that septins have roles during particle entry. Incubating cells with InIB-coated beads confirmed an essential role for SEPT2. Moreover, SEPT2-depletion impaired InIB-mediated stimulation of Met-dependent signaling as shown by FRET. Conclusions/Significance: Together these findings highlight novel roles for SEPT2, and distinguish the roles of septin and actin in bacterial entry.	[Mostowy, Serge; Tham, To Nam; Boisson-Dupuis, Stephanie; Pizarro-Cerda, Javier; Cossart, Pascale] Inst Pasteur, Unite Interact Bacteries Cellules, Paris, France; [Mostowy, Serge; Tham, To Nam; Boisson-Dupuis, Stephanie; Pizarro-Cerda, Javier; Cossart, Pascale] Inserm, U604, Paris, France; [Mostowy, Serge; Tham, To Nam; Boisson-Dupuis, Stephanie; Pizarro-Cerda, Javier; Cossart, Pascale] INRA, USC2020, Paris, France; [Danckaert, Anne] Inst Pasteur, Plate forme Imagerie Dynamique, Paris, France; [Guadagnini, Stephanie] Inst Pasteur, Plateforme Microscop Electron, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Mostowy, S (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, Paris, France.	pcossart@pasteur.fr	Boisson-Dupuis, Stephanie/AAF-5066-2021; Boisson-Dupuis, Stéphanie/I-2040-2017	Boisson-Dupuis, Stéphanie/0000-0002-7115-116X; Mostowy, Serge/0000-0002-7286-6503	Canadian Institutes of Health Research [fellowship]; Canadian Foundation Louis Pasteur; Fondation pour la Recherche Medicale; Howard Hughes Medical Institute; ANR [ANR-05-MIME-O13-01]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation Louis Pasteur; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Howard Hughes Medical Institute(Howard Hughes Medical Institute); ANR(French National Research Agency (ANR))	S.M. is supported by a long-term fellowship from the Canadian Institutes of Health Research, the Canadian Foundation Louis Pasteur, and the Fondation pour la Recherche Medicale. P.C. is an international research scholar from the Howard Hughes Medical Institute. This study received financial support from an ANR grant (ANR-05-MIME-O13-01).	Barral Y, 2008, CURR OPIN CELL BIOL, V20, P12, DOI 10.1016/j.ceb.2007.12.001; Beites CL, 1999, NAT NEUROSCI, V2, P434, DOI 10.1038/8100; Bierne H, 2005, J CELL SCI, V118, P1537, DOI 10.1242/jcs.02285; Bierne H, 2001, J CELL BIOL, V155, P101, DOI 10.1083/jcb.200104037; Bierne H, 2007, MICROBIOL MOL BIOL R, V71, P377, DOI 10.1128/MMBR.00039-06; Braun L, 1998, MOL MICROBIOL, V27, P1077, DOI 10.1046/j.1365-2958.1998.00750.x; Braun L, 1997, MOL MICROBIOL, V25, P285, DOI 10.1046/j.1365-2958.1997.4621825.x; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Greber UF, 2006, CELL, V124, P741, DOI 10.1016/j.cell.2006.02.018; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Huang YW, 2008, MOL BIOL CELL, V19, P1717, DOI 10.1091/mbc.E07-07-0641; Ihara M, 2007, NEURON, V53, P519, DOI 10.1016/j.neuron.2007.01.019; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; Ito H, 2005, ONCOGENE, V24, P7064, DOI 10.1038/sj.onc.1208862; Jaumouille V, 2008, EMBO J, V27, P447, DOI 10.1038/sj.emboj.7601976; Joberty G, 1999, MOL CELL BIOL, V19, P6585; Joberty G, 2001, NAT CELL BIOL, V3, P861, DOI 10.1038/ncb1001-861; Joo E, 2005, TRAFFIC, V6, P626, DOI 10.1111/j.1600-0854.2005.00305.x; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Kinoshita M, 2003, J BIOCHEM, V134, P491, DOI 10.1093/jb/mvg182; Kinoshita M, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-236; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kuhlenbaumer G, 2005, NAT GENET, V37, P1044, DOI 10.1038/ng1649; Kuhn M, 1998, FEMS MICROBIOL LETT, V160, P87, DOI 10.1016/S0378-1097(98)00017-2; Lecuit M, 2004, P NATL ACAD SCI USA, V101, P6152, DOI 10.1073/pnas.0401434101; Lecuit M, 1997, INFECT IMMUN, V65, P5309, DOI 10.1128/IAI.65.12.5309-5319.1997; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Nagata K, 2004, J BIOL CHEM, V279, P55895, DOI 10.1074/jbc.M406153200; Nagata KI, 2005, ONCOGENE, V24, P65, DOI 10.1038/sj.onc.1208101; Ogawa M, 2008, NAT REV MICROBIOL, V6, P11, DOI 10.1038/nrmicro1814; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Pizarro-Cerda J, 2002, METHOD MICROBIOL, V31, P161, DOI 10.1016/S0580-9517(02)31009-2; Pizarro-Cerda J, 2002, CELL MICROBIOL, V4, P101, DOI 10.1046/j.1462-5822.2002.00169.x; Pizarro-Cerda J, 2007, CELL MICROBIOL, V9, P2381, DOI 10.1111/j.1462-5822.2007.00967.x; Seveau S, 2007, CELL MICROBIOL, V9, P790, DOI 10.1111/j.1462-5822.2006.00832.x; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Sousa S, 2005, NAT CELL BIOL, V7, P954, DOI 10.1038/ncb1308; Spiliotis ET, 2008, J CELL BIOL, V180, P295, DOI 10.1083/jcb.200710039; Spiliotis ET, 2006, J CELL SCI, V119, P4, DOI 10.1242/jcs.02746; Veiga E, 2007, CELL HOST MICROBE, V2, P340, DOI 10.1016/j.chom.2007.10.001; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Xie YL, 2007, CURR BIOL, V17, P1746, DOI 10.1016/j.cub.2007.08.042; Yoshida S, 2003, TRENDS MICROBIOL, V11, P139, DOI 10.1016/S0966-842X(03)00023-4; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3	55	70	78	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2009	4	1							e4196	10.1371/journal.pone.0004196	http://dx.doi.org/10.1371/journal.pone.0004196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IG	19145258	gold, Green Published, Green Submitted			2022-12-25	WOS:000265479800004
J	Brookfield, KF; Cheung, MC; Yang, R; Byrne, MM; Koniaris, LG				Brookfield, Kathleen F.; Cheung, Michael C.; Yang, Relin; Byrne, Margaret M.; Koniaris, Leonidas G.			Will Patients Benefit from Regionalization of Gynecologic Cancer Care?	PLOS ONE			English	Article								Objective: Patient chances for cure and palliation for a variety of malignancies may be greatly affected by the care provided by a treating hospital. We sought to determine the effect of volume and teaching status on patient outcomes for five gynecologic malignancies: endometrial, cervical, ovarian and vulvar carcinoma and uterine sarcoma. Methods: The Florida Cancer Data System dataset was queried for all patients undergoing treatment for gynecologic cancers from 1990-2000. Results: Overall, 48,981 patients with gynecologic malignancies were identified. Endometrial tumors were the most common, representing 43.2% of the entire cohort, followed by ovarian cancer (30.9%), cervical cancer (20.8%), vulvar cancer (4.6%), and uterine sarcoma (0.5%). By univariate analysis, although patients treated at high volume centers (HVC) were significantly younger, they benefited from an improved short-term (30-day and/or 90-day) survival for cervical, ovarian and endometrial cancers. Multivariate analysis (MVA), however, failed to demonstrate significant survival benefit for gynecologic cancer patients treated at teaching facilities (TF) or HVC. Significant prognostic factors at presentation by MVA were age over 65 (HR = 2.6, p < 0.01), African-American race (HR = 1.36, p < 0.01), and advanced stage (regional HR = 2.08, p < 0.01; advanced HR = 3.82, p < 0.01, respectively). Surgery and use of chemotherapy were each significantly associated with improved survival. Conclusion: No difference in patient survival was observed for any gynecologic malignancy based upon treating hospital teaching or volume status. Although instances of improved outcomes may occur, overall further regionalization would not appear to significantly improve patient survival.	Univ Miami, Miller Sch Med, Dept Obstet & Gynecol, Miami, FL 33136 USA; [Cheung, Michael C.; Yang, Relin; Koniaris, Leonidas G.] Univ Miami, Miller Sch Med, DeWitt Daughtry Family Dept Surg, Miami, FL USA; [Byrne, Margaret M.] Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL USA	University of Miami; University of Miami; University of Miami	Brookfield, KF (corresponding author), Univ Miami, Miller Sch Med, Dept Obstet & Gynecol, Miami, FL 33136 USA.	lkoniaris@med.miami.edu						Bristow RE, 2004, GYNECOL ONCOL, V93, P353, DOI 10.1016/j.ygyno.2004.02.010; Carney ME, 2002, GYNECOL ONCOL, V84, P36, DOI 10.1006/gyno.2001.6460; Casson AG, 2005, J SURG ONCOL, V92, P262, DOI 10.1002/jso.20368; CHEUNG MC, 2008, ANN SURG ONCOL; Cheung MC, 2008, J GASTROINTEST SURG, V12, P731, DOI 10.1007/s11605-007-0417-3; Diaz-Montes TP, 2007, GYNECOL ONCOL, V107, P436, DOI 10.1016/j.ygyno.2007.07.060; Diaz-Montes TP, 2006, GYNECOL ONCOL, V103, P1043, DOI 10.1016/j.ygyno.2006.06.018; Earle CC, 2006, J NATL CANCER I, V98, P172, DOI 10.1093/jnci/djj019; EISENKOP SM, 1992, GYNECOL ONCOL, V47, P203, DOI 10.1016/0090-8258(92)90107-T; Gutierrez JC, 2007, J GASTROINTEST SURG, V11, P1441, DOI 10.1007/s11605-007-0308-7; Gutierrez JC, 2007, ANN SURG, V245, P952, DOI 10.1097/01.sla.0000250438.04393.a8; Hillner BE, 2000, J CLIN ONCOL, V18, P2327, DOI 10.1200/JCO.2000.18.11.2327; Hodgson N, 2005, SURG ENDOSC, V19, P1610, DOI 10.1007/s00464-005-0232-4; Hoekstra A, 2006, GYNECOL ONCOL, V103, P897, DOI 10.1016/j.ygyno.2006.05.019; Junor EJ, 1999, BRIT J OBSTET GYNAEC, V106, P1130, DOI 10.1111/j.1471-0528.1999.tb08137.x; Macdonald OK, 2005, GYNECOL ONCOL, V99, P730, DOI 10.1016/j.ygyno.2005.07.111; MAYER AR, 1992, GYNECOL ONCOL, V47, P223, DOI 10.1016/0090-8258(92)90110-5; Meguid RA, 2008, ANN THORAC SURG, V85, P1015, DOI 10.1016/j.athoracsur.2007.09.046; MOLINA MA, 2008, CANCER IN PRESS; NGUYEN HN, 1993, CANCER, V72, P3663, DOI 10.1002/1097-0142(19931215)72:12<3663::AID-CNCR2820721218>3.0.CO;2-S; Panageas KS, 2003, ANN INTERN MED, V139, P658, DOI 10.7326/0003-4819-139-8-200310210-00009; Perez EA, 2006, J AM COLL SURGEONS, V202, P623, DOI 10.1016/j.jamcollsurg.2006.01.002; Perez EA, 2007, WORLD J SURG, V31, P1022, DOI 10.1007/s00268-005-0774-6; PETRELLI NJ, 2008, J CLIN ONCOL; Puls LE, 1997, SOUTHERN MED J, V90, P1097; Riall TS, 2007, J GASTROINTEST SURG, V11, P1242, DOI 10.1007/s11605-007-0245-5; Schrag D, 2006, JNCI-J NATL CANCER I, V98, P163, DOI 10.1093/jnci/djj018; Silber JH, 2007, J CLIN ONCOL, V25, P1169, DOI 10.1200/JCO.2006.08.2933; Vernooij F, 2007, GYNECOL ONCOL, V105, P801, DOI 10.1016/j.ygyno.2007.02.030; Woodman C, 1997, BRIT J OBSTET GYNAEC, V104, P135, DOI 10.1111/j.1471-0528.1997.tb11032.x	30	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2009	4	1							e4049	10.1371/journal.pone.0004049	http://dx.doi.org/10.1371/journal.pone.0004049			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FV	19125205	gold, Green Published, Green Submitted			2022-12-25	WOS:000265473100001
J	Mairal, T; Nieto, J; Pinto, M; Almeida, MR; Gales, L; Ballesteros, A; Barluenga, J; Perez, JJ; Vazquez, JT; Centeno, NB; Saraiva, MJ; Damas, AM; Planas, A; Arsequell, G; Valencia, G				Mairal, Teresa; Nieto, Joan; Pinto, Marta; Almeida, Maria Rosario; Gales, Luis; Ballesteros, Alfredo; Barluenga, Jose; Perez, Juan J.; Vazquez, Jesus T.; Centeno, Nuria B.; Saraiva, Maria Joao; Damas, Ana M.; Planas, Antoni; Arsequell, Gemma; Valencia, Gregorio			Iodine Atoms: A New Molecular Feature for the Design of Potent Transthyretin Fibrillogenesis Inhibitors	PLOS ONE			English	Article								The thyroid hormone and retinol transporter protein known as transthyretin ( TTR) is in the origin of one of the 20 or so known amyloid diseases. TTR self assembles as a homotetramer leaving a central hydrophobic channel with two symmetrical binding sites. The aggregation pathway of TTR into amiloid fibrils is not yet well characterized but in vitro binding of thyroid hormones and other small organic molecules to TTR binding channel results in tetramer stabilization which prevents amyloid formation in an extent which is proportional to the binding constant. Up to now, TTR aggregation inhibitors have been designed looking at various structural features of this binding channel others than its ability to host iodine atoms. In the present work, greatly improved inhibitors have been designed and tested by taking into account that thyroid hormones are unique in human biochemistry owing to the presence of multiple iodine atoms in their molecules which are probed to interact with specific halogen binding domains sitting at the TTR binding channel. The new TTR fibrillogenesis inhibitors are based on the diflunisal core structure because diflunisal is a registered salicylate drug with NSAID activity now undergoing clinical trials for TTR amyloid diseases. Biochemical and biophysical evidence confirms that iodine atoms can be an important design feature in the search for candidate drugs for TTR related amyloidosis.	[Arsequell, Gemma; Valencia, Gregorio] CSIC, IQAC, Unit Glycoconjugate Chem, Barcelona, Spain; [Nieto, Joan; Planas, Antoni] Univ Ramon Llull, Inst Quim Sarria, Lab Biochem, Barcelona, Spain; [Pinto, Marta; Perez, Juan J.] Univ Politecn Barcelona, ETSEIB, Dept Ingenieria Quim, Barcelona, Spain; [Almeida, Maria Rosario; Gales, Luis; Saraiva, Maria Joao; Damas, Ana M.] Univ Porto, IBMC, Oporto, Portugal; [Ballesteros, Alfredo; Barluenga, Jose] Univ Porto, ICBAS, Oporto, Portugal; [Vazquez, Jesus T.] Univ Oviedo, Unidad Asociada CSIC, Instituto Univ Quim Organometal Enrique Moles, Oviedo, Spain; [Centeno, Nuria B.] Univ la Laguna, Inst Univ Bio Organ Antonio Gonzalez, San Cristobal de la Laguna, Spain; Univ Pompeu Fabra, IMIM, GRIB, Comp Assisted Drug Design Lab, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); Universitat Ramon Llull; Institut Quimic de Sarria; Universitat Politecnica de Catalunya; Universidade do Porto; Universidade do Porto; Consejo Superior de Investigaciones Cientificas (CSIC); University of Oviedo; Universidad de la Laguna; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Pompeu Fabra University	Mairal, T (corresponding author), CSIC, IQAC, Unit Glycoconjugate Chem, Barcelona, Spain.	gvpqbp@iiqab.csic.es	Centeno, Nuria B/G-9548-2014; PLANAS, ANTONI/I-4803-2015; Ballesteros, Alfredo/P-5834-2014; Gasull, Martina/J-4076-2019; Arsequell, Gemma/ABG-7934-2020; Saraiva, Maria João/K-3907-2013; Perez, Juan J/E-3710-2010; Almeida, Maria Rosario/K-3938-2013; Vázquez, Jesús T/K-6549-2014; Gales, Luis/J-8716-2013	Centeno, Nuria B/0000-0001-7905-2329; PLANAS, ANTONI/0000-0001-7073-3320; Ballesteros, Alfredo/0000-0003-2093-4444; Saraiva, Maria João/0000-0002-3360-6899; Perez, Juan J/0000-0002-0748-8147; Almeida, Maria Rosario/0000-0001-9289-3835; Gales, Luis/0000-0002-8352-6539; Trujillo Vazquez, Jesus/0000-0002-3622-3148; ARSEQUELL, GEMMA/0000-0002-7009-3738	MCYT (Spain) [EET2002 05157 CO5]; MEC (Spain) [CTQ2004 08077 CO2, BIO2007 67904]; CEC Principado de Asturias [IB05 136]; Generalitat de Catalunya [2005SGR00883]; red Heracles ISCIII (Spain) [DR06/0009]; Fundacao Ciencia e Tecnologia (FCT) (Portugal); FEDER [POCI/SAU-MMO/57321/ 2004, POCTI/SAU NEU/58735/2004, PTDC/SAU NEU/69123/2006]	MCYT (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MEC (Spain)(Spanish Government); CEC Principado de Asturias; Generalitat de Catalunya(Generalitat de Catalunya); red Heracles ISCIII (Spain); Fundacao Ciencia e Tecnologia (FCT) (Portugal)(Portuguese Foundation for Science and Technology); FEDER(European Commission)	This work was supported by grants: EET2002 05157 CO5 (to G.V., J.B., A.P.) from MCYT (Spain), CTQ2004 08077 CO2 (to J.B.) and BIO2007 67904 (to A.P.) from MEC (Spain), IB05 136 (to J.B.) from CEC Principado de Asturias, 2005SGR00883 (to A.P.) from Generalitat de Catalunya, DR06/0009 (to N.B.C.) from red Heracles ISCIII (Spain). Funding from Fundacao Ciencia e Tecnologia (FCT) (Portugal) through POCTI and POCI programmes (Programa Operacional Ciencia e Inovacao 2010) (to M.J.S.) and FEDER (Project POCI/SAU-MMO/57321/ 2004 to M.R.A.). POCTI/SAU NEU/58735/2004 (to A.M.D.), PTDC/SAU NEU/69123/2006 (to A.M.D.) and FEDER funds (to A.M.D.) are acknowledged. Diffraction data were collected at ESRF beam line ID14 1.	Adamski-Werner SL, 2004, J MED CHEM, V47, P355, DOI 10.1021/jm030347n; Almeida M. R., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P587, DOI 10.2174/156800705774322076; Almeida MR, 2004, BIOCHEM J, V381, P351, DOI 10.1042/BJ20040011; Almeida MR, 1997, ENDOCRINE, V6, P309, DOI 10.1007/BF02820508; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; Babbes ARH, 2008, BIOCHEMISTRY-US, V47, P6969, DOI 10.1021/bi800636q; BARLUENGA J, 1992, J CHEM SOC CHEM COMM, P1016, DOI 10.1039/c39920001016; Barluenga J, 1999, PURE APPL CHEM, V71, P431, DOI 10.1351/pac199971030431; Barluenga J., 1999, CURRENT TRENDS ORGAN, P145; Baures PW, 1998, BIOORGAN MED CHEM, V6, P1389, DOI 10.1016/S0968-0896(98)00130-8; Baures PW, 1999, BIOORGAN MED CHEM, V7, P1339, DOI 10.1016/S0968-0896(99)00066-8; Benson MD, 2007, MUSCLE NERVE, V36, P411, DOI 10.1002/mus.20821; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; BLAKE CCF, 1971, J MOL BIOL, V61, P217, DOI 10.1016/0022-2836(71)90218-X; *BOST U FDA NINDS, NCT00294671 BOST U F; Brunger AT, 1998, CURR OPIN STRUC BIOL, V8, P606, DOI 10.1016/S0959-440X(98)80152-8; CASE DA, 1999, AMBER VERSION 6; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cordeiro Y, 2006, BIOPHYS J, V91, P957, DOI 10.1529/biophysj.106.085928; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Damas AM, 2000, J STRUCT BIOL, V130, P290, DOI 10.1006/jsbi.2000.4273; De la Paz P., 1992, DESIGN DRUGS MACROMO, P119; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Dolado I, 2005, J COMB CHEM, V7, P246, DOI 10.1021/cc049849s; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Foss TR, 2005, J MOL BIOL, V347, P841, DOI 10.1016/j.jmb.2005.01.050; Foss TR, 2005, BIOCHEMISTRY-US, V44, P15525, DOI 10.1021/bi051608t; Gales L, 2005, BIOCHEM J, V388, P615, DOI 10.1042/BJ20042035; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Green NS, 2003, J AM CHEM SOC, V125, P13404, DOI 10.1021/ja030294z; Green NS, 2005, P NATL ACAD SCI USA, V102, P14545, DOI 10.1073/pnas.0501609102; HAGEN GA, 1973, J CLIN ENDOCR METAB, V37, P415, DOI 10.1210/jcem-37-3-415; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Hammarstrom P, 2002, P NATL ACAD SCI USA, V99, P16427, DOI 10.1073/pnas.202495199; Hammarstrom P, 2001, BIOCHEMISTRY-US, V40, P11453, DOI 10.1021/bi010673+; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Johnson SM, 2005, ACCOUNTS CHEM RES, V38, P911, DOI 10.1021/ar020073i; Johnson SM, 2005, J MED CHEM, V48, P1576, DOI 10.1021/jm049274d; Johnson SM, 2008, J MED CHEM, V51, P6348, DOI 10.1021/jm800435s; Johnson SM, 2008, J MED CHEM, V51, P260, DOI 10.1021/jm0708735; Julius RL, 2007, P NATL ACAD SCI USA, V104, P4808, DOI 10.1073/pnas.0700316104; KANAI M, 1968, J CLIN INVEST, V47, P2025, DOI 10.1172/JCI105889; Kingsbury JS, 2008, J BIOL CHEM, V283, P11887, DOI 10.1074/jbc.M709638200; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; LANS MC, 1993, CHEM-BIOL INTERACT, V88, P7, DOI 10.1016/0009-2797(93)90081-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P238; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, V5, P50; Liu F, 2008, P NATL ACAD SCI USA, V105, P2369, DOI 10.1073/pnas.0711908105; McCarthy RE, 1998, CLIN CARDIOL, V21, P547; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miller SR, 2004, LAB INVEST, V84, P545, DOI 10.1038/labinvest.3700059; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NILSSON SF, 1975, J BIOL CHEM, V250, P8554; Oravcova J, 1996, J CHROMATOGR B, V677, P1, DOI 10.1016/0378-4347(95)00425-4; Oza VB, 1999, BIOORG MED CHEM LETT, V9, P1, DOI 10.1016/S0960-894X(98)00696-9; Oza VB, 2002, J MED CHEM, V45, P321, DOI 10.1021/jm010257n; Palaninathan SK, 2008, J MOL BIOL, V382, P1157, DOI 10.1016/j.jmb.2008.07.029; Petrassi HM, 2005, J AM CHEM SOC, V127, P6662, DOI 10.1021/ja044351f; Purkey HE, 2004, CHEM BIOL, V11, P1719, DOI 10.1016/j.chembiol.2004.10.009; Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200; Razavi H, 2003, ANGEW CHEM INT EDIT, V42, P2758, DOI 10.1002/anie.200351179; Razavi H, 2005, BIOORG MED CHEM LETT, V15, P1075, DOI 10.1016/j.bmcl.2004.12.022; Reixach N, 2008, J BIOL CHEM, V283, P2098, DOI 10.1074/jbc.M708028200; Reixach N, 2006, BIOCHEM BIOPH RES CO, V348, P889, DOI 10.1016/j.bbrc.2006.07.109; ROUSSEL A, 1991, TURBOFRODO SILICON G; Saraiva MJM, 2001, HUM MUTAT, V17, P493, DOI 10.1002/humu.1132; Sebastiao MP, 2001, J MOL BIOL, V306, P733, DOI 10.1006/jmbi.2000.4415; Sekijima Y, 2006, AMYLOID, V13, P236, DOI 10.1080/13506120600960882; *SIM IM, 2000, INS 2 VERS 2000; STEELMAN SL, 1978, CURR MED RES OPIN, V5, P506, DOI 10.1185/03007997809108993; Tagoe CE, 2007, AMYLOID, V14, P227, DOI 10.1080/13506120701464396; Tojo K, 2006, NEUROSCI RES, V56, P441, DOI 10.1016/j.neures.2006.08.014; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Wiseman RL, 2005, BIOCHEMISTRY-US, V44, P9265, DOI 10.1021/bi050352o; Wiseman RL, 2005, J AM CHEM SOC, V127, P5540, DOI 10.1021/ja042929f; Wiseman RL, 2005, BIOCHEMISTRY-US, V44, P16612, DOI 10.1021/bi0511484	79	45	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2009	4	1							e4124	10.1371/journal.pone.0004124	http://dx.doi.org/10.1371/journal.pone.0004124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FV	19125186	Green Published, gold			2022-12-25	WOS:000265473100003
J	Wang, S; Ziman, B; Bodi, I; Rubio, M; Zhou, YY; D'Souza, K; Bishopric, NH; Schwartz, A; Lakatta, EG				Wang, Su; Ziman, Bruce; Bodi, Ilona; Rubio, Marta; Zhou, Ying-Ying; D'Souza, Karen; Bishopric, Nanette H.; Schwartz, Arnold; Lakatta, Edward G.			Dilated Cardiomyopathy with Increased SR Ca2+ Loading Preceded by a Hypercontractile State and Diastolic Failure in the alpha(1C)TG Mouse	PLOS ONE			English	Article								Mice over-expressing the alpha(1)-subunit (pore) of the L-type Ca2+ channel (alpha(1C)TG) by 4months (mo) of age exhibit an enlarged heart, hypertrophied myocytes, increased Ca2+ current and Ca2+ transient amplitude, but a normal SR Ca2+ load. With advancing age (8-11 mo), some mice demonstrate advanced hypertrophy but are not in congestive heart failure (NFTG), while others evolve to frank dilated congestive heart failure (FTG). We demonstrate that older NFTG myocytes exhibit a hypercontractile state over a wide range of stimulation frequencies, but maintain a normal SR Ca2+ load compared to age matched non-transgenic (NTG) myocytes. However, at high stimulation rates (2-4 Hz) signs of diastolic contractile failure appear in NFTG cells. The evolution of frank congestive failure in FTG is accompanied by a further increase in heart mass and myocyte size, and phospholamban and ryanodine receptor protein levels and phosphorylation become reduced. In FTG, the SR Ca2+ load increases and Ca2+ release following excitation, increases further. An enhanced NCX function in FTG, as reflected by an accelerated relaxation of the caffeine-induced Ca2+ transient, is insufficient to maintain a normal diastolic Ca2+ during high rates of stimulation. Although a high SR Ca2+ release following excitation is maintained, the hypercontractile state is not maintained at high rates of stimulation, and signs of both systolic and diastolic contractile failure appear. Thus, the dilated cardiomyopathy that evolves in this mouse model exhibits signs of both systolic and diastolic failure, but not a deficient SR Ca2+ loading or release, as occurs in some other cardiomyopathic models.	[Wang, Su; Ziman, Bruce; Zhou, Ying-Ying; Lakatta, Edward G.] NIA, Cardiovasc Sci Lab, Gerontol Res Ctr, Baltimore, MD USA; [Bodi, Ilona; Rubio, Marta; D'Souza, Karen; Schwartz, Arnold] Univ Cincinnati, Coll Med, Dept Surg, Inst Mol Pharmacol & Biophys, Cincinnati, OH 45221 USA; [Bishopric, Nanette H.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol Med & Pediat, Miami, FL USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University System of Ohio; University of Cincinnati; University of Miami	Wang, S (corresponding author), NIA, Cardiovasc Sci Lab, Gerontol Res Ctr, Baltimore, MD USA.	schwara@email.uc.edu; LakattaE@grc.nia.nih.gov	Lakatta, Edward G/AAL-1447-2020	Lakatta, Edward/0000-0002-4772-0035	Intramural Research Program of the National Institutes of Health, National Institute on Aging [R01 HL079599, T-32 HL07382]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079599, T32HL007382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000235] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Institute on Aging, and in part by R01 HL079599 (AS), and T-32 HL07382 (AS).	Antoons G, 2006, J MOL CELL CARDIOL, V40, P350, DOI 10.1016/j.yjmcc.2005.12.002; Balke CW, 1998, CARDIOVASC RES, V37, P290, DOI 10.1016/S0008-6363(97)00272-1; Benkusky NA, 2007, CIRC RES, V101, P819, DOI 10.1161/CIRCRESAHA.107.153007; Bito V, 2004, CIRC RES, V94, P794, DOI 10.1161/01.RES.0000124934.84048.DF; Bodi I, 2005, J CLIN INVEST, V115, P3306, DOI 10.1172/JCI27167; Boluyt MO, 1995, EUR HEART J, V16, P19, DOI 10.1093/eurheartj/16.suppl_N.19; Bridge JHB, 2008, CIRC RES, V102, pE65, DOI 10.1161/CIRCRESAHA.108.176172; BROOKSBY P, 1993, CARDIOVASC RES, V27, P1268, DOI 10.1093/cvr/27.7.1268; Chen XW, 2005, CIRC RES, V97, P1009, DOI 10.1161/01.RES.0000189270.72915.D1; Chu GX, 2002, CARDIOVASC RES, V54, P105, DOI 10.1016/S0008-6363(02)00230-4; DELMONTE F, 1995, CARDIOVASC RES, V30, P281, DOI 10.1016/S0008-6363(95)00040-2; Eisner DA, 2002, CIRC RES, V91, P979, DOI 10.1161/01.RES.0000045654.34731.FF; GWATHMEY JK, 1991, J CLIN INVEST, V87, P1023, DOI 10.1172/JCI115061; HARIGAYA S, 1969, CIRC RES, V25, P781, DOI 10.1161/01.RES.25.6.781; Harris DM, 2005, CIRC RES, V96, P543, DOI 10.1161/01.RES.0000158966.58380.37; Houser SR, 1999, CIRCULATION, V99, P600, DOI 10.1161/01.CIR.99.5.600; Hullin R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000292; Lakatta EG, 2004, J MOL CELL CARDIOL, V36, P1, DOI 10.1016/j.yjmcc.2003.10.014; Lehnart SE, 2005, CELL, V123, P25, DOI 10.1016/j.cell.2005.07.030; Li ZH, 1997, AM J PHYSIOL-HEART C, V272, pH2313, DOI 10.1152/ajpheart.1997.272.5.H2313; MacDonnell SM, 2008, CIRC RES, V102, pE65, DOI 10.1161/CIRCRESAHA.108.174722; MELZER W, 1987, BIOPHYS J, V51, P849, DOI 10.1016/S0006-3495(87)83413-6; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Palomeque J, 2007, J CARD FAIL, V13, P143, DOI 10.1016/j.cardfail.2006.11.002; Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B; Reiken S, 2003, J BIOL CHEM, V278, P444, DOI 10.1074/jbc.M207028200; SCHWARTZ A, 1973, AM J CARDIOL, V32, P407, DOI 10.1016/S0002-9149(73)80031-1; Sen LY, 2000, AM J PHYSIOL-HEART C, V279, pH709, DOI 10.1152/ajpheart.2000.279.2.H709; Sipido KR, 2005, CARDIOVASC RES, V68, P167, DOI 10.1016/j.cardiores.2005.08.011; SIRI FM, 1991, AM J PHYSIOL, V261, pH514, DOI 10.1152/ajpheart.1991.261.2.H514; Song LS, 2006, P NATL ACAD SCI USA, V103, P4305, DOI 10.1073/pnas.0509324103; Song LS, 2005, CIRC RES, V97, P457, DOI 10.1161/01.RES.0000179722.79295.d4; Song LS, 1998, J PHYSIOL-LONDON, V512, P677, DOI 10.1111/j.1469-7793.1998.677bd.x; STERN MD, 1989, AM J PHYSIOL, V257, pH665, DOI 10.1152/ajpheart.1989.257.2.H665; Takeishi Y, 1998, J CLIN INVEST, V102, P72, DOI 10.1172/JCI2709; Yano M, 2005, J CLIN INVEST, V115, P556, DOI 10.1172/JCI200524159	36	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2009	4	1							e4133	10.1371/journal.pone.0004133	http://dx.doi.org/10.1371/journal.pone.0004133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FV	19125184	Green Published, gold, Green Submitted			2022-12-25	WOS:000265473100007
J	Field, KL; Bachmanov, AA; Mennella, JA; Beauchamp, GK; Kimball, BA				Field, Kristin L.; Bachmanov, Alexander A.; Mennella, Julie A.; Beauchamp, Gary K.; Kimball, Bruce A.			Protein Hydrolysates Are Avoided by Herbivores but Not by Omnivores in Two-Choice Preference Tests	PLOS ONE			English	Article								Background: The negative sensory properties of casein hydrolysates (HC) often limit their usage in products intended for human consumption, despite HC being nutritious and having many functional benefits. Recent, but taxonomically limited, evidence suggests that other animals also avoid consuming HC when alternatives exist. Methodology/Principal Findings: We evaluated ingestive responses of five herbivorous species (guinea pig, mountain beaver, gopher, vole, and rabbit) and five omnivorous species (rat, coyote, house mouse, white-footed mouse, and deer mouse; N = 16-18/species) using solid foods containing 20% HC in a series of two-choice preference tests that used a nonprotein, cellulose-based alternative. Individuals were also tested with collagen hydrolysate (gelatin; GE) to determine whether it would induce similar ingestive responses to those induced by HC. Despite HC and GE having very different nutritional and sensory qualities, both hydrolysates produced similar preference score patterns. We found that the herbivores generally avoided the hydrolysates while the omnivores consumed them at similar levels to the cellulose diet or, more rarely, preferred them (HC by the white-footed mouse; GE by the rat). Follow-up preference tests pairing HC and the nutritionally equivalent intact casein (C) were performed on the three mouse species and the guinea pigs. For the mice, mean HC preference scores were lower in the HC v C compared to the HC v Cel tests, indicating that HC's sensory qualities negatively affected its consumption. However, responses were species-specific. For the guinea pigs, repeated exposure to HC or C (4.7-h sessions; N = 10) were found to increase subsequent HC preference scores in an HC v C preference test, which was interpreted in the light of conservative foraging strategies thought to typify herbivores. Conclusions/Significance: This is the first empirical study of dietary niche-related taxonomic differences in ingestive responses to protein hydrolysates using multiple species under comparable conditions. Our results provide a basis for future work in sensory, physiological, and behavioral mechanisms of hydrolysate avoidance and on the potential use of hydrolysates for pest management.	[Field, Kristin L.; Bachmanov, Alexander A.; Mennella, Julie A.; Beauchamp, Gary K.; Kimball, Bruce A.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Kimball, Bruce A.] USDA, APHIS, Natl Wildlife Res Ctr, Ft Collins, CO USA	Monell Chemical Senses Center; United States Department of Agriculture (USDA)	Field, KL (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	bkimball@monell.org	Bachmanov, Alexander A./AAH-8857-2020	Bachmanov, Alexander A./0000-0002-2861-3322; Mennella, Julie/0000-0002-8855-0204	USDA-NWRC Monell Cooperative agreement [07-7442-0585-CA]; California Dept. of Food and Agriculture Vertebrate Pest Control Research Advisory Committee [2 T32 DC 00014]; KLF: Ruth L. Kirschstein National Research Service Award; National Institutes of Health [DC00882, HD37119]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000014, R01DC000882] Funding Source: NIH RePORTER	USDA-NWRC Monell Cooperative agreement; California Dept. of Food and Agriculture Vertebrate Pest Control Research Advisory Committee; KLF: Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	USDA-NWRC Monell Cooperative agreement (07-7442-0585-CA) California Dept. of Food and Agriculture Vertebrate Pest Control Research Advisory Committee. Author funding sources: KLF: Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant (2 T32 DC 00014) from the National Institutes of Health. AAB and GKB: National Institutes of Health R01 grant (DC00882). JAM: National Institutes of Health R01 grant (HD37119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker L. M., 1977, LEARNING MECH FOOD S; BEAUCHAMP GK, 1977, J COMP PHYSIOL PSYCH, V91, P1118, DOI 10.1037/h0077380; BLUNDELL JE, 1983, NUTR BRAIN, P163; CASTLE KT, 1995, J COMP PHYSIOL B, V164, P609, DOI 10.1007/BF00389801; Day JEL, 1998, NUTR RES REV, V11, P25, DOI 10.1079/NRR19980004; DErchia AM, 1996, NATURE, V381, P597, DOI 10.1038/381597a0; Dominy NJ, 2001, EVOL ANTHROPOL, V10, P171, DOI 10.1002/evan.1031; Domjan M., 1977, LEARNING MECH FOOD S, P151; Feurte S, 2002, NUTR NEUROSCI, V5, P269, DOI 10.1080/10284150290032003; Feurte S, 2000, PHYSIOL BEHAV, V68, P423, DOI 10.1016/S0031-9384(99)00202-4; Field KL, 2008, PHYSIOL BEHAV, V93, P189, DOI 10.1016/j.physbeh.2007.08.010; Figueroa JA, 2008, CROP PROT, V27, P851, DOI 10.1016/j.cropro.2007.07.004; FitzGerald RJ, 2006, BIOTECHNOL ADV, V24, P234, DOI 10.1016/j.biotechadv.2005.11.002; FREELAND WJ, 1974, AM NAT, V108, P269, DOI 10.1086/282907; Gietzen DW, 2006, TRENDS NEUROSCI, V29, P91, DOI 10.1016/j.tins.2005.12.007; Haq AU, 1996, J NUTR, V126, P3083, DOI 10.1093/jn/126.12.3083; Harris JA, 2004, J EXP PSYCHOL-ANIM B, V30, P177, DOI 10.1037/0097-7403.30.3.177; Host A, 2004, ALLERGY, V59, P45, DOI 10.1111/j.1398-9995.2004.00574.x; HUME ID, 1994, DIGESTIVE SYSTEM IN MAMMALS: FOOD, FORM, AND FUNCTION, P315, DOI 10.1017/CBO9780511661716.020; Kilara A, 2003, CRIT REV FOOD SCI, V43, P607, DOI 10.1080/10408690390251138; Kimball B., 2006, ADV VERTEBRATE PEST, P59; Kimball BA, 2006, WEST J APPL FOR, V21, P108, DOI 10.1093/wjaf/21.2.108; Kimball BA, 2005, HORTSCIENCE, V40, P1810, DOI 10.21273/HORTSCI.40.6.1810; Korhonen H, 2006, INT DAIRY J, V16, P945, DOI 10.1016/j.idairyj.2005.10.012; LANDRY SO, 1970, Q REV BIOL, V45, P351, DOI 10.1086/406647; Lax P, 1998, PHYSIOL BEHAV, V65, P69, DOI 10.1016/S0031-9384(98)00123-1; Linden M. C., 1985, NUTR BIOCH METABOLIS, P51; Linhart SB, 2002, J WILDLIFE DIS, V38, P363, DOI 10.7589/0090-3558-38.2.363; Marples NM, 1999, EVOL ECOL, V13, P641, DOI 10.1023/A:1011077731153; MATOBA T, 1969, AGR BIOL CHEM TOKYO, V33, P1662, DOI 10.1080/00021369.1969.10859521; Meisel H, 1998, INT DAIRY J, V8, P363, DOI 10.1016/S0958-6946(98)00059-4; Mennella JA, 2002, EARLY HUM DEV, V68, P71, DOI 10.1016/S0378-3782(02)00008-7; Mennella JA, 2004, PEDIATRICS, V113, P840, DOI 10.1542/peds.113.4.840; Mennella JA, 2005, CHEM SENSES, V30, pI242, DOI 10.1093/chemse/bjh204; MURRAY TK, 1952, J SCI FOOD AGR, V3, P470, DOI 10.1002/jsfa.2740031006; NCNAB BK, 2002, DIET NUTR PHYSL ECOL, P390; Ohsumi M, 2007, AMINO ACIDS, V32, P247, DOI 10.1007/s00726-006-0362-6; PEDERSEN B, 1994, FOOD TECHNOL-CHICAGO, V48, P96; Pedrosa M, 2006, J INVEST ALLERG CLIN, V16, P351; PIQUARD F, 1978, PHYSIOL BEHAV, V20, P771, DOI 10.1016/0031-9384(78)90304-9; Ribeiro RPP, 1998, PHYSIOL BEHAV, V63, P185, DOI 10.1016/S0031-9384(97)00419-8; RoudotAlgaron F, 1996, LAIT, V76, P313, DOI 10.1051/lait:1996425; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Saha BC, 2001, BIOTECHNOL ADV, V19, P355, DOI 10.1016/S0734-9750(01)00070-2; SAKAGUCHI E, 1987, BRIT J NUTR, V58, P149, DOI 10.1079/BJN19870078; SHINODA I, 1986, AGR BIOL CHEM TOKYO, V50, P1247, DOI 10.1080/00021369.1986.10867553; SLADE LM, 1969, J ANIM SCI, V28, P842, DOI 10.2527/jas1969.286842x; Sokal R. R., 2012, BIOMETRY; *STATSOFT INC, 2002, STATISTICA 6 1; Stevens CE, 1998, PHYSIOL REV, V78, P393, DOI 10.1152/physrev.1998.78.2.393; Villalba JJ, 2004, OIKOS, V107, P100, DOI 10.1111/j.0030-1299.2004.12983.x; White T. C. R., 1993, INADEQUATE ENV NITRO; Williams TD, 2002, AM J PHYSIOL-REG I, V282, pR1459, DOI 10.1152/ajpregu.00612.2001	53	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2009	4	1							e4126	10.1371/journal.pone.0004126	http://dx.doi.org/10.1371/journal.pone.0004126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FT	19122811	gold, Green Submitted, Green Published			2022-12-25	WOS:000265472900006
J	Di Gennaro, A; Kenne, E; Wan, M; Soehnlein, O; Lindbom, L; Haeggstrom, JZ				Di Gennaro, Antonio; Kenne, Ellinor; Wan, Min; Soehnlein, Oliver; Lindbom, Lennart; Haeggstrom, Jesper Z.			Leukotriene B-4-induced changes in vascular permeability are mediated by neutrophil release of heparin-binding protein (HBP/CAP37/azurocidin)	FASEB JOURNAL			English	Article						inflammation; antimicrobial peptides; eicosanoid	HUMAN POLYMORPHONUCLEAR LEUKOCYTES; SRC FAMILY KINASES; ENDOTHELIAL-CELLS; ACTIVATION; B-4; DEGRANULATION; BIOSYNTHESIS; INFLAMMATION; SECRETION; RECEPTOR	In humans, heparin-binding protein (HBP) and the potent chemotactic lipid leukotriene B-4 (LTB4) are important mediators of innate immune reponses. Here we show that human neutrophils (PMNs) challenged with LTB4 (30 s to 5 min) release HBP as determined by Western blot analysis. This response peaks at 100 nM of agonist and is mediated by the BLT1 receptor. Protein phosphatase-1 (30 mu M) and wortmannin (0.5 mu M) block the LTB4-mediated HBP release from PMNs, which suggests involvement of the 1-phosphatidylinositol 3-kinase intracellular pathway during degranulation. Furthermore, postsecretory supernatants from LTB4-stimulated PMNs induce intracellular calcium mobilization in endothelial cells in vitro and increase in vascular permeability in vivo, as assessed in a mouse model of pleurisy. Selective removal of HBP from the supernatant significantly reduces these activities attributing a key role to HBP in the LTB4-induced change in vascular permeability. This lipid-protein axis could offer novel opportunities for pharmacological intervention in key steps of the vascular response to inflammation.-Di Gennaro, A., Kenne, E., Wan, M., Soehnlein, O., Lindbom, L., Haeggstrom, J. Z. Leukotriene B-4-induced changes in vascular permeability are mediated by neutrophil release of heparin-binding protein (HBP/CAP37/azurocidin). FASEB J. 23, 1750-1757 (2009)	[Di Gennaro, Antonio; Wan, Min; Haeggstrom, Jesper Z.] Karolinska Inst, Div Chem 2, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Kenne, Ellinor; Soehnlein, Oliver; Lindbom, Lennart] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Haeggstrom, JZ (corresponding author), Karolinska Inst, Div Chem 2, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	lennart.lindbom@ki.se; jesper.haeggstrom@ki.se	Kenne, Ellinor/HCH-1218-2022	Lindbom, Lennart/0000-0001-9243-257X; Kenne, Ellinor/0000-0002-2784-5244	Swedish Research Council [10350, 04342, 20854]; CERIC; EICOSANOX [005033]; Atheroremo [201668]; Swedish Heart-Lung Foundation; CIDaT; Italian Ministry of University and Research; Deutsche Forschungsgemeinschaft [SO876/1-1]	Swedish Research Council(Swedish Research CouncilEuropean Commission); CERIC; EICOSANOX; Atheroremo; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); CIDaT; Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Swedish Research Council (10350, 04342, 20854, and Linneus Grant CERIC), the EU integrated projects EICOSANOX (005033) and Atheroremo (201668), the Swedish Heart-Lung Foundation, the CIDaT consortium (Vinnova), and the Italian Ministry of University and Research (MIUR, "Internazionalizzazione del Sistema Universitario"). O.S. is recipient of a postdoctorate grant from the Deutsche Forschungsgemeinschaft (SO876/1-1). This publication reflects only the authors' point of view. The European Commission is not liable for any use that may be made of information herein. The authors thank Antonio G. Rothfuchs (NIH, Bethesda, MD, USA) for donation of mAb RB6-8C5 and Hans Flodgaard (Leukotech, Copenhagen) for gift of HBP antibody. The authors disclose that there are no conflicts of interest.	Almeida RP, 1996, PROTEIN EXPRES PURIF, V7, P355, DOI 10.1006/prep.1996.0053; BJORK J, 1982, INFLAMMATION, V6, P189, DOI 10.1007/BF00916243; BREZINSKI DA, 1992, CIRCULATION, V86, P56, DOI 10.1161/01.CIR.86.1.56; Chen M, 2006, J EXP MED, V203, P837, DOI 10.1084/jem.20052371; Chertov O, 1996, J BIOL CHEM, V271, P2935, DOI 10.1074/jbc.271.6.2935; Funk CD, 2005, NAT REV DRUG DISCOV, V4, P664, DOI 10.1038/nrd1796; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gaudreault E, 2005, J IMMUNOL, V174, P3617, DOI 10.4049/jimmunol.174.6.3617; Gautam N, 2001, NAT MED, V7, P1123, DOI 10.1038/nm1001-1123; Gautam N, 2000, J EXP MED, V191, P1829, DOI 10.1084/jem.191.11.1829; GOLDMAN DW, 1982, J IMMUNOL, V129, P1600; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Heimburger M, 1996, CLIN EXP IMMUNOL, V103, P454; Iizuka Y, 2005, J BIOL CHEM, V280, P24816, DOI 10.1074/jbc.M413257200; Lee TD, 2003, MICROVASC RES, V66, P38, DOI 10.1016/S0026-2862(03)00010-4; Levy O, 2004, J LEUKOCYTE BIOL, V76, P909, DOI 10.1189/jlb.0604320; Lindmark A, 1999, J LEUKOCYTE BIOL, V66, P634, DOI 10.1002/jlb.66.4.634; Mocsai A, 2000, J IMMUNOL, V164, P4321, DOI 10.4049/jimmunol.164.8.4321; Mocsai A, 1999, J IMMUNOL, V162, P1120; Nanamori M, 2007, J IMMUNOL, V178, P416, DOI 10.4049/jimmunol.178.1.416; Olofsson AM, 1999, J CLIN INVEST, V104, P885, DOI 10.1172/JCI6671; PALMBLAD J, 1994, J IMMUNOL, V152, P262; Penrose JF, 1999, CLIN REV ALLERG IMMU, V17, P133, DOI 10.1007/BF02737601; PETERSON MW, 1987, J APPL PHYSIOL, V62, P1521, DOI 10.1152/jappl.1987.62.4.1521; Provost P, 1998, BRIT J PHARMACOL, V123, P251, DOI 10.1038/sj.bjp.0701611; Qiu H, 2006, P NATL ACAD SCI USA, V103, P8161, DOI 10.1073/pnas.0602414103; ROSENGREN S, 1991, J APPL PHYSIOL, V71, P1322, DOI 10.1152/jappl.1991.71.4.1322; ROSENGREN S, 1991, INFLAMMATION, V15, P159, DOI 10.1007/BF00918643; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Serezani CHC, 2005, BLOOD, V106, P1067, DOI 10.1182/blood-2004-08-3323; SERHAN CN, 1983, ADV PROSTAG THROMB L, V11, P53; SMITH MJH, 1980, J PHARM PHARMACOL, V32, P517, DOI 10.1111/j.2042-7158.1980.tb12985.x; Soehnlein O, 2005, J IMMUNOL, V174, P6399, DOI 10.4049/jimmunol.174.10.6399; Soehnlein O, 2008, J CLIN INVEST, V118, P3491, DOI 10.1172/JCI35740; Soehnlein O, 2008, BLOOD, V112, P1461, DOI 10.1182/blood-2008-02-139634; SUMIMOTO H, 1984, BIOCHIM BIOPHYS ACTA, V803, P271, DOI 10.1016/0167-4889(84)90117-4; SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2; Tager AM, 2003, PROSTAG LEUKOTR ESS, V69, P123, DOI 10.1016/S0952-3278(03)00073-5; Tapper H, 2002, BLOOD, V99, P1785, DOI 10.1182/blood.V99.5.1785; Wan M, 2007, FASEB J, V21, P2897, DOI 10.1096/fj.06-7974com; Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	44	56	56	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2009	23	6					1750	1757		10.1096/fj.08-121277	http://dx.doi.org/10.1096/fj.08-121277			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19151333				2022-12-25	WOS:000266652400015
J	Deng, M; Li, FH; Ballif, BA; Li, S; Chen, X; Guo, L; Ye, X				Deng, Min; Li, Fahui; Ballif, Bryan A.; Li, Shan; Chen, Xi; Guo, Lin; Ye, Xin			Identification and Functional Analysis of a Novel Cyclin E/Cdk2 Substrate Ankrd17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE GENE-TRANSCRIPTION; S-PHASE PROGRESSION; CELL-CYCLE; ANKYRIN-REPEAT; CENTROSOME DUPLICATION; MAMMALIAN-CELLS; G1/S TRANSITION; DNA-SYNTHESIS; COMPLEX; PHOSPHORYLATION	Cyclin E/Cdk2 is a key regulator in G1-S transition. We have identified a novel cyclin E/Cdk2 substrate called Ankrd17 (ankyrin repeat protein 17) using the TAP tag purification technique. Ankrd17 protein contains two clusters of a total 25 ankyrin repeats at its N terminus, one NES (nuclear exporting signal) and one NLS (nuclear localization signal) in the middle, and one RXL motif at its C terminus. Ankrd17 is expressed in various tissues and associates with cyclin E/Cdk2 in an RXL-dependent manner. It can be phosphorylated by cyclin E/Cdk2 at 3 phosphorylation sites (Ser1791, Ser1794, and Ser2150). Overexpression of Ankrd17 promotes S phase entry, whereas depletion of Ankrd17 expression by small interfering RNA inhibits DNA replication and blocks cell cycle progression as well as up-regulates the expression of p53 and p21. Ankrd17 is localized to the nucleus and interacts with DNA replication factors including MCM family members, Cdc6 and PCNA. Depletion of Ankrd17 results in decreased loading of Cdc6 and PCNA onto DNA suggesting that Ankrd17 may be directly involved in the DNA replication process. Taken together, these data indicate that Ankrd17 is an important downstream effector of cyclin E/Cdk2 and positively regulates G1/S transition.	[Deng, Min; Li, Fahui; Ye, Xin] Chinese Acad Sci, Inst Microbiol, Dept Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Ballif, Bryan A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Li, Shan] Shandong Normal Univ, Jinan 250014, Shandong, Peoples R China; [Chen, Xi; Guo, Lin] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Deng, Min; Li, Fahui] Chinese Acad Sci, Grad Univ, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Harvard University; Harvard Medical School; Shandong Normal University; Wuhan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ye, X (corresponding author), Chinese Acad Sci, Inst Microbiol, Dept Pathogen Microbiol & Immunol, 3 Datun Rd,Rm A318, Beijing 100101, Peoples R China.	yex@im.ac.cn						Adams PD, 1996, MOL CELL BIOL, V16, P6623; Ait-Si-Ali S, 2000, ONCOGENE, V19, P2430, DOI 10.1038/sj.onc.1203562; Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Braden WA, 2006, MOL CELL BIOL, V26, P7667, DOI 10.1128/MCB.00045-06; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Chi Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r149; Choi BY, 2005, NAT STRUCT MOL BIOL, V12, P699, DOI 10.1038/nsmb960; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; Dawson S, 2002, J BIOL CHEM, V277, P10893, DOI 10.1074/jbc.M107313200; Deran M, 2008, MOL CELL BIOL, V28, P435, DOI 10.1128/MCB.00607-07; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Fujita M, 1999, J BIOL CHEM, V274, P25927, DOI 10.1074/jbc.274.36.25927; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Hall C, 2001, MOL CELL BIOL, V21, P1854, DOI 10.1128/MCB.21.5.1854-1865.2001; Hara T, 2001, J BIOL CHEM, V276, P48937, DOI 10.1074/jbc.M107274200; Higashitsuji H, 2000, NAT MED, V6, P96, DOI 10.1038/71600; Hofmann S, 2005, MOL CELL PROTEOMICS, V4, P1888, DOI 10.1074/mcp.M500076-MCP200; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Izumi M, 2004, J BIOL CHEM, V279, P32569, DOI 10.1074/jbc.M314017200; Komamura-Kohno Y, 2006, FEBS J, V273, P1224, DOI 10.1111/j.1742-4658.2006.05146.x; Kreitz S, 2001, J BIOL CHEM, V276, P6337, DOI 10.1074/jbc.M009473200; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Lin DI, 2008, P NATL ACAD SCI USA, V105, P8079, DOI 10.1073/pnas.0800077105; Luscher-Firzlaff JM, 2006, FEBS LETT, V580, P1716, DOI 10.1016/j.febslet.2006.02.021; Ma TL, 2000, GENE DEV, V14, P2298, DOI 10.1101/gad.829500; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Morris L, 2000, NAT CELL BIOL, V2, P232, DOI 10.1038/35008660; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Ortiz CM, 2008, INT J CANCER, V122, P325, DOI 10.1002/ijc.23106; Pagano M, 2004, MOL CELL, V14, P414, DOI 10.1016/S1097-2765(04)00268-0; Prior M, 2007, J VIROL, V81, P11195, DOI 10.1128/JVI.02559-06; Reed SI, 1997, CANCER SURV, V29, P7; Reyes JC, 1997, J CELL BIOL, V137, P263, DOI 10.1083/jcb.137.2.263; Scanlan M J, 2001, Cancer Immun, V1, P4; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Tarapore P, 2006, FEBS LETT, V580, P399, DOI 10.1016/j.febslet.2005.12.022; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Wang HT, 2007, J BIOL CHEM, V282, P24679, DOI 10.1074/jbc.M705066200; Watt AJ, 2001, MECH DEVELOP, V100, P205, DOI 10.1016/S0925-4773(00)00530-X; Wei Y, 2003, MOL CELL BIOL, V23, P3669, DOI 10.1128/MCB.23.10.3669-3680.2003; Wheeler LW, 2008, CELL CYCLE, V7, P2179, DOI 10.4161/cc.7.14.6270; Wolff B, 1999, ONCOGENE, V18, P2663, DOI 10.1038/sj.onc.1202617; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Ye X, 2003, MOL CELL BIOL, V23, P8586, DOI 10.1128/MCB.23.23.8586-8600.2003; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700	53	27	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7875	7888		10.1074/jbc.M807827200	http://dx.doi.org/10.1074/jbc.M807827200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19150984	Green Published, hybrid			2022-12-25	WOS:000264195600049
J	Chen, CS; Nelson, CM; Khauv, D; Bennett, S; Radisky, ES; Hirai, Y; Bissell, MJ; Radisky, DC				Chen, Connie S.; Nelson, Celeste M.; Khauv, Davitte; Bennett, Simone; Radisky, Evette S.; Hirai, Yohei; Bissell, Mina J.; Radisky, Derek C.			Homology with Vesicle Fusion Mediator Syntaxin-1a Predicts Determinants of Epimorphin/Syntaxin-2 Function in Mammary Epithelial Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN-BETA; ENRICHED INHIBITORY PROTEIN; C/EBP-BETA; EPIMORPHIN EXPRESSION; MESSENGER-RNA; SNARE COMPLEX; TRANSCRIPTIONAL ACTIVATOR; BRANCHING MORPHOGENESIS; 3-DIMENSIONAL STRUCTURE; UBIQUITINATED-CARGO	We have shown that branching morphogenesis of mammary ductal structures requires the action of the morphogen epimorphin/syntaxin-2. Epimorphin, originally identified as an extracellular molecule, is identical to syntaxin-2, an intracellular molecule that is a member of the extensively investigated syntaxin family of proteins that mediate vesicle trafficking. We show here that, although epimorphin/syntaxin-2 is highly homologous to syntaxin-1a, only epimorphin/syntaxin-2 can stimulate mammary branching morphogenesis. We construct a homology model of epimorphin/syntaxin-2 based on the published structure of syntaxin-1a, and we use this model to identify the structural motif responsible for the morphogenic activity. We identify four residues located within the cleft between helices B and C that differ between syntaxin-1a and epimorphin/syntaxin-2; through site-directed mutagenesis of these four amino acids, we confer the properties of epimorphin for cell adhesion, gene activation, and branching morphogenesis onto the inactive syntaxin-1a template. These results provide a dramatic demonstration of the use of structural information about one molecule to define a functional motif of a second molecule that is related at the sequence level but highly divergent functionally.	[Chen, Connie S.; Bennett, Simone; Bissell, Mina J.; Radisky, Derek C.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Nelson, Celeste M.] Princeton Univ, Dept Chem Engn, Princeton, NJ 08544 USA; [Khauv, Davitte; Radisky, Evette S.; Radisky, Derek C.] Mayo Clin, Ctr Canc, Jacksonville, FL 32224 USA; [Hirai, Yohei] Kyoto Univ, Inst Frontier Med Sci, Dept Morphoregulat, Sakyo Ku, Kyoto 6068507, Japan	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Princeton University; Mayo Clinic; Kyoto University	Bissell, MJ (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, 1 Cyclotron Rd,MS 977, Berkeley, CA 94720 USA.	mjbissell@lbl.gov; radisky.derek@mayo.edu	Nelson, Celeste/AAT-7612-2021; Radisky, Evette S/C-8526-2012; Radisky, Derek/B-6569-2018	Nelson, Celeste/0000-0001-9973-8870; Radisky, Evette S/0000-0003-3121-109X; Radisky, Derek/0000-0002-1962-8784	NATIONAL CANCER INSTITUTE [R21CA128660, R01CA122086, R01CA057621, R37CA064786, R01CA064786] Funding Source: NIH RePORTER; NCI NIH HHS [CA128660, CA57621, CA122086, CA64786] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akiyama M, 1999, BRIT J DERMATOL, V141, P447; Akutsu M, 2005, FEBS LETT, V579, P5385, DOI 10.1016/j.febslet.2005.08.076; Antonin W, 2002, J BIOL CHEM, V277, P36449, DOI 10.1074/jbc.M204369200; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Bascom JL, 2005, CANCER RES, V65, P8617, DOI 10.1158/0008-5472.CAN-05-1985; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BUCK M, 1994, EMBO J, V13, P851, DOI 10.1002/j.1460-2075.1994.tb06328.x; Bundy LM, 2003, ONCOGENE, V22, P869, DOI 10.1038/sj.onc.1206216; Chen XC, 2008, J BIOMOL NMR, V41, P43, DOI 10.1007/s10858-008-9239-1; Dearth LR, 2001, J CELL BIOCHEM, V82, P357, DOI 10.1002/jcb.1167; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Eaton EM, 2001, J CELL PHYSIOL, V189, P91, DOI 10.1002/jcp.1139; Fata JE, 2004, BREAST CANCER RES, V6, P1, DOI 10.1186/bcr634; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fritsch C, 2002, J CLIN INVEST, V110, P1629, DOI 10.1172/200213588; Gilbert KA, 2004, AM J PHYSIOL-LUNG C, V286, pL1179, DOI 10.1152/ajplung.00188.2003; Glasner ME, 2006, CURR OPIN CHEM BIOL, V10, P492, DOI 10.1016/j.cbpa.2006.08.012; GUMBINER BM, 1992, CELL, V69, P385, DOI 10.1016/0092-8674(92)90440-N; Haga A, 2000, BBA-PROTEIN STRUCT M, V1480, P235, DOI 10.1016/S0167-4838(00)00075-3; Hata K, 2005, MOL CELL BIOL, V25, P1971, DOI 10.1128/MCB.25.5.1971-1979.2005; HIRAI Y, 1992, CELL, V69, P471, DOI 10.1016/0092-8674(92)90448-L; Hirai Y, 2001, J CELL BIOL, V153, P785, DOI 10.1083/jcb.153.4.785; Hirai Y, 1998, J CELL BIOL, V140, P159, DOI 10.1083/jcb.140.1.159; Hirai Y, 2007, J CELL SCI, V120, P2032, DOI 10.1242/jcs.006247; Horikoshi S, 2001, EXP NEPHROL, V9, P412; Lehnert L, 2001, J CELL BIOL, V152, P911, DOI 10.1083/jcb.152.5.911; Lerman JC, 2000, BIOCHEMISTRY-US, V39, P8470, DOI 10.1021/bi0003994; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Matsuzaki T, 2005, HISTOCHEM CELL BIOL, V123, P501, DOI 10.1007/s00418-005-0753-x; Mattera R, 2003, EMBO J, V22, P78, DOI 10.1093/emboj/cdg015; Mattera R, 2004, J BIOL CHEM, V279, P31409, DOI 10.1074/jbc.M402183200; Milde-Langosch K, 2003, BREAST CANCER RES TR, V79, P175, DOI 10.1023/A:1023929504884; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Miura K, 2003, BIOCHEM BIOPH RES CO, V311, P415, DOI 10.1016/j.bbrc.2003.09.225; OKA Y, 2006, DEV BIOL; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; PELHAM HRB, 1993, CELL, V73, P425, DOI 10.1016/0092-8674(93)90128-D; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Prag G, 2005, P NATL ACAD SCI USA, V102, P2334, DOI 10.1073/pnas.0500118102; Prudovsky I, 2003, J CELL SCI, V116, P4871, DOI 10.1242/jcs.00872; Radisky DC, 2003, TRENDS CELL BIOL, V13, P426, DOI 10.1016/S0962-8924(03)00146-6; Redfern OC, 2008, CURR OPIN STRUC BIOL, V18, P394, DOI 10.1016/j.sbi.2008.05.007; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Segawa D, 2005, J GASTROEN HEPATOL, V20, P1769, DOI 10.1111/j.1440-1746.2005.03944.x; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Shirasaka T, 2003, J GASTROEN HEPATOL, V18, P570, DOI 10.1046/j.1440-1746.2003.02972.x; Sieber JJ, 2006, BIOPHYS J, V90, P2843, DOI 10.1529/biophysj.105.079574; Simian M, 2001, DEVELOPMENT, V128, P3117; Song J, 2000, J CLIN INVEST, V106, P1209, DOI 10.1172/JCI10411; SPRING J, 1993, TRENDS BIOCHEM SCI, V18, P124, DOI 10.1016/0968-0004(93)90018-I; Suer S, 2003, P NATL ACAD SCI USA, V100, P4451, DOI 10.1073/pnas.0831133100; Sun YJ, 1999, P NATL ACAD SCI USA, V96, P5412, DOI 10.1073/pnas.96.10.5412; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takebe K, 2003, FASEB J, V17, P2037, DOI 10.1096/fj.03-0386com; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Terasaki Y, 2000, AM J RESP CELL MOL, V23, P168, DOI 10.1165/ajrcmb.23.2.3973; Terasaki Y, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-6; TSUBURA A, 1991, HISTOPATHOLOGY, V18, P517, DOI 10.1111/j.1365-2559.1991.tb01478.x; Tulachan SS, 2006, DEV GROWTH DIFFER, V48, P65, DOI 10.1111/j.1440-169x.2006.00846.x; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Wang Y, 2006, J CLIN INVEST, V116, P1535, DOI 10.1172/JCI25442; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; Wiseman BS, 2003, J CELL BIOL, V162, P1123, DOI 10.1083/jcb.200302090; Zahnow CA, 2001, CANCER RES, V61, P261; Zhai P, 2003, BIOCHEMISTRY-US, V42, P13901, DOI 10.1021/bi035392b	67	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6877	6884		10.1074/jbc.M805908200	http://dx.doi.org/10.1074/jbc.M805908200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19129200	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000263919000035
J	Race, PR; Bentley, ML; Melvin, JA; Crow, A; Hughes, RK; Smith, WD; Sessions, RB; Kehoe, MA; McCafferty, DG; Banfield, MJ				Race, Paul R.; Bentley, Matthew L.; Melvin, Jeff A.; Crow, Allister; Hughes, Richard K.; Smith, Wendy D.; Sessions, Richard B.; Kehoe, Michael A.; McCafferty, Dewey G.; Banfield, Mark J.			Crystal Structure of Streptococcus pyogenes Sortase A IMPLICATIONS FOR SORTASE MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS SORTASE; SORTING SIGNAL BINDING; IMIDAZOLIUM ION-PAIR; SURFACE-PROTEINS; CELL-WALL; SUBSTRATE-SPECIFICITY; KINETIC MECHANISM; A TRANSPEPTIDASE; ANCHOR STRUCTURE; SRTA GENE	Sortases are a family of Gram-positive bacterial transpeptidases that anchor secreted proteins to bacterial cell surfaces. These include many proteins that play critical roles in the virulence of Gram-positive bacterial pathogens such that sortases are attractive targets for development of novel antimicrobial agents. All Gram-positive pathogens express a "housekeeping" sortase that recognizes the majority of secreted proteins containing an LPXTG wall-sorting motif and covalently attaches these to bacterial cell wall peptidoglycan. Many Gram-positive pathogens also express additional sortases that link a small number of proteins, often with variant wall-sorting motifs, to either other surface proteins or peptidoglycan. To better understand the mechanisms of catalysis and substrate recognition by the housekeeping sortase produced by the important human pathogen Streptococcus pyogenes, the crystal structure of this protein has been solved and its transpeptidase activity established in vitro. The structure reveals a novel arrangement of key catalytic residues in the active site of a sortase, the first that is consistent with kinetic analysis. The structure also provides a complete description of residue positions surrounding the active site, overcoming the limitation of localized disorder in previous structures of sortase A-type proteins. Modification of the active site Cys through oxidation to its sulfenic acid form or by an alkylating reagent supports a role for a reactive thiol/thiolate in the catalytic mechanism. These new insights into sortase structure and function could have important consequences for inhibitor design.	[Crow, Allister; Hughes, Richard K.; Banfield, Mark J.] John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Race, Paul R.; Smith, Wendy D.; Kehoe, Michael A.; Banfield, Mark J.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Bentley, Matthew L.; Melvin, Jeff A.; McCafferty, Dewey G.] Duke Univ, Dept Chem, Durham, NC 27708 USA; [Sessions, Richard B.] Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Newcastle University - UK; Duke University; University of Bristol	Banfield, MJ (corresponding author), John Innes Ctr Plant Sci Res, Dept Biol Chem, Colney Lne, Norwich NR4 7UH, Norfolk, England.	mark.banfield@bbsrc.ac.uk	Crow, Allister/F-2147-2018; Banfield, Mark/C-7453-2013; Hughes, Richard/E-9642-2015	Crow, Allister/0000-0001-6856-5962; Banfield, Mark/0000-0001-8921-3835; Hughes, Richard/0000-0001-9910-6566; Melvin, Jeffrey/0000-0003-2864-365X; Sessions, Richard/0000-0003-0320-0895	BBSRC [BBS/E/J/000C0624] Funding Source: UKRI; MRC [G0400849] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0624] Funding Source: Medline; Medical Research Council [G0400849, g0400849] Funding Source: Medline; NCRR NIH HHS [P41 RR006009] Funding Source: Medline; NIAID NIH HHS [AI46611, R01 AI046611] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046611] Funding Source: NIH RePORTER	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barnett TC, 2002, J BACTERIOL, V184, P2181, DOI 10.1128/JB.184.8.2181-2191.2002; Bentley ML, 2008, J BIOL CHEM, V283, P14762, DOI 10.1074/jbc.M800974200; Bentley ML, 2007, J BIOL CHEM, V282, P6571, DOI 10.1074/jbc.M610519200; Bierne H, 2004, J BACTERIOL, V186, P1972, DOI 10.1128/JB.186.7.1972-1982.2004; Bolken TC, 2001, INFECT IMMUN, V69, P75, DOI 10.1128/IAI.69.1.75-80.2001; Clow F, 2008, BIOTECHNOL LETT, V30, P1603, DOI 10.1007/s10529-008-9718-1; Connolly KM, 2003, J BIOL CHEM, V278, P34061, DOI 10.1074/jbc.M305245200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Frankel BA, 2005, BIOCHEMISTRY-US, V44, P11188, DOI 10.1021/bi050141j; Frankel BA, 2007, BIOCHEMISTRY-US, V46, P7269, DOI 10.1021/bi700448e; Garandeau C, 2002, INFECT IMMUN, V70, P1382, DOI 10.1128/IAI.70.3.1382-1390.2002; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; Huang XY, 2003, BIOCHEMISTRY-US, V42, P11307, DOI 10.1021/bi034391g; Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198; Jonsson IM, 2002, J INFECT DIS, V185, P1417, DOI 10.1086/340503; Jonsson IM, 2003, MICROBES INFECT, V5, P775, DOI 10.1016/S1286-4579(03)00143-6; Kharat AS, 2003, INFECT IMMUN, V71, P2758, DOI 10.1128/IAI.71.5.2758-2765.2003; Kleywegt G. J., 2001, INT TABLES CRYSTALLO, VF, P353, DOI DOI 10.1107/97809553602060000111; Kleywegt GJ, 2004, ACTA CRYSTALLOGR D, V60, P2240, DOI 10.1107/S0907444904013253; Kruger RG, 2004, BIOCHEMISTRY-US, V43, P1541, DOI 10.1021/bi035920j; Kruger RG, 2004, ANAL BIOCHEM, V326, P42, DOI 10.1016/j.ab.2003.10.023; Lee SF, 2003, INFECT IMMUN, V71, P676, DOI 10.1128/IAI.71.2.676-681.2003; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lewin A, 2006, J BIOL CHEM, V281, P35467, DOI 10.1074/jbc.M607047200; Liew CK, 2004, FEBS LETT, V571, P221, DOI 10.1016/j.febslet.2004.06.070; Mao HY, 2004, PROTEIN EXPRES PURIF, V37, P253, DOI 10.1016/j.pep.2004.06.013; Mao HY, 2004, J AM CHEM SOC, V126, P2670, DOI 10.1021/ja039915e; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Marraffini LA, 2004, J BIOL CHEM, V279, P37763, DOI 10.1074/jbc.M405282200; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2001, MOL MICROBIOL, V40, P1049, DOI 10.1046/j.1365-2958.2001.02411.x; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naik MT, 2006, J BIOL CHEM, V281, P1817, DOI 10.1074/jbc.M506123200; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Pallen MJ, 2001, TRENDS MICROBIOL, V9, P97, DOI 10.1016/S0966-842X(01)01956-4; Paterson GK, 2004, TRENDS MICROBIOL, V12, P89, DOI 10.1016/j.tim.2003.12.007; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Ruzin A, 2002, J BACTERIOL, V184, P2141, DOI 10.1128/JB.184.8.2141-2147.2002; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; SMITH WD, 2004, THESIS NEWCASTLE U N; Suree N, 2007, MINI-REV MED CHEM, V7, P991, DOI 10.2174/138955707782110097; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Ton-That H, 1999, J BIOL CHEM, V274, P24316, DOI 10.1074/jbc.274.34.24316; Ton-That H, 2000, J BIOL CHEM, V275, P9876, DOI 10.1074/jbc.275.13.9876; Ton-That H, 2002, J BIOL CHEM, V277, P7447, DOI 10.1074/jbc.M109945200; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; TonThat H, 1997, J BIOL CHEM, V272, P22285, DOI 10.1074/jbc.272.35.22285; Zhang RG, 2004, STRUCTURE, V12, P1147, DOI 10.1016/j.str.2004.06.001; Zong YN, 2004, J BIOL CHEM, V279, P31383, DOI 10.1074/jbc.M401374200; Zong YN, 2004, STRUCTURE, V12, P105, DOI 10.1016/j.str.2003.11.021	59	106	114	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6924	6933		10.1074/jbc.M805406200	http://dx.doi.org/10.1074/jbc.M805406200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19129180	Green Published, hybrid			2022-12-25	WOS:000263919000040
J	Sigal, N; Fluman, N; Siemion, S; Bibi, E				Sigal, Nadejda; Fluman, Nir; Siemion, Shira; Bibi, Eitan			The Secondary Multidrug/Proton Antiporter MdfA Tolerates Displacements of an Essential Negatively Charged Side Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; TRANSPORTER MDFA; RESISTANCE PROTEIN; ACIDIC RESIDUES; EFFLUX; MECHANISMS; MODEL; TETRACYCLINE; RECOGNITION; PROMISCUITY	The largest family of solute transporters includes ion motive force-driven secondary transporters. Several well characterized solute-specific transport systems in this group have at least one irreplaceable acidic residue that plays a critical role in energy coupling during transport. Previous studies have established the importance of acidic residues in substrate recognition by major facilitator superfamily secondary multidrug transporters, but their role in the transport mechanism remained unknown. We have been investigating the involvement of acidic residues in the mechanism of MdfA, an Escherichia coli secondary multidrug/proton antiporter. We demonstrated that no single negatively charged side chain plays an irreplaceable role in MdfA. Accordingly, we hypothesized that MdfA might be able to utilize at least two acidic residues alternatively. In this study, we present evidence that indeed, unlike solute-specific secondary transporters, MdfA tolerates displacements of an essential negative charge to various locations in the putative drug translocation pathway. The results suggest that MdfA utilizes a proton translocation strategy that is less sensitive to perturbations in the geometry of the proton-binding site, further illustrating the exceptional structural promiscuity of multidrug transporters.	[Sigal, Nadejda; Fluman, Nir; Siemion, Shira; Bibi, Eitan] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Bibi, E (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	e.bibi@weizmann.ac.il		Bibi, Eitan/0000-0003-3700-2707; Fluman, Nir/0000-0001-9909-0779	Israel Cancer Research Foundation; the Minerva Foundation; the Israel Science Foundation	Israel Cancer Research Foundation; the Minerva Foundation; the Israel Science Foundation(Israel Science Foundation)	This work was supported by the Israel Cancer Research Foundation, the Minerva Foundation, and the Israel Science Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Adler J, 2005, J BIOL CHEM, V280, P2721, DOI 10.1074/jbc.M412332200; Adler J, 2004, J BIOL CHEM, V279, P8957, DOI 10.1074/jbc.M313422200; Adler J, 2004, BIOCHEMISTRY-US, V43, P518, DOI 10.1021/bi035485t; BIBI E, 1993, P NATL ACAD SCI USA, V90, P9209, DOI 10.1073/pnas.90.19.9209; Diez-Sampedro A, 2004, BIOCHEMISTRY-US, V43, P13175, DOI 10.1021/bi048652d; Edgar R, 1997, J BACTERIOL, V179, P2274, DOI 10.1128/jb.179.7.2274-2280.1997; Edgar R, 1999, EMBO J, V18, P822, DOI 10.1093/emboj/18.4.822; Fujihira E, 1996, FEBS LETT, V391, P243, DOI 10.1016/0014-5793(96)00743-0; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Krulwich TA, 2005, NAT REV MICROBIOL, V3, P566, DOI 10.1038/nrmicro1181; Krulwich TA, 2001, J MOL MICROB BIOTECH, V3, P237; LEE JA, 1989, BIOCHEMISTRY-US, V28, P2540, DOI 10.1021/bi00432a029; Levy SB, 2002, J APPL MICROBIOL, V92, p65S, DOI 10.1046/j.1365-2672.92.5s1.4.x; Lewinson O, 2004, P NATL ACAD SCI USA, V101, P14073, DOI 10.1073/pnas.0405375101; Lewinson O, 2003, P NATL ACAD SCI USA, V100, P1667, DOI 10.1073/pnas.0435544100; Lewinson O, 2006, MOL MICROBIOL, V61, P277, DOI 10.1111/j.1365-2958.2006.05254.x; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Mine T, 1998, J BIOCHEM-TOKYO, V124, P187, DOI 10.1093/oxfordjournals.jbchem.a022078; Neyfakh AA, 1997, TRENDS MICROBIOL, V5, P309, DOI 10.1016/S0966-842X(97)01064-0; Nilsen IW, 1996, J BACTERIOL, V178, P3188, DOI 10.1128/jb.178.11.3188-3193.1996; Poole K, 2000, ANTIMICROB AGENTS CH, V44, P2595, DOI 10.1128/AAC.44.10.2595-2599.2000; POOLMAN B, 1995, J BIOL CHEM, V270, P12995, DOI 10.1074/jbc.270.22.12995; POURCHER T, 1993, J BIOL CHEM, V268, P3209; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Sigal N, 2005, BIOCHEMISTRY-US, V44, P14870, DOI 10.1021/bi051574p; Sigal N, 2006, J MOL MICROB BIOTECH, V11, P308, DOI 10.1159/000095633; Sigal N, 2006, J BACTERIOL, V188, P5635, DOI 10.1128/JB.00422-06; Tamura N, 2003, CURR OPIN CHEM BIOL, V7, P570, DOI 10.1016/j.cbpa.2003.08.014; YAMAGUCHI A, 1992, BIOCHEMISTRY-US, V31, P8344, DOI 10.1021/bi00150a031; Yerushalmi H, 2000, BIOCHEMISTRY-US, V39, P14711, DOI 10.1021/bi001892i; Zgurskaya HI, 2000, MOL MICROBIOL, V37, P219, DOI 10.1046/j.1365-2958.2000.01926.x	34	32	32	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6966	6971		10.1074/jbc.M808877200	http://dx.doi.org/10.1074/jbc.M808877200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19129186	hybrid, Green Published			2022-12-25	WOS:000263919000044
J	Winkler, M; Lutz, R; Russ, U; Quast, U; Bryan, J				Winkler, Marcus; Lutz, Rebekka; Russ, Ulrich; Quast, Ulrich; Bryan, Joseph			Analysis of Two KCNJ11 Neonatal Diabetes Mutations, V59G and V59A, and the Analogous KCNJ8 I60G Substitution DIFFERENCES BETWEEN THE CHANNEL SUBTYPES FORMED WITH SUR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-ATP CHANNELS; SENSITIVE POTASSIUM CHANNELS; SULFONYLUREA RECEPTOR SUR2B; INSULIN-SECRETION; HIGH-AFFINITY; ACTIVATING MUTATIONS; N-TERMINUS; FUNCTIONAL-ANALYSIS; CRYSTAL-STRUCTURE; TOLBUTAMIDE SITE	beta-Cell-type K-ATP channels are octamers assembled from Kir6.2/KCNJ11 and SUR1/ABCC8. Adenine nucleotides play a major role in their regulation. Nucleotide binding to Kir6.2 inhibits channel activity, whereas ATP binding/hydrolysis on sulfonylurea receptor 1 (SUR1) opposes inhibition. Segments of the Kir6.2 N terminus are important for open-to-closed transitions, form part of the Kir ATP, sulfonylurea, and phosphoinositide binding sites, and interact with L0, an SUR cytoplasmic loop. Inputs from these elements link to the pore via the interfacial helix, which forms an elbow with the outer pore helix. Mutations that destabilize the interfacial helix increase channel activity, reduce sensitivity to inhibitory ATP and channel inhibitors, glibenclamide and repaglinide, and cause neonatal diabetes. We compared Kir6.x/SUR1 channels carrying the V59G substitution, a cause of the developmental delay, epilepsy, and neonatal diabetes syndrome, with a V59A substitution and the equivalent I60G mutation in the related Kir6.1 subunit from vascular smooth muscle. The substituted channels have increased PO values, decreased sensitivity to inhibitors, and impaired stimulation by phosphoinositides but retain sensitivity to Ba2+-block. The V59G and V59A channels are either not, or poorly, stimulated by phosphoinositides, respectively. Inhibition by sequestrating phosphatidylinositol 4,5-bisphosphate with neomycin and polylysine is reduced in V59A, and abolished in V59G channels. Stimulation by SUR1 is intact, and increasing the concentration of inhibitory-ATP restores the sensitivity of Val-59-substituted channels to glibenclamide. The I60G channels, strongly dependent on SUR stimulation, remain sensitive to sulfonylureas. The results suggest the interfacial helix dynamically links inhibitory inputs from the Kir N terminus to the gate and that sulfonylureas stabilize an inhibitory configuration.	[Bryan, Joseph] Pacific NW Diabet Res Inst, Seattle, WA 98122 USA; [Winkler, Marcus; Lutz, Rebekka; Russ, Ulrich; Quast, Ulrich] Univ Tubingen, Fac Med, Dept Pharmacol & Toxicol, D-72074 Tubingen, Germany	Pacific Northwest Diabetes Research Institute (PNDRI); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Bryan, J (corresponding author), Pacific NW Diabet Res Inst, 720 Broadway, Seattle, WA 98122 USA.	jbryan@pnri.org			National Institutes of Health [DK044311]; Deutsche Forschungsgemeinschaft [Qu100/4-1]; Dr. Karl Kuhn-Stiftung; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dr. Karl Kuhn-Stiftung; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK044311 ( to J. B.). This work was also supported by the Deutsche Forschungsgemeinschaft Grant Qu100/4-1 ( to U. Q.) and a grant from the Dr. Karl Kuhn-Stiftung ( to U. R.).	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Aguilar-Bryan L, 2008, ENDOCR REV, V29, P265, DOI 10.1210/er.2007-0029; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Antcliff JF, 2005, EMBO J, V24, P229, DOI 10.1038/sj.emboj.7600487; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Ashfield R, 1999, DIABETES, V48, P1341, DOI 10.2337/diabetes.48.6.1341; Babenko ADP, 2005, J MOL CELL CARDIOL, V39, P79, DOI 10.1016/j.yjmcc.2004.12.004; Babenko AP, 2008, J BIOL CHEM, V283, P8778, DOI 10.1074/jbc.C700243200; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Babenko AP, 1998, ANNU REV PHYSIOL, V60, P667, DOI 10.1146/annurev.physiol.60.1.667; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Babenko AP, 1999, FEBS LETT, V445, P131, DOI 10.1016/S0014-5793(99)00102-7; Babenko AP, 2002, J BIOL CHEM, V277, P43997, DOI 10.1074/jbc.M208085200; Babenko AP, 2001, J BIOL CHEM, V276, P49083, DOI 10.1074/jbc.M108763200; Babenko AP, 1999, BIOCHEM BIOPH RES CO, V255, P231, DOI 10.1006/bbrc.1999.0172; Babenko AP, 1999, FEBS LETT, V459, P367, DOI 10.1016/S0014-5793(99)01215-6; BEECH DJ, 1993, BRIT J PHARMACOL, V110, P573, DOI 10.1111/j.1476-5381.1993.tb13849.x; Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Christopoulos A, 1998, TRENDS PHARMACOL SCI, V19, P351, DOI 10.1016/S0165-6147(98)01240-1; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Cukras CA, 2002, J GEN PHYSIOL, V120, P437, DOI 10.1085/jgp.20028621; Drain P, 1998, P NATL ACAD SCI USA, V95, P13953, DOI 10.1073/pnas.95.23.13953; DUNNE MJ, 1986, FEBS LETT, V208, P59, DOI 10.1016/0014-5793(86)81532-0; Enkvetchakul D, 2000, BIOPHYS J, V78, P2334, DOI 10.1016/S0006-3495(00)76779-8; Flanagan SE, 2007, DIABETES, V56, P1930, DOI 10.2337/db07-0043; Flanagan SE, 2006, DIABETOLOGIA, V49, P1190, DOI 10.1007/s00125-006-0246-z; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Haider S, 2007, EMBO J, V26, P3749, DOI 10.1038/sj.emboj.7601809; Hambrock A, 2001, MOL PHARMACOL, V60, P190, DOI 10.1124/mol.60.1.190; Hambrock A, 1998, BRIT J PHARMACOL, V125, P577, DOI 10.1038/sj.bjp.0702109; Hansen AMK, 2005, BRIT J PHARMACOL, V144, P551, DOI 10.1038/sj.bjp.0706082; Hattersley AT, 2005, DIABETES, V54, P2503, DOI 10.2337/diabetes.54.9.2503; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; Kondo C, 1998, RECEPTOR CHANNEL, V6, P129; Koster JC, 2005, DIABETES, V54, P3065, DOI 10.2337/diabetes.54.11.3065; Koster JC, 2005, DIABETES, V54, P2645, DOI 10.2337/diabetes.54.9.2645; Koster JC, 1999, J PHYSIOL-LONDON, V515, P19, DOI 10.1111/j.1469-7793.1999.019ad.x; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Lin CW, 2006, DIABETES, V55, P1738, DOI 10.2337/db05-1571; MacGregor GG, 2002, P NATL ACAD SCI USA, V99, P2726, DOI 10.1073/pnas.042688899; Matsuo M, 2005, J MOL CELL CARDIOL, V38, P907, DOI 10.1016/j.yjmcc.2004.11.021; MISLER S, 1986, P NATL ACAD SCI USA, V83, P7119, DOI 10.1073/pnas.83.18.7119; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Proks P, 2005, HUM MOL GENET, V14, P2717, DOI 10.1093/hmg/ddi305; Proks P, 2004, P NATL ACAD SCI USA, V101, P17539, DOI 10.1073/pnas.0404756101; Proks P, 2002, DIABETES, V51, pS368, DOI 10.2337/diabetes.51.2007.S368; Reimann F, 1999, J PHYSIOL-LONDON, V518, P325, DOI 10.1111/j.1469-7793.1999.0325p.x; Rost Burkhard, 2003, Methods Biochem Anal, V44, P559; Russ U, 1999, MOL PHARMACOL, V56, P955, DOI 10.1124/mol.56.5.955; Satoh E, 1998, J PHYSIOL-LONDON, V511, P663, DOI 10.1111/j.1469-7793.1998.663bg.x; Schulze D, 2003, J BIOL CHEM, V278, P10500, DOI 10.1074/jbc.M208413200; Seino S, 2003, PROG BIOPHYS MOL BIO, V81, P133, DOI 10.1016/S0079-6107(02)00053-6; Stephan D, 2006, DIABETOLOGIA, V49, P2039, DOI 10.1007/s00125-006-0307-3; Takano M, 1998, J PHYSIOL-LONDON, V512, P395, DOI 10.1111/j.1469-7793.1998.395be.x; Trapp S, 1998, J GEN PHYSIOL, V112, P333, DOI 10.1085/jgp.112.3.333; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Vila-Carriles WH, 2007, FASEB J, V21, P18, DOI 10.1096/fj.06-6730hyp; Winkler M, 2007, J PHARMACOL EXP THER, V322, P701, DOI 10.1124/jpet.107.123224; Yamada M, 1997, J PHYSIOL-LONDON, V499, P715, DOI 10.1113/jphysiol.1997.sp021963; Zingman LV, 2001, NEURON, V31, P233, DOI 10.1016/S0896-6273(01)00356-7	62	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6752	6762		10.1074/jbc.M805435200	http://dx.doi.org/10.1074/jbc.M805435200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19139106	hybrid, Green Published			2022-12-25	WOS:000263919000020
J	Bengoechea-Alonso, MT; Ericsson, J				Bengoechea-Alonso, Maria T.; Ericsson, Johan			A Phosphorylation Cascade Controls the Degradation of Active SREBP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEINS; DEPENDENT DEGRADATION; CYCLIN-E; TRANSCRIPTION FACTOR; C-MYC; NOTCH; COACTIVATOR; CHOLESTEROL; FAMILY; UBIQUITINATION	Sterol regulatory element-binding proteins (SREBPs) are a family of transcription factors that regulates cholesterol and lipid metabolism. The active forms of these transcription factors are targeted by a number of post-translational modifications, including phosphorylation. Phosphorylation of Thr-426 and Ser-430 in SREBP1a creates a docking site for the ubiquitin ligase Fbw7, resulting in the degradation of the transcription factor. Here, we identify a novel phosphorylation site in SREBP1a, Ser-434, which regulates the Fbw7-dependent degradation of SREBP1. We demonstrate that both SREBP1a and SREBP1c are phosphorylated on this residue (Ser-410 in SREBP1c). Importantly, we demonstrate that the mature form of endogenous SREBP1 is phosphorylated on Ser-434. Glycogen synthase kinase-3 phosphorylates Ser-434, and the phosphorylation of this residue is attenuated in response to insulin signaling. Interestingly, phosphorylation of Ser-434 promotes the glycogen synthase kinase-3-dependent phosphorylation of Thr-426 and Ser-430 and destabilizes SREBP1. Consequently, mutation of Ser-434 blocks the interaction between SREBP1 and Fbw7 and attenuates Fbw7-dependent degradation of SREBP1. Importantly, insulin fails to enhance the levels of mature SREBP1 in cells lacking Fbw7. Thus, the degradation of mature SREBP1 is controlled by cross-talk between multiple phosphorylated residues in its C-terminal domain and the phosphorylation of Ser-434 could function as a molecular switch to control these processes.	[Bengoechea-Alonso, Maria T.; Ericsson, Johan] Univ Coll Dublin, Sch Med & Med Sci, Conway Inst, Dublin 4, Ireland; [Bengoechea-Alonso, Maria T.; Ericsson, Johan] Uppsala Univ, Biomed Ctr, Ludwig Inst Canc Res, S-75124 Uppsala, Sweden	University College Dublin; Ludwig Institute for Cancer Research; Uppsala University	Ericsson, J (corresponding author), Univ Coll Dublin, Sch Med & Med Sci, Conway Inst, Dublin 4, Ireland.	johan.ericsson@ucd.ie	Ericsson, Johan/AAA-6664-2020	Ericsson, Johan/0000-0003-1186-6574	Ludwig Institute for Cancer Research Ltd; Swedish Research Council; Novo Nordisk Foundation; Royal Swedish Academy of Sciences; Knut and Alice Wallenberg Foundation	Ludwig Institute for Cancer Research Ltd; Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Royal Swedish Academy of Sciences; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported in part by the Ludwig Institute for Cancer Research Ltd. and grants from the Swedish Research Council and the Novo Nordisk Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; A Research Fellow of the Royal Swedish Academy of Sciences through a grant from the Knut and Alice Wallenberg Foundation. To whom correspondence should be addressed: UCD Conway Institute, School of Medicine and Medical Science, University College Dublin, Belfield, Dublin 4, Ireland. Tel.: 353-1-716-6753; Fax: 353-1-716-6701; E-mail:johan.ericsson@ucd.ie.	Bengoechea-Alonso MT, 2007, CURR OPIN CELL BIOL, V19, P215, DOI 10.1016/j.ceb.2007.02.004; Bengoechea-Alonso MT, 2006, CELL CYCLE, V5, P1708, DOI 10.4161/cc.5.15.3131; Bengoechea-Alonso MT, 2005, P NATL ACAD SCI USA, V102, P11681, DOI 10.1073/pnas.0501494102; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Ericsson J, 1996, J BIOL CHEM, V271, P24359, DOI 10.1074/jbc.271.40.24359; Espenshade PJ, 2006, J CELL SCI, V119, P973, DOI 10.1242/jcs02866; Ferre P, 2007, HORM RES, V68, P72, DOI 10.1159/000100426; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hirano Y, 2003, J BIOL CHEM, V278, P16809, DOI 10.1074/jbc.M212448200; Hirano Y, 2001, J BIOL CHEM, V276, P36431, DOI 10.1074/jbc.M105200200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kotzka J, 2004, J BIOL CHEM, V279, P22404, DOI 10.1074/jbc.M401198200; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Olson BL, 2008, GENE DEV, V22, P252, DOI 10.1101/gad.1624208; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Punga T, 2006, J BIOL CHEM, V281, P25278, DOI 10.1074/jbc.M604983200; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Rawson RB, 2003, NAT REV MOL CELL BIO, V4, P631, DOI 10.1038/nrm1174; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Sundqvist A, 2003, P NATL ACAD SCI USA, V100, P13833, DOI 10.1073/pnas.2335135100; Tetzlaff MT, 2004, P NATL ACAD SCI USA, V101, P3338, DOI 10.1073/pnas.0307875101; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; WELCKER M, 2007, NAT REV CANCER, V20, P83; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217	40	103	110	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5885	5895		10.1074/jbc.M807906200	http://dx.doi.org/10.1074/jbc.M807906200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19126544	hybrid			2022-12-25	WOS:000263560600052
J	Nagarajan, P; Onami, TM; Rajagopalan, S; Kania, S; Donnell, R; Venkatachalam, S				Nagarajan, P.; Onami, T. M.; Rajagopalan, S.; Kania, S.; Donnell, R.; Venkatachalam, S.			Role of chromodomain helicase DNA-binding protein 2 in DNA damage response signaling and tumorigenesis	ONCOGENE			English	Article						chromatin remodeling; lymphoma; hematopoiesis; mutant mice; tumor suppressor and DNA damage	CHROMATIN REMODELING FACTORS; HISTONE VARIANT EXCHANGE; TUMOR-SUPPRESSOR; CHD1; H2AX; H3; MUTATIONS; COMPLEX; CANCER; FAMILY	The chromodomain helicase DNA-binding proteins (CHDs) are known to affect transcription through their ability to remodel chromatin and modulate histone deacetylation. In an effort to understand the functional role of the CHD2 in mammals, we have generated a Chd2 mutant mouse model. Remarkably, the Chd2 protein appears to play a critical role in the development, hematopoiesis and tumor suppression. The Chd2 heterozygous mutant mice exhibit increased extramedullary hematopoiesis and susceptibility to lymphomas. At the cellular level, Chd2 mutants are defective in hematopoietic stem cell differentiation, accumulate higher levels of the chromatin-associated DNA damage response mediator, gamma H2AX, and exhibit an aberrant DNA damage response after X-ray irradiation. Our data suggest a direct role for the chromatin remodeling protein in DNA damage signaling and genome stability maintenance.	[Nagarajan, P.; Rajagopalan, S.; Venkatachalam, S.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA; [Onami, T. M.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Kania, S.; Donnell, R.] Univ Tennessee, Dept Pathobiol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Venkatachalam, S (corresponding author), Univ Tennessee, Dept Biochem & Cell & Mol Biol, M407,Walters Life Sci Bldg, Knoxville, TN 37996 USA.	sundar@utk.edu	NAGARAJAN, PRABAKARAN/AAA-2881-2020; Kania, Stephen/ABF-6920-2021	NAGARAJAN, PRABAKARAN/0000-0001-6124-3274; Kania, Stephen/0000-0002-4490-7347; Donnell, Robert L./0000-0002-6778-954X	University of Tennessee; PMERF; NIH [00293621, AI05771901]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI057719] Funding Source: NIH RePORTER	University of Tennessee; PMERF; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are thankful to Dr Bruce McKee for critically reading the manuscript. This work was supported by the University of Tennessee startup funds, PMERF seed funds, and NIH funds (00293621) to SV and funding from NIH (AI05771901) to TMO.	Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Banath JP, 2003, CANCER RES, V63, P4347; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Brehm A, 2000, EMBO J, V19, P4332, DOI 10.1093/emboj/19.16.4332; BRONSON RT, 1991, GROWTH DEVELOP AGING, V55, P169; Cowell IG, 1997, BBA-PROTEIN STRUCT M, V1337, P198, DOI 10.1016/S0167-4838(96)00165-3; DELMAS V, 1993, P NATL ACAD SCI USA, V90, P2414, DOI 10.1073/pnas.90.6.2414; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Feys T, 2007, HAEMATOL-HEMATOL J, V92, P40; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Fukasawa M, 2006, CYTOGENET GENOME RES, V113, P138, DOI 10.1159/000090825; Gao XC, 2007, AM J HUM GENET, V80, P957, DOI 10.1086/513571; Gonzalez-Billault C, 2000, MOL CELL NEUROSCI, V16, P408, DOI 10.1006/mcne.2000.0880; Hasan S, 2002, J MOL MED, V80, P463, DOI 10.1007/s00109-002-0341-7; Heyworth C, 2002, EMBO J, V21, P3770, DOI 10.1093/emboj/cdf368; Iwasaki H, 2003, IMMUNITY, V19, P451, DOI 10.1016/S1074-7613(03)00242-5; Jeganathan K, 2007, J CELL BIOL, V179, P255, DOI 10.1083/jcb.200706015; Jin JJ, 2005, TRENDS BIOCHEM SCI, V30, P680, DOI 10.1016/j.tibs.2005.10.003; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; Kang J, 2005, MOL CELL BIOL, V25, P661, DOI 10.1128/MCB.25.2.661-670.2005; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; Kulkarni S, 2008, AM J MED GENET A, V146A, P1117, DOI 10.1002/ajmg.a.32178; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Lalani SR, 2006, AM J HUM GENET, V78, P303, DOI 10.1086/500273; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Marfella CGA, 2006, J CELL PHYSIOL, V209, P162, DOI 10.1002/jcp.20718; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Muller C, 2001, CURR OPIN GENET DEV, V11, P167, DOI 10.1016/S0959-437X(00)00175-1; Ney PA, 2006, CURR OPIN HEMATOL, V13, P203, DOI 10.1097/01.moh.0000231415.18333.2c; Osley MA, 2007, MUTAT RES-FUND MOL M, V618, P65, DOI 10.1016/j.mrfmmm.2006.07.011; PARO R, 1991, P NATL ACAD SCI USA, V88, P263, DOI 10.1073/pnas.88.1.263; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Qin S, 2002, MOL CELL BIOL, V22, P8353, DOI 10.1128/MCB.22.23.8353-8365.2002; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Schuster EF, 2002, MAMM GENOME, V13, P117, DOI 10.1007/s00335-001-3042-6; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; SINGH PB, 1991, NUCLEIC ACIDS RES, V19, P789, DOI 10.1093/nar/19.4.789; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Spike BT, 2004, EMBO J, V23, P4319, DOI 10.1038/sj.emboj.7600432; STOKES DG, 1995, MOL CELL BIOL, V15, P2745; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Takeda Yoshihiko, 2001, Frontiers in Bioscience, V6, pd1412, DOI 10.2741/Takeda; TARGOFF IN, 1985, ARTHRITIS RHEUM, V28, P796, DOI 10.1002/art.1780280711; Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Tran HG, 2000, EMBO J, V19, P2323, DOI 10.1093/emboj/19.10.2323; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Voss AK, 1998, DEV DYNAM, V212, P258; Wang GG, 2007, TRENDS MOL MED, V13, P373, DOI 10.1016/j.molmed.2007.07.004; Wang GG, 2007, TRENDS MOL MED, V13, P363, DOI 10.1016/j.molmed.2007.07.003; Whiteford M L, 2000, J Med Genet, V37, pE11, DOI 10.1136/jmg.37.8.e11; WILSON GN, 1985, J MED GENET, V22, P233, DOI 10.1136/jmg.22.3.233; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472; Wu C, 1997, J BIOL CHEM, V272, P28171, DOI 10.1074/jbc.272.45.28171; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	64	80	81	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2009	28	8					1053	1062		10.1038/onc.2008.440	http://dx.doi.org/10.1038/onc.2008.440			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	412KE	19137022	Green Accepted			2022-12-25	WOS:000263722900001
J	Allemand, MC; Irving, BA; Asmann, YW; Klaus, KA; Tatpati, L; Coddington, CC; Nair, KS				Allemand, Michael C.; Irving, Brian A.; Asmann, Yan W.; Klaus, Katherine A.; Tatpati, Laura; Coddington, Charles C.; Nair, K. Sreekumaran			Effect of Testosterone on Insulin Stimulated IRS1 Ser Phosphorylation in Primary Rat Myotubes-A Potential Model for PCOS-Related Insulin Resistance	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; SKELETAL-MUSCLE CELLS; RECEPTOR SUBSTRATE-1; GLUCOSE-TRANSPORT; FEMALE RATS; PATHWAY; KINASE; SENSITIVITY; WOMEN; RISK	Background: Polycystic ovary syndrome (PCOS) is characterized by a hyperandrogenic state and frequently develops skeletal muscle insulin resistance. We determined whether testosterone adversely affects insulin action by increasing serine phosphorylation of IRS-1(636/639) in differentiated rat skeletal muscle myotubes. The phosphorylation of Akt, mTOR, and S6K, downstream targets of the PI3-kinase-IRS-1 complex were also studied. Methods: Primary differentiated rat skeletal muscle myotubes were subjected to insulin for 30 min after 16-hour pre-exposure to either low (20 ng/ml) or high (200 ng/ml) doses of testosterone. Protein phosphorylation of IRS-1 Ser(636/639), Akt Ser(473), mTOR-Ser(2448), and S6K-Thr(389) were measured by Western blot with signal intensity measured by immunofluorescence. Results: Cells exposed to 100 nM of insulin had increased IRS-1 Ser(636/639) and Akt Ser(473) phosphorylation. Cells pre-exposed to low-dose testosterone had significantly increased insulin-induced mTOR-Ser(2448) and S6K-Thr(389) phosphorylation (p < 0.05), and further increased insulin-induced IRS-1 Ser(636/639) phosphorylation (p = 0.042) compared to control cells. High-dose testosterone pre-exposure attenuated the insulin-induced mTOR-Ser(2448) and S6K-Thr(389) phosphorylation. Conclusions: The data demonstrated an interaction between testosterone and insulin on phosphorylation of intracellular signaling proteins, and suggests a link between a hyperandrogenic, hyperinsulinemic environment and the development of insulin resistance involving serine phosphorylation of IRS-1 Ser(636/639). These results may guide further investigations of potential mechanisms of PCOS-related insulin resistance.	[Allemand, Michael C.; Tatpati, Laura; Coddington, Charles C.] Mayo Clin, Grad Sch Med, Div Reprod Endocrinol & Infertil, Dept Obstet & Gynecol, Rochester, MN 55905 USA; [Irving, Brian A.; Asmann, Yan W.; Klaus, Katherine A.; Nair, K. Sreekumaran] Mayo Clin, Grad Sch Med, Dept Internal Med, Endocrine Res Unit, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Allemand, MC (corresponding author), Mayo Clin, Grad Sch Med, Div Reprod Endocrinol & Infertil, Dept Obstet & Gynecol, Rochester, MN 55905 USA.	nair.sree@mayo.edu	Irving, Brian/B-9683-2016	Irving, Brian/0000-0002-4131-9523	NIH [RO1 DK 41973]; David Murdock Dole Professorship [KL2 RR024151]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041973] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David Murdock Dole Professorship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH RO1 DK 41973 and David Murdock Dole Professorship (KSN), KL2 RR024151 (BAI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khalili L, 2003, CELL MOL LIFE SCI, V60, P991, DOI 10.1007/s00018-003-3001-3; Bertacca A, 2005, METABOLISM, V54, P1687, DOI 10.1016/j.metabol.2005.06.019; Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; Bouzakri K, 2006, DIABETES, V55, P785, DOI 10.2337/diabetes.55.03.06.db05-0796; Corbould A, 2005, AM J PHYSIOL-ENDOC M, V288, pE1047, DOI 10.1152/ajpendo.00361.2004; Coviello AD, 2006, J CLIN ENDOCR METAB, V91, P492, DOI 10.1210/jc.2005-1666; Diamond MP, 1998, J CLIN ENDOCR METAB, V83, P4420, DOI 10.1210/jc.83.12.4420; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; DUNAIF A, 1995, J CLIN INVEST, V96, P801, DOI 10.1172/JCI118126; Dunaif A, 2001, AM J PHYSIOL-ENDOC M, V281, pE392, DOI 10.1152/ajpendo.2001.281.2.E392; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Gual P, 2003, DIABETOLOGIA, V46, P1532, DOI 10.1007/s00125-003-1223-4; Hiratani K, 2005, BIOCHEM BIOPH RES CO, V335, P836, DOI 10.1016/j.bbrc.2005.07.152; HOLMANG A, 1990, AM J PHYSIOL, V259, pE555, DOI 10.1152/ajpendo.1990.259.4.E555; Holmang A, 2001, ACTA PHYSIOL SCAND, V171, P427, DOI 10.1046/j.1365-201X.2001.00801.x; HOLMANG A, 1992, AM J PHYSIOL, V262, pE851, DOI 10.1152/ajpendo.1992.262.6.E851; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Legro RS, 1999, J CLIN ENDOCR METAB, V84, P165, DOI 10.1210/jc.84.1.165; Li M, 2002, J CLIN ENDOCR METAB, V87, P4088, DOI 10.1210/jc.2002-020363; Moghetti P, 1996, J CLIN ENDOCR METAB, V81, P952, DOI 10.1210/jc.81.3.952; Mussig K, 2005, BIOCHEM BIOPH RES CO, V335, P819, DOI 10.1016/j.bbrc.2005.07.154; O'Connor JC, 2003, METABOLISM, V52, P666, DOI 10.1016/S0026-0495(03)00026-X; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Partridge T A, 1997, Methods Mol Biol, V75, P131; Rincon J, 1996, DIABETES, V45, P615, DOI 10.2337/diabetes.45.5.615; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Sweeney G, 1999, J BIOL CHEM, V274, P10071, DOI 10.1074/jbc.274.15.10071; Takano T, 2001, MOL CELL BIOL, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; Tremblay F, 2001, J BIOL CHEM, V276, P38052; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001	31	45	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2009	4	1							e4274	10.1371/journal.pone.0004274	http://dx.doi.org/10.1371/journal.pone.0004274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JE	19169352	Green Submitted, Green Published, gold			2022-12-25	WOS:000265482800004
J	Beaslas, O; Cueille, C; Delers, F; Chateau, D; Chambaz, J; Rousset, M; Carriere, V				Beaslas, Olivier; Cueille, Carine; Delers, Francois; Chateau, Danielle; Chambaz, Jean; Rousset, Monique; Carriere, Veronique			Sensing of Dietary Lipids by Enterocytes: A New Role for SR-BI/CLA-1	PLOS ONE			English	Article								Background: The intestine is responsible for absorbing dietary lipids and delivering them to the organism as triglyceride-rich lipoproteins (TRL). It is important to determine how this process is regulated in enterocytes, the absorptive cells of the intestine, as prolonged postprandial hypertriglyceridemia is a known risk factor for atherosclerosis. During the postprandial period, dietary lipids, mostly triglycerides (TG) hydrolyzed by pancreatic enzymes, are combined with bile products and reach the apical membrane of enterocytes as postprandial micelles (PPM). Our aim was to determine whether these micelles induce, in enterocytes, specific early cell signaling events that could control the processes leading to TRL secretion. Methodology/Principal Findings: The effects of supplying PPM to the apex of Caco-2/TC7 enterocytes were analyzed. Micelles devoid of TG hydrolysis products, like those present in the intestinal lumen in the interprandial period, were used as controls. The apical delivery of PPM specifically induced a number of cellular events that are not induced by interprandial micelles. These early events included the trafficking of apolipoprotein B, a structural component of TRL, from apical towards secretory domains, and the rapid, dose-dependent activation of ERK and p38MAPK. PPM supply induced the scavenger receptor SR-BI/CLA-1 to cluster at the apical brush border membrane and to move from non-raft to raft domains. Competition, inhibition or knockdown of SR-BI/CLA-1 impaired the PPM-dependent apoB trafficking and ERK activation. Conclusions/Significance: These results are the first evidence that enterocytes specifically sense postprandial dietary lipid-containing micelles. SR-BI/CLA-1 is involved in this process and could be a target for further study with a view to modifying intestinal TRL secretion early in the control pathway.	[Beaslas, Olivier; Cueille, Carine; Delers, Francois; Chateau, Danielle; Chambaz, Jean; Rousset, Monique; Carriere, Veronique] Univ Paris 06, UMR S 872, Paris, France; [Beaslas, Olivier; Cueille, Carine; Delers, Francois; Chateau, Danielle; Chambaz, Jean; Rousset, Monique; Carriere, Veronique] INSERM, U 872, Paris, France; [Beaslas, Olivier; Cueille, Carine; Delers, Francois; Chateau, Danielle; Chambaz, Jean; Rousset, Monique; Carriere, Veronique] Univ Paris 05, UMR S 872, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Beaslas, O (corresponding author), Univ Paris 06, UMR S 872, Paris, France.	veronique.carriere@crc.jussieu.fr	Carrière, Véronique/AAQ-5027-2021	Carrière, Véronique/0000-0002-6263-0847	Ministere de l'Enseignement Superieur et de la Recherche [fellowship]; Fondation pour la Recherche Medicale; Le Conseil Regional d'Ile de France [fellowship]	Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Le Conseil Regional d'Ile de France	O.B. is recipient of a fellowship from Ministere de l'Enseignement Superieur et de la Recherche and from Fondation pour la Recherche Medicale. C.C. is recipient of a fellowship from Le Conseil Regional d'Ile de France. This work was supported in part by a grant from Groupe Lipides Nutrition.	Abumrad N, 1999, BBA-MOL CELL BIOL L, V1441, P4, DOI 10.1016/S1388-1981(99)00137-7; Alqub M, 2008, CHEM PHYS LIPIDS, V154, pS57, DOI 10.1016/j.chemphyslip.2008.05.155; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Assanasen C, 2005, J CLIN INVEST, V115, P969, DOI 10.1172/JCI23858; Babitt J, 1997, J BIOL CHEM, V272, P13242, DOI 10.1074/jbc.272.20.13242; Baranova IN, 2005, J BIOL CHEM, V280, P8031, DOI 10.1074/jbc.M405009200; Beaslas O, 2008, AM J PHYSIOL-GASTR L, V295, pG942, DOI 10.1152/ajpgi.90237.2008; Bietrix F, 2006, J BIOL CHEM, V281, P7214, DOI 10.1074/jbc.M508868200; Boisfer E, 1999, J BIOL CHEM, V274, P11564, DOI 10.1074/jbc.274.17.11564; Braccia A, 2003, J BIOL CHEM, V278, P15679, DOI 10.1074/jbc.M211228200; Cai SF, 2001, J LIPID RES, V42, P902; Carriere V, 2005, J BIOL CHEM, V280, P5406, DOI 10.1074/jbc.M408002200; CHANTRET I, 1994, J CELL SCI, V107, P213; Chateau D, 2005, J CELL PHYSIOL, V202, P767, DOI 10.1002/jcp.20173; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Davidson NO, 2000, ANNU REV NUTR, V20, P169, DOI 10.1146/annurev.nutr.20.1.169; Davies JP, 2005, J BIOL CHEM, V280, P12710, DOI 10.1074/jbc.M409110200; Drozdowski L, 2006, WORLD J GASTROENTERO, V12, P4614, DOI 10.3748/wjg.v12.i29.4614; Federico LM, 2006, DIABETES, V55, P1316, DOI 10.2337/db04-1084; Grewal T, 2003, J BIOL CHEM, V278, P16478, DOI 10.1074/jbc.C300085200; Hansen GH, 2003, GUT, V52, P1424, DOI 10.1136/gut.52.10.1424; Hauser H, 1998, BIOCHEMISTRY-US, V37, P17843, DOI 10.1021/bi982404y; HERNELL O, 1990, BIOCHEMISTRY-US, V29, P2041, DOI 10.1021/bi00460a012; Hui DY, 2005, SEMIN CELL DEV BIOL, V16, P183, DOI 10.1016/j.semcdb.2005.01.003; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; Labonte ED, 2007, BBA-MOL CELL BIOL L, V1771, P1132, DOI 10.1016/j.bbalip.2007.03.002; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Leng SY, 2007, AM J PHYSIOL-GASTR L, V293, pG475, DOI 10.1152/ajpgi.00072.2007; Levy E, 2004, J CELL SCI, V117, P327, DOI 10.1242/jcs.00856; Levy E, 2007, CURR OPIN LIPIDOL, V18, P310, DOI 10.1097/MOL.0b013e32813fa2e2; Lobo MVT, 2001, J HISTOCHEM CYTOCHEM, V49, P1253, DOI 10.1177/002215540104901007; Mardones P, 2001, J LIPID RES, V42, P170; McLaughlin J, 2007, BIOCHEM SOC T, V35, P1199, DOI 10.1042/BST0351199; Mineo C, 2003, TRENDS CARDIOVAS MED, V13, P226, DOI 10.1016/S1050-1738(03)00098-7; Morel E, 2004, MOL BIOL CELL, V15, P132, DOI 10.1091/mbc.E03-04-0215; Mu HL, 2004, PROG LIPID RES, V43, P105, DOI 10.1016/S0163-7827(03)00050-X; Nguyen HTT, 2006, BIOCHEM BIOPH RES CO, V342, P236, DOI 10.1016/j.bbrc.2006.01.141; Nieland TJF, 2008, BIOCHEMISTRY-US, V47, P460, DOI 10.1021/bi701277x; Nordskog BK, 2001, ADV DRUG DELIVER REV, V50, P21, DOI 10.1016/S0169-409X(01)00147-8; Orlowski S, 2007, EUR BIOPHYS J BIOPHY, V36, P869, DOI 10.1007/s00249-007-0193-8; Pauquai T, 2006, BIOCHEM J, V395, P393, DOI 10.1042/BJ20051359; Peng Y, 2004, MOL BIOL CELL, V15, P384, DOI 10.1091/mbc.e03-06-0445; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Porter CJH, 2007, NAT REV DRUG DISCOV, V6, P231, DOI 10.1038/nrd2197; POTTER BJ, 1989, ANNU REV NUTR, V9, P253, DOI 10.1146/annurev.nu.09.070189.001345; Qin BL, 2007, DIABETES, V56, P450, DOI 10.2337/db06-0518; Qin XF, 2005, CURR DRUG TARGETS, V6, P145, DOI 10.2174/1389450053174541; Raybould HE, 1999, AM J PHYSIOL-GASTR L, V277, pG751, DOI 10.1152/ajpgi.1999.277.4.G751; Reboul E, 2005, BIOCHEM J, V387, P455, DOI 10.1042/BJ20040554; Rhainds D, 2004, INT J BIOCHEM CELL B, V36, P39, DOI 10.1016/S1357-2725(03)00173-0; Robertson MD, 2003, GUT, V52, P834, DOI 10.1136/gut.52.6.834; Sanderson IR, 2000, ANNU REV NUTR, V20, P311, DOI 10.1146/annurev.nutr.20.1.311; Schulthess G, 2000, BIOCHEMISTRY-US, V39, P12623, DOI 10.1021/bi0011633; Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b; Shikany JM, 2000, SOUTH MED J, V93, P1138, DOI 10.1097/00007611-200093120-00001; Tomkin GH, 2001, DIABETES-METAB RES, V17, P27, DOI 10.1002/dmrr.179; Tondu AL, 2005, J BIOL CHEM, V280, P33536, DOI 10.1074/jbc.M502392200; Van Eck M, 2005, CURR OPIN LIPIDOL, V16, P307; Voshol PJ, 2001, BIOCHEM J, V356, P317, DOI 10.1042/0264-6021:3560317; Yesilaltay A, 2006, J BIOL CHEM, V281, P28975, DOI 10.1074/jbc.M603802200; Yvan-Charvet L, 2007, ARTERIOSCL THROM VAS, V27, P1340, DOI 10.1161/ATVBAHA.106.136382; Zucco F, 2005, ATLA-ALTERN LAB ANIM, V33, P603, DOI 10.1177/026119290503300618	62	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2009	4	1							e4278	10.1371/journal.pone.0004278	http://dx.doi.org/10.1371/journal.pone.0004278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JE	19169357	Green Submitted, gold, Green Published			2022-12-25	WOS:000265482800008
J	Mabilleau, G; Sabokbar, A				Mabilleau, Guillaume; Sabokbar, Afsie			Interleukin-32 Promotes Osteoclast Differentiation but Not Osteoclast Activation	PLOS ONE			English	Article								Background: Interleukin-32 (IL-32) is a newly described cytokine produced after stimulation by IL-2 or IL-18 and IFN-gamma. IL-32 has the typical properties of a pro-inflammatory mediator and although its role in rheumatoid arthritis has been recently reported its effect on the osteoclastogenesis process remains unclear. Methodology/Principal Findings: In the present study, we have shown that IL-32 was a potent modulator of osteoclastogenesis in vitro, whereby it promoted the differentiation of osteoclast precursors into TRAcP+ VNR+ multinucleated cells expressing specific osteoclast markers (up-regulation of NFATc1, OSCAR, Cathepsin K), but it was incapable of inducing the maturation of these multinucleated cells into bone-resorbing cells. The lack of bone resorption in IL-32-treated cultures could in part be explain by the lack of F-actin ring formation by the multinucleated cells generated. Moreover, when IL-32 was added to PBMC cultures maintained with soluble RANKL, although the number of newly generated osteoclast was increased, a significant decrease of the percentage of lacunar resorption was evident suggesting a possible inhibitory effect of this cytokine on osteoclast activation. To determine the mechanism by which IL-32 induces such response, we sought to determine the intracellular pathways activated and the release of soluble mediators in response to IL-32. Our results indicated that compared to RANKL, IL-32 induced a massive activation of ERK1/2 and Akt. Moreover, IL-32 was also capable of stimulating the release of IL-4 and IFN-gamma, two known inhibitors of osteoclast formation and activation. Conclusions/Significance: This is the first in vitro report on the complex role of IL-32 on osteoclast precursors. Further clarification on the exact role of IL-32 in vivo is required prior to the development of any potential therapeutic approach.	[Mabilleau, Guillaume; Sabokbar, Afsie] Univ Oxford, Nuffield Dept Orthopaed Surg, Oxford, England	University of Oxford	Mabilleau, G (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Surg, Oxford, England.	guillaume.mabilleau@ndos.ox.ac.uk	Mabilleau, Guillaume/M-8261-2018	Mabilleau, Guillaume/0000-0003-1445-329X	Musculoskeletal Biomedical Research Unit; Nuffield Department of Orthopaedic Surgery; Nuffield Orthopaedic Centre	Musculoskeletal Biomedical Research Unit; Nuffield Department of Orthopaedic Surgery; Nuffield Orthopaedic Centre	The authors are also grateful for the support provided by Musculoskeletal Biomedical Research Unit in partnership with Nuffield Department of Orthopaedic Surgery and Nuffield Orthopaedic Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulos IE, 2006, BIOCHEM BIOPH RES CO, V350, P478, DOI 10.1016/j.bbrc.2006.09.076; Armstrong AP, 2002, J BIOL CHEM, V277, P44347, DOI 10.1074/jbc.M202009200; BEGG SK, 1993, J EXP MED, V177, P237, DOI 10.1084/jem.177.1.237; BEGG SK, 1993, EXP HEMATOL, V21, P493; Bendre MS, 2003, BONE, V33, P28, DOI 10.1016/S8756-3282(03)00086-3; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cagnard N, 2005, EUR CYTOKINE NETW, V16, P289; Csernok E, 2008, CLIN EXP RHEUMATOL, V26, pS112; DAHL CA, 1992, J IMMUNOL, V148, P597; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Drake FH, 1996, J BIOL CHEM, V271, P12511, DOI 10.1074/jbc.271.21.12511; Edwards JR, 2006, ARTHRITIS RHEUM-US, V54, P1451, DOI 10.1002/art.21821; FELIX R, 1990, ENDOCRINOLOGY, V127, P2592, DOI 10.1210/endo-127-5-2592; Fujikawa Y, 1996, ENDOCRINOLOGY, V137, P4058, DOI 10.1210/en.137.9.4058; Fuller K, 2002, ENDOCRINOLOGY, V143, P1108, DOI 10.1210/en.143.3.1108; Fuller K, 1998, J EXP MED, V188, P997, DOI 10.1084/jem.188.5.997; Gao YH, 2007, J CLIN INVEST, V117, P122, DOI 10.1172/JCI30074; Hofbauer LC, 2000, J BONE MINER RES, V15, P2, DOI 10.1359/jbmr.2000.15.1.2; HORTON MA, 1985, CANCER RES, V45, P5663; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Husheem M, 2005, CALCIFIED TISSUE INT, V76, P222, DOI 10.1007/s00223-004-0123-z; Itonaga I, 2004, BONE, V34, P57, DOI 10.1016/j.bone.2003.08.008; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Kim N, 2000, P NATL ACAD SCI USA, V97, P10905, DOI 10.1073/pnas.200294797; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Kim N, 2005, J EXP MED, V202, P589, DOI 10.1084/jem.20050978; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kotake S, 2001, ARTHRITIS RHEUM, V44, P1003, DOI 10.1002/1529-0131(200105)44:5<1003::AID-ANR179>3.0.CO;2-#; Kudo O, 2002, J PATHOL, V198, P220, DOI 10.1002/path.1190; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lawrence MC, 2008, CELL RES, V18, P436, DOI 10.1038/cr.2008.37; Lean JM, 2001, BLOOD, V98, P2707, DOI 10.1182/blood.V98.9.2707; Mabilleau G, 2008, DIABETOLOGIA, V51, P1035, DOI 10.1007/s00125-008-0992-1; Marcondes AM, 2008, P NATL ACAD SCI USA, V105, P2865, DOI 10.1073/pnas.0712391105; Massey HM, 1999, BRIT J HAEMATOL, V106, P167; MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252; Nakagawa N, 1998, BIOCHEM BIOPH RES CO, V253, P395, DOI 10.1006/bbrc.1998.9788; Netea MG, 2005, P NATL ACAD SCI USA, V102, P16309, DOI 10.1073/pnas.0508237102; Netea MG, 2006, PLOS MED, V3, P1310, DOI 10.1371/journal.pmed.0030277; Niida S, 1999, J EXP MED, V190, P293, DOI 10.1084/jem.190.2.293; Novick D, 2006, P NATL ACAD SCI USA, V103, P3316, DOI 10.1073/pnas.0511206103; O'Gradaigh D, 2004, RHEUMATOLOGY, V43, P122, DOI 10.1093/rheumatology/keh447; Polek TC, 2003, J BIOL CHEM, V278, P32317, DOI 10.1074/jbc.M302518200; Quinn JMW, 1998, ENDOCRINOLOGY, V139, P4424, DOI 10.1210/endo.139.10.6331; Rasool ST, 2008, IMMUNOL LETT, V117, P161, DOI 10.1016/j.imlet.2008.01.007; Shalhoub V, 2000, BRIT J HAEMATOL, V111, P501, DOI 10.1046/j.1365-2141.2000.02379.x; Shioya M, 2007, CLIN EXP IMMUNOL, V149, P480, DOI 10.1111/j.1365-2249.2007.03439.x; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takeshita S, 2007, J BIOL CHEM, V282, P18980, DOI 10.1074/jbc.M610938200; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; Udagawa N, 2003, J BONE MINER METAB, V21, P337, DOI 10.1007/s00774-003-0439-1; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zhou P, 2006, J IMMUNOL, V177, P8777, DOI 10.4049/jimmunol.177.12.8777	60	68	73	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2009	4	1							e4173	10.1371/journal.pone.0004173	http://dx.doi.org/10.1371/journal.pone.0004173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ID	19137064	Green Published, Green Submitted, gold			2022-12-25	WOS:000265479500004
J	Kalea, AZ; Reiniger, N; Yang, HJ; Arriero, M; Schmidt, AM; Hudson, BI				Kalea, Anastasia Z.; Reiniger, Nina; Yang, Hojin; Arriero, Maria; Schmidt, Ann Marie; Hudson, Barry I.			Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene	FASEB JOURNAL			English	Article						DNA cloning; mRNA; soluble receptor; species-specific splicing; protein evolution	CELL-SURFACE RECEPTOR; SOLUBLE RECEPTOR; CYTOPLASMIC DOMAIN; NEURITE OUTGROWTH; PLASMA-LEVELS; HUMAN BRAIN; EXPRESSION; ATHEROSCLEROSIS; DISEASE; ACTIVATION	The alternative splicing of pre-mRNAs is a critical mechanism in genomic complexity, disease, and development. Studies of the receptor for advanced glycation end-products (RAGE) indicate that this gene undergoes a variety of splice events in humans. However, no studies have extensively analyzed the tissue distribution in other species or compared evolutionary differences of RAGE isoforms. Because the majority of studies probing RAGE function have been performed in murine models, we therefore performed studies to identify and characterize the splice variants of the murine RAGE gene, and we compared these to human isoforms. Here, using mouse tissues, we identified numerous splice variants including changes in the extracellular domain or the removal of the transmembrane and cytoplasmic domains, which produce soluble splice isoforms. Comparison of splice variants between humans and mice revealed homologous regions in the RAGE gene that undergo splicing as well as key species-specific mechanisms of splicing. Further analysis of tissue splice variant distribution in mice revealed major differences between lung, kidney, heart, and brain. To probe the potential impact of disease- like pathological states, we studied diabetic mice and report that RAGE splice variation changed dramatically, resulting in an increase in production of soluble RAGE (sRAGE) splice variants, which were not associated with detectable levels of sRAGE in murine plasma. In conclusion, we have determined that the murine RAGE gene undergoes extensive splicing with distinct splice isoforms being uniquely distributed in different tissues. These differences in RAGE splicing in both physiological and pathogenic states further expand our understanding of the biological repertoire of this receptor in health and disease.-Kalea, A. Z., Reiniger, N., Yang, H., Arriero, M., Schmidt, A. M., Hudson, B. I. Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene. FASEB J. 23, 1766-1774 (2009)	[Kalea, Anastasia Z.; Reiniger, Nina; Yang, Hojin; Arriero, Maria; Schmidt, Ann Marie; Hudson, Barry I.] Columbia Univ, Dept Surg, Coll Phys & Surg, Div Surg Sci, New York, NY 10032 USA	Columbia University	Hudson, BI (corresponding author), Columbia Univ, Dept Surg, Coll Phys & Surg, Div Surg Sci, 630 W 168th St,P&S 17-401, New York, NY 10032 USA.	bh2021@columbia.edu	Hudson, Barry/B-3122-2009; Kalea, Anastasia Z./G-4053-2010	Hudson, Barry/0000-0001-7647-8121; Kalea, Anastasia Z./0000-0001-5775-3984	U.S. Public Health Service; Juvenile Diabetes Research Foundation; National Institutes of Health	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the U.S. Public Health Service and the Juvenile Diabetes Research Foundation. B.I.H. is a recipient of a Career Development Award from the Juvenile Diabetes Research Foundation International. A.M.S. is a recipient of a Scholar Award from the Juvenile Diabetes Research Foundation International. A.Z.K. is a recipient of a postdoctoral fellowship from the Juvenile Diabetes Research Foundation International. N.R. is a recipient of a National Research Service Award from the National Institutes of Health.	Basta G, 2006, J CLIN ENDOCR METAB, V91, P4628, DOI 10.1210/jc.2005-2559; Brown LF, 2008, ANN CLIN BIOCHEM, V45, P518, DOI 10.1258/acb.2008.008043; Ding QX, 2005, NEUROSCI LETT, V373, P67, DOI 10.1016/j.neulet.2004.09.059; Emanuele E, 2005, ARCH NEUROL-CHICAGO, V62, P1734, DOI 10.1001/archneur.62.11.1734; Falcone C, 2005, ARTERIOSCL THROM VAS, V25, P1032, DOI 10.1161/01.ATV.0000160342.20342.00; Galichet A, 2008, BIOCHEM BIOPH RES CO, V370, P1, DOI 10.1016/j.bbrc.2008.02.163; Geroldi D, 2005, J HYPERTENS, V23, P1725, DOI 10.1097/01.hjh.0000177535.45785.64; Goova MT, 2001, AM J PATHOL, V159, P513, DOI 10.1016/S0002-9440(10)61723-3; Hanford LE, 2004, J BIOL CHEM, V279, P50019, DOI 10.1074/jbc.M409782200; Harashima A, 2006, BIOCHEM J, V396, P109, DOI 10.1042/BJ20051573; Harja E, 2008, J CLIN INVEST, V118, P183, DOI 10.1172/JCI32703; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Hudson BI, 2005, ANTIOXID REDOX SIGN, V7, P1588, DOI 10.1089/ars.2005.7.1588; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Katakami N, 2005, DIABETES CARE, V28, P2716, DOI 10.2337/diacare.28.11.2716; Kislinger T, 2001, ARTERIOSCL THROM VAS, V21, P905, DOI 10.1161/01.ATV.21.6.905; Koyama H, 2005, ARTERIOSCL THROM VAS, V25, P2587, DOI 10.1161/01.ATV.0000190660.32863.cd; Lareau LF, 2004, CURR OPIN STRUC BIOL, V14, P273, DOI 10.1016/j.sbi.2004.05.002; Lizotte PP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-15; Malherbe P, 1999, MOL BRAIN RES, V71, P159, DOI 10.1016/S0169-328X(99)00174-6; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nurtdinov RN, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-249; Nurtdinov RN, 2003, HUM MOL GENET, V12, P1313, DOI 10.1093/hmg/ddg137; Park IH, 2004, MOL IMMUNOL, V40, P1203, DOI 10.1016/j.molimm.2003.11.027; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Sakaguchi T, 2003, J CLIN INVEST, V111, P959, DOI 10.1172/JCI200317115; Schlueter C, 2003, BBA-GENE STRUCT EXPR, V1630, P1, DOI 10.1016/j.bbaexp.2003.08.008; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Wain HM, 2002, GENOMICS, V79, P464, DOI 10.1006/geno.2002.6748; Wendt T, 2006, ATHEROSCLEROSIS, V185, P70, DOI 10.1016/j.atherosclerosis.2005.06.013; Wendt TM, 2003, AM J PATHOL, V162, P1123, DOI 10.1016/S0002-9440(10)63909-0; Xing Y, 2003, FEBS LETT, V555, P572, DOI 10.1016/S0014-5793(03)01354-1; Xu Q, 2003, NUCLEIC ACIDS RES, V31, P5635, DOI 10.1093/nar/gkg786; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371	41	90	92	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1766	1774		10.1096/fj.08-117739	http://dx.doi.org/10.1096/fj.08-117739			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19164451	Green Published			2022-12-25	WOS:000266652400017
J	Carroll, RK; Liao, XB; Morgan, LK; Cicirelli, EM; Li, YH; Sheng, WY; Feng, XH; Kenney, LJ				Carroll, Ronan K.; Liao, Xiubei; Morgan, Leslie K.; Cicirelli, Elisha M.; Li, Yuanhe; Sheng, Wanyun; Feng, Xiuhong; Kenney, Linda J.			Structural and Functional Analysis of the C-terminal DNA Binding Domain of the Salmonella typhimurium SPI-2 Response Regulator SsrB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGENICITY ISLAND 2; III SECRETION SYSTEM; ESCHERICHIA-COLI; ERWINIA-AMYLOVORA; CRYSTAL-STRUCTURE; H-NS; PROTEIN; OMPR; RECOGNITION; PHOSPHORYLATION	In bacterial pathogenesis, virulence gene regulation is controlled by two-component regulatory systems. In Escherichia coli, the EnvZ/OmpR two-component system is best understood as regulating expression of outer membrane proteins, but in Salmonella enterica, OmpR activates transcription of the SsrA/B two-component system located on Salmonella pathogenicity island 2 (SPI-2). The response regulator SsrB controls expression of a type III secretory system in which effectors modify the vacuolar membrane and prevent its degradation via the endocytic pathway. Vacuolar modification enables Salmonella to survive and replicate in the macrophage phagosome and disseminate to the liver and spleen to cause systemic infection. The signals that activate EnvZ and SsrA are unknown but are related to the acidic pH encountered in the vacuole. Our previous work established that SsrB binds to regions of DNA that are AT-rich, with poor sequence conservation. Although SsrB is a major virulence regulator in Salmonella, very little is known regarding how it binds DNA and activates transcription. In the present work, we solved the structure of the C-terminal DNA binding domain of SsrB (SsrBC) by NMR and analyzed the effect of amino acid substitutions on function. We identified residues in the DNA recognition helix (Lys(179), Met(186)) and the dimerization interface (Val(197), Leu(201)) that are important for SsrB transcriptional activation and DNA binding. An essential cysteine residue in the N-terminal receiver domain was also identified (Cys(45)), and the effect of Cys(203) on dimerization was evaluated. Our results suggest that although disulfide bond formation is not required for dimerization, dimerization occurs upon DNA binding and is required for subsequent activation of transcription. Disruption of the dimer interface by a C203E substitution reduces SsrB activity. Modification of Cys(203) or Cys(45) may be an important mode of SsrB inactivation inside the host.	[Carroll, Ronan K.; Morgan, Leslie K.; Cicirelli, Elisha M.; Kenney, Linda J.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Liao, Xiubei; Li, Yuanhe; Sheng, Wanyun] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60612 USA; [Feng, Xiuhong] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97202 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Oregon Health & Science University	Kenney, LJ (corresponding author), 835 S Wolcott,M-C 790, Chicago, IL 60612 USA.	kenneyl@uic.edu			National Institutes of Health [GM058746]; National Science Foundation [MCB0613014]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant GM058746 from the National Institutes of Health (to L.J.K.). This work was also supported by Grant MCB0613014 from the National Science Foundation.	Ames SK, 1999, P NATL ACAD SCI USA, V96, P11792, DOI 10.1073/pnas.96.21.11792; Baikalov I, 1996, BIOCHEMISTRY-US, V35, P11053, DOI 10.1021/bi960919o; Chen GZ, 2007, P NATL ACAD SCI USA, V104, P16474, DOI 10.1073/pnas.0704843104; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Collazo CM, 1997, GENE, V192, P51, DOI 10.1016/S0378-1119(96)00825-6; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Ducros VMA, 2001, J MOL BIOL, V306, P759, DOI 10.1006/jmbi.2001.4443; Feng XH, 2004, MOL MICROBIOL, V54, P823, DOI 10.1111/j.1365-2958.2004.04317.x; Feng XH, 2003, MOL MICROBIOL, V48, P1131, DOI 10.1046/j.1365-2958.2003.03502.x; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hensel M, 2000, MOL MICROBIOL, V36, P1015, DOI 10.1046/j.1365-2958.2000.01935.x; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Hoch JA, 1995, 2 COMPONENT SIGNAL T; Kanelis V, 2001, IUBMB LIFE, V52, P291, DOI 10.1080/152165401317291147; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Kurashima-Ito K, 2005, BIOCHEMISTRY-US, V44, P14835, DOI 10.1021/bi0509043; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; Maris AE, 2005, BIOCHEMISTRY-US, V44, P14538, DOI 10.1021/bi050734u; Maris AE, 2005, J MOL BIOL, V350, P843, DOI 10.1016/j.jmb.2005.05.057; Maris AE, 2002, NAT STRUCT BIOL, V9, P771, DOI 10.1038/nsb845; Mattison K, 2002, J MOL BIOL, V315, P497, DOI 10.1006/jmbi.2001.5222; McCollister BD, 2005, J EXP MED, V202, P625, DOI 10.1084/jem.20050246; Milani M, 2005, STRUCTURE, V13, P1289, DOI 10.1016/j.str.2005.05.014; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MILLS DM, 1995, MOL MICROBIOL, V15, P749, DOI 10.1111/j.1365-2958.1995.tb02382.x; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Navarre WW, 2005, MOL MICROBIOL, V56, P492, DOI 10.1111/j.1365-2958.2005.04553.x; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; OSBORNE S, 2009, P NATL ACAD SCI USA, V106, P3892; Pristovsek P, 2003, J BIOL CHEM, V278, P17752, DOI 10.1074/jbc.M301328200; Rhee JE, 2008, J BIOL CHEM, V283, P8664, DOI 10.1074/jbc.M705550200; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Tran VK, 2000, J MOL BIOL, V299, P1257, DOI 10.1006/jmbi.2000.3809; Vannini A, 2002, EMBO J, V21, P4393, DOI 10.1093/emboj/cdf459; Walthers D, 2007, MOL MICROBIOL, V65, P477, DOI 10.1111/j.1365-2958.2007.05800.x; Wehland M, 1999, J BIOL CHEM, V274, P3300, DOI 10.1074/jbc.274.6.3300; Wisedchaisri G, 2005, J MOL BIOL, V354, P630, DOI 10.1016/j.jmb.2005.09.048; Worley MJ, 2000, MOL MICROBIOL, V36, P749, DOI 10.1046/j.1365-2958.2000.01902.x; Zhang RG, 2002, NATURE, V417, P971, DOI 10.1038/nature00833	42	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12008	12019		10.1074/jbc.M806261200	http://dx.doi.org/10.1074/jbc.M806261200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19126546	Green Published, hybrid			2022-12-25	WOS:000265494600033
J	Suuronen, EJ; Zhang, PC; Kuraitis, D; Cao, XD; Melhuish, A; Mckee, D; Li, FF; Mesana, TG; Veinot, JP; Ruel, M				Suuronen, Erik J.; Zhang, Pingchuan; Kuraitis, Drew; Cao, Xudong; Melhuish, Angela; McKee, Daniel; Li, Fengfu; Mesana, Thierry G.; Veinot, John P.; Ruel, Marc			An acellular matrix-bound ligand enhances the mobilization, recruitment and therapeutic effects of circulating progenitor cells in a hindlimb ischemia model	FASEB JOURNAL			English	Article						tissue engineering; stem cells; angiogenesis; cell homing; paracrine effects; apoptosis	EMBRYONIC STEM-CELLS; BONE-MARROW; PERIPHERAL-BLOOD; L-SELECTIN; NEOVASCULARIZATION CAPACITY; MUSCLE; ANGIOGENESIS; REGENERATION; CONTRIBUTES; EXPRESSION	Circulating progenitor cells home to and engraft to sites of ischemia, mediated in part by the adhesion molecule L-selectin; however, accumulation in tissues such as the heart is low. In this study, an acellular collagen-based matrix containing sialyl Lewis(X) (sLe(X)), which binds L-selectin, was developed in order to enhance the endogenous progenitor cell therapeutic response. Its effect on progenitor cells and angiogenesis were assessed in vitro and using a hindlimb ischemia model with rats. In culture, the sLe(X)-collagen matrix recruited more CD133(+)CD34(+)L-selectin(+) cells than collagen-only matrix, with adhesion mediated by L-selectin binding. Increased angiogenic/chemotactic cytokine production and improved resistance to apoptosis appeared in cells cultured on sLe(X)-collagen matrix. In vivo, mobilization of endogenous circulating progenitor cells was increased, and greater recruitment of these and systemically injected human peripheral blood CXCR4(+)L-selectin(+) cells to sLe(X)-collagen treated limbs was observed compared to collagen-only. This condition was associated with differences in angiogenic/chemotactic cytokine levels, with greater arteriole density and increased perfusion in sLe(X)-collagen treated hindlimbs. With these factors taken together, we demonstrated that an acellular matrix-bound ligand approach can enhance the mobilization, recruitment, and therapeutic effects of endogenous and/or transplanted progenitor cells, possibly through paracrine and antiapoptotic mechanisms, and could be used to improve cell-based regenerative therapies.-Suuronen, E. J., Zhang, P., Kuraitis, D., Cao, X., Melhuish, A., McKee, D., Li, F., Mesana, T. G., Veinot, J. P., Ruel, M. An acellular matrix-bound ligand enhances the mobilization, recruitment and therapeutic effects of circulating progenitor cells in a hindlimb ischemia model. FASEB J. 23, 1447-1458 (2009)	[Suuronen, Erik J.; Zhang, Pingchuan; Kuraitis, Drew; McKee, Daniel; Mesana, Thierry G.; Ruel, Marc] Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON K1Y 4W7, Canada; [Suuronen, Erik J.; Kuraitis, Drew; McKee, Daniel; Ruel, Marc] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1Y 4W7, Canada; [Cao, Xudong; Melhuish, Angela] Univ Ottawa, Dept Chem Engn, Ottawa, ON K1Y 4W7, Canada; [Veinot, John P.] Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON K1Y 4W7, Canada; [Li, Fengfu] Ottawa Hlth Res Inst, Dept Vis, Ottawa, ON, Canada	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Suuronen, EJ (corresponding author), Univ Ottawa, Inst Heart, Div Cardiac Surg, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.	esuuronen@ottawaheart.ca		RUEL, MARC/0000-0002-0487-1319	Heart and Stroke Foundation of Ontario [NA6121]; Canadian Institutes of Health Research [MOP-77536]; University of Ottawa Interfaculty research; Natural Sciences and Engineering Research Council of Canada; Lawrence Soloway Research Fellowship	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Ottawa Interfaculty research; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Lawrence Soloway Research Fellowship	We thank Suzanne Crowe, Samir Hazra, Dan deVette, and Drs. Fraser Rubens and Naoshi Shinozaki for their assistance and Drs. Ross Milne and Robert Roberts for their helpful insights. This work was supported by grant NA6121 from the Heart and Stroke Foundation of Ontario (to E. S.), by grant MOP-77536 from the Canadian Institutes of Health Research (to M. R. and E. S.), by a University of Ottawa Interfaculty research grant (E. S. and X. C.) and by a Natural Sciences and Engineering Research Council of Canada Grant (to X. C.). P.Z. is recipient of the Lawrence Soloway Research Fellowship, and D. K. is supported by a master's studentship award from the Heart and Stroke Foundation of Ontario.	Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Aicher A, 2005, HYPERTENSION, V45, P321, DOI 10.1161/01.HYP.0000154789.28695.ea; Arbab AS, 2008, FASEB J, V22, P3234, DOI 10.1096/fj.07-105676; Biancone L, 2004, J IMMUNOL, V173, P5268, DOI 10.4049/jimmunol.173.8.5268; Chavakis E, 2005, J EXP MED, V201, P63, DOI 10.1084/jem.20041402; Cho HJ, 2007, J EXP MED, V204, P3257, DOI 10.1084/jem.20070166; Doyle B, 2007, J NUCL MED, V48, P1708, DOI 10.2967/jnumed.107.042838; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hickey MJ, 2000, J IMMUNOL, V165, P7164, DOI 10.4049/jimmunol.165.12.7164; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Hristov M, 2007, CIRC RES, V100, P590, DOI 10.1161/01.RES.0000259043.42571.68; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Kang HJ, 2006, CIRCULATION, V114, pI145, DOI 10.1161/CIRCULATIONAHA.105.001107; Kapila V, 2005, EXPERT OPIN INV DRUG, V14, P37, DOI 10.1517/13543784.14.1.37; Krenning G, 2009, J CELL MOL MED, V13, P2521, DOI 10.1111/j.1582-4934.2008.00479.x; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lev EI, 2005, J VASC RES, V42, P408, DOI 10.1159/000087370; Lipinski MJ, 2007, J AM COLL CARDIOL, V50, P1761, DOI 10.1016/j.jacc.2007.07.041; Martin-Rendon E, 2007, STEM CELLS, V25, P1003, DOI 10.1634/stemcells.2006-0398; Morimoto H, 2008, CARDIOVASC RES, V78, P554, DOI 10.1093/cvr/cvn035; Murry CE, 2006, J AM COLL CARDIOL, V47, P1777, DOI 10.1016/j.jacc.2006.02.002; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Oh HK, 2007, CANCER RES, V67, P4851, DOI 10.1158/0008-5472.CAN-06-2979; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Retuerto MA, 2004, J THORAC CARDIOV SUR, V127, P1041, DOI 10.1016/j.jtcvs.2003.09.049; Ruel M, 2005, J THORAC CARDIOV SUR, V130, P633, DOI 10.1016/j.jtcvs.2005.01.013; Ruel M, 2004, MOL CELL BIOCHEM, V264, P119, DOI 10.1023/B:MCBI.0000044381.01098.03; Sanders WJ, 1996, BIOCHEMISTRY-US, V35, P14862, DOI 10.1021/bi9613640; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Singla DK, 2007, AM J PHYSIOL-HEART C, V293, pH1590, DOI 10.1152/ajpheart.00431.2007; Skarja GA, 1997, J BIOMED MATER RES, V34, P427, DOI 10.1002/(SICI)1097-4636(19970315)34:4<427::AID-JBM4>3.3.CO;2-R; Stamenkovic I, 1995, Curr Opin Hematol, V2, P68; Steiner S, 2005, ATHEROSCLEROSIS, V181, P305, DOI 10.1016/j.atherosclerosis.2005.01.006; Suuronen EJ, 2007, J THORAC CARDIOV SUR, V134, P1249, DOI 10.1016/j.jtcvs.2007.07.028; Suuronen EJ, 2006, CIRCULATION, V114, pI138, DOI 10.1161/CIRCULATIONAHA.105.001081; Tillmanns J, 2008, P NATL ACAD SCI USA, V105, P1668, DOI 10.1073/pnas.0706315105; Torrente Y, 2003, J CELL BIOL, V162, P511, DOI 10.1083/jcb.200210006; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; van Weel V, 2007, ARTERIOSCL THROM VAS, V27, P1426, DOI 10.1161/ATVBAHA.107.139642; Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c; Wojakowski W, 2004, CIRCULATION, V110, P3213, DOI 10.1161/01.CIR.0000147609.39780.02; Ziebart T, 2008, CIRC RES, V103, P1327, DOI 10.1161/CIRCRESAHA.108.180463; Zvibel I, 2002, CELL TRANSPLANT, V11, P621, DOI 10.3727/000000002783985404	44	41	41	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2009	23	5					1447	1458		10.1096/fj.08-111054	http://dx.doi.org/10.1096/fj.08-111054			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19136616				2022-12-25	WOS:000266651700021
J	Kolbel, K; Ihling, C; Bellmann-Sickert, K; Neundorf, I; Beck-Sickinger, AG; Sinz, A; Kuhn, U; Wahle, E				Koelbel, Knut; Ihling, Christian; Bellmann-Sickert, Kathrin; Neundorf, Ines; Beck-Sickinger, Annette G.; Sinz, Andrea; Kuehn, Uwe; Wahle, Elmar			Type I Arginine Methyltransferases PRMT1 and PRMT-3 Act Distributively	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR POLY(A)-BINDING PROTEIN; MESSENGER-RNA POLYADENYLATION; SM PROTEINS; H3K4 TRIMETHYLATION; SUBSTRATE PEPTIDES; HISTONE H3R2; METHYLATION; COMPLEX; BINDING; PROTEIN-ARGININE-METHYLTRANSFERASE-1	Asymmetric dimethylation of arginine residues is a common posttranslational modification of proteins carried out by type I protein arginine methyltransferases, including PRMT1 and -3. We report that the consecutive transfer of two methyl groups to a single arginine side chain by PRMT1 and -3 occurs in a distributive manner, i.e. with intermittent release of the monomethylated intermediate. The oligomeric state of PRMTs together with the clustering of methylated arginine residues in most proteins carrying this type of modification suggests that multiple methyl transfers to a single polypeptide chain might proceed in a processive manner by cooperation of multiple active sites. However, three different types of experiments provide evidence that the reaction is distributive even with substrates containing multiple methyl-accepting arginines, including one with 13 such residues. PRMT1 also does not prefer substrates already containing one or more singly or doubly methylated arginine residues. Even though the reaction is distributive, the efficiency of methylation of one particular protein strongly depends on the number of methyl-accepting arginine residues it contains.	[Kuehn, Uwe; Wahle, Elmar] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Germany; [Ihling, Christian; Sinz, Andrea] Univ Halle Wittenberg, Inst Pharm, D-06120 Halle, Germany; [Bellmann-Sickert, Kathrin; Neundorf, Ines; Beck-Sickinger, Annette G.] Univ Leipzig, Inst Biochem, D-04103 Leipzig, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Leipzig University	Wahle, E (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, Kurt Mothes Str 3, D-06120 Halle, Germany.	ewahle@biochemtech.uni-halle.de	Bellmann-Sickert, Kathrin/AFP-0609-2022	Bellmann-Sickert, Kathrin/0000-0002-0007-008X; Wahle, Elmar/0000-0003-2504-0677; Neundorf, Ines/0000-0001-6450-3991	European Union [LSHM-CT-2005-018675]; Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by European Union Grant LSHM-CT-2005-018675, the Deutsche Forschungsgemeinschaft, and the Fonds der Chemischen Industrie.	Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cornish-Bowden A, 2012, FUNDAMENTALS ENZYME, V4th; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Fronz K, 2008, J BIOL CHEM, V283, P20408, DOI 10.1074/jbc.M802329200; GARY JD, 1998, NUCLEIC ACIDS RES, V98, P65; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Kerwitz Y, 2003, EMBO J, V22, P3705, DOI 10.1093/emboj/cdg347; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Kuhn U, 2003, J BIOL CHEM, V278, P16916, DOI 10.1074/jbc.M209886200; Lakowski TM, 2008, J BIOL CHEM, V283, P10015, DOI 10.1074/jbc.M710176200; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; NEMETH A, 1995, NUCLEIC ACIDS RES, V23, P4034, DOI 10.1093/nar/23.20.4034; Obianyo O, 2008, BIOCHEMISTRY-US, V47, P10420, DOI 10.1021/bi800904m; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Ostareck-Lederer A, 2006, J BIOL CHEM, V281, P11115, DOI 10.1074/jbc.M513053200; Pahlich S, 2005, PROTEINS, V61, P164, DOI 10.1002/prot.20579; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Perreault A, 2007, J BIOL CHEM, V282, P7552, DOI 10.1074/jbc.M610512200; SMITH BC, 2008, BIOCHIM BIOPHYS ACTA, V1789, P45; Smith JJ, 1999, J BIOL CHEM, V274, P13229, DOI 10.1074/jbc.274.19.13229; Troffer-Charlier N, 2007, EMBO J, V26, P4391, DOI 10.1038/sj.emboj.7601855; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; WAHLE E, 1995, J BIOL CHEM, V270, P2800, DOI 10.1074/jbc.270.6.2800; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; Yue WW, 2007, EMBO J, V26, P4402, DOI 10.1038/sj.emboj.7601856; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509	35	37	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8274	8282		10.1074/jbc.M809547200	http://dx.doi.org/10.1074/jbc.M809547200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19158082	hybrid, Green Published			2022-12-25	WOS:000264397800011
J	Gao, SY; Li, EM; Cui, L; Lu, XF; Meng, LY; Yuan, HM; Xie, JJ; Du, ZP; Pang, JX; Xu, LY				Gao, Shu-Ying; Li, En-Min; Cui, Lei; Lu, Xiao-Feng; Meng, Ling-Ying; Yuan, Hua-Min; Xie, Jian-Jun; Du, Ze-Peng; Pang, Jian-Xin; Xu, Li-Yan			Sp1 and AP-1 Regulate Expression of the Human Gene VIL2 in Esophageal Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; GROWTH-FACTOR; C-FOS; EZRIN EXPRESSION; EPITHELIAL-CELLS; ORGANIZER EZRIN; PROTEIN-KINASE; LINKER EZRIN; ACTIVATION; PHOSPHORYLATION	Ezrin, encoded by VIL2, is a membrane-cytoskeletal linker protein that has been suggested to be involved in tumorigenesis. Ezrin expression in esophageal squamous cell carcinoma (ESCC) was described recently, but its clinical significance and the molecular mechanism underlying its regulated expression remain unclear. Thus, we retrospectively evaluated ezrin expression by immunohistochemistry in a tissue microarray representing 193 ESCCs. Ezrin overexpression in 90 of 193 tumors (46.6%) was associated with poor survival (p = 0.048). We then explored the mechanism by which ezrin expression is controlled in ESCC by assessing the transcriptional regulatory regions of human VIL2 by fusing deletions or site-directed mutants of the 5'-flanking region of the gene to a luciferase reporter. We found that the region -87/-32 containing consensus Sp1 (-75/-69) and AP-1 (-64/-58) binding sites is crucial for VIL2 promoter activity in esophageal carcinoma cells (EC109) derived from ESCC. AP-1 is comprised of c-Jun and c-Fos. Electrophoretic mobility shift and chromatin immunoprecipitation experiments demonstrated that Sp1 and c-Jun bound specifically to their respective binding sites within the VIL2 promoter. In addition, transient expression of Sp1, c-Jun, or c-Fos increased ezrin expression and VIL2 promoter activity. Use of selective inhibitors revealed that VIL2 transactivation required the MEK1/2 signal transduction pathway but not JNK or p38 MAPK. Taken together, we propose a possible signal transduction pathway whereby MEK1/2 phosphorylates ERK1/2, which phosphorylates Sp1 and AP-1 that in turn bind to their respective binding sites to regulate the expression of human VIL2 in ESCC cells.	[Gao, Shu-Ying; Li, En-Min; Cui, Lei; Meng, Ling-Ying; Xie, Jian-Jun; Du, Ze-Peng] Shantou Univ, Dept Biochem & Mol Biol, Shantou 515041, Peoples R China; [Gao, Shu-Ying; Lu, Xiao-Feng; Yuan, Hua-Min; Xu, Li-Yan] Shantou Univ, Inst Oncol Pathol, Coll Med, Shantou 515041, Peoples R China; [Pang, Jian-Xin] So Med Univ, Sch Pharmaceut Sci, Ctr Drug Evaluat & Res, Guangzhou 510515, Guangdong, Peoples R China	Shantou University; Shantou University; Southern Medical University - China	Li, EM (corresponding author), Shantou Univ, Dept Biochem & Mol Biol, Shantou 515041, Peoples R China.	nmli@stu.edu.cn; liyanxu1130@yahoo.com.cn	xu, li/GNH-3667-2022		National High Technology Research and Development Program of China [2006AA02A403]; National Natural Science Foundation of China [30772485, 30672376, 30570849]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20050560002, 20050560003]; Guangdong Scientific Fund Key Items [7118419, 37788, 05104541]; Natural Science Foundation of Guangdong Province [7301043]; National Science Foundation for Post-doctoral Scientists of China [20070410846]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Guangdong Scientific Fund Key Items; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); National Science Foundation for Post-doctoral Scientists of China(China Postdoctoral Science FoundationNational Natural Science Foundation of China (NSFC))	This work was supported by the National High Technology Research and Development Program of China Grant 2006AA02A403, National Natural Science Foundation of China Grants 30772485, 30672376, and 30570849, Specialized Research Fund for the Doctoral Program of Higher Education of China Grants 20050560002 and 20050560003, Guangdong Scientific Fund Key Items (7118419, 37788, and 05104541), Natural Science Foundation of Guangdong Province Grant 7301043, and the National Science Foundation for Post-doctoral Scientists of China Grant 20070410846.	Akisawa N, 1999, BIOCHEM BIOPH RES CO, V258, P395, DOI 10.1006/bbrc.1999.0653; ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; BALL AR, 1988, COLD SPRING HARB SYM, V53, P687, DOI 10.1101/SQB.1988.053.01.078; Banks EB, 1998, BIOCHEM J, V331, P61, DOI 10.1042/bj3310061; Benasciutti E, 2004, BLOOD, V104, P256, DOI 10.1182/blood-2003-08-2661; BESSEREAU JL, 1993, EMBO J, V12, P443, DOI 10.1002/j.1460-2075.1993.tb05676.x; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; Chu SJ, 2005, GENE, V348, P1, DOI 10.1016/j.gene.2005.01.013; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; D'Addario M, 2006, GENE, V379, P51, DOI 10.1016/j.gene.2006.04.012; Deng XY, 2007, CLIN EXP METASTAS, V24, P107, DOI 10.1007/s10585-007-9059-9; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7689; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Gautreau A, 1999, P NATL ACAD SCI USA, V96, P7300, DOI 10.1073/pnas.96.13.7300; Ge XK, 2002, CANCER LETT, V179, P133, DOI 10.1016/S0304-3835(02)00004-6; Ge YB, 2001, BIOCHEM J, V357, P97, DOI 10.1042/0264-6021:3570097; GEGONNE A, 1993, EMBO J, V12, P1169, DOI 10.1002/j.1460-2075.1993.tb05758.x; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Hapgood JP, 2001, CELL BIOL INT, V25, P17, DOI 10.1006/cbir.2000.0674; Hatzoglou A, 2007, MOL BIOL CELL, V18, P1242, DOI 10.1091/mbc.E06-06-0510; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hiscox S, 1999, J CELL SCI, V112, P3081; Jang SI, 2002, J BIOL CHEM, V277, P42268, DOI 10.1074/jbc.M205593200; Jiang WG, 1996, ANTICANCER RES, V16, P861; JOOSS KU, 1995, ONCOGENE, V10, P603; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; KHACHIGIAN LM, 1995, J BIOL CHEM, V270, P27679, DOI 10.1074/jbc.270.46.27679; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kishore R, 2005, J CLIN INVEST, V115, P1785, DOI 10.1172/JCI22849; Kobel M, 2006, MODERN PATHOL, V19, P581, DOI 10.1038/modpathol.3800567; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; LEE YH, 1994, MOL CELL BIOL, V14, P1383, DOI 10.1128/MCB.14.2.1383; Look DC, 1995, J BIOL CHEM, V270, P30264, DOI 10.1074/jbc.270.51.30264; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; MATSUI M, 1990, ONCOGENE, V5, P249; Monje P, 2003, MOL CELL BIOL, V23, P7030, DOI 10.1128/MCB.23.19.7030-7043.2003; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Noti JD, 1996, MOL CELL BIOL, V16, P2940; Ogino W, 2007, J PEDIAT HEMATOL ONC, V29, P435, DOI 10.1097/MPH.0b013e3180640d18; Ohtani K, 2002, CANCER LETT, V179, P79, DOI 10.1016/S0304-3835(01)00857-6; Pan Q G, 1980, Zhonghua Zhong Liu Za Zhi, V2, P187; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; Pujuguet P, 2003, MOL BIOL CELL, V14, P2181, DOI 10.1091/mbc.E02-07-0410; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; SAMBROOK J, 2000, MOL CLONING LAB MANU; Shen ZY, 2003, WORLD J GASTROENTERO, V9, P1182, DOI 10.3748/wjg.v9.i6.1182; Srivastava J, 2005, MOL BIOL CELL, V16, P1481, DOI 10.1091/mbc.e04-08-0721; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Tanos T, 2005, J BIOL CHEM, V280, P18842, DOI 10.1074/jbc.M500620200; XIE JJ, 2009, INT J CANC IN PRESS; Xu R, 2007, BIOCHEM BIOPH RES CO, V356, P286, DOI 10.1016/j.bbrc.2007.02.140; Yeh TS, 2005, ARCH SURG-CHICAGO, V140, P1184, DOI 10.1001/archsurg.140.12.1184; Yu YL, 2006, CANCER RES, V66, P1982, DOI 10.1158/0008-5472.CAN-05-2360; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zeng HM, 2006, J HISTOCHEM CYTOCHEM, V54, P889, DOI 10.1369/jhc.5A6881.2006; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x; Zhang FR, 2008, J HISTOCHEM CYTOCHEM, V56, P193, DOI 10.1369/jhc.7A7353.2007; Zhang Y, 2006, J CANCER RES CLIN, V132, P685, DOI 10.1007/s00432-006-0117-5	60	54	65	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7995	8004		10.1074/jbc.M809734200	http://dx.doi.org/10.1074/jbc.M809734200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19164283	Green Published, hybrid			2022-12-25	WOS:000264195600062
J	Hu, CL; Depuy, SD; Yao, JL; McIntire, WE; Barrett, PQ				Hu, Changlong; Depuy, Seth D.; Yao, Junlan; McIntire, William E.; Barrett, Paula Q.			Protein Kinase A Activity Controls the Regulation of T-type Ca(V)3.2 Channels by G beta gamma Dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CALCIUM CURRENTS; ADRENAL GLOMERULOSA CELLS; DOPAMINE D2 RECEPTOR; CA2+ CHANNELS; ALDOSTERONE SECRETION; MOLECULAR-BASIS; GENE FAMILY; LOW-VOLTAGE; MODULATION; INHIBITION	Low voltage-activated (LVA), T-type, calcium channels mediate diverse biological functions and are inhibited by G beta gamma dimers, yet the molecular events required for channel inhibition remain unknown. Here, we identify protein kinase A (PKA) as a molecular switch that allows G beta(2)gamma x dimers to effect voltage-independent inhibition of Ca(v)3.2 channels. Inhibition requires phosphorylation of Ser(1107), a critical serine residue on the II-III loop of the channel pore protein. S1107A prevents inhibition of unitary currents by recombinant G beta(2)gamma x dimers but does not disrupt dimer binding nor change its specificity. G beta gamma dimers released upon receptor activation also require PKA activity for their inhibitory actions. Hence, dopamine inhibition of Cav3.2 whole cell current is precluded by G beta gamma-scavenger proteins or a peptide that blocks PKA catalytic activity. Fittingly, when used alone at receptor-selective concentrations, D-1 or D-2 agonists do not elicit channel inhibition yet together synergize to inhibit Cav3.2 channel currents. We propose that a dual-receptor regulatory mechanism is used by dopamine to control Cav3.2 channel activity. This mechanism, for example, would be important in aldosterone producing adrenal glomerulosa cells where channel dysregulation would lead to overproduction of aldosterone and consequent cardiac, renal, and brain target organ damage.	[Hu, Changlong; Depuy, Seth D.; Yao, Junlan; McIntire, William E.; Barrett, Paula Q.] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA	University of Virginia	Barrett, PQ (corresponding author), 1300 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	pqb4b@virginia.edu	Barrett, Paula/AAY-1056-2021; Hu, Changlong/AAQ-8348-2020	Hu, Changlong/0000-0002-8609-8947	NHLBI NIH HHS [HL36977] Funding Source: Medline; NIDDK NIH HHS [P30 DK067629] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alvarez JL, 1996, J PHYSIOL-LONDON, V491, P321, DOI 10.1113/jphysiol.1996.sp021218; Armando I, 2007, HYPERTENSION, V49, P672, DOI 10.1161/01.HYP.0000254486.00883.3d; Arnot MI, 2000, J PHYSIOL-LONDON, V527, P203, DOI 10.1111/j.1469-7793.2000.00203.x; Barrett PQ, 2000, AM J PHYSIOL-CELL PH, V279, pC1694, DOI 10.1152/ajpcell.2000.279.6.C1694; Bonci A, 2005, NEURON, V47, P335, DOI 10.1016/j.neuron.2005.07.015; CAREY RM, 1980, J CLIN INVEST, V66, P10, DOI 10.1172/JCI109822; CAREY RM, 1982, J CLIN ENDOCR METAB, V54, P463, DOI 10.1210/jcem-54-2-463; Chemin J, 2007, J BIOL CHEM, V282, P32710, DOI 10.1074/jbc.M702746200; Chemin J, 2006, CELL CALCIUM, V40, P121, DOI 10.1016/j.ceca.2006.04.015; Chen C, 2000, IMMUNOL CELL BIOL, V78, P356, DOI 10.1046/j.1440-1711.2000.00917.x; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Cote M, 2001, J CLIN ENDOCR METAB, V86, P4495, DOI 10.1210/jc.86.9.4495; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; Depuy SD, 2006, P NATL ACAD SCI USA, V103, P14590, DOI 10.1073/pnas.0603945103; Dolphin AC, 2003, PHARMACOL REV, V55, P607, DOI 10.1124/pr.55.4.3; Drolet P, 1997, MOL ENDOCRINOL, V11, P503, DOI 10.1210/me.11.4.503; Garcia DE, 1998, J NEUROSCI, V18, P9163; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; GROSS RA, 1990, P NATL ACAD SCI USA, V87, P7025, DOI 10.1073/pnas.87.18.7025; GROSS RA, 1990, J PHYSIOL-LONDON, V429, P483, DOI 10.1113/jphysiol.1990.sp018268; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Hopf FW, 2003, J NEUROSCI, V23, P5079; Jarvis SE, 2001, TRENDS PHARMACOL SCI, V22, P519, DOI 10.1016/S0165-6147(00)01800-9; Kawai F, 1999, NAT NEUROSCI, V2, P133, DOI 10.1038/5686; KEJA JA, 1992, J PHYSIOL-LONDON, V450, P409, DOI 10.1113/jphysiol.1992.sp019134; Kim JA, 2006, J PHARMACOL EXP THER, V318, P230, DOI 10.1124/jpet.106.101402; KOBRINSKY EM, 1994, NEUROSCIENCE, V58, P539, DOI 10.1016/0306-4522(94)90079-5; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; Lenglet S, 2000, ENDOCR RES, V26, P597, DOI 10.3109/07435800009048577; LLEDO PM, 1990, BRAIN RES, V528, P143, DOI 10.1016/0006-8993(90)90207-R; LLEDO PM, 1990, ENDOCRINOLOGY, V127, P990, DOI 10.1210/endo-127-3-990; MARCHETTI C, 1986, PFLUG ARCH EUR J PHY, V406, P104, DOI 10.1007/BF00586670; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Myung CS, 1999, J BIOL CHEM, V274, P16595, DOI 10.1074/jbc.274.23.16595; NILIUS B, 1985, NATURE, V316, P443, DOI 10.1038/316443a0; NOTH RH, 1980, J CLIN ENDOCR METAB, V51, P64, DOI 10.1210/jcem-51-1-64; OSIPENKO ON, 1994, ENDOCRINOLOGY, V134, P511, DOI 10.1210/en.134.1.511; PEREZREYES E, 1994, FEBS LETT, V342, P119, DOI 10.1016/0014-5793(94)80484-2; PFEIFFERLINN C, 1993, J GEN PHYSIOL, V102, P277, DOI 10.1085/jgp.102.2.277; Pivonello R, 2004, J CLIN ENDOCR METAB, V89, P4493, DOI 10.1210/jc.2003-031746; Ruiz-Velasco V, 2000, J NEUROSCI, V20, P2183; Schrier AD, 2001, AM J PHYSIOL-CELL PH, V280, pC265, DOI 10.1152/ajpcell.2001.280.2.C265; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; Talley EM, 1999, J NEUROSCI, V19, P1895; Tao J, 2008, MOL PHARMACOL, V73, P1596, DOI 10.1124/mol.107.043612; Welsby PJ, 2003, J NEUROSCI, V23, P10116, DOI 10.1523/jneurosci.23-31-10116.2003; WILLIAMS PJ, 1990, J NEUROSCI, V10, P757; Wolfe JT, 2003, NATURE, V424, P209, DOI 10.1038/nature01772; Wu KD, 2001, J CLIN ENDOCR METAB, V86, P4460, DOI 10.1210/jc.86.9.4460; Yao JL, 2006, J CLIN INVEST, V116, P2403, DOI 10.1172/JCI27918; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zeng CY, 2004, PHYSIOL GENOMICS, V19, P233, DOI 10.1152/physiolgenomics.00127.2004	54	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7465	7473		10.1074/jbc.M808049200	http://dx.doi.org/10.1074/jbc.M808049200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19131331	Green Published, hybrid			2022-12-25	WOS:000264195600010
J	Hasadsri, L; Kreuter, J; Hattori, H; Iwasaki, T; George, JM				Hasadsri, Linda; Kreuter, Joerg; Hattori, Hiroaki; Iwasaki, Tadao; George, Julia M.			Functional Protein Delivery into Neurons Using Polymeric Nanoparticles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEIN; BLOOD-BRAIN-BARRIER; CHAPERONE-MEDIATED AUTOPHAGY; SOLID LIPID NANOPARTICLES; RESONANCE ENERGY-TRANSFER; ALPHA-SYNUCLEIN; GENE DELIVERY; HIGH-EFFICIENCY; NEURODEGENERATIVE DISEASES; PARKINSONS-DISEASE	An efficient route for delivering specific proteins and peptides into neurons could greatly accelerate the development of therapies for various diseases, especially those involving intracellular defects such as Parkinson disease. Here we report the novel use of polybutylcyanoacrylate nanoparticles for delivery of intact, functional proteins into neurons and neuronal cell lines. Uptake of these particles is primarily dependent on endocytosis via the low density lipoprotein receptor. The nanoparticles are rapidly turned over and display minimal toxicity to cultured neurons. Delivery of three different functional cargo proteins is demonstrated. When primary neuronal cultures are treated with recombinant Escherichia coli beta-galactosidase as nanoparticle cargo, persistent enzyme activity is measured beyond the period of nanoparticle degradation. Delivery of the small GTPase rhoG induces neurite outgrowth and differentiation in PC12 cells. Finally, a monoclonal antibody directed against synuclein is capable of interacting with endogenous alpha-synuclein in cultured neurons following delivery via nanoparticles. Polybutylcyanoacrylate nanoparticles are thus useful for intracellular protein delivery in vitro and have potential as carriers of therapeutic proteins for treatment of neuronal disorders in vivo.	[George, Julia M.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Hasadsri, Linda] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Hasadsri, Linda] Univ Illinois, Coll Med, Med Scholars Program, Urbana, IL 61801 USA; [Kreuter, Joerg] Univ Frankfurt, Biozentrum, Inst Pharmazeut Technol, D-60439 Frankfurt, Germany; [Hattori, Hiroaki; Iwasaki, Tadao] BML Inc, Dept Adv Med Technol & Dev, Kawagoe, Saitama 3501101, Japan	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Goethe University Frankfurt; BML, Inc.	George, JM (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, 524 Burrill Hall,407 S Goodwin Ave, Urbana, IL 61801 USA.	j-george@illinois.edu	George, Julia M/B-2169-2008	George, Julia M/0000-0001-6194-6914	NIA NIH HHS [R01 AG13762] Funding Source: Medline; NIGMS NIH HHS [5T32 GM07283] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013762] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Almeida CG, 2006, J NEUROSCI, V26, P4277, DOI 10.1523/JNEUROSCI.5078-05.2006; AltmanHamamdzic S, 1997, GENE THER, V4, P815, DOI 10.1038/sj.gt.3300458; ALYAUTDIN R, 1995, EUR J PHARM BIOPHARM, V41, P44; Amalfitano Andrea, 2002, Current Gene Therapy, V2, P111, DOI 10.2174/1566523024605618; Barka T, 2000, J HISTOCHEM CYTOCHEM, V48, P1453, DOI 10.1177/002215540004801102; Beffert U, 2004, J LIPID RES, V45, P403, DOI 10.1194/jlr.R300017-JLR200; Bender FLP, 2007, HISTOCHEM CELL BIOL, V127, P439, DOI 10.1007/s00418-006-0247-5; Bergen JM, 2008, PHARM RES-DORDR, V25, P983, DOI 10.1007/s11095-007-9439-5; Berges BK, 2007, MOL THER, V15, P20, DOI 10.1038/sj.mt.6300018; Blasi P, 2007, ADV DRUG DELIVER REV, V59, P454, DOI 10.1016/j.addr.2007.04.011; Buchser WJ, 2006, BIOTECHNIQUES, V41, P619, DOI 10.2144/000112279; Cai D, 2005, NAT METHODS, V2, P449, DOI 10.1038/NMETH761; Cesnulevicius K, 2006, STEM CELLS, V24, P2776, DOI 10.1634/stemcells.2006-0176; CHANDLER LP, 1985, J BIOL CHEM, V260, P3360; Chauvierre C, 2007, INT J PHARM, V338, P327, DOI 10.1016/j.ijpharm.2007.01.034; Day RN, 2003, MOL ENDOCRINOL, V17, P333, DOI 10.1210/me.2002-0136; Dehouck B, 1997, J CELL BIOL, V138, P877, DOI 10.1083/jcb.138.4.877; DOUGLAS SJ, 1987, CRIT REV THER DRUG, V3, P233; Ehrengruber MU, 2001, MOL CELL NEUROSCI, V17, P855, DOI 10.1006/mcne.2001.0982; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; Elkabetz Y, 2003, J BIOL CHEM, V278, P18922, DOI 10.1074/jbc.M208730200; Emadi S, 2004, BIOCHEMISTRY-US, V43, P2871, DOI 10.1021/bi036281f; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Gartner A, 2006, METHOD ENZYMOL, V406, P374, DOI 10.1016/S0076-6879(06)06027-7; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Goppert TM, 2005, J DRUG TARGET, V13, P179, DOI 10.1080/10611860500071292; Gresch O, 2004, METHODS, V33, P151, DOI 10.1016/j.ymeth.2003.11.009; Gulyaev AE, 1999, PHARM RES-DORDR, V16, P1564, DOI 10.1023/A:1018983904537; HAYLETT T, 1991, J BIOL CHEM, V266, P8322; Huang CJ, 2006, J MOL BIOL, V364, P323, DOI 10.1016/j.jmb.2006.08.062; Janson CG, 2001, TRENDS NEUROSCI, V24, P706, DOI 10.1016/S0166-2236(00)01954-8; Katoh H, 2000, MOL CELL BIOL, V20, P7378, DOI 10.1128/MCB.20.19.7378-7387.2000; Kaushik S., 2008, V445, P227, DOI 10.1007/978-1-59745-157-4_15; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; KINGSLEY DM, 1984, P NATL ACAD SCI-BIOL, V81, P5454, DOI 10.1073/pnas.81.17.5454; Kosaka S, 2001, CIRCULATION, V103, P1142, DOI 10.1161/01.CIR.103.8.1142; Kreuter J, 2003, PHARM RES-DORDR, V20, P409, DOI 10.1023/A:1022604120952; Kreuter J, 2002, J DRUG TARGET, V10, P317, DOI 10.1080/10611860290031877; Kreuter J, 2001, ADV DRUG DELIVER REV, V47, P65, DOI 10.1016/S0169-409X(00)00122-8; KREUTER J, 1995, BRAIN RES, V674, P171, DOI 10.1016/0006-8993(95)00023-J; KUBIAK C, 1989, BIOMATERIALS, V10, P553, DOI 10.1016/0142-9612(89)90062-8; Leclere PG, 2005, J NEUROSCI METH, V142, P137, DOI 10.1016/j.jneumeth.2004.08.012; Luo D, 2000, NAT BIOTECHNOL, V18, P33, DOI 10.1038/71889; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; MERESSE S, 1989, J NEUROCHEM, V53, P340, DOI 10.1111/j.1471-4159.1989.tb07340.x; Messer A, 2006, BIODRUGS, V20, P327, DOI 10.2165/00063030-200620060-00002; Mills JC, 1997, EXP CELL RES, V231, P337, DOI 10.1006/excr.1997.3474; Mochizuki H, 1998, J VIROL, V72, P8873, DOI 10.1128/JVI.72.11.8873-8883.1998; MOGHIMI SM, 1993, BIOCHIM BIOPHYS ACTA, V1179, P157, DOI 10.1016/0167-4889(93)90137-E; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; MULLER RH, 1992, INT J PHARM, V84, P1, DOI 10.1016/0378-5173(92)90209-K; Nagel F, 2008, J NEUROCHEM, V105, P853, DOI 10.1111/j.1471-4159.2007.05204.x; Ohki EC, 2001, J NEUROSCI METH, V112, P95, DOI 10.1016/S0165-0270(01)00441-1; Olivier JC, 1999, PHARMACEUT RES, V16, P1836, DOI 10.1023/A:1018947208597; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com; Reis SA, 2004, J MOL HISTOL, V35, P389; Royo NC, 2008, BRAIN RES, V1190, P15, DOI 10.1016/j.brainres.2007.11.015; Sharma N, 2001, AM J PATHOL, V159, P339, DOI 10.1016/S0002-9440(10)61700-2; Slack RS, 1996, CURR OPIN NEUROBIOL, V6, P576, DOI 10.1016/S0959-4388(96)80088-2; SMITH RL, 1995, J VIROL, V69, P4593, DOI 10.1128/JVI.69.8.4593-4599.1995; Soto C, 2008, ARCH NEUROL-CHICAGO, V65, P184, DOI 10.1001/archneurol.2007.56; Takahashi M, 2001, CLIN GENET, V59, P290, DOI 10.1034/j.1399-0004.2001.590414.x; Teruel MN, 1999, J NEUROSCI METH, V93, P37, DOI 10.1016/S0165-0270(99)00112-0; VASILE E, 1983, J CELL BIOL, V96, P1677, DOI 10.1083/jcb.96.6.1677; Vauthier C, 2003, ADV DRUG DELIVER REV, V55, P519, DOI 10.1016/S0169-409X(03)00041-3; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Washbourne P, 2002, CURR OPIN NEUROBIOL, V12, P566, DOI 10.1016/S0959-4388(02)00365-3; Whittlesey KJ, 2006, BIOMATERIALS, V27, P2477, DOI 10.1016/j.biomaterials.2005.11.016; Windisch M, 2008, NEURODEGENER DIS, V5, P218, DOI 10.1159/000113707; Windisch M, 2004, J MOL NEUROSCI, V24, P155, DOI 10.1385/JMN:24:1:155; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Yu L, 2001, J CONTROL RELEASE, V72, P179, DOI 10.1016/S0168-3659(01)00274-7; Zeitelhofer M, 2007, NAT PROTOC, V2, P1692, DOI 10.1038/nprot.2007.226; Zhou C, 2004, MOL THER, V10, P1023, DOI 10.1016/j.ymthe.2004.08.019	75	102	127	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6972	6981		10.1074/jbc.M805956200	http://dx.doi.org/10.1074/jbc.M805956200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19129199	Green Published, hybrid			2022-12-25	WOS:000263919000045
J	Zang, Y; Yu, LF; Nan, FJ; Feng, LY; Li, J				Zang, Yi; Yu, Li-Fang; Nan, Fa-Jun; Feng, Lin-Yin; Li, Jia			AMP-activated Protein Kinase Is Involved in Neural Stem Cell Growth Suppression and Cell Cycle Arrest by 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and Glucose Deprivation by Down-regulating Phospho-retinoblastoma Protein and Cyclin D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATION IN-VITRO; SELF-RENEWAL; DIFFERENTIATION; BRAIN; PHOSPHORYLATION; APOPTOSIS; DERIVATIVES; GLYCOLYSIS; EXPRESSION; SURVIVAL	The fate of neural stem cells (NSCs), including their proliferation, differentiation, survival, and death, is regulated by multiple intrinsic signals and the extrinsic environment. We had previously reported that 5-aminoimidazole-4-carboxamide-1-beta D-ribofuranoside (AICAR) directly induces astroglial differentiation of NSCs by activation of the Janus kinase (JAK)/ Signal transducer and activator of transcription 3 (STAT3) pathway independently of AMP-activated protein kinase (AMPK). Here, we reported the observation that AICAR inhibited NSC proliferation and its underlying mechanism. Analysis of caspase activity and cell cycle showed that AICAR induced G(1)/G(0) cell cycle arrest in NSCs, associated with decreased levels of poly(ADP-ribose) polymerase, phosphoretinoblastoma protein (Rb), and cyclin D but did not cause apoptosis. Iodotubericidin and Compound C, inhibitors of adenosine kinase and AMPK, respectively, or overexpression of a dominant-negative mutant of AMPK, but not JAK inhibitor, were able to reverse the anti-proliferative effect of AICAR. Glucose deprivation also activated the AMPK pathway, induced G(0)/G(1) arrest, and suppressed the proliferation of NSCs, an effect associated with decreased levels of phospho-Rb and cyclin D protein. Furthermore, Compound C and overexpression of dominant-negative AMPK in C17.2 NSCs could block the glucose deprivation-mediated down-regulation of cyclin D and partially reverse the suppression of proliferation. These results suggest that AICAR and glucose deprivation might induce G(1)/G(0) cell cycle arrest and suppress proliferation of NSCs via phospho-Rb and cyclin D down-regulation. AMPK, but not JAK/STAT3, activation is key for this inhibitory effect and may play an important role in the responses of NSCs to metabolic stresses such as glucose deprivation.	[Zang, Yi; Yu, Li-Fang; Nan, Fa-Jun; Li, Jia] Chinese Acad Sci, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China; [Feng, Lin-Yin] Chinese Acad Sci, Neurol Pharmacol Dept, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS	Li, J (corresponding author), 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China.	jli@mail.shcnc.ac.cn	Zang, Yi/C-5683-2014; Li, Jia/F-9116-2011; li, jia/GVT-7587-2022	Zang, Yi/0000-0001-9835-922X; 	National Natural Science Foundation of China [30800559]; National Basic Research Program of China [2007CB914201, 2009CB940900]; Shanghai Commission of Science and Technology [08ZR1403700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by National Natural Science Foundation of China Grant 30800559, National Basic Research Program of China Grants 2007CB914201 and 2009CB940900, and Shanghai Commission of Science and Technology Grant 08ZR1403700.	Almeida A, 2004, NAT CELL BIOL, V6, P45, DOI 10.1038/ncb1080; Ambrogini P, 2005, NEUROENDOCRINOLOGY, V81, P244, DOI 10.1159/000087648; ANCHAN RM, 1995, J NEUROBIOL, V28, P133, DOI 10.1002/neu.480280202; Ayuso-Sacido Angel, 2006, Curr Stem Cell Res Ther, V1, P387; Blazquez C, 2001, FEBS LETT, V489, P149, DOI 10.1016/S0014-5793(01)02089-0; Brandenberger Ralph, 2004, BMC Developmental Biology, V4, P1; Brannvall K, 2002, MOL CELL NEUROSCI, V21, P512, DOI 10.1006/mcne.2002.1194; Carbone M, 2008, ONCOGENE, V27, P6083, DOI 10.1038/onc.2008.221; Carling D, 2004, CURR BIOL, V14, pR220, DOI 10.1016/j.cub.2004.02.048; Chen HL, 2007, STEM CELLS, V25, P63, DOI 10.1634/stemcells.2006-0339; Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Cremisi F, 2003, CURR OPIN NEUROBIOL, V13, P26, DOI 10.1016/S0959-4388(03)00005-9; Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45; De Blasio A, 2005, FEBS LETT, V579, P615, DOI 10.1016/j.febslet.2004.12.028; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Fowler CD, 2005, J COMP NEUROL, V489, P166, DOI 10.1002/cne.20638; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Georgopoulou N, 2006, J BIOL CHEM, V281, P33606, DOI 10.1074/jbc.M602689200; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Harnacke K, 2005, EUR J CELL BIOL, V84, P885, DOI 10.1016/j.ejcb.2005.08.009; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hienola A, 2004, MOL CELL NEUROSCI, V26, P75, DOI 10.1016/j.mcn.2004.01.018; Igata M, 2005, CIRC RES, V97, P837, DOI 10.1161/01.RES.0000185823.73556.06; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Karsten SL, 2003, DEV BIOL, V261, P165, DOI 10.1016/S0012-1606(03)00274-4; Kishi Y, 2005, J NEUROSCI RES, V79, P279, DOI 10.1002/jnr.20362; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lasky JL, 2005, PEDIATR RES, V57, p104R, DOI 10.1203/01.PDR.0000159632.70510.3D; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Miller JP, 2007, CELL CYCLE, V6, P2932, DOI 10.4161/cc.6.23.5042; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Oliver TG, 2004, NEURON, V42, P885, DOI 10.1016/j.neuron.2004.06.011; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; Sayama K, 2001, J BIOL CHEM, V276, P999, DOI 10.1074/jbc.M003425200; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Sommer L, 2002, PROG NEUROBIOL, V66, P1, DOI 10.1016/S0301-0082(01)00022-3; Villa A, 2004, EXP CELL RES, V294, P559, DOI 10.1016/j.yexcr.2003.11.025; Wada K, 2006, J BIOL CHEM, V281, P12673, DOI 10.1074/jbc.M513786200; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6; Yeoh JSG, 2007, MECH AGEING DEV, V128, P17, DOI 10.1016/j.mad.2006.11.005; Yoshikawa K, 2000, NEUROSCI RES, V37, P1, DOI 10.1016/S0168-0102(00)00101-2; Zang Y, 2008, J BIOL CHEM, V283, P6201, DOI 10.1074/jbc.M708619200; Zeng XM, 2007, STEM CELL REV, V3, P270, DOI 10.1007/s12015-007-9005-x; Zhang YH, 2006, FEBS J, V273, P4842, DOI 10.1111/j.1742-4658.2006.05483.x	56	40	42	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6175	6184		10.1074/jbc.M806887200	http://dx.doi.org/10.1074/jbc.M806887200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19144636	hybrid			2022-12-25	WOS:000263742700020
J	Ito, K; Inoue, K; Bae, SC; Ito, Y				Ito, K.; Inoue, K-i; Bae, S-C; Ito, Y.			Runx3 expression in gastrointestinal tract epithelium: resolving the controversy	ONCOGENE			English	Article						detection of Runx3; immunohistochemistry; gastrointestinal epithelial cells; monoclonal antibody	ROOT GANGLION NEURONS; GASTRIC-CANCER; GROWTH-FACTOR; TUMOR-SUPPRESSOR; REGULATES DEVELOPMENT; CELLS; GENE; ADENOCARCINOMA; METASTASIS; RUNX1/AML1	We reported earlier that RUNX3 is expressed in human and mouse gastrointestinal tract (GIT) epithelium and that it functions as a tumor suppressor in gastric and colorectal tissues. However, there have been conflicting reports describing the absence of Runx3 in GIT epithelial cells. A part of the controversy may be derived from the use of a specific antibody by other groups ( referred to as G-poly). Here, we show further evidence to support our earlier observations and provide a possible explanation for this apparent controversy. We generated multiple anti-RUNX3 monoclonal antibodies and found that RUNX3 antibodies recognizing the RUNX3 N-terminal region (residues 1-234) react with RUNX3 in gastric epithelial cells, whereas those recognizing the C-terminal region (beyond residue 234) did not. G-poly primarily recognizes the region beyond 234 and hence, is unable to detect Runx3 in this tissue.	[Ito, K.; Inoue, K-i; Ito, Y.] Inst Mol & Cell Biol, Singapore 138673, Singapore; [Ito, K.; Ito, Y.] Natl Univ Singapore, Oncol Res Inst, Singapore 117548, Singapore; [Bae, S-C] Chungbuk Natl Univ, Sch Med, Dept Biochem, Cheongju, South Korea; [Bae, S-C] Chungbuk Natl Univ, Inst Tumor Res, Cheongju, South Korea	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Chungbuk National University; Chungbuk National University	Ito, Y (corresponding author), Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	itoy@imcb.a-star.edu.sg						Brenner O, 2004, P NATL ACAD SCI USA, V101, P16016, DOI 10.1073/pnas.0407180101; Carvalho R, 2005, ONCOGENE, V24, P8252, DOI 10.1038/sj.onc.1208963; Chen AI, 2006, NEURON, V49, P395, DOI 10.1016/j.neuron.2005.12.028; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Chi XZ, 2005, MOL CELL BIOL, V25, P8097, DOI 10.1128/MCB.25.18.8097-8107.2005; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Inoue KI, 2007, J BIOL CHEM, V282, P24175, DOI 10.1074/jbc.M703746200; Ito K, 2005, CANCER RES, V65, P7743, DOI 10.1158/0008-5472.CAN-05-0743; Ito K, 2008, CANCER CELL, V14, P226, DOI 10.1016/j.ccr.2008.08.004; Ito Y, 2008, ADV CANCER RES, V99, P33, DOI 10.1016/S0065-230X(07)99002-8; Katuri V, 2006, ONCOGENE, V25, P1871, DOI 10.1038/sj.onc.1209211; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; Le XF, 1999, J BIOL CHEM, V274, P21651, DOI 10.1074/jbc.274.31.21651; Levanon D, 2003, EMBO REP, V4, P560, DOI 10.1038/sj.embor.embor868; Levanon D, 2001, MECH DEVELOP, V109, P413, DOI 10.1016/S0925-4773(01)00537-8; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Marmigere F, 2006, NAT NEUROSCI, V9, P180, DOI 10.1038/nn1631; Nakamura S, 2008, DEVELOPMENT, V135, P1703, DOI 10.1242/dev.015248; Osaki M, 2004, EUR J CLIN INVEST, V34, P605, DOI 10.1111/j.1365-2362.2004.01401.x; Oshimo Y, 2004, PATHOBIOLOGY, V71, P137, DOI 10.1159/000076468; Peng ZH, 2006, CLIN CANCER RES, V12, P6386, DOI 10.1158/1078-0432.CCR-05-2359; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Torquati A, 2004, SURGERY, V136, P310, DOI 10.1016/j.surg.2004.05.005; Usui T, 2006, INT J ONCOL, V29, P779; Wei DY, 2005, CANCER RES, V65, P4809, DOI 10.1158/0008-5472.CAN-04-3741; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Yano T, 2006, MOL CELL BIOL, V26, P4474, DOI 10.1128/MCB.01926-05; Zavros Y, 2005, ONCOGENE, V24, P2354, DOI 10.1038/sj.onc.1208407	29	23	25	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2009	28	10					1379	1384		10.1038/onc.2008.496	http://dx.doi.org/10.1038/onc.2008.496			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	417ZC	19169278				2022-12-25	WOS:000264116000010
J	Salcedo, E; Farrell, DM; Zheng, LJ; Phistry, M; Bagg, EE; Britt, SG				Salcedo, Ernesto; Farrell, David M.; Zheng, Lijun; Phistry, Meridee; Bagg, Eve E.; Britt, Steven G.			The Green-absorbing Drosophila Rh6 Visual Pigment Contains a Blue-shifting Amino Acid Substitution That Is Conserved in Vertebrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINYLIDENE SCHIFF-BASE; BOVINE RHODOPSIN; MOLECULAR-DYNAMICS; COLOR-VISION; ECTOPIC EXPRESSION; NIGHT BLINDNESS; PROTON AFFINITY; CONE PIGMENT; BACTERIORHODOPSIN; GENE	The molecular mechanisms that regulate invertebrate visual pigment absorption are poorly understood. Through sequence analysis and functional investigation of vertebrate visual pigments, numerous amino acid substitutions important for this adaptive process have been identified. Here we describe a serine/alanine (S/A) substitution in long wavelength-absorbing Drosophila visual pigments that occurs at a site corresponding to Ala-292 in bovine rhodopsin. This S/A substitution accounts for a 10-17-nm absorption shift in visual pigments of this class. Additionally, we demonstrate that substitution of a cysteine at the same site, as occurs in the blue-absorbing Rh5 pigment, accounts for a 4-nm shift. Substitutions at this site are the first spectrally significant amino acid changes to be identified for invertebrate pigments sensitive to visible light and are the first evidence of a conserved tuning mechanism in vertebrate and invertebrate pigments of this class.	[Salcedo, Ernesto; Zheng, Lijun; Phistry, Meridee; Bagg, Eve E.; Britt, Steven G.] Univ Colorado Denver, Dept Cell & Dev Biol, Aurora, CO 80045 USA; [Britt, Steven G.] Univ Colorado Denver, Dept Ophthalmol, Aurora, CO 80045 USA; [Farrell, David M.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Britt, Steven G.] Univ Colorado Denver, Rocky Mt Lions Eye Inst, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Britt, SG (corresponding author), Univ Colorado Denver, Dept Cell & Dev Biol, Mail Stop 8108,12801 E 17th Ave, Aurora, CO 80045 USA.	steve.britt@ucdenver.edu	Britt, Steven/GVT-1340-2022	Britt, Steven/0000-0001-7656-7984	National Institutes of Health [R01-EY10759]; National Science Foundation [IOB-0449367]; NATIONAL EYE INSTITUTE [R01EY010759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-EY10759 from the NEI (to S.G.B.). This work was also supported by Grant IOB-0449367 from the National Science Foundation.	Altun A, 2008, J PHYS CHEM B, V112, P6814, DOI 10.1021/jp709730b; Baudry J, 1997, J CHEM INF COMP SCI, V37, P1018, DOI 10.1021/ci9702398; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Detto T, 2007, P ROY SOC B-BIOL SCI, V274, P2785, DOI 10.1098/rspb.2007.1059; DRYJA TP, 1993, NAT GENET, V4, P280, DOI 10.1038/ng0793-280; Dyer AG, 2004, J EXP BIOL, V207, P1683, DOI 10.1242/jeb.00941; Fasick JI, 1999, BIOCHEMISTRY-US, V38, P11593, DOI 10.1021/bi991600h; Fasick JI, 1998, BIOCHEMISTRY-US, V37, P433, DOI 10.1021/bi972500j; FEILER R, 1992, J NEUROSCI, V12, P3862; FEILER R, 1988, NATURE, V333, P737, DOI 10.1038/333737a0; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Gross AK, 2003, BIOCHEMISTRY-US, V42, P2009, DOI 10.1021/bi020613j; HARANISHIMURA I, 1993, FEBS LETT, V317, P5, DOI 10.1016/0014-5793(93)81480-N; Hayashi S, 2000, J PHYS CHEM B, V104, P10678, DOI 10.1021/jp001508r; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunt DM, 2001, J EXP BIOL, V204, P3333; Hunt DM, 1996, VISION RES, V36, P1217, DOI 10.1016/0042-6989(95)00228-6; Janz JM, 2001, BIOCHEMISTRY-US, V40, P7219, DOI 10.1021/bi002937i; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Lin SW, 1998, J BIOL CHEM, V273, P24583, DOI 10.1074/jbc.273.38.24583; Marshall J, 2007, ARTHROPOD STRUCT DEV, V36, P420, DOI 10.1016/j.asd.2007.01.006; Maximov VV, 2000, PHILOS T ROY SOC B, V355, P1239, DOI 10.1098/rstb.2000.0675; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; NAKAYAMA TA, 1991, J BIOL CHEM, V266, P4269; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P9746, DOI 10.1021/bi00493a034; NINA M, 1995, BIOPHYS J, V68, P25, DOI 10.1016/S0006-3495(95)80184-0; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Porter ML, 2007, MOL BIOL EVOL, V24, P253, DOI 10.1093/molbev/msl152; Ramos LS, 2007, BIOCHEMISTRY-US, V46, P5330, DOI 10.1021/bi700138g; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Salcedo E, 1999, J NEUROSCI, V19, P10716, DOI 10.1523/JNEUROSCI.19-24-10716.1999; Salcedo E, 2003, J NEUROSCI, V23, P10873; Sugawara T, 2005, P NATL ACAD SCI USA, V102, P5448, DOI 10.1073/pnas.0405302102; Sun H, 1997, P NATL ACAD SCI USA, V94, P8860, DOI 10.1073/pnas.94.16.8860; Tajkhorshid E, 1999, J PHYS CHEM B, V103, P5581, DOI 10.1021/jp983742b; Tajkhorshid E, 2000, BIOPHYS J, V78, P683, DOI 10.1016/S0006-3495(00)76626-4; Tajkhorshid E, 1997, J PHYS CHEM B, V101, P8021, DOI 10.1021/jp971283t; Takahashi Y, 2003, BIOCHEMISTRY-US, V42, P6025, DOI 10.1021/bi020629+; Wilkie SE, 2000, BIOCHEMISTRY-US, V39, P7895, DOI 10.1021/bi992776m; Yokoyama S, 1999, P NATL ACAD SCI USA, V96, P6279, DOI 10.1073/pnas.96.11.6279; Yokoyama S, 2000, P NATL ACAD SCI USA, V97, P7366, DOI 10.1073/pnas.97.13.7366; Yokoyama S, 2008, P NATL ACAD SCI USA, V105, P13480, DOI 10.1073/pnas.0802426105; Zhang L, 1996, PROTEINS, V24, P433, DOI 10.1002/(SICI)1097-0134(199604)24:4<433::AID-PROT3>3.0.CO;2-F; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	47	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5717	5722		10.1074/jbc.M807368200	http://dx.doi.org/10.1074/jbc.M807368200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19126545	hybrid, Green Published			2022-12-25	WOS:000263560600035
J	Henry, M; Guetard, D; Suspene, R; Rusniok, C; Wain-Hobson, S; Vartanian, JP				Henry, Michel; Guetard, Denise; Suspene, Rodolphe; Rusniok, Christophe; Wain-Hobson, Simon; Vartanian, Jean-Pierre			Genetic Editing of HBV DNA by Monodomain Human APOBEC3 Cytidine Deaminases and the Recombinant Nature of APOBEC3G	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SINGLE-STRANDED-DNA; CRYSTAL-STRUCTURE; DOMAIN ORGANIZATION; CYTOSINE DEAMINASE; ADAPTIVE EVOLUTION; HUMAN HEPATOCYTES; PROVIDES INSIGHT; HIV-1 INFECTION; IN-VITRO	Hepatitis B virus (HBV) DNA is vulnerable to editing by human cytidine deaminases of the APOBEC3 (A3A-H) family albeit to much lower levels than HIV cDNA. We have analyzed and compared HBV editing by all seven enzymes in a quail cell line that does not produce any endogenous DNA cytidine deaminase activity. Using 3DPCR it was possible to show that all but A3DE were able to deaminate HBV DNA at levels from 10(-2) to 10(-5) in vitro, with A3A proving to be the most efficient editor. The amino terminal domain of A3G alone was completely devoid of deaminase activity to within the sensitivity of 3DPCR (similar to 10(-4) to 10(-5)). Detailed analysis of the dinucleotide editing context showed that only A3G and A3H have strong preferences, notably CpC and TpC. A phylogenic analysis of A3 exons revealed that A3G is in fact a chimera with the first two exons being derived from the A3F gene. This might allow co-expression of the two genes that are able to restrict HIV-1 Delta vif efficiently.	[Henry, Michel; Guetard, Denise; Suspene, Rodolphe; Wain-Hobson, Simon; Vartanian, Jean-Pierre] Inst Pasteur, CNRS, URA 3015, Mol Retrovirol Unit, Paris, France; [Rusniok, Christophe] Inst Pasteur, Biol Intracellular Bacteria Unit, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Henry, M (corresponding author), Inst Pasteur, CNRS, URA 3015, Mol Retrovirol Unit, Paris, France.	jean-pierre.vartanian@pasteur.fr		Vartanian, Jean-Pierre/0000-0001-8079-8814	Institut Pasteur and Agence Nationale de Recherche sur le SIDA (ANRS)	Institut Pasteur and Agence Nationale de Recherche sur le SIDA (ANRS)(ANRS)	Institut Pasteur and Agence Nationale de Recherche sur le SIDA (ANRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Benjamin J, 2005, J MOL BIOL, V346, P577, DOI 10.1016/j.jmb.2004.11.064; BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; Biebricher CK, 2005, VIRUS RES, V107, P117, DOI 10.1016/j.virusres.2004.11.002; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Delebecque F, 2006, J VIROL, V80, P605, DOI 10.1128/JVI.80.2.605-614.2006; Endo Y, 2007, ONCOGENE, V26, P5587, DOI 10.1038/sj.onc.1210344; Endo Y, 2008, GASTROENTEROLOGY, V135, P889, DOI 10.1053/j.gastro.2008.06.091; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Gooch BD, 2008, VIROLOGY, V379, P118, DOI 10.1016/j.virol.2008.06.013; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Janini M, 2001, J VIROL, V75, P7973, DOI 10.1128/JVI.75.17.7973-7986.2001; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Jern P, 2007, PLOS GENET, V3, P2014, DOI 10.1371/journal.pgen.0030183; Johansson E, 2002, BIOCHEMISTRY-US, V41, P2563, DOI 10.1021/bi011849a; Jonsson SR, 2006, NUCLEIC ACIDS RES, V34, P5683, DOI 10.1093/nar/gkl721; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Ko TP, 2003, J BIOL CHEM, V278, P19111, DOI 10.1074/jbc.M300874200; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; Larue RS, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-104; LARUE RS, 2008, J VIROL IN PRESS; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Lei YC, 2006, WORLD J GASTROENTERO, V12, P7488, DOI 10.3748/wjg.v12.i46.7488; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Lochelt M, 2005, P NATL ACAD SCI USA, V102, P7982, DOI 10.1073/pnas.0501445102; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Morisawa T, 2008, INT J CANCER, V123, P2735, DOI 10.1002/ijc.23853; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Munk C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r48; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Nguyen DH, 2007, J VIROL, V81, P4465, DOI 10.1128/JVI.02510-06; Noguchi C, 2005, HEPATOLOGY, V41, P626, DOI 10.1002/hep.20580; Noguchi C, 2007, J GEN VIROL, V88, P432, DOI 10.1099/vir.0.82319-0; OhAinle M, 2006, J VIROL, V80, P3853, DOI 10.1128/JVI.80.8.3853-3862.2006; OhAinle M, 2008, CELL HOST MICROBE, V4, P249, DOI 10.1016/j.chom.2008.07.005; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Ortiz M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-11; Petersen-Mahrt SK, 2003, J BIOL CHEM, V278, P19583, DOI 10.1074/jbc.C300114200; PETIT V, 2008, J MOL BIOL IN PRESS; Rosler C, 2005, HEPATOLOGY, V42, P301, DOI 10.1002/hep.20801; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Schumacher AJ, 2005, P NATL ACAD SCI USA, V102, P9854, DOI 10.1073/pnas.0501694102; Schumacher AJ, 2008, J VIROL, V82, P2652, DOI 10.1128/JVI.02391-07; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stenglein MD, 2008, J VIROL, V82, P9591, DOI 10.1128/JVI.02471-07; Stunkel W, 1999, J VIROL, V73, P1918; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Suspene R, 2005, J GEN VIROL, V86, P125, DOI 10.1099/vir.0.80426-0; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Vartanian JP, 2003, TRENDS MOL MED, V9, P409, DOI 10.1016/j.molmed.2003.08.008; Vartanian JP, 1997, J MOL BIOL, V270, P139, DOI 10.1006/jmbi.1997.1104; Watts NR, 2002, EMBO J, V21, P876, DOI 10.1093/emboj/21.5.876; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Xie KF, 2004, P NATL ACAD SCI USA, V101, P8114, DOI 10.1073/pnas.0400493101; Xu HZ, 2007, VIROLOGY, V360, P247, DOI 10.1016/j.virol.2006.10.036; Xu RZ, 2007, HEPATOLOGY, V46, P1810, DOI 10.1002/hep.21893; YAMANAKA S, 1995, P NATL ACAD SCI USA, V92, P8483, DOI 10.1073/pnas.92.18.8483; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	75	64	69	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2009	4	1							e4277	10.1371/journal.pone.0004277	http://dx.doi.org/10.1371/journal.pone.0004277			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JE	19169351	Green Published, gold			2022-12-25	WOS:000265482800007
J	Meani, N; Pezzimenti, F; Deflorian, G; Mione, M; Alcalay, M				Meani, Natalia; Pezzimenti, Federica; Deflorian, Gianluca; Mione, Marina; Alcalay, Myriam			The Tumor Suppressor PRDM5 Regulates Wnt Signaling at Early Stages of Zebrafish Development	PLOS ONE			English	Article								PRDM genes are a family of transcriptional regulators that modulate cellular processes such as differentiation, cell growth and apoptosis. Some family members are involved in tissue or organ maturation, and are differentially expressed in specific phases of embryonic development. PRDM5 is a recently identified family member that functions as a transcriptional repressor and behaves as a putative tumor suppressor in different types of cancer. Using gene expression profiling, we found that transcriptional targets of PRDM5 in human U2OS cells include critical genes involved in developmental processes, and specifically in regulating wnt signaling. We therefore assessed PRDM5 function in vivo by performing loss-of-function and gain-of-function experiments in zebrafish embryos. Depletion of prdm5 resulted in impairment of morphogenetic movements during gastrulation and increased the occurrence of the masterblind phenotype in axin+/- embryos, characterized by the loss of eyes and telencephalon. Overexpression of PRDM5 mRNA had opposite effects on the development of anterior neural structures, and resulted in embryos with a shorter body axis due to posterior truncation, a bigger head and abnormal somites. In situ hybridization experiments aimed at analyzing the integrity of wnt pathways during gastrulation at the level of the prechordal plate revealed inhibition of non canonical PCP wnt signaling in embryos overexpressing PRDM5, and over-activation of wnt/beta-catenin signaling in embryos lacking Prdm5. Our data demonstrate that PRDM5 regulates the expression of components of both canonical and non canonical wnt pathways and negatively modulates wnt signaling in vivo.	[Alcalay, Myriam] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Pezzimenti, Federica; Deflorian, Gianluca; Alcalay, Myriam] Cogentech, Milan, Italy; [Deflorian, Gianluca; Mione, Marina] Inst Molecular Oncol Fdn, IFOM, FIRC, Milan, Italy; [Alcalay, Myriam] Univ Studi Milano, Dipartimento Med, Chirurg Odontoiat, Milan, Italy	IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology; University of Milan	Meani, N (corresponding author), European Inst Oncol, Dept Expt Oncol, Milan, Italy.	marina.mione@ifom-ieo-campus.it; myriam.alcalay@ifom-ieo-campus.it	Alcalay, Myriam/AAB-4300-2019; Alcalay, Myriam/B-3182-2016; Mione, Maria Caterina/ABG-9926-2021; Mione, Maria Caterina/I-3073-2013	Alcalay, Myriam/0000-0002-5558-4272; Alcalay, Myriam/0000-0002-5558-4272; Mione, Maria Caterina/0000-0002-9040-3705	Associazione Italiana per la Ricerca sul Cancro (AIRC); Fondazione Cariplo	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariplo(Fondazione Cariplo)	This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro (AIRC) and from Fondazione Cariplo to M.A.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki T, 1996, NEURON, V17, P353, DOI 10.1016/S0896-6273(00)80166-X; Caneparo L, 2007, GENE DEV, V21, P465, DOI 10.1101/gad.406007; Cavodeassi F, 2005, NEURON, V47, P43, DOI 10.1016/j.neuron.2005.05.026; Chadwick RB, 2000, P NATL ACAD SCI USA, V97, P2662, DOI 10.1073/pnas.040579497; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Costagli A, 2002, J COMP NEUROL, V450, P73, DOI 10.1002/cne.10292; Deng QD, 2004, ONCOGENE, V23, P4903, DOI 10.1038/sj.onc.1207615; Duan Z, 2007, MOL CELL BIOL, V27, P6889, DOI 10.1128/MCB.00762-07; Finocchiaro G, 2004, BIOINFORMATICS, V20, P3670, DOI 10.1093/bioinformatics/bth416; Gibson MA, 1999, J BIOL CHEM, V274, P13060, DOI 10.1074/jbc.274.19.13060; He LS, 1998, CANCER RES, V58, P4238; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Hoyt PR, 1997, MECH DEVELOP, V65, P55, DOI 10.1016/S0925-4773(97)00057-9; Huang S, 2002, NAT REV CANCER, V2, P469, DOI 10.1038/nrc819; Jiang GL, 1999, INT J CANCER, V83, P541, DOI 10.1002/(SICI)1097-0215(19991112)83:4<541::AID-IJC17>3.0.CO;2-F; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; MITANI K, 1994, EMBO J, V13, P504, DOI 10.1002/j.1460-2075.1994.tb06288.x; Mochizuki N, 2000, BLOOD, V96, P3209, DOI 10.1182/blood.V96.9.3209.h8003209_3209_3214; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Peeters P, 1997, CANCER RES, V57, P564; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Sakurada K, 2001, GENE CHROMOSOME CANC, V30, P207, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1080>3.0.CO;2-V; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; SolnicaKrezel L, 1996, DEVELOPMENT, V123, P67; Song HH, 2002, BBA-GEN SUBJECTS, V1573, P241, DOI 10.1016/S0304-4165(02)00390-2; Song HH, 2005, J BIOL CHEM, V280, P2116, DOI 10.1074/jbc.M410090200; Tada M, 2000, DEVELOPMENT, V127, P2227; Tam W, 2006, BLOOD, V107, P4090, DOI 10.1182/blood-2005-09-3778; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; Watanabe Y, 2007, CLIN CANCER RES, V13, P4786, DOI 10.1158/1078-0432.CCR-07-0305; Wilm TP, 2005, DEVELOPMENT, V132, P393, DOI 10.1242/dev.01572; WU Y, 2007, J MOL CELL CARDIOL; Yang XH, 1999, GENOMICS, V61, P319, DOI 10.1006/geno.1999.5967	38	40	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2009	4	1							e4273	10.1371/journal.pone.0004273	http://dx.doi.org/10.1371/journal.pone.0004273			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JE	19169355	Green Published, gold, Green Submitted			2022-12-25	WOS:000265482800003
J	Mruk, K; Kobertz, WR				Mruk, Karen; Kobertz, William R.			Discovery of a Novel Activator of KCNQ1-KCNE1 K+ Channel Complexes	PLOS ONE			English	Article								KCNQ1 voltage-gated K+ channels (Kv7.1) associate with the family of five KCNE peptides to form complexes with diverse gating properties and pharmacological sensitivities. The varied gating properties of the different KCNQ1-KCNE complexes enables the same K+ channel to function in both excitable and non excitable tissues. Small molecule activators would be valuable tools for dissecting the gating mechanisms of KCNQ1-KCNE complexes; however, there are very few known activators of KCNQ1 channels and most are ineffective on the physiologically relevant KCNQ1-KCNE complexes. Here we show that a simple boronic acid, phenylboronic acid (PBA), activates KCNQ1/KCNE1 complexes co-expressed in Xenopus oocytes at millimolar concentrations. PBA shifts the voltage sensitivity of KCNQ1 channel complexes to favor the open state at negative potentials. Analysis of different- sized charge carriers revealed that PBA also targets the permeation pathway of KCNQ1 channels. Activation by the boronic acid moiety has some specificity for the Kv7 family members (KCNQ1, KCNQ2/3, and KCNQ4) since PBA does not activate Shaker or hERG channels. Furthermore, the commercial availability of numerous PBA derivatives provides a large class of compounds to investigate the gating mechanisms of KCNQ1-KCNE complexes.	[Mruk, Karen; Kobertz, William R.] Univ Massachusetts, Sch Med, Program Neurosci, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Mruk, K (corresponding author), Univ Massachusetts, Sch Med, Program Neurosci, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	william.kobertz@umassmed.edu	Mruk, Karen/J-7135-2019	Mruk, Karen/0000-0003-4560-4951	NIH (NIDCD) [DC007669]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007669] Funding Source: NIH RePORTER	NIH (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work was supported by the NIH (NIDCD) DC007669. The NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitbol I, 1999, EMBO J, V18, P4137, DOI 10.1093/emboj/18.15.4137; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Baukrowitz T, 1996, SCIENCE, V271, P653, DOI 10.1126/science.271.5249.653; Bunn PA, 2004, CLIN CANCER RES, V10, p4263S, DOI 10.1158/1078-0432.CCR-040011; Busch AE, 1997, BRIT J PHARMACOL, V122, P187, DOI 10.1038/sj.bjp.0701434; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; Cooper EC, 2003, ARCH NEUROL-CHICAGO, V60, P496, DOI 10.1001/archneur.60.4.496; Gage SD, 2004, J GEN PHYSIOL, V124, P759, DOI 10.1085/jgp.200409114; Gao ZB, 2008, J BIOL CHEM, V283, P22649, DOI 10.1074/jbc.M802426200; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Jespersen T, 2005, PHYSIOLOGY, V20, P408, DOI 10.1152/physiol.00031.2005; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lerche C, 2000, BRIT J PHARMACOL, V131, P1503, DOI 10.1038/sj.bjp.0703734; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Li Y, 2004, J NEUROSCI, V24, P5079, DOI 10.1523/JNEUROSCI.0882-04.2004; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; Mitcheson JS, 2000, J GEN PHYSIOL, V115, P229, DOI 10.1085/jgp.115.3.229; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Nakajo K, 2007, J GEN PHYSIOL, V130, P269, DOI 10.1085/jgp.200709805; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Panaghie G, 2007, J GEN PHYSIOL, V129, P121, DOI 10.1085/jgp.200609612; PATTHY L, 1975, J BIOL CHEM, V250, P557; Pusch M, 2000, BIOPHYS J, V78, P211, DOI 10.1016/S0006-3495(00)76586-6; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Roche JP, 2002, BRIT J PHARMACOL, V137, P1173, DOI 10.1038/sj.bjp.0704989; Rocheleau JM, 2008, J GEN PHYSIOL, V131, P59, DOI 10.1085/jgp.200709816; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Salata JJ, 1998, MOL PHARMACOL, V54, P220, DOI 10.1124/mol.54.1.220; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Seebohm G, 2003, J PHYSIOL-LONDON, V552, P369, DOI 10.1113/jphysiol.2003.046490; Seebohm G, 2003, MOL PHARMACOL, V64, P70, DOI 10.1124/mol.64.1.70; Selyanko AA, 2001, J PHYSIOL-LONDON, V534, P15, DOI 10.1111/j.1469-7793.2001.00015.x; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Springsteen G, 2002, TETRAHEDRON, V58, P5291, DOI 10.1016/S0040-4020(02)00489-1; Xiong QJ, 2008, TRENDS PHARMACOL SCI, V29, P99, DOI 10.1016/j.tips.2007.11.010; Yan J, 2004, TETRAHEDRON, V60, P11205, DOI 10.1016/j.tet.2004.08.051; Yang YS, 1998, J GEN PHYSIOL, V112, P665, DOI 10.1085/jgp.112.6.665; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494	44	25	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4236	10.1371/journal.pone.0004236	http://dx.doi.org/10.1371/journal.pone.0004236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JB	19156197	Green Published, Green Submitted, gold			2022-12-25	WOS:000265482100008
J	Schmid, AW; Chiappe, D; Pignat, V; Grimminger, V; Hang, I; Moniatte, M; Lashuel, HA				Schmid, Adrien W.; Chiappe, Diego; Pignat, Verene; Grimminger, Valerie; Hang, Ivan; Moniatte, Marc; Lashuel, Hilal A.			Dissecting the Mechanisms of Tissue Transglutaminase-induced Cross-linking of alpha-Synuclein IMPLICATIONS FOR THE PATHOGENESIS OF PARKINSON DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; POLYGLUTAMINE DOMAINS; HUNTINGTON-DISEASE; FIBRIL FORMATION; AMYLOID PROTEIN; LEWY BODIES; AGGREGATION; TAU; MUTATION; REPEATS	Tissue transglutaminase (tTG) has been implicated in the pathogenesis of Parkinson disease (PD). However, exactly how tTG modulates the structural and functional properties of alpha-synuclein (alpha-syn) and contributes to the pathogenesis of PD remains unknown. Using site-directed mutagenesis combined with detailed biophysical and mass spectrometry analyses, we sought to identify the exact residues involved in tTG-catalyzed cross-linking of wild-type alpha-syn and alpha-syn mutants associated with PD. To better understand the structural consequences of each cross-linking reaction, we determined the effect of tTG-catalyzed cross-linking on the oligomerization, fibrillization, and membrane binding of alpha-syn in vitro. Our findings show that tTG-catalyzed cross-linking of monomeric alpha-syn involves multiple cross-links (specifically 2-3). We subjected tTG-catalyzed cross-linked monomeric alpha-syn composed of either wild-type or Gln -> Asn mutants to sequential proteolysis by multiple enzymes and peptide mapping by mass spectrometry. Using this approach, we identified the glutamine and lysine residues involved in tTG-catalyzed intramolecular cross-linking of alpha-syn. These studies demonstrate for the first time that Gln(79) and Gln(109) serve as the primary tTG reactive sites. Mutating both residues to asparagine abolishes tTG-catalyzed cross-linking of alpha-syn and tTG-induced inhibition of alpha-syn fibrillization in vitro. To further elucidate the sequence and structural basis underlying these effects, we identified the lysine residues that form isopeptide bonds with Gln(79) and Gln(109). This study provides mechanistic insight into the sequence and structural basis of the inhibitory effects of tTG on alpha-syn fibrillogenesis in vivo, and it sheds light on the potential role of tTG cross-linking on modulating the physiological and pathogenic properties of alpha-syn.	[Schmid, Adrien W.; Pignat, Verene; Grimminger, Valerie; Hang, Ivan; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol Neurobiol & Neuroprote, CH-1015 Lausanne, Switzerland; [Chiappe, Diego; Moniatte, Marc; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Prote Core Facil, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Lashuel, HA (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol Neurobiol & Neuroprote, CH-1015 Lausanne, Switzerland.	hilal.lashuel@epfl.ch	Lashuel, Hilal/M-3500-2017; Schmid, Adrien/CAG-1527-2022	Moniatte, Marc/0000-0003-2235-4523	Swiss Federal Institute of Technology Lausanne	Swiss Federal Institute of Technology Lausanne	This work was supported by the Swiss Federal Institute of Technology Lausanne.	Andringa G, 2004, FASEB J, V18, P932, DOI 10.1096/fj.03-0829fje; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bonelli RM, 2002, NEUROBIOL DIS, V11, P106, DOI 10.1006/nbdi.2002.0535; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Chun WJ, 2001, J CELL BIOL, V153, P25, DOI 10.1083/jcb.153.1.25; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cooper AJL, 2002, NEUROCHEM INT, V40, P53, DOI 10.1016/S0197-0186(01)00058-4; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; De Vivo G, 2008, CNS NEUROL DISORD-DR, V7, P370, DOI 10.2174/187152708786441821; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Duda JE, 2000, AM J PATHOL, V157, P1439, DOI 10.1016/S0002-9440(10)64781-5; DUDEK SM, 1993, J NEUROCHEM, V61, P1159, DOI 10.1111/j.1471-4159.1993.tb03636.x; Emanuelsson Cecilia Sundby, 2005, J Biomol Tech, V16, P197; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Gentile V, 1998, ARCH BIOCHEM BIOPHYS, V352, P314, DOI 10.1006/abbi.1998.0592; Goedert M, 1997, NATURE, V388, P232, DOI 10.1038/40767; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; HO GJ, 1994, FEBS LETT, V349, P151, DOI 10.1016/0014-5793(94)00663-6; IKURA K, 1993, FEBS LETT, V326, P109, DOI 10.1016/0014-5793(93)81772-R; JENSEN PH, 1995, BIOCHEM J, V310, P91, DOI 10.1042/bj3100091; Junn E, 2003, P NATL ACAD SCI USA, V100, P2047, DOI 10.1073/pnas.0438021100; Karpuj MV, 2002, NAT MED, V8, P143, DOI 10.1038/nm0202-143; Kim SY, 2005, NEUROCHEM RES, V30, P1245, DOI 10.1007/s11064-005-8796-x; Konno T, 2005, BIOCHEMISTRY-US, V44, P2072, DOI 10.1021/bi047722d; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lai TS, 2004, J NEUROCHEM, V88, P1253, DOI 10.1046/j.1471-4159.2003.02249.x; Lesort M, 2002, NEUROCHEM INT, V40, P37, DOI 10.1016/S0197-0186(01)00059-6; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; MILLER ML, 1995, J NEUROCHEM, V65, P1760; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Park SC, 1999, J GERONTOL A-BIOL, V54, pB78, DOI 10.1093/gerona/54.2.B78; POLLANEN MS, 1993, BRAIN RES, V603, P121, DOI 10.1016/0006-8993(93)91307-E; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Riess O, 1998, MOL MED TODAY, V4, P438, DOI 10.1016/S1357-4310(98)01343-4; Segers-Nolten IMJ, 2008, PROTEIN SCI, V17, P1395, DOI 10.1110/ps.036103.108; SELKOE DJ, 1982, P NATL ACAD SCI-BIOL, V79, P6070, DOI 10.1073/pnas.79.19.6070; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tucholski J, 1999, J NEUROCHEM, V73, P1871; Violante V, 2001, BRAIN RES BULL, V56, P169, DOI 10.1016/S0361-9230(01)00576-7; Wang DS, 2008, INT J CLIN EXP PATHO, V1, P5; Yamin G, 2003, FEBS LETT, V542, P147, DOI 10.1016/S0014-5793(03)00367-3; Zemaitaitis MO, 2000, J NEUROPATH EXP NEUR, V59, P983, DOI 10.1093/jnen/59.11.983; Zhang JW, 1998, J NEUROCHEM, V71, P240	45	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13128	13142		10.1074/jbc.M809067200	http://dx.doi.org/10.1074/jbc.M809067200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19164286	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000265688300060
J	Meyer, NJ; Huang, Y; Singleton, PA; Sammani, S; Moitra, J; Evenoski, CL; Husain, AN; Mitra, S; Moreno-Vinasco, L; Jacobson, JR; Lussier, YA; Garcia, JGN				Meyer, Nuala J.; Huang, Yong; Singleton, Patrick A.; Sammani, Saad; Moitra, Jaideep; Evenoski, Carrie L.; Husain, Aliya N.; Mitra, Sumegha; Moreno-Vinasco, Liliana; Jacobson, Jeffrey R.; Lussier, Yves A.; Garcia, Joe G. N.			GADD45a is a novel candidate gene in inflammatory lung injury via influences on Akt signaling	FASEB JOURNAL			English	Article						mechanical ventilation; biomarker; vascular barrier regulation; ubiquitination	RESPIRATORY-DISTRESS-SYNDROME; CELL BARRIER FUNCTION; SPHINGOSINE 1-PHOSPHATE; PHOSPHOINOSITIDE 3-KINASE; TIDAL VOLUME; GENOMIC INSTABILITY; EXPRESSION ANALYSIS; P110-DELTA ISOFORM; PULMONARY-EDEMA; RECEPTOR	We explored the mechanistic involvement of the growth arrest and DNA damage-inducible gene GADD45a in lipopolysaccharide (LPS)- and ventilator-induced inflammatory lung injury (VILI). Multiple biochemical and genomic parameters of inflammatory lung injury indicated that GADD45a(-/-) mice are modestly susceptible to intratracheal LPS-induced lung injury and profoundly susceptible to high tidal volume VILI, with increases in microvascular permeability and bronchoalveolar lavage levels of inflammatory cytokines. Expression profiling of lung tissues from VILI-challenged GADD45a(-/-) mice revealed strong dysregulation in the B-cell receptor signaling pathway compared with wild-type mice and suggested the involvement of PI3 kinase/Akt signaling components. Western blot analyses of lung homogenates confirmed similar to 50% reduction in Akt protein levels in GADD45a(-/-) mice accompanied by marked increases in Akt ubiquitination. Electrical resistance measurements across human lung endothelial cell monolayers with either reduced GADD45a or Akt expression (siRNAs) revealed significant potentiation of LPS-induced human lung endothelial barrier dysfunction, which was attenuated by overexpression of a constitutively active Akt1 transgene. These studies validate GADD45a as a novel candidate gene in inflammatory lung injury and a significant participant in vascular barrier regulation via effects on Akt-mediated endothelial signaling.-Meyer, N. J., Huang, Y., Singleton, P. A., Sammani, S., Moitra, J., Evenoski, C. L., Husain, A. N., Mitra, S., Moreno-Vinasco, L., Jacobson, J. R., Lussier, Y. A., Garcia, J. G. N. GADD45a is a novel candidate gene in inflammatory lung injury via influences on Akt signaling. FASEB J. 23, 1325-1337 (2009)	[Meyer, Nuala J.; Singleton, Patrick A.; Sammani, Saad; Moitra, Jaideep; Evenoski, Carrie L.; Mitra, Sumegha; Moreno-Vinasco, Liliana; Jacobson, Jeffrey R.; Garcia, Joe G. N.] Univ Chicago, Pritzker Sch Med, Dept Med, Pulm & Crit Care Med Sect, Chicago, IL 60637 USA; [Huang, Yong; Lussier, Yves A.] Univ Chicago, Pritzker Sch Med, Dept Med, Med Genet Sect, Chicago, IL 60637 USA; [Husain, Aliya N.] Univ Chicago, Pritzker Sch Med, Dept Pathol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Garcia, JGN (corresponding author), Univ Chicago, Pritzker Sch Med, Dept Med, Pulm & Crit Care Med Sect, W604,5841 S Maryland Ave, Chicago, IL 60637 USA.	jgarcia@medicine.bsd.uchicago.edu	Garcia, Joe GN/E-8862-2010; Lussier, Yves/N-4891-2017	Lussier, Yves/0000-0001-9854-1005; Mitra, Sumegha/0000-0002-5567-3347	U.S. National Institutes of Health [PPG HL-58064, F32 HL-088858-01, R01 HL-088144, K08 HL-077134-01, K22 LMV-008308]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088144, P01HL058064, F32HL088858, K08HL077134] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM008308] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We are extremely grateful to Dr. Michael O'Reilly (University of Rochester, Rochester, NY, USA) and Dr. Albert Fornace (Brigham and Women's Hospital, Boston, MA, USA) for generously providing the GADD45a<SUP>-/-</SUP> mice. We acknowledge the invaluable contributions of Dr. Shwu-Fan Ma, for her genomic expertise and other important insights. We also acknowledge Lakshmi Natarajan, Darrel Sparkman, Annette Westerberg, and Nicholas Shank, for their outstanding expertise and invaluable assistance. This work was supported by U.S. National Institutes of Health grants PPG HL-58064, F32 HL-088858-01, R01 HL-088144, K08 HL-077134-01, and K22 LMV-008308.	AGUADO MT, 1987, J IMMUNOL, V139, P1080; Altemeier WA, 2005, J IMMUNOL, V175, P3369, DOI 10.4049/jimmunol.175.5.3369; Bajwa EK, 2006, P AM THORAC SOC, V3, pA272; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Befort K, 2003, EUR J NEUROSCI, V18, P911, DOI 10.1046/j.1460-9568.2003.02827.x; Birukov KG, 2003, AM J PHYSIOL-LUNG C, V285, pL785, DOI 10.1152/ajplung.00336.2002; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; CORBRIDGE TC, 1990, AM REV RESPIR DIS, V142, P311, DOI 10.1164/ajrccm/142.2.311; DREYFUSS D, 1985, AM REV RESPIR DIS, V132, P880; DREYFUSS D, 1993, AM REV RESPIR DIS, V148, P1194, DOI 10.1164/ajrccm/148.5.1194; EILAT D, 1989, EUR J IMMUNOL, V19, P1241, DOI 10.1002/eji.1830190714; FORNACE AJ, 1988, P NATL ACAD SCI USA, V85, P8800, DOI 10.1073/pnas.85.23.8800; Frank JA, 2006, CHEST, V130, P1906, DOI 10.1378/chest.130.6.1906; Gajic O, 2005, INTENS CARE MED, V31, P922, DOI 10.1007/s00134-005-2625-1; Gajic O, 2004, CRIT CARE MED, V32, P1817, DOI 10.1097/01.CCM.0000133019.52531.30; Garcia JGN, 1997, AM J PHYSIOL-LUNG C, V273, pL172, DOI 10.1152/ajplung.1997.273.1.L172; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Gong MN, 2004, CHEST, V125, P203, DOI 10.1378/chest.125.1.203; Gong MN, 2005, EUR RESPIR J, V26, P382, DOI 10.1183/09031936.05.00000505; Grigoryev DN, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r34; Hebeis BJ, 2004, BIOCHEM SOC T, V32, P789, DOI 10.1042/BST0320789; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; HOLLANDER MC, 1993, J BIOL CHEM, V268, P24385; Hollander MC, 2005, CELL CYCLE, V4, P704, DOI 10.4161/cc.4.5.1675; Hong SB, 2008, AM J RESP CRIT CARE, V178, P605, DOI 10.1164/rccm.200712-1822OC; HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182; Jacobson JR, 2005, AM J PHYSIOL-LUNG C, V288, pL1026, DOI 10.1152/ajplung.00354.2004; Jung HJ, 2007, ONCOGENE, V26, P7517, DOI 10.1038/sj.onc.1210557; Kim N, 2007, BLOOD, V110, P3202, DOI 10.1182/blood-2007-02-075366; Kittleson MM, 2005, PHYSIOL GENOMICS, V21, P299, DOI 10.1152/physiolgenomics.00255.2004; Lionetti V, 2006, CRIT CARE MED, V34, P134, DOI 10.1097/01.CCM.0000190909.70601.2C; Liu F, 2002, FASEB J, V16, P950, DOI 10.1096/fj.01-0870com; Ma SF, 2005, AM J PHYSIOL-LUNG C, V289, pL468, DOI 10.1152/ajplung.00109.2005; Marshall RP, 2002, AM J RESP CRIT CARE, V166, P646, DOI 10.1164/rccm.2108086; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; McVerry BJ, 2004, AM J RESP CRIT CARE, V170, P987, DOI 10.1164/rccm.200405-684oc; Meyer Nuala J, 2007, Proc Am Thorac Soc, V4, P69, DOI 10.1513/pats.200609-157JG; Miyahara T, 2007, AM J PHYSIOL-LUNG C, V293, pL11, DOI 10.1152/ajplung.00279.2005; MONESTIER M, 1986, J CLIN INVEST, V78, P753, DOI 10.1172/JCI112637; MONESTIER M, 1987, J EXP MED, V166, P1109, DOI 10.1084/jem.166.4.1109; Moss M, 2002, CRIT CARE MED, V30, P1679, DOI 10.1097/00003246-200208000-00001; Nonas SA, 2007, AM J PHYSIOL-LUNG C, V293, pL292, DOI 10.1152/ajplung.00481.2006; Nonas Stephanie A, 2005, Proc Am Thorac Soc, V2, P188, DOI 10.1513/pats.200501-005AC; O'Reilly MA, 2000, AM J PHYSIOL-LUNG C, V278, pL552, DOI 10.1152/ajplung.2000.278.3.L552; Okada T, 2000, IMMUNITY, V13, P817, DOI 10.1016/S1074-7613(00)00079-0; Okkenhaug K, 2007, TRENDS IMMUNOL, V28, P80, DOI 10.1016/j.it.2006.12.007; Okkenhaug K, 2006, J IMMUNOL, V177, P5122, DOI 10.4049/jimmunol.177.8.5122; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; PEPE PE, 1982, AM J SURG, V144, P124, DOI 10.1016/0002-9610(82)90612-2; Puri KD, 2005, BLOOD, V106, P150, DOI 10.1182/blood-2005-01-0023; Roper JM, 2005, AM J PHYSIOL-LUNG C, V288, pL663, DOI 10.1152/ajplung.00355.2004; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Salvador JM, 2005, NAT IMMUNOL, V6, P396, DOI 10.1038/ni1176; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Schreibelt G, 2007, FASEB J, V21, P3666, DOI 10.1096/fj.07-8329com; Sheikh MS, 2000, BIOCHEM PHARMACOL, V59, P43, DOI 10.1016/S0006-2952(99)00291-9; Shi S, 1998, ENDOTHELIUM-J ENDOTH, V6, P153, DOI 10.3109/10623329809072202; Singleton PA, 2006, J BIOL CHEM, V281, P34381, DOI 10.1074/jbc.M603680200; *TEAM R D C, 2006, R LANG ENV STAT COMP; Wang ZX, 2008, AM J RESP CELL MOL, V38, P724, DOI 10.1165/rcmb.2007-0354OC; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; WEBB HH, 1974, AM REV RESPIR DIS, V110, P556; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Ye SQ, 2005, AM J RESP CRIT CARE, V171, P361, DOI 10.1164/rccm.200404-563OC; Young SH, 2008, J IMMUNOL METHODS, V331, P59, DOI 10.1016/j.jim.2007.11.004; Zerbini LF, 2004, P NATL ACAD SCI USA, V101, P13618, DOI 10.1073/pnas.0402069101	66	49	52	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2009	23	5					1325	1337		10.1096/fj.08-119073	http://dx.doi.org/10.1096/fj.08-119073			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19124556	Green Published			2022-12-25	WOS:000266651700009
J	Song, SX; Liu, D; Peng, JL; Deng, HW; Guo, Y; Xu, LX; Miller, AD; Xu, YH				Song, Shuxian; Liu, Dan; Peng, Jinliang; Deng, Hongwei; Guo, Yan; Xu, Lisa X.; Miller, Andrew D.; Xu, Yuhong			Novel peptide ligand directs liposomes toward EGF-R high-expressing cancer cells in vitro and in vivo	FASEB JOURNAL			English	Article						AutoDock; epidermal growth factor; computer aided design; proteomic code; PEG; lipid	EPIDERMAL-GROWTH-FACTOR; PROLONGED CIRCULATION TIME; EFFICIENT DRUG-DELIVERY; FACTOR RECEPTOR; AUTOMATED DOCKING; TARGETED DELIVERY; COATED LIPOSOMES; TUMOR-CELLS; IMMUNOLIPOSOMES; DOXORUBICIN	Epidermal growth factor receptor (EGF-R) is an important target in anticancer therapy. Here we report how a novel EGF-R peptide ligand (D4: Leu-Ala-Arg-Leu-Leu-Thr) is identified using a computer-aided design approach from a virtual peptide library of putative EGF-R binding peptides by screening against the EGF-R X-ray crystal structure in silico and in vitro. The selected peptide is conjugated with a polyethylene glycol (PEG) lipid, and the lipid moiety of the peptide-PEG-lipid conjugate is inserted into liposome membranes by a postmodification process. D4 peptide-conjugated liposomes are found to bind to and enter cells by endocytosis specifically and efficiently in vitro in a process apparently mediated by EGF-R high-expressing cancer cells (H1299). In vivo, the D4 peptide-conjugated liposomes are found to accumulate in EGF-R-expressing xenograft tumor tissues up to 80 h after intravenous delivery, in marked contrast to controls. These results demonstrate how structure-based peptide design can be an efficient approach to identify highly novel binding ligands against important receptors. These data could have important consequences for the development of peptide-directed drug delivery systems with engineered specificities and prolonged times of action.-Song, S., Liu, D., Peng, J., Deng, H., Guo, Y., Xu, L. X., Miller, A. D., Xu, Y. Novel peptide ligand directs liposomes toward EGF-R high-expressing cancer cells in vitro and in vivo. FASEB J. 23, 1396-1404 (2009)	[Miller, Andrew D.] Univ London Imperial Coll Sci Technol & Med, Dept Chem, Genet Therapies Ctr, London SW7 2AZ, England; [Song, Shuxian; Liu, Dan; Guo, Yan; Xu, Lisa X.] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China; [Peng, Jinliang] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Shanghai 200240, Peoples R China; [Deng, Hongwei; Xu, Yuhong] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China; [Miller, Andrew D.] ImuThes Ltd, London, England	Imperial College London; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Miller, AD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Chem, Genet Therapies Ctr, London SW7 2AZ, England.	a.miller@imperial.ac.uk; yhxu@sjtu.edu.cn	Miller, Andrew/G-8291-2019; Xu, Yuhong/E-4247-2012	Miller, Andrew/0000-0003-0661-249X; 	National Science Foundation of China [30472097]; Fok Ying Tong Education Foundation [91035]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fok Ying Tong Education Foundation(Fok Ying Tung Education Foundation)	Funding was provided by National Science Foundation of China grant 30472097 and Fok Ying Tong Education Foundation grant 91035.	Bhakoo A, 2004, MOL IMMUNOL, V41, P1217, DOI 10.1016/j.molimm.2004.05.011; Blessing T, 2001, BIOCONJUGATE CHEM, V12, P529, DOI 10.1021/bc0001488; Chen P, 2002, NUCL MED BIOL, V29, P693, DOI 10.1016/S0969-8051(02)00325-6; de Graaf C, 2005, J MED CHEM, V48, P2308, DOI 10.1021/jm049650u; de Menezes DEL, 1998, CANCER RES, V58, P3320; DERKSEN JTP, 1988, BIOCHIM BIOPHYS ACTA, V971, P127, DOI 10.1016/S0005-2728(88)80099-9; GABIZON A, 1994, CANCER RES, V54, P987; Gabizon A, 2003, CLIN CANCER RES, V9, P6551; Gabizon AA, 2006, J LIPOSOME RES, V16, P175, DOI 10.1080/08982100600848769; Goren D, 1996, BRIT J CANCER, V74, P1749, DOI 10.1038/bjc.1996.625; HARAN G, 1993, BIOCHIM BIOPHYS ACTA, V1151, P201, DOI 10.1016/0005-2736(93)90105-9; HARAN G, 1994, BBA-BIOMEMBRANES, V1190, P197; Heal JR, 2002, CHEMBIOCHEM, V3, P137, DOI 10.1002/1439-7633(20020301)3:2/3<136::AID-CBIC136>3.0.CO;2-7; Hetenyi C, 2002, PROTEIN SCI, V11, P1729, DOI 10.1110/ps.0202302; Hsu AR, 2006, MOL IMAGING BIOL, V8, P315, DOI 10.1007/s11307-006-0059-y; Huwyler J, 1997, J PHARMACOL EXP THER, V282, P1541; Ishida T, 1999, FEBS LETT, V460, P129, DOI 10.1016/S0014-5793(99)01320-4; Jinno H, 1996, CANCER CHEMOTH PHARM, V38, P303, DOI 10.1007/s002800050487; Kamaly N, 2008, BIOCONJUGATE CHEM, V19, P118, DOI 10.1021/bc7001715; Ke S, 2003, CANCER RES, V63, P7870; Kirpotin DB, 2006, CANCER RES, V66, P6732, DOI 10.1158/0008-5472.CAN-05-4199; Koning GA, 2003, PHARMACEUT RES, V20, P1249, DOI 10.1023/A:1025009300562; Koning GA, 2001, PHARMACEUT RES, V18, P1291, DOI 10.1023/A:1013085811044; Kullberg EB, 2003, PHARMACEUT RES, V20, P229, DOI 10.1023/A:1022223204460; LEE RJ, 1995, BBA-BIOMEMBRANES, V1233, P134, DOI 10.1016/0005-2736(94)00235-H; Li ZH, 2005, FASEB J, V19, P1978, DOI 10.1096/fj.05-4058com; Liu X, 2002, CANCER GENE THER, V9, P100, DOI 10.1038/sj/cgt/7700400; Lutsenko SV, 2002, J DRUG TARGET, V10, P567, DOI 10.1080/1061186021000038058; Ma GB, 2007, APPL OPTICS, V46, P1650, DOI 10.1364/AO.46.001650; Mamot C, 2005, CANCER RES, V65, P11631, DOI 10.1158/0008-5472.CAN-05-1093; Mamot C, 2003, CANCER RES, V63, P3154; Mamot C, 2006, J DRUG TARGET, V14, P215, DOI 10.1080/10611860600691049; Maruyama K, 1997, FEBS LETT, V413, P177, DOI 10.1016/S0014-5793(97)00905-8; MARUYAMA K, 1995, BBA-BIOMEMBRANES, V1234, P74, DOI 10.1016/0005-2736(94)00263-O; Mastrobattista E, 1999, ADV DRUG DELIVER REV, V40, P103, DOI 10.1016/S0169-409X(99)00043-5; Matsumura Y, 2004, ANN ONCOL, V15, P517, DOI 10.1093/annonc/mdh092; MAYER LD, 1990, BIOCHIM BIOPHYS ACTA, V1025, P143, DOI 10.1016/0005-2736(90)90091-2; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; PARK JW, 1995, P NATL ACAD SCI USA, V92, P1327, DOI 10.1073/pnas.92.5.1327; Perez-Soler R, 2004, ONCOLOGIST, V9, P58, DOI 10.1634/theoncologist.9-1-58; Rogers JP, 2006, J MED CHEM, V49, P1658, DOI 10.1021/jm051033y; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Sapra P, 2004, CLIN CANCER RES, V10, P1100, DOI 10.1158/1078-0432.CCR-03-0041; Schiffelers RM, 2003, J CONTROL RELEASE, V91, P115, DOI 10.1016/S0168-3659(03)00240-2; Schmidt M, 1997, BRIT J CANCER, V75, P1575, DOI 10.1038/bjc.1997.270; Song SX, 2008, INT J PHARMACEUT, V363, P155, DOI 10.1016/j.ijpharm.2008.07.012; Terada T, 2006, J DRUG TARGET, V14, P536, DOI 10.1080/10611860600849498	47	107	114	2	42	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2009	23	5					1396	1404		10.1096/fj.08-117002	http://dx.doi.org/10.1096/fj.08-117002			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19124558				2022-12-25	WOS:000266651700016
J	Tarry-Adkins, JL; Chen, JH; Smith, NS; Jones, RH; Cherif, H; Ozanne, SE				Tarry-Adkins, J. L.; Chen, J. H.; Smith, N. S.; Jones, R. H.; Cherif, H.; Ozanne, S. E.			Poor maternal nutrition followed by accelerated postnatal growth leads to telomere shortening and increased markers of cell senescence in rat islets	FASEB JOURNAL			English	Article						cellular stress; antioxidative defense; DNA damage; DNA repair	LOW-BIRTH-WEIGHT; LOW-PROTEIN-DIET; ENZYME GENE-EXPRESSION; OXIDATIVE STRESS; GLUCOSE-TOLERANCE; INSULIN SENSITIVITY; DIABETES-MELLITUS; PANCREATIC-ISLETS; DNA-DAMAGE; FETAL	Low birth weight (LBW) followed by accelerated postnatal growth is associated with increased risk of developing age-associated diseases such as type 2 diabetes. Gestational protein restriction in rats causes LBW, beta-cell dysfunction, and reduced longevity. These effects may be mediated by accelerated cellular aging. This study tested the hypothesis that LBW followed by rapid postnatal catch-up growth leads to islet telomere shortening through alterations in antioxidant defense capacity, stress/senescence marker proteins, and DNA repair mechanisms at the gene expression level. We used our rat model of gestational protein restriction (recuperated offspring) and control offspring. Southern blotting revealed shorter (P < 0.001) islet telomeres in recuperated animals compared to controls. This was associated with increased expression of peroxiredoxin 1 (P < 0.05), peroxiredoxin 3 (P < 0.01), and heme oxygenase-1 (HO-1) (P < 0.05), which are up-regulated under stress conditions. MnSOD expression was significantly (P < 0.05) decreased in recuperated offspring, suggesting partial impairment of mitochondrial antioxidant defenses. Markers of cellular senescence p21 and p16 were also increased (P < 0.01 and P < 0.05, respectively) in the recuperated group. We conclude that maternal diet influences expression of markers of cellular stress and telomere length in pancreatic islets. This may provide a mechanistic link between early nutrition and growth and type 2 diabetes.-Tarry-Adkins, J. L., Chen, J. H., Smith, N. S., Jones, R. H., Cherif, H., Ozanne, S. E. Poor maternal nutrition followed by accelerated postnatal growth leads to telomere shortening and increased markers of cell senescence in rat islets. FASEB J. 23, 1521-1528 (2009)	[Tarry-Adkins, J. L.] Univ Cambridge, Metab Res Labs, Inst Metab Sci, Addenbrookes Treatment Ctr,Addenbrookes Hosp, Cambridge CB2 OQQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Tarry-Adkins, JL (corresponding author), Univ Cambridge, Metab Res Labs, Inst Metab Sci, Addenbrookes Treatment Ctr,Addenbrookes Hosp, Level 4,Box 289,Hills Rd, Cambridge CB2 OQQ, England.	janeadkins@googlemail.com		Ozanne, Susan/0000-0001-8753-5144; Tarry-Adkins, Jane/0000-0001-9569-6132	Biotechnology and Biological Sciences Research Council; British Heart Foundation; MRC CORD; Parthenon Trust; BBSRC [BB/E002161/1, BB/D007909/1, BB/E00797X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E002161/1, BB/E00797X/1, BB/D007909/1] Funding Source: researchfish; Medical Research Council [G0600717B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); MRC CORD(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Parthenon Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Wayman and D. Hawkes for their technical expertise. This work was supported by the Biotechnology and Biological Sciences Research Council, The British Heart Foundation, MRC CORD, and the Parthenon Trust.	Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Bast A, 2002, DIABETOLOGIA, V45, P867, DOI 10.1007/s00125-002-0846-1; Bo S, 2000, DIABETIC MED, V17, P365, DOI 10.1046/j.1464-5491.2000.00288.x; Chen HN, 2005, DIABETES, V54, P1437, DOI 10.2337/diabetes.54.5.1437; Crowther NJ, 1998, DIABETOLOGIA, V41, P1163, DOI 10.1007/s001250051046; DAHRI S, 1991, DIABETES, V40, P115, DOI 10.2337/diab.40.2.S115; Elouil H, 2005, DIABETOLOGIA, V48, P496, DOI 10.1007/s00125-004-1664-4; Espejel S, 2004, EMBO REP, V5, P503, DOI 10.1038/sj.embor.7400127; Esposito F, 2000, FEBS LETT, V470, P211, DOI 10.1016/S0014-5793(00)01318-1; Forsen T, 2000, ANN INTERN MED, V133, P176, DOI 10.7326/0003-4819-133-3-200008010-00008; Grunnet L, 2007, J INTERN MED, V262, P96, DOI 10.1111/j.1365-2796.2007.01793.x; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Haussmann MF, 2003, P ROY SOC B-BIOL SCI, V270, P1387, DOI 10.1098/rspb.2003.2385; Ishii Tetsuro, 2007, V44, P375; Jemielity S, 2007, AGING CELL, V6, P225, DOI 10.1111/j.1474-9726.2007.00279.x; Jennings BJ, 1999, FEBS LETT, V448, P4, DOI 10.1016/S0014-5793(99)00336-1; Kajimoto Y, 2004, ANN NY ACAD SCI, V1011, P168, DOI 10.1196/annals.1293.017; Kaneto H, 1999, DIABETOLOGIA, V42, P1093, DOI 10.1007/s001250051276; KARAWICZBINISKA A, 2008, MED SCI MONITOR, V8, pCR211; Kawanishi S, 2004, ANN NY ACAD SCI, V1019, P278, DOI 10.1196/annals.1297.047; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; KRISHNAMURTHY J, 2006, NATURE, V28, P404; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lithell HO, 1996, BMJ-BRIT MED J, V312, P406; McPherson JP, 2006, HUM MOL GENET, V15, P831, DOI 10.1093/hmg/ddl002; Mericq V, 2005, DIABETOLOGIA, V48, P2609, DOI 10.1007/s00125-005-0036-z; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Ong KK, 2004, DIABETOLOGIA, V47, P1064, DOI 10.1007/s00125-004-1405-8; Ozanne SE, 2005, DIABETOLOGIA, V48, P547, DOI 10.1007/s00125-005-1669-7; Ozanne SE, 2003, J ENDOCRINOL, V177, P235, DOI 10.1677/joe.0.1770235; Pastwa E, 2003, ACTA BIOCHIM POL, V50, P891; Petrik J, 1999, ENDOCRINOLOGY, V140, P4861, DOI 10.1210/en.140.10.4861; Petry C J, 2001, Int J Exp Diabetes Res, V2, P139; Poulsen P, 1997, DIABETOLOGIA, V40, P439, DOI 10.1007/s001250050698; Rajeevan MS, 2001, METHODS, V25, P443, DOI 10.1006/meth.2001.1266; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Richter T, 2007, EXP GERONTOL, V42, P1039, DOI 10.1016/j.exger.2007.08.005; Sharpless NE, 2004, EXP GERONTOL, V39, P1751, DOI 10.1016/j.exger.2004.06.025; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Shelley P, 2007, MECH AGEING DEV, V128, P681, DOI 10.1016/j.mad.2007.10.002; Simmons RA, 2006, FREE RADICAL BIO MED, V40, P917, DOI 10.1016/j.freeradbiomed.2005.12.018; Simmons RA, 2005, J BIOL CHEM, V280, P28785, DOI 10.1074/jbc.M505695200; Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279; Simmons RA, 2007, REV ENDOCR METAB DIS, V8, P95, DOI 10.1007/s11154-007-9045-1; Sitte N, 1998, FREE RADICAL BIO MED, V24, P885, DOI 10.1016/S0891-5849(97)00363-8; SNOECK A, 1990, BIOL NEONATE, V57, P107, DOI 10.1159/000243170; Tarry-Adkins JL, 2008, FASEB J, V22, P2037, DOI 10.1096/fj.07-099523; Tarry-Adkins JL, 2006, AM J PHYSIOL-RENAL, V290, pF509, DOI 10.1152/ajprenal.00215.2005; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003; Yajnik CS, 2004, J NUTR, V134, P205, DOI 10.1093/jn/134.1.205	53	140	144	0	31	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2009	23	5					1521	1528		10.1096/fj.08-122796	http://dx.doi.org/10.1096/fj.08-122796			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19126595				2022-12-25	WOS:000266651700028
J	Brozzi, F; Arcuri, C; Giambanco, I; Donato, R				Brozzi, Flora; Arcuri, Cataldo; Giambanco, Ileana; Donato, Rosario			S100B Protein Regulates Astrocyte Shape and Migration via Interaction with Src Kinase IMPLICATIONS FOR ASTROCYTE DEVELOPMENT, ACTIVATION, AND TUMOR GROWTH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRILLARY ACIDIC PROTEIN; NEURAL STEM-CELLS; INTERMEDIATE-FILAMENTS; S-100 PROTEIN; BETA-SUBUNIT; RHO-GTPASES; BRAIN; EXPRESSION; BINDING; GFAP	S100B is a Ca2(+)-binding protein of the EF-hand type that is abundantly expressed in astrocytes and has been implicated in the regulation of several intracellular activities, including proliferation and differentiation. We show here that reducing S100B levels in the astrocytoma cell line GL15 and the Muller cell line MIO-M1 by small interference RNA technique results in a rapid disassembly of stress fibers, collapse of F-actin onto the plasma membrane and reduced migration, and acquisition of a stellate shape. Also, S100B-silenced GL15 and MIO-M1 Muller cells show a higher abundance of glial fibrillary acidic protein filaments, which mark differentiated astrocytes, compared with control cells. These effects are dependent on reduced activation of the phosphatidylinositol 3-kinase (PI3K) downstream effectors, Akt and RhoA, and consequently elevated activity of GSK3 beta and Rac1 and decreased activity of the RhoA-associated kinase. Also, rat primary astrocytes transiently down-regulate S100B expression when exposed to the differentiating agent dibutyryl cyclic AMP and re-express S100B at later stages of dibutyryl cyclic AMP-induced differentiation. Moreover, reducing S100B levels results in a remarkably slow resumption of S100B expression, suggesting the S100B might regulate its own expression. Finally, we show that S100B interacts with Src kinase, thereby stimulating the PI3K/Akt and PI3K/RhoA pathways. These results suggest that S100B might contribute to reduce the differentiation potential of cells of the astrocytic lineage and participate in the astrocyte activation process in the case of brain insult and in invasive properties of glioma cells.	[Brozzi, Flora; Arcuri, Cataldo; Giambanco, Ileana; Donato, Rosario] Univ Perugia, Dept Expt Med & Biochem Sci, I-06122 Perugia, Italy	University of Perugia	Donato, R (corresponding author), Univ Perugia, Dept Expt Med & Biochem Sci, CP 81 Succ 3, I-06122 Perugia, Italy.	donato@unipg.it	Donato, Rosario/I-3943-2019	Giambanco, Ileana/0000-0003-0286-6302; Arcuri, Cataldo/0000-0002-3114-8812	Ministero dell'Universita e della Ricerca-University of Perugia FIRB 2001 [RBAU014TJ8_001]; Consorzio Interuniversitario per le Biotecnologie; Fondazione Cassa di Risparmio di Perugia [2004.0282.020_001]	Ministero dell'Universita e della Ricerca-University of Perugia FIRB 2001(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Consorzio Interuniversitario per le Biotecnologie; Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia)	This work was supported by Ministero dell'Universita e della Ricerca-University of Perugia FIRB 2001 Grant RBAU014TJ8_001, Consorzio Interuniversitario per le Biotecnologie, and Fondazione Cassa di Risparmio di Perugia Project 2004.0282.020_001 (to R.D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ALLORE R, 1988, SCIENCE, V239, P1311, DOI 10.1126/science.2964086; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Arcuri C, 2005, J BIOL CHEM, V280, P4402, DOI 10.1074/jbc.M406440200; BIANCHI R, 1993, J BIOL CHEM, V268, P12669; BOCCHINI V, 1991, CELL TISSUE RES, V265, P73, DOI 10.1007/BF00318141; Bonfanti L, 2007, PROG NEUROBIOL, V83, P24, DOI 10.1016/j.pneurobio.2006.11.002; BRENNER M, 1994, BRAIN PATHOL, V4, P245, DOI 10.1111/j.1750-3639.1994.tb00840.x; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Castellino RC, 2007, NAT CLIN PRACT NEURO, V3, P682, DOI 10.1038/ncpneuro0661; Ciccarelli R, 1999, GLIA, V27, P275, DOI 10.1002/(SICI)1098-1136(199909)27:3<275::AID-GLIA9>3.0.CO;2-0; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DONATO R, 1988, J BIOL CHEM, V263, P106; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Edwards MM, 2006, J NEURAL TRANSM, V113, P1709, DOI 10.1007/s00702-006-0479-5; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Farooqui R, 2006, EXP CELL RES, V312, P1514, DOI 10.1016/j.yexcr.2006.01.018; Fischer AJ, 2003, GLIA, V43, P70, DOI 10.1002/glia.10218; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Hachem S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-17; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Holtje M, 2005, J NEUROCHEM, V95, P1237, DOI 10.1111/j.1471-4159.2005.03443.x; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; John GR, 2004, J NEUROSCI, V24, P2837, DOI 10.1523/JNEUROSCI.4789-03.2004; Kim L, 2006, CURR DRUG TARGETS, V7, P1411, DOI 10.2174/1389450110607011411; Koivisto L, 2003, J CELL SCI, V116, P3749, DOI 10.1242/jcs.00693; LANDRY CF, 1989, MOL BRAIN RES, V6, P251, DOI 10.1016/0169-328X(89)90071-5; Lawrence JM, 2007, STEM CELLS, V25, P2033, DOI 10.1634/stemcells.2006-0724; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; Lin J, 2004, J BIOL CHEM, V279, P34071, DOI 10.1074/jbc.M405419200; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Markowitz J, 2007, MINI-REV MED CHEM, V7, P609; Mbele GO, 2002, J BIOL CHEM, V277, P49998, DOI 10.1074/jbc.M205363200; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Merkle FT, 2006, CURR OPIN CELL BIOL, V18, P704, DOI 10.1016/j.ceb.2006.09.008; Millward TA, 1998, EMBO J, V17, P5913, DOI 10.1093/emboj/17.20.5913; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Mrak RE, 2004, J NEUROPATH EXP NEUR, V63, P679, DOI 10.1093/jnen/63.7.679; Mrak RE, 2001, NEUROBIOL AGING, V22, P903, DOI 10.1016/S0197-4580(01)00287-1; Ooto S, 2004, P NATL ACAD SCI USA, V101, P13654, DOI 10.1073/pnas.0402129101; Park CM, 2006, CANCER RES, V66, P8511, DOI 10.1158/0008-5472.CAN-05-4340; Perez V, 2005, EUR J NEUROSCI, V21, P26, DOI 10.1111/j.1460-9568.2004.03845.x; Pinto SS, 2000, FEBS LETT, V486, P203, DOI 10.1016/S0014-5793(00)02301-2; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rakic P, 2003, CEREB CORTEX, V13, P541, DOI 10.1093/cercor/13.6.541; RAMBOTTI MG, 1990, J HISTOCHEM CYTOCHEM, V38, P1583, DOI 10.1177/38.11.2212618; Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445; Reh TA, 2006, METHOD ENZYMOL, V419, P52, DOI 10.1016/S0076-6879(06)19003-5; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Reymond A, 2002, NATURE, V420, P582, DOI 10.1038/nature01178; Rustandi RR, 2000, NAT STRUCT BIOL, V7, P570; Saito T, 2007, EMBO REP, V8, P504, DOI 10.1038/sj.embor.7400934; Salhia B, 2005, CANCER RES, V65, P8792, DOI 10.1158/0008-5472.CAN-05-0160; SELINFREUND RH, 1990, J CELL BIOL, V111, P2021, DOI 10.1083/jcb.111.5.2021; SHASHOUA VE, 1984, J NEUROCHEM, V42, P1536, DOI 10.1111/j.1471-4159.1984.tb12739.x; Skaper SD, 2007, ANN NY ACAD SCI, V1122, P23, DOI 10.1196/annals.1403.002; Sorci G, 1998, BBA-MOL CELL RES, V1448, P277, DOI 10.1016/S0167-4889(98)00134-7; Sorci G, 2003, MOL CELL BIOL, V23, P4870, DOI 10.1128/MCB.23.14.4870-4881.2003; Tardy M, 1990, Adv Exp Med Biol, V265, P41; Van Eldik LJ, 2003, RESTOR NEUROL NEUROS, V21, P97; VANELDIK LJ, 1987, BRAIN RES, V436, P367, DOI 10.1016/0006-8993(87)91681-7; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; WHITAKERAZMITIA PM, 1990, BRAIN RES, V528, P155, DOI 10.1016/0006-8993(90)90210-3; Williams A, 2007, GLIA, V55, P1300, DOI 10.1002/glia.20546; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	72	102	108	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8788	8802		10.1074/jbc.M805897200	http://dx.doi.org/10.1074/jbc.M805897200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19147496	Green Published, hybrid			2022-12-25	WOS:000264397800063
J	Haggie, PM; Verkman, AS				Haggie, Peter M.; Verkman, A. S.			Unimpaired Lysosomal Acidification in Respiratory Epithelial Cells in Cystic Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOSOMAL ACIDIFICATION; CFTR; DISEASE; CLC-7; HYPERACIDIFICATION; ACCUMULATION; LEADS; PH	The mechanisms remain uncertain by which mutations in CFTR cause lung disease in cystic fibrosis (CF). Teichgraber et al. recently reported increased ceramide in CF lungs, which was proposed to result from defective lysosomal acidification in airway epithelial cells and consequent impairment of pH-dependent ceramide-metabolizing enzymes (Teichgraber, V., Ulrich, M., Endlich, N., Reithmuller, J., Wilker, B., Conceicao Ce Olivereira-Munding, C., van Heeckeren, A. M., Barr, M. L., von Kurthy, G., Schmid, K. W., Weller, M., Tummler, B., Lang, F., Grassme, H., Doring, G., and Gulbins, E. (2008) Nat. Med. 14, 382-391). Here, we measured lysosomal pH in several CFTR-expressing and -deficient cell lines, freshly isolated airway epithelial cells from non-CF and CF mice and humans, and well-differentiated primary cultures of human non-CF and CF airway epithelial cells. Lysosomal pH was measured by ratio imaging using a fluorescent pH indicator consisting of 40-kDa dextran conjugated to Oregon Green 488 and tetramethylrhodamine. In all cell types, lysosomal pH was similar to 4.5, unaffected by the thiazolidinone CFTR inhibitor CFTRinh-172, and increased to similar to 6.5 following bafilomycin inhibition of the vacuolar proton pump. Lysosomal pH did not differ significantly in airway epithelial cells from non-CF versus CF humans or mice. Our results provide direct evidence against the conclusions of Teichgraber et al. that lysosomal acidification is CFTR-dependent, impaired in CF, or responsible for ceramide accumulation. As such, alternative mechanisms are needed to explain increased ceramide in CF airways. Non-CFTR mechanisms, such as ClC-type chloride channels, are likely involved in maintaining electroneutrality during organellar acidification.	[Haggie, Peter M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Haggie, PM (corresponding author), Univ Calif San Francisco, Dept Med, 1246 Hlth Sci E, San Francisco, CA 94143 USA.	peter.haggie@ucsf.edu			National Institutes of Health [EB00415, DK35124, HL73856, HL59198, EY13574, DK72517, DK81355]; Cystic Fibrosis Foundation (Research Development Program and Drug Discovery grants); American Heart Association [0765070Y]; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415, R01EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081355, R37DK035124, P30DK072517, R01DK035124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation (Research Development Program and Drug Discovery grants); American Heart Association(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants EB00415, DK35124, HL73856, HL59198, EY13574, DK72517, and DK81355. This work was also supported by the Cystic Fibrosis Foundation (Research Development Program and Drug Discovery grants) and from the American Heart Association (0765070Y). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BARASCH J, 1991, NATURE, V352, P70, DOI 10.1038/352070a0; BIWERSI J, 1994, AM J PHYSIOL, V266, pC149, DOI 10.1152/ajpcell.1994.266.1.C149; Boucher RC, 2007, TRENDS MOL MED, V13, P231, DOI 10.1016/j.molmed.2007.05.001; Caci E, 2008, BIOCHEM J, V413, P135, DOI 10.1042/BJ20080029; Chandy G, 2001, AM J PHYSIOL-CELL PH, V281, pC908, DOI 10.1152/ajpcell.2001.281.3.C908; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; DUNN KW, 1994, J BIOL CHEM, V269, P5336; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Haggie PM, 2007, J BIOL CHEM, V282, P31422, DOI 10.1074/jbc.M705296200; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Hara-Chikuma M, 2005, BIOCHEM BIOPH RES CO, V329, P941, DOI 10.1016/j.bbrc.2005.02.060; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Lamothe J, 2008, MICROBIOL-SGM, V154, P3825, DOI 10.1099/mic.0.2008/023200-0; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; LUKACS GL, 1992, J BIOL CHEM, V267, P14568; Maeda Y, 2008, NAT CELL BIOL, V10, P1135, DOI 10.1038/ncb1773; Mohamed A, 1997, BIOCHEM J, V322, P259, DOI 10.1042/bj3220259; OHKUMA S, 1989, METHOD ENZYMOL, V174, P131; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; Poschet JF, 2006, EMBO REP, V7, P553, DOI 10.1038/sj.embor.7400674; Poschet JF, 2002, J BIOL CHEM, V277, P13959, DOI 10.1074/jbc.M105441200; Poschet JF, 2001, P NATL ACAD SCI USA, V98, P13972, DOI 10.1073/pnas.241182598; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Seksek O, 1996, J BIOL CHEM, V271, P15542, DOI 10.1074/jbc.271.26.15542; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Sonawane ND, 2003, J CELL BIOL, V160, P1129, DOI 10.1083/jcb.200211098; Sonawane ND, 2002, J BIOL CHEM, V277, P5506, DOI 10.1074/jbc.M110818200; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; VANDYKE RW, 1992, BIOCHEM BIOPH RES CO, V184, P300, DOI 10.1016/0006-291X(92)91192-S; Varghese B, 2008, MOL CELL BIOL, V28, P5275, DOI 10.1128/MCB.00350-08; Verkman AS, 2003, AM J PHYSIOL-CELL PH, V284, pC2, DOI 10.1152/ajpcell.00417.2002; VONBONSDORFF CH, 1985, EMBO J, V4, P2781, DOI 10.1002/j.1460-2075.1985.tb04004.x; Wu MM, 2000, CHEM BIOL, V7, P197, DOI 10.1016/S1074-5521(00)00088-0; YAMAYA M, 1992, AM J PHYSIOL, V262, pL713, DOI 10.1152/ajplung.1992.262.6.L713; ZEN K, 1992, J CELL BIOL, V119, P99, DOI 10.1083/jcb.119.1.99	39	48	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7681	7686		10.1074/jbc.M809161200	http://dx.doi.org/10.1074/jbc.M809161200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19136560	hybrid, Green Published			2022-12-25	WOS:000264195600030
J	Murphy, RM; Lamb, GD				Murphy, Robyn M.; Lamb, Graham D.			Endogenous Calpain-3 Activation Is Primarily Governed by Small Increases in Resting Cytoplasmic [Ca2+] and Is Not Dependent on Stretch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-SPECIFIC CALPAIN; HUMAN SKELETAL-MUSCLE; DYSTROPHY TYPE 2A; MOUSE EDL MUSCLE; MUSCULAR-DYSTROPHY; IN-VIVO; ECCENTRIC CONTRACTIONS; PROTEIN EXPRESSION; CALCIUM-RELEASE; MU-CALPAIN	Proteolytically active calpain-3/p94 is clearly vital for normal muscle function, since its absence leads to limb girdle muscular dystrophy 2A, but its function and regulatory control are poorly understood. Here we use single muscle fibers, individually skinned by microdissection, to investigate the diffusibility and autolytic activation of calpain-3 in situ. Virtually all calpain-3 present in mature muscle fibers is tightly bound in the vicinity of the titin N2A line and triad junctions and remains so irrespective of fiber stretching or raised [Ca2+]. Most calpain-3 is evidently bound within the contractile filament lattice, because (i) its slow diffusional loss is slowed further by locking myosin and actin into rigor and (ii) detergent dispersion of membranes causes rapid washout of most ryanodine receptors and sarcoplasmic reticulum Ca2+ pumps with little accompanying washout of calpain-3. Calpain-3 autolyzes (becoming proteolytically active) in a tightly calcium-dependent manner. It remains in its nonactivated full-length form if [Ca2+] is maintained at <= 50 nM, the normal resting level, even with brief increases to 2-20 mu M during repeated tetanic contractions, but it becomes active (though still bound) if [Ca2+] is kept slightly elevated at 200 nM (similar to 20% autolysis in 1 h). Calpain-3 did not spontaneously autolyze even when free in solution with 200 nM Ca2+ for up to 60 min. These findings explain why calpain-3 remains quiescent with normal exercise but is activated following eccentric (stretching) contractions, when resting [Ca2+] is elevated, and how a protease such as calpain-3 can be very Ca2+-sensitive yet highly specific in its actions.	[Murphy, Robyn M.; Lamb, Graham D.] La Trobe Univ, Dept Zool, Melbourne, Vic 3086, Australia	La Trobe University	Murphy, RM (corresponding author), La Trobe Univ, Dept Zool, Melbourne, Vic 3086, Australia.	r.murphy@latrobe.edu.au		Murphy, Robyn/0000-0003-3697-589X	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Anderson LVB, 1998, AM J PATHOL, V153, P1169, DOI 10.1016/S0002-9440(10)65661-1; ARMSTRONG RB, 1983, J APPL PHYSIOL, V54, P80, DOI 10.1152/jappl.1983.54.1.80; Baghdiguian S, 2001, J MOL MED, V79, P254, DOI 10.1007/s001090100225; BALNAVE CD, 1995, J PHYSIOL-LONDON, V488, P25, DOI 10.1113/jphysiol.1995.sp020943; Baylor SM, 2003, J PHYSIOL-LONDON, V551, P125, DOI 10.1113/jphysiol.2003.041608; Beckmann JS, 2008, NEUROMUSCULAR DISORD, V18, P913, DOI 10.1016/j.nmd.2008.08.005; Branca D, 1999, EUR J BIOCHEM, V265, P839, DOI 10.1046/j.1432-1327.1999.00817.x; Diaz BEG, 2006, BIOCHEMISTRY-US, V45, P3714, DOI 10.1021/bi051917j; Diaz BG, 2004, J BIOL CHEM, V279, P27656, DOI 10.1074/jbc.M313290200; Duguez S, 2006, FEBS J, V273, P3427, DOI 10.1111/j.1742-4658.2006.05351.x; Fanin M, 2003, AM J PATHOL, V163, P1929, DOI 10.1016/S0002-9440(10)63551-1; Fougerousse F, 1998, GENOMICS, V48, P145, DOI 10.1006/geno.1997.5160; GIBALA MJ, 1995, J APPL PHYSIOL, V78, P702, DOI 10.1152/jappl.1995.78.2.702; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Granzier H, 2007, MUSCLE NERVE, V36, P740, DOI 10.1002/mus.20886; Huebsch KA, 2005, HUM MOL GENET, V14, P2801, DOI 10.1093/hmg/ddi313; Ingalls CP, 1998, J APPL PHYSIOL, V85, P58, DOI 10.1152/jappl.1998.85.1.58; Keira Y, 2003, J BIOCHEM, V133, P659, DOI 10.1093/jb/mvg084; Kinbara K, 1998, BIOCHEM J, V335, P589, DOI 10.1042/bj3350589; Kramerova I, 2004, HUM MOL GENET, V13, P1373, DOI 10.1093/hmg/ddh153; Kramerova I, 2008, HUM MOL GENET, V17, P3271, DOI 10.1093/hmg/ddn223; Lamb GD, 1995, J PHYSIOL-LONDON, V489, P349, DOI 10.1113/jphysiol.1995.sp021056; LAMB GD, 1994, J PHYSIOL-LONDON, V478, P331, DOI 10.1113/jphysiol.1994.sp020253; Lynch GS, 1997, CELL CALCIUM, V22, P373, DOI 10.1016/S0143-4160(97)90022-1; Morgan DL, 2004, CLIN EXP PHARMACOL P, V31, P541, DOI 10.1111/j.1440-1681.2004.04029.x; Murphy RM, 2006, AM J PHYSIOL-CELL PH, V290, pC116, DOI 10.1152/ajpcell.00291.2005; MURPHY RM, 2009, EXP CELL RE IN PRESS; Murphy RM, 2007, J APPL PHYSIOL, V103, P926, DOI 10.1152/japplphysiol.01422.2006; Murphy RM, 2006, J PHYSIOL-LONDON, V576, P595, DOI 10.1113/jphysiol.2006.114090; Ojima K, 2007, J BIOL CHEM, V282, P14493, DOI 10.1074/jbc.M610806200; Ojima K, 2005, J MUSCLE RES CELL M, V26, P409, DOI 10.1007/s10974-005-9023-8; Ono Y, 2004, J BIOL CHEM, V279, P2761, DOI 10.1074/jbc.M308789200; Ono Y, 2008, FEBS LETT, V582, P691, DOI 10.1016/j.febslet.2008.01.044; Posterino GS, 2000, J PHYSIOL-LONDON, V527, P131, DOI 10.1111/j.1469-7793.2000.t01-2-00131.x; Ravulapalli R, 2005, BIOCHEM J, V388, P585, DOI 10.1042/BJ20041821; Richard I, 1999, AM J HUM GENET, V64, P1524, DOI 10.1086/302426; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; SORIMACHI H, 1989, J BIOL CHEM, V264, P20106; SORIMACHI H, 1993, J BIOL CHEM, V268, P10593; Sorimachi H, 1995, J BIOL CHEM, V270, P31158, DOI 10.1074/jbc.270.52.31158; Spencer MJ, 1997, J NEUROL SCI, V146, P173, DOI 10.1016/S0022-510X(96)00304-8; Spencer MJ, 2002, P NATL ACAD SCI USA, V99, P8874, DOI 10.1073/pnas.132269299; STEPHENSON GMM, 1993, PFLUG ARCH EUR J PHY, V424, P30, DOI 10.1007/BF00375099; Taveau M, 2003, MOL CELL BIOL, V23, P9127, DOI 10.1128/MCB.23.24.9127-9135.2003; Tavi P, 2003, J PHYSIOL-LONDON, V551, P5, DOI 10.1113/jphysiol.2003.042002; Verburg E, 2006, AM J PHYSIOL-CELL PH, V290, pC1199, DOI 10.1152/ajpcell.00469.2005; Warren GL, 2002, AM J PHYSIOL-REG I, V282, pR1122, DOI 10.1152/ajpregu.00671.2001	47	36	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7811	7819		10.1074/jbc.M808655200	http://dx.doi.org/10.1074/jbc.M808655200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19144634	hybrid, Green Published			2022-12-25	WOS:000264195600043
J	Pimkin, M; Pimkina, J; Markham, GD				Pimkin, Maxim; Pimkina, Julia; Markham, George D.			A Regulatory Role of the Bateman Domain of IMP Dehydrogenase in Adenylate Nucleotide Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSINE 5'-MONOPHOSPHATE DEHYDROGENASE; DOMINANT RETINITIS-PIGMENTOSA; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; CRYSTAL-STRUCTURE; MUTATIONS; KINASE; MUTANT; GENE; INHIBITION	The Bateman domain (CBS subdomain) of IMP dehydrogenase (IMPDH), a rate-limiting enzyme of the de novo GMP biosynthesis, is evolutionarily conserved but has no established function. Deletion of the Bateman domain has no effect on the in vitro IMPDH activity. We report that in vivo deletion of the Bateman domain of IMPDH in Escherichia coli (guaB(Delta CBS)) sensitizes the bacterium to growth arrest by adenosine and inosine. These nucleosides exert their growth inhibitory effect via a dramatic increase in the intracellular adenylate nucleotide pool, which results in the enhanced allosteric inhibition of PRPP synthetase and consequently a PRPP deficit. The ensuing starvation for pyrimidine nucleotides culminates in growth arrest. Thus, deletion of the Bateman domain of IMPDH derepresses the synthesis of AMP from IMP. The growth inhibitory effect of inosine can be rescued by second-site suppressor mutations in the genes responsible for the conversion of inosine to AMP (gsk, purA, and purB) as well as by the prsA1 allele, which encodes a PRPP synthetase that is insensitive to allosteric inhibition by adenylate nucleotides. Importantly, the guaB(Delta CBS) phenotype can be complemented in trans by a mutant guaB allele, which encodes a catalytically disabled IMPDHC305A protein containing an intact Bateman domain. We conclude that the Bateman domain of IMPDH is a negative trans-regulator of adenylate nucleotide synthesis, and that this role is independent of the catalytic function of IMPDH in the de novo GMP biosynthesis.	[Pimkin, Maxim; Pimkina, Julia; Markham, George D.] Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Markham, GD (corresponding author), 333 Cottman Ave, Philadelphia, PA 19111 USA.	gd_markham@fccc.edu			National Institutes of Health [GM072425, CA06927]; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM072425 and CA06927. This work was also supported by an appropriation from the Commonwealth of Pennsylvania. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute, or any other sponsoring organization.	Aherne A, 2004, HUM MOL GENET, V13, P641, DOI 10.1093/hmg/ddh061; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; BOWER SG, 1989, J BIOL CHEM, V264, P10287; Bowne SJ, 2006, INVEST OPHTH VIS SCI, V47, P34, DOI 10.1167/iovs.05-0868; Bowne SJ, 2002, HUM MOL GENET, V11, P559, DOI 10.1093/hmg/11.5.559; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Gan L, 2002, BIOCHEMISTRY-US, V41, P13309, DOI 10.1021/bi0203785; GILBERT HJ, 1979, BIOCHEM J, V183, P481, DOI 10.1042/bj1830481; Gunter JH, 2008, INT J BIOCHEM CELL B, V40, P1716, DOI 10.1016/j.biocel.2007.12.018; Hedstrom L, 2008, NUCLEOS NUCLEOT NUCL, V27, P839, DOI 10.1080/15257770802146486; Hedstrom L, 2006, CURR OPIN CHEM BIOL, V10, P520, DOI 10.1016/j.cbpa.2006.08.005; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; JOCHIMSEN BU, 1985, J GEN MICROBIOL, V131, P245; JUANG RH, 1993, ARCH BIOCHEM BIOPHYS, V304, P392, DOI 10.1006/abbi.1993.1367; Kawasaki H, 2000, BIOSCI BIOTECH BIOCH, V64, P972, DOI 10.1271/bbb.64.972; KELLN RA, 1975, J BACTERIOL, V124, P764, DOI 10.1128/JB.124.2.764-774.1975; Kemp BE, 2004, J CLIN INVEST, V113, P182, DOI 10.1172/JCI200420846; Kennan A, 2005, TRENDS GENET, V21, P103, DOI 10.1016/j.tig.2004.12.001; Kennan A, 2002, HUM MOL GENET, V11, P547, DOI 10.1093/hmg/11.5.547; McLean JE, 2004, BIOCHEM J, V379, P243, DOI 10.1042/BJ20031585; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MORI H, 1995, J BACTERIOL, V177, P4921, DOI 10.1128/jb.177.17.4921-4926.1995; Mortimer SE, 2008, J BIOL CHEM, V283, P36354, DOI 10.1074/jbc.M806143200; Mortimer SE, 2005, BIOCHEM J, V390, P41, DOI 10.1042/BJ20042051; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nimmesgern E, 1999, PROTEIN EXPRES PURIF, V17, P282, DOI 10.1006/prep.1999.1136; NYGAARD P, 1983, METABOLISM NUCLEOTID, P27; Pankiewicz K.W., 2003, INOSINE MONOPHOSPHAT; Pankiewicz KW, 2004, CURR MED CHEM, V11, P887, DOI 10.2174/0929867043455648; Petersen C, 1999, J BIOL CHEM, V274, P5348, DOI 10.1074/jbc.274.9.5348; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pimkin M, 2008, MOL MICROBIOL, V68, P342, DOI 10.1111/j.1365-2958.2008.06153.x; ROYBURMAN S, 1975, J BIOL CHEM, V250, P9270; Sambrook J, 2001, MOL CLONING LAB MANU; STAYTON MM, 1983, CURR TOP CELL REGUL, V22, P103; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Xu D, 2008, ARCH BIOCHEM BIOPHYS, V472, P100, DOI 10.1016/j.abb.2008.02.012; Yuan J, 2006, NAT CHEM BIOL, V2, P529, DOI 10.1038/nchembio816; ZALKIN H, 1996, ESCHERICHIA COLI SAL, P561; Zhang RG, 1999, BIOCHEMISTRY-US, V38, P4691, DOI 10.1021/bi982858v	43	35	37	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7960	7969		10.1074/jbc.M808541200	http://dx.doi.org/10.1074/jbc.M808541200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19153081	hybrid, Green Published			2022-12-25	WOS:000264195600058
J	Tokutsu, R; Iwai, M; Minagawa, J				Tokutsu, Ryutaro; Iwai, Masakazu; Minagawa, Jun			CP29, a Monomeric Light-harvesting Complex II Protein, Is Essential for State Transitions in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCITATION-ENERGY TRANSFER; PHOTOSYSTEM-II; ELECTRON-TRANSPORT; PHOTOSYNTHETIC MEMBRANES; ANTENNA PROTEINS; GREEN PLANTS; PHOSPHORYLATION; FLUORESCENCE; ARABIDOPSIS; POLYPEPTIDES	In oxygen-evolving photosynthesis, the two photosystems, photosystem I (PSI) and photosystem II (PSII), function in parallel, and their excitation levels must be balanced to maintain an optimal photosynthetic rate under various light conditions. State transitions balance excitation energy between the two photosystems by redistributing light-harvesting complex II (LHCII) proteins. Here we describe two RNA interference (RNAi) mutants of the green alga Chlamydomonas reinhardtii with one of the minor monomeric LHCII proteins, CP29 or CP26, knocked down. These two proteins have been identified in PSI-LHCI supercomplexes that harbor mobile LHCII proteins from PSII under a state where PSII is preferentially excited (State 2). We show that both the CP29 and CP26 RNAi mutants undergo reductions in the PSII antenna size during a transition from State 1 (a state where PSI is preferentially excited) to State 2, as reflected by nonphotochemical quenching of fluorescence, low temperature fluorescence spectra, and functional absorption cross-section. However, the undocked LHCIIs from PSII do not re-associate with PSI in the CP29-RNAi (b4i) mutant because the antenna size of PSI was not complementary increased. The mobile LHCIIs in the CP26-RNAi (b5i) mutant, however, re-associate with PSI, whose PSI-LHCI/II supercomplex is visualized on a sucrose density gradient. This study clarifies that CP29, not CP26, is an essential component in state transitions and demonstrates that CP29 is crucial when mobile LHCIIs re-associate with PSI under State 2 conditions.	[Tokutsu, Ryutaro; Iwai, Masakazu; Minagawa, Jun] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan	Hokkaido University	Minagawa, J (corresponding author), Hokkaido Univ, Inst Low Temp Sci, North 19 West 8, Sapporo, Hokkaido 0600819, Japan.	minagawa@lowtem.hokudai.ac.jp	Tokutsu, Ryutaro/V-7596-2019; Tokutsu, Ryutaro/GRF-0208-2022	Tokutsu, Ryutaro/0000-0003-2037-255X; Iwai, Masakazu/0000-0002-0986-9015; Minagawa, Jun/0000-0002-3028-3203	Japan Science Society; Japan Society for the Promotion of Science [18004526]; Ministry of Education, Culture, Sports, Science and Technology [18GS0318]	Japan Science Society; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Sasakawa Scientific Research grant from The Japan Science Society (to R.T.), a Research Fellowship for Young Scientists from Japan Society for the Promotion of Science 18004526 (to M.I.) and Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology 18GS0318 (to J.M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ALLEN JF, 1981, NATURE, V291, P25, DOI 10.1038/291025a0; Allen JF, 2001, TRENDS PLANT SCI, V6, P317, DOI 10.1016/S1360-1385(01)02010-6; Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; BENNETT J, 1980, P NATL ACAD SCI-BIOL, V77, P5253, DOI 10.1073/pnas.77.9.5253; BOEKEMA EJ, 1995, P NATL ACAD SCI USA, V92, P175, DOI 10.1073/pnas.92.1.175; BONAVENTURA C, 1969, BIOCHIM BIOPHYS ACTA, V189, P366, DOI 10.1016/0005-2728(69)90168-6; de Bianchi S, 2008, PLANT CELL, V20, P1012, DOI 10.1105/tpc.107.055749; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Finazzi G, 1999, BBA-BIOENERGETICS, V1413, P117, DOI 10.1016/S0005-2728(99)00089-4; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Gohre V, 2006, PLANT CELL, V18, P1454, DOI 10.1105/tpc.105.038695; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Harrer R, 1998, EUR J BIOCHEM, V255, P196, DOI 10.1046/j.1432-1327.1998.2550196.x; Iwai M, 2008, PLANT CELL, V20, P2177, DOI 10.1105/tpc.108.059352; Iwai M, 2007, PHOTOSYNTH RES, V94, P307, DOI 10.1007/s11120-007-9220-y; KANNO A, 2005, PHOTOSYNTHESIS FUNDA, P483; Kargul J, 2005, FEBS J, V272, P4797, DOI 10.1111/j.1742-4658.2005.04894.x; Kouril R, 2005, BIOCHEMISTRY-US, V44, P10935, DOI 10.1021/bi051097a; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; LIN S, 1991, PHOTOSYNTH RES, V27, P157, DOI 10.1007/BF00035837; Lunde C, 2000, NATURE, V408, P613, DOI 10.1038/35046121; Minagawa J, 2004, PHOTOSYNTH RES, V82, P241, DOI 10.1007/s11120-004-2079-2; MURATA N, 1969, BIOCHIM BIOPHYS ACTA, V172, P242, DOI 10.1016/0005-2728(69)90067-X; Naumann B, 2005, J BIOL CHEM, V280, P20431, DOI 10.1074/jbc.M414486200; Nield J, 2000, NAT STRUCT BIOL, V7, P44; Rochaix JD, 2007, FEBS LETT, V581, P2768, DOI 10.1016/j.febslet.2007.04.038; Rohr J, 2004, PLANT J, V40, P611, DOI 10.1111/j.1365-313X.2004.02227.x; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P30, DOI 10.1016/0005-2728(92)90061-6; Schroda M, 2006, CURR GENET, V49, P69, DOI 10.1007/s00294-005-0042-1; Shimogawara K, 1998, GENETICS, V148, P1821; SUEOKA N, 1960, P NATL ACAD SCI USA, V46, P83, DOI 10.1073/pnas.46.1.83; Takahashi H, 2006, P NATL ACAD SCI USA, V103, P477, DOI 10.1073/pnas.0509952103; Turkina MV, 2006, MOL CELL PROTEOMICS, V5, P1412, DOI 10.1074/mcp.M600066-MCP200; Vener AV, 1997, P NATL ACAD SCI USA, V94, P1585, DOI 10.1073/pnas.94.4.1585; WOLLMAN FA, 1988, BIOCHIM BIOPHYS ACTA, V933, P85, DOI 10.1016/0005-2728(88)90058-8; Yakushevska AE, 2003, BIOCHEMISTRY-US, V42, P608, DOI 10.1021/bi027109z; Zito F, 2002, J BIOL CHEM, V277, P12446, DOI 10.1074/jbc.M110914200	38	57	57	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7777	7782		10.1074/jbc.M809360200	http://dx.doi.org/10.1074/jbc.M809360200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19144643	Green Published, hybrid			2022-12-25	WOS:000264195600039
J	Hirakawa, K; Kobayashi, S; Inoue, T; Endoh-Yamagami, S; Fukuda, R; Ohta, A				Hirakawa, Kiyoshi; Kobayashi, Satoshi; Inoue, Takuro; Endoh-Yamagami, Setsu; Fukuda, Ryouichi; Ohta, Akinori			Yas3p, an Opi1 Family Transcription Factor, Regulates Cytochrome P450 Expression in Response to n-Alkanes in Yarrowia lipolytica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID BIOSYNTHETIC GENES; LIPID-BINDING PROTEINS; LOOP-HELIX PROTEINS; SACCHAROMYCES-CEREVISIAE; CANDIDA-TROPICALIS; MULTIGENE FAMILY; HEMIASCOMYCETOUS YEASTS; DECANE ASSIMILATION; GENOMIC EXPLORATION; NEGATIVE REGULATOR	In the alkane-assimilating yeast Yarrowia lipolytica, the expression of ALK1, a gene encoding cytochrome P450 that catalyzes the first step of n-alkane oxidation, is induced by n-alkanes. We previously demonstrated that two basic helix-loop-helix proteins, Yas1p and Yas2p, activate the transcription of ALK1 in an alkane-dependent manner by forming a heterocomplex and binding to alkane-responsive element 1 (ARE1), a cis-acting element in the ALK1 promoter. Here we identified an Opi1 family transcription factor, Yas3p, involved in the alkane-dependent transcription regulation of ALK genes. Deletion of YAS3 caused a significant increase in ALK1 mRNA in cells grown on glucose, glycerol, and n-alkanes. The YAS3 deletion also resulted in a marked elevation of reporter gene expression driven by an ARE1-containing promoter on glycerol and n-decane. Bacterially expressed Yas3p bound specifically to Yas2p, but not to Yas1p, in vitro. In addition, although green fluorescent protein-tagged Yas3p was localized in the nucleus in glucose-containing medium, it changed its localization to an endoplasmic reticulum-like compartment upon transfer to medium containing n-decane. These findings suggest that Yas3p functions as a master regulator of transcriptional response, which changes its localization between the nucleus and endoplasmic reticulum membrane in response to different carbon sources. Furthermore, quantitative real time PCR analysis of 12 ALK genes in YAS1, YAS2, and YAS3 deletion mutants suggested that Yas3p is involved in the transcriptional repression of a variety of ALK genes, including ALK1. In contrast, YAS3 deletion did not affect the mRNA level of an INO1 ortholog in Y. lipolytica, indicating functional diversity of Opi1 family transcription factors.	[Hirakawa, Kiyoshi; Kobayashi, Satoshi; Inoue, Takuro; Endoh-Yamagami, Setsu; Fukuda, Ryouichi; Ohta, Akinori] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Ohta, A (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	aaohta@mail.ecc.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This work was performed using the facilities of the Biotechnology Research Center of the University of Tokyo. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AMBROZIAK J, 1994, J BIOL CHEM, V269, P15344; Atchley WR, 1997, P NATL ACAD SCI USA, V94, P5172, DOI 10.1073/pnas.94.10.5172; BACHHAWAT N, 1995, J BIOL CHEM, V270, P25087, DOI 10.1074/jbc.270.42.25087; Barth G, 1997, FEMS MICROBIOL REV, V19, P219, DOI 10.1016/S0168-6445(97)00002-8; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Broughton J, 1997, J CELL SCI, V110, P2715; CARDINI G, 1970, J BIOL CHEM, V245, P2789; Casaregola S, 2000, FEBS LETT, V487, P95, DOI 10.1016/S0014-5793(00)02288-2; Chang YF, 2006, J BIOL CHEM, V281, P4754, DOI 10.1074/jbc.M513064200; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Endoh-Yamagami S, 2007, EUKARYOT CELL, V6, P734, DOI 10.1128/EC.00412-06; Fickers P, 2005, FEMS YEAST RES, V5, P527, DOI 10.1016/j.femsyr.2004.09.004; Greenberg ML, 1996, MICROBIOL REV, V60, P1; GREENBERG ML, 1982, GENETICS, V100, P19; Heyken WT, 2005, MOL MICROBIOL, V56, P696, DOI 10.1111/j.1365-2958.2004.04499.x; Heyken WT, 2003, YEAST, V20, P1177, DOI 10.1002/yea.1031; Hoppen J, 2007, MOL GENET GENOMICS, V278, P317, DOI 10.1007/s00438-007-0253-x; HOSHIZAKI DK, 1990, J BIOL CHEM, V265, P4736; Iida T, 1998, YEAST, V14, P1387; Kaadige MR, 2006, CURR GENET, V49, P30, DOI 10.1007/s00294-005-0021-6; Kaadige MR, 2003, MOL MICROBIOL, V48, P823, DOI 10.1046/j.1365-2958.2003.03472.x; Kagiwada S, 2003, J BIOCHEM, V133, P515, DOI 10.1093/jb/mvg068; Kobayashi S, 2008, BIOSCI BIOTECH BIOCH, V72, P2219, DOI 10.1271/bbb.80230; LEBEAULT JM, 1971, BIOCHEM BIOPH RES CO, V42, P413, DOI 10.1016/0006-291X(71)90386-X; Lida T, 2000, YEAST, V16, P1077, DOI 10.1002/1097-0061(20000915)16:12<1077::AID-YEA601>3.0.CO;2-K; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; MURRE C, 1994, BBA-GENE STRUCT EXPR, V1218, P129, DOI 10.1016/0167-4781(94)90001-9; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Nikawa JI, 2004, J BIOSCI BIOENG, V97, P369, DOI 10.1016/S1389-1723(04)70220-0; NIKOLOFF DM, 1992, NUCLEIC ACIDS RES, V20, P3253, DOI 10.1093/nar/20.12.3253; OHKUMA M, 1995, DNA CELL BIOL, V14, P163, DOI 10.1089/dna.1995.14.163; OHKUMA M, 1991, DNA CELL BIOL, V10, P271, DOI 10.1089/dna.1991.10.271; SANGLARD D, 1987, BIOCHEM BIOPH RES CO, V144, P251, DOI 10.1016/S0006-291X(87)80503-X; Santiago TC, 2003, J BIOL CHEM, V278, P38723, DOI 10.1074/jbc.M303008200; SCHWANK S, 1995, NUCLEIC ACIDS RES, V23, P230, DOI 10.1093/nar/23.2.230; SEGHEZZI W, 1992, DNA CELL BIOL, V11, P767, DOI 10.1089/dna.1992.11.767; SEGHEZZI W, 1991, GENE, V106, P51, DOI 10.1016/0378-1119(91)90565-S; Souciet JL, 2000, FEBS LETT, V487, P3, DOI 10.1016/S0014-5793(00)02272-9; Sreenivas A, 2003, J BIOL CHEM, V278, P20673, DOI 10.1074/jbc.M300132200; Sreenivas A, 2001, J BIOL CHEM, V276, P29915, DOI 10.1074/jbc.M105147200; Sumita T, 2002, BIOCHEM BIOPH RES CO, V294, P1071, DOI 10.1016/S0006-291X(02)00607-1; TANAKA A, 1989, YEASTS, V3, P261; Wagner C, 2001, MOL MICROBIOL, V41, P155, DOI 10.1046/j.1365-2958.2001.02495.x; WHITE MJ, 1991, J BIOL CHEM, V266, P863; Yamagami S, 2004, J BIOL CHEM, V279, P22183, DOI 10.1074/jbc.M313313200; Yamagami S, 2001, BIOCHEM BIOPH RES CO, V282, P832, DOI 10.1006/bbrc.2001.4653	49	38	38	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7126	7137		10.1074/jbc.M806864200	http://dx.doi.org/10.1074/jbc.M806864200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19131334	Green Published, hybrid			2022-12-25	WOS:000263919000060
J	Nezu, A; Parvin, MN; Turner, RJ				Nezu, Akihiro; Parvin, Most. Nahid; Turner, R. James			A Conserved Hydrophobic Tetrad near the C Terminus of the Secretory Na+-K+-2Cl(-) Cotransporter (NKCC1) Is Required for Its Correct Intracellular Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEPHROGENIC DIABETES-INSIPIDUS; ENDOPLASMIC-RETICULUM; CHLORIDE COTRANSPORTERS; FUNCTIONAL EXPRESSION; CARBOXYL-TERMINUS; QUALITY-CONTROL; RECEPTOR; PROTEIN; TRANSPORT; DOMAIN	Little is known about the intracellular folding and trafficking of integral membrane proteins. Here we identify a hydrophobic amino acid tetrad (ILLV) close to the C terminus of the secretory Na+-K+-2Cl(-) cotransporter (NKCC1) that is important for the proper intracellular processing of this protein. This tetrad appears in a C-terminal sequence pattern that is conserved across species in a number of members of the NKCC1 gene family (slc12) of electroneutral salt transporters. We studied the effects of various mutations of these amino acids on NKCC1 transiently transfected into HEK-293 cells. Our results show that mutation of two of these residues to alanine leads to a>50% reduction in expression and complex glycosylation levels and that multiple mutations to alanine have cumulative effects. By contrast, scrambling of these amino acids, or mutation of other nearby conserved C-terminal residues, has little effect on these parameters. Mutation of ILLV to AAA reduces complex glycosylation of NKCC1 by similar to 90% and results in a protein that does not form stable dimers and is retained in the endoplasmic reticulum in a highly aggregated state. Our results are consistent with the hypothesis that mutation of the hydrophobic tetrad ILLV to AAAA leads to the ab initio misfolding and concomitant aggregation of this NKCC1 mutant, resulting in its retention in the endoplasmic reticulum.	[Nezu, Akihiro; Parvin, Most. Nahid; Turner, R. James] Natl Inst Hlth, Membrane Biol Sect, Mol Physiol & Therapeut Branch, NIDCR,Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Turner, RJ (corresponding author), Natl Inst Hlth, Membrane Biol Sect, Mol Physiol & Therapeut Branch, NIDCR,Dept Hlth & Human Serv, Bldg 10,Rm 1A01,10 Ctr Dr,MSC 1190, Bethesda, MD 20892 USA.	rjturner@nih.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [ZIADE000415, Z01DE000415] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Cheung JC, 2008, BIOCHEMISTRY-US, V47, P1465, DOI 10.1021/bi702209s; De Jong JC, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017904.77985.03; Dehaye JP, 2003, J BIOL CHEM, V278, P11811, DOI 10.1074/jbc.M213148200; Delpire E, 2002, ANNU REV PHYSIOL, V64, P803, DOI 10.1146/annurev.physiol.64.081501.155847; Dohke Y, 2002, J BIOL CHEM, V277, P15215, DOI 10.1074/jbc.C100646200; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Evans RL, 2000, J BIOL CHEM, V275, P26720; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gavrikov KE, 2006, P NATL ACAD SCI USA, V103, P18793, DOI 10.1073/pnas.0604551103; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Iodice L, 2001, J BIOL CHEM, V276, P28920, DOI 10.1074/jbc.M103558200; Kaneko H, 2004, J NEUROSCI, V24, P7931, DOI 10.1523/JNEUROSCI.2115-04.2004; Kasir J, 1999, J BIOL CHEM, V274, P24873, DOI 10.1074/jbc.274.35.24873; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; Krause G, 2000, MOL PHARMACOL, V57, P232; Kurihara K, 1999, AM J PHYSIOL-CELL PH, V277, pC1184, DOI 10.1152/ajpcell.1999.277.6.C1184; Larsen MB, 2006, BIOCHEMISTRY-US, V45, P1331, DOI 10.1021/bi0508688; Lippincott-Schwartz Jennifer, 2006, Trends Cell Biol, V16, pe1, DOI 10.1016/j.tcb.2006.08.008; Loo TW, 2005, J BIOL CHEM, V280, P2522, DOI 10.1074/jbc.M411483200; Miranda M, 2004, J BIOL CHEM, V279, P30760, DOI 10.1074/jbc.M312774200; Moore-Hoon ML, 2000, BIOCHEMISTRY-US, V39, P3718, DOI 10.1021/bi992301v; Mueller GM, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M707339200; Pankevych H, 2003, J BIOL CHEM, V278, P30283, DOI 10.1074/jbc.M212918200; Parvin MN, 2007, BIOCHEMISTRY-US, V46, P9630, DOI 10.1021/bi700881a; Pena-Muzenmayer G, 2005, J CELL SCI, V118, P4243, DOI 10.1242/jcs.02525; Robben JH, 2005, AM J PHYSIOL-RENAL, V289, pF265, DOI 10.1152/ajprenal.00404.2004; Robben JH, 2006, AM J PHYSIOL-RENAL, V291, pF257, DOI 10.1152/ajprenal.00491.2005; Sabath E, 2004, AM J PHYSIOL-RENAL, V287, pF195, DOI 10.1152/ajprenal.00044.2004; Sharma N, 1999, J BIOL CHEM, V274, P20628, DOI 10.1074/jbc.274.29.20628; Sorensen S, 2006, J BIOL CHEM, V281, P468, DOI 10.1074/jbc.M507071200; White SH, 2004, CURR OPIN STRUC BIOL, V14, P397, DOI 10.1016/j.sbi.2004.07.003; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	33	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6869	6876		10.1074/jbc.M804302200	http://dx.doi.org/10.1074/jbc.M804302200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19129177	Green Published			2022-12-25	WOS:000263919000034
J	Liu, AG; Garg, P; Yang, SQ; Gong, P; Pallero, MA; Annis, DS; Liu, YY; Passaniti, A; Mann, D; Mosher, DF; Murphy-Ullrich, JE; Goldblum, SE				Liu, Anguo; Garg, Pallavi; Yang, Shiqi; Gong, Ping; Pallero, Manuel A.; Annis, Douglas S.; Liu, Yuanyuan; Passaniti, Antonino; Mann, Dean; Mosher, Deane F.; Murphy-Ullrich, Joanne E.; Goldblum, Simeon E.			Epidermal Growth Factor-like Repeats of Thrombospondins Activate Phospholipase C gamma and Increase Epithelial Cell Migration through Indirect Epidermal Growth Factor Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGF RECEPTOR; TYROSINE PHOSPHORYLATION; KINASE ACTIVATION; SIGNATURE DOMAINS; TERMINAL DOMAIN; BINDING; PROTEIN; TYPE-1; ROLES; MATRIX-METALLOPROTEINASE-9	Thrombospondin (TSP) 1 is a trimeric multidomain protein that contains motifs that recognize distinct host cell receptors coupled to multiple signaling pathways. Selected TSP1-induced cellular responses are tyrosine kinase-dependent, and TSP1 contains epidermal growth factor (EGF)-like repeats. Specific receptor interactions or functions for the EGF-like repeats have not been identified. We asked whether one or more biological responses to TSP1 might be explained through EGF receptor (EGFR) activation. In A431 cells, TSP1 increased autophosphorylation of Tyr-1068 of EGFR in a dose- and time-dependent manner. The ability of TSP1 to activate EGFR was replicated by the tandem EGF-like repeats as a recombinant protein. The three EGF-like repeats alone produced a high level of Tyr-1068 phosphorylation. EGF-like repeats from TSP2 and TSP4 also activated EGFR. Tyr-1068 phosphorylation was less when individual EGF-like repeats were tested or flanking sequences were added to the three EGF-like repeats. TSP1 and its EGF-like repeats also increased phosphorylation of EGFR Tyr-845, Tyr-992, Tyr-1045, Tyr-1086, and Tyr-1173, activated phospholipase C gamma, and increased cell migration. No evidence was found for binding of the EGF-like repeats to EGFR. Instead, EGFR activation in response to TSP1 or its EGF-like repeats required matrix metalloprotease activity, including activity of matrix metalloprotease 9. Access to the ligand-binding portion of the EGFR ectodomain was also required. These findings suggest release of an endogenous EGFR ligand in response to ligation of a second unknown receptor by the TSPs.	[Liu, Anguo; Garg, Pallavi; Yang, Shiqi; Gong, Ping; Passaniti, Antonino; Mann, Dean; Goldblum, Simeon E.] Univ Maryland, Mucosal Biol Res Ctr, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Liu, Anguo; Garg, Pallavi; Yang, Shiqi; Gong, Ping; Passaniti, Antonino; Mann, Dean; Goldblum, Simeon E.] Univ Maryland, Mucosal Biol Res Ctr, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Liu, Anguo; Garg, Pallavi; Yang, Shiqi; Gong, Ping; Passaniti, Antonino; Mann, Dean; Goldblum, Simeon E.] Univ Maryland, Sch Med, Marlene & Stewart Greenbaum Canc Ctr, Baltimore, MD 21201 USA; [Pallero, Manuel A.; Murphy-Ullrich, Joanne E.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Annis, Douglas S.; Liu, Yuanyuan; Mosher, Deane F.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Annis, Douglas S.; Liu, Yuanyuan; Mosher, Deane F.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Alabama System; University of Alabama Birmingham; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Goldblum, SE (corresponding author), Univ Maryland, Mucosal Biol Res Ctr, Sch Med, Dept Med, 20 Penn St,Rm 351, Baltimore, MD 21201 USA.	sgoldblu@mbrc.umaryland.edu	Liu, Yuanyuan/E-9439-2013		National Institutes of Health [HL084223, HL54462, HL079644]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants HL084223 (to S. E. G.), HL54462 (to D. F. M.), and HL079644 (to J.M.-U.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Annis DS, 2007, J BIOL CHEM, V282, P27067, DOI 10.1074/jbc.M703804200; Annis DS, 2006, J THROMB HAEMOST, V4, P459, DOI 10.1111/j.1538-7836.2006.01723.x; APPELLA E, 1988, FEBS LETT, V231, P1, DOI 10.1016/0014-5793(88)80690-2; Apte SS, 2004, INT J BIOCHEM CELL B, V36, P981, DOI 10.1016/j.biocel.2004.01.014; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Bein K, 2000, J BIOL CHEM, V275, P32167, DOI 10.1074/jbc.M003834200; Bonnefoy A, 2006, BLOOD, V107, P955, DOI 10.1182/blood-2004-12-4856; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Calzada MJ, 2004, J BIOL CHEM, V279, P41734, DOI 10.1074/jbc.M406267200; Calzada MJ, 2003, J BIOL CHEM, V278, P40679, DOI 10.1074/jbc.M302014200; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Carlson CB, 2005, NAT STRUCT MOL BIOL, V12, P910, DOI 10.1038/nsmb997; Carpenter G, 1999, J CELL BIOL, V146, P697, DOI 10.1083/jcb.146.4.697; Chattopadhyay A, 1999, J BIOL CHEM, V274, P26091, DOI 10.1074/jbc.274.37.26091; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; DiPietro LA, 1996, AM J PATHOL, V148, P1851; Donnini S, 2004, LIFE SCI, V74, P2975, DOI 10.1016/j.lfs.2003.09.075; Gao AG, 1996, J BIOL CHEM, V271, P21, DOI 10.1074/jbc.271.1.21; GILL GN, 1984, J BIOL CHEM, V259, P7755; Goldblum SE, 1999, MOL BIOL CELL, V10, P1537, DOI 10.1091/mbc.10.5.1537; Gong P, 2008, J BIOL CHEM, V283, P13437, DOI 10.1074/jbc.M707986200; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Holbro T, 2003, EXP CELL RES, V284, P99, DOI 10.1016/S0014-4827(02)00099-X; HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; KIM JW, 1990, J BIOL CHEM, V265, P3940; KOSFELD MD, 1993, J BIOL CHEM, V268, P8808; Kruger A, 2005, CANCER RES, V65, P3523, DOI 10.1158/0008-5472.CAN-04-3570; Kurisaki T, 2003, MOL CELL BIOL, V23, P55, DOI 10.1128/MCB.23.1.55-61.2003; LAHAV J, 1993, BIOCHIM BIOPHYS ACTA, V1182, P1, DOI 10.1016/0925-4439(93)90146-R; LAWLER J, 1985, J BIOL CHEM, V260, P3762; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; LAWLER J, 1988, J CELL BIOL, V107, P2351, DOI 10.1083/jcb.107.6.2351; LAWLER J, 1986, BLOOD, V67, P1197; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Malashkevich VN, 1996, SCIENCE, V274, P761, DOI 10.1126/science.274.5288.761; Mariner DJ, 2004, J CELL SCI, V117, P1339, DOI 10.1242/jcs.01001; MARINIDES GN, 1994, KIDNEY INT, V46, P350, DOI 10.1038/ki.1994.281; Misenheimer TM, 2005, J BIOL CHEM, V280, P41229, DOI 10.1074/JBC.M504696200; Misenheimer TM, 2003, BIOCHEMISTRY-US, V42, P5125, DOI 10.1021/bi026983p; Misenheimer TM, 2000, J BIOL CHEM, V275, P40938, DOI 10.1074/jbc.M007022200; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; O-charoenrat P, 2000, CANCER RES, V60, P1121; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Orr AW, 2003, J CELL BIOL, V161, P1179, DOI 10.1083/jcb.200302069; OSHEA KS, 1988, J CELL BIOL, V107, P2737, DOI 10.1083/jcb.107.6.2737; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Ringerike T, 2002, J CELL SCI, V115, P1331; ROBERTS DD, 1985, J BIOL CHEM, V260, P9405; Rocks N, 2008, BIOCHIMIE, V90, P369, DOI 10.1016/j.biochi.2007.08.008; Rodriguez-Manzaneque JC, 2001, P NATL ACAD SCI USA, V98, P12485, DOI 10.1073/pnas.171460498; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Schenk S, 2003, J CELL BIOL, V161, P197, DOI 10.1083/jcb.200208145; Soula-Rothhut M, 2005, EXP CELL RES, V304, P187, DOI 10.1016/j.yexcr.2004.10.026; Streit M, 2000, EMBO J, V19, P3272, DOI 10.1093/emboj/19.13.3272; Swindle CS, 2001, J CELL BIOL, V154, P459, DOI 10.1083/jcb.200103103; Tan K, 2006, STRUCTURE, V14, P33, DOI 10.1016/j.str.2005.09.017; TARABOLETTI G, 1987, J CELL BIOL, V105, P2409, DOI 10.1083/jcb.105.5.2409; TUSZYNSKI GP, 1987, CANCER RES, V47, P4130; Uno K, 2004, BIOCHEM BIOPH RES CO, V315, P928, DOI 10.1016/j.bbrc.2004.01.146; Wang WG, 1999, J CELL BIOCHEM, V73, P321; Xie H, 1998, J CELL SCI, V111, P615; YAISH P, 1988, SCIENCE, V242, P933, DOI 10.1126/science.3263702	66	41	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6389	6402		10.1074/jbc.M809198200	http://dx.doi.org/10.1074/jbc.M809198200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19129184	Green Published, hybrid			2022-12-25	WOS:000263742700042
J	Sakamoto, H; Matsuda, KI; Zuloaga, DG; Nishiura, N; Takanami, K; Jordan, CL; Breedlove, SM; Kawata, M				Sakamoto, Hirotaka; Matsuda, Ken-Ichi; Zuloaga, Damian G.; Nishiura, Nobuko; Takanami, Keiko; Jordan, Cynthia L.; Breedlove, S. Marc; Kawata, Mitsuhiro			Stress Affects a Gastrin-Releasing Peptide System in the Spinal Cord That Mediates Sexual Function: Implications for Psychogenic Erectile Dysfunction	PLOS ONE			English	Article							SINGLE-PROLONGED STRESS; PLASMA TESTOSTERONE LEVELS; COMBAT VETERANS; MALE RATS; DISORDER; RECEPTOR; BOMBESIN; NEURONS; EXPRESSION; PTSD	Background: Many men suffering from stress, including post-traumatic stress disorder (PTSD), report sexual dysfunction, which is traditionally treated via psychological counseling. Recently, we identified a gastrin-releasing peptide (GRP) system in the lumbar spinal cord that is a primary mediator for male reproductive functions. Methodology/Principal Findings: To ask whether an acute severe stress could alter the male specific GRP system, we used a single-prolonged stress (SPS), a putative rat model for PTSD in the present study. Exposure of SPS to male rats decreases both the local content and axonal distribution of GRP in the lower lumbar spinal cord and results in an attenuation of penile reflexes in vivo. Remarkably, pharmacological stimulation of GRP receptors restores penile reflexes in SPS-exposed males, and induces spontaneous ejaculation in a dose-dependent manner. Furthermore, although the level of plasma testosterone is normal 7 days after SPS exposure, we found a significant decrease in the expression of androgen receptor protein in this spinal center. Conclusions/Significance: We conclude that the spinal GRP system appears to be a stress-vulnerable center for male reproductive functions, which may provide new insight into a clinical target for the treatment of erectile dysfunction triggered by stress and psychiatric disorders.	[Sakamoto, Hirotaka; Matsuda, Ken-Ichi; Nishiura, Nobuko; Takanami, Keiko; Kawata, Mitsuhiro] Kyoto Prefectural Univ Med, Dept Anat & Neurobiol, Kamigyo Ku, Kyoto, Japan; [Zuloaga, Damian G.; Jordan, Cynthia L.; Breedlove, S. Marc] Michigan State Univ, Dept Psychol & Zool, Program Neurosci, E Lansing, MI 48824 USA	Kyoto Prefectural University of Medicine; Michigan State University	Sakamoto, H (corresponding author), Kyoto Prefectural Univ Med, Dept Anat & Neurobiol, Kamigyo Ku, Kawaramachi Hirokoji, Kyoto, Japan.	hsakamo@koto.kpu-m.ac.jp	Sakamoto, Hirotaka/AAE-3720-2021; SAKAMOTO, Hirotaka/C-3009-2015; Waldvogel, Henry/D-6691-2012	Sakamoto, Hirotaka/0000-0002-6224-4591; Waldvogel, Henry/0000-0003-2165-8568; Breedlove, S. Marc/0000-0003-4359-4315	Ministry of Education, Science, Sports, Culture and Technology, Japan [Grants-in-Aid for Scientific Research]; NIH [NS28421]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028421] Funding Source: NIH RePORTER	Ministry of Education, Science, Sports, Culture and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, Culture and Technology, Japan (to HS K-IM MK) and NIH Grant NS28421 (to SMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANASTASI A, 1971, EXPERIENTIA, V27, P166, DOI 10.1007/BF02145873; BAUER M, 1994, PSYCHIAT RES, V51, P75, DOI 10.1016/0165-1781(94)90048-5; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Cheng GJ, 2004, P NATL ACAD SCI USA, V101, P3739, DOI 10.1073/pnas.0307864100; Chrousos GP, 2007, STRESS, V10, P213, DOI 10.1080/10253890701292119; Cosgrove DJ, 2002, UROLOGY, V60, P881, DOI 10.1016/S0090-4295(02)01899-X; Cui H, 2008, NEUROSCIENCE, V152, P703, DOI 10.1016/j.neuroscience.2007.12.028; HOLSBOER F, 1994, ANN NY ACAD SCI, V746, P345; Iwamoto Y, 2007, PROG NEURO-PSYCHOPH, V31, P642, DOI 10.1016/j.pnpbp.2006.12.010; Kang JH, 2007, CANCER LETT, V253, P273, DOI 10.1016/j.canlet.2007.02.007; KAPLAN HS, 1988, J CLIN PSYCHIAT, V49, P21; KAPLAN PM, 1989, J SEX MARITAL THER, V15, P74; Khan S, 2004, PSYCHOPHARMACOLOGY, V172, P225, DOI 10.1007/s00213-003-1634-4; Kohda K, 2007, NEUROSCIENCE, V148, P22, DOI 10.1016/j.neuroscience.2007.05.041; KREUZ LE, 1972, ARCH GEN PSYCHIAT, V26, P479; Ladenheim EE, 1996, AM J PHYSIOL-REG I, V271, pR180, DOI 10.1152/ajpregu.1996.271.1.R180; Letourneau EJ, 1997, J TRAUMA STRESS, V10, P125, DOI 10.1023/A:1024868632543; Levine L, 2003, CANCER RES, V63, P3495; Liberzon I, 1997, PSYCHONEUROENDOCRINO, V22, P443, DOI 10.1016/S0306-4530(97)00044-9; MASON JW, 1988, BIOL PSYCHIAT, V23, P357, DOI 10.1016/0006-3223(88)90286-7; Matsumoto A, 2005, STRESS, V8, P133, DOI 10.1080/10253890500140642; MCDONALD TJ, 1979, BIOCHEM BIOPH RES CO, V90, P227, DOI 10.1016/0006-291X(79)91614-0; Merali Z, 2006, J NEUROSCI, V26, P10387, DOI 10.1523/JNEUROSCI.1219-06.2006; MONAGHAN EP, 1992, BRAIN RES, V587, P178, DOI 10.1016/0006-8993(92)91443-I; Mulchahey JJ, 2001, PSYCHONEUROENDOCRINO, V26, P273, DOI 10.1016/S0306-4530(00)00052-4; PANULA P, 1988, ANN NY ACAD SCI, V547, P54, DOI 10.1111/j.1749-6632.1988.tb23875.x; Pitman RK, 1997, ANN NY ACAD SCI, V821, P1, DOI 10.1111/j.1749-6632.1997.tb48264.x; Rajfer J, 2000, Rev Urol, V2, P122; Retana-Marquez S, 2003, HORM BEHAV, V44, P327, DOI 10.1016/j.yhbeh.2003.04.001; SACHS BD, 1982, J REPROD FERTIL, V66, P433, DOI 10.1530/jrf.0.0660433; Sakamoto H, 2008, NAT NEUROSCI, V11, P634, DOI 10.1038/nn.2126; Sakamoto H, 2007, ENDOCRINOLOGY, V148, P5842, DOI 10.1210/en.2007-0436; SHINOHARA K, 1993, J NEUROSCI, V13, P793; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Truitt WA, 2002, SCIENCE, V297, P1566, DOI 10.1126/science.1073885; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941; Yehuda R, 1997, ANN NY ACAD SCI, V821, P57, DOI 10.1111/j.1749-6632.1997.tb48269.x; YESAVAGE JA, 1985, BIOL PSYCHIAT, V20, P222, DOI 10.1016/0006-3223(85)90088-5; Yoshii T, 2008, NEUROSCIENCE, V156, P466, DOI 10.1016/j.neuroscience.2008.07.049	39	25	27	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2009	4	1							e4276	10.1371/journal.pone.0004276	http://dx.doi.org/10.1371/journal.pone.0004276			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JE	19169356	gold, Green Published, Green Submitted			2022-12-25	WOS:000265482800006
J	Bezuidenhout, J; Roberts, T; Muller, L; van Helden, P; Walzl, G				Bezuidenhout, Juanita; Roberts, Teri; Muller, Liesel; van Helden, Paul; Walzl, Gerhard			Pleural Tuberculosis in Patients with Early HIV Infection Is Associated with Increased TNF-Alpha Expression and Necrosis in Granulomas	PLOS ONE			English	Article							PROTECTIVE IMMUNE-RESPONSE; INTERFERON-GAMMA-RECEPTOR; MYCOBACTERIUM-TUBERCULOSIS; T-CELLS; MACROPHAGE APOPTOSIS; MESSENGER-RNA; IFN-GAMMA; IN-VITRO; CYTOKINE; IMMUNODEFICIENCY	Although granulomas may be an essential host response against persistent antigens, they are also associated with immunopathology. We investigated whether HIV co-infection affects histopathological appearance and cytokine profiles of pleural granulomas in patients with active pleural tuberculosis (TB). Granulomas were investigated in pleural biopsies from HIV positive and negative TB pleuritis patients. Granulomas were characterised as necrotic or non-necrotic, graded histologically and investigated for the mRNA expression of IL-12, IFN-gamma, TNF-alpha and IL-4 by in situ hybridisation. In all TB patients a mixed Th1/Th2 profile was noted. Necrotic granulomas were more evident in HIV positive patients with a clear association between TNF- alpha and necrosis. This study demonstrates immune dysregulation which may include TNF-alpha-mediated immunopathology at the site of disease in HIV infected pleural TB patients.	[Bezuidenhout, Juanita] Tygerberg Hosp, Dept Histopathol, Cape Town, Western Cape, South Africa; [Roberts, Teri; Muller, Liesel; van Helden, Paul; Walzl, Gerhard] Univ Stellenbosch, Fac Hlth Sci, Dept Biomed Sci, DST, Ctr Excellence Biomed TB Res, NRF, ZA-7600 Stellenbosch, South Africa	Tygerberg Hospital; National Research Foundation - South Africa; Stellenbosch University	Bezuidenhout, J (corresponding author), Tygerberg Hosp, Dept Histopathol, Cape Town, Western Cape, South Africa.	teri.roberts@uct.ac.za	Walzl, Gerhard/N-6371-2016	Walzl, Gerhard/0000-0003-2487-125X	GlaxoSmithKline Action TB; South African MRC; South African National Research Foundation; University of Stellenbosch	GlaxoSmithKline Action TB; South African MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); South African National Research Foundation(National Research Foundation - South Africa); University of Stellenbosch	GlaxoSmithKline Action TB, South African MRC, South African National Research Foundation, University of Stellenbosch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algood HMS, 2003, CYTOKINE GROWTH F R, V14, P467, DOI 10.1016/S1359-6101(03)00054-6; BARNES PF, 1989, J IMMUNOL, V142, P1114; BARNES PF, 1990, J IMMUNOL, V145, P149; Bekker LG, 2000, INFECT IMMUN, V68, P6954, DOI 10.1128/IAI.68.12.6954-6961.2000; BRAUN MM, 1991, AM REV RESPIR DIS, V143, P501, DOI 10.1164/ajrccm/143.3.501; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; Condos R, 1998, AM J RESP CRIT CARE, V157, P729, DOI 10.1164/ajrccm.157.3.9705044; Das SD, 2004, FEMS IMMUNOL MED MIC, V41, P85, DOI 10.1016/j.femsim.2004.01.006; de Noronha ALL, 2008, PATHOL RES PRACT, V204, P155, DOI 10.1016/j.prp.2007.10.008; Dheda K, 2005, AIDS, V19, P1601, DOI 10.1097/01.aids.0000183520.52760.ef; Dheda K, 2005, J INFECT DIS, V192, P1201, DOI 10.1086/444545; Dheda K, 2005, AM J RESP CRIT CARE, V172, P501, DOI 10.1164/rccm.200502-278OC; Dorman SE, 1998, J CLIN INVEST, V101, P2364, DOI 10.1172/JCI2901; Ehlers S, 2000, J IMMUNOL, V165, P483, DOI 10.4049/jimmunol.165.1.483; Ellner J J, 1988, Semin Respir Infect, V3, P335; Fairbairn IP, 2004, BIOCHEM SOC T, V32, P496, DOI 10.1042/BST0320496; Fayyazi A, 2000, J PATHOL, V191, P417, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH664&gt;3.0.CO;2-R; Fenhalls G, 2000, INFECT IMMUN, V68, P2827, DOI 10.1128/IAI.68.5.2827-2836.2000; Fenhalls G, 2002, IMMUNOLOGY, V105, P325, DOI 10.1046/j.1365-2567.2002.01378.x; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Garrait V, 1997, J IMMUNOL, V159, P2824; Gately MK, 1998, ANNU REV IMMUNOL, V16, P495, DOI 10.1146/annurev.immunol.16.1.495; Goletti D, 1998, J INFECT DIS, V177, P1332, DOI 10.1086/515276; Hart DNJ, 1997, BLOOD, V90, P3245, DOI 10.1182/blood.V90.9.3245; HASLETON PS, 1996, SPENCERS PATHOLOGY L, pCH7; HERNANDEZPANDO R, 1994, IMMUNOLOGY, V82, P591; Hirsch CS, 1999, J INFECT DIS, V179, P945, DOI 10.1086/314667; HOEFAKKER S, 1995, J IMMUNOL METHODS, V185, P149, DOI 10.1016/0022-1759(95)00122-Q; Imperiali FG, 2001, CLIN EXP IMMUNOL, V123, P435, DOI 10.1046/j.1365-2249.2001.01481.x; Jalapathy KV, 2004, FEMS IMMUNOL MED MIC, V40, P139, DOI 10.1016/S0928-8244(03)00303-1; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Lawn SD, 2001, CLIN MICROBIOL REV, V14, P753, DOI 10.1128/CMR.14.4.753-777.2001; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; LYNCH ML, 1969, MED LAB TECHNOLOGY C, pCH26; MAGGI E, 1994, SCIENCE, V265, P244, DOI 10.1126/science.8023142; MUKADI Y, 1993, LANCET, V342, P143, DOI 10.1016/0140-6736(93)91346-N; MULLER KM, 1993, J IMMUNOL, V150, P5576; MYATT N, 1994, J CLIN PATHOL, V47, P423, DOI 10.1136/jcp.47.5.423; OYAIZU N, 1990, P NATL ACAD SCI USA, V87, P2379, DOI 10.1073/pnas.87.6.2379; Polyak S, 1997, J IMMUNOL, V159, P2177; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Rhodes SG, 2000, INFECT IMMUN, V68, P5393, DOI 10.1128/IAI.68.9.5393-5400.2000; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; ROPER WH, 1955, AM REV TUBERC PULM, V71, P616; Rydell-Tormanen K, 2006, EUR RESPIR J, V28, P268, DOI 10.1183/09031936.06.00126905; Saunders BM, 2000, IMMUNOL CELL BIOL, V78, P334, DOI 10.1046/j.1440-1711.2000.00933.x; Schluger NW, 2001, RESP RES, V2, P157, DOI 10.1186/rr53; Seah GT, 2000, J INFECT DIS, V181, P385, DOI 10.1086/315200; Subramanyam S, 2004, J INTERF CYTOK RES, V24, P101, DOI 10.1089/107999004322813345; Tan JS, 1997, J IMMUNOL, V159, P290; THURLBECK W, 1995, PATHOLOGY LUNG, pCH13; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Uhal BD, 2002, CHEST, V122, p293S, DOI 10.1378/chest.122.6_suppl.293S; van Crevel R, 2000, J INFECT DIS, V181, P1194, DOI 10.1086/315325; Viorritto ICB, 2007, CLIN IMMUNOL, V122, P125, DOI 10.1016/j.clim.2006.07.012; VYAKARNAM A, 1995, IMMUNOLOGY, V86, P85; Wigginton JE, 2001, J IMMUNOL, V166, P1951, DOI 10.4049/jimmunol.166.3.1951; Zhang M, 1999, J IMMUNOL, V162, P2441	62	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2009	4	1							e4228	10.1371/journal.pone.0004228	http://dx.doi.org/10.1371/journal.pone.0004228			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IZ	19156215	Green Published, Green Submitted, gold			2022-12-25	WOS:000265481900010
J	Fukushima, F; Nakao, K; Shinoe, T; Fukaya, M; Muramatsu, S; Sakimura, K; Kataoka, H; Mori, H; Watanabe, M; Manabe, T; Mishina, M				Fukushima, Fumiaki; Nakao, Kazuhito; Shinoe, Toru; Fukaya, Masahiro; Muramatsu, Shin-ichi; Sakimura, Kenji; Kataoka, Hirotaka; Mori, Hisashi; Watanabe, Masahiko; Manabe, Toshiya; Mishina, Masayoshi			Ablation of NMDA Receptors Enhances the Excitability of Hippocampal CA3 Neurons	PLOS ONE			English	Article								Synchronized discharges in the hippocampal CA3 recurrent network are supposed to underlie network oscillations, memory formation and seizure generation. In the hippocampal CA3 network, NMDA receptors are abundant at the recurrent synapses but scarce at the mossy fiber synapses. We generated mutant mice in which NMDA receptors were abolished in hippocampal CA3 pyramidal neurons by postnatal day 14. The histological and cytological organizations of the hippocampal CA3 region were indistinguishable between control and mutant mice. We found that mutant mice lacking NMDA receptors selectively in CA3 pyramidal neurons became more susceptible to kainate-induced seizures. Consistently, mutant mice showed characteristic large EEG spikes associated with multiple unit activities (MUA), suggesting enhanced synchronous firing of CA3 neurons. The electrophysiological balance between fast excitatory and inhibitory synaptic transmission was comparable between control and mutant pyramidal neurons in the hippocampal CA3 region, while the NMDA receptor-slow AHP coupling was diminished in the mutant neurons. In the adult brain, inducible ablation of NMDA receptors in the hippocampal CA3 region by the viral expression vector for Cre recombinase also induced similar large EEG spikes. Furthermore, pharmacological blockade of CA3 NMDA receptors enhanced the susceptibility to kainate-induced seizures. These results raise an intriguing possibility that hippocampal CA3 NMDA receptors may suppress the excitability of the recurrent network as a whole in vivo by restricting synchronous firing of CA3 neurons.	[Fukushima, Fumiaki; Nakao, Kazuhito; Kataoka, Hirotaka; Mori, Hisashi; Mishina, Masayoshi] Univ Tokyo, Dept Mol Neurobiol & Pharmacol, Grad Sch Med, Tokyo, Japan; [Shinoe, Toru; Manabe, Toshiya] Univ Tokyo, Inst Med Sci, Div Neuronal Network, Tokyo, Japan; [Fukaya, Masahiro; Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 060, Japan; [Muramatsu, Shin-ichi] Jichi Med Univ, Dept Med, Div Neurol, Tochigi, Japan; [Sakimura, Kenji] Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata 95021, Japan; [Manabe, Toshiya] JST, CREST, Kawaguchi, Japan	University of Tokyo; University of Tokyo; Hokkaido University; Jichi Medical University; Niigata University; Japan Science & Technology Agency (JST)	Fukushima, F (corresponding author), Univ Tokyo, Dept Mol Neurobiol & Pharmacol, Grad Sch Med, Tokyo, Japan.	mishina@m.u-tokyo.ac.jp	Watanabe, Masahiko/S-3614-2019; Muramatsu, Shinichi/ABC-6093-2021; WATANABE, Masahiko/A-4055-2012; Muramatsu, Shin-ichi/K-9420-2013; nakao, kazuhito/J-9419-2019	Watanabe, Masahiko/0000-0001-5037-7138; Muramatsu, Shinichi/0000-0002-3185-7790; WATANABE, Masahiko/0000-0001-5037-7138; Muramatsu, Shin-ichi/0000-0002-3185-7790; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid]; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-Aid for Scientific Research on Priority Areas (Molecular Brain Science) and Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. F.F. was supported by Japan Society for the Promotion of Science, and S.T. by the 21st Century COE Program, the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Bains JS, 1999, NAT NEUROSCI, V2, P720, DOI 10.1038/11184; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Behrens CJ, 2005, NAT NEUROSCI, V8, P1560, DOI 10.1038/nn1571; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; Colgin LL, 2005, NEUROSCI LETT, V385, P46, DOI 10.1016/j.neulet.2005.05.005; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Franklin K. B. J., 1996, MOUSE BRAIN STEREOTA; Fukaya M, 2005, NEUROSCI RES, V53, P376, DOI 10.1016/j.neures.2005.08.009; Fukaya M, 2003, P NATL ACAD SCI USA, V100, P4855, DOI 10.1073/PNAS.0830996100; Fukaya M, 2000, J COMP NEUROL, V426, P572; Galvan CD, 2000, J NEUROSCI, V20, P2904; Galvan CD, 2003, EUR J NEUROSCI, V18, P1861, DOI 10.1046/j.1460-9568.2003.02920.x; Huang CS, 2005, CELL, V123, P105, DOI 10.1016/j.cell.2005.07.033; Isaacson JS, 2001, NEURON, V31, P1027, DOI 10.1016/S0896-6273(01)00428-7; Jefferys JGR, 1993, TXB EPILEPSY, P241; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; Li XG, 2006, MOL THER, V13, P160, DOI 10.1016/j.ymthe.2005.08.009; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041; Lubenov EV, 2008, NEURON, V58, P118, DOI 10.1016/j.neuron.2008.01.036; Luthi A, 2001, NAT NEUROSCI, V4, P1102, DOI 10.1038/nn744; MACVICAR BA, 1980, BRAIN RES, V184, P220, DOI 10.1016/0006-8993(80)90602-2; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; MILES R, 1983, NATURE, V306, P371, DOI 10.1038/306371a0; Mishina M, 2007, NEUROSCI RES, V58, P105, DOI 10.1016/j.neures.2007.01.004; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; Morris RGM, 2003, PHILOS T ROY SOC B, V358, P643, DOI 10.1098/rstb.2002.1230; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Murakami M, 2005, NEURON, V46, P285, DOI 10.1016/j.neuron.2005.02.025; Nakagama S, 1998, J COMP NEUROL, V395, P112, DOI 10.1002/(SICI)1096-9861(19980525)395:1<112::AID-CNE8>3.0.CO;2-3; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; NICOLL RA, 1981, SCIENCE, V212, P957, DOI 10.1126/science.6262912; Rajji T, 2006, J NEUROSCI, V26, P908, DOI 10.1523/JNEUROSCI.4194-05.2006; Scammell TE, 2003, J NEUROSCI, V23, P5762; SCHWARTZKROIN PA, 1980, SCIENCE, V210, P1125, DOI 10.1126/science.6777871; Shimuta M, 2001, MOL CELL NEUROSCI, V17, P921, DOI 10.1006/mcne.2001.0981; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; Takeuchi T, 2005, J NEUROSCI, V25, P2146, DOI 10.1523/JNEUROSCI.4740-04.2005; Takeuchi T, 2002, BIOCHEM BIOPH RES CO, V293, P953, DOI 10.1016/S0006-291X(02)00321-2; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; TRAUB RD, 1991, NEURONAL NETWORKS HI, P119; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0; Westbrook G. L., 2000, PRINCIPLES NEURAL SC, P910; Yamada K, 2000, J COMP NEUROL, V418, P106; Yamada K, 2001, EUR J NEUROSCI, V13, P2025, DOI 10.1046/j.0953-816x.2001.01580.x; YAMAZAKI M, 1992, FEBS LETT, V300, P39, DOI 10.1016/0014-5793(92)80160-I; YLINEN A, 1995, J NEUROSCI, V15, P30	61	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e3993	10.1371/journal.pone.0003993	http://dx.doi.org/10.1371/journal.pone.0003993			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142228	Green Published, Green Submitted, gold			2022-12-25	WOS:000265479700001
J	Boo, JH; Song, HD; Kim, JE; Kang, DE; Mook-Jung, I				Boo, Jung H.; Song, Hyundong; Kim, Ji E.; Kang, David E.; Mook-Jung, Inhee			Accumulation of Phosphorylated beta-Catenin Enhances ROS-Induced Cell Death in Presenilin-Deficient Cells	PLOS ONE			English	Article								Presenilin (PS) is involved in many cellular events under physiological and pathological conditions. Previous reports have revealed that PS deficiency results in hyperproliferation and resistance to apoptotic cell death. In the present study, we investigated the effects of PS on beta-catenin and cell mortality during serum deprivation. Under these conditions, PS1/PS2 double-knockout MEFs showed aberrant accumulation of phospho-beta-catenin, higher ROS generation, and notable cell death. Inhibition of beta-catenin phosphorylation by LiCl reversed ROS generation and cell death in PS deficient cells. In addition, the K19/49R mutant form of beta-catenin, which undergoes normal phosphorylation but not ubiquitination, induced cytotoxicity, while the phosphorylation deficient S37A beta-catenin mutant failed to induce cytotoxicity. These results indicate that aberrant accumulation of phospho-beta-catenin underlies ROS-mediated cell death in the absence of PS. We propose that the regulation of beta-catenin is useful for identifying therapeutic targets of hyperproliferative diseases and other degenerative conditions.	[Boo, Jung H.; Mook-Jung, Inhee] Seoul Natl Univ, Coll Med, Sch Biol Sci, Interdisciplinary Program Brain Sci, Seoul, South Korea; [Boo, Jung H.; Song, Hyundong; Kim, Ji E.; Mook-Jung, Inhee] Seoul Natl Univ, Coll Med, Dept Biochem & Biomed Sci, Seoul 151, South Korea; [Kang, David E.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Seoul National University (SNU); Seoul National University (SNU); University of California System; University of California San Diego	Boo, JH (corresponding author), Seoul Natl Univ, Coll Med, Sch Biol Sci, Interdisciplinary Program Brain Sci, Seoul, South Korea.	inhee@snu.ac.kr	Kang, David E./E-5234-2012; Mook, Inhee/J-2754-2012		21 C Frontier Functional Proteomics Project [FPR08K1301-02210]; New Drug Target Discovery project [08N4800-09610]; AARC [R11-2002-097-08001]	21 C Frontier Functional Proteomics Project(Ministry of Education, Science & Technology (MEST), Republic of Korea); New Drug Target Discovery project; AARC	This work was supported by grants from the 21 C Frontier Functional Proteomics Project (FPR08K1301-02210), the New Drug Target Discovery project (08N4800-09610), and the AARC program project (R11-2002-097-08001) for IMJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Arumugam TV, 2006, NAT MED, V12, P621, DOI 10.1038/nm1403; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; Damalas A, 1999, EMBO J, V18, P3054, DOI 10.1093/emboj/18.11.3054; Drexler HCA, 1997, P NATL ACAD SCI USA, V94, P855, DOI 10.1073/pnas.94.3.855; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; Kim K, 2000, MOL BIOL CELL, V11, P3509, DOI 10.1091/mbc.11.10.3509; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Pack-Chung E, 2000, J BIOL CHEM, V275, P14440, DOI 10.1074/jbc.M909882199; Pandey S, 2003, APOPTOSIS, V8, P497, DOI 10.1023/A:1025542424986; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Repetto E, 2007, J BIOL CHEM, V282, P31504, DOI 10.1074/jbc.M704273200; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Shaw RW, 2006, FASEB J, V20, pA898, DOI 10.1096/fj.05-4055fje; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Soriano S, 2001, J CELL BIOL, V152, P785, DOI 10.1083/jcb.152.4.785; Usami N, 2003, ONCOGENE, V22, P7922, DOI 10.1038/sj.onc.1206533; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208	33	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2009	4	1							e4172	10.1371/journal.pone.0004172	http://dx.doi.org/10.1371/journal.pone.0004172			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ID	19137062	Green Published, gold, Green Submitted			2022-12-25	WOS:000265479500003
J	Foygel, K; Choi, B; Jun, S; Leong, DE; Lee, A; Wong, CC; Zuo, E; Eckart, M; Pera, RAR; Wong, WH; Yao, MWM				Foygel, Kira; Choi, Bokyung; Jun, Sunny; Leong, Denise E.; Lee, Alan; Wong, Connie C.; Zuo, Elizabeth; Eckart, Michael; Pera, Renee A. Reijo; Wong, Wing H.; Yao, Mylene W. M.			A Novel and Critical Role for Oct4 as a Regulator of the Maternal-Embryonic Transition	PLOS ONE			English	Article								Background: Compared to the emerging embryonic stem cell (ESC) gene network, little is known about the dynamic gene network that directs reprogramming in the early embryo. We hypothesized that Oct4, an ESC pluripotency regulator that is also highly expressed at the 1- to 2-cell stages in embryos, may be a critical regulator of the earliest gene network in the embryo. Methodology/Principal Findings: Using antisense morpholino oligonucleotide (MO)-mediated gene knockdown, we show that Oct4 is required for development prior to the blastocyst stage. Specifically, Oct4 has a novel and critical role in regulating genes that encode transcriptional and post-transcriptional regulators as early as the 2-cell stage. Our data suggest that the key function of Oct4 may be to switch the developmental program from one that is predominantly regulated by post-transcriptional control to one that depends on the transcriptional network. Further, we propose to rank candidate genes quantitatively based on the inter-embryo variation in their differential expression in response to Oct4 knockdown. Of over 30 genes analyzed according to this proposed paradigm, Rest and Mta2, both of which have established pluripotency functions in ESCs, were found to be the most tightly regulated by Oct4 at the 2-cell stage. Conclusions/Significance: We show that the Oct4-regulated gene set at the 1-to 2-cell stages of early embryo development is large and distinct from its established network in ESCs. Further, our experimental approach can be applied to dissect the gene regulatory network of Oct4 and other pluripotency regulators to deconstruct the dynamic developmental program in the early embryo.	[Foygel, Kira; Jun, Sunny; Leong, Denise E.; Lee, Alan; Wong, Connie C.; Pera, Renee A. Reijo; Yao, Mylene W. M.] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Choi, Bokyung] Stanford Univ, Sch Humanities & Sci, Dept Appl Phys, Stanford, CA 94305 USA; [Wong, Connie C.; Pera, Renee A. Reijo] Stanford Univ, Inst Stem Cell Biol & Regen Med, Ctr Human Embryo and Embryon Stem Cell Res & Ed, Palo Alto, CA USA; [Zuo, Elizabeth; Eckart, Michael] Stanford Univ, Beckman Ctr, Protein & Nucleic Acid Facil, Stanford, CA 94305 USA; [Wong, Wing H.] Stanford Univ, Sch Humanities & Sci, Dept Stat, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Foygel, K (corresponding author), Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA.	mylene.yao@stanford.edu		Reijo Pera, Renee/0000-0002-6487-1329	NIH [HD057970, HD00849, HD01249, GM067250]; American Society for Reproductive Medicine; March of Dimes; William R. Hewlett Stanford Graduate Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057970, K12HD000849] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD001249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067250] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society for Reproductive Medicine; March of Dimes(March of Dimes); William R. Hewlett Stanford Graduate Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M.Y. and this project are supported by NIH (HD057970, HD00849, HD01249), and the American Society for Reproductive Medicine; W.H.W. is supported by NIH GM067250; R.A.R.P. is supported by the March of Dimes; B.C. is supported by the William R. Hewlett Stanford Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano H, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-11; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Barratt CLR, 2004, LANCET, V364, P115, DOI 10.1016/S0140-6736(04)16649-X; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Gore AV, 2005, NATURE, V438, P1030, DOI 10.1038/nature04184; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hara KT, 2005, DEV BIOL, V286, P102, DOI 10.1016/j.ydbio.2005.07.012; Haraguchi S, 2004, MOL REPROD DEV, V68, P17, DOI 10.1002/mrd.20047; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Imai KS, 2006, SCIENCE, V312, P1183, DOI 10.1126/science.1123404; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kim MH, 2002, BIOCHEM BIOPH RES CO, V296, P1372, DOI 10.1016/S0006-291X(02)02070-3; Kim SK, 2005, STEM CELLS, V23, P458, DOI 10.1634/stemcells.2004-0245; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Ralston A, 2008, DEV BIOL, V313, P614, DOI 10.1016/j.ydbio.2007.10.054; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Stefanovic S, 2007, CELL CYCLE, V6, P8, DOI 10.4161/cc.6.1.3633; Sumanas Saulius, 2002, Briefings in Functional Genomics & Proteomics, V1, P239; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamada L, 2003, DEVELOPMENT, V130, P6485, DOI 10.1242/dev.00847; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Zeng FY, 2005, DEV BIOL, V283, P40, DOI 10.1016/j.ydbio.2005.03.038; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	37	83	88	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4109	10.1371/journal.pone.0004109	http://dx.doi.org/10.1371/journal.pone.0004109			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19129941	Green Submitted, gold, Green Published			2022-12-25	WOS:000265466600024
J	Palpant, NJ; D'Alecy, LG; Metzger, JM				Palpant, Nathan J.; D'Alecy, Louis G.; Metzger, Joseph M.			Single histidine button in cardiac troponin I sustains heart performance in response to severe hypercapnic respiratory acidosis in vivo	FASEB JOURNAL			English	Article						myocardial function; myofilaments; pH	POSITIVE-PRESSURE VENTILATION; THIN FILAMENT; TRANSGENIC MICE; GENE-TRANSFER; SKELETAL; PH; CALCIUM; MUSCLE; FAILURE; ADULT	Intracellular acidosis is a profound negative regulator of myocardial performance. We hypothesized that titrating myofilament calcium sensitivity by a single histidine substituted cardiac troponin I (A164H) would protect the whole animal physiological response to acidosis in vivo. To experimentally induce severe hypercapnic acidosis, mice were exposed to a 40% CO2 challenge. By echocardiography, it was found that systolic function and ventricular geometry were maintained in cTnI A164H transgenic (Tg) mice. By contrast, non-Tg (Ntg) littermates experienced rapid and marked cardiac decompensation during this same challenge. For detailed hemodymanic assessment, Millar pressure-conductance catheterization was performed while animals were treated with a beta-blocker, esmolol, during a severe hypercapnic acidosis challenge. Survival and load-independent measures of contractility were significantly greater in Tg vs. Ntg mice. This assay showed that Ntg mice had 100% mortality within 5 min of acidosis. By contrast, systolic and diastolic function were protected in Tg mice during acidosis, and they had 100% survival. This study shows that, independent of any beta-adrenergic compensation, myofilament-based molecular manipulation of inotropy by histidine-modified troponin I maintains cardiac inotropic and lusitropic performance and markedly improves survival during severe acidosis in vivo.-Palpant, N. J., D'Alecy, L. G., Metzger, J. M. Single histidine button in cardiac troponin I sustains heart performance in response to severe hypercapnic respiratory acidosis in vivo. FASEB J. 23, 1529-1540 (2009)	[Metzger, Joseph M.] Univ Minnesota, Sch Med, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA; [Palpant, Nathan J.; D'Alecy, Louis G.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA	University of Minnesota System; University of Minnesota Twin Cities; University of Michigan System; University of Michigan	Metzger, JM (corresponding author), Univ Minnesota, Sch Med, Dept Integrat Biol & Physiol, 6-125 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	metzgerj@umn.edu	Palpant, Nathan/B-1641-2017	Palpant, Nathan/0000-0002-9334-8107	NIH; American Heart Association	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	We thank Dr. Robert Bartlett for generous use of his blood gas analysis machine and Dr. Terry Major for assistance with analysis of blood gas parameters. Drs. Margaret Westfall and Sharlene Day provided invaluable insight into the development of this manuscript. We also thank Steven Whitesall for his assistance with telemetered mice and Kimber Converso for her expert murine echocardiography measurements. This work was supported by grants from the NIH (J.M.) and the American Heart Association (N.P.).	ALLEN DG, 1983, J PHYSIOL-LONDON, V335, P555, DOI 10.1113/jphysiol.1983.sp014550; Arteaga GM, 2005, AM J PHYSIOL-HEART C, V289, pH2183, DOI 10.1152/ajpheart.00520.2005; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Blumenschein TMA, 2001, J BIOL CHEM, V276, P36606, DOI 10.1074/jbc.M105130200; CAMPBELL AP, 1991, J MOL BIOL, V222, P405, DOI 10.1016/0022-2836(91)90219-V; Cho MC, 1999, J BIOL CHEM, V274, P22251, DOI 10.1074/jbc.274.32.22251; Crampin EJ, 2006, BIOPHYS J, V90, P3074, DOI 10.1529/biophysj.105.070557; Dargis R, 2002, J BIOL CHEM, V277, P34662, DOI 10.1074/jbc.C200419200; Davis J, 2007, CIRC RES, V100, P1494, DOI 10.1161/01.RES.0000268412.34364.50; Day SM, 2007, J MOL MED, V85, P911, DOI 10.1007/s00109-007-0181-6; Day SM, 2006, NAT MED, V12, P181, DOI 10.1038/nm1346; del Monte F, 2004, P NATL ACAD SCI USA, V101, P5622, DOI 10.1073/pnas.0305778101; Ding X L, 1996, J Card Fail, V2, P319, DOI 10.1016/S1071-9164(96)80019-4; F'entzke RC, 1999, J PHYSIOL-LONDON, V517, P143, DOI 10.1111/j.1469-7793.1999.0143z.x; FABIATO A, 1978, J PHYSIOL-LONDON, V276, P233, DOI 10.1113/jphysiol.1978.sp012231; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; Fu Y, 2006, CIRC RES, V98, P659, DOI 10.1161/01.RES.0000207497.50477.60; Givertz MM, 2007, CIRCULATION, V115, P1218, DOI 10.1161/CIRCULATIONAHA.106.668640; GODT RE, 1989, J PHYSIOL-LONDON, V412, P155, DOI 10.1113/jphysiol.1989.sp017609; Harper RM, 2005, J NEUROPHYSIOL, V93, P1647, DOI 10.1152/jn.00863.2004; Jorgensen K, 2008, CIRCULATION, V117, P1075, DOI 10.1161/CIRCULATIONAHA.107.722868; KORETSUNE Y, 1989, CIRCULATION, V80, P369, DOI 10.1161/01.CIR.80.2.369; LEE JA, 1991, J CLIN INVEST, V88, P361, DOI 10.1172/JCI115311; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Linder AE, 2005, J CARDIOVASC PHARM, V46, P438, DOI 10.1097/01.fjc.0000175879.14994.63; Lindhout DA, 2003, J BIOL CHEM, V278, P27024, DOI 10.1074/jbc.M302497200; Liou YM, 2008, PFLUG ARCH EUR J PHY, V456, P787, DOI 10.1007/s00424-008-0456-y; Lutgens E, 1999, CARDIOVASC RES, V41, P586, DOI 10.1016/S0008-6363(98)00216-8; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; Metzger JM, 2004, CIRC RES, V94, P146, DOI 10.1161/01.RES.0000110083.17024.60; Metzger JM, 2003, J BIOL CHEM, V278, P13118, DOI 10.1074/jbc.M212601200; METZGER JM, 1995, BIOPHYS J, V68, P1430, DOI 10.1016/S0006-3495(95)80316-4; Michele DE, 2002, CIRC RES, V91, P255, DOI 10.1161/01.RES.0000027530.58419.82; O'Croinin DF, 2008, CRIT CARE MED, V36, P2128, DOI 10.1097/CCM.0b013e31817d1b59; Oldner A, 2001, CRIT CARE MED, V29, P2185, DOI 10.1097/00003246-200111000-00022; ORCHARD CH, 1990, AM J PHYSIOL, V258, pC967, DOI 10.1152/ajpcell.1990.258.6.C967; PALPANT NJ, 2008, CARDIOVASC RES; Parsons B, 1997, J MUSCLE RES CELL M, V18, P599, DOI 10.1023/A:1018623604365; RICCIARDI L, 1994, J MOL CELL CARDIOL, V26, P601, DOI 10.1006/jmcc.1994.1072; RICCIARDI L, 1986, CARDIOVASC RES, V20, P117, DOI 10.1093/cvr/20.2.117; Rocker GM, 1999, CHEST, V115, P173, DOI 10.1378/chest.115.1.173; SOLARO RJ, 1989, MOL CELL BIOCHEM, V89, P163; SOLARO RJ, 1988, CIRC RES, V63, P779, DOI 10.1161/01.RES.63.4.779; Sorsa T, 2004, MOL CELL BIOCHEM, V266, P87, DOI 10.1023/B:MCBI.0000049141.37823.19; Steg PG, 2004, CIRCULATION, V109, P494, DOI 10.1161/01.CIR.0000109691.16944.DA; Szatkowski ML, 2001, J CLIN INVEST, V107, P191, DOI 10.1172/JCI9862; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tardiff JC, 1999, J CLIN INVEST, V104, P469, DOI 10.1172/JCI6067; Tsunezuka Y, 2000, ARTIF ORGANS, V24, P70, DOI 10.1046/j.1525-1594.2000.06339.x; Ucgun I, 2008, RESPIRATION, V76, P270, DOI 10.1159/000131707; Urboniene D, 2005, CIRC RES, V97, P70, DOI 10.1161/01.RES.0000173849.68636.1e; Westfall MV, 2007, J MOL CELL CARDIOL, V43, P107, DOI 10.1016/j.yjmcc.2007.05.017; Westfall MV, 1997, P NATL ACAD SCI USA, V94, P5444, DOI 10.1073/pnas.94.10.5444; Westfall MV, 2000, CIRC RES, V86, P470, DOI 10.1161/01.RES.86.4.470; Westfall MV, 2003, ADV EXP MED BIOL, V538, P169; Westfall MV, 2002, CIRC RES, V91, P525, DOI 10.1161/01.RES.0000034710.46739.C0; Westfall MV, 2001, NEWS PHYSIOL SCI, V16, P278; Westfall MV, 2001, BIOPHYS J, V80, p356A; Whitesall SE, 2004, AM J PHYSIOL-HEART C, V286, pH2408, DOI 10.1152/ajpheart.01089.2003; Windisch W, 2005, CHEST, V128, P657, DOI 10.1378/chest.128.2.657; Wolska BM, 2001, J PHYSIOL-LONDON, V536, P863, DOI 10.1111/j.1469-7793.2001.00863.x	61	12	12	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2009	23	5					1529	1540		10.1096/fj.08-121996	http://dx.doi.org/10.1096/fj.08-121996			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19141534	Green Submitted, Green Published			2022-12-25	WOS:000266651700029
J	Tanimura, A; Morita, T; Nezu, A; Shitara, A; Hashimoto, N; Tojyo, Y				Tanimura, Akihiko; Morita, Takao; Nezu, Akihiro; Shitara, Akiko; Hashimoto, Noboru; Tojyo, Yosuke			Use of Fluorescence Resonance Energy Transfer-based Biosensors for the Quantitative Analysis of Inositol 1,4,5-Trisphosphate Dynamics in Calcium Oscillations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVING CELLS; CA2+ OSCILLATIONS; LUMINAL CA2+; HSY CELLS; TRISPHOSPHATE; RECEPTOR; IDENTIFICATION; FREQUENCY; RELEASE; IP3	Inositol 1,4,5-trisphosphate (IP3) is an intracellular messenger that elicits a wide range of spatial and temporal Ca2+ signals, and this signaling versatility is exploited to regulate diverse cellular responses. In this study, we have developed a series of IP3 biosensors that exhibit strong pH stability and varying affinities for IP3, as well as a method for the quantitative measurement of cytosolic concentrations of I3 ([I3](i)) in single living cells. We applied this method to elucidate IP3 dynamics during agonist-induced Ca2+ oscillations, and we demonstrated cell type-dependent differences in IP3 dynamics, a nonfluctuating rise in [IP3] i and repetitive IP3 spikes during Ca2+ oscillations in COS-7 cells and HSY-EA1 cells, respectively. The size of the IP3 spikes in HSY-EA1 cells varied from 10 to 100 nM, and the [IP3](i) spike peak was preceded by a Ca2+ spike peak. These results suggest that repetitive IP3 spikes in HSY-EA1 cells are passive reflections of Ca2+ oscillations, and are unlikely to be essential for driving Ca2+ oscillations. In addition, the interspike periods of Ca2+ oscillations that occurred during the slow rise in [IP3](i) were not shortened by the rise in [IP3](i), indicating that IP3-dependent and -independent mechanisms may regulate the frequency of Ca2+ oscillations. The novel method described herein as well as the quantitative information obtained by using this method should provide a valuable and sound basis for future studies on the spatial and temporal regulations of IP3 and Ca2+.	[Tanimura, Akihiko; Morita, Takao; Nezu, Akihiro; Shitara, Akiko; Tojyo, Yosuke] Hlth Sci Univ Hokkaido, Sch Dent, Dept Pharmacol, Ishikari, Hokkaido 0610293, Japan; [Hashimoto, Noboru] Hlth Sci Univ Hokkaido, Sch Dent, Dept Integrated Human Sci, Ishikari, Hokkaido 0610293, Japan	Health Sciences University of Hokkaido; Health Sciences University of Hokkaido	Tanimura, A (corresponding author), Hlth Sci Univ Hokkaido, Sch Dent, Dept Pharmacol, Ishikari, Hokkaido 0610293, Japan.	tanimura@hoku-iryo-u.ac.jp		Shitara, Akiko/0000-0003-4899-8538	Ministry of Education, Culture, Sports, Science and Technology of Japan [16390532]; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by Grant-in-aid for Scientific Research 16390532 (to A. T.), by HAITEKU (2007) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Japan Science and Technology Agency. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Berridge MJ, 2007, BIOCHEM SOC SYMP, V74, P1, DOI 10.1002/9780470514696.ch1; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Dupont G, 2007, INT REV CYTOL, V261, P193, DOI 10.1016/S0074-7696(07)61005-5; Hajnoczky G, 1997, EMBO J, V16, P3533, DOI 10.1093/emboj/16.12.3533; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Iwai M, 2007, J BIOL CHEM, V282, P12755, DOI 10.1074/jbc.M609833200; Matsu-ura T, 2006, J CELL BIOL, V173, P755, DOI 10.1083/jcb.200512141; MEYER T, 1991, ANNU REV BIOPHYS BIO, V20, P153, DOI 10.1146/annurev.bb.20.060191.001101; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nash MS, 2002, J BIOL CHEM, V277, P35947, DOI 10.1074/jbc.M205622200; Nezu A, 2006, BBA-GEN SUBJECTS, V1760, P1274, DOI 10.1016/j.bbagen.2006.04.004; PARKER I, 1992, AM J PHYSIOL, V263, pC154, DOI 10.1152/ajpcell.1992.263.1.C154; Politi A, 2006, BIOPHYS J, V90, P3120, DOI 10.1529/biophysj.105.072249; Remus TP, 2006, J BIOL CHEM, V281, P608, DOI 10.1074/jbc.M509645200; Sato M, 2005, ANAL CHEM, V77, P4751, DOI 10.1021/ac040195j; Sneyd J, 2006, P NATL ACAD SCI USA, V103, P1675, DOI 10.1073/pnas.0506135103; Tanimura A, 1996, J CELL BIOL, V132, P607, DOI 10.1083/jcb.132.4.607; Tanimura A, 1996, J BIOL CHEM, V271, P30904, DOI 10.1074/jbc.271.48.30904; Tanimura A, 2004, J BIOL CHEM, V279, P38095, DOI 10.1074/jbc.C400312200; Tanimura A, 2002, J BIOL CHEM, V277, P29054, DOI 10.1074/jbc.M201130200; Tojyo Y, 2001, BBA-MOL CELL RES, V1539, P114, DOI 10.1016/S0167-4889(01)00098-2; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; WAKUI M, 1989, NATURE, V339, P317, DOI 10.1038/339317a0; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277; Zhang LY, 2007, CHEMMEDCHEM, V2, P1281, DOI 10.1002/cmdc.200700071	28	55	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8901	8908		10.1074/jbc.M805865200	http://dx.doi.org/10.1074/jbc.M805865200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19158094	Green Published, hybrid			2022-12-25	WOS:000264397800073
J	Ballottari, M; Mozzo, M; Croce, R; Morosinotto, T; Bassi, R				Ballottari, Matteo; Mozzo, Milena; Croce, Roberta; Morosinotto, Tomas; Bassi, Roberto			Occupancy and Functional Architecture of the Pigment Binding Sites of Photosystem II Antenna Complex Lhcb5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; RESOLVED FLUORESCENCE ANALYSIS; HIGHER-PLANTS; MUTATION ANALYSIS; IN-VITRO; CHLOROPHYLL FLUORESCENCE; ENERGY-DISSIPATION; PROTEIN CP26; SPECTROSCOPIC CHARACTERIZATION; CHROMOPHORE-BINDING	Lhcb5 is an antenna protein that is highly conserved in plants and green algae. It is part of the inner layer of photosystem II antenna system retained in high light acclimated plants. To study the structure-function relation and the role of individual pigments in this complex, we (i) "knocked out" each of the chromophores bound to multiple (nine total) chlorophyll sites and (ii) exchanged the xanthophylls bound to the three xanthophyll sites. The occupancy and associated energy of the pigment binding sites were determined. The role of the individual pigments in protein folding, stability, energy transfer, and dissipation was studied in vitro. The results indicate that lutein has a primary role in the folding and stability of the complex, whereas violaxanthin and zeaxanthin have a negative effect on folding yield and stability, respectively. The data showed a distinct function for the L1 and L2 carotenoid binding sites, the former preferentially involved in gathering the excitation energy to chlorophyll a (Chl a), whereas the latter modulates the concentration of chlorophyll singlet excited states dependent on the xanthophylls bound to it, likely via an interaction with Chl-603. Our results also underscored the role of zeaxanthin and lutein in quenching the excitation energy, whereas violaxanthin was shown to be very effective in energy transfer. The characteristics of the isolated proteins were consistent with the observed role of Lhcb5 in vivo in catalyzing fluorescence quenching upon zeaxanthin binding.	[Ballottari, Matteo; Bassi, Roberto] Univ Verona, Dipartimento Sci & Tecnol, I-37134 Verona, Italy; [Mozzo, Milena; Croce, Roberta] Univ Groningen, Groningen Biotechnol & Biochem Sci Inst, Dept Biophys Chem, NL-9747 AG Groningen, Netherlands; [Morosinotto, Tomas] Univ Padua, Dipartimento Biol, I-35121 Padua, Italy	University of Verona; University of Groningen; University of Padua	Bassi, R (corresponding author), Univ Verona, Dipartimento Sci & Tecnol, Ca Vignal 1,Str Grazie 15, I-37134 Verona, Italy.	bassi@sci.univr.it	Croce, Roberta/HGU-9554-2022; Croce, Roberta/ABG-3595-2021; Ballottari, Matteo/N-1916-2019; Croce, Roberta/F-1174-2014; Morosinotto, Tomas/AAC-3188-2019; Croce, Roberta/N-4067-2014	Croce, Roberta/0000-0003-3469-834X; Croce, Roberta/0000-0003-3469-834X; Ballottari, Matteo/0000-0001-8410-3397; Morosinotto, Tomas/0000-0002-0803-7591; Croce, Roberta/0000-0003-3469-834X; bassi, roberto/0000-0002-4140-8446	Italian Ministry of Research Special Fund for Basic Research [FIRB RBLA03455F-002, RBIP06CPBR006]; The Netherlands Organization for Scientific Research; Earth and Life Science	Italian Ministry of Research Special Fund for Basic Research(Ministry of Education, Universities and Research (MIUR)); The Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Earth and Life Science	This work was supported by Grants FIRB RBLA03455F-002 and RBIP06CPBR006 from the Italian Ministry of Research Special Fund for Basic Research and by a Vidi grant (to R. C.) from The Netherlands Organization for Scientific Research (NWO), Earth and Life Science.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; ALBERTSSON PA, 1990, FEBS LETT, V273, P36, DOI 10.1016/0014-5793(90)81045-P; Alboresi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002033; Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; Andersson J, 2003, PLANT J, V35, P350, DOI 10.1046/j.1365-313X.2003.01811.x; Andersson J, 2001, PLANT CELL, V13, P1193, DOI 10.1105/tpc.13.5.1193; Avenson TJ, 2009, J BIOL CHEM, V284, P2830, DOI 10.1074/jbc.M807192200; Bassi R, 1999, P NATL ACAD SCI USA, V96, P10056, DOI 10.1073/pnas.96.18.10056; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; Bonente G, 2008, J BIOL CHEM, V283, P8434, DOI 10.1074/jbc.M708291200; Caffarri S, 2004, BIOCHEMISTRY-US, V43, P9467, DOI 10.1021/bi036265i; Caffarri S, 2001, J BIOL CHEM, V276, P35924, DOI 10.1074/jbc.M105199200; Caffarri S, 2007, FEBS LETT, V581, P4704, DOI 10.1016/j.febslet.2007.08.066; Castelletti S, 2003, BIOCHEMISTRY-US, V42, P4226, DOI 10.1021/bi027398r; Crimi M, 2001, EUR J BIOCHEM, V268, P260, DOI 10.1046/j.1432-1033.2001.01874.x; Croce R, 1999, FEBS LETT, V456, P1, DOI 10.1016/S0014-5793(99)00907-2; Croce R, 2002, BBA-BIOENERGETICS, V1556, P29, DOI 10.1016/S0005-2728(02)00304-3; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Croce R, 2000, PHOTOSYNTH RES, V64, P221, DOI 10.1023/A:1006455230379; DAINESE P, 1991, J BIOL CHEM, V266, P8136; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; de Bianchi S, 2008, PLANT CELL, V20, P1012, DOI 10.1105/tpc.107.055749; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; DEMMIGADAMS B, 1989, PLANT BIOLOGY, V8, P375; Eggink LL, 2000, J BIOL CHEM, V275, P9087, DOI 10.1074/jbc.275.13.9087; Formaggio E, 2001, J MOL BIOL, V314, P1157, DOI 10.1006/jmbi.2000.5179; Frank HA, 2001, BIOCHEMISTRY-US, V40, P1220, DOI 10.1021/bi001160q; Ganeteg U, 2004, PLANT PHYSIOL, V134, P502, DOI 10.1104/pp.103.033324; Gastaldelli M, 2003, J BIOL CHEM, V278, P19190, DOI 10.1074/jbc.M212125200; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Giuffra E, 1996, EUR J BIOCHEM, V238, P112, DOI 10.1111/j.1432-1033.1996.0112q.x; GOODWIN TW, 1981, CHEM BIOCH PLANT PIG, P3; Green BR, 1996, ANNU REV PLANT PHYS, V47, P685, DOI 10.1146/annurev.arplant.47.1.685; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Hoober JK, 1999, PHOTOSYNTH RES, V61, P197; Horn R, 2004, J BIOL CHEM, V279, P44400, DOI 10.1074/jbc.M407188200; Horn R, 2007, J MOL BIOL, V366, P1045, DOI 10.1016/j.jmb.2006.11.069; JAHNS P, 1995, PLANT PHYSIOL BIOCH, V33, P683; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Matsubara S, 2007, PLANT PHYSIOL, V144, P926, DOI 10.1104/pp.107.099077; Morosinotto T, 2005, J BIOL CHEM, V280, P20612, DOI 10.1074/jbc.M500705200; Morosinotto T, 2003, PHYSIOL PLANTARUM, V119, P347, DOI 10.1034/j.1399-3054.2003.00213.x; Morosinotto T, 2002, J BIOL CHEM, V277, P36253, DOI 10.1074/jbc.M205062200; Morosinotto T, 2002, J BIOL CHEM, V277, P36913, DOI 10.1074/jbc.M205339200; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Mozzo M, 2008, BBA-BIOENERGETICS, V1777, P1263, DOI 10.1016/j.bbabio.2008.04.036; Mozzo M, 2008, J BIOL CHEM, V283, P6184, DOI 10.1074/jbc.M708961200; Mozzo M, 2006, BBA-BIOENERGETICS, V1757, P1607, DOI 10.1016/j.bbabio.2006.06.018; NAGAI K, 1987, METHOD ENZYMOL, V153, P461; NOCTOR G, 1991, BIOCHIM BIOPHYS ACTA, V1057, P320, DOI 10.1016/S0005-2728(05)80143-4; Novoderezhkin VI, 2005, J PHYS CHEM B, V109, P10493, DOI 10.1021/jp044082f; Pagano A, 1998, J BIOL CHEM, V273, P17154, DOI 10.1074/jbc.273.27.17154; Pascal A, 1999, EUR J BIOCHEM, V262, P817, DOI 10.1046/j.1432-1327.1999.00457.x; PAULSEN H, 1993, EUR J BIOCHEM, V215, P809, DOI 10.1111/j.1432-1033.1993.tb18096.x; Remelli R, 1999, J BIOL CHEM, V274, P33510, DOI 10.1074/jbc.274.47.33510; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Schmid VHR, 2008, CELL MOL LIFE SCI, V65, P3619, DOI 10.1007/s00018-008-8333-6; van Amerongen H, 2001, J PHYS CHEM B, V105, P604, DOI 10.1021/jp0028406; Wentworth M, 2000, FEBS LETT, V471, P71, DOI 10.1016/S0014-5793(00)01369-7; Young AJ, 1996, J PHOTOCH PHOTOBIO B, V36, P3, DOI 10.1016/S1011-1344(96)07397-6	64	35	35	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8103	8113		10.1074/jbc.M808326200	http://dx.doi.org/10.1074/jbc.M808326200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19129188	Green Published, hybrid			2022-12-25	WOS:000264195600073
J	Chan, W; Tian, R; Lee, YF; Sit, ST; Lim, L; Manser, E				Chan, Wing; Tian, Rui; Lee, Yeow-Fong; Sit, Soon Tuck; Lim, Louis; Manser, Ed			Down-regulation of Active ACK1 Is Mediated by Association with the E3 Ubiquitin Ligase Nedd4-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDC42-ASSOCIATED TYROSINE KINASE; GROWTH-FACTOR RECEPTOR; EPITHELIAL NA+ CHANNEL; UBA DOMAINS; NEGATIVE REGULATOR; WW DOMAIN; TARGET; CDC42; DEGRADATION; INTERACTS	ACK1 (activated Cdc42-associated kinase 1) is a cytoplasmic tyrosine kinase implicated in trafficking through binding to epidermal growth factor (EGF) receptor and clathrin. Here, we have identified a new ACK1-binding partner, the E3 ubiquitin ligase Nedd4-2, which binds ACK1 via a conserved PPXY-containing region. We show that this motif also binds Nedd4-related proteins and several other WW domain-containing proteins, including the tumor suppressor oxidoreductase Wwox. In HeLa cells ACK1 colocalizes with Nedd4-2 in clathrin-rich vesicles, requiring this PPXY motif. Nedd4-2 strongly down-regulates ACK1 levels when coexpressed, and this process can be blocked by proteasome inhibitor MG132. ACK1 degradation via Nedd4 requires their mutual interaction and a functional E3 ligase; it is also driven by ACK1 activity. ACK1 is polyubiquitinated in vivo, and dominant inhibitory Nedd4 blocks endogenous ACK1 turnover in response to acute EGF treatment. Because EGF stimulation activates ACK1 (Galisteo, M., Y., Y., Urena, J., and Schlessinger, J. (2006) Proc. Natl. Acad. Sci. U. S. A. 103, 9796 - 9801), our result suggest that EGF receptor-mediated ACK1 activation allows Nedd4-2 to drive kinase degradation. Thus the interplay between Nedd4-2-related E3 ligases that regulate ACK1 levels and Cbl that modifies EGF receptor impinges on cell receptor dynamics. These processes are particularly pertinent given the report of genomic amplification of the ACK1 locus in metastatic tumors.	[Chan, Wing; Tian, Rui; Lee, Yeow-Fong; Sit, Soon Tuck; Lim, Louis; Manser, Ed] Inst Mol & Cell Biol, GSK, Singapore 138673, Singapore; [Lim, Louis] UCL, Inst Neurol, Dept Mol Sci, London WC1N PJ, England	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); GlaxoSmithKline; University of London; University College London	Manser, E (corresponding author), Inst Mol & Cell Biol, GSK, 61 Biopolis Dr, Singapore 138673, Singapore.	mcbmansr@imcb.a-star.edu.sg	Manser, Edward/ABD-2301-2020		GSK (Singapore) Research Fund	GSK (Singapore) Research Fund(GlaxoSmithKline)	This work was supported by the GSK (Singapore) Research Fund. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anan T, 1998, GENES CELLS, V3, P751, DOI 10.1046/j.1365-2443.1998.00227.x; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Bertolaet BL, 2001, J MOL BIOL, V313, P955, DOI 10.1006/jmbi.2001.5105; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Chen L, 2001, EMBO REP, V2, P933, DOI 10.1093/embo-reports/kve203; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; Galisteo ML, 2006, P NATL ACAD SCI USA, V103, P9796, DOI 10.1073/pnas.0603714103; Grovdal LM, 2008, EXP CELL RES, V314, P1292, DOI 10.1016/j.yexcr.2007.12.017; Haglund K, 2002, P NATL ACAD SCI USA, V99, P12191, DOI 10.1073/pnas.192462299; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Kato-Stankiewicz J, 2001, BIOCHEM BIOPH RES CO, V284, P470, DOI 10.1006/bbrc.2001.5004; Katz M, 2002, TRAFFIC, V3, P740, DOI 10.1034/j.1600-0854.2002.31006.x; Konstas AA, 2002, J BIOL CHEM, V277, P29406, DOI 10.1074/jbc.M203018200; Leung T, 1996, MOL CELL BIOL, V16, P5313; Lin Q, 2002, J BIOL CHEM, V277, P10134, DOI 10.1074/jbc.M110329200; Lott JS, 2002, BIOCHEM J, V361, P481, DOI 10.1042/0264-6021:3610481; Lougheed JC, 2004, J BIOL CHEM, V279, P44039, DOI 10.1074/jbc.M406703200; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; MANMOR M, 2004, ONCOGENE, V23, P2057; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Omerovic J, 2007, FASEB J, V21, P2849, DOI 10.1096/fj.06-7925com; Ortolan TG, 2000, NAT CELL BIOL, V2, P601, DOI 10.1038/35023547; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Reggiori F, 2001, EMBO J, V20, P5176, DOI 10.1093/emboj/20.18.5176; Sanchez-Perez A, 2007, BIOCHEM BIOPH RES CO, V359, P611, DOI 10.1016/j.bbrc.2007.05.134; Shen F, 2007, MOL BIOL CELL, V18, P732, DOI 10.1091/mbc.E06-02-0142; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Teo M, 2001, J BIOL CHEM, V276, P18392, DOI 10.1074/jbc.M008795200; Thelemann A, 2005, MOL CELL PROTEOMICS, V4, P356, DOI 10.1074/mcp.M400118-MCP200; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; vanDelft S, 1997, J BIOL CHEM, V272, P14013, DOI 10.1074/jbc.272.22.14013; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Xu DZ, 2005, J BIOL CHEM, V280, P2924, DOI 10.1074/jbc.M408907200; Yang W, 2004, BIOCHEM J, V382, P199, DOI 10.1042/BJ20040623; Yang WN, 1997, J BIOL CHEM, V272, P24819, DOI 10.1074/jbc.272.40.24819; Yang WN, 1999, J BIOL CHEM, V274, P8524, DOI 10.1074/jbc.274.13.8524; Yang WN, 2001, J BIOL CHEM, V276, P43987, DOI 10.1074/jbc.M104819200; Yang WN, 2001, J BIOL CHEM, V276, P17468, DOI 10.1074/jbc.M010893200; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; Yeow-Fong L, 2005, FEBS LETT, V579, P5040, DOI 10.1016/j.febslet.2005.07.093; Yokoyama N, 2003, J BIOL CHEM, V278, P47713, DOI 10.1074/jbc.M306716200	48	48	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8185	8194		10.1074/jbc.M806877200	http://dx.doi.org/10.1074/jbc.M806877200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19144635	Green Published, hybrid			2022-12-25	WOS:000264195600080
J	Kaur, KH; Baur, R; Sigel, E				Kaur, Kuldeep H.; Baur, Roland; Sigel, Erwin			Unanticipated Structural and Functional Properties of delta-Subunit-containing GABA(A) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOBUTYRIC ACID(A) RECEPTOR; TONIC INHIBITION; A RECEPTORS; NEUROSTEROID MODULATION; ACTIVATION; RECOMBINANT; SENSITIVITY; DIVERSITY; CHANNELS; SUBTYPES	GABA(A) receptors mediate inhibitory neurotransmission in the mammalian brain via synaptic and extrasynaptic receptors. The delta (delta)-subunit-containing receptors are expressed exclusively extra-synaptically and mediate tonic inhibition. In the present study, we were interested in determining the architecture of receptors containing the delta-subunit. To investigate this, we predefined the subunit arrangement by concatenation. We prepared five dual and three triple concatenated subunit constructs. These concatenated dual and triple constructs were used to predefine nine different GABA(A) receptor pentamers. These pentamers composed of alpha(1)-, beta(3)-, and delta-subunits were expressed in Xenopus oocytes and maximal currents elicited in response to 1 mM GABA were determined in the presence and absence of THDOC (3 alpha, 21-dihydroxy-5 alpha-pregnane-20-one). beta(3)- alpha(1)- delta/alpha(1)-beta(3) and beta(3)-alpha(1)-delta/beta(3)-alpha(1) resulted in the expression of large currents in response to GABA. Interestingly, the presence of the neurosteroid THDOC uncovered alpha(1)-beta(3)-alpha(1)/beta(3)-delta receptors, additionally. The functional receptors were characterized in detail using the agonist GABA, THDOC, Zn2+, and ethanol and their properties were compared with those of non-concatenated alpha(1)beta(3) and alpha(1)beta(3)delta receptors. Each concatenated receptor isoform displayed a specific set of properties, but none of them responded to 30 mM ethanol. We conclude from the investigated receptors that delta can assume multiple positions in the receptor pentamer. The GABA dose-response properties of alpha(1)-beta(3)-alpha(1)/beta(3)-delta and beta(3)-alpha(1)-delta/alpha(1)-beta(3) match most closely the properties of non-concatenated alpha 1 beta 3 delta receptors. Furthermore, we show that the delta-subunit can contribute to the formation of an agonist site in alpha 1-beta 3-alpha 1/beta 3-delta receptors.	[Kaur, Kuldeep H.; Baur, Roland; Sigel, Erwin] Univ Bern, Inst Biochem & Mol Biol, CH-3012 Bern, Switzerland	University of Bern	Sigel, E (corresponding author), Univ Bern, Inst Biochem & Mol Biol, Buhlstr 28, CH-3012 Bern, Switzerland.	erwin.sigel@mci.unibe.ch	Sigel, Erwin/F-7736-2015		Swiss National Science Foundation [3100A0-105272/1, 3100A0-105272/2]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation Grants 3100A0-105272/1 and 3100A0-105272/2. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	AMIN J, 1993, NATURE, V366, P565, DOI 10.1038/366565a0; Araujo F, 1998, EUR J PHARMACOL, V347, P347, DOI 10.1016/S0014-2999(98)00122-8; Barnard EA, 1998, PHARMACOL REV, V50, P291; Barrera NP, 2008, MOL PHARMACOL, V73, P960, DOI 10.1124/mol.107.042481; Baumann SW, 2003, J NEUROSCI, V23, P11158; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; Baur R, 2006, FEBS LETT, V580, P1616, DOI 10.1016/j.febslet.2006.02.002; Bianchi MT, 2003, J NEUROSCI, V23, P10934; Boileau AJ, 2002, NEUROPHARMACOLOGY, V43, P695, DOI 10.1016/S0028-3908(02)00036-9; Bollan KA, 2008, MOL CELL NEUROSCI, V37, P610, DOI 10.1016/j.mcn.2007.12.011; Borghese CM, 2006, J PHARMACOL EXP THER, V316, P1360, DOI 10.1124/jpet.105.092452; Cope DW, 2005, J NEUROSCI, V25, P11553, DOI 10.1523/JNEUROSCI.3362-05.2005; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Feng HJ, 2004, J NEUROPHYSIOL, V92, P1577, DOI 10.1152/jn.00285.2004; Fisher JL, 1997, J PHYSIOL-LONDON, V505, P283, DOI 10.1111/j.1469-7793.1997.283bb.x; Glykys J, 2007, NAT NEUROSCI, V10, P40, DOI 10.1038/nn1813; Hadley SH, 2007, J PHYSIOL-LONDON, V581, P1001, DOI 10.1113/jphysiol.2007.132886; Hanchar HJ, 2005, NAT NEUROSCI, V8, P339, DOI 10.1038/nn1398; Herd MB, 2007, PHARMACOL THERAPEUT, V116, P20, DOI 10.1016/j.pharmthera.2007.03.007; Jechlinger M, 1998, J NEUROSCI, V18, P2449; Jia F, 2005, J NEUROPHYSIOL, V94, P4491, DOI 10.1152/jn.00421.2005; Jones A, 1997, J NEUROSCI, V17, P1350; Krishek BJ, 1998, J PHYSIOL-LONDON, V507, P639, DOI 10.1111/j.1469-7793.1998.639bs.x; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; MERTENS S, 1993, J BIOL CHEM, V268, P5965; Minier F, 2004, TRENDS PHARMACOL SCI, V25, P499, DOI 10.1016/j.tips.2004.07.005; Minier F, 2004, P NATL ACAD SCI USA, V101, P7769, DOI 10.1073/pnas.0400220101; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Mody I, 2001, NEUROCHEM RES, V26, P907, DOI 10.1023/A:1012376215967; Mody I, 2008, NEUROCHEM INT, V52, P60, DOI 10.1016/j.neuint.2007.07.010; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; QUIRK K, 1995, EUR J PHARM-MOLEC PH, V290, P175, DOI 10.1016/0922-4106(95)00061-5; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; Saxena NC, 1996, MOL PHARMACOL, V49, P567; SAXENA NC, 1994, J NEUROSCI, V14, P7077; Scimemi A, 2006, EUR J NEUROSCI, V24, P1157, DOI 10.1111/j.1460-9568.2006.04989.x; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; SIGEL E, 1992, EMBO J, V11, P2017, DOI 10.1002/j.1460-2075.1992.tb05258.x; SIGEL E, 1987, J PHYSIOL-LONDON, V386, P73, DOI 10.1113/jphysiol.1987.sp016523; SIGEL E, 1990, NEURON, V5, P703, DOI 10.1016/0896-6273(90)90224-4; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Storustovu SI, 2006, J PHARMACOL EXP THER, V316, P1351, DOI 10.1124/jpet.105.092403; Sur C, 1999, MOL PHARMACOL, V56, P110, DOI 10.1124/mol.56.1.110; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Wei WZ, 2004, J NEUROSCI, V24, P8379, DOI 10.1523/JNEUROSCI.2040-04.2004; Whiting PJ, 1999, ANN NY ACAD SCI, V868, P645, DOI 10.1111/j.1749-6632.1999.tb11341.x; Wohlfarth KM, 2002, J NEUROSCI, V22, P1541, DOI 10.1523/JNEUROSCI.22-05-01541.2002; Zheleznova N, 2008, BRIT J PHARMACOL, V153, P1062, DOI 10.1038/sj.bjp.0707665; Zhu WJ, 1996, J NEUROSCI, V16, P6648	52	64	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7889	7896		10.1074/jbc.M806484200	http://dx.doi.org/10.1074/jbc.M806484200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19141615	Green Published, hybrid			2022-12-25	WOS:000264195600050
J	Maarouf, AB; Sheng, N; Chen, JX; Winarski, KL; Okumura, S; Carattino, MD; Boyd, CR; Kleyman, TR; Sheng, SH				Maarouf, Ahmad B.; Sheng, Nan; Chen, Jingxin; Winarski, Katie L.; Okumura, Sora; Carattino, Marcelo D.; Boyd, Cary R.; Kleyman, Thomas R.; Sheng, Shaohu			Novel Determinants of Epithelial Sodium Channel Gating within Extracellular Thumb Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ SELF-INHIBITION; HELICAL MEMBRANE-PROTEINS; HISTIDINE-RESIDUES; ALPHA-SUBUNIT; GAMMA-SUBUNIT; PORE REGION; ENAC; FURIN; TEMPERATURE; SELECTIVITY	Activity of the epithelial Na+ channel (ENaC) is modulated by Na+ self-inhibition, an allosteric down-regulation of channel open probability by extracellular Na+. We searched for determinants of Na+ self-inhibition by analyzing changes in this inhibitory response resulting from specific mutations within the extracellular domains of mouse ENaC subunits. Mutations at gamma Met(438) altered the Na+ self-inhibition response in a substitution-specific manner. Fourteen substitutions (Ala, Arg, Asp, Cys, Gln, Glu, His, Ile, Phe, Pro, Ser, Thr, Tyr, and Val) significantly suppressed Na+ self-inhibition, whereas three mutations (Asn, Gly, and Leu) moderately enhanced the inhibition. Met to Lys mutation did not alter Na+ self-inhibition. Mutations at the homologous site in the alpha subunit (G481A, G481C, and G481M) dramatically increased the magnitude and speed of Na+ self-inhibition. Mutations at the homologous beta Ala(422) resulted in minimal or no change in Na+ self-inhibition. Low, high, and intermediate open probabilities were observed in oocytes expressing alpha G481M beta gamma, alpha beta gamma M438V, and alpha G481M/beta gamma M438V, respectively. This pair of residues map to the alpha 5 helixin the extracellular thumb domain in the chicken acid sensing ion channel 1 structure. Both residues likely reside near the channel surface because both alpha G481C beta gamma and alpha beta gamma M438C channels were inhibited by an externally applied and membrane-impermeant sulfhydryl reagent. Our results demonstrate that alpha Gly(481) and gamma Met(438) are functional determinants of Na+ self-inhibition and of ENaC gating and suggest that the thumb domain contributes to the channel gating machinery.	[Maarouf, Ahmad B.; Sheng, Nan; Chen, Jingxin; Winarski, Katie L.; Okumura, Sora; Carattino, Marcelo D.; Boyd, Cary R.; Kleyman, Thomas R.; Sheng, Shaohu] Univ Pittsburgh, Renal Electrolyte Div, Dept Med, Sch Med, Pittsburgh, PA 15261 USA; [Kleyman, Thomas R.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kleyman, TR (corresponding author), Univ Pittsburgh, Renal Electrolyte Div, Dept Med, Sch Med, 3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu; shaohu@pitt.edu	Sheng, Shaohu/G-7052-2016	Sheng, Shaohu/0000-0002-7198-1702	National Institutes of Health [R01 DK054354, R01 ES014701, P30 DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054354, P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK054354, R01 ES014701, and P30 DK079307. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Adebamiro A, 2007, J GEN PHYSIOL, V130, P611, DOI 10.1085/jgp.200709781; Babini E, 2003, J BIOL CHEM, V278, P28418, DOI 10.1074/jbc.M301315200; Bize V, 2007, AM J PHYSIOL-RENAL, V293, pF1137, DOI 10.1152/ajprenal.00100.2007; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; Carattino MD, 2005, J BIOL CHEM, V280, P4393, DOI 10.1074/jbc.M413123200; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; Chraibi A, 2003, PFLUG ARCH EUR J PHY, V447, P316, DOI 10.1007/s00424-003-1178-9; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Condliffe SB, 2004, J BIOL CHEM, V279, P10085, DOI 10.1074/jbc.M313592200; Curran AR, 2003, CURR OPIN STRUC BIOL, V13, P412, DOI 10.1016/S0959-440X(03)00102-7; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; GARTY H, 1988, PHYSIOL REV, V68, P309, DOI 10.1152/physrev.1988.68.2.309; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; Horisberger Jean-Daniel, 2004, Nephron, V96, pp37, DOI 10.1159/000076406; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2005, J BIOL CHEM, V280, P7739, DOI 10.1074/jbc.M409955200; Kellenberger S, 2002, J PHYSIOL-LONDON, V543, P413, DOI 10.1113/jphysiol.2002.022020; Kim S, 2005, P NATL ACAD SCI USA, V102, P14278, DOI 10.1073/pnas.0501234102; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Palmer LG, 1998, J PHYSIOL-LONDON, V509, P151, DOI 10.1111/j.1469-7793.1998.151bo.x; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; SCHULZ AR, 1994, ENZYME KINETICS DIS, P38; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Shahrestanifar MS, 1996, NEUROCHEM RES, V21, P1295, DOI 10.1007/BF02532370; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; SHENG S, 2007, SELDIN GIEBISCHS KID, P743; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2000, J BIOL CHEM, V275, P8572, DOI 10.1074/jbc.275.12.8572; Sheng SH, 2002, J BIOL CHEM, V277, P50098, DOI 10.1074/jbc.M209975200; Sheng SH, 2001, J BIOL CHEM, V276, P1326, DOI 10.1074/jbc.M008117200; Sheng SH, 2007, J BIOL CHEM, V282, P20180, DOI 10.1074/jbc.M611761200; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; VANDRIESSCHE W, 1985, PHYSIOL REV, V65, P833, DOI 10.1152/physrev.1985.65.4.833; Zauhar RJ, 2000, BIOPOLYMERS, V53, P233, DOI 10.1002/(SICI)1097-0282(200003)53:3<233::AID-BIP3>3.3.CO;2-W; [No title captured]	39	39	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7756	7765		10.1074/jbc.M807060200	http://dx.doi.org/10.1074/jbc.M807060200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19158091	hybrid, Green Published			2022-12-25	WOS:000264195600037
J	Frago, S; Velazquez-Campoy, A; Medina, M				Frago, Susana; Velazquez-Campoy, Adrian; Medina, Milagros			The Puzzle of Ligand Binding to Corynebacterium ammoniagenes FAD Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE; ISOTHERMAL TITRATION CALORIMETRY; RIBOFLAVIN KINASE REVEALS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; RAT-LIVER; FLAVIN-BINDING; PURIFICATION; PROTEIN; BIOSYNTHESIS	In bacteria, riboflavin phosphorylation and subsequent conversion of FMN into FAD are carried out by FAD synthetase, a single bifunctional enzyme. Both reactions require ATP and Mg2+. The N-terminal domain of FAD synthetase appears to be responsible for the adenylyltransferase activity, whereas the C-terminal domain would be in charge of the kinase activity. Binding to Corynebacterium ammoniagenes FAD synthetase of its products and substrates, as well as of several analogues, is analyzed. Binding parameters for adenine nucleotides to each one of the two adenine nucleotide sites are reported. In addition, it is demonstrated for the first time that the enzyme presents two independent flavin sites, each one related with one of the enzymatic activities. The binding parameters of flavins to these sites are also provided. The presence of Mg2+ and of both adenine nucleotides and flavins cooperatively modulates the interaction parameters for the other ligands. Our data also suggest that during its double catalytic cycle FAD synthetase must suffer conformational changes induced by adenine nucleotide-Mg2+ or flavin binding. They might include not only rearrangement of the different protein loops but also alternative conformations between domains.	[Frago, Susana; Medina, Milagros] Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Fac Ciencias, E-50009 Zaragoza, Spain; [Frago, Susana; Medina, Milagros] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst, E-50009 Zaragoza, Spain; [Velazquez-Campoy, Adrian] Univ Zaragoza, Fdn Aragon I D, E-50009 Zaragoza, Spain; [Velazquez-Campoy, Adrian] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst, E-50009 Zaragoza, Spain	University of Zaragoza; University of Zaragoza; University of Zaragoza; University of Zaragoza	Medina, M (corresponding author), Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Fac Ciencias, Pedro Cerbuna 12, E-50009 Zaragoza, Spain.	mmedina@unizar.es	Medina, Milagros/F-8310-2012; Frago, Susana/L-1477-2017; Velazquez-Campoy, Adrian/E-7946-2012	Medina, Milagros/0000-0001-8743-0182; Frago, Susana/0000-0002-1369-1328; Velazquez-Campoy, Adrian/0000-0001-5702-4538	Spanish Ministry of Education and Science [BIO2007-65890-C02-01, SAF2004-07722]	Spanish Ministry of Education and Science(Spanish Government)	This work was supported by Spanish Ministry of Education and Science Grants BIO2007-65890-C02-01 ( to M. M.) and SAF2004-07722 ( to A. V.-C.).; Recipient of a Ramon y Cajal Research Contract from the Spanish Ministry of Science and Technology.	Barile M, 2000, EUR J BIOCHEM, V267, P4888, DOI 10.1046/j.1432-1327.2000.01552.x; Bauer S, 2003, J MOL BIOL, V326, P1463, DOI 10.1016/S0022-2836(03)00059-7; BURROWS SD, 1994, BIOCHEMISTRY-US, V33, P12741, DOI 10.1021/bi00209a002; D'Angelo I, 2000, STRUCTURE, V8, P993, DOI 10.1016/S0969-2126(00)00190-8; Efimov I, 1998, BIOCHEMISTRY-US, V37, P9716, DOI 10.1021/bi972817j; Frago S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-160; Freire E, 1995, METHOD ENZYMOL, V259, P144; Freire E, 1995, Methods Mol Biol, V40, P191; Galluccio M, 2007, PROTEIN EXPRES PURIF, V52, P175, DOI 10.1016/j.pep.2006.09.002; Garavaglia S, 2004, J BIOL CHEM, V279, P40980, DOI 10.1074/jbc.M406586200; Gasteiger E., 2005, PROTEIN IDENTIFICATI, DOI 10.1385/1592598900; Giancaspero TA, 2009, FEBS J, V276, P219, DOI 10.1111/j.1742-4658.2008.06775.x; HAGIHARA T, 1995, APPL MICROBIOL BIOT, V42, P724; Izard T, 1999, EMBO J, V18, P2021, DOI 10.1093/emboj/18.8.2021; Izard T, 2002, J MOL BIOL, V315, P487, DOI 10.1006/jmbi.2001.5272; Karthikeyan S, 2003, BIOCHEMISTRY-US, V42, P12532, DOI 10.1021/bi035450t; Karthikeyan S, 2003, STRUCTURE, V11, P265, DOI 10.1016/S0969-2126(03)00024-8; Krupa A, 2003, TRENDS BIOCHEM SCI, V28, P9, DOI 10.1016/S0968-0004(02)00009-9; Mack M, 1998, J BACTERIOL, V180, P950, DOI 10.1128/JB.180.4.950-955.1998; MANSTEIN DJ, 1986, J BIOL CHEM, V261, P6169; McCormick DB, 1997, METHOD ENZYMOL, V280, P407; MERRILL AH, 1980, J BIOL CHEM, V255, P1335; NAKAGAWA S, 1995, BIOSCI BIOTECH BIOCH, V59, P694, DOI 10.1271/bbb.59.694; OKA M, 1987, J BIOL CHEM, V262, P7418; Perozzo R, 2000, J BIOL CHEM, V275, P16139, DOI 10.1074/jbc.M000509200; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; SANCHO J, 1991, ARCH BIOCHEM BIOPHYS, V288, P231, DOI 10.1016/0003-9861(91)90189-P; Santos MA, 2000, J BIOL CHEM, V275, P28618, DOI 10.1074/jbc.M004621200; Saridakis V, 2003, J BIOL CHEM, V278, P34356, DOI 10.1074/jbc.M205369200; Velazquez-Campoy A, 2006, BIOPHYS J, V91, P1887, DOI 10.1529/biophysj.106.086561; Velazquez-Campoy Adrian, 2004, Methods Mol Biol, V261, P35; Wang WR, 2005, PROTEINS, V58, P246, DOI 10.1002/prot.20207; Wang WR, 2003, PROTEINS, V52, P633, DOI 10.1002/prot.10353; YAMADA Y, 1990, ARCH BIOCHEM BIOPHYS, V278, P125, DOI 10.1016/0003-9861(90)90240-Y; Zhang H, 2002, STRUCTURE, V10, P69, DOI 10.1016/S0969-2126(01)00693-1	35	26	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6610	6619		10.1074/jbc.M808142200	http://dx.doi.org/10.1074/jbc.M808142200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19136717	Green Published, hybrid			2022-12-25	WOS:000263919000005
J	De Santis, G; Miotti, S; Mazzi, M; Canevari, S; Tomassetti, A				De Santis, G.; Miotti, S.; Mazzi, M.; Canevari, S.; Tomassetti, A.			E-cadherin directly contributes to PI3K/AKT activation by engaging the PI3K-p85 regulatory subunit to adherens junctions of ovarian carcinoma cells	ONCOGENE			English	Article						E-cadherin; PI3K; cell/cell adhesion; ovarian carcinoma	BETA-CATENIN; PHOSPHOINOSITIDE 3-KINASE; PIK3CA GENE; PHOSPHATIDYLINOSITOL 3-KINASE; SURFACE EPITHELIUM; PROTEIN-KINASE; ALPHA-CATENIN; ADHESION; CANCER; EXPRESSION	E-cadherin (cadh), a member of a family of integral membrane glycoproteins that represent the major component of adherens junctions (AJs), mediates cell-cell adhesion through the calcium-dependent homophilic interaction of its extracellular domain. Metastatic human carcinomas frequently lose E-cadh expression, whereas epithelial ovarian cancer (EOCs) maintain properties characteristic of Mullerian epithelium during tumor progression, including E-cadh expression. Here, we examined the potential role of cell-cell contacts in EOCs through E-cadh homophilic interactions in PI3K/AKT activation whose altered signaling has been implicated in EOC pathogenesis. We show that E-cadh is predominantly expressed at cell-cell contacts and its functionality is necessary and sufficient for the activation of the PI3K/AKT pathway. E-cadh knockdown and phosphoinositide-3-kinase (PI3K) inhibition complement each other in impairing cell-cycle progression and proliferation of ovarian carcinoma cells. E-cadh is stably bound to the PI3K complex, and the de novo formation of E-cadh/beta-catenin complexes following calcium deprivation and subsequent calcium restoration recruits the PI3K p85 subunit to the site of the cell-cell contacts. The finding that E-cadh-mediated AJ formation contributes to PI3K/AKT activation in EOC cells by a mechanism that appears to be restricted to these cells provides the underpinning for therapeutic strategies that exploit PI3K inhibition to halt EOCs.	[De Santis, G.; Miotti, S.; Mazzi, M.; Canevari, S.; Tomassetti, A.] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol, Unit Mol Therapies, I-20133 Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan	Tomassetti, A (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol, Unit Mol Therapies, Via Venezian 1, I-20133 Milan, Italy.	antonella.tomassetti@istitutotumori.mi.it	Tomassetti, Antonella/G-7906-2015	Tomassetti, Antonella/0000-0001-6772-9937	Associazione Italiana Ricerca Cancro (AIRC); Cariplo Foundation [2003-1740]	Associazione Italiana Ricerca Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Cariplo Foundation(Fondazione Cariplo)	We thank Gloria Bosco for her secretarial assistance. This work was supported by grants to SC from Associazione Italiana Ricerca Cancro (AIRC) and the Cariplo Foundation (grant number 2003-1740).	Ahmed N, 2007, J CELL PHYSIOL, V213, P581, DOI 10.1002/jcp.21240; Amzel LM, 2008, NAT REV CANCER, V8, P665, DOI 10.1038/nrc2443; Anderson CB, 2002, P NATL ACAD SCI USA, V99, P8683, DOI 10.1073/pnas.122235399; Andl CD, 2005, CANCER BIOL THER, V4, P28, DOI 10.4161/cbt.4.1.1431; Aunoble B, 2000, INT J ONCOL, V16, P567; Brugge J, 2007, CANCER CELL, V12, P104, DOI 10.1016/j.ccr.2007.07.014; Calautti E, 2005, J BIOL CHEM, V280, P32856, DOI 10.1074/jbc.M506119200; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Carneiro F, 2008, J CLIN PATHOL, V61, P25, DOI 10.1136/jcp.2006.043679; Castellano G, 2006, CANCER RES, V66, P10709, DOI 10.1158/0008-5472.CAN-06-1327; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; Davies BR, 1998, HISTOPATHOLOGY, V32, P69; Herzig M, 2007, ONCOGENE, V26, P2290, DOI 10.1038/sj.onc.1210029; Himanen JP, 2007, CURR OPIN CELL BIOL, V19, P534, DOI 10.1016/j.ceb.2007.08.004; Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200; Levine DA, 2005, CLIN CANCER RES, V11, P2875, DOI 10.1158/1078-0432.CCR-04-2142; Marques FR, 2004, GYNECOL ONCOL, V94, P16, DOI 10.1016/j.ygyno.2004.03.037; McLachlan RW, 2007, MOL BIOL CELL, V18, P3214, DOI 10.1091/mbc.E06-12-1154; McLachlan RW, 2007, J MOL MED-JMM, V85, P545, DOI 10.1007/s00109-007-0198-x; Miotti S, 2005, AM J PATHOL, V167, P1411, DOI 10.1016/S0002-9440(10)61228-X; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Pang JH, 2005, J BIOL CHEM, V280, P3043, DOI 10.1074/jbc.M412148200; Pece S, 1999, J BIOL CHEM, V274, P19347, DOI 10.1074/jbc.274.27.19347; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; Reddy P, 2005, MOL ENDOCRINOL, V19, P2564, DOI 10.1210/me.2004-0342; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sanna E, 2007, EXP CELL RES, V313, P1307, DOI 10.1016/j.yexcr.2007.02.005; Seidel B, 2004, ONCOGENE, V23, P5532, DOI 10.1038/sj.onc.1207718; Sundfeldt K, 2003, MOL CELL ENDOCRINOL, V202, P89, DOI 10.1016/S0303-7207(03)00068-6; Tomassetti A, 2008, NEOPLASIA, V10, P1481, DOI 10.1593/neo.81004; van Hengel J, 2007, BBA-MOL CELL RES, V1773, P78, DOI 10.1016/j.bbamcr.2006.08.033; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; VIRNEKAS B, 1994, NUCLEIC ACIDS RES, V22, P5600, DOI 10.1093/nar/22.25.5600; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vogt PK, 2007, TRENDS BIOCHEM SCI, V32, P342, DOI 10.1016/j.tibs.2007.05.005; Wang Y, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9316; Woenckhaus J, 2007, VIRCHOWS ARCH, V450, P387, DOI 10.1007/s00428-006-0358-3; Wong AST, 2003, J CELL BIOL, V161, P1191, DOI 10.1083/jcb.200212033; Woodfield RJ, 2001, BIOCHEM J, V360, P335, DOI 10.1042/0264-6021:3600335; Xie ZJ, 2007, J BIOL CHEM, V282, P8695, DOI 10.1074/jbc.M609135200; Yap AS, 2007, CURR OPIN CELL BIOL, V19, P508, DOI 10.1016/j.ceb.2007.09.008; Zhang L, 2007, CLIN CANCER RES, V13, P5314, DOI 10.1158/1078-0432.CCR-06-2660	43	73	75	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 5	2009	28	9					1206	1217		10.1038/onc.2008.470	http://dx.doi.org/10.1038/onc.2008.470			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	415AH	19151754				2022-12-25	WOS:000263906200005
J	Liang, YJ; Zhang, SC; Wang, ZP				Liang, Yujun; Zhang, Shicui; Wang, Zhiping			Alternative Complement Activity in the Egg Cytosol of Amphioxus Branchiostoma belcheri: Evidence for the Defense Role of Maternal Complement Components	PLOS ONE			English	Article								Background: The eggs in most invertebrates are fertilized externally, and therefore their resulting embryos are exposed to an environment full of microbes, many of which are pathogens capable of killing other organisms. How the developing embryos of invertebrates defend themselves against pathogenic attacks is an intriguing question to biologists, and remains largely unknown. Methodology/Principal Findings: Here we clearly demonstrated that the egg cytosol prepared from the newly fertilized eggs of amphioxus Branchiostoma belcheri, an invertebrate chordate, was able to inhibit the growth of both the Gramnegative bacterium Vibrio anguillarum and the Gram-positive bacterium Staphylococcus aureus. All findings point to that it is the complement system operating via the alternative pathway that is attributable to the bacteriostatic activity. Conclusions/Significance: This appears to be the first report providing the evidence for the functional role of the maternal complement components in the eggs of invertebrate species, paving the way for the study of maternal immunity in other invertebrate organisms whose eggs are fertilized in vitro. It also supports the notion that the early developing embryos share some defense mechanisms common with the adult species.	[Liang, Yujun; Zhang, Shicui; Wang, Zhiping] Ocean Univ China, Dept Marine Biol, Qingdao, Peoples R China; [Wang, Zhiping] Hebei Agr Univ, Ocean Coll, Qingdao, Peoples R China	Ocean University of China; Hebei Agricultural University	Liang, YJ (corresponding author), Ocean Univ China, Dept Marine Biol, Qingdao, Peoples R China.	sczhang@ouc.edu.cn		Liang, Yujun/0000-0002-1253-8364	Ministry of Science and Technology (MOST) [2006CB101805]; Natural Science Foundation of China (NSFC) [30730072]	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants (2006CB101805; 30730072) of Ministry of Science and Technology (MOST) and Natural Science Foundation of China (NSFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boshra H, 2006, FISH SHELLFISH IMMUN, V20, P239, DOI 10.1016/j.fsi.2005.04.004; Clow LA, 2004, J EXP BIOL, V207, P2147, DOI 10.1242/jeb.01001; Dishaw LJ, 2005, IMMUNOGENETICS, V57, P535, DOI 10.1007/s00251-005-0005-1; GROOMBRIDGE B, 1992, GLOBAL DIVERSITY STA, P17; He YN, 2008, FISH SHELLFISH IMMUN, V24, P768, DOI 10.1016/j.fsi.2008.03.004; Hemmrich G, 2007, TRENDS IMMUNOL, V28, P449, DOI 10.1016/j.it.2007.08.003; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Huang CC, 1999, DEV COMP IMMUNOL, V23, P545, DOI 10.1016/S0145-305X(99)00038-5; Huang SF, 2008, GENOME RES, V18, P1112, DOI 10.1101/gr.069674.107; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Kuo MM, 2000, J PARASITOL, V86, P1223, DOI 10.1645/0022-3395(2000)086[1223:ACSOMA]2.0.CO;2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li ZM, 2008, FISH SHELLFISH IMMUN, V24, P215, DOI 10.1016/j.fsi.2007.10.016; Little TJ, 2003, CURR BIOL, V13, P489, DOI 10.1016/S0960-9822(03)00163-5; Lvoll M, 2006, IMMUNOGENETICS, V58, P168, DOI 10.1007/s00251-006-0096-3; MORGAN BP, 1995, CRIT REV CL LAB SCI, V32, P265, DOI 10.3109/10408369509084686; Nonaka M, 2004, IMMUNOL REV, V198, P203, DOI 10.1111/j.0105-2896.2004.00118.x; Robertson M, 1998, CURR BIOL, V8, pR595, DOI 10.1016/S0960-9822(98)70384-7; Rubio-Godoy M, 2004, FISH SHELLFISH IMMUN, V17, P95, DOI 10.1016/j.fsi.2003.11.005; RUDDY S, 1974, TRANSPLANT P, V6, P1; Sadd BM, 2007, CURR BIOL, V17, pR1046, DOI 10.1016/j.cub.2007.11.007; Smith LC, 2001, IMMUNOL REV, V180, P16, DOI 10.1034/j.1600-065X.2001.1800102.x; SUNYER JO, 1995, VET IMMUNOL IMMUNOP, V45, P333, DOI 10.1016/0165-2427(94)05430-Z; Suzuki MM, 2002, J MOL EVOL, V54, P671, DOI 10.1007/s00239-001-0068-z; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Turner MW, 1996, IMMUNOL TODAY, V17, P532, DOI 10.1016/0167-5699(96)10062-1; Wang ZP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001463; Yano Tomoki, 1996, Fish Physiology, V15, P105; ZHANG S, 2008, PROG NAT SC IN PRESS; Zhang SC, 2003, ZOOL SCI, V20, P1207, DOI 10.2108/zsj.20.1207; Zhang SC, 2001, OPHELIA, V54, P115, DOI 10.1080/00785236.2001.10409459; Zhu Y, 2005, EMBO J, V24, P382, DOI 10.1038/sj.emboj.7600533	32	17	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4234	10.1371/journal.pone.0004234	http://dx.doi.org/10.1371/journal.pone.0004234			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JB	19156196	gold, Green Published, Green Submitted			2022-12-25	WOS:000265482100006
J	Xu, P; Shi, M; Chen, XX				Xu, Peng; Shi, Min; Chen, Xue-xin			Antimicrobial Peptide Evolution in the Asiatic Honey Bee Apis cerana	PLOS ONE			English	Article							NOSEMA-CERANAE; MICROSPORIDIAN PARASITE; APIDAECIN; ANTIBIOTICS; BIODIVERSITY; INFECTION; MELLIFERA; GENETICS; MAMMALS; VIRUS	The Asiatic honeybee, Apis cerana Fabricius, is an important honeybee species in Asian countries. It is still found in the wild, but is also one of the few bee species that can be domesticated. It has acquired some genetic advantages and significantly different biological characteristics compared with other Apis species. However, it has been less studied, and over the past two decades, has become a threatened species in China. We designed primers for the sequences of the four antimicrobial peptide cDNA gene families (abaecin, defensin, apidaecin, and hymenoptaecin) of the Western honeybee, Apis mellifera L. and identified all the antimicrobial peptide cDNA genes in the Asiatic honeybee for the first time. All the sequences were amplified by reverse transcriptase-polymerase chain reaction (RT-PCR). In all, 29 different defensin cDNA genes coding 7 different defensin peptides, 11 different abaecin cDNA genes coding 2 different abaecin peptides, 13 different apidaecin cDNA genes coding 4 apidaecin peptides and 34 different hymenoptaecin cDNA genes coding 13 different hymenoptaecin peptides were cloned and identified from the Asiatic honeybee adult workers. Detailed comparison of these four antimicrobial peptide gene families with those of the Western honeybee revealed that there are many similarities in the quantity and amino acid components of peptides in the abaecin, defensin and apidaecin families, while many more hymenoptaecin peptides are found in the Asiatic honeybee than those in the Western honeybee (13 versus 1). The results indicated that the Asiatic honeybee adult generated more variable antimicrobial peptides, especially hymenoptaecin peptides than the Western honeybee when stimulated by pathogens or injury. This suggests that, compared to the Western honeybee that has a longer history of domestication, selection on the Asiatic honeybee has favored the generation of more variable antimicrobial peptides as protection against pathogens.	[Xu, Peng; Shi, Min; Chen, Xue-xin] Zhejiang Univ, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Xu, P (corresponding author), Zhejiang Univ, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China.	xxchen@zju.edu.cn	Chen, Xue-xin/D-1592-2010	Chen, Xue-xin/0000-0002-9109-8853	973 Program [2006CB102005, 2007CB109202]; National Science Fund for Distinguished Young Scholars [30625006]; Innovation Research Team Program of the Ministry of Education of China [IRT0355]; National S&T Infrastructure Project [2005DKA21402, 2005DKA21105]	973 Program(National Basic Research Program of China); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Innovation Research Team Program of the Ministry of Education of China(Ministry of Education, China); National S&T Infrastructure Project	Funding for this study was provided jointly by 973 Program (2006CB102005, 2007CB109202), the National Science Fund for Distinguished Young Scholars (30625006), Innovation Research Team Program of the Ministry of Education of China (IRT0355), and the National S&T Infrastructure Project (2005DKA21402, 2005DKA21105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SIGNALP 3 0 SERVER; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; CASTEELS P, 1994, J BIOL CHEM, V269, P26107; CASTEELS P, 1989, EMBO J, V8, P2387, DOI 10.1002/j.1460-2075.1989.tb08368.x; CASTEELS P, 1990, EUR J BIOCHEM, V187, P381, DOI 10.1111/j.1432-1033.1990.tb15315.x; CASTEELS P, 1993, J BIOL CHEM, V268, P7044; CASTEELSJOSSON K, 1994, J BIOL CHEM, V269, P28569; CASTEELSJOSSON K, 1993, EMBO J, V12, P1569, DOI 10.1002/j.1460-2075.1993.tb05801.x; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Chen YP, 2007, AM BEE J, V147, P1027; EIPPER BA, 1983, P NATL ACAD SCI-BIOL, V80, P5144, DOI 10.1073/pnas.80.16.5144; Evans JD, 2005, EVOLUTION, V59, P2270, DOI 10.1111/j.0014-3820.2005.tb00935.x; Fontana R, 2004, PEPTIDES, V25, P919, DOI 10.1016/j.peptides.2004.03.016; FUJIWARA S, 1990, J BIOL CHEM, V265, P11333; Girardin SE, 2002, TRENDS MICROBIOL, V10, P193, DOI 10.1016/S0966-842X(02)02334-X; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Kasprzak Sylwia, 2007, Wiadomosci Parazytologiczne, V53, P281; Klaudiny J, 2005, INSECT BIOCHEM MOLEC, V35, P11, DOI 10.1016/j.ibmb.2004.09.007; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Li WF, 2006, PEPTIDES, V27, P2350, DOI 10.1016/j.peptides.2006.03.016; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Mueller Uwe, 2008, V15, P21, DOI 10.1159/000135684; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Poinar GO, 2006, SCIENCE, V314, P614, DOI 10.1126/science.1134103; Santillan-Galicia MT, 2008, J GEN VIROL, V89, P1685, DOI 10.1099/vir.0.83223-0; Souza RM, 2007, Z NATURFORSCH C, V62, P801; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Williams GR, 2008, J INVERTEBR PATHOL, V97, P189, DOI 10.1016/j.jip.2007.08.005; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yang Guan-Huang, 2005, Acta Entomologica Sinica, V48, P401; Zhou XX, 2008, APPL MICROBIOL BIOT, V78, P947, DOI 10.1007/s00253-008-1380-y	36	76	88	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4239	10.1371/journal.pone.0004239	http://dx.doi.org/10.1371/journal.pone.0004239			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JB	19156201	Green Published, gold			2022-12-25	WOS:000265482100011
J	Maas, S; Gommans, WM				Maas, Stefan; Gommans, Willemijn M.			Novel Exon of Mammalian ADAR2 Extends Open Reading Frame	PLOS ONE			English	Article								Background: The post-transcriptional processing of pre-mRNAs by RNA editing contributes significantly to the complexity of the mammalian transcriptome. RNA editing by site-selective A-to-I modification also regulates protein function through recoding of genomically specified sequences. The adenosine deaminase ADAR2 is the main enzyme responsible for recoding editing and loss of ADAR2 function in mice leads to a phenotype of epilepsy and premature death. Although A-to-I RNA editing is known to be subject to developmental and cell-type specific regulation, there is little knowledge regarding the mechanisms that regulate RNA editing in vivo. Therefore, the characterization of ADAR expression and identification of alternative ADAR variants is an important prerequisite for understanding the mechanisms for regulation of RNA editing and the causes for deregulation in disease. Methodology/Principal Findings: Here we present evidence for a new ADAR2 splice variant that extends the open reading frame of ADAR2 by 49 amino acids through the utilization of an exon located 18 kilobases upstream of the previously annotated first coding exon and driven by a candidate alternative promoter. Interestingly, the 49 amino acid extension harbors a sequence motif that is closely related to the R-domain of ADAR3 where it has been shown to function as a basic, single-stranded RNA binding domain. Quantitative expression analysis shows that expression of the novel ADAR2 splice variant is tissue specific being highest in the cerebellum. Conclusions/Significance: The strong sequence conservation of the ADAR2 R-domain between human, mouse and rat ADAR2 genes suggests a conserved function for this isoform of the RNA editing enzyme.	[Maas, Stefan; Gommans, Willemijn M.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA	Lehigh University	Maas, S (corresponding author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	smaas@lehigh.edu			National Institutes of Health [NS057739]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS057739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by funds to S.M. from the National Institutes of Health (NS057739). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Blow M, 2004, GENOME RES, V14, P2379, DOI 10.1101/gr.2951204; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170; Feng Y, 2006, MOL CELL BIOL, V26, P480, DOI 10.1128/MCB.26.2.480-488.2006; George CX, 1999, P NATL ACAD SCI USA, V96, P4621, DOI 10.1073/pnas.96.8.4621; George CX, 2005, J BIOL CHEM, V280, P15020, DOI 10.1074/jbc.M500476200; Gerber A, 1997, RNA, V3, P453; Gommans W.M., 2008, DNA RNA EDITING, P3; HAUSSLER DAS, 2004, P 8 ANN INT C RES CO, P177; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Kuhn RM, 2007, NUCLEIC ACIDS RES, V35, pD668, DOI 10.1093/nar/gkl928; Lai F, 1997, MOL CELL BIOL, V17, P2413, DOI 10.1128/MCB.17.5.2413; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Maas Stefan, 2006, RNA Biol, V3, P1; Maydanovych O, 2006, CHEM REV, V106, P3397, DOI 10.1021/cr050314a; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795; Mittaz L, 1997, GENOMICS, V41, P210, DOI 10.1006/geno.1997.4655; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Singh M, 2007, J BIOL CHEM, V282, P22448, DOI 10.1074/jbc.M700265200; Slavov D, 2002, GENE, V299, P83, DOI 10.1016/S0378-1119(02)01016-8; Villard L, 1997, SOMAT CELL MOLEC GEN, V23, P135, DOI 10.1007/BF02679972; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yang WD, 2004, MOL BRAIN RES, V124, P70, DOI 10.1016/j.molbrainres.2004.02.010	30	38	41	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2009	4	1							e4225	10.1371/journal.pone.0004225	http://dx.doi.org/10.1371/journal.pone.0004225			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IZ	19156214	Green Published, gold, Green Submitted			2022-12-25	WOS:000265481900007
J	Wang, SZ; Liu, BH; Tao, HW; Xia, K; Zhang, LI				Wang, Sheng-zhi; Liu, Bao-hua; Tao, Huizhong W.; Xia, Kun; Zhang, Li I.			A Genetic Strategy for Stochastic Gene Activation with Regulated Sparseness (STARS)	PLOS ONE			English	Article								It remains a challenge to establish a straightforward genetic approach for controlling the probability of gene activation or knockout at a desired level. Here, we developed a method termed STARS: stochastic gene activation with genetically regulated sparseness. The stochastic expression was achieved by two cross-linked, mutually-exclusive Cre-mediated recombinations. The stochastic level was further controlled by regulating Cre/lox reaction kinetics through varying the intrachromosomal distance between the lox sites mediating one of the recombinations. In mammalian cell lines stably transfected with a single copy of different STARS transgenes, the activation/knockout of reporter genes was specifically controlled to occur in from 5% to 50% of the cell population. STARS can potentially provide a convenient way for genetic labeling as well as gene expression/knockout in a population of cells with a desired sparseness level.	[Wang, Sheng-zhi; Liu, Bao-hua; Tao, Huizhong W.; Zhang, Li I.] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Wang, Sheng-zhi; Liu, Bao-hua; Zhang, Li I.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA USA; [Tao, Huizhong W.] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA USA; [Xia, Kun] Cent S Univ, State Key Lab Med Genet, Changsha, Peoples R China	University of Southern California; University of Southern California; University of Southern California; Central South University	Wang, SZ (corresponding author), Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA.	liizhang@usc.edu	XIA, KUN/AAO-3525-2020; Tao, Huizhong W/HDM-9767-2022		Searle Scholar Program; Klingenstein Foundation; David and Lucile Packard Foundation [Packard Fellowships for Science and Engineering]; NATIONAL EYE INSTITUTE [R01EY019049, R21EY018718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC008588, R01DC008983] Funding Source: NIH RePORTER	Searle Scholar Program; Klingenstein Foundation(Klingenstein Philanthropies); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants to L.I.Z. from the Searle Scholar Program, the Klingenstein Foundation, and the David and Lucile Packard Foundation (Packard Fellowships for Science and Engineering). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badea TC, 2003, J NEUROSCI, V23, P2314; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Karasawa S, 2004, BIOCHEM J, V381, P307, DOI 10.1042/BJ20040321; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; Liu PT, 2002, NAT GENET, V30, P66, DOI 10.1038/ng788; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Luo L, 2007, BRAIN RES REV, V55, P220, DOI 10.1016/j.brainresrev.2007.01.012; Muzumdar MD, 2007, P NATL ACAD SCI USA, V104, P4495, DOI 10.1073/pnas.0606491104; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; SAUER B, 1993, METHOD ENZYMOL, V225, P890; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Wang W, 2007, P NATL ACAD SCI USA, V104, P4501, DOI 10.1073/pnas.0607953104; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118; Zheng BH, 2000, MOL CELL BIOL, V20, P648, DOI 10.1128/MCB.20.2.648-655.2000; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	25	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2009	4	1							e4200	10.1371/journal.pone.0004200	http://dx.doi.org/10.1371/journal.pone.0004200			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IG	19145242	Green Published, Green Submitted, gold			2022-12-25	WOS:000265479800006
J	Watson, KK; Ghodasra, JH; Platt, ML				Watson, Karli K.; Ghodasra, Jason H.; Platt, Michael L.			Serotonin Transporter Genotype Modulates Social Reward and Punishment in Rhesus Macaques	PLOS ONE			English	Article							GENE VARIATION; HUMAN AMYGDALA; EYE-MOVEMENTS; LIFE STRESS; MONKEYS; FACES; RISK; POLYMORPHISM; AUTISM; GAZE	Background: Serotonin signaling influences social behavior in both human and nonhuman primates. In humans, variation upstream of the promoter region of the serotonin transporter gene (5-HTTLPR) has recently been shown to influence both behavioral measures of social anxiety and amygdala response to social threats. Here we show that length polymorphisms in 5-HTTLPR predict social reward and punishment in rhesus macaques, a species in which 5-HTTLPR variation is analogous to that of humans. Methodology/Principal Findings: In contrast to monkeys with two copies of the long allele (L/L), monkeys with one copy of the short allele of this gene (S/L) spent less time gazing at face than non-face images, less time looking in the eye region of faces, and had larger pupil diameters when gazing at photos of a high versus low status male macaques. Moreover, in a novel primed gambling task, presentation of photos of high status male macaques promoted risk-aversion in S/L monkeys but promoted risk-seeking in L/L monkeys. Finally, as measured by a "pay-per-view" task, S/L monkeys required juice payment to view photos of high status males, whereas L/L monkeys sacrificed fluid to see the same photos. Conclusions/Significance: These data indicate that genetic variation in serotonin function contributes to social reward and punishment in rhesus macaques, and thus shapes social behavior in humans and rhesus macaques alike.	[Watson, Karli K.; Platt, Michael L.] Duke Univ, Dept Neurobiol, Durham, NC 27706 USA; [Ghodasra, Jason H.] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA	Duke University; Northwestern University; Feinberg School of Medicine	Watson, KK (corresponding author), Duke Univ, Dept Neurobiol, LSRC Room, Durham, NC 27706 USA.	karlikiiko@gmail.com		WATSON, KARLI/0000-0002-5513-1492	Cure Autism Now Foundation; National Institutes of Health [R01 5R01-EY-013496-07]; Howard Hughes Medical Institute;  [Training Grant in Fundamental and Translational Neuroscience]; NATIONAL EYE INSTITUTE [R01EY013496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086712] Funding Source: NIH RePORTER	Cure Autism Now Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We gratefully acknowledge financial support from the Cure Autism Now Foundation (KKW), National Institutes of Health (R01 5R01-EY-013496-07 to MLP and Training Grant in Fundamental and Translational Neuroscience to KKW), and Howard Hughes Medical Institute (JHG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr CS, 2004, BIOL PSYCHIAT, V55, P733, DOI 10.1016/j.biopsych.2003.12.008; Barr CS, 2003, ALCOHOL CLIN EXP RES, V27, P812, DOI 10.1097/01.ALC.0000067976.62827.ED; BELLAMY RJ, 1991, HUM GENET, V87, P341; Bennett AJ, 2002, MOL PSYCHIATR, V7, P118, DOI 10.1038/sj/mp/4000949; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Champoux M, 2002, MOL PSYCHIATR, V7, P1058, DOI 10.1038/sj.mp.4001157; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; DEANER RO, 2005, J VISION, V5, P394; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Ghazanfar AA, 2006, COGNITION, V101, P515, DOI 10.1016/j.cognition.2005.12.007; Guo K, 2003, EXP BRAIN RES, V150, P363, DOI 10.1007/s00221-003-1429-1; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hariri AR, 2005, ARCH GEN PSYCHIAT, V62, P146, DOI 10.1001/archpsyc.62.2.146; Hauser, 1996, EVOL COMMUN; Hayden BY, 2007, CURR BIOL, V17, P49, DOI 10.1016/j.cub.2006.10.055; Horley K, 2003, J ANXIETY DISORD, V17, P33, DOI 10.1016/S0887-6185(02)00180-9; JOHNSON EJ, 1983, J PERS SOC PSYCHOL, V45, P20, DOI 10.1037/0022-3514.45.1.20; KLEIN JT, 2008, CURR BIOL IN PRESS; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Lerner JS, 2006, J BEHAV DECIS MAKING, V19, P115, DOI 10.1002/bdm.515; Lerner JS, 2000, COGNITION EMOTION, V14, P473, DOI 10.1080/026999300402763; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; MAURER D, 1976, CHILD DEV, V47, P523, DOI 10.2307/1128813; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; MENDELSON MJ, 1982, DEV PSYCHOL, V18, P222, DOI 10.1037/0012-1649.18.2.222; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Nahm FKD, 1997, J COGNITIVE NEUROSCI, V9, P611, DOI 10.1162/jocn.1997.9.5.611; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; ROSENFELD SA, 1979, NEUROPSYCHOLOGIA, V17, P503, DOI 10.1016/0028-3932(79)90057-5; Spezio ML, 2007, NEUROPSYCHOLOGIA, V45, P144, DOI 10.1016/j.neuropsychologia.2006.04.027; Suomi SJ, 2006, ANN NY ACAD SCI, V1094, P52, DOI 10.1196/annals.1376.006; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Uher R, 2008, MOL PSYCHIATR, V13, P131, DOI 10.1038/sj.mp.4002067; VAN HOOF J. A. R. A. M., 1967, P7; Wendland JR, 2006, BEHAV GENET, V36, P163, DOI 10.1007/s10519-005-9017-8; WRIGHT S, 1922, COEFFICIENTS INBREED, P330; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	43	78	79	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4156	10.1371/journal.pone.0004156	http://dx.doi.org/10.1371/journal.pone.0004156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437IF	19142220	Green Published, gold, Green Submitted			2022-12-25	WOS:000265479700003
J	Chang, H; Yoshimoto, M; Umeda, K; Iwasa, T; Mizuno, Y; Fukada, S; Yamamoto, H; Motohashi, N; Suzuki, YM; Takeda, S; Heike, T; Nakahata, T				Chang, Hsi; Yoshimoto, Momoko; Umeda, Katsutsugu; Iwasa, Toru; Mizuno, Yuta; Fukada, So-ichiro; Yamamoto, Hiroshi; Motohashi, Norio; Suzuki, Yuko Miyagoe; Takeda, Shin'ichi; Heike, Toshio; Nakahata, Tatsutoshi			Generation of transplantable, functional satellite-like cells from mouse embryonic stem cells	FASEB JOURNAL			English	Article						long-term engraftment; secondary transplantation; high engraftment efficiency; self-renewal	SKELETAL-MUSCLE REGENERATION; DUCHENNE MUSCULAR-DYSTROPHY; MYOGENIC CELLS; EXPRESSION; MYOBLASTS; PAX7; DIFFERENTIATION; RECONSTITUTION; HETEROGENEITY; PURIFICATION	Satellite cells are myogenic stem cells responsible for the postnatal regeneration of skeletal muscle. Here we report the successful in vitro induction of Pax7-positive satellite-like cells from mouse embryonic stem (mES) cells. Embryoid bodies were generated from mES cells and cultured on Matrigel-coated dishes with Dulbecco's modified Eagle medium containing fetal bovine serum and horse serum. Pax7-positive satellite-like cells were enriched by fluorescence-activated cell sorting using a novel anti-satellite cell antibody, SM/C-2.6. SM/C-2.6-positive cells efficiently differentiate into skeletal muscle fibers both in vitro and in vivo. Furthermore, the cells demonstrate satellite cell characteristics such as extensive self-renewal capacity in subsequent muscle injury model, long-term engraftment up to 24 wk, and the ability to be secondarily transplanted with remarkably high engraftment efficiency compared to myoblast transplantation. This is the first report of transplantable, functional satellite-like cells derived from mES cells and will provide a foundation for new therapies for degenerative muscle disorders.-Chang, H., Yoshimoto, M., Umeda, K., Iwasa, T., Mizuno, Y., Fukada, S., Yamamoto, H., Motohashi, N., Yuko-Miyagoe-Suzuki, Takeda, S., Heike, T., Nakahata, T. Generation of transplantable, functional satellite-like cells from mouse embryonic stem cells. FASEB J. 23, 1907-1919 (2009)	[Chang, Hsi; Yoshimoto, Momoko; Umeda, Katsutsugu; Iwasa, Toru; Mizuno, Yuta; Heike, Toshio; Nakahata, Tatsutoshi] Kyoto Univ, Grad Sch Med, Dept Pediat, Sakyo Ku, Kyoto 6068507, Japan; [Yoshimoto, Momoko] Indiana Univ, Sch Med, Wells Ctr Pediat Res, Indianapolis, IN USA; [Fukada, So-ichiro; Yamamoto, Hiroshi] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Osaka, Japan; [Motohashi, Norio; Suzuki, Yuko Miyagoe; Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Tokyo, Japan	Kyoto University; Indiana University System; Indiana University-Purdue University Indianapolis; Osaka University; National Center for Neurology & Psychiatry - Japan	Heike, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pediat, Sakyo Ku, 54 Syogoin Kawahara Cho, Kyoto 6068507, Japan.	heike@kuhp.kyoto-u.ac.jp	Motohashi, Norio/AGE-8809-2022; Yoshimoto, Momoko/N-4238-2014; Yoshimoto, Momoko/AFP-3523-2022; Fukada, So-ichiro/AAI-9151-2020	Motohashi, Norio/0000-0002-8172-4339; Yoshimoto, Momoko/0000-0002-7272-6682; Yoshimoto, Momoko/0000-0002-7272-6682; Fukada, So-ichiro/0000-0003-4051-5108	Scientific Research (S) [19109006]; Ministry of Education, Science, Technology, Sports, and Culture of Japan [18390298]; Grants-in-Aid for Scientific Research [21300149] Funding Source: KAKEN	Scientific Research (S)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Science, Technology, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (S) (19109006) and a Grant-in-Aid for Scientific Research (B) (18390298) from the Ministry of Education, Science, Technology, Sports, and Culture of Japan.	Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533; BONILLA E, 1988, CELL, V54, P447, DOI 10.1016/0092-8674(88)90065-7; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; DEKEL I, 1992, NEW BIOL, V4, P217; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; Fukada S, 2002, J CELL SCI, V115, P1285; Gross JG, 1999, MUSCLE NERVE, V22, P174, DOI 10.1002/(SICI)1097-4598(199902)22:2<174::AID-MUS5>3.0.CO;2-S; Harris JB, 2003, TOXICON, V42, P933, DOI 10.1016/j.toxicon.2003.11.011; HARRISON DE, 1978, J EXP MED, V147, P1526, DOI 10.1084/jem.147.5.1526; Hashimoto N, 2004, DEVELOPMENT, V131, P5481, DOI 10.1242/dev.01395; Hirsinger E, 2001, DEVELOPMENT, V128, P107; Hollnagel A, 2002, MOL CELL BIOL, V22, P4760, DOI 10.1128/MCB.22.13.4760-4770.2002; Jejurikar SS, 2003, APOPTOSIS, V8, P573, DOI 10.1023/A:1026127307457; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; Kiefer JC, 2001, DEV BIOL, V232, P77, DOI 10.1006/dbio.2000.0114; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; MENDELL JR, 1995, NEW ENGL J MED, V333, P832, DOI 10.1056/NEJM199509283331303; Michalak M, 1997, CURR OPIN NEUROL, V10, P436, DOI 10.1097/00019052-199710000-00014; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; MOSS FP, 1971, ANAT REC, V170, P421, DOI 10.1002/ar.1091700405; Nawrotzki R, 1996, TRENDS GENET, V12, P294, DOI 10.1016/0168-9525(96)10033-0; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; ROHWEDEL J, 1994, DEV BIOL, V164, P87, DOI 10.1006/dbio.1994.1182; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; SCHULTZ E, 1985, MECH AGEING DEV, V30, P63, DOI 10.1016/0047-6374(85)90059-4; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; SMITH TH, 1993, DEVELOPMENT, V117, P1125; SNOW MH, 1978, CELL TISSUE RES, V186, P535; SUZUKI A, 1994, EUR J BIOCHEM, V220, P283, DOI 10.1111/j.1432-1033.1994.tb18624.x; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; WEBSTER C, 1990, SOMAT CELL MOLEC GEN, V16, P557, DOI 10.1007/BF01233096; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; YAO SN, 1993, J CELL SCI, V105, P957; Yoshimoto M, 2005, STEM CELLS, V23, P610, DOI 10.1634/stemcells.2004-0220; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908	46	64	69	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1907	1919		10.1096/fj.08-123661	http://dx.doi.org/10.1096/fj.08-123661			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19168704	Green Submitted			2022-12-25	WOS:000266652400030
J	Palermo, A; Doyonnas, R; Bhutani, N; Pomerantz, J; Alkan, O; Blau, HM				Palermo, Adam; Doyonnas, Regis; Bhutani, Nidhi; Pomerantz, Jason; Alkan, Ozan; Blau, Helen M.			Nuclear reprogramming in heterokaryons is rapid, extensive, and bidirectional	FASEB JOURNAL			English	Article						gene expression; time course; microarrays; somatic fate change; balance of regulators	EMBRYONIC STEM-CELLS; GENE-EXPRESSION; SOMATIC-CELLS; DIFFERENTIATED FUNCTIONS; TRANSIENT HETEROKARYONS; ALBUMIN PRODUCTION; MUSCLE GENES; ACTIVATION; HYBRIDS; HYBRIDIZATION	An understanding of nuclear reprogramming is fundamental to the use of cells in regenerative medicine. Due to technological obstacles, the time course and extent of reprogramming of cells following fusion has not been assessed to date. Here, we show that hundreds of genes are activated or repressed within hours of fusion of human keratinocytes and mouse muscle cells in heterokaryons, and extensive changes are observed within 4 days. This study was made possible by the development of a broadly applicable approach, species-specific transcriptome amplification (SSTA), which enables global resolution of transcripts derived from the nuclei of two species, even when the proportions of species-specific transcripts are highly skewed. Remarkably, either phenotype can be dominant; an excess of primary keratinocytes leads to activation of the keratinocyte program in muscle cells and the converse is true when muscle cells are in excess. We conclude that nuclear reprogramming in heterokaryons is rapid, extensive, bidirectional, and dictated by the balance of regulators contributed by the cell types.-Adam Palermo, Regis Doyonnas, Nidhi Bhutani, Jason Pomerantz, Ozan Alkan, Helen M. Blau. Nuclear reprogramming in heterokaryons is rapid, extensive, and bidirectional. FASEB J. 23, 1431-1440 (2009)	[Palermo, Adam; Doyonnas, Regis; Bhutani, Nidhi; Pomerantz, Jason; Alkan, Ozan; Blau, Helen M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Palermo, Adam; Doyonnas, Regis; Bhutani, Nidhi; Pomerantz, Jason; Alkan, Ozan; Blau, Helen M.] Stanford Univ, Sch Med, Stem Cell Inst, Stanford, CA 94305 USA; [Palermo, Adam] Genzyme Corp, Framingham, MA 01701 USA; [Pomerantz, Jason] Univ Calif San Francisco, Dept Surg, Div Plast & Reconstruct Surg, San Francisco, CA 94143 USA; [Alkan, Ozan] MIT, Broad Inst, Cambridge, MA 02139 USA; [Alkan, Ozan] Harvard Univ, Cambridge, MA 02138 USA	Stanford University; Stanford University; Sanofi-Aventis; Genzyme Corporation; University of California System; University of California San Francisco; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Blau, HM (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, 269 Campus Dr, Stanford, CA 94305 USA.	hblau@stanford.edu		Doyonnas, Regis/0000-0002-3818-0807	National Science Foundation; National Institutes of Health National Research Service Award [AF051678, AG009521, AG020961, AG024987, HD018179]; MDA [MDA4320]; Baxter Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024987, R37AG009521, R01AG009521, R01AG020961] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MDA(Muscular Dystrophy Association); Baxter Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Sally Pennypacker and Walt Holleran (Department of Dermatology, University of California, San Francisco, CA, USA) for providing human neonatal foreskin keratinocytes. We are grateful to the members of the H. M. B laboratory for helpful discussions and critical reading of the manuscript. This work was supported by a National Science Foundation fellowship (to A. T. P.); National Institutes of Health National Research Service Award AF051678 (to J.H.P.); NIH grants AG009521, AG020961, AG024987, and HD018179; MDA grant MDA4320; and the Baxter Foundation (to H. M.B).	Adjaye J, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-83; Ambrosi DJ, 2007, STEM CELLS, V25, P1104, DOI 10.1634/stemcells.2006-0532; BARON MH, 1986, CELL, V46, P591, DOI 10.1016/0092-8674(86)90885-8; BLAU HM, 1991, J CELL BIOL, V112, P781, DOI 10.1083/jcb.112.5.781; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; BLAU HM, 1992, ANNU REV BIOCHEM, V61, P1213, DOI 10.1146/annurev.bi.61.070192.010025; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; CHENCHIK A, 1998, RT PCR METHODS GENE; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; DARLINGTON GJ, 1974, SCIENCE, V185, P859, DOI 10.1126/science.185.4154.859; EPHRUSSI B, 1969, NATURE, V224, P1314, DOI 10.1038/2241314a0; FOUGERE C, 1978, CELL, V15, P843, DOI 10.1016/0092-8674(78)90269-6; Grigoryev DN, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-62; Ji W, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh084; MASHAL RD, 1995, NAT GENET, V9, P177, DOI 10.1038/ng0295-177; Naef F, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni104; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; PAVLATH GK, 1986, J CELL BIOL, V102, P124, DOI 10.1083/jcb.102.1.124; PETERSEN JA, 1972, P NATL ACAD SCI USA, V69, P571, DOI 10.1073/pnas.69.3.571; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; SPEAR BT, 1990, MOL CELL BIOL, V10, P5047, DOI 10.1128/MCB.10.10.5047; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Terranova R, 2006, J CELL SCI, V119, P2065, DOI 10.1242/jcs.02945; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; WRIGHT WE, 1984, EXP CELL RES, V151, P55, DOI 10.1016/0014-4827(84)90355-0; WRIGHT WE, 1984, J CELL BIOL, V98, P427, DOI 10.1083/jcb.98.2.427; Xu WY, 2001, GENE, V272, P61, DOI 10.1016/S0378-1119(01)00516-9; Zhang F, 2007, P NATL ACAD SCI USA, V104, P4395, DOI 10.1073/pnas.0700181104; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	30	40	43	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2009	23	5					1431	1440		10.1096/fj.08-122903	http://dx.doi.org/10.1096/fj.08-122903			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19141533	Green Published			2022-12-25	WOS:000266651700019
J	Pujal, J; Huch, M; Jose, A; Abasolo, I; Rodolosse, A; Duch, A; Sanchez-Palazon, L; Smith, FJD; McLean, WHI; Fillat, C; Real, FX				Pujal, Judit; Huch, Meritxell; Jose, Anabel; Abasolo, Ibane; Rodolosse, Annie; Duch, Alba; Sanchez-Palazon, Luis; Smith, Frances J. D.; Irwin McLean, W. H.; Fillat, Cristina; Real, Francisco X.			Keratin 7 promoter selectively targets transgene expression to normal and neoplastic pancreatic ductal cells in vitro and in vivo	FASEB JOURNAL			English	Article						cytokeratins; adenovirus; cystic fibrosis; bioluminescent imaging	RECOMBINANT ADENOVIRUS; GENE-TRANSCRIPTION; CANCER; SP1; POTENT; TUMORS; ADENOCARCINOMAS; HEPATOTOXICITY; CYTOKERATINS; PROTEINS	Keratin 7 is expressed in simple epithelia but is expressed at low or undetectable levels in gastrointestinal epithelial cells. In the pancreas, it is present in ductal but not in acinar cells. K7 mRNA is overexpressed in pancreatic cancers. Here we use luciferase reporter assays to analyze the tissue-specific regulatory elements of murine keratin 7 (Krt7) promoter in vitro and in vivo. All elements required for appropriate cell and tissue specificity in reporter assays are present within the Krt7-234 bp sequence. This fragment appears more selective to pancreatic ductal cells than the Krt19 promoter. GC-rich sequences corresponding to putative Sp1, AP-2 binding sites are essential for in vitro activity. Krt7-LacZ transgenic mice were generated to analyze in vivo activity. Sequences located 1.5 or 0.25 kb upstream of the transcription initiation site drive reporter expression to ductal, but not acinar, cells in transgenic mice. LacZ mRNA was detected in the pancreas as well as in additional epithelial tissues such as the intestine and the lung-using both promoter constructs. An AdK7Luc adenovirus was generated to assess targeting selectivity in vivo by intravenous injection to immunocompetent mice and in a xenograft model of pancreatic cancer. The -0.25 kb region showed pancreatic selectivity, high activity in pancreatic cancers, and sustained transgene expression in xenografts. In conclusion, the krt7 promoter is useful to target pancreatic ductal adenocarcinoma cells in vitro and in vivo.-Pujal, J., Huch, M., Jose, A., Abasolo, I., Rodolosse, A., Duch, A., Sanchez-Palazon, L., Smith, F. J. D., McLean, W. H. I., Fillat, C., Real, F. X. Keratin 7 promoter selectively targets transgene expression to normal and neoplastic pancreatic ductal cells in vitro and in vivo. FASEB J. 23, 1366-1375 (2009)	[Huch, Meritxell; Jose, Anabel; Sanchez-Palazon, Luis; Fillat, Cristina] Univ Pompeu Fabra, Ctr Regulacio Genom, Barcelona 08003, Spain; [Pujal, Judit; Abasolo, Ibane; Rodolosse, Annie; Duch, Alba; Real, Francisco X.] Inst Municipal Invest Med, Unitat Biol Cellular & Mol, E-08003 Barcelona, Spain; [Rodolosse, Annie; Duch, Alba; Real, Francisco X.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona 08003, Spain; [Huch, Meritxell; Fillat, Cristina] Ctr Invest Biomed Red Enfermedades Raras, Barcelona, Spain; [Smith, Frances J. D.; Irwin McLean, W. H.] Univ Dundee, Coll Life Sci & Med, Div Mol Med, Epithelial Genet Grp, Dundee, Scotland; [Smith, Frances J. D.; Irwin McLean, W. H.] Univ Dundee, Coll Dent, Dundee, Scotland; [Smith, Frances J. D.; Irwin McLean, W. H.] Univ Dundee, Coll Nursing, Dundee, Scotland; [Real, Francisco X.] Ctr Nacl Invest Oncol, Programa Patol Mol, Madrid, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Dundee; University of Dundee; University of Dundee	Fillat, C (corresponding author), Univ Pompeu Fabra, Ctr Regulacio Genom, Edifici Parc Rec Biomed Barcelona,Carrer Dr Aigua, Barcelona 08003, Spain.	cristina.fillat@crg.es; freal@cnio.es	Fillat, Cristina/ABH-1674-2020; Abasolo, Ibane/H-7741-2012; Arribas, Francisco X Real/H-5275-2015; McLean, William HI/C-6352-2009; Duch, Alba/AGI-1035-2022	Abasolo, Ibane/0000-0001-5970-6276; Arribas, Francisco X Real/0000-0001-9501-498X; Duch, Alba/0000-0001-6041-1360; Fillat, Cristina/0000-0002-0801-3338; McLean, William Henry Irwin/0000-0001-5539-5757	Plan Nacional de I + D [SAF2001-0420, SAF2004-01137, SAF2007-60860]; Accion Especial de Genomica [GEN2001-4748-c05-01]; CIRIT (Generalitat de Catalunya) [SGR-00410]; Marato de TV-3; Biomed Program [QLG-CT-2002-01196]; Spanish Ministry of Education and Science [BIO2005-08682-C03-02]; Generalitat de Catalunya [SGR0500008]; CIBERER; Instituto de Salud Carlos III; Wellcome Trust Senior Research Fellowship in Basic Biomedical Science; Basque government; MRC [G0700314] Funding Source: UKRI; Medical Research Council [G0700314] Funding Source: researchfish	Plan Nacional de I + D; Accion Especial de Genomica; CIRIT (Generalitat de Catalunya)(Generalitat de Catalunya); Marato de TV-3; Biomed Program; Spanish Ministry of Education and Science(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); CIBERER; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Wellcome Trust Senior Research Fellowship in Basic Biomedical Science(Wellcome Trust); Basque government(Basque Government); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank all investigators mentioned in the main text and Supplemental Information for providing cells and reagents; members of the Unitat de Biologia Cel.lular i Molecular, IMIM, for valuable contributions; Dr. C. Ciudad (Universitat de Barcelona, Barcelona, Spain) for valuable discussions and reagents; and Drs. M. I. Hernandez-Munoz, A. Skoudy, X. Mayol, and A. Merlos for critical reading of the manuscript. We also thank the Clinical Biochemistry Service of the Veterinary Faculty of the Autonomous University of Barcelona for the determination of serum transaminases. This work was supported, in part, by grants from Plan Nacional de I + D (SAF2001-0420, SAF2004-01137, and SAF2007-60860), Accion Especial de Genomica (GEN2001-4748-c05-01), CIRIT (Generalitat de Catalunya) (SGR-00410), Marato de TV-3, and Biomed Program (QLG-CT-2002-01196) to F.X.R., and grants BIO2005-08682-C03-02 from the Spanish Ministry of Education and Science and SGR0500008 from the Generalitat de Catalunya to C.F. The group of C.F. is also partially funded by CIBERER, Instituto de Salud Carlos III. W.H.I.M. and F.J.D.S. were supported by a Wellcome Trust Senior Research Fellowship in Basic Biomedical Science (to W.H.I.M.). M.H. was a predoctoral fellow (BEFI) at the Instituto de Salud Carlos III. A.J. was supported by a predoctoral fellowship (FPU) granted by the Spanish Ministry of Education and Science. I.A. was supported by a postdoctoral fellowship from the Basque government. The authors declare no conflict of interest.	Adell T, 2000, CELL GROWTH DIFFER, V11, P137; Alemany R, 2001, GENE THER, V8, P1347, DOI 10.1038/sj.gt.3301515; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Brembeck FH, 2000, J BIOL CHEM, V275, P28230; Brembeck FH, 2003, CANCER RES, V63, P2005; Brembeck FH, 2001, GASTROENTEROLOGY, V120, P1720, DOI 10.1053/gast.2001.24846; Cascante A, 2007, GENE THER, V14, P1471, DOI 10.1038/sj.gt.3303008; Chen TT, 1997, MOL CELL BIOL, V17, P3056, DOI 10.1128/MCB.17.6.3056; Christ M, 2000, HUM GENE THER, V11, P415, DOI 10.1089/10430340050015888; Goldstein NS, 2001, AM J CLIN PATHOL, V115, P695; GUNTHER M, 1995, MOL CELL BIOL, V15, P2490; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hernandez-Munoz I, 2008, PANCREATOLOGY, V8, P462, DOI 10.1159/000151537; Huch M, 2006, HUM GENE THER, V17, P1187, DOI 10.1089/hum.2006.17.1187; Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614; Iacobuzio-Donahue CA, 2002, AM J PATHOL, V160, P1239, DOI 10.1016/S0002-9440(10)62551-5; Kaufman CK, 2002, MOL CELL BIOL, V22, P4293, DOI 10.1128/MCB.22.12.4293-4308.2002; Krishnan M, 2005, FASEB J, V19, P106, DOI 10.1096/fj.05-4551fje; Ku NO, 1996, J CLIN INVEST, V98, P1034, DOI 10.1172/JCI118864; Leach SD, 2004, CANCER CELL, V5, P7, DOI 10.1016/S1535-6108(03)00337-4; Liu N, 1998, AM J PATHOL, V153, P263, DOI 10.1016/S0002-9440(10)65567-8; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Opitz OG, 2000, CANCER RES, V60, P2825; OSBORN M, 1986, LAB INVEST, V55, P497; Owens DW, 2003, BIOESSAYS, V25, P748, DOI 10.1002/bies.10316; Porter RM, 2003, TRENDS GENET, V19, P278, DOI 10.1016/S0168-9525(03)00071-4; Real FX, 2003, GASTROENTEROLOGY, V124, P1958, DOI 10.1016/S0016-5085(03)00389-5; Rodolosse A, 2004, GASTROENTEROLOGY, V127, P937, DOI 10.1053/j.gastro.2004.06.058; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SCHUSSLER MH, 1992, AM J PATHOL, V140, P559; Smith FJD, 2003, AM J CLIN DERMATOL, V4, P347, DOI 10.2165/00128071-200304050-00005; Smith FJD, 2002, BIOCHEM BIOPH RES CO, V297, P818, DOI 10.1016/S0006-291X(02)02288-X; Steward MC, 2005, ANNU REV PHYSIOL, V67, P377, DOI 10.1146/annurev.physiol.67.031103.153247; Strelkov SV, 2003, BIOESSAYS, V25, P243, DOI 10.1002/bies.10246; Tamai Y, 2000, J CELL BIOL, V151, P563, DOI 10.1083/jcb.151.3.563; Van Seuningen I, 2001, FRONT BIOSCI-LANDMRK, V6, pD1216; VILA MR, 1995, LAB INVEST, V72, P395; Xie XM, 2007, CANCER CELL, V12, P52, DOI 10.1016/j.ccr.2007.05.009; Yuan P, 2007, CANCER-AM CANCER SOC, V110, P2682, DOI 10.1002/cncr.23092	39	13	13	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2009	23	5					1366	1375		10.1096/fj.08-115576	http://dx.doi.org/10.1096/fj.08-115576			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19124560				2022-12-25	WOS:000266651700013
J	Harris, KS; Casey, JL; Coley, AM; Karas, JA; Sabo, JK; Tan, YY; Dolezal, O; Norton, RS; Hughes, AB; Scanlon, D; Foley, M				Harris, Karen S.; Casey, Joanne L.; Coley, Andrew M.; Karas, John A.; Sabo, Jennifer K.; Tan, Yen Yee; Dolezal, Olan; Norton, Raymond S.; Hughes, Andrew B.; Scanlon, Denis; Foley, Michael			Rapid Optimization of a Peptide Inhibitor of Malaria Parasite Invasion by Comprehensive N-Methyl Scanning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APICAL MEMBRANE ANTIGEN-1; PLASMODIUM-FALCIPARUM APICAL-MEMBRANE-ANTIGEN-1; NUCLEAR-MAGNETIC-RESONANCE; VACCINE CANDIDATE; CRYSTAL-STRUCTURE; ERYTHROCYTE INVASION; NMR-SPECTROSCOPY; SELF-ASSOCIATION; AMINO-ACIDS; SOLID-PHASE	Apical membrane antigen 1 (AMA1) of the malaria parasite Plasmodium falciparum has been implicated in the invasion of host erythrocytes and is an important vaccine candidate. We have previously described a 20-residue peptide, R1, that binds to AMA1 and subsequently blocks parasite invasion. Because this peptide appears to target a site critical for AMA1 function, it represents an important lead compound for anti-malarial drug development. However, the effectiveness of this peptide inhibitor was limited to a subset of parasite isolates, indicating a requirement for broader strain specificity. Furthermore, a barrier to the utility of any peptide as a potential therapeutic is its susceptibility to rapid proteolytic degradation. In this study, we sought to improve the proteolytic stability and AMA1 binding properties of the R1 peptide by systematic methylation of backbone amides (N-methylation). The inclusion of a single N-methyl group in the R1 peptide backbone dramatically increased AMA1 affinity, bioactivity, and proteolytic stability without introducing global structural alterations. In addition, N-methylation of multiple R1 residues further improved these properties. Therefore, we have shown that modifications to a biologically active peptide can dramatically enhance activity. This approach could be applied to many lead peptides or peptide therapeutics to simultaneously optimize a number of parameters.	[Hughes, Andrew B.] La Trobe Univ, Dept Chem, Bundoora, Vic 3086, Australia; [Harris, Karen S.; Casey, Joanne L.; Coley, Andrew M.; Foley, Michael] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia; [Casey, Joanne L.; Foley, Michael] AdAlta Pty Ltd, Bundoora, Vic 3083, Australia; [Karas, John A.; Scanlon, Denis] Univ Melbourne, BIO21 Mol Sci & Biotechnol Inst, Melbourne, Vic 3010, Australia; [Sabo, Jennifer K.; Tan, Yen Yee; Norton, Raymond S.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Dolezal, Olan] CSIRO Mol & Hlth Technol, Parkville, Vic 3052, Australia	La Trobe University; La Trobe University; University of Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Hughes, AB (corresponding author), La Trobe Univ, Dept Chem, Bundoora, Vic 3086, Australia.	a.hughes@latrobe.edu.au; m.foley@latrobe.edu.au	Karas, John/AAE-9729-2019; Dolezal, Olan/E-1691-2015	Karas, John/0000-0002-3800-5152; Norton, Raymond/0000-0001-8893-0584; Foley, Michael/0000-0003-1349-4698	National Institutes of Health [NIH RO1AI59229]; National Health and Medical Research Council of Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059229] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant NIH RO1AI59229. This work was also supported by the National Health and Medical Research Council of Australia. The authors declare that they have no competing financial interests. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Anders RF, 1998, VACCINE, V16, P240, DOI 10.1016/S0264-410X(97)88331-4; Aurelio L, 2003, J ORG CHEM, V68, P2652, DOI 10.1021/jo026722l; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bergseng E, 2005, J BIOL CHEM, V280, P21791, DOI 10.1074/jbc.M501558200; Bowman MJ, 2004, BIOORG MED CHEM LETT, V14, P1395, DOI 10.1016/j.bmcl.2003.09.099; Bruehlmeier M, 2002, NUCL MED BIOL, V29, P321, DOI 10.1016/S0969-8051(01)00304-3; CASEY JL, 2007, AFFINITY CHROMATOGR, P111; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; Coley AM, 2006, INFECT IMMUN, V74, P2628, DOI 10.1128/IAI.74.5.2628-2636.2006; Coley AM, 2007, PLOS PATHOG, V3, P1308, DOI 10.1371/journal.ppat.0030138; Collins CR, 2007, J BIOL CHEM, V282, P7431, DOI 10.1074/jbc.M610562200; COLLINS WE, 1994, AM J TROP MED HYG, V51, P711, DOI 10.4269/ajtmh.1994.51.711; Cranmer SL, 1997, T ROY SOC TROP MED H, V91, P363, DOI 10.1016/S0035-9203(97)90110-3; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; DINGLEY AJ, 1995, J BIOMOL NMR, V6, P321; Dutta S, 2005, INFECT IMMUN, V73, P2116, DOI 10.1128/IAI.73.4.2116-2122.2005; EBATA M, 1966, B CHEM SOC JPN, V39, P2535, DOI 10.1246/bcsj.39.2535; Egleton RD, 1997, PEPTIDES, V18, P1431, DOI 10.1016/S0196-9781(97)00242-8; FAIRLIE DP, 1995, CURR MED CHEM, V2, P654; GIBBS SJ, 1991, J MAGN RESON, V93, P395, DOI 10.1016/0022-2364(91)90014-K; GOODMAN M, 1974, J AM CHEM SOC, V96, P1479, DOI 10.1021/ja00812a034; HANCOCK WS, 1976, ANAL BIOCHEM, V71, P260, DOI 10.1016/0003-2697(76)90034-8; Harris KS, 2005, INFECT IMMUN, V73, P6981, DOI 10.1128/IAI.73.10.6981-6989.2005; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; Hehl AB, 2000, INFECT IMMUN, V68, P7078, DOI 10.1128/IAI.68.12.7078-7086.2000; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Keizer DW, 2003, BIOCHEMISTRY-US, V42, P9915, DOI 10.1021/bi034376b; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Kocken CHM, 1998, J BIOL CHEM, V273, P15119, DOI 10.1074/jbc.273.24.15119; Koradi R, 1996, J MOL GRAPHICS, V14, P29; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Li F, 2002, J BIOL CHEM, V277, P50303, DOI 10.1074/jbc.M207985200; LUDVIGSEN S, 1992, J BIOMOL NMR, V2, P227, DOI 10.1007/BF01875318; Manfredi R, 2006, CURR MED CHEM, V13, P2369, DOI 10.2174/092986706777935069; Miller SC, 1997, J AM CHEM SOC, V119, P2301, DOI 10.1021/ja9635443; Mitchell GH, 2004, INFECT IMMUN, V72, P154, DOI 10.1128/IAI.72.1.154-158.2004; Myszka DG, 1998, ANAL BIOCHEM, V265, P326, DOI 10.1006/abio.1998.2937; Papalia GA, 2006, ANAL BIOCHEM, V359, P112, DOI 10.1016/j.ab.2006.08.032; PETTIT GR, 1993, TETRAHEDRON, V49, P9151, DOI 10.1016/0040-4020(93)80003-C; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Rajeswaran WG, 2001, J MED CHEM, V44, P1305, DOI 10.1021/jm0005048; Ramanjulu JM, 1997, J ORG CHEM, V62, P4961, DOI 10.1021/jo9623696; Ridley RG, 2002, NATURE, V415, P686, DOI 10.1038/415686a; Sagan S, 2004, CURR MED CHEM, V11, P2799, DOI 10.2174/0929867043364108; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SEAVEY B R, 1991, Journal of Biomolecular NMR, V1, P217, DOI 10.1007/BF01875516; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Trzepalka E, 2004, J PEPT RES, V63, P333, DOI 10.1111/j.1399-3011.2004.00103.x; TULIP WR, 1992, J MOL BIOL, V227, P122, DOI 10.1016/0022-2836(92)90687-F; VOJKOVSKY T, 1995, PEPTIDE RES, V8, P236; WENGER RM, 1984, HELV CHIM ACTA, V67, P502, DOI 10.1002/hlca.19840670220; Yao SG, 2000, J BIOMOL NMR, V16, P109, DOI 10.1023/A:1008382624724	58	48	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9361	9371		10.1074/jbc.M808762200	http://dx.doi.org/10.1074/jbc.M808762200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19164290	Green Published, hybrid			2022-12-25	WOS:000264669100042
J	Juarez, O; Morgan, JE; Barquera, B				Juarez, Oscar; Morgan, Joel E.; Barquera, Blanca			The Electron Transfer Pathway of the Na+-pumping NADH: Quinone Oxidoreductase from Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATING NADH; UBIQUINONE OXIDOREDUCTASE; COMPLEX-I; ALGINOLYTICUS; REDUCTASE; NQR; FAD; STOICHIOMETRY; PURIFICATION; RIBOFLAVIN	The Na+-pumping NADH: quinone oxidoreductase (Na+-NQR) is the only respiratory enzyme that operates as a Na+ pump. This redox-driven Na+ pump is amenable to experimental approaches not available for H+ pumps, providing an excellent system for mechanistic studies of ion translocation. An understanding of the internal electron transfer steps and their Na+ dependence is an essential prerequisite for such studies. To this end, we analyzed the reduction kinetics of the wild type Na+-NQR, as well as site-directed mutants of the enzyme, which lack specific cofactors. NADH and ubiquinol were used as reductants in separate experiments, and a full spectrum UV-visible stopped flow kinetic method was employed. The results make it possible to define the complete sequence of redox carriers in the electrons transfer pathway through the enzyme. Electrons flow from NADH to quinone through the FAD in subunit F, the 2Fe-2S center, the FMN in subunit C, the FMN in subunit B, and finally riboflavin. The reduction of the FMNC to its anionic flavosemiquinone state is the first Na+-dependent process, suggesting that reduction of this site is linked to Na+ uptake. During the reduction reaction, two FMNs are transformed to their anionic flavosemiquinone in a single kinetic step. Subsequently, FMNC is converted to the flavohydroquinone, accounting for the single anionic flavosemiquinone radical in the fully reduced enzyme. A model of the electron transfer steps in the catalytic cycle of Na+-NQR is presented to account for the kinetic and spectroscopic data.	[Barquera, Blanca] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Barquera, B (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, 110 8th St, Troy, NY 12180 USA.	barqub@rpi.edu		Juarez, Oscar/0000-0002-2915-8413	NIGMS NIH HHS [GM 060036] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Barquera B, 2004, BIOCHEMISTRY-US, V43, P12322, DOI 10.1021/bi048689y; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Barquera B, 2003, J AM CHEM SOC, V125, P265, DOI 10.1021/ja0207201; Barquera B, 2006, J BIOL CHEM, V281, P36482, DOI 10.1074/jbc.M605765200; BEATTIE P, 1994, FEBS LETT, V356, P333, DOI 10.1016/0014-5793(94)01275-X; Bogachev AV, 2007, BIOCHEMISTRY-US, V46, P10186, DOI 10.1021/bi700440w; Bogachev AV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P143, DOI 10.1007/s10541-005-0093-4; Bogachev AV, 2002, BBA-BIOENERGETICS, V1556, P113, DOI 10.1016/S0005-2728(02)00342-0; Bogachev AV, 2006, BIOCHEMISTRY-US, V45, P3421, DOI 10.1021/bi052422x; Bogachev AV, 1997, FEBS LETT, V409, P475, DOI 10.1016/S0014-5793(97)00536-X; DIBROV PA, 1986, BIOCHIM BIOPHYS ACTA, V850, P449, DOI 10.1016/0005-2728(86)90113-1; Galkin A, 2006, BBA-BIOENERGETICS, V1757, P1575, DOI 10.1016/j.bbabio.2006.10.001; Hayashi M, 1996, FEBS LETT, V381, P174, DOI 10.1016/0014-5793(96)00114-7; HAYASHI M, 1986, FEBS LETT, V202, P327, DOI 10.1016/0014-5793(86)80711-6; Juarez O, 2008, J BIOL CHEM, V283, P33162, DOI 10.1074/jbc.M806913200; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; RICH PR, 1995, FEBS LETT, V375, P5, DOI 10.1016/0014-5793(95)01164-A; Steuber J, 1997, EUR J BIOCHEM, V249, P770, DOI 10.1111/j.1432-1033.1997.t01-2-00770.x; Stolpe S, 2004, J BIOL CHEM, V279, P18377, DOI 10.1074/jbc.M311242200; Tao ML, 2008, BBA-BIOENERGETICS, V1777, P696, DOI 10.1016/j.bbabio.2008.04.006; Tao M, 2008, J INORG BIOCHEM, V102, P1366, DOI 10.1016/j.jinorgbio.2008.01.009; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697	24	49	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8963	8972		10.1074/jbc.M809395200	http://dx.doi.org/10.1074/jbc.M809395200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19155212	hybrid, Green Published			2022-12-25	WOS:000264397800079
J	Kurokawa, K; Lee, H; Roh, KB; Asanuma, M; Kim, YS; Nakayama, H; Shiratsuchi, A; Choi, Y; Takeuchi, O; Kang, HJ; Dohmae, N; Nakanishi, Y; Akira, S; Sekimizu, K; Lee, BL				Kurokawa, Kenji; Lee, Hanna; Roh, Kyung-Baeg; Asanuma, Miwako; Kim, Young Sook; Nakayama, Hiroshi; Shiratsuchi, Akiko; Choi, Youngnim; Takeuchi, Osamu; Kang, Hee Jung; Dohmae, Naoshi; Nakanishi, Yoshinobu; Akira, Shizuo; Sekimizu, Kazuhisa; Lee, Bok Luel			The Triacylated ATP Binding Cluster Transporter Substrate-binding Lipoprotein of Staphylococcus aureus Functions as a Native Ligand for Toll-like Receptor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOTEICHOIC ACID; BACTERIAL LIPOPROTEINS; IMMUNE ACTIVATION; ESCHERICHIA-COLI; INNATE IMMUNITY; CUTTING EDGE; RECOGNITION; LIPOPEPTIDE; DISCRIMINATION; INFECTION	Some synthetic lipopeptides, in addition to native lipoproteins derived from both Gram-negative bacteria and mycoplasmas, are known to activate TLR2 (Toll-like receptor 2). However, the native lipoproteins inherent to Gram-positive bacteria, which function as TLR2 ligands, have not been characterized. Here, we have purified a native lipoprotein to homogeneity from Staphylococcus aureus to study as a native TLR2 ligand. The purified 33-kDa lipoprotein was capable of stimulating TLR2 and was identified as a triacylated SitC lipoprotein, which belongs to a family of ATP binding cluster (ABC) transporter substrate-binding proteins. Analyses of the SitC-mediated production of cytokine using mouse peritoneal macrophages revealed that the SitC protein (3 nM) induced the production of tumor necrosis factor-alpha and interleukin-6. Moreover, analysis of knock-out mice showed that SitC required TLR2 and MyD88, but not TLR1 or TLR6, for the induction of cytokines. In addition to the S. aureus SitC lipoprotein, we purified two other native ABC transporter substrate-binding lipoproteins from Bacillus subtilis and Micrococcus luteus, which were both shown to stimulate TLR2. These results demonstrate that S. aureus SitC lipoprotein is triacylated and that the ABC transporter substrate-binding lipoproteins of Gram-positive bacteria function as native ligands for TLR2.	[Kurokawa, Kenji; Lee, Hanna; Roh, Kyung-Baeg; Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea; [Kurokawa, Kenji; Sekimizu, Kazuhisa] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Tokyo 1130033, Japan; [Asanuma, Miwako; Nakayama, Hiroshi; Dohmae, Naoshi] RIKEN, Biomol Characterizat Team, Wako, Saitama 3510198, Japan; [Kim, Young Sook; Choi, Youngnim] Seoul Natl Univ, Sch Dent, Dept Oromaxillofacial Infect & Immun, Seoul 110749, South Korea; [Shiratsuchi, Akiko; Nakanishi, Yoshinobu] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan; [Lee, Hanna; Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; [Kang, Hee Jung] Hallym Univ, Coll Med, Dept Lab Med, Gyeonggi Do 431070, South Korea	Pusan National University; University of Tokyo; RIKEN; Seoul National University (SNU); Kanazawa University; Osaka University; Hallym University	Lee, BL (corresponding author), Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea.	brlee@pusan.ac.kr	Akira, Shizuo/C-3134-2009; Choi, Youngnim/AAL-8140-2020; Nakanishi, Yoshinobu/D-4602-2014; Dohmae, Naoshi/C-2040-2011; Takeuchi, Osamu/D-6007-2011; Shiratsuchi, Akiko/D-8391-2015; Takeuchi, Osamu/AAG-9359-2019; Asanuma, Miwako/AAI-1843-2019	Choi, Youngnim/0000-0002-6496-5560; Nakanishi, Yoshinobu/0000-0002-8767-3587; Dohmae, Naoshi/0000-0002-5242-9410; Shiratsuchi, Akiko/0000-0002-7811-4409; Takeuchi, Osamu/0000-0002-1260-6232; 	National Research Laboratory Grants [M10400000028-04J0000-02]; MOST/KOSEF Bioscience Grant [20080576001]; BK21 program	National Research Laboratory Grants(Korea Science and Engineering Foundation); MOST/KOSEF Bioscience Grant(Korea Science and Engineering Foundation); BK21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by National Research Laboratory Grants M10400000028-04J0000-02 and MOST/KOSEF Bioscience Grant 20080576001. This work was also partially supported by the BK21 program.	Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Bullen J J, 1978, Curr Top Microbiol Immunol, V80, P1; Buwitt-Beckmann U, 2006, J BIOL CHEM, V281, P9049, DOI 10.1074/jbc.M512525200; Buwitt-Beckmann U, 2005, EUR J IMMUNOL, V35, P282, DOI 10.1002/eji.200424955; CHOI DS, 1986, J BIOL CHEM, V261, P8953; Cockayne A, 1998, INFECT IMMUN, V66, P3767, DOI 10.1128/IAI.66.8.3767-3774.1998; FISCHER W, 1994, MED MICROBIOL IMMUN, V183, P61, DOI 10.1007/BF00277157; GAN K, 1993, J BIOL CHEM, V268, P16544; Grundling A, 2007, J BACTERIOL, V189, P2521, DOI 10.1128/JB.01683-06; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Henneke P, 2008, J IMMUNOL, V180, P6149, DOI 10.4049/jimmunol.180.9.6149; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Lee SJ, 2007, TRENDS MICROBIOL, V15, P389, DOI 10.1016/j.tim.2007.08.002; Li SL, 1998, J BIOCHEM-TOKYO, V124, P332, DOI 10.1093/oxfordjournals.jbchem.a022116; Machata S, 2008, J IMMUNOL, V181, P2028, DOI 10.4049/jimmunol.181.3.2028; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Muhlradt PF, 1997, J EXP MED, V185, P1951, DOI 10.1084/jem.185.11.1951; Oku Y, 2009, J BACTERIOL, V191, P141, DOI 10.1128/JB.01221-08; Omueti KO, 2005, J BIOL CHEM, V280, P36616, DOI 10.1074/jbc.M504320200; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Stoll H, 2005, INFECT IMMUN, V73, P2411, DOI 10.1128/IAI.73.4.2411-2423.2005; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; TOKUNAGA M, 1982, P NATL ACAD SCI-BIOL, V79, P2255, DOI 10.1073/pnas.79.7.2255; Wardenburg JB, 2006, P NATL ACAD SCI USA, V103, P13831, DOI 10.1073/pnas.0603072103	31	115	117	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8406	8411		10.1074/jbc.M809618200	http://dx.doi.org/10.1074/jbc.M809618200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19139093	Green Published, hybrid			2022-12-25	WOS:000264397800024
J	Guan, RB; Feng, XY; Wu, XQ; Zhang, ML; Zhang, XS; Hebert, TE; Segaloff, DL				Guan, Rongbin; Feng, Xiuyan; Wu, Xueqing; Zhang, Meilin; Zhang, Xuesen; Hebert, Terence E.; Segaloff, Deborah L.			Bioluminescence Resonance Energy Transfer Studies Reveal Constitutive Dimerization of the Human Lutropin Receptor and a Lack of Correlation between Receptor Activation and the Propensity for Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; LUTEINIZING-HORMONE-RECEPTOR; MUTATION-INDUCED ACTIVATION; CELL-SURFACE; LUTROPIN/CHORIOGONADOTROPIN RECEPTOR; GONADOTROPIN RECEPTOR; ENDOPLASMIC-RETICULUM; SELF-ASSOCIATION; CB1 RECEPTOR; LH RECEPTOR	Previous studies from our laboratory using co-immunoprecipitation techniques suggested that the human lutropin receptor (hLHR) constitutively self-associates into dimers/oligomers and that agonist treatment of cells either increased hLHR dimerization/oligomerization and/or stabilized hLHR dimers/ oligomers to detergent solubilization (Tao, Y.X., Johnson, N.B., and Segaloff, D.L. (2004) J.Biol. Chem. 279, 5904-5914). In this study, bioluminescence resonance energy transfer (BRET2) analyses confirmed that the hLHR constitutively self-associates in living cells. After subcellular fractionation, hLHR dimers/ oligomers were detected in both the plasma membrane and endoplasmic reticulum (ER). Further evidence supporting the constitutive formation of hLHR dimer/oligomers in the ER is provided by data showing homodimerization of misfolded hLHR mutants that are retained in the ER. These mutants, when co-expressed with wild-type receptor, are shown by BRET2 to heterodimerize, accounting for their dominant-negative effects on cell surface receptor expression. Hormone desorption assays using intact cells demonstrate allosterism between hLHR protomers, indicating functional cell surface hLHR dimers. However, quantitative BRET2 analyses in intact cells indicate a lack of effect of agonist on the propensity of the hLHR to dimerize. Using purified plasma membranes, human chorionic gonadotropin was similarly observed to have no effect on the BRET2 signal. An examination of the propensity for constitutively active and signaling inactive hLHR mutants to dimerize further showed no correlation between dimerization and the activation state of the hLHR. Taken altogether, our data suggest that hLHR dimers/ oligomers are formed early in the biosynthetic pathway in the ER, are constitutively expressed on the plasma membrane, and are not affected by the activation state of the hLHR.	[Guan, Rongbin; Feng, Xiuyan; Wu, Xueqing; Zhang, Meilin; Zhang, Xuesen; Segaloff, Deborah L.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Hebert, Terence E.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada	University of Iowa; McGill University	Segaloff, DL (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, 5-470 Bowen Sci Bldg, Iowa City, IA 52242 USA.	deborah-segaloff@uiowa.edu			National Institutes of Health [DK068614, HD22196]; Canadian Institutes of Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD022196] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD022196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK068614 and HD22196 (to D.L.S.). This work was also supported by grants from the Canadian Institutes of Health Research (to T.E.H.).	AbdAlla S, 1999, J BIOL CHEM, V274, P26079, DOI 10.1074/jbc.274.37.26079; AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; Angelova K, 2002, J BIOL CHEM, V277, P32202, DOI 10.1074/jbc.M203272200; ASCOLI M, 1978, P NATL ACAD SCI USA, V75, P99, DOI 10.1073/pnas.75.1.99; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Ascoli M, 2007, MOL CELL ENDOCRINOL, V260, P244, DOI 10.1016/j.mce.2005.09.016; Bai M, 2004, CELL SIGNAL, V16, P175, DOI 10.1016/S0898-6568(03)00128-1; Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; Bouvier M, 2007, NAT METHODS, V4, P3, DOI 10.1038/nmeth0107-3; Breit A, 2006, MOL PHARMACOL, V70, P686, DOI 10.1124/mol.106.022897; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Chidiac P, 1997, BIOCHEMISTRY-US, V36, P7361, DOI 10.1021/bi961939t; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; CRINE P, 1984, ANN NY ACAD SCI, V438, P224, DOI 10.1111/j.1749-6632.1984.tb38289.x; Dalrymple MB, 2008, PHARMACOL THERAPEUT, V118, P359, DOI 10.1016/j.pharmthera.2008.03.004; El-Asmar L, 2005, MOL PHARMACOL, V67, P460, DOI 10.1124/mol.104.003624; Ellis J, 2006, J BIOL CHEM, V281, P38812, DOI 10.1074/jbc.M602494200; Fabritz J, 1998, BIOCHEMISTRY-US, V37, P664, DOI 10.1021/bi972355+; Fanelli F, 2000, J MOL BIOL, V296, P1333, DOI 10.1006/jmbi.2000.3516; Fanelli F, 2004, MOL ENDOCRINOL, V18, P1499, DOI 10.1210/me.2003-0050; Fanelli F, 2001, IUBMB LIFE, V51, P149, DOI 10.1080/152165401753544214; Feng XY, 2008, ENDOCRINOLOGY, V149, P1705, DOI 10.1210/en.2007-1341; Gomes I, 2004, P NATL ACAD SCI USA, V101, P5135, DOI 10.1073/pnas.0307601101; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Hebert TE, 2006, CELL BIOCHEM BIOPHYS, V45, P85, DOI 10.1385/CBB:45:1:85; Herrick-Davis K, 2006, J BIOL CHEM, V281, P27109, DOI 10.1074/jbc.M604390200; Hilairet S, 2003, J BIOL CHEM, V278, P23731, DOI 10.1074/jbc.M212369200; Hirakawa T, 2003, ENDOCRINOLOGY, V144, P3872, DOI 10.1210/en.2003-0365; Horvat RD, 2001, MOL ENDOCRINOL, V15, P534, DOI 10.1210/me.15.4.534; Horvat RD, 2001, MOL ENDOCRINOL, V15, P695, DOI 10.1210/me.15.5.695; Hunzicker-Dunn M, 2003, J BIOL CHEM, V278, P42744, DOI 10.1074/jbc.M306133200; Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200; Jaquette J, 2002, MOL CELL ENDOCRINOL, V194, P211, DOI 10.1016/S0303-7207(02)00220-4; Jastrzebska B, 2006, J BIOL CHEM, V281, P11917, DOI 10.1074/jbc.M600422200; Ji IH, 2002, MOL ENDOCRINOL, V16, P1299, DOI 10.1210/me.16.6.1299; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kishi M, 2001, MOL ENDOCRINOL, V15, P1624, DOI 10.1210/me.15.9.1624; KREMER H, 1995, NAT GENET, V9, P160, DOI 10.1038/ng0295-160; Kroeger KM, 2001, J BIOL CHEM, V276, P12736, DOI 10.1074/jbc.M011311200; KUSUDA S, 1988, J BIOL CHEM, V263, P3046; Latif R, 2002, J BIOL CHEM, V277, P45059, DOI 10.1074/jbc.M206693200; Latronico AC, 1999, AM J HUM GENET, V65, P949, DOI 10.1086/302602; Latronico AC, 1996, NEW ENGL J MED, V334, P507, DOI 10.1056/NEJM199602223340805; Lee CW, 2002, J BIOL CHEM, V277, P15795, DOI 10.1074/jbc.M111818200; Lei Y, 2007, MOL CELL ENDOCRINOL, V260, P65, DOI 10.1016/j.mce.2005.11.046; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Milligan G, 2008, BRIT J PHARMACOL, V153, pS216, DOI 10.1038/sj.bjp.0707490; Milligan G, 2005, FEBS J, V272, P2914, DOI 10.1111/j.1742-4658.2005.04731.x; Milligan G, 2007, TRENDS PHARMACOL SCI, V28, P615, DOI 10.1016/j.tips.2007.11.001; Milligan G, 2007, BBA-BIOMEMBRANES, V1768, P825, DOI 10.1016/j.bbamem.2006.09.021; Mizrachi D, 2004, MOL ENDOCRINOL, V18, P1768, DOI 10.1210/me.2003-0406; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pidasheva S, 2006, HUM MOL GENET, V15, P2200, DOI 10.1093/hmg/ddl145; Rebois RV, 2006, J CELL SCI, V119, P2807, DOI 10.1242/jcs.03021; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; Rodriguez-Frade JM, 1999, P NATL ACAD SCI USA, V96, P3628, DOI 10.1073/pnas.96.7.3628; Roess DA, 2003, BIOL REPROD, V69, P1765, DOI 10.1095/biolreprod.103.018846; Roess DA, 2000, ENDOCRINOLOGY, V141, P4518, DOI 10.1210/en.141.12.4518; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; Springael JY, 2007, PHARMACOL THERAPEUT, V115, P410, DOI 10.1016/j.pharmthera.2007.06.004; Suzuki Y, 2004, J BIOL CHEM, V279, P35526, DOI 10.1074/jbc.M404831200; Tao YX, 2004, J BIOL CHEM, V279, P5904, DOI 10.1074/jbc.M311162200; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; Themmen APN, 2000, ENDOCR REV, V21, P551, DOI 10.1210/er.21.5.551; Thomas RM, 2007, ENDOCRINOLOGY, V148, P1987, DOI 10.1210/en.2006-1672; Toledo SPA, 1996, J CLIN ENDOCR METAB, V81, P3850, DOI 10.1210/jc.81.11.3850; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Vila-Coro AJ, 2000, P NATL ACAD SCI USA, V97, P3388, DOI 10.1073/pnas.050457797; Wilson S, 2005, J BIOL CHEM, V280, P28663, DOI 10.1074/jbc.M413475200; WONG HMS, 1986, BIOCHEMISTRY-US, V25, P6995, DOI 10.1021/bi00370a037; WREGGETT KA, 1995, J BIOL CHEM, V270, P22488, DOI 10.1074/jbc.270.38.22488; Zhang ML, 2007, J BIOL CHEM, V282, P25527, DOI 10.1074/jbc.M703500200; Zhang ML, 2005, J BIOL CHEM, V280, P26169, DOI 10.1074/jbc.M502102200; Zhou FG, 2006, CELL SIGNAL, V18, P318, DOI 10.1016/j.cellsig.2005.05.014	79	46	46	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7483	7494		10.1074/jbc.M809150200	http://dx.doi.org/10.1074/jbc.M809150200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19147490	Green Published, hybrid			2022-12-25	WOS:000264195600012
J	Miyagi, H; Kawai, S; Murata, K				Miyagi, Hikaru; Kawai, Shigeyuki; Murata, Kousaku			Two Sources of Mitochondrial NADPH in the Yeast Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOCITRATE DEHYDROGENASE; MOLECULAR-CLONING; STRUCTURAL GENE; KINASE; IDENTIFICATION; SEQUENCE; ACID; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; DISRUPTION; EXPRESSION	Cells of the yeast Saccharomyces cerevisiae contain three NAD kinases; namely, cytosolic Utr1p, cytosolic Yef1p, and mitochondrial Pos5p. Previously, the NADH kinase reaction catalyzed by Pos5p, rather than the NAD kinase reaction followed by the NADP(+)-dependent dehydrogenase reaction, had been regarded as a critical source of mitochondrial NADPH, which plays vital roles in various mitochondrial functions. This study demonstrates that the mitochondrial NADH kinase reaction is dispensable as a source of mitochondrial NADPH and emphasizes the importance of the NAD kinase reaction, followed by the mitochondrial NADP(+)-dependent dehydrogenase reaction. Of the potential dehydrogenases (malic enzyme, Mae1p; isocitrate dehydrogenase, Idp1p; and acetaldehyde dehydrogenases, Ald4/5p), evidence is presented that acetaldehyde dehydrogenases, and in particular Ald4p, play a prominent role in generating mitochondrial NADPH in the absence of the NADH kinase reaction. The physiological significance of the mitochondrial NADH kinase reaction in the absence of Ald4p is also demonstrated. In addition, Pos5p is confirmed to have a considerably higher NADH kinase activity than NAD kinase activity. Taking these results together, it is proposed that there are two sources of mitochondrial NADPH in yeast: one is the mitochondrial Pos5p NADH kinase reaction and the other is the mitochondrial Pos5p NAD kinase reaction followed by the mitochondrial NADP(+)-dependent acetaldehyde dehydrogenase reaction.	[Miyagi, Hikaru; Kawai, Shigeyuki; Murata, Kousaku] Kyoto Univ, Grad Sch Agr, Dept Basic & Appl Mol Biotechnol, Kyoto 6110011, Japan	Kyoto University	Murata, K (corresponding author), Kyoto Univ, Grad Sch Agr, Dept Basic & Appl Mol Biotechnol, Kyoto 6110011, Japan.	kmurata@kais.kyoto-u.ac.jp						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bieganowski P, 2006, J BIOL CHEM, V281, P22439, DOI 10.1074/jbc.M513919200; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Boles E, 1998, J BACTERIOL, V180, P2875, DOI 10.1128/JB.180.11.2875-2882.1998; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DAUM G, 1982, J BIOL CHEM, V257, P3028; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; EVANS TC, 1985, ARCH BIOCHEM BIOPHYS, V243, P492, DOI 10.1016/0003-9861(85)90526-0; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Grabowska D, 2003, J BIOL CHEM, V278, P13984, DOI 10.1074/jbc.M210076200; GUTHRIE C, 1991, GUIDE YEAST GENETICS, P3; HASELBECK RJ, 1991, J BIOL CHEM, V266, P2339; IWAHASHI Y, 1989, J BIOCHEM-TOKYO, V105, P588, DOI 10.1093/oxfordjournals.jbchem.a122709; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; Kawai S, 2001, EUR J BIOCHEM, V268, P4359, DOI 10.1046/j.1432-1327.2001.02358.x; Kawai S, 2001, FEMS MICROBIOL LETT, V200, P181, DOI 10.1111/j.1574-6968.2001.tb10712.x; Minard KI, 1998, J BIOL CHEM, V273, P31486, DOI 10.1074/jbc.273.47.31486; Minard KI, 2005, J BIOL CHEM, V280, P39890, DOI 10.1074/jbc.M509461200; Mori S, 2005, J BIOL CHEM, V280, P24104, DOI 10.1074/jbc.M502518200; NOLTMANN E, 1961, J BIOL CHEM, V236, P1225; Ochiai A, 2004, PROTEIN EXPRES PURIF, V36, P124, DOI 10.1016/j.pep.2004.03.012; Outten CE, 2005, BIOCHEM J, V388, P93, DOI 10.1042/BJ20041914; Outten CE, 2003, EMBO J, V22, P2015, DOI 10.1093/emboj/cdg211; Pollak N, 2007, J BIOL CHEM, V282, P33562, DOI 10.1074/jbc.M704442200; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Saint-Prix F, 2004, MICROBIOL-SGM, V150, P2209, DOI 10.1099/mic.0.26999-0; Shi F, 2005, FEBS J, V272, P3337, DOI 10.1111/j.1742-4658.2005.04749.x; Shianna KV, 2006, MITOCHONDRION, V6, P94, DOI 10.1016/j.mito.2006.02.003; SIKORSKI RS, 1989, GENETICS, V122, P19; Slekar KH, 1996, J BIOL CHEM, V271, P28831, DOI 10.1074/jbc.271.46.28831; Strand MK, 2003, EUKARYOT CELL, V2, P809, DOI 10.1128/EC.2.4.809-820.2003; THOMAS D, 1991, EMBO J, V10, P547, DOI 10.1002/j.1460-2075.1991.tb07981.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner WL, 2005, BIOCHEM J, V385, P217, DOI 10.1042/BJ20040292; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B	37	39	47	4	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7553	7560		10.1074/jbc.M804100200	http://dx.doi.org/10.1074/jbc.M804100200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19158096	Green Published, hybrid			2022-12-25	WOS:000264195600018
J	Kuzuhara, T; Kise, D; Yoshida, H; Horita, T; Murazaki, Y; Nishimura, A; Echigo, N; Utsunomiya, H; Tsuge, H				Kuzuhara, Takashi; Kise, Daisuke; Yoshida, Hiroko; Horita, Takahiro; Murazaki, Yoshimi; Nishimura, Akie; Echigo, Noriko; Utsunomiya, Hiroko; Tsuge, Hideaki			Structural Basis of the Influenza A Virus RNA Polymerase PB2 RNA-binding Domain Containing the Pathogenicity-determinant Lysine 627 Residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID; SUBUNIT; NUCLEOPROTEIN; OSELTAMIVIR; PROMOTER; PROGRAM; PROTEIN	Because the influenza A virus has an RNA genome, its RNA-dependent RNA polymerase, comprising the PA, PB1, and PB2 subunits, is essential for viral transcription and replication. The binding of RNAprimers/promoters to the polymerases is an initiation step in viral transcription. In our current study, we reveal the 2.7 A tertiary structure of the C-terminal RNA-binding domain of PB2 by x-ray crystallography. This domain incorporates lysine 627 of PB2, and this residue is associated with the high pathogenicity and host range restriction of influenza A virus. We found from our current analyses that this lysine is located in a unique "phi"-shaped structure consisting of a helix and an encircled loop within the PB2 domain. By electrostatic analysis, we identified a highly basic groove along with this phi loop and found that lysine 627 is located in the phi loop. A PB2 domain mutant in which glutamic acid is substituted at position 627 shows significantly lower RNA binding activity. This is the first report to show a relationship between RNA binding activity and the pathogenicity-determinant lysine 627. Using the Matras program for protein three-dimensional structural comparisons, we further found that the helix bundles in the PB2 domain are similar to that of activator 1, the 40-kDa subunit of DNA replication clamp loader (replication factor C), which is also an RNA-binding protein. This suggests a functional and structural relationship between the RNA-binding mechanisms underlying both influenza A viral transcription and cellular DNA replication. Our present results thus provide important new information for developing novel drugs that target the primer/promoter RNA binding of viral RNA polymerases.	[Kuzuhara, Takashi; Kise, Daisuke; Yoshida, Hiroko; Horita, Takahiro; Murazaki, Yoshimi; Nishimura, Akie; Echigo, Noriko] Tokushima Bunri Univ, Fac Pharmaceut Sci, Biochem Lab, Tokushima 7708514, Japan; [Utsunomiya, Hiroko; Tsuge, Hideaki] Tokushima Bunri Univ, Inst Hlth Sci, Tokushima 7708514, Japan	Tokushima Bunri University; Tokushima Bunri University	Kuzuhara, T (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Biochem Lab, Yamashiro Cho, Tokushima 7708514, Japan.	kuzuhara@ph.bunri-u.ac.jp; tsuge@tokushima.bunri-u.ac.jp	Tsuge, Hideaki/ABF-6424-2021	Kuzuhara, Takashi/0000-0003-0565-6060; Tsuge, Hideaki/0000-0003-0166-9163	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Crescenzo-Chaigne B, 2002, VIROLOGY, V303, P240, DOI 10.1006/viro.2002.1637; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Hendrickson WA, 1997, METHOD ENZYMOL, V276, P494, DOI 10.1016/S0076-6879(97)76074-9; Honda A, 1997, BIOL CHEM, V378, P483; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Izumi Y, 2007, NEUROSCI LETT, V426, P54, DOI 10.1016/j.neulet.2007.08.054; Jung TE, 2006, J GEN VIROL, V87, P679, DOI 10.1099/vir.0.81453-0; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Morse SS, 2007, NAT MED, V13, P681, DOI 10.1038/nm1597; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reece PA, 2007, J MED VIROL, V79, P1577, DOI 10.1002/jmv.20951; SHI LC, 1995, VIROLOGY, V208, P38, DOI 10.1006/viro.1995.1127; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Torreira E, 2007, NUCLEIC ACIDS RES, V35, P3774, DOI 10.1093/nar/gkm336; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379	33	77	83	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6855	6860		10.1074/jbc.C800224200	http://dx.doi.org/10.1074/jbc.C800224200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19144639	hybrid, Green Published			2022-12-25	WOS:000263919000032
J	Ortel, I; Keller, U				Ortel, Ingo; Keller, Ullrich			Combinatorial Assembly of Simple and Complex D-Lysergic Acid Alkaloid Peptide Classes in the Ergot Fungus Claviceps purpurea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-CLUSTER; ADENYLATION DOMAINS; CONDENSATION DOMAIN; LYS2 GENE; SYNTHETASE; BIOSYNTHESIS; ENDOPHYTE; SEQUENCE; EPIMERIZATION; ERGOVALINE	The ergot fungus Claviceps purpurea produces both ergopeptines and simple D-lysergic acid alkylamides. In the ergopeptines, such as ergotamine, D-lysergic acid is linked to a bicyclic tripeptide in amide-like fashion, whereas in the D-lysergylalkanolamides it is linked to an amino alcohol derived from alanine. We show here that these compound classes are synthesized by a set of three non-ribosomal lysergyl peptide synthetases (LPSs), which interact in a combinatorial fashion for synthesis of the relevant product. The trimodular LPS1 assembles with LPS2, the D-lysergic acid recruiting module, to synthesize the D-lysergyltripeptide precursors of ergopeptines from D-lysergic acid and the three amino acids of the peptide chain. Alternatively, LPS2 can assemble with a distinct monomodular non-ribosomal peptide synthetase (NRPS) subunit (ergometrine synthetase) to synthesize the D-lysergic acid alkanolamide ergometrine from D-lysergic acid and alanine. The synthesis proceeds via covalently bound D-lysergyl alanine and release of dipeptide as alcohol with consumption of NADPH. Enzymatic and immunochemical analyses showed that ergometrine synthetase is most probably the enzyme LPS3 whose gene had been identified previously as part of the ergot alkaloid biosynthesis gene cluster in C. purpurea. Inspections of all LPS sequences showed no recognizable peptide linkers for their protein-protein interactions as in NRPS subunits of bacteria. Instead, they all carry conserved N-terminal domains (C0-domains) with similarity to the C-terminal halves of NRPS condensation domains pointing to an alternative mechanism of subunit-subunit interactions in fungal NRPS systems. Phylogenetic analysis of LPS modules and the C0-domains suggests that these enzyme systems most probably evolved by module duplications and rearrangements from a bimodular ancestor.	[Ortel, Ingo; Keller, Ullrich] Tech Univ Berlin, Inst Chem, Arbeitsgrp Biochem & Mol Biol, D-10587 Berlin, Germany	Technical University of Berlin	Keller, U (corresponding author), Tech Univ Berlin, Inst Chem, Arbeitsgrp Biochem & Mol Biol, Franklinstr 29, D-10587 Berlin, Germany.	ullrich.keller@tu-berlin.de			Deutsche Forschungsgemeinschaft SPP 1152 [Ke 452/11-4]	Deutsche Forschungsgemeinschaft SPP 1152(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft SPP 1152 ( Grant Ke 452/11-4).	AGURELL S, 1966, ACTA PHARM SUEC, V3, P71; BASMADJIAN GP, 1969, CHEM COMMUN, V1, P418; Berde B., 1978, INTRO PHARM ERGOT AL, P1, DOI 10.1007/978-3-642-66775-6_1; Bergendahl V, 2002, EUR J BIOCHEM, V269, P620, DOI 10.1046/j.0014-2956.2001.02691.x; Burkhalter A, 1998, BASIC CLIN PHARM, P261; Casqueiro J, 1998, MOL GEN GENET, V259, P549, DOI 10.1007/s004380050847; CASTAGNO.N, 1970, BIOCHEM J, V117, P451, DOI 10.1042/bj1170451; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Correia T, 2003, CHEM BIOL, V10, P1281, DOI 10.1016/j.chembiol.2003.11.013; Damrongkool P, 2005, DNA SEQUENCE, V16, P379, DOI 10.1080/10425170500273005; De Costa C, 2002, LANCET, V359, P1768, DOI 10.1016/S0140-6736(02)08658-0; Duitman EH, 1999, P NATL ACAD SCI USA, V96, P13294, DOI 10.1073/pnas.96.23.13294; Fedorov A, 2002, P NATL ACAD SCI USA, V99, P16128, DOI 10.1073/pnas.242624899; Fleetwood DJ, 2007, APPL ENVIRON MICROB, V73, P2571, DOI 10.1128/AEM.00257-07; Flieger M, 1997, FOLIA MICROBIOL, V42, P3, DOI 10.1007/BF02898641; Gaitatzis N, 2001, P NATL ACAD SCI USA, V98, P11136, DOI 10.1073/pnas.201167098; Gokhale RS, 2000, CURR OPIN CHEM BIOL, V4, P22, DOI 10.1016/S1367-5931(99)00046-0; Haarmann T, 2005, PHYTOCHEMISTRY, V66, P1312, DOI 10.1016/j.phytochem.2005.04.011; Haarmann T, 2006, CHEMBIOCHEM, V7, P645, DOI 10.1002/cbic.200500487; Hahn M, 2004, P NATL ACAD SCI USA, V101, P15585, DOI 10.1073/pnas.0404932101; Hillson NJ, 2004, BIOCHEMISTRY-US, V43, P11344, DOI 10.1021/bi0489199; HOFMANN A, 1964, MUTTERKORNALKALOIDE; Hornbogen T, 2005, MYCOLOGY S, V22, P449; Keating TA, 2002, NAT STRUCT BIOL, V9, P522, DOI 10.1038/nsb810; KELLER U, 1988, BIOCHEMISTRY-US, V27, P6164, DOI 10.1021/bi00416a051; KELLER U, 1982, APPL ENVIRON MICROB, V46, P580; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Klotz JL, 2006, J ANIM SCI, V84, P3167, DOI 10.2527/jas.2006-038; Kobel H, 1986, BIOTECHNOLOGY, P569, DOI Weinheim; Linne U, 2000, BIOCHEMISTRY-US, V39, P10439, DOI 10.1021/bi000768w; MORRIS ME, 1991, GENE, V98, P141, DOI 10.1016/0378-1119(91)90117-T; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Panaccione DG, 2003, J AGR FOOD CHEM, V51, P6429, DOI 10.1021/jf0346859; Panaccione DG, 2001, P NATL ACAD SCI USA, V98, P12820, DOI 10.1073/pnas.221198698; POSPIECH A, 1995, MICROBIOL-SGM, V141, P1793, DOI 10.1099/13500872-141-8-1793; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Riederer B, 1996, J BIOL CHEM, V271, P27524, DOI 10.1074/jbc.271.44.27524; Samel SA, 2007, STRUCTURE, V15, P781, DOI 10.1016/j.str.2007.05.008; Sieber SA, 2005, CHEM REV, V105, P715, DOI 10.1021/cr0301191; Stadler P. A., 1984, NATURAL PRODUCTS DRU, P463; STADLER PA, 1982, PLANTA MED, V46, P131, DOI 10.1055/s-2007-970038; Tanaka A, 2005, MOL MICROBIOL, V57, P1036, DOI 10.1111/j.1365-2958.2005.04747.x; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tudzynski P, 1999, MOL GEN GENET, V261, P133, DOI 10.1007/s004380050950; Walzel B, 1997, CHEM BIOL, V4, P223, DOI 10.1016/S1074-5521(97)90292-1; WALZEL B, 1997, THESIS TU BERLIN GER	47	41	56	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6650	6660		10.1074/jbc.M807168200	http://dx.doi.org/10.1074/jbc.M807168200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19139103	hybrid, Green Published			2022-12-25	WOS:000263919000009
J	Uesugi, K; Oinuma, I; Katoh, H; Negishi, M				Uesugi, Kanami; Oinuma, Izumi; Katoh, Hironori; Negishi, Manabu			Different Requirement for Rnd GTPases of R-Ras GAP Activity of Plexin-C1 and Plexin-D1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-FAMILY; ACTIVATING PROTEIN; AXONAL REPULSION; RECEPTOR; GROWTH; NEURONS; CELLS; EFFECTOR; COLLAPSE; ADHESION	Plexins, comprising Plexin-A, -B, -C, and -D subfamilies, are receptors for semaphorins governing cell adhesion, migration, and axon guidance. Among plexin subfamilies, Plexin-A1 and Plexin-B1 have been shown to function as an R-Ras GAP, inducing repulsive responses, and the expression of R-Ras GAP activity requires the binding of Rnd1, a member of Rnd subfamily of Rho GTPases. However, signaling pathways of Plexin-D1 and Plexin-C1 still remain obscure. Here, we found that Plexin-D1 displayed R-Ras GAP activity and inhibited migration of COS-7 cells, and these actions required Rnd2, another Rnd subfamily GTPase. Rnd2 bound to Plexin-D1 in cortical neurons, and Sema3E/Plexin-D1-induced inhibition of axon outgrowth of cortical neurons required Rnd2 and down-regulation of R-Ras activity. On the other hand, Plexin-C1 displayed R-Ras GAP activity and inhibited cell migration of COS-7 cells without Rnd proteins. Therefore, R-Ras GAP activity is a common function of plexin subfamilies but the regulation of R-Ras GAP activity of plexins by Rnd proteins is different among plexin subfamilies.	[Uesugi, Kanami; Oinuma, Izumi; Katoh, Hironori; Negishi, Manabu] Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Negishi, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068501, Japan.	mnegishi@pharm.kyoto-u.ac.jp		Katoh, Hironori/0000-0002-8191-8117	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan.	Aoki J, 2000, BIOCHEM BIOPH RES CO, V278, P604, DOI 10.1006/bbrc.2000.3842; Barberis D, 2004, FASEB J, V18, P592, DOI 10.1096/fj.03-0957fje; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Chauvet S, 2007, NEURON, V56, P807, DOI 10.1016/j.neuron.2007.10.019; Christensen CRL, 1998, CANCER RES, V58, P1238; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; Decourt B, 2005, DEV BRAIN RES, V159, P36, DOI 10.1016/j.devbrainres.2005.06.013; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fujita H, 2002, J BIOL CHEM, V277, P45428, DOI 10.1074/jbc.M208090200; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Holmes S, 2002, SCAND J IMMUNOL, V56, P270, DOI 10.1046/j.1365-3083.2002.01129.x; Ito Y, 2006, EMBO REP, V7, P704, DOI 10.1038/sj.embor.7400737; Katoh H, 2002, MOL CELL BIOL, V22, P2952, DOI 10.1128/MCB.22.9.2952-2964.2002; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kumanogoh A, 2003, J CELL SCI, V116, P3463, DOI 10.1242/jcs.00674; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Nakamura K, 2006, NEUROSCI RES, V54, P149, DOI 10.1016/j.neures.2005.10.008; Negishi M, 2002, J BIOCHEM, V132, P157, DOI 10.1093/oxfordjournals.jbchem.a003205; Nishi M, 1999, MOL BRAIN RES, V67, P74, DOI 10.1016/S0169-328X(99)00039-X; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Oinuma I, 2003, J BIOL CHEM, V278, P25671, DOI 10.1074/jbc.M303047200; Oinuma I, 2006, J CELL BIOL, V173, P601, DOI 10.1083/jcb.200508204; Rohm B, 2000, FEBS LETT, V486, P68, DOI 10.1016/S0014-5793(00)02240-7; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tanaka H, 2006, J BIOL CHEM, V281, P10355, DOI 10.1074/jbc.M511314200; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Toyofuku T, 2005, NAT NEUROSCI, V8, P1712, DOI 10.1038/nn1596; Van Der Zwaag B, 2002, DEV DYNAM, V225, P336, DOI 10.1002/dvdy.10159; Walzer T, 2005, J IMMUNOL, V174, P51, DOI 10.4049/jimmunol.174.1.51; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Zanata SM, 2002, J NEUROSCI, V22, P471, DOI 10.1523/JNEUROSCI.22-02-00471.2002	38	70	70	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6743	6751		10.1074/jbc.M805213200	http://dx.doi.org/10.1074/jbc.M805213200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19136556	Green Published, hybrid			2022-12-25	WOS:000263919000019
J	Sherrer, SM; Brown, JA; Pack, LR; Jasti, VP; Fowler, JD; Basu, AK; Suo, ZC				Sherrer, Shanen M.; Brown, Jessica A.; Pack, Lindsey R.; Jasti, Vijay P.; Fowler, Jason D.; Basu, Ashis K.; Suo, Zucai			Mechanistic Studies of the Bypass of a Bulky Single-base Lesion Catalyzed by a Y-family DNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYN THYMINE DIMER; ERROR-FREE BYPASS; ABASIC LESION; STEADY-STATE; CRYSTAL-STRUCTURE; ADDUCT STRUCTURE; FIDELITY; DPO4; REPLICATION; 1-NITROPYRENE	1-Nitropyrene, the most abundant nitro polycyclic aromatic hydrocarbon in diesel emissions, has been found to react with DNA to form predominantly N-(deoxyguanosin-8-yl)-1-aminopyrene (dG(AP)). This bulky adduct has been shown to induce genetic mutations, which may implicate Y-family DNA polymerases in its bypass in vivo. To establish a kinetic mechanism for the bypass of such a prototype single-base lesion, we employed pre-steady-state kinetic methods to investigate individual nucleotide incorporations upstream, opposite, and downstream from a site-specifically placed dGAP lesion catalyzed by Sulfolobus solfataricus DNA polymerase IV (Dpo4), a model Y-family DNA polymerase. Dpo4 was able to bypassd G(AP) but paused strongly at two sites: opposite the lesion and immediately downstream from the lesion. Both nucleotide incorporation efficiency and fidelity decreased significantly at the pause sites, especially during extension of the bypass product. Interestingly, a 4-fold tighter binding affinity of damaged DNA to Dpo4 promoted catalysis through putative interactions between the active site residues of Dpo4 and 1-aminopyrene moiety at the first pause site. In the presence of a DNA trap, the kinetics of nucleotide incorporation at these sites was biphasic in which a small, fast phase preceded a larger, slow phase. In contrast, only a large, fast phase was observed during nucleotide incorporation at non-pause sites. Our kinetic studies support a general kinetic mechanism for lesion bypass catalyzed by numerous DNA polymerases.	[Sherrer, Shanen M.; Brown, Jessica A.; Pack, Lindsey R.; Fowler, Jason D.; Suo, Zucai] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; [Sherrer, Shanen M.; Brown, Jessica A.; Fowler, Jason D.; Suo, Zucai] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Suo, Zucai] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; [Suo, Zucai] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Jasti, Vijay P.; Basu, Ashis K.] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA; [Suo, Zucai] Ohio State Univ, Ohio State Biophys Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Connecticut; University System of Ohio; Ohio State University	Suo, ZC (corresponding author), 740 Biol Sci,484 West 12th Ave, Columbus, OH 43210 USA.	suo.3@osu.edu	Brown, Jessica/E-2172-2017	Sherrer, Shanen/0000-0002-3269-3134	National Science Foundation Career Award [MCB-0447889]; National Institutes of Health [ES-09127]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009127, R56ES009127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008512] Funding Source: NIH RePORTER	National Science Foundation Career Award(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Science Foundation Career Award Grant MCB-0447889 (to Z.S.). This work was also supported by National Institutes of Health Grant ES-09127 (to A.K.B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Bauer J, 2007, P NATL ACAD SCI USA, V104, P14905, DOI 10.1073/pnas.0700717104; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Brown JA, 2008, NUCLEIC ACIDS RES, V36, P3867, DOI 10.1093/nar/gkn309; Broyde S, 2008, CHEM RES TOXICOL, V21, P45, DOI 10.1021/tx700193x; Chang KL, 1996, CHINESE J PHYS, V34, P1; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; Choi JY, 2004, J BIOL CHEM, V279, P19217, DOI 10.1074/jbc.M313759200; Duvauchelle JB, 2002, NUCLEIC ACIDS RES, V30, P2061, DOI 10.1093/nar/30.9.2061; Einolf HJ, 2001, J BIOL CHEM, V276, P3764, DOI 10.1074/jbc.M006696200; ELBAYOUMY K, 1984, CARCINOGENESIS, V5, P1449, DOI 10.1093/carcin/5.11.1449; Eoff RL, 2007, J BIOL CHEM, V282, P13573, DOI 10.1074/jbc.M700656200; Eoff RL, 2007, J BIOL CHEM, V282, P1456, DOI 10.1074/jbc.M609661200; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2116, DOI 10.1021/bi035746z; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2106, DOI 10.1021/bi0357457; Fiala KA, 2008, NUCLEIC ACIDS RES, V36, P1990, DOI 10.1093/nar/gkn004; Fiala KA, 2007, J BIOL CHEM, V282, P8199, DOI 10.1074/jbc.M610719200; Fiala KA, 2007, J BIOL CHEM, V282, P8188, DOI 10.1074/jbc.M610718200; Fiala KA, 2007, J MOL BIOL, V365, P590, DOI 10.1016/j.jmb.2006.10.008; Fowler JD, 2006, CHEM REV, V106, P2092, DOI 10.1021/cr040445w; Freisinger E, 2004, EMBO J, V23, P1494, DOI 10.1038/sj.emboj.7600158; Gu ZT, 1999, BIOCHEMISTRY-US, V38, P10843, DOI 10.1021/bi9912138; Hatanaka N, 2001, MUTAT RES-GEN TOX EN, V497, P223, DOI 10.1016/S1383-5718(01)00254-6; HIROSE M, 1984, CANCER RES, V44, P1158; Hogg M, 2004, EMBO J, V23, P1483, DOI 10.1038/sj.emboj.7600150; Johnson RE, 2005, P NATL ACAD SCI USA, V102, P12359, DOI 10.1073/pnas.0504380102; Kokoska RJ, 2003, J BIOL CHEM, V278, P50537, DOI 10.1074/jbc.M308515200; Kokoska RJ, 2002, J BIOL CHEM, V277, P19633, DOI 10.1074/jbc.M202021200; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Levine RL, 2001, J BIOL CHEM, V276, P18717, DOI 10.1074/jbc.M102158200; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Ling H, 2004, P NATL ACAD SCI USA, V101, P2265, DOI 10.1073/pnas.0308332100; Ling H, 2003, NATURE, V424, P1083, DOI 10.1038/nature01919; Liu YY, 2005, BIOCHEM J, V385, P519, DOI 10.1042/BJ20041151; MALIA SA, 1995, BIOCHEMISTRY-US, V34, P96, DOI 10.1021/bi00001a012; Malia SA, 1996, BIOCHEMISTRY-US, V35, P4568, DOI 10.1021/bi9525132; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Miller H, 1997, BIOCHEMISTRY-US, V36, P15336, DOI 10.1021/bi971927n; Mitchelmore CL, 1998, BIOMARKERS, V3, P21, DOI 10.1080/135475098231345; Mizukami S, 2006, BIOCHEMISTRY-US, V45, P2772, DOI 10.1021/bi051961z; Nolan SJ, 1996, CARCINOGENESIS, V17, P133, DOI 10.1093/carcin/17.1.133; Ohashi E, 2000, J BIOL CHEM, V275, P39678, DOI 10.1074/jbc.M005309200; Pohjola SK, 2004, POLYCYCL AROMAT COMP, V24, P451, DOI 10.1080/10406630490471465; Pohjola SK, 2003, MUTAGENESIS, V18, P429, DOI 10.1093/mutage/geg021; RAFII F, 1991, APPL ENVIRON MICROB, V57, P962, DOI 10.1128/AEM.57.4.962-968.1991; Rechkoblit O, 2006, PLOS BIOL, V4, P25, DOI 10.1371/journal.pbio.0040011; Sabbioni G, 2002, BIOMARKERS, V7, P347, DOI 10.1080/13547500210147253; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; Suo ZC, 1999, BIOCHEMISTRY-US, V38, P715, DOI 10.1021/bi981854n; Wang LH, 2006, NUCLEIC ACIDS RES, V34, P785, DOI 10.1093/nar/gkj479; Watt DL, 2007, CHEM RES TOXICOL, V20, P1658, DOI 10.1021/tx700131e; Wong JH, 2008, J MOL BIOL, V379, P317, DOI 10.1016/j.jmb.2008.03.038; Woodside AM, 2002, BIOCHEMISTRY-US, V41, P1039, DOI 10.1021/bi011496f; WOOSTER R, 1994, NAT GENET, V6, P152, DOI 10.1038/ng0294-152; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zang H, 2006, CHEM RES TOXICOL, V19, P859, DOI 10.1021/tx060056s; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4147, DOI 10.1093/nar/28.21.4147; Zou Y, 2003, BIOCHEMISTRY-US, V42, P12654, DOI 10.1021/bi034446e	60	31	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6379	6388		10.1074/jbc.M808161200	http://dx.doi.org/10.1074/jbc.M808161200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19124465	hybrid, Green Published			2022-12-25	WOS:000263742700041
J	Parker, SK; Barkley, RM; Rino, JG; Vasil, ML				Parker, Sarah K.; Barkley, Robert M.; Rino, John G.; Vasil, Michael L.			Mycobacterium tuberculosis Rv3802c Encodes a Phospholipase/Thioesterase and Is Inhibited by the Antimycobacterial Agent Tetrahydrolipstatin	PLOS ONE			English	Article								The cell wall of M. tuberculosis is central to its success as a pathogen. Mycolic acids are key components of this cell wall. The genes involved in joining the a and mero mycolates are located in a cluster, beginning with Rv3799c and extending at least until Rv3804c. The role of each enzyme encoded by these five genes is fairly well understood, except for Rv3802c. Rv3802 is one of seven putative cutinases encoded by the genome of M. tuberculosis. In phytopathogens, cutinases hydrolyze the waxy layer of plants, cutin. In a strictly mammalian pathogen, such as M. tuberculosis, it is likely that these proteins perform a different function. Of the seven, we chose to focus on Rv3802c because of its location in a mycolic acid synthesis gene cluster, its putative essentiality, its ubiquitous presence in actinomycetes, and its conservation in the minimal genome of Mycobacterium leprae. We expressed Rv3802 in Escherichia coli and purified the enzymatically active form. We probed its activities and inhibitors characterizing those relevant to its possible role in mycolic acid biosynthesis. In addition to its reported phospholipase A activity, Rv3802 has significant thioesterase activity, and it is inhibited by tetrahydrolipstatin (THL). THL is a described anti-tuberculous compound with an unknown mechanism, but it reportedly targets cell wall synthesis. Taken together, these data circumstantially support a role for Rv3802 in mycolic acid synthesis and, as the cell wall is integral to M. tuberculosis pathogenesis, identification of a novel cell wall enzyme and its inhibition has therapeutic and diagnostic implications.	[Rino, John G.] Univ Colorado Denver, Dept Pediat, Aurora, CO USA; [Vasil, Michael L.] Univ Colorado Denver, Dept Microbiol, Aurora, CO USA; [Barkley, Robert M.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Parker, SK (corresponding author), Univ Colorado Denver, Dept Pediat, Aurora, CO USA.	sarah.parker@ucdenver.edu			National Institute of Allergy and Infectious Diseases [K08 AI050646]; Potts Foundation; The Children's Hospital Research Institute; American Lung Foundation; National Heart, Lung and Blood Institute [HL062608]; LIPID MAPS; National Institutes of Health [GM-069338]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI050646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Potts Foundation; The Children's Hospital Research Institute; American Lung Foundation; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); LIPID MAPS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant (K08 AI050646) from National Institute of Allergy and Infectious Diseases, a grant from the Potts Foundation, a grant from The Children's Hospital Research Institute and a grant from the American Lung Foundation to Sarah K. Parker, and by a grant (HL062608) from the National Heart, Lung and Blood Institute to Michael L. Vasil. The contribution of Robert M. Barkley was supported by LIPID MAPS, a Large-Scale Collabrative Grant from the National Institutes of Health (Grant GM-069338). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry CE, 2001, TRENDS MICROBIOL, V9, P237, DOI 10.1016/S0966-842X(01)02018-2; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; BESRA GS, 1994, P NATL ACAD SCI USA, V91, P12735, DOI 10.1073/pnas.91.26.12735; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Browne CD, 2006, FASEB J, V20, P2027, DOI 10.1096/fj.05-5404com; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Cotes K, 2007, BIOCHEM J, V408, P417, DOI 10.1042/BJ20070745; Deems RA, 2000, ANAL BIOCHEM, V287, P1, DOI 10.1006/abio.2000.4766; Devedjiev Y, 2000, STRUCTURE, V8, P1137, DOI 10.1016/S0969-2126(00)00529-3; Egmond MR, 2000, BIOCHIMIE, V82, P1015, DOI 10.1016/S0300-9084(00)01183-4; Etienne G, 2005, MICROBIOL-SGM, V151, P2075, DOI 10.1099/mic.0.27869-0; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gilleron M, 2006, ANAL CHEM, V78, P8543, DOI 10.1021/ac061574a; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; Jackson M, 1999, MOL MICROBIOL, V31, P1573, DOI 10.1046/j.1365-2958.1999.01310.x; Keating TA, 1999, CURR OPIN CHEM BIOL, V3, P598, DOI 10.1016/S1367-5931(99)00015-0; Koglin A, 2006, SCIENCE, V312, P273, DOI 10.1126/science.1122928; Koglin A, 2008, NATURE, V454, P907, DOI 10.1038/nature07161; Kremer L, 2005, MOL MICROBIOL, V57, P1113, DOI 10.1111/j.1365-2958.2005.04717.x; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; KURIOKA S, 1976, ANAL BIOCHEM, V75, P281, DOI 10.1016/0003-2697(76)90078-6; Kusner DJ, 2005, CLIN IMMUNOL, V114, P239, DOI 10.1016/j.clim.2004.07.016; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lea-Smith DJ, 2007, J BIOL CHEM, V282, P11000, DOI 10.1074/jbc.M608686200; Linne U, 2004, EUR J BIOCHEM, V271, P1536, DOI 10.1111/j.1432-1033.2004.04063.x; MARTINEZ C, 1994, BIOCHEMISTRY-US, V33, P83, DOI 10.1021/bi00167a011; Mattow J, 2007, PROTEOMICS, V7, P1687, DOI 10.1002/pmic.200600928; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Parker SK, 2007, J BACTERIOL, V189, P4153, DOI 10.1128/JB.01909-06; Pemble CW, 2007, NAT STRUCT MOL BIOL, V14, P704, DOI 10.1038/nsmb1265; Portevin D, 2005, J BIOL CHEM, V280, P8862, DOI 10.1074/jbc.M408578200; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Richardson RD, 2008, J MED CHEM, V51, P5285, DOI 10.1021/jm800321h; Richardson RD, 2007, MOL CANCER THER, V6, P2120, DOI 10.1158/1535-7163.MCT-07-0187; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schwarzer D, 2002, P NATL ACAD SCI USA, V99, P14083, DOI 10.1073/pnas.212382199; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; VISSA VD, 2001, GENOME BIOL, V2; West NP, 2008, VACCINE, V26, P3853, DOI 10.1016/j.vaccine.2008.05.007; WHEELER PR, 1988, J GEN MICROBIOL, V134, P2111; WHEELER PR, 1993, BIOCHIM BIOPHYS ACTA, V1167, P182, DOI 10.1016/0005-2760(93)90160-B; *WHO, 2006, 104 WHO; Zhang W, 2008, BIOORG MED CHEM LETT, V18, P2491, DOI 10.1016/j.bmcl.2008.02.043	45	51	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2009	4	1							e4281	10.1371/journal.pone.0004281	http://dx.doi.org/10.1371/journal.pone.0004281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JE	19169353	Green Published, gold, Green Submitted			2022-12-25	WOS:000265482800011
J	Bjorklund, P; Svedlund, J; Olsson, AK; Akerstrom, G; Westin, G				Bjoerklund, Peyman; Svedlund, Jessica; Olsson, Anna-Karin; Akerstroem, Goeran; Westin, Gunnar			The Internally Truncated LRP5 Receptor Presents a Therapeutic Target in Breast Cancer	PLOS ONE			English	Article								Background: Breast cancer is a common malignant disease, which may be caused by a number of genes deregulated by genomic or epigenomic events. Deregulated WNT/beta-catenin signaling with accumulation of beta-catenin is common in breast tumors, but mutations in WNT signaling pathway components have been rare. An aberrantly spliced internally truncated LRP5 receptor (LRP5 Delta 666-809, LRP5 Delta) was shown recently to be resistant to DKK1 inhibition, and was required for beta-catenin accumulation in hyperparathyroid tumors and parathyroid tumor growth. Methodology/Principal Findings: Here we show, by reverse transcription PCR and Western blot analysis, that LRP5D is frequently expressed in breast tumors of different cancer stage (58-100%), including carcinoma in situ and metastatic carcinoma. LRP5 Delta was required in MCF7 breast cancer cells for the non-phosphorylated active beta-catenin level, transcription activity of beta-catenin, cell growth in vitro, and breast tumor growth in a xenograft SCID mouse model. WNT3 ligand, but not WNT1 and WNT3A augmented the endogenous beta-catenin activity of MCF7 cells in a DKK1-insensitive manner. Furthermore, an anti-LRP5 antibody attenuated beta-catenin activity, inhibited cell growth, and induced apoptosis in LRP5 Delta-positive MCF7 and T-47D breast cancer cells, but not in control cells. Conclusions/Significance: Our results suggest that the LRP5 Delta receptor is strongly implicated in mammary gland tumorigenesis and that its aberrant expression present an early event during disease progression. LRP5 antibody therapy may have a significant role in the treatment of breast cancer.	[Bjoerklund, Peyman; Svedlund, Jessica; Akerstroem, Goeran; Westin, Gunnar] Uppsala Univ, Univ Uppsala Hosp, Endocrine Unit, Dept Surg Sci, Uppsala, Sweden; [Olsson, Anna-Karin] Uppsala Univ, Uppsala Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden	Uppsala University; Uppsala University Hospital; Uppsala University	Bjorklund, P (corresponding author), Uppsala Univ, Univ Uppsala Hosp, Endocrine Unit, Dept Surg Sci, Uppsala, Sweden.	gunnar.westin@surgsci.uu.se	Björklund, Peyman/A-1509-2014	Björklund, Peyman/0000-0002-9398-4496	Swedish Research Council; Swedish Cancer Society; Lions Fund for Cancer Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Lions Fund for Cancer Research	This work was supported by the Swedish Research Council, Swedish Cancer Society, and Lions Fund for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish or the preparation of the manuscript.	Ai LB, 2006, CARCINOGENESIS, V27, P1341, DOI 10.1093/carcin/bgi379; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; [Anonymous], 1988, LAB ANIM-UK, V22, P195; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Benhaj K, 2006, ONCOL REP, V15, P701; Bjorklund P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-53; Bjorklund P, 2007, PLOS MED, V4, P1829, DOI 10.1371/journal.pmed.0040328; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Candidus S, 1996, CANCER RES, V56, P49; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Chung GG, 2004, CANCER, V100, P2084, DOI 10.1002/cncr.20232; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Fuerer C, 2008, EMBO REP, V9, P134, DOI 10.1038/sj.embor.7401159; Gebeshuber CA, 2007, CELLS TISSUES ORGANS, V185, P51, DOI 10.1159/000101303; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Lindvall C, 2007, STEM CELL REV, V3, P157, DOI 10.1007/s12015-007-0025-3; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nakopoulou L, 2006, MODERN PATHOL, V19, P556, DOI 10.1038/modpathol.3800562; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Pfeiffer P, 2007, ONCOGENE, V26, P3661, DOI 10.1038/sj.onc.1210377; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Prasad CP, 2007, ONCOLOGY-BASEL, V73, P112, DOI 10.1159/000120999; ROELINK H, 1992, ONCOGENE, V7, P487; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Segersten U, 2005, BREAST CANCER RES, V7, pR980, DOI 10.1186/bcr1332; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Shekhar MPV, 2008, CANCER RES, V68, P1741, DOI 10.1158/0008-5472.CAN-07-2111; Shekhar MPV, 2006, MOL CANCER RES, V4, P729, DOI 10.1158/1541-7786.MCR-06-0136; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Turashvili G, 2006, PATHOBIOLOGY, V73, P213, DOI 10.1159/000098207; van de Wetering M, 2001, CANCER RES, V61, P278; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Veeck J, 2006, ONCOGENE, V25, P3479, DOI 10.1038/sj.onc.1209386; Zafir-Lavie I, 2007, ONCOGENE, V26, P3714, DOI 10.1038/sj.onc.1210372; Zhang YH, 2004, MOL CELL BIOL, V24, P4677, DOI 10.1128/MCB.24.11.4677-4684.2004	43	52	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2009	4	1							e4243	10.1371/journal.pone.0004243	http://dx.doi.org/10.1371/journal.pone.0004243			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JC	19158955	gold, Green Published			2022-12-25	WOS:000265482200001
J	Willemse, J; van Wezel, GP				Willemse, Joost; van Wezel, Gilles P.			Imaging of Streptomyces coelicolor A3(2) with Reduced Autofluorescence Reveals a Novel Stage of FtsZ Localization	PLOS ONE			English	Article								Imaging of low abundance proteins in time and space by fluorescence microscopy is typically hampered by host-cell autofluorescence. Streptomycetes are an important model system for the study of bacterial development, and undergo multiple synchronous cell division during the sporulation stage. To analyse this phenomenon in detail, fluorescence microscopy, and in particular also the recently published novel live imaging techniques, require optimal signal to noise ratios. Here we describe the development of a novel derivative of Streptomyces coelicolor A3(2) with strongly reduced autofluorescence, allowing the imaging of fluorescently labelled proteins at significantly higher resolution. The enhanced image detail provided novel localization information for the cell division protein FtsZ, demonstrating a new developmental stage where multiple FtsZ foci accumulate at the septal plane. This suggests that multiple foci are sequentially produced, ultimately connecting to form the complete Z ring. The enhanced imaging properties are an important step forward for the confocal and live imaging of less abundant proteins and for the use of lower intensity fluorophores in streptomycetes.	[Willemse, Joost; van Wezel, Gilles P.] Leiden Univ, Leiden Inst Chem, Dept Mol Genet, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Willemse, J (corresponding author), Leiden Univ, Leiden Inst Chem, Dept Mol Genet, NL-2300 RA Leiden, Netherlands.	g.wezel@chem.leidenuniv.nl	Willemse, Joost/B-1861-2008; van Wezel, Gilles/ABC-7854-2021	Willemse, Joost/0000-0001-9312-6021; van Wezel, Gilles/0000-0003-0341-1561	Dutch government (Netherlands Organization for scientific research NWO) [ECHO]	Dutch government (Netherlands Organization for scientific research NWO)(Netherlands Organization for Scientific Research (NWO))	Joost Willemse is supported by an ECHO grant from the Dutch government (Netherlands Organization for scientific research NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; Chater KF, 2001, CURR OPIN MICROBIOL, V4, P667, DOI 10.1016/S1369-5274(01)00267-3; CHATER KF, 1997, MYCELIAL LIFE STYLE, P149; Claessen D, 2006, TRENDS MICROBIOL, V14, P313, DOI 10.1016/j.tim.2006.05.008; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Grantcharova N, 2003, MOL MICROBIOL, V47, P645, DOI 10.1046/j.1365-2958.2003.03334.x; Heintzmann Rainer, 2006, Briefings in Functional Genomics & Proteomics, V5, P289, DOI 10.1093/bfgp/ell036; Houtsmuller AB, 1999, SCIENCE, V284, P958, DOI 10.1126/science.284.5416.958; Jakimowicz D, 2007, MOL MICROBIOL, V65, P625, DOI 10.1111/j.1365-2958.2007.05815.x; Jyothikumar V, 2008, APPL ENVIRON MICROB, V74, P6774, DOI 10.1128/AEM.01233-08; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Manteca A, 2007, FEMS MICROBIOL LETT, V274, P118, DOI 10.1111/j.1574-6968.2007.00825.x; Manteca A, 2006, PROTEOMICS, V6, P6008, DOI 10.1002/pmic.200600147; MCCORMICK JR, 1994, MOL MICROBIOL, V14, P243, DOI 10.1111/j.1365-2958.1994.tb01285.x; Noens EE, 2007, MOL MICROBIOL, V64, P1244, DOI 10.1111/j.1365-2958.2007.05732.x; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Rigali S, 2008, EMBO REP, V9, P670, DOI 10.1038/embor.2008.83; Rigali S, 2006, MOL MICROBIOL, V61, P1237, DOI 10.1111/j.1365-2958.2006.05319.x; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; Schwedock J, 1997, MOL MICROBIOL, V25, P847, DOI 10.1111/j.1365-2958.1997.mmi507.x; Shah K, 2002, GENE DEV, V16, P1707, DOI 10.1101/gad.220402; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Wang L, 1998, J BACTERIOL, V180, P2810, DOI 10.1128/JB.180.11.2810-2816.1998; Willig KI, 2006, NAT METHODS, V3, P721, DOI 10.1038/NMETH922; Yuste R, 2005, NAT METHODS, V2, P902, DOI 10.1038/nmeth1205-902	30	28	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4242	10.1371/journal.pone.0004242	http://dx.doi.org/10.1371/journal.pone.0004242			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JB	19156202	Green Submitted, Green Published, gold			2022-12-25	WOS:000265482100014
J	Becker, M; Korn, C; Sienerth, AR; Voswinckel, R; Luetkenhaus, K; Ceteci, F; Rapp, UR				Becker, Matthias; Korn, Christian; Sienerth, Arnold R.; Voswinckel, Robert; Luetkenhaus, Katharina; Ceteci, Fatih; Rapp, Ulf R.			Polycomb Group Protein Bmi1 Is Required for Growth of RAF Driven Non-Small-Cell Lung Cancer	PLOS ONE			English	Article								Background: We have previously described a RAF oncogene driven transgenic mouse model for non small cell lung cancer (NSCLC). Here we examine whether tumor initiation and growth requires the stem cell self-renewal factor Bmi1. Principal Findings: In order to evaluate Bmi1 function in NSCLC two founder lines that differ in incidence and latency of tumor formation were compared. Ablation of Bmi1 expression in both lines had a dramatically decreased tumor growth. As the line with shorter latency matched the life span of Bmi1 knock out mice, these mice were chosen for further study. The absence of Bmi1 did not decrease the number of tumor initiation in these mice as only the size and not the number of tumors decreased. Reduction in tumor growth resulted from an increase in cell death and decrease in cell cycle progression that corresponded with up-regulation of the p16(INK4a) and p19(ARF). Significance: The data identifies Bmi1 as an important factor for expansion but not initiation of RAF driven NSCLC.	[Becker, Matthias; Korn, Christian; Sienerth, Arnold R.; Luetkenhaus, Katharina; Ceteci, Fatih; Rapp, Ulf R.] Univ Wurzburg, Bayer Krebsforschungszentrum MSZ, Wurzburg, Germany; [Voswinckel, Robert] Univ Hosp Giessen, Lung Ctr, Dept Internal Med, D-35390 Giessen, Germany	University of Wurzburg; University Hospital of Giessen & Marburg	Becker, M (corresponding author), Univ Wurzburg, Bayer Krebsforschungszentrum MSZ, Wurzburg, Germany.	rappur@mail.uni-wuerzburg.de		Sienerth, Arnold/0000-0003-1497-5020	DFG	DFG(German Research Foundation (DFG))	MB and CK were supported by SFB TR 17 of the DFG, ARS and KL were supported by the DFG graduate college 1141 Wuerzburg-Nice. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKEMA MJ, 1995, NATURE, V374, P724, DOI 10.1038/374724a0; Breuer RHJ, 2004, NEOPLASIA, V6, P736, DOI 10.1593/neo.04160; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Ceteci F, 2007, CANCER CELL, V12, P145, DOI 10.1016/j.ccr.2007.06.014; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Fedorov LM, 2003, CANCER RES, V63, P2268; Fedorov LM, 2002, CANCER RES, V62, P6297; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Gotz R, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-85; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kerkhoff E, 2000, CELL GROWTH DIFFER, V11, P185; Kramer BW, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-24; Lee C, 2005, CANCER RES, V65, P9834, DOI 10.1158/0008-5472.CAN-05-1759; Liu L, 2006, ONCOGENE, V25, P4370, DOI 10.1038/sj.onc.1209454; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Marks JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000426; Menges CW, 2008, ONCOGENE, V27, P2934, DOI 10.1038/sj.onc.1210957; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; Meuwissen R, 2001, ONCOGENE, V20, P6551, DOI 10.1038/sj.onc.1204837; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Pardal R, 2005, COLD SH Q B, V70, P177, DOI 10.1101/sqb.2005.70.057; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Roper JM, 2003, AM J PHYSIOL-LUNG C, V285, pL691, DOI 10.1152/ajplung.00034.2003; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Voncken JW, 2005, J BIOL CHEM, V280, P5178, DOI 10.1074/jbc.M407155200; Voswinckel R, 2004, EUR RESPIR J, V24, P524, DOI 10.1183/09031936.04.10004904; Vrzalikova K, 2008, J CANC RES CLIN ONCO; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Yu Q, 2007, OLIGONUCLEOTIDES, V17, P327, DOI 10.1089/oli.2007.0070; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhuang D, 2008, ONCOGENE, V27, P6623, DOI 10.1038/onc.2008.258; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	38	25	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2009	4	1							e4230	10.1371/journal.pone.0004230	http://dx.doi.org/10.1371/journal.pone.0004230			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IZ	19156217	gold, Green Published, Green Submitted			2022-12-25	WOS:000265481900011
J	Creary, LE; Ulug, P; Menzel, S; McKenzie, CA; Hanchard, NA; Taylor, V; Farrall, M; Forrester, TE; Thein, SL				Creary, Lisa E.; Ulug, Pinar; Menzel, Stephan; McKenzie, Colin A.; Hanchard, Neil A.; Taylor, Veronica; Farrall, Martin; Forrester, Terrence E.; Thein, Swee Lay			Genetic Variation on Chromosome 6 Influences F Cell Levels in Healthy Individuals of African Descent and HbF Levels in Sickle Cell Patients	PLOS ONE			English	Article								Fetal haemoglobin (HbF) is a major ameliorating factor in sickle cell disease. We investigated if a quantitative trait locus on chromosome 6q23 was significantly associated with HbF and F cell levels in individuals of African descent. Single nucleotide polymorphisms (SNPs) in a 24-kb intergenic region, 33-kb upstream of the HBS1L gene and 80-kb upstream of the MYB gene, were typed in 177 healthy Afro-Caribbean subjects (AC) of approximately 7% European admixture, 631 healthy Afro-Germans (AG, a group of African and German descendents located in rural Jamaica with about 20% European admixture), 87 West African and Afro-Caribbean individuals with sickle cell anaemia (HbSS), as well as 75 Northern Europeans, which served as a contrasting population. Association with a tag SNP for the locus was detected in all four groups (AC, P=0.005, AG, P=0.002, HbSS patients, P=0.019, Europeans, P=1.5x10(-7)). The association signal varied across the interval in the African-descended groups, while it is more uniform in Europeans. The 6q QTL for HbF traits is present in populations of African origin and is also acting in sickle cell anaemia patients. We have started to distinguish effects originating from European and African ancestral populations in our admixed study populations.	[Creary, Lisa E.; Ulug, Pinar; Menzel, Stephan; Thein, Swee Lay] Kings Coll London, Sch Med, Div Gene & Cell, James Black Ctr, London WC2R 2LS, England; [McKenzie, Colin A.; Hanchard, Neil A.; Forrester, Terrence E.] Univ W Indies, Trop Med Res Inst, Trop Metabolism Res Unit, Kingston, Jamaica; [Taylor, Veronica] Natl Blood Transfusion Ctr, Kingston, Jamaica; [Farrall, Martin] Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Oxford OX1 2JD, England; [Thein, Swee Lay] Kings Coll Hosp, Dept Haematol Med, London, England	University of London; King's College London; University West Indies Mona Jamaica; University of Oxford; Wellcome Centre for Human Genetics; King's College Hospital NHS Foundation Trust; King's College Hospital	Creary, LE (corresponding author), Kings Coll London, Sch Med, Div Gene & Cell, James Black Ctr, Denmark Hill Campus, London WC2R 2LS, England.	sl.thein@kcl.ac.uk	Hanchard, Neil/AAY-9075-2021; Menzel, Stephan/U-6906-2019	Hanchard, Neil/0000-0003-1925-2665; ULUG, PINAR/0000-0001-9719-1090; Menzel, Stephan/0000-0002-1590-9108	Medical Research Council [G0000111, ID51640]; MRC [G0000111] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from the Medical Research Council (MRC G0000111, ID51640) to S L Thein and T Forrester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BOYER SH, 1975, SCIENCE, V188, P361, DOI 10.1126/science.804182; CRAIG JE, 1993, BRIT J HAEMATOL, V84, P106, DOI 10.1111/j.1365-2141.1993.tb03032.x; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; CREARY LE, 2008, BRIT J HAEM IN PRESS; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garner C, 2000, BLOOD, V95, P342; Garner C, 2000, GENESCREEN, V1, P9, DOI DOI 10.1046/J.1466-9218.2000.00001.X; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; McKenzie CA, 2001, HUM MOL GENET, V10, P1077, DOI 10.1093/hmg/10.10.1077; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104; THORPE SJ, 1994, BRIT J HAEMATOL, V87, P125, DOI 10.1111/j.1365-2141.1994.tb04881.x; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105	16	60	62	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2009	4	1							e4218	10.1371/journal.pone.0004218	http://dx.doi.org/10.1371/journal.pone.0004218			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IH	19148297	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000265479900010
J	Kakiuchi, C; Ishigaki, S; Oslowski, CM; Fonseca, SG; Kato, T; Urano, F				Kakiuchi, Chihiro; Ishigaki, Shinsuke; Oslowski, Christine M.; Fonseca, Sonya G.; Kato, Tadafumi; Urano, Fumihiko			Valproate, a Mood Stabilizer, Induces WFS1 Expression and Modulates Its Interaction with ER Stress Protein GRP94	PLOS ONE			English	Article								Background: Valproate is a standard treatment for bipolar disorder and a first-line mood stabilizer. The molecular mechanisms underlying its actions in bipolar disorder are unclear. It has been suggested that the action of valproate is linked to changes in gene expression and induction of endoplasmic reticulum (ER) stress-response proteins. Principal Findings: Here we show that valproate modulates the ER stress response through the regulation of WFS1, an important component for mitigating ER stress. Therapeutic concentrations of valproate induce expression of WFS1 mRNA and activate the WFS1 promoter. In addition, WFS1 forms a complex with GRP94, an ER stress-response protein, in which valproate dose-dependently enhances its dissociation from GRP94. Conclusions: These results suggest that the therapeutic effects of valproate in bipolar disorder may be mediated by WFS1 expression and its dissociation from GRP94.	[Kakiuchi, Chihiro; Ishigaki, Shinsuke; Oslowski, Christine M.; Fonseca, Sonya G.; Urano, Fumihiko] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Urano, Fumihiko] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Kakiuchi, Chihiro; Kato, Tadafumi] RIKEN Brain Sci Inst, Wako, Saitama, Japan	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; RIKEN	Kakiuchi, C (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	Fumihiko.Urano@umassmed.edu	ISHIGAKI, Shinsuke/I-7305-2014; Kakiuchi, Chihiro/AAO-1103-2020; Urano, Fumihiko/AAF-4492-2020; Kato, Tadafumi/J-3583-2014	Kato, Tadafumi/0000-0001-7856-3952; Ishigaki, Shinsuke/0000-0002-9555-0659	NIH [R01DK067493]; Diabetes and Endocrinology Research Center at the University of Massachusetts Medical School; Juvenile Diabetes Research Foundation; Iacocca Foundation; Worcester Foundation for Biomedical Research Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067493] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes and Endocrinology Research Center at the University of Massachusetts Medical School; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Iacocca Foundation; Worcester Foundation for Biomedical Research Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research in the laboratory of F. Urano is supported by an NIH R01DK067493 grant, a grant from the Diabetes and Endocrinology Research Center at the University of Massachusetts Medical School, a Juvenile Diabetes Research Foundation Regular Research Grant, an Iacocca Foundation Grant, and an Worcester Foundation for Biomedical Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bown CD, 2000, NEUROPHARMACOLOGY, V39, P2162, DOI 10.1016/S0028-3908(00)00029-0; Chen G, 1997, NEUROPSYCHOPHARMACOL, V16, P238; Chen S., 1999, HALLYM INT J AGING, V1, P58, DOI DOI 10.2190/HA1.2.F; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Fonseca SG, 2005, J BIOL CHEM, V280, P39609, DOI 10.1074/jbc.M507426200; Goodwin F, 1990, MANIC DEPRESSIVE ILL; Hardy C, 1999, AM J HUM GENET, V65, P1279, DOI 10.1086/302609; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Johannessen CU, 2000, NEUROCHEM INT, V37, P103, DOI 10.1016/S0197-0186(00)00013-9; Johannessen CU, 2003, CNS DRUG REV, V9, P199; Kakiuchi C, 2006, J NEUROCHEM, V97, P545, DOI 10.1111/j.1471-4159.2006.03772.x; Kakiuchi C., 2007, J HUM GENET; Kato T, 2007, PSYCHIAT CLIN NEUROS, V61, P3, DOI 10.1111/j.1440-1819.2007.01604.x; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Lawson B, 1998, J CELL PHYSIOL, V174, P170, DOI 10.1002/(SICI)1097-4652(199802)174:2<170::AID-JCP4>3.3.CO;2-A; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosenberg G, 2007, CELL MOL LIFE SCI, V64, P2090, DOI 10.1007/s00018-007-7079-x; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Strom TM, 1998, HUM MOL GENET, V7, P2021, DOI 10.1093/hmg/7.13.2021; Swift M, 2005, MOL PSYCHIATR, V10, P799, DOI 10.1038/sj.mp.4001681; Swift RG, 1998, MOL PSYCHIATR, V3, P86, DOI 10.1038/sj.mp.4000344; SWIFT RG, 1990, LANCET, V336, P667, DOI 10.1016/0140-6736(90)92157-D; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	24	43	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2009	4	1							e4134	10.1371/journal.pone.0004134	http://dx.doi.org/10.1371/journal.pone.0004134			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FV	19125190	Green Published, gold			2022-12-25	WOS:000265473100008
J	Zurier, RB; Sun, YP; George, KL; Stebulis, JA; Rossetti, RG; Skulas, A; Judge, E; Serhan, CN				Zurier, Robert B.; Sun, Yee-Ping; George, Kerri L.; Stebulis, Judith A.; Rossetti, Ronald G.; Skulas, Ann; Judge, Erica; Serhan, Charles N.			Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A(4)	FASEB JOURNAL			English	Article						lipoxygenase; resolution; arthritis; nephritis	CELLS; INFLAMMATION; SUPPRESSION; RESOLUTION; RECEPTOR	Ajulemic acid (AjA), a synthetic nonpsychoactive cannabinoid, and lipoxin A(4) (LXA(4)), an eicosanoid formed from sequential actions of 5- and 15-lipoxygenases (LOX), facilitate resolution of inflammation. The purpose of this study was to determine whether the ability of AjA to limit the progress of inflammation might relate to an increase in LXA(4), a known anti-inflammatory and proresolving mediator. Addition of AjA (0-30 mu M) in vitro to human blood and synovial cells increased production of LXA(4) (ELISA) 2- to 5-fold. Administration of AjA to mice with peritonitis resulted in a 25-75% reduction of cells invading the peritoneum, and a 7-fold increase in LXA(4) identified by mass spectrometry. Blockade of 12/15 LOX, which leads to LXA(4) synthesis via 15-HETE production, reduced (> 90%) the ability of AjA to enhance production of LXA(4) in vitro. These results suggest that AjA and other agents that increase endogenous compounds that facilitate resolution of inflammation may be useful for conditions characterized by inflammation and tissue injury.-Zurier, R. B., Sun, Y.-P., George, K. L., Stebulis, J. A., Rossetti, R. G., Skulas, A., Judge, E., Serhan, C. N. Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A(4). FASEB J. 23, 1503-1509 (2009)	[Zurier, Robert B.; George, Kerri L.; Stebulis, Judith A.; Rossetti, Ronald G.; Skulas, Ann; Judge, Erica] Univ Massachusetts, Sch Med, Div Rheumatol, Worcester, MA 01655 USA; [Sun, Yee-Ping; Serhan, Charles N.] Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesia Perioperat & Pain Med, Boston, MA 02115 USA; [Sun, Yee-Ping; Serhan, Charles N.] Harvard Univ, Sch Med, Boston, MA USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Zurier, RB (corresponding author), Univ Massachusetts, Sch Med, Div Rheumatol, 55 Lake Ave, Worcester, MA 01655 USA.	robert.zurier@umassmed.edu			U.S. National Institutes of Health (NIH) [DA 3691, AI 1056362, GM38765, P50-DE016191, 5T35HL00771]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE016191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038765, R29GM038765, R37GM038765] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by U.S. National Institutes of Health (NIH) grants DA 3691 and AI 1056362 (R.B.Z.) and GM38765 and P50-DE016191 (C.N.S.). E.J. was supported by NIH 5T35HL00771 (Short-Term Training for Minority Students). We thank Dr. Sumner Burstein for helpful discussion of the manuscript.	ABEL EL, 1980, MARIJUANA 1 1000 YEA; ABRAMSON SB, 1989, ARTHRITIS RHEUM, V32, P1, DOI 10.1002/anr.1780320102; BADR KF, 1989, P NATL ACAD SCI USA, V86, P3438, DOI 10.1073/pnas.86.9.3438; BURSTEIN S, 1972, SCIENCE, V176, P422, DOI 10.1126/science.176.4033.422; Burstein S, 2005, AAPS J, V7, pE143, DOI 10.1208/aapsj070115; BURSTEIN S, 1994, BIOCHEM PHARMACOL, V48, P1253, DOI 10.1016/0006-2952(94)90163-5; Burstein SH, 2000, CURR PHARM DESIGN, V6, P1339, DOI 10.2174/1381612003399473; BURSTEIN SH, 1992, J MED CHEM, V35, P3135, DOI 10.1021/jm00095a007; Chiang N, 2005, PROSTAG LEUKOTR ESS, V73, P163, DOI 10.1016/j.plefa.2005.05.003; Clarkson MR, 1998, NEPHROL DIAL TRANSPL, V13, P3043, DOI 10.1093/ndt/13.12.3043; Cuzzocrea S, 2002, MOL PHARMACOL, V61, P997, DOI 10.1124/mol.61.5.997; Dajani EZ, 1999, J PHARMACOL EXP THER, V291, P31; EDENIUS C, 1988, BIOCHEM BIOPH RES CO, V157, P801, DOI 10.1016/S0006-291X(88)80320-6; Fiore S, 1995, BIOCHEMISTRY-US, V34, P16678, DOI 10.1021/bi00051a016; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Johnson DR, 2007, J CELL BIOCHEM, V100, P184, DOI 10.1002/jcb.21046; Karst M, 2003, JAMA-J AM MED ASSOC, V290, P1757, DOI 10.1001/jama.290.13.1757; Lawrence T, 2007, INT J EXP PATHOL, V88, P85, DOI 10.1111/j.1365-2613.2006.00507.x; LOEV B, 1973, J MED CHEM, V16, P1200, DOI 10.1021/jm00269a002; MULLERLADNER U, 1995, ARTHRITIS RHEUM, V38, P1328, DOI 10.1002/art.1780380922; Ohse T, 2004, J AM SOC NEPHROL, V15, P919, DOI 10.1097/01.ASN.0000119962.69573.CC; Olsen NJ, 2005, NEW ENGL J MED, V352, P2578, DOI 10.1056/NEJMp058105; PAPAYIANNI A, 1995, KIDNEY INT, V47, P1295, DOI 10.1038/ki.1995.184; Parker J, 2008, RHEUMATOL INT, V28, P631, DOI 10.1007/s00296-007-0489-0; Perez-Reyes M., 1985, PHARMACOKINETICS PHA, P287; Perretti Mauro, 2003, Methods Mol Biol, V225, P139; PORTNEY LG, 1993, FDN CLIN RES APPL PR, P474; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Schwab JM, 2006, CURR OPIN PHARMACOL, V6, P414, DOI 10.1016/j.coph.2006.02.006; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2001, J CLIN INVEST, V107, P1481, DOI 10.1172/JCI13375; SODINSEMRL S, 2000, J EXP MED, V9, P1693; Stebulis JA, 2005, J RHEUMATOL, V32, P301; Stebulis JA, 2008, LIFE SCI, V83, P666, DOI 10.1016/j.lfs.2008.09.004; Takano T, 1997, J EXP MED, V185, P1693, DOI 10.1084/jem.185.9.1693; ZURIER RB, 1990, J RHEUMATOL, V17, P1439; Zurier RB, 2003, J CELL BIOCHEM, V88, P462, DOI 10.1002/jcb.10291; Zurier RB, 2003, BIOCHEM PHARMACOL, V65, P649, DOI 10.1016/S0006-2952(02)01604-0; Zurier RB, 1998, ARTHRITIS RHEUM-US, V41, P163, DOI 10.1002/1529-0131(199801)41:1<163::AID-ART20>3.0.CO;2-9	39	37	40	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2009	23	5					1503	1509		10.1096/fj.08-118323	http://dx.doi.org/10.1096/fj.08-118323			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZP	19124557	Green Published			2022-12-25	WOS:000266651700026
J	Campbell, ZT; Baldwin, TO				Campbell, Zachary T.; Baldwin, Thomas O.			Fre Is the Major Flavin Reductase Supporting Bioluminescence from Vibrio harveyi Luciferase in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH-FMN OXIDOREDUCTASE; BACTERIAL LUCIFERASE; NAD(P)H-FLAVIN OXIDOREDUCTASE; REDUCED FLAVIN; CRYSTAL-STRUCTURE; STRUCTURAL GENES; MECHANISM; FISCHERI; IDENTIFICATION; CLONING	Unlike the vast majority of flavoenzymes, bacterial luciferase requires an exogenous source of reduced flavin mononucleotide for bioluminescence activity. Within bioluminescent bacterial cells, species-specific oxidoreductases are believed to provide reduced flavin for luciferase activity. The source of reduced flavin in Escherichia coli-expressing bioluminescence is not known. There are two candidate proteins potentially involved in this process in E. coli, a homolog of the Vibrio harveyi Frp oxidoreductase, NfsA, and a luxG type oxidoreductase, Fre. Using single gene knock-out strains, we show that deletion of fre decreased light output by greater than two orders of magnitude, yet had no effect on luciferase expression in E. coli. Purified Fre is capable of supporting bioluminescence in vitro with activity comparable to that with the endogenous V. harveyi reductase (Frp), using either FMN or riboflavin as substrate. In a pull-down experiment, we found that neither Fre nor Frp co-purify with luciferase. In contrast to prior work, we find no evidence for stable complex formation between luciferase and oxidoreductase. We conclude that in E. coli, an enzyme primarily responsible for riboflavin reduction (Fre) can also be utilized to support high levels of bioluminescence.	Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA; [Baldwin, Thomas O.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of Arizona; University of California System; University of California Riverside	Baldwin, TO (corresponding author), Coll Nat & Agr Sci, 302 Coll Bldg N, Riverside, CA 92521 USA.	thomas.baldwin@ucr.edu		Campbell, Zachary/0000-0002-3768-6996	National Science Foundation [0078363]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB 0078363. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BALDWIN TO, 1984, BIOCHEMISTRY-US, V23, P3663, DOI 10.1021/bi00311a014; BALDWIN TO, 1992, CHEM BIOCH FLAVOENZY, P467; BALNY C, 1975, BIOCHEMISTRY-US, V14, P4719, DOI 10.1021/bi00692a024; Becker D, 1997, EUR J BIOCHEM, V249, P739, DOI 10.1111/j.1432-1033.1997.t01-1-00739.x; BLANC V, 1995, J BACTERIOL, V177, P5206, DOI 10.1128/jb.177.18.5206-5214.1995; DEVINE JH, 1989, P NATL ACAD SCI USA, V86, P5688, DOI 10.1073/pnas.86.15.5688; DUANE W, 1975, MOL CELL BIOCHEM, V6, P53, DOI 10.1007/BF01731866; EBERHARD A, 1972, BIOCHEM BIOPH RES CO, V47, P348, DOI 10.1016/0006-291X(72)90719-X; Fieschi F, 1995, J BIOL CHEM, V270, P30392, DOI 10.1074/jbc.270.51.30392; FRANCISCO WA, 1993, J BIOL CHEM, V268, P24734; Francisco WA, 1998, BIOCHEMISTRY-US, V37, P2596, DOI 10.1021/bi972266x; Galan B, 2000, J BACTERIOL, V182, P627, DOI 10.1128/JB.182.3.627-636.2000; GAUDU P, 1994, J BIOL CHEM, V269, P8182; GIBSON QH, 1962, BIOCHEM J, V83, P368, DOI 10.1042/bj0830368; Gordon S, 1998, METH MOL B, V101, P235, DOI 10.1385/0-89603-471-2:235; HASTINGS JW, 1978, METHODS ENZYMOLOGY; Ingelman M, 1999, BIOCHEMISTRY-US, V38, P7040, DOI 10.1021/bi982849m; INOUYE S, 1994, FEBS LETT, V347, P163, DOI 10.1016/0014-5793(94)00528-1; JABLONSKI E, 1976, P NATL ACAD SCI USA, V73, P3848, DOI 10.1073/pnas.73.11.3848; JABLONSKI E, 1977, BIOCHEMISTRY-US, V16, P2932, DOI 10.1021/bi00632a020; Jeffers CE, 2003, BIOCHEMISTRY-US, V42, P529, DOI 10.1021/bi026877n; Koike H, 1998, J MOL BIOL, V280, P259, DOI 10.1006/jmbi.1998.1871; LEI BF, 1994, J BIOL CHEM, V269, P5612; LEI BF, 1994, J BACTERIOL, V176, P3552, DOI 10.1128/JB.176.12.3552-3558.1994; Lei BF, 1998, BIOCHEMISTRY-US, V37, P14623, DOI 10.1021/bi981841+; Li X, 2006, ARCH BIOCHEM BIOPHYS, V454, P26, DOI 10.1016/j.abb.2006.07.016; Lin JW, 1998, BIOCHEM BIOPH RES CO, V246, P446, DOI 10.1006/bbrc.1998.8641; LIU Y, 1995, J BACTERIOL, V177, P2080, DOI 10.1128/jb.177.8.2080-2086.1995; MEIGHEN EA, 1973, BIOCHEMISTRY-US, V12, P1482, DOI 10.1021/bi00732a003; MEIGHEN EA, 1991, MICROBIOL REV, V55, P123, DOI 10.1128/MMBR.55.1.123-142.1991; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Parry RJ, 1997, J BIOL CHEM, V272, P23303, DOI 10.1074/jbc.272.37.23303; PUGET K, 1972, BIOCHIMIE, V54, P1197, DOI 10.1016/S0300-9084(72)80024-5; RAUSHEL FM, 1989, BIOCHEM BIOPH RES CO, V164, P1137, DOI 10.1016/0006-291X(89)91787-7; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHMIDT TM, 1989, APPL ENVIRON MICROB, V55, P2607, DOI 10.1128/AEM.55.10.2607-2612.1989; Sparks JM, 2001, BIOCHEMISTRY-US, V40, P15436, DOI 10.1021/bi0111855; SPYROU G, 1991, J BACTERIOL, V173, P3673, DOI 10.1128/JB.173.12.3673-3679.1991; Tanner JJ, 1999, PROTEIN SCI, V8, P1725, DOI 10.1110/ps.8.9.1725; TU S, 1975, BIOCHEMISTRY-US, V14, P4310, DOI 10.1021/bi00690a027; TU SC, 1980, P NATL ACAD SCI-BIOL, V77, P249, DOI 10.1073/pnas.77.1.249; Tu SC, 2001, ANTIOXID REDOX SIGN, V3, P881, DOI 10.1089/15230860152665046; Tu SC, 2000, J NUTR, V130, p331S, DOI 10.1093/jn/130.2.331S; Wang H, 2000, BIOCHEMISTRY-US, V39, P7813, DOI 10.1021/bi0003745; ZENNO S, 1994, J BACTERIOL, V176, P3536, DOI 10.1128/JB.176.12.3536-3543.1994; Zenno S, 1998, J BACTERIOL, V180, P422, DOI 10.1128/JB.180.2.422-425.1998; Zenno S, 1996, J BACTERIOL, V178, P4508, DOI 10.1128/jb.178.15.4508-4514.1996; ZENNO S, 1994, J BACTERIOL, V176, P3544, DOI 10.1128/JB.176.12.3544-3551.1994; Zenno SH, 1996, J BACTERIOL, V178, P4731, DOI 10.1128/jb.178.15.4731-4733.1996	51	35	36	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8322	8328		10.1074/jbc.M808977200	http://dx.doi.org/10.1074/jbc.M808977200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19139094	Green Published, hybrid			2022-12-25	WOS:000264397800016
J	Cheng, CM; Kong, XF; Wang, HZ; Gan, HC; Hao, YQ; Zou, WY; Wu, JW; Chi, YY; Yang, JW; Hong, Y; Chen, KL; Gu, JX				Cheng, Chunming; Kong, Xiangfei; Wang, Hanzhou; Gan, Huachen; Hao, Yuqing; Zou, Weiying; Wu, Jingwen; Chi, Yayun; Yang, Junwu; Hong, Yi; Chen, Kangli; Gu, Jianxin			Trihydrophobin 1 Interacts with PAK1 and Regulates ERK/MAPK Activation and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P21-ACTIVATED KINASE; PROTEIN-KINASE; DROSOPHILA-MELANOGASTER; SIGNAL-TRANSDUCTION; MAPK ACTIVATION; PHOSPHORYLATION; ACTIN; ERK; MOTILITY; ASSOCIATION	The Rac1/Cdc42 effector, p21-activated kinase (PAK), is activated by various signaling cascades, including receptor-tyrosine kinases and integrins, and regulates a number of processes such as cell proliferation and motility. PAK activity has been shown to be required for maximal activation of the canonical RAF-MEK-MAPK signaling cascade, possibly because of PAK co-activation of RAF and MEK. Here we have shown that trihydrophobin 1 (TH1), originally identified as a negative regulator of A-RAF kinase, also interacted with PAK1 in cultured cells. Confocal microscopy assay indicated that TH1 colocalized with PAK1 in both the cytoplasm and nucleus, which is consistent with our previous results. GST pulldown and coimmunoprecipitation experiments demonstrated that TH1 interacted directly with PAK1 and bound selectively to the carboxyl-terminal kinase domain of PAK1, and the ability of the binding was enhanced along with activation of PAK1. The binding pattern of PAK1 implies that this interaction was mediated in part by PAK1 kinase activity. As indicated by in vitro kinase activity assays and Western blot detections, TH1 inhibited PAK1 kinase activity and negatively regulated MAPK signal transduction. Interestingly, TH1 bound with MEK1/ERK in cells and in vitro without directly suppressing their kinase activity. Furthermore, we observed that TH1 localized to focal adhesions and filopodia in the leading edge of cells, where TH1 reduced cell migration through affecting actin and adhesion dynamics. Based on these observations, we propose a model in which TH1 interacts with PAK1 and specifically restricts the activation of MAPK modules through the upstream region of the MAPK pathway, thereby influencing cell migration.	[Chi, Yayun; Yang, Junwu; Hong, Yi; Chen, Kangli; Gu, Jianxin] Fudan Univ, Shanghai Med Coll, Ctr Gene Res, Shanghai 200032, Peoples R China; [Cheng, Chunming; Gu, Jianxin] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Gu, JX (corresponding author), Fudan Univ, Shanghai Med Coll, Ctr Gene Res, Box 103,181 Yi Xue Yuan Rd, Shanghai 200032, Peoples R China.	jxgu@shmu.edu.cn	Wang, Hanzhou/G-9814-2012; cheng, chunming/AAU-6273-2021; Gan, Huachen/AAE-5925-2021	Wang, Hanzhou/0000-0002-0493-827X; cheng, chunming/0000-0001-9036-1683; 				Alahari SK, 2004, EMBO J, V23, P2777, DOI 10.1038/sj.emboj.7600291; BANGA SS, 1995, MOL GEN GENET, V246, P148, DOI 10.1007/BF00294677; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bonthron DT, 2000, HUM GENET, V107, P165, DOI 10.1007/s004390000344; Buchwald G, 2001, MOL CELL BIOL, V21, P5179, DOI 10.1128/MCB.21.15.5179-5189.2001; Carragher NO, 2003, CURR BIOL, V13, P1442, DOI 10.1016/S0960-9822(03)00544-X; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Dan C, 2002, MOL CELL BIOL, V22, P567, DOI 10.1128/MCB.22.2.567-577.2002; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Frost JA, 1998, J BIOL CHEM, V273, P28191, DOI 10.1074/jbc.273.43.28191; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Guo DG, 2007, CELL, V128, P341, DOI 10.1016/j.cell.2006.11.048; HARI KL, 1995, CELL, V82, P815, DOI 10.1016/0092-8674(95)90478-6; Howe AK, 2000, NAT CELL BIOL, V2, P593, DOI 10.1038/35023536; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Hunger-Glaser I, 2003, J BIOL CHEM, V278, P22631, DOI 10.1074/jbc.M210876200; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Jin SH, 2005, J BIOL CHEM, V280, P24698, DOI 10.1074/jbc.M413374200; Jo M, 2002, J BIOL CHEM, V277, P12479, DOI 10.1074/jbc.M111147200; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Kiosses WB, 1999, J CELL BIOL, V147, P831, DOI 10.1083/jcb.147.4.831; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Knaus UG, 1998, INT J BIOCHEM CELL B, V30, P857, DOI 10.1016/S1357-2725(98)00059-4; Koestler SA, 2008, NAT CELL BIOL, V10, P306, DOI 10.1038/ncb1692; Koh CG, 2002, CURR BIOL, V12, P317, DOI 10.1016/S0960-9822(02)00652-8; Krueger JS, 2001, ONCOGENE, V20, P4209, DOI 10.1038/sj.onc.1204541; Kumar R, 2002, J CELL PHYSIOL, V193, P133, DOI 10.1002/jcp.10167; Lee SR, 2002, MOL ENDOCRINOL, V16, P85, DOI 10.1210/me.16.1.85; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lei M, 2005, STRUCTURE, V13, P769, DOI 10.1016/j.str.2005.03.007; Liu WC, 2004, J BIOL CHEM, V279, P10167, DOI 10.1074/jbc.M307994200; Liu ZX, 2002, J BIOL CHEM, V277, P10452, DOI 10.1074/jbc.M107551200; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Narita T, 2003, MOL CELL BIOL, V23, P1863, DOI 10.1128/MCB.23.6.1863-1873.2003; Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Pullikuth A, 2005, MOL CELL BIOL, V25, P5119, DOI 10.1128/MCB.25.12.5119-5133.2005; Rayala SK, 2006, CANCER RES, V66, P1694, DOI 10.1158/0008-5472.CAN-05-2922; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Schrantz N, 2004, J BIOL CHEM, V279, P1922, DOI 10.1074/jbc.M311145200; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sells MA, 2000, J CELL BIOL, V151, P1449, DOI 10.1083/jcb.151.7.1449; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Stahle M, 2003, J CELL SCI, V116, P3835, DOI 10.1242/jcs.00679; Sundberg-Smith LJ, 2005, J BIOL CHEM, V280, P2055, DOI 10.1074/jbc.M406013200; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; Wu WS, 2008, CANCER METAST REV, V27, P303, DOI 10.1007/s10555-008-9112-4; Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200; Yang YZ, 2007, J CELL BIOCHEM, V101, P167, DOI 10.1002/jcb.21164; Zang MW, 2002, J BIOL CHEM, V277, P4395, DOI 10.1074/jbc.M110000200	62	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8786	8796		10.1074/jbc.M806144200	http://dx.doi.org/10.1074/jbc.M806144200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19136554	hybrid, Green Published			2022-12-25	WOS:000264397800062
J	Kallen, J; Goepfert, A; Blechschmidt, A; Izaac, A; Geiser, M; Tavares, G; Ramage, P; Furet, P; Masuya, K; Lisztwan, J				Kallen, Joerg; Goepfert, Arnaud; Blechschmidt, Anke; Izaac, Aude; Geiser, Martin; Tavares, Gisele; Ramage, Paul; Furet, Pascal; Masuya, Keiichi; Lisztwan, Joanna			Crystal Structures of Human MdmX (HdmX) in Complex with p53 Peptide Analogues Reveal Surprising Conformational Changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPPRESSOR TRANSACTIVATION DOMAIN; EMBRYONIC LETHALITY; IN-VIVO; MDM2-DEFICIENT MICE; PROTEIN; ACTIVATION; PATHWAY; ANTAGONISTS; RESCUE; CELLS	p53 tumor suppressor activity is negatively regulated through binding to the oncogenic proteins Hdm2 and HdmX. The p53 residues Leu(26), Trp(23), and Phe(19) are crucial to mediate these interactions. Inhibiting p53 binding to both Hdm2 and HdmX should be a promising clinical approach to reactivate p53 in the cancer setting, but previous studies have suggested that the discovery of dual Hdm2/HdmX inhibitors will be difficult. We have determined the crystal structures at 1.3A of the N-terminal domain of HdmX bound to two p53 peptidomimetics without and with a 6-chlorine substituent on the indole (which binds in the same subpocket as Trp23 of p53). The latter compound is the most potent peptide-based antagonist of the p53-Hdm2 interaction yet to be described. The x-ray structures revealed surprising conformational changes of the binding cleft of HdmX, including an "open conformation" of Tyr(99) and unexpected "cross-talk" between the Trp and Leu pockets. Notably, the 6-chloro p53 peptidomimetic bound with high affinity to both HdmX and Hdm2(K-d values of 36 and 7 nM, respectively). Our results suggest that the development of potent dual inhibitors for HdmX and Hdm2 should be feasible. They also reveal possible conformational states of HdmX, which should lead to a better prediction of its interactions with potential biological partners.	[Kallen, Joerg] Novartis Inst BioMed Res, Prot Struct Unit, CH-4002 Basel, Switzerland	Novartis	Kallen, J (corresponding author), Novartis Inst BioMed Res, Prot Struct Unit, CH-4002 Basel, Switzerland.	joerg.kallen@novartis.com						Bottger V, 1999, ONCOGENE, V18, P189, DOI 10.1038/sj.onc.1202281; Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Cummings MD, 2006, J BIOMOL SCREEN, V11, P854, DOI 10.1177/1087057106292746; Ding K, 2006, J MED CHEM, V49, P3432, DOI 10.1021/jm051122a; Dudkina AS, 2007, CURR TOP MED CHEM, V7, P952, DOI 10.2174/156802607780906762; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finch RA, 2002, CANCER RES, V62, P3221; Garcia-Echeverria C, 2000, J MED CHEM, V43, P3205, DOI 10.1021/jm990966p; Grasberger BL, 2005, J MED CHEM, V48, P909, DOI 10.1021/jm049137g; Hu B, 2007, CANCER RES, V67, P8810, DOI 10.1158/0008-5472.CAN-07-1140; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOSHLAND DE, 1958, FED PROC, V17, P1145; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; LAMZIN VS, 2006, INT TABLES CRYSTALLO, P720; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; LUNA RMD, 1995, NATURE, V378, P203; Macchiarulo A, 2008, J CHEM INF MODEL, V48, P1999, DOI 10.1021/ci800146m; Marine JCW, 2007, J CELL SCI, V120, P371, DOI 10.1242/jcs.03362; Migliorini D, 2002, MOL CELL BIOL, V22, P5527, DOI 10.1128/MCB.22.15.5527-5538.2002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Patton JT, 2006, CANCER RES, V66, P3169, DOI 10.1158/0008-5472.CAN-05-3832; Popowicz GM, 2008, CELL CYCLE, V7, P2441, DOI 10.4161/cc.6365; Popowicz GM, 2007, CELL CYCLE, V6, P2386, DOI 10.4161/cc.6.19.4740; Sakurai K, 2006, J AM CHEM SOC, V128, P11000, DOI 10.1021/ja063102j; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wade M, 2006, J BIOL CHEM, V281, P33036, DOI 10.1074/jbc.M605405200; Zhang Z, 2005, CURR CANCER DRUG TAR, V5, P9, DOI 10.2174/1568009053332618	38	65	77	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8803	8812		10.1074/jbc.M809096200	http://dx.doi.org/10.1074/jbc.M809096200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19153082	Green Published, hybrid			2022-12-25	WOS:000264397800064
J	Pratt, EB; Yan, FF; Gay, JW; Stanley, CA; Shyng, SL				Pratt, Emily B.; Yan, Fei-Fei; Gay, Joel W.; Stanley, Charles A.; Shyng, Show-Ling			Sulfonylurea Receptor 1 Mutations That Cause Opposite Insulin Secretion Defects with Chemical Chaperone Exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE POTASSIUM CHANNELS; K-ATP CHANNELS; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA; CORRECT TRAFFICKING DEFECTS; CONGENITAL HYPERINSULINISM; KIR6.2; DISEASE; BINDING; INFANCY; GLIBENCLAMIDE	The beta-cell ATP-sensitive potassium (K-ATP) channel composed of sulfonylurea receptor SUR1 and potassium channel Kir6.2 serves a key role in insulin secretion regulation by linking glucose metabolism to cell excitability. Mutations in SUR1 or Kir6.2 that decrease channel function are typically associated with congenital hyperinsulinism, whereas those that increase channel function are associated with neonatal diabetes. Here we report that two hyperinsulinism-associated SUR1 missense mutations, R74W and E128K, surprisingly reduce channel inhibition by intracellular ATP, a gating defect expected to yield the opposite disease phenotype neonatal diabetes. Under normal conditions, both mutant channels showed poor surface expression due to retention in the endoplasmic reticulum, accounting for the loss of channel function phenotype in the congenital hyperinsulinism patients. This trafficking defect, however, could be corrected by treating cells with the oral hypoglycemic drugs sulfonylureas, which we have shown previously to act as small molecule chemical chaperones for K-ATP channels. The R74W and E128K mutants thus rescued to the cell surface paradoxically exhibited ATP sensitivity 6-and 12-fold lower than wild-type channels, respectively. Further analyses revealed a nucleotide-independent decrease in mutant channel intrinsic open probability, suggesting the mutations may reduce ATP sensitivity by causing functional uncoupling between SUR1 and Kir6.2. In insulin-secreting cells, rescue of both mutant channels to the cell surface led to hyperpolarized membrane potentials and reduced insulin secretion upon glucose stimulation. Our results show that sulfonylureas, as chemical chaperones, can dictate manifestation of the two opposite insulin secretion defects by altering the expression levels of the disease mutants.	[Pratt, Emily B.; Yan, Fei-Fei; Gay, Joel W.; Shyng, Show-Ling] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97239 USA; [Stanley, Charles A.] Childrens Hosp Philadelphia, Div Endocrinol Diabet, Philadelphia, PA 19104 USA	Oregon Health & Science University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Shyng, SL (corresponding author), Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	shyngs@ohsu.edu		STANLEY, CHARLES/0000-0003-4881-9392	National Institutes of Health Predoctoral Fellowship [F30DK081305, R01DK57699, DK66485, R01DK56268, UL1-RRO24134]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056268, F30DK081305, R01DK057699, R01DK066485] Funding Source: NIH RePORTER	National Institutes of Health Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Predoctoral Fellowship F30DK081305 (to E. B. P.), Grants R01DK57699 and DK66485 (to S.-L. S.), and Grants R01DK56268 and UL1-RRO24134 (to C. A. S.).	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Cartier EA, 2001, P NATL ACAD SCI USA, V98, P2882, DOI 10.1073/pnas.051499698; Chan KW, 2003, EMBO J, V22, P3833, DOI 10.1093/emboj/cdg376; de Wet H, 2007, P NATL ACAD SCI USA, V104, P18988, DOI 10.1073/pnas.0707428104; Dempster J., 2001, LAB COMPUTER PRACTIC; Dunne MJ, 2004, PHYSIOL REV, V84, P239, DOI 10.1152/physrev.00022.2003; Enkvetchakul D, 2000, BIOPHYS J, V78, P2334, DOI 10.1016/S0006-3495(00)76779-8; GULLO D, 1991, J ENDOCRINOL INVEST, V14, P287, DOI 10.1007/BF03346813; Hattersley AT, 2005, DIABETES, V54, P2503, DOI 10.2337/diabetes.54.9.2503; Henwood MJ, 2005, J CLIN ENDOCR METAB, V90, P789, DOI 10.1210/jc.2004-1604; Heusser K, 2006, J CELL SCI, V119, P4353, DOI 10.1242/jcs.03196; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Kawaki J, 1999, DIABETES, V48, P2001, DOI 10.2337/diabetes.48.10.2001; Lin CW, 2006, DIABETES, V55, P1738, DOI 10.2337/db05-1571; Lin CW, 2005, DIABETES, V54, P2852, DOI 10.2337/diabetes.54.10.2852; Lin YW, 2003, J GEN PHYSIOL, V122, P225, DOI 10.1085/jgp.200308822; Lin YW, 2006, J BIOL CHEM, V281, P3006, DOI 10.1074/jbc.M511875200; Neagoe I, 2005, J MOL CELL CARDIOL, V38, P887, DOI 10.1016/j.yjmcc.2004.11.023; NEHER E, 1977, ANNU REV BIOPHYS BIO, V6, P345, DOI 10.1146/annurev.bb.06.060177.002021; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Pinney SE, 2008, J CLIN INVEST, V118, P2877, DOI 10.1172/JCI35414; Proks P, 2005, HUM MOL GENET, V14, P2717, DOI 10.1093/hmg/ddi305; Proks P, 2004, P NATL ACAD SCI USA, V101, P17539, DOI 10.1073/pnas.0404756101; Proks P, 2007, HUM MOL GENET, V16, P2011, DOI 10.1093/hmg/ddm149; Proks P, 2006, HUM MOL GENET, V15, P1793, DOI 10.1093/hmg/ddl101; Shyng SL, 1997, J GEN PHYSIOL, V110, P141, DOI 10.1085/jgp.110.2.141; Shyng SL, 1998, DIABETES, V47, P1145, DOI 10.2337/diabetes.47.7.1145; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Suchi M, 2006, MODERN PATHOL, V19, P122, DOI 10.1038/modpathol.3800497; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Yan FF, 2007, DIABETES, V56, P2339, DOI 10.2337/db07-0150; Yan FF, 2006, J BIOL CHEM, V281, P33403, DOI 10.1074/jbc.M605195200; Yan FF, 2005, AM J PHYSIOL-CELL PH, V289, pC1351, DOI 10.1152/ajpcell.00240.2005; Yan FF, 2004, J BIOL CHEM, V279, P11096, DOI 10.1074/jbc.M312810200; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	39	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7951	7959		10.1074/jbc.M807012200	http://dx.doi.org/10.1074/jbc.M807012200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19151370	Green Published, hybrid			2022-12-25	WOS:000264195600057
J	Hidaka, M; Nishimoto, M; Kitaoka, M; Wakagi, T; Shoun, H; Fushinobu, S				Hidaka, Masafumi; Nishimoto, Mamoru; Kitaoka, Motomitsu; Wakagi, Takayoshi; Shoun, Hirofumi; Fushinobu, Shinya			The Crystal Structure of Galacto-N-biose/Lacto-N-biose I Phosphorylase A LARGE DEFORMATION OF A TIM BARREL SCAFFOLD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSIDE HYDROLASE FAMILY; BIFIDOBACTERIUM-BIFIDUM; CLOSTRIDIUM-PERFRINGENS; BETA-GALACTOSIDASE; NEUTRAL OLIGOSACCHARIDES; CONFORMATIONAL ITINERARY; MILK OLIGOSACCHARIDES; VIBRIO-VULNIFICUS; MOLECULAR-CLONING; IDENTIFICATION	Galacto-N-biose/lacto-N-biose I phosphorylase (GLNBP) from Bifidobacterium longum, a key enzyme for intestinal growth, phosphorolyses galacto-N-biose and lacto-N-biose I with anomeric inversion. GLNBP homologues are often found in human pathogenic and commensal bacteria, and their substrate specificities potentially define the nutritional acquisition ability of these microbes in their habitat. We report the crystal structures of GLNBP in five different ligand-binding forms. This is the first three-dimensional structure of glycoside hydrolase (GH) family 112. The GlcNAc-and GalNAc-bound forms provide structural insights into distinct substrate preferences of GLNBP and its homologues from pathogens. The catalytic domain consists of a partially broken TIM barrel fold that is structurally similar to a thermophilic beta-galactosidase, strongly supporting the current classification of GLNBP homologues as one of the GH families. Anion binding induces a large conformational change by rotating a half-unit of the barrel. This is an unusual example of molecular adaptation of a TIM barrel scaffold to substrates.	[Hidaka, Masafumi; Wakagi, Takayoshi; Shoun, Hirofumi; Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Nishimoto, Mamoru; Kitaoka, Motomitsu] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	University of Tokyo; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Fushinobu, S (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	asfushi@mail.ecc.u-tokyo.ac.jp	Wakagi, Takayoshi/AAJ-4145-2021; Kitaoka, Motomitsu/R-1536-2019; Fushinobu, Shinya/E-4987-2011	Kitaoka, Motomitsu/0000-0002-0083-1838; Fushinobu, Shinya/0000-0003-1346-6435	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Japan Society for the Promotion of Science for Young Scientists Research Fellowship [17-00182]	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Japan Society for the Promotion of Science for Young Scientists Research Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN) and Japan Society for the Promotion of Science for Young Scientists Research Fellowship 17-00182 (to M. H.). The costs of publication of this article were defrayed in part by the payment of page charges.	Akanuma S, 2008, J MOL BIOL, V382, P458, DOI 10.1016/j.jmb.2008.07.040; Asakuma S, 2008, EUR J CLIN NUTR, V62, P488, DOI 10.1038/sj.ejcn.1602738; Bezirtzoglou E, 2006, COMP IMMUNOL MICROB, V29, P345, DOI 10.1016/j.cimid.2006.09.002; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Daniels G., 2002, HUMAN BLOOD GROUPS; Davies GJ, 2003, BIOCHEM SOC T, V31, P523, DOI 10.1042/BST0310523; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Derensy-Dron D, 1999, BIOTECHNOL APPL BIOC, V29, P3; DESLONGCHAMPS P, 1993, PURE APPL CHEM, V65, P1161, DOI 10.1351/pac199365061161; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erney RM, 2000, J PEDIATR GASTR NUTR, V30, P181, DOI 10.1097/00005176-200002000-00016; Espinosa JF, 1998, J AM CHEM SOC, V120, P1309, DOI 10.1021/ja972291q; Fujita K, 2005, J BIOL CHEM, V280, P37415, DOI 10.1074/jbc.M506874200; Fushinobu S, 2007, J APPL GLYCOSCI, V54, P95; Fushinobu S, 2008, CARBOHYD RES, V343, P1023, DOI 10.1016/j.carres.2008.02.026; Gagnon M, 2004, INT J FOOD MICROBIOL, V92, P69, DOI 10.1016/j.ijfoodmicro.2003.07.010; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Haarman M, 2005, APPL ENVIRON MICROB, V71, P2318, DOI 10.1128/AEM.71.5.2318-2324.2005; Hakomori SI, 2008, BBA-GEN SUBJECTS, V1780, P325, DOI 10.1016/j.bbagen.2007.08.015; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Hidaka M, 2004, STRUCTURE, V12, P937, DOI 10.1016/j.str.2004.03.027; Hidaka M, 2002, J MOL BIOL, V322, P79, DOI 10.1016/S0022-2836(02)00746-5; Hidaka M, 2006, BIOCHEM J, V398, P37, DOI 10.1042/BJ20060274; Hlady WG, 1996, J INFECT DIS, V173, P1176, DOI 10.1093/infdis/173.5.1176; Hocker B, 2001, NAT STRUCT BIOL, V8, P32; Iwabuchi N, 2007, MICROBIOL IMMUNOL, V51, P649, DOI 10.1111/j.1348-0421.2007.tb03953.x; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; Kitaoka M, 2005, APPL ENVIRON MICROB, V71, P3158, DOI 10.1128/AEM.71.6.3158-3162.2005; Kitaoka M, 2002, TRENDS GLYCOSCI GLYC, V14, P35, DOI 10.4052/tigg.14.35; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Knol J, 2005, J PEDIATR GASTR NUTR, V40, P36, DOI 10.1097/00005176-200501000-00007; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lang D, 2000, SCIENCE, V289, P1546, DOI 10.1126/science.289.5484.1546; MAGNANI JL, 1983, CANCER RES, V43, P5489; Mancia F, 1998, STRUCTURE, V6, P711, DOI 10.1016/S0969-2126(98)00073-2; MCDONEL JL, 1980, PHARMACOL THERAPEUT, V10, P617, DOI 10.1016/0163-7258(80)90031-5; Mocchetti I, 2005, CELL MOL LIFE SCI, V62, P2283, DOI 10.1007/s00018-005-5188-y; Moro G, 2006, ARCH DIS CHILD, V91, P814, DOI 10.1136/adc.2006.098251; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Motes ML, 1998, APPL ENVIRON MICROB, V64, P1459; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakajima M, 2008, APPL ENVIRON MICROB, V74, P6333, DOI 10.1128/AEM.02846-07; Nakajima M, 2008, APPL MICROBIOL BIOT, V78, P465, DOI 10.1007/s00253-007-1319-8; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2101, DOI 10.1271/bbb.70320; Nishimoto M, 2007, APPL ENVIRON MICROB, V73, P6444, DOI 10.1128/AEM.01425-07; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1587, DOI 10.1271/bbb.70064; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parracho H, 2007, P NUTR SOC, V66, P405, DOI 10.1017/S0029665107005678; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Petit L, 1999, TRENDS MICROBIOL, V7, P104, DOI 10.1016/S0966-842X(98)01430-9; RING M, 1990, ARCH BIOCHEM BIOPHYS, V283, P342, DOI 10.1016/0003-9861(90)90652-F; SAAVEDRA JM, 1994, LANCET, V344, P1046, DOI 10.1016/S0140-6736(94)91708-6; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Springer G F, 1990, Immunol Ser, V53, P587; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Suzuki R, 2008, J BIOL CHEM, V283, P13165, DOI 10.1074/jbc.M709777200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van den Broek LAM, 2008, MOL NUTR FOOD RES, V52, P146, DOI 10.1002/mnfr.200700121; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; Wada J, 2008, APPL ENVIRON MICROB, V74, P3996, DOI 10.1128/AEM.00149-08; Ward RE, 2006, APPL ENVIRON MICROB, V72, P4497, DOI 10.1128/AEM.02515-05; Withers SG, 2002, CHEM BIOL, V9, P1270, DOI 10.1016/S1074-5521(02)00291-0; Yasui H, 1999, ANTON LEEUW INT J G, V76, P383, DOI 10.1023/A:1002041616085	67	44	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7273	7283		10.1074/jbc.M808525200	http://dx.doi.org/10.1074/jbc.M808525200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19124470	Green Published, hybrid			2022-12-25	WOS:000263919000074
J	Shi, S; Mercer, S; Eckert, GJ; Trippel, SB				Shi, Shuiliang; Mercer, Scott; Eckert, George J.; Trippel, Stephen B.			Growth Factor Regulation of Growth Factors in Articular Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFECTS IN-VIVO; FACTOR-BETA; IGF-I; PROTEOGLYCAN SYNTHESIS; OSTEOGENIC PROTEIN-1; CARTILAGE EXPLANTS; ENHANCED REPAIR; TGF-BETA; METABOLISM; COLLAGEN	Several lines of evidence indicate that polypeptide growth factors are important in articular cartilage homeostasis and repair. It is not yet clear how these growth factors are regulated. We tested the hypothesis that the growth factors responsible for regulating cartilage are themselves regulated by growth factors. We delivered insulin-like growth factor I (IGF-I), fibroblast growth factor-2 (FGF-2), and/or transforming growth factor-beta 1 (TGF-beta 1) to adult bovine articular chondrocytes in primary culture and measured the resulting changes in IGF-I, FGF-2, and TGF-beta 1 gene expression and protein production. These growth factors differentially regulated their own and each others gene expression and protein production. In concert, they regulated each other in an interactive fashion. Their interactions ranged from inhibitory to synergistic. The time course of the regulatory effects differed among the individual growth factors and combinations. Growth factor-induced changes in growth factor protein production by articular chondrocytes generally corresponded to the changes in gene expression patterns. These studies suggest that interactions among IGF-I, FGF-2, and TGF-beta 1 substantially modulate their regulatory functions. The results may help guide the application of growth factors to articular cartilage repair.	[Shi, Shuiliang; Mercer, Scott; Trippel, Stephen B.] Indiana Univ, Sch Med, Dept Orthopaed Surg, Indianapolis, IN 46202 USA; [Eckert, George J.] Indiana Univ, Sch Med, Dept Med, Div Biostat, Indianapolis, IN 46202 USA; [Trippel, Stephen B.] Indiana Univ, Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Trippel, SB (corresponding author), 541 Clin Dr,CL600, Indianapolis, IN 46202 USA.	strippel@iupui.edu			NIAMS [AR047702]; Department of Veterans Affairs; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047702] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR047702 from NIAMS ( to S. B. T.) and the Department of Veterans Affairs.	Bonassar LJ, 2001, J ORTHOP RES, V19, P11, DOI 10.1016/S0736-0266(00)00004-8; BRADHAM DM, 1994, J CELL PHYSIOL, V158, P61, DOI 10.1002/jcp.1041580109; Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J; CARRINGTON JL, 1990, EXP CELL RES, V186, P368, DOI 10.1016/0014-4827(90)90318-5; Chopra R, 1998, J RHEUMATOL, V25, P1578; Cucchiarini M, 2005, MOL THER, V12, P229, DOI 10.1016/j.ymthe.2005.03.012; Danielpour D, 2006, CYTOKINE GROWTH F R, V17, P59, DOI 10.1016/j.cytogfr.2005.09.007; ELFORD PR, 1990, ENDOCRINOLOGY, V127, P1635, DOI 10.1210/endo-127-4-1635; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fanning PJ, 2003, J BIOL CHEM, V278, P50940, DOI 10.1074/jbc.M305107200; FROGERGAILLARD B, 1989, ENDOCRINOLOGY, V124, P2365, DOI 10.1210/endo-124-5-2365; Fujimoto E, 1999, ARCH ORTHOP TRAUM SU, V119, P139, DOI 10.1007/s004020050377; GUERNE PA, 1994, J CELL PHYSIOL, V158, P476, DOI 10.1002/jcp.1041580312; Henson FMD, 2005, OSTEOARTHR CARTILAGE, V13, P537, DOI 10.1016/j.joca.2005.02.007; HORTON WE, 1989, J CELL PHYSIOL, V141, P8, DOI 10.1002/jcp.1041410103; KATO Y, 1987, J CELL PHYSIOL, V133, P491, DOI 10.1002/jcp.1041330309; Loeser RF, 2005, ARTHRITIS RHEUM-US, V52, P3910, DOI 10.1002/art.21472; Loeser RF, 2003, ARTHRITIS RHEUM, V48, P2188, DOI 10.1002/art.11209; LUYTEN FP, 1988, ARCH BIOCHEM BIOPHYS, V267, P416, DOI 10.1016/0003-9861(88)90047-1; Madry H, 2001, GENE THER, V8, P1443, DOI 10.1038/sj.gt.3301535; Madry H, 2005, GENE THER, V12, P1171, DOI 10.1038/sj.gt.3302515; Madry H, 2000, GENE THER, V7, P286, DOI 10.1038/sj.gt.3301086; MCQUILLAN DJ, 1986, BIOCHEM J, V240, P423, DOI 10.1042/bj2400423; MORALES TI, 1988, J BIOL CHEM, V263, P12828; Nixon AJ, 1999, J ORTHOPAED RES, V17, P475, DOI 10.1002/jor.1100170404; Nixon AJ, 2001, J ORTHOPAED RES, V19, P26, DOI 10.1016/S0736-0266(00)00013-9; OSBORN KD, 1989, J ORTHOP RES, V7, P35, DOI 10.1002/jor.1100070106; PRAEMER A, 1999, MUSCULOSKELETAL COND, P3; PRINS APA, 1982, ARTHRITIS RHEUM, V25, P1228, DOI 10.1002/art.1780251012; REDINI F, 1988, FEBS LETT, V234, P172, DOI 10.1016/0014-5793(88)81327-9; ROSIER RN, 1989, CONNECT TISSUE RES, V20, P295, DOI 10.3109/03008208909023900; SAH RL, 1994, ARCH BIOCHEM BIOPHYS, V308, P137, DOI 10.1006/abbi.1994.1020; SANDELL LJ, 1988, J ORTHOP T, V12, P377; Shida J, 2001, J ORTHOPAED RES, V19, P259, DOI 10.1016/S0736-0266(00)90009-3; Trippel S B, 1997, Instr Course Lect, V46, P473; TRIPPEL SB, 1995, J RHEUMATOL, V22, P129; TRIPPEL SB, 1989, PEDIATR RES, V25, P76, DOI 10.1203/00006450-198901000-00017; TSUKAZAKI T, 1994, EXP CELL RES, V215, P9, DOI 10.1006/excr.1994.1307; VANDERKRAAN PM, 1992, ANN RHEUM DIS, V51, P643, DOI 10.1136/ard.51.5.643; WELLMITZ G, 1980, EXP PATHOL-JENA, V18, P282, DOI 10.1016/S0014-4908(80)80033-0; WROBLEWSKI J, 1995, J BONE MINER RES, V10, P735	41	39	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6697	6704		10.1074/jbc.M807859200	http://dx.doi.org/10.1074/jbc.M807859200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19136669	Green Published, hybrid			2022-12-25	WOS:000263919000014
J	Boyman, L; Mikhasenko, H; Hiller, R; Khananshvili, D				Boyman, Liron; Mikhasenko, Helen; Hiller, Reuben; Khananshvili, Daniel			Kinetic and Equilibrium Properties of Regulatory Calcium Sensors of NCX1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC NA+-CA2+ EXCHANGER; NA+/CA2+ EXCHANGER; CA2+-BINDING DOMAIN; BINDING PROPERTIES; MEMBRANE-BINDING; CONFORMATIONAL-CHANGES; DYNAMIC PROPERTIES; STOPPED-FLOW; STEADY-STATE; CA2+	The crystal structures of the CBD1 and CBD2 domains of the Na+/Ca2+ exchanger protein (NCX1) provided a major breakthrough in Ca2+-dependent regulation of NCX1, although the dynamic aspects of the underlying molecular mechanisms are still not clear. Here we provide new experimental approaches for evaluating the kinetic and equilibrium properties of Ca2+ interaction with regulatory sites by using purified preparations of CBD1, CBD2, and CBD12 proteins. CBD12 binds similar to 6 Ca2+ ions (mol/mol), whereas the binding of only similar to 2Ca(2+) ions is observed (with a Hill coefficient of n(H) = similar to 2) either for CBD1 or CBD2. In the absence of Mg2+, CBD1 has a much higher affinity for Ca2+ (K-d = 0.3 +/- 1.2 mu M) than CBD2 (K-d = 5.0 +/- 1.2 mu M). The Ca2+ dissociation from CBD2 (k(off) = 230 +/- 70 s(-1)) is at least 25 times faster than from CBD1(koff = 10 +/- 3 s(-1)), whereas the k(on) values indicate fast kinetics for Ca2+ binding (k(on) = k(off)/K-d = 10(7) - 10(8) MG(2+), CBD1) for both CBDs. At 2-5 mM Mg2+, both CBDs bind Ca2+, with a K-d of 1-2 mu M (Mg2+ has very little effect on Ca2+ off rates). Mg2+ cannot occupy the primary site of CBD2, whereas the other Ca2+ sites of CBDs interact with Mg2+ as well. There is no competition between Na+ and Ca2+ for any CBD site. The kinetically diverse [Ca2+] sensors may sense differentially the dynamic swings in [Ca2+] within specific subcellular compartments (dyadic cleft, submembrane space, bulk cytosol, etc.).	[Boyman, Liron; Mikhasenko, Helen; Hiller, Reuben; Khananshvili, Daniel] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Ramat Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Khananshvili, D (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Ramat Aviv, Israel.	dhanan@post.tau.ac.il		Khananshvili, Daniel/0000-0002-4202-9966	Israeli Ministry of Health [3000003019]; United States-Israeli Binational Research [2003-372]	Israeli Ministry of Health; United States-Israeli Binational Research	This work was supported in part by Israeli Ministry of Health Grant 3000003019 and United States-Israeli Binational Research Grant 2003-372.	Ames JB, 2000, BIOCHEMISTRY-US, V39, P12149, DOI 10.1021/bi0012890; BAYLEY P, 1984, BIOCHEM BIOPH RES CO, V120, P185, DOI 10.1016/0006-291X(84)91431-1; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2007, ANN NY ACAD SCI, V1099, P326, DOI 10.1196/annals.1387.060; Besserer GM, 2007, P NATL ACAD SCI USA, V104, P18467, DOI 10.1073/pnas.0707417104; Blaustein MP, 2007, P NATL ACAD SCI USA, V104, P18349, DOI 10.1073/pnas.0709008104; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.biochem.56.1.395; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Dipolo R, 2006, PHYSIOL REV, V86, P155, DOI 10.1152/physrev.00018.2005; Dunn J, 2002, J BIOL CHEM, V277, P33957, DOI 10.1074/jbc.M206677200; Dyck C, 1999, J GEN PHYSIOL, V114, P701, DOI 10.1085/jgp.114.5.701; EBERHARD M, 1994, EUR J BIOCHEM, V222, P21, DOI 10.1111/j.1432-1033.1994.tb18836.x; EBERHARD M, 1991, EUR J BIOCHEM, V202, P1333, DOI 10.1111/j.1432-1033.1991.tb16508.x; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Guatimosim S, 2002, J MOL CELL CARDIOL, V34, P941, DOI 10.1006/jmcc.2002.2032; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P905, DOI 10.1085/jgp.100.6.905; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P933, DOI 10.1085/jgp.100.6.933; Jerala R, 1996, J BIOMOL NMR, V7, P107; Johnson E, 2008, J MOL BIOL, V377, P945, DOI 10.1016/j.jmb.2008.01.046; Kargacin GJ, 2003, J THEOR BIOL, V221, P245, DOI 10.1006/jtbi.2003.3187; KHANANSHVILI D, 1995, BIOCHEMISTRY-US, V34, P10290, DOI 10.1021/bi00032a024; KHANANSHVILI D, 1994, BIOCHEMISTRY-US, V33, P312, DOI 10.1021/bi00167a041; Khananshvili D, 1996, ANN NY ACAD SCI, V779, P217, DOI 10.1111/j.1749-6632.1996.tb44789.x; KHANANSHVILI D, 1998, ADV MOL CEL A&B, V23, P311; KOFUJI P, 1994, J BIOL CHEM, V269, P5145; LADANT D, 1995, J BIOL CHEM, V270, P3179; LEE SL, 1994, J BIOL CHEM, V269, P14849; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; LEVITSKY DO, 1994, J BIOL CHEM, V269, P22847; Levitsky DO, 1996, MOL CELL BIOCHEM, V161, P27, DOI 10.1007/BF00240027; Maack C, 2005, CIRC RES, V96, P91, DOI 10.1161/01.RES.0000151334.48676.68; MARTIN SR, 1992, EUR J BIOCHEM, V205, P1107, DOI 10.1111/j.1432-1033.1992.tb16879.x; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; MATSUOKA S, 1993, P NATL ACAD SCI USA, V90, P3870, DOI 10.1073/pnas.90.9.3870; Nalefski EA, 1997, BIOCHEMISTRY-US, V36, P12011, DOI 10.1021/bi9717340; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; Ottolia M, 2004, BIOPHYS J, V87, P899, DOI 10.1529/biophysj.104.043471; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; REEVES JP, 1985, CURR TOP MEMBR TRANS, V25, P77; Reuter H, 2005, CARDIOVASC RES, V67, P198, DOI 10.1016/j.cardiores.2005.04.031; Shao XG, 1996, SCIENCE, V273, P248, DOI 10.1126/science.273.5272.248; Sher AA, 2008, PROG BIOPHYS MOL BIO, V96, P377, DOI 10.1016/j.pbiomolbio.2007.07.018; Urbanczyk J, 2006, J PHYSIOL-LONDON, V575, P693, DOI 10.1113/jphysiol.2006.113910; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Wei SK, 2002, CARDIOVASC RES, V53, P334, DOI 10.1016/S0008-6363(01)00501-6; Wingard JN, 2005, J BIOL CHEM, V280, P37461, DOI 10.1074/jbc.M508541200; Xie Y, 2008, AM J PHYSIOL-CELL PH, V295, pC388, DOI 10.1152/ajpcell.00178.2008	52	53	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6185	6193		10.1074/jbc.M809012200	http://dx.doi.org/10.1074/jbc.M809012200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19141619	hybrid			2022-12-25	WOS:000263742700021
J	Komori, K; Takagi, Y; Sanada, M; Lim, TH; Nakatsu, Y; Tsuzuki, T; Sekiguchi, M; Hidaka, M				Komori, K.; Takagi, Y.; Sanada, M.; Lim, T-H; Nakatsu, Y.; Tsuzuki, T.; Sekiguchi, M.; Hidaka, M.			A novel protein, MAPO1, that functions in apoptosis triggered by O-6-methylguanine mispair in DNA	ONCOGENE			English	Article						apoptosis; gene-trap mutagenesis; Mapo1; MGMT; O-6-methylguanine	EMBRYONIC STEM-CELLS; ALKYLATION-INDUCED APOPTOSIS; MISMATCH REPAIR; O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; ANTINEOPLASTIC DRUGS; ESCHERICHIA-COLI; INDUCE APOPTOSIS; KNOCKOUT MICE; MUTL-ALPHA; ATR KINASE	O-6-Methylguanine produced in DNA induces mutation due to its ambiguous base-pairing properties during DNA replication. To suppress such an outcome, organisms possess a mechanism to eliminate cells carrying O-6-methylguanine by inducing apoptosis that requires the function of mismatch repair proteins. To identify other factors involved in this apoptotic process, we performed retrovirus-mediated gene-trap mutagenesis and isolated a mutant that acquired resistance to a simple alkylating agent, N-methyl-N-nitrosourea (MNU). However, it was still sensitive to methyl methanesulfonate, 1-(4-amino-2methyl- 5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea, etoposide and ultraviolet irradiation. Moreover, the mutant exhibited an increased mutant frequency after exposure to MNU. The gene responsible was identified and designated Mapo1 (O-6-methylguanine- induced apoptosis 1). When the expression of the gene was inhibited by small interfering RNA, MNU-induced apoptosis was significantly suppressed. In the Mapo1-defective mutant cells treated with MNU, the mitochondrial membrane depolarization and caspase-3 activation were severely suppressed, although phosphorylation of p53, CHK1 and histone H2AX was observed. The orthologs of the Mapo1 gene are present in various organisms from nematode to humans. Both mouse and human MAPO1 proteins expressed in cells localize in the cytoplasm. We therefore propose that MAPO1 may play a role in the signaltransduction pathway of apoptosis induced by O-6-methyl-guanine-mispaired lesions.	[Hidaka, M.] Fukuoka Dent Coll, Dept Physiol Sci & Mol Biol, Sawara Ku, Fukuoka 8140193, Japan; [Komori, K.; Sekiguchi, M.; Hidaka, M.] Biomol Engn Res Inst, Dept Mol Biol, Suita, Osaka, Japan; [Takagi, Y.; Sekiguchi, M.] Fukuoka Dent Coll, Frontier Res Ctr, Fukuoka 8140193, Japan; [Lim, T-H; Nakatsu, Y.; Tsuzuki, T.; Hidaka, M.] Kyushu Univ, Fac Med Sci, Dept Med Biophys & Radiat Biol, Fukuoka 812, Japan	Fukuoka Dental College (FDC); Fukuoka Dental College (FDC); Kyushu University	Hidaka, M (corresponding author), Fukuoka Dent Coll, Dept Physiol Sci & Mol Biol, Sawara Ku, 2-15-1 Tamura, Fukuoka 8140193, Japan.	hidaka@college.fdcnet.ac.jp		Nakatsu, Yoshimichi/0000-0001-7408-7071	Kazusa DNA Research Institute [hKIAA1450cDNA]; Ministry of Education, Culture, Sports, Science and Technology of Japan	Kazusa DNA Research Institute; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank the Kazusa DNA Research Institute for providing hKIAA1450cDNA. This study was supported by grants (including a Frontier Research Grant) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; Caporali S, 2004, MOL PHARMACOL, V66, P478; Cejka P, 2003, EMBO J, V22, P2245, DOI 10.1093/emboj/cdg216; Christmann M, 2000, J BIOL CHEM, V275, P36256, DOI 10.1074/jbc.M005377200; COSSARIZZA A, 1994, EXP CELL RES, V214, P323, DOI 10.1006/excr.1994.1264; COULONDRE C, 1977, J MOL BIOL, V117, P577, DOI 10.1016/0022-2836(77)90059-6; Fishel R, 1998, GENE DEV, V12, P2096, DOI 10.1101/gad.12.14.2096; Glaab WE, 1998, MUTAT RES-FUND MOL M, V398, P197, DOI 10.1016/S0027-5107(98)00004-9; Glassner BJ, 1999, MUTAGENESIS, V14, P339, DOI 10.1093/mutage/14.3.339; Guo G, 2004, NATURE, V429, P891, DOI 10.1038/nature02653; Haracska L, 2000, MOL CELL BIOL, V20, P8001, DOI 10.1128/MCB.20.21.8001-8007.2000; Hickman MJ, 2004, MOL CELL, V14, P105, DOI 10.1016/S1097-2765(04)00162-5; Hickman MJ, 1999, P NATL ACAD SCI USA, V96, P10764, DOI 10.1073/pnas.96.19.10764; Hidaka M, 2005, NUCLEIC ACIDS RES, V33, P5703, DOI 10.1093/nar/gki878; Ishida Y, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.24.e35; ITO T, 1994, MUTAT RES, V314, P273, DOI 10.1016/0921-8777(94)90071-X; KAINA B, 1991, CARCINOGENESIS, V12, P1857; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; Karran P, 2001, CARCINOGENESIS, V22, P1931, DOI 10.1093/carcin/22.12.1931; KAT A, 1993, P NATL ACAD SCI USA, V90, P6424, DOI 10.1073/pnas.90.14.6424; Kawate H, 2000, CARCINOGENESIS, V21, P301, DOI 10.1093/carcin/21.2.301; Kawate H, 1998, P NATL ACAD SCI USA, V95, P5116, DOI 10.1073/pnas.95.9.5116; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; LOECHLER EL, 1984, P NATL ACAD SCI-BIOL, V81, P6271, DOI 10.1073/pnas.81.20.6271; Margison GP, 2002, BIOESSAYS, V24, P255, DOI 10.1002/bies.10063; Meikrantz W, 1998, CARCINOGENESIS, V19, P369, DOI 10.1093/carcin/19.2.369; Ochs K, 2000, CANCER RES, V60, P5815; Pegg AE, 2000, MUTAT RES-REV MUTAT, V462, P83, DOI 10.1016/S1383-5742(00)00017-X; Peng M, 2007, EMBO J, V26, P3238, DOI 10.1038/sj.emboj.7601754; Pepponi R, 2003, J PHARMACOL EXP THER, V304, P661, DOI 10.1124/jpet.102.043950; Sakumi K, 1997, CANCER RES, V57, P2415; Sanada M, 2007, CARCINOGENESIS, V28, P2657, DOI 10.1093/carcin/bgm188; SINGER B, 1989, P NATL ACAD SCI USA, V86, P8271, DOI 10.1073/pnas.86.21.8271; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Takagi Y, 2003, DNA REPAIR, V2, P1135, DOI 10.1016/S1568-7864(03)00134-4; Takagi Y, 2008, BIOCHEM PHARMACOL, V76, P303, DOI 10.1016/j.bcp.2008.05.008; Tominaga Y, 1997, CARCINOGENESIS, V18, P889, DOI 10.1093/carcin/18.5.889; Tsuzuki T, 1996, CARCINOGENESIS, V17, P1215, DOI 10.1093/carcin/17.6.1215; Wiles MV, 2000, NAT GENET, V24, P13, DOI 10.1038/71622; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023	41	8	10	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB	2009	28	8					1142	1150		10.1038/onc.2008.462	http://dx.doi.org/10.1038/onc.2008.462			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	412KE	19137017				2022-12-25	WOS:000263722900009
J	Budd, ME; Campbell, JL				Budd, Martin E.; Campbell, Judith L.			Interplay of Mre11 Nuclease with Dna2 plus Sgs1 in Rad51-Dependent Recombinational Repair	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE MRE11; YEAST DNA2; ENDONUCLEASE ACTIVITY; REPLICATION; HELICASE; RAD50; MUTANTS; PROTEIN; EXO1	The Mre11/Rad50/Xrs2 complex initiates IR repair by binding to the end of a double-strand break, resulting in 5' to 3' exonuclease degradation creating a single-stranded 3' overhang competent for strand invasion into the unbroken chromosome. The nuclease(s) involved are not well understood. Mre11 encodes a nuclease, but it has 3' to 5', rather than 5' to 3' activity. Furthermore, mutations that inactivate only the nuclease activity of Mre11 but not its other repair functions, mre11-D56N and mre11-H125N, are resistant to IR. This suggests that another nuclease can catalyze 5' to 3' degradation. One candidate nuclease that has not been tested to date because it is encoded by an essential gene is the Dna2 helicase/nuclease. We recently reported the ability to suppress the lethality of a dna2 Delta with a pif1 Delta. The dna2 Delta pif1 Delta mutant is IR-resistant. We have determined that dna2 Delta pif1 Delta mre11-D56N and dna2 Delta pif1 Delta mre11-H125N strains are equally as sensitive to IR as mre11 Delta strains, suggesting that in the absence of Dna2, Mre11 nuclease carries out repair. The dna2 Delta pif1 Delta mre11-D56N triple mutant is complemented by plasmids expressing Mre11, Dna2 or dna2K1080E, a mutant with defective helicase and functional nuclease, demonstrating that the nuclease of Dna2 compensates for the absence of Mre11 nuclease in IR repair, presumably in 5' to 3' degradation at DSB ends. We further show that sgs1 Delta mre11-H125N, but not sgs1 Delta, is very sensitive to IR, implicating the Sgs1 helicase in the Dna2-mediated pathway.	[Budd, Martin E.; Campbell, Judith L.] CALTECH, Div Biol, Braun Labs, Pasadena, CA 91125 USA	California Institute of Technology	Budd, ME (corresponding author), CALTECH, Div Biol, Braun Labs, Pasadena, CA 91125 USA.	jcampbel@caltech.edu			NIH [GM087666]; Philip Morris External Research Program; Ellison Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip Morris External Research Program; Ellison Foundation(Lawrence Ellison Foundation)	This work was supported by NIH GM087666, the Philip Morris External Research Program, and the Ellison Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALANI E, 1989, GENETICS, V122, P47; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bessler JB, 2001, TRENDS CELL BIOL, V11, P60, DOI 10.1016/S0962-8924(00)01877-8; Budd ME, 2005, PLOS GENET, V1, P634, DOI 10.1371/journal.pgen.0010061; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Budd ME, 2000, MUTAT RES-DNA REPAIR, V459, P173, DOI 10.1016/S0921-8777(99)00072-5; Choe W, 2002, MOL CELL BIOL, V22, P4202, DOI 10.1128/MCB.22.12.4202-4217.2002; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; D'Amours D, 2001, GENE DEV, V15, P2238, DOI 10.1101/gad.208701; Fiorentino DF, 1997, MOL BIOL CELL, V8, P2519, DOI 10.1091/mbc.8.12.2519; Formosa T, 1999, GENETICS, V151, P1459; Frank CJ, 2006, MOL CELL, V24, P423, DOI 10.1016/j.molcel.2006.10.020; Gangloff S, 1999, EMBO J, V18, P1701, DOI 10.1093/emboj/18.6.1701; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Imamura O, 2003, P NATL ACAD SCI USA, V100, P8193, DOI 10.1073/pnas.1431624100; Ira G, 2002, MOL CELL BIOL, V22, P6384, DOI 10.1128/MCB.22.18.6384-6392.2002; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; JINKSROBERTSON S, 1993, MOL CELL BIOL, V13, P3937, DOI 10.1128/MCB.13.7.3937; Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lewis LK, 2004, GENETICS, V166, P1701, DOI 10.1534/genetics.166.4.1701; Lewis LK, 2002, GENETICS, V160, P49; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; Masuda-Sasa T, 2006, J BIOL CHEM, V281, P38555, DOI 10.1074/jbc.M604925200; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Moncalian G, 2004, J MOL BIOL, V335, P937, DOI 10.1016/j.jmb.2003.11.026; Moreau S, 1999, MOL CELL BIOL, V19, P556; Moreau S, 2001, GENETICS, V159, P1423; Parenteau J, 1999, MOL CELL BIOL, V19, P4143; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; RESNICK MA, 1976, MOL GEN GENET, V143, P119, DOI 10.1007/BF00266917; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Tomita K, 2004, MOL CELL BIOL, V24, P9557, DOI 10.1128/MCB.24.21.9557-9567.2004; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Vernon M, 2008, GENETICS, V179, P237, DOI 10.1534/genetics.107.086603; Wagner M, 2006, GENETICS, V174, P555, DOI 10.1534/genetics.104.036905; Weitao T, 2003, MUTAT RES-FUND MOL M, V532, P157, DOI 10.1016/j.mrfmmm.2003.08.015; Weitao T, 2003, J BIOL CHEM, V278, P22513, DOI 10.1074/jbc.M301610200; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	51	57	58	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2009	4	1							e4267	10.1371/journal.pone.0004267	http://dx.doi.org/10.1371/journal.pone.0004267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JD	19165339	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000265482400011
J	Bondar, NP; Boyarskikh, UA; Kovalenko, IL; Filipenko, ML; Kudryavtseva, NN				Bondar, Natalia P.; Boyarskikh, Ul'yana A.; Kovalenko, Irina L.; Filipenko, Maxim L.; Kudryavtseva, Natalia N.			Molecular Implications of Repeated Aggression: Th, Dat1, Snca and Bdnf Gene Expression in the VTA of Victorious Male Mice	PLOS ONE			English	Article								Background: It is generally recognized that recurrent aggression can be the result of various psychiatric disorders. The aim of our study was to analyze the mRNA levels, in the ventral tegmental area (VTA) of the midbrain, of the genes that may possibly be associated with aggression consistently shown by male mice in special experimental settings. Methodology/Principal Findings: The genes were Th, Dat1, Snca and Bdnf; the male mice were a group of animals that had each won 20 daily encounters in succession and a group of animals that had the same winning track record followed by a no-fight period for 14 days. Increased Th, Dat1 and Snca mRNA levels were in the fresh-from-the-fight group as compared to the controls. Increased Th and Dat1 mRNA levels were in the no-fight winners as compared to the controls. Significant positive correlations were found between the level of aggression and Th and Snca mRNA levels. Conclusions: Repeated positive fighting experience enhances the expression of the Th, Dat1 and Snca genes, which are associated with brain dopaminergic systems. The expression of the Th and Dat1 genes stays enhanced for a long time.	[Bondar, Natalia P.; Kovalenko, Irina L.; Kudryavtseva, Natalia N.] RAS, SD, Inst Cytol & Genet, Novosibirsk, Russia; [Boyarskikh, Ul'yana A.; Filipenko, Maxim L.] RAS, SD, Inst Chem Biol & Basic Med, Novosibirsk, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Russian Academy of Sciences	Bondar, NP (corresponding author), RAS, SD, Inst Cytol & Genet, Novosibirsk, Russia.	natnik@bionet.nsc.ru	Boyarskikh, Ulyana/AAU-9540-2020; Kudryavtseva, Natalia/AAI-1127-2019; Bondar, Natalya/Q-7908-2016	Bondar, Natalya/0000-0002-5602-5149	Russian Academy of Sciences (Molecular and Cellular Biology Program) [10.13]; Russian Foundation for Basic Research [07-04-00014]	Russian Academy of Sciences (Molecular and Cellular Biology Program)(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported in part by research grant 10.13 from the Russian Academy of Sciences (Molecular and Cellular Biology Program) and grant 07-04-00014 from the Russian Foundation for Basic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Abumaria N, 2007, EUR NEUROPSYCHOPHARM, V17, P417, DOI 10.1016/j.euroneuro.2006.08.009; Andrade M. L., 1987, HOUSE MOUSE AGGRESSI, P223; APA, 1994, DIAGN STAT MAN MENT; Azaryan AV, 1998, CAN J PHYSIOL PHARM, V76, P278, DOI 10.1139/cjpp-76-3-278; Baron R., 1994, HUMAN AGGRESSION, DOI 10.1002/1098-2337(1994)20:63.0.CO;2-O; Bartolomucci A, 2003, BRAIN RES BULL, V62, P173, DOI 10.1016/j.brainresbull.2003.09.009; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Boer U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000431; Caramaschi D, 2008, BEHAV BRAIN RES, V189, P263, DOI 10.1016/j.bbr.2008.01.003; Chen NH, 2000, EUR J PHARMACOL, V405, P329, DOI 10.1016/S0014-2999(00)00563-X; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COOPER SJ, 1991, MESOLIMBIC DOPAMINE SYSTEM : FROM MOTIVATION TO ACTION, P331; Crespo JA, 2001, NEUROPSYCHOPHARMACOL, V25, P185, DOI 10.1016/S0893-133X(01)00221-4; Devoino L V, 1998, Vestn Ross Akad Med Nauk, P19; Filipenko ML, 2002, STRESS: NEURAL, ENDOCRINE AND MOLECULAR STUDIES, P157; Filipenko ML, 2001, MOL BRAIN RES, V96, P77, DOI 10.1016/S0169-328X(01)00270-4; Filipenko ML, 2002, BIOCHEMISTRY-MOSCOW+, V67, P451, DOI 10.1023/A:1015238124000; Fish EW, 2002, PSYCHOPHARMACOLOGY, V163, P459, DOI 10.1007/s00213-002-1211-2; GOLDSMITH JF, 1976, AGGRESSIVE BEHAV, V2, P307, DOI 10.1002/1098-2337(1976)2:4<307::AID-AB2480020407>3.0.CO;2-I; Goloshchapov AV, 2005, MOL BRAIN RES, V135, P290, DOI 10.1016/j.molbrainres.2004.11.009; Groves JO, 2007, MOL PSYCHIATR, V12, P1079, DOI 10.1038/sj.mp.4002075; Hoffman BJ, 1998, FRONT NEUROENDOCRIN, V19, P187, DOI 10.1006/frne.1998.0168; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Kollack-Walker S, 1999, J NEUROENDOCRINOL, V11, P547; Kudryavtseva N.N., 2006, PERSPECTIVES PSYCHOL, P35; Kudryavtseva NN, 1998, AGGRESSIVE BEHAV, V24, P271, DOI 10.1002/(SICI)1098-2337(1998)24:4<271::AID-AB3>3.0.CO;2-M; KUDRYAVTSEVA NN, 1991, ZH VYSSH NERV DEYAT+, V41, P459; Kudryavtseva NN, 2004, RUSS J GENET+, V40, P590, DOI 10.1023/B:RUGE.0000033307.59669.d6; KUDRYAVTSEVA NN, 1991, AGGRESSIVE BEHAV, V17, P285, DOI 10.1002/1098-2337(1991)17:5<285::AID-AB2480170505>3.0.CO;2-P; Lagerspetz K.M.J., 1964, ANN ACAD SCI FENN B, V131, P1; Martinez M, 1998, EUR J NEUROSCI, V10, P20, DOI 10.1046/j.1460-9568.1998.00011.x; Matsuda S, 1996, NEUROSCI RES, V26, P157, DOI 10.1016/S0168-0102(96)01088-7; Meyer U, 2001, HIPPOCAMPUS, V11, P329, DOI 10.1002/hipo.1047; Miczek K.A., 2007, HDB NEUROCHEMISTRY M, P285, DOI DOI 10.1007/978-0-387-30405-2_7; Miczek KA, 2008, PHARMACOL THERAPEUT, V120, P102, DOI 10.1016/j.pharmthera.2008.07.006; Miller GW, 1999, TRENDS PHARMACOL SCI, V20, P424, DOI 10.1016/S0165-6147(99)01379-6; MOYER KE, 1987, VIOLENCE AGGRESSION; Nichols CD, 2003, MOL BRAIN RES, V111, P182, DOI 10.1016/S0169-328X(03)00029-9; Nikulina EM, 1999, NEUROREPORT, V10, P3015, DOI 10.1097/00001756-199909290-00026; PARMIGIANI S, 1983, BEHAV PROCESS, V8, P45, DOI 10.1016/0376-6357(83)90042-6; Pizarro JM, 2004, BRAIN RES, V1025, P10, DOI 10.1016/j.brainres.2004.06.085; Rosen GD, 2000, INT MOUSE GENOME C, V14, P166; Sacchetti P, 2001, J NEUROCHEM, V76, P1565, DOI 10.1046/j.1471-4159.2001.00181.x; Scott J.P., 1971, PHYSL AGGRESSION DEF, P11; Sidhu A, 2004, ANN NY ACAD SCI, V1035, P250, DOI 10.1196/annals.1332.016; Spangler R, 1996, MOL BRAIN RES, V38, P71, DOI 10.1016/0169-328X(95)00319-N; van Erp AMM, 2000, J NEUROSCI, V20, P9320; Van Ree JM, 1999, PHARMACOL REV, V51, P341; VANDEPOLL NE, 1982, BEHAV PROCESS, V7, P143, DOI 10.1016/0376-6357(82)90023-7; Yavich L, 2004, J NEUROSCI, V24, P11165, DOI 10.1523/JNEUROSCI.2559-04.2004; Zhang T, 2007, NEUROSCI LETT, V423, P118, DOI 10.1016/j.neulet.2007.06.041	52	34	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4190	10.1371/journal.pone.0004190	http://dx.doi.org/10.1371/journal.pone.0004190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142237	Green Published, gold, Green Submitted			2022-12-25	WOS:000265479700011
J	Oyama, S; Yamakawa, H; Sasagawa, N; Hosoi, Y; Futai, E; Ishiura, S				Oyama, Satoko; Yamakawa, Hidekuni; Sasagawa, Noboru; Hosoi, Yoshio; Futai, Eugene; Ishiura, Shoichi			Dysbindin-1, a Schizophrenia-Related Protein, Functionally Interacts with the DNA- Dependent Protein Kinase Complex in an Isoform-Dependent Manner	PLOS ONE			English	Article								DTNBP1 has been recognized as a schizophrenia susceptible gene, and its protein product, dysbindin-1, is down-regulated in the brains of schizophrenic patients. However, little is known about the physiological role of dysbindin-1 in the central nervous system. We hypothesized that disruption of dysbindin-1 with unidentified proteins could contribute to pathogenesis and the symptoms of schizophrenia. GST pull-down from human neuroblastoma lysates showed an association of dysbindin-1 with the DNA-dependent protein kinase (DNA-PK) complex. The DNA-PK complex interacts only with splice isoforms A and B, but not with C. We found that isoforms A and B localized in nucleus, where the kinase complex exist, whereas the isoform C was found exclusively in cytosol. Furthermore, results of phosphorylation assay suggest that the DNA-PK complex phosphorylated dysbindin-1 isoforms A and B in cells. These observations suggest that DNA-PK regulates the dysbindin-1 isoforms A and B by phosphorylation in nucleus. Isoform C does not contain exons from 1 to 6. Since schizophrenia-related single nucleotide polymorphisms (SNPs) occur in these introns between exon 1 and exon 6, we suggest that these SNPs might affect splicing of DTNBP1, which leads to impairment of the functional interaction between dysbindin-1 and DNA-PK in schizophrenic patients.	[Oyama, Satoko; Yamakawa, Hidekuni; Sasagawa, Noboru; Futai, Eugene; Ishiura, Shoichi] Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan; [Hosoi, Yoshio] Niigata Univ, Sch Hlth Sci, Dept Radiol Technol, Niigata 95021, Japan	University of Tokyo; Niigata University	Oyama, S (corresponding author), Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan.	cishiura@mail.ecc.u-tokyo.ac.jp		Futai, Eugene/0000-0002-0879-6117	Ministry of Health, Labor, and Welfare, Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The Ministry of Health, Labor, and Welfare, Japan (to S.I.), and the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to E.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON CW, 1993, TRENDS BIOCHEM SCI, V18, P433, DOI 10.1016/0968-0004(93)90144-C; Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Bray NJ, 2003, HUM GENET, V113, P149, DOI 10.1007/s00439-003-0956-y; Bray NJ, 2005, HUM MOL GENET, V14, P1947, DOI 10.1093/hmg/ddi199; CAO QP, 1994, BIOCHEMISTRY-US, V33, P8548, DOI 10.1021/bi00194a021; Chu G, 1996, CURR TOP MICROBIOL, V217, P113; Chu G, 1997, J BIOL CHEM, V272, P24097, DOI 10.1074/jbc.272.39.24097; Ciciotte SL, 2003, BLOOD, V101, P4402, DOI 10.1182/blood-2003-01-0020; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Critchlow SE, 1997, CURR BIOL, V7, P588, DOI 10.1016/S0960-9822(06)00258-2; Dell'Angelica EC, 2000, J BIOL CHEM, V275, P1300, DOI 10.1074/jbc.275.2.1300; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Di Pietro SM, 2006, MOL BIOL CELL, V17, P4027, DOI 10.1091/mbc.E06-05-0379; Duan JB, 2007, HUM HERED, V64, P97, DOI 10.1159/000101961; Endoh D, 2001, RADIAT RES, V155, P320, DOI 10.1667/0033-7587(2001)155[0320:HTIRIN]2.0.CO;2; Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200; FELDMANN H, 1993, J BIOL CHEM, V268, P12895; Feng LJ, 2000, GENOMICS, V69, P370, DOI 10.1006/geno.2000.6350; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; Feng LJ, 2002, BLOOD, V99, P1651, DOI 10.1182/blood.V99.5.1651.h8001651_1651_1658; Fewell JW, 1996, J CELL SCI, V109, P1937; Funke B, 2004, AM J HUM GENET, V75, P891, DOI 10.1086/425279; Gahl WA, 1998, NEW ENGL J MED, V338, P1258, DOI 10.1056/NEJM199804303381803; Gornick MC, 2005, J AUTISM DEV DISORD, V35, P831, DOI 10.1007/s10803-005-0028-3; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Grawunder U, 1996, EUR J BIOCHEM, V241, P931, DOI 10.1111/j.1432-1033.1996.00931.x; Gwynn B, 2004, BLOOD, V104, P3181, DOI 10.1182/blood-2004-04-1538; Gwynn B, 2000, BLOOD, V96, P4227; HERMANSKY F, 1959, BLOOD, V14, P162, DOI 10.1182/blood.V14.2.162.162; Huizing M, 2000, TRAFFIC, V1, P823, DOI 10.1034/j.1600-0854.2000.011103.x; Huizing M, 2002, PEDIATR RES, V51, P150, DOI 10.1203/00006450-200202000-00006; Iizuka Y, 2007, J NEUROSCI, V27, P12390, DOI 10.1523/JNEUROSCI.1689-07.2007; Jin SF, 1997, EMBO J, V16, P6874, DOI 10.1093/emboj/16.22.6874; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kirov G, 2004, BIOL PSYCHIAT, V55, P971, DOI 10.1016/j.biopsych.2004.01.025; Ko L, 2000, P NATL ACAD SCI USA, V97, P6212, DOI 10.1073/pnas.97.11.6212; Ko L, 2003, J BIOL CHEM, V278, P11471, DOI 10.1074/jbc.M209723200; Koike M, 1998, BIOCHEM BIOPH RES CO, V252, P679, DOI 10.1006/bbrc.1998.9368; Koike M, 1999, J CELL SCI, V112, P4031; Koike M, 1996, GENOMICS, V38, P38, DOI 10.1006/geno.1996.0589; Kretzschmar D, 2000, GENETICS, V155, P213; Kumamoto N, 2006, BIOCHEM BIOPH RES CO, V345, P904, DOI 10.1016/j.bbrc.2006.04.163; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Matsumoto Y, 1997, BIOCHEM BIOPH RES CO, V234, P568, DOI 10.1006/bbrc.1997.6689; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Morgan NV, 2006, AM J HUM GENET, V78, P160, DOI 10.1086/499338; Murotani T, 2007, NEUROSCI LETT, V421, P47, DOI 10.1016/j.neulet.2007.05.019; Numakawa T, 2004, HUM MOL GENET, V13, P2699, DOI 10.1093/hmg/ddh280; RATHMELL WK, 1994, P NATL ACAD SCI USA, V91, P7623, DOI 10.1073/pnas.91.16.7623; Salazar G, 2006, MOL BIOL CELL, V17, P4014, DOI 10.1091/mbc.E06-02-0103; Schwab SG, 2003, AM J HUM GENET, V72, P185, DOI 10.1086/345463; Setaluri V, 2000, PIGM CELL RES, V13, P128, DOI 10.1034/j.1600-0749.2000.130302.x; Shotelersuk V, 1998, MOL GENET METAB, V65, P85, DOI 10.1006/mgme.1998.2729; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; SUWA A, 1994, P NATL ACAD SCI USA, V91, P6904, DOI 10.1073/pnas.91.15.6904; Swank RT, 2000, PIGM CELL RES, V13, P59, DOI 10.1034/j.1600-0749.13.s8.12.x; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; Tang JX, 2003, MOL PSYCHIATR, V8, P717, DOI 10.1038/sj.mp.4001287; Tochigi M, 2006, NEUROSCI RES, V56, P154, DOI 10.1016/j.neures.2006.06.009; Tosato S, 2007, AM J MED GENET B, V144B, P647, DOI 10.1002/ajmg.b.30484; Turunen JA, 2007, SCHIZOPHR RES, V91, P27, DOI 10.1016/j.schres.2006.11.028; Van Den Bogaert A, 2003, AM J HUM GENET, V73, P1438, DOI 10.1086/379928; van den Oord EJCG, 2003, MOL PSYCHIATR, V8, P499, DOI 10.1038/sj.mp.4001263; Vilella E, 2008, J PSYCHIATR RES, V42, P278, DOI 10.1016/j.jpsychires.2007.02.005; Weaver DT, 1996, CRIT REV EUKAR GENE, V6, P345, DOI 10.1615/CritRevEukarGeneExpr.v6.i4.20; Weickert CS, 2004, ARCH GEN PSYCHIAT, V61, P544, DOI 10.1001/archpsyc.61.6.544; Weickert CS, 2008, SCHIZOPHR RES, V98, P105, DOI 10.1016/j.schres.2007.05.041; Williams NM, 2004, ARCH GEN PSYCHIAT, V61, P336, DOI 10.1001/archpsyc.61.4.336; Yaneva M, 1997, EMBO J, V16, P5098, DOI 10.1093/emboj/16.16.5098; Yavuzer U, 1998, GENE DEV, V12, P2188, DOI 10.1101/gad.12.14.2188; Zhen LJ, 1999, BLOOD, V94, P146, DOI 10.1182/blood.V94.1.146.413k39_146_155	75	26	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4199	10.1371/journal.pone.0004199	http://dx.doi.org/10.1371/journal.pone.0004199			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142223	gold, Green Published, Green Submitted			2022-12-25	WOS:000265479700017
J	Lin, JH; Li, H; Zhang, YH; Ron, D; Walter, P				Lin, Jonathan H.; Li, Han; Zhang, Yuhong; Ron, David; Walter, Peter			Divergent Effects of PERK and IRE1 Signaling on Cell Viability	PLOS ONE			English	Article								Protein misfolding in the endoplasmic reticulum ( ER) activates a set of intracellular signaling pathways, collectively termed the Unfolded Protein Response (UPR). UPR signaling promotes cell survival by reducing misfolded protein levels. If homeostasis cannot be restored, UPR signaling promotes cell death. The molecular basis for the switch between prosurvival and proapoptotic UPR function is poorly understood. The ER-resident proteins, PERK and IRE1, control two key UPR signaling pathways. Protein misfolding concomitantly activates PERK and IRE1 and has clouded insight into their contributions toward life or death cell fates. Here, we employed chemical-genetic strategies to activate individually PERK or IRE1 uncoupled from protein misfolding. We found that sustained PERK signaling impaired cell proliferation and promoted apoptosis. By contrast, equivalent durations of IRE1 signaling enhanced cell proliferation without promoting cell death. These results demonstrate that extended PERK and IRE1 signaling have opposite effects on cell viability. Differential activation of PERK and IRE1 may determine life or death decisions after ER protein misfolding.	[Lin, Jonathan H.; Li, Han; Walter, Peter] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Lin, Jonathan H.; Li, Han; Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Zhang, Yuhong; Ron, David] NYU, Sch Med, Dept Cell Biol & Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; New York University	Lin, JH (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	JLin@ucsd.edu	Longo, Kenneth A/A-5631-2010	Ron, David/0000-0002-3014-5636; Lin, Jonathan/0000-0002-7438-6941	NIH [DK047119, ES08681, EY018313, GM032384]; Cystic Fibrosis Foundation; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [K08EY018313, R01EY020846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047119, R29DK047119, R37DK047119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032384, R01GM032384] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants DK047119, ES08681, EY018313, and GM032384, and the Cystic Fibrosis Foundation. Peter Walter is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr RK, 2001, INT J BIOCHEM CELL B, V33, P1047, DOI 10.1016/S1357-2725(01)00093-0; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Dan H, 2008, BIOCHEM BIOPH RES CO, V365, P777, DOI 10.1016/j.bbrc.2007.11.040; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Kimata Y, 2007, J CELL BIOL, V179, P75, DOI 10.1083/jcb.200704166; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Pennuto M, 2008, NEURON, V57, P393, DOI 10.1016/j.neuron.2007.12.021; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Southwood CM, 2002, NEURON, V36, P585, DOI 10.1016/S0896-6273(02)01045-0; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	37	235	250	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2009	4	1							e4170	10.1371/journal.pone.0004170	http://dx.doi.org/10.1371/journal.pone.0004170			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ID	19137072	Green Submitted, Green Published, gold			2022-12-25	WOS:000265479500001
J	Heidelberg, JF; Nelson, WC; Schoenfeld, T; Bhaya, D				Heidelberg, John F.; Nelson, William C.; Schoenfeld, Thomas; Bhaya, Devaki			Germ Warfare in a Microbial Mat Community: CRISPRs Provide Insights into the Co-Evolution of Host and Viral Genomes	PLOS ONE			English	Article								CRISPR arrays and associated cas genes are widespread in bacteria and archaea and confer acquired resistance to viruses. To examine viral immunity in the context of naturally evolving microbial populations we analyzed genomic data from two thermophilic Synechococcus isolates (Syn OS-A and Syn OS-B9) as well as a prokaryotic metagenome and viral metagenome derived from microbial mats in hotsprings at Yellowstone National Park. Two distinct CRISPR types, distinguished by the repeat sequence, are found in both the Syn OS-A and Syn OS-B9 genomes. The genome of Syn OS-A contains a third CRISPR type with a distinct repeat sequence, which is not found in Syn OS-B9, but appears to be shared with other microorganisms that inhabit the mat. The CRISPR repeats identified in the microbial metagenome are highly conserved, while the spacer sequences (hereafter referred to as "viritopes'' to emphasize their critical role in viral immunity) were mostly unique and had no high identity matches when searched against GenBank. Searching the viritopes against the viral metagenome, however, yielded several matches with high similarity some of which were within a gene identified as a likely viral lysozyme/lysin protein. Analysis of viral metagenome sequences corresponding to this lysozyme/lysin protein revealed several mutations all of which translate into silent or conservative mutations which are unlikely to affect protein function, but may help the virus evade the host CRISPR resistance mechanism. These results demonstrate the varied challenges presented by a natural virus population, and support the notion that the CRISPR/viritope system must be able to adapt quickly to provide host immunity. The ability of metagenomics to track population-level variation in viritope sequences allows for a culture-independent method for evaluating the fast co-evolution of host and viral genomes and its consequence on the structuring of complex microbial communities.	[Nelson, William C.] Univ So Calif, Dept Biol Sci, Marine Environm Biol Div, Wrigley Inst Environm Studies, Avalon, CA USA; [Schoenfeld, Thomas] Lucigen Corp, Middleton, WI USA; [Bhaya, Devaki] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA USA	University of Southern California; Carnegie Institution for Science	Heidelberg, JF (corresponding author), Univ So Calif, Dept Biol Sci, Marine Environm Biol Div, Wrigley Inst Environm Studies, Avalon, CA USA.	jheidelb@usc.edu	Nelson, William C/E-9263-2016	Nelson, William C/0000-0002-1873-3929; Heidelberg, John/0000-0003-0673-3224	Nation Science Foundation Frontiers in Integrative Biological Research (FIBR) award [EF-0328698]	Nation Science Foundation Frontiers in Integrative Biological Research (FIBR) award	This research was supported by the Nation Science Foundation Frontiers in Integrative Biological Research (FIBR) award (EF-0328698).	Ackermann HW, 2007, RES MICROBIOL, V158, P555, DOI 10.1016/j.resmic.2007.07.006; Allewalt JP, 2006, APPL ENVIRON MICROB, V72, P544, DOI 10.1128/AEM.72.1.544-550.2006; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; BELOGLAZOVA N, 2008, J BIOL CHEM; Bhaya D, 2007, ISME J, V1, P703, DOI 10.1038/ismej.2007.46; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Brock T.D., 1978, THERMOPHILIC MICROOR; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fischetti VA, 2005, TRENDS MICROBIOL, V13, P491, DOI 10.1016/j.tim.2005.08.007; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; MOJICA FJM, 1995, MOL MICROBIOL, V17, P85, DOI 10.1111/j.1365-2958.1995.mmi_17010085.x; Nubel U, 2002, APPL ENVIRON MICROB, V68, P4593, DOI 10.1128/AEM.68.9.4593-4603.2002; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Ramsing NB, 2000, APPL ENVIRON MICROB, V66, P1038, DOI 10.1128/AEM.66.3.1038-1049.2000; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; SCHOENFELD T, 2008, APPL ENV MICROBIOL; Snyder JC, 2004, MICROB ECOL, V48, P561, DOI 10.1007/s00248-004-0246-9; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; Ueda K, 2004, NUCLEIC ACIDS RES, V32, P4937, DOI 10.1093/nar/gkh830; Ward DM, 2006, ANTON LEEUW INT J G, V90, P309, DOI 10.1007/s10482-006-9090-x; Ward DM, 1998, MICROBIOL MOL BIOL R, V62, P1353, DOI 10.1128/MMBR.62.4.1353-1370.1998; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000	40	107	126	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2009	4	1							e4169	10.1371/journal.pone.0004169	http://dx.doi.org/10.1371/journal.pone.0004169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GB	19132092	gold, Green Published, Green Submitted			2022-12-25	WOS:000265473700008
J	Cudney-Bueno, R; Lavin, MF; Marinone, SG; Raimondi, PT; Shaw, WW				Cudney-Bueno, Richard; Lavin, Miguel F.; Marinone, Silvio G.; Raimondi, Peter T.; Shaw, William W.			Rapid Effects of Marine Reserves via Larval Dispersal	PLOS ONE			English	Article								Marine reserves have been advocated worldwide as conservation and fishery management tools. It is argued that they can protect ecosystems and also benefit fisheries via density-dependent spillover of adults and enhanced larval dispersal into fishing areas. However, while evidence has shown that marine reserves can meet conservation targets, their effects on fisheries are less understood. In particular, the basic question of if and over what temporal and spatial scales reserves can benefit fished populations via larval dispersal remains unanswered. We tested predictions of a larval transport model for a marine reserve network in the Gulf of California, Mexico, via field oceanography and repeated density counts of recently settled juvenile commercial mollusks before and after reserve establishment. We show that local retention of larvae within a reserve network can take place with enhanced, but spatially-explicit, recruitment to local fisheries. Enhancement occurred rapidly ( 2 yrs), with up to a three-fold increase in density of juveniles found in fished areas at the downstream edge of the reserve network, but other fishing areas within the network were unaffected. These findings were consistent with our model predictions. Our findings underscore the potential benefits of protecting larval sources and show that enhancement in recruitment can be manifested rapidly. However, benefits can be markedly variable within a local seascape. Hence, effects of marine reserve networks, positive or negative, may be overlooked when only focusing on overall responses and not considering finer spatially-explicit responses within a reserve network and its adjacent fishing grounds. Our results therefore call for future research on marine reserves that addresses this variability in order to help frame appropriate scenarios for the spatial management scales of interest.	[Shaw, William W.] Univ Arizona, Sch Nat Resources, Tucson, AZ 85721 USA; [Cudney-Bueno, Richard; Raimondi, Peter T.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Cudney-Bueno, Richard] CEDO, Puerto Penasco, Mexico; [Lavin, Miguel F.; Marinone, Silvio G.] CICESE, Dept Oceanografia Fisica, Ensenada, Baja California, Mexico	University of Arizona; University of California System; University of California Santa Cruz; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada	Cudney-Bueno, R (corresponding author), Univ Arizona, Sch Nat Resources, Tucson, AZ 85721 USA.	cud@ag.arizona.edu			David and Lucile Packard Foundation; PADI-Project AWARE; Sandler Family Foundation; Tinker Foundation; Wallace Research Foundation; World Wildlife Fund	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); PADI-Project AWARE; Sandler Family Foundation; Tinker Foundation; Wallace Research Foundation; World Wildlife Fund	Research was funded by the David and Lucile Packard Foundation, PADI-Project AWARE, Sandler Family Foundation, Tinker Foundation, Wallace Research Foundation, and World Wildlife Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; BAQUEIRO E, 1988, I NACL PESCA MEXIC D, V11, P1; Botsford LW, 2001, ECOL LETT, V4, P144; Botsford LW, 2003, ECOL APPL, V13, pS25; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cudney-Bueno R, 2008, B MAR SCI, V83, P285; DASARO CN, 1991, OPHELIA, V35, P1; Gaines SD, 2003, ECOL APPL, V13, pS32; Gaylord B, 2005, ECOL APPL, V15, P2180, DOI 10.1890/04-1810; Halpern BS, 2003, ECOL APPL, V13, pS117; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Hastings A, 2003, ECOL APPL, V13, pS65; Hastings A, 1999, SCIENCE, V284, P1537, DOI 10.1126/science.284.5419.1537; Lavin MF, 1997, J PHYS OCEANOGR, V27, P2298, DOI 10.1175/1520-0485(1997)027<2298:LOOTCI>2.0.CO;2; Marinone SG, 2005, ESTUAR COAST SHELF S, V64, P519, DOI 10.1016/j.ecss.2005.03.009; Marinone SG, 2004, ESTUAR COAST SHELF S, V60, P611, DOI 10.1016/j.ecss.2004.03.002; Marinone SG, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001720; Mateos E, 2006, DEEP-SEA RES PT II, V53, P60, DOI 10.1016/j.dsr2.2005.07.010; National Research Council, 2001, MAR PROT AR TOOLS SU; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; Ostrom E., 1990, GOVERNING COMMONS EV; Parnell PE, 2002, VELIGER, V45, P58; Roberts C., 2000, WWF ENDANGERED SEAS; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Russ GR, 2004, ECOL APPL, V14, P597, DOI 10.1890/03-5076; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Sale PF, 2004, INTEGR COMP BIOL, V44, P390, DOI 10.1093/icb/44.5.390; Villalejo-Fuerte M, 2002, J SHELLFISH RES, V21, P103	29	87	87	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2009	4	1							e4140	10.1371/journal.pone.0004140	http://dx.doi.org/10.1371/journal.pone.0004140			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FZ	19129910	Green Published, gold			2022-12-25	WOS:000265473500001
J	Stolze-Rybczynski, JL; Cui, YL; Stevens, MHH; Davis, DJ; Fischer, MWF; Money, NP				Stolze-Rybczynski, Jessica L.; Cui, Yunluan; Stevens, M. Henry H.; Davis, Diana J.; Fischer, Mark W. F.; Money, Nicholas P.			Adaptation of the Spore Discharge Mechanism in the Basidiomycota	PLOS ONE			English	Article								Spore discharge in the majority of the 30,000 described species of Basidiomycota is powered by the rapid motion of a fluid droplet, called Buller's drop, over the spore surface. In basidiomycete yeasts, and phytopathogenic rusts and smuts, spores are discharged directly into the airflow around the fungal colony. Maximum discharge distances of 12 mm have been reported for these fungi. In mushroom-forming species, however, spores are propelled over much shorter ranges. In gilled mushrooms, for example, discharge distances of <0.1 mm ensure that spores do not collide with opposing gill surfaces. The way in which the range of the mechanism is controlled has not been studied previously. Methodology/Principal Findings: In this study, we report high-speed video analysis of spore discharge in selected basidiomycetes ranging from yeasts to wood-decay fungi with poroid fruiting bodies. Analysis of these video data and mathematical modeling show that discharge distance is determined by both spore size and the size of the Buller's drop. Furthermore, because the size of Buller's drop is controlled by spore shape, these experiments suggest that seemingly minor changes in spore morphology exert major effects upon discharge distance. Conclusions/Significance: This biomechanical analysis of spore discharge mechanisms in mushroom-forming fungi and their relatives is the first of its kind and provides a novel view of the incredible variety of spore morphology that has been catalogued by traditional taxonomists for more than 200 years. Rather than representing non-selected variations in micromorphology, the new experiments show that changes in spore architecture have adaptive significance because they control the distance that the spores are shot through air. For this reason, evolutionary modifications to fruiting body architecture, including changes in gill separation and tube diameter in mushrooms, must be tightly linked to alterations in spore morphology.	[Stolze-Rybczynski, Jessica L.; Cui, Yunluan; Stevens, M. Henry H.; Davis, Diana J.; Money, Nicholas P.] Miami Univ, Dept Bot, Oxford, OH 45056 USA; [Davis, Diana J.; Fischer, Mark W. F.] Coll Mt St Joseph, Dept Chem & Phys Sci, Cincinnati, OH USA	University System of Ohio; Miami University; Mount St. Joseph University	Stolze-Rybczynski, JL (corresponding author), Miami Univ, Dept Bot, Oxford, OH 45056 USA.	moneynp@muohio.edu			National Science Foundation [0743074]; National Institutes of Health [1R15 ES016425]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R15ES016425] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project was funded by grants from the National Science Foundation (0743074) to N.P.M. and D.J.D., and the National Institutes of Health (1R15 ES016425) to N.P.M. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buller A.H.R., 1922, RES FUNGI, V2; Buller AHR, 1909, RES FUNGI, VI; Gilbertson R. L., 1987, N AM POLYPORES, V2; Ingold C. T., 1992, Mycologist, V6, P111; Ingold C. Terence, 2001, Mycologist, V15, P165; Majdalani J., 2006, VISCOUS FLUID FLOW, V3; PEGLER DN, 1971, NOVA HEDWIGIA, V35; Pringle A, 2005, MYCOLOGIA, V97, P866, DOI 10.3852/mycologia.97.4.866; Ryvarden L., 1986, N AM POLYPORES, VI; TURNER JCR, 1991, CHEM ENG SCI, V46, P1145, DOI 10.1016/0009-2509(91)85107-9; TURNER JCR, 1995, CHEM ENG SCI, V50, P2359, DOI 10.1016/0009-2509(95)00097-O; WEBSTER J, 1995, MYCOL RES, V99, P833, DOI 10.1016/S0953-7562(09)80737-5; WEBSTER J, 1984, T BRIT MYCOL SOC, V83, P524, DOI 10.1016/S0007-1536(84)80055-8; Webster J., 2007, INTRO FUNGI, V3rd; Yafetto L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003237; ZOBERI MH, 1969, T BRIT MYCOL SOC, V52, P170, DOI 10.1016/S0007-1536(69)80172-5	16	26	28	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2009	4	1							e4163	10.1371/journal.pone.0004163	http://dx.doi.org/10.1371/journal.pone.0004163			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FZ	19129912	Green Published, gold, Green Submitted			2022-12-25	WOS:000265473500010
J	Emadi, S; Kasturirangan, S; Wang, MS; Schulz, P; Sierks, MR				Emadi, Sharareh; Kasturirangan, Srinath; Wang, Min S.; Schulz, Philip; Sierks, Michael R.			Detecting Morphologically Distinct Oligomeric Forms of alpha-Synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BY-PASSING IMMUNIZATION; MULTIPLE SYSTEM ATROPHY; A-BETA COMPONENT; PARKINSONS-DISEASE; PROTEIN MORPHOLOGIES; CEREBROSPINAL-FLUID; HUMAN-ANTIBODIES; PHAGE DISPLAY; LEWY BODIES; CELL-DEATH	Neuropathologic and genetics studies as well as transgenic animal models have provided strong evidence linking misfolding and aggregation of alpha-synuclein to the progression of Parkinson disease (PD) and other related disorders. A growing body of evidence implicates various oligomeric forms of alpha-synuclein as the toxic species responsible for neurodegeneration and neuronal cell death. Although numerous different oligomeric forms of alpha-synuclein have been identified in vitro, it is not known which forms are involved in PD or how, when, and where different forms contribute to the progression of PD. Reagents that can interact with specific aggregate forms of alpha-synuclein would be very useful not only as tools to study how different aggregate forms affect cell function, but also as potential diagnostic and therapeutic agents for PD. Here we show that a single chain antibody fragment (syn-10H scFv) isolated from a phage display antibody library binds to a larger, later stage oligomeric form of alpha-synuclein than a previously reported oligomeric specific scFv isolated in our laboratory. The scFv described here inhibits aggregation of alpha-synuclein in vitro, blocks extracellular alpha-synuclein-induced toxicity in both undifferentiated and differentiated human neuroblastoma cell lines (SH-SY5Y), and specifically recognizes naturally occurring aggregates in PD but not in healthy human brain tissue.	[Emadi, Sharareh; Kasturirangan, Srinath; Wang, Min S.; Schulz, Philip; Sierks, Michael R.] Arizona State Univ, Dept Chem Engn, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Sierks, MR (corresponding author), Box 876006, Tempe, AZ 85287 USA.	sierks@asu.edu	Wang, Min/C-6495-2009	Wang, Min/0000-0002-8978-4918	Michael J. Fox Foundation; Michael J. Fox Foundation, the Arizona Department of Health Services for the Arizona Alzheimer's Consortium; Arizona Biomedical Research Commission	Michael J. Fox Foundation; Michael J. Fox Foundation, the Arizona Department of Health Services for the Arizona Alzheimer's Consortium; Arizona Biomedical Research Commission	This work was supported by grants from the Michael J. Fox Foundation, the Arizona Department of Health Services for the Arizona Alzheimer's Consortium, and the Arizona Biomedical Research Commission. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Apetri MM, 2006, J MOL BIOL, V355, P63, DOI 10.1016/j.jmb.2005.10.071; Baba M, 1998, AM J PATHOL, V152, P879; Barkhordarian H, 2006, PROTEIN ENG DES SEL, V19, P497, DOI 10.1093/protein/gzl036; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Bodles AM, 2000, EUR J BIOCHEM, V267, P2186, DOI 10.1046/j.1432-1327.2000.01219.x; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; CARTER P, 1985, NUCLEIC ACIDS RES, V13, P4431, DOI 10.1093/nar/13.12.4431; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Conway KA, 2000, ANN NY ACAD SCI, V920, P42; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Du HN, 2003, BIOCHEMISTRY-US, V42, P8870, DOI 10.1021/bi034028+; El-Agnaf OMA, 2004, FASEB J, V18, P1315, DOI 10.1096/fj.03-1346fje; El-Agnaf OMA, 1998, FEBS LETT, V440, P71, DOI 10.1016/S0014-5793(98)01418-5; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Emadi S, 2007, J MOL BIOL, V368, P1132, DOI 10.1016/j.jmb.2007.02.089; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Golts N, 2002, J BIOL CHEM, V277, P16116, DOI 10.1074/jbc.M107866200; Gomez-Tortosa E, 1999, NEUROLOGY, V53, P1284, DOI 10.1212/WNL.53.6.1284; Gosavi N, 2002, J BIOL CHEM, V277, P48984, DOI 10.1074/jbc.M208194200; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; HOOGENBOOM HR, 1992, J MOL BIOL, V227, P381, DOI 10.1016/0022-2836(92)90894-P; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lashuel Hilal A., 2004, V299, P19; Lecerf JM, 2001, P NATL ACAD SCI USA, V98, P4764, DOI 10.1073/pnas.071058398; Lee EN, 2004, BIOCHEMISTRY-US, V43, P3704, DOI 10.1021/bi0356707; Lee PH, 2006, J NEURAL TRANSM, V113, P1435, DOI 10.1007/s00702-005-0427-9; Liu RT, 2004, BIOCHEMISTRY-US, V43, P6959, DOI 10.1021/bi049933o; Marcus WD, 2006, BIOCHEM BIOPH RES CO, V342, P1123, DOI 10.1016/j.bbrc.2006.02.073; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Murphy RC, 2004, MOL BRAIN RES, V121, P141, DOI 10.1016/j.molbrainres.2003.11.011; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; PAHLMAN S, 1995, EUR J CANCER, V31A, P453, DOI 10.1016/0959-8049(95)00033-F; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Presgraves SP, 2004, NEUROTOX RES, V5, P579, DOI 10.1007/bf03033178; Price DL, 1999, NATURE, V399, pA3, DOI 10.1038/399a003; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schapira AHV, 1997, BAILLIERE CLIN NEUR, V6, P15; Seo JH, 2002, FASEB J, V16, P1826, DOI 10.1096/fj.02-0041fje; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Sung JY, 2001, J BIOL CHEM, V276, P27441, DOI 10.1074/jbc.M101318200; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Wakabayashi K, 1998, ACTA NEUROPATHOL, V96, P445, DOI 10.1007/s004010050918; Wang MS, 2009, LANGMUIR, V25, P912, DOI 10.1021/la8025914; Wheeler YRY, 2003, MOL THER, V8, P355, DOI 10.1016/S1525-0016(03)00183-7; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Zameer A, 2008, J MOL BIOL, V384, P917, DOI 10.1016/j.jmb.2008.09.068; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhou C, 2004, MOL THER, V10, P1023, DOI 10.1016/j.ymthe.2004.08.019	66	74	86	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11048	11058		10.1074/jbc.M806559200	http://dx.doi.org/10.1074/jbc.M806559200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19141614	Green Published, hybrid			2022-12-25	WOS:000265494500009
J	Rechtman, MM; Nakaryakov, A; Shapira, KE; Ehrlich, M; Henis, YI				Rechtman, Maya Mouler; Nakaryakov, Alex; Shapira, Keren E.; Ehrlich, Marcelo; Henis, Yoav I.			Different Domains Regulate Homomeric and Heteromeric Complex Formation among Type I and Type II Transforming Growth Factor-beta Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-VIRUS HEMAGGLUTININ; HETEROOLIGOMERIC COMPLEXES; EXTRACELLULAR DOMAIN; OLIGOMERIC STRUCTURE; CYTOPLASMIC DOMAIN; CELL-MEMBRANE; PROTEIN; SIGNAL; FORM; MECHANISMS	Transforming growth factor-beta(TGF-beta) binds to and signals via two serine-threonine kinase receptors, type I (T beta RI) and type II (T beta RII). The oligomerization of TGF-beta receptors modulates ligand binding and receptor trafficking and may contribute to signal diversification. However, numerous features of the molecular domains that determine the homo- and hetero-oligomerization of full-length receptors at the cell surface and the mode of these interactions remain unclear. Here, we address these questions through computerized immunofluorescence co-patching and patch/fluorescence recovery after photo-bleaching measurements of different combinations of epitope-tagged receptors and their mutants in live cells. We show that T beta RI and T beta RII are present on the plasma membrane both as monomers and homo- and hetero-oligomers. The homodimerization of T beta RII depends on a cytoplasmic juxtamembrane region (amino acid residues 200-220). In contrast, the cytoplasmic domain of T beta RI is dispensable for its homodimerization. T beta RI.T beta RII hetero-oligomerization depends on the cytoplasmic domain of T beta RI and on a C-terminal region of T beta RII (residues 419-565). TGF-beta 1 elevates T beta RII homodimerization to some degree and strongly enhances T beta RI.T beta RII heteromeric complex formation. Both ligand-induced effects depend on the region encompassed between residues 200-242 of T beta RII. Furthermore, the kinase activity of T beta RI is also necessary for the latter effect. All forms of the homo- and hetero-oligomers, whether constitutively present on the membrane or formed upon TGF-beta 1 stimulation, were stable in the time-scale of our patch/FRAP measurements. We suggest that the different forms of receptor oligomerization may serve as a basis for the heterogeneity of TGF-beta signaling responses.	[Ehrlich, Marcelo] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Rechtman, Maya Mouler; Nakaryakov, Alex; Shapira, Keren E.; Henis, Yoav I.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Ehrlich, M (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	marceloe@tauex.tau.ac.il; henis@post.tau.ac.il		Ehrlich, Marcelo/0000-0002-2352-1808; Henis, Yoav/0000-0002-1408-3877	Israel Science Foundation [185/05]; Israel Cancer Research Fund; Israel Cancer Association	Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund; Israel Cancer Association	This work was supported in part by Israel Science Foundation Grant 185/05 and by The Israel Cancer Research Fund and The Israel Cancer Association (to Y.I.H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ALEXANDROW MG, 1995, CANCER RES, V55, P1452; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; CHEN RH, 1995, J BIOL CHEM, V270, P12235, DOI 10.1074/jbc.270.20.12235; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; Ehrlich M, 2001, J CELL SCI, V114, P1777; Eisenberg S, 2006, MOL CELL BIOL, V26, P7190, DOI 10.1128/MCB.01059-06; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; Gilboa L, 1998, J CELL BIOL, V140, P767, DOI 10.1083/jcb.140.4.767; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; HENIS YI, 1990, J CELL BIOL, V111, P1409, DOI 10.1083/jcb.111.4.1409; HENIS YI, 1994, J CELL BIOL, V126, P139, DOI 10.1083/jcb.126.1.139; Hu PPC, 1998, ENDOCR REV, V19, P349, DOI 10.1210/er.19.3.349; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; INAGAKI M, 1993, P NATL ACAD SCI USA, V90, P5359, DOI 10.1073/pnas.90.11.5359; KEMBLE GW, 1994, CELL, V76, P383, DOI 10.1016/0092-8674(94)90344-1; Keren T, 2001, J BIOL CHEM, V276, P28356, DOI 10.1074/jbc.M102235200; KOPPEL DE, 1976, BIOPHYS J, V16, P1315, DOI 10.1016/S0006-3495(76)85776-1; Lachmanovich E, 2003, J MICROSC-OXFORD, V212, P122, DOI 10.1046/j.1365-2818.2003.01239.x; LAIHO M, 1991, J BIOL CHEM, V266, P9108; Letourneur O, 1996, BIOCHEM BIOPH RES CO, V224, P709, DOI 10.1006/bbrc.1996.1088; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; LIN HY, 1995, J BIOL CHEM, V270, P2747, DOI 10.1074/jbc.270.6.2747; Lin SS, 1998, J CELL BIOL, V142, P51, DOI 10.1083/jcb.142.1.51; Liu XD, 2000, ONCOGENE, V19, P5926, DOI 10.1038/sj.onc.1203991; Liu XD, 2000, ANAL BIOCHEM, V280, P20, DOI 10.1006/abio.2000.4478; Luo KX, 1996, EMBO J, V15, P4485, DOI 10.1002/j.1460-2075.1996.tb00826.x; Luo KX, 1997, EMBO J, V16, P1970, DOI 10.1093/emboj/16.8.1970; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MOUSTAKAS A, 1993, J BIOL CHEM, V268, P22215; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; PETERSEN NO, 1986, HDB EXPT IMMUNOLOGY; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; ROBERTS AB, 1990, PEPTIDE GROWTH FACTO, P419; RODRIGUEZ C, 1995, J BIOL CHEM, V270, P15919, DOI 10.1074/jbc.270.27.15919; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shvartsman DE, 2003, J CELL BIOL, V163, P879, DOI 10.1083/jcb.200308142; Stockwell BR, 1998, CURR BIOL, V8, P761, DOI 10.1016/S0960-9822(98)70299-4; WeisGarcia F, 1996, EMBO J, V15, P276, DOI 10.1002/j.1460-2075.1996.tb00358.x; Wells RG, 1999, J BIOL CHEM, V274, P5716, DOI 10.1074/jbc.274.9.5716; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; YAMASHITA H, 1994, J BIOL CHEM, V269, P20172; Zhu HJ, 1999, J BIOL CHEM, V274, P29220, DOI 10.1074/jbc.274.41.29220; Zuniga JE, 2005, J MOL BIOL, V354, P1052, DOI 10.1016/j.jmb.2005.10.014	48	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7843	7852		10.1074/jbc.M809215200	http://dx.doi.org/10.1074/jbc.M809215200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19147499	hybrid, Green Published			2022-12-25	WOS:000264195600046
J	Tremblay, F; Revett, T; Huard, C; Zhang, Y; Tobin, JF; Martinez, RV; Gimeno, RE				Tremblay, Frederic; Revett, Tracy; Huard, Christine; Zhang, Ying; Tobin, James F.; Martinez, Robert V.; Gimeno, Ruth E.			Bidirectional Modulation of Adipogenesis by the Secreted Protein Ccdc80/DRO1/URB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-GAMMA; GLYCOGEN-SYNTHASE KINASE-3-BETA; ADIPOSE-TISSUE; PPAR-GAMMA; ADIPOCYTE DIFFERENTIATION; INSULIN-RESISTANCE; GENE-EXPRESSION; KINASE PATHWAY; INHIBITION; OBESITY	Adipocyte-secreted proteins play important roles in metabolic regulation through autocrine, paracrine, and endocrine mechanisms. Using transcriptional profiling, we identified coiled-coil domain containing 80 (Ccdc80; also known as DRO1 and URB) as a novel secreted protein highly expressed in white adipose tissue. In 3T3-L1 cells Ccdc80 is expressed and secreted in a biphasic manner with high levels in postconfluent preadipocytes and terminally differentiated adipocytes. To determine whether Ccdc80 regulates adipocyte differentiation, Ccdc80 expression was manipulated using both knockdown and overexpression approaches. Small hairpin RNA-mediated silencing of Ccdc80 in 3T3-L1 cells inhibits adipocyte differentiation. This phenotype was partially reversed by treating the knockdown cells with Ccdc80-containing conditioned medium from differentiated 3T3-L1 cells. Molecular studies indicate that Ccdc80 is required for the full inhibition of T-cell factor-mediated transcriptional activity, down-regulation of Wnt/beta-catenin target genes during clonal expansion, and the subsequent induction of C/EBP alpha and peroxisome proliferator-activated receptor gamma. Surprisingly, overexpression of Ccdc80 in 3T3-L1 cells also inhibits adipocyte differentiation without affecting the repression of the Wnt/beta-catenin signaling pathway. Taken together, these data suggest that Ccdc80 plays dual roles in adipogenesis by mechanisms that involve at least in part down-regulation of Wnt/beta-catenin signaling and induction of C/EBP alpha and peroxisome proliferator-activated receptor gamma.	[Tremblay, Frederic; Revett, Tracy; Tobin, James F.; Gimeno, Ruth E.] Wyeth Res, Dept Metab Dis, Cambridge, MA 02140 USA; [Huard, Christine; Zhang, Ying; Martinez, Robert V.] Wyeth Res, Dept Biol Technol, Cambridge, MA 02140 USA	Pfizer; Pfizer	Gimeno, RE (corresponding author), Wyeth Res, Dept Metab Dis, 200 Cambridge Pk Dr, Cambridge, MA 02140 USA.	rgimeno@wyeth.com						Aoki K, 2002, BIOCHEM BIOPH RES CO, V290, P1282, DOI 10.1006/bbrc.2002.6337; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Berasi SP, 2006, J BIOL CHEM, V281, P27167, DOI 10.1074/jbc.M602416200; Bommer GT, 2005, J BIOL CHEM, V280, P7962, DOI 10.1074/jbc.M412593200; Bost F, 2005, DIABETES, V54, P402, DOI 10.2337/diabetes.54.2.402; Cheung KJ, 2007, CELL METAB, V5, P115, DOI 10.1016/j.cmet.2007.01.005; Christodoulides C, 2006, DIABETOLOGIA, V49, P678, DOI 10.1007/s00125-006-0144-4; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Hosooka T, 2008, NAT MED, V14, P188, DOI 10.1038/nm1706; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; KAESTNER KH, 1989, P NATL ACAD SCI USA, V86, P3150, DOI 10.1073/pnas.86.9.3150; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kim KA, 2007, MOL CELL BIOL, V27, P2294, DOI 10.1128/MCB.02207-06; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lake AC, 2005, J LIPID RES, V46, P2477, DOI 10.1194/jlr.M500290-JLR200; Lee KW, 2002, J ENDOCRINOL, V175, P33, DOI 10.1677/joe.0.1750033; Liu JJ, 2006, MOL CELL BIOL, V26, P5827, DOI 10.1128/MCB.00441-06; Liu JQ, 2004, J BIOL CHEM, V279, P24493, DOI [10.1074/jbc.M402920200, 10.1074/jbc.M407050200]; Liu Y, 2004, BIOCHEM BIOPH RES CO, V322, P497, DOI 10.1016/j.bbrc.2004.07.161; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; MACDOUGALD OA, 1995, P NATL ACAD SCI USA, V92, P9034, DOI 10.1073/pnas.92.20.9034; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Marcantonio D, 2001, ENDOCRINOLOGY, V142, P2409, DOI 10.1210/endo.142.6.8154; Mei BS, 2002, BIOCHEM J, V364, P137, DOI 10.1042/bj3640137; Moldes M, 2003, BIOCHEM J, V376, P607, DOI 10.1042/BJ20030426; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nawrocki AR, 2005, DRUG DISCOV TODAY, V10, P1219, DOI 10.1016/S1359-6446(05)03569-5; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Okada T, 2008, BIOCHEM BIOPH RES CO, V367, P370, DOI 10.1016/j.bbrc.2007.12.164; Orlicky DJ, 2001, J LIPID RES, V42, P460; Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross DA, 2004, MOL CELL BIOL, V24, P3505, DOI 10.1128/MCB.24.8.3505-3513.2004; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Shinohara ML, 2008, P NATL ACAD SCI USA, V105, P7235, DOI 10.1073/pnas.0802301105; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Visconti R, 2003, ONCOGENE, V22, P1087, DOI 10.1038/sj.onc.1206194; Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010; Wang J, 2006, J BIOL CHEM, V281, P33842, DOI 10.1074/jbc.M607873200; Wang YH, 2006, MOL CELL BIOL, V26, P5421, DOI 10.1128/MCB.02437-05; Wright WS, 2007, DIABETES, V56, P295, DOI 10.2337/db06-1339	55	41	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8136	8147		10.1074/jbc.M809535200	http://dx.doi.org/10.1074/jbc.M809535200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19141617	Green Published, hybrid			2022-12-25	WOS:000264195600076
J	Suarez, J; Ranguelova, K; Jarzecki, AA; Manzerova, J; Krymov, V; Zhao, XB; Yu, SW; Metlitsky, L; Gerfen, GJ; Magliozzo, RS				Suarez, Javier; Ranguelova, Kalina; Jarzecki, Andrzej A.; Manzerova, Julia; Krymov, Vladimir; Zhao, Xiangbo; Yu, Shengwei; Metlitsky, Leonid; Gerfen, Gary J.; Magliozzo, Richard S.			An Oxyferrous Heme/Protein-based Radical Intermediate Is Catalytically Competent in the Catalase Reaction of Mycobacterium tuberculosis Catalase-Peroxidase (KatG)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; HIGH-FIELD EPR; COLI RIBONUCLEOTIDE REDUCTASE; SITE-DIRECTED MUTAGENESIS; CYTOCHROME-C PEROXIDASE; TRP CROSS-LINK; ESCHERICHIA-COLI; COMPOUND-I; HYDROGEN-PEROXIDE; TYROSYL RADICALS	Amechanism accounting for the robust catalase activity in catalase-peroxidases (KatG) presents a new challenge in heme protein enzymology. In Mycobacterium tuberculosis, KatG is the sole catalase and is also responsible for peroxidative activation of isoniazid, an anti-tuberculosis pro-drug. Here, optical stopped-flow spectrophotometry, rapid freeze-quench EPR spectroscopy both at the X-band and at the D-band, and mutagenesis are used to identify catalase reaction intermediates in M. tuberculosis KatG. In the presence of millimolar H2O2 at neutral pH, oxyferrous heme is formed within milliseconds from ferric (resting) KatG, whereas at pH 8.5, low spin ferric heme is formed. Using rapid freeze-quench EPR at X-band under both of these conditions, a narrow doublet radical signal with an 11 G principal hyperfine splitting was detected within the first milliseconds of turnover. The radical and the unique heme intermediates persist in wild-type KatG only during the time course of turnover of excess H2O2 (1000-fold or more). Mutation of Met(255), Tyr(229), or Trp(107), which have covalently linked side chains in a unique distal side adduct (MYW) in wild-type KatG, abolishes this radical and the catalase activity. The D-band EPR spectrum of the radical exhibits a rhombic g tensor with dual g(x) values (2.00550 and 2.00606) and unique g(y) (2.00344) and g(z) values (2.00186) similar to but not typical of native tyrosyl radicals. Density functional theory calculations based on a model of an MYW adduct radical built from x-ray coordinates predict experimentally observed hyperfine interactions and a shift in g values away from the native tyrosyl radical. A catalytic role for an MYW adduct radical in the catalase mechanism of KatG is proposed.	[Suarez, Javier; Ranguelova, Kalina; Jarzecki, Andrzej A.; Zhao, Xiangbo; Yu, Shengwei; Metlitsky, Leonid; Magliozzo, Richard S.] CUNY Brooklyn Coll, Dept Chem, Brooklyn, NY 11210 USA; [Suarez, Javier; Jarzecki, Andrzej A.; Magliozzo, Richard S.] CUNY, Grad Ctr, Dept Chem, New York, NY 10016 USA; [Suarez, Javier; Jarzecki, Andrzej A.; Magliozzo, Richard S.] CUNY, Grad Ctr, Dept Biochem, New York, NY 10016 USA; [Manzerova, Julia; Krymov, Vladimir; Gerfen, Gary J.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA	City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; Yeshiva University; Albert Einstein College of Medicine	Magliozzo, RS (corresponding author), CUNY Brooklyn Coll, Dept Chem, 2900 Bedford Ave, Brooklyn, NY 11210 USA.	rmaglioz@brooklyn.cun.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI060014, R01AI060014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075920] Funding Source: NIH RePORTER; NIAID NIH HHS [AI060014] Funding Source: Medline; NIGMS NIH HHS [GM075920] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson KK, 2002, SPECTROCHIM ACTA A, V58, P1101, DOI 10.1016/S1386-1425(01)00700-4; BAERENDS EJ, 2007, ADF 2007 01 SCM; BEERS RF, 1952, J BIOL CHEM, V195, P133; BENDER CJ, 1989, J AM CHEM SOC, V111, P8076, DOI 10.1021/ja00203a002; Bleifuss G, 2001, BIOCHEMISTRY-US, V40, P15362, DOI 10.1021/bi010707d; BOX HC, 1976, J CHEM SOC PERK T 2, P553, DOI 10.1039/p29760000553; BURGHAUS O, 1992, MEAS SCI TECHNOL, V3, P765, DOI 10.1088/0957-0233/3/8/013; Carpena X, 2006, BIOCHEMISTRY-US, V45, P5171, DOI 10.1021/bi060017f; Chouchane S, 2000, BIOCHEMISTRY-US, V39, P9975, DOI 10.1021/bi0005815; Chouchane S, 2002, J BIOL CHEM, V277, P42633, DOI 10.1074/jbc.M207916200; Collins DM, 1996, TRENDS MICROBIOL, V4, P426, DOI 10.1016/0966-842X(96)10066-4; Cossi M, 2002, J CHEM PHYS, V117, P43, DOI 10.1063/1.1480445; DeGray JA, 1997, J BIOL CHEM, V272, P2359; Denisov IG, 2002, J BIOL CHEM, V277, P42706, DOI 10.1074/jbc.M207949200; Dorlet P, 2002, BIOCHEMISTRY-US, V41, P6107, DOI 10.1021/bi015871f; Duboc-Toia C, 2003, J AM CHEM SOC, V125, P38, DOI 10.1021/ja026690j; Faller P, 2003, P NATL ACAD SCI USA, V100, P8732, DOI 10.1073/pnas.1530926100; Farrar CT, 1997, J PHYS CHEM B, V101, P6634, DOI 10.1021/jp9709518; Frisch M., 2016, GAUSSIAN 16 REVISION; Garcia-Serres R, 2007, J AM CHEM SOC, V129, P1402, DOI 10.1021/ja067209i; Gerfen GJ, 1996, J PHYS CHEM-US, V100, P16739, DOI 10.1021/jp960709l; GERFEN GJ, 1993, J AM CHEM SOC, V115, P6420, DOI 10.1021/ja00067a071; Gerfen GJ, 1996, J AM CHEM SOC, V118, P8192, DOI 10.1021/ja960363s; Ghiladi RA, 2005, BIOCHEMISTRY-US, V44, P15093, DOI 10.1021/bi051463q; Ghiladi RA, 2005, J BIOL CHEM, V280, P22651, DOI 10.1074/jbc.M502486200; Glendening E. D., 2001, NBO 5 0; Gunther MR, 2000, FREE RADICAL BIO MED, V28, P709, DOI 10.1016/S0891-5849(00)00164-7; Hazbon MH, 2006, ANTIMICROB AGENTS CH, V50, P2640, DOI 10.1128/AAC.00112-06; Hillar A, 2000, BIOCHEMISTRY-US, V39, P5868, DOI 10.1021/bi0000059; Ivancich A, 1999, J AM CHEM SOC, V121, P5743, DOI 10.1021/ja990562m; Ivancich A, 2001, J AM CHEM SOC, V123, P5050, DOI 10.1021/ja0036514; Ivancich A, 1997, BIOCHEMISTRY-US, V36, P9356, DOI 10.1021/bi970886s; Ivancich A, 1996, J AM CHEM SOC, V118, P12852, DOI 10.1021/ja9628361; Jakopitsch C, 2005, J BIOL CHEM, V280, P9037, DOI 10.1074/jbc.M413317200; Jakopitsch C, 2005, J BIOL CHEM, V280, P42411, DOI 10.1074/jbc.M508009200; Jakopitsch C, 2003, J BIOL CHEM, V278, P20185, DOI 10.1074/jbc.M211625200; Jakopitsch C, 2007, BIOCHEMISTRY-US, V46, P1183, DOI 10.1021/bi062266+; Jakopitsch C, 2006, J INORG BIOCHEM, V100, P1091, DOI 10.1016/j.jinorgbio.2006.02.009; Jeschke G, 2005, BBA-BIOENERGETICS, V1707, P91, DOI 10.1016/j.bbabio.2004.02.012; JOHNSSON K, 1995, J AM CHEM SOC, V117, P5009, DOI 10.1021/ja00122a038; Kato S, 2004, J BIOL CHEM, V279, P52376, DOI 10.1074/jbc.M403532200; KOU WWH, 1976, J CHEM PHYS, V64, P3060, DOI 10.1063/1.432568; Lendzian F, 1996, J AM CHEM SOC, V118, P8111, DOI 10.1021/ja960917r; Liu AM, 2000, J AM CHEM SOC, V122, P1974, DOI 10.1021/ja990123n; MARCINKEVICIENE JA, 1995, J BIOL CHEM, V270, P22290, DOI 10.1074/jbc.270.38.22290; MILLER MA, 1992, BIOCHEMISTRY-US, V31, P2789, DOI 10.1021/bi00125a020; MIYAGAWA I, 1960, J CHEM PHYS, V6, P1599; Pogni R, 2005, BIOCHEMISTRY-US, V44, P4267, DOI 10.1021/bi047474l; Putnam CD, 2000, J MOL BIOL, V296, P295, DOI 10.1006/jmbi.1999.3458; Pym A. S., 2002, Bacterial resistance to antimicrobials, P355; Pym AS, 2001, MOL MICROBIOL, V40, P879, DOI 10.1046/j.1365-2958.2001.02427.x; Ranguelova K, 2008, BIOCHEMISTRY-US, V47, P11377, DOI 10.1021/bi800952b; Ranguelova K, 2007, J BIOL CHEM, V282, P6255, DOI 10.1074/jbc.M607309200; Regelsberger G, 1999, BIOCHEMISTRY-US, V38, P10480, DOI 10.1021/bi990886n; Regelsberger G, 2001, BIOCHEM SOC T, V29, P99; Singh R, 2007, J AM CHEM SOC, V129, P15954, DOI 10.1021/ja075108u; Svistunenko DA, 2004, BIOPHYS J, V87, P582, DOI 10.1529/biophysj.104.041046; Un S, 2005, MAGN RESON CHEM, V43, pS229, DOI 10.1002/mrc.1660; Un S, 2001, J AM CHEM SOC, V123, P3048, DOI 10.1021/ja003650b; VANDERDONK WA, 1995, J AM CHEM SOC, V117, P8908, DOI 10.1021/ja00140a003; Vidossich P, 2007, J AM CHEM SOC, V129, P13436, DOI 10.1021/ja072245i; Vlasits J, 2007, FEBS LETT, V581, P320, DOI 10.1016/j.febslet.2006.12.037; Wilson JC, 2005, J AM CHEM SOC, V127, P1618, DOI 10.1021/ja043853q; Winterbourn CC, 2004, BIOCHEM J, V381, P241, DOI 10.1042/BJ20040259; Yu SW, 2003, J BIOL CHEM, V278, P14769, DOI 10.1074/jbc.M300326200; Yu SW, 2002, PROTEIN SCI, V11, P58, DOI 10.1110/ps.ps.09902; Yu SW, 2003, J BIOL CHEM, V278, P44121, DOI 10.1074/jbc.M304757200; Zhao XB, 2004, J BIOL CHEM, V279, P7606, DOI 10.1074/jbc.M311884200; Zhao XB, 2009, J BIOL CHEM, V284, P7030, DOI 10.1074/jbc.M808107200	69	66	68	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7017	7029		10.1074/jbc.M808106200	http://dx.doi.org/10.1074/jbc.M808106200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19139099	Green Published, hybrid			2022-12-25	WOS:000263919000050
J	Xu, S; Huo, J; Lee, KG; Kurosaki, T; Lam, KP				Xu, Shengli; Huo, Jianxin; Lee, Koon-Guan; Kurosaki, Tomohiro; Lam, Kong-Peng			Phospholipase C gamma 2 Is Critical for Dectin-1-mediated Ca2+ Flux and Cytokine Production in Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLUCAN RECEPTOR; C-TYPE LECTINS; ANTIGEN RECEPTOR; TYROSINE KINASE; B-CELLS; PNEUMOCYSTIS-CARINII; ANTIFUNGAL IMMUNITY; CANDIDA-ALBICANS; INNATE IMMUNITY; DC-SIGN	Dectin-1 is a C-type lectin that recognizes beta-glucan in the cell walls of fungi and plays an important role in anti-fungal immunity. It signals via tyrosine kinase Syk and adaptor protein Card9 to activate NF-kappa B leading to proinflammatory cytokine production in dendritic cells (DCs). Other than this, not much else is known of the mechanism of Dectin-1 signaling. We demonstrate here that stimulation of DCs with zymosan triggers an intracellular Ca2+ flux that can be attenuated by a blocking anti-Dectin-1 antibody or by pre-treatment of cells with the phospholipase C( PLC) gamma-inhibitor U73122, suggesting that Dectin-1 signals via a PLC gamma pathway to induce Ca2+ flux in DCs. Interestingly, treatment of DCs with particulate curdlan, which specifically engages Dectin-1, results in the phosphorylation of both PLC gamma 1 and PLC gamma 2. However, we show that PLC gamma 2 is the critical enzyme for Dectin-1 signaling in DCs. PLC gamma 2-deficient DCs have drastic impairment of Ca2+ signaling and are defective in their secretion of interleukin 2 (IL-2), IL-6, IL-10, IL-12, IL-23, and tumor necrosis factor alpha. PLC gamma 2-deficient DCs also exhibit impaired activation of ERK and JNK MAPKs and AP-1 and NFAT transcription factors in response to Dectin-1 stimulation. In addition, PLC gamma 2-deficient DCs are also impaired in their activation of NF-kappa B upon Dectin-1 engagement due to defective assembly of the Card9-Bcl10-Malt1 complex and impaired IKK alpha/beta activation and I kappa B alpha degradation. Thus, our data indicate that pattern recognition receptors such as Dectin-1 could elicit Ca2+ signaling and that PLC gamma 2 is a critical player in the Dectin-1 signal transduction pathway.	[Kurosaki, Tomohiro] RIKEN Res Ctr Allergy & Immunol, Lab Lymphocyte Differentiat, Yokohama, Kanagawa 2300045, Japan; [Xu, Shengli; Huo, Jianxin; Lee, Koon-Guan; Lam, Kong-Peng] Agcy Sci Technol & Res, Bioproc Technol Inst, Immunol Lab, Singapore 138668, Singapore	RIKEN; Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI)	Lam, KP (corresponding author), 20 Biopolis Way,06-01 Centros, Singapore 138668, Singapore.	lam_kong_peng@bti.a-star.edu.sg	Kurosaki, Tomohiro/D-1306-2009; Lam, Kong-Peng/G-5374-2012; HUO, JIANXIN/GXH-0232-2022	Kurosaki, Tomohiro/0000-0002-6352-304X; HUO, JIANXIN/0000-0003-2913-6537; Lam, Kong-Peng/0000-0002-1316-4333	Biomedical Research Council of A*STAR	Biomedical Research Council of A*STAR(Agency for Science Technology & Research (A*STAR))	This work was supported by the Biomedical Research Council of A*STAR. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Bush TJV, 2008, EUR J IMMUNOL, V38, P400, DOI 10.1002/eji.200737602; CAMBIER JC, 1994, ANNU REV IMMUNOL, V12, P457, DOI 10.1146/annurev.immunol.12.1.457; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hara H, 2008, J IMMUNOL, V181, P918, DOI 10.4049/jimmunol.181.2.918; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; HOLMSKOV U, 1994, IMMUNOL TODAY, V15, P67, DOI 10.1016/0167-5699(94)90136-8; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kurosaki T, 2000, IMMUNOL REV, V176, P19; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Lee KG, 2008, J BIOL CHEM, V283, P11189, DOI 10.1074/jbc.M708516200; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; Patke A, 2004, CURR OPIN IMMUNOL, V16, P251, DOI 10.1016/j.coi.2004.01.007; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Rothfuchs AG, 2007, J IMMUNOL, V179, P3463, DOI 10.4049/jimmunol.179.6.3463; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Seminario MC, 2003, IMMUNOL REV, V192, P80, DOI 10.1034/j.1600-065X.2003.00013.x; Slack EC, 2007, EUR J IMMUNOL, V37, P1600, DOI 10.1002/eji.200636830; Steele C, 2003, J EXP MED, V198, P1677, DOI 10.1084/jem.20030932; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; Weiss A, 1991, Semin Immunol, V3, P313; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012; Xu SL, 2007, BLOOD, V109, P3377, DOI 10.1182/blood-2006-07-036418; Yadav M, 2006, BLOOD, V108, P3168, DOI 10.1182/blood-2006-05-024406; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758	42	114	115	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7038	7046		10.1074/jbc.M806650200	http://dx.doi.org/10.1074/jbc.M806650200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19136564	Green Published, hybrid			2022-12-25	WOS:000263919000052
J	Mariscotti, JF; Garcia-del Portillo, F; Pucciarelli, MG				Mariscotti, Javier F.; Garcia-del Portillo, Francisco; Graciela Pucciarelli, M.			The Listeria monocytogenes Sortase-B Recognizes Varied Amino Acids at Position 2 of the Sorting Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL; SURFACE-PROTEINS; STAPHYLOCOCCUS-AUREUS; LPXTG MOTIF; BACILLUS-ANTHRACIS; EPITHELIAL-CELLS; BACTERIA; SRTA; VIRULENCE; INIB	Sortases are bacterial enzymes that anchor surface proteins covalently to the peptidoglycan upon cleavage of a motif located at their C-terminal end. Motifs recognized by sortases of the class-B (SrtB) are defined by the consensus sequence NP(Q/K)(T/S)(N/G/S)(D/A). Evidence supporting this consensus is limited to IsdC of Staphylococcus aureus and Bacillus anthracis, cleaved at motifs NPQTN and NPKTG, respectively. In Listeria monocytogenes, StrB has two substrates, Lmo2185 and Lmo2186, containing NAKTN and NKVTN (or the overlapping sequence NPKSS) as putative sorting motifs. Some of these motifs do not match the consensus, because they lack either proline (P) at position 2 or glutamine/lysine (Q/K) at position 3. Here, we identified NPKSS as a sorting motif of Lmo2186 by monitoring anchoring to peptidoglycan of chimeras lacking each of its two predicted motifs. Motif-swapping experiments confirmed that NPKSS, but not NKVTN, could replace NAKTN for anchoring of an Lmo2185 chimera. Residue substitutions in the NPKSS sequence revealed the essentiality of proline at position 2 for recognition of this particular motif. Lysine at position 3 was however dispensable. Deletion of NAKTN, on the other hand, abrogated SrtB-mediated anchoring of the Lmo2185 chimera. NAKTN, therefore, represents an exception to the rule of a conserved proline in position 2 of the sorting motif. Taken together, our data indicate that proline is not absolutely required for substrate recognition by sortases of the class-B. In addition, they prove the capacity of a single sortase, as SrtB of L. monocytogenes, to recognize varied amino acids at position 2 of the sorting motif.	[Mariscotti, Javier F.; Garcia-del Portillo, Francisco; Graciela Pucciarelli, M.] CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Madrid 28049, Spain; [Mariscotti, Javier F.; Graciela Pucciarelli, M.] Univ Autonoma Madrid, Dept Biol Mol, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Autonomous University of Madrid	Pucciarelli, MG (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Darwin 3, Madrid 28049, Spain.	mg.pucciarelli@uam.es	García-del Portillo, Francisco/D-2576-2009	Mariscotti, Javier Fernando/0000-0002-0103-9885; Garcia-del Portillo, Francisco/0000-0002-4120-0530; Pucciarelli Morrone, Maria Graciela/0000-0002-4268-2316	Ministry of Science and Innovation of Spain [BIO2006-14230, GEN2006-27774-C2-1-E/PAT]	Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Grants BIO2006-14230 ( to M. G. P.) and GEN2006-27774-C2-1-E/PAT ( to F. G.-P.) from the Ministry of Science and Innovation of Spain.	Bierne H, 2002, MOL MICROBIOL, V43, P869, DOI 10.1046/j.1365-2958.2002.02798.x; Bierne H, 2004, J BACTERIOL, V186, P1972, DOI 10.1128/JB.186.7.1972-1982.2004; Bierne H, 2007, MICROBIOL MOL BIOL R, V71, P377, DOI 10.1128/MMBR.00039-06; Boekhorst J, 2005, J BACTERIOL, V187, P4928, DOI 10.1128/JB.187.14.4928-4934.2005; Braun L, 1998, MOL MICROBIOL, V27, P1077, DOI 10.1046/j.1365-2958.1998.00750.x; Braun L, 1997, MOL MICROBIOL, V25, P285, DOI 10.1046/j.1365-2958.1997.4621825.x; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; DeDent AC, 2007, J BACTERIOL, V189, P4473, DOI 10.1128/JB.00227-07; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Dramsi S, 2008, FEMS MICROBIOL REV, V32, P307, DOI 10.1111/j.1574-6976.2008.00102.x; Garandeau C, 2002, INFECT IMMUN, V70, P1382, DOI 10.1128/IAI.70.3.1382-1390.2002; Gaspar AH, 2005, J BACTERIOL, V187, P4646, DOI 10.1128/JB.187.13.4646-4655.2005; Glaser P, 2001, SCIENCE, V294, P849; Jonquieres R, 1999, MOL MICROBIOL, V34, P902, DOI 10.1046/j.1365-2958.1999.01652.x; Kruger RG, 2004, BIOCHEMISTRY-US, V43, P1541, DOI 10.1021/bi035920j; Lalioui L, 2005, INFECT IMMUN, V73, P3342, DOI 10.1128/IAI.73.6.3342-3350.2005; Litou Zoi I., 2008, Journal of Bioinformatics and Computational Biology, V6, P387, DOI 10.1142/S0219720008003382; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Newton SMC, 2005, MOL MICROBIOL, V55, P927, DOI 10.1111/j.1365-2958.2004.04436.x; Pucciarelli M. G., 2007, LISTERIA MONOCYTOGEN, P81; Pucciarelli MG, 2005, PROTEOMICS, V5, P4808, DOI 10.1002/pmic.200402075; SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; TRIEUCUOT P, 1991, GENE, V102, P99, DOI 10.1016/0378-1119(91)90546-N; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861	30	17	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6140	6146		10.1074/jbc.M807989200	http://dx.doi.org/10.1074/jbc.M807989200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19129190	hybrid			2022-12-25	WOS:000263742700016
J	Park, J; Feng, J; Li, Y; Hammarsten, O; Brazil, DP; Hemmings, BA				Park, Jongsun; Feng, Jianhua; Li, Yuwen; Hammarsten, Ola; Brazil, Derek P.; Hemmings, Brian A.			DNA-dependent Protein Kinase-mediated Phosphorylation of Protein Kinase B Requires a Specific Recognition Sequence in the C-terminal Hydrophobic Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; IN-VIVO; TYROSINE PHOSPHORYLATION; ATAXIA-TELANGIECTASIA; CATALYTIC SUBUNIT; SIGNALING PATHWAY; CANCER-CELLS; ACTIVATION; ATM; PK	DNA-dependent protein kinase (DNA-PK) has been implicated in a variety of nuclear processes including DNA double strand break repair, V(D)J recombination, and transcription. A recent study showed that DNA-PK is responsible for Ser-473 phosphorylation in the hydrophobic motif of protein kinase B (PKB/Akt) in genotoxic-stressed cells, suggesting a novel role for DNA-PK in cell signaling. Here, we report that DNA-PK activity toward PKB peptides is impaired in DNA-PK knock-out mouse embryonic fibroblast cells when compared with wild type. In addition, human glioblastoma cells expressing a mutant form of DNA-PK (M059J) displayed a lower DNA-PK activity when compared with glioblastoma cells expressing wild-type DNA- PK (M059K) when PKB peptide substrates were tested. DNA- PK preferentially phosphorylated PKB on Ser-473 when compared with its known in vitro substrate, p53. A consensus hydrophobic amino acid surrounding the Ser-473 phospho-acceptor site in PKB containing amino acids Phe at position +1 and +4 and Tyr at position -1 are critical for DNA- PK activity. Thus, these data define the specificity of DNA- PK action as a Ser-473 kinase for PKB in DNA repair signaling.	[Park, Jongsun; Li, Yuwen] Chungnam Natl Univ, Coll Med, Dept Pharmacol,Canc Res Inst,Res Inst Med Sci, Cell Signaling Lab,Daejeon Reg Canc Ctr, Taejon 301131, South Korea; [Park, Jongsun; Feng, Jianhua; Hemmings, Brian A.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Hammarsten, Ola] Goeteborg Univ, Sahlgrens Univ Hosp, Dept Clin Chem, S-41345 Gothenburg, Sweden; [Brazil, Derek P.] Univ Coll Dublin, Conway Inst, Sch Med & Med Sci, Dublin 2, Ireland	Chungnam National University; Friedrich Miescher Institute for Biomedical Research; Sahlgrenska University Hospital; University College Dublin	Park, J (corresponding author), Chungnam Natl Univ, Coll Med, Dept Pharmacol,Canc Res Inst,Res Inst Med Sci, Cell Signaling Lab,Daejeon Reg Canc Ctr, 6 Munhwa Dong, Taejon 301131, South Korea.	insulin@cnu.ac.kr; hemmings@fmi.ch	Hammarsten, Ola/A-2791-2012; Park, Jongsun/E-7465-2010; li, yuwen/HGU-6435-2022	Park, Jongsun/0000-0002-4690-1854; Brazil, Derek/0000-0003-1375-1076	Korean government [R112002- 100-02006-0]; Basic Research Program [R01-2005-000-10240-0, F01-2005-000-10011-0]; Ministry of Health and Welfare : National RD Program [0720560]	Korean government(Korean Government); Basic Research Program; Ministry of Health and Welfare : National RD Program	This work was supported by grants from the Korean government (Ministry of Science and Technology: Engineering Research Center Program (R112002- 100-02006-0), Basic Research Program (R01-2005-000-10240-0 and F01-2005-000-10011-0); and Ministry of Health and Welfare: National R&D Program (0720560)).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Beamish HJ, 2000, NUCLEIC ACIDS RES, V28, P1506, DOI 10.1093/nar/28.7.1506; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burma S, 2004, DNA REPAIR, V3, P909, DOI 10.1016/j.dnarep.2004.03.021; Byrum J, 2004, NUCLEIC ACIDS RES, V32, P2776, DOI 10.1093/nar/gkh592; Caporali S, 2008, MOL PHARMACOL, V74, P173, DOI 10.1124/mol.107.044743; Chan DW, 2000, J BIOL CHEM, V275, P7803, DOI 10.1074/jbc.275.11.7803; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Dragoi AM, 2005, EMBO J, V24, P779, DOI 10.1038/sj.emboj.7600539; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Gottschalk AR, 2005, INT J RADIAT ONCOL, V63, P1221, DOI 10.1016/j.ijrobp.2005.08.014; Gupta AK, 2003, INT J RADIAT ONCOL, V56, P846, DOI 10.1016/S0360-3016(03)00214-1; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; Hill MM, 2002, CURR BIOL, V12, P1251, DOI 10.1016/S0960-9822(02)00973-9; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Huston E, 2008, P NATL ACAD SCI USA, V105, P12791, DOI 10.1073/pnas.0805167105; JACKSON SP, 1995, TRENDS BIOCHEM SCI, V20, P412, DOI 10.1016/S0968-0004(00)89090-8; Jeggo P, 2002, DNA REPAIR, V1, P771, DOI 10.1016/S1568-7864(02)00096-4; Jeggo PA, 2005, CELL CYCLE, V4, P359, DOI 10.4161/cc.4.3.1527; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; LEESMILLER SP, 1990, MOL CELL BIOL, V10, P6472, DOI 10.1128/MCB.10.12.6472; Li B, 2004, ONCOGENE, V23, P4594, DOI 10.1038/sj.onc.1207602; Li XQ, 2005, BREAST CANCER RES, V7, pR589, DOI 10.1186/bcr1259; Ma YM, 2002, J BIOL CHEM, V277, P10756, DOI 10.1074/jbc.C200030200; Martensson S, 2002, J BIOL CHEM, V277, P3020, DOI 10.1074/jbc.M106711200; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; O'Neill T, 2000, J BIOL CHEM, V275, P22719, DOI 10.1074/jbc.M001002200; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Park J, 2001, J BIOL CHEM, V276, P37459, DOI 10.1074/jbc.M105916200; Quevedo C, 2007, CURR BIOL, V17, P286, DOI 10.1016/j.cub.2006.12.038; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Surucu B, 2008, J BIOL CHEM, V283, P30025, DOI 10.1074/jbc.M803053200; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; Viniegra JG, 2005, J BIOL CHEM, V280, P4029, DOI 10.1074/jbc.M410344200; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yang KJ, 2008, J BIOL CHEM, V283, P1480, DOI 10.1074/jbc.M706361200	48	49	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6169	6174		10.1074/jbc.C800210200	http://dx.doi.org/10.1074/jbc.C800210200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19144640	hybrid			2022-12-25	WOS:000263742700019
J	Cole, MD; Cowling, VH				Cole, M. D.; Cowling, V. H.			Specific regulation of mRNA cap methylation by the c-Myc and E2F1 transcription factors	ONCOGENE			English	Article						E2F1; gene expression; mRNA cap methylation; Myc; translation	CONDITIONAL MUTANTS; POLYMERASE-II; GENES; EXPRESSION; TRANSLATION; BINDING; IDENTIFICATION; ONCOPROTEINS; RECRUITMENT; ACTIVATION	Methylation of the mRNA 50 guanosine cap is essential for efficient gene expression. The 50 methyl cap binds to eIF4E, which is the first step in the recruitment of mRNA to the 40S ribosomal subunit. To investigate whether mRNA cap methylation is regulated in a gene-specific manner, we established a method to detect the relative level of cap methylation on specific mRNAs. We found that two transcription factors, c-Myc and E2F1, induce cap methylation of their transcriptional target genes, and therefore, c-Myc and E2F1 upregulate gene expression by simultaneously inducing transcription and promoting translation. c-Myc-induced cap methylation is greater than transcriptional induction for the majority of its target genes, indicating that this is a major mechanism by which Myc regulates gene expression.	[Cowling, V. H.] Univ Dundee, Coll Life Sci, Div Cell Biol & Immunol, Dundee DD1 5EH, Scotland; [Cole, M. D.] Dartmouth Med Sch, Dept Pharmacol, Lebanon, NH USA; [Cole, M. D.] Dartmouth Med Sch, Dept Genet, Lebanon, NH USA	University of Dundee; Dartmouth College; Dartmouth College	Cowling, VH (corresponding author), Univ Dundee, Coll Life Sci, Div Cell Biol & Immunol, Dow St,MSI WTB Complex, Dundee DD1 5EH, Scotland.	v.h.cowling@dundee.ac.uk		Cowling, Victoria/0000-0001-7638-4870	NIH; MRC; MRC [G0700240] Funding Source: UKRI; Medical Research Council [G0700240] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA055248, P30CA023108] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Klara Acs for much helpful advice. We thank Kristian Helin for the E2F1-ER construct. This study was funded by NIH grants to MDC and an MRC grant to VHC.	Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Blais A, 2007, CURR OPIN CELL BIOL, V19, P658, DOI 10.1016/j.ceb.2007.10.003; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; Bush A, 1998, GENE DEV, V12, P3797, DOI 10.1101/gad.12.24.3797; Cowling VH, 2007, MOL CELL BIOL, V27, P2059, DOI 10.1128/MCB.01828-06; Cowling VH, 2006, SEMIN CANCER BIOL, V16, P242, DOI 10.1016/j.semcancer.2006.08.001; Cowling VH, 2006, MOL CELL BIOL, V26, P4226, DOI 10.1128/MCB.01959-05; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gomez-Roman N, 2006, BIOCHEM SOC SYMP, V73, P141, DOI 10.1042/bss0730141; Gu MG, 2005, CURR OPIN STRUC BIOL, V15, P99, DOI 10.1016/j.sbi.2005.01.009; Guo QM, 2000, CANCER RES, V60, P5922; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; Kim S, 2000, P NATL ACAD SCI USA, V97, P11198, DOI 10.1073/pnas.200372597; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Moteki S, 2002, MOL CELL, V10, P599, DOI 10.1016/S1097-2765(02)00660-3; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5054, DOI 10.1128/MCB.22.14.5054-5063.2002; Schmidt EV, 2004, ONCOGENE, V23, P3217, DOI 10.1038/sj.onc.1207548; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Schwer B, 1998, NUCLEIC ACIDS RES, V26, P2050, DOI 10.1093/nar/26.9.2050; Schwer B, 2000, GENETICS, V155, P1561; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8; Shuman S, 2002, NAT REV MOL CELL BIO, V3, P619, DOI 10.1038/nrm880; Sims RJ, 2004, CURR OPIN CELL BIOL, V16, P263, DOI 10.1016/j.ceb.2004.04.004; von der Haar T, 2004, NAT STRUCT MOL BIOL, V11, P503, DOI 10.1038/nsmb779; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69	29	56	57	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 5	2009	28	9					1169	1175		10.1038/onc.2008.463	http://dx.doi.org/10.1038/onc.2008.463			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	415AH	19137018	Green Accepted			2022-12-25	WOS:000263906200001
J	Guo, C; Gasparian, AV; Zhuang, Z; Bosykh, DA; Komar, AA; Gudkov, AV; Gurova, KV				Guo, C.; Gasparian, A. V.; Zhuang, Z.; Bosykh, D. A.; Komar, A. A.; Gudkov, A. V.; Gurova, K. V.			9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-kappa B and p53 pathways	ONCOGENE			English	Article						proteomics; quinacrine; cell death; PI3 kinase-gamma; PTEN	MESSENGER-RNAS; INFLAMMATION; PI3K-GAMMA; TRANSLATION; INHIBITION; ACTIVATION; MECHANISM; RAPAMYCIN; CELLS; MDM2	Acquisition of a transformed phenotype involves deregulation of several signal transduction pathways contributing to unconstrained cell growth. Understanding the interplay of different cancer-related signaling pathways is important for development of efficacious multitargeted anticancer drugs. The small molecule 9-aminoacridine (9AA) and its derivative, the antimalaria drug quinacrine, have selective toxicity for tumor cells and can simultaneously suppress nuclear factor-kappa B (NF-kappa B) and activate p53 signaling. To investigate the mechanism underlying these drug activities, we used a combination of two-dimensional protein separation by gel electrophoresis and mass spectrometry to identify proteins whose expression is altered in tumor cells by 9AA treatment. We found that 9AA treatment results in selective downregulation of a specific catalytic subunit of the phosphoinositide 3-kinase (PI3K) family, p110 gamma. Further exploration of this observation demonstrated that the mechanism of action of 9AA involves inhibition of the prosurvival AKT/ mammalian target of rapamycin (mTOR) pathway that lies downstream of PI3K. p110 gamma translation appears to be regulated by mTOR and feeds back to further modulate mTOR and AKT, there by impacting the p53 and NF-kappa B pathways as well. These results reveal functional interplay among the PI3K/AKT/mTOR, p53 and NF-kappa B pathways that are frequently deregulated in cancer and suggest that their simultaneous targeting by a single small molecule such as 9AA could result in efficacious and selective killing of transformed cells.	[Gudkov, A. V.; Gurova, K. V.] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA; [Guo, C.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Guo, C.] Lerner Res Inst, Dept Mol Genet, Cleveland, OH USA; [Gasparian, A. V.; Bosykh, D. A.; Gudkov, A. V.; Gurova, K. V.] Cleveland Biolabs Inc, Buffalo, NY USA; [Zhuang, Z.] Natl Inst Hlth, Bethesda, MD USA; [Komar, A. A.] Cleveland State Univ, Dept Biol, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA	Roswell Park Cancer Institute; Case Western Reserve University; Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA; University System of Ohio; Cleveland State University	Gudkov, AV (corresponding author), Roswell Pk Canc Inst, Dept Cell Stress Biol, BLSC L3-301,Elm & Carlton St, Buffalo, NY 14263 USA.	andrei.gudkov@roswellpark.org; katerina.gurova@roswellpark.org		Komar, Anton/0000-0003-4188-0633; Gudkov, Andrei/0000-0003-2548-0154				Bensaad K, 2005, NAT MED, V11, P1278, DOI 10.1038/nm1205-1278; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Furuta M, 2004, ONCOGENE, V23, P6806, DOI 10.1038/sj.onc.1207770; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Gudkov AV, 2005, PROTEIN REV, V2, P225, DOI 10.1007/0-387-30127-5_10; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; Jeong SJ, 2005, ONCOGENE, V24, P6719, DOI 10.1038/sj.onc.1208825; Jung KJ, 2008, J VIROL, V82, P8537, DOI 10.1128/JVI.00690-08; Kang S, 2006, P NATL ACAD SCI USA, V103, P1289, DOI 10.1073/pnas.0510772103; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Mayo LD, 2002, J BIOL CHEM, V277, P5484, DOI 10.1074/jbc.M108302200; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Okamoto H, 2007, CANCER BIOL THER, V6, P391, DOI 10.4161/cbt.6.3.3731; Ozes ON, 1999, NATURE, V401, P82; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; STONE KL, 1993, PRACTICAL GUIDE PROT; TERADA N, 1994, P NATL ACAD SCI USA, V91, P11477, DOI 10.1073/pnas.91.24.11477; Yamboliev IA, 2000, AM J PHYSIOL-CELL PH, V279, pC352, DOI 10.1152/ajpcell.2000.279.2.C352	29	98	102	2	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2009	28	8					1151	1161		10.1038/onc.2008.460	http://dx.doi.org/10.1038/onc.2008.460			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	412KE	19137016				2022-12-25	WOS:000263722900010
J	White-Gilbertson, S; Mullen, T; Senkal, C; Lu, P; Ogretmen, B; Obeid, L; Voelkel-Johnson, C				White-Gilbertson, S.; Mullen, T.; Senkal, C.; Lu, P.; Ogretmen, B.; Obeid, L.; Voelkel-Johnson, C.			Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase-3 in colon cancer cells	ONCOGENE			English	Article						TRAIL; ceramide; apoptosis; ceramide synthase; longevity assurance homologue	LONGEVITY ASSURANCE GENE-1; INDUCED APOPTOSIS; FAMILY-MEMBERS; HUMAN HEAD; RESISTANCE; DEATH; METASTASIS; ACTIVATION; GROWTH; IDENTIFICATION	We have previously shown that the death receptor ligand TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) induces an increase of intracellular C-16-ceramide in sensitive SW480 but not in resistant SW620 cells. Resistance in SW620 cells was overcome by exogenous ceramide, leading us to propose that defective ceramide signaling contributes to TRAIL resistance. In this study we found that the increase in C16-ceramide in SW480 cells was inhibited by fumonisin B1, an inhibitor of ceramide synthases (CerS). Protein analysis revealed that TRAIL-resistant SW620 cells expressed lower levels of ceramide synthase 6 (CerS6, also known as longevity assurance homologue 6), which prompted us to investigate the effect of CerS6 modulation on TRAIL phenotype. RNAi against CerS6 resulted in a specific and significant decrease of the C-16-ceramide species, which was sufficient to inhibit TRAIL-induced apoptosis. In cells with decreased levels of CerS6, caspase-3 was activated but failed to translocate into the nucleus. CerS6 localized primarily to the perinuclear region, suggesting this enzyme may be important in regulation of nuclear permeability. Moderate elevation in CerS6 expression was sufficient to reverse TRAIL resistance in SW620 cells. These results suggest that modulation of CerS6 expression may constitute a new therapeutic strategy to alter apoptotic susceptibility.	[White-Gilbertson, S.; Lu, P.; Voelkel-Johnson, C.] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29403 USA; [Mullen, T.; Obeid, L.] Med Univ S Carolina, Dept Med, Charleston, SC 29403 USA; [Senkal, C.; Ogretmen, B.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29403 USA; [Obeid, L.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Voelkel-Johnson, C (corresponding author), Med Univ S Carolina, Dept Microbiol & Immunol, POB 250504,173 Ashley Ave, Charleston, SC 29403 USA.	johnsocv@musc.edu		obeid, lina/0000-0002-0734-0847	NCI NIH HHS [R01 CA088932-07, CA-097132, R01 CA088932, CA-088932, P01 CA097132-060004, P01CA097132, P01 CA097132] Funding Source: Medline; NCRR NIH HHS [P20 RR017698, P20 RR017698-02, P20 RR017698-01, P20 RR017698-03, C06 RR018823, 1P20-RR17698] Funding Source: Medline; NIA NIH HHS [R01 AG016583, AG016583] Funding Source: Medline; NIDCR NIH HHS [DE016572, R01 DE016572, R01 DE016572-04] Funding Source: Medline; NIEHS NIH HHS [1T32ES012878, T32 ES012878] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA088932, P01CA097132] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018823, P20RR017698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES012878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016583] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ashkenazi A, 2008, J CLIN INVEST, V118, P1979, DOI 10.1172/JCI34359; BARUA S, 2008, MOL PHARM IN PRESS, DOI DOI 10.1021/MP80057J; Basnakian AG, 2005, AM J PHYSIOL-RENAL, V288, pF308, DOI 10.1152/ajprenal.00204.2004; Beckman M, 2004, APOPTOSIS, V9, P363, DOI 10.1023/B:APPT.0000025813.75258.b5; Birbes H, 2005, BIOCHEM J, V386, P445, DOI 10.1042/BJ20041627; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Charles AG, 2001, CANCER CHEMOTH PHARM, V47, P444, DOI 10.1007/s002800000265; Cremesti A, 2001, J BIOL CHEM, V276, P23954, DOI 10.1074/jbc.M101866200; de Jong S, 2001, CANCER METAST REV, V20, P51, DOI 10.1023/A:1013112624971; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Eto M, 2003, PROSTATE, V57, P66, DOI 10.1002/pros.10275; Faleiro L, 2000, J CELL BIOL, V151, P951, DOI 10.1083/jcb.151.5.951; Ferrando-May E, 2001, CELL DEATH DIFFER, V8, P495, DOI 10.1038/sj.cdd.4400837; Garzotto M, 1999, CANCER RES, V59, P5194; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Huerta S, 2007, J SURG RES, V142, P184, DOI 10.1016/j.jss.2006.12.551; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; Kamada S, 2005, MOL CELL BIOL, V25, P9469, DOI 10.1128/MCB.25.21.9469-9477.2005; Kamada S, 2005, J BIOL CHEM, V280, P857, DOI 10.1074/jbc.C400538200; Karahatay S, 2007, CANCER LETT, V256, P101, DOI 10.1016/j.canlet.2007.06.003; Kelley SK, 2001, J PHARMACOL EXP THER, V299, P31; Kitatani K, 2006, J BIOL CHEM, V281, P36793, DOI 10.1074/jbc.M608137200; Koschny R, 2007, J MOL MED, V85, P923, DOI 10.1007/s00109-007-0194-1; Koybasi S, 2004, J BIOL CHEM, V279, P44311, DOI 10.1074/jbc.M406920200; Kroesen BJ, 2003, J BIOL CHEM, V278, P14723, DOI 10.1074/jbc.M210756200; MacFarlane M, 2003, TOXICOL LETT, V139, P89, DOI 10.1016/S0378-4274(02)00422-8; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Moulin M, 2007, APOPTOSIS, V12, P1703, DOI 10.1007/s10495-007-0096-2; Ndozangue-Touriguine O, 2008, ONCOGENE, V27, P6012, DOI 10.1038/onc.2008.197; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Peter Marcus E, 2004, Biochem J, V382, pe1; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Provenzani A, 2006, CARCINOGENESIS, V27, P1323, DOI 10.1093/carcin/bgi377; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Selzner M, 2001, CANCER RES, V61, P1233; Senkal CE, 2007, MOL CANCER THER, V6, P712, DOI 10.1158/1535-7163.MCT-06-0558; Sharpe JC, 2004, BBA-MOL CELL RES, V1644, P107, DOI 10.1016/j.bbamcr.2003.10.016; Siskind LJ, 2000, J BIOL CHEM, V275, P38640, DOI 10.1074/jbc.C000587200; Stiban J, 2008, J LIPID RES, V49, P625, DOI 10.1194/jlr.M700480-JLR200; Thomas RL, 1999, J BIOL CHEM, V274, P30580, DOI 10.1074/jbc.274.43.30580; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Ueda N, 2001, J AM SOC NEPHROL, V12, P2384, DOI 10.1681/ASN.V12112384; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Voelkel-Johnson C, 2005, MOL CANCER THER, V4, P1320, DOI 10.1158/1535-7163.MCT-05-0086; Widlak P, 2005, J CELL BIOCHEM, V94, P1078, DOI 10.1002/jcb.20409; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wilson MR, 1998, CELL DEATH DIFFER, V5, P646, DOI 10.1038/sj.cdd.4400394; Xu ZW, 2005, J LIPID RES, V46, P1229, DOI 10.1194/jlr.M500001-JLR200; Yasuhara N, 1997, GENES CELLS, V2, P55, DOI 10.1046/j.1365-2443.1997.1010302.x	50	106	109	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2009	28	8					1132	1141		10.1038/onc.2008.468	http://dx.doi.org/10.1038/onc.2008.468			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	412KE	19137010	Green Accepted			2022-12-25	WOS:000263722900008
J	Tamura, T; Sone, M; Yamashita, M; Wanker, EE; Okazawa, H				Tamura, Takuya; Sone, Masaki; Yamashita, Mayumi; Wanker, Erich E.; Okazawa, Hitoshi			Glial Cell Lineage Expression of Mutant Ataxin-1 and Huntingtin Induces Developmental and Late-Onset Neuronal Pathologies in Drosophila Models	PLOS ONE			English	Article								Background: In several neurodegenerative disorders, toxic effects of glial cells on neurons are implicated. However the generality of the non-cell autonomous pathologies derived from glial cells has not been established, and the specificity among different neurodegenerative disorders remains unknown. Methodology/Principal Findings: We newly generated Drosophila models expressing human mutant huntingtin (hHtt103Q) or ataxin-1 (hAtx1-82Q) in the glial cell lineage at different stages of differentiation, and analyzed their morphological and behavioral phenotypes. To express hHtt103Q and hAtx1-82Q, we used 2 different Gal4 drivers, gcm-Gal4 and repo-Gal4. Gcm-Gal4 is known to be a neuroglioblast/glioblast-specific driver whose effect is limited to development. Repo-Gal4 is known to be a pan-glial driver and the expression starts at glioblasts and continues after terminal differentiation. Gcm-Gal4-induced hHtt103Q was more toxic than repo-Gal4-induced hHtt103Q from the aspects of development, locomotive activity and survival of flies. When hAtx1-82Q was expressed by gcm-or repo-Gal4 driver, no fly became adult. Interestingly, the head and brain sizes were markedly reduced in a part of pupae expressing hAtx1-82Q under the control of gcm-Gal4, and these pupae showed extreme destruction of the brain structure. The other pupae expressing hAtx1-82Q also showed brain shrinkage and abnormal connections of neurons. These results suggested that expression of polyQ proteins in neuroglioblasts provided a remarkable effect on the developmental and adult brains, and that glial cell lineage expression of hAtx1-82Q was more toxic than that of hHtt103Q in our assays. Conclusion/Significance: All these studies suggested that the non-cell autonomous effect of glial cells might be a common pathology shared by multiple neurodegenerative disorders. In addition, the fly models would be available for analyzing molecular pathologies and developing novel therapeutics against the non-cell autonomous polyQ pathology. In conclusion, our novel fly models have extended the non-cell autonomous pathology hypothesis as well as the developmental effect hypothesis to multiple polyQ diseases. The two pathologies might be generally shared in neurodegeneration.	[Tamura, Takuya; Yamashita, Mayumi; Okazawa, Hitoshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Neuropathol, Tokyo, Japan; [Sone, Masaki] Tokyo Med & Dent Univ, Med Res Inst, Med Top Track Program, Tokyo, Japan; [Wanker, Erich E.] Max Delbruck Ctr Molecular Med, Dept Neurogenet, Berlin, Germany	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Tamura, T (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Neuropathol, Tokyo, Japan.	okazawa-tky@umin.ac.jp	Sone, Masaki/Q-9058-2019	Wanker, Erich/0000-0001-8072-1630	Japan Science Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan [16390249, 16650076, 18390254, 18650097, 17025017, 18023014, 20023011]	Japan Science Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants to H.O. from Japan Science Technology Agency (PRESTO, JST, Japan) and from Ministry of Education, Culture, Sports, Science and Technology of Japan (16390249, 16650076, 18390254, 18650097, Research on Pathomechanisms of Brain Disorders: 17025017, 18023014, 20023011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama-Oda Y, 2000, DEVELOPMENT, V127, P3513; Badenhorst P, 2001, DEVELOPMENT, V128, P4093; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Bernardoni R, 1999, DEV BIOL, V216, P265, DOI 10.1006/dbio.1999.9511; Busch A, 2003, J BIOL CHEM, V278, P41452, DOI 10.1074/jbc.M303354200; Custer SK, 2006, NAT NEUROSCI, V9, P1302, DOI 10.1038/nn1750; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; HALTER DA, 1995, DEVELOPMENT, V121, P317; Hoshino M, 2006, J CELL BIOL, V172, P589, DOI 10.1083/jcb.200509132; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; Kretzschmar D, 2005, GLIA, V49, P59, DOI 10.1002/glia.20098; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lievens JC, 2008, HUM MOL GENET, V17, P882, DOI 10.1093/hmg/ddm360; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Qi ML, 2007, NAT CELL BIOL, V9, P402, DOI 10.1038/ncb1553; Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Soustelle L, 2007, DEV DYNAM, V236, P2101, DOI 10.1002/dvdy.21232; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Wegner M, 2001, TRENDS GENET, V17, P286, DOI 10.1016/S0168-9525(01)02275-2; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047	25	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2009	4	1							e4262	10.1371/journal.pone.0004262	http://dx.doi.org/10.1371/journal.pone.0004262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JD	19165334	Green Published, Green Accepted, gold			2022-12-25	WOS:000265482400009
J	Tu, CT; Yang, TC; Tsai, HJ				Tu, Chi-Tang; Yang, Tzu-Ching; Tsai, Huai-Jen			Nkx2.7 and Nkx2.5 Function Redundantly and Are Required for Cardiac Morphogenesis of Zebrafish Embryos	PLOS ONE			English	Article							HEART PROGENITOR CELLS; HOMEOBOX GENE; TINMAN; EXPRESSION; SPECIFICATION; FAMILY; MYOGENESIS; XNKX-2.3; HOMOLOGS; DEFECTS	Background: Nkx2.7 is the tinman-related gene, as well as orthologs of Nkx2.5 and Nkx-2.3. Nkx2.7 and Nkx2.5 express in zebrafish heart fields of lateral plate mesoderm. The temporal and spatial expression patterns of Nkx2.7 are similar to those of Nkx2.5, but their functions during cardiogenesis remain unclear. Methodology/Principal Findings: Here, Nkx2.7 is demonstrated to compensate for Nkx2.5 loss of function and play a predominant role in the lateral development of the heart, including normal cardiac looping and chamber formation. Knocking down Nkx2.5 showed that heart development was normal from 24 to 72 hpf. However, when knocking down either Nkx2.7 or Nkx2.5 together with Nkx2.7, it appeared that the heart failed to undergo looping and showed defective chambers, although embryos developed normally before the early heart tube stage. Decreased ventricular myocardium proliferation and defective myocardial differentiation appeared to result from late-stage up-regulation of bmp4, versican, tbx5 and tbx20, which were all expressed normally in hearts at an early stage. We also found that tbx5 and tbx20 were modulated by Nkx2.7 through the heart maturation stage because an inducible overexpression of Nkx2.7 in the heart caused down-regulation of tbx5 and tbx20. Although heart defects were induced by overexpression of an injection of 150-pg Nkx2.5 or 5-pg Nkx2.7 mRNA, either Nkx2.5 or Nkx2.7 mRNA rescued the defects induced by Nkx2.7-morpholino(MO) and Nkx2.5-MO with Nkx2.7-MO. Conclusions and Significance: Therefore, we conclude that redundant activities of Nkx2.5 and Nkx2.7 are required for cardiac morphogenesis, but that Nkx2.7 plays a more critical function, specifically indicated by the gain-of-function and loss-of-function experiments where Nkx2.7 is observed to regulate the expressions of tbx5 and tbx20 through the maturation stage.	Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan	National Taiwan University	Tu, CT (corresponding author), Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan.	hjtsai@ntu.edu.tw			National Science Council, ROC	National Science Council, ROC(Ministry of Science and Technology, Taiwan)	This paper was partially supported by the grant from National Science Council, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biben C, 1998, MECH DEVELOP, V73, P125, DOI 10.1016/S0925-4773(98)00037-9; BODMER R, 1993, DEVELOPMENT, V118, P719; Brand T, 2003, DEV BIOL, V258, P1, DOI 10.1016/S0012-1606(03)00112-X; Brand T, 1997, MECH DEVELOP, V64, P53, DOI 10.1016/S0925-4773(97)00044-0; Bruneau BG, 2002, CIRC RES, V90, P509, DOI 10.1161/01.RES.0000013072.51957.B7; Buchberger A, 1996, MECH DEVELOP, V56, P151, DOI 10.1016/0925-4773(96)00521-7; Chen JN, 1996, DEVELOPMENT, V122, P3809; Chen L M, 2001, Matern Child Health J, V5, P35, DOI 10.1023/A:1011345801673; Cleaver OB, 1996, DEVELOPMENT, V122, P3549; EVANS SM, 1995, DEVELOPMENT, V121, P3889; Fu YC, 1998, DEVELOPMENT, V125, P4439; Garrity DM, 2002, DEVELOPMENT, V129, P4635; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Huang HG, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-7; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; Lee KH, 1996, DEV BIOL, V180, P722, DOI 10.1006/dbio.1996.0341; Liberatore CM, 2000, DEV BIOL, V223, P169, DOI 10.1006/dbio.2000.9748; Lin CY, 2006, DEV BIOL, V299, P594, DOI 10.1016/j.ydbio.2006.08.042; LINTS TJ, 1993, DEVELOPMENT, V119, P419; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; MartinezBarbera JP, 1997, GENE, V198, P53, DOI 10.1016/S0378-1119(97)00292-8; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Moore JL, 2002, BIOTECHNIQUES, V32, P296, DOI 10.2144/02322st03; Newman CS, 1998, DEV GENET, V22, P230; Pabst O, 1997, DEV DYNAM, V209, P29; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Reecy JM, 1997, DEV BIOL, V188, P295, DOI 10.1006/dbio.1997.8641; Schultheiss TM, 1995, DEVELOPMENT, V121, P4203; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Szeto DP, 2002, DEVELOPMENT, V129, P5093; Tanaka M, 2000, MOL CELL BIOL, V20, P2874, DOI 10.1128/MCB.20.8.2874-2879.2000; Tanaka M, 2001, MOL CELL BIOL, V21, P4391, DOI 10.1128/MCB.21.13.4391-4398.2001; Targoff KL, 2008, DEV BIOL, V322, P314, DOI 10.1016/j.ydbio.2008.07.037; Vaughan CJ, 2000, AM J MED GENET, V97, P304, DOI 10.1002/1096-8628(200024)97:4<304::AID-AJMG1281>3.0.CO;2-#; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406	41	39	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2009	4	1							e4249	10.1371/journal.pone.0004249	http://dx.doi.org/10.1371/journal.pone.0004249			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JC	19158954	Green Published, Green Submitted, gold			2022-12-25	WOS:000265482200006
J	Lindorff-Larsen, K; Ferkinghoff-Borg, J				Lindorff-Larsen, Kresten; Ferkinghoff-Borg, Jesper			Similarity Measures for Protein Ensembles	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; NMR STRUCTURES; DISTANCE; ENERGY; PROBABILITY; BACKBONE; CONVERGENCE; INFORMATION; VALIDATION; RELAXATION	Analyses of similarities and changes in protein conformation can provide important information regarding protein function and evolution. Many scores, including the commonly used root mean square deviation, have therefore been developed to quantify the similarities of different protein conformations. However, instead of examining individual conformations it is in many cases more relevant to analyse ensembles of conformations that have been obtained either through experiments or from methods such as molecular dynamics simulations. We here present three approaches that can be used to compare conformational ensembles in the same way as the root mean square deviation is used to compare individual pairs of structures. The methods are based on the estimation of the probability distributions underlying the ensembles and subsequent comparison of these distributions. We first validate the methods using a synthetic example from molecular dynamics simulations. We then apply the algorithms to revisit the problem of ensemble averaging during structure determination of proteins, and find that an ensemble refinement method is able to recover the correct distribution of conformations better than standard single-molecule refinement.	Univ Copenhagen, Dept Mol Biol, Copenhagen O, Denmark; [Ferkinghoff-Borg, Jesper] Tech Univ Denmark, Lyngby, Denmark	University of Copenhagen; Technical University of Denmark	Lindorff-Larsen, K (corresponding author), Univ Copenhagen, Dept Mol Biol, Copenhagen O, Denmark.	Lindorff@DEShawResearch.com	Lindorff-Larsen, Kresten/K-6469-2014	Lindorff-Larsen, Kresten/0000-0002-4750-6039				Agrafiotis DK, 2002, P NATL ACAD SCI USA, V99, P15869, DOI 10.1073/pnas.242424399; Allen LR, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/28/285211; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Andricioaei I, 2001, J CHEM PHYS, V115, P6289, DOI 10.1063/1.1401821; Beck DAC, 2005, BIOCHEMISTRY-US, V44, P609, DOI 10.1021/bi0486381; BEGLOV D, 1995, BIOPOLYMERS, V35, P171, DOI 10.1002/bip.360350205; Best RB, 2006, P NATL ACAD SCI USA, V103, P10901, DOI 10.1073/pnas.0511156103; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Bonvin AMJJ, 1996, J BIOMOL NMR, V7, P72; BONVIN AMJJ, 1995, J MOL BIOL, V250, P80, DOI 10.1006/jmbi.1995.0360; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BROOKS BR, 1995, J COMPUT CHEM, V16, P1522, DOI 10.1002/jcc.540161209; Bruschweiler R, 2003, PROTEINS, V50, P26, DOI 10.1002/prot.10250; BRUSCHWEILER R, 1992, J AM CHEM SOC, V114, P2289, DOI 10.1021/ja00033a002; Burling FT, 1996, SCIENCE, V271, P72, DOI 10.1126/science.271.5245.72; Carugo O, 2007, PROTEIN ENG DES SEL, V20, P33, DOI 10.1093/protein/gzl051; Chalaoux FR, 1999, PROTEINS, V34, P453, DOI 10.1002/(SICI)1097-0134(19990301)34:4<453::AID-PROT5>3.0.CO;2-7; Clore GM, 2006, J MOL BIOL, V355, P879, DOI 10.1016/j.jmb.2005.11.042; Cover TM, 1991, ELEMENTS INFORM THEO; Das P, 2006, P NATL ACAD SCI USA, V103, P9885, DOI 10.1073/pnas.0603553103; DePristo MA, 2004, STRUCTURE, V12, P831, DOI 10.1016/j.str.2004.02.031; DING C, 2004, P 21 INT C ICML 2004; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Furnham N, 2006, NAT STRUCT MOL BIOL, V13, P184, DOI 10.1038/nsmb0306-184; Goldsmith-Fischman S, 2003, PROTEIN SCI, V12, P1813, DOI 10.1110/ps.0242903; GRAY AG, 2003, VERY FAST MULTIVARIA; Grossfield A, 2007, PROTEINS, V67, P31, DOI 10.1002/prot.21308; GUHA R, 2007, C IMPLEMENTATION STO; HALL P, 1991, BIOMETRIKA, V78, P263; Hess B, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031910; Hess B, 2000, PHYS REV E, V62, P8438, DOI 10.1103/PhysRevE.62.8438; Hou JT, 2003, P NATL ACAD SCI USA, V100, P2386, DOI 10.1073/pnas.2628030100; Ihler A., 2003, KERNEL DENSITY ESTIM; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; JEFFREYS H, 1946, PROC R SOC LON SER-A, V186, P453, DOI 10.1098/rspa.1946.0056; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Kitao A, 1999, CURR OPIN STRUC BIOL, V9, P164, DOI 10.1016/S0959-440X(99)80023-2; Kondrashov DA, 2007, STRUCTURE, V15, P169, DOI 10.1016/j.str.2006.12.006; Krzanowski WJ, 2003, J APPL STAT, V30, P743, DOI 10.1080/0266476032000076029; KULLBACK S, 1952, ANN MATH STAT, V23, P88, DOI 10.1214/aoms/1177729487; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; KURIYAN J, 1991, PROTEINS, V10, P340, DOI 10.1002/prot.340100407; Latzer J, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2375121; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Ledoit O, 2004, J MULTIVARIATE ANAL, V88, P365, DOI 10.1016/S0047-259X(03)00096-4; Levin EJ, 2007, STRUCTURE, V15, P1040, DOI 10.1016/j.str.2007.06.019; LEVITT M, 1983, J MOL BIOL, V168, P621, DOI 10.1016/S0022-2836(83)80306-4; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199; Lindorff-Larsen K, 2005, TRENDS BIOCHEM SCI, V30, P13, DOI 10.1016/j.tibs.2004.11.008; Lyman E, 2006, BIOPHYS J, V91, P164, DOI 10.1529/biophysj.106.082941; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Ming DM, 2005, PROTEINS, V59, P697, DOI 10.1002/prot.20440; Murdock SE, 2006, J CHEM THEORY COMPUT, V2, P1477, DOI 10.1021/ct6001708; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; Opgen-Rhein R, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1252; Osterreicher F, 2003, ANN I STAT MATH, V55, P639, DOI 10.1007/BF02517812; Paci E, 1999, J MOL BIOL, V288, P441, DOI 10.1006/jmbi.1999.2670; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; POST CB, 1992, J MOL BIOL, V224, P1087, DOI 10.1016/0022-2836(92)90471-U; Qian H, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.042103; Richter B, 2007, J BIOMOL NMR, V37, P117, DOI 10.1007/s10858-006-9117-7; Rieping W, 2005, SCIENCE, V309, P303, DOI 10.1126/science.1110428; ROTHER D, 2007, IEEE ACM T IN PRESS; Rueda M, 2007, P NATL ACAD SCI USA, V104, P796, DOI 10.1073/pnas.0605534104; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; SCHEEK RM, 1991, STRUCTURE DETERMINAT, P209; SCHLITTER J, 1993, CHEM PHYS LETT, V215, P617, DOI 10.1016/0009-2614(93)89366-P; Schneider TR, 1999, J MOL BIOL, V285, P727, DOI 10.1006/jmbi.1998.2323; SIBSON R, 1969, Z WAHRSCHEINLICHKEIT, V14, P149, DOI 10.1007/BF00537520; Sierk ML, 2004, PROTEIN SCI, V13, P773, DOI 10.1110/ps.03328504; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; TROPP J, 1980, J CHEM PHYS, V72, P6035, DOI 10.1063/1.439059; Wall ME, 2006, LIGAND BINDING PROTE, P16; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zagrovic B, 2006, PROTEINS, V63, P210, DOI 10.1002/prot.20872; Zhou SK, 2006, IEEE T PATTERN ANAL, V28, P917, DOI 10.1109/TPAMI.2006.120; Zidek L, 1999, NAT STRUCT BIOL, V6, P1118	84	49	49	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2009	4	1							e4203	10.1371/journal.pone.0004203	http://dx.doi.org/10.1371/journal.pone.0004203			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IG	19145244	gold, Green Published, Green Submitted			2022-12-25	WOS:000265479800009
J	Meunier, MC; Baron, C; Perreault, C				Meunier, Marie-Christine; Baron, Chantal; Perreault, Claude			Two Host Factors Regulate Persistence of H7(a)-Specific T Cells Injected in Tumor-Bearing Mice	PLOS ONE			English	Article								Background: Injection of CD8 T cells primed against immunodominant minor histocompatibility antigens (MiHA) such as H7(a) can eradicate leukemia and solid tumors. To understand why MiHA-targeted T cells have such a potent antitumor effect it is essential to evaluate their in vivo behavior. In the present work, we therefore addressed two specific questions: what is the proliferative dynamics of H7(a)-specifc T cells in tumors, and do H7(a)-specific T cells persist long-term after adoptive transfer? Methodology/Principal Findings: By day 3 after adoptive transfer, we observed a selective infiltration of melanomas by anti-H7(a) T cells. Over the next five days, anti-H7(a) T cells expanded massively in the tumor but not in the spleen. Thus, by day 8 after injection, anti-H7(a) T cells in the tumor had undergone more cell divisions than those in the spleen. These data strongly suggest that anti-H7(a) T cells proliferate preferentially and extensively in the tumors. We also found that two host factors regulated long-term persistence of anti-H7(a) memory T cells: thymic function and expression of H7(a) by host cells. On day 100, anti-H7(a) memory T cells were abundant in euthymic H7(a)-negative (B10.H7(b)) mice, present in low numbers in thymectomized H7(a)-positive (B10) hosts, and undetectable in euthymic H7(a)-positive recipients. Conclusions/Significance: Although in general the tumor environment is not propitious to T-cell invasion and expansion, the present work shows that this limitation may be overcome by adoptive transfer of primed CD8 T cells targeted to an immunodominant MiHA (here H7(a)). At least in some cases, prolonged persistence of adoptively transferred T cells may be valuable for prevention of late cancer relapse in adoptive hosts. Our findings therefore suggest that it may be advantageous to target MiHAs with a restricted tissue distribution in order to promote persistence of memory T cells and thereby minimize the risk of cancer recurrence.	[Meunier, Marie-Christine; Baron, Chantal; Perreault, Claude] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Meunier, Marie-Christine; Baron, Chantal; Perreault, Claude] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Meunier, Marie-Christine; Baron, Chantal; Perreault, Claude] Maisonneuve Rosemont Hosp, Div Hematol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Meunier, MC (corresponding author), Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada.	c.perreault@videotron.ca	Perreault, Claude/A-7220-2008	Perreault, Claude/0000-0001-9453-7383	Canadian Cancer Society; National Cancer Institute of Canada; Canada Research Chair in Immunobiology	Canadian Cancer Society(Canadian Cancer Society (CCS)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canada Research Chair in Immunobiology(Canada Research Chairs)	This work was supported by the Canadian Cancer Society. MCM was supported by a training grant from the National Cancer Institute of Canada. CP holds a Canada Research Chair in Immunobiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelbaum FR, 2001, NATURE, V411, P385, DOI 10.1038/35077251; Baron C, 2006, J IMMUNOL, V177, P8466, DOI 10.4049/jimmunol.177.12.8466; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Blais ME, 2004, BLOOD, V103, P3102, DOI 10.1182/blood-2003-09-3311; Bleakley M, 2004, NAT REV CANCER, V4, P371, DOI 10.1038/nrc1365; Bonnett D, 1999, P NATL ACAD SCI USA, V96, P8639, DOI 10.1073/pnas.96.15.8639; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Brickner AG, 2006, BLOOD, V107, P3779, DOI 10.1182/blood-2005-08-3501; Choi EY, 2002, BLOOD, V100, P4259, DOI 10.1182/blood-2002-05-1299; Di Rosa F, 2005, TRENDS IMMUNOL, V26, P360, DOI 10.1016/j.it.2005.04.011; Dulude G, 1999, J EXP MED, V189, P1329, DOI 10.1084/jem.189.8.1329; Eden PA, 1999, J IMMUNOL, V162, P4502; Fontaine P, 2001, NAT MED, V7, P789, DOI 10.1038/89907; Ge Q, 2004, P NATL ACAD SCI USA, V101, P3041, DOI 10.1073/pnas.0307339101; Gudmundsdottir H, 1999, J IMMUNOL, V162, P5212; Hakim FT, 2005, J CLIN INVEST, V115, P930, DOI 10.1172/JCI200522492; Hambach L, 2005, CURR OPIN IMMUNOL, V17, P202, DOI 10.1016/j.coi.2005.01.010; Heemskerk MHM, 2004, J EXP MED, V199, P885, DOI 10.1084/jem.20031110; Ho WY, 2003, CANCER CELL, V3, P431, DOI 10.1016/S1535-6108(03)00113-2; Klein CA, 2002, J EXP MED, V196, P359, DOI 10.1084/jem.20011838; Korngold R, 1997, Biol Blood Marrow Transplant, V3, P57; Lane C, 2004, CANCER RES, V64, P1509, DOI 10.1158/0008-5472.CAN-03-3227; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; McBride K, 2002, IMMUNOGENETICS, V54, P562, DOI 10.1007/s00251-002-0502-4; Meunier MC, 2005, NAT MED, V11, P1222, DOI 10.1038/nm1311; Meunier MC, 2003, BLOOD, V101, P766, DOI 10.1182/blood-2002-04-1032; Molldrem JJ, 2000, NAT MED, V6, P1018, DOI 10.1038/79526; Mutis T, 1999, NAT MED, V5, P839, DOI 10.1038/10563; Nijmeijer BA, 2005, EXP HEMATOL, V33, P1172, DOI 10.1016/j.exphem.2005.06.034; Obhrai JS, 2006, J IMMUNOL, V176, P4051, DOI 10.4049/jimmunol.176.7.4051; Ochsenbein AF, 2001, NATURE, V411, P1058, DOI 10.1038/35082583; Oosten LEM, 2004, BLOOD, V104, P224, DOI 10.1182/blood-2003-07-2461; Perreault C, 2002, J MOL MED, V80, P212, DOI 10.1007/s00109-001-0315-1; Pion S, 1997, EUR J IMMUNOL, V27, P421, DOI 10.1002/eji.1830270212; Rice J, 2006, CANCER RES, V66, P5436, DOI 10.1158/0008-5472.CAN-05-3130; Riddell SR, 2006, BIOL BLOOD MARROW TR, V12, P9, DOI 10.1016/j.bbmt.2005.10.025; Rijke BC, 2005, J CLIN INVEST, V115, P3506, DOI 10.1172/JCI24832; Rocha B, 2004, CURR OPIN IMMUNOL, V16, P259, DOI 10.1016/j.coi.2004.03.004; Roy-Proulx G, 2005, BIOL BLOOD MARROW TR, V11, P260, DOI 10.1016/j.bbmt.2004.12.334; Roy-Proulx G, 2001, EUR J IMMUNOL, V31, P2284, DOI 10.1002/1521-4141(200108)31:8<2284::AID-IMMU2284>3.0.CO;2-E; Spierings E, 2004, TRENDS IMMUNOL, V25, P56, DOI 10.1016/j.it.2003.12.002; STORB R, 1983, ANN INTERN MED, V98, P461, DOI 10.7326/0003-4819-98-4-461; Truitt RL, 2004, BIOL BLOOD MARROW TR, V10, P505, DOI 10.1016/j.bbmt.2004.05.005; Uhr JW, 1997, NAT MED, V3, P505, DOI 10.1038/nm0597-505; van Elsas A, 2001, J EXP MED, V194, P481, DOI 10.1084/jem.194.4.481; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099; Yu P, 2006, CURR OPIN IMMUNOL, V18, P226, DOI 10.1016/j.coi.2006.01.004; Zecca M, 2002, BLOOD, V100, P1192, DOI 10.1182/blood-2001-11-0059; Zinkernagel RM, 1999, IMMUNOL REV, V168, P305, DOI 10.1111/j.1600-065X.1999.tb01300.x; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	53	7	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4116	10.1371/journal.pone.0004116	http://dx.doi.org/10.1371/journal.pone.0004116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FX	19127288	Green Submitted, gold, Green Published			2022-12-25	WOS:000265473300002
J	Fulton, A; Peters, ST; Perkins, GA; Jarosinski, KW; Damiani, A; Brosnahan, M; Buckles, EL; Osterrieder, N; Van de Walle, GR				Fulton, Amy; Peters, Sarah T.; Perkins, Gillian A.; Jarosinski, Keith W.; Damiani, Armando; Brosnahan, Margaret; Buckles, Elizabeth L.; Osterrieder, Nikolaus; Van de Walle, Gerlinde R.			Effective Treatment of Respiratory Alphaherpesvirus Infection Using RNA Interference	PLOS ONE			English	Article								Background: Equine herpesvirus type 1 (EHV-1), a member of the Alphaherpesvirinae, is spread via nasal secretions and causes respiratory disease, neurological disorders and abortions. The virus is a significant equine pathogen, but current EHV-1 vaccines are only partially protective and effective metaphylactic and therapeutic agents are not available. Small interfering RNAs (siRNA's), delivered intranasally, could prove a valuable alternative for infection control. siRNA's against two essential EHV-1 genes, encoding the viral helicase (Ori) and glycoprotein B, were evaluated for their potential to decrease EHV-1 infection in a mouse model. Methodology/Principal Fndings: siRNA therapy in vitro significantly reduced virus production and plaque size. Viral titers were reduced 80-fold with 37.5 pmol of a single siRNA or with as little as 6.25 pmol of each siRNA when used in combination. siRNA therapy in vivo significantly reduced viral replication and clinical signs. Intranasal treatment did not require a transport vehicle and proved effective when given up to 12 h before or after infection. Conclusions/Significance: siRNA treatment has potential for both prevention and early treatment of EHV-1 infections.	[Fulton, Amy; Peters, Sarah T.; Jarosinski, Keith W.; Damiani, Armando; Brosnahan, Margaret; Osterrieder, Nikolaus; Van de Walle, Gerlinde R.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Perkins, Gillian A.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA; [Buckles, Elizabeth L.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Osterrieder, Nikolaus] Free Univ Berlin, Inst Virol, Berlin, Germany	Cornell University; Cornell University; Cornell University; Free University of Berlin	Fulton, A (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.	no34@cornell.edu		Van de Walle, Gerlinde/0000-0002-2064-8029; Jarosinski, Keith/0000-0002-0391-9018; Osterrieder, Nikolaus/0000-0002-5313-2176	Harry M. Zweig Fund for Equine Research at Cornell University	Harry M. Zweig Fund for Equine Research at Cornell University	This work was supported by the Harry M. Zweig Fund for Equine Research at Cornell University to G.A.P and N.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN FH, 1987, J CHEM SOC P2, V11, P1; Allen G P, 1986, Prog Vet Microbiol Immunol, V2, P78; AWAN AR, 1990, J GEN VIROL, V71, P1131, DOI 10.1099/0022-1317-71-5-1131; Barik S, 2006, EXPERT OPIN BIOL TH, V6, P1151, DOI 10.1517/14712598.6.11.1151; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Bitko V, 2001, BMC Microbiol, V1, P34, DOI 10.1186/1471-2180-1-34; Bitko V, 2007, CURR OPIN MOL THER, V9, P119; Boden D, 2003, J VIROL, V77, P11531, DOI 10.1128/JVI.77.21.11531-11535.2003; COLLINS LF, 1996, OT PRACTICE, V1, P43; Dallas A, 2006, MED SCI MONITOR, V12, pRA67; Dykxhoorn DM, 2006, PLOS MED, V3, P1000, DOI 10.1371/journal.pmed.0030242; Dykxhoorn DM, 2006, CELL, V126, P231, DOI 10.1016/j.cell.2006.07.007; Frampton AR, 2002, VIRUS RES, V90, P287, DOI 10.1016/S0168-1702(02)00245-9; Galosi CM, 2004, VET MICROBIOL, V103, P1, DOI 10.1016/j.vetmic.2004.07.015; Garre B, 2007, ANTIMICROB AGENTS CH, V51, P4308, DOI 10.1128/AAC.00116-07; Garre B, 2007, VET MICROBIOL, V122, P43, DOI 10.1016/j.vetmic.2007.01.004; GARRE B, 2008, VET MICROBIOL, DOI DOI 10.1016/J.TVJL.2008.03.027; GIBSON JS, 1992, ARCH VIROL, V123, P351, DOI 10.1007/BF01317269; Goodman LB, 2007, PLOS PATHOG, V3, P1583, DOI 10.1371/journal.ppat.0030160; Goodman LB, 2006, VACCINE, V24, P3636, DOI 10.1016/j.vaccine.2006.01.062; Heidel JD, 2004, NAT BIOTECHNOL, V22, P1579, DOI 10.1038/nbt1038; Henninger RW, 2007, J VET INTERN MED, V21, P157, DOI 10.1892/0891-6640(2007)21[157:OONDCB]2.0.CO;2; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Jarosinski KW, 2007, VIRUS GENES, V34, P9, DOI 10.1007/s11262-006-0004-9; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kydd JH, 2006, VET IMMUNOL IMMUNOP, V111, P15, DOI 10.1016/j.vetimm.2006.01.005; Li BJ, 2005, NAT MED, V11, P944, DOI 10.1038/nm1280; MARTIN DW, 1994, J VIROL, V68, P3674, DOI 10.1128/JVI.68.6.3674-3681.1994; MARTIN DW, 1994, VIROLOGY, V198, P71, DOI 10.1006/viro.1994.1009; Massaro D, 2004, AM J PHYSIOL-LUNG C, V287, pL1066, DOI 10.1152/ajplung.00067.2004; Neubauer A, 1997, VIROLOGY, V227, P281, DOI 10.1006/viro.1996.8336; Palliser D, 2006, NATURE, V439, P89, DOI 10.1038/nature04263; PELLETT PE, 2007, HERPESVIRIDAE, P2479; Ruitenberg KM, 1999, VET MICROBIOL, V68, P35, DOI 10.1016/S0378-1135(99)00059-0; Ruitenberg KM, 1999, VACCINE, V17, P237, DOI 10.1016/S0264-410X(98)00192-3; Scherer L, 2007, GENE THER, V14, P1057, DOI 10.1038/sj.gt.3302977; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Tsujimura K, 2006, J VET MED SCI, V68, P1029, DOI 10.1292/jvms.68.1029; *USDA APHIS, 2007, EQ HERP MYEL POT EM; Van de Walle GR, 2008, J VIROL, V82, P1714, DOI 10.1128/JVI.02137-07; Van de Walle GR, 2007, J IMMUNOL, V179, P4161, DOI 10.4049/jimmunol.179.6.4161; VANWOENSEL PAM, 1995, J VIROL METHODS, V54, P39, DOI 10.1016/0166-0934(95)00024-O; von Einem J, 2007, VIROLOGY, V362, P151, DOI 10.1016/j.virol.2006.12.008; Wilson JA, 2005, J VIROL, V79, P7050, DOI 10.1128/JVI.79.11.7050-7058.2005; Zhang J, 2007, MOL BIOTECHNOL, V37, P225, DOI 10.1007/s12033-007-9000-0; Zheng BJ, 2004, ANTIVIR THER, V9, P365	46	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2009	4	1							e4118	10.1371/journal.pone.0004118	http://dx.doi.org/10.1371/journal.pone.0004118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FT	19122813	Green Published, gold, Green Submitted			2022-12-25	WOS:000265472900003
J	Cellini, B; Montioli, R; Paiardini, A; Lorenzetto, A; Voltattorni, CB				Cellini, Barbara; Montioli, Riccardo; Paiardini, Alessandro; Lorenzetto, Antonio; Voltattorni, Carla Borri			Molecular Insight into the Synergism between the Minor Allele of Human Liver Peroxisomal Alanine: Glyoxylate Aminotransferase and the F152I Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY HYPEROXALURIA TYPE-1; I PRIMARY HYPEROXALURIA; PHENOTYPE; GENOTYPE	Human liver peroxisomal alanine: glyoxylate aminotransferase (AGT) is a pyridoxal 5'- phosphate (PLP)-dependent enzyme that converts glyoxylate into glycine. AGT deficiency causes primary hyperoxaluria type 1 (PH1), a rare autosomal recessive disorder, due to a marked increase in hepatic oxalate production. Normal human AGT exists as two polymorphic variants: the major (AGT-Ma) and the minor (AGT-Mi) allele. AGT-Mi causes the PH1 disease only when combined with some mutations. In this study, the molecular basis of the synergism between AGT-Mi and F152I mutation has been investigated through a detailed biochemical characterization of AGT-Mi and the Phe(152) variants combined either with the major (F152I-Ma, F152A-Ma) or the minor allele (F152I-Mi). Although these species show spectral features, kinetic parameters, and PLP binding affinity similar to those of AGT-Ma, the Phe(152) variants exhibit the following differences with respect to AGT-Ma and AGT-Mi: (i) pyridoxamine 5'-phosphate (PMP) is released during the overall transamination leading to the conversion into apoenzymes, and (ii) the PMP binding affinity is at least 200-1400-fold lower. Thus, Phe152 is not an essential residue for transaminase activity, but plays a role in selectively stabilizing the AGT-PMP complex, by a proper orientation of Trp(108), as suggested by bioinformatic analysis. These data, together with the finding that apoF152I-Mi is the only species that at physiological temperature undergoes a time-dependent inactivation and concomitant aggregation, shed light on the molecular defects resulting from the association of the F152I mutation with AGT-Mi, and allow to speculate on the responsiveness to pyridoxine therapy of PH1 patients carrying this mutation.	[Cellini, Barbara; Montioli, Riccardo; Lorenzetto, Antonio; Voltattorni, Carla Borri] Univ Verona, Fac Med & Chirurg, Dipartimento Sci Morfol Biomed, Sez Chim Biol, I-37134 Verona, Italy; [Paiardini, Alessandro] Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy; [Paiardini, Alessandro] Univ Roma La Sapienza, Ctr Biol Mol, CNR, I-00185 Rome, Italy	University of Verona; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome	Voltattorni, CB (corresponding author), Univ Verona, Fac Med & Chirurg, Dipartimento Sci Morfol Biomed, Sez Chim Biol, Str Grazie 8, I-37134 Verona, Italy.	carla.borrivoltattorni@univr.it	Paiardini, Alessandro/G-8058-2011; Cellini, Barbara/AAC-6401-2019	Cellini, Barbara/0000-0002-5221-9288; Paiardini, Alessandro/0000-0001-9078-7545	Oxalosis and Hyperoxaluria Foundation (OHF); Ministero dell'Universita e della Ricerca (PRIN 2007)	Oxalosis and Hyperoxaluria Foundation (OHF); Ministero dell'Universita e della Ricerca (PRIN 2007)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by grants from the Oxalosis and Hyperoxaluria Foundation (OHF) and Ministero dell'Universita e della Ricerca (PRIN 2007) to C. B. V.).	Bertoldi M, 2000, BIOCHEM J, V352, P533, DOI 10.1042/0264-6021:3520533; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Cellini B, 2003, FEBS LETT, V554, P306, DOI 10.1016/S0014-5793(03)01178-5; Cellini B, 2008, PROTEIN PEPTIDE LETT, V15, P153; Cellini B, 2007, BIOCHEM J, V408, P39, DOI 10.1042/BJ20070637; DANPURE CJ, 1994, J INHERIT METAB DIS, V17, P27, DOI 10.1007/BF00735393; DANPURE CJ, 1993, AM J HUM GENET, V53, P417; DANPURE CJ, 1988, CLIN SCI, V75, P315, DOI 10.1042/cs0750315; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Hopper ED, 2008, J BIOL CHEM, V283, P30493, DOI 10.1074/jbc.M803525200; Leiper JM, 1996, J CELL BIOL, V135, P939, DOI 10.1083/jcb.135.4.939; Lumb MJ, 2000, J BIOL CHEM, V275, P36415, DOI 10.1074/jbc.M006693200; MACKIE MBC, 2008, MOL GENET METAB, V94, P368; Monico CG, 2005, AM J NEPHROL, V25, P183, DOI 10.1159/000085411; Monico CG, 2005, KIDNEY INT, V67, P1704, DOI 10.1111/j.1523-1755.2005.00267.x; Zhang XX, 2003, J MOL BIOL, V331, P643, DOI 10.1016/S0022-2836(03)00791-5	17	48	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8349	8358		10.1074/jbc.M808965200	http://dx.doi.org/10.1074/jbc.M808965200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19155213	Green Published, hybrid			2022-12-25	WOS:000264397800019
J	Trojer, P; Zhang, J; Yonezawa, M; Schmidt, A; Zheng, HY; Jenuwein, T; Reinberg, D				Trojer, Patrick; Zhang, Jin; Yonezawa, Masato; Schmidt, Andreas; Zheng, Haiyan; Jenuwein, Thomas; Reinberg, Danny			Dynamic Histone H1 Isotype 4 Methylation and Demethylation by Histone Lysine Methyltransferase G9a/KMT1C and the Jumonji Domain-containing JMJD2/KDM4 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKER-HISTONE; FACULTATIVE HETEROCHROMATIN; SUBSTRATE-SPECIFICITY; CHROMATIN-STRUCTURE; MOUSE DEVELOPMENT; EUGLENA-GRACILIS; GENE-EXPRESSION; MICE LACKING; IN-VIVO; G9A	The linker histone H1 generally participates in the establishment of chromatin structure. However, of the seven somatic H1 isotypes in humans some are also implicated in the regulation of local gene expression. Histone H1 isotype 4 (H1.4) represses transcription, and its lysine residue 26 (Lys(26)) was found to be important in this aspect. H1.4K26 is known to be methylated and acetylated in vivo, but the enzymes responsible for these post-translational modifications and the regulatory cues that promote H1.4 residence on chromatin are poorly characterized. Here we report that the euchromatic histone lysine methyltransferase G9a/KMT1C mediates H1.4K26 mono- and dimethylation in vitro and in vivo and thereby provides a recognition surface for the chromatin-binding proteins HP1 and L3MBTL1. Moreover, we show evidence that G9a promotes H1 deposition and is required for retention of H1 on chromatin. We also identify members of the JMJD2/KDM4 subfamily of jumonji-C type histone demethylases as being responsible for the removal of H1.4K26 methylation.	[Trojer, Patrick; Reinberg, Danny] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Trojer, Patrick; Zhang, Jin; Reinberg, Danny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Yonezawa, Masato; Jenuwein, Thomas] Vienna Bioctr, Res Inst Mol Pathol, IMP, A-1030 Vienna, Austria; [Schmidt, Andreas] Univ Vienna, Vienna Bioctr, Christian Doppler Lab Proteome Anal, Dept Biochem, A-1030 Vienna, Austria; [Zheng, Haiyan] Univ Med & Dent New Jersey, Ctr Adv Biotechnol & Med, Dept Pharmacol, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; New York University; New York University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Vienna; Vienna Biocenter (VBC); Rutgers State University New Brunswick; Rutgers State University Medical Center	Reinberg, D (corresponding author), 522 1st Ave, New York, NY 10016 USA.	reinbd01@nyumc.org		Reinberg, Danny/0000-0003-4288-2016	National Institutes of Health [RR020932, RR017992, GM64844]; Howard Hughes Medical Institute; Institute of Molecular Pathology (IMP) [HPRN-CT2000-00078]; Austrian GEN-AU Initiative (financed by the Austrian Ministry of Education, Science, and Culture); NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017992, S10RR020932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064844] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Institute of Molecular Pathology (IMP); Austrian GEN-AU Initiative (financed by the Austrian Ministry of Education, Science, and Culture); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Shared Instrumentation Grants RR020932 and RR017992 ( to P. L.) and National Institutes of Health Grant GM64844 ( to D. R.). This work was also supported by a grant from the Howard Hughes Medical Institute ( to D. R.), the Institute of Molecular Pathology (IMP) through Boehringer Ingelheim, European Union network Grant HPRN-CT2000-00078, and the Austrian GEN-AU Initiative (financed by the Austrian Ministry of Education, Science, and Culture) ( to T. J.).	Alami R, 2003, P NATL ACAD SCI USA, V100, P5920, DOI 10.1073/pnas.0736105100; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Barra JL, 2000, MOL CELL BIOL, V20, P61, DOI 10.1128/MCB.20.1.61-69.2000; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Escher D, 1997, MOL GEN GENET, V256, P456, DOI 10.1007/s004380050589; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Fan YH, 2001, MOL CELL BIOL, V21, P7933, DOI 10.1128/MCB.21.23.7933-7943.2001; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Garcia BA, 2006, MOL CELL PROTEOMICS, V5, P1593, DOI 10.1074/mcp.M600086-MCP200; Godde JS, 2008, J BIOCHEM, V143, P287, DOI 10.1093/jb/mvn013; Hilpert K, 2007, NAT PROTOC, V2, P1333, DOI 10.1038/nprot.2007.160; Jason LJM, 2005, J BIOL CHEM, V280, P4975, DOI 10.1074/jbc.M410203200; Koop R, 2003, EMBO J, V22, P588, DOI 10.1093/emboj/cdg052; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; LANGAN TA, 1967, FED PROC, V26, P603; Lee N, 2007, NAT STRUCT MOL BIOL, V14, P341, DOI 10.1038/nsmb1216; Lin QC, 2000, MOL CELL BIOL, V20, P2122, DOI 10.1128/MCB.20.6.2122-2128.2000; Martin C, 2006, J BIOL CHEM, V281, P8365, DOI 10.1074/jbc.M513425200; Ng SS, 2007, NATURE, V448, P87, DOI 10.1038/nature05971; Nishioka K, 2003, METHODS, V31, P49, DOI 10.1016/S1046-2023(03)00087-2; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; OHE Y, 1986, J BIOCHEM-TOKYO, V100, P359, DOI 10.1093/oxfordjournals.jbchem.a121722; Patnaik D, 2004, J BIOL CHEM, V279, P53248, DOI 10.1074/jbc.M409604200; Perez-Burgos L, 2004, METHOD ENZYMOL, V376, P234; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Pham AD, 2000, SCIENCE, V289, P2357, DOI 10.1126/science.289.5488.2357; Ramon A, 2000, MOL MICROBIOL, V35, P223, DOI 10.1046/j.1365-2958.2000.01702.x; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Robinson PJJ, 2006, CURR OPIN STRUC BIOL, V16, P336, DOI 10.1016/j.sbi.2006.05.007; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Rudolph T, 2007, MOL CELL, V26, P103, DOI 10.1016/j.molcel.2007.02.025; Sarcevic B, 2003, ONCOLOGY-BASEL, V64, P443, DOI 10.1159/000070305; Shin S, 2007, BIOCHEM BIOPH RES CO, V359, P742, DOI 10.1016/j.bbrc.2007.05.179; Shin S, 2007, BIOCHEM BIOPH RES CO, V353, P973, DOI 10.1016/j.bbrc.2006.12.147; SIROTKIN AM, 1995, P NATL ACAD SCI USA, V92, P6434, DOI 10.1073/pnas.92.14.6434; SYED S, 1992, J PROTEIN CHEM, V11, P239, DOI 10.1007/BF01024862; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; Trojer P, 2008, NAT CHEM BIOL, V4, P332, DOI 10.1038/nchembio0608-332; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; TUCK MT, 1985, J BIOL CHEM, V260, P7114; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Villar-Garea A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001553; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Woodcock CL, 2006, CURR OPIN STRUC BIOL, V16, P213, DOI 10.1016/j.sbi.2006.02.005; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Wozniak RJ, 2007, ONCOGENE, V26, P77, DOI 10.1038/sj.onc.1209763; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024	59	146	149	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8395	8405		10.1074/jbc.M807818200	http://dx.doi.org/10.1074/jbc.M807818200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19144645	Green Published, hybrid			2022-12-25	WOS:000264397800023
J	Gil, M; McCormack, FX; Levine, AM				Gil, Malgorzata; McCormack, Francis X.; Levine, Ann Marie			Surfactant Protein A Modulates Cell Surface Expression of CR3 on Alveolar Macrophages and Enhances CR3-mediated Phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING LECTIN SITE; MYCOBACTERIUM-TUBERCULOSIS; HOST-DEFENSE; STREPTOCOCCUS-PNEUMONIAE; RECEPTOR; CD11B/CD18; LUNG; INFECTION; MICE; AGGREGATION	Pulmonary surfactant protein A (SP-A), a member of the collectin family, plays an important role in innate immune defense of the lung. In this study, we examined the role of SP-A in modulating complement receptor-mediated phagocytosis. Complement receptors (CR), CR3 (CD11b), and CR4 (CD11c) were expressed at reduced levels on the surface of alveolar macrophages from Sp-a(-/-) compared with Sp-a(-/-) mice. Administration of intratracheal SP-A to Sp-a(+/+) mice induced the translocation of CR3 from alveolar macrophage intracellular pools to the cell surface. Intratracheal challenge with Haemophilus influenza enhanced CR3 expression on the surface of alveolar macrophages from Sp-a(-/-) and Sp-a(+/+) mice, but relative expression remained lower in the Sp-a(-/-) mice at all time points post-inoculation. The effects of SP-A on macrophage and neutrophil CR3 redistribution between intracellular and cell surface pools were restricted to cells isolated from the lung. SP-A augmented CR3-mediated phagocytosis in a manner that was attenuated by N-glycanase or collagenase treatment of SP- A, implicating the N-linked sugar and collagen-like domains in that function. The binding of CR3 to SP-A was calcium dependent and mediated by the I-domain of CR3 and to a lesser extent by the CR3 lectin domain. Mapping of the domains of SP- A that were required for optimal binding to CR3 revealed that the N-linked sugars were more critical than the collagen-like domain or the extent of oligomeric assembly. We conclude that SP-A modulates the cell surface expression of CR3 on alveolar macrophages, binds to CR3, and enhances CR3-mediated phagocytosis.	[Gil, Malgorzata; Levine, Ann Marie] Univ Florida, Dept Pediat, Div Crit Care Med, Gainesville, FL 32610 USA; [McCormack, Francis X.] Univ Cincinnati, Sch Med, Div Pulm Crit Care & Sleep Med, Dept Internal Med, Cincinnati, OH 45267 USA	State University System of Florida; University of Florida; University System of Ohio; University of Cincinnati	Levine, AM (corresponding author), 1600 SW Archer Rd,RG114, Gainesville, FL 32610 USA.	levineam@peds.ufl.edu	McCormack, Francis X./ABE-8398-2020	McCormack, Francis X./0000-0001-7168-9464	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071522] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL071522] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BLAU H, 1994, AM J PHYSIOL, V266, pL148, DOI 10.1152/ajplung.1994.266.2.L148; Bolger MS, 2007, AM J PHYSIOL-LUNG C, V292, pL748, DOI 10.1152/ajplung.00127.2006; CAMPBELL JR, 1991, INFECT IMMUN, V59, P1978, DOI 10.1128/IAI.59.6.1978-1983.1991; Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9; FALLMAN M, 1993, J IMMUNOL, V151, P330; GAYNOR CD, 1995, J IMMUNOL, V155, P5343; GEERTSMA MF, 1994, AM J PHYSIOL-LUNG C, V267, pL578, DOI 10.1152/ajplung.1994.267.5.L578; HAAGSMAN HP, 1987, J BIOL CHEM, V262, P13877; Hu CG, 2000, J IMMUNOL, V165, P2596, DOI 10.4049/jimmunol.165.5.2596; Kabha K, 1997, AM J PHYSIOL-LUNG C, V272, pL344, DOI 10.1152/ajplung.1997.272.2.L344; KHOOR A, 1993, J HISTOCHEM CYTOCHEM, V41, P1311, DOI 10.1177/41.9.8354874; Korfhagen TR, 2001, AM J RESP CELL MOL, V25, P668, DOI 10.1165/ajrcmb.25.6.f221; Kuronuma K, 2004, J BIOL CHEM, V279, P21421, DOI 10.1074/jbc.M312490200; LARSON RS, 1990, IMMUNOL REV, V114, P181, DOI 10.1111/j.1600-065X.1990.tb00565.x; LeVine AM, 2001, MICROBES INFECT, V3, P161, DOI 10.1016/S1286-4579(00)01363-0; LeVine AM, 1998, AM J RESP CELL MOL, V19, P700, DOI 10.1165/ajrcmb.19.4.3254; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; Lu HF, 1997, J CLIN INVEST, V99, P1340, DOI 10.1172/JCI119293; MANZKEINKE H, 1992, EUR J CELL BIOL, V57, P95; McCormack FX, 1997, BIOCHEMISTRY-US, V36, P13963, DOI 10.1021/bi970745q; MCCORMACK FX, 1994, J BIOL CHEM, V269, P29801; MEERSCHAERT J, 1995, J IMMUNOL, V154, P4099; Melo MD, 2000, CELL IMMUNOL, V205, P13, DOI 10.1006/cimm.2000.1710; NOEL GJ, 1988, J INFECT DIS, V157, P85, DOI 10.1093/infdis/157.1.85; OHMERSCHROCK D, 1995, J CELL SCI, V108, P3695; Prince JE, 2001, J IMMUNOL, V166, P7362, DOI 10.4049/jimmunol.166.12.7362; ROSS GD, 1993, CLIN EXP IMMUNOL, V92, P181; ROSS GD, 1985, J IMMUNOL, V134, P3307; Sano H, 1999, J IMMUNOL, V163, P387; SENTT AP, 2007, AM J PHYSIOL, V292, pL469; TENNER AJ, 1989, J BIOL CHEM, V264, P13923; Thornton BP, 1996, J IMMUNOL, V156, P1235; VANIWAARDEN F, 1990, AM J RESP CELL MOL, V2, P91, DOI 10.1165/ajrcmb/2.1.91; VONASMUTH EJU, 1991, J IMMUNOL, V147, P3869; Watford WT, 2001, J IMMUNOL, V167, P6593, DOI 10.4049/jimmunol.167.11.6593; Wright JR, 1997, PHYSIOL REV, V77, P931, DOI 10.1152/physrev.1997.77.4.931; Xia Y, 1999, J IMMUNOL, V162, P7285; Yamada C, 2006, J BIOL CHEM, V281, P21771, DOI 10.1074/jbc.M513041200	38	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7495	7504		10.1074/jbc.M808643200	http://dx.doi.org/10.1074/jbc.M808643200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19155216	hybrid, Green Published			2022-12-25	WOS:000264195600013
J	Wientjes, E; Oostergetel, GT; Jansson, S; Boekema, EJ; Croce, R				Wientjes, Emilie; Oostergetel, Gert T.; Jansson, Stefan; Boekema, Egbert J.; Croce, Roberta			The Role of Lhca Complexes in the Supramolecular Organization of Higher Plant Photosystem I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; ANGSTROM RESOLUTION; PIGMENT-BINDING; ANTENNA POLYPEPTIDES; ARABIDOPSIS-THALIANA; CRYSTAL-STRUCTURE; PSI-LHCI; PROTEINS; FLUORESCENCE; CHLOROPHYLLS	In this work, Photosystem I supercomplexes have been purified from Lhca-deficient lines of Arabidopsis thaliana using a mild detergent treatment that does not induce loss of outer antennas. The complexes have been studied by integrating biochemical analysis with electron microscopy. This allows the direct correlation of changes in protein content with changes in supramolecular structure of Photosystem I to get information about the position of the individual Lhca subunits, the association of the antenna to the core, and the influence of the individual subunits on the stability of the system. Photosystem I complexes with only two or three antenna complexes were purified, showing that the binding of Lhca1/4 and Lhca2/3 dimers to the core is not interdependent, although weak binding of Lhca2/3 to the core is stabilized by the presence of Lhca4. Moreover, Lhca2 and Lhca4 can be associated with the core in the absence of their "dimeric partners." The structure of Photosystem I is very rigid, and the absence of one antenna complex leaves a "hole" in the structure that cannot be filled by other Lhcas, clearly indicating that the docking sites for the individual subunits are highly specific. There is, however, an exception to the rule: Lhca5 can substitute for Lhca4, yielding highly stable PSI supercomplexes with a supramolecular organization identical to the WT.	[Wientjes, Emilie; Oostergetel, Gert T.; Boekema, Egbert J.; Croce, Roberta] Univ Groningen, Dept Biophys Chem, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Jansson, Stefan] Umea Plant Sci Ctr, Dept Plant Physiol, SE-90189 Umea, Sweden	University of Groningen; Umea University	Croce, R (corresponding author), Univ Groningen, Dept Biophys Chem, Groningen Biomol Sci & Biotechnol Inst, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	R.Croce@rug.nl	Croce, Roberta/ABG-3595-2021; Croce, Roberta/N-4067-2014; Wientjes, Emilie/M-6387-2014; Croce, Roberta/HGU-9554-2022; Jansson, Stefan/A-1119-2009; Croce, Roberta/F-1174-2014; Wientjes, Emilie/AAC-8491-2019	Croce, Roberta/0000-0003-3469-834X; Croce, Roberta/0000-0003-3469-834X; Wientjes, Emilie/0000-0003-2625-8045; Croce, Roberta/0000-0003-3469-834X; Jansson, Stefan/0000-0002-7906-6891; Wientjes, Emilie/0000-0003-2625-8045	Nederlandse Organisatie voor Wetenschappelijk Onderzoek via a VIDI	Nederlandse Organisatie voor Wetenschappelijk Onderzoek via a VIDI(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Council for Earth and Life Sciences of the Nederlandse Organisatie voor Wetenschappelijk Onderzoek via a VIDI grant (to R.C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Amunts A, 2008, PLANT PHYSIOL BIOCH, V46, P228, DOI 10.1016/j.plaphy.2007.12.013; Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; Bailey S, 2001, PLANTA, V213, P794, DOI 10.1007/s004250100556; Ballottari M, 2004, EUR J BIOCHEM, V271, P4659, DOI 10.1111/j.1432-1033.2004.04426.x; Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; Boekema EJ, 2001, BIOCHEMISTRY-US, V40, P1029, DOI 10.1021/bi0015358; Caffarri S, 2001, J BIOL CHEM, V276, P35924, DOI 10.1074/jbc.M105199200; Castelletti S, 2003, BIOCHEMISTRY-US, V42, P4226, DOI 10.1021/bi027398r; Croce R, 1996, BIOCHEMISTRY-US, V35, P8572, DOI 10.1021/bi960214m; Croce R, 1998, BIOCHEMISTRY-US, V37, P17355, DOI 10.1021/bi9813227; Croce R, 2002, BBA-BIOENERGETICS, V1556, P29, DOI 10.1016/S0005-2728(02)00304-3; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Fromme P, 2001, BBA-BIOENERGETICS, V1507, P5, DOI 10.1016/S0005-2728(01)00195-5; Ganeteg U, 2004, PLANT MOL BIOL, V54, P641, DOI 10.1023/B:PLAN.0000040813.05224.94; Ganeteg U, 2004, PLANT PHYSIOL, V134, P502, DOI 10.1104/pp.103.033324; Ganeteg U, 2001, PLANT PHYSIOL, V127, P150, DOI 10.1104/pp.127.1.150; GANETEG U, 2004, THESIS UMEA PLANT SC; Ihalainen JA, 2005, FEBS LETT, V579, P4787, DOI 10.1016/j.febslet.2005.06.091; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Jennings RC, 2003, BBA-BIOENERGETICS, V1557, P91, DOI 10.1016/S0005-2728(02)00399-7; Jensen PE, 2000, J BIOL CHEM, V275, P24701, DOI 10.1074/jbc.M000550200; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Klimmek F, 2005, BIOCHEMISTRY-US, V44, P3065, DOI 10.1021/bi047873g; KNOETZEL J, 1992, EUR J BIOCHEM, V206, P209, DOI 10.1111/j.1432-1033.1992.tb16918.x; Kouril R, 2005, BIOCHEMISTRY-US, V44, P10935, DOI 10.1021/bi051097a; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Lucinski R, 2006, FEBS LETT, V580, P6485, DOI 10.1016/j.febslet.2006.10.063; Morosinotto T, 2005, J BIOL CHEM, V280, P31050, DOI 10.1074/jbc.M502935200; Morosinotto T, 2003, J BIOL CHEM, V278, P49223, DOI 10.1074/jbc.M309203200; NUSSBERGER S, 1994, BIOCHEMISTRY-US, V33, P14775, DOI 10.1021/bi00253a016; Oostergetel GT, 1998, ULTRAMICROSCOPY, V74, P47, DOI 10.1016/S0304-3991(98)00022-9; PETER GF, 1991, J BIOL CHEM, V266, P16745; Ruban AV, 2003, NATURE, V421, P648, DOI 10.1038/nature01344; Schmid VHR, 1997, P NATL ACAD SCI USA, V94, P7667, DOI 10.1073/pnas.94.14.7667; Schmid VHR, 2002, J BIOL CHEM, V277, P37307, DOI 10.1074/jbc.M205889200; Storf S, 2005, J BIOL CHEM, V280, P5163, DOI 10.1074/jbc.M411248200; Storf S, 2004, BIOCHEMISTRY-US, V43, P9214, DOI 10.1021/bi0498196; Tikkanen M, 2006, PLANT MOL BIOL, V62, P795, DOI 10.1007/s11103-006-9088-9; van Oort B, 2008, BIOPHYS J, V95, P5851, DOI 10.1529/biophysj.108.140467; Varotto C, 2002, PLANT PHYSIOL, V129, P616, DOI 10.1104/pp.002089; Wollman FA, 1999, BBA-BIOENERGETICS, V1411, P21, DOI 10.1016/S0005-2728(99)00043-2	43	76	81	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7803	7810		10.1074/jbc.M808395200	http://dx.doi.org/10.1074/jbc.M808395200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19139095	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000264195600042
J	Jin, Z; Shi, J; Saraf, A; Mei, W; Zhu, GZ; Strack, S; Yang, J				Jin, Zhigang; Shi, Jianli; Saraf, Amit; Mei, Wenyan; Zhu, Guo-Zhang; Strack, Stefan; Yang, Jing			The 48-kDa Alternative Translation Isoform of PP2A:B56 epsilon Is Required for Wnt Signaling during Midbrain-Hindbrain Boundary Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; REGULATORY SUBUNIT; GENE IEX-1; PP2A; EXPRESSION; GENOME; FAMILY; RNA; INITIATION; INDUCTION	Alternative translation is an underappreciated post-transcriptional regulation mechanism. Although only a small number of genes are found to be alternatively translated, most genes undergoing alternative translation play important roles in tumorigenesis and development. Protein phosphatase 2A (PP2A) is involved in many cellular events during tumorigenesis and development. The specificity, localization, and activity of PP2A are regulated by B regulatory subunits. B56 epsilon, a member of the B56 regulatory subunit family, is involved in multiple signaling pathways and regulates a number of developmental processes. Here we report that B56 epsilon is alternatively translated, leading to the production of a full-length form and a shorter isoform that lacks the N-terminal 76 amino acid residues of the full-length form. Alternative translation of B56 epsilon occurs through a cap-dependent mechanism. We provide evidence that the shorter isoform is required for Wnt signaling and regulates the midbrain/hindbrain boundary formation during Xenopus embryonic development. This demonstrates that the shorter isoform of B56 epsilon has important biological functions. Furthermore, we show that the N-terminal sequence of B56 epsilon, which is not present in the shorter isoform, contains a nuclear localization signal, whereas the C terminus of B56 epsilon contains a nuclear export signal. The shorter isoform, which lacks the N-terminal nuclear localization signal, is restricted to the cytoplasm. In contrast, the full-length form can be localized to the nucleus in a cell type-specific manner. The finding that B56 epsilon is alternatively translated adds a new level of regulation to PP2A holoenzymes.	[Jin, Zhigang; Shi, Jianli; Mei, Wenyan; Yang, Jing] Ohio State Univ, Nationwide Childrens Hosp, Res Inst, Ctr Cell & Dev Biol,Dept Pediat, Columbus, OH 43205 USA; [Saraf, Amit; Strack, Stefan] Univ Iowa, Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA; [Zhu, Guo-Zhang] Marshall Univ, Dept Biol Sci, Huntington, WV 25755 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Iowa; Marshall University	Yang, J (corresponding author), Ohio State Univ, Nationwide Childrens Hosp, Res Inst, Ctr Cell & Dev Biol,Dept Pediat, Columbus, OH 43205 USA.	Jing.Yang@nationwidechildrens.org	Saraf, amit/GZL-0533-2022; Jin, Zhigang/T-7125-2019	Saraf, amit/0000-0002-0823-2266; Jin, Zhigang/0000-0001-7557-2968; Strack, Stefan/0000-0002-6175-7280	Nationwide Children's Hospital internal startup fund; Madison Foundation	Nationwide Children's Hospital internal startup fund; Madison Foundation	This work was supported by a Nationwide Children's Hospital internal startup fund (to J. Y.) and by The Madison Foundation. The costs of publication of this article were defrayed in part by the payment of page charges.	BRADLEY LC, 1993, MECH DEVELOP, V40, P73, DOI 10.1016/0925-4773(93)90089-G; Cameron RA, 2000, P NATL ACAD SCI USA, V97, P9514, DOI 10.1073/pnas.160261897; Chen F, 2007, CURR BIOL, V17, P293, DOI 10.1016/j.cub.2007.01.068; CHRISTIAN JL, 1991, DEV BIOL, V143, P230, DOI 10.1016/0012-1606(91)90073-C; Csortos C, 1996, J BIOL CHEM, V271, P2578, DOI 10.1074/jbc.271.5.2578; Deardorff' MA, 1998, DEVELOPMENT, V125, P2687; Deardorff MA, 2001, DEVELOPMENT, V128, P3655; Eichhorn P.J., 2008, BBA-REV CANCER, V1795, P1, DOI DOI 10.1016/J.BBCAN.2008.05.005; Gao ZH, 2002, P NATL ACAD SCI USA, V99, P1182, DOI 10.1073/pnas.032468199; Gingras AC, 2001, GENE DEV, V15, P2852; Hannus M, 2002, DEVELOPMENT, V129, P3493; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; HEMMATIBRIVANLOU A, 1991, DEVELOPMENT, V111, P715; Holland AJ, 2007, J BIOL CHEM, V282, P24623, DOI 10.1074/jbc.M702545200; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jia H, 2009, DEVELOPMENT, V136, P307, DOI 10.1242/dev.030015; Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; KOZAK M, 1978, CELL, V15, P1109, DOI 10.1016/0092-8674(78)90039-9; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Li XH, 2002, MOL CELL BIOL, V22, P3674, DOI 10.1128/MCB.22.11.3674-3684.2002; Li XH, 2001, EMBO J, V20, P4122, DOI 10.1093/emboj/20.15.4122; Liu W, 2007, MOL CELL PROTEOMICS, V6, P319, DOI 10.1074/mcp.M600272-MCP200; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Mayer C, 2003, BIOCHEMISTRY-US, V42, P4787, DOI 10.1021/bi034011r; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; MCCRIGHT B, 1995, J BIOL CHEM, V270, P26123, DOI 10.1074/jbc.270.44.26123; McGrew LL, 1999, MECH DEVELOP, V87, P21, DOI 10.1016/S0925-4773(99)00136-7; MOODY SA, 1987, DEV BIOL, V119, P560, DOI 10.1016/0012-1606(87)90059-5; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Muneer S, 2002, GENOMICS, V79, P344, DOI 10.1006/geno.2002.6721; Nybakken K, 2005, NAT GENET, V37, P1323, DOI 10.1038/ng1682; Pennisi E, 2003, SCIENCE, V300, P1484, DOI 10.1126/science.300.5625.1484b; Ratcliffe MJ, 2000, J BIOL CHEM, V275, P35680, DOI 10.1074/jbc.C000639200; Rocher G, 2007, J BIOL CHEM, V282, P5468, DOI 10.1074/jbc.M609712200; Rorick AM, 2007, DEV BIOL, V302, P477, DOI 10.1016/j.ydbio.2006.10.011; SaintJeannet JP, 1997, P NATL ACAD SCI USA, V94, P13713, DOI 10.1073/pnas.94.25.13713; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; SHARPE CR, 1987, CELL, V50, P749, DOI 10.1016/0092-8674(87)90333-3; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Sive H., 2000, EARLY DEV XENOPUS LA, P91; Van Kanegan MJ, 2005, J BIOL CHEM, V280, P36029, DOI 10.1074/jbc.M506986200; Van Raay TJ, 2005, NEURON, V46, P23, DOI 10.1016/j.neuron.2005.02.023; Yang J, 2003, DEVELOPMENT, V130, P5569, DOI 10.1242/dev.00762	47	21	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7190	7200		10.1074/jbc.M807907200	http://dx.doi.org/10.1074/jbc.M807907200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19129191	Green Published, hybrid			2022-12-25	WOS:000263919000066
J	Lee, YY; Cevallos, RC; Jan, E				Lee, Yun-Young; Cevallos, Randal C.; Jan, Eric			An Upstream Open Reading Frame Regulates Translation of GADD34 during Cellular Stresses That Induce eIF2 alpha Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA TRANSLATION; INDUCED GENE-EXPRESSION; INITIATION FACTOR-II; EUKARYOTIC RIBOSOMES; DISTINCT MECHANISMS; PROTEIN TRANSLATION; MAMMALIAN-CELLS; GROWTH ARREST; ENTRY SITE	Cellular stress such as endoplasmic reticulum stress, hypoxia, and viral infection activates an integrated stress response, which includes the phosphorylation of the eukaryotic initiation factor 2 alpha (eIF2 alpha) to inhibit overall protein synthesis. Paradoxically, this leads to translation of a subset of mRNAs, like transcription factor ATF4, which in turn induces transcription of downstream stress-induced genes such as growth arrest DNA-inducible gene 34 (GADD34). GADD34 interacts with protein phosphatase 1 to dephosphorylate eIF2 alpha, resulting in a negative feedback loop to recover protein synthesis and allow translation of stress-induced transcripts. Here, we show that GADD34 is not only transcriptionally induced but also translationally regulated to ensure maximal expression during eIF2 alpha phosphorylation. GADD34 mRNAs are preferentially associated with polysomes during eIF2 alpha phosphorylation, which is mediated by its 5'-untranslated region (5'UTR). The human GADD34 5'UTR contains two non-overlapping upstream open reading frames (uORFs), whereas the mouse version contains two overlapping and out of frame uORFs. Using 5'UTR GADD34 reporter constructs, we show that the downstream uORF mediates repression of basal translation and directs translation during eIF2 alpha phosphorylation. Furthermore, we show that the upstream uORF is poorly translated and that a proportion of scanning ribosomes bypasses the upstream uORF to recognize the downstream uORF. These findings suggest that GADD34 translation is regulated by a unique 5'UTR uORF mechanism to ensure proper GADD34 expression during eIF2 alpha phosphorylation. This mechanism may serve as a model for understanding how other 5'UTR uORF-containing mRNAs are regulated during cellular stress.	[Lee, Yun-Young; Jan, Eric] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Cevallos, Randal C.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	University of British Columbia; Stanford University	Jan, E (corresponding author), 5457-2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	ej@interchange.ubc.ca	Jan, Eric/O-1923-2019		Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by a Canadian Institutes for Health Research operating grant ( to E. J.).	Adler HT, 1999, MOL CELL BIOL, V19, P7050; Alwine JC, 2008, CURR TOP MICROBIOL, V325, P263; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Calkhoven CF, 2000, GENE DEV, V14, P1920; CHEN JJ, 1991, P NATL ACAD SCI USA, V88, P7729, DOI 10.1073/pnas.88.17.7729; Child SJ, 1999, J BIOL CHEM, V274, P24335, DOI 10.1074/jbc.274.34.24335; Connor JH, 2001, MOL CELL BIOL, V21, P6841, DOI 10.1128/MCB.21.20.6841-6850.2001; Dever T.E., 2007, TRANSLATIONAL CONTRO, P319; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Fang P, 2000, J BIOL CHEM, V275, P26710; Fang P, 2004, P NATL ACAD SCI USA, V101, P4059, DOI 10.1073/pnas.0400554101; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Gaba A, 2005, MOL CELL, V20, P449, DOI 10.1016/j.molcel.2005.09.019; Gaba A, 2001, EMBO J, V20, P6453, DOI 10.1093/emboj/20.22.6453; GRANT CM, 1994, MOL CELL BIOL, V14, P2616, DOI 10.1128/MCB.14.4.2616; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hollander MC, 2003, ONCOGENE, V22, P3827, DOI 10.1038/sj.onc.1206567; Hollander MC, 1997, J BIOL CHEM, V272, P13731, DOI 10.1074/jbc.272.21.13731; Iacono M, 2005, GENE, V349, P97, DOI 10.1016/j.gene.2004.11.041; Jackson R. J., 2007, TRANSLATIONAL CONTRO, P197; Jan E, 2003, P NATL ACAD SCI USA, V100, P15410, DOI 10.1073/pnas.2535183100; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; Jan E, 2006, VIRUS RES, V119, P16, DOI 10.1016/j.virusres.2005.10.011; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Kenzelmann M, 2007, P NATL ACAD SCI USA, V104, P6164, DOI 10.1073/pnas.0610439104; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; KOSTURA M, 1989, MOL CELL BIOL, V9, P1576, DOI 10.1128/MCB.9.4.1576; Kozak M, 2001, NUCLEIC ACIDS RES, V29, P5226, DOI 10.1093/nar/29.24.5226; KOZAK M, 1984, NATURE, V308, P241, DOI 10.1038/308241a0; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Poyry TAA, 2004, GENE DEV, V18, P62, DOI 10.1101/gad.276504; Poyry TAA, 2007, GENE DEV, V21, P3149, DOI 10.1101/gad.439507; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Ron D, 2007, TRANSLATIONAL CONTRO, P345; ROWLANDS AG, 1988, J BIOL CHEM, V263, P5526; Sachs MS, 2006, GENE DEV, V20, P915, DOI 10.1101/gad.1427006; SCHNEIDER RJ, 2007, TRANSLATIONAL CONTRO, P401; Tardif KD, 2002, J VIROL, V76, P7453, DOI 10.1128/JVI.76.15.7453-7459.2002; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Watatani Y, 2008, J BIOL CHEM, V283, P2543, DOI 10.1074/jbc.M707781200; Yaman I, 2003, CELL, V113, P519, DOI 10.1016/S0092-8674(03)00345-3; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200	56	148	149	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6661	6673		10.1074/jbc.M806735200	http://dx.doi.org/10.1074/jbc.M806735200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19131336	hybrid, Green Published			2022-12-25	WOS:000263919000010
J	Ujino, S; Yamaguchi, S; Shimotohno, K; Takaku, H				Ujino, Saneyuki; Yamaguchi, Saori; Shimotohno, Kunitada; Takaku, Hiroshi			Heat-shock Protein 90 Is Essential for Stabilization of the Hepatitis C Virus Nonstructural Protein NS3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; 3' NONTRANSLATED REGION; SERINE-TYPE PROTEINASE; AMINO-TERMINAL DOMAIN; PROTEASOMAL DEGRADATION; IN-VITRO; NON-A; REPLICATION; IDENTIFICATION; GELDANAMYCIN	The hepatitis C virus (HCV) is a major cause of chronic liver disease. Here, we report a new and effective strategy for inhibiting HCV replication using 17-allylaminogeldanamycin (17-AAG), an inhibitor of heat-shock protein 90 (Hsp90). Hsp90 is a molecular chaperone with a key role in stabilizing the conformation of many oncogenic signaling proteins. We examined the inhibitory effects of 17-AAG on HCV replication in an HCV replicon cell culture system. In HCV replicon cells treated with 17-AAG, we found that HCV RNA replication was suppressed in a dose-dependent manner, and interestingly, the only HCV protein degraded in these cells was NS3 (nonstructural protein 3). Immunoprecipitation experiments showed that NS3 directly interacted with Hsp90, as did proteins expressed from Delta NS3 protease expression vectors. These results suggest that the suppression of HCV RNA replication is due to the destabilization of NS3 in disruption of the Hsp90 chaperone complex by 17-AAG.	[Ujino, Saneyuki; Yamaguchi, Saori; Takaku, Hiroshi] Chiba Inst Technol, Dept Life & Environm Sci, Narashino, Chiba 2750016, Japan; [Takaku, Hiroshi] Chiba Inst Technol, High Technol Res Ctr, Narashino, Chiba 2750016, Japan; [Shimotohno, Kunitada] Chiba Inst Technol, Res Inst, Narashino, Chiba 2750016, Japan; [Shimotohno, Kunitada] Keio Univ, Sch Med, Ctr Integrated Med Res, Tokyo 1608582, Japan	Chiba Institute of Technology; Chiba Institute of Technology; Chiba Institute of Technology; Keio University	Takaku, H (corresponding author), Chiba Inst Technol, Dept Life & Environm Sci, 2-17-1 Tsudanuma, Narashino, Chiba 2750016, Japan.	hiroshi.takaku@it-chiba.ac.jp						ALTER HJ, 1989, NEW ENGL J MED, V321, P1494, DOI 10.1056/NEJM198911303212202; BARTENSCHLAGER R, 1993, J VIROL, V67, P3835, DOI 10.1128/JVI.67.7.3835-3844.1993; Bartenschlager R, 2001, ANTIVIR RES, V52, P1, DOI 10.1016/S0166-3542(01)00164-4; BARTENSCHLAGER R, 1995, J VIROL, V69, P7519, DOI 10.1128/JVI.69.12.7519-7528.1995; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Blagosklonny MV, 1996, P NATL ACAD SCI USA, V93, P8379, DOI 10.1073/pnas.93.16.8379; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Bonvini P, 2004, CANCER RES, V64, P3256, DOI 10.1158/0008-5472.CAN-03-3531; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; FAILLA C, 1995, J VIROL, V69, P1769, DOI 10.1128/JVI.69.3.1769-1777.1995; Friebe P, 2002, J VIROL, V76, P5326, DOI 10.1128/JVI.76.11.5326-5338.2002; Glue P, 2000, HEPATOLOGY, V32, P647, DOI 10.1053/jhep.2000.16661; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993; GRAKOUI A, 1993, P NATL ACAD SCI USA, V90, P10583, DOI 10.1073/pnas.90.22.10583; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; Guo JT, 2001, J VIROL, V75, P8516, DOI 10.1128/JVI.75.18.8516-8523.2001; HIJIKATA M, 1993, J VIROL, V67, P4665, DOI 10.1128/JVI.67.8.4665-4675.1993; Ishii N, 2006, J VIROL, V80, P4510, DOI 10.1128/JVI.80.9.4510-4520.2006; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kishine H, 2002, BIOCHEM BIOPH RES CO, V293, P993, DOI 10.1016/S0006-291X(02)00342-X; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Lohmann V, 2003, J VIROL, V77, P3007, DOI 10.1128/JVI.77.5.3007-3019.2003; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; McClellan AJ, 2001, NAT CELL BIOL, V3, pE51, DOI 10.1038/35055162; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796, DOI 10.1074/jbc.271.37.22796; Nakagawa S, 2007, BIOCHEM BIOPH RES CO, V353, P882, DOI 10.1016/j.bbrc.2006.12.117; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Seeff LB, 1997, HEPATOLOGY, V26, pS21, DOI 10.1002/hep.510260704; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Smith DF, 1998, PHARMACOL REV, V50, P493; SUPKO JG, 1995, CANCER CHEMOTH PHARM, V36, P305, DOI 10.1007/BF00689048; Takeuchi T, 1999, GASTROENTEROLOGY, V116, P636, DOI 10.1016/S0016-5085(99)70185-X; TANJI Y, 1995, J VIROL, V69, P1575, DOI 10.1128/JVI.69.3.1575-1581.1995; Taylor DR, 1999, SCIENCE, V285, P107, DOI 10.1126/science.285.5424.107; Waxman L, 2001, P NATL ACAD SCI USA, V98, P13931, DOI 10.1073/pnas.241510898; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Yanagi M, 1999, P NATL ACAD SCI USA, V96, P2291, DOI 10.1073/pnas.96.5.2291; Yi MK, 2003, J VIROL, V77, P3557, DOI 10.1128/JVI.77.6.3557-3568.2003	46	65	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6841	6846		10.1074/jbc.M806452200	http://dx.doi.org/10.1074/jbc.M806452200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19150985	Green Published, hybrid			2022-12-25	WOS:000263919000030
J	Lee, IH; Finkel, T				Lee, In Hye; Finkel, Toren			Regulation of Autophagy by the p300 Acetyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-ELEGANS; LIFE-SPAN; MICE; RESTRICTION; EXTENSION; DISEASE; GENES; CELLS; MTOR	Autophagy is a regulated process of intracellular catabolism required for normal cellular maintenance, as well as serving as an adaptive response under various stress conditions, including starvation. The molecular regulation of autophagy in mammalian cells remains incompletely understood. Here we demonstrate a role for protein acetylation in the execution and regulation of autophagy. In particular, we demonstrate that the p300 acetyltransferase can regulate the acetylation of various known components of the autophagy machinery. Knockdown of p300 reduces acetylation of Atg5, Atg7, Atg8, and Atg12, although overexpressed p300 increases the acetylation of these same proteins. Furthermore, p300 and Atg7 colocalize within cells, and the two proteins physically interact. The interaction between p300 and Atg7 is dependent on nutrient availability. Finally, we demonstrate that knockdown of p300 can stimulate autophagy, whereas overexpression of p300 inhibits starvation-induced autophagy. These results demonstrate a role for protein acetylation and particularly p300 in the regulation of autophagy under conditions of limited nutrient availability.	[Lee, In Hye; Finkel, Toren] NHLBI, Translat Med Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Finkel, T (corresponding author), NHLBI, Translat Med Branch, NIH, Bldg 10,CRC 5-3330,10 Ctr Dr, Bethesda, MD 20892 USA.	finkelt@nih.gov	LEE, IN HYE/T-2714-2019	LEE, IN HYE/0000-0003-2334-3594	National Institutes of Health staff; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005012, ZIAHL005012, ZICHL006019] Funding Source: NIH RePORTER	National Institutes of Health staff(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was authored, in whole or in part, by National Institutes of Health staff. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bergamini E, 2007, ANN NY ACAD SCI, V1114, P69, DOI 10.1196/annals.1396.020; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Mavrakis M, 2006, HUM MOL GENET, V15, P2962, DOI 10.1093/hmg/ddl239; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Toth ML, 2008, AUTOPHAGY, V4, P330, DOI 10.4161/auto.5618	17	189	205	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6322	6328		10.1074/jbc.M807135200	http://dx.doi.org/10.1074/jbc.M807135200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19124466	Green Published, hybrid			2022-12-25	WOS:000263742700035
J	Thomas, CG; Spyrou, G				Thomas, Christophoros G.; Spyrou, Giannis			ERdj5 Sensitizes Neuroblastoma Cells to Endoplasmic Reticulum Stress-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED-PROTEIN RESPONSE; HUMAN HEPATOCELLULAR-CARCINOMA; INDUCED GENE-EXPRESSION; ER STRESS; TUMOR-GROWTH; CANCER-CELLS; THIOREDOXIN REDUCTASE; DISULFIDE-ISOMERASE; UP-REGULATION; TRANSLATION	Down-regulation of the unfolded protein response (UPR) can be therapeutically valuable in cancer treatment, and endoplasmic reticulum (ER)-resident chaperone proteins may thus be targets for developing novel chemotherapeutic strategies. ERdj5 is a novel ER chaperone that regulates the ER-associated degradation of misfolded proteins through its associations with EDEM and the ER stress sensor BiP. To investigate whether ERdj5 can regulate ER stress signaling pathways, we exposed neuroblastoma cells overexpressing ERdj5 to ER stress inducers. ERdj5 promoted apoptosis in tunicamycin, thapsigargin, and bortezomib-treated cells. To provide further evidence that ERdj5 induces ER stress-regulated apoptosis, we targeted Bcl-2 to ER of ERdj5-overexpressing cells. Targeting the Bcl-2 to ER prevented the apoptosis induced by ER stress inducers but not by non-ER stress apoptotic stimuli, suggesting induction of ER stress-regulated apoptosis by ERdj5. ERdj5 enhanced apoptosis by abolishing the ER stress-induced phosphorylation of eukaryotic translation initiation factor 2 alpha(eIF2 alpha) and the subsequent translational repression. ERdj5 was found to inhibit the eIF2 alpha phosphorylation under ER stress through inactivating the pancreatic endoplasmic reticulum kinase. The compromised integrated stress response observed in ERdj5-overexpressing ER-stressed cells due to repressed eIF2 alpha phosphorylation correlated with impaired neuroblastoma cell resistance under ER stress. These results demonstrate that ERdj5 decreases neuroblastoma cell survival by down-regulating the UPR, raising the possibility that this protein could be a target for anti-tumor approaches.	[Thomas, Christophoros G.] Karolinska Inst, Dept Biosci & Nutr, S-14157 Huddinge, Sweden; [Spyrou, Giannis] Acad Athens, Fdn Biomed Res, Athens 11527, Greece	Karolinska Institutet; Academy of Athens	Thomas, CG (corresponding author), Karolinska Inst, Dept Biosci & Nutr, S-14157 Huddinge, Sweden.	chrtho@ki.se			Swedish Research Council [K99-13X-10370]; Karolinska Institute and Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institute and Foundation(Karolinska Institutet)	This work was supported by the Swedish Research Council Project K99-13X-10370, Karolinska Institute and Foundation for Biomedical Research, Academy of Athens. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Cai B, 1998, J CELL PHYSIOL, V177, P282, DOI 10.1002/(SICI)1097-4652(199811)177:2<282::AID-JCP10>3.0.CO;2-C; Castilla J, 2004, CURR MOL MED, V4, P397, DOI 10.2174/1566524043360654; Corazzari M, 2007, BRIT J CANCER, V96, P1062, DOI 10.1038/sj.bjc.6603672; Cunnea P, 2007, INT J IMMUNOPATH PH, V20, P17, DOI 10.1177/039463200702000103; Cunnea PM, 2003, J BIOL CHEM, V278, P1059, DOI 10.1074/jbc.M206995200; Delom F, 2007, CELL DEATH DIFFER, V14, P586, DOI 10.1038/sj.cdd.4402012; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; Fassio A, 2002, HISTOCHEM CELL BIOL, V117, P151, DOI 10.1007/s00418-001-0364-0; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Fu Y, 2006, CANCER BIOL THER, V5, P741, DOI 10.4161/cbt.5.7.2970; Gan L, 2005, J CELL BIOCHEM, V96, P653, DOI 10.1002/jcb.20585; Garber K, 2006, J NATL CANCER I, V98, P512, DOI 10.1093/jnci/djj174; Gladyshev VN, 1998, BIOCHEM BIOPH RES CO, V251, P488, DOI 10.1006/bbrc.1998.9495; Goplen D, 2006, CANCER RES, V66, P9895, DOI 10.1158/0008-5472.CAN-05-4589; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hayashi E, 2005, PROTEOMICS, V5, P1024, DOI 10.1002/pmic.200401132; Koong AC, 2006, CANCER BIOL THER, V5, P756, DOI 10.4161/cbt.5.7.2973; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Lee E, 2006, CANCER RES, V66, P7849, DOI 10.1158/0008-5472.CAN-06-1660; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Luk JM, 2006, PROTEOMICS, V6, P1049, DOI 10.1002/pmic.200500306; Mann MI, 2006, CANCER BIOL THER, V5, P736, DOI 10.4161/cbt.5.7.2969; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Nawrocki ST, 2005, CANCER RES, V65, P11510, DOI 10.1158/0008-5472.CAN-05-2394; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Okunaga T, 2006, CANCER RES, V66, P8662, DOI 10.1158/0008-5472.CAN-05-4256; Richardson Paul G, 2003, Clin Adv Hematol Oncol, V1, P596; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tanaka S, 2000, J BIOL CHEM, V275, P10388, DOI 10.1074/jbc.275.14.10388; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; York TP, 2005, MOL CARCINOGEN, V44, P242, DOI 10.1002/mc.20139	43	28	29	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6282	6290		10.1074/jbc.M806189200	http://dx.doi.org/10.1074/jbc.M806189200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19122239	hybrid			2022-12-25	WOS:000263742700031
J	Beverly, LJ; Varmus, HE				Beverly, L. J.; Varmus, H. E.			MYC-induced myeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family	ONCOGENE			English	Article						BCL2; BCLxl; BCLw; MCL1; BFL1; BCLb	CELL LUNG-CANCER; BH3 MIMETIC ABT-737; C-MYC; DRUG-RESISTANCE; LEUKEMIA; APOPTOSIS; PROTEINS; SURVIVAL; DEATH; GENE	Signals that control the. ne balance between cell death and cell survival are altered during tumorigenesis. Understanding the mechanisms by which this balance is perturbed, leading to excessive cell survival, is important for designing effective therapies. Proteins belonging to the B-cell lymphoma (BCL) family are known to regulate death responses to apoptotic signals, especially those originating within cells. A subset of BCL family members capable of inhibiting cell death is known to contribute to tumorigenesis; however, it is not known whether all six antiapoptotic BCL family members play a causal role in tumor development. Using a mouse model of MYC-driven leukemia, we showed that, in addition to the well characterized BCL2 and BCLxl (BCL2L1), the other four family members-BCLw (BCL2L2), BCLb (BCL2L10), BFL1 (BCL2A1) and MCL1-also cooperate with MYC to accelerate leukemogenesis. In addition, high levels of each family member are found in either solid human tumors or cell lines derived from human leukemias or lymphomas.	[Beverly, L. J.; Varmus, H. E.] Mem Sloan Kettering Canc Ctr, Dept Canc Genet & Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Beverly, LJ (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Canc Genet & Biol, 1275 York Ave,Box 62, New York, NY 10065 USA.	BeverlyL@mskcc.org			NIH [P01 2PO1CA094060-06A1]; NATIONAL CANCER INSTITUTE [P01CA094060] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Varmus laboratory, especially G Sanchez, A Giannakou and MA Melnick, for expert handling of the mouse colony, including genotyping, and for performing immunohistochemistry on embedded tissue sections. Funding for this project was provided, in part, by NIH P01 2PO1CA094060-06A1 to HEV.	Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Cosulich SC, 1997, CURR BIOL, V7, P913, DOI 10.1016/S0960-9822(06)00410-6; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Holinger EP, 1999, J BIOL CHEM, V274, P13298, DOI 10.1074/jbc.274.19.13298; Horvitz HR, 1999, CANCER RES, V59, p1701S; Kawasaki T, 2007, CANCER SCI, V98, P1070, DOI 10.1111/j.1349-7006.2007.00491.x; Kohl TM, 2007, LEUKEMIA, V21, P1763, DOI 10.1038/sj.leu.2404776; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Lanave C, 2004, GENE, V333, P71, DOI 10.1016/j.gene.2004.02.017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letai A, 2004, CANCER CELL, V6, P241, DOI 10.1016/j.ccr.2004.07.011; Luo H, 2005, BLOOD, V106, P2452, DOI 10.1182/blood-2005-02-0734; Mandal M, 2005, J EXP MED, V201, P603, DOI 10.1084/jem.20041924; Reed JC, 2006, NAT CLIN PRACT ONCOL, V3, P388, DOI 10.1038/ncponc0538; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shoemaker AR, 2008, CLIN CANCER RES, V14, P3268, DOI 10.1158/1078-0432.CCR-07-4622; Swanson PJ, 2004, J IMMUNOL, V172, P6684, DOI 10.4049/jimmunol.172.11.6684; Valdez BC, 2008, LEUKEMIA RES, V32, P1684, DOI 10.1016/j.leukres.2008.01.016; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Wesarg E, 2007, INT J CANCER, V121, P2387, DOI 10.1002/ijc.22977; Yasui K, 2004, CANCER RES, V64, P1403, DOI 10.1158/0008-5472.CAN-3263-2; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhai D, 2006, CELL DEATH DIFFER, V13, P1419, DOI 10.1038/sj.cdd.4401937	26	86	89	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 5	2009	28	9					1274	1279		10.1038/onc.2008.466	http://dx.doi.org/10.1038/onc.2008.466			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	415AH	19137012	Green Accepted			2022-12-25	WOS:000263906200011
J	Zhang, T; Liu, WD; Saunee, NA; Breslin, MB; Lan, MS				Zhang, Tao; Liu, Wei-Dong; Saunee, Nicolle A.; Breslin, Mary B.; Lan, Michael S.			Zinc Finger Transcription Factor INSM1 Interrupts Cyclin D1 and CDK4 Binding and Induces Cell Cycle Arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROENDOCRINE DIFFERENTIATION; GENE-EXPRESSION; BETA-CELLS; IA-1; PROGENITORS; MECHANISM; REPRESSOR; PANCREAS; PROTEIN; RECRUITMENT	INSM1 is a zinc finger transcription factor that plays an important role in pancreatic beta-cell development. To further evaluate its role in cell fate determination, we investigated INSM1 effects on cell cycle function. The cyclin box of cyclin D1 is essential for INSM1 binding. Competitive pull-down and co-immunoprecipitation revealed that INSM1 binding to cyclin D1 interrupts its association with CDK4 and induces hypophosphorylation of the retinoblastoma protein. An inducible Tet-on-system was established in Cos-7 and Panc-1 cells. Using serum starvation, we synchronized the cell cycle and subsequently induced cell cycle progression by serum stimulation. Comparison of the INSM1 induction group with the noninduced control group, INSM1 ectopic expression causes cell cycle arrest, whereas the INSM1-mediated cell cycle arrest could be reversed by cyclin D1 and CDK4 overexpression. The proline-rich N-terminal portion of INSM1 is required for cyclin D1 binding. Mutation of proline residues abolished cyclin D1 binding and also diminished its ability to induce cell cycle arrest. Cellular proliferation of Panc-1 cells was inhibited by INSM1 overexpression demonstrated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, soft agar colony formation, as well as tumor growth in a nude mouse model. Taken together, we provide evidence to support that INSM1 binds to cyclin D1, interrupts cell cycle signaling, and inhibits cellular proliferation.	[Lan, Michael S.] Childrens Hosp, Res Inst Children, New Orleans, LA 70118 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA 70112 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA 70112 USA	Children's Hospital of New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Lan, MS (corresponding author), Childrens Hosp, Res Inst Children, 200 Henry Clay Ave,Res & Educ Bldg,Rm 2211, New Orleans, LA 70118 USA.	mlan@chnola-research.org	Lan, Michael/CAF-1839-2022; zhang, tao/F-2905-2010		National Institutes of Health [DK61436]; Research Institute for Children, Children's Hospital at New Orleans; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061436] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Institute for Children, Children's Hospital at New Orleans; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK61436 ( to M. S. L.). This work was also supported by funds from the Research Institute for Children, Children's Hospital at New Orleans. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adnane J, 1999, ONCOGENE, V18, P239, DOI 10.1038/sj.onc.1202297; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Bienvenu F, 2001, J BIOL CHEM, V276, P16840, DOI 10.1074/jbc.M100795200; Breslin MB, 2007, FEBS LETT, V581, P949, DOI 10.1016/j.febslet.2007.01.087; Breslin MB, 2003, J BIOL CHEM, V278, P38991, DOI 10.1074/jbc.M306795200; Breslin MB, 2002, NUCLEIC ACIDS RES, V30, P1038, DOI 10.1093/nar/30.4.1038; Candal E, 2007, DEV BIOL, V309, P1, DOI 10.1016/j.ydbio.2007.04.038; De Smaele E, 2008, NEOPLASIA, V10, P89, DOI 10.1593/neo.07891; Duggan A, 2008, J COMP NEUROL, V507, P1497, DOI 10.1002/cne.21629; Farkas LM, 2008, NEURON, V60, P40, DOI 10.1016/j.neuron.2008.09.020; Fu MF, 2005, J BIOL CHEM, V280, P16934, DOI 10.1074/jbc.M500403200; Ganter B, 1998, EMBO J, V17, P255, DOI 10.1093/emboj/17.1.255; Gierl MS, 2006, GENE DEV, V20, P2465, DOI 10.1101/gad.381806; GOTO Y, 1992, J BIOL CHEM, V267, P15252; GOUYER V, 1994, INT J CANCER, V58, P818, DOI 10.1002/ijc.2910580612; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Inoue K, 1998, MOL CELL BIOL, V18, P1590, DOI 10.1128/MCB.18.3.1590; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; Knudsen KE, 1999, CANCER RES, V59, P2297; LAN MS, 1993, CANCER RES, V53, P4169; Lin HM, 2002, J BIOL CHEM, V277, P28733, DOI 10.1074/jbc.M203380200; Liu WD, 2006, BIOCHEM J, V397, P169, DOI 10.1042/BJ20051669; Lubensky IA, 2007, ENDOCR PATHOL, V18, P156, DOI 10.1007/s12022-007-9007-x; Mellitzer G, 2006, EMBO J, V25, P1344, DOI 10.1038/sj.emboj.7601011; MORI N, 1990, ONCOGENE, V5, P1713; Ratineau C, 2002, J BIOL CHEM, V277, P8847, DOI 10.1074/jbc.M110747200; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Skapek SX, 1996, MOL CELL BIOL, V16, P7043; Wang HY, 2008, BIOELECTROMAGNETICS, V29, P39, DOI 10.1002/bem.20360; Wildner H, 2008, DEVELOPMENT, V135, P473, DOI 10.1242/dev.011783; Wildwater M, 2007, DEV CELL, V12, P841, DOI 10.1016/j.devcel.2007.05.005; Xie JP, 2002, GENOMICS, V80, P54, DOI 10.1006/geno.2002.6800; Zhu M, 2002, PANCREAS, V24, P139, DOI 10.1097/00006676-200203000-00004; Zwicker J, 1999, ONCOGENE, V18, P19, DOI 10.1038/sj.onc.1202286	36	35	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5574	5581		10.1074/jbc.M808843200	http://dx.doi.org/10.1074/jbc.M808843200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19124461	Green Published, hybrid			2022-12-25	WOS:000263560600020
J	Fernandez, E; Fu, M; Pascual, JA; Lopez, MJ; Perez-Rios, M; Schiaffino, A; Martinez-Sanchez, JM; Ariza, C; Salto, E; Nebot, M				Fernandez, Esteve; Fu, Marcela; Pascual, Jose A.; Lopez, Maria J.; Perez-Rios, Monica; Schiaffino, Anna; Martinez-Sanchez, Jose M.; Ariza, Carles; Salto, Esteve; Nebot, Manel		Spanish Smoking Law Evaluation Grp	Impact of the Spanish Smoking Law on Exposure to Second-Hand Smoke and Respiratory Health in Hospitality Workers: A Cohort Study	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; SECONDHAND SMOKE; BAR WORKERS; PASSIVE SMOKING; CIGARETTE-SMOKE; SALIVA COTININE; FREE WORKPLACES; PUBLIC PLACES; AIR NICOTINE; PREVALENCE	Background: A smoke-free law came into effect in Spain on 1st January 2006, affecting all enclosed workplaces except hospitality venues, whose proprietors can choose among totally a smoke-free policy, a partial restriction with designated smoking areas, or no restriction on smoking on the premises. We aimed to evaluate the impact of the law among hospitality workers by assessing second-hand smoke (SHS) exposure and the frequency of respiratory symptoms before and one year after the ban. Methods and Finding: We formed a baseline cohort of 431 hospitality workers in Spain and 45 workers in Portugal and Andorra. Of them, 318 (66.8%) were successfully followed up 12 months after the ban, and 137 nonsmokers were included in this analysis. We obtained self-reported exposure to SHS and the presence of respiratory symptoms, and collected saliva samples for cotinine measurement. Salivary cotinine decreased by 55.6% after the ban among nonsmoker workers in venues where smoking was totally prohibited (from median of 1.6 ng/ml before to 0.5 ng/ml, p < 0.01). Cotinine concentration decreased by 27.6% (p = 0.068) among workers in venues with designated smoking areas, and by 10.7% (p = 0.475) among workers in venues where smoking was allowed. In Portugal and Andorra, no differences between cotinine concentration were found before (1.2 ng/ml) and after the ban (1.2 ng/ml). In Spain, reported respiratory symptom declined significantly (by 71.9%; p < 0.05) among workers in venues that became smoke-free. After adjustment for potential confounders, salivary cotinine and respiratory symptoms decreased significantly among workers in Spanish hospitality venues where smoking was totally banned. Conclusions: Among nonsmoker hospitality workers in bars and restaurants where smoking was allowed, exposure to SHS after the ban remained similar to pre-law levels. The partial restrictions on smoking in Spanish hospitality venues do not sufficiently protect hospitality workers against SHS or its consequences for respiratory health.	[Fu, Marcela; Martinez-Sanchez, Jose M.] ICO, Tobacco Res & Control Unit, Barcelona, Spain; [Fernandez, Esteve; Fu, Marcela; Martinez-Sanchez, Jose M.] Univ Barcelona, Hosp, Dept Clin Sci, E-08007 Barcelona, Spain; [Fernandez, Esteve; Fu, Marcela; Martinez-Sanchez, Jose M.] Hosp Llobregat, IDIBELL, Barcelona, Spain; [Pascual, Jose A.; Schiaffino, Anna; Nebot, Manel] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain; [Pascual, Jose A.] Hosp Mar, IMIM, Bioanalysis Res Grp, Neuropsychopharmacol Programme, Barcelona, Spain; [Lopez, Maria J.; Ariza, Carles; Nebot, Manel] ASPB, Evaluat & Intervent Methods Unit, Barcelona, Spain; [Lopez, Maria J.; Perez-Rios, Monica; Ariza, Carles; Nebot, Manel] CIBERESP, Barcelona, Spain; [Lopez, Maria J.] Univ Autonoma Barcelona, Programme Publ Hlth & Biomed Res, Bellaterra, Spain; [Perez-Rios, Monica] Consejeria Salud, Xunta Galicia, Santiago De Compostela, Spain; [Perez-Rios, Monica] Univ Santiago Compostela, Dept Publ Hlth, Santiago De Compostela, Spain; [Schiaffino, Anna] IMSABS, Terrassa, Spain; [Salto, Esteve] Univ Barcelona, Dept Publ Hlth, E-08007 Barcelona, Spain; [Salto, Esteve] Generalitat Catalunya, Dept Hlth, Barcelona, Spain	University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Public Health Agency of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Autonomous University of Barcelona; Universidade de Santiago de Compostela; University of Barcelona	Fernandez, E (corresponding author), ICO, Tobacco Res & Control Unit, Barcelona, Spain.	efernandez@ico.scs.es	Fernandez, Esteve/A-9750-2008; Pérez-Ríos, Mónica/AAA-5941-2019; Pascual, José Antonio/F-3884-2015; Martínez-Sánchez, Jose M/ABH-3093-2020; Lopez, Maria/HHC-3659-2022; Martínez-Sánchez, Jose/AAA-6343-2019; Pérez-Ortuño, Raúl/AAB-6105-2019	Fernandez, Esteve/0000-0003-4239-723X; Pascual, José Antonio/0000-0003-0837-4026; Martínez-Sánchez, Jose M/0000-0002-9632-5701; Pérez-Ortuño, Raúl/0000-0002-1837-5447; Borras, Josep M/0000-0001-7330-6308; Salto, Esteve/0000-0002-6739-8936; ARIZA, Carles/0000-0002-0101-1911; Fu, Marcela/0000-0002-4962-0927; Lopez Medina, Maria Jose/0000-0003-4402-2239; Precioso, Jose/0000-0002-7889-8290; Perez-Rios, Monica/0000-0003-4456-6631	Public Health Directorates of the Departments of Health of the Regional Governments of Balearic Islands, Cantabria, Catalonia, Galicia and Valencian Community; Spanish Ministry of Health [FIS PI052072, CIBERESP CB06/02/0032, RTICC RD06/0020/0089]; Ministry of Universities and Research, Government of Catalonia [SGR200500646]	Public Health Directorates of the Departments of Health of the Regional Governments of Balearic Islands, Cantabria, Catalonia, Galicia and Valencian Community; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Ministry of Universities and Research, Government of Catalonia	This project was funded by the Public Health Directorates of the Departments of Health of the Regional Governments of Balearic Islands, Cantabria, Catalonia, Galicia and Valencian Community, the Spanish Ministry of Health (FIS PI052072, CIBERESP CB06/02/0032, and RTICC RD06/0020/0089), and the Ministry of Universities and Research, Government of Catalonia (SGR200500646). We thank Chupa Chups Spain for providing the Smint candies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams SM, 2006, AM J PUBLIC HEALTH, V96, P296, DOI 10.2105/AJPH.2004.055012; Allwright S, 2005, BMJ-BRIT MED J, V331, P1117, DOI 10.1136/bmj.38636.499225.55; Barker LE, 2002, AM J EPIDEMIOL, V156, P1056, DOI 10.1093/aje/kwf149; Bates MN, 2002, TOB CONTROL, V11, P125, DOI 10.1136/tc.11.2.125; Benowitz NL, 1999, ENVIRON HEALTH PERSP, V107, P349, DOI 10.2307/3434427; Blackford AL, 2006, CANCER EPIDEM BIOMAR, V15, P1799, DOI 10.1158/1055-9965.EPI-06-0427; Chen R, 2002, J Cancer Epidemiol Prev, V7, P85, DOI 10.1080/147666502321082746; Coll M, 2000, REV EPIDEMIOL SANTE, V48, P305; Dearlove JV, 2002, TOB CONTROL, V11, P94, DOI 10.1136/tc.11.2.94; Delgado-Rodriguez M, 2004, J EPIDEMIOL COMMUN H, V58, P635, DOI 10.1136/jech.2003.008466; Dimich-Ward H, 2005, SCAND J WORK ENV HEA, V31, P75, DOI 10.5271/sjweh.851; DWYER J, 1992, STAT MODELS LONGITUD, P3; EISNER MD, 1988, JAMA-J AM MED ASSOC, V280, P1909; Ellingsen DG, 2006, J ENVIRON MONITOR, V8, P362, DOI 10.1039/b600050a; *ENC POBL ACT, 2008, AS SEX RAM ACT VAL A; ETZEL RA, 1990, PREV MED, V19, P190, DOI 10.1016/0091-7435(90)90020-K; *EUR PUBL HLTH ALL, 2007, EUR SMOK BANS EV LEG; Farrelly MC, 2005, TOB CONTROL, V14, P236, DOI 10.1136/tc.2004.008839; Fernandez E, 2006, TOB CONTROL, V15, P79; Fernandez E, 2007, GAC SANIT, V21, P5, DOI 10.1016/S0213-9111(07)71962-3; Fichtenberg CM, 2002, BMJ-BRIT MED J, V325, P188, DOI 10.1136/bmj.325.7357.188; GALAN I, 2008, GAC SANIT IN PRESS, V23; Garcia-Algar O, 2003, JAMA-J AM MED ASSOC, V290, P196, DOI 10.1001/jama.290.2.196; Goodman P, 2007, AM J RESP CRIT CARE, V175, P840, DOI 10.1164/rccm.200608-1085OC; Gorini G, 2008, TUMORI, V94, P798; Hahn EJ, 2006, J OCCUP ENVIRON MED, V48, P906, DOI 10.1097/01.jom.0000215709.09305.01; *HLTH CONS PROT, 2007, DIR GEN GREEN PAP EU; Janson C, 2001, LANCET, V358, P2103, DOI 10.1016/S0140-6736(01)07214-2; JARVIS MJ, 1992, BRIT J ADDICT, V87, P111; Johnsson T, 2006, ANN OCCUP HYG, V50, P331, DOI 10.1093/annhyg/mel011; Joossens L, 2006, TOB CONTROL, V15, P247, DOI 10.1136/tc.2005.015347; Koh HK, 2007, NEW ENGL J MED, V356, P1496, DOI 10.1056/NEJMp068279; Lui KJ, 1997, STAT MED, V16, P1777, DOI 10.1002/(SICI)1097-0258(19970815)16:15<1777::AID-SIM608>3.0.CO;2-3; Lushchenkova O, 2008, REV ESP CARDIOL, V61, P687, DOI 10.1016/S1885-5857(08)60205-4; MARTIN A, 2007, GAC SANIT S, V1, P13; Martin-Luengo IA, 2007, OCU SALUD, P13; MARTINEZSANCHEZ JM, 2009, ARCH PREV R IN PRESS; Menzies D, 2006, JAMA-J AM MED ASSOC, V296, P1742, DOI 10.1001/jama.296.14.1742; Mulcahy M, 2005, TOB CONTROL, V14, P384, DOI 10.1136/tc.2005.011635; Nebot M, 2007, GAC SANIT, V21, P95, DOI 10.1157/13101033; Pascual JA, 2003, RAPID COMMUN MASS SP, V17, P2853, DOI 10.1002/rcm.1279; Pichini S, 2003, J EXPO ANAL ENV EPID, V13, P144, DOI 10.1038/sj.jea.7500264; Poetschke-Langer M, 2001, TOB CONTROL, V10, P300, DOI 10.1136/tc.10.4.300; Precioso J, 2007, REV SAUDE PUBL, V41, P808, DOI 10.1590/S0034-89102007000500015; Repace J L, 1987, IARC Sci Publ, P25; Repace JL, 1998, RISK ANAL, V18, P71, DOI 10.1111/j.1539-6924.1998.tb00917.x; RUTTER CM, 1994, STAT MED, V13, P1211, DOI 10.1002/sim.4780131204; Sanchez-Martinez F, 2007, MED CLIN-BARCELONA, V129, P100, DOI 10.1157/13107374; Santos AC, 2004, PREV MED, V38, P114, DOI 10.1016/j.ypmed.2003.09.040; Sebrie EM, 2007, TOB CONTROL, V16, DOI 10.1136/tc.2006.018275; Semple S, 2007, ANN OCCUP HYG, V51, P571, DOI 10.1093/annhyg/mem044; Shiell A, 2000, SOC SCI MED, V51, P1111, DOI 10.1016/S0277-9536(00)00018-6; Siegel Michael, 2006, Clin Occup Environ Med, V5, P31; Spinney L, 2007, LANCET, V369, P1507, DOI 10.1016/S0140-6736(07)60691-6; Stark MJ, 2007, AM J PUBLIC HEALTH, V97, P1457, DOI 10.2105/AJPH.2006.094086; Sunyer J, 2000, AM J RESP CRIT CARE, V162, P930, DOI 10.1164/ajrccm.162.3.9911062; Toledo J, 2006, TOB CONTROL, V15, P147; TRAVIS CC, 1987, ENVIRON SCI TECHNOL, V21, P415, DOI 10.1021/es00159a001; Twose J, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-194; Valente P, 2007, TOB CONTROL, V16, P312, DOI 10.1136/tc.2006.019646; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; Villalbí Joan R., 2006, Gac Sanit, V20, P1, DOI 10.1157/13084119; *WHO, 2003, EUR COUNTR PROF TOB; *WHO, 2007, PROT EXP 2 HAND TOB; World Health Organization Regional Office for Europe, 2007, EUR TOB CONTR REP 20; WYNDER EL, 1990, J CLIN EPIDEMIOL, V43, P619, DOI 10.1016/0895-4356(90)90167-N; Zocchetti C, 1997, INT J EPIDEMIOL, V26, P220, DOI 10.1093/ije/26.1.220; 2007, EUR NEWS B, V208, P6	68	99	102	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2009	4	1							e4244	10.1371/journal.pone.0004244	http://dx.doi.org/10.1371/journal.pone.0004244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JD	19165321	gold, Green Published, Green Submitted			2022-12-25	WOS:000265482400002
J	Wang, Z; Johnston, PR; Yang, ZL; Townsend, JP				Wang, Zheng; Johnston, Peter R.; Yang, Zhu L.; Townsend, Jeffrey P.			Evolution of Reproductive Morphology in Leaf Endophytes	PLOS ONE			English	Article								The endophytic lifestyle has played an important role in the evolution of the morphology of reproductive structures (body) in one of the most problematic groups in fungal classification, the Leotiomycetes (Ascomycota). Mapping fungal morphologies to two groups in the Leiotiomycetes, the Rhytismatales and Hemiphacidiaceae reveals significant divergence in body size, shape and complexity. Mapping ecological roles to these taxa reveals that the groups include endophytic fungi living on leaves and saprobic fungi living on duff or dead wood. Finally, mapping of the morphologies to ecological roles reveals that leaf endophytes produce small, highly reduced fruiting bodies covered with fungal tissue or dead host tissue, while saprobic species produce large and intricate fruiting bodies. Intriguingly, resemblance between asexual conidiomata and sexual ascomata in some leotiomycetes implicates some common developmental pathways for sexual and asexual development in these fungi.	[Townsend, Jeffrey P.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Johnston, Peter R.] Landcare Res, Herbarium PDD, Auckland, New Zealand; [Yang, Zhu L.] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeography, Kunming, Peoples R China	Yale University; Landcare Research - New Zealand; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Wang, Z (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	wang.zheng@yale.edu	Townsend, Jeffrey/H-2747-2019; Johnston, Peter/AAP-6300-2021; Johnston, Peter/GZL-2513-2022; Wang, Zheng/A-2318-2011	Townsend, Jeffrey/0000-0002-9890-3907; Johnston, Peter/0000-0003-0761-9116; Wang, Zheng/0000-0002-8849-8549	Yale University [Postdoctoral Fellowship]	Yale University	This research was supported by Yale University Anonymous Postdoctoral Fellowship (ZW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold AE, 2007, MYCOLOGIA, V99, P185, DOI 10.3852/mycologia.99.2.185; Barker D, 2005, PLOS COMPUT BIOL, V1, P24, DOI 10.1371/journal.pcbi.0010003; Gamundi IJ, 1995, NEW ZEAL J BOT, V33, P513; HAWKSWORTH DL, 2004, STUD MYCOL, V50, P9; Hendrikse JL, 2007, EVOL DEV, V9, P393, DOI 10.1111/j.1525-142X.2007.00176.x; Hibbett DS, 2007, MYCOL RES, V111, P1001, DOI 10.1016/j.mycres.2007.01.012; Higgins KL, 2007, MOL PHYLOGENET EVOL, V42, P543, DOI 10.1016/j.ympev.2006.07.012; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; JOHNSTON PR, 1989, NEW ZEAL J BOT, V27, P243, DOI 10.1080/0028825X.1989.10410377; Landvik Sara, 1996, Mycoscience, V37, P237, DOI 10.1007/BF02461292; Liu YJ, 2004, P NATL ACAD SCI USA, V101, P4507, DOI 10.1073/pnas.0400938101; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Roy K, 2008, SCIENCE, V321, P1451, DOI 10.1126/science.1163097; SAENZ GS, 1994, MYCOLOGIA, V86, P212, DOI 10.2307/3760639; Spatafora JW, 2006, MYCOLOGIA, V98, P1018, DOI 10.3852/mycologia.98.6.1018; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang Z, 2002, MYCOLOGIA, V94, P641, DOI 10.2307/3761715; Wang Z, 2006, MYCOLOGIA, V98, P1065, DOI 10.3852/mycologia.98.6.1065; Wang Z, 2006, MOL PHYLOGENET EVOL, V41, P295, DOI 10.1016/j.ympev.2006.05.031	22	38	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2009	4	1							e4246	10.1371/journal.pone.0004246	http://dx.doi.org/10.1371/journal.pone.0004246			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JC	19158947	gold, Green Published, Green Submitted			2022-12-25	WOS:000265482200003
J	Nath, AK; Krauthammer, M; Li, PY; Davidov, E; Butler, LC; Copel, J; Katajamaa, M; Oresic, M; Buhimschi, I; Buhimschi, C; Snyder, M; Madri, JA				Nath, Anjali K.; Krauthammer, Michael; Li, Puyao; Davidov, Eugene; Butler, Lucas C.; Copel, Joshua; Katajamaa, Mikko; Oresic, Matej; Buhimschi, Irina; Buhimschi, Catalin; Snyder, Michael; Madri, Joseph A.			Proteomic-Based Detection of a Protein Cluster Dysregulated during Cardiovascular Development Identifies Biomarkers of Congenital Heart Defects	PLOS ONE			English	Article								Background: Cardiovascular development is vital for embryonic survival and growth. Early gestation embryo loss or malformation has been linked to yolk sac vasculopathy and congenital heart defects (CHDs). However, the molecular pathways that underlie these structural defects in humans remain largely unknown hindering the development of molecular-based diagnostic tools and novel therapies. Methodology/Principal Findings: Murine embryos were exposed to high glucose, a condition known to induce cardiovascular defects in both animal models and humans. We further employed a mass spectrometry-based proteomics approach to identify proteins differentially expressed in embryos with defects from those with normal cardiovascular development. The proteins detected by mass spectrometry (WNT16, ST14, Pcsk1, Jumonji, Morca2a, TRPC5, and others) were validated by Western blotting and immunoflorescent staining of the yolk sac and heart. The proteins within the proteomic dataset clustered to adhesion/migration, differentiation, transport, and insulin signaling pathways. A functional role for several proteins (WNT16, ADAM15 and NOGO-A/B) was demonstrated in an ex vivo model of heart development. Additionally, a successful application of a cluster of protein biomarkers (WNT16, ST14 and Pcsk1) as a prenatal screen for CHDs was confirmed in a study of human amniotic fluid (AF) samples from women carrying normal fetuses and those with CHDs. Conclusions/Significance: The novel finding that WNT16, ST14 and Pcsk1 protein levels increase in fetuses with CHDs suggests that these proteins may play a role in the etiology of human CHDs. The information gained through this bed-side to bench translational approach contributes to a more complete understanding of the protein pathways dysregulated during cardiovascular development and provides novel avenues for diagnostic and therapeutic interventions, beneficial to fetuses at risk for CHDs.	[Davidov, Eugene; Snyder, Michael] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Nath, Anjali K.; Krauthammer, Michael; Li, Puyao; Butler, Lucas C.; Madri, Joseph A.] Yale Univ, Dept Pathol, New Haven, CT 06520 USA; [Copel, Joshua; Buhimschi, Irina; Buhimschi, Catalin] Yale Univ, Dept Obstet & Gynecol, New Haven, CT 06520 USA; [Katajamaa, Mikko; Oresic, Matej] VTT Tech Res Ctr Finland, Espoo, Finland	Yale University; Yale University; Yale University; VTT Technical Research Center Finland	Nath, AK (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	anjali.nath@aya.yale.edu	Oresic, Matej/K-7673-2016; Buhimschi, Irina/AAY-6619-2021; Oresic, Matej/AAV-3978-2020	Oresic, Matej/0000-0002-2856-9165; Buhimschi, Irina/0000-0002-1701-1326; Snyder, Michael/0000-0003-0784-7987; Krauthammer, Michael/0000-0002-4808-1845	NIHR [37HL28373];  [HG02357];  [5 T32 GM07499]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL028373, R01HL028373] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007499] Funding Source: NIH RePORTER	NIHR(National Institute for Health Research (NIHR)); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This investigation was supported by NIHR37HL28373 to JAM, HG02357 to MS and 5 T32 GM07499 to AKN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo L, 2004, NAT MED, V10, P382, DOI 10.1038/nm1020; Ahmed S, 2006, FEBS J, V273, P615, DOI 10.1111/j.1742-4658.2005.05094.x; Akazawa Shoichi, 2005, Congenital Anomalies, V45, P73, DOI 10.1111/j.1741-4520.2005.00070.x; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; BERNANKE DH, 1982, DEV BIOL, V91, P235, DOI 10.1016/0012-1606(82)90030-6; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Carvalho JS, 1998, LANCET, V351, P1023, DOI 10.1016/S0140-6736(97)08406-7; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Chen L, 2005, AM J NEPHROL, V25, P459, DOI 10.1159/000087853; Cheyssac C, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-44; Chrast R, 2000, HUM MOL GENET, V9, P1853, DOI 10.1093/hmg/9.12.1853; Cutillas PR, 2007, MOL CELL PROTEOMICS, V6, P1560, DOI 10.1074/mcp.M700037-MCP200; Darragh MR, 2008, FRONT BIOSCI-LANDMRK, V13, P528, DOI 10.2741/2698; de Lange FJ, 2004, CIRC RES, V95, P645, DOI 10.1161/01.RES.0000141429.13560.cb; DELACRUZ MV, 1977, J ANAT, V123, P661; DELACRUZ MV, 1983, AM J ANAT, V166, P63, DOI 10.1002/aja.1001660105; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; EISENBERG CA, 1995, DEV BIOL, V167, P469, DOI 10.1006/dbio.1995.1042; Enciso JM, 2003, J CELL BIOL, V160, P605, DOI 10.1083/jcb.200209014; ERIKSSON UJ, 1991, DIABETOLOGIA, V34, P325, DOI 10.1007/BF00405004; Finney GL, 2008, ANAL CHEM, V80, P961, DOI 10.1021/ac701649e; Flanagan TC, 2006, CELLS TISSUES ORGANS, V183, P12, DOI 10.1159/000094902; Galang CK, 2004, J BIOL CHEM, V279, P11281, DOI 10.1074/jbc.M311887200; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Hatzopoulos AK, 1998, DEVELOPMENT, V125, P1457; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; HOFFMAN JIE, 1995, PEDIATR CARDIOL, V16, P155; Horiuchi K, 2003, MOL CELL BIOL, V23, P5614, DOI 10.1128/MCB.23.16.5614-5624.2003; HUNTER ES, 1992, TERATOLOGY, V45, P195, DOI 10.1002/tera.1420450213; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Joshua IG, 2005, J CELL BIOCHEM, V96, P1149, DOI 10.1002/jcb.20620; Jung J, 2005, DEV DYNAM, V232, P21, DOI 10.1002/dvdy.20204; Katajamaa M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-179; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kern CB, 2006, DEV DYNAM, V235, P2238, DOI 10.1002/dvdy.20838; Kurohara K, 2004, DEV BIOL, V267, P14, DOI 10.1016/j.ydbio.2003.10.021; Laigaard J, 2005, PRENATAL DIAG, V25, P45, DOI 10.1002/pd.1029; LAMERS WH, 1995, CIRCULATION, V91, P111, DOI 10.1161/01.CIR.91.1.111; Li X, 2001, J LEUKOCYTE BIOL, V69, P565; Liebner S, 2004, J CELL BIOL, V166, P359, DOI 10.1083/jcb.200403050; LINASK KK, 1993, DEV DYNAM, V196, P62, DOI 10.1002/aja.1001960108; Loffredo CA, 2001, TERATOLOGY, V64, P98, DOI 10.1002/tera.1051; Masmiquel L, 2000, AM J OPHTHALMOL, V129, P347, DOI 10.1016/S0002-9394(99)00361-X; MCBRIDE RE, 1981, AM J ANAT, V160, P309, DOI 10.1002/aja.1001600308; MILLS JL, 1979, DIABETES, V28, P292, DOI 10.2337/diabetes.28.4.292; Minami T, 2006, J BIOL CHEM, V281, P20503, DOI 10.1074/jbc.M513112200; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Moat SJ, 2004, J NUTR BIOCHEM, V15, P64, DOI 10.1016/j.jnutbio.2003.08.010; Moens AL, 2008, AM J PHYSIOL-HEART C, V294, pH1971, DOI 10.1152/ajpheart.91503.2007; Najy AJ, 2008, J BIOL CHEM, V283, P18393, DOI 10.1074/jbc.M801329200; Nath AK, 2004, DEVELOPMENT, V131, P2485, DOI 10.1242/dev.01131; NEW DAT, 1991, HUM REPROD, V6, P58, DOI 10.1093/oxfordjournals.humrep.a137259; Nielsen GL, 2005, DIABETIC MED, V22, P693, DOI 10.1111/j.1464-5491.2005.01477.x; Nyberg DA, 2006, RADIOL CLIN N AM, V44, P837, DOI 10.1016/j.rcl.2006.10.017; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; Person AD, 2005, DEV BIOL, V278, P35, DOI 10.1016/j.ydbio.2004.10.013; Pinter E, 1999, AM J PATHOL, V154, P1367, DOI 10.1016/S0002-9440(10)65391-6; PINTER E, 1986, TERATOLOGY, V33, P73, DOI 10.1002/tera.1420330110; Pinter E, 2001, AM J PATHOL, V158, P1199, DOI 10.1016/S0002-9440(10)64069-2; Root-Bernstein R, 2002, J THEOR BIOL, V216, P345, DOI 10.1006/jtbi.2002.2535; Rudge MVC, 2000, GYNECOL OBSTET INVES, V50, P108, DOI 10.1159/000010293; RUNYAN RB, 1983, DEV BIOL, V95, P108, DOI 10.1016/0012-1606(83)90010-6; SADLER TW, 1988, AM J PERINAT, V5, P319, DOI 10.1055/s-2007-999717; Satomi S, 2001, BIOCHEM BIOPH RES CO, V287, P995, DOI 10.1006/bbrc.2001.5686; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Shelton EL, 2007, DEV BIOL, V302, P376, DOI 10.1016/j.ydbio.2006.09.047; Small M, 2004, PEDIATR CARDIOL, V25, P210, DOI 10.1007/s00246-003-0587-z; Smrcek JM, 2006, J ULTRAS MED, V25, P173, DOI 10.7863/jum.2006.25.2.173; Smrcek JM, 2006, J ULTRAS MED, V25, P187, DOI 10.7863/jum.2006.25.2.187; Spencer-Jones NJ, 2005, DIABETES, V54, P3296, DOI 10.2337/diabetes.54.11.3296; Summerhurst K, 2008, GENE EXPR PATTERNS, V8, P331, DOI 10.1016/j.gep.2008.01.007; Takanaga H, 2004, PFLUG ARCH EUR J PHY, V447, P677, DOI 10.1007/s00424-003-1104-1; White JM, 2003, CURR OPIN CELL BIOL, V15, P598, DOI 10.1016/j.ceb.2003.08.001; Wilson RD, 2007, J OBSTET GYNAECOL CA, V29, P1003, DOI 10.1016/S1701-2163(16)32685-8; Wren C, 2003, HEART, V89, P1217, DOI 10.1136/heart.89.10.1217; Wren C, 2000, HEART, V83, P414, DOI 10.1136/heart.83.4.414; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Yutzey KEE, 2002, DEV DYNAM, V223, P307, DOI 10.1002/dvdy.10068	82	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2009	4	1							e4221	10.1371/journal.pone.0004221	http://dx.doi.org/10.1371/journal.pone.0004221			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IZ	19156209	Green Published, gold, Green Submitted			2022-12-25	WOS:000265481900004
J	Arce, F; Novick, I; Shahar, M; Link, Y; Ghez, C; Vaadia, E				Arce, Fritzie; Novick, Itai; Shahar, Maayan; Link, Yuval; Ghez, Claude; Vaadia, Eilon			Differences in Context and Feedback Result in Different Trajectories and Adaptation Strategies in Reaching	PLOS ONE			English	Article								Computational models of motor control have often explained the straightness of horizontal planar reaching movements as a consequence of optimal control. Departure from rectilinearity is thus regarded as sub-optimal. Here we examine if subjects may instead select to make curved trajectories following adaptation to force fields and visuomotor rotations. Separate subjects adapted to force fields with or without visual feedback of their hand trajectory and were retested after 24 hours. Following adaptation, comparable accuracies were achieved in two ways: with visual feedback, adapted trajectories in force fields were straight whereas without it, they remained curved. The results suggest that trajectory shape is not always straight, but is also influenced by the calibration of available feedback signals for the state estimation required by the task. In a follow-up experiment, where additional subjects learned a visuomotor rotation immediately after force field, the trajectories learned in force fields (straight or curved) were transferred when directions of the perturbations were similar but not when directions were opposing. This demonstrates a strong bias by prior experience to keep using a recently acquired control policy that continues to produce successful performance inspite of differences in tasks and feedback conditions. On relearning of force fields on the second day, facilitation by intervening visuomotor rotations occurred only when required motor adjustments and calibration of feedback signals were similar in both tasks. These results suggest that both the available feedback signals and prior history of learning influence the choice and maintenance of control policy during adaptations.	[Arce, Fritzie; Novick, Itai; Shahar, Maayan; Link, Yuval; Vaadia, Eilon] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel; [Vaadia, Eilon] Interdisciplinary Ctr Neural Computat, Jerusalem, Israel; [Arce, Fritzie; Novick, Itai; Shahar, Maayan; Link, Yuval; Vaadia, Eilon] Hebrew Univ Jerusalem, IL-91905 Jerusalem, Israel; [Ghez, Claude] Columbia Univ, Coll Physicians & Surgeons, Ctr Neurobiol & Behavior, New York, NY 10027 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Columbia University	Arce, F (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel.	fritziea@ekmd.huji.ac.il	Vaadia, Eilon/E-9347-2011	Arce-McShane, Fritzie/0000-0001-6616-3564	Binational Science Foundation (BSF); Israel Science Foundation (ISF); Johnson&Johnson Fund for Innovative Science; Rosetrees Trust; Ida Baruch fund; Jack H. Skirball Chair of Brain Research	Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Israel Science Foundation (ISF)(Israel Science Foundation); Johnson&Johnson Fund for Innovative Science; Rosetrees Trust(Rosetrees Trust); Ida Baruch fund; Jack H. Skirball Chair of Brain Research	This work was supported in part by the Binational Science Foundation (BSF), the Israel Science Foundation (ISF), the Johnson&Johnson Fund for Innovative Science and special contributions from the Rosetrees Trust and the Ida Baruch fund. EV is the Jack H. Skirball Chair of Brain Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEND W, 1982, BRAIN, V105, P331, DOI 10.1093/brain/105.2.331; Chib VS, 2006, J NEUROPHYSIOL, V95, P1068, DOI 10.1152/jn.00610.2005; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FLANAGAN JR, 1995, J NEUROPHYSIOL, V74, P2174, DOI 10.1152/jn.1995.74.5.2174; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Franklin DW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001336; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Gandolfo F, 2000, P NATL ACAD SCI USA, V97, P2259, DOI 10.1073/pnas.040567097; GHEZ C, 2007, J NEUROPHYSIOL; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Izawa J, 2008, J NEUROSCI, V28, P2883, DOI 10.1523/JNEUROSCI.5359-07.2008; Jax SA, 2007, J EXP PSYCHOL HUMAN, V33, P425, DOI 10.1037/0096-1523.33.2.425; Jordan Michael I., 1995, P597; Krakauer JW, 2005, J NEUROSCI, V25, P473, DOI 10.1523/JNEUROSCI.4218-04.2005; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; Kurtzer I, 2005, NAT NEUROSCI, V8, P498, DOI 10.1038/nn1420; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; Liu XL, 2008, J NEUROPHYSIOL, V99, P2546, DOI 10.1152/jn.01044.2007; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Osborne LC, 2005, NATURE, V437, P412, DOI 10.1038/nature03961; Padoa-Schioppa C, 2002, NEURON, V36, P751, DOI 10.1016/S0896-6273(02)01028-0; Paillard J, 1996, CAN J PHYSIOL PHARM, V74, P401, DOI 10.1139/cjpp-74-4-401; Paz R, 2005, J NEUROSCI, V25, P10941, DOI 10.1523/JNEUROSCI.0164-05.2005; Paz R, 2003, NAT NEUROSCI, V6, P882, DOI 10.1038/nn1097; Pine ZM, 1996, NEUROREPORT, V7, P2357, DOI 10.1097/00001756-199610020-00016; PRABLANC C, 1992, J NEUROPHYSIOL, V67, P455, DOI 10.1152/jn.1992.67.2.455; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Sainburg RL, 1999, J NEUROPHYSIOL, V81, P1045, DOI 10.1152/jn.1999.81.3.1045; SAINBURG RL, 1995, J NEUROPHYSIOL, V73, P820, DOI 10.1152/jn.1995.73.2.820; Scheidt R. A., 2007, J NEUROPHYSIOL; Scheidt RA, 2005, J NEUROPHYSIOL, V93, P3200, DOI 10.1152/jn.00947.2004; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shen LM, 1997, J NEUROPHYSIOL, V77, P1171, DOI 10.1152/jn.1997.77.3.1171; Smeets JBJ, 2006, P NATL ACAD SCI USA, V103, P18781, DOI 10.1073/pnas.0607687103; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 1998, J NEUROPHYSIOL, V80, P696, DOI 10.1152/jn.1998.80.2.696; Tong C, 2002, J NEUROSCI, V22, P1108, DOI 10.1523/JNEUROSCI.22-03-01108.2002; van Beers RJ, 2002, PHILOS T R SOC B, V357, P1137, DOI 10.1098/rstb.2002.1101; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; WANN JP, 1992, EXP BRAIN RES, V91, P162; Wise SP, 1998, EXP BRAIN RES, V121, P285, DOI 10.1007/s002210050462; [No title captured]	44	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2009	4	1							e4214	10.1371/journal.pone.0004214	http://dx.doi.org/10.1371/journal.pone.0004214			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IH	19148302	Green Submitted, gold, Green Published			2022-12-25	WOS:000265479900008
J	Chakraborty, A; Uechi, T; Higa, S; Torihara, H; Kenmochi, N				Chakraborty, Anirban; Uechi, Tamayo; Higa, Sayomi; Torihara, Hidetsugu; Kenmochi, Naoya			Loss of Ribosomal Protein L11 Affects Zebrafish Embryonic Development through a p53-Dependent Apoptotic Response	PLOS ONE			English	Article							DIAMOND-BLACKFAN ANEMIA; P53; GENE; RNA; ACTIVATION; CHECKPOINT; SUBUNIT; IDENTIFICATION; NUCLEOLUS; MINUTE	Ribosome is responsible for protein synthesis in all organisms and ribosomal proteins (RPs) play important roles in the formation of a functional ribosome. L11 was recently shown to regulate p53 activity through a direct binding with MDM2 and abrogating the MDM2-induced p53 degradation in response to ribosomal stress. However, the studies were performed in cell lines and the significance of this tumor suppressor function of L11 has yet to be explored in animal models. To investigate the effects of the deletion of L11 and its physiological relevance to p53 activity, we knocked down the rp/11 gene in zebrafish and analyzed the p53 response. Contrary to the cell line-based results, our data indicate that an L11 deficiency in a model organism activates the p53 pathway. The L11-deficient embryos (morphants) displayed developmental abnormalities primarily in the brain, leading to embryonic lethality within 6-7 days post fertilization. Extensive apoptosis was observed in the head region of the morphants, thus correlating the morphological defects with apparent cell death. A decrease in total abundance of genes involved in neural patterning of the brain was observed in the morphants, suggesting a reduction in neural progenitor cells. Upregulation of the genes involved in the p53 pathway were observed in the morphants. Simultaneous knockdown of the p53 gene rescued the developmental defects and apoptosis in the morphants. These results suggest that ribosomal dysfunction due to the loss of L11 activates a p53-dependent checkpoint response to prevent improper embryonic development.	[Chakraborty, Anirban; Uechi, Tamayo; Higa, Sayomi; Torihara, Hidetsugu; Kenmochi, Naoya] Miyazaki Univ, Frontier Sci Res Ctr, Miyazaki, Japan	University of Miyazaki	Chakraborty, A (corresponding author), Miyazaki Univ, Frontier Sci Res Ctr, Miyazaki, Japan.	kenmochi@med.miyazaki-u.ac.jp	Chakraborty, Anirban/AAP-5348-2020; Kenmochi, Naoya/ABF-3564-2021	/0000-0003-3476-6576	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [Grants-in-Aid]; Japan Society for the Promotion of Science (JSPS) [P06457]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by 'Grants-in-Aid' from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and the Japan Society for the Promotion of Science (JSPS). AC is a research fellow of JSPS (P06457). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Anderson SJ, 2007, IMMUNITY, V26, P759, DOI 10.1016/j.immuni.2007.04.012; Azuma M, 2006, J BIOL CHEM, V281, P13309, DOI 10.1074/jbc.M601892200; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; CMEJLA R, 2007, HUM MUTAT, P1; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; DANILOVA N, 2008, BLOOD IN PRESS; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Farrar JE, 2008, BLOOD, V112, P1582, DOI 10.1182/blood-2008-02-140012; Gazda HT, 2006, AM J HUM GENET, V79, P1110, DOI 10.1086/510020; Heisenberg CP, 1999, DEVELOPMENT, V126, P2129; KENMOCHI N, 2003, NATURE ENCY HUMAN GE, V5, P77; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Leary DJ, 2001, FEBS LETT, V509, P145, DOI 10.1016/S0014-5793(01)03143-X; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; MacInnes AW, 2008, P NATL ACAD SCI USA, V105, P10408, DOI 10.1073/pnas.0805036105; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; MCGOWAN KA, 2008, NATURE GENE IN PRESS; Miyoshi K, 2004, FEBS LETT, V565, P106, DOI 10.1016/j.febslet.2004.03.087; Noller HF, 2005, SCIENCE, V309, P1508, DOI 10.1126/science.1111771; Oeffinger M, 2002, RNA, V8, P626, DOI 10.1017/S1355838202020022; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Opferman JT, 2006, CELL DEATH DIFFER, V13, P898, DOI 10.1038/sj.cdd.4401923; Panic L, 2006, MOL CELL BIOL, V26, P8880, DOI 10.1128/MCB.00751-06; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; SKARIE JM, 2008, HUM MOL GEN IN PRESS; Soulet F, 2001, BIOCHEM BIOPH RES CO, V289, P591, DOI 10.1006/bbrc.2001.5960; STERN S, 1989, SCIENCE, V244, P783, DOI 10.1126/science.2658053; Strezoska Z, 2002, J BIOL CHEM, V277, P29617, DOI 10.1074/jbc.M204381200; Sun XX, 2008, J BIOL CHEM, V283, P12387, DOI 10.1074/jbc.M801387200; Thisse B, 2004, ZFIN DIRECT DATA SUB; Uechi T, 2008, HUM MOL GENET, V17, P3204, DOI 10.1093/hmg/ddn216; Uechi T, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000037; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WOOL IG, 1979, ANNU REV BIOCHEM, V48, P719, DOI 10.1146/annurev.bi.48.070179.003443; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; ZFIN, ZEBR MOD ORG DAT; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	50	101	105	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2009	4	1							e4152	10.1371/journal.pone.0004152	http://dx.doi.org/10.1371/journal.pone.0004152			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FZ	19129914	Green Submitted, Green Published, gold			2022-12-25	WOS:000265473500005
J	Martin, B; Pearson, M; Brenneman, R; Golden, E; Wood, W; Prabhu, V; Becker, KG; Mattson, MP; Maudsley, S				Martin, Bronwen; Pearson, Michele; Brenneman, Randall; Golden, Erin; Wood, William, III; Prabhu, Vinayakumar; Becker, Kevin G.; Mattson, Mark P.; Maudsley, Stuart			Gonadal Transcriptome Alterations in Response to Dietary Energy Intake: Sensing the Reproductive Environment	PLOS ONE			English	Article								Reproductive capacity and nutritional input are tightly linked and animals' specific responses to alterations in their physical environment and food availability are crucial to ensuring sustainability of that species. We have assessed how alterations in dietary energy intake (both reductions and excess), as well as in food availability, via intermittent fasting (IF), affect the gonadal transcriptome of both male and female rats. Starting at four months of age, male and female rats were subjected to a 20% or 40% caloric restriction (CR) dietary regime, every other day feeding (IF) or a high fat-high glucose (HFG) diet for six months. The transcriptional activity of the gonadal response to these variations in dietary energy intake was assessed at the individual gene level as well as at the parametric functional level. At the individual gene level, the females showed a higher degree of coherency in gonadal gene alterations to CR than the males. The gonadal transcriptional and hormonal response to IF was also significantly different between the male and female rats. The number of genes significantly regulated by IF in male animals was almost 5 times greater than in the females. These IF males also showed the highest testosterone to estrogen ratio in their plasma. Our data show that at the level of gonadal gene responses, the male rats on the IF regime adapt to their environment in a manner that is expected to increase the probability of eventual fertilization of females that the males predict are likely to be sub-fertile due to their perception of a food deficient environment.	[Martin, Bronwen; Pearson, Michele; Brenneman, Randall; Golden, Erin; Mattson, Mark P.] NIA, Neurosci Lab, Baltimore, MD 21224 USA; [Wood, William, III; Prabhu, Vinayakumar; Becker, Kevin G.] NIA, Gene Express & Genom Unit, Baltimore, MD USA; [Maudsley, Stuart] NIA, Receptor Pharmacol Unit, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Martin, B (corresponding author), NIA, Neurosci Lab, Baltimore, MD 21224 USA.	maudsleyst@grc.nia.nih.gov	Maudsley, Stuart/AAV-9929-2021; Maudsley, Stuart/Q-4782-2019; Mattson, Mark P/F-6038-2012	Maudsley, Stuart/0000-0002-1868-184X; Becker, Kevin/0000-0002-6794-6656; Martin, Bronwen/0000-0002-9185-6925	Intramural Research Program of the National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000915, ZICAG000616, ZIAAG000318, ZIAAG000916, Z01AG000616] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assa-Kunik E, 2007, DEVELOPMENT, V134, P1161, DOI 10.1242/dev.02800; Baes M, 2000, J BIOL CHEM, V275, P16329, DOI 10.1074/jbc.M001994200; Brinton LA, 2008, JNCI-J NATL CANCER I, V100, P1477, DOI 10.1093/jnci/djn329; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Cal S, 2002, GENE, V283, P49, DOI 10.1016/S0378-1119(01)00861-7; Cheadle Chris, 2003, Appl Bioinformatics, V2, P209; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Donjacour AA, 2003, DEV BIOL, V261, P39, DOI 10.1016/S0012-1606(03)00250-1; Ewertz M, 2001, ACTA ONCOL, V40, P467, DOI 10.1080/028418601750288181; Gokool S, 2007, TRAFFIC, V8, P1873, DOI 10.1111/j.1600-0854.2007.00652.x; Greendale GA, 1997, J BONE MINER RES, V12, P1833, DOI 10.1359/jbmr.1997.12.11.1833; GREWAL T, 1971, P SOC EXP BIOL MED, V138, P723, DOI 10.3181/00379727-138-35976; Hahn JS, 2005, FEBS LETT, V579, P4513, DOI 10.1016/j.febslet.2005.07.024; Holekamp KE, 1999, J REPROD FERTIL, V116, P87; HOWLAND BE, 1975, J REPROD FERTIL, V44, P429, DOI 10.1530/jrf.0.0440429; Huyghe S, 2001, BIOCHEM J, V353, P673, DOI 10.1042/0264-6021:3530673; Jabbour HN, 1999, J CLIN ENDOCR METAB, V84, P4260, DOI 10.1210/jc.84.11.4260; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; KAMAT BR, 1995, AM J PATHOL, V146, P157; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Kimura M, 2001, CYTOGENET CELL GENET, V94, P33, DOI 10.1159/000048779; Kitaya K, 2007, INT J MOL MED, V20, P689; Kress C, 2007, MOL CELL BIOL, V27, P1146, DOI 10.1128/MCB.01009-06; LENFANTPEJOVIC MH, 1990, INT J CANCER, V45, P661, DOI 10.1002/ijc.2910450415; Liang JH, 2001, J MED PRIMATOL, V30, P107, DOI 10.1034/j.1600-0684.2001.300206.x; Lu ZH, 2006, MOL CELL BIOL, V26, P8410, DOI 10.1128/MCB.01196-06; Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161; Martin B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002398; McNatty KP, 2005, REPRODUCTION, V129, P481, DOI 10.1530/rep.1.00517; Menke Douglas B., 2002, Gene Expression Patterns, V2, P359, DOI 10.1016/S1567-133X(02)00022-4; Mottershead DG, 2008, MOL CELL ENDOCRINOL, V283, P58, DOI 10.1016/j.mce.2007.11.007; Muniz LC, 2006, BIOL REPROD, V75, P279, DOI 10.1095/biolreprod.105.049486; Naslavsky N, 2007, BIOCHEM BIOPH RES CO, V357, P792, DOI 10.1016/j.bbrc.2007.04.022; Niessen P, 2005, GASTROENTEROLOGY, V129, P1592, DOI 10.1053/j.gastro.2005.08.018; Peterson EA, 2007, MAMM GENOME, V18, P796, DOI 10.1007/s00335-007-9065-x; PHILLIPS HS, 1990, ENDOCRINOLOGY, V127, P965, DOI 10.1210/endo-127-2-965; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Rapaport D, 2006, TRAFFIC, V7, P52, DOI 10.1111/j.1600-0854.2005.00359.x; Reynolds LP, 1998, J ANIM SCI, V76, P1671; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Silva FP, 2006, ONCOGENE, V25, P5063, DOI 10.1038/sj.onc.1209517; Singh SR, 2006, ONCOGENE, V25, P5933, DOI 10.1038/sj.onc.1209593; Sorensen HT, 1998, AM J GASTROENTEROL, V93, P231, DOI 10.1016/S0002-9270(97)00050-6; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tabibzadeh S, 1996, HUM REPROD, V11, P633, DOI 10.1093/HUMREP/11.3.633; THOMAS DB, 1992, AM J EPIDEMIOL, V135, P734, DOI 10.1093/oxfordjournals.aje.a116360; Whitney LW, 1999, ANN NEUROL, V46, P425; Williams JG, 2005, TRENDS GENET, V21, P392, DOI 10.1016/j.tig.2005.05.002; Wu JC, 2005, FEBS LETT, V579, P421, DOI 10.1016/j.febslet.2004.12.005; Yissachar N, 2006, FEBS LETT, V580, P6489, DOI 10.1016/j.febslet.2006.10.069; Zhang MQ, 2007, P NATL ACAD SCI USA, V104, P10057, DOI 10.1073/pnas.0700169104	54	30	30	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4146	10.1371/journal.pone.0004146	http://dx.doi.org/10.1371/journal.pone.0004146			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FX	19127293	Green Submitted, Green Published, gold			2022-12-25	WOS:000265473300011
J	Kucera, T; Strilic, B; Regener, K; Schubert, M; Laudet, V; Lammert, E				Kucera, Tomas; Strilic, Boris; Regener, Kathrin; Schubert, Michael; Laudet, Vincent; Lammert, Eckhard			Ancestral Vascular Lumen Formation via Basal Cell Surfaces	PLOS ONE			English	Article								The cardiovascular system of bilaterians developed from a common ancestor. However, no endothelial cells exist in invertebrates demonstrating that primitive cardiovascular tubes do not require this vertebrate-specific cell type in order to form. This raises the question of how cardiovascular tubes form in invertebrates? Here we discovered that in the invertebrate cephalochordate amphioxus, the basement membranes of endoderm and mesoderm line the lumen of the major vessels, namely aorta and heart. During amphioxus development a laminin-containing extracellular matrix (ECM) was found to fill the space between the basal cell surfaces of endoderm and mesoderm along their anterior-posterior (A-P) axes. Blood cells appear in this ECM-filled tubular space, coincident with the development of a vascular lumen. To get insight into the underlying cellular mechanism, we induced vessels in vitro with a cell polarity similar to the vessels of amphioxus. We show that basal cell surfaces can form a vascular lumen filled with ECM, and that phagocytotic blood cells can clear this luminal ECM to generate a patent vascular lumen. Therefore, our experiments suggest a mechanism of blood vessel formation via basal cell surfaces in amphioxus and possibly in other invertebrates that do not have any endothelial cells. In addition, a comparison between amphioxus and mouse shows that endothelial cells physically separate the basement membranes from the vascular lumen, suggesting that endothelial cells create cardiovascular tubes with a cell polarity of epithelial tubes in vertebrates and mammals.	[Kucera, Tomas; Strilic, Boris; Regener, Kathrin; Lammert, Eckhard] Max Planck Inst Mol Cell Biol & Genet MPI CBG, Dresden, Germany; [Kucera, Tomas] Charles Univ Prague, First Fac Med, Inst Histol & Embryol, Prague, Czech Republic; [Schubert, Michael; Laudet, Vincent] Univ Lyon, Inst Genom Fonct Lyon, Ecole Normale Superieure Lyon, CNRS, Lyon, France; [Lammert, Eckhard] Univ Dusseldorf, Inst Animal Physiol, Dusseldorf, Germany	Max Planck Society; Charles University Prague; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Heinrich Heine University Dusseldorf	Kucera, T (corresponding author), Max Planck Inst Mol Cell Biol & Genet MPI CBG, Dresden, Germany.	lammert@uni-duesseldorf.de	Kučera, Tomáš/C-7532-2017; Schubert, Michael/C-1875-2008	Kučera, Tomáš/0000-0003-2134-4657; Schubert, Michael/0000-0002-2341-712X	Deutsche Forschungsgemeinschaft; Behrens Weise Foundation; Ministry of Education, Youth and Sports of Czech Republic [MSM0021620807]; ANR; CNRS; MENRT; CRESCENDO	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Behrens Weise Foundation; Ministry of Education, Youth and Sports of Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); ANR(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); MENRT; CRESCENDO(European Commission)	The Sonderforschungsbereich SFB 655 "Cells into tissues" (Deutsche Forschungsgemeinschaft) and the Behrens Weise Foundation funded this work. Tomas Kucera was also supported by the Research Project MSM0021620807 from the Ministry of Education, Youth and Sports of Czech Republic. Michael Schubert was supported by the ANR, the CNRS, the MENRT and CRESCENDO, a European Union Integrated Project of FP6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishopric NH, 2005, ANN NY ACAD SCI, V1047, P13, DOI 10.1196/annals.1341.002; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Connolly JO, 2002, MOL BIOL CELL, V13, P2474, DOI 10.1091/mbc.E02-01-0006; De Robertis EM, 2008, CELL, V132, P185, DOI 10.1016/j.cell.2008.01.003; Devine WP, 2005, P NATL ACAD SCI USA, V102, P17014, DOI 10.1073/pnas.0506676102; Durbeej M, 1996, MATRIX BIOL, V15, P397, DOI 10.1016/S0945-053X(96)90159-6; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Hartenstein V, 2006, ANNU REV CELL DEV BI, V22, P677, DOI 10.1146/annurev.cellbio.22.010605.093317; Hartenstein V, 2006, BIOESSAYS, V28, P1203, DOI 10.1002/bies.20497; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Holland LZ, 2007, NATURE, V447, P153, DOI 10.1038/447153a; Holland ND, 2003, DEV BIOL, V255, P128, DOI 10.1016/S0012-1606(02)00050-7; Jazwinska A, 2003, NAT CELL BIOL, V5, P895, DOI 10.1038/ncb1049; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Malinda KM, 1999, FASEB J, V13, P53, DOI 10.1096/fasebj.13.1.53; Mandal L, 2004, NAT GENET, V36, P1019, DOI 10.1038/ng1404; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Medioni C, 2008, J CELL BIOL, V182, P249, DOI 10.1083/jcb.200801100; MOLLER PC, 1973, J MORPHOL, V139, P389, DOI 10.1002/jmor.1051390403; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; RHODES CP, 1982, SCIENCE, V217, P263, DOI 10.1126/science.7089565; RUPPERT E, 1997, MICROSCOPIC ANATOMY, P394; RUPPERT EE, 1983, ZOOMORPHOLOGY, V103, P193, DOI 10.1007/BF00310477; Santiago-Martinez E, 2008, J CELL BIOL, V182, P241, DOI 10.1083/jcb.200804120; Schubert M, 2006, TRENDS ECOL EVOL, V21, P269, DOI 10.1016/j.tree.2006.01.009; Sixt M, 2001, J CELL BIOL, V153, P933, DOI 10.1083/jcb.153.5.933; Stach T, 1998, BIOL BULL, V195, P260, DOI 10.2307/1543137; STACH T, 2000, MICROSCOPIC ANATOMY, P1; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008; VERNON RB, 1992, LAB INVEST, V66, P536; WANG AZ, 1990, J CELL SCI, V95, P137; Yano K, 2007, BLOOD, V109, P613, DOI 10.1182/blood-2006-05-026401	36	30	30	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2009	4	1							e4132	10.1371/journal.pone.0004132	http://dx.doi.org/10.1371/journal.pone.0004132			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FV	19125185	Green Published, gold			2022-12-25	WOS:000265473100006
J	Kang, Y; Choi, M; Lee, J; Koh, GY; Kwon, K; Choi, C				Kang, Yujung; Choi, Myunghwan; Lee, Jungsul; Koh, Gou Young; Kwon, Kihwan; Choi, Chulhee			Quantitative Analysis of Peripheral Tissue Perfusion Using Spatiotemporal Molecular Dynamics	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; CEREBRAL-BLOOD-FLOW; INDOCYANINE GREEN; IN-VIVO; PHOTODYNAMIC THERAPY; CONTRAST; PATHOPHYSIOLOGY; ARTERIOGENESIS; ANGIOGENESIS; INJECTION	Background: Accurate measurement of peripheral tissue perfusion is challenging but necessary to diagnose peripheral vascular insufficiency. Because near infrared (NIR) radiation can penetrate relatively deep into tissue, significant attention has been given to intravital NIR fluorescence imaging. Methodology/Principal Findings: We developed a new optical imaging-based strategy for quantitative measurement of peripheral tissue perfusion by time-series analysis of local pharmacokinetics of the NIR fluorophore, indocyanine green (ICG). Time-series NIR fluorescence images were obtained after injecting ICG intravenously in a murine hindlimb ischemia model. Mathematical modeling and computational simulations were used for translating time-series ICG images into quantitative pixel perfusion rates and a perfusion map. We could successfully predict the prognosis of ischemic hindlimbs based on the perfusion profiles obtained immediately after surgery, which were dependent on the preexisting collaterals. This method also reflected increases in perfusion and improvements in prognosis of ischemic hindlimbs induced by treatment with vascular endothelial growth factor and COMP-angiopoietin-1. Conclusions/Significance: We propose that this novel NIR-imaging-based strategy is a powerful tool for biomedical studies related to the evaluation of therapeutic interventions directed at stimulating angiogenesis.	[Kang, Yujung; Choi, Myunghwan; Lee, Jungsul; Choi, Chulhee] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Koh, Gou Young] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon, South Korea; [Koh, Gou Young; Choi, Chulhee] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon, South Korea; [Koh, Gou Young; Choi, Chulhee] Korea Adv Inst Sci & Technol, Taejon, South Korea; [Kwon, Kihwan] Ewha Womans Univ, Sch Med, Dept Cardiol, Seoul, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Ewha Womans University	Kang, Y (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea.	cchoi@kaist.ac.kr	Koh, Gou Young/C-1615-2011; Choi, Chulhee/C-1642-2011; Lee, Jungsul/A-7851-2013; Maunsell, John/G-5702-2010	Choi, Chulhee/0000-0001-5542-9136; Lee, Jungsul/0000-0002-8600-5851; Lauwereyns, Jan/0000-0003-0551-2550; Lee, Joonyeol/0000-0001-9929-6080; Maunsell, John/0000-0003-0018-4439; Choi, Myunghwan (Mark)/0000-0002-4235-7003	Chung Moon Soul Center for BioInformation and BioElectronics, KAIST	Chung Moon Soul Center for BioInformation and BioElectronics, KAIST	This work was supported by the Chung Moon Soul Center for BioInformation and BioElectronics, KAIST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abels C, 2004, PHOTOCH PHOTOBIO SCI, V3, P765, DOI 10.1039/b314241h; Buschmann I, 2000, J PATHOL, V190, P338, DOI 10.1002/(SICI)1096-9896(200002)190:3<338::AID-PATH594>3.0.CO;2-7; Cai QY, 2007, INVEST RADIOL, V42, P797, DOI 10.1097/RLI.0b013e31811ecdcd; CARSON ER, 1979, NEW ENGL J MED, V300, P1078, DOI 10.1056/NEJM197905103001904; Chalothorn D, 2007, PHYSIOL GENOMICS, V30, P179, DOI 10.1152/physiolgenomics.00047.2007; Costa LA, 2004, DIABETIC MED, V21, P252, DOI 10.1111/j.1464-5491.2004.01124.x; Crescenzi E, 2004, MOL CANCER THER, V3, P537; El-Desoky A, 1999, BRIT J SURG, V86, P1005, DOI 10.1046/j.1365-2168.1999.01186.x; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; Gora F, 2002, J NEUROSURG ANESTH, V14, P218, DOI 10.1097/00008506-200207000-00008; Henneman MM, 2006, BRIT MED BULL, V79-80, P187, DOI 10.1093/bmb/ldl014; Keller E, 2001, J NEUROSURG ANESTH, V13, P43, DOI 10.1097/00008506-200101000-00008; LEITGEB RA, 2007, C P IEEE ENG MED BIO, V1, P530; Leung TS, 2007, APPL OPTICS, V46, P1604, DOI 10.1364/AO.46.001604; Leung TS, 2004, PEDIATR RES, V55, P134, DOI 10.1203/01.PDR.0000099775.87684.FB; Liddell RP, 2005, J VASC INTERV RADIOL, V16, P991, DOI 10.1097/01.RVI.0000161381.48445.48; Luscher TF, 2003, CIRCULATION, V108, P1655, DOI 10.1161/01.CIR.0000089189.70578.E2; Ntziachristos V, 2003, EUR RADIOL, V13, P195, DOI 10.1007/s00330-002-1524-x; PORTER TR, 1995, J AM COLL CARDIOL, V25, P509, DOI 10.1016/0735-1097(94)00376-2; Ryu JK, 2006, MOL THER, V13, P705, DOI 10.1016/j.ymthe.2005.10.016; Schmidt-Erfurth U, 2005, OPHTHALMOLOGY, V112, P2061, DOI 10.1016/j.ophtha.2005.09.007; Scholz D, 2006, CELL TISSUE RES, V324, P395, DOI 10.1007/s00441-005-0072-5; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Shireman PK, 2005, J SURG RES, V129, P242, DOI 10.1016/j.jss.2005.06.013; Tirziu D, 2005, CIRCULATION, V112, P2501, DOI 10.1161/CIRCULATIONAHA.105.542829; Wang XD, 2004, OPT LETT, V29, P730, DOI 10.1364/OL.29.000730; Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684; WHEELER HO, 1958, P SOC EXP BIOL MED, V99, P11; Zbinden S, 2007, AM J PHYSIOL-HEART C, V292, pH1891, DOI 10.1152/ajpheart.00537.2006; Ziv K, 2004, MAGN RESON MED, V51, P304, DOI 10.1002/mrm.10687	30	70	74	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2009	4	1							e4275	10.1371/journal.pone.0004275	http://dx.doi.org/10.1371/journal.pone.0004275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JE	19247494	Green Published, gold, Green Submitted			2022-12-25	WOS:000265482800005
